{"comparison_id":"a68bcce9-5df0-42c0-b14c-7461702dc54a","query_id":"53","doc_a_id":"45638119","doc_b_id":"14241418","presented_order":["14241418","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 as a marker and its correlation with poor prognosis in breast cancer; Document A is unrelated.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010394Z"}
{"comparison_id":"73122966-3590-45f9-a4cf-80e094bc6de9","query_id":"53","doc_a_id":"15113221","doc_b_id":"14241418","presented_order":["14241418","15113221"],"winner_id":"15113221","reasoning":"Document B is more relevant — it addresses gene expression signatures associated with poor prognosis in carcinomas, which is closer to the query about expression markers and prognosis than Document A's drug/inhibitor focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010417Z"}
{"comparison_id":"455aaf64-9915-4acb-a14c-d4523c7b0b13","query_id":"53","doc_a_id":"21439640","doc_b_id":"14241418","presented_order":["21439640","14241418"],"winner_id":"21439640","reasoning":"Document A is more relevant — it addresses mechanisms of tumor progression in breast cancer, which is more directly related to prognostic factors than Document B's focus on a targeted therapy for PI3K-mutant cancers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010426Z"}
{"comparison_id":"ea4a5d43-8d68-4629-8a0a-678d702efe14","query_id":"53","doc_a_id":"24349992","doc_b_id":"14241418","presented_order":["14241418","24349992"],"winner_id":"24349992","reasoning":"Both documents don't mention ALDH1 or its prognostic value. Document B is marginally more relevant because it discusses factors driving tumor aggressiveness and prognosis, while A focuses on a targeted inhibitor.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010434Z"}
{"comparison_id":"84171985-6813-40b9-bda1-53dd5908680c","query_id":"53","doc_a_id":"8963413","doc_b_id":"14241418","presented_order":["14241418","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — it discusses biomarker expression and clinical outcomes in breast cancer, whereas Document A focuses on a PI3K/mTOR inhibitor and does not address ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010441Z"}
{"comparison_id":"5fcb4d80-12fe-48b6-9cc3-ff62cbe5da51","query_id":"53","doc_a_id":"22401720","doc_b_id":"14241418","presented_order":["22401720","14241418"],"winner_id":"22401720","reasoning":"Document A is more relevant because it examines marker expression in primary breast cancers and links expression levels to prognosis, whereas Document B discusses a PI3K/mTOR inhibitor unrelated to ALDH1 or prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010448Z"}
{"comparison_id":"c0a2a1ce-6341-4df8-9728-d837fa864c1e","query_id":"53","doc_a_id":"7795952","doc_b_id":"14241418","presented_order":["7795952","14241418"],"winner_id":"7795952","reasoning":"Document A is more relevant — it discusses protein expression linked to poor cancer prognosis (though not ALDH1), whereas Document B focuses on a PI3K/mTOR inhibitor and growth inhibition. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010456Z"}
{"comparison_id":"11ead65f-aab3-4ac6-8698-91a20cbd409e","query_id":"53","doc_a_id":"25973484","doc_b_id":"14241418","presented_order":["14241418","25973484"],"winner_id":"25973484","reasoning":"Document B is more relevant because it discusses factors affecting breast cancer prognosis, whereas Document A focuses on a PI3K/mTOR inhibitor and tumor growth mechanisms, not prognosis or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010463Z"}
{"comparison_id":"2a146dc2-c2e9-4f2b-a323-72048cfa24c4","query_id":"53","doc_a_id":"42731834","doc_b_id":"14241418","presented_order":["14241418","42731834"],"winner_id":"14241418","reasoning":"Document A is more relevant because it addresses cancer signaling and trastuzumab-resistant (breast) cancer contexts, whereas Document B concerns AIM2 in colorectal cancer; neither mentions ALDH1 but A is closer to breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010470Z"}
{"comparison_id":"6a203a9a-2a4e-4ee9-b1d2-5b17add21940","query_id":"53","doc_a_id":"7821634","doc_b_id":"14241418","presented_order":["7821634","14241418"],"winner_id":"7821634","reasoning":"Document A is more relevant because it discusses biomarkers (DUSP4) linked to poor outcomes/prognosis in breast cancer, whereas Document B focuses on a drug's inhibitory effects without prognosis data. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010477Z"}
{"comparison_id":"d4ffd923-b02d-4a3e-a705-6be6c0555e46","query_id":"53","doc_a_id":"3899896","doc_b_id":"14241418","presented_order":["3899896","14241418"],"winner_id":"14241418","reasoning":"Document B — it relates to breast cancer biology (trastuzumab resistance/PI3K pathway) and cancer prognosis/treatment, whereas A concerns RDW in rectal cancer and is unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010485Z"}
{"comparison_id":"a11d47a1-5926-4177-86b5-7e847bf1015a","query_id":"53","doc_a_id":"12762485","doc_b_id":"14241418","presented_order":["14241418","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses a stem-cell phenotype in breast cancer (linked to poorer features), which is more relevant to ALDH1 as a stem-cell marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010492Z"}
{"comparison_id":"c9fa5b7f-0873-46c7-b716-93ab81331722","query_id":"53","doc_a_id":"24205118","doc_b_id":"14241418","presented_order":["24205118","14241418"],"winner_id":"24205118","reasoning":"Document A is more relevant — it addresses the association between expression of a molecular marker and prognosis (though in cervical cancer and a different marker), whereas B focuses on a drug and signaling pathway, not marker–prognosis links.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010499Z"}
{"comparison_id":"44681343-0d56-4300-9a7d-96c7e0faeaab","query_id":"53","doc_a_id":"10024681","doc_b_id":"14241418","presented_order":["10024681","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer (including trastuzumab-resistant breast cancer contexts), so it's closer to the query about prognosis in breast cancer than Document A, which is specific to prostate cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010507Z"}
{"comparison_id":"49fbd575-6589-48e3-956a-888310efb996","query_id":"53","doc_a_id":"2061878","doc_b_id":"14241418","presented_order":["2061878","14241418"],"winner_id":"2061878","reasoning":"Reason: Document A discusses a cancer-related biomarker (NEAT1) whose expression correlates with poor prognosis in solid tumors, which is more related to the claim about a prognostic marker in breast cancer than Document B's drug mechanism study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010514Z"}
{"comparison_id":"e4671005-9216-400a-9e83-c9fa02f4cb7f","query_id":"53","doc_a_id":"4889228","doc_b_id":"14241418","presented_order":["14241418","4889228"],"winner_id":"4889228","reasoning":"Reason: Document B addresses factors linked to prognosis in breast cancer (TNBC), whereas A focuses on a PI3K/mTOR inhibitor and not prognosis or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010521Z"}
{"comparison_id":"c5fad485-7f47-480e-bad9-e33e2f54bbd3","query_id":"53","doc_a_id":"52925737","doc_b_id":"14241418","presented_order":["52925737","14241418"],"winner_id":"14241418","reasoning":"Document B — it relates to breast cancer (trastuzumab-resistant cells), while A discusses gastric cancer prognosis, so B is more relevant to the breast cancer prognosis claim.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010529Z"}
{"comparison_id":"bdf66a4e-7349-4e18-898f-21a60bef3198","query_id":"53","doc_a_id":"4429932","doc_b_id":"14241418","presented_order":["4429932","14241418"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses molecular marker expression linked to poor outcomes in breast cancer, whereas Document B focuses on a PI3K/mTOR inhibitor unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010536Z"}
{"comparison_id":"e683e0d3-4ed5-4161-aa12-79aa46849c1b","query_id":"53","doc_a_id":"2389574","doc_b_id":"14241418","presented_order":["2389574","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer (including trastuzumab-resistant breast cancer) and pathways affecting prognosis/treatment, whereas A is about endometrial cancer and a different marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010544Z"}
{"comparison_id":"f780721a-68ae-43c6-8c28-386154ae7f67","query_id":"53","doc_a_id":"1171121","doc_b_id":"14241418","presented_order":["1171121","14241418"],"winner_id":"1171121","reasoning":"Document A — it discusses prognostic markers in breast cancer (MVD and p53), so it is more relevant to a claim about marker expression and prognosis; Document B concerns a PI3K/mTOR inhibitor and therapy, not prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010551Z"}
{"comparison_id":"258b241a-b24f-4af4-9a3b-cf0fd0a9ac15","query_id":"53","doc_a_id":"7583725","doc_b_id":"14241418","presented_order":["14241418","7583725"],"winner_id":"7583725","reasoning":"Document B is more relevant because it directly discusses how high expression of a protein predicts poor outcomes in breast cancer, which parallels the claim about marker expression and prognosis. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010558Z"}
{"comparison_id":"55a89699-af48-4e99-8718-024f22563337","query_id":"53","doc_a_id":"32721137","doc_b_id":"14241418","presented_order":["14241418","32721137"],"winner_id":"32721137","reasoning":"Document B is more relevant — it discusses associations between molecular markers and tumor aggressiveness/prognosis (though in endometrial cancer), whereas A focuses on a PI3K/mTOR inhibitor's activity.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010566Z"}
{"comparison_id":"a04147ce-8404-4188-bc46-fedccff64ec8","query_id":"53","doc_a_id":"12358173","doc_b_id":"14241418","presented_order":["12358173","14241418"],"winner_id":"12358173","reasoning":"Document A is more relevant — it discusses a protein's expression correlating with tumor angiogenesis and prognosis (conceptually similar), whereas B focuses on a PI3K/mTOR inhibitor and not prognosis markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010573Z"}
{"comparison_id":"a412ce20-e8fd-4b4b-aa74-bdf9b1c958c8","query_id":"53","doc_a_id":"39580129","doc_b_id":"14241418","presented_order":["39580129","14241418"],"winner_id":"14241418","reasoning":"Document B — it at least relates to breast cancer (trastuzumab-resistant cells), whereas Document A is about colorectal cancer; neither mentions ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010580Z"}
{"comparison_id":"b9bc237b-07ac-459c-b7aa-b65779932752","query_id":"53","doc_a_id":"22963769","doc_b_id":"14241418","presented_order":["14241418","22963769"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses breast cancer treatment/resistance (trastuzumab context), whereas B concerns oral squamous cell carcinoma and is unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010587Z"}
{"comparison_id":"8c1c3ee7-7d09-4746-b8f9-ebf208634e48","query_id":"53","doc_a_id":"654735","doc_b_id":"14241418","presented_order":["654735","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and signaling pathways tied to prognosis/treatment, while A is about glioma and miR-21. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010595Z"}
{"comparison_id":"7c47e60b-8fd4-4d1b-bcfe-58bbc6a415e1","query_id":"53","doc_a_id":"19673227","doc_b_id":"14241418","presented_order":["14241418","19673227"],"winner_id":"19673227","reasoning":"Document B — it discusses prognostic/predictive markers and correlations with disease-free survival/time to progression, which is more relevant to a claim about prognostic markers in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010602Z"}
{"comparison_id":"83c44dc2-e14e-4fb8-b58b-5ffd2f173145","query_id":"53","doc_a_id":"20839751","doc_b_id":"14241418","presented_order":["14241418","20839751"],"winner_id":"20839751","reasoning":"Document B is more relevant — it discusses prognostic markers and prognosis in breast cancer, whereas Document A focuses on a PI3K/mTOR inhibitor unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010608Z"}
{"comparison_id":"f2276eb2-b21f-4260-9f4b-01147f9d896e","query_id":"53","doc_a_id":"13007205","doc_b_id":"14241418","presented_order":["14241418","13007205"],"winner_id":"13007205","reasoning":"Document B — it discusses factors influencing breast cancer invasion and progression, which is closer to prognosis than a paper focused on a PI3K/mTOR inhibitor. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010615Z"}
{"comparison_id":"0378d26c-896b-4f44-b918-e1cb9b25e55e","query_id":"53","doc_a_id":"31591262","doc_b_id":"14241418","presented_order":["31591262","14241418"],"winner_id":"31591262","reasoning":"Document A — it reports marker gene expression linked to poorer recurrence-free survival (a prognosis association), while B discusses a drug mechanism unrelated to marker-prognosis relationships.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010622Z"}
{"comparison_id":"acc821cf-5570-4006-a576-c1482e262d23","query_id":"53","doc_a_id":"313403","doc_b_id":"14241418","presented_order":["313403","14241418"],"winner_id":"313403","reasoning":"Document A is more relevant because it addresses prognostic markers and clinical outcomes in breast cancer, whereas Document B focuses on a PI3K/mTOR inhibitor and drug response. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010629Z"}
{"comparison_id":"f223419d-f978-4c0a-8992-af19cf47d772","query_id":"53","doc_a_id":"29366489","doc_b_id":"14241418","presented_order":["29366489","14241418"],"winner_id":"29366489","reasoning":"Document A — it discusses a tumor suppressor and molecular markers for cancer prognosis, which is more related to prognosis than Document B's focus on a PI3K/mTOR inhibitor. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010637Z"}
{"comparison_id":"28fa12af-de39-4c5c-8052-58d95b16b093","query_id":"53","doc_a_id":"32001951","doc_b_id":"14241418","presented_order":["32001951","14241418"],"winner_id":"32001951","reasoning":"Document A is more relevant — it discusses enzyme expression regulation in a breast cancer cell line, whereas B focuses on a PI3K/mTOR inhibitor unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010643Z"}
{"comparison_id":"a74c78c7-eb8c-4dfe-a61b-f416063922ae","query_id":"53","doc_a_id":"20886584","doc_b_id":"14241418","presented_order":["14241418","20886584"],"winner_id":"14241418","reasoning":"Document A — it discusses tumor biology and treatment resistance in breast cancer (whereas B focuses on chemotherapy neurotoxicity), so A is marginally more related to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010650Z"}
{"comparison_id":"781e145e-e6fc-44a8-ae8c-deccc3f7074b","query_id":"53","doc_a_id":"38808600","doc_b_id":"14241418","presented_order":["14241418","38808600"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses breast cancer (trastuzumab resistance and PI3K/mTOR signaling), whereas Document B concerns glioma and integrin α5β1, not breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010657Z"}
{"comparison_id":"aaa20869-39de-4f6f-89ec-de8e26a55386","query_id":"53","doc_a_id":"13030852","doc_b_id":"14241418","presented_order":["13030852","14241418"],"winner_id":"13030852","reasoning":"Document A is slightly more relevant because it discusses biomarkers and prognosis-related monitoring in breast cancer (metastases), whereas Document B focuses on a specific inhibitor and PI3K signaling without addressing ALDH1 or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010664Z"}
{"comparison_id":"6bbec5db-b02f-4322-8428-81900c68e34a","query_id":"53","doc_a_id":"4820792","doc_b_id":"14241418","presented_order":["4820792","14241418"],"winner_id":"4820792","reasoning":"Document A is more relevant — it addresses survival pathways and therapy resistance in breast cancer, which is closer to prognosis-related factors than Document B's focus on a specific PI3K/mTOR inhibitor. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010671Z"}
{"comparison_id":"125e3573-c41e-4c05-8158-ff5a80c956f2","query_id":"53","doc_a_id":"24341590","doc_b_id":"14241418","presented_order":["14241418","24341590"],"winner_id":"24341590","reasoning":"Document B is more relevant — it examines an association between a biological marker (CYP2D6 activity) and breast cancer outcomes, matching the claim's focus on a biomarker linked to prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010678Z"}
{"comparison_id":"05f3e417-64ba-45d9-920f-df57a6fa2df1","query_id":"53","doc_a_id":"43385013","doc_b_id":"14241418","presented_order":["43385013","14241418"],"winner_id":"43385013","reasoning":"Document A — it discusses breast epithelial/mesenchymal subpopulations and stem cell/progenitor properties (ALDH1 is a stem cell marker), while Document B focuses on a PI3K/mTOR inhibitor unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010685Z"}
{"comparison_id":"74c57669-0184-4e54-a3c9-2d188f2331a6","query_id":"53","doc_a_id":"2931832","doc_b_id":"14241418","presented_order":["2931832","14241418"],"winner_id":"2931832","reasoning":"Document A is more relevant because it addresses prognostic biomarkers in breast cancer, while Document B focuses on a PI3K/mTOR inhibitor and cell signaling rather than prognosis markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010692Z"}
{"comparison_id":"4e4760b7-8218-4f76-89b7-d0eb6cb7d367","query_id":"53","doc_a_id":"8037453","doc_b_id":"14241418","presented_order":["14241418","8037453"],"winner_id":"8037453","reasoning":"Document B is more relevant — it discusses biomarkers linked to prognosis and clinical outcomes, whereas Document A focuses on a PI3K/mTOR inhibitor without prognostic marker data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010763Z"}
{"comparison_id":"03880fbe-ddf8-4593-8c65-c7c9a933e1b8","query_id":"53","doc_a_id":"17648235","doc_b_id":"14241418","presented_order":["17648235","14241418"],"winner_id":"17648235","reasoning":"Document A is more relevant — it directly addresses breast cancer cell signaling and tumor cell proliferation pathways (more likely tied to markers of prognosis like ALDH1) whereas Document B focuses on a specific PI3K/mTOR inhibitor and drug response. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010783Z"}
{"comparison_id":"04e0ae08-9ae5-4d76-af10-3f1562f68668","query_id":"53","doc_a_id":"15081770","doc_b_id":"14241418","presented_order":["15081770","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer treatments including trastuzumab-resistant (breast) cancer, whereas A is about B‑cell lymphomas and IL4I1, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010795Z"}
{"comparison_id":"5c413cde-7edf-4f9d-af34-5cbe48a1c4be","query_id":"53","doc_a_id":"8512633","doc_b_id":"14241418","presented_order":["8512633","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer treatment in breast cancer contexts (trastuzumab-resistant cells), whereas Document A is about prostate cancer and unrelated lncRNAs. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010803Z"}
{"comparison_id":"f214b7e7-d4c1-493e-ad90-a4fd0b542b22","query_id":"53","doc_a_id":"15721252","doc_b_id":"14241418","presented_order":["15721252","14241418"],"winner_id":"15721252","reasoning":"Neither abstract mentions ALDH1 or directly addresses prognosis; Document A is slightly more relevant because it discusses molecular markers in breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010810Z"}
{"comparison_id":"fef0a85c-c2ad-4b21-9cf7-719debbedb20","query_id":"53","doc_a_id":"6517763","doc_b_id":"14241418","presented_order":["6517763","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses a therapy relevant to breast cancer (mentions trastuzumab-resistant cells), whereas A is about glioblastoma and unrelated to breast cancer markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010817Z"}
{"comparison_id":"dfdaca38-efed-4d1c-9fb1-0f8cdb5598e4","query_id":"53","doc_a_id":"3730196","doc_b_id":"14241418","presented_order":["3730196","14241418"],"winner_id":"14241418","reasoning":"Document B is slightly more relevant because it addresses therapeutic resistance in (trastuzumab-treated) breast cancer, whereas Document A focuses on small cell lung cancer and does not relate to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010824Z"}
{"comparison_id":"682aea92-4f8c-4e77-a6f7-e8b4912722cc","query_id":"53","doc_a_id":"26561572","doc_b_id":"14241418","presented_order":["26561572","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses breast cancer-related therapy (trastuzumab resistance), so it's marginally more relevant to prognosis in breast cancer than Document A which is about lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010832Z"}
{"comparison_id":"8f102bbf-8477-46a0-9426-b7d7d270628b","query_id":"53","doc_a_id":"15335331","doc_b_id":"14241418","presented_order":["14241418","15335331"],"winner_id":"14241418","reasoning":"Document A is more relevant — it relates to breast cancer (mentions trastuzumab resistance), whereas B concerns oral squamous cell carcinoma and is unrelated to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010839Z"}
{"comparison_id":"ab17a0fe-2d16-4c8d-95ae-4e836793aaec","query_id":"53","doc_a_id":"19358586","doc_b_id":"14241418","presented_order":["14241418","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it links molecular markers to poor survival in breast cancer (whereas A discusses a PI3K/mTOR inhibitor, not prognosis or ALDH1). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010846Z"}
{"comparison_id":"66ef84df-2f7b-42a5-844c-d85a4c8da7dd","query_id":"53","doc_a_id":"2140497","doc_b_id":"14241418","presented_order":["2140497","14241418"],"winner_id":"2140497","reasoning":"Document A — it relates to breast cancer risk/prognosis factors, whereas Document B discusses a targeted drug and PI3K/mTOR signaling unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010852Z"}
{"comparison_id":"7f02e5a5-9c5e-4091-be22-d02ec0a22db7","query_id":"53","doc_a_id":"601033","doc_b_id":"14241418","presented_order":["601033","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer treatment in contexts that include breast cancer (trastuzumab resistance), whereas Document A addresses ATLL/viral reactivation unrelated to breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010860Z"}
{"comparison_id":"b3116697-f678-4868-b37f-8dcffff03cb3","query_id":"53","doc_a_id":"16734530","doc_b_id":"14241418","presented_order":["14241418","16734530"],"winner_id":"16734530","reasoning":"Document B — it deals directly with breast cancer clinical associations (ER status and nodal involvement), while A focuses on a PI3K/mTOR inhibitor unrelated to ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010866Z"}
{"comparison_id":"8a636231-ae0e-4971-b9a1-063ab40c8940","query_id":"53","doc_a_id":"20127522","doc_b_id":"14241418","presented_order":["20127522","14241418"],"winner_id":"20127522","reasoning":"Document A is more relevant — it addresses prognostic markers and outcomes in breast cancer, whereas Document B focuses on a PI3K/mTOR inhibitor and tumor growth mechanisms. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010873Z"}
{"comparison_id":"44cd3251-0698-4317-9797-0d1d2922846d","query_id":"53","doc_a_id":"4467129","doc_b_id":"14241418","presented_order":["4467129","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer), while A is about neuroblastoma and let-7 microRNA. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010881Z"}
{"comparison_id":"0752bb29-ba25-4b9b-b7bb-15cdaa6198a1","query_id":"53","doc_a_id":"5500086","doc_b_id":"14241418","presented_order":["5500086","14241418"],"winner_id":"5500086","reasoning":"Document A is more relevant — it discusses clinical outcome correlations in breast cancer (prognosis), whereas B focuses on a PI3K/mTOR inhibitor's growth inhibition. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010887Z"}
{"comparison_id":"43c4cfed-3c62-4755-bb97-4afff509e80b","query_id":"53","doc_a_id":"17755060","doc_b_id":"14241418","presented_order":["17755060","14241418"],"winner_id":"17755060","reasoning":"Document A is more relevant — it explicitly discusses poor prognosis in human cancers (ties to metabolic markers), whereas B focuses on a PI3K/mTOR inhibitor and not prognosis or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010894Z"}
{"comparison_id":"6b666dc8-66d3-4cce-819c-2e87045ac489","query_id":"53","doc_a_id":"25732836","doc_b_id":"14241418","presented_order":["14241418","25732836"],"winner_id":"25732836","reasoning":"Document B — it concerns prognostic markers in breast cancer, so it's more relevant to a claim about prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010901Z"}
{"comparison_id":"fddb9c0f-bad3-4f11-ac92-e7749b70a34c","query_id":"53","doc_a_id":"38243984","doc_b_id":"14241418","presented_order":["14241418","38243984"],"winner_id":"14241418","reasoning":"Document A — neither abstract mentions ALDH1, but A relates to breast cancer (trastuzumab resistance) while B is about pancreatic cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010907Z"}
{"comparison_id":"78c40582-f4e2-42cf-b940-bc8774e5a3e7","query_id":"53","doc_a_id":"27240667","doc_b_id":"14241418","presented_order":["14241418","27240667"],"winner_id":"27240667","reasoning":"Document B — it discusses breast cancer mortality and prognosis trends, which is more relevant to a claim about prognostic markers than Document A's focus on a PI3K/mTOR inhibitor. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010915Z"}
{"comparison_id":"bfa9eba8-875e-4f35-9b1a-d5299b3a9c56","query_id":"53","doc_a_id":"16806763","doc_b_id":"14241418","presented_order":["16806763","14241418"],"winner_id":"14241418","reasoning":"Document B — it concerns breast-cancer–relevant therapy and mechanisms (trastuzumab resistance/PI3K signaling), whereas A is about colorectal cancer and neither mentions ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010921Z"}
{"comparison_id":"80b3c39c-a0a8-4c34-b470-de6b23a03bda","query_id":"53","doc_a_id":"9486930","doc_b_id":"14241418","presented_order":["9486930","14241418"],"winner_id":"9486930","reasoning":"Doc A is more relevant — it discusses a stem cell-related \"self-renewal\" signature linked to poorer treatment response, which is conceptually related to ALDH1 as a cancer stem cell marker (even though the study is in glioblastoma rather than breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010929Z"}
{"comparison_id":"f573b336-49df-4028-8160-84fe919d193f","query_id":"53","doc_a_id":"19882228","doc_b_id":"14241418","presented_order":["19882228","14241418"],"winner_id":"19882228","reasoning":"Document A is more relevant because it discusses factors linked to poor tumour prognosis, whereas Document B focuses on a PI3K/mTOR inhibitor unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010935Z"}
{"comparison_id":"1611f287-05de-41bf-b615-0f060eb7c895","query_id":"53","doc_a_id":"22521091","doc_b_id":"14241418","presented_order":["22521091","14241418"],"winner_id":"22521091","reasoning":"Document A — it discusses a biomarker whose expression correlates with cancer progression and survival (though in HCC), which is more conceptually relevant to ALDH1 as a prognostic marker than a drug-study paper. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010943Z"}
{"comparison_id":"b88cced7-8190-4451-b698-fbc3fca94635","query_id":"53","doc_a_id":"4999633","doc_b_id":"14241418","presented_order":["4999633","14241418"],"winner_id":"4999633","reasoning":"Document A is more directly about breast cancer cell behavior (MCF-7), so it's slightly more relevant to a claim about breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010949Z"}
{"comparison_id":"5984f34f-8e47-48f7-bab5-0e4a05e08512","query_id":"53","doc_a_id":"34189936","doc_b_id":"14241418","presented_order":["14241418","34189936"],"winner_id":"14241418","reasoning":"Reason: Document A relates to breast cancer (mentions trastuzumab-resistant cancer cells), while Document B concerns mesothelioma and is unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010956Z"}
{"comparison_id":"323725be-e405-4b9f-864c-5c67115b22cf","query_id":"53","doc_a_id":"16701509","doc_b_id":"14241418","presented_order":["16701509","14241418"],"winner_id":"14241418","reasoning":"Neither document discusses ALDH1 or its prognostic significance; Document B is marginally more relevant because it deals with tumor biology and treatment resistance, which is closer to prognosis than HDL-C risk factors. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010963Z"}
{"comparison_id":"ff80fcc6-74fb-4ff5-b02f-a72654194e25","query_id":"53","doc_a_id":"24249915","doc_b_id":"14241418","presented_order":["24249915","14241418"],"winner_id":"24249915","reasoning":"Document A — it discusses expression changes of a breast cancer marker (ERβ) and prognosis-related expression patterns, so it's more relevant to a claim about marker expression and prognosis than a drug study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010970Z"}
{"comparison_id":"71bf696f-094e-4723-91ed-23a39e5bad04","query_id":"53","doc_a_id":"4455466","doc_b_id":"14241418","presented_order":["14241418","4455466"],"winner_id":"4455466","reasoning":"Document B—although it discusses ZMYND11 rather than ALDH1, it directly links gene expression levels to prognosis in breast cancer; Document A focuses on a PI3K/mTOR inhibitor and not prognosis markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010977Z"}
{"comparison_id":"dc4763a3-1842-403e-a8f5-197bf964024e","query_id":"53","doc_a_id":"37480103","doc_b_id":"14241418","presented_order":["37480103","14241418"],"winner_id":"14241418","reasoning":"Reason: Neither abstract mentions ALDH1 or prognosis, but Document B concerns breast cancer cell biology and treatment resistance (more directly related to tumor behavior/prognosis) while A addresses pregnancy-related risk.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010984Z"}
{"comparison_id":"87c2c69f-d200-45f9-9776-50229c27b631","query_id":"53","doc_a_id":"4489217","doc_b_id":"14241418","presented_order":["14241418","4489217"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer signaling and therapies relevant to breast cancer (trastuzumab resistance), whereas B is about renal carcinoma heterogeneity and not breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010992Z"}
{"comparison_id":"25176981-7236-4333-aa64-8f1a297ee86b","query_id":"53","doc_a_id":"3285322","doc_b_id":"14241418","presented_order":["3285322","14241418"],"winner_id":"3285322","reasoning":"Document A is more relevant — it discusses clinical and pathologic features and prognosis-related tumor characteristics in breast cancer, whereas Document B focuses on a PI3K/mTOR inhibitor and drug responses.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.010999Z"}
{"comparison_id":"5068ca16-0a69-4973-b0de-e1776f672c34","query_id":"53","doc_a_id":"7165938","doc_b_id":"14241418","presented_order":["7165938","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer therapies including activity against trastuzumab-resistant cells (breast cancer context), while A focuses on colorectal cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011005Z"}
{"comparison_id":"6c199a88-9175-4499-817c-39c04486ef12","query_id":"53","doc_a_id":"515489","doc_b_id":"14241418","presented_order":["515489","14241418"],"winner_id":"14241418","reasoning":"Doc B is more relevant because it discusses cancer treatment in a breast cancer context (trastuzumab resistance), while Doc A focuses on hepatocellular carcinoma and a different molecule. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011013Z"}
{"comparison_id":"e07767d6-26eb-4131-b9e3-c21b115dd835","query_id":"53","doc_a_id":"29124963","doc_b_id":"14241418","presented_order":["14241418","29124963"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses breast cancer therapy and tumor biology (trastuzumab resistance), whereas Document B is about lung adenocarcinoma and EML4-ALK. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011019Z"}
{"comparison_id":"2e107542-56a9-4a4b-b0f1-d379f4850497","query_id":"53","doc_a_id":"23304931","doc_b_id":"14241418","presented_order":["23304931","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer therapeutics relevant to breast cancer (trastuzumab-resistant cases), while Document A is about AIDS-related DLBCL (unrelated to ALDH1 or breast cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011026Z"}
{"comparison_id":"4cfc8351-3295-41e0-acac-a9d461f6d957","query_id":"53","doc_a_id":"19047331","doc_b_id":"14241418","presented_order":["19047331","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — neither paper addresses ALDH1, but B concerns a drug and resistance in a breast cancer context (trastuzumab), while A is about ovarian cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011033Z"}
{"comparison_id":"0594f09c-7967-4948-903a-c53b42946c6f","query_id":"53","doc_a_id":"11615422","doc_b_id":"14241418","presented_order":["11615422","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer (including trastuzumab-resistant breast cancer) and pathways affecting prognosis/treatment, while A concerns leukemia and PAX5, not breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011041Z"}
{"comparison_id":"fb0970b6-59e0-4821-8130-549ff3cf22c6","query_id":"53","doc_a_id":"23665162","doc_b_id":"14241418","presented_order":["14241418","23665162"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it discusses cancer (including trastuzumab-resistant breast cancer) mechanisms, whereas Document B is about LINE-1 hypomethylation and hepatocellular carcinoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011048Z"}
{"comparison_id":"bfa69eb6-5014-40bc-93aa-13ec20c9b319","query_id":"53","doc_a_id":"9600826","doc_b_id":"14241418","presented_order":["9600826","14241418"],"winner_id":"9600826","reasoning":"Document A is more relevant — it addresses breast cancer biology and pathways linked to invasion/angiogenesis (more likely related to prognosis) while B focuses on a drug inhibitor unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011054Z"}
{"comparison_id":"b79197b0-e391-49ce-a922-6b49611fd06a","query_id":"53","doc_a_id":"20280410","doc_b_id":"14241418","presented_order":["20280410","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer cell growth and treatment resistance relevant to breast-cancer outcomes, while A concerns BRCA2 risk/prenatal viability rather than prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011061Z"}
{"comparison_id":"cbb1e041-5bfd-4f55-aaf6-969973330b8b","query_id":"53","doc_a_id":"27123743","doc_b_id":"14241418","presented_order":["14241418","27123743"],"winner_id":"14241418","reasoning":"Document A is more related to tumor biology and markers affecting breast cancer outcomes, while Document B concerns birthweight and cancer risk. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011067Z"}
{"comparison_id":"e9aa4d99-1187-4457-8f2f-6574bd4ba87f","query_id":"53","doc_a_id":"17021845","doc_b_id":"14241418","presented_order":["14241418","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a cancer stem-cell marker and its association with prognosis (though in lung and a different marker), which is more conceptually related to ALDH1's prognostic role than Document A. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011074Z"}
{"comparison_id":"741da15c-5297-4183-ae24-e6b1c8cce646","query_id":"53","doc_a_id":"8677721","doc_b_id":"14241418","presented_order":["14241418","8677721"],"winner_id":"14241418","reasoning":"Document A is more relevant because it discusses cancer (including trastuzumab-resistant cases, suggesting breast cancer context), whereas Document B is about hepatocellular carcinoma and unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011081Z"}
{"comparison_id":"d23d8799-8e22-489f-875a-aecc0187af74","query_id":"53","doc_a_id":"23830488","doc_b_id":"14241418","presented_order":["14241418","23830488"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it discusses breast cancer–related therapy (trastuzumab resistance) whereas Document B is about colorectal cancer and circadian genes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011087Z"}
{"comparison_id":"5869d437-588f-4ce9-bbb3-67e5bbaa510d","query_id":"53","doc_a_id":"13069283","doc_b_id":"14241418","presented_order":["14241418","13069283"],"winner_id":"13069283","reasoning":"Document B — it concerns breast cancer patient data and treatment-related prognostic factors; Document A is preclinical PI3K/mTOR inhibitor work not addressing ALDH1 or prognosis.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011095Z"}
{"comparison_id":"42020d84-94ce-4c5f-ac01-a1943c5ef77d","query_id":"53","doc_a_id":"38551172","doc_b_id":"14241418","presented_order":["14241418","38551172"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses molecular pathways and markers in breast cancer, which is closer to evidence about a biomarker's prognostic significance than the epidemiologic vitamin D/density study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011102Z"}
{"comparison_id":"3432b4f5-d77e-49d2-a504-fdf81e9996d8","query_id":"53","doc_a_id":"2130391","doc_b_id":"14241418","presented_order":["2130391","14241418"],"winner_id":"2130391","reasoning":"Document A is more focused on factors linked to breast cancer progression and prognosis (invasion, tumor size, lymph node involvement), while Document B is about a targeted drug mechanism unrelated to prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011109Z"}
{"comparison_id":"665771fd-ebe5-4f5f-8871-a228cf306457","query_id":"53","doc_a_id":"22509015","doc_b_id":"14241418","presented_order":["22509015","14241418"],"winner_id":"22509015","reasoning":"Document A — it directly studies breast cancer biology and metastasis (more related to prognosis), while B focuses on a PI3K/mTOR inhibitor drug. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011115Z"}
{"comparison_id":"cabeeacb-9353-402c-ba9d-a6f82c960e48","query_id":"53","doc_a_id":"21181273","doc_b_id":"14241418","presented_order":["21181273","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer (including trastuzumab-resistant breast cancer) and pathways linked to breast cancer prognosis, whereas A is about colorectal cancer unrelated to ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011122Z"}
{"comparison_id":"8e5a8c53-3ab7-4277-99df-77c128f62660","query_id":"53","doc_a_id":"36950726","doc_b_id":"14241418","presented_order":["14241418","36950726"],"winner_id":"14241418","reasoning":"Document A is more relevant — it deals with cancer biology and therapies related to breast cancer (trastuzumab resistance), whereas Document B concerns melanoma and unrelated epigenetic markers. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011129Z"}
{"comparison_id":"3b8291d0-9248-4f15-9109-83e44a508eae","query_id":"53","doc_a_id":"17088791","doc_b_id":"14241418","presented_order":["17088791","14241418"],"winner_id":"14241418","reasoning":"Neither abstract mentions ALDH1 or directly addresses prognosis. Document B is slightly more relevant because it deals with breast cancer cell growth and treatment resistance, which relate more to outcome than the genetic-susceptibility focus of A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011136Z"}
{"comparison_id":"90806442-cb60-4a75-83ab-9ff36880b240","query_id":"53","doc_a_id":"18340282","doc_b_id":"14241418","presented_order":["14241418","18340282"],"winner_id":"18340282","reasoning":"Document B is focused on a large breast cancer cohort, so it's more likely to address prognostic biomarkers than a drug-mechanism paper.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011142Z"}
{"comparison_id":"97bbb777-bf47-453d-8c9b-039e036ae3c5","query_id":"53","doc_a_id":"10169908","doc_b_id":"14241418","presented_order":["10169908","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) while Document A concerns lung cancer SLC1A5, neither mentions ALDH1 but B is closer to breast cancer context.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011149Z"}
{"comparison_id":"a0e611b0-b732-49de-b122-4022f9046ed4","query_id":"53","doc_a_id":"1866911","doc_b_id":"14241418","presented_order":["1866911","14241418"],"winner_id":"1866911","reasoning":"Doc A discusses mammary progenitor cell populations and markers related to tumor origin, which is more relevant to ALDH1 as a stem/progenitor marker and prognosis than a drug study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011156Z"}
{"comparison_id":"a7ba4572-5565-449f-afab-43b07dd8e09c","query_id":"53","doc_a_id":"21033230","doc_b_id":"14241418","presented_order":["14241418","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it discusses molecular profiling and prognostic markers in metastatic breast cancer, whereas A focuses on a PI3K/mTOR inhibitor unrelated to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011162Z"}
{"comparison_id":"3d1f52e3-ea70-4eb8-9bb4-7adcdbbd2360","query_id":"53","doc_a_id":"21902400","doc_b_id":"14241418","presented_order":["21902400","14241418"],"winner_id":"21902400","reasoning":"Document A discusses prognostic factors and clinical outcomes in solid tumors, making it more relevant to a claim about a prognostic marker in breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011168Z"}
{"comparison_id":"8e30f313-7292-469b-97d7-f3ae82802054","query_id":"53","doc_a_id":"17450673","doc_b_id":"14241418","presented_order":["14241418","17450673"],"winner_id":"14241418","reasoning":"Document A is more focused on breast cancer biology and treatment, so it's more likely to contain prognostic marker information than a perinatal risk meta-analysis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011175Z"}
{"comparison_id":"db60ddc3-deeb-477d-88ca-cd1a4c49cd36","query_id":"53","doc_a_id":"1782201","doc_b_id":"14241418","presented_order":["14241418","1782201"],"winner_id":"1782201","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it addresses factors driving tumor progression and metastasis (related to prognosis), whereas A focuses on a PI3K/mTOR inhibitor.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011181Z"}
{"comparison_id":"a09f8bcf-717c-44e7-b458-4e18ccc8b7fc","query_id":"53","doc_a_id":"24980622","doc_b_id":"14241418","presented_order":["14241418","24980622"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer signaling and therapies related to breast cancer (trastuzumab resistance), whereas B covers colorectal liver metastases unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011188Z"}
{"comparison_id":"1fecc772-977a-415b-94ec-d70203f1b12a","query_id":"53","doc_a_id":"5774746","doc_b_id":"14241418","presented_order":["14241418","5774746"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it concerns trastuzumab-resistant cancer cells (breast cancer context); Document B focuses on colorectal carcinoma. Neither mentions ALDH1 or directly addresses prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011195Z"}
{"comparison_id":"5307327e-66ba-44d5-9f55-c16124e66d7f","query_id":"53","doc_a_id":"4418878","doc_b_id":"14241418","presented_order":["14241418","4418878"],"winner_id":"4418878","reasoning":"Doc B is more relevant — it discusses gene expression signatures and their links to cancer subtype and prognosis, which relates to ALDH1 expression as a prognostic marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011202Z"}
{"comparison_id":"fa2ea000-dc8a-4f75-9d87-43bbf1b2ead9","query_id":"53","doc_a_id":"20454006","doc_b_id":"14241418","presented_order":["20454006","14241418"],"winner_id":"20454006","reasoning":"Document A is about biomarker modulation in breast cancer patients (clinical context), whereas B focuses on a PI3K/mTOR inhibitor in preclinical models; A is more relevant to a prognostic biomarker claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011208Z"}
{"comparison_id":"11f6c66b-d64c-46be-bffe-af3c2f086de8","query_id":"53","doc_a_id":"5372432","doc_b_id":"14241418","presented_order":["5372432","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer biology and therapies related to breast cancer (trastuzumab resistance), which is closer to ALDH1's prognostic role than Document A's focus on geographic access and post-mortem diagnoses. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011215Z"}
{"comparison_id":"c75d0474-2a8a-4e38-a734-4d6a1f01883d","query_id":"53","doc_a_id":"52180874","doc_b_id":"14241418","presented_order":["52180874","14241418"],"winner_id":"52180874","reasoning":"Document A is marginally more relevant because it discusses biomarker expression (PD-L1) and associations with overall survival across cancers, which is conceptually closer to a claim about a biomarker (ALDH1) and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011222Z"}
{"comparison_id":"69d26299-da04-43eb-9e04-c082aecf52e4","query_id":"53","doc_a_id":"1554348","doc_b_id":"14241418","presented_order":["1554348","14241418"],"winner_id":"1554348","reasoning":"Document A — it examines protein expression in MCF-7 breast cancer cells, which is more related to marker–prognosis questions than a drug efficacy study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011228Z"}
{"comparison_id":"cc604659-c3c9-4ddf-8c33-cc10d6502abb","query_id":"53","doc_a_id":"2727303","doc_b_id":"14241418","presented_order":["2727303","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses breast cancer–related therapy and tumor growth (trastuzumab-resistant cancers), whereas A focuses on HDAC6/STIM1 signaling without relation to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011235Z"}
{"comparison_id":"5448f1d2-1138-4dda-8fdd-1a0ac442e690","query_id":"53","doc_a_id":"38623601","doc_b_id":"14241418","presented_order":["38623601","14241418"],"winner_id":"38623601","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it discusses markers and prognosis-related therapy in breast cancer, while B focuses on a PI3K/mTOR inhibitor and mutations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011259Z"}
{"comparison_id":"cf03ad8f-4f34-4728-bf2c-ec79b627b237","query_id":"53","doc_a_id":"5864770","doc_b_id":"14241418","presented_order":["5864770","14241418"],"winner_id":"5864770","reasoning":"Reason: Document A discusses breast cancer risk and biology, making it more directly related to prognosis in breast cancer than Document B, which focuses on a PI3K/mTOR inhibitor.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011270Z"}
{"comparison_id":"270b659c-7a0e-4e04-b5ca-2a62a6d6640a","query_id":"53","doc_a_id":"21502234","doc_b_id":"14241418","presented_order":["14241418","21502234"],"winner_id":"14241418","reasoning":"Document A is more related to breast cancer (mentions trastuzumab-resistant cancer cells and cancer prognosis/therapy), whereas Document B concerns endometrial cancer and mismatch repair, unrelated to ALDH1 or breast prognosis.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011279Z"}
{"comparison_id":"0b0ec85b-7722-47d5-9c8e-d3e68fc93d63","query_id":"53","doc_a_id":"3329824","doc_b_id":"14241418","presented_order":["14241418","3329824"],"winner_id":"3329824","reasoning":"Document B. It deals with clinical prognosis-related outcomes in breast cancer (risk of CNS metastases), whereas A focuses on a PI3K/mTOR inhibitor and cell growth, not ALDH1 or prognostic biomarkers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011287Z"}
{"comparison_id":"215ef4b8-6ff2-4430-b65f-1107340ba775","query_id":"53","doc_a_id":"15521377","doc_b_id":"14241418","presented_order":["15521377","14241418"],"winner_id":"15521377","reasoning":"Neither abstract mentions ALDH1 or prognosis, but Document A (senescence/SASP) is marginally more related to tumor biology and prognosis than Document B (drug targeting PI3K/mTOR). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011294Z"}
{"comparison_id":"464e65d3-f991-4f48-abd8-b6339e265074","query_id":"53","doc_a_id":"4414547","doc_b_id":"14241418","presented_order":["4414547","14241418"],"winner_id":"4414547","reasoning":"Document A is more relevant because it specifically addresses breast cancer (though it discusses PPM1D mutations and predisposition rather than ALDH1 expression or prognosis). Document B focuses on a PI3K/mTOR inhibitor and tumor growth, not on ALDH1 or prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011301Z"}
{"comparison_id":"52e179ea-24ae-4f63-8c91-5ed6dd94c009","query_id":"53","doc_a_id":"13831842","doc_b_id":"14241418","presented_order":["13831842","14241418"],"winner_id":"14241418","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it addresses molecular oncology and therapeutic implications, whereas A concerns height/weight epidemiology.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011307Z"}
{"comparison_id":"631772c7-9d81-48df-92b0-a9e26d2706a4","query_id":"53","doc_a_id":"1389264","doc_b_id":"14241418","presented_order":["14241418","1389264"],"winner_id":"1389264","reasoning":"Document B is more relevant — it discusses treatment responses and clinical outcomes (durable remissions and biomarkers) in breast cancer, whereas Document A focuses on a drug's activity without prognosis or biomarkers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011315Z"}
{"comparison_id":"46d50497-1afe-49f4-8656-0b3c05797dc6","query_id":"53","doc_a_id":"14471161","doc_b_id":"14241418","presented_order":["14241418","14471161"],"winner_id":"14241418","reasoning":"Document A is more related to breast cancer (mentions trastuzumab-resistant cancer and PI3K signaling) while Document B focuses on pancreatic cancer circadian effects. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011322Z"}
{"comparison_id":"d2e14ea3-f65e-409e-a792-6206e3a3e488","query_id":"53","doc_a_id":"22482820","doc_b_id":"14241418","presented_order":["22482820","14241418"],"winner_id":"22482820","reasoning":"Document A is more likely to discuss breast cancer prognostic markers and clinical correlations, while Document B focuses narrowly on a PI3K/mTOR inhibitor unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011328Z"}
{"comparison_id":"79d15f73-ccca-4da8-ba89-05afd71bbb4b","query_id":"53","doc_a_id":"13831558","doc_b_id":"14241418","presented_order":["13831558","14241418"],"winner_id":"14241418","reasoning":"Document B — it deals with molecular biology and therapy-related markers in cancer (more closely related to biomarkers and prognosis) while A is about mammographic density and detection risk. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011335Z"}
{"comparison_id":"b92b357a-3959-42b5-bee5-ebfe9fd1c329","query_id":"53","doc_a_id":"23577867","doc_b_id":"14241418","presented_order":["14241418","23577867"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns breast cancer biology and treatment (mentions trastuzumab resistance), while Document B addresses endometrial cancer risk factors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011342Z"}
{"comparison_id":"62e41208-5b12-4315-82db-d86ac0af1f97","query_id":"53","doc_a_id":"9239963","doc_b_id":"14241418","presented_order":["9239963","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant cells, relevant to breast cancer), whereas A concerns endometrial cancer and steroidogenesis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011349Z"}
{"comparison_id":"68a17a0a-0158-47ac-b40b-43da9e656697","query_id":"53","doc_a_id":"15559582","doc_b_id":"14241418","presented_order":["14241418","15559582"],"winner_id":"15559582","reasoning":"Document B — it discusses clinical markers and prognosis-related features in breast cancer (lipids, prolactin, differentiation), which is more relevant to a claim about prognostic markers than a paper on a PI3K/mTOR inhibitor.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011356Z"}
{"comparison_id":"10dd0347-a0d9-499c-814a-706e7fbdd3b0","query_id":"53","doc_a_id":"25523969","doc_b_id":"14241418","presented_order":["25523969","14241418"],"winner_id":"25523969","reasoning":"Document A is more relevant — it discusses molecular markers and immunohistochemical analysis related to cancer metastasis, which is closer to biomarker/prognostic studies than a drug-targeting study. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011363Z"}
{"comparison_id":"18eafe39-a28b-4005-8b17-0f228005174d","query_id":"53","doc_a_id":"25576204","doc_b_id":"14241418","presented_order":["14241418","25576204"],"winner_id":"14241418","reasoning":"Document A is more relevant — it mentions breast cancer (trastuzumab-resistant cells) and therapeutic outcomes, whereas B discusses autophagy gene tumorigenesis without relation to ALDH1 or breast cancer prognosis.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011371Z"}
{"comparison_id":"4a46fef6-ee03-4427-ac27-f9b137444bca","query_id":"53","doc_a_id":"11271123","doc_b_id":"14241418","presented_order":["11271123","14241418"],"winner_id":"14241418","reasoning":"Document B — it relates to cancer (including trastuzumab-resistant breast cancer) and PI3K pathway biology, whereas Document A concerns endometrial cancer and is not about breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011378Z"}
{"comparison_id":"f1b9acf0-4423-41b2-9293-9e685ab811fd","query_id":"53","doc_a_id":"8671456","doc_b_id":"14241418","presented_order":["8671456","14241418"],"winner_id":"8671456","reasoning":"Document A is more directly related to breast cancer outcomes (tumor growth and survival in models), whereas B focuses on PI3K/mTOR inhibition and drug resistance rather than prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011385Z"}
{"comparison_id":"24968eff-cc97-44ae-b97d-fab18e3c267a","query_id":"53","doc_a_id":"31311495","doc_b_id":"14241418","presented_order":["14241418","31311495"],"winner_id":"31311495","reasoning":"Document B — it discusses breast cancer aggressiveness, EMT and therapy resistance (more related to prognosis) whereas A focuses on a PI3K/mTOR inhibitor without prognostic markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011392Z"}
{"comparison_id":"58b712f3-993a-4fc9-9026-e2adb376e338","query_id":"53","doc_a_id":"31439189","doc_b_id":"14241418","presented_order":["14241418","31439189"],"winner_id":"14241418","reasoning":"Document A is more relevant — it addresses breast cancer (trastuzumab resistance and PI3K/mTOR signaling), whereas Document B concerns prostate cancer stem cells and doesn't relate to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011400Z"}
{"comparison_id":"727f5584-1799-42a5-af8b-e4f796a097ec","query_id":"53","doc_a_id":"2272614","doc_b_id":"14241418","presented_order":["14241418","2272614"],"winner_id":"14241418","reasoning":"Document A is slightly more related (discusses cancer therapies including trastuzumab resistance relevant to breast cancer), while B focuses on lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011407Z"}
{"comparison_id":"27f6552a-323b-4366-afbe-adac4435424b","query_id":"53","doc_a_id":"16630996","doc_b_id":"14241418","presented_order":["14241418","16630996"],"winner_id":"14241418","reasoning":"Doc A discusses breast-cancer–related therapy and tumor signaling/resistance (trastuzumab, PI3K/mTOR), so it's closer to prognosis markers in breast cancer than B, which is about pancreatic gemcitabine transport.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011414Z"}
{"comparison_id":"2beca53a-81f4-49cb-8925-26f4692257f7","query_id":"53","doc_a_id":"25832301","doc_b_id":"14241418","presented_order":["25832301","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer therapy including trastuzumab-resistant (HER2+) breast cancer, whereas A concerns multiple myeloma and is not about breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011421Z"}
{"comparison_id":"557ecdb7-fa71-4e4b-89a9-1fb1a5bdfb51","query_id":"53","doc_a_id":"4886637","doc_b_id":"14241418","presented_order":["4886637","14241418"],"winner_id":"4886637","reasoning":"Document A is more relevant — it discusses breast cancer risk and prognosis-related factors, whereas B focuses on a specific targeted inhibitor and PI3K signaling without addressing ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011428Z"}
{"comparison_id":"74f084be-6ba6-480d-939c-97e37f85e881","query_id":"53","doc_a_id":"7639744","doc_b_id":"14241418","presented_order":["7639744","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and pathways affecting tumor behavior, whereas A is about smoking cessation in lung cancer and unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011435Z"}
{"comparison_id":"a7fbaafb-3cbe-4c0b-a92e-ebb4a08bae1f","query_id":"53","doc_a_id":"4828631","doc_b_id":"14241418","presented_order":["14241418","4828631"],"winner_id":"14241418","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it deals with breast cancer biology and treatment resistance, whereas Document B addresses BMI and cancer risk. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011442Z"}
{"comparison_id":"084d1e7f-dd8f-4f7c-8c8c-1d240941ade1","query_id":"53","doc_a_id":"24349430","doc_b_id":"14241418","presented_order":["14241418","24349430"],"winner_id":"14241418","reasoning":"Document A is more relevant because it discusses PI3K/mTOR signaling and trastuzumab-resistant cancer cells (breast cancer context), whereas Document B is a lung cancer (A549) study unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011449Z"}
{"comparison_id":"25fcfa0a-c0d3-42fd-bebe-50be126dbe7c","query_id":"53","doc_a_id":"1507222","doc_b_id":"14241418","presented_order":["1507222","14241418"],"winner_id":"14241418","reasoning":"Document B is slightly more relevant because it discusses cancer (including trastuzumab-resistant, often HER2+ breast cancer) and signaling pathways related to prognosis and treatment, whereas A is about cachexia in a murine model unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011456Z"}
{"comparison_id":"9e25f562-0b9b-468b-b658-1af6aedf02d6","query_id":"53","doc_a_id":"7736860","doc_b_id":"14241418","presented_order":["7736860","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer (including trastuzumab-resistant breast cancer) and treatment relevance, whereas A is about cervical cancer and unrelated to ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011463Z"}
{"comparison_id":"9ed98233-bd3f-43c8-bd17-ac557b2029c7","query_id":"53","doc_a_id":"16098747","doc_b_id":"14241418","presented_order":["14241418","16098747"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns cancer cell behavior and treatment resistance/proliferation, which relate to prognosis; Document B addresses breast density risk factors, not prognosis or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011469Z"}
{"comparison_id":"8a57d5a3-c550-4632-9374-e3e248b87829","query_id":"53","doc_a_id":"5649538","doc_b_id":"14241418","presented_order":["5649538","14241418"],"winner_id":"5649538","reasoning":"Document A is more relevant because it examines gene expression profiles and genomic markers in breast cancer, which is directly related to associations between marker expression (like ALDH1) and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011476Z"}
{"comparison_id":"add92567-1538-4f89-aa31-19c3d17c7b34","query_id":"53","doc_a_id":"22975806","doc_b_id":"14241418","presented_order":["22975806","14241418"],"winner_id":"22975806","reasoning":"Both documents do not address ALDH1, but Document A discusses breast tumorigenesis and clinical implications, making it marginally more relevant to prognosis in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011482Z"}
{"comparison_id":"5271016f-e624-460c-8aed-767f6477af35","query_id":"53","doc_a_id":"14672919","doc_b_id":"14241418","presented_order":["14241418","14672919"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer signaling and therapies related to trastuzumab-resistant, PI3K-mutant tumors (pertinent to breast cancer contexts), whereas B concerns esophageal cancer prognosis measures.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011489Z"}
{"comparison_id":"f563cd92-cc5d-4da7-9a10-96c88207aafd","query_id":"53","doc_a_id":"5222182","doc_b_id":"14241418","presented_order":["14241418","5222182"],"winner_id":"14241418","reasoning":"Neither document addresses ALDH1 or prognosis directly; Document A is slightly more relevant because it concerns breast cancer cell growth and treatment, while Document B focuses on mammographic density risk factors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011496Z"}
{"comparison_id":"1d80ff04-ebb4-4b63-a80c-18676c9243fa","query_id":"53","doc_a_id":"16086778","doc_b_id":"14241418","presented_order":["16086778","14241418"],"winner_id":"16086778","reasoning":"Document A — it addresses mechanisms of breast carcinogenesis and prognosis-related signaling, making it more relevant than a drug-focused study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011502Z"}
{"comparison_id":"c68ae3c5-1d16-4d8d-a760-0ecac824fa58","query_id":"53","doc_a_id":"16322674","doc_b_id":"14241418","presented_order":["14241418","16322674"],"winner_id":"14241418","reasoning":"Document A — it concerns breast cancer biology and treatment, so it's closer to prognosis-related evidence than the birth-size epidemiology in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011509Z"}
{"comparison_id":"17f07533-6230-4bab-bcd6-253651367332","query_id":"53","doc_a_id":"6790197","doc_b_id":"14241418","presented_order":["6790197","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer (including trastuzumab-resistant breast cancer via PI3K pathway), so it's closer to breast cancer prognosis; Document A is prostate-specific. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011516Z"}
{"comparison_id":"479ba4bb-6bb7-4bbb-9100-b2ed6e360fa4","query_id":"53","doc_a_id":"5377642","doc_b_id":"14241418","presented_order":["14241418","5377642"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant — it concerns cancer therapy and trastuzumab resistance in breast cancer, whereas B addresses T-cell PD‑1 regulation unrelated to ALDH1 or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011523Z"}
{"comparison_id":"dbc713d0-d086-4541-8ea0-0973a0cef4fb","query_id":"53","doc_a_id":"13964633","doc_b_id":"14241418","presented_order":["14241418","13964633"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses breast cancer treatment and tumor behavior (trastuzumab resistance), closer to prognosis/clinical outcomes than the miRNA/3'UTR focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011529Z"}
{"comparison_id":"3ac7aaf3-777b-441d-a059-60be73707e60","query_id":"53","doc_a_id":"29495185","doc_b_id":"14241418","presented_order":["29495185","14241418"],"winner_id":"29495185","reasoning":"Document A is more relevant — it discusses molecular predictors of cancer prognosis (which would include markers like ALDH1), whereas Document B focuses on a PI3K/mTOR inhibitor and not prognosis markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011536Z"}
{"comparison_id":"ea7138af-a3c7-439e-9140-d17fb3a56d7b","query_id":"53","doc_a_id":"3684342","doc_b_id":"14241418","presented_order":["3684342","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses a therapy relevant to breast cancer (trastuzumab-resistant cells), whereas A is about lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011543Z"}
{"comparison_id":"f0d5b855-2130-4798-8c18-ce5ac4eee6a7","query_id":"53","doc_a_id":"4702639","doc_b_id":"14241418","presented_order":["14241418","4702639"],"winner_id":"4702639","reasoning":"Document B is more relevant — it addresses tumour stemness and stem-cell markers (related to ALDH1's role as a stemness/prognostic marker), whereas A focuses on PI3K/mTOR inhibition and PI3K-mutant cancers without discussing ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011549Z"}
{"comparison_id":"b8638fd8-b894-408c-b7fe-ab3fb31ecdf7","query_id":"53","doc_a_id":"1379127","doc_b_id":"14241418","presented_order":["1379127","14241418"],"winner_id":"1379127","reasoning":"Document A is more relevant — it addresses factors (tumor migration/metastasis) directly tied to breast cancer prognosis, whereas Document B focuses on a PI3K/mTOR inhibitor unrelated to ALDH1 or prognostic biomarkers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011556Z"}
{"comparison_id":"81f86878-9de6-46ce-ab49-ab4574047680","query_id":"53","doc_a_id":"24834968","doc_b_id":"14241418","presented_order":["24834968","14241418"],"winner_id":"24834968","reasoning":"Document A — it discusses biological markers in breast cancer (though not ALDH1 specifically), so it's more relevant than B which focuses on a PI3K/mTOR inhibitor unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011563Z"}
{"comparison_id":"bb88e860-4cbb-4eb3-bb8b-83d3f83aabf2","query_id":"53","doc_a_id":"39929509","doc_b_id":"14241418","presented_order":["14241418","39929509"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and pathways tied to prognosis/therapy, whereas B concerns WT1 binding in kidney cells and is unrelated to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011570Z"}
{"comparison_id":"289e0ee8-d73c-413e-b445-4918d8459e7b","query_id":"53","doc_a_id":"46617075","doc_b_id":"14241418","presented_order":["46617075","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer (including trastuzumab-resistant breast cancer contexts), so it's slightly more related than a lung-cancer–focused review. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011577Z"}
{"comparison_id":"dc09b724-cdaa-43ef-9f9f-b2ecd8ad8b8f","query_id":"53","doc_a_id":"31313782","doc_b_id":"14241418","presented_order":["14241418","31313782"],"winner_id":"14241418","reasoning":"Document A — it discusses cancer (including trastuzumab-resistant tumors, a breast cancer context); Document B is about lung disease. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011584Z"}
{"comparison_id":"e1aa33a7-ed5b-46c7-bc40-7b4772c3766d","query_id":"53","doc_a_id":"24144677","doc_b_id":"14241418","presented_order":["24144677","14241418"],"winner_id":"24144677","reasoning":"Document A is more relevant — it directly studies genetic associations with breast cancer (clinical risk/prognosis context), whereas Document B focuses on a PI3K/mTOR inhibitor and treatment mechanisms not related to ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011591Z"}
{"comparison_id":"037a8961-62e8-43f9-977f-0f715941a423","query_id":"53","doc_a_id":"67045088","doc_b_id":"14241418","presented_order":["14241418","67045088"],"winner_id":"67045088","reasoning":"Document B is more relevant — it specifically discusses mechanisms affecting tumor behavior in breast cancer, whereas A focuses on a PI3K/mTOR inhibitor and drug resistance. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011598Z"}
{"comparison_id":"0587e5eb-6c10-41cd-88b5-cdcb50338ed3","query_id":"53","doc_a_id":"14180565","doc_b_id":"14241418","presented_order":["14180565","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer therapy and trastuzumab-resistant (breast) cancer cells, whereas A concerns glioblastoma and neither mentions ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011605Z"}
{"comparison_id":"4be6b4d6-dc48-43a6-8dc0-74d383886346","query_id":"53","doc_a_id":"39758684","doc_b_id":"14241418","presented_order":["39758684","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant. It discusses cancer (including trastuzumab-resistant breast cancer) and therapeutic/prognostic implications, whereas A focuses on DNA polymerase beta–driven tumorigenesis without connection to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011613Z"}
{"comparison_id":"2266f361-4f38-45ea-a615-f47f61a2243b","query_id":"53","doc_a_id":"195680777","doc_b_id":"14241418","presented_order":["195680777","14241418"],"winner_id":"195680777","reasoning":"Document A is more relevant because it addresses breast cancer outcomes and prognosis, whereas Document B focuses on a PI3K/mTOR inhibitor and not on prognostic markers like ALDH1.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011620Z"}
{"comparison_id":"b8f66b76-3a9f-42ed-9229-337d73050791","query_id":"53","doc_a_id":"641786","doc_b_id":"14241418","presented_order":["641786","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and signaling pathways that could relate to prognosis, whereas Document A is about NT5C2 mutations in childhood ALL and is unrelated to breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011627Z"}
{"comparison_id":"905cb8d7-fdaf-4755-82c8-b71b7c221273","query_id":"53","doc_a_id":"15946643","doc_b_id":"14241418","presented_order":["14241418","15946643"],"winner_id":"15946643","reasoning":"Document B is more relevant — it addresses breast cancer chemoresistance and metastasis, which relate to prognosis, whereas Document A focuses on a PI3K/mTOR inhibitor without link to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011634Z"}
{"comparison_id":"5d59e2ce-d034-4359-81b9-963a815261ae","query_id":"53","doc_a_id":"33370","doc_b_id":"14241418","presented_order":["14241418","33370"],"winner_id":"14241418","reasoning":"Document A — mentions breast cancer context (trastuzumab resistance) making it more relevant to a claim about prognostic markers in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011641Z"}
{"comparison_id":"1fa10039-a398-4a8c-9e30-5fe6af4548f9","query_id":"53","doc_a_id":"31616203","doc_b_id":"14241418","presented_order":["14241418","31616203"],"winner_id":"31616203","reasoning":"Document B is more relevant — it reports clinical outcomes/prognosis in breast cancer patients, whereas Document A is a preclinical drug study without prognostic marker data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011648Z"}
{"comparison_id":"0142ffa6-422b-460c-a007-60b06dafa48b","query_id":"53","doc_a_id":"6550579","doc_b_id":"14241418","presented_order":["14241418","6550579"],"winner_id":"6550579","reasoning":"Neither document mentions ALDH1. Document B is marginally more relevant because it discusses biomarkers/targets and prognosis/therapy in breast cancer, whereas A focuses on a PI3K/mTOR inhibitor unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011655Z"}
{"comparison_id":"91c8ec87-2b56-432d-9d4f-3d7eeb188067","query_id":"53","doc_a_id":"27306942","doc_b_id":"14241418","presented_order":["14241418","27306942"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and tumor biology, whereas B focuses on pediatric leukemia unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011662Z"}
{"comparison_id":"446eec72-a19d-443e-b32e-dd5c7198b609","query_id":"53","doc_a_id":"3067015","doc_b_id":"14241418","presented_order":["3067015","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer (including trastuzumab-resistant breast cancer) and tumor behavior, while Document A addresses ALDH2 and blood pressure unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011669Z"}
{"comparison_id":"6dda680f-be74-45c4-92e6-5c07a0bf4734","query_id":"53","doc_a_id":"32852283","doc_b_id":"14241418","presented_order":["32852283","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and molecular markers/pathways, whereas A is about zoledronic acid in non-small-cell lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011676Z"}
{"comparison_id":"0072850e-ff85-4d22-9759-e55b7ebc8ef3","query_id":"53","doc_a_id":"878526","doc_b_id":"14241418","presented_order":["14241418","878526"],"winner_id":"878526","reasoning":"Document B — it directly concerns breast cancer metastasis and factors affecting metastatic initiation/prognosis, so it's more related to prognostic markers than A, which focuses on a PI3K/mTOR inhibitor. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011683Z"}
{"comparison_id":"58d6ff72-0122-4222-a637-7a2f5a833791","query_id":"53","doc_a_id":"23557241","doc_b_id":"14241418","presented_order":["14241418","23557241"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it discusses molecular markers and treatment effects in breast cancer, whereas Document B addresses birth-related risk factors rather than tumor markers or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011690Z"}
{"comparison_id":"24ce63fe-5f15-4426-b4d8-54763fd69331","query_id":"53","doc_a_id":"9211173","doc_b_id":"14241418","presented_order":["9211173","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer therapy including trastuzumab-resistant cells (breast cancer context), whereas Document A concerns ovarian carcinomas unrelated to ALDH1 or breast prognosis.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011696Z"}
{"comparison_id":"e78976f4-2ba7-4727-ae94-24a317cfdd7f","query_id":"53","doc_a_id":"22123421","doc_b_id":"14241418","presented_order":["22123421","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer (including trastuzumab-resistant breast cancer) and molecular markers/pathways relevant to prognosis and therapy, whereas A is about platelet ratios in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011704Z"}
{"comparison_id":"0547ecff-e686-4f82-988f-ab771ac84d83","query_id":"53","doc_a_id":"20738970","doc_b_id":"14241418","presented_order":["20738970","14241418"],"winner_id":"14241418","reasoning":"Document B is slightly more relevant because it discusses a therapy affecting breast cancer cells (trastuzumab-resistant), whereas A is about small cell lung cancer and unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011780Z"}
{"comparison_id":"4329f61d-6298-4a55-ad6c-1030199be646","query_id":"53","doc_a_id":"9394119","doc_b_id":"14241418","presented_order":["14241418","9394119"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it discusses molecular cancer signaling and treatment response, which is closer to studies on tumor markers and prognosis than a genetic risk-mutation study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011801Z"}
{"comparison_id":"503b2159-ffb8-4339-a5e8-cbb39e73510a","query_id":"53","doc_a_id":"3210545","doc_b_id":"14241418","presented_order":["14241418","3210545"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses breast cancer (trastuzumab resistance), whereas B concerns KRAS in endometrial cancer and is unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011815Z"}
{"comparison_id":"8e0ab918-8d1e-40b7-a1ca-cbb678903aef","query_id":"53","doc_a_id":"22007333","doc_b_id":"14241418","presented_order":["14241418","22007333"],"winner_id":"14241418","reasoning":"Document A is marginally more relevant because it discusses cancer biology and treatments (breast cancer context) rather than unrelated mammographic density/reproductive factors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011825Z"}
{"comparison_id":"0435f61c-f40a-44f7-9e7f-dc22670dd7de","query_id":"53","doc_a_id":"23284774","doc_b_id":"14241418","presented_order":["14241418","23284774"],"winner_id":"14241418","reasoning":"Document A is more relevant — it addresses molecular and treatment-related aspects of breast cancer (closer to biomarker/prognosis discussions), whereas B covers psychosocial issues unrelated to ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011834Z"}
{"comparison_id":"f2a0ebe1-5e20-456f-b7f9-ec6a5201f201","query_id":"53","doc_a_id":"6121668","doc_b_id":"14241418","presented_order":["14241418","6121668"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses breast cancer–related signaling and therapy (trastuzumab resistance), whereas B concerns endometrial carcinoma unrelated to ALDH1 or breast cancer.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011845Z"}
{"comparison_id":"32d986f2-f889-4b5f-af15-27bb820cb0e5","query_id":"53","doc_a_id":"23863551","doc_b_id":"14241418","presented_order":["14241418","23863551"],"winner_id":"23863551","reasoning":"Both documents are unrelated to ALDH1, but B is slightly more relevant because it discusses factors (feedback HER3 upregulation) that affect therapeutic response and outcomes in breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011854Z"}
{"comparison_id":"cdd4545d-9546-42e8-8605-d36e194532cf","query_id":"53","doc_a_id":"23509593","doc_b_id":"14241418","presented_order":["23509593","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer therapies including trastuzumab-resistant (HER2+) tumors, whereas A concerns prostate stromal cells and STIM1, unrelated to breast cancer or ALDH1.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011863Z"}
{"comparison_id":"8cb23dff-4830-4a56-8977-4208b00aa67c","query_id":"53","doc_a_id":"26079071","doc_b_id":"14241418","presented_order":["26079071","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses pathways and treatments tied to breast cancer (mentions trastuzumab resistance), whereas Document A concerns ROS1-rearranged non-small-cell lung cancer and is unrelated to ALDH1 in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011873Z"}
{"comparison_id":"b68e7741-fd36-481e-a149-e4bf4cf0cc3d","query_id":"53","doc_a_id":"9285396","doc_b_id":"14241418","presented_order":["9285396","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer signaling and drug response in (including) breast cancer contexts (trastuzumab resistance), whereas A is about gastric cancer RDW and unrelated to ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011883Z"}
{"comparison_id":"beced706-9e23-45db-b109-7f24203a9d7b","query_id":"53","doc_a_id":"5386514","doc_b_id":"14241418","presented_order":["14241418","5386514"],"winner_id":"14241418","reasoning":"Document A — mentions breast cancer (trastuzumab resistance) and tumor cell growth, while B focuses on inflammasome-driven immunity without link to ALDH1 or breast prognosis.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011892Z"}
{"comparison_id":"5fb47217-0b43-47b0-9a22-bf92c674360c","query_id":"53","doc_a_id":"20183360","doc_b_id":"14241418","presented_order":["20183360","14241418"],"winner_id":"20183360","reasoning":"Document A is more relevant — it addresses molecular drivers of breast cancer invasiveness and progression, which is closer to prognosis-related markers than the PI3K inhibitor study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011902Z"}
{"comparison_id":"cacce1f6-a14f-43f1-bdaf-ac4d15297d23","query_id":"53","doc_a_id":"3710557","doc_b_id":"14241418","presented_order":["14241418","3710557"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it discusses cancer signaling and resistance relevant to breast cancer contexts (trastuzumab), whereas Document B is about liver-specific β-catenin biology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011912Z"}
{"comparison_id":"2b88fcd5-d802-41bf-9f23-a6298dbabc39","query_id":"53","doc_a_id":"14664424","doc_b_id":"14241418","presented_order":["14241418","14664424"],"winner_id":"14241418","reasoning":"Document A is more relevant because it discusses cancer (including trastuzumab-resistant/HER2+ contexts likely breast cancer) and prognostic treatment pathways, whereas B concerns cervical cancer markers unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011924Z"}
{"comparison_id":"1b77334a-2047-4756-8185-c51bec6fc78a","query_id":"53","doc_a_id":"13765757","doc_b_id":"14241418","presented_order":["13765757","14241418"],"winner_id":"13765757","reasoning":"Document A is more relevant — it addresses breast cancer risk and tumor characteristics, which is closer to prognosis-related information than Document B's focus on a PI3K/mTOR inhibitor.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011933Z"}
{"comparison_id":"3e1a69d1-5eb6-4af0-9c8c-6fc449a17e7b","query_id":"53","doc_a_id":"7875158","doc_b_id":"14241418","presented_order":["14241418","7875158"],"winner_id":"7875158","reasoning":"Document B is more relevant — it studies multidrug-resistant breast cancer cells (MCF-7/ADR) and mechanisms of resistance, which is closer to ALDH1's role in chemoresistance and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011942Z"}
{"comparison_id":"fce458d5-2d38-4304-b689-1ba9c2118004","query_id":"53","doc_a_id":"3222187","doc_b_id":"14241418","presented_order":["3222187","14241418"],"winner_id":"3222187","reasoning":"Neither abstract addresses ALDH1 or prognosis; Document A is slightly more relevant because it stems from a breast cancer cohort (more likely to include prognostic analyses). \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011949Z"}
{"comparison_id":"55cb3d4c-b5a5-4008-9482-d4e668712aa3","query_id":"53","doc_a_id":"20754359","doc_b_id":"14241418","presented_order":["20754359","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer signaling and therapies including contexts (trastuzumab resistance) related to breast cancer, whereas A focuses on adult T‑cell leukemia/lymphoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011956Z"}
{"comparison_id":"a292278a-aaa0-46d7-bd0a-5d75f130a778","query_id":"53","doc_a_id":"53211308","doc_b_id":"14241418","presented_order":["53211308","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer signaling and mentions trastuzumab-resistant cells (breast cancer context), whereas A focuses on ovarian cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011964Z"}
{"comparison_id":"9087fbf7-ab62-480a-8784-18a25811d1cf","query_id":"53","doc_a_id":"2015126","doc_b_id":"14241418","presented_order":["2015126","14241418"],"winner_id":"2015126","reasoning":"Neither abstract addresses ALDH1 or its prognostic value; however, Document A discusses breast cancer management generally, so it's marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011970Z"}
{"comparison_id":"1cc12c15-1636-476b-8922-a3e63383149b","query_id":"53","doc_a_id":"3355397","doc_b_id":"14241418","presented_order":["3355397","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses mechanisms and therapies for cancer cells (including trastuzumab-resistant breast cancer), which is closer to prognostic markers in breast cancer than an epidemiologic study of pioglitazone and bladder/prostate/pancreatic cancers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011982Z"}
{"comparison_id":"54cc2082-3f40-4688-8c6a-2672334edc18","query_id":"53","doc_a_id":"25628793","doc_b_id":"14241418","presented_order":["25628793","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer (including trastuzumab-resistant tumors, i.e., breast cancer contexts) and pathways tied to prognosis, whereas Document A concerns endometriosis/ovarian lesions and is unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011990Z"}
{"comparison_id":"9aec0d06-4e08-462e-828f-43f213723524","query_id":"53","doc_a_id":"36212758","doc_b_id":"14241418","presented_order":["14241418","36212758"],"winner_id":"14241418","reasoning":"Document A — it discusses breast cancer–relevant therapy (trastuzumab resistance/PI3K pathway), so is more likely to address markers and prognosis in breast cancer than Document B, which concerns lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.011998Z"}
{"comparison_id":"87691f01-85ec-4211-9f2d-cf153e4526a8","query_id":"53","doc_a_id":"17462437","doc_b_id":"14241418","presented_order":["14241418","17462437"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses breast cancer-related signaling and therapy context (trastuzumab resistance), whereas Document B is about KRAS in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012006Z"}
{"comparison_id":"0dc79f3d-acf6-4a1f-9384-ad5d11fc2610","query_id":"53","doc_a_id":"2360905","doc_b_id":"14241418","presented_order":["14241418","2360905"],"winner_id":"14241418","reasoning":"Document A discusses cancer (including trastuzumab-resistant breast cancer) and treatment pathways, making it more related to breast cancer prognostic markers than pediatric glioma findings.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012014Z"}
{"comparison_id":"8f81f2b6-c15f-47d6-b116-0d3527b15fd5","query_id":"53","doc_a_id":"16346504","doc_b_id":"14241418","presented_order":["14241418","16346504"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses therapies and pathways in cancers including trastuzumab-resistant (HER2+) breast cancer, whereas Document B addresses endometrial cancer unrelated to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012022Z"}
{"comparison_id":"785ce229-3bbf-495a-907f-98a4758a1e8b","query_id":"53","doc_a_id":"16390264","doc_b_id":"14241418","presented_order":["14241418","16390264"],"winner_id":"16390264","reasoning":"Neither paper mentions ALDH1; Document B is slightly more relevant because it concerns breast cancer prognosis/outcomes, while A focuses on a PI3K/mTOR inhibitor. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012028Z"}
{"comparison_id":"debc5556-d396-4feb-bb9e-3b3db76f235d","query_id":"53","doc_a_id":"20645538","doc_b_id":"14241418","presented_order":["14241418","20645538"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer signaling and treatment resistance related to breast cancer (trastuzumab), whereas B is about pleural effusion in lung cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012036Z"}
{"comparison_id":"a880c5a7-da01-45c6-9546-a57c971f4fee","query_id":"53","doc_a_id":"33638477","doc_b_id":"14241418","presented_order":["33638477","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer treatment in the context of trastuzumab resistance (breast cancer), whereas A addresses BCL9 in other cancers and doesn't relate to breast cancer prognosis or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012043Z"}
{"comparison_id":"a3fd5485-9528-4cee-80c2-e401cc1786ec","query_id":"53","doc_a_id":"3805841","doc_b_id":"14241418","presented_order":["14241418","3805841"],"winner_id":"14241418","reasoning":"Document A is more related to breast cancer (mentions trastuzumab resistance and PI3K-driven tumor growth); Document B focuses on MYC and neuroblastoma. Neither mentions ALDH1, but A is closer to the query topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012049Z"}
{"comparison_id":"7a146ec1-7877-4d69-ba40-84156259700e","query_id":"53","doc_a_id":"14663842","doc_b_id":"14241418","presented_order":["14241418","14663842"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it discusses cancer (including trastuzumab-resistant breast cancer context); Document B focuses on IDH1 metabolic changes unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012057Z"}
{"comparison_id":"e5d3d3ce-a726-4fc6-a0f7-1792ef46d0b4","query_id":"53","doc_a_id":"4841908","doc_b_id":"14241418","presented_order":["14241418","4841908"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer signaling and treatment in contexts including trastuzumab-resistant breast cancer, whereas Document B focuses on metabolomics and longevity with no cancer relevance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012064Z"}
{"comparison_id":"19a1a4cd-fb6c-4bd4-9762-ea16fad48f99","query_id":"53","doc_a_id":"17163294","doc_b_id":"14241418","presented_order":["17163294","14241418"],"winner_id":"17163294","reasoning":"Document A is more relevant because it specifically addresses breast cancer (where prognosis markers like ALDH1 would apply), while Document B focuses on a PI3K/mTOR inhibitor and not on ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012071Z"}
{"comparison_id":"a5887f04-d836-4e04-9909-311c4ae9c04f","query_id":"53","doc_a_id":"26848994","doc_b_id":"14241418","presented_order":["14241418","26848994"],"winner_id":"14241418","reasoning":"Document A is more relevant — it addresses breast cancer (trastuzumab resistance), whereas Document B concerns hepatocellular carcinoma; neither mentions ALDH1 or prognosis directly.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012078Z"}
{"comparison_id":"c51bcfa1-9058-4ade-898b-efe7a56da9af","query_id":"53","doc_a_id":"14938990","doc_b_id":"14241418","presented_order":["14241418","14938990"],"winner_id":"14241418","reasoning":"Document A — it discusses cancer therapeutics and trastuzumab-resistant (breast) cancer contexts, so it's more related to breast cancer prognosis than the SLE-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012085Z"}
{"comparison_id":"e4b6667b-9a84-4ee7-95bd-7014cbccd91a","query_id":"53","doc_a_id":"32534305","doc_b_id":"14241418","presented_order":["32534305","14241418"],"winner_id":"14241418","reasoning":"Neither abstract mentions ALDH1. Document B is marginally more relevant because it addresses molecular cancer pathways and treatment resistance (which relate to prognosis), whereas A focuses on diabetes and breast cancer incidence. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012092Z"}
{"comparison_id":"8186a988-3dad-4f6f-a105-335ce3405984","query_id":"53","doc_a_id":"1780819","doc_b_id":"14241418","presented_order":["1780819","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer therapy in contexts including trastuzumab-resistant (HER2+) breast cancer, while A is about HAND2 methylation in endometrial cancer; neither mentions ALDH1 but B is closer to the breast cancer topic.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012841Z"}
{"comparison_id":"0e54a5e1-cace-48b3-abba-ea7ea3028949","query_id":"53","doc_a_id":"26902591","doc_b_id":"14241418","presented_order":["26902591","14241418"],"winner_id":"14241418","reasoning":"Document B is slightly more relevant because it discusses cancer (including trastuzumab-resistant breast cancer) and molecular markers/pathways related to prognosis and therapy, whereas Document A focuses on adipose browning/cachexia. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012850Z"}
{"comparison_id":"97860914-3e60-4932-8de5-b4ce9e7f9283","query_id":"53","doc_a_id":"34066665","doc_b_id":"14241418","presented_order":["34066665","14241418"],"winner_id":"34066665","reasoning":"Doc A is more relevant because it reviews molecular markers and clinical outcomes in breast cancer (therapy resistance/prognosis), whereas Doc B focuses on a specific PI3K/mTOR inhibitor and cell growth. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012857Z"}
{"comparison_id":"ba3b7eb5-bdd0-4631-958b-3d0683d2f245","query_id":"53","doc_a_id":"19368793","doc_b_id":"14241418","presented_order":["19368793","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer (including trastuzumab-resistant breast cancer) and tumor biology, whereas Document A is about miRNAs in hepatocellular carcinoma and not breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012864Z"}
{"comparison_id":"c61158dd-df80-4abe-8d1f-565c49be7c0c","query_id":"53","doc_a_id":"5487448","doc_b_id":"14241418","presented_order":["14241418","5487448"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it discusses tumor biology and treatment resistance in breast cancer, whereas Document B concerns birth weight and mammographic density (risk), not tumor markers or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012871Z"}
{"comparison_id":"402dc1b3-3837-4c7a-8098-1af00fab0ae9","query_id":"53","doc_a_id":"12438901","doc_b_id":"14241418","presented_order":["14241418","12438901"],"winner_id":"12438901","reasoning":"Document B is more relevant because it addresses breast cancer prognosis and long-term outcomes, whereas A focuses on a PI3K/mTOR inhibitor mechanism without discussing prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012878Z"}
{"comparison_id":"69f619cb-6c93-4e46-a960-e336c28a49ca","query_id":"53","doc_a_id":"3524352","doc_b_id":"14241418","presented_order":["3524352","14241418"],"winner_id":"3524352","reasoning":"Document A is more relevant — it concerns breast cancer mortality/prognosis (though it doesn't mention ALDH1), whereas B focuses on a PI3K/mTOR inhibitor and PI3K-mutant cancer cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012885Z"}
{"comparison_id":"bea53c20-1bd0-4621-815e-654bdaff7758","query_id":"53","doc_a_id":"16180601","doc_b_id":"14241418","presented_order":["16180601","14241418"],"winner_id":"14241418","reasoning":"Document B — it concerns cancer biology and therapies (including breast cancer contexts), whereas A is about stroke prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012891Z"}
{"comparison_id":"a6518b62-945d-4af5-9fb3-e631144518d4","query_id":"53","doc_a_id":"4959368","doc_b_id":"14241418","presented_order":["4959368","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer (including trastuzumab-resistant breast cancer cells), whereas A addresses pancreatic cancer unrelated to ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012898Z"}
{"comparison_id":"a8602e01-8b49-4c5d-bdf5-24f5b68c9892","query_id":"53","doc_a_id":"16691520","doc_b_id":"14241418","presented_order":["14241418","16691520"],"winner_id":"16691520","reasoning":"Document B is more relevant — it addresses genome-wide gene regulation in breast cancer (more likely to include biomarkers like ALDH1), whereas A focuses on a PI3K/mTOR inhibitor unrelated to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012905Z"}
{"comparison_id":"68c8330e-8707-4091-8e33-83805f53326f","query_id":"53","doc_a_id":"38485364","doc_b_id":"14241418","presented_order":["14241418","38485364"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it mentions trastuzumab resistance, which relates to breast cancer, while Document B focuses on podosome formation and invasion without breast cancer context.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012912Z"}
{"comparison_id":"f3fb9a76-11f8-46c9-a1d0-19d642dbde69","query_id":"53","doc_a_id":"3376731","doc_b_id":"14241418","presented_order":["14241418","3376731"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses mechanisms and treatment resistance in cancer contexts related to breast cancer (trastuzumab resistance), whereas Document B concerns esophageal cancer and unrelated pathways.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012919Z"}
{"comparison_id":"21e7b9f8-d65e-4142-aa26-f6a2a00e6a57","query_id":"53","doc_a_id":"7228140","doc_b_id":"14241418","presented_order":["7228140","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer (including trastuzumab-resistant breast cancer contexts), whereas A is about pancreatic ductal adenocarcinoma and not breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012926Z"}
{"comparison_id":"5f4ee633-34f9-41d2-ad3d-2fe40e50e567","query_id":"53","doc_a_id":"5278233","doc_b_id":"14241418","presented_order":["14241418","5278233"],"winner_id":"14241418","reasoning":"Document A is more relevant because it concerns cancer signaling and treatment (including trastuzumab-resistant breast cancer), whereas Document B discusses imprinting in Beckwith-Wiedemann syndrome, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012932Z"}
{"comparison_id":"fa4816dd-af28-47dc-bdf1-9ec1c6a15d90","query_id":"53","doc_a_id":"29806339","doc_b_id":"14241418","presented_order":["14241418","29806339"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it mentions breast cancer (trastuzumab resistance), whereas B discusses general mitotic exit without breast-cancer context.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012939Z"}
{"comparison_id":"d51c0668-3ac2-405e-8500-857b6c3f0f4a","query_id":"53","doc_a_id":"13768432","doc_b_id":"14241418","presented_order":["14241418","13768432"],"winner_id":"14241418","reasoning":"Document A is cancer-related (mentions trastuzumab-resistant cancer cells relevant to breast cancer), while Document B is about cardiac amyloidosis and unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012946Z"}
{"comparison_id":"db42e6e4-c55e-43b5-b684-5e628727ea98","query_id":"53","doc_a_id":"13205096","doc_b_id":"14241418","presented_order":["13205096","14241418"],"winner_id":"14241418","reasoning":"Document B — it concerns cancer therapy including trastuzumab-resistant (breast) cancer, whereas Document A is about AML and not breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012953Z"}
{"comparison_id":"56a35ed6-ee6d-41cf-9f46-bfa8c72acc3b","query_id":"53","doc_a_id":"36432234","doc_b_id":"14241418","presented_order":["14241418","36432234"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer growth and therapy resistance pathways tied to outcomes, whereas B only describes estrogenic stimulation without prognostic implications.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012960Z"}
{"comparison_id":"bbdcd9c6-91d9-49a8-a819-4781a4ae1064","query_id":"53","doc_a_id":"85665741","doc_b_id":"14241418","presented_order":["14241418","85665741"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it discusses cancer (including trastuzumab-resistant cases, i.e., breast cancer context), whereas B is about BRAF in NSCLC and unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012967Z"}
{"comparison_id":"4d0712e5-112d-41c9-bf6a-29c9f83a5dd3","query_id":"53","doc_a_id":"831167","doc_b_id":"14241418","presented_order":["14241418","831167"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer signaling and trastuzumab-resistant (HER2+) contexts related to breast cancer, whereas Document B focuses on glioblastoma (a different cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012973Z"}
{"comparison_id":"2025285c-8fce-472f-b12b-0a4e2754ddd5","query_id":"53","doc_a_id":"11880289","doc_b_id":"14241418","presented_order":["14241418","11880289"],"winner_id":"11880289","reasoning":"Document B is more relevant — it concerns breast cancer mortality/prognosis, whereas Document A discusses a targeted inhibitor and not prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012980Z"}
{"comparison_id":"2e7f6499-bdef-491a-a263-dac0faa84a42","query_id":"53","doc_a_id":"26488879","doc_b_id":"14241418","presented_order":["26488879","14241418"],"winner_id":"14241418","reasoning":"Document B is slightly more relevant because it concerns cancer biology and therapies (including trastuzumab-resistant cells relevant to breast cancer), whereas Document A is about H. pylori and gastric inflammation. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012987Z"}
{"comparison_id":"ce59d65e-3b44-43e6-9be5-7df856ed30f8","query_id":"53","doc_a_id":"9558539","doc_b_id":"14241418","presented_order":["9558539","14241418"],"winner_id":"9558539","reasoning":"Document A is more related because it discusses cancer stem cell markers and metastasis (closer to marker–prognosis associations) while B focuses on a PI3K/mTOR inhibitor. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.012994Z"}
{"comparison_id":"1a3bfd78-494c-4c52-a876-5f5f2743d20b","query_id":"53","doc_a_id":"13519661","doc_b_id":"14241418","presented_order":["14241418","13519661"],"winner_id":"13519661","reasoning":"Neither document addresses ALDH1 or its prognostic significance; both are irrelevant. Document B is slightly more relevant because it directly concerns breast cancer (genetic risk), whereas A focuses on a PI3K/mTOR inhibitor mechanism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013001Z"}
{"comparison_id":"4215da8f-d5ae-4a24-a5bc-37d5cbc9336c","query_id":"53","doc_a_id":"38784540","doc_b_id":"14241418","presented_order":["14241418","38784540"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses molecular cancer signaling and treatment implications tied to tumor behavior and outcomes, which is closer to prognosis than life-course breast density factors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013008Z"}
{"comparison_id":"7b8989ab-3498-4c09-a17d-42fa1bcbe555","query_id":"53","doc_a_id":"6363093","doc_b_id":"14241418","presented_order":["6363093","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and therapeutic implications, whereas A is about glioblastoma and unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013014Z"}
{"comparison_id":"f3f25430-107a-4164-be5a-a0e798af2706","query_id":"53","doc_a_id":"33677323","doc_b_id":"14241418","presented_order":["33677323","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses a therapy affecting breast cancer cells (including trastuzumab-resistant cases), whereas A focuses on hematopoietic malignancies unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013022Z"}
{"comparison_id":"0f3fe41f-946f-41fa-8110-7a7a4e62ba53","query_id":"53","doc_a_id":"4500832","doc_b_id":"14241418","presented_order":["4500832","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer therapies and trastuzumab-resistant cells (breast cancer context), whereas A is about vitamin E unrelated to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013028Z"}
{"comparison_id":"b3da7ebc-70a7-4e99-9040-85e40db97a45","query_id":"53","doc_a_id":"4387494","doc_b_id":"14241418","presented_order":["4387494","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer cell growth and resistance in contexts that include breast cancer (trastuzumab-resistant cells), whereas Document A focuses on acute myeloid leukemia. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013034Z"}
{"comparison_id":"dca679b5-92a1-4fba-9657-fb36e42e200e","query_id":"53","doc_a_id":"11900630","doc_b_id":"14241418","presented_order":["11900630","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses a cancer therapy affecting breast cancer cells (trastuzumab-resistant), whereas A concerns bcl-2 in hematopoietic cells, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013041Z"}
{"comparison_id":"f174d5da-8b8a-43cd-8ebc-70c3041a94ea","query_id":"53","doc_a_id":"20333864","doc_b_id":"14241418","presented_order":["20333864","14241418"],"winner_id":"20333864","reasoning":"Document A is more relevant — it addresses mechanisms of breast cancer progression and tumor microenvironment, which relate to prognosis; Document B focuses on a targeted therapy unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013047Z"}
{"comparison_id":"a5b2694e-b5e7-4dd3-a3be-b9245e664e87","query_id":"53","doc_a_id":"15600979","doc_b_id":"14241418","presented_order":["14241418","15600979"],"winner_id":"15600979","reasoning":"Document B is more focused on breast cancer biology (BRCA2/EMSY) and implications for cancer outcomes, whereas A discusses a PI3K/mTOR inhibitor and drug resistance without addressing biomarkers or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013053Z"}
{"comparison_id":"7a00e3d9-74c7-46c8-a659-27dadee2e363","query_id":"53","doc_a_id":"41790911","doc_b_id":"14241418","presented_order":["14241418","41790911"],"winner_id":"14241418","reasoning":"Reason: Document A discusses cancer therapeutics and trastuzumab-resistant cancer cells (relevant to breast cancer), while Document B concerns adipose angiogenesis in obesity and is unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013060Z"}
{"comparison_id":"f7ff0cec-0879-4dcb-97c0-4e938df0aa63","query_id":"53","doc_a_id":"42150015","doc_b_id":"14241418","presented_order":["42150015","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including breast cancer) biology and treatments, whereas Document A concerns anti-Müllerian hormone in a general reproductive study and is unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013066Z"}
{"comparison_id":"e02edffa-3e63-445a-a45c-e1338bdc9fcc","query_id":"53","doc_a_id":"23269537","doc_b_id":"14241418","presented_order":["23269537","14241418"],"winner_id":"14241418","reasoning":"Document B is slightly more relevant because it discusses therapy for cancers (including trastuzumab-resistant breast cancer), whereas Document A focuses on cyclin D1 in B-cell malignancies and not breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013072Z"}
{"comparison_id":"16a1c70d-7f4f-4569-a52a-e142a62eecda","query_id":"53","doc_a_id":"13905670","doc_b_id":"14241418","presented_order":["13905670","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer (including trastuzumab-resistant breast cancer), while A discusses a FOXO3 SNP in inflammatory/infectious diseases unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013079Z"}
{"comparison_id":"e73b184a-569b-4adc-9bbf-b2db8e4fa779","query_id":"53","doc_a_id":"25488034","doc_b_id":"14241418","presented_order":["14241418","25488034"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer (including breast cancer contexts and therapy resistance), whereas B focuses on glutathione/oxidative stress without addressing ALDH1 or breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013085Z"}
{"comparison_id":"c23091d5-98bc-42b5-b711-c2b2882a1dfa","query_id":"53","doc_a_id":"9171913","doc_b_id":"14241418","presented_order":["14241418","9171913"],"winner_id":"14241418","reasoning":"Neither document mentions ALDH1. Document A is marginally more relevant because it concerns tumor biology and treatment outcomes, while B addresses blood lipids and cancer risk, not prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013091Z"}
{"comparison_id":"11d38923-9123-48d2-9707-b648859fdbdc","query_id":"53","doc_a_id":"21551568","doc_b_id":"14241418","presented_order":["21551568","14241418"],"winner_id":"14241418","reasoning":"Neither document mentions ALDH1 or breast‑cancer prognosis, but Document B touches on therapies relevant to breast cancer (trastuzumab-resistant cases), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013097Z"}
{"comparison_id":"f05952ff-f812-4894-b2a2-5afecf61a634","query_id":"53","doc_a_id":"9095394","doc_b_id":"14241418","presented_order":["9095394","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and signaling related to tumor behavior, while A concerns keratin expression in oral squamous neoplasms, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013104Z"}
{"comparison_id":"f5a1e649-4c7b-474e-963c-d6cd5ee23e43","query_id":"53","doc_a_id":"7028976","doc_b_id":"14241418","presented_order":["14241418","7028976"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses breast cancer contexts (trastuzumab resistance/PI3K pathway), whereas B is about EGFR in glioblastoma and unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013110Z"}
{"comparison_id":"1d84b056-8337-4590-b3b5-dfc30d986ca4","query_id":"53","doc_a_id":"2014909","doc_b_id":"14241418","presented_order":["14241418","2014909"],"winner_id":"2014909","reasoning":"Document B — it discusses tumor-initiating cells and analyses of primary breast cancers (where ALDH1, a stem cell marker, is relevant to prognosis). \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013116Z"}
{"comparison_id":"0e8582c4-a6d1-41f6-881e-1822568d7c59","query_id":"53","doc_a_id":"46602807","doc_b_id":"14241418","presented_order":["46602807","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer biology and targeted therapy in breast cancer contexts (trastuzumab resistance), whereas A is about antibiotic synergy unrelated to cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013122Z"}
{"comparison_id":"ebb1dd25-a264-44e4-9fcf-a6354f65693c","query_id":"53","doc_a_id":"6969753","doc_b_id":"14241418","presented_order":["14241418","6969753"],"winner_id":"6969753","reasoning":"Document B is more relevant — it deals with mechanisms of tumor invasiveness and metastasis, which relate to prognosis, whereas Document A focuses on a targeted inhibitor and PI3K signaling without addressing prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013129Z"}
{"comparison_id":"73debfbb-29db-4658-a199-c09447050645","query_id":"53","doc_a_id":"11968641","doc_b_id":"14241418","presented_order":["14241418","11968641"],"winner_id":"14241418","reasoning":"Document A is more related—it discusses therapies relevant to breast cancer (trastuzumab resistance/HER2 context), whereas B covers melanoma and colon carcinoma; neither mentions ALDH1 but A is closer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013136Z"}
{"comparison_id":"c181d875-a73e-4d69-8223-a022fa9de1eb","query_id":"53","doc_a_id":"7808055","doc_b_id":"14241418","presented_order":["7808055","14241418"],"winner_id":"7808055","reasoning":"Document A is slightly more relevant because it mentions cancer-related changes (age acceleration) broadly; neither document discusses ALDH1 or breast cancer prognosis specifically. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013142Z"}
{"comparison_id":"8b82db3c-5bdf-425e-b9ba-d1a550224aad","query_id":"53","doc_a_id":"663464","doc_b_id":"14241418","presented_order":["14241418","663464"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns cancer biology and treatments including trastuzumab-resistant (breast) cancer contexts, whereas Document B is an aging/microRNA study unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013148Z"}
{"comparison_id":"2c7fe0ac-6874-4981-a2d1-190109ba3fba","query_id":"53","doc_a_id":"26735905","doc_b_id":"14241418","presented_order":["26735905","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer therapy including trastuzumab-resistant (HER2+) breast cancers, whereas A focuses on prostate stromal fibroblasts and not breast cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013154Z"}
{"comparison_id":"4accbf85-798d-4ec5-b771-e8c242d20170","query_id":"53","doc_a_id":"23934390","doc_b_id":"14241418","presented_order":["23934390","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer therapy in the context of trastuzumab-resistant (HER2+) tumors, which is closer to breast cancer prognosis than Document A (NSCLC). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013160Z"}
{"comparison_id":"9a516d21-e85d-4b7b-9c9e-ed18853599e4","query_id":"53","doc_a_id":"2494748","doc_b_id":"14241418","presented_order":["2494748","14241418"],"winner_id":"14241418","reasoning":"Document B — it relates to breast cancer therapy (trastuzumab resistance) and PI3K pathway activity, whereas A concerns methylation in gastric carcinoma and is unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013166Z"}
{"comparison_id":"252cc0bb-7768-4c61-8e81-80a01e7a64a2","query_id":"53","doc_a_id":"16016673","doc_b_id":"14241418","presented_order":["14241418","16016673"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns cancer (including trastuzumab-resistant breast cancer), whereas Document B is about bladder cancer detection and unrelated to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013172Z"}
{"comparison_id":"355cf6c3-e8de-4647-a512-e2c0a0ee3b27","query_id":"53","doc_a_id":"1976183","doc_b_id":"14241418","presented_order":["14241418","1976183"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it discusses cancer biology and treatments in contexts (trastuzumab resistance/PI3K pathway) that include breast cancer, whereas Document B is about oral cancer and microRNA with no connection to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013179Z"}
{"comparison_id":"90c7e57e-f299-4d2c-8e15-3d63d050d5d0","query_id":"53","doc_a_id":"33030946","doc_b_id":"14241418","presented_order":["14241418","33030946"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns cancer signaling and treatment (mentions trastuzumab-resistant cells relevant to breast cancer), whereas B covers macrophage/osteoclast biology unrelated to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013186Z"}
{"comparison_id":"f4eed102-9da0-4c6c-bb7f-23730e2e3bc9","query_id":"53","doc_a_id":"13400643","doc_b_id":"14241418","presented_order":["13400643","14241418"],"winner_id":"14241418","reasoning":"Reason: Neither abstract mentions ALDH1, but B references trastuzumab-resistant cancer (breast cancer context), making it slightly more relevant to a breast cancer prognosis claim.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013194Z"}
{"comparison_id":"594d6739-097f-4ced-93a5-d6279cd56cdb","query_id":"53","doc_a_id":"22901758","doc_b_id":"14241418","presented_order":["14241418","22901758"],"winner_id":"14241418","reasoning":"Document A — it discusses cancer signaling and drug effects relevant to breast cancer (mentions trastuzumab resistance), whereas B is about glioblastoma; neither mentions ALDH1, but A is closer to the query. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013200Z"}
{"comparison_id":"bfcbdd21-83b0-4872-964b-e956dfe130e4","query_id":"53","doc_a_id":"17876040","doc_b_id":"14241418","presented_order":["17876040","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses PI3K/mTOR signaling and trastuzumab-resistant cancer cells (breast cancer context), whereas A focuses on AML therapy. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013206Z"}
{"comparison_id":"74880ad8-4955-4fcb-b90b-b2f57942e536","query_id":"53","doc_a_id":"3756384","doc_b_id":"14241418","presented_order":["3756384","14241418"],"winner_id":"3756384","reasoning":"Document A is more relevant — it links a cancer stem cell–like gene signature (which includes stem cell markers such as ALDH1) to poorer prognosis, whereas Document B concerns a PI3K/mTOR inhibitor and not ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013212Z"}
{"comparison_id":"44da91e0-8f13-46bb-9777-2ada904d7d3c","query_id":"53","doc_a_id":"23078022","doc_b_id":"14241418","presented_order":["23078022","14241418"],"winner_id":"14241418","reasoning":"Neither document mentions ALDH1 or directly addresses prognosis. Document B is slightly more relevant because it discusses breast cancer–related therapy resistance (trastuzumab) and tumor growth pathways, which relate more to clinical outcomes than the molecular signaling focus of A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013219Z"}
{"comparison_id":"dd44b273-c0a8-4ff7-94a1-14edc25e8c0b","query_id":"53","doc_a_id":"14315749","doc_b_id":"14241418","presented_order":["14315749","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses a therapy affecting pathways and resistance mechanisms in breast cancer (trastuzumab-resistant cells), whereas A is about colorectal cancer and a different gene. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013225Z"}
{"comparison_id":"e3ee9e7d-f666-4bd4-965e-0c6c87e2e1c3","query_id":"53","doc_a_id":"4583180","doc_b_id":"14241418","presented_order":["14241418","4583180"],"winner_id":"4583180","reasoning":"Document B — it discusses a molecular pathway linked to tumor progression and reduced patient survival (prognosis), whereas A focuses on a PI3K/mTOR inhibitor without addressing prognosis or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013232Z"}
{"comparison_id":"2749a5cd-df51-4d56-85b7-4d08063969bf","query_id":"53","doc_a_id":"4729644","doc_b_id":"14241418","presented_order":["14241418","4729644"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer treatment in a breast cancer context (trastuzumab resistance), whereas Document B is about nasopharyngeal carcinoma unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013238Z"}
{"comparison_id":"cbb43f56-f3a4-42bb-8d56-9414642bcfc8","query_id":"53","doc_a_id":"38355793","doc_b_id":"14241418","presented_order":["38355793","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer (including trastuzumab-resistant breast cancer contexts), while A is about glioma and unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013245Z"}
{"comparison_id":"8cb18a3f-4fc0-494c-87e5-42685ac596fe","query_id":"53","doc_a_id":"7020505","doc_b_id":"14241418","presented_order":["14241418","7020505"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses breast cancer-related molecular signaling and therapy, whereas Document B focuses on chronic lymphocytic leukemia and is unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013251Z"}
{"comparison_id":"e01287c0-5c76-4998-8986-c1c7f4cd89ca","query_id":"53","doc_a_id":"12903921","doc_b_id":"14241418","presented_order":["14241418","12903921"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns cancer signaling and trastuzumab-resistant (breast) cancer, whereas B studies leukemia in rats and is unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013257Z"}
{"comparison_id":"cc0e510d-5621-4ee2-8e3a-0eb1e972b8d3","query_id":"53","doc_a_id":"57783564","doc_b_id":"14241418","presented_order":["14241418","57783564"],"winner_id":"14241418","reasoning":"Reason: Neither mentions ALDH1, but Document A relates to cancer therapy including trastuzumab-resistant (breast) cancer, making it slightly more relevant than Document B which is specific to colon cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013263Z"}
{"comparison_id":"1743e27f-5040-470f-8004-de99665fc73d","query_id":"53","doc_a_id":"15832146","doc_b_id":"14241418","presented_order":["15832146","14241418"],"winner_id":"15832146","reasoning":"Document A is more relevant because it addresses tumor progression and factors affecting breast cancer prognosis, whereas Document B focuses on a PI3K/mTOR inhibitor and therapeutic response, not prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013269Z"}
{"comparison_id":"10524ae6-5b21-40cf-92a4-604512eb0b71","query_id":"53","doc_a_id":"6807122","doc_b_id":"14241418","presented_order":["14241418","6807122"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer (including trastuzumab-resistant cells relevant to breast cancer), whereas B focuses on EndMT and fibroblasts without relation to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013276Z"}
{"comparison_id":"1e2525ab-9413-42de-99c5-43eda0602215","query_id":"53","doc_a_id":"9648896","doc_b_id":"14241418","presented_order":["9648896","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses a therapy relevant to breast cancer (trastuzumab resistance), while Document A focuses on lung cancer, so B is more related to the breast cancer prognosis query.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013282Z"}
{"comparison_id":"204cf013-e0af-477f-a560-721d3954061b","query_id":"53","doc_a_id":"16853734","doc_b_id":"14241418","presented_order":["14241418","16853734"],"winner_id":"14241418","reasoning":"Document A — it discusses cancer (including trastuzumab-resistant cases relevant to breast cancer), so it's marginally more related to the query than Document B about glioma/MSC migration.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013288Z"}
{"comparison_id":"a3ced3ce-77c7-4774-8e7c-666f925a0699","query_id":"53","doc_a_id":"12074066","doc_b_id":"14241418","presented_order":["12074066","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and tumor biology, while A is about vitamin D and colorectal cancer prevention. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013295Z"}
{"comparison_id":"ff2da4e0-e3e9-4f48-8261-23522ed5bfc9","query_id":"53","doc_a_id":"43334921","doc_b_id":"14241418","presented_order":["14241418","43334921"],"winner_id":"14241418","reasoning":"Document A — it's about breast cancer (trastuzumab resistance) while Document B concerns colorectal cancer; neither mentions ALDH1, but A is more relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013301Z"}
{"comparison_id":"9181b7d3-c2b6-41df-817d-cb68ca0e75a9","query_id":"53","doc_a_id":"22267225","doc_b_id":"14241418","presented_order":["22267225","14241418"],"winner_id":"22267225","reasoning":"Document A is more relevant — it discusses breast cancer in a clinical/preventive context, while Document B focuses on a PI3K/mTOR inhibitor and not on prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013307Z"}
{"comparison_id":"5c8b48dc-e6dd-41f9-9e5d-e2a1c1b023a1","query_id":"53","doc_a_id":"41293601","doc_b_id":"14241418","presented_order":["14241418","41293601"],"winner_id":"14241418","reasoning":"Document A — it discusses a breast cancer–relevant therapy (trastuzumab resistance/PI3K pathway), so it's more related to breast cancer prognosis than a glioblastoma mutation study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013314Z"}
{"comparison_id":"bc3f075d-47a3-42b2-962a-c28dee615691","query_id":"53","doc_a_id":"21414718","doc_b_id":"14241418","presented_order":["14241418","21414718"],"winner_id":"14241418","reasoning":"Document A is more relevant — it addresses breast cancer biology (where ALDH1's prognostic role would pertain), while Document B concerns gastric cancer and unrelated proteins.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013320Z"}
{"comparison_id":"432221fd-d508-46df-8e17-576ee0a83061","query_id":"53","doc_a_id":"25452937","doc_b_id":"14241418","presented_order":["25452937","14241418"],"winner_id":"14241418","reasoning":"Document B is slightly more relevant because it concerns cancer signaling and therapy related to trastuzumab-resistant tumors (breast cancer context), whereas Document A is about thyroid cancer and tumor-associated macrophages. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013326Z"}
{"comparison_id":"7eadb01d-6f78-4aaf-8535-53360dab5a06","query_id":"53","doc_a_id":"12145359","doc_b_id":"14241418","presented_order":["14241418","12145359"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns cancer biology and therapies related to breast cancer (trastuzumab resistance), whereas Document B is about lung function and lung cancer risk, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013333Z"}
{"comparison_id":"e5e53bb1-f97b-4320-b8f2-9607e4a41bb6","query_id":"53","doc_a_id":"22478394","doc_b_id":"14241418","presented_order":["22478394","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer (including trastuzumab-resistant breast cancer) and tumor markers/therapy, while A is about liver PPAR-γ in NAFLD unrelated to breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013339Z"}
{"comparison_id":"ccd7db26-e0ac-46b0-a80d-14bf99ff54a0","query_id":"53","doc_a_id":"5884524","doc_b_id":"14241418","presented_order":["5884524","14241418"],"winner_id":"14241418","reasoning":"Document B — it's about cancer (including trastuzumab-resistant cells relevant to breast cancer), whereas Document A concerns diabetes and cardiac outcomes and is unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013346Z"}
{"comparison_id":"0cd9f38c-0649-4a27-9d03-f7ee7d0ebc61","query_id":"53","doc_a_id":"24624992","doc_b_id":"14241418","presented_order":["14241418","24624992"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant — it concerns cancer signaling and trastuzumab resistance (breast cancer context), whereas Document B focuses on leukemia cell lines unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013352Z"}
{"comparison_id":"9a7bc25a-c9f3-48ce-922c-59120a40de5c","query_id":"53","doc_a_id":"3848469","doc_b_id":"14241418","presented_order":["14241418","3848469"],"winner_id":"3848469","reasoning":"Doc B is more relevant — it addresses cancer stemness markers (the category ALDH1 belongs to) and their association with aggressive behavior, whereas A focuses on a PI3K/mTOR inhibitor and not on ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013359Z"}
{"comparison_id":"3d901180-454d-433c-b7e6-cab19a9b830c","query_id":"53","doc_a_id":"29190724","doc_b_id":"14241418","presented_order":["29190724","14241418"],"winner_id":"14241418","reasoning":"Document B is slightly more relevant because it discusses treatment of breast cancer cells (trastuzumab-resistant), whereas A is about gastric cancer and unrelated. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013366Z"}
{"comparison_id":"9ba7582a-49fd-45cd-8d91-a4d2d559b6a6","query_id":"53","doc_a_id":"3056682","doc_b_id":"14241418","presented_order":["3056682","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer biology and therapies (including trastuzumab-resistant breast cancer), while A is about unstable angina and unrelated to ALDH1 or breast cancer.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013373Z"}
{"comparison_id":"385b989b-8ca0-465d-a9d8-de9984c10148","query_id":"53","doc_a_id":"1649738","doc_b_id":"14241418","presented_order":["14241418","1649738"],"winner_id":"14241418","reasoning":"Document A — it discusses breast cancer treatment/resistance (trastuzumab-related) and cancer prognosis context, whereas Document B concerns Hodgkin's lymphoma genetics and is unrelated to breast cancer biomarkers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013380Z"}
{"comparison_id":"1db7a57e-62e3-44a0-ace6-abf0d2c20639","query_id":"53","doc_a_id":"3590806","doc_b_id":"14241418","presented_order":["3590806","14241418"],"winner_id":"14241418","reasoning":"Document B is slightly more relevant because it discusses cancer (including trastuzumab-resistant breast cancer), whereas A concerns colorectal cancer and is unrelated to ALDH1 or breast cancer prognosis.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013386Z"}
{"comparison_id":"7cdafc22-530f-4acf-a1f2-82fd5d0974cd","query_id":"53","doc_a_id":"8774475","doc_b_id":"14241418","presented_order":["8774475","14241418"],"winner_id":"8774475","reasoning":"Document A is more relevant because it addresses molecular changes and tumorigenesis in mammary tissue (breast cancer context), whereas Document B focuses on a PI3K/mTOR inhibitor and PI3K-mutant cancers without relation to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013392Z"}
{"comparison_id":"a159af81-379f-4d04-88d3-7ef773954445","query_id":"53","doc_a_id":"17671145","doc_b_id":"14241418","presented_order":["17671145","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer (including trastuzumab-resistant breast cancer contexts), while Document A concerns prostate cancer only. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013399Z"}
{"comparison_id":"a6acefee-ef51-427a-8898-291ccbab2f9c","query_id":"53","doc_a_id":"9196472","doc_b_id":"14241418","presented_order":["14241418","9196472"],"winner_id":"14241418","reasoning":"Document A — it discusses cancer biology and treatment relevance, whereas B focuses on monocyte transcriptomes and atherosclerosis, not breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013405Z"}
{"comparison_id":"2300225b-28e9-45ad-aa3a-13e153023d9a","query_id":"53","doc_a_id":"19541444","doc_b_id":"14241418","presented_order":["14241418","19541444"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer growth and trastuzumab resistance (breast cancer context), whereas B is a general tumorigenesis piece unrelated to ALDH1 or breast prognosis.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013411Z"}
{"comparison_id":"e7403fdd-138c-4d01-88b0-d6f46410515e","query_id":"53","doc_a_id":"24705390","doc_b_id":"14241418","presented_order":["14241418","24705390"],"winner_id":"14241418","reasoning":"Document A is more related to cancer (mentions trastuzumab-resistant cancer cells relevant to breast cancer biology); Document B concerns H. pylori gastric mutations in mice and is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013418Z"}
{"comparison_id":"4bf9077c-b311-4f2b-a58d-52a719383418","query_id":"53","doc_a_id":"14726759","doc_b_id":"14241418","presented_order":["14726759","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer (including trastuzumab-resistant breast cancer and PI3K pathway), whereas A is about cervicocerebral artery dissection and unrelated to breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013424Z"}
{"comparison_id":"5e542e57-ac1e-4314-97ad-5fe2bb088df9","query_id":"53","doc_a_id":"12337611","doc_b_id":"14241418","presented_order":["12337611","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses a therapy relevant to breast cancer (trastuzumab resistance), whereas A is about neuroblastoma and unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013430Z"}
{"comparison_id":"438cd23d-5e6e-4707-a0ba-5ae78a6d3e3a","query_id":"53","doc_a_id":"38009906","doc_b_id":"14241418","presented_order":["14241418","38009906"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it discusses cancer (including trastuzumab-resistant breast cancer contexts), whereas Document B focuses on ANRIL/CBX7-mediated silencing with implications for prostate. Neither directly addresses ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013436Z"}
{"comparison_id":"48d03a9f-f5b3-489e-b231-19d5d2309c28","query_id":"53","doc_a_id":"4445629","doc_b_id":"14241418","presented_order":["14241418","4445629"],"winner_id":"14241418","reasoning":"Document A — it discusses cancer treatment and signaling in tumor cells (more closely related to breast cancer biology) while Document B is about cardiac biomarkers and heart failure. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013443Z"}
{"comparison_id":"828a44b3-bbe7-4bce-913f-56208899ee7c","query_id":"53","doc_a_id":"7046487","doc_b_id":"14241418","presented_order":["14241418","7046487"],"winner_id":"14241418","reasoning":"Document A is more relevant — it mentions cancer treatment/resistance related to breast cancer (trastuzumab), while Document B is a general review of NF-κB without breast cancer or ALDH1 specifics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013449Z"}
{"comparison_id":"4558af14-b927-4153-bfdd-f2652b4c1838","query_id":"53","doc_a_id":"8702697","doc_b_id":"14241418","presented_order":["14241418","8702697"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer cell signaling and trastuzumab resistance (breast cancer context), whereas B focuses on prostate cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013455Z"}
{"comparison_id":"964ec9dc-7d5f-445e-a928-b0d231b081a7","query_id":"53","doc_a_id":"3559136","doc_b_id":"14241418","presented_order":["14241418","3559136"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and pathways linked to prognosis, whereas Document B focuses on stromal/immune interactions without relation to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013461Z"}
{"comparison_id":"b1a5c249-911a-4c9c-bb6b-8ecbb8b0968b","query_id":"53","doc_a_id":"23576165","doc_b_id":"14241418","presented_order":["23576165","14241418"],"winner_id":"23576165","reasoning":"Document A is slightly more relevant because it discusses tumor metabolism and microenvironmental heterogeneity, which is more related to markers of tumor behavior and prognosis than a drug-specific PI3K/mTOR inhibitor study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013467Z"}
{"comparison_id":"369a11e3-adc0-436d-b77f-d90057776225","query_id":"53","doc_a_id":"25738896","doc_b_id":"14241418","presented_order":["25738896","14241418"],"winner_id":"14241418","reasoning":"Document B. It relates to cancer (including trastuzumab-resistant breast cancer) and pathways affecting prognosis/treatment, whereas A concerns melanoma immunology and is unrelated to breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013474Z"}
{"comparison_id":"ab9e20ec-5a94-449a-afc5-4df2713f2e07","query_id":"53","doc_a_id":"6121555","doc_b_id":"14241418","presented_order":["14241418","6121555"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns breast cancer-related signaling and therapy (trastuzumab resistance), whereas Document B focuses on glioma and does not relate to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013480Z"}
{"comparison_id":"221c5095-423b-4eb0-aebb-5a17cbabc5db","query_id":"53","doc_a_id":"6948886","doc_b_id":"14241418","presented_order":["6948886","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses a therapy affecting breast cancer-related signaling (trastuzumab resistance), while A is about glioblastoma and unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013487Z"}
{"comparison_id":"e1be87f4-7069-4ef2-a0b2-20b8f21c145e","query_id":"53","doc_a_id":"10699587","doc_b_id":"14241418","presented_order":["14241418","10699587"],"winner_id":"14241418","reasoning":"Document A — it concerns cancer biology and therapies related to pathways relevant in breast cancer (mentions trastuzumab resistance), whereas Document B is about prostate cancer prognostics and is unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013493Z"}
{"comparison_id":"4d2f9e36-3410-484f-98d3-b2cee660bc24","query_id":"53","doc_a_id":"6171953","doc_b_id":"14241418","presented_order":["6171953","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer (including trastuzumab-resistant breast cancer) and therapeutic markers, whereas A discusses Sirtuin-1 in inflammation/obesity unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013500Z"}
{"comparison_id":"0d2c4366-4bf5-47ff-8de2-d9e3f3c7d2f9","query_id":"53","doc_a_id":"8764879","doc_b_id":"14241418","presented_order":["14241418","8764879"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and therapies tied to prognosis pathways, whereas Document B is about AML/leukemia and not breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013506Z"}
{"comparison_id":"5b597ced-1252-40e7-bdd9-8fb89f645f72","query_id":"53","doc_a_id":"2359152","doc_b_id":"14241418","presented_order":["14241418","2359152"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and pathways affecting tumor behavior; Document B is about myelodysplastic syndromes, unrelated to breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013513Z"}
{"comparison_id":"1f8cb3e5-4e76-4cf4-b5cf-f812961abb4e","query_id":"53","doc_a_id":"67787658","doc_b_id":"14241418","presented_order":["14241418","67787658"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer (including trastuzumab-resistant cases relevant to breast cancer), whereas Document B concerns glioblastoma and unrelated microRNA mechanisms. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013519Z"}
{"comparison_id":"82ed8c25-ba50-4714-9610-0cf26002610a","query_id":"53","doc_a_id":"45764440","doc_b_id":"14241418","presented_order":["14241418","45764440"],"winner_id":"14241418","reasoning":"Document A — it mentions trastuzumab-resistant cancer cells (breast cancer context) and is more related to breast cancer prognosis than Document B which is about pancreatic cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013526Z"}
{"comparison_id":"14de87f6-4b19-4af0-9a1a-b2749b741ebb","query_id":"53","doc_a_id":"3173489","doc_b_id":"14241418","presented_order":["3173489","14241418"],"winner_id":"14241418","reasoning":"Document B is slightly more relevant because it discusses cancer (including trastuzumab-resistant breast cancer) while Document A focuses on lymphomagenesis unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013532Z"}
{"comparison_id":"ab5a6e5c-144e-4e5a-a72d-be50b0a5142e","query_id":"53","doc_a_id":"21692235","doc_b_id":"14241418","presented_order":["21692235","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses a cancer therapy relevant to breast cancer (trastuzumab resistance), whereas A focuses on glioblastoma subtypes and is unrelated to breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013539Z"}
{"comparison_id":"e8f394e1-b1af-4400-9e60-4773175ba8f4","query_id":"53","doc_a_id":"31803596","doc_b_id":"14241418","presented_order":["14241418","31803596"],"winner_id":"31803596","reasoning":"Document B is more relevant because it involves gene expression analysis and links expression patterns to tumor differentiation/prognosis, which is closer to evaluating a marker like ALDH1 than a drug-mechanism study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013545Z"}
{"comparison_id":"6d81356b-eab5-4b35-872b-0a6ed2a329ed","query_id":"53","doc_a_id":"42377686","doc_b_id":"14241418","presented_order":["42377686","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses therapeutics relevant to breast cancer (trastuzumab resistance), whereas A is about CLL/SLL and unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013551Z"}
{"comparison_id":"3dd42801-5436-41a2-ae86-71156aca7d8c","query_id":"53","doc_a_id":"35993767","doc_b_id":"14241418","presented_order":["14241418","35993767"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses breast cancer (trastuzumab resistance context), while B covers hepatocellular carcinoma unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013557Z"}
{"comparison_id":"dff25b68-ae1b-47ed-9599-6cf3f87efc83","query_id":"53","doc_a_id":"4434951","doc_b_id":"14241418","presented_order":["4434951","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer (including breast cancer) biology and treatments, whereas A is about aging epigenetics in mice and unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013564Z"}
{"comparison_id":"1e46b23a-0caf-4ee7-ab72-1b707b3576f2","query_id":"53","doc_a_id":"27647593","doc_b_id":"14241418","presented_order":["14241418","27647593"],"winner_id":"27647593","reasoning":"Document B is more relevant — it discusses tumor microenvironment and mechanisms that drive metastasis and aggressive behavior, which relate to prognosis, whereas A focuses on a specific PI3K/mTOR inhibitor unrelated to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013571Z"}
{"comparison_id":"73b30465-e9ba-41c0-b60f-1ba0f01e1dc2","query_id":"53","doc_a_id":"10279084","doc_b_id":"14241418","presented_order":["14241418","10279084"],"winner_id":"10279084","reasoning":"Document B is slightly more relevant because it mentions dysregulation in breast cancer, whereas Document A focuses on a PI3K/mTOR inhibitor without addressing breast cancer prognosis or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013577Z"}
{"comparison_id":"55bc3ff5-3c19-4ced-9e9c-c35bd3d5a65d","query_id":"53","doc_a_id":"16511863","doc_b_id":"14241418","presented_order":["14241418","16511863"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer signaling and therapeutic context (breast cancer-related pathways), whereas Document B concerns cardiac hypertrophy unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013583Z"}
{"comparison_id":"59ac54ca-b461-4a67-8d42-441926239f56","query_id":"53","doc_a_id":"10145528","doc_b_id":"14241418","presented_order":["14241418","10145528"],"winner_id":"14241418","reasoning":"Document A is more relevant because it discusses cancer (including trastuzumab-resistant cells relevant to breast cancer), whereas Document B focuses on ATM genetic variation without relation to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013590Z"}
{"comparison_id":"1a732a12-b8ce-4034-90e0-62d2a5c0f5d5","query_id":"53","doc_a_id":"3619931","doc_b_id":"14241418","presented_order":["14241418","3619931"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and tumor biology, whereas Document B is about lung fibrosis and unrelated to breast cancer biomarkers.  \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013596Z"}
{"comparison_id":"90409ee5-0e3c-41ae-86ab-281513d364a1","query_id":"53","doc_a_id":"6766459","doc_b_id":"14241418","presented_order":["6766459","14241418"],"winner_id":"14241418","reasoning":"Document B — it concerns cancer (including trastuzumab-resistant breast cancer) and prognosis-related signaling, whereas Document A is about fever/immune thermomiRs and unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013603Z"}
{"comparison_id":"1386bf4a-a80d-4d6f-8c75-2cc17db50f03","query_id":"53","doc_a_id":"26887439","doc_b_id":"14241418","presented_order":["26887439","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses therapy and resistance in (HER2+) breast cancer contexts (trastuzumab resistance), whereas A focuses on K‑Ras-transformed cells; neither mentions ALDH1 but B is closer to breast cancer prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013610Z"}
{"comparison_id":"fda5f6ef-0afa-4b27-a70e-d6a222f70d0f","query_id":"53","doc_a_id":"26495128","doc_b_id":"14241418","presented_order":["14241418","26495128"],"winner_id":"14241418","reasoning":"Document A is more relevant — it deals with cancer (including trastuzumab-resistant breast cancer) and clinical outcomes pathways, whereas Document B is basic ribosome biology without breast cancer or prognosis relevance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013617Z"}
{"comparison_id":"2dc035d9-23f5-485d-8479-15981763aa63","query_id":"53","doc_a_id":"36310858","doc_b_id":"14241418","presented_order":["14241418","36310858"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses breast cancer context (trastuzumab resistance and PI3K pathway), whereas Document B is about pancreatic cancer and unrelated to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013623Z"}
{"comparison_id":"fa069a7e-b7d6-473b-be69-a20f82d6627c","query_id":"53","doc_a_id":"5783785","doc_b_id":"14241418","presented_order":["5783785","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses a drug active against trastuzumab-resistant (HER2+) breast cancer cells, whereas Document A is about gastric cancer and unrelated to breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013630Z"}
{"comparison_id":"60aaccd6-c873-4058-9f39-54729a174a1a","query_id":"53","doc_a_id":"22059387","doc_b_id":"14241418","presented_order":["22059387","14241418"],"winner_id":"14241418","reasoning":"Document B — it concerns cancer (including trastuzumab-resistant breast cancer) and signaling pathways relevant to prognosis and therapy; Document A is about parasite-induced cholangiocarcinoma in hamsters and is unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013637Z"}
{"comparison_id":"2c88509d-8c97-4b42-8ae7-d63691c003d1","query_id":"53","doc_a_id":"54561709","doc_b_id":"14241418","presented_order":["54561709","14241418"],"winner_id":"54561709","reasoning":"Document A is about breast cancer (MCF-7) cell line variability that can affect biomarker studies and prognosis research, while Document B focuses on a PI3K/mTOR inhibitor in cancer cells. A is more related.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013644Z"}
{"comparison_id":"053ad63e-e43c-4695-9f5c-fbb9ab392a7e","query_id":"53","doc_a_id":"5271210","doc_b_id":"14241418","presented_order":["14241418","5271210"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer treatments including trastuzumab-resistant cases (breast cancer context), whereas Document B focuses on hepatocellular carcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013651Z"}
{"comparison_id":"b3c9f156-1fbd-4192-85a2-e91363b15cbe","query_id":"53","doc_a_id":"9226649","doc_b_id":"14241418","presented_order":["9226649","14241418"],"winner_id":"14241418","reasoning":"Document B is more related to breast cancer biology and therapy (mentions trastuzumab-resistant cancer cells), whereas A is about colon tumorigenesis and unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013657Z"}
{"comparison_id":"0fa9511e-914a-470c-a00f-613fab41e390","query_id":"53","doc_a_id":"13283919","doc_b_id":"14241418","presented_order":["13283919","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) whereas A is about mast cell function in mice and unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013664Z"}
{"comparison_id":"a6c68514-97ae-4825-8220-f55761df57c7","query_id":"53","doc_a_id":"11935250","doc_b_id":"14241418","presented_order":["11935250","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer biology and therapeutic response, which is more related to breast cancer prognosis than age-related DNA methylation in mice. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013671Z"}
{"comparison_id":"302cb3da-83e1-426c-90c9-0516ebcfe963","query_id":"53","doc_a_id":"15215393","doc_b_id":"14241418","presented_order":["14241418","15215393"],"winner_id":"14241418","reasoning":"Document A — it mentions trastuzumab-resistant cancer cells (breast cancer context), while B is about glioblastoma; neither discusses ALDH1 but A is closer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013677Z"}
{"comparison_id":"abea4b12-8f16-4c87-b7bd-c54b82ee6872","query_id":"53","doc_a_id":"29473081","doc_b_id":"14241418","presented_order":["14241418","29473081"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses a therapy and signaling in breast cancer (trastuzumab resistance), whereas B focuses on multiple myeloma unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013684Z"}
{"comparison_id":"5b42112f-e853-4289-8953-42f5044abc71","query_id":"53","doc_a_id":"13290521","doc_b_id":"14241418","presented_order":["14241418","13290521"],"winner_id":"13290521","reasoning":"Document B is more relevant — it discusses cancer-related biomarkers and prognostic applications, whereas A focuses on a PI3K/mTOR inhibitor with no mention of ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013690Z"}
{"comparison_id":"844d57a7-5acf-4a13-bd7f-6486b22e9020","query_id":"53","doc_a_id":"5123516","doc_b_id":"14241418","presented_order":["14241418","5123516"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses a drug affecting PI3K-driven (including trastuzumab-resistant) cancer cells, relating to breast cancer contexts; Document B is about glioblastoma and unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013697Z"}
{"comparison_id":"276a6a70-5776-449f-af6d-18586288a41f","query_id":"53","doc_a_id":"26008063","doc_b_id":"14241418","presented_order":["26008063","14241418"],"winner_id":"14241418","reasoning":"Doc B is more related to cancer biology/therapy (including breast cancer contexts) while Document A is about kidney development and unrelated. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013703Z"}
{"comparison_id":"2e8a93ac-1641-4f3f-b71c-ce2442fd79d1","query_id":"53","doc_a_id":"22180793","doc_b_id":"14241418","presented_order":["22180793","14241418"],"winner_id":"14241418","reasoning":"Document B is slightly more relevant because it discusses cancer therapies including trastuzumab-resistant (breast) cancers; Document A is specific to prostate cancer and unrelated to ALDH1 or prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013710Z"}
{"comparison_id":"15343563-5ede-4946-84e4-a0a2ed9e5988","query_id":"53","doc_a_id":"33387953","doc_b_id":"14241418","presented_order":["33387953","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer (including trastuzumab-resistant breast cancer) and therapeutic/prognostic context, whereas A focuses on G protein beta mutations unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013737Z"}
{"comparison_id":"1ccca8c8-e825-4c50-931f-bc58a35e882c","query_id":"53","doc_a_id":"25513319","doc_b_id":"14241418","presented_order":["14241418","25513319"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns breast cancer (mentions trastuzumab-resistant cancer) while Document B is about prostate cancer; neither mentions ALDH1 but A is closer to the query context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013751Z"}
{"comparison_id":"b7b251ce-6409-4cca-acd1-eeded84cb3a7","query_id":"53","doc_a_id":"10165723","doc_b_id":"14241418","presented_order":["14241418","10165723"],"winner_id":"14241418","reasoning":"Document A is more related because it concerns breast cancer biology and therapy (mentions trastuzumab resistance), whereas Document B addresses melanoma. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013759Z"}
{"comparison_id":"e8464ceb-f141-46d6-8542-65dbefb7b2df","query_id":"53","doc_a_id":"1836154","doc_b_id":"14241418","presented_order":["1836154","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer (including trastuzumab-resistant breast cancer) and pathways relevant to breast cancer, while A is specific to glioblastoma and unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013766Z"}
{"comparison_id":"bc1b4a11-be93-482c-b356-b691c857067b","query_id":"53","doc_a_id":"18358026","doc_b_id":"14241418","presented_order":["14241418","18358026"],"winner_id":"14241418","reasoning":"Document A is more directly in the breast cancer context (mentions trastuzumab-resistant tumor growth and therapeutic/prognostic implications); Document B discusses general oxidative DNA methylation mechanisms not specific to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013774Z"}
{"comparison_id":"a556049a-3b6b-45e9-b138-d3c46ebf8d9d","query_id":"53","doc_a_id":"5270265","doc_b_id":"14241418","presented_order":["14241418","5270265"],"winner_id":"5270265","reasoning":"Document B is more relevant — it addresses mechanisms of treatment resistance and potential impact on outcomes in breast cancer, which is closer to prognosis than a paper about a PI3K/mTOR inhibitor. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013780Z"}
{"comparison_id":"40205c84-4255-46a3-b8f1-ec69d9d0d280","query_id":"53","doc_a_id":"37204802","doc_b_id":"14241418","presented_order":["14241418","37204802"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses therapies and mechanisms in breast cancer (mentions trastuzumab resistance), while Document B concerns colon cancer and is unrelated. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013787Z"}
{"comparison_id":"95aff465-5f11-47ff-91a9-258b49bc24fe","query_id":"53","doc_a_id":"6290112","doc_b_id":"14241418","presented_order":["6290112","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer biology and therapy (including trastuzumab-resistant breast cancer), while Document A discusses AMY1 and obesity, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013794Z"}
{"comparison_id":"76e27a2b-cd36-4d77-ad07-7ff4c191530d","query_id":"53","doc_a_id":"40127292","doc_b_id":"14241418","presented_order":["14241418","40127292"],"winner_id":"40127292","reasoning":"Document B — it discusses chemoresistance and cancer models, which is more related to biomarker-associated prognosis than a paper focused on a specific PI3K/mTOR inhibitor.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013800Z"}
{"comparison_id":"cc6b4d6d-646d-4c62-b139-d81928793113","query_id":"53","doc_a_id":"17911973","doc_b_id":"14241418","presented_order":["17911973","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses breast cancer therapeutics and tumor behavior (trastuzumab resistance), whereas A focuses on retrotransposons and lung cancer mutagenesis and does not address ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013807Z"}
{"comparison_id":"9e214b10-1b22-4616-b073-c90db602d740","query_id":"53","doc_a_id":"11484808","doc_b_id":"14241418","presented_order":["11484808","14241418"],"winner_id":"11484808","reasoning":"Document A is more relevant — it covers clinical implications and biomarkers in endocrine-related (including breast) cancers and is likelier to discuss ALDH1 and prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013814Z"}
{"comparison_id":"84393c3b-5641-437e-ab43-6ff81cdc5d0f","query_id":"53","doc_a_id":"7975937","doc_b_id":"14241418","presented_order":["14241418","7975937"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer (including trastuzumab-resistant contexts relevant to breast cancer), whereas B focuses on COX-driven immune evasion in melanoma and other cancers, not ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013821Z"}
{"comparison_id":"76542c2d-bd30-4105-8225-46d1f7aa6c4f","query_id":"53","doc_a_id":"15928989","doc_b_id":"14241418","presented_order":["14241418","15928989"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns cancer (including trastuzumab-resistant breast cancer) and pathways tied to prognosis, whereas Document B is about pregnancy biology and unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013828Z"}
{"comparison_id":"b2fe9af3-c054-4511-aa10-3b3afdc54ef4","query_id":"53","doc_a_id":"8385277","doc_b_id":"14241418","presented_order":["8385277","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and signaling pathways affecting prognosis/treatment, whereas A is about Fanconi anemia and leukemia. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013835Z"}
{"comparison_id":"e260e669-7bca-4e23-af44-fc929b2b4e5f","query_id":"53","doc_a_id":"28334217","doc_b_id":"14241418","presented_order":["14241418","28334217"],"winner_id":"14241418","reasoning":"Doc A is more related to breast cancer (mentions trastuzumab-resistant cancer cells), while Document B concerns liver cancer and lymphoma; neither mentions ALDH1 but A is closer to the query context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013842Z"}
{"comparison_id":"2c8c9f0f-f838-4d6c-9162-c076a723ce9e","query_id":"53","doc_a_id":"7869794","doc_b_id":"14241418","presented_order":["7869794","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer therapies including trastuzumab-resistant cases (relevant to breast cancer context), whereas A focuses on neutrophil calcium signaling unrelated to ALDH1 or prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013849Z"}
{"comparison_id":"0a2e5f33-ca26-4673-b5ca-4d84a3ec705e","query_id":"53","doc_a_id":"864491","doc_b_id":"14241418","presented_order":["864491","14241418"],"winner_id":"14241418","reasoning":"Document B is slightly more relevant because it discusses targeted therapy in cancers with trastuzumab resistance (breast cancer context), whereas A focuses on CDK4/6 inhibition without breast-specific prognostic markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013856Z"}
{"comparison_id":"96555781-1863-4d5d-ab5f-019342d9cfed","query_id":"53","doc_a_id":"42782688","doc_b_id":"14241418","presented_order":["14241418","42782688"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns cancer biology/therapy (including trastuzumab-resistant cancers), whereas Document B addresses probiotics and colitis with no relation to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013862Z"}
{"comparison_id":"14e66166-ca62-4e25-b57e-1061cb3c8e76","query_id":"53","doc_a_id":"22703082","doc_b_id":"14241418","presented_order":["14241418","22703082"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns cancer signaling and therapies (including trastuzumab-resistant cells, relevant to breast cancer), whereas B is about H. pylori-driven gastric carcinogenesis and unrelated to ALDH1 or breast cancer.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013870Z"}
{"comparison_id":"0e48eba6-bcbf-4ec6-ad16-3c3438426525","query_id":"53","doc_a_id":"21521236","doc_b_id":"14241418","presented_order":["14241418","21521236"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses breast cancer treatment pathways (trastuzumab resistance), whereas Document B focuses on NEAT1 and replication stress without relation to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013877Z"}
{"comparison_id":"26758a60-e29c-4c0e-b7bd-18fd1769b8b7","query_id":"53","doc_a_id":"3831884","doc_b_id":"14241418","presented_order":["14241418","3831884"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns cancer (including trastuzumab-resistant cells related to breast cancer/PI3K pathway), while B is specific to pancreatic cancer metabolism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013883Z"}
{"comparison_id":"2e84a26c-f5f4-4cae-bb43-49d1200b40b2","query_id":"53","doc_a_id":"4325398","doc_b_id":"14241418","presented_order":["14241418","4325398"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns cancer signaling and mentions trastuzumab-resistant (breast) cancer cells, whereas Document B is about pancreatic cancer genomics. Neither directly addresses ALDH1, but A is closer in context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013890Z"}
{"comparison_id":"1f80ee0e-a88c-4cd9-8165-2294f9977fc0","query_id":"53","doc_a_id":"3504761","doc_b_id":"14241418","presented_order":["3504761","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer treatment relevant to breast cancer (trastuzumab resistance), whereas A is about liver metabolism and hepatosteatosis, not breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013897Z"}
{"comparison_id":"5c8404c7-6b50-4978-93f0-70ddb68d2e72","query_id":"53","doc_a_id":"9791313","doc_b_id":"14241418","presented_order":["9791313","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses a therapy active against breast cancer cells (trastuzumab-resistant), while A focuses on SETD2 and RCC, not breast cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013903Z"}
{"comparison_id":"b8ecf03b-f488-4d84-a641-4a505937b5d9","query_id":"53","doc_a_id":"5468807","doc_b_id":"14241418","presented_order":["14241418","5468807"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns PI3K/mTOR signaling and trastuzumab-resistant cancer cells (breast cancer context), whereas Document B is about ovarian cancer and unrelated to ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013911Z"}
{"comparison_id":"f40b4d3a-d74f-4702-9dcb-490c9dce2dac","query_id":"53","doc_a_id":"10365787","doc_b_id":"14241418","presented_order":["14241418","10365787"],"winner_id":"14241418","reasoning":"Document A — it discusses cancer therapy relevant to breast cancer (mentions trastuzumab-resistant cells), whereas B is about cell-cycle regulation and genomic stability without relation to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013918Z"}
{"comparison_id":"6dbedbe3-1359-4faa-a0eb-f0265d1a03fa","query_id":"53","doc_a_id":"40735046","doc_b_id":"14241418","presented_order":["40735046","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses molecular pathways and therapeutic resistance in cancer, closer to biomarker-driven prognosis than a screening trial. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013924Z"}
{"comparison_id":"8773b8da-059c-4133-9a54-24506f578ac6","query_id":"53","doc_a_id":"24783597","doc_b_id":"14241418","presented_order":["14241418","24783597"],"winner_id":"14241418","reasoning":"Document A — it concerns cancer (including trastuzumab-resistant breast cancer) and pathways relevant to prognosis/treatment, whereas Document B is about inflammatory bowel disease. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013930Z"}
{"comparison_id":"06f0b57e-9968-43e6-b4c0-515732df7f7b","query_id":"53","doc_a_id":"3858268","doc_b_id":"14241418","presented_order":["14241418","3858268"],"winner_id":"3858268","reasoning":"Document B — it discusses cancer stem cell markers and metabolism (more related to ALDH1 as a CSC marker), whereas A focuses on a PI3K/mTOR inhibitor unrelated to ALDH1 or prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013938Z"}
{"comparison_id":"fe5c8868-c0cf-484f-88a5-836cd801c651","query_id":"53","doc_a_id":"1522336","doc_b_id":"14241418","presented_order":["14241418","1522336"],"winner_id":"14241418","reasoning":"Document A — it discusses targeted therapy in cancers including trastuzumab-resistant (HER2+) breast cancer, so it's more relevant than a review on statins in head and neck cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013944Z"}
{"comparison_id":"aed4e19d-96b2-4a34-9e75-8682b5e7a221","query_id":"53","doc_a_id":"24190159","doc_b_id":"14241418","presented_order":["14241418","24190159"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and prognostic/therapeutic pathways, whereas B is specific to rectal cancer and KRAS. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013951Z"}
{"comparison_id":"963c412f-e0ca-4346-bc1d-e2286aad7c20","query_id":"53","doc_a_id":"25036988","doc_b_id":"14241418","presented_order":["25036988","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer therapy relevant to breast cancer (trastuzumab resistance), while A concerns lamin B1 in colon cancer; neither mentions ALDH1 but B is closer to the query topic. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013958Z"}
{"comparison_id":"7ba7e5d6-7193-4db2-88e7-0181a7a923ea","query_id":"53","doc_a_id":"26231129","doc_b_id":"14241418","presented_order":["14241418","26231129"],"winner_id":"26231129","reasoning":"Document B is more relevant — it addresses concepts around residual disease and targeting tumor cell subpopulations, which is more closely related to prognostic markers like ALDH1 than the drug-specific focus of Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013964Z"}
{"comparison_id":"d39ec343-1c2f-4405-aaff-da44baafba0c","query_id":"53","doc_a_id":"12685434","doc_b_id":"14241418","presented_order":["12685434","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer (including trastuzumab-resistant breast cancer) and therapeutic/prognostic context, whereas A is about glioblastoma and unrelated to breast cancer biomarkers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013971Z"}
{"comparison_id":"a6994d6e-951b-4a4d-b195-198d187dd69d","query_id":"53","doc_a_id":"18682109","doc_b_id":"14241418","presented_order":["14241418","18682109"],"winner_id":"14241418","reasoning":"Document A — it discusses breast-cancer–related biology (trastuzumab-resistant cells), while Document B is about lung cancer and RB loss, so A is more related to the query. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013978Z"}
{"comparison_id":"2268dc52-3bf7-4946-abfe-d1568ddc8200","query_id":"53","doc_a_id":"2466614","doc_b_id":"14241418","presented_order":["14241418","2466614"],"winner_id":"14241418","reasoning":"Document A — it discusses cancer biology and therapeutic response, which is closer to a claim about breast cancer prognosis than Document B's aging study. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013984Z"}
{"comparison_id":"3c0a61b8-4dbb-4e0b-9afb-8383b4faeaeb","query_id":"53","doc_a_id":"2374637","doc_b_id":"14241418","presented_order":["14241418","2374637"],"winner_id":"2374637","reasoning":"Neither document provides direct evidence about ALDH1 and breast cancer prognosis; Document B is marginally more relevant because it concerns gene-expression analysis methods that could be used to study ALDH1 associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013991Z"}
{"comparison_id":"86659d94-ed6b-4618-be02-77ab98a12e70","query_id":"53","doc_a_id":"14019636","doc_b_id":"14241418","presented_order":["14019636","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer treatment including trastuzumab-resistant cells (breast cancer context), whereas A is about rDNA copy number generally and not breast-cancer prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.013998Z"}
{"comparison_id":"7ca8a85a-f72d-43b6-8a4d-bfbc6885858a","query_id":"53","doc_a_id":"17717391","doc_b_id":"14241418","presented_order":["17717391","14241418"],"winner_id":"17717391","reasoning":"Document A discusses marker expression and its relationship to tumorigenesis/prognosis, whereas Document B focuses on a PI3K/mTOR inhibitor and treatment. A is therefore slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014004Z"}
{"comparison_id":"4f7ef1e3-b195-41d1-b7f7-f4d86f445751","query_id":"53","doc_a_id":"18988265","doc_b_id":"14241418","presented_order":["18988265","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer biology and treatments (including trastuzumab-resistant cancer), whereas A is about COPD and unrelated to breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014010Z"}
{"comparison_id":"0dbe90f5-e95a-43ad-b22a-e108b2d98ed2","query_id":"53","doc_a_id":"20501163","doc_b_id":"14241418","presented_order":["20501163","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer (including trastuzumab-resistant breast cancer) and pathways affecting prognosis/treatment, whereas A focuses on tumor-induced metabolic/immune effects without mention of ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014017Z"}
{"comparison_id":"b3fa0d15-66c8-481f-bf16-e78c00887691","query_id":"53","doc_a_id":"22049489","doc_b_id":"14241418","presented_order":["22049489","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses a therapy affecting breast cancer cells (trastuzumab-resistant), whereas A focuses on gastric cancer and RUNX1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014023Z"}
{"comparison_id":"f46386ef-9b7a-41b0-b2b2-d08d244166a5","query_id":"53","doc_a_id":"21063817","doc_b_id":"14241418","presented_order":["14241418","21063817"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer signaling and therapies including trastuzumab-resistant breast cancer, whereas B concerns keratins in oral carcinoma, not breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014030Z"}
{"comparison_id":"56109e7f-085b-41b4-99be-5f92f9e6266e","query_id":"53","doc_a_id":"19427410","doc_b_id":"14241418","presented_order":["14241418","19427410"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it discusses cancer and breast cancer therapy resistance (trastuzumab), whereas Document B focuses on IL-33 in adipocytes and is unrelated to cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014036Z"}
{"comparison_id":"1e18f490-3b34-4c62-bba7-dea9954a9e20","query_id":"53","doc_a_id":"23599024","doc_b_id":"14241418","presented_order":["14241418","23599024"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses mechanisms in trastuzumab-resistant (breast) cancer cells, whereas B concerns lung cancer (NSCLC) and is unrelated to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014043Z"}
{"comparison_id":"c14bdda7-9846-41b4-ae93-82cce208d011","query_id":"53","doc_a_id":"195689757","doc_b_id":"14241418","presented_order":["195689757","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns targeted therapy in cancers including trastuzumab-resistant breast cancer, whereas A focuses on glioblastoma, not breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014049Z"}
{"comparison_id":"52447df4-5b96-4a44-bc2e-2aa12da701a0","query_id":"53","doc_a_id":"36838958","doc_b_id":"14241418","presented_order":["14241418","36838958"],"winner_id":"14241418","reasoning":"Document A — it discusses cancer signaling and therapies (mentions trastuzumab-resistant cancer cells, relevant to breast cancer), while Document B is about adipose tissue metabolism and unrelated to breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014056Z"}
{"comparison_id":"d2ea9c67-c199-4b8f-a3e7-086bdb68b5ea","query_id":"53","doc_a_id":"15322518","doc_b_id":"14241418","presented_order":["14241418","15322518"],"winner_id":"14241418","reasoning":"Document A — it discusses PI3K/mTOR inhibition in cancer including trastuzumab-resistant (HER2+) breast cancer, which is more related to breast cancer prognosis than Document B on rhabdoid tumors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014063Z"}
{"comparison_id":"3599f6d0-c364-4a85-8b1f-774d215547c6","query_id":"53","doc_a_id":"1617327","doc_b_id":"14241418","presented_order":["1617327","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer treatment/resistance in the breast cancer context (trastuzumab-resistant cells), whereas A addresses bone progenitors and leukemia, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014070Z"}
{"comparison_id":"730b5667-3ab9-4602-b866-3078db483931","query_id":"53","doc_a_id":"11578459","doc_b_id":"14241418","presented_order":["14241418","11578459"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it relates to cancer signaling and mentions trastuzumab-resistant (breast) cancer contexts, whereas B is specific to glioblastoma and HOX signatures. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014076Z"}
{"comparison_id":"cf7b7f4f-a1ff-498d-9dc3-08d2f623ab9f","query_id":"53","doc_a_id":"9159495","doc_b_id":"14241418","presented_order":["14241418","9159495"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and tumor biomarkers/pathways, whereas Document B is about miRNA regulation in C. elegans aging and unrelated to breast cancer or ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014083Z"}
{"comparison_id":"fa615570-cdbd-4c64-9e6e-cf6de077a780","query_id":"53","doc_a_id":"18810195","doc_b_id":"14241418","presented_order":["14241418","18810195"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it addresses targeted therapy and resistance in contexts (PI3K pathway, trastuzumab) linked to breast cancer, whereas Document B focuses on PGAM1 phosphorylation without connection to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014090Z"}
{"comparison_id":"28172e44-1da9-4715-891d-a753f0dce25b","query_id":"53","doc_a_id":"1686997","doc_b_id":"14241418","presented_order":["1686997","14241418"],"winner_id":"14241418","reasoning":"Neither abstract mentions ALDH1 or directly addresses prognosis. Document B is marginally more relevant because it discusses trastuzumab-resistant breast cancer specifically, whereas A focuses on 6PGD and metabolic signaling in tumors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014096Z"}
{"comparison_id":"8eca2a07-6ee5-46a8-a248-9dcf18cb2861","query_id":"53","doc_a_id":"28249680","doc_b_id":"14241418","presented_order":["28249680","14241418"],"winner_id":"14241418","reasoning":"Doc B discusses targeted therapy in breast cancer (trastuzumab-resistant cells), so it's more directly related to breast cancer prognosis/markers than Doc A, which focuses on apoptosis mechanisms unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014103Z"}
{"comparison_id":"f722a513-b8a7-4d71-adbd-7316d3c4bab2","query_id":"53","doc_a_id":"40349336","doc_b_id":"14241418","presented_order":["14241418","40349336"],"winner_id":"14241418","reasoning":"Document A — it mentions breast cancer context (trastuzumab resistance) and cancer prognosis-related therapy, making it marginally more relevant than the mouse ATR/stem-cell aging study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014109Z"}
{"comparison_id":"570389d9-6e77-440c-bd41-dec67d9bd8b5","query_id":"53","doc_a_id":"16364639","doc_b_id":"14241418","presented_order":["16364639","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer treatments relevant to breast cancer (trastuzumab resistance), while Document A focuses on glioblastoma and is unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014116Z"}
{"comparison_id":"4592a0bb-ae9e-4620-8c81-4d4fd9da22c0","query_id":"53","doc_a_id":"825728","doc_b_id":"14241418","presented_order":["825728","14241418"],"winner_id":"825728","reasoning":"Document A. It links EMT reversion to acquisition of stem‑cell properties and patient survival/metastasis, which is more relevant to ALDH1 (a cancer stem cell marker) and prognosis than the drug‑mechanism study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014123Z"}
{"comparison_id":"3f4fcc17-5776-4df1-b994-b73aaa5157ba","query_id":"53","doc_a_id":"22483580","doc_b_id":"14241418","presented_order":["14241418","22483580"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns cancer biology and breast cancer (trastuzumab resistance), whereas Document B is about bipolar disorder and IL-6 and is unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014130Z"}
{"comparison_id":"693f3703-5825-4062-abb8-20aad863f164","query_id":"53","doc_a_id":"5573975","doc_b_id":"14241418","presented_order":["5573975","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant cells relevant to breast cancer) and therapeutic markers, whereas Document A is kidney-specific and unrelated to breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014136Z"}
{"comparison_id":"26182647-c1a8-43d5-b9dc-a775f2f7d2c8","query_id":"53","doc_a_id":"16201748","doc_b_id":"14241418","presented_order":["16201748","14241418"],"winner_id":"14241418","reasoning":"Document B is slightly more relevant because it discusses breast cancer-related therapy (trastuzumab resistance), whereas Document A concerns PTEN in endometrium, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014143Z"}
{"comparison_id":"e5c4eaac-0a7d-452a-b91e-e2b7137bcea7","query_id":"53","doc_a_id":"2547636","doc_b_id":"14241418","presented_order":["2547636","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer therapies and breast cancer contexts (trastuzumab resistance), whereas A discusses epidermal stem cell circadian rhythms unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014150Z"}
{"comparison_id":"db7f6c3f-e636-43d9-be4e-b9ae72ba8015","query_id":"53","doc_a_id":"4312169","doc_b_id":"14241418","presented_order":["4312169","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses a cancer therapy affecting trastuzumab-resistant (HER2-positive) breast cancer cells, whereas A is about pediatric glioblastoma and unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014157Z"}
{"comparison_id":"5456d9c1-1af4-4bb8-bf04-bae267e871b5","query_id":"53","doc_a_id":"6259170","doc_b_id":"14241418","presented_order":["6259170","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer treatments and breast cancer–related resistance (trastuzumab), while Document A focuses on Nrf2/mitochondria without connection to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014164Z"}
{"comparison_id":"887f5b15-7035-4bce-aba2-168de416e775","query_id":"53","doc_a_id":"24294572","doc_b_id":"14241418","presented_order":["24294572","14241418"],"winner_id":"14241418","reasoning":"Document B is slightly more relevant — it discusses PI3K/mTOR signaling and effects on cancer cells including trastuzumab-resistant (breast) cancer, whereas A focuses on PTEN enzymology without breast cancer/ALDH1 context. Neither mentions ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014171Z"}
{"comparison_id":"dd544ba2-5138-42b4-9993-0035f163f3ce","query_id":"53","doc_a_id":"5752492","doc_b_id":"14241418","presented_order":["5752492","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer (including trastuzumab-resistant breast cancer) and pathways related to tumor behavior, whereas Document A is about PD-1H in HIV.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014177Z"}
{"comparison_id":"d72cdae6-da9a-4b1a-9516-8bfa8282abb7","query_id":"53","doc_a_id":"30297355","doc_b_id":"14241418","presented_order":["30297355","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer signaling and breast cancer treatment contexts (trastuzumab resistance), whereas Document A is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014183Z"}
{"comparison_id":"e154a62d-f91b-4861-98ee-b35ccd11ba24","query_id":"53","doc_a_id":"24347647","doc_b_id":"14241418","presented_order":["24347647","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and pathways linked to prognosis and therapy, whereas Document A is about proteasomal activity and aging/metabolism. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014190Z"}
{"comparison_id":"f4352ca2-f897-4bcc-a2f4-380a73d6c449","query_id":"53","doc_a_id":"9478135","doc_b_id":"14241418","presented_order":["9478135","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses a therapy affecting breast cancer cells (mentions trastuzumab resistance), whereas Document A is about AML genetics and unrelated to breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014197Z"}
{"comparison_id":"ef0a3bc5-80ed-4a15-b99b-4a94335ae101","query_id":"53","doc_a_id":"33076846","doc_b_id":"14241418","presented_order":["33076846","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer (including trastuzumab-resistant breast cancer) and therapeutic/prognostic implications, whereas A focuses on megakaryocyte biology unrelated to ALDH1 or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014203Z"}
{"comparison_id":"48d31c46-8475-4ddb-a78a-14abecaa1029","query_id":"53","doc_a_id":"19644821","doc_b_id":"14241418","presented_order":["19644821","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer therapies including trastuzumab-resistant (breast) cancer, whereas A is about liver cancer; neither mentions ALDH1 but B is closer to the breast cancer context.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014210Z"}
{"comparison_id":"68ddd3de-0655-4928-bfbe-48faa73cb9da","query_id":"53","doc_a_id":"5254463","doc_b_id":"14241418","presented_order":["5254463","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses therapies for cancer types including trastuzumab-resistant breast cancer, whereas A is about intestinal/colorectal tumorigenesis and does not relate to breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014216Z"}
{"comparison_id":"c7c70b2f-b03a-4277-9ccf-5bde47a7f172","query_id":"53","doc_a_id":"4993011","doc_b_id":"14241418","presented_order":["14241418","4993011"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses breast cancer biology and treatment context (trastuzumab resistance), which is closer to prognosis-related markers than the ATRX/rDNA focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014223Z"}
{"comparison_id":"0cd0003c-80ce-4021-a214-d3d591648523","query_id":"53","doc_a_id":"4457160","doc_b_id":"14241418","presented_order":["4457160","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer (including trastuzumab-resistant breast cancer) and pathways relevant to breast cancer prognosis, whereas A focuses on pancreatic cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014230Z"}
{"comparison_id":"45368d6c-4999-4948-9c2c-5f4182827f4b","query_id":"53","doc_a_id":"13398997","doc_b_id":"14241418","presented_order":["13398997","14241418"],"winner_id":"14241418","reasoning":"Document B. It discusses cancer (including trastuzumab‑resistant breast cancer contexts), so it's more relevant to ALDH1/prognosis in breast cancer than Document A, which concerns CTLA‑4 in renal transplant T cells. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014238Z"}
{"comparison_id":"b1d1036a-a2e4-41f1-a369-4b8f647a773a","query_id":"53","doc_a_id":"23887844","doc_b_id":"14241418","presented_order":["23887844","14241418"],"winner_id":"14241418","reasoning":"Neither abstract mentions ALDH1 or prognosis. Document B is more relevant because it directly addresses breast cancer–related therapy and signaling (trastuzumab resistance/PI3K pathway), whereas A is a general metabolism/apoptosis study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014244Z"}
{"comparison_id":"d0419070-dbb7-40e7-8760-3b63f3f12ac6","query_id":"53","doc_a_id":"6421734","doc_b_id":"14241418","presented_order":["6421734","14241418"],"winner_id":"14241418","reasoning":"Document B — it concerns cancer biology and therapy (relevant context), while A is unrelated to cancer care. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014251Z"}
{"comparison_id":"045dd7b4-37a0-4cd8-ab97-460d59cad2bd","query_id":"53","doc_a_id":"8724666","doc_b_id":"14241418","presented_order":["8724666","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer treatment including trastuzumab-resistant (HER2+) breast cancer, whereas A focuses on hematopoiesis and leukemia, not breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014257Z"}
{"comparison_id":"4ee4503c-411e-4db1-bde6-3b5ca04054f2","query_id":"53","doc_a_id":"31624828","doc_b_id":"14241418","presented_order":["31624828","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and pathways affecting prognosis/therapy, whereas A focuses on p53-mediated apoptotic cell clearance unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014264Z"}
{"comparison_id":"a850a856-93ca-43de-b9dd-9e6f22b54747","query_id":"53","doc_a_id":"25344732","doc_b_id":"14241418","presented_order":["25344732","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer treatment in a breast cancer context (trastuzumab resistance), whereas A is about osteosarcoma and PHC3. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014270Z"}
{"comparison_id":"7a50c07b-d261-47f1-8d31-79f3dc6e9c28","query_id":"53","doc_a_id":"2576811","doc_b_id":"14241418","presented_order":["14241418","2576811"],"winner_id":"2576811","reasoning":"Document B is more relevant — it specifically studies human breast epithelial cells, whereas Document A focuses on a PI3K/mTOR inhibitor without addressing ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014276Z"}
{"comparison_id":"2e4a5432-1a2d-42e0-8671-966306b516c7","query_id":"53","doc_a_id":"10542877","doc_b_id":"14241418","presented_order":["10542877","14241418"],"winner_id":"14241418","reasoning":"Document B is slightly more relevant because it discusses PI3K/mTOR inhibition in cancer cells including trastuzumab-resistant (breast) cancer, whereas A focuses on STAT3 in lymphoma and lung cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014325Z"}
{"comparison_id":"9c0dc7ee-b1ec-43cc-bcda-6d2c25e65b09","query_id":"53","doc_a_id":"20460020","doc_b_id":"14241418","presented_order":["14241418","20460020"],"winner_id":"14241418","reasoning":"Document A is more relevant because it discusses cancer (including trastuzumab-resistant breast cancer) while Document B concerns wound healing and macrophages, which is unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014332Z"}
{"comparison_id":"ef0ef32a-ec81-4d4c-82c6-d51abe7c9348","query_id":"53","doc_a_id":"25141908","doc_b_id":"14241418","presented_order":["14241418","25141908"],"winner_id":"14241418","reasoning":"Document A — relates to cancer biology and therapy, while Document B concerns viral gene expression unrelated to breast cancer markers or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014339Z"}
{"comparison_id":"40debb11-e083-4dcd-91ca-1c9aa16101ec","query_id":"53","doc_a_id":"30543439","doc_b_id":"14241418","presented_order":["14241418","30543439"],"winner_id":"14241418","reasoning":"Reason: Neither abstract mentions ALDH1, but Document A discusses cancer (including trastuzumab-resistant breast cancer), making it slightly more contextually relevant than Document B which focuses on MTH1/NUDT15 without breast cancer context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014345Z"}
{"comparison_id":"bdff138c-41af-44a1-8e83-a418388a9e3e","query_id":"53","doc_a_id":"15727984","doc_b_id":"14241418","presented_order":["15727984","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer therapeutics including trastuzumab-resistant (HER2+) contexts relevant to breast cancer, whereas A is about lung cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014352Z"}
{"comparison_id":"e86b7923-ea81-408e-82f8-39e756fb2b7b","query_id":"53","doc_a_id":"219475","doc_b_id":"14241418","presented_order":["14241418","219475"],"winner_id":"219475","reasoning":"Document B — it discusses factors promoting metastasis in mammary (breast) cancer, which is more related to prognosis than the PI3K inhibitor focus of Document A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014358Z"}
{"comparison_id":"9dd15895-ff2f-47e0-b12d-b13b8ae49c3a","query_id":"53","doc_a_id":"14972169","doc_b_id":"14241418","presented_order":["14241418","14972169"],"winner_id":"14241418","reasoning":"Reason: Document A discusses cancer-related signaling and therapy (including trastuzumab-resistant cells), making it more relevant to breast cancer prognosis than Document B, which is about embryonic oxidative stress.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014364Z"}
{"comparison_id":"d555ce12-bf13-423a-8fb0-57b336494248","query_id":"53","doc_a_id":"28644298","doc_b_id":"14241418","presented_order":["28644298","14241418"],"winner_id":"14241418","reasoning":"Document B — it concerns cancer (including trastuzumab-resistant breast cancer) and pathways relevant to prognosis/therapy, whereas A is about EBV-infected lymphoid cells, unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014371Z"}
{"comparison_id":"bf52db78-6d55-4a74-93f4-f2ea11edc5b0","query_id":"53","doc_a_id":"19800147","doc_b_id":"14241418","presented_order":["19800147","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant, i.e., breast cancer) signaling and prognosis-related treatment implications, whereas A is about colon cancer exosomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014378Z"}
{"comparison_id":"eb078020-8186-4603-85b7-c6939f8d7135","query_id":"53","doc_a_id":"4464565","doc_b_id":"14241418","presented_order":["4464565","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer signaling and treatment in contexts including trastuzumab-resistant breast cancer, whereas A studies cocoa effects in intestinal Caco-2 cells and doesn't address ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014384Z"}
{"comparison_id":"940ec45b-99f2-45db-8c07-65850f4aa091","query_id":"53","doc_a_id":"8994465","doc_b_id":"14241418","presented_order":["14241418","8994465"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses breast cancer biology and treatment context (trastuzumab resistance), whereas B is about melanoma and a different marker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014391Z"}
{"comparison_id":"3829e39f-bf81-44d0-96f0-dab6ca9d29b3","query_id":"53","doc_a_id":"20888849","doc_b_id":"14241418","presented_order":["14241418","20888849"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer (including trastuzumab-resistant cases, implying breast cancer contexts), whereas Document B is about pancreatic cancer and unrelated to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014397Z"}
{"comparison_id":"36bdbfd1-ada2-4274-b040-7a99147c8401","query_id":"53","doc_a_id":"23326722","doc_b_id":"14241418","presented_order":["14241418","23326722"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns breast cancer-related signaling and treatment context, whereas B is about adult T‑cell leukemia/lymphoma and is unrelated to breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014404Z"}
{"comparison_id":"b3c2c4df-8d3d-4529-b125-f4ddc0c022ef","query_id":"53","doc_a_id":"22890091","doc_b_id":"14241418","presented_order":["14241418","22890091"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) context, while Document B is about leukocyte apoptosis and not breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014411Z"}
{"comparison_id":"a29cbbbb-9ace-4d1b-9428-8cc56d1e5e91","query_id":"53","doc_a_id":"21372171","doc_b_id":"14241418","presented_order":["14241418","21372171"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns cancer biology and therapeutic response, which is closer to breast cancer prognosis than a study on peripheral artery disease.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014418Z"}
{"comparison_id":"9d0228b8-f203-47a8-a815-738243078498","query_id":"53","doc_a_id":"2205779","doc_b_id":"14241418","presented_order":["2205779","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and therapeutic markers, whereas A is about gastric cancer biomarkers unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014425Z"}
{"comparison_id":"a5d8a22c-89e4-4ff7-ae04-21192dccb995","query_id":"53","doc_a_id":"17775228","doc_b_id":"14241418","presented_order":["14241418","17775228"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns breast cancer signaling and therapy (trastuzumab resistance), whereas B is about colorectal cancer and imprinting; neither mentions ALDH1 but A is closer in topic. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014432Z"}
{"comparison_id":"6f6fb541-82f7-4d70-9490-b7050345f82b","query_id":"53","doc_a_id":"41782935","doc_b_id":"14241418","presented_order":["41782935","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it's about cancer (including breast cancer and therapy resistance), whereas Document A concerns Alzheimer's disease and is unrelated to breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014438Z"}
{"comparison_id":"4ce2f02b-ed41-4c1f-9dbd-ebcdbbb52ad6","query_id":"53","doc_a_id":"16627684","doc_b_id":"14241418","presented_order":["14241418","16627684"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and pathways related to prognosis/treatment, whereas Document B is about neural stem cells in mice and unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014445Z"}
{"comparison_id":"052dd1c0-c03f-4d0a-9c12-a0fbffd778ad","query_id":"53","doc_a_id":"42106119","doc_b_id":"14241418","presented_order":["42106119","14241418"],"winner_id":"42106119","reasoning":"Document A is more relevant — it discusses stem cell–related proteins and links between stem cell factors and cancer, which is closer to ALDH1 as a cancer stem cell marker than a drug-focused PI3K/mTOR inhibitor study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014452Z"}
{"comparison_id":"9add53f9-88a7-4ec3-a4a9-681400fb2ba9","query_id":"53","doc_a_id":"38025907","doc_b_id":"14241418","presented_order":["38025907","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer (including trastuzumab-resistant breast cancer) and pathways tied to prognosis, whereas Document A addresses liver disease unrelated to breast cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014459Z"}
{"comparison_id":"b81999ca-fbbd-423b-bdd2-050179cfbb3a","query_id":"53","doc_a_id":"19343151","doc_b_id":"14241418","presented_order":["14241418","19343151"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns cancer biology and breast cancer therapy (trastuzumab resistance), whereas Document B is about skin aging and p16INK4A, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014465Z"}
{"comparison_id":"980e0b8f-9a7c-44cb-9dfe-b188c1316858","query_id":"53","doc_a_id":"1727493","doc_b_id":"14241418","presented_order":["14241418","1727493"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it addresses breast cancer treatment/resistance (trastuzumab context), whereas Document B is about ovarian cancer and miR21; neither mentions ALDH1 or prognosis directly. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014472Z"}
{"comparison_id":"2e65c14c-83a6-41a2-8f7f-9d9b7b6d1168","query_id":"53","doc_a_id":"10450725","doc_b_id":"14241418","presented_order":["10450725","14241418"],"winner_id":"14241418","reasoning":"Reason: Document B relates to cancer treatment including trastuzumab-resistant (breast) cancer, making it more relevant to a breast cancer prognosis claim than Document A, which concerns hepatocellular carcinoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014478Z"}
{"comparison_id":"2cf024d1-0bee-430f-80f5-207271238fe1","query_id":"53","doc_a_id":"3701541","doc_b_id":"14241418","presented_order":["14241418","3701541"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer signaling and drug resistance in contexts that include breast cancer (trastuzumab resistance), whereas Document B is focused on liver fibrosis/cancer and not breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014485Z"}
{"comparison_id":"1fef447d-be27-44eb-8aa5-04a9624476b6","query_id":"53","doc_a_id":"26059876","doc_b_id":"14241418","presented_order":["26059876","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer therapy in a breast cancer context (trastuzumab resistance), whereas A concerns Ku70 in colorectal cancer; neither mentions ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014491Z"}
{"comparison_id":"cd705eb3-ad3d-4943-9ed7-0009fc80bc9f","query_id":"53","doc_a_id":"18953920","doc_b_id":"14241418","presented_order":["18953920","14241418"],"winner_id":"18953920","reasoning":"Doc A is more relevant — it links EMT to stem-cell markers and increased tumorigenic potential in mammary epithelial cells, which relates to ALDH1 as a breast cancer stem-cell marker and prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014498Z"}
{"comparison_id":"69c18386-bc5d-42eb-aa8f-6a5cc8b52dc9","query_id":"53","doc_a_id":"164985","doc_b_id":"14241418","presented_order":["164985","14241418"],"winner_id":"164985","reasoning":"Document A is more relevant — it addresses mechanisms promoting breast tumor progression and the tumor microenvironment (macrophage-driven immunosuppression), which relates to prognosis, whereas Document B focuses on PI3K/mTOR inhibition and drug response, not prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014505Z"}
{"comparison_id":"63a4f524-dd32-44d6-a1f8-75e512212c8a","query_id":"53","doc_a_id":"27822315","doc_b_id":"14241418","presented_order":["27822315","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer (including trastuzumab-resistant breast cancer) and prognosis-related pathways, whereas A focuses on LRH-1 and steroidogenesis unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014512Z"}
{"comparison_id":"dae66109-b78e-4364-9416-28394df2b22c","query_id":"53","doc_a_id":"52865789","doc_b_id":"14241418","presented_order":["52865789","14241418"],"winner_id":"14241418","reasoning":"Document B — it relates to cancer (including trastuzumab-resistant breast cancer) and is more likely to address markers affecting prognosis than the obesity/IL-15 study in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014518Z"}
{"comparison_id":"6227263f-d954-4811-a283-1a2d2dedda3c","query_id":"53","doc_a_id":"39225849","doc_b_id":"14241418","presented_order":["39225849","14241418"],"winner_id":"14241418","reasoning":"Document B. It discusses cancer (including trastuzumab-resistant breast cancer) and therapeutic relevance, which is closer to prognosis/clinical markers than the BLM/DNA replication focus in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014525Z"}
{"comparison_id":"f118b3c8-184d-4a2d-a25e-5b3edd1669a9","query_id":"53","doc_a_id":"20977638","doc_b_id":"14241418","presented_order":["14241418","20977638"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer therapies and pathways (PI3K/mTOR) related to breast cancer contexts like trastuzumab resistance, whereas Document B is about embryonic teratogenicity. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014531Z"}
{"comparison_id":"963e2842-894c-4814-a836-eb6893725d12","query_id":"53","doc_a_id":"32776084","doc_b_id":"14241418","presented_order":["32776084","14241418"],"winner_id":"14241418","reasoning":"Document B — it concerns cancer (including trastuzumab-resistant cells, relevant to breast cancer) and prognosis/therapy, while A is about mouse embryonic stem cells and imprinting, unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014538Z"}
{"comparison_id":"2f4b946d-beae-4ffb-94d7-2d978072e2e2","query_id":"53","doc_a_id":"1871499","doc_b_id":"14241418","presented_order":["14241418","1871499"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer therapy and breast cancer–related resistance (trastuzumab), whereas Document B is about Huntington's disease and unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014544Z"}
{"comparison_id":"6a6492de-fbde-48f6-9e09-427945a1af99","query_id":"53","doc_a_id":"15491308","doc_b_id":"14241418","presented_order":["14241418","15491308"],"winner_id":"14241418","reasoning":"Document A is more related to breast cancer tumor biology and therapy (mentions trastuzumab-resistant cancer), whereas Document B focuses on mesenchymal stem cells and is unrelated to breast cancer prognosis.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014551Z"}
{"comparison_id":"767d8048-368f-4a39-b06d-cbcabaa6e7e2","query_id":"53","doc_a_id":"41133176","doc_b_id":"14241418","presented_order":["14241418","41133176"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it discusses cancer signaling and mentions trastuzumab-resistant cancer cells (breast cancer context), whereas Document B is about pancreatic islets and antioxidants. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014557Z"}
{"comparison_id":"d66730b1-11ac-41c5-8755-1914e48f9dfa","query_id":"53","doc_a_id":"24285403","doc_b_id":"14241418","presented_order":["14241418","24285403"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer), whereas Document B concerns vascular disease and cognitive decline unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014564Z"}
{"comparison_id":"4700feee-1abb-4a64-bc63-74a3e9582af6","query_id":"53","doc_a_id":"18938992","doc_b_id":"14241418","presented_order":["14241418","18938992"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses breast cancer-related signaling and therapies (trastuzumab resistance), whereas B is about EBV effects in B lymphocytes and unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014570Z"}
{"comparison_id":"911391e6-3264-4edf-bc7b-6ec09ca14347","query_id":"53","doc_a_id":"3863543","doc_b_id":"14241418","presented_order":["3863543","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer (including trastuzumab-resistant breast cancer) and therapy-related markers, making it more relevant to a claim about prognosis in breast cancer than Document A, which concerns pre-leukemia.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014577Z"}
{"comparison_id":"d4705c1b-42f1-4e80-bbdc-07efd780d973","query_id":"53","doc_a_id":"23816832","doc_b_id":"14241418","presented_order":["23816832","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and pathways linked to prognosis, whereas Document A is about CSF in multiple sclerosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014583Z"}
{"comparison_id":"fa82dddf-7843-47bb-8fea-2a593c04790d","query_id":"53","doc_a_id":"24586989","doc_b_id":"14241418","presented_order":["14241418","24586989"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer biology and therapies (breast cancer contexts), whereas Document B is about heart failure genetics and unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014590Z"}
{"comparison_id":"b454f2e3-e94b-43dc-9bc6-12494c271d3a","query_id":"53","doc_a_id":"8417211","doc_b_id":"14241418","presented_order":["14241418","8417211"],"winner_id":"14241418","reasoning":"Document A is more relevant — it deals with cancer signaling and therapies related to breast cancer contexts (trastuzumab resistance), whereas Document B is about Drosophila heterochromatin and unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014596Z"}
{"comparison_id":"cd5a2c46-effb-466b-ba7a-6bb8f0116c14","query_id":"53","doc_a_id":"2919030","doc_b_id":"14241418","presented_order":["2919030","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including trastuzumab-resistant breast cancer) and therapeutic prognosis-related pathways, while A is a yeast/mammalian metabolism study not addressing ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014603Z"}
{"comparison_id":"0d29cb4a-0552-4a2e-b075-02e73e59a711","query_id":"53","doc_a_id":"22896384","doc_b_id":"14241418","presented_order":["22896384","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer biology and treatments (including trastuzumab-resistant cells relevant to breast cancer), while A is about lung/esophagus development and unrelated. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014609Z"}
{"comparison_id":"e71c4069-d682-4a90-be70-8b52afe0f3b4","query_id":"53","doc_a_id":"32372280","doc_b_id":"14241418","presented_order":["32372280","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer (therapeutics for PI3K-driven tumors), whereas Document A is about optineurin and glaucoma and is unrelated to breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014616Z"}
{"comparison_id":"55018dd0-8d33-4e00-9acc-bd99c1f4f8e5","query_id":"53","doc_a_id":"25022826","doc_b_id":"14241418","presented_order":["14241418","25022826"],"winner_id":"14241418","reasoning":"Document A is slightly more relevant because it discusses cancer cell behavior and treatment effects, whereas Document B is about MSC osteogenic differentiation and unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014622Z"}
{"comparison_id":"8e66d1ce-b9b1-463f-9dc4-72f27461f630","query_id":"53","doc_a_id":"3514072","doc_b_id":"14241418","presented_order":["14241418","3514072"],"winner_id":"14241418","reasoning":"Document A is more relevant — it's about cancer signaling and treatment (including trastuzumab-resistant cells), whereas Document B is plant genomics and unrelated to breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014628Z"}
{"comparison_id":"d2374290-906e-4e4f-aee5-e697067a17e0","query_id":"53","doc_a_id":"20179918","doc_b_id":"14241418","presented_order":["14241418","20179918"],"winner_id":"14241418","reasoning":"Document A — mentions breast cancer-related therapy and tumor growth, while Document B focuses on embryonic stem cell regulation; neither mentions ALDH1, but A is more related to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014634Z"}
{"comparison_id":"65a800c0-e49d-473f-aab0-4a18cbfde5f6","query_id":"53","doc_a_id":"19958277","doc_b_id":"14241418","presented_order":["19958277","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer signaling and trastuzumab-resistant (HER2+) breast cancer, whereas Document A focuses on RecQ helicases unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014640Z"}
{"comparison_id":"1bea0180-03d6-4d70-af76-2cd1f1915d39","query_id":"53","doc_a_id":"12580014","doc_b_id":"14241418","presented_order":["14241418","12580014"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses therapies for PI3K-activated (including trastuzumab-resistant) breast cancer, while Document B is about skin tumor keratinocytes and not breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014647Z"}
{"comparison_id":"c4f574d7-6dfe-4268-9226-3c47fad732e2","query_id":"53","doc_a_id":"17412260","doc_b_id":"14241418","presented_order":["17412260","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer treatments and specifically mentions trastuzumab-resistant (HER2) breast cancer contexts, whereas A focuses on senescence signaling without addressing ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014653Z"}
{"comparison_id":"4df1eb36-fb6a-45be-81a5-9bebc71bead2","query_id":"53","doc_a_id":"11738716","doc_b_id":"14241418","presented_order":["11738716","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer cell signaling and therapies (including trastuzumab-resistant cells), whereas A studies C. elegans lifespan and is unrelated to human breast cancer biomarkers/prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014660Z"}
{"comparison_id":"6d4133a2-0ab6-43e9-a87a-2609014a0e5f","query_id":"53","doc_a_id":"7221410","doc_b_id":"14241418","presented_order":["7221410","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer (including trastuzumab-resistant breast cancer), whereas Document A is about Alzheimer's disease and unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014666Z"}
{"comparison_id":"bd98fcf4-171e-4b2c-8583-1defe1677af4","query_id":"53","doc_a_id":"12887068","doc_b_id":"14241418","presented_order":["14241418","12887068"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns breast cancer biology/treatment, whereas Document B addresses pediatric gliomas; neither mentions ALDH1 but A is closer to the query context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014672Z"}
{"comparison_id":"c125008e-8745-4ba6-858b-6f6c2123f3b3","query_id":"53","doc_a_id":"5765455","doc_b_id":"14241418","presented_order":["5765455","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant because it concerns cancer (including trastuzumab-resistant breast cancer contexts), whereas Document A deals with myeloid leukemia, not breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014678Z"}
{"comparison_id":"2453e1eb-710e-4ecc-bdc2-e071db02d152","query_id":"53","doc_a_id":"12462961","doc_b_id":"14241418","presented_order":["12462961","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer (including trastuzumab-resistant cases relevant to breast cancer), while A concerns adrenal P450c17 regulation unrelated to ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014684Z"}
{"comparison_id":"852fc0af-b080-497e-98a1-d02de6dc66be","query_id":"53","doc_a_id":"2829179","doc_b_id":"14241418","presented_order":["14241418","2829179"],"winner_id":"14241418","reasoning":"Document A is more relevant — it addresses breast cancer biology/therapy, whereas Document B covers pre-eclampsia and is unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014690Z"}
{"comparison_id":"c1e0b851-35e2-4873-a451-9e25f3c58c58","query_id":"53","doc_a_id":"28390999","doc_b_id":"14241418","presented_order":["14241418","28390999"],"winner_id":"14241418","reasoning":"Document A — it discusses cancer cell signaling and drug response (including trastuzumab-resistant cells), which is closer to breast cancer prognosis than a study on chicken gonad gene expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014696Z"}
{"comparison_id":"5a7c3ecd-17f8-47bc-bba0-0a3200c2073d","query_id":"53","doc_a_id":"2356950","doc_b_id":"14241418","presented_order":["14241418","2356950"],"winner_id":"14241418","reasoning":"Document A is cancer-focused (mentions trastuzumab-resistant cancer cells relevant to breast cancer), while Document B is about neural stem cells and unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014702Z"}
{"comparison_id":"3a73bab5-b4ab-44dc-90df-b4774cc13fc1","query_id":"53","doc_a_id":"6947286","doc_b_id":"14241418","presented_order":["6947286","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it addresses cancer biology and therapy, whereas A is about Alzheimer's disease and unrelated genes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014708Z"}
{"comparison_id":"b220cb1f-10de-4026-bf5c-85f12c19ecfb","query_id":"53","doc_a_id":"38028419","doc_b_id":"14241418","presented_order":["14241418","38028419"],"winner_id":"14241418","reasoning":"Document A — it discusses cancer signaling and therapies (including trastuzumab resistance relevant to breast cancer), whereas Document B is about alcoholic fatty liver disease and unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014715Z"}
{"comparison_id":"4e9809da-7fd8-4b8c-b326-cd4bcade62cf","query_id":"53","doc_a_id":"11255504","doc_b_id":"14241418","presented_order":["14241418","11255504"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns breast cancer-related signaling and therapy (mentions trastuzumab resistance), whereas Document B focuses on liver cancer and unrelated genes; neither directly addresses ALDH1 but A is closer in context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014721Z"}
{"comparison_id":"b171b818-0253-4685-b17c-aba6d88e9b9c","query_id":"53","doc_a_id":"13350374","doc_b_id":"14241418","presented_order":["13350374","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer (including trastuzumab-resistant breast cancer) and signaling pathways tied to prognosis, whereas Document A is about circadian gene deficiency and aging in mice.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014727Z"}
{"comparison_id":"be0b4501-edce-4017-bc16-29654e601768","query_id":"53","doc_a_id":"9641846","doc_b_id":"14241418","presented_order":["9641846","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant because it addresses cancer therapies and mechanisms (including trastuzumab-resistant tumors relevant to breast cancer), whereas A is about developmental cell-cycle control unrelated to breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014734Z"}
{"comparison_id":"2c783cf9-48a9-434c-a6f3-1a4660f5f552","query_id":"53","doc_a_id":"34316341","doc_b_id":"14241418","presented_order":["34316341","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses cancer (including breast cancer contexts and treatment resistance), whereas Document A focuses on developmental imprinting genes unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014740Z"}
{"comparison_id":"62b18059-1850-4671-89d7-bd2193620f53","query_id":"53","doc_a_id":"25748308","doc_b_id":"14241418","presented_order":["14241418","25748308"],"winner_id":"14241418","reasoning":"Document A is more relevant — it addresses breast cancer-related signaling and therapy (trastuzumab resistance), whereas B is a general review of GAPDH not specific to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014746Z"}
{"comparison_id":"deeafb87-e203-4746-9cb7-d8d0c7fd9de4","query_id":"53","doc_a_id":"13791206","doc_b_id":"14241418","presented_order":["14241418","13791206"],"winner_id":"14241418","reasoning":"Document A — it discusses cancer (including trastuzumab-resistant breast cancer) and therapy-related markers, whereas Document B focuses on DNA repair mechanisms in BRCA1-deficient cells and not on ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014753Z"}
{"comparison_id":"7d4bc02b-bcbb-4cdb-8a66-76fcae5dd8e3","query_id":"53","doc_a_id":"22914228","doc_b_id":"14241418","presented_order":["22914228","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses therapy relevant to breast cancer (trastuzumab resistance), whereas A covers pancreatic cancer and is unrelated to breast cancer/ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014759Z"}
{"comparison_id":"5950511c-2f63-4ac0-8896-39096559d419","query_id":"53","doc_a_id":"23513818","doc_b_id":"14241418","presented_order":["23513818","14241418"],"winner_id":"14241418","reasoning":"Document B is slightly more relevant because it discusses a therapy for cancer (including trastuzumab-resistant breast cancer), whereas A focuses on Mcl-1 regulation without connection to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014765Z"}
{"comparison_id":"0fe3a777-c31a-4dd2-94f6-015ed189da2f","query_id":"53","doc_a_id":"5811042","doc_b_id":"14241418","presented_order":["14241418","5811042"],"winner_id":"14241418","reasoning":"Document A is more relevant — it concerns cancer and trastuzumab-resistant tumors (breast cancer context), whereas B addresses T-cell autoinflammation and not breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014771Z"}
{"comparison_id":"1710acfe-65c9-43e3-aa47-ffb264618364","query_id":"53","doc_a_id":"21602220","doc_b_id":"14241418","presented_order":["14241418","21602220"],"winner_id":"14241418","reasoning":"Document A — it's cancer-related (targets pathways relevant in breast cancer), while B is about E. coli fermentation and unrelated to ALDH1 or breast cancer.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014778Z"}
{"comparison_id":"d0a6d722-47c4-4eb8-858c-0b01109a0178","query_id":"53","doc_a_id":"42484543","doc_b_id":"14241418","presented_order":["42484543","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it concerns cancer biology and therapeutics, whereas A focuses on embryonic stem cell transcriptomes and is unrelated to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014784Z"}
{"comparison_id":"13069521-f8c9-4447-8749-7f85c36dfb4b","query_id":"53","doc_a_id":"40901687","doc_b_id":"14241418","presented_order":["14241418","40901687"],"winner_id":"14241418","reasoning":"Doc A is more related — it discusses cancer signaling and therapy (including trastuzumab resistance relevant to breast cancer), whereas Doc B concerns a DNA damage pathway with no link to ALDH1 or breast cancer prognosis.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014791Z"}
{"comparison_id":"3dd3fdbc-e874-4ba0-8766-961174d4683c","query_id":"53","doc_a_id":"1982286","doc_b_id":"14241418","presented_order":["1982286","14241418"],"winner_id":"14241418","reasoning":"Document B — it discusses cancer treatment relevant to breast cancer (trastuzumab resistance), whereas A is specific to T‑ALL and unrelated to breast cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014797Z"}
{"comparison_id":"0680bad8-84ec-4c5e-a86a-c704b9ec7c3a","query_id":"53","doc_a_id":"4444861","doc_b_id":"14241418","presented_order":["14241418","4444861"],"winner_id":"14241418","reasoning":"Neither document discusses ALDH1 or its prognostic association. Document A is slightly more relevant because it mentions breast cancer (trastuzumab resistance), whereas B focuses narrowly on BRCA-related replication fork stability.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014804Z"}
{"comparison_id":"eecfa59e-ead1-4390-815e-7f84ebbfcf79","query_id":"53","doc_a_id":"4795303","doc_b_id":"14241418","presented_order":["14241418","4795303"],"winner_id":"14241418","reasoning":"Document A is more relevant — it's cancer-focused (targets PI3K/mTOR signaling in tumor cells including trastuzumab-resistant cases), whereas Document B concerns neuroprotection in PC12 cells and is unrelated to breast cancer markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014810Z"}
{"comparison_id":"549b8938-ab5c-4b8e-9d90-f7f13d0a64f1","query_id":"53","doc_a_id":"14848619","doc_b_id":"14241418","presented_order":["14848619","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant — it discusses therapy in cancer including trastuzumab-resistant (breast) tumors, whereas A concerns Noxa and hypoxic cell death unrelated to ALDH1 or breast cancer prognosis.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014817Z"}
{"comparison_id":"a5304834-e2fd-4814-8efa-ff34f400f693","query_id":"53","doc_a_id":"5956380","doc_b_id":"14241418","presented_order":["14241418","5956380"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer therapies and mentions trastuzumab-resistant cancer cells (breast cancer context), whereas Document B focuses on brainstem gliomas. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:01.014822Z"}
{"comparison_id":"244ac147-475b-44f0-a134-3e2150db4615","query_id":"53","doc_a_id":"45638119","doc_b_id":"4414547","presented_order":["45638119","4414547"],"winner_id":"45638119","reasoning":"Document A directly links ALDH1 expression to poor clinical outcome in breast cancer; Document B is about PPM1D mutations and unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587460Z"}
{"comparison_id":"89b514fe-6701-4b6e-a8b3-e118db2d61e4","query_id":"53","doc_a_id":"15113221","doc_b_id":"4414547","presented_order":["4414547","15113221"],"winner_id":"15113221","reasoning":"Document B — it discusses gene expression signatures linked to poor prognosis in carcinomas, which is more relevant to a claim about expression-associated prognosis than a study on PPM1D germline mutations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587481Z"}
{"comparison_id":"683fd187-b010-469a-b25d-cabe429c2eb8","query_id":"53","doc_a_id":"21439640","doc_b_id":"4414547","presented_order":["4414547","21439640"],"winner_id":"21439640","reasoning":"Document B is more relevant — it addresses expression changes and tumor progression in breast cancer, whereas A focuses on PPM1D germline mutations and cancer predisposition. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587489Z"}
{"comparison_id":"c20fd3cd-852e-4ed7-a8b5-1905c257bdfd","query_id":"53","doc_a_id":"24349992","doc_b_id":"4414547","presented_order":["4414547","24349992"],"winner_id":"24349992","reasoning":"Document B is more relevant — it addresses mechanisms of tumor aggressiveness and microenvironmental factors tied to poor prognosis, which is closer to the ALDH1–prognosis claim than PPM1D mutation predisposition. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587497Z"}
{"comparison_id":"379d114b-2520-46e6-80ff-f8853efa05d4","query_id":"53","doc_a_id":"8963413","doc_b_id":"4414547","presented_order":["4414547","8963413"],"winner_id":"8963413","reasoning":"B — Document B discusses biomarker expression and its association with clinical outcomes in breast cancer, which is more relevant to a claim about ALDH1 expression and prognosis than Document A about PPM1D mutations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587504Z"}
{"comparison_id":"0cacdacf-b529-4c1f-97cd-f70b1bb03bdf","query_id":"53","doc_a_id":"22401720","doc_b_id":"4414547","presented_order":["22401720","4414547"],"winner_id":"22401720","reasoning":"Document A is more relevant because it examines expression of tumor markers and their relation to prognosis in breast cancer, whereas Document B concerns genetic predisposition unrelated to ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587512Z"}
{"comparison_id":"43bc4d63-0435-431e-9b06-fa51610175da","query_id":"53","doc_a_id":"7795952","doc_b_id":"4414547","presented_order":["7795952","4414547"],"winner_id":"7795952","reasoning":"Document A — it discusses a protein linked to poor cancer prognosis and tumor aggressiveness, which is more related to prognosis than the genetic predisposition focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587519Z"}
{"comparison_id":"32340d3b-5230-497c-ba85-a9256ca62707","query_id":"53","doc_a_id":"25973484","doc_b_id":"4414547","presented_order":["4414547","25973484"],"winner_id":"25973484","reasoning":"Document B — it discusses factors linked to breast cancer prognosis (though not ALDH1 specifically), whereas A focuses on PPM1D mutations and predisposition. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587526Z"}
{"comparison_id":"bd151bb0-f1f5-4d4b-8e19-8eb4fb4ce2c3","query_id":"53","doc_a_id":"7821634","doc_b_id":"4414547","presented_order":["7821634","4414547"],"winner_id":"7821634","reasoning":"Document A is more relevant — it discusses expression of a marker (DUSP4) linked to poor outcomes in breast cancer, whereas B concerns genetic predisposition unrelated to prognostic marker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587532Z"}
{"comparison_id":"b9257ff2-aa6e-4b1b-8d07-50cb817d14f8","query_id":"53","doc_a_id":"12762485","doc_b_id":"4414547","presented_order":["12762485","4414547"],"winner_id":"12762485","reasoning":"Document A — it discusses a stem-cell-like phenotype in breast cancer (linked to poorer differentiation and higher proliferation), which is more relevant to ALDH1 (a stem cell marker) and prognosis than the genetic predisposition focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587539Z"}
{"comparison_id":"466f925b-5645-4a6d-b626-027c861e5793","query_id":"53","doc_a_id":"24205118","doc_b_id":"4414547","presented_order":["4414547","24205118"],"winner_id":"4414547","reasoning":"Document A — it concerns breast cancer (though not ALDH1), while B is about cervical cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587546Z"}
{"comparison_id":"423dd99d-67cb-4759-b482-83e536fe5481","query_id":"53","doc_a_id":"2061878","doc_b_id":"4414547","presented_order":["2061878","4414547"],"winner_id":"2061878","reasoning":"Reason: Document A discusses biomarkers and associations with poor prognosis in solid tumors, which is more related to a prognostic marker claim than Document B's focus on PPM1D germline predisposition.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587554Z"}
{"comparison_id":"c8542b96-981e-4840-a669-de057b66d05c","query_id":"53","doc_a_id":"4889228","doc_b_id":"4414547","presented_order":["4414547","4889228"],"winner_id":"4889228","reasoning":"Document B is more relevant because it discusses gene expression levels (TDP43) being associated with poor prognosis in breast cancer, which is conceptually closer to the ALDH1 expression–prognosis claim than the genetic predisposition focus of Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587561Z"}
{"comparison_id":"53b258e3-f36a-436d-9325-f00b7a4a2f54","query_id":"53","doc_a_id":"4429932","doc_b_id":"4414547","presented_order":["4414547","4429932"],"winner_id":"4429932","reasoning":"Document B — it discusses factors associated with poor outcomes in breast cancer (prognosis-related), whereas A is about PPM1D mutations and cancer predisposition. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587569Z"}
{"comparison_id":"b3deef84-8c6d-4eb1-b926-38c3b6ff198d","query_id":"53","doc_a_id":"1171121","doc_b_id":"4414547","presented_order":["4414547","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it discusses prognostic markers in breast cancer, whereas A focuses on PPM1D mutations and cancer predisposition. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587576Z"}
{"comparison_id":"f478924b-f644-4f9a-b6fc-e8f1a591b063","query_id":"53","doc_a_id":"7583725","doc_b_id":"4414547","presented_order":["7583725","4414547"],"winner_id":"7583725","reasoning":"Document A is more relevant — it describes a protein's expression being linked to poor outcomes in breast cancer, which is analogous to an ALDH1 expression–prognosis relationship. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587583Z"}
{"comparison_id":"5f041cea-b204-4635-b300-a777d6476cbe","query_id":"53","doc_a_id":"32721137","doc_b_id":"4414547","presented_order":["4414547","32721137"],"winner_id":"4414547","reasoning":"Document A is about genetic alterations linked to breast cancer risk, so it's more relevant to a claim about prognosis in breast cancer than Document B, which studies endometrial carcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587590Z"}
{"comparison_id":"92520e23-75a4-4904-bda5-6dbca921f03a","query_id":"53","doc_a_id":"12358173","doc_b_id":"4414547","presented_order":["12358173","4414547"],"winner_id":"4414547","reasoning":"Document B — it concerns breast cancer (though not ALDH1), while A is about a different cancer type (lung). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587597Z"}
{"comparison_id":"e6ed6530-c7a4-4e56-bbac-ada329d0d513","query_id":"53","doc_a_id":"19673227","doc_b_id":"4414547","presented_order":["4414547","19673227"],"winner_id":"19673227","reasoning":"Document B is more relevant — it addresses prognostic/predictive biomarkers and survival outcomes, whereas A focuses on PPM1D germline mutations and predisposition. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587604Z"}
{"comparison_id":"eac4fafa-f663-4d2c-b0c0-e7043fc127f6","query_id":"53","doc_a_id":"20839751","doc_b_id":"4414547","presented_order":["20839751","4414547"],"winner_id":"20839751","reasoning":"Document A is more relevant — it discusses prognostic factors in breast cancer, whereas Document B is about PPM1D mutations unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587611Z"}
{"comparison_id":"0a1413a9-4070-46cb-ae67-25d9cfc45759","query_id":"53","doc_a_id":"13007205","doc_b_id":"4414547","presented_order":["13007205","4414547"],"winner_id":"13007205","reasoning":"Reason: Document A discusses tumor progression and factors enhancing breast cancer invasiveness, which is more related to prognosis than Document B's focus on germline predisposition via PPM1D mutations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587617Z"}
{"comparison_id":"edb8269d-c368-492b-8874-7062eecf72d8","query_id":"53","doc_a_id":"31591262","doc_b_id":"4414547","presented_order":["31591262","4414547"],"winner_id":"4414547","reasoning":"Reason: Document B concerns genetic findings in breast cancer (though not ALDH1), whereas Document A is about markers in rectal cancer and is less relevant to breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587624Z"}
{"comparison_id":"e555c4fa-09d4-4090-96ff-b0b8b5a140cd","query_id":"53","doc_a_id":"313403","doc_b_id":"4414547","presented_order":["4414547","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it addresses prognostic markers and associations with poor outcome in breast cancer, whereas Document A concerns PPM1D mutations and cancer predisposition. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587632Z"}
{"comparison_id":"7b008877-31ba-4915-b842-09a2dc873aa1","query_id":"53","doc_a_id":"29366489","doc_b_id":"4414547","presented_order":["4414547","29366489"],"winner_id":"29366489","reasoning":"Document B — it discusses a tumor suppressor and its potential as a molecular marker for cancer prognosis, which is more relevant to a claim about expression markers and prognosis in breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587639Z"}
{"comparison_id":"54f32223-fe07-4401-ab89-b8661ea75c2e","query_id":"53","doc_a_id":"32001951","doc_b_id":"4414547","presented_order":["32001951","4414547"],"winner_id":"32001951","reasoning":"Document A is more relevant — it discusses regulation of enzyme expression in breast cancer cells (closer to ALDH1 expression) while Document B concerns PPM1D mutations unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587646Z"}
{"comparison_id":"af190fe8-fbb6-4787-817b-1652aa08100c","query_id":"53","doc_a_id":"13030852","doc_b_id":"4414547","presented_order":["4414547","13030852"],"winner_id":"13030852","reasoning":"Document B is more relevant — it deals with biomarkers and clinical prognosis/monitoring in breast cancer, whereas A addresses genetic predisposition (PPM1D) unrelated to ALDH1 expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587653Z"}
{"comparison_id":"76f3179f-7d33-4128-87e3-3641567c9d03","query_id":"53","doc_a_id":"4820792","doc_b_id":"4414547","presented_order":["4820792","4414547"],"winner_id":"4820792","reasoning":"Neither abstract mentions ALDH1 or provides direct evidence. Document A is slightly more relevant because it addresses breast cancer cell survival and therapy resistance (more related to prognosis) while B focuses on germline predisposition.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587661Z"}
{"comparison_id":"c9434c9a-eefd-4d62-9154-7eae67bf9617","query_id":"53","doc_a_id":"24341590","doc_b_id":"4414547","presented_order":["24341590","4414547"],"winner_id":"24341590","reasoning":"Document A is more relevant because it addresses clinical outcomes and prognosis in breast cancer, whereas Document B focuses on genetic predisposition rather than prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587667Z"}
{"comparison_id":"2a517c96-656a-4174-a399-4082390ba55b","query_id":"53","doc_a_id":"43385013","doc_b_id":"4414547","presented_order":["4414547","43385013"],"winner_id":"43385013","reasoning":"Document B — it addresses stem cell/progenitor properties in breast cells (ALDH1 is a stem cell marker), whereas Document A focuses on PPM1D mutations unrelated to ALDH1 or prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587674Z"}
{"comparison_id":"cee110ee-a64b-454e-b39d-bf4831053968","query_id":"53","doc_a_id":"2931832","doc_b_id":"4414547","presented_order":["2931832","4414547"],"winner_id":"2931832","reasoning":"Document A is more relevant because it studies a prognostic biomarker in breast cancer, whereas Document B addresses genetic predisposition rather than prognosis.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587681Z"}
{"comparison_id":"ded9a3e9-91b7-4482-bfe8-0fed781f8773","query_id":"53","doc_a_id":"8037453","doc_b_id":"4414547","presented_order":["8037453","4414547"],"winner_id":"8037453","reasoning":"Document A is more relevant — it discusses marker expression and associations with prognosis in cancer patients, aligning with the query about a prognostic marker. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587688Z"}
{"comparison_id":"bc4e35c5-9b27-488e-a656-ea328a8bf802","query_id":"53","doc_a_id":"17648235","doc_b_id":"4414547","presented_order":["4414547","17648235"],"winner_id":"17648235","reasoning":"Document B is more relevant — it addresses breast cancer tumor biology (proliferation/apoptosis) and pathways that can affect prognosis, whereas A focuses on PPM1D germline mutations unrelated to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587695Z"}
{"comparison_id":"f00e1097-ecfe-41d6-8104-1203b869538f","query_id":"53","doc_a_id":"15721252","doc_b_id":"4414547","presented_order":["4414547","15721252"],"winner_id":"15721252","reasoning":"Document B — it addresses molecular markers and prognostic/predictive features in breast cancer, while A focuses on PPM1D mutations unrelated to ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587702Z"}
{"comparison_id":"83970062-b4de-4ea2-96e1-b1d3a639e1ac","query_id":"53","doc_a_id":"19358586","doc_b_id":"4414547","presented_order":["19358586","4414547"],"winner_id":"19358586","reasoning":"Document A is more relevant — it discusses protein expression signatures linked to poor survival in breast cancer, which relates to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587708Z"}
{"comparison_id":"120bdfb9-cac8-4e65-95fa-566572a94f9f","query_id":"53","doc_a_id":"2140497","doc_b_id":"4414547","presented_order":["4414547","2140497"],"winner_id":"4414547","reasoning":"Document A is slightly more relevant — it addresses molecular/genetic factors linked to breast cancer biology, whereas B focuses on benign-disease risk factors. Neither mentions ALDH1 or prognosis specifically.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587715Z"}
{"comparison_id":"ffa78efd-9dba-4c71-91f7-fd097569c6c6","query_id":"53","doc_a_id":"16734530","doc_b_id":"4414547","presented_order":["16734530","4414547"],"winner_id":"16734530","reasoning":"Document A is more relevant — it links genetic markers to breast cancer clinical features (ER status, nodal involvement), which is closer to prognosis-related evidence than the PPM1D predisposition study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587722Z"}
{"comparison_id":"c587e2a9-5dfd-4caa-8723-66931d0d101e","query_id":"53","doc_a_id":"20127522","doc_b_id":"4414547","presented_order":["20127522","4414547"],"winner_id":"20127522","reasoning":"Document A is more relevant — it addresses prognostic markers and outcomes in breast cancer (poorer progression-free survival), whereas Document B focuses on genetic predisposition not prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587730Z"}
{"comparison_id":"3ce2ce99-d04e-4f0b-8b73-12bd29f486d0","query_id":"53","doc_a_id":"5500086","doc_b_id":"4414547","presented_order":["4414547","5500086"],"winner_id":"5500086","reasoning":"B — Document B discusses factors tied to clinical outcomes and prognosis in breast cancer (type I IFN signature and response), making it more relevant to a claim about a prognostic marker than Document A, which focuses on germline PPM1D mutations and cancer predisposition.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587738Z"}
{"comparison_id":"82660666-f249-4768-aa72-7cd3eb408e44","query_id":"53","doc_a_id":"17755060","doc_b_id":"4414547","presented_order":["17755060","4414547"],"winner_id":"17755060","reasoning":"Document A is more relevant — it discusses tumor metabolic markers and links deficiency to increased tumorigenesis and poor prognosis in human cancers, whereas Document B focuses on PPM1D germline mutations and cancer predisposition, not prognosis or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587745Z"}
{"comparison_id":"7ce7ca9b-e960-4c48-ae0c-432833bda75a","query_id":"53","doc_a_id":"25732836","doc_b_id":"4414547","presented_order":["25732836","4414547"],"winner_id":"25732836","reasoning":"Document A is more relevant — it concerns prognostic markers and outcome prediction in breast cancer, whereas Document B focuses on genetic predisposition and not prognosis or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587752Z"}
{"comparison_id":"e99fa0a6-39ef-48f9-adf9-0dd3b733dfb0","query_id":"53","doc_a_id":"27240667","doc_b_id":"4414547","presented_order":["4414547","27240667"],"winner_id":"27240667","reasoning":"Document B — it discusses breast cancer prognosis/mortality trends, which is more directly related to the claim about prognosis than Document A (which focuses on genetic predisposition). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587759Z"}
{"comparison_id":"7cd6ef91-adc3-47f9-87b2-c4e1fc445666","query_id":"53","doc_a_id":"9486930","doc_b_id":"4414547","presented_order":["4414547","9486930"],"winner_id":"4414547","reasoning":"Document A is more relevant because it discusses genetic findings in breast cancer (even though not ALDH1), whereas Document B concerns glioblastoma. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587766Z"}
{"comparison_id":"e0a35055-4f7d-460e-99bf-955811e1f642","query_id":"53","doc_a_id":"19882228","doc_b_id":"4414547","presented_order":["19882228","4414547"],"winner_id":"19882228","reasoning":"Document A is slightly more relevant because it discusses tumor features linked to poor prognosis, whereas Document B focuses on genetic predisposition (PPM1D) unrelated to ALDH1 or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587773Z"}
{"comparison_id":"4709cbe4-4d3c-4ce3-b5a2-ded5ba96856f","query_id":"53","doc_a_id":"22521091","doc_b_id":"4414547","presented_order":["4414547","22521091"],"winner_id":"4414547","reasoning":"Document A is more relevant — it concerns breast cancer (even though it focuses on PPM1D rather than ALDH1), while Document B addresses a different gene in hepatocellular carcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587780Z"}
{"comparison_id":"edecacfa-e800-4df7-b48d-00f174248adc","query_id":"53","doc_a_id":"4999633","doc_b_id":"4414547","presented_order":["4414547","4999633"],"winner_id":"4999633","reasoning":"Document B is more relevant — it studies how protein expression levels in breast cancer cells affect proliferation, which is closer to an expression–prognosis question than a germline mutation predisposition study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587788Z"}
{"comparison_id":"faad4a91-fc7f-4981-ab33-3c400bd1f3d9","query_id":"53","doc_a_id":"24249915","doc_b_id":"4414547","presented_order":["24249915","4414547"],"winner_id":"24249915","reasoning":"Document A is more relevant — it addresses expression changes in breast cancer tissues (similar topic to ALDH1 expression and prognosis), whereas Document B focuses on germline/mosaic PPM1D mutations unrelated to ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587795Z"}
{"comparison_id":"1c9e7ee1-d01c-497f-b25a-32571b3f1ab1","query_id":"53","doc_a_id":"4455466","doc_b_id":"4414547","presented_order":["4414547","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it links gene expression levels to breast cancer prognosis (mentions low expression associated with poor prognosis), whereas A is about PPM1D mutations unrelated to ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587802Z"}
{"comparison_id":"d5546daf-f258-4cd3-aec3-3ca148c4c259","query_id":"53","doc_a_id":"3285322","doc_b_id":"4414547","presented_order":["4414547","3285322"],"winner_id":"3285322","reasoning":"Document B is more relevant — it discusses clinical and pathologic features and prognosis-related tumor characteristics in breast cancer, which is closer to an expression–prognosis claim than a genetic predisposition study. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587810Z"}
{"comparison_id":"3d6e2ec3-aae4-41d3-933a-35a4a8c37f35","query_id":"53","doc_a_id":"9600826","doc_b_id":"4414547","presented_order":["9600826","4414547"],"winner_id":"9600826","reasoning":"Document A is more relevant — it discusses molecular pathways and overexpression in breast cancer related to invasion/angiogenesis, which is closer to ALDH1's role as a prognostic molecular marker; Document B concerns unrelated PPM1D mutations. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587817Z"}
{"comparison_id":"f6329436-84a8-466b-8260-d20c85400ece","query_id":"53","doc_a_id":"17021845","doc_b_id":"4414547","presented_order":["4414547","17021845"],"winner_id":"4414547","reasoning":"Document A is more relevant — it addresses breast cancer (though not ALDH1 specifically), whereas Document B concerns Nanog in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587824Z"}
{"comparison_id":"2de70dea-da38-45b4-8a7f-50ec6f283eda","query_id":"53","doc_a_id":"13069283","doc_b_id":"4414547","presented_order":["13069283","4414547"],"winner_id":"13069283","reasoning":"Document A is slightly more relevant because it concerns biomarkers and treatment outcomes in breast cancer patients, whereas Document B focuses on genetic predisposition unrelated to ALDH1 expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587830Z"}
{"comparison_id":"fb2927af-661c-42c7-a85e-66ad54217659","query_id":"53","doc_a_id":"2130391","doc_b_id":"4414547","presented_order":["4414547","2130391"],"winner_id":"2130391","reasoning":"Document B is more relevant — it addresses tumor progression and factors influencing breast cancer invasion/prognosis, whereas Document A concerns PPM1D mutations unrelated to ALDH1 expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587838Z"}
{"comparison_id":"2b688f2a-f445-4bb2-a36a-7363836a078d","query_id":"53","doc_a_id":"22509015","doc_b_id":"4414547","presented_order":["4414547","22509015"],"winner_id":"22509015","reasoning":"Reason: Document B discusses tumor signaling and metastasis in breast cancer (related to prognosis and tumor markers), while Document A focuses on germline PPM1D mutations and cancer predisposition, so B is more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587845Z"}
{"comparison_id":"69c4ce3b-67f9-4572-9fe7-3db175ef8f2c","query_id":"53","doc_a_id":"18340282","doc_b_id":"4414547","presented_order":["18340282","4414547"],"winner_id":"4414547","reasoning":"Neither abstract addresses ALDH1 or prognosis directly; however, B is slightly more relevant because it reports molecular genetic alterations linked to cancer predisposition and functional tumor biology, whereas A focuses on gene–environment risk interactions. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587852Z"}
{"comparison_id":"d6d85b8a-2077-4476-84c1-351427fec0fa","query_id":"53","doc_a_id":"1866911","doc_b_id":"4414547","presented_order":["1866911","4414547"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses breast tumor cell populations and marker expression (luminal progenitor markers) related to tumor phenotype/prognosis, whereas Document B focuses on PPM1D germline mutations and cancer predisposition without marker/prognosis data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587859Z"}
{"comparison_id":"1a4a15c5-4346-491b-b2e2-9055b13f44e2","query_id":"53","doc_a_id":"21033230","doc_b_id":"4414547","presented_order":["4414547","21033230"],"winner_id":"21033230","reasoning":"Document B — it discusses molecular markers and prognosis in metastatic breast cancer, which is more relevant to a claim about ALDH1 as a prognostic marker than Document A, which focuses on PPM1D mutations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587866Z"}
{"comparison_id":"fab88cc3-51c9-4e64-b0e9-b5d54d6f33ca","query_id":"53","doc_a_id":"21902400","doc_b_id":"4414547","presented_order":["4414547","21902400"],"winner_id":"21902400","reasoning":"Document B — it discusses prognostic markers and adverse prognostic factors in tumors, making it more relevant to a claim about prognosis than Document A, which focuses on PPM1D mutations. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587873Z"}
{"comparison_id":"8aa55ad7-aee0-4534-8fd6-93b878bc9779","query_id":"53","doc_a_id":"1782201","doc_b_id":"4414547","presented_order":["4414547","1782201"],"winner_id":"4414547","reasoning":"Document A is more relevant because it directly concerns breast cancer (whereas B focuses on pancreatic/other carcinomas) and is more likely to discuss prognostic markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587881Z"}
{"comparison_id":"2847166c-4f6e-4d5b-a7d7-9a6422cb7be9","query_id":"53","doc_a_id":"4418878","doc_b_id":"4414547","presented_order":["4418878","4414547"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and their links to cancer prognosis, which relates to ALDH1 expression as a prognostic marker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587887Z"}
{"comparison_id":"8303d7ac-381f-46fc-a14d-e164b12a18bd","query_id":"53","doc_a_id":"20454006","doc_b_id":"4414547","presented_order":["4414547","20454006"],"winner_id":"20454006","reasoning":"Neither document addresses ALDH1. Document B is slightly more relevant because it deals with breast cancer biomarkers and clinical outcomes, whereas A focuses on PPM1D germline mutations and cancer predisposition. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587894Z"}
{"comparison_id":"ef0b04c7-3050-4027-a045-310c95061797","query_id":"53","doc_a_id":"52180874","doc_b_id":"4414547","presented_order":["52180874","4414547"],"winner_id":"4414547","reasoning":"Document B is more relevant — it concerns genetic factors linked to breast cancer specifically, while Document A addresses PD-1/PD-L1 therapy across cancers and doesn't relate to ALDH1 or prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587902Z"}
{"comparison_id":"603e9ee2-d1d7-4eef-83c3-d81d8f299064","query_id":"53","doc_a_id":"1554348","doc_b_id":"4414547","presented_order":["4414547","1554348"],"winner_id":"1554348","reasoning":"Document B is more relevant — it deals with protein expression in breast cancer cells (though not ALDH1 or prognosis specifically), whereas Document A concerns PPM1D germline mutations and cancer predisposition. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587909Z"}
{"comparison_id":"eaa6f174-da64-4b07-aa1b-faa1d48a92ce","query_id":"53","doc_a_id":"38623601","doc_b_id":"4414547","presented_order":["4414547","38623601"],"winner_id":"38623601","reasoning":"Document B is more relevant — it discusses protein expression levels (ASS1) and clinical implications in breast cancer, which is closer to a claim about marker expression and prognosis than a paper on mosaic PPM1D germline mutations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587916Z"}
{"comparison_id":"2dfcb926-c7f1-4a87-8b1f-90a72ed71016","query_id":"53","doc_a_id":"5864770","doc_b_id":"4414547","presented_order":["4414547","5864770"],"winner_id":"5864770","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it discusses molecular factors and mechanisms affecting breast cancer prognosis/risk, whereas A focuses on PPM1D germline mutations unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587923Z"}
{"comparison_id":"2fb65269-103a-4016-9ea0-079695399745","query_id":"53","doc_a_id":"3329824","doc_b_id":"4414547","presented_order":["4414547","3329824"],"winner_id":"3329824","reasoning":"Document B is more relevant — it addresses breast cancer outcomes (risk of CNS recurrence) while Document A focuses on genetic predisposition, not prognostic markers like ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587930Z"}
{"comparison_id":"c95b3342-de24-4acf-99b4-33be8c7a5301","query_id":"53","doc_a_id":"15521377","doc_b_id":"4414547","presented_order":["15521377","4414547"],"winner_id":"15521377","reasoning":"Document A is slightly more relevant because it discusses cancer-related cellular processes affecting tumor behavior and prognosis, whereas Document B concerns genetic predisposition rather than markers linked to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587937Z"}
{"comparison_id":"2c4744ba-dc4e-4c01-afb6-2941ef055f4e","query_id":"53","doc_a_id":"164985","doc_b_id":"4414547","presented_order":["4414547","164985"],"winner_id":"164985","reasoning":"Document B — it concerns tumor progression mechanisms in mammary (breast) cancer and the tumor microenvironment, which is more related to prognosis than a genetic predisposition study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587944Z"}
{"comparison_id":"8ff6fb12-f764-4c8f-b360-d0014c091dcc","query_id":"53","doc_a_id":"1389264","doc_b_id":"4414547","presented_order":["1389264","4414547"],"winner_id":"1389264","reasoning":"Document A is more relevant — it discusses biomarkers and treatment outcomes in breast cancer, whereas Document B focuses on genetic predisposition rather than prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587951Z"}
{"comparison_id":"a9ab03cb-962e-4b3b-ba16-39e26e97a8fa","query_id":"53","doc_a_id":"22482820","doc_b_id":"4414547","presented_order":["22482820","4414547"],"winner_id":"22482820","reasoning":"Document A is more relevant — it addresses breast cancer classifications, treatment challenges (including markers and drug resistance) and is more likely to discuss prognostic markers like ALDH1 than a genetic predisposition study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587958Z"}
{"comparison_id":"1fe8fe0a-3ea0-4b6f-ab4b-a90f2dddd5fc","query_id":"53","doc_a_id":"15559582","doc_b_id":"4414547","presented_order":["4414547","15559582"],"winner_id":"15559582","reasoning":"Document B — it discusses biomarkers and associations with invasive/poorly differentiated breast cancer (relating to prognosis), whereas A is about PPM1D mutations and cancer predisposition. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587965Z"}
{"comparison_id":"40c649b4-1f35-4e4c-a44e-74cc9cda58f5","query_id":"53","doc_a_id":"25523969","doc_b_id":"4414547","presented_order":["25523969","4414547"],"winner_id":"25523969","reasoning":"Document A is more relevant — it involves expression profiling and immunohistochemical analysis of markers in metastatic cancers, which is closer to evaluating protein expression (like ALDH1) and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587972Z"}
{"comparison_id":"316b6593-d15f-47c7-b2ed-2590bbe55197","query_id":"53","doc_a_id":"8671456","doc_b_id":"4414547","presented_order":["8671456","4414547"],"winner_id":"8671456","reasoning":"Document A is more relevant — it concerns breast cancer treatment and survival outcomes, which relate to prognosis, whereas Document B focuses on genetic predisposition unrelated to ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587979Z"}
{"comparison_id":"c439e843-0dee-462b-95f9-c19200a7e9ba","query_id":"53","doc_a_id":"31311495","doc_b_id":"4414547","presented_order":["31311495","4414547"],"winner_id":"31311495","reasoning":"Document A is more relevant — it discusses mechanisms driving increased aggressiveness/EMT in breast cancer, which relates to prognosis, whereas B concerns PPM1D germline mutations and cancer predisposition, not markers like ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587986Z"}
{"comparison_id":"6a8ba958-9e24-4094-85c4-55ff11888379","query_id":"53","doc_a_id":"4886637","doc_b_id":"4414547","presented_order":["4886637","4414547"],"winner_id":"4886637","reasoning":"Neither document addresses ALDH1 or its prognostic value. If one must be chosen, ANSWER: A — it discusses breast cancer clinical associations (risk/prognosis) more broadly, whereas B focuses on a distinct genetic mutation.","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.587993Z"}
{"comparison_id":"48b2caed-3153-4f7a-9c6b-ef3fc495357f","query_id":"53","doc_a_id":"5649538","doc_b_id":"4414547","presented_order":["5649538","4414547"],"winner_id":"5649538","reasoning":"Document A is more relevant — it deals with gene expression markers in breast cancer (more likely to address expression-prognosis links), whereas Document B concerns PPM1D germline mutations and cancer predisposition, not ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588000Z"}
{"comparison_id":"74391f46-28b5-4cc9-9742-8c1e71b5f7d1","query_id":"53","doc_a_id":"22975806","doc_b_id":"4414547","presented_order":["22975806","4414547"],"winner_id":"22975806","reasoning":"Document A is more relevant — it discusses breast tumorigenesis and clinical implications, whereas B focuses on inherited predisposition via PPM1D mutations and not prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588008Z"}
{"comparison_id":"ead54803-b3cf-4863-a226-1df02315fe18","query_id":"53","doc_a_id":"16086778","doc_b_id":"4414547","presented_order":["16086778","4414547"],"winner_id":"16086778","reasoning":"Document A is more relevant — it addresses molecular pathways and tumor behavior in breast cancer, which is closer to prognostic marker studies than a paper on PPM1D genetic predisposition. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588015Z"}
{"comparison_id":"e84ceb62-28f2-4cdf-8d6b-90b6255c83b9","query_id":"53","doc_a_id":"29495185","doc_b_id":"4414547","presented_order":["4414547","29495185"],"winner_id":"29495185","reasoning":"Document B — it discusses molecular predictors of cancer prognosis and survival, which is relevant to ALDH1 as a prognostic marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588021Z"}
{"comparison_id":"f99e0dfd-4772-45b7-a15e-83642854109d","query_id":"53","doc_a_id":"4702639","doc_b_id":"4414547","presented_order":["4414547","4702639"],"winner_id":"4702639","reasoning":"Document B is more relevant — it addresses tumour stemness and markers linked to resistance/poor outcomes, which is closer to ALDH1 (a cancer stem cell marker) than PPM1D mutation predisposition.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588029Z"}
{"comparison_id":"e0db19b9-4ed7-4d68-a96d-983c61a7bf68","query_id":"53","doc_a_id":"1379127","doc_b_id":"4414547","presented_order":["4414547","1379127"],"winner_id":"1379127","reasoning":"Document B is more relevant — it addresses factors (migration/metastasis) tied to cancer prognosis, whereas A concerns PPM1D germline mutations unrelated to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588035Z"}
{"comparison_id":"04a51318-ea6e-4ab6-81fe-3907b0ca5386","query_id":"53","doc_a_id":"24834968","doc_b_id":"4414547","presented_order":["4414547","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it evaluates biological markers and their relation to breast cancer outcomes, whereas A focuses on PPM1D germline mutations and cancer predisposition. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588042Z"}
{"comparison_id":"a1a222fc-6621-411b-8596-416499ba5310","query_id":"53","doc_a_id":"24144677","doc_b_id":"4414547","presented_order":["4414547","24144677"],"winner_id":"24144677","reasoning":"Neither abstract mentions ALDH1. Both are irrelevant, but Document B is slightly more related since it reports an association study in breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588049Z"}
{"comparison_id":"6b8c7178-6977-49da-b3b8-a3462c43594a","query_id":"53","doc_a_id":"67045088","doc_b_id":"4414547","presented_order":["67045088","4414547"],"winner_id":"67045088","reasoning":"Document A is more related because it discusses tumor biology in breast cancer, whereas B focuses on PPM1D mutations and cancer predisposition, not ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588055Z"}
{"comparison_id":"ee786bf2-3157-4d0c-95f7-e515dda5cd68","query_id":"53","doc_a_id":"195680777","doc_b_id":"4414547","presented_order":["195680777","4414547"],"winner_id":"195680777","reasoning":"Reason: Document A addresses prognosis and long-term outcomes in breast cancer, which is more relevant to a claim about a prognostic biomarker than Document B's focus on genetic predisposition.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588062Z"}
{"comparison_id":"42241d32-58e5-4e66-9db5-ffb7b5656db0","query_id":"53","doc_a_id":"15946643","doc_b_id":"4414547","presented_order":["15946643","4414547"],"winner_id":"15946643","reasoning":"Document A is about mechanisms of chemoresistance and metastasis in breast cancer (topics directly related to prognosis and markers like ALDH1), while Document B concerns germline/somatic PPM1D mutations and predisposition, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588069Z"}
{"comparison_id":"f6b8f887-4b3a-4439-97d5-5b62f02fdcfc","query_id":"53","doc_a_id":"31616203","doc_b_id":"4414547","presented_order":["4414547","31616203"],"winner_id":"31616203","reasoning":"Document B is more relevant — it reports outcomes and prognosis-related treatment responses in breast cancer, while A discusses germline predisposition not prognostic markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588075Z"}
{"comparison_id":"c325c52c-d775-4e18-9aad-66f84826d298","query_id":"53","doc_a_id":"6550579","doc_b_id":"4414547","presented_order":["6550579","4414547"],"winner_id":"6550579","reasoning":"Neither abstract mentions ALDH1. Document A is marginally more relevant because it addresses prognosis/therapy in breast cancer, whereas B focuses on genetic predisposition. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588082Z"}
{"comparison_id":"36a93a38-0db6-4c54-8741-9093feac7fac","query_id":"53","doc_a_id":"878526","doc_b_id":"4414547","presented_order":["4414547","878526"],"winner_id":"878526","reasoning":"Document B is more relevant because it addresses mechanisms of breast cancer metastasis and tumor behavior tied to prognosis, whereas A focuses on germline PPM1D mutations and cancer predisposition. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588089Z"}
{"comparison_id":"b94168a8-9f1a-4385-b969-e0a5a8a259cf","query_id":"53","doc_a_id":"23863551","doc_b_id":"4414547","presented_order":["23863551","4414547"],"winner_id":"23863551","reasoning":"A is more relevant — it discusses expression changes and treatment response in breast cancer (closer to prognostic biomarkers) while B concerns genetic predisposition, not tumor marker expression or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588095Z"}
{"comparison_id":"c9c6bd3d-0c25-4de9-a64c-2d114a28767d","query_id":"53","doc_a_id":"20183360","doc_b_id":"4414547","presented_order":["20183360","4414547"],"winner_id":"20183360","reasoning":"Document A is more relevant — it discusses mechanisms of breast cancer invasiveness and tumor progression (related to prognosis), whereas B focuses on germline/somatic predisposition unrelated to ALDH1 expression or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588102Z"}
{"comparison_id":"4583d7ce-57ff-4521-b390-486609debdf3","query_id":"53","doc_a_id":"13765757","doc_b_id":"4414547","presented_order":["13765757","4414547"],"winner_id":"4414547","reasoning":"Neither abstract mentions ALDH1 or prognosis; both are irrelevant. Document B is marginally more related because it addresses molecular/genetic factors in breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588109Z"}
{"comparison_id":"39af6095-451c-4392-86b5-b7b16abcfa05","query_id":"53","doc_a_id":"7875158","doc_b_id":"4414547","presented_order":["4414547","7875158"],"winner_id":"7875158","reasoning":"Neither document addresses ALDH1 or prognosis directly. Document B is slightly more related because it concerns multidrug-resistant breast cancer cells (ALDH1 is a stem-cell/drug-resistance marker), while A focuses on PPM1D mutations. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588116Z"}
{"comparison_id":"42ae40d8-610b-4f7d-b112-c6f588df53f8","query_id":"53","doc_a_id":"3222187","doc_b_id":"4414547","presented_order":["3222187","4414547"],"winner_id":"4414547","reasoning":"Document B — it concerns genetic factors linked directly to breast cancer predisposition and tumor biology, which is closer to prognosis than vitamin D level determinants. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588123Z"}
{"comparison_id":"06524c27-e899-4567-8019-c5836132b0cb","query_id":"53","doc_a_id":"2015126","doc_b_id":"4414547","presented_order":["2015126","4414547"],"winner_id":"2015126","reasoning":"Reason: Neither document discusses ALDH1 or prognosis directly, but Document A (management of genetically predisposed women) is marginally more related to clinical outcomes in breast cancer than the genetic mutation-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588130Z"}
{"comparison_id":"04721f3f-3f91-42f9-8755-47f442e7d586","query_id":"53","doc_a_id":"16390264","doc_b_id":"4414547","presented_order":["4414547","16390264"],"winner_id":"4414547","reasoning":"Document A is more relevant — it concerns molecular genetic factors linked to breast cancer, which is closer to a claim about a molecular marker and prognosis than a study of social access to care.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588137Z"}
{"comparison_id":"b4f970be-737a-459c-bde7-52df35feb46d","query_id":"53","doc_a_id":"17163294","doc_b_id":"4414547","presented_order":["17163294","4414547"],"winner_id":"17163294","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it discusses biomarkers/metabolic profiles in breast cancer, whereas B concerns genetic predisposition (PPM1D) unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588144Z"}
{"comparison_id":"97d205e2-a6f3-4265-89c6-0b170a5ca828","query_id":"53","doc_a_id":"34066665","doc_b_id":"4414547","presented_order":["34066665","4414547"],"winner_id":"34066665","reasoning":"Document A — it deals with breast cancer signaling and clinical prognosis/treatment implications, making it more likely to address markers like ALDH1 than a paper on PPM1D germline predisposition. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588151Z"}
{"comparison_id":"21cbb951-606f-4fa1-9a81-b39058a74745","query_id":"53","doc_a_id":"12438901","doc_b_id":"4414547","presented_order":["4414547","12438901"],"winner_id":"4414547","reasoning":"Document A is slightly more relevant because it addresses molecular/genetic factors linked to breast cancer biology, whereas Document B focuses on treatment duration outcomes unrelated to ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588157Z"}
{"comparison_id":"42ce22ed-758a-4db0-9a77-15f219d8a955","query_id":"53","doc_a_id":"3524352","doc_b_id":"4414547","presented_order":["3524352","4414547"],"winner_id":"4414547","reasoning":"Document B is more relevant — it addresses molecular/genetic factors in breast cancer (though not ALDH1 specifically), whereas A is a geographic mortality study unrelated to molecular markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588164Z"}
{"comparison_id":"7b139ae6-8c0d-4fed-b174-4547c79f84e4","query_id":"53","doc_a_id":"16691520","doc_b_id":"4414547","presented_order":["4414547","16691520"],"winner_id":"16691520","reasoning":"Document B — it addresses genome-wide gene regulation in breast cancer and is more likely to include data on gene expression relevant to prognosis than Document A, which focuses on PPM1D mutations unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588171Z"}
{"comparison_id":"4c9fecf5-2c46-4e4f-9977-fb5ac569d635","query_id":"53","doc_a_id":"11880289","doc_b_id":"4414547","presented_order":["11880289","4414547"],"winner_id":"11880289","reasoning":"Document A — it reports breast cancer mortality/outcomes (prognosis), whereas B concerns genetic predisposition not expression or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588177Z"}
{"comparison_id":"f008141e-e9d0-4953-8a88-dbd829957e3a","query_id":"53","doc_a_id":"9558539","doc_b_id":"4414547","presented_order":["9558539","4414547"],"winner_id":"4414547","reasoning":"Document B — it concerns breast (and ovarian) cancer, whereas A focuses on colorectal cancer; neither mentions ALDH1 but B is more topically relevant.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588184Z"}
{"comparison_id":"e6a9a522-cd3b-47ae-ab3b-a6a1808bf4b2","query_id":"53","doc_a_id":"13519661","doc_b_id":"4414547","presented_order":["13519661","4414547"],"winner_id":"4414547","reasoning":"Neither paper discusses ALDH1 or prognosis; however, B is slightly more relevant because it addresses genetic alterations and functional effects related to breast cancer biology (potentially linked to outcomes). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588190Z"}
{"comparison_id":"e5495393-1ffc-4d7a-8db3-5a3d23ca0402","query_id":"53","doc_a_id":"20333864","doc_b_id":"4414547","presented_order":["20333864","4414547"],"winner_id":"20333864","reasoning":"Document A is more relevant — it addresses mechanisms of breast tumor progression and invasion (contexts where markers like ALDH1 and their prognostic significance are relevant), whereas Document B focuses on PPM1D germline/mosaic mutations and cancer predisposition not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588198Z"}
{"comparison_id":"136594db-5f29-4635-84e4-bbfcb37c43d8","query_id":"53","doc_a_id":"15600979","doc_b_id":"4414547","presented_order":["15600979","4414547"],"winner_id":"15600979","reasoning":"Neither abstract mentions ALDH1. Document A is slightly more relevant because it discusses tumor biology and implications for cancer progression/therapy, which relates more to prognosis than the germline predisposition focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588204Z"}
{"comparison_id":"9c65b0a2-9078-435f-bf3c-98bf17488fb7","query_id":"53","doc_a_id":"2014909","doc_b_id":"4414547","presented_order":["2014909","4414547"],"winner_id":"2014909","reasoning":"Document A is more relevant — it analyzes tumor-initiating cells in primary breast cancers (ALDH1 is a marker of such cells and linked to prognosis), whereas Document B focuses on PPM1D germline/mosaic mutations unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588211Z"}
{"comparison_id":"94c9193e-1406-4d51-88fd-20dc641ed9b7","query_id":"53","doc_a_id":"6969753","doc_b_id":"4414547","presented_order":["6969753","4414547"],"winner_id":"6969753","reasoning":"Document A is slightly more relevant — it discusses tumor invasive mechanisms related to metastasis and prognosis, whereas Document B focuses on germline/mosaic PPM1D mutations and cancer predisposition. Neither mentions ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588218Z"}
{"comparison_id":"27106eb9-02cd-4ce2-8af8-9225e6f9d84f","query_id":"53","doc_a_id":"7808055","doc_b_id":"4414547","presented_order":["7808055","4414547"],"winner_id":"4414547","reasoning":"Document B is more relevant — it directly concerns genetic factors linked to breast cancer, whereas A discusses DNA methylation age across tissues and only broadly mentions cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588225Z"}
{"comparison_id":"d22f72fa-dc5a-440d-a6dc-fc578cb3db6e","query_id":"53","doc_a_id":"3756384","doc_b_id":"4414547","presented_order":["3756384","4414547"],"winner_id":"4414547","reasoning":"Document B — it specifically concerns breast cancer (predisposition), whereas A focuses on HBV-related hepatocellular carcinoma and not breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588231Z"}
{"comparison_id":"be74997d-fdf6-49a5-afce-393b54ee25ef","query_id":"53","doc_a_id":"4583180","doc_b_id":"4414547","presented_order":["4583180","4414547"],"winner_id":"4583180","reasoning":"Document A is more relevant — it links gene expression changes to reduced patient survival/tumor progression, which is closer to a prognosis-related claim than a study on germline PPM1D predisposition. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588238Z"}
{"comparison_id":"0495c0b0-840b-4a58-9436-05e827a864cd","query_id":"53","doc_a_id":"15832146","doc_b_id":"4414547","presented_order":["4414547","15832146"],"winner_id":"15832146","reasoning":"Document B is more relevant — it discusses tumor progression and factors that worsen breast cancer behavior (growth/angiogenesis), which relates more to prognosis than the genetic predisposition focus of Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588245Z"}
{"comparison_id":"128ba3f7-ac5f-4b8c-a841-ee38451aedd4","query_id":"53","doc_a_id":"22267225","doc_b_id":"4414547","presented_order":["22267225","4414547"],"winner_id":"22267225","reasoning":"Document A is more relevant — it discusses breast cancer topics broadly (chemoprevention and clinical outcomes), whereas Document B focuses on PPM1D mutations and predisposition, not prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588252Z"}
{"comparison_id":"b2cddb9f-5ab7-42ff-853f-71f51059dd2c","query_id":"53","doc_a_id":"3848469","doc_b_id":"4414547","presented_order":["3848469","4414547"],"winner_id":"4414547","reasoning":"Document B is more relevant because it specifically concerns breast cancer, while Document A studies stemness markers in lung cancer rather than breast tumor prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588258Z"}
{"comparison_id":"9341fcc9-568b-430f-a91d-28e92323b4c0","query_id":"53","doc_a_id":"8774475","doc_b_id":"4414547","presented_order":["8774475","4414547"],"winner_id":"8774475","reasoning":"Doc A is more directly about breast tumor biology and progression, which is closer to prognosis-related markers than germline PPM1D mutation predisposition. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588265Z"}
{"comparison_id":"aba9dad7-f4be-415c-8667-3938a3042d5c","query_id":"53","doc_a_id":"23576165","doc_b_id":"4414547","presented_order":["23576165","4414547"],"winner_id":"23576165","reasoning":"Reason: Document A discusses tumor metabolic behavior and therapeutic/prognostic implications, which is closer to biomarker expression and prognosis than Document B's focus on germline/mosaic PPM1D mutations and cancer predisposition.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588272Z"}
{"comparison_id":"4e4757c9-0a68-4c20-befa-d07f2a00da05","query_id":"53","doc_a_id":"31803596","doc_b_id":"4414547","presented_order":["31803596","4414547"],"winner_id":"4414547","reasoning":"Document B is more relevant — it concerns breast cancer genetics, whereas Document A studies oral squamous cell carcinoma and is unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588278Z"}
{"comparison_id":"ebbe2598-1b46-443b-a49c-1fb50ef0fe06","query_id":"53","doc_a_id":"27647593","doc_b_id":"4414547","presented_order":["27647593","4414547"],"winner_id":"27647593","reasoning":"Document A is more relevant — it addresses tumor microenvironment and metabolic markers linked to cancer behavior and prognosis, whereas Document B focuses on PPM1D germline/mosaic mutations unrelated to ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588285Z"}
{"comparison_id":"d29bf499-935b-4569-87b8-e7d7cff76382","query_id":"53","doc_a_id":"10279084","doc_b_id":"4414547","presented_order":["4414547","10279084"],"winner_id":"10279084","reasoning":"Neither abstract mentions ALDH1. Document B is slightly more relevant because it discusses altered protein expression/splice variants in cancer cells and specifically references breast cancer, whereas A focuses on germline PPM1D mutations and cancer predisposition. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588291Z"}
{"comparison_id":"6745b0cd-267a-4cc9-ab70-e000df059b75","query_id":"53","doc_a_id":"54561709","doc_b_id":"4414547","presented_order":["4414547","54561709"],"winner_id":"4414547","reasoning":"Document A is more relevant — it discusses genetic factors associated with breast cancer predisposition, whereas B concerns cell line variability and not clinical prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588298Z"}
{"comparison_id":"7012598c-e94d-4020-8e58-e3e4ef818f25","query_id":"53","doc_a_id":"13290521","doc_b_id":"4414547","presented_order":["13290521","4414547"],"winner_id":"13290521","reasoning":"Document A is more relevant — it discusses molecular markers and prognostic applications in cancer, whereas Document B focuses on genetic predisposition (PPM1D mutations) rather than biomarker expression or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588305Z"}
{"comparison_id":"1c9d1e16-956d-4761-b813-5850851a42c1","query_id":"53","doc_a_id":"5270265","doc_b_id":"4414547","presented_order":["5270265","4414547"],"winner_id":"5270265","reasoning":"Reason: Document A discusses factors affecting treatment outcomes and resistance in breast cancer, which is more related to prognosis than Document B's focus on genetic predisposition.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588312Z"}
{"comparison_id":"de833bf0-afa3-422b-a3ce-7b9bd0f37562","query_id":"53","doc_a_id":"40127292","doc_b_id":"4414547","presented_order":["40127292","4414547"],"winner_id":"40127292","reasoning":"Document A is more relevant — it discusses cancer therapy, resistance, and models that could pertain to prognostic markers like ALDH1, whereas Document B focuses on PPM1D germline mosaic mutations and predisposition, not ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588320Z"}
{"comparison_id":"7a261d34-5340-4de9-bd49-06a220e7a77a","query_id":"53","doc_a_id":"11484808","doc_b_id":"4414547","presented_order":["11484808","4414547"],"winner_id":"11484808","reasoning":"Document A is more related to biomarkers and clinical prognostic factors in endocrine-related cancers, making it more likely to discuss markers like ALDH1 than the PPM1D genetic study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588327Z"}
{"comparison_id":"46766ed5-4bae-434f-9cae-45252d03b062","query_id":"53","doc_a_id":"3858268","doc_b_id":"4414547","presented_order":["3858268","4414547"],"winner_id":"4414547","reasoning":"Document B — it relates to breast cancer genetics and prognosis/predisposition, while Document A focuses on ovarian cancer stem cell metabolism and not on ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588334Z"}
{"comparison_id":"9d9ef5ad-77ac-44bd-a3ef-4d365e144bb1","query_id":"53","doc_a_id":"26231129","doc_b_id":"4414547","presented_order":["4414547","26231129"],"winner_id":"26231129","reasoning":"Document B is more relevant — it addresses tumor behavior and residual disease in solid cancers, which is closer to prognosis markers than a study on PPM1D germline mutations. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588340Z"}
{"comparison_id":"42e7e9a0-023c-4089-8d0e-8b90c0428bfb","query_id":"53","doc_a_id":"2374637","doc_b_id":"4414547","presented_order":["4414547","2374637"],"winner_id":"4414547","reasoning":"Document A is more related to gene-level findings in breast cancer (though not about ALDH1 specifically), while Document B is a methods paper. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588346Z"}
{"comparison_id":"e5798724-f9d9-4e92-a662-c48ca9bb4565","query_id":"53","doc_a_id":"17717391","doc_b_id":"4414547","presented_order":["17717391","4414547"],"winner_id":"4414547","reasoning":"Neither document discusses ALDH1 expression. Document B is slightly more relevant because it directly concerns genetic factors in breast cancer, while A focuses on a p16 reporter model and aging.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588354Z"}
{"comparison_id":"b468f077-e0be-465a-ad97-3475c05cc64a","query_id":"53","doc_a_id":"825728","doc_b_id":"4414547","presented_order":["825728","4414547"],"winner_id":"825728","reasoning":"Document A — it links EMT/stem-cell properties to patient survival and metastasis, which is more relevant to ALDH1 (a cancer stem-cell marker) and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588360Z"}
{"comparison_id":"0dbfbec0-2b8e-45d9-8b70-ab0596978eee","query_id":"53","doc_a_id":"2576811","doc_b_id":"4414547","presented_order":["2576811","4414547"],"winner_id":"4414547","reasoning":"Neither document addresses ALDH1 or its association with prognosis. Document B is marginally more relevant because it deals with genetic factors and clinical predisposition in breast cancer, whereas A is basic cell biology.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588368Z"}
{"comparison_id":"a6899397-47bb-4b40-98f0-6724b29e5d3d","query_id":"53","doc_a_id":"219475","doc_b_id":"4414547","presented_order":["219475","4414547"],"winner_id":"219475","reasoning":"Document A is more related to tumor progression/metastasis (which impacts prognosis), while Document B focuses on genetic predisposition and not ALDH1 or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588375Z"}
{"comparison_id":"13a33409-594e-4f1e-8fe8-6d3e193eee5b","query_id":"53","doc_a_id":"42106119","doc_b_id":"4414547","presented_order":["42106119","4414547"],"winner_id":"4414547","reasoning":"B is more relevant — it directly concerns breast cancer biology, whereas A focuses on embryonic stem cell Oct4 networks unrelated to ALDH1 expression or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588382Z"}
{"comparison_id":"552a8f9f-e55e-49f7-9b43-a1e5908a1e60","query_id":"53","doc_a_id":"18953920","doc_b_id":"4414547","presented_order":["4414547","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses acquisition of stem-cell markers and increased tumorigenicity in mammary epithelial cells, which is relevant to ALDH1 as a breast cancer stem-cell marker and its association with prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:38:52.588389Z"}
{"comparison_id":"ba6d70cd-2c7c-450b-9233-cfb6dd6197ec","query_id":"53","doc_a_id":"45638119","doc_b_id":"38623601","presented_order":["38623601","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly reports that ALDH1 marks mammary stem cells and correlates with poor prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288193Z"}
{"comparison_id":"67b056bd-d4c6-4c0a-8b68-b741f97d090e","query_id":"53","doc_a_id":"15113221","doc_b_id":"38623601","presented_order":["15113221","38623601"],"winner_id":"15113221","reasoning":"Document A — it discusses a gene expression signature linked to poor prognosis in carcinomas, so it's more relevant to a claim about a marker (ALDH1) and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288213Z"}
{"comparison_id":"f72f2783-a7b4-4600-83ce-399388e016fe","query_id":"53","doc_a_id":"21439640","doc_b_id":"38623601","presented_order":["38623601","21439640"],"winner_id":"21439640","reasoning":"Document B — it discusses mechanisms that promote tumor progression and thus relates more to prognosis than Document A, which focuses on arginine-starvation therapy for ASS1-deficient cells. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288221Z"}
{"comparison_id":"06ef2f67-baa1-4707-8a0a-1bb5cd7804a4","query_id":"53","doc_a_id":"24349992","doc_b_id":"38623601","presented_order":["24349992","38623601"],"winner_id":"24349992","reasoning":"Document A — it discusses mechanisms driving tumor aggressiveness and survival, which is more related to prognosis than the therapy-focused, ASS1-specific findings in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288229Z"}
{"comparison_id":"00294c56-2c05-42de-a8ca-9e4129d7f4be","query_id":"53","doc_a_id":"8963413","doc_b_id":"38623601","presented_order":["38623601","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — it discusses expression of a biomarker (PD-L1) and its association with clinical outcomes in breast cancer, which is closer to the claim about a prognostic biomarker. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288236Z"}
{"comparison_id":"f8eb7e6e-954a-4a9f-b370-9b8785011df6","query_id":"53","doc_a_id":"22401720","doc_b_id":"38623601","presented_order":["22401720","38623601"],"winner_id":"22401720","reasoning":"Document A is more relevant — it examines expression of tumor markers in breast cancer and links marker expression (VEGF) to prognosis, which is analogous to the claim about ALDH1 and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288243Z"}
{"comparison_id":"bdd74684-af51-4aa2-b279-c9d003b4e8a1","query_id":"53","doc_a_id":"7795952","doc_b_id":"38623601","presented_order":["7795952","38623601"],"winner_id":"7795952","reasoning":"Document A — it discusses a protein linked to poor cancer prognosis and metastasis, so it's more related to prognostic markers than Document B. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288249Z"}
{"comparison_id":"79a80d94-db0f-41e6-911f-5d8832d976f7","query_id":"53","doc_a_id":"25973484","doc_b_id":"38623601","presented_order":["25973484","38623601"],"winner_id":"25973484","reasoning":"Document A is more relevant — it discusses breast cancer prognosis and factors linked to aggressive tumor phenotypes, whereas Document B focuses on arginine starvation in ASS1-deficient cells and not prognosis markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288257Z"}
{"comparison_id":"d2ebbfc3-800b-426e-9b5a-6d374a84e242","query_id":"53","doc_a_id":"7821634","doc_b_id":"38623601","presented_order":["7821634","38623601"],"winner_id":"7821634","reasoning":"Document A discusses a molecular marker (DUSP4 deficiency) associated with poor outcomes and drug resistance in breast cancer, so it's more relevant to a prognosis-related claim than Document B, which focuses on arginine starvation therapy.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288264Z"}
{"comparison_id":"d15aa15b-48c2-44f4-9190-a1a26aa40b07","query_id":"53","doc_a_id":"12762485","doc_b_id":"38623601","presented_order":["38623601","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses a stem-cell phenotype and poor-prognosis features in breast cancer (which is related to ALDH1 as a stem-cell marker), whereas A does not address ALDH1 or prognosis. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288271Z"}
{"comparison_id":"e79797e4-4ea9-4432-8d63-343307154e1f","query_id":"53","doc_a_id":"2061878","doc_b_id":"38623601","presented_order":["2061878","38623601"],"winner_id":"2061878","reasoning":"Document A — it discusses gene expression linked to poor prognosis in solid tumors (more related to prognostic markers). Document B focuses on arginine starvation/ASS1 and therapy, unrelated to prognosis markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288278Z"}
{"comparison_id":"0133837a-cf28-4678-831a-5248afbbbf22","query_id":"53","doc_a_id":"4889228","doc_b_id":"38623601","presented_order":["38623601","4889228"],"winner_id":"4889228","reasoning":"B — Document B discusses a gene whose expression correlates with poor prognosis in breast cancer (similar topic of marker expression and prognosis), while Document A focuses on arginine metabolism/ASS1 and therapy, not prognostic marker expression.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288286Z"}
{"comparison_id":"4ad6b61f-e25e-4376-9d79-db8d8aa0b1cc","query_id":"53","doc_a_id":"4429932","doc_b_id":"38623601","presented_order":["38623601","4429932"],"winner_id":"4429932","reasoning":"Document B is more relevant — it discusses a biomarker (LOX) associated with poor patient outcomes in breast cancer, whereas A focuses on ASS1 and arginine-starvation therapy, not prognosis or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288294Z"}
{"comparison_id":"9f184a31-4908-43a4-9cd9-2aa3c78c8dfe","query_id":"53","doc_a_id":"1171121","doc_b_id":"38623601","presented_order":["1171121","38623601"],"winner_id":"1171121","reasoning":"Document A is more relevant because it evaluates prognostic factors in breast cancer (though not ALDH1 specifically), whereas Document B focuses on arginine starvation in ASS1-deficient cells and is unrelated to prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288302Z"}
{"comparison_id":"2ecf0486-8964-4b61-8c0d-1692ac1f49e8","query_id":"53","doc_a_id":"7583725","doc_b_id":"38623601","presented_order":["7583725","38623601"],"winner_id":"7583725","reasoning":"Document A is more relevant — it discusses a specific gene's expression (TRPM7) predicting poor outcomes in breast cancer, which aligns with the claim's structure about marker expression and prognosis.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288309Z"}
{"comparison_id":"cbf71319-8da5-496a-a4ef-76fe7318d406","query_id":"53","doc_a_id":"19673227","doc_b_id":"38623601","presented_order":["19673227","38623601"],"winner_id":"19673227","reasoning":"Document A is more relevant — it discusses prognostic correlations (disease-free survival/time to progression), whereas B focuses on arginine-starvation therapy mechanisms unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288316Z"}
{"comparison_id":"917258fb-8955-4b82-8c06-f0c465cfceac","query_id":"53","doc_a_id":"20839751","doc_b_id":"38623601","presented_order":["38623601","20839751"],"winner_id":"20839751","reasoning":"Document B is more relevant — it addresses markers associated with prognosis in breast cancer (apoptotic index and prognosis), whereas A focuses on arginine metabolism (ASS1) and therapy. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288324Z"}
{"comparison_id":"2ea4db42-d250-425a-b77e-34613e2a1012","query_id":"53","doc_a_id":"13007205","doc_b_id":"38623601","presented_order":["38623601","13007205"],"winner_id":"13007205","reasoning":"Neither document addresses ALDH1 or its prognostic value directly. Document B is slightly more relevant because it discusses factors (fibroblast-driven invasion) that relate to tumor progression and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288331Z"}
{"comparison_id":"e8223448-edaf-4bc7-a0c7-5d6345a804c8","query_id":"53","doc_a_id":"313403","doc_b_id":"38623601","presented_order":["38623601","313403"],"winner_id":"313403","reasoning":"Neither document mentions ALDH1; both are irrelevant. Document B is marginally more relevant because it addresses prognostic biomarkers in breast cancer, whereas A focuses on arginine metabolism. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288338Z"}
{"comparison_id":"596dedd0-9e87-4246-aa3e-f0666d559f2c","query_id":"53","doc_a_id":"29366489","doc_b_id":"38623601","presented_order":["38623601","29366489"],"winner_id":"29366489","reasoning":"Document B is more relevant — it discusses a gene's role as a prognostic molecular marker, whereas Document A focuses on arginine starvation therapy in ASS1-deficient breast cancer and not prognosis markers like ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288345Z"}
{"comparison_id":"b6554366-f0ce-4e5e-8d13-4f31dc74061a","query_id":"53","doc_a_id":"32001951","doc_b_id":"38623601","presented_order":["38623601","32001951"],"winner_id":"32001951","reasoning":"Document B is more relevant — it discusses regulation of enzyme expression in a breast cancer cell line (closer to ALDH1 expression issues), whereas Document A focuses on arginine starvation/ASS1 and mitochondrial effects, not on ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288352Z"}
{"comparison_id":"9b9afc8e-bf64-4e3b-b01a-1da74be73870","query_id":"53","doc_a_id":"13030852","doc_b_id":"38623601","presented_order":["13030852","38623601"],"winner_id":"13030852","reasoning":"Document A is more relevant — it addresses biomarkers and clinical prognosis/monitoring in breast cancer, whereas Document B focuses on arginine metabolism and a specific therapeutic approach unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288359Z"}
{"comparison_id":"2f7c6881-c351-4335-87c1-2c37ae847491","query_id":"53","doc_a_id":"4820792","doc_b_id":"38623601","presented_order":["4820792","38623601"],"winner_id":"4820792","reasoning":"Document A is marginally more relevant because it addresses survival pathways and therapy resistance in breast cancer, which is closer to prognosis-related biology than the metabolic focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288366Z"}
{"comparison_id":"30138b99-47a5-46e7-93f8-3385d55c8f5d","query_id":"53","doc_a_id":"24341590","doc_b_id":"38623601","presented_order":["24341590","38623601"],"winner_id":"24341590","reasoning":"Document A is more relevant — it addresses clinical outcomes and prognosis in breast cancer, whereas B focuses on metabolic therapy in ASS1-deficient cells and not on prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288373Z"}
{"comparison_id":"fe10ec41-559d-40ed-b6d5-1016b1b512ab","query_id":"53","doc_a_id":"43385013","doc_b_id":"38623601","presented_order":["43385013","38623601"],"winner_id":"43385013","reasoning":"Document A is more relevant — it examines breast epithelial/mesenchymal subpopulations and stem/progenitor properties (the context in which ALDH1 is used as a prognostic stem-cell marker), while Document B concerns arginine metabolism/ASS1 and is unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288380Z"}
{"comparison_id":"ae813fda-d67a-4e30-923b-04b17d124553","query_id":"53","doc_a_id":"2931832","doc_b_id":"38623601","presented_order":["38623601","2931832"],"winner_id":"2931832","reasoning":"Document B is more relevant — it addresses prognostic biomarkers in breast cancer, whereas A focuses on arginine starvation therapy in ASS1-deficient cells and not prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288388Z"}
{"comparison_id":"afba5501-e343-40d5-a435-e9c18048e95b","query_id":"53","doc_a_id":"8037453","doc_b_id":"38623601","presented_order":["8037453","38623601"],"winner_id":"8037453","reasoning":"Document A — discusses prognostic markers and links marker levels to disease progression and mortality; Document B focuses on cell-line therapy mechanisms, not prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288394Z"}
{"comparison_id":"ebd411d3-a3ad-41c1-b983-e8ea92ecb180","query_id":"53","doc_a_id":"17648235","doc_b_id":"38623601","presented_order":["17648235","38623601"],"winner_id":"17648235","reasoning":"Neither abstract mentions ALDH1. Document A is marginally more relevant because it addresses signaling pathways tied to tumor aggressiveness and prognosis, whereas B focuses on arginine metabolism in ASS1-deficient cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288402Z"}
{"comparison_id":"e72bdb10-d545-499f-ac70-71e9fd139ca7","query_id":"53","doc_a_id":"15721252","doc_b_id":"38623601","presented_order":["38623601","15721252"],"winner_id":"15721252","reasoning":"Reason: Neither abstract mentions ALDH1, but Document B discusses molecular markers linked to breast cancer outcomes/sensitivity, so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288409Z"}
{"comparison_id":"a8a2f938-17b1-4bbc-8867-61d353ce2dbc","query_id":"53","doc_a_id":"19358586","doc_b_id":"38623601","presented_order":["19358586","38623601"],"winner_id":"19358586","reasoning":"Document A — it discusses a protein signature linked to poor survival in breast cancer, so it's more related to prognosis than Document B. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288415Z"}
{"comparison_id":"85f8aef7-512d-4dbf-94b9-22249c7d1c63","query_id":"53","doc_a_id":"16734530","doc_b_id":"38623601","presented_order":["16734530","38623601"],"winner_id":"16734530","reasoning":"Document A is slightly more relevant because it reports clinical associations (estrogen receptor status and lymph node involvement) related to breast cancer prognosis, whereas Document B focuses on a metabolic therapy in cell lines and ASS1 deficiency.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288423Z"}
{"comparison_id":"9e41a958-7754-4b7d-9cdd-0559659d7924","query_id":"53","doc_a_id":"20127522","doc_b_id":"38623601","presented_order":["38623601","20127522"],"winner_id":"20127522","reasoning":"Document B is more relevant — it concerns biomarkers (CTCs) associated with prognosis in breast cancer, while Document A focuses on ASS1 and arginine starvation, unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288430Z"}
{"comparison_id":"a523f3f5-f1bf-484b-bf4b-c2221e881172","query_id":"53","doc_a_id":"5500086","doc_b_id":"38623601","presented_order":["38623601","5500086"],"winner_id":"5500086","reasoning":"B is more relevant — it links a molecular marker/signature to clinical outcomes in breast cancer, while A focuses on arginine metabolism in ASS1-deficient cells and not prognosis markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288437Z"}
{"comparison_id":"32149848-380e-4c96-aa81-4a0e39c370f6","query_id":"53","doc_a_id":"17755060","doc_b_id":"38623601","presented_order":["17755060","38623601"],"winner_id":"17755060","reasoning":"Document A is more relevant — it discusses metabolic changes linked to increased tumorigenesis and poorer prognosis in human cancers, whereas B focuses on ASS1/arginine therapy and not prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288444Z"}
{"comparison_id":"55744688-5ae4-4124-998b-fa8560ebbbb2","query_id":"53","doc_a_id":"25732836","doc_b_id":"38623601","presented_order":["25732836","38623601"],"winner_id":"25732836","reasoning":"Document A is more relevant — it addresses prognostic factors and outcome prediction in breast cancer, while Document B focuses on arginine metabolism/therapy, not ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288451Z"}
{"comparison_id":"4b420d43-5502-45a2-a104-251e39354613","query_id":"53","doc_a_id":"27240667","doc_b_id":"38623601","presented_order":["38623601","27240667"],"winner_id":"27240667","reasoning":"Document B — it addresses prognosis/mortality trends in breast cancer, so it's more relevant to a claim about prognostic markers than Document A's focus on arginine metabolism. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288458Z"}
{"comparison_id":"65546960-d915-4149-896b-d1d1951881e8","query_id":"53","doc_a_id":"19882228","doc_b_id":"38623601","presented_order":["19882228","38623601"],"winner_id":"19882228","reasoning":"Document A is more relevant — it discusses tumor features linked to poor prognosis (hypoxia), while Document B focuses on ASS1/arginine starvation and does not mention ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288465Z"}
{"comparison_id":"5d4197f7-3f5a-4693-8f74-5fc012cac09c","query_id":"53","doc_a_id":"4999633","doc_b_id":"38623601","presented_order":["38623601","4999633"],"winner_id":"4999633","reasoning":"Document B — neither document mentions ALDH1, but B discusses a biomarker (mER-α) linked to proliferation/predictive responses, making it slightly more relevant to a claim about marker-associated prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288472Z"}
{"comparison_id":"bd09fb4f-f2dc-4146-ab94-ca4a5b9e0974","query_id":"53","doc_a_id":"24249915","doc_b_id":"38623601","presented_order":["24249915","38623601"],"winner_id":"24249915","reasoning":"Document A is more related—it discusses expression of a molecular marker in breast cancer and its loss in invasive tumors, whereas Document B focuses on arginine metabolism unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288478Z"}
{"comparison_id":"d240f860-af0f-488b-8aed-6ccb2a4880ac","query_id":"53","doc_a_id":"4455466","doc_b_id":"38623601","presented_order":["4455466","38623601"],"winner_id":"4455466","reasoning":"Document A — it links gene expression level to poor prognosis in breast cancer, which is the same type of association asked about (even though it’s a different marker). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288485Z"}
{"comparison_id":"1584b5b9-456b-4ae8-8426-b6ddbcc91afa","query_id":"53","doc_a_id":"3285322","doc_b_id":"38623601","presented_order":["38623601","3285322"],"winner_id":"3285322","reasoning":"Document B — it addresses clinical/pathologic prognostic features in breast cancer (more relevant to prognosis than the molecular/therapy focus of Document A).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288492Z"}
{"comparison_id":"275a39bf-249e-4a97-ba69-2ceefcd64d60","query_id":"53","doc_a_id":"9600826","doc_b_id":"38623601","presented_order":["9600826","38623601"],"winner_id":"9600826","reasoning":"Document A is more relevant — it discusses pathways linked to breast cancer invasion, metastasis and angiogenesis (factors tied to prognosis), while Document B focuses on ASS1/arginine metabolism unrelated to ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288499Z"}
{"comparison_id":"8b6b8711-a222-460c-a259-edba5677a865","query_id":"53","doc_a_id":"13069283","doc_b_id":"38623601","presented_order":["13069283","38623601"],"winner_id":"13069283","reasoning":"Neither abstract mentions ALDH1. Document A is slightly more relevant because it discusses genetic/metabolic factors affecting breast cancer treatment outcomes (prognostic implications), whereas B focuses on arginine starvation in ASS1-deficient cells and not prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288507Z"}
{"comparison_id":"38ae7ab6-7b76-4af6-b477-567508ca6bbe","query_id":"53","doc_a_id":"2130391","doc_b_id":"38623601","presented_order":["2130391","38623601"],"winner_id":"2130391","reasoning":"Document A is more relevant — it discusses mechanisms that promote breast cancer invasion and tumor progression (which relate to prognosis), whereas Document B focuses on arginine-starvation therapy in ASS1-deficient cells and does not address ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288514Z"}
{"comparison_id":"3c37764c-25d3-49bb-8d97-19df27b896b2","query_id":"53","doc_a_id":"22509015","doc_b_id":"38623601","presented_order":["22509015","38623601"],"winner_id":"22509015","reasoning":"Document A is more relevant — it discusses mechanisms of metastasis and tumor aggressiveness in breast cancer (which relate to prognosis), whereas Document B focuses on arginine metabolism in ASS1-deficient tumors and not prognosis markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288521Z"}
{"comparison_id":"974cc066-1540-4cfa-8dc1-9d852af7212b","query_id":"53","doc_a_id":"1866911","doc_b_id":"38623601","presented_order":["1866911","38623601"],"winner_id":"1866911","reasoning":"Document A is more relevant — it addresses breast cancer cell-of-origin and progenitor markers (more related to stem/progenitor marker ALDH1 and tumor behavior), while Document B focuses on arginine metabolism/ASS1 and not on ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288529Z"}
{"comparison_id":"6874d504-221a-45e6-b431-28ce06c66eb2","query_id":"53","doc_a_id":"21033230","doc_b_id":"38623601","presented_order":["38623601","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it addresses molecular prognostic markers and survival in breast cancer (while A discusses ASS1/arginine starvation, unrelated to ALDH1). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288536Z"}
{"comparison_id":"67a742fd-3d66-4f20-a5c0-0dcc4d3894d3","query_id":"53","doc_a_id":"21902400","doc_b_id":"38623601","presented_order":["38623601","21902400"],"winner_id":"21902400","reasoning":"Document B. Reason: B discusses prognostic factors in tumors (impact on clinical outcome), whereas A focuses on ASS1/arginine therapy in breast cancer and does not address prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288543Z"}
{"comparison_id":"4fc2ec97-a82f-4c0e-9864-7909b19c60da","query_id":"53","doc_a_id":"4418878","doc_b_id":"38623601","presented_order":["4418878","38623601"],"winner_id":"4418878","reasoning":"Document A is more relevant — it addresses gene expression signatures linked to cancer prognosis (which could include markers like ALDH1), while Document B focuses on ASS1 and arginine metabolism unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288550Z"}
{"comparison_id":"32e43bed-3f4d-4871-b8b9-24cb57d93e60","query_id":"53","doc_a_id":"20454006","doc_b_id":"38623601","presented_order":["38623601","20454006"],"winner_id":"38623601","reasoning":"Document A is more relevant — it discusses expression of a metabolic marker (ASS1) in breast cancer and links marker-low tumors to therapy implications, whereas B focuses on tamoxifen metabolism and not marker expression or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288557Z"}
{"comparison_id":"93f52701-8227-4ea5-a366-f403434a2084","query_id":"53","doc_a_id":"1554348","doc_b_id":"38623601","presented_order":["38623601","1554348"],"winner_id":"38623601","reasoning":"Document A is more relevant — it addresses expression of a tumor-related enzyme in breast cancer samples and clinical implications, whereas Document B is an in vitro study of stress-response proteins not linked to prognosis or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288565Z"}
{"comparison_id":"b82cfba7-379c-4cd1-ac65-ef2ebc2d0539","query_id":"53","doc_a_id":"18953920","doc_b_id":"38623601","presented_order":["38623601","18953920"],"winner_id":"18953920","reasoning":"Doc B is more relevant — it links EMT to acquisition of stem-cell markers and increased tumorigenicity, which pertains to ALDH1 as a breast cancer stem-cell marker associated with prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288576Z"}
{"comparison_id":"982e91cb-7407-417a-8a1e-4b5db739f4a2","query_id":"53","doc_a_id":"5864770","doc_b_id":"38623601","presented_order":["5864770","38623601"],"winner_id":"5864770","reasoning":"Document A is more focused on factors influencing breast cancer biology and prognosis (hormone effects), whereas Document B concerns ASS1/arginine metabolism unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288583Z"}
{"comparison_id":"fea2102b-936e-49d1-9236-90f7bbbda0d5","query_id":"53","doc_a_id":"3329824","doc_b_id":"38623601","presented_order":["38623601","3329824"],"winner_id":"38623601","reasoning":"Document A is more relevant — it discusses expression of a tumor-related enzyme and prognosis/therapy implications in breast cancer, whereas Document B focuses only on CNS metastasis risk with trastuzumab and not molecular markers like ALDH1.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288590Z"}
{"comparison_id":"a580c52a-4505-4e3e-855b-28c05ec7cbf6","query_id":"53","doc_a_id":"15521377","doc_b_id":"38623601","presented_order":["15521377","38623601"],"winner_id":"15521377","reasoning":"Document A is more generally about cancer cell behavior and tumorigenic processes (more likely to relate to prognostic markers) while Document B focuses narrowly on arginine metabolism in ASS1-deficient cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288597Z"}
{"comparison_id":"d20e91f1-17c5-4b07-b62d-95ed7a6df482","query_id":"53","doc_a_id":"164985","doc_b_id":"38623601","presented_order":["164985","38623601"],"winner_id":"164985","reasoning":"Neither document discusses ALDH1 or its prognostic value, but Document A is slightly more relevant because it addresses mechanisms that promote tumor progression (immune-suppressive M2d macrophages), whereas Document B focuses on arginine metabolism in ASS1-deficient cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288605Z"}
{"comparison_id":"1d7d3233-471a-4238-8240-1f9f40d1fe2c","query_id":"53","doc_a_id":"1389264","doc_b_id":"38623601","presented_order":["1389264","38623601"],"winner_id":"1389264","reasoning":"Neither document mentions ALDH1 or directly addresses prognosis. Document A is slightly more relevant because it discusses biomarkers and treatment response/prognostic implications in breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288611Z"}
{"comparison_id":"55217c59-7b9e-4fd3-a0ba-705720728455","query_id":"53","doc_a_id":"22482820","doc_b_id":"38623601","presented_order":["38623601","22482820"],"winner_id":"22482820","reasoning":"Neither document discusses ALDH1. Document B is slightly more relevant because it covers breast cancer classification and prognostic/treatment challenges, making it more likely to address prognostic markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288618Z"}
{"comparison_id":"664fac07-0ad0-4f6d-88b2-a5a6368b2cc6","query_id":"53","doc_a_id":"15559582","doc_b_id":"38623601","presented_order":["38623601","15559582"],"winner_id":"15559582","reasoning":"Document B is more relevant — it examines biomarker levels in relation to cancer severity (invasive/poorly differentiated), which is closer to prognosis than A's focus on ASS1 and arginine-starvation therapy.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288625Z"}
{"comparison_id":"e0a70171-7220-4fc5-8959-b3e2f2423928","query_id":"53","doc_a_id":"25523969","doc_b_id":"38623601","presented_order":["38623601","25523969"],"winner_id":"38623601","reasoning":"Document A is more relevant because it specifically studies breast cancer (where ALDH1’s prognostic role would apply), while Document B focuses on miRNA signatures in metastatic cancers and does not address ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288699Z"}
{"comparison_id":"8fba29aa-bf51-4b3b-9a29-47e213c2dbc1","query_id":"53","doc_a_id":"8671456","doc_b_id":"38623601","presented_order":["38623601","8671456"],"winner_id":"8671456","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it reports effects on tumor growth and survival (prognosis-related outcomes), whereas A focuses on ASS1 and metabolic therapy. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288715Z"}
{"comparison_id":"ceb9f575-e4c4-4465-b449-de3c38d25943","query_id":"53","doc_a_id":"31311495","doc_b_id":"38623601","presented_order":["31311495","38623601"],"winner_id":"31311495","reasoning":"Document A — it discusses EMT-like changes and increased aggressiveness/tumor progression in breast cancer, which is more related to prognosis than Document B's ASS1/arginine-starvation focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288727Z"}
{"comparison_id":"4a793d92-f537-41cb-9329-e7cfca3f2362","query_id":"53","doc_a_id":"4886637","doc_b_id":"38623601","presented_order":["38623601","4886637"],"winner_id":"38623601","reasoning":"Reason: Document A discusses molecular characteristics of breast cancer cells and prognosis-related treatment implications, so it's closer to a claim about a molecular prognostic marker than the epidemiologic focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288734Z"}
{"comparison_id":"cb187029-cfc1-441d-bd61-d0ae80fba241","query_id":"53","doc_a_id":"5649538","doc_b_id":"38623601","presented_order":["5649538","38623601"],"winner_id":"5649538","reasoning":"Neither abstract mentions ALDH1. Both are irrelevant to the prognostic role of ALDH1, but Document A (gene-expression markers in breast cancer) is marginally closer in scope.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288741Z"}
{"comparison_id":"74f5a9ec-d386-4e8f-94ca-7b034872aa69","query_id":"53","doc_a_id":"22975806","doc_b_id":"38623601","presented_order":["38623601","22975806"],"winner_id":"38623601","reasoning":"Document A is slightly more relevant because it discusses expression levels (ASS1) in breast cancer and their clinical implications, whereas Document B focuses on BRCA allele loss and tumorigenesis rather than marker expression or prognosis.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288748Z"}
{"comparison_id":"0d12b895-9b14-4305-88e9-d1412ff45e16","query_id":"53","doc_a_id":"16086778","doc_b_id":"38623601","presented_order":["38623601","16086778"],"winner_id":"16086778","reasoning":"Document B — it discusses molecular mechanisms (Numb/Notch) tied to breast cancer progression and prognosis, so it's marginally more relevant than a therapy-focused study on ASS1/arginine. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288756Z"}
{"comparison_id":"75bd3776-ccbe-4df6-8d95-ac78440ba3c5","query_id":"53","doc_a_id":"29495185","doc_b_id":"38623601","presented_order":["38623601","29495185"],"winner_id":"29495185","reasoning":"Document B is more relevant — it discusses molecular predictors of prognosis in cancer, whereas A focuses on ASS1/arginine metabolism with no mention of ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288764Z"}
{"comparison_id":"8d49db81-043e-42f7-848b-e956d7f060bb","query_id":"53","doc_a_id":"4702639","doc_b_id":"38623601","presented_order":["4702639","38623601"],"winner_id":"4702639","reasoning":"Doc A is more relevant — it addresses tumor stemness and stem-cell markers in breast cancer, which is related to ALDH1's role as a stemness/prognostic marker; Document B focuses on arginine metabolism unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288771Z"}
{"comparison_id":"ac2a9da9-ac15-4058-a090-a172de550aaf","query_id":"53","doc_a_id":"1379127","doc_b_id":"38623601","presented_order":["38623601","1379127"],"winner_id":"1379127","reasoning":"Document B — it addresses factors (migration/metastasis) directly linked to prognosis in breast cancer, so it's more relevant to a claim about markers associated with poorer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288778Z"}
{"comparison_id":"efc9fcd5-2f80-425b-8b3a-ea2b8cc45ad3","query_id":"53","doc_a_id":"24834968","doc_b_id":"38623601","presented_order":["24834968","38623601"],"winner_id":"24834968","reasoning":"Reason: Document A discusses biomarkers and clinical predictors of breast cancer outcome/response, which is closer to prognosis than Document B's focus on arginine-starvation therapy in ASS1-deficient cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288785Z"}
{"comparison_id":"a1dc5517-a258-4847-ab2f-89073c92d6b1","query_id":"53","doc_a_id":"24144677","doc_b_id":"38623601","presented_order":["24144677","38623601"],"winner_id":"24144677","reasoning":"Document A is slightly more relevant because it studies an association between a molecular marker and breast cancer risk/outcome, whereas Document B focuses on arginine starvation therapy in ASS1-deficient cells and not prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288792Z"}
{"comparison_id":"efaced9f-d30f-4da4-95a7-b57885cb6d9c","query_id":"53","doc_a_id":"67045088","doc_b_id":"38623601","presented_order":["67045088","38623601"],"winner_id":"67045088","reasoning":"Neither abstract mentions ALDH1. Document A is slightly more relevant because it discusses breast cancer tumor control and therapy-related prognosis implications, while B focuses on arginine metabolism in ASS1-deficient cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288798Z"}
{"comparison_id":"8ee65f76-2113-4889-b3c6-c7b593c2b38d","query_id":"53","doc_a_id":"195680777","doc_b_id":"38623601","presented_order":["38623601","195680777"],"winner_id":"195680777","reasoning":"Document B is more relevant — it addresses breast cancer outcomes and prognosis (mortality), while Document A focuses on ASS1/arginine metabolism and not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288805Z"}
{"comparison_id":"b5b48440-b205-41c8-bdb9-65672fb750d2","query_id":"53","doc_a_id":"15946643","doc_b_id":"38623601","presented_order":["15946643","38623601"],"winner_id":"15946643","reasoning":"Document A is more relevant — it addresses factors (chemoresistance and metastasis) that link to poorer prognosis in breast cancer, whereas Document B focuses on arginine/ASS1-specific metabolic therapy. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288812Z"}
{"comparison_id":"343a46a0-44d0-4279-84b2-47932c9a24b4","query_id":"53","doc_a_id":"31616203","doc_b_id":"38623601","presented_order":["38623601","31616203"],"winner_id":"31616203","reasoning":"Document B is slightly more relevant because it reports clinical outcomes and prognosis-related treatment responses in breast cancer, whereas Document A focuses on ASS1 and arginine starvation at the cellular level unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288819Z"}
{"comparison_id":"c1957f9f-e749-4149-ac61-e9ed1449e7b3","query_id":"53","doc_a_id":"6550579","doc_b_id":"38623601","presented_order":["38623601","6550579"],"winner_id":"6550579","reasoning":"Document B is more relevant — it discusses a specific breast cancer marker (HER3) and therapeutic/prognostic implications, whereas Document A focuses on metabolic targeting of ASS1-deficient tumors and not prognostic marker associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288826Z"}
{"comparison_id":"0a0681ed-16c6-41b9-aa78-b3349129a30c","query_id":"53","doc_a_id":"878526","doc_b_id":"38623601","presented_order":["38623601","878526"],"winner_id":"38623601","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it discusses expression of a cancer-related enzyme (ASS1) and clinical implications in breast cancer, whereas Document B focuses on neutrophil-mediated metastasis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288833Z"}
{"comparison_id":"820384b6-4c5c-41fe-9bd5-0a1a0c1808c3","query_id":"53","doc_a_id":"23863551","doc_b_id":"38623601","presented_order":["23863551","38623601"],"winner_id":"23863551","reasoning":"Neither document addresses ALDH1 or its prognostic value. Document A is slightly more relevant because it discusses markers and therapy response impacting outcome, whereas Document B focuses on arginine starvation in ASS1-deficient tumors, which is unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288840Z"}
{"comparison_id":"0d6a34b6-4329-4c71-b9da-9fa96e92f9a8","query_id":"53","doc_a_id":"20183360","doc_b_id":"38623601","presented_order":["38623601","20183360"],"winner_id":"20183360","reasoning":"Document B is more relevant — it addresses molecular factors (GATA3/Smad4) influencing invasiveness and tumor progression, which relate more closely to prognosis than arginine/ASS1 metabolic therapy in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288847Z"}
{"comparison_id":"b9c7be9b-c030-4ff9-b0d7-164c3d298f33","query_id":"53","doc_a_id":"7875158","doc_b_id":"38623601","presented_order":["38623601","7875158"],"winner_id":"38623601","reasoning":"Document A is more focused on expression of a marker (ASS1) and its clinical implications in breast cancer, closer to a prognosis-related claim than Document B, which studies metabolic stress mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288854Z"}
{"comparison_id":"5478fd1b-8bbf-4a6e-aeb9-ccbd5a9ac7e2","query_id":"53","doc_a_id":"2015126","doc_b_id":"38623601","presented_order":["2015126","38623601"],"winner_id":"2015126","reasoning":"Document A is marginally more relevant because it discusses breast cancer management and prognosis-related issues, while Document B focuses on arginine metabolism in ASS1-deficient tumors and not on prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288861Z"}
{"comparison_id":"c2ce8c8e-ded9-49c7-9ba2-f72df850aada","query_id":"53","doc_a_id":"17163294","doc_b_id":"38623601","presented_order":["17163294","38623601"],"winner_id":"38623601","reasoning":"Document B is more relevant — it addresses molecular features and therapeutic implications in breast cancer, whereas A focuses on metabolite-based cancer-type classification without prognosis markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288867Z"}
{"comparison_id":"05a9fd59-4606-4e78-9d35-640d98e20751","query_id":"53","doc_a_id":"34066665","doc_b_id":"38623601","presented_order":["38623601","34066665"],"winner_id":"34066665","reasoning":"Neither document mentions ALDH1 or gives evidence about its prognostic value. Of the two, B is marginally more relevant because it discusses factors (receptor crosstalk and therapy resistance) that relate to prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288874Z"}
{"comparison_id":"66cb3c0c-25b4-483f-afb2-5acf74fc4656","query_id":"53","doc_a_id":"16691520","doc_b_id":"38623601","presented_order":["38623601","16691520"],"winner_id":"16691520","reasoning":"Neither document mentions ALDH1 or prognosis. Document B is slightly more relevant because it addresses genome-wide gene regulation in breast cancer and could encompass ALDH1 expression, whereas Document A focuses specifically on ASS1-deficiency and arginine starvation.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288881Z"}
{"comparison_id":"0a283d06-a78a-47c5-b495-79bcb0122575","query_id":"53","doc_a_id":"11880289","doc_b_id":"38623601","presented_order":["38623601","11880289"],"winner_id":"38623601","reasoning":"Document A discusses molecular characteristics and therapy-relevant markers in breast cancer, making it more related to a biomarker/prognosis claim than a population screening trial. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288888Z"}
{"comparison_id":"7e9c6843-2495-49e5-bb43-d5cbb31cd8fe","query_id":"53","doc_a_id":"20333864","doc_b_id":"38623601","presented_order":["38623601","20333864"],"winner_id":"20333864","reasoning":"Document B is more relevant — it addresses tumor progression and factors influencing invasion (which relate to prognosis), whereas Document A focuses on arginine metabolism in ASS1-deficient cells and not on ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288895Z"}
{"comparison_id":"ab6d0d1e-77f0-4bbb-9585-d48a7c2456a0","query_id":"53","doc_a_id":"15600979","doc_b_id":"38623601","presented_order":["15600979","38623601"],"winner_id":"38623601","reasoning":"Document B is slightly more relevant — it discusses biomarkers and prognosis/treatment implications in breast cancer, whereas A focuses on BRCA2/RAD51 pathway mechanics without prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288902Z"}
{"comparison_id":"c5815fe5-759f-4a39-8acc-217e0007b8a2","query_id":"53","doc_a_id":"2014909","doc_b_id":"38623601","presented_order":["38623601","2014909"],"winner_id":"2014909","reasoning":"Document B — it addresses tumor-initiating cells and primary breast cancers (ALDH1 is a cancer stem/tumor-initiating cell marker), so it's more likely to bear on prognostic associations than the ASS1/arginine-focused Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288909Z"}
{"comparison_id":"ed28fda0-0384-4951-b54b-dceefcbee0d6","query_id":"53","doc_a_id":"6969753","doc_b_id":"38623601","presented_order":["6969753","38623601"],"winner_id":"6969753","reasoning":"Document A — it addresses mechanisms of tumor invasiveness and metastasis (more directly related to prognosis) while Document B focuses on arginine metabolism in ASS1-deficient cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288916Z"}
{"comparison_id":"35b3466c-9df7-4efd-87de-0355ed9ed466","query_id":"53","doc_a_id":"4583180","doc_b_id":"38623601","presented_order":["38623601","4583180"],"winner_id":"4583180","reasoning":"Document B. It links gene expression changes to reduced patient survival (prognosis), while Document A focuses on ASS1 and arginine starvation without addressing prognosis or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288922Z"}
{"comparison_id":"25721cc1-271c-4a71-9489-50b4418a539d","query_id":"53","doc_a_id":"15832146","doc_b_id":"38623601","presented_order":["38623601","15832146"],"winner_id":"15832146","reasoning":"Document B — it discusses factors (CAFs, SDF-1/CXCL12) that promote tumor progression and angiogenesis and is more directly related to tumor behavior and prognosis than the metabolic/therapy-focused Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288929Z"}
{"comparison_id":"36912dd7-f4dc-4e52-a675-333a016f5b01","query_id":"53","doc_a_id":"22267225","doc_b_id":"38623601","presented_order":["22267225","38623601"],"winner_id":"22267225","reasoning":"Document A — it discusses breast cancer prevention/clinical context and is more likely to address prognostic markers, while Document B focuses specifically on ASS1/arginine metabolism unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288936Z"}
{"comparison_id":"833f0148-f85b-4753-a71d-4418ddfe1a86","query_id":"53","doc_a_id":"8774475","doc_b_id":"38623601","presented_order":["38623601","8774475"],"winner_id":"8774475","reasoning":"Document B is more relevant — it addresses mechanisms of breast tumorigenesis and factors affecting cancer progression, whereas Document A focuses on arginine starvation in ASS1-deficient cells, not prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288943Z"}
{"comparison_id":"6c3af986-aa5a-4120-8b3a-05a1614e85cd","query_id":"53","doc_a_id":"23576165","doc_b_id":"38623601","presented_order":["38623601","23576165"],"winner_id":"38623601","reasoning":"Document A is more relevant — it specifically studies breast cancer biology (though not ALDH1), whereas B is a general tumor metabolism review. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288949Z"}
{"comparison_id":"fe929d64-d7cc-413e-8b67-09c08526b5a8","query_id":"53","doc_a_id":"27647593","doc_b_id":"38623601","presented_order":["27647593","38623601"],"winner_id":"38623601","reasoning":"Neither paper mentions ALDH1. Document B is slightly more relevant because it directly studies breast cancer cell biomarkers and clinical implications, whereas A is a general review of stromal–epithelial metabolism. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288956Z"}
{"comparison_id":"b202cf21-05d4-4d5a-9c01-26d61acce504","query_id":"53","doc_a_id":"10279084","doc_b_id":"38623601","presented_order":["10279084","38623601"],"winner_id":"10279084","reasoning":"Document A is slightly more relevant because it discusses molecular alterations in breast cancer that could relate to prognosis, whereas Document B concerns metabolic therapy in ASS1-deficient tumors and does not relate to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288963Z"}
{"comparison_id":"f5231a34-0cfd-403d-89f0-b45243815682","query_id":"53","doc_a_id":"13290521","doc_b_id":"38623601","presented_order":["13290521","38623601"],"winner_id":"13290521","reasoning":"Document A — it discusses prognostic roles of molecular markers in cancer (broadly), whereas B focuses on ASS1/arginine therapy with no link to ALDH1 or prognosis in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288970Z"}
{"comparison_id":"7a0df1b5-6141-4d84-9739-8a3c323dd7d6","query_id":"53","doc_a_id":"5270265","doc_b_id":"38623601","presented_order":["5270265","38623601"],"winner_id":"5270265","reasoning":"Neither document addresses ALDH1 or its prognostic value. If forced to choose, DOCUMENT A is slightly more relevant because it discusses treatment resistance and clinical outcomes in breast cancer, whereas DOCUMENT B focuses on metabolic therapy in ASS1‑deficient cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288977Z"}
{"comparison_id":"f5f71f1f-b4a2-4a76-9a1d-7d6425c7f059","query_id":"53","doc_a_id":"40127292","doc_b_id":"38623601","presented_order":["40127292","38623601"],"winner_id":"40127292","reasoning":"Document A is marginally more relevant because it addresses mechanisms (apoptosis, chemoresistance) that influence treatment outcomes and prognosis in cancer; Document B focuses on ASS1/arginine metabolism unrelated to ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288984Z"}
{"comparison_id":"308995d4-6fa2-476d-9049-76354ca3d025","query_id":"53","doc_a_id":"11484808","doc_b_id":"38623601","presented_order":["38623601","11484808"],"winner_id":"11484808","reasoning":"Document B is more relevant — it discusses clinical implications and biomarkers in cancer (including prognosis-related factors), whereas Document A focuses narrowly on arginine starvation in ASS1‑deficient cells and does not address ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288991Z"}
{"comparison_id":"5a5f53aa-c851-4e6a-a5c5-5e64278b8bd2","query_id":"53","doc_a_id":"26231129","doc_b_id":"38623601","presented_order":["38623601","26231129"],"winner_id":"26231129","reasoning":"Reason: Neither abstract mentions ALDH1 or prognosis in breast cancer, but Document B discusses broader molecular bases of residual disease and targeting in solid cancers, which is marginally more related to prognostic biomarkers than the ASS1/arginine-specific study in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.288997Z"}
{"comparison_id":"8a85ab2a-0798-4468-8372-e55789e20a1d","query_id":"53","doc_a_id":"825728","doc_b_id":"38623601","presented_order":["38623601","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it discusses EMT, acquisition of stem-cell properties and links to patient survival/metastasis, which relates to prognostic markers like ALDH1; Document A focuses on arginine starvation/ASS1 and not prognosis or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.289004Z"}
{"comparison_id":"2f538a3e-4465-4a99-a698-b6a3a0a73a6e","query_id":"53","doc_a_id":"219475","doc_b_id":"38623601","presented_order":["219475","38623601"],"winner_id":"219475","reasoning":"Document A is more relevant — it addresses factors that promote metastasis and tumor progression (which relate to prognosis), whereas B focuses on arginine starvation and ASS1-deficiency without connection to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:39:38.289011Z"}
{"comparison_id":"e3f598b2-64e4-4cf2-9173-62aed8bbf502","query_id":"53","doc_a_id":"45638119","doc_b_id":"22509015","presented_order":["22509015","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 as a marker and predictor of poor clinical outcome in breast cancer, matching the claim.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206341Z"}
{"comparison_id":"e711d351-85eb-4f29-908b-659e8d18e3f7","query_id":"53","doc_a_id":"15113221","doc_b_id":"22509015","presented_order":["15113221","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it specifically studies breast cancer (basal-like subtype) and factors tied to metastasis/prognosis, whereas A discusses PTEN-related signatures in carcinomas generally and does not address ALDH1 or breast-specific prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206366Z"}
{"comparison_id":"061f93db-9479-4d24-80ce-d3a2c5be9ccd","query_id":"53","doc_a_id":"21439640","doc_b_id":"22509015","presented_order":["22509015","21439640"],"winner_id":"22509015","reasoning":"Document A is more relevant — it addresses signaling linked to metastasis and aggressive basal-like breast cancer (prognosis-related), whereas Document B focuses on macrophage-induced COX-2 signaling and not prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206376Z"}
{"comparison_id":"0a474ef9-68d3-4832-be6f-f97f9354a4a8","query_id":"53","doc_a_id":"24349992","doc_b_id":"22509015","presented_order":["22509015","24349992"],"winner_id":"22509015","reasoning":"Document A is more directly about breast cancer biology and metastasis, so it's more likely to bear on prognostic markers than the stromal/metabolism focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206385Z"}
{"comparison_id":"6c878bab-5b55-491a-ba87-145a150fd034","query_id":"53","doc_a_id":"8963413","doc_b_id":"22509015","presented_order":["22509015","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant because it discusses biomarker expression (PD-L1) and associations with clinical outcomes in breast cancer, which is conceptually closer to a claim about a prognostic marker. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206393Z"}
{"comparison_id":"52e044f7-14b3-452a-a699-ef5487b6aa31","query_id":"53","doc_a_id":"22401720","doc_b_id":"22509015","presented_order":["22401720","22509015"],"winner_id":"22401720","reasoning":"Document A is more relevant — it discusses prognostic marker expression and links (high VEGF) to poor prognosis in breast cancer, whereas Document B focuses on WNT signaling/metastasis without addressing prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206402Z"}
{"comparison_id":"70b35ffe-56ff-404d-8a6f-73b00dc92319","query_id":"53","doc_a_id":"7795952","doc_b_id":"22509015","presented_order":["22509015","7795952"],"winner_id":"22509015","reasoning":"Neither document mentions ALDH1, but Document A is more relevant because it directly addresses signaling and metastasis in breast cancer (prognosis-related topic) while B focuses on fascin and TGFβ in cell invasion. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206411Z"}
{"comparison_id":"51b582b3-d2e3-4758-a9ec-83f835151a76","query_id":"53","doc_a_id":"25973484","doc_b_id":"22509015","presented_order":["25973484","22509015"],"winner_id":"25973484","reasoning":"Document A is more relevant because it discusses factors linked to breast cancer prognosis generally, while Document B focuses narrowly on WNT signaling and brain metastasis without addressing prognostic biomarkers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206419Z"}
{"comparison_id":"8e9bc015-8610-4d46-89fc-edafe2edcb6e","query_id":"53","doc_a_id":"7821634","doc_b_id":"22509015","presented_order":["22509015","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it directly discusses a molecular marker (DUSP4) whose low expression correlates with poor outcomes in breast cancer, which is analogous to assessing prognostic associations like ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206428Z"}
{"comparison_id":"9dbe94d4-5d88-473f-8ef2-7cc33e790ab7","query_id":"53","doc_a_id":"12762485","doc_b_id":"22509015","presented_order":["12762485","22509015"],"winner_id":"12762485","reasoning":"Document A is more relevant because it discusses a stem cell phenotype in breast cancer (ALDH1 is a stem cell marker) and its association with poorer differentiation and higher proliferation, whereas B focuses on WNT signaling and metastasis without stem cell marker mention.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206435Z"}
{"comparison_id":"4817fc04-1594-4423-a4fb-24f80ce322d9","query_id":"53","doc_a_id":"2061878","doc_b_id":"22509015","presented_order":["22509015","2061878"],"winner_id":"22509015","reasoning":"Reason: Document A focuses on breast cancer biology and metastasis (directly relevant to prognosis in breast cancer); Document B discusses NEAT1 in various cancers but not ALDH1 or breast-specific prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206442Z"}
{"comparison_id":"be198b1b-b3df-4ea2-8c82-3a72c1c44c44","query_id":"53","doc_a_id":"4889228","doc_b_id":"22509015","presented_order":["4889228","22509015"],"winner_id":"4889228","reasoning":"Document A — it links expression of a molecular marker to prognosis in breast cancer, whereas B focuses on WNT signaling/metastasis and does not address marker–prognosis associations. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206450Z"}
{"comparison_id":"2235421c-d704-4349-9863-78f6e73643f0","query_id":"53","doc_a_id":"4429932","doc_b_id":"22509015","presented_order":["22509015","4429932"],"winner_id":"4429932","reasoning":"Document B is more relevant — it discusses factors linked to poor patient outcomes in breast cancer (prognosis), whereas A focuses on WNT signaling and brain metastasis without addressing prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206458Z"}
{"comparison_id":"09279966-5562-4d62-8477-d00dd9a37fad","query_id":"53","doc_a_id":"1171121","doc_b_id":"22509015","presented_order":["22509015","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it examines prognostic markers in breast cancer, whereas Document A focuses on WNT signaling and brain metastasis and does not address prognostic marker expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206465Z"}
{"comparison_id":"641d9423-30dd-4d6e-ba34-27348d328f5a","query_id":"53","doc_a_id":"7583725","doc_b_id":"22509015","presented_order":["22509015","7583725"],"winner_id":"7583725","reasoning":"Document B. It links expression level of a specific protein to patient outcomes in breast cancer, whereas A addresses WNT signaling and metastasis without relating a marker's expression to prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206471Z"}
{"comparison_id":"7162075d-74d5-4f20-b12c-4dd33448f536","query_id":"53","doc_a_id":"19673227","doc_b_id":"22509015","presented_order":["22509015","19673227"],"winner_id":"22509015","reasoning":"Document A is more relevant — it focuses specifically on breast cancer biology and metastasis, whereas B addresses general chemosensitivity profiling across epithelial tumors. Neither document mentions ALDH1 or directly addresses its prognostic value.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206479Z"}
{"comparison_id":"abda9f84-3e37-4602-8083-93a1ada38887","query_id":"53","doc_a_id":"20839751","doc_b_id":"22509015","presented_order":["20839751","22509015"],"winner_id":"20839751","reasoning":"Document A is more relevant because it discusses prognostic factors in breast cancer, whereas Document B focuses on WNT signaling and metastasis without addressing ALDH1 or overall prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206485Z"}
{"comparison_id":"fec46b69-2961-41c6-b362-c309c93ba5e9","query_id":"53","doc_a_id":"13007205","doc_b_id":"22509015","presented_order":["22509015","13007205"],"winner_id":"22509015","reasoning":"Document A is more relevant — it addresses mechanisms of metastasis and aggressive breast cancer subtypes linked to poorer outcomes, whereas B focuses on fibroblast MMP-3 genotype and invasion without relation to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206492Z"}
{"comparison_id":"3e32d4aa-f811-476a-9503-17c2c4b947bb","query_id":"53","doc_a_id":"313403","doc_b_id":"22509015","presented_order":["313403","22509015"],"winner_id":"313403","reasoning":"Document A is more relevant because it addresses prognostic markers and clinical outcomes in breast cancer, whereas Document B focuses on WNT signaling and metastasis mechanisms without discussing prognostic biomarkers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206499Z"}
{"comparison_id":"67c3254d-a4c7-4a03-89cd-9a5121064da5","query_id":"53","doc_a_id":"29366489","doc_b_id":"22509015","presented_order":["29366489","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it deals directly with breast cancer biology and metastasis, which is closer to a claim about prognostic markers in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206506Z"}
{"comparison_id":"84688702-9c09-4fd8-b2d4-5f5301076023","query_id":"53","doc_a_id":"32001951","doc_b_id":"22509015","presented_order":["32001951","22509015"],"winner_id":"22509015","reasoning":"Doc B is more related: it addresses mechanisms of breast cancer metastasis and aggressiveness (prognosis-related), while Doc A concerns alkaline phosphatase regulation unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206513Z"}
{"comparison_id":"fec1be5c-ffe2-4ba1-aa81-a6444eb7fc76","query_id":"53","doc_a_id":"13030852","doc_b_id":"22509015","presented_order":["22509015","13030852"],"winner_id":"22509015","reasoning":"Document A is more relevant — it addresses molecular signaling and metastasis in breast cancer (which relates to prognosis), whereas Document B focuses on alkaline phosphatase for detecting metastases and not on molecular prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206520Z"}
{"comparison_id":"d013b7c0-f690-489a-8ddd-f8472da6c716","query_id":"53","doc_a_id":"4820792","doc_b_id":"22509015","presented_order":["22509015","4820792"],"winner_id":"22509015","reasoning":"Document A addresses metastasis and basal-like breast cancer—topics more relevant to prognosis and stem-cell–related markers like ALDH1—whereas B focuses on drug resistance in HER2+ cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206527Z"}
{"comparison_id":"57b2440e-fb5c-4276-a3af-2fecb616602c","query_id":"53","doc_a_id":"24341590","doc_b_id":"22509015","presented_order":["24341590","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it deals with basal-like breast cancer and mechanisms of metastasis, which is closer to studies of prognostic markers like ALDH1; Document A focuses on CYP2D6/tamoxifen pharmacogenetics and is unrelated. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206535Z"}
{"comparison_id":"0dec153f-ac7e-4b71-be12-7aa31e2a75b6","query_id":"53","doc_a_id":"43385013","doc_b_id":"22509015","presented_order":["43385013","22509015"],"winner_id":"43385013","reasoning":"Document A is more relevant because it discusses stem cell/progenitor properties in breast cell subpopulations (ALDH1 is a stem cell marker tied to prognosis), whereas Document B focuses on WNT signaling and metastasis without addressing stem cell markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206542Z"}
{"comparison_id":"f4746a06-34f4-4d4d-a66f-071cd0405847","query_id":"53","doc_a_id":"2931832","doc_b_id":"22509015","presented_order":["2931832","22509015"],"winner_id":"2931832","reasoning":"Document A is more relevant — it directly investigates prognostic markers and survival in breast cancer, whereas B focuses on WNT signaling and metastasis mechanisms. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206549Z"}
{"comparison_id":"33db1023-cf44-490c-88b5-f1c7a5cf87f1","query_id":"53","doc_a_id":"8037453","doc_b_id":"22509015","presented_order":["8037453","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it deals with breast cancer biology and metastasis, whereas A focuses on bone resorption markers in mixed cancers and is not breast-specific. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206556Z"}
{"comparison_id":"0dae9e63-5a0c-455d-a968-b5c3a4288187","query_id":"53","doc_a_id":"17648235","doc_b_id":"22509015","presented_order":["17648235","22509015"],"winner_id":"22509015","reasoning":"B is more relevant — it links WNT signaling to metastasis and clinical progression (worse outcomes), whereas A focuses on cell-line proliferation mechanisms. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206564Z"}
{"comparison_id":"36f423f1-40b9-4f8d-be75-d76f1987f647","query_id":"53","doc_a_id":"15721252","doc_b_id":"22509015","presented_order":["22509015","15721252"],"winner_id":"22509015","reasoning":"Document A is more relevant — it addresses basal-like breast cancer and metastasis (prognosis-related processes), whereas Document B focuses on drug response markers in ER+ lines and doesn't relate to ALDH1 or prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206571Z"}
{"comparison_id":"3d564c1e-b7c7-4553-907b-77e672a53cae","query_id":"53","doc_a_id":"19358586","doc_b_id":"22509015","presented_order":["22509015","19358586"],"winner_id":"19358586","reasoning":"B is more relevant — it addresses molecular expression signatures tied to poor survival in breast cancer, whereas A focuses on WNT signaling and metastasis without prognostic marker data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206578Z"}
{"comparison_id":"c5a916c2-77eb-4adc-b2e2-c4f98a6dac5d","query_id":"53","doc_a_id":"16734530","doc_b_id":"22509015","presented_order":["22509015","16734530"],"winner_id":"22509015","reasoning":"Document A is more relevant — it addresses mechanisms of metastasis (a direct contributor to poor prognosis in breast cancer), whereas Document B focuses on ORAI1 SNP associations without direct links to prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206585Z"}
{"comparison_id":"26551032-0807-4304-9b6d-bef5d2eb335a","query_id":"53","doc_a_id":"20127522","doc_b_id":"22509015","presented_order":["20127522","22509015"],"winner_id":"20127522","reasoning":"Reason: Document A concerns prognostic markers and links higher tumor cell metrics to poorer outcomes in breast cancer, making it more relevant to a claim about ALDH1 and prognosis than a mechanistic WNT signaling study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206592Z"}
{"comparison_id":"75db3f6a-d503-4172-a90a-7d744825a726","query_id":"53","doc_a_id":"5500086","doc_b_id":"22509015","presented_order":["22509015","5500086"],"winner_id":"22509015","reasoning":"Document A is more focused on breast cancer biology and metastasis (closely related to prognosis), while B addresses chemotherapy immune mechanisms rather than prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206598Z"}
{"comparison_id":"c8367aa2-0faf-4862-9c63-e6f2f15ebf87","query_id":"53","doc_a_id":"17755060","doc_b_id":"22509015","presented_order":["22509015","17755060"],"winner_id":"22509015","reasoning":"Document A is more directly about breast cancer subtypes and metastasis, making it more relevant to a claim about prognostic markers in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206605Z"}
{"comparison_id":"796d2531-2c11-4305-ae69-07ab6d60200d","query_id":"53","doc_a_id":"25732836","doc_b_id":"22509015","presented_order":["22509015","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant because it addresses prognostic markers and outcome prediction in breast cancer, whereas Document A focuses on WNT signaling and metastasis mechanisms. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206611Z"}
{"comparison_id":"d9880b99-6d87-4f41-9537-33d282494fb9","query_id":"53","doc_a_id":"27240667","doc_b_id":"22509015","presented_order":["22509015","27240667"],"winner_id":"22509015","reasoning":"Document A is more relevant — it addresses molecular markers and mechanisms linked to aggressive breast cancer subtypes and metastasis, which is closer to prognostic biomarker studies than population mortality trends.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206634Z"}
{"comparison_id":"860aec16-ef22-481a-ae3c-f3cd5ca3c3cd","query_id":"53","doc_a_id":"19882228","doc_b_id":"22509015","presented_order":["19882228","22509015"],"winner_id":"22509015","reasoning":"Document B — it specifically addresses breast cancer biology and metastasis, so it's more relevant to a claim about prognostic markers in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206651Z"}
{"comparison_id":"45d66b11-6eb2-41c5-bd2e-278f48a48528","query_id":"53","doc_a_id":"4999633","doc_b_id":"22509015","presented_order":["22509015","4999633"],"winner_id":"22509015","reasoning":"Document A is more relevant — it addresses signaling and metastasis in basal-like breast cancer, which relates to prognosis, whereas Document B focuses on estrogen receptor signaling in a cell line and not clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206661Z"}
{"comparison_id":"ed190ea4-bdce-4e9d-bcd8-1dd1c3a527a7","query_id":"53","doc_a_id":"24249915","doc_b_id":"22509015","presented_order":["24249915","22509015"],"winner_id":"22509015","reasoning":"Document B is more related—its focus on signaling linked to metastasis (a driver of poor prognosis) is closer to prognostic implications in breast cancer than Document A's focus on ERβ expression and methylation. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206669Z"}
{"comparison_id":"78dd9207-6915-4a58-9290-bf4826013b8b","query_id":"53","doc_a_id":"4455466","doc_b_id":"22509015","presented_order":["4455466","22509015"],"winner_id":"4455466","reasoning":"Document A is more relevant — it directly discusses a protein's expression level being associated with poor prognosis in breast cancer, whereas B focuses on WNT signaling and metastasis without addressing prognostic marker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206676Z"}
{"comparison_id":"cedc23fe-7ce3-4c28-bae0-4cc1c07633f6","query_id":"53","doc_a_id":"3285322","doc_b_id":"22509015","presented_order":["22509015","3285322"],"winner_id":"3285322","reasoning":"Document B is more relevant — it addresses clinical and prognostic features of breast cancer patients, whereas Document A focuses on WNT signaling and brain metastasis mechanisms.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206683Z"}
{"comparison_id":"82ce177e-24f6-46d2-b061-553abd44aad2","query_id":"53","doc_a_id":"9600826","doc_b_id":"22509015","presented_order":["9600826","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it addresses signaling pathways tied to metastasis and aggressive breast cancer subtypes (more related to prognosis), whereas A focuses on an angiogenesis pathway without relation to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206691Z"}
{"comparison_id":"ab1dba69-9cb8-44f4-b234-22bbf4485c1a","query_id":"53","doc_a_id":"13069283","doc_b_id":"22509015","presented_order":["13069283","22509015"],"winner_id":"22509015","reasoning":"B — It addresses signaling linked to metastasis and aggressive breast cancer behavior (more directly related to prognosis) while A focuses on tamoxifen metabolism/genetics. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206698Z"}
{"comparison_id":"599a3022-a5f3-48ac-b863-a11db074d291","query_id":"53","doc_a_id":"2130391","doc_b_id":"22509015","presented_order":["2130391","22509015"],"winner_id":"22509015","reasoning":"Document B is more focused on tumor-intrinsic signaling and metastasis, which is closer to markers like ALDH1 being linked to poor prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206706Z"}
{"comparison_id":"d5d38dc7-840e-4ec2-b9e8-ee4050338ed9","query_id":"53","doc_a_id":"219475","doc_b_id":"22509015","presented_order":["219475","22509015"],"winner_id":"22509015","reasoning":"Document B is more directly about breast cancer biology and metastasis, so it's more likely to address prognostic markers like ALDH1 than Document A, which focuses on myeloid cells in premetastatic lungs.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206716Z"}
{"comparison_id":"2b3fe286-c140-4aed-bc9f-ff558a0454ff","query_id":"53","doc_a_id":"1866911","doc_b_id":"22509015","presented_order":["1866911","22509015"],"winner_id":"1866911","reasoning":"Document A — it discusses progenitor/stem-like cell populations in breast cancer (more closely related to ALDH1 as a stem/progenitor marker) while B focuses on WNT signaling and metastasis without connection to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206723Z"}
{"comparison_id":"634a1304-da06-443e-bec4-a5f512b4e3de","query_id":"53","doc_a_id":"21033230","doc_b_id":"22509015","presented_order":["21033230","22509015"],"winner_id":"21033230","reasoning":"Document A is more relevant — it discusses molecular profiling and prognostic markers in metastatic breast cancer, whereas Document B focuses on WNT signaling and metastasis without addressing ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206730Z"}
{"comparison_id":"30a44694-47af-443c-925e-2014b4f9335d","query_id":"53","doc_a_id":"21902400","doc_b_id":"22509015","presented_order":["22509015","21902400"],"winner_id":"21902400","reasoning":"Document B is more relevant — it discusses prognostic indicators and clinical outcome in cancer (ties to markers associated with poor prognosis), whereas A focuses on WNT signaling and brain metastasis without addressing ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206737Z"}
{"comparison_id":"da195b6b-ae96-4cd2-8480-7003d452c0db","query_id":"53","doc_a_id":"4418878","doc_b_id":"22509015","presented_order":["4418878","22509015"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and their link to cancer prognosis, which relates to whether ALDH1 expression predicts poorer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206744Z"}
{"comparison_id":"751130c2-0f93-41c4-a09c-2a2585a8a902","query_id":"53","doc_a_id":"18953920","doc_b_id":"22509015","presented_order":["18953920","22509015"],"winner_id":"18953920","reasoning":"Document A is more relevant — it links EMT to acquisition of stem-cell markers and increased tumorigenicity, which pertains to ALDH1 as a stem cell marker associated with prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206751Z"}
{"comparison_id":"e8411237-c02c-4cbd-8dfc-8edfe519c6f8","query_id":"53","doc_a_id":"5864770","doc_b_id":"22509015","presented_order":["5864770","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it addresses mechanisms and metastasis in breast cancer subtypes (impacting prognosis), whereas A focuses on hormones and proliferation without prognostic markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206758Z"}
{"comparison_id":"e981b811-993d-48da-ae01-a0670f8ea818","query_id":"53","doc_a_id":"15521377","doc_b_id":"22509015","presented_order":["15521377","22509015"],"winner_id":"22509015","reasoning":"Document B is more directly about breast cancer (metastasis and molecular markers) while Document A is a general review of senescence unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206765Z"}
{"comparison_id":"df0b8481-a1fd-42de-8d3a-3674816845ab","query_id":"53","doc_a_id":"164985","doc_b_id":"22509015","presented_order":["22509015","164985"],"winner_id":"22509015","reasoning":"Document A is more relevant — it directly addresses breast cancer biology and metastasis (which relate to prognosis), whereas Document B focuses on macrophage IL-6 regulation and immune modulation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206772Z"}
{"comparison_id":"5da8e306-78d6-48fa-8e17-a30ec02720e1","query_id":"53","doc_a_id":"1389264","doc_b_id":"22509015","presented_order":["1389264","22509015"],"winner_id":"22509015","reasoning":"B is more relevant — it addresses signaling in basal-like breast cancer and brain metastasis (closer to prognosis and biology/markers like ALDH1) while A focuses on HER2-positive therapy response. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206779Z"}
{"comparison_id":"d2ffa7e9-b3fe-4801-8393-04f483dee916","query_id":"53","doc_a_id":"22482820","doc_b_id":"22509015","presented_order":["22482820","22509015"],"winner_id":"22482820","reasoning":"Document A is more relevant — it discusses breast cancer classification and treatment challenges where prognostic markers like ALDH1 are more likely addressed; Document B focuses specifically on WNT signaling and brain metastasis, not ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206786Z"}
{"comparison_id":"56baf739-3b86-470e-88ce-359521a73098","query_id":"53","doc_a_id":"15559582","doc_b_id":"22509015","presented_order":["15559582","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it addresses molecular markers and mechanisms linked to metastasis and aggressive breast cancer behavior, which relate to prognosis; Document A discusses lipids and prolactin, unrelated to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206794Z"}
{"comparison_id":"b86da0cd-e0a9-4978-a7a2-2b0081d46514","query_id":"53","doc_a_id":"8671456","doc_b_id":"22509015","presented_order":["8671456","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it addresses signaling pathways linked to aggressive, metastatic breast cancer subtypes and prognosis, whereas A focuses on a therapeutic virus. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206801Z"}
{"comparison_id":"3f380740-322d-4555-becc-6c48536ce63d","query_id":"53","doc_a_id":"31311495","doc_b_id":"22509015","presented_order":["22509015","31311495"],"winner_id":"22509015","reasoning":"Document A is more relevant because it addresses pathways linked to metastasis and aggressive basal-like breast cancer, which relate to poorer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206808Z"}
{"comparison_id":"2cbe2703-355e-48ec-a467-04473c6397c6","query_id":"53","doc_a_id":"5649538","doc_b_id":"22509015","presented_order":["5649538","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it addresses mechanisms in basal-like, metastatic breast cancer (linked to poor prognosis), whereas A focuses on dasatinib sensitivity markers unrelated to ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206814Z"}
{"comparison_id":"3012dfc1-3e16-4aca-93a3-cc7e988d1b29","query_id":"53","doc_a_id":"16086778","doc_b_id":"22509015","presented_order":["16086778","22509015"],"winner_id":"16086778","reasoning":"Document A is more related—it addresses pathways (Numb/Notch) tied to tumor progression and clinical relevance in breast cancer, which is closer to prognosis than the metastasis-focused study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206821Z"}
{"comparison_id":"badb8900-0eef-475b-8a3a-38d389a64e1f","query_id":"53","doc_a_id":"29495185","doc_b_id":"22509015","presented_order":["22509015","29495185"],"winner_id":"29495185","reasoning":"Document B is more relevant — it covers molecular predictors of cancer prognosis (where ALDH1 as a prognostic marker would fit), whereas A focuses on WNT signaling and brain metastasis without mentioning ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206828Z"}
{"comparison_id":"4ad1dd77-47b8-4755-9885-c8dfdb79464f","query_id":"53","doc_a_id":"4702639","doc_b_id":"22509015","presented_order":["22509015","4702639"],"winner_id":"4702639","reasoning":"Document B is more relevant — it addresses tumour stemness and markers associated with aggressive behavior/resistance (closer to ALDH1's role as a stem-cell/prognostic marker), whereas Document A focuses on WNT signaling and brain metastasis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206835Z"}
{"comparison_id":"390b98c0-bcf5-4489-982c-fc7dd69b6536","query_id":"53","doc_a_id":"1379127","doc_b_id":"22509015","presented_order":["1379127","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it discusses basal-like breast cancer and metastasis (factors tied to prognosis). Neither abstract mentions ALDH1 or directly addresses its association with prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206842Z"}
{"comparison_id":"a453f2b5-84db-49da-82ff-7c30b5162fdc","query_id":"53","doc_a_id":"24834968","doc_b_id":"22509015","presented_order":["22509015","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it evaluates biological markers and clinical outcomes in breast cancer, whereas A focuses on WNT signaling and brain metastasis without addressing markers like ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206849Z"}
{"comparison_id":"f58ee579-501c-4778-be38-ac3a61f38a9d","query_id":"53","doc_a_id":"24144677","doc_b_id":"22509015","presented_order":["24144677","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it discusses signaling pathways and metastasis in breast cancer (which relate to prognosis), whereas Document A focuses on an ATM germline mutation risk and not prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206856Z"}
{"comparison_id":"313f4d00-589e-44f3-81a6-e21660a2b261","query_id":"53","doc_a_id":"67045088","doc_b_id":"22509015","presented_order":["22509015","67045088"],"winner_id":"22509015","reasoning":"Document A is more relevant — it addresses mechanisms of breast cancer progression and metastasis (which relate to prognosis), whereas B focuses on immune modulation and tumor control without linkage to ALDH1 or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206863Z"}
{"comparison_id":"a7d837b7-0c67-4fa9-a189-b7090f08ca4c","query_id":"53","doc_a_id":"195680777","doc_b_id":"22509015","presented_order":["195680777","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it addresses molecular signaling and metastatic behavior in breast cancer subtypes (more closely related to biomarkers and prognosis), whereas A is about chemotherapy regimens.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206871Z"}
{"comparison_id":"6409b214-72fe-45e6-b55f-6de9df20b189","query_id":"53","doc_a_id":"15946643","doc_b_id":"22509015","presented_order":["15946643","22509015"],"winner_id":"15946643","reasoning":"Document A is more relevant — it addresses factors (chemoresistance and metastasis) tied to poorer prognosis in breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206877Z"}
{"comparison_id":"5943c686-46ee-45ed-a496-3a08df11b2ac","query_id":"53","doc_a_id":"31616203","doc_b_id":"22509015","presented_order":["31616203","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it addresses molecular mechanisms in aggressive/basal-like breast cancer and brain metastasis, which is closer to prognostic biomarkers than a HER2 drug trial. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206884Z"}
{"comparison_id":"8b4e3836-17a9-4e13-892f-70dfab20ba9d","query_id":"53","doc_a_id":"6550579","doc_b_id":"22509015","presented_order":["6550579","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it addresses mechanisms of aggressive, metastatic (poor-prognosis) breast cancer subtypes, whereas Document A focuses on HER3-targeted therapy in HER2-amplified disease. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206891Z"}
{"comparison_id":"2bb47d45-fddc-4f85-8e6f-7aedb9d28ce8","query_id":"53","doc_a_id":"23863551","doc_b_id":"22509015","presented_order":["22509015","23863551"],"winner_id":"22509015","reasoning":"Document A is more relevant — it addresses aggressive basal-like breast cancer and brain metastasis (prognostic factors), whereas Document B focuses on PI3K inhibitor feedback mechanisms and therapy. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206898Z"}
{"comparison_id":"df4e5d3a-0417-4f10-96f0-d22b91d17a18","query_id":"53","doc_a_id":"20183360","doc_b_id":"22509015","presented_order":["20183360","22509015"],"winner_id":"22509015","reasoning":"Document B is slightly more relevant because it addresses metastasis (brain metastasis), which directly relates to poorer prognosis; Document A focuses on molecular regulation of invasion but not clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206904Z"}
{"comparison_id":"607c5c8d-9d3b-4ed7-aa4f-d383b858e72f","query_id":"53","doc_a_id":"2015126","doc_b_id":"22509015","presented_order":["22509015","2015126"],"winner_id":"22509015","reasoning":"Document A is more relevant — it addresses molecular markers and pathways in breast cancer biology (metastasis), which is closer to a claim about a molecular prognostic marker like ALDH1 than a paper on genetic-management strategies. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206912Z"}
{"comparison_id":"cfe962bb-aaea-40d8-ba53-59691a932406","query_id":"53","doc_a_id":"34066665","doc_b_id":"22509015","presented_order":["22509015","34066665"],"winner_id":"22509015","reasoning":"Document A is more relevant — it addresses mechanisms of breast cancer metastasis (which relate to prognosis) and basal-like subtype context, whereas B focuses on ER/HER-mediated endocrine resistance; neither mentions ALDH1 specifically. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206919Z"}
{"comparison_id":"05260efe-fb73-4b63-b685-2f7398d568c0","query_id":"53","doc_a_id":"16691520","doc_b_id":"22509015","presented_order":["22509015","16691520"],"winner_id":"22509015","reasoning":"Document A is more relevant — it addresses mechanisms of metastasis and aggressive basal-like breast cancer (contexts where ALDH1 as a poor-prognosis marker is typically discussed), whereas Document B focuses on estrogen receptor binding in ER-driven regulation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206927Z"}
{"comparison_id":"c8ab2a60-55b1-493c-a42f-7ff165f137db","query_id":"53","doc_a_id":"20333864","doc_b_id":"22509015","presented_order":["20333864","22509015"],"winner_id":"20333864","reasoning":"Document A — it addresses factors controlling progression from in situ to invasive breast cancer and tumor progression (more directly related to prognosis), while Document B focuses on WNT signaling and brain metastasis in a specific subtype.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206934Z"}
{"comparison_id":"12550313-40c5-48ca-b6ca-c4da4c970bd9","query_id":"53","doc_a_id":"2014909","doc_b_id":"22509015","presented_order":["22509015","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — it discusses tumor-initiating cells in primary breast cancers (ALDH1 is a tumor-initiating/stem cell marker linked to prognosis).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206941Z"}
{"comparison_id":"8a059ebd-c367-4639-8287-ddd55369ddfd","query_id":"53","doc_a_id":"6969753","doc_b_id":"22509015","presented_order":["6969753","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it discusses breast cancer subtype behavior and metastasis (related to prognosis), whereas A focuses on invadopodia mechanics and MT1-MMP/cortactin. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206948Z"}
{"comparison_id":"3248f4f4-1bc9-4603-b612-9ebe3f6ce811","query_id":"53","doc_a_id":"4583180","doc_b_id":"22509015","presented_order":["4583180","22509015"],"winner_id":"4583180","reasoning":"Document A is more directly relevant because it links gene expression changes to tumor progression and reduced patient survival, which relates to prognosis; Document B focuses on WNT signaling and metastasis mechanisms without directly addressing prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206955Z"}
{"comparison_id":"96e6629c-f141-4474-b100-0a103b7e6ebe","query_id":"53","doc_a_id":"15832146","doc_b_id":"22509015","presented_order":["15832146","22509015"],"winner_id":"22509015","reasoning":"Neither document mentions ALDH1, but Document B (WNT signaling and metastasis) is slightly more related to tumor-cell markers and prognosis than Document A (stromal fibroblasts/angiogenesis). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206962Z"}
{"comparison_id":"1694a452-4081-4abc-9d35-98336cc2428e","query_id":"53","doc_a_id":"22267225","doc_b_id":"22509015","presented_order":["22267225","22509015"],"winner_id":"22509015","reasoning":"Document B is more directly about breast cancer biology and metastasis, so it's more relevant to a claim about a breast cancer prognostic marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206968Z"}
{"comparison_id":"443c7d6a-015f-4f62-b4ca-70119d735626","query_id":"53","doc_a_id":"8774475","doc_b_id":"22509015","presented_order":["8774475","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it addresses basal-like breast cancer and metastasis (factors tied to prognosis), whereas A focuses on cell polarity/Scribble and not prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206975Z"}
{"comparison_id":"4d3ca6d2-3b4a-4127-af86-da3f58ec5a8e","query_id":"53","doc_a_id":"10279084","doc_b_id":"22509015","presented_order":["22509015","10279084"],"winner_id":"22509015","reasoning":"Document A is more relevant: it directly studies signaling and metastasis in breast cancer (which relate to prognosis), whereas Document B focuses on a MAP kinase phosphatase splice variant with only tangential mention of breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206982Z"}
{"comparison_id":"652f525c-e69d-421c-bfad-8870e00cd1e5","query_id":"53","doc_a_id":"13290521","doc_b_id":"22509015","presented_order":["22509015","13290521"],"winner_id":"22509015","reasoning":"Document A is focused on breast cancer biology and metastasis, so it's more likely to discuss markers tied to prognosis; Document B is a general review of miR-7 not specific to ALDH1 or breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206989Z"}
{"comparison_id":"8b664455-0019-4ca5-be6c-658c3a4a23b9","query_id":"53","doc_a_id":"5270265","doc_b_id":"22509015","presented_order":["5270265","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it addresses basal-like breast cancer and metastasis (contexts where ALDH1 stem-cell marker is commonly studied), whereas A focuses on SRC in trastuzumab-resistant HER2+ disease.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.206996Z"}
{"comparison_id":"66b38960-6d16-497d-937b-d815771daf4c","query_id":"53","doc_a_id":"40127292","doc_b_id":"22509015","presented_order":["40127292","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it directly studies breast cancer biology and metastasis, whereas A discusses general transgenic cancer models and chemoresistance. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.207002Z"}
{"comparison_id":"c47cc4a1-7f53-401e-9d0e-55e06ad26fd5","query_id":"53","doc_a_id":"11484808","doc_b_id":"22509015","presented_order":["11484808","22509015"],"winner_id":"22509015","reasoning":"Document B — it directly studies breast cancer subtypes and metastasis-related pathways tied to prognosis, so it's more likely to address prognostic markers like ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.207009Z"}
{"comparison_id":"d10ce63c-60e1-4058-bdee-b0fefab01230","query_id":"53","doc_a_id":"26231129","doc_b_id":"22509015","presented_order":["26231129","22509015"],"winner_id":"22509015","reasoning":"Document B is more focused on breast cancer biology and metastasis, making it more relevant to prognosis-related claims than the broad framework in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.207015Z"}
{"comparison_id":"0564e893-2ea1-405a-b15d-0e74c3b855f8","query_id":"53","doc_a_id":"825728","doc_b_id":"22509015","presented_order":["825728","22509015"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT repression, acquisition of stem-cell–like properties, and patient survival, which relates to prognostic markers like ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:18.207022Z"}
{"comparison_id":"ef1d1e7e-954a-4bfa-8161-047409387d9d","query_id":"53","doc_a_id":"45638119","doc_b_id":"25732836","presented_order":["25732836","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly reports that ALDH1 marks malignant mammary stem cells and correlates with poor prognosis in breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420360Z"}
{"comparison_id":"c5323175-6b77-49cc-8153-eb722ec36a89","query_id":"53","doc_a_id":"8963413","doc_b_id":"25732836","presented_order":["25732836","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — it discusses tumor biomarker expression and associations with clinical outcomes in breast cancer, which is closer to the claim about ALDH1 expression and prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420381Z"}
{"comparison_id":"1dc49f4c-c457-4048-8b9f-f696a488fba9","query_id":"53","doc_a_id":"22401720","doc_b_id":"25732836","presented_order":["22401720","25732836"],"winner_id":"22401720","reasoning":"Reason: Neither document mentions ALDH1, but Document A discusses tumor marker expression and links a molecular marker (VEGF) to prognosis, making it more relevant than Document B which focuses on CTCs and imaging.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420391Z"}
{"comparison_id":"72ee801f-6f00-438a-ae5a-3095f9272b0c","query_id":"53","doc_a_id":"25973484","doc_b_id":"25732836","presented_order":["25973484","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant because it addresses prognostic markers and outcome prediction in breast cancer, whereas Document A focuses on obesity-related risk and broad prognosis factors without molecular markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420399Z"}
{"comparison_id":"2275f84f-553b-4aa3-8cbd-3dc1e9cfc499","query_id":"53","doc_a_id":"7821634","doc_b_id":"25732836","presented_order":["25732836","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it links tumor protein expression levels (DUSP4) to prognosis and treatment response, which is directly analogous to the claim about ALDH1 expression and outcome. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420406Z"}
{"comparison_id":"7006e0d2-b670-4ded-ba3c-f9962bec2047","query_id":"53","doc_a_id":"12762485","doc_b_id":"25732836","presented_order":["12762485","25732836"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses a stem-cell phenotype (linked to markers like ALDH1) associated with poorer prognostic features in breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420413Z"}
{"comparison_id":"dfce6db4-a62f-48c2-83f7-18bdd9d2734a","query_id":"53","doc_a_id":"4889228","doc_b_id":"25732836","presented_order":["4889228","25732836"],"winner_id":"4889228","reasoning":"Document A is more relevant — it discusses tumor biomarker expression (TDP43) linked to prognosis in breast cancer, which is conceptually closer to the claim about ALDH1 expression and outcome.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420420Z"}
{"comparison_id":"8430d243-00e6-46ff-ad7b-764084aa29f7","query_id":"53","doc_a_id":"4429932","doc_b_id":"25732836","presented_order":["25732836","4429932"],"winner_id":"4429932","reasoning":"Reason: Document B links expression of a specific enzyme (LOX) to poor patient outcomes in breast cancer, which is more analogous to a claim about a molecular marker (ALDH1) being associated with prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420426Z"}
{"comparison_id":"80ae5f10-24fc-4cf1-93f4-1af6fd4db70e","query_id":"53","doc_a_id":"1171121","doc_b_id":"25732836","presented_order":["25732836","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it examines molecular/protein prognostic markers in breast cancer (p53, MVD), which is closer to assessing biomarker-associated prognosis than imaging/CTC-focused Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420433Z"}
{"comparison_id":"84143800-00f4-4d3f-be41-860a2230fab7","query_id":"53","doc_a_id":"7583725","doc_b_id":"25732836","presented_order":["7583725","25732836"],"winner_id":"7583725","reasoning":"Document A is more relevant — it discusses tumor cell protein expression (like ALDH1) linked to patient outcomes, whereas B focuses on imaging/CTCs. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420440Z"}
{"comparison_id":"cc26914a-e42f-488b-990b-a2fc84775037","query_id":"53","doc_a_id":"20839751","doc_b_id":"25732836","presented_order":["25732836","20839751"],"winner_id":"20839751","reasoning":"Document B is more relevant — it discusses tumor biomarkers and their association with prognosis in breast cancer, whereas Document A focuses on CTCs and PET/CT imaging. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420446Z"}
{"comparison_id":"88e802be-fc5d-4b11-8701-ea6a2415c93f","query_id":"53","doc_a_id":"313403","doc_b_id":"25732836","presented_order":["25732836","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it examines a tumor-associated cellular marker (TAM infiltration) as a prognostic indicator in breast cancer, which is conceptually closer to ALDH1 expression as a prognostic biomarker. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420454Z"}
{"comparison_id":"4a6ae985-282e-4fd4-acab-55d94d293f3d","query_id":"53","doc_a_id":"43385013","doc_b_id":"25732836","presented_order":["43385013","25732836"],"winner_id":"43385013","reasoning":"Document A is more relevant — it addresses breast epithelial/mesenchymal subpopulations and stem cell/progenitor properties (ALDH1 is a stem cell marker), whereas Document B focuses on CTCs and PET/CT without ALDH1-related data.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420462Z"}
{"comparison_id":"3154c54b-b3b4-4019-9905-65d9a0d44b96","query_id":"53","doc_a_id":"2931832","doc_b_id":"25732836","presented_order":["25732836","2931832"],"winner_id":"2931832","reasoning":"Both discuss prognostic biomarkers in breast cancer; Document B evaluates a biomarker linked to poorer disease-free survival, making it more relevant to a claim about a prognostic marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420470Z"}
{"comparison_id":"aa585c29-f89e-47ff-8b65-1b4e356572fe","query_id":"53","doc_a_id":"19358586","doc_b_id":"25732836","presented_order":["19358586","25732836"],"winner_id":"19358586","reasoning":"Reason: Document A links specific molecular expression signatures to poor survival in breast cancer (a molecular prognostic marker study), making it more relevant to a claim about expression (ALDH1) and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420478Z"}
{"comparison_id":"758c0980-0195-4a5e-ae51-30383740679a","query_id":"53","doc_a_id":"20127522","doc_b_id":"25732836","presented_order":["25732836","20127522"],"winner_id":"20127522","reasoning":"Reason: Document B directly links a biomarker (CTC levels) to poorer progression-free survival in breast cancer, which is more analogous to the claim about ALDH1 expression and prognosis than Document A's imaging-focused study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420486Z"}
{"comparison_id":"bf63a655-fae6-4208-8903-3a442d39ad03","query_id":"53","doc_a_id":"825728","doc_b_id":"25732836","presented_order":["825728","25732836"],"winner_id":"825728","reasoning":"Reason: Document A discusses acquisition of stem cell properties and links to patient survival/metastasis, which is more directly related to ALDH1 (a cancer stem cell marker) and prognosis than Document B's focus on CTCs and PET/CT monitoring.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420493Z"}
{"comparison_id":"e6c41b61-5f66-4d0e-8ba6-fb9f1e353d71","query_id":"53","doc_a_id":"4455466","doc_b_id":"25732836","presented_order":["25732836","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it discusses gene expression levels and their association with prognosis in breast cancer, whereas A focuses on CTCs and imaging and does not address marker expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420500Z"}
{"comparison_id":"a1f5de4b-6eb5-4570-9f6b-43023e4b1d0b","query_id":"53","doc_a_id":"3285322","doc_b_id":"25732836","presented_order":["3285322","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant — it deals with prognostic biomarkers and outcome prediction in breast cancer, which is closer to the query about ALDH1 as a prognostic marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420506Z"}
{"comparison_id":"391505ab-ffeb-4f77-9308-66722ab90199","query_id":"53","doc_a_id":"1866911","doc_b_id":"25732836","presented_order":["1866911","25732836"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses luminal progenitor and stem-like cell populations in breast cancer, which relates to ALDH1 as a stem/progenitor marker. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420513Z"}
{"comparison_id":"88a75470-a17d-498b-91ae-86e06a934734","query_id":"53","doc_a_id":"21033230","doc_b_id":"25732836","presented_order":["21033230","25732836"],"winner_id":"21033230","reasoning":"Document A is more relevant — it discusses molecular profiling of tumor cells and prognostic markers in breast cancer, which is closer to an association between marker expression (like ALDH1) and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420520Z"}
{"comparison_id":"3aa8b4f9-80c1-403e-b69a-7343ac558abf","query_id":"53","doc_a_id":"21902400","doc_b_id":"25732836","presented_order":["21902400","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant — it specifically studies prognostic markers in breast cancer (CTCs and imaging), whereas Document A discusses hypoxia generally and not breast cancer markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420527Z"}
{"comparison_id":"80f7ad2e-0479-42b4-bbc9-c15efeb75711","query_id":"53","doc_a_id":"4418878","doc_b_id":"25732836","presented_order":["25732836","4418878"],"winner_id":"4418878","reasoning":"Document B — it discusses links between gene expression signatures and prognosis, which is more relevant to a claim about ALDH1 expression and outcome than a study on CTCs and PET/CT. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420534Z"}
{"comparison_id":"957d7a28-805d-42cc-b32a-9a0663ac1df3","query_id":"53","doc_a_id":"18953920","doc_b_id":"25732836","presented_order":["25732836","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses acquisition of stem-cell markers and increased tumorigenicity in mammary epithelial cells, which is directly relevant to ALDH1 as a breast cancer stem-cell marker linked to prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420542Z"}
{"comparison_id":"4b7d3e46-e5d9-4b75-9b3a-76525dfc042a","query_id":"53","doc_a_id":"22482820","doc_b_id":"25732836","presented_order":["25732836","22482820"],"winner_id":"25732836","reasoning":"Document A is more relevant — it deals with prognostic markers and outcome prediction in breast cancer, whereas B focuses on treatment strategies and drug delivery. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420548Z"}
{"comparison_id":"ab7f7e00-00d4-496f-9b64-0bf7c91b2cee","query_id":"53","doc_a_id":"16086778","doc_b_id":"25732836","presented_order":["16086778","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant — it addresses prognostic factors and outcome prediction in breast cancer, whereas Document A focuses on Numb/Notch biology without prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420555Z"}
{"comparison_id":"ada7d4e0-fd4a-4208-b4db-06532af3dbed","query_id":"53","doc_a_id":"29495185","doc_b_id":"25732836","presented_order":["29495185","25732836"],"winner_id":"29495185","reasoning":"Document A is more relevant — it discusses molecular predictors of prognosis in cancer (though not ALDH1 specifically), whereas Document B focuses on CTCs and imaging. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420562Z"}
{"comparison_id":"2f271302-3802-4615-b9f2-f61d9bef0fa1","query_id":"53","doc_a_id":"4702639","doc_b_id":"25732836","presented_order":["4702639","25732836"],"winner_id":"4702639","reasoning":"Document A is more relevant — it addresses tumor stemness and markers associated with aggressive, treatment‑resistant behavior, which is directly related to ALDH1 as a cancer stem cell marker tied to prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420569Z"}
{"comparison_id":"20e61b31-93cb-4b3f-89f2-6ce8ecc5bf54","query_id":"53","doc_a_id":"24834968","doc_b_id":"25732836","presented_order":["25732836","24834968"],"winner_id":"25732836","reasoning":"Document A is more relevant — it evaluates prognostic markers and overall survival in breast cancer, while Document B focuses on chemotherapy response predictors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420576Z"}
{"comparison_id":"cbf66c50-4991-4e95-b481-6bf275d84c0e","query_id":"53","doc_a_id":"15946643","doc_b_id":"25732836","presented_order":["25732836","15946643"],"winner_id":"25732836","reasoning":"Document A is more focused on prognostic markers and outcome prediction in breast cancer, which is closer to the claim about ALDH1 and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420583Z"}
{"comparison_id":"16ab4d4b-2e30-4264-a6cc-93baa0138884","query_id":"53","doc_a_id":"20333864","doc_b_id":"25732836","presented_order":["20333864","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant — it addresses prognostic markers and overall survival in breast cancer, while Document A focuses on cellular mechanisms of progression and doesn't discuss prognosis or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420590Z"}
{"comparison_id":"b3ddb95c-d559-41de-80ee-711b70fa6d10","query_id":"53","doc_a_id":"2014909","doc_b_id":"25732836","presented_order":["2014909","25732836"],"winner_id":"2014909","reasoning":"Reason: Document A discusses tumor-initiating cells and analyses of primary breast cancers (where ALDH1, a stem cell marker, is commonly evaluated), making it more likely to address ALDH1 prognostic associations than Document B, which focuses on CTCs and imaging.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420597Z"}
{"comparison_id":"92e09878-d3be-4322-93f0-5c8964aa816c","query_id":"53","doc_a_id":"4583180","doc_b_id":"25732836","presented_order":["25732836","4583180"],"winner_id":"25732836","reasoning":"Document A is more relevant — it specifically studies prognostic markers in metastatic breast cancer, whereas Document B is a general tumor biology study not about ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:34.420603Z"}
{"comparison_id":"75d10d23-77dc-47c0-9ccd-be4e84f90de1","query_id":"53","doc_a_id":"45638119","doc_b_id":"43385013","presented_order":["45638119","43385013"],"winner_id":"45638119","reasoning":"Document A is directly about ALDH1 as a marker and predictor of poor clinical outcome in breast cancer; Document B does not address ALDH1 or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541433Z"}
{"comparison_id":"31c562f1-0614-474b-8232-f2cabf5f1f16","query_id":"53","doc_a_id":"8963413","doc_b_id":"43385013","presented_order":["43385013","8963413"],"winner_id":"43385013","reasoning":"Document A — it addresses stem cell/progenitor properties in breast cell subpopulations (ALDH1 is a stem cell marker), while Document B focuses on PD-L1, not ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541456Z"}
{"comparison_id":"d653ab75-074e-4498-b0fe-e63292a1d553","query_id":"53","doc_a_id":"22401720","doc_b_id":"43385013","presented_order":["22401720","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it addresses stem cell/progenitor properties (ALDH1 is a stem cell marker), whereas A focuses on angiogenic factors not ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541465Z"}
{"comparison_id":"a4f3fa68-d3f1-4318-80db-e02b4ae0d92a","query_id":"53","doc_a_id":"7821634","doc_b_id":"43385013","presented_order":["43385013","7821634"],"winner_id":"43385013","reasoning":"Document A is more relevant — it addresses stem cell/progenitor properties in breast cells (ALDH1 is a stem cell marker), whereas Document B concerns DUSP4 and drug resistance without mention of ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541472Z"}
{"comparison_id":"a7e07879-71ca-4456-84ff-59ab534198df","query_id":"53","doc_a_id":"12762485","doc_b_id":"43385013","presented_order":["43385013","12762485"],"winner_id":"12762485","reasoning":"Document B — it links a stem-cell-like phenotype in breast cancer to aggressive features (p53 positivity, ER/PgR negativity, higher proliferation) relevant to prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541480Z"}
{"comparison_id":"3cd3a2bd-e227-48bb-9be7-6d4c0e6667b3","query_id":"53","doc_a_id":"4889228","doc_b_id":"43385013","presented_order":["4889228","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it addresses stem cell/progenitor properties in breast cells (ALDH1 is a breast cancer stem cell marker linked to prognosis), while Document A focuses on TDP43 in TNBC and does not mention ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541487Z"}
{"comparison_id":"a6b940b6-13d2-486e-a0db-e12f26758235","query_id":"53","doc_a_id":"4429932","doc_b_id":"43385013","presented_order":["4429932","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it discusses stem cell/progenitor properties in breast cells (ALDH1 is a stem cell marker), whereas A focuses on LOX/hypoxia and not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541494Z"}
{"comparison_id":"27e8179a-e566-4d54-8ad4-a3ae06001829","query_id":"53","doc_a_id":"1171121","doc_b_id":"43385013","presented_order":["43385013","1171121"],"winner_id":"43385013","reasoning":"Document A is more relevant — it addresses breast epithelial/mesenchymal subpopulations and stem cell/progenitor properties (ALDH1 is a stem-cell marker), while Document B focuses on MVD and p53 unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541501Z"}
{"comparison_id":"fd97ea78-b7f6-44e7-82dd-0cd18db37d2d","query_id":"53","doc_a_id":"7583725","doc_b_id":"43385013","presented_order":["7583725","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it discusses stem cell/progenitor properties in breast cell subpopulations (ALDH1 is a common stem cell marker), whereas Document A focuses on TRPM7 and metastasis without addressing ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541508Z"}
{"comparison_id":"bf7cfd24-ac7f-4b57-a31a-d78749f4f01b","query_id":"53","doc_a_id":"20839751","doc_b_id":"43385013","presented_order":["43385013","20839751"],"winner_id":"43385013","reasoning":"Document A — it discusses breast cell subpopulations and stem/progenitor properties (ALDH1 is a stem cell marker), so it's more related to ALDH1 and prognosis than the apoptosis-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541515Z"}
{"comparison_id":"058eebad-429b-4275-86dd-65531250edd4","query_id":"53","doc_a_id":"313403","doc_b_id":"43385013","presented_order":["313403","43385013"],"winner_id":"43385013","reasoning":"Reason: Document B discusses stem cell/progenitor properties in breast cell subpopulations (related to markers like ALDH1), while Document A focuses on tumor-associated macrophages and not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541533Z"}
{"comparison_id":"2d89f983-ebc4-428f-9c1f-d60cb03391fe","query_id":"53","doc_a_id":"2014909","doc_b_id":"43385013","presented_order":["43385013","2014909"],"winner_id":"43385013","reasoning":"Document A is more relevant — it addresses stem cell/progenitor properties in breast cells (ALDH1 is a known stem cell marker), whereas Document B focuses on mTOR and immune recruitment without discussion of ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541552Z"}
{"comparison_id":"63132f0c-a3aa-4f14-be0e-7f8f124f69c5","query_id":"53","doc_a_id":"2931832","doc_b_id":"43385013","presented_order":["43385013","2931832"],"winner_id":"43385013","reasoning":"Document A is more relevant — it addresses stem cell/progenitor properties in breast cell subpopulations (ALDH1 is a stem cell marker), whereas Document B concerns a platelet-based prognostic marker unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541563Z"}
{"comparison_id":"a0a5f8f9-14db-45af-9db1-cecd6dc6a81d","query_id":"53","doc_a_id":"19358586","doc_b_id":"43385013","presented_order":["19358586","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it addresses epithelial/mesenchymal and stem/progenitor properties in breast cells (ALDH1 is a stem cell marker linked to prognosis), whereas A focuses on a Myc/p27/phospho-Rb signature and miRNAs.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541572Z"}
{"comparison_id":"f9ca6267-7c2b-46e2-b38a-b5430a72df7e","query_id":"53","doc_a_id":"20127522","doc_b_id":"43385013","presented_order":["43385013","20127522"],"winner_id":"20127522","reasoning":"Document B is more relevant — it concerns prognostic markers and survival outcomes in breast cancer, whereas A discusses cellular phenotypes without addressing prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541580Z"}
{"comparison_id":"1a325fd0-1629-4a96-ae8b-c325403e242e","query_id":"53","doc_a_id":"825728","doc_b_id":"43385013","presented_order":["43385013","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it links EMT regulation to acquisition of stem-cell properties and patient survival/metastasis, which relates to prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541587Z"}
{"comparison_id":"bf6d4942-7b6e-4a9a-9828-1d257e29247f","query_id":"53","doc_a_id":"4455466","doc_b_id":"43385013","presented_order":["4455466","43385013"],"winner_id":"43385013","reasoning":"Doc B is more relevant — it addresses epithelial/mesenchymal subpopulations and stem cell/progenitor properties (related to ALDH1 as a stem cell marker), while Doc A concerns ZMYND11, not ALDH1.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541594Z"}
{"comparison_id":"568a78e9-df66-47c5-9f2c-7a77db2a7c7b","query_id":"53","doc_a_id":"1866911","doc_b_id":"43385013","presented_order":["43385013","1866911"],"winner_id":"43385013","reasoning":"Document A is more relevant — it examines stem cell/progenitor properties in breast cells (ALDH1 is a common stem cell marker), whereas B focuses on BRCA1-associated luminal progenitors and c-KIT, not ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541600Z"}
{"comparison_id":"b26b8871-fde3-4613-8e23-d740a10579b6","query_id":"53","doc_a_id":"21033230","doc_b_id":"43385013","presented_order":["21033230","43385013"],"winner_id":"43385013","reasoning":"Document B — it addresses stem cell/progenitor properties in breast cells (ALDH1 is a stem cell marker), making it more relevant than Document A which focuses on CTC markers and survival but not ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541607Z"}
{"comparison_id":"74554158-5cb5-4b4b-b9dc-b51bfc85cf2d","query_id":"53","doc_a_id":"4418878","doc_b_id":"43385013","presented_order":["4418878","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it directly addresses stem cell/progenitor properties in breast cells (the context for ALDH1 as a cancer stem cell marker), whereas A is a broad paper on pathway signatures without specific linkage to ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541614Z"}
{"comparison_id":"b7e017d5-0957-4178-92fe-fe26fed00999","query_id":"53","doc_a_id":"18953920","doc_b_id":"43385013","presented_order":["18953920","43385013"],"winner_id":"18953920","reasoning":"Document A is more relevant — it links acquisition of stem-cell markers and increased tumorigenicity in mammary cells, which relates to ALDH1 (a stem-cell marker) and poorer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541621Z"}
{"comparison_id":"fcb3af36-b7b5-49c1-ad98-c540507f6957","query_id":"53","doc_a_id":"29495185","doc_b_id":"43385013","presented_order":["29495185","43385013"],"winner_id":"29495185","reasoning":"Document A — it discusses molecular predictors of cancer prognosis (more directly related to links between markers like ALDH1 and outcomes). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541628Z"}
{"comparison_id":"da821751-ea39-4f70-938d-56d29bf8652e","query_id":"53","doc_a_id":"4702639","doc_b_id":"43385013","presented_order":["4702639","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it examines stem cell/progenitor properties in breast cell subpopulations (where ALDH1 is a known stem cell marker), whereas A focuses on integrin αvβ3–KRAS–RalB signaling and drug resistance without addressing ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:46.541635Z"}
{"comparison_id":"b4b525a5-6017-4d69-970c-424c4d397d26","query_id":"53","doc_a_id":"45638119","doc_b_id":"20127522","presented_order":["45638119","20127522"],"winner_id":"45638119","reasoning":"Document A directly reports that ALDH1 marks mammary stem cells and predicts poor clinical outcome in breast cancer; Document B concerns circulating tumor cells and is unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:50.164555Z"}
{"comparison_id":"83c4bd26-fa9c-4862-b48c-cdf184599a22","query_id":"53","doc_a_id":"12762485","doc_b_id":"20127522","presented_order":["12762485","20127522"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses a stem cell phenotype in breast cancer linked to poorer features (p53+, ER/PgR−, higher proliferation), which relates to ALDH1 as a stem cell marker associated with prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:50.164579Z"}
{"comparison_id":"7784da13-c6f8-4ddf-ad38-1ffd899eff52","query_id":"53","doc_a_id":"29495185","doc_b_id":"20127522","presented_order":["20127522","29495185"],"winner_id":"29495185","reasoning":"Reason: Document B discusses molecular predictors of prognosis (more likely to address biomarkers like ALDH1), whereas A focuses on circulating tumor cells and not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:50.164587Z"}
{"comparison_id":"b59361b1-56b5-41c9-b4e9-50d8f4ef94d4","query_id":"53","doc_a_id":"825728","doc_b_id":"20127522","presented_order":["20127522","825728"],"winner_id":"20127522","reasoning":"Document A is more relevant — it addresses prognosis in breast cancer directly (though via CTCs), whereas B focuses on Prrx1/EMT mechanisms unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:50.164594Z"}
{"comparison_id":"10126d67-b615-4a3a-b59d-ccb42a77f4dc","query_id":"53","doc_a_id":"18953920","doc_b_id":"20127522","presented_order":["18953920","20127522"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses breast epithelial cells acquiring stem-cell markers and increased tumorigenic potential, which relates to ALDH1 as a stem-cell/prognostic marker in breast cancer.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:50.164602Z"}
{"comparison_id":"f45ca8fe-9b6e-42bd-8597-feff8e55471a","query_id":"53","doc_a_id":"45638119","doc_b_id":"12762485","presented_order":["12762485","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 as a marker and predictor of poor prognosis in breast cancer; Document A does not mention ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:55.227626Z"}
{"comparison_id":"5b5307a8-37ef-457c-a26b-33fef0c4e3d9","query_id":"53","doc_a_id":"18953920","doc_b_id":"12762485","presented_order":["12762485","18953920"],"winner_id":"18953920","reasoning":"Document B — it links acquisition of stem-cell markers and increased tumorigenicity in mammary cells, which is more directly related to ALDH1 as a stem-cell–associated prognostic marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:55.227648Z"}
{"comparison_id":"e5ac6e70-8cef-41af-b238-552d41df4a68","query_id":"53","doc_a_id":"29495185","doc_b_id":"12762485","presented_order":["29495185","12762485"],"winner_id":"29495185","reasoning":"Document A is more relevant — it addresses molecular predictors of cancer prognosis and survival, which directly relates to the claim about ALDH1 as a prognostic marker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:55.227657Z"}
{"comparison_id":"2e45480a-045b-44e4-8dae-9d3aca8afa75","query_id":"53","doc_a_id":"45638119","doc_b_id":"18953920","presented_order":["45638119","18953920"],"winner_id":"45638119","reasoning":"Document A directly states ALDH1 is a marker of malignant mammary stem cells and a predictor of poor clinical outcome in breast cancer, whereas Document B does not mention ALDH1 or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:59.096936Z"}
{"comparison_id":"0998d085-e4a9-471e-a055-4546fb883f8d","query_id":"53","doc_a_id":"29495185","doc_b_id":"18953920","presented_order":["29495185","18953920"],"winner_id":"18953920","reasoning":"Reason: Document B discusses acquisition of stem-cell markers and increased tumorigenic potential in mammary cells, which is directly relevant to ALDH1 as a breast cancer stem-cell marker linked to prognosis; Document A is general and non-specific.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:40:59.096956Z"}
{"comparison_id":"db71d3fc-0d5f-4cd9-aa1c-5df51ffd6ac6","query_id":"53","doc_a_id":"8963413","doc_b_id":"313403","presented_order":["313403","8963413"],"winner_id":"313403","reasoning":"Document A is more relevant — it reports a biomarker (TAM infiltration) linked to poorer prognosis specifically in breast cancer, whereas Document B discusses PD-L1 with mixed outcomes across cancers. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:11.244373Z"}
{"comparison_id":"3f221688-e9b0-496e-b6de-a0ffa69796b9","query_id":"53","doc_a_id":"22401720","doc_b_id":"313403","presented_order":["22401720","313403"],"winner_id":"22401720","reasoning":"Document A — it reports tumor marker (VEGF) expression linked to poor prognosis, which is more similar to an ALDH1–prognosis association than the immune‑infiltrate focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:11.244395Z"}
{"comparison_id":"76e46564-5555-4e82-a53a-8ed45c6f983b","query_id":"53","doc_a_id":"7821634","doc_b_id":"313403","presented_order":["7821634","313403"],"winner_id":"7821634","reasoning":"Document A is more relevant — it links expression of a molecular marker (DUSP4) to breast cancer prognosis, which is conceptually closer to a claim about ALDH1 expression and prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:11.244404Z"}
{"comparison_id":"e97bcf3e-3616-4424-a285-07f17188786d","query_id":"53","doc_a_id":"4889228","doc_b_id":"313403","presented_order":["4889228","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it discusses a prognostic marker (tumor-associated macrophage infiltration) linked to poorer outcomes in breast cancer, which is more directly related to the claim about a marker (ALDH1) and prognosis than Document A's focus on TDP43 in TNBC.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:11.244411Z"}
{"comparison_id":"e8c2a5bd-0d02-4827-8d80-e59188c67cfd","query_id":"53","doc_a_id":"4429932","doc_b_id":"313403","presented_order":["313403","4429932"],"winner_id":"313403","reasoning":"Document A is more directly about a prognostic marker linked to poor outcome in breast cancer, whereas B discusses LOX and metastasis more broadly. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:11.244418Z"}
{"comparison_id":"cd882334-fa92-4387-b948-f3be0bba826b","query_id":"53","doc_a_id":"1171121","doc_b_id":"313403","presented_order":["313403","1171121"],"winner_id":"313403","reasoning":"Document A is more relevant — it directly examines a tumor biomarker (TAM density) linked to poorer prognosis in breast cancer, which is closer to the claim about a biomarker (ALDH1) and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:11.244425Z"}
{"comparison_id":"5a149f19-1bad-4bae-825e-39498bf213d2","query_id":"53","doc_a_id":"7583725","doc_b_id":"313403","presented_order":["313403","7583725"],"winner_id":"7583725","reasoning":"Document B is more relevant — it links tumor-cell protein expression levels (TRPM7) to poor prognosis, which parallels the claim about ALDH1 expression; Document A concerns immune cell infiltration rather than tumor-cell expression. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:11.244433Z"}
{"comparison_id":"83d5e40f-ce91-4b3b-bfb3-98073d731618","query_id":"53","doc_a_id":"20839751","doc_b_id":"313403","presented_order":["20839751","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it reports a specific tumor marker (TAM infiltration) as an independent predictor of poor prognosis, which is analogous to assessing ALDH1 as a prognostic marker. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:11.244440Z"}
{"comparison_id":"2b9d1573-9f4f-4683-9f5f-31f83eb9cb1d","query_id":"53","doc_a_id":"4702639","doc_b_id":"313403","presented_order":["4702639","313403"],"winner_id":"4702639","reasoning":"Document A is more relevant — it discusses tumor stemness and markers/drivers of stem-like cancer cells, which is the context in which ALDH1 is a prognostic marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:11.244447Z"}
{"comparison_id":"2ed80d0c-03d6-4177-a42c-a9232b207b12","query_id":"53","doc_a_id":"2014909","doc_b_id":"313403","presented_order":["313403","2014909"],"winner_id":"313403","reasoning":"Document A is more directly about prognostic markers and clinical outcome in breast cancer, which is relevant to a claim linking a marker (ALDH1) to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:11.244454Z"}
{"comparison_id":"48d168fa-0aa9-4eb0-979c-6c5391f09833","query_id":"53","doc_a_id":"2931832","doc_b_id":"313403","presented_order":["2931832","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it reports a tumor-related cellular marker (TAM infiltration) linked to prognosis, which is closer to ALDH1 expression as a tumor biomarker than a platelet index. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:11.244461Z"}
{"comparison_id":"7edf99b4-4bf8-47c2-a135-2da7215ad1a4","query_id":"53","doc_a_id":"19358586","doc_b_id":"313403","presented_order":["313403","19358586"],"winner_id":"19358586","reasoning":"Document B — it links tumor cell expression signatures (protein/miRNA-driven) to poor survival in breast cancer, which is more directly comparable to a claim about a marker's expression being prognostic. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:11.244469Z"}
{"comparison_id":"2d7007bc-8b14-405f-9e07-79ee498979b5","query_id":"53","doc_a_id":"4455466","doc_b_id":"313403","presented_order":["4455466","313403"],"winner_id":"4455466","reasoning":"Doc A is more relevant because it discusses how the expression level of a specific gene is linked to breast cancer prognosis, matching the claim's focus on biomarker expression and outcome. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:11.244477Z"}
{"comparison_id":"07ad8cf4-7b49-4a6c-b0d0-c9b22128ab41","query_id":"53","doc_a_id":"1866911","doc_b_id":"313403","presented_order":["313403","1866911"],"winner_id":"313403","reasoning":"Reason: Document A addresses factors associated with prognosis in breast cancer (though not ALDH1 specifically), while Document B focuses on cell-of-origin biology in BRCA1 carriers and not prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:11.244484Z"}
{"comparison_id":"de8a4280-b463-490e-b010-39a00f038364","query_id":"53","doc_a_id":"21033230","doc_b_id":"313403","presented_order":["313403","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it addresses molecular markers and prognostic significance in breast cancer, while A focuses on tumor-associated macrophages rather than marker expression like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:11.244491Z"}
{"comparison_id":"25b63481-a394-4b4f-92ad-535edaf52212","query_id":"53","doc_a_id":"4418878","doc_b_id":"313403","presented_order":["313403","4418878"],"winner_id":"4418878","reasoning":"B is more relevant — it discusses gene expression signatures and their links to prognosis (which could include ALDH1 expression), whereas A focuses on tumor-associated macrophages, not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:11.244499Z"}
{"comparison_id":"3090593d-f2b7-45bd-bd9c-c002ff7f8ef4","query_id":"53","doc_a_id":"22401720","doc_b_id":"4702639","presented_order":["4702639","22401720"],"winner_id":"4702639","reasoning":"Document A — it discusses tumor stemness markers and stem-like properties relevant to ALDH1's role as a cancer stem cell marker, whereas Document B focuses on angiogenic factors (not ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:17.753134Z"}
{"comparison_id":"19b0a7a0-40cc-4107-85ea-5827c3bc19c5","query_id":"53","doc_a_id":"7821634","doc_b_id":"4702639","presented_order":["4702639","7821634"],"winner_id":"4702639","reasoning":"Document A is more relevant — it discusses tumor stemness and markers linked to resistance/poorer outcomes, which is conceptually related to ALDH1 as a cancer stem cell marker; Document B focuses on DUSP4-driven drug resistance without addressing stem-cell markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:17.753154Z"}
{"comparison_id":"1dff9873-7418-4781-af32-1a5813cb8dba","query_id":"53","doc_a_id":"7583725","doc_b_id":"4702639","presented_order":["4702639","7583725"],"winner_id":"7583725","reasoning":"Document B is more relevant — it directly links a specific protein's expression to poor outcomes in breast cancer, while A focuses on integrin-mediated stemness and drug resistance without addressing ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:17.753163Z"}
{"comparison_id":"10621f64-a62f-4e01-8dd1-96db33948af2","query_id":"53","doc_a_id":"4418878","doc_b_id":"4702639","presented_order":["4702639","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it covers gene expression signatures and their links to prognosis in cancers, which relates to associations like ALDH1 expression and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:17.753171Z"}
{"comparison_id":"0bc0cc65-1930-4de6-aa6b-fb5c661d85ba","query_id":"53","doc_a_id":"19358586","doc_b_id":"4702639","presented_order":["4702639","19358586"],"winner_id":"4702639","reasoning":"Document A is more relevant — it addresses tumor \"stemness\" markers and cancer stem–like properties (ALDH1 is a cancer stem cell marker), whereas Document B focuses on a Myc/p27/phospho-Rb signature unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:17.753178Z"}
{"comparison_id":"e7648689-e70d-4899-8b4a-01c6d78e2956","query_id":"53","doc_a_id":"4455466","doc_b_id":"4702639","presented_order":["4455466","4702639"],"winner_id":"4455466","reasoning":"Document A is more relevant — it discusses gene expression linked to breast cancer prognosis, while Document B focuses on integrin/KRAS-driven stemness and drug resistance and does not address prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:17.753185Z"}
{"comparison_id":"a5516140-5f70-4598-be6b-f6ae8101cfab","query_id":"53","doc_a_id":"21033230","doc_b_id":"4702639","presented_order":["4702639","21033230"],"winner_id":"21033230","reasoning":"Document B — it concerns prognostic markers and survival in metastatic breast cancer, so it's more relevant to an ALDH1–prognosis claim than Document A which focuses on integrin-driven stemness and drug resistance. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:17.753192Z"}
{"comparison_id":"dd281e71-68b6-457c-b978-37c2ee02917a","query_id":"53","doc_a_id":"7583725","doc_b_id":"4418878","presented_order":["4418878","7583725"],"winner_id":"4418878","reasoning":"Document A is about gene expression signatures and their link to prognosis, which is directly relevant to evaluating whether a marker like ALDH1 predicts poorer outcomes. Document B focuses on TRPM7, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:22.472287Z"}
{"comparison_id":"67257655-5b7e-44fd-b5d5-ea0a9a7440bd","query_id":"53","doc_a_id":"21033230","doc_b_id":"4418878","presented_order":["4418878","21033230"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and their link to prognosis in cancers, which relates to markers like ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:22.472311Z"}
{"comparison_id":"59f30523-d879-4710-a494-4af3813fa820","query_id":"53","doc_a_id":"4455466","doc_b_id":"4418878","presented_order":["4455466","4418878"],"winner_id":"4455466","reasoning":"Doc A mentions a specific gene's expression being linked to poor prognosis in breast cancer, so it's more closely related to the query about marker expression and prognosis than the general pathway-signature paper.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:22.472320Z"}
{"comparison_id":"df0cdaad-d08d-4230-9536-c2dc248c9877","query_id":"53","doc_a_id":"7583725","doc_b_id":"21033230","presented_order":["21033230","7583725"],"winner_id":"21033230","reasoning":"Document A is more relevant — it discusses molecular profiling and prognostic markers in breast cancer (though it doesn't mention ALDH1 specifically). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:26.943227Z"}
{"comparison_id":"976cc588-7b88-483c-acdf-c0b969f25b06","query_id":"53","doc_a_id":"22401720","doc_b_id":"7821634","presented_order":["22401720","7821634"],"winner_id":"22401720","reasoning":"Document A is slightly more relevant because it discusses biomarkers linked to prognosis in primary breast cancer, whereas Document B focuses on DUSP4 and chemotherapy resistance without addressing ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:33.894019Z"}
{"comparison_id":"16a9b89d-9379-4f33-bfcb-da8b87aabaaa","query_id":"53","doc_a_id":"19358586","doc_b_id":"7821634","presented_order":["19358586","7821634"],"winner_id":"19358586","reasoning":"Document A is more relevant — it discusses a protein signature explicitly linked to poor survival in breast cancer, whereas Document B focuses on DUSP4 and chemotherapy resistance. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:33.894044Z"}
{"comparison_id":"06ab4968-7e2d-4657-9231-57730e144c67","query_id":"53","doc_a_id":"22401720","doc_b_id":"19358586","presented_order":["22401720","19358586"],"winner_id":"22401720","reasoning":"Document A is more focused on tumor marker expression and its link to prognosis in breast cancer, which is closer to the claim about ALDH1 expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:40.100140Z"}
{"comparison_id":"97bc69e6-d32d-404c-8499-f7865d7c574b","query_id":"53","doc_a_id":"8963413","doc_b_id":"1171121","presented_order":["8963413","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it discusses prognostic biomarkers specifically in breast cancer, whereas Document A focuses on PD-L1 across cancers. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:48.140306Z"}
{"comparison_id":"19521ae3-821d-4a6d-b421-afac40ba95a1","query_id":"53","doc_a_id":"4889228","doc_b_id":"1171121","presented_order":["1171121","4889228"],"winner_id":"1171121","reasoning":"Neither abstract mentions ALDH1. Document A is marginally more relevant because it addresses prognostic markers in breast cancer generally, whereas B focuses narrowly on TDP43 in TNBC.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:48.140327Z"}
{"comparison_id":"9861c2ad-f5c9-4ba4-abfc-5624401acbac","query_id":"53","doc_a_id":"4429932","doc_b_id":"1171121","presented_order":["4429932","1171121"],"winner_id":"1171121","reasoning":"Reason: Document B discusses prognostic markers in breast cancer (MVD and p53), so it's more relevant to a claim about a prognostic biomarker than Document A, which focuses on LOX and metastasis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:48.140336Z"}
{"comparison_id":"399efa42-8973-4311-8a9b-0402fec1f2de","query_id":"53","doc_a_id":"1866911","doc_b_id":"1171121","presented_order":["1171121","1866911"],"winner_id":"1866911","reasoning":"Document B is more relevant — it discusses breast epithelial progenitor cell populations and marker expression related to tumor origin, which is closer to ALDH1 (a stem/progenitor marker) than Document A's focus on MVD and p53. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:48.140344Z"}
{"comparison_id":"6e280572-d4dd-46e1-b94e-780c2dbb3aa5","query_id":"53","doc_a_id":"20839751","doc_b_id":"1171121","presented_order":["1171121","20839751"],"winner_id":"20839751","reasoning":"Document B is slightly more relevant — it examines a molecular marker's association with prognosis in breast cancer (apoptotic index), whereas A focuses on MVD and p53 in a chemotherapy context; neither mentions ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:48.140351Z"}
{"comparison_id":"26e6e1bb-5dc2-4500-a8fa-632b87c0244d","query_id":"53","doc_a_id":"2014909","doc_b_id":"1171121","presented_order":["1171121","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers (more likely to address stem cell markers like ALDH1), whereas A focuses on MVD and p53 and does not pertain to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:48.140359Z"}
{"comparison_id":"b3f35dc3-a4dc-47e5-974f-fdce577a9eab","query_id":"53","doc_a_id":"2931832","doc_b_id":"1171121","presented_order":["1171121","2931832"],"winner_id":"1171121","reasoning":"Document A is slightly more relevant because it examines tumor protein expression (p53) and tissue-based prognostic factors, whereas Document B addresses a blood platelet index; neither mentions ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:48.140366Z"}
{"comparison_id":"0acdb8c0-f4b7-41c3-aefb-6a82308e3bb1","query_id":"53","doc_a_id":"1866911","doc_b_id":"20839751","presented_order":["1866911","20839751"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses progenitor cell populations and markers linked to aggressive/basal-like breast cancer, which is related to stem-cell markers like ALDH1; Document B focuses on apoptosis and unrelated prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:53.735512Z"}
{"comparison_id":"28b4a5a3-5b7a-4d21-b5da-3396e7f45e30","query_id":"53","doc_a_id":"2014909","doc_b_id":"20839751","presented_order":["20839751","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — it addresses tumor-initiating cells and analyses of primary breast cancers (contexts where ALDH1 is typically studied), while Document A focuses on apoptosis and does not relate to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:53.735533Z"}
{"comparison_id":"9e19a306-84a4-43ee-8637-fcb625e8b43b","query_id":"53","doc_a_id":"1866911","doc_b_id":"2014909","presented_order":["1866911","2014909"],"winner_id":"2014909","reasoning":"Document B — it discusses tumor-initiating cells and analyses of primary breast cancers (where ALDH1 is commonly studied as a stem/tumor-initiating marker), making it more likely to address ALDH1 and prognosis than Document A which focuses on c-KIT and BRCA1-related progenitors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:41:59.354848Z"}
{"comparison_id":"3ca66c13-f861-403e-99d8-25da311cbf21","query_id":"53","doc_a_id":"8963413","doc_b_id":"4889228","presented_order":["4889228","8963413"],"winner_id":"4889228","reasoning":"Document A is more relevant — it reports that high expression of a molecular marker in triple-negative breast cancer correlates with poor prognosis, matching the claim's topic of marker expression and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:06.044708Z"}
{"comparison_id":"c02d3090-f41b-4e37-8a08-ca8cfb117cc9","query_id":"53","doc_a_id":"2931832","doc_b_id":"4889228","presented_order":["4889228","2931832"],"winner_id":"4889228","reasoning":"Reason: Document A addresses gene expression linked to prognosis in breast cancer (molecular marker context), which is more relevant to ALDH1 expression than a platelet-based prognostic study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:06.044729Z"}
{"comparison_id":"178ac2bd-c5bc-42f6-bb91-3d78f045478f","query_id":"53","doc_a_id":"4429932","doc_b_id":"4889228","presented_order":["4429932","4889228"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses a molecular marker (LOX) being associated with poor patient outcomes in breast cancer, which is closer to the claim about ALDH1 and prognosis than the TNBC-specific splicing factor in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:06.044739Z"}
{"comparison_id":"2f8c5167-e395-47e3-b431-4f354c63615d","query_id":"53","doc_a_id":"8963413","doc_b_id":"2931832","presented_order":["2931832","8963413"],"winner_id":"2931832","reasoning":"Document A is more relevant — it directly addresses prognostic biomarkers in breast cancer, whereas Document B focuses on PD-L1 across cancers and is less directly related to ALDH1 or poor prognosis in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:10.813062Z"}
{"comparison_id":"6ee2d24e-58cd-45cf-b912-b9d94ac0a63d","query_id":"53","doc_a_id":"25973484","doc_b_id":"16086778","presented_order":["16086778","25973484"],"winner_id":"25973484","reasoning":"Document B is more relevant — it discusses breast cancer prognosis (though not ALDH1 specifically), whereas A focuses on Numb/Notch regulation without addressing prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:18.880588Z"}
{"comparison_id":"3ccb7bc4-39b5-4478-a9fd-93a1770c1d8d","query_id":"53","doc_a_id":"3285322","doc_b_id":"16086778","presented_order":["3285322","16086778"],"winner_id":"16086778","reasoning":"Document B — it deals with molecular mechanisms (Numb/Notch) tied to tumor aggressiveness and prognosis, which is closer to biomarker-related prognostic discussion; Document A focuses on BRCA clinical features and is less relevant to ALDH1 expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:18.880611Z"}
{"comparison_id":"c4a9dabe-e47f-44f8-a711-bbacfc6479e9","query_id":"53","doc_a_id":"21902400","doc_b_id":"16086778","presented_order":["16086778","21902400"],"winner_id":"16086778","reasoning":"Document A — directly addresses molecular mechanisms in breast cancer and prognosis, whereas Document B discusses hypoxia across solid tumors and is less specific to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:18.880620Z"}
{"comparison_id":"98bc4945-af12-4026-8f69-e8f89c5746b8","query_id":"53","doc_a_id":"22482820","doc_b_id":"16086778","presented_order":["22482820","16086778"],"winner_id":"22482820","reasoning":"Document A is more relevant — it discusses breast cancer classification, drug resistance and therapeutic strategies where markers like ALDH1 and prognosis associations are more likely to be addressed, whereas B focuses narrowly on Numb/Notch signaling.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:18.880627Z"}
{"comparison_id":"bfc7157b-59e8-4730-92de-4cd9d4ae22c2","query_id":"53","doc_a_id":"4583180","doc_b_id":"16086778","presented_order":["16086778","4583180"],"winner_id":"16086778","reasoning":"Document A is more relevant — it addresses molecular mechanisms in breast cancer specifically, whereas Document B discusses general tumor progression and survival without breast-cancer focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:18.880635Z"}
{"comparison_id":"e41cd972-77fc-425c-8712-4b4d6349bad1","query_id":"53","doc_a_id":"24834968","doc_b_id":"16086778","presented_order":["24834968","16086778"],"winner_id":"24834968","reasoning":"Document A is more relevant — it evaluates biological markers and their relation to treatment response/prognosis in breast cancer, whereas B focuses on Numb/Notch signaling mechanism without broader prognostic marker analysis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:18.880642Z"}
{"comparison_id":"4a00bdcc-f235-4c9a-9f75-b9bf440998c9","query_id":"53","doc_a_id":"15946643","doc_b_id":"16086778","presented_order":["16086778","15946643"],"winner_id":"15946643","reasoning":"Document B — it addresses chemoresistance and metastasis, which relate directly to poorer prognosis in breast cancer; Document A focuses on Numb/Notch regulation without links to prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:18.880649Z"}
{"comparison_id":"a99b7c3f-caac-45f9-ae1f-651da5e2555b","query_id":"53","doc_a_id":"20333864","doc_b_id":"16086778","presented_order":["16086778","20333864"],"winner_id":"16086778","reasoning":"Document A is more relevant — it discusses Notch-related tumor proliferation and prognosis-related pathways in breast cancer, which is closer to biomarker-driven prognostic associations than the DCIS invasion focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:18.880655Z"}
{"comparison_id":"c0283b49-381f-4953-9eed-e38715294ab8","query_id":"53","doc_a_id":"25973484","doc_b_id":"22482820","presented_order":["25973484","22482820"],"winner_id":"22482820","reasoning":"Document B is more relevant — it discusses breast cancer subtypes and therapy resistance (contexts where ALDH1 as a prognostic/stemness marker is typically addressed). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:27.791260Z"}
{"comparison_id":"c428b55b-488a-4249-8032-0b88825cb380","query_id":"53","doc_a_id":"15946643","doc_b_id":"22482820","presented_order":["22482820","15946643"],"winner_id":"15946643","reasoning":"Document B is more relevant — it addresses mechanisms (chemoresistance and metastasis) that affect prognosis, whereas Document A focuses on combination therapy strategies and does not discuss biomarkers like ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:27.791282Z"}
{"comparison_id":"9d486bcf-5261-42cf-87c7-fc5116a1d25a","query_id":"53","doc_a_id":"24834968","doc_b_id":"22482820","presented_order":["22482820","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it evaluates biological markers as predictors of outcome in breast cancer (closer to a prognosis/biomarker question) while A focuses on combination therapy strategies. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:27.791291Z"}
{"comparison_id":"729f4aca-d227-4113-a4d1-50700301037b","query_id":"53","doc_a_id":"15946643","doc_b_id":"24834968","presented_order":["24834968","15946643"],"winner_id":"24834968","reasoning":"Document A is more focused on breast cancer biomarkers and their link to treatment response/prognosis; Document B discusses a CXCL1 signaling network unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:33.043830Z"}
{"comparison_id":"86a08d6d-c0de-4ef7-ae34-f49aba271956","query_id":"53","doc_a_id":"3285322","doc_b_id":"21902400","presented_order":["3285322","21902400"],"winner_id":"3285322","reasoning":"Document A — it directly addresses prognostic clinical/pathologic features in breast cancer, whereas B discusses hypoxia broadly and not breast cancer-specific markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:36.252588Z"}
{"comparison_id":"fb1c1318-6a43-47c8-9f3f-4e54640a9880","query_id":"53","doc_a_id":"20333864","doc_b_id":"21902400","presented_order":["21902400","20333864"],"winner_id":"21902400","reasoning":"Document A — it discusses prognostic markers and outcome relevance in tumors, while Document B focuses on cellular mechanisms of DCIS-to-invasive transition without addressing prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:36.252609Z"}
{"comparison_id":"d5b10f38-8c4c-421d-b2f6-c151209566a2","query_id":"53","doc_a_id":"4583180","doc_b_id":"21902400","presented_order":["21902400","4583180"],"winner_id":"21902400","reasoning":"Reason: Document A discusses prognostic factors in cancer and clinical outcomes, which is more directly related to the claim about ALDH1 and prognosis than Document B's focus on SREBP2 and acidity.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:36.252619Z"}
{"comparison_id":"b6cc3fcf-5d01-4d23-9809-9ae18f66d479","query_id":"53","doc_a_id":"20333864","doc_b_id":"4583180","presented_order":["20333864","4583180"],"winner_id":"20333864","reasoning":"Document A is focused specifically on breast carcinoma progression, making it more relevant to a claim about prognosis in breast cancer than Document B, which addresses general tumor metabolism and survival. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:42:40.511110Z"}
{"comparison_id":"1b830963-6539-438d-aaff-f2c2675c9471","query_id":"53","doc_a_id":"15113221","doc_b_id":"15521377","presented_order":["15521377","15113221"],"winner_id":"15113221","reasoning":"Document B is more relevant — it discusses a gene expression signature linked to poor prognosis in carcinomas (though it doesn't mention ALDH1 specifically). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775728Z"}
{"comparison_id":"cb7b22d9-7bc7-4d98-bb05-e4922b012aee","query_id":"53","doc_a_id":"21439640","doc_b_id":"15521377","presented_order":["15521377","21439640"],"winner_id":"21439640","reasoning":"Reason: Document B specifically studies molecular mechanisms in breast cancer (tumor progression), making it more directly relevant than the general senescence overview in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775750Z"}
{"comparison_id":"1a9c380c-642f-4f3f-a639-03b1de65e26f","query_id":"53","doc_a_id":"24349992","doc_b_id":"15521377","presented_order":["24349992","15521377"],"winner_id":"24349992","reasoning":"Document A is more relevant — it directly addresses mechanisms driving tumor aggressiveness and poor outcomes in cancer, which relates to prognostic markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775759Z"}
{"comparison_id":"4f680ca3-c575-4b10-8b52-b49e7f6e84bb","query_id":"53","doc_a_id":"7795952","doc_b_id":"15521377","presented_order":["15521377","7795952"],"winner_id":"7795952","reasoning":"Document B is more relevant because it discusses a specific protein linked to poor cancer prognosis, whereas Document A focuses broadly on senescence and SASP without addressing expression markers or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775766Z"}
{"comparison_id":"0e3a6a33-cb15-433d-afbf-609006ccbf8e","query_id":"53","doc_a_id":"2061878","doc_b_id":"15521377","presented_order":["15521377","2061878"],"winner_id":"2061878","reasoning":"Document B — it discusses a cancer biomarker (NEAT1) whose expression correlates with poor prognosis, which is more directly relevant to a claim about expression markers and prognosis than the general senescence topic in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775774Z"}
{"comparison_id":"11bb35d2-69f7-4302-b243-cedbc5cda30a","query_id":"53","doc_a_id":"19673227","doc_b_id":"15521377","presented_order":["19673227","15521377"],"winner_id":"19673227","reasoning":"Document A is more relevant — it addresses prognostic markers and survival outcomes in cancer, whereas B discusses cellular senescence broadly and not prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775782Z"}
{"comparison_id":"d27c8915-5159-4a16-9b6f-0bff4760967b","query_id":"53","doc_a_id":"13007205","doc_b_id":"15521377","presented_order":["13007205","15521377"],"winner_id":"13007205","reasoning":"Document A is more relevant — it discusses factors (fibroblast genotype, MMP-3) that directly affect breast cancer invasion and progression, which relates to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775789Z"}
{"comparison_id":"2be42c47-2fb9-4833-a6e7-45fd8f635caf","query_id":"53","doc_a_id":"29366489","doc_b_id":"15521377","presented_order":["29366489","15521377"],"winner_id":"29366489","reasoning":"Reason: Document A discusses a tumor suppressor and molecular markers related to cancer prognosis, which is closer to ALDH1 as a prognostic marker in breast cancer than the general senescence focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775796Z"}
{"comparison_id":"29475c3d-0879-4d4d-8cc3-8a3f019e2145","query_id":"53","doc_a_id":"32001951","doc_b_id":"15521377","presented_order":["15521377","32001951"],"winner_id":"32001951","reasoning":"Document B is slightly more relevant because it addresses expression regulation in a breast cancer cell line, whereas Document A discusses senescence broadly and does not pertain to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775803Z"}
{"comparison_id":"4435ab95-a2fe-4581-b5d2-2d999832f27f","query_id":"53","doc_a_id":"13030852","doc_b_id":"15521377","presented_order":["13030852","15521377"],"winner_id":"13030852","reasoning":"Doc A is about breast cancer clinical markers and prognosis-related metastasis detection, so it's more on-topic than the general senescence review. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775810Z"}
{"comparison_id":"f4fd42c2-019d-4e9b-9ca8-50601dc2548f","query_id":"53","doc_a_id":"4820792","doc_b_id":"15521377","presented_order":["4820792","15521377"],"winner_id":"4820792","reasoning":"Document A is more relevant — it addresses breast cancer biology and therapeutic outcomes, whereas B is a general review of senescence; neither mentions ALDH1 but A is closer to the query topic.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775816Z"}
{"comparison_id":"808f4370-e530-4206-acdb-ea32e1ea4c76","query_id":"53","doc_a_id":"24341590","doc_b_id":"15521377","presented_order":["15521377","24341590"],"winner_id":"24341590","reasoning":"Document B is more relevant — it discusses clinical outcomes and prognostic factors in breast cancer (treatment response/recurrence), whereas Document A covers senescence generally and does not address ALDH1 or breast cancer prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775824Z"}
{"comparison_id":"6322c3f3-4bc3-4604-8e33-b03fc60cf836","query_id":"53","doc_a_id":"8037453","doc_b_id":"15521377","presented_order":["15521377","8037453"],"winner_id":"8037453","reasoning":"Document B is more relevant — it discusses prognostic biomarkers in cancer patients, whereas A focuses on cellular senescence and SASP without addressing ALDH1 or prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775831Z"}
{"comparison_id":"26b2c6ae-c2d9-41ef-8e6a-d010883ab9b2","query_id":"53","doc_a_id":"17648235","doc_b_id":"15521377","presented_order":["17648235","15521377"],"winner_id":"17648235","reasoning":"Document A is more relevant — it directly addresses breast cancer signaling and tumor cell proliferation, which relates to prognosis, whereas Document B is a general review on senescence and not specific to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775839Z"}
{"comparison_id":"4b4214c6-640d-4b10-9bb2-79344dd5be53","query_id":"53","doc_a_id":"15721252","doc_b_id":"15521377","presented_order":["15721252","15521377"],"winner_id":"15721252","reasoning":"Document A is more relevant — it directly concerns molecular markers in breast cancer, whereas B discusses general cellular senescence without breast-cancer prognostic markers.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775846Z"}
{"comparison_id":"a36e57fc-ee7b-451d-9a7f-8e1d5dbb6360","query_id":"53","doc_a_id":"16734530","doc_b_id":"15521377","presented_order":["16734530","15521377"],"winner_id":"16734530","reasoning":"Document A is more relevant — it directly studies genetic markers and clinicopathologic features in breast cancer (which relate to prognosis), while Document B discusses cellular senescence generally and does not address ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775853Z"}
{"comparison_id":"799e6631-3e0f-49a8-8517-6c852e74c422","query_id":"53","doc_a_id":"5500086","doc_b_id":"15521377","presented_order":["15521377","5500086"],"winner_id":"5500086","reasoning":"Document B is more relevant — it discusses clinical outcomes in breast cancer (links molecular signatures to prognosis), while A focuses on senescence/SASP without addressing ALDH1 or prognosis.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775861Z"}
{"comparison_id":"781bb84f-4ff5-460e-8b58-76932af23b7c","query_id":"53","doc_a_id":"17755060","doc_b_id":"15521377","presented_order":["17755060","15521377"],"winner_id":"17755060","reasoning":"Document A — it discusses tumorigenesis and poor prognosis in human cancers, which is more directly related to the claim about prognosis than the general senescence topic in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775867Z"}
{"comparison_id":"b5b91923-8a3f-4c95-b056-10fb0fddf4d4","query_id":"53","doc_a_id":"27240667","doc_b_id":"15521377","presented_order":["15521377","27240667"],"winner_id":"27240667","reasoning":"Reason: Document B discusses breast cancer mortality and prognosis factors; Document A is about cellular senescence and not about ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775879Z"}
{"comparison_id":"95ad5c51-acbf-411b-be91-267285556d4b","query_id":"53","doc_a_id":"19882228","doc_b_id":"15521377","presented_order":["19882228","15521377"],"winner_id":"19882228","reasoning":"Document A is more relevant because it directly links a tumor feature to poor prognosis, whereas Document B discusses senescence without addressing prognosis in cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775886Z"}
{"comparison_id":"ec2e5719-8eb3-42d3-b42b-a54b5f05c4ec","query_id":"53","doc_a_id":"4999633","doc_b_id":"15521377","presented_order":["15521377","4999633"],"winner_id":"4999633","reasoning":"Document B is more relevant — it studies how a specific marker's expression level in breast cancer cells predicts proliferation responses, which is closer to assessing marker-associated prognosis than the general discussion of senescence in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775893Z"}
{"comparison_id":"4938976d-838e-4985-8209-0331d3757750","query_id":"53","doc_a_id":"24249915","doc_b_id":"15521377","presented_order":["24249915","15521377"],"winner_id":"24249915","reasoning":"Doc A is more relevant — it directly addresses expression changes in breast cancer tissues, whereas Document B discusses cellular senescence generally and does not pertain to breast cancer marker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775900Z"}
{"comparison_id":"ab02c78b-e1f6-46bc-b783-c8c162354bb9","query_id":"53","doc_a_id":"9600826","doc_b_id":"15521377","presented_order":["9600826","15521377"],"winner_id":"9600826","reasoning":"Document A is more directly about breast cancer biology (invasion/angiogenesis) and thus more relevant to a prognosis-related claim than the general senescence review.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775907Z"}
{"comparison_id":"f4bb9664-d000-4fcf-9670-3890018a0bbf","query_id":"53","doc_a_id":"13069283","doc_b_id":"15521377","presented_order":["15521377","13069283"],"winner_id":"13069283","reasoning":"Document B is more directly about breast cancer (treatment-related biomarkers) whereas Document A discusses general senescence, so B is slightly more relevant to prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775914Z"}
{"comparison_id":"cbae14b9-0e4c-4a9c-b2ab-4583e306ad57","query_id":"53","doc_a_id":"2130391","doc_b_id":"15521377","presented_order":["2130391","15521377"],"winner_id":"2130391","reasoning":"Document A is more specific to breast cancer progression and factors (invasion, tumor growth) that relate to prognosis, while B discusses general cellular senescence without breast-cancer–specific prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775922Z"}
{"comparison_id":"cc402670-689a-4da0-ac0f-ec74339d6199","query_id":"53","doc_a_id":"219475","doc_b_id":"15521377","presented_order":["219475","15521377"],"winner_id":"219475","reasoning":"Document A is more relevant — it discusses mechanisms in mammary (breast) cancer metastasis and prognosis-related processes, whereas B focuses broadly on senescence without relation to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775929Z"}
{"comparison_id":"319184ec-63fb-4dbe-8655-b860fb706a44","query_id":"53","doc_a_id":"5864770","doc_b_id":"15521377","presented_order":["15521377","5864770"],"winner_id":"5864770","reasoning":"Reason: Document B discusses breast cancer biology and factors influencing breast cancer risk/progression, making it more directly related to a prognostic marker in breast cancer than Document A's general discussion of senescence.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775936Z"}
{"comparison_id":"3d7b5908-7898-459c-8222-d3b2dd38fc06","query_id":"53","doc_a_id":"26231129","doc_b_id":"15521377","presented_order":["15521377","26231129"],"winner_id":"26231129","reasoning":"Document B is more relevant — it addresses molecular bases of residual disease in solid cancers and strategies tied to biomarkers/prognosis, whereas A focuses on senescence broadly without link to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775944Z"}
{"comparison_id":"026907ee-1236-417c-90ec-567aaa5fc82f","query_id":"53","doc_a_id":"164985","doc_b_id":"15521377","presented_order":["15521377","164985"],"winner_id":"164985","reasoning":"Document B — it discusses mechanisms in mammary (breast) carcinoma relevant to tumor progression and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775951Z"}
{"comparison_id":"c159f324-cbce-4892-89f8-d978668904a5","query_id":"53","doc_a_id":"1389264","doc_b_id":"15521377","presented_order":["15521377","1389264"],"winner_id":"1389264","reasoning":"Document B — it specifically studies breast cancer (HER2-positive) while Document A is a general review of senescence and not about ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775958Z"}
{"comparison_id":"576eda4c-4c80-45c0-90c9-9190d02792ae","query_id":"53","doc_a_id":"15559582","doc_b_id":"15521377","presented_order":["15559582","15521377"],"winner_id":"15559582","reasoning":"Document A is more relevant — it deals directly with clinical markers in breast cancer patients, whereas B is a general review of cellular senescence not specific to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775965Z"}
{"comparison_id":"da21056f-8236-4e35-87f9-7cccfd101c31","query_id":"53","doc_a_id":"8671456","doc_b_id":"15521377","presented_order":["15521377","8671456"],"winner_id":"15521377","reasoning":"Document A is more relevant — it discusses cancer biology and factors that influence tumor behavior and prognosis, whereas Document B focuses on a specific therapeutic virus and not on prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775973Z"}
{"comparison_id":"fad780b6-ec70-4040-ba53-b5f5b9a59cbd","query_id":"53","doc_a_id":"31311495","doc_b_id":"15521377","presented_order":["15521377","31311495"],"winner_id":"31311495","reasoning":"Document B — it specifically addresses breast cancer cell behavior and factors tied to aggressiveness/resistance, which is closer to prognosis than the general senescence topic in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775980Z"}
{"comparison_id":"ee88f6d6-7ac3-4514-b824-fd415f5b6231","query_id":"53","doc_a_id":"5649538","doc_b_id":"15521377","presented_order":["5649538","15521377"],"winner_id":"5649538","reasoning":"Document A — it discusses gene expression markers in breast cancer, so it's more likely to address associations like ALDH1 and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775987Z"}
{"comparison_id":"fbfa17e0-34fa-441e-977e-f65d5ffc0116","query_id":"53","doc_a_id":"1379127","doc_b_id":"15521377","presented_order":["1379127","15521377"],"winner_id":"1379127","reasoning":"Reason: Document A specifically addresses breast tumor behavior (migration/metastasis), making it more relevant to prognosis in breast cancer than Document B's general discussion of senescence.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.775994Z"}
{"comparison_id":"8ee93719-8aca-4a45-a150-369f9aa8b7a7","query_id":"53","doc_a_id":"24144677","doc_b_id":"15521377","presented_order":["24144677","15521377"],"winner_id":"24144677","reasoning":"Document A is more relevant — it directly addresses breast cancer molecular markers/risks, while Document B discusses general cellular senescence and not ALDH1 or breast-cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776001Z"}
{"comparison_id":"1341a111-0cc3-430b-9565-7be5bf99ad4f","query_id":"53","doc_a_id":"67045088","doc_b_id":"15521377","presented_order":["15521377","67045088"],"winner_id":"67045088","reasoning":"Document B is more relevant — it specifically addresses breast cancer and tumor biology, while A discusses general cellular senescence without reference to breast cancer or ALDH1.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776007Z"}
{"comparison_id":"ce154e69-2102-4f87-b8ab-2dbf5e977bdf","query_id":"53","doc_a_id":"195680777","doc_b_id":"15521377","presented_order":["195680777","15521377"],"winner_id":"15521377","reasoning":"Document B is more relevant — it discusses cellular mechanisms in cancer (senescence/SASP) that relate to tumor behavior and prognosis, whereas Document A focuses on chemotherapy regimens and mortality without addressing biomarkers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776014Z"}
{"comparison_id":"8704d45d-fc47-45fa-804d-a04e9dfad8f0","query_id":"53","doc_a_id":"31616203","doc_b_id":"15521377","presented_order":["15521377","31616203"],"winner_id":"15521377","reasoning":"Document A is slightly more relevant because it discusses general tumor biology and factors influencing prognosis, while Document B focuses on a specific drug trial for brain metastases. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776021Z"}
{"comparison_id":"e32eeeaf-4176-4f1a-82dd-a3b99e5c0279","query_id":"53","doc_a_id":"6550579","doc_b_id":"15521377","presented_order":["15521377","6550579"],"winner_id":"6550579","reasoning":"Reason: Document B discusses molecular markers and targeted signaling pathways in breast cancer (HER3/HER2), which is closer to a claim about a molecular marker's prognostic significance than Document A's general discussion of cellular senescence.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776028Z"}
{"comparison_id":"e24bf34d-3884-4529-af18-9021cc9938b3","query_id":"53","doc_a_id":"23863551","doc_b_id":"15521377","presented_order":["15521377","23863551"],"winner_id":"23863551","reasoning":"Document B is more relevant — it specifically discusses breast cancer biology and therapy, whereas Document A is a general review of cellular senescence not directly about breast cancer prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776035Z"}
{"comparison_id":"415d9d18-f0a1-4707-a1ab-51539b3290bd","query_id":"53","doc_a_id":"20183360","doc_b_id":"15521377","presented_order":["20183360","15521377"],"winner_id":"20183360","reasoning":"Document A is more relevant — it addresses molecular mechanisms of breast cancer progression (invasion) which relate to prognosis; Document B is a general review of senescence not specific to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776042Z"}
{"comparison_id":"add27bc5-3631-418b-8572-3b1eeada939d","query_id":"53","doc_a_id":"2015126","doc_b_id":"15521377","presented_order":["2015126","15521377"],"winner_id":"15521377","reasoning":"Reason: Neither abstract mentions ALDH1 or prognosis in breast cancer, but Document B discusses cancer-related cellular mechanisms (senescence/SASP) which is closer to tumor biology than Document A's focus on genetic-risk management.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776049Z"}
{"comparison_id":"f9746c36-3e42-4261-aa20-ec8f101bc6c4","query_id":"53","doc_a_id":"34066665","doc_b_id":"15521377","presented_order":["15521377","34066665"],"winner_id":"34066665","reasoning":"Document B is more relevant — it focuses on breast cancer molecular pathways and clinical implications, whereas A discusses general cellular senescence without breast-cancer-specific prognostic markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776056Z"}
{"comparison_id":"92593feb-cba5-42ad-9739-d3ff27299913","query_id":"53","doc_a_id":"16691520","doc_b_id":"15521377","presented_order":["15521377","16691520"],"winner_id":"15521377","reasoning":"Document A is more relevant — it discusses cancer-related cellular mechanisms and tumorigenic/prognostic contexts, whereas Document B focuses narrowly on estrogen receptor binding sites. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776063Z"}
{"comparison_id":"4d8be26e-9924-4752-a1fa-0023abbeb590","query_id":"53","doc_a_id":"6969753","doc_b_id":"15521377","presented_order":["15521377","6969753"],"winner_id":"6969753","reasoning":"Document B is more relevant — it discusses mechanisms of tumor invasion and metastasis, which relate to prognosis, whereas A focuses on cellular senescence broadly. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776069Z"}
{"comparison_id":"406bfff1-2efa-4b41-babe-9990c4576e68","query_id":"53","doc_a_id":"15832146","doc_b_id":"15521377","presented_order":["15832146","15521377"],"winner_id":"15832146","reasoning":"Document A is more relevant — it specifically addresses invasive human breast carcinomas and tumor-promoting factors, whereas B discusses general cellular senescence and SASP without breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776076Z"}
{"comparison_id":"7dfc9967-c7fc-475e-ba10-96c60ab4e905","query_id":"53","doc_a_id":"22267225","doc_b_id":"15521377","presented_order":["22267225","15521377"],"winner_id":"22267225","reasoning":"Document A is more relevant — it discusses breast cancer specifically (even if not ALDH1), whereas B is general about cellular senescence. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776083Z"}
{"comparison_id":"5155912a-8a49-41d6-b136-7153ee6257b6","query_id":"53","doc_a_id":"8774475","doc_b_id":"15521377","presented_order":["15521377","8774475"],"winner_id":"8774475","reasoning":"Document B is more directly about mammary (breast) tumorigenesis and mechanisms of breast cancer progression, whereas A discusses general senescence. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776090Z"}
{"comparison_id":"1a431a16-17b0-446e-833a-2e3342532ce9","query_id":"53","doc_a_id":"10279084","doc_b_id":"15521377","presented_order":["15521377","10279084"],"winner_id":"10279084","reasoning":"Document B is more relevant — it discusses molecular alterations in cancer and specifically mentions breast cancer, whereas A is a general review of senescence and doesn't address ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776096Z"}
{"comparison_id":"f5a89069-fdc1-41e9-8e9b-f1ae7fa436eb","query_id":"53","doc_a_id":"13290521","doc_b_id":"15521377","presented_order":["13290521","15521377"],"winner_id":"13290521","reasoning":"Document A is more focused on cancer-related biomarkers and prognostic applications, whereas Document B discusses cellular senescence mechanisms not directly related to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776103Z"}
{"comparison_id":"7203ed2d-32bd-424a-b639-4e34347f6769","query_id":"53","doc_a_id":"5270265","doc_b_id":"15521377","presented_order":["15521377","5270265"],"winner_id":"5270265","reasoning":"Document B is more directly about breast cancer mechanisms and treatment, so it's more relevant to a claim about prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776110Z"}
{"comparison_id":"1ab4f2e7-aed6-4ce5-9667-fe9e29e8cc28","query_id":"53","doc_a_id":"40127292","doc_b_id":"15521377","presented_order":["40127292","15521377"],"winner_id":"40127292","reasoning":"Document A is more relevant — it discusses chemoresistance and cancer models related to prognosis and treatment response, which is closer to ALDH1's role in breast cancer prognosis than a general review of senescence. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776117Z"}
{"comparison_id":"6bfe6600-8485-4830-bfeb-390290d991ca","query_id":"53","doc_a_id":"11484808","doc_b_id":"15521377","presented_order":["11484808","15521377"],"winner_id":"11484808","reasoning":"Document A is more likely to discuss biomarkers and prognosis in endocrine-related cancers (including breast cancer), whereas Document B focuses on cellular senescence rather than breast cancer prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:01.776123Z"}
{"comparison_id":"cfcdbcdb-f0a2-438a-ad2e-d224ee14b3a0","query_id":"53","doc_a_id":"15113221","doc_b_id":"2130391","presented_order":["15113221","2130391"],"winner_id":"15113221","reasoning":"Document A is more relevant because it links a gene expression signature to poor prognosis in carcinoma, which is closer to assessing prognostic markers like ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001198Z"}
{"comparison_id":"b8a8440a-7e13-4745-94c6-993ba4231d12","query_id":"53","doc_a_id":"21439640","doc_b_id":"2130391","presented_order":["21439640","2130391"],"winner_id":"2130391","reasoning":"Document B is more relevant — it discusses factors (invasion, tumor size, lymph node involvement) tied to breast cancer progression and prognosis, whereas A focuses on macrophage-induced COX-2 without prognosis context.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001220Z"}
{"comparison_id":"5a609a86-288f-4c9c-87d4-2772e54144f9","query_id":"53","doc_a_id":"24349992","doc_b_id":"2130391","presented_order":["2130391","24349992"],"winner_id":"2130391","reasoning":"Document A is more relevant — it specifically addresses factors promoting breast cancer invasion and tumor progression (tumor size, lymph node involvement), which relate to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001229Z"}
{"comparison_id":"ee36e433-1f56-46f2-9921-8d31507efd00","query_id":"53","doc_a_id":"7795952","doc_b_id":"2130391","presented_order":["2130391","7795952"],"winner_id":"2130391","reasoning":"Reason: Document A specifically addresses breast cancer progression and prognostic features (tumor size, lymph node involvement), so it's more likely to bear on prognostic markers than Document B, which focuses on fascin and TGFβ in general tumor invasion.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001237Z"}
{"comparison_id":"80a5b133-94c0-4a0a-9cce-138a01b5ad1e","query_id":"53","doc_a_id":"2061878","doc_b_id":"2130391","presented_order":["2130391","2061878"],"winner_id":"2130391","reasoning":"Document A is more relevant — it discusses breast cancer progression and factors linked to worse outcomes (invasion, larger tumors, node involvement), whereas B focuses on a different molecule (NEAT1) across cancers. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001244Z"}
{"comparison_id":"6acf811c-67bc-41aa-9ecc-891456c34809","query_id":"53","doc_a_id":"19673227","doc_b_id":"2130391","presented_order":["19673227","2130391"],"winner_id":"19673227","reasoning":"Document A is more relevant — it discusses prognostic biomarkers and correlation with disease-free survival/time to progression, which is closer to assessing markers like ALDH1. Document B focuses on adipocytes and invasion, not prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001251Z"}
{"comparison_id":"9efa2cd4-2009-4ce5-bd67-702e8674a722","query_id":"53","doc_a_id":"13007205","doc_b_id":"2130391","presented_order":["2130391","13007205"],"winner_id":"2130391","reasoning":"Neither abstract mentions ALDH1, but Document A discusses tumor progression and lymph node involvement (prognostic factors), making it slightly more relevant to prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001258Z"}
{"comparison_id":"e86035f5-579a-4bdb-9898-b59c4ceffec5","query_id":"53","doc_a_id":"29366489","doc_b_id":"2130391","presented_order":["2130391","29366489"],"winner_id":"2130391","reasoning":"Document A is more directly about breast cancer progression and factors affecting tumor aggressiveness, so it's more relevant to prognosis than the general DLC-1 paper.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001265Z"}
{"comparison_id":"f7000be3-1c82-4957-a4a3-8bcaaccc06f1","query_id":"53","doc_a_id":"32001951","doc_b_id":"2130391","presented_order":["2130391","32001951"],"winner_id":"2130391","reasoning":"Document A — it discusses tumor progression and factors linked to poorer outcomes (invasion, lymph node involvement), which is more related to prognosis than Document B's focus on alkaline phosphatase regulation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001273Z"}
{"comparison_id":"314eca12-38ef-4fba-a949-96de12dd2438","query_id":"53","doc_a_id":"13030852","doc_b_id":"2130391","presented_order":["2130391","13030852"],"winner_id":"2130391","reasoning":"Document A is more relevant — it discusses factors (tumor progression, invasion, lymph node involvement) linked to worse breast cancer outcomes, while Document B focuses on diagnostic enzyme assays for metastasis rather than prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001280Z"}
{"comparison_id":"9162f00a-c6e7-4054-aaf9-cc8a3aac013e","query_id":"53","doc_a_id":"4820792","doc_b_id":"2130391","presented_order":["2130391","4820792"],"winner_id":"2130391","reasoning":"Document A discusses tumor progression and invasion factors linked to worse clinical outcomes in breast cancer, making it more relevant to prognosis than Document B's focus on a specific drug-resistance pathway.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001287Z"}
{"comparison_id":"da9d03bf-0a6c-4230-b7ca-3b7059c4cd63","query_id":"53","doc_a_id":"24341590","doc_b_id":"2130391","presented_order":["24341590","2130391"],"winner_id":"24341590","reasoning":"Document A is more relevant — it discusses clinical outcomes and prognosis in breast cancer patients, whereas Document B focuses on adipocyte-mediated invasion mechanisms rather than prognostic markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001295Z"}
{"comparison_id":"a5585b8b-aad1-491b-b15b-abe266e6b647","query_id":"53","doc_a_id":"8037453","doc_b_id":"2130391","presented_order":["2130391","8037453"],"winner_id":"2130391","reasoning":"Document A is more relevant — it discusses breast cancer biology and tumor progression (while Document B focuses on bone markers in metastatic patients), making A closer to the claim context. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001302Z"}
{"comparison_id":"e3971be4-0682-4d84-835b-0df19ea06ad9","query_id":"53","doc_a_id":"17648235","doc_b_id":"2130391","presented_order":["17648235","2130391"],"winner_id":"17648235","reasoning":"Document A is more relevant — it addresses tumor cell–intrinsic signaling (WNT/β-catenin) tied to proliferation and stem-like behavior that relate to markers such as ALDH1, whereas Document B focuses on adipocyte-driven invasion and microenvironmental effects. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001310Z"}
{"comparison_id":"ff2f498e-dc56-4600-9057-3d7594d6a93e","query_id":"53","doc_a_id":"15721252","doc_b_id":"2130391","presented_order":["15721252","2130391"],"winner_id":"2130391","reasoning":"Document B is more relevant — it discusses factors (CAAs) that promote tumor invasion and progression, which relate to prognosis, whereas Document A focuses on drug sensitivity markers not prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001317Z"}
{"comparison_id":"adf773be-037e-40da-8353-bbabac73d2c4","query_id":"53","doc_a_id":"16734530","doc_b_id":"2130391","presented_order":["16734530","2130391"],"winner_id":"2130391","reasoning":"Document B is more relevant — it discusses mechanisms (adipocyte-driven invasion and tumor progression) tied to poorer prognosis, whereas Document A focuses on ORAI1 SNPs unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001324Z"}
{"comparison_id":"eab2afdb-0bd9-4460-8ee1-7c0fc2e9bc8e","query_id":"53","doc_a_id":"5500086","doc_b_id":"2130391","presented_order":["5500086","2130391"],"winner_id":"2130391","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it discusses mechanisms (invasion, tumor progression, lymph node involvement) that relate to poorer prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001332Z"}
{"comparison_id":"0add71f2-e4c7-4030-8c7c-51b759aa22bb","query_id":"53","doc_a_id":"17755060","doc_b_id":"2130391","presented_order":["2130391","17755060"],"winner_id":"2130391","reasoning":"Document A is more relevant: it specifically addresses breast cancer biology and tumor progression, whereas Document B focuses on metabolic enzymes and PKCζ across cancers without breast-specific ALDH1 information.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001339Z"}
{"comparison_id":"bc822d10-65d8-4c34-a5a6-a07501f3e2b3","query_id":"53","doc_a_id":"27240667","doc_b_id":"2130391","presented_order":["2130391","27240667"],"winner_id":"27240667","reasoning":"Document B is more relevant — it addresses breast cancer prognosis/mortality directly, whereas Document A covers adipocyte-related invasion mechanisms without discussing prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001346Z"}
{"comparison_id":"9a31370e-fe29-454b-a0bf-51270d45c645","query_id":"53","doc_a_id":"19882228","doc_b_id":"2130391","presented_order":["2130391","19882228"],"winner_id":"2130391","reasoning":"Reason: Document A specifically addresses breast cancer tumor progression and factors linked to worse outcomes, making it more relevant to a claim about prognostic markers in breast cancer than the general review of hypoxia in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001354Z"}
{"comparison_id":"b4e271d5-be40-4786-9b6c-aa8aed382d22","query_id":"53","doc_a_id":"4999633","doc_b_id":"2130391","presented_order":["2130391","4999633"],"winner_id":"2130391","reasoning":"Document A is more relevant because it addresses tumor progression and clinical features linked to worse outcomes in breast cancer, whereas Document B is an in vitro signaling study unrelated to prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001361Z"}
{"comparison_id":"ae57fc51-1c1c-4da8-9b94-ba5ef1176450","query_id":"53","doc_a_id":"24249915","doc_b_id":"2130391","presented_order":["24249915","2130391"],"winner_id":"2130391","reasoning":"Document B is more relevant — it discusses tumor invasion and factors that promote progression and poorer outcomes, which is closer to ALDH1's association with aggressive prognosis than Document A's focus on ERβ methylation. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001368Z"}
{"comparison_id":"16c3d116-bcad-4835-b36f-bd5164d7ed15","query_id":"53","doc_a_id":"9600826","doc_b_id":"2130391","presented_order":["9600826","2130391"],"winner_id":"2130391","reasoning":"Document B is more relevant — it links tumor microenvironment factors to increased invasion and progression (lymph node involvement), which relates to prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001376Z"}
{"comparison_id":"8242bb47-20a5-4225-9ee3-d961f172de6b","query_id":"53","doc_a_id":"13069283","doc_b_id":"2130391","presented_order":["13069283","2130391"],"winner_id":"2130391","reasoning":"Document B — it discusses mechanisms of tumor invasion and progression in breast cancer, which is more related to prognosis than Document A's tamoxifen pharmacogenetics. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001383Z"}
{"comparison_id":"6f9f89ed-2d5f-4a7c-84dd-5d07cbc4aff1","query_id":"53","doc_a_id":"11484808","doc_b_id":"2130391","presented_order":["11484808","2130391"],"winner_id":"11484808","reasoning":"Document A is more likely to discuss prognostic biomarkers and clinical implications relevant to ALDH1 expression, whereas Document B focuses on adipocytes and tumor invasion without addressing ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001391Z"}
{"comparison_id":"7f4cbecd-f3cf-4c4c-9289-6cce7850d68f","query_id":"53","doc_a_id":"219475","doc_b_id":"2130391","presented_order":["2130391","219475"],"winner_id":"2130391","reasoning":"Document A is more directly about breast tumor progression and invasion, which relates to prognosis; Document B focuses on premetastatic lung myeloid cells and metastasis mechanisms. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001397Z"}
{"comparison_id":"f04199e7-e38a-4496-be30-0b4c6b9c204c","query_id":"53","doc_a_id":"5864770","doc_b_id":"2130391","presented_order":["5864770","2130391"],"winner_id":"2130391","reasoning":"Document B is more relevant — it discusses mechanisms (tumor invasion/progression) that relate to poorer prognosis in breast cancer, whereas A focuses on hormonal influence on proliferation/risk.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001404Z"}
{"comparison_id":"e18c8ed2-536e-4669-939a-4527aa8efc0b","query_id":"53","doc_a_id":"26231129","doc_b_id":"2130391","presented_order":["26231129","2130391"],"winner_id":"2130391","reasoning":"Document B is more relevant — it specifically studies breast cancer tumor biology and factors linked to progression and worse outcomes, whereas A is a general framework across solid cancers. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001411Z"}
{"comparison_id":"ed92972b-2ee9-4c64-8871-9c6d8ac89d9c","query_id":"53","doc_a_id":"164985","doc_b_id":"2130391","presented_order":["164985","2130391"],"winner_id":"2130391","reasoning":"Document B is more relevant — it discusses factors (adipocyte-induced invasion, tumor progression, lymph node involvement) that relate to prognosis in breast cancer, whereas A focuses on macrophage IL-6 regulation without linking to prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001419Z"}
{"comparison_id":"0ab3ad8d-d478-4c68-8ac4-76df71130fc4","query_id":"53","doc_a_id":"1389264","doc_b_id":"2130391","presented_order":["2130391","1389264"],"winner_id":"2130391","reasoning":"Document A is more relevant — it addresses factors tied to tumor progression and poor outcomes in breast cancer, whereas Document B focuses on targeted therapy in HER2+ brain metastases and not prognostic biomarkers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001426Z"}
{"comparison_id":"374ef75d-cc89-47c7-8c28-b3deb1ece9a4","query_id":"53","doc_a_id":"15559582","doc_b_id":"2130391","presented_order":["2130391","15559582"],"winner_id":"2130391","reasoning":"Document A — it addresses tumor biology and factors promoting invasion/progression, which is more related to prognosis than plasma lipid/prolactin findings. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001433Z"}
{"comparison_id":"8cac1133-500f-4536-9eda-b9806cd9d65b","query_id":"53","doc_a_id":"31311495","doc_b_id":"2130391","presented_order":["2130391","31311495"],"winner_id":"31311495","reasoning":"Document B — it addresses therapy resistance and increased aggressiveness/EMT in breast cancer cells, which is more directly related to factors (like ALDH1) linked to poorer prognosis than the adipocyte-focused invasion study in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001440Z"}
{"comparison_id":"d051fe05-a688-49a4-9e22-29224766b8ba","query_id":"53","doc_a_id":"5649538","doc_b_id":"2130391","presented_order":["2130391","5649538"],"winner_id":"5649538","reasoning":"Document B — it addresses gene expression markers in breast cancer (more likely to discuss prognostic markers like ALDH1), while A focuses on adipocytes and invasion without gene-expression prognostic markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001447Z"}
{"comparison_id":"d63866cc-a35d-431b-9995-8c75d02512d7","query_id":"53","doc_a_id":"1379127","doc_b_id":"2130391","presented_order":["1379127","2130391"],"winner_id":"1379127","reasoning":"Document A is more relevant — it addresses tumor cell migration and metastasis, which are directly related to prognosis, whereas Document B focuses on adipocyte-mediated invasion without linking to prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001454Z"}
{"comparison_id":"ded90097-aa86-4f5d-bbc3-bb814387a785","query_id":"53","doc_a_id":"24144677","doc_b_id":"2130391","presented_order":["2130391","24144677"],"winner_id":"2130391","reasoning":"Document A is more relevant — it discusses tumor progression and factors linked to worse breast cancer outcomes, while Document B focuses on ATM germline mutations and cancer risk rather than prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001461Z"}
{"comparison_id":"5a912e3d-c50f-44fb-a81e-2cb957cffec5","query_id":"53","doc_a_id":"67045088","doc_b_id":"2130391","presented_order":["2130391","67045088"],"winner_id":"2130391","reasoning":"Document A is more relevant — it discusses factors (adipocyte effects, invasion, lymph node involvement) linked to breast cancer progression and prognosis, whereas B focuses on DPP4/IL-33–mediated immune control. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001468Z"}
{"comparison_id":"9418687a-5584-4c3a-b289-b164d7d5be60","query_id":"53","doc_a_id":"6550579","doc_b_id":"2130391","presented_order":["6550579","2130391"],"winner_id":"2130391","reasoning":"Document B is more relevant — it addresses factors (tumor invasion/progression) linked to poorer outcomes in breast cancer, whereas Document A focuses on HER3-targeted therapy for HER2-amplified tumors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001475Z"}
{"comparison_id":"44a96566-b025-4928-8087-68d462fe51c6","query_id":"53","doc_a_id":"23863551","doc_b_id":"2130391","presented_order":["2130391","23863551"],"winner_id":"2130391","reasoning":"Document A is more related to tumor progression and invasive behavior, which is more relevant to prognostic markers like ALDH1 than a study focused on PI3K/HER3 drug response. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001482Z"}
{"comparison_id":"2a59d79f-7510-4832-8651-cf13a73c23bc","query_id":"53","doc_a_id":"20183360","doc_b_id":"2130391","presented_order":["2130391","20183360"],"winner_id":"2130391","reasoning":"Reason: Neither abstract mentions ALDH1, but Document A addresses tumor progression and clinical correlates (invasion, larger tumors, lymph node involvement) which relate to prognosis, making it more relevant than the mechanistic transcription-factor focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001489Z"}
{"comparison_id":"bc742e50-5fa0-4166-8d4e-bdff2d6d3c88","query_id":"53","doc_a_id":"34066665","doc_b_id":"2130391","presented_order":["34066665","2130391"],"winner_id":"34066665","reasoning":"Reason: Document A discusses molecular mechanisms and clinical implications affecting breast cancer outcomes (prognosis and therapy resistance), making it more relevant to a claim about a prognostic marker than Document B, which focuses on adipocytes and invasion.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001497Z"}
{"comparison_id":"f979cb7e-9584-47b9-a6f9-228892c2497f","query_id":"53","doc_a_id":"6969753","doc_b_id":"2130391","presented_order":["6969753","2130391"],"winner_id":"2130391","reasoning":"Document B is more relevant — it links tumor microenvironment changes to breast cancer invasion and progression (size, lymph node involvement), which relates to prognosis; Document A focuses on invadopodia mechanics and does not address ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001505Z"}
{"comparison_id":"54881849-78c9-4e02-a8c0-17139666864b","query_id":"53","doc_a_id":"15832146","doc_b_id":"2130391","presented_order":["2130391","15832146"],"winner_id":"15832146","reasoning":"Neither document mentions ALDH1; both are only indirectly related. Document B is slightly more relevant because it links stromal cells to tumor growth and angiogenesis (factors tied to prognosis), whereas A focuses mainly on adipocyte-mediated invasion.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001512Z"}
{"comparison_id":"8fc68dda-1f19-4fb3-8bdf-300aee35c89c","query_id":"53","doc_a_id":"22267225","doc_b_id":"2130391","presented_order":["22267225","2130391"],"winner_id":"2130391","reasoning":"Document B is more related to tumor progression and factors affecting breast cancer aggressiveness, which is closer to prognosis than a general chemoprevention review. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001519Z"}
{"comparison_id":"2d95ab04-1a30-48d7-8f92-d4aef900f94b","query_id":"53","doc_a_id":"8774475","doc_b_id":"2130391","presented_order":["8774475","2130391"],"winner_id":"2130391","reasoning":"Reason: Document B discusses tumor progression, invasion, and factors tied to worse clinical outcomes (larger tumors, lymph node involvement), making it more related to prognosis than Document A, which focuses on cell polarity mechanisms.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001526Z"}
{"comparison_id":"71ce8ba3-d9b0-4477-8c84-03e671ce4d77","query_id":"53","doc_a_id":"10279084","doc_b_id":"2130391","presented_order":["10279084","2130391"],"winner_id":"2130391","reasoning":"Document B is more relevant — it discusses factors (invasion, tumor progression, lymph node involvement) tied to breast cancer prognosis, whereas Document A focuses on a MAP kinase phosphatase splice variant without addressing prognosis or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001533Z"}
{"comparison_id":"2a620542-7bc7-4b12-a289-d6281008262e","query_id":"53","doc_a_id":"13290521","doc_b_id":"2130391","presented_order":["2130391","13290521"],"winner_id":"2130391","reasoning":"Document A is more focused on breast cancer progression and tumor features linked to worse outcomes, making it more relevant to a claim about prognostic markers in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001539Z"}
{"comparison_id":"462ccc73-635f-4c6c-bed7-deb5e0a64157","query_id":"53","doc_a_id":"5270265","doc_b_id":"2130391","presented_order":["5270265","2130391"],"winner_id":"2130391","reasoning":"Neither document mentions ALDH1, but Document B (cancer-associated adipocytes promoting invasion and tumor progression) is more related to factors affecting prognosis than Document A (trastuzumab resistance via SRC). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001546Z"}
{"comparison_id":"d0bb7ff2-4860-4d54-974b-ffd3d8d11e83","query_id":"53","doc_a_id":"40127292","doc_b_id":"2130391","presented_order":["40127292","2130391"],"winner_id":"2130391","reasoning":"Document B is more relevant — it specifically addresses factors that influence breast cancer progression and prognosis, whereas A is a general discussion of apoptosis and chemoresistance in transgenic models.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:27.001553Z"}
{"comparison_id":"66ac8df8-4a68-4843-886d-053931ca46e0","query_id":"53","doc_a_id":"15113221","doc_b_id":"11484808","presented_order":["11484808","15113221"],"winner_id":"11484808","reasoning":"Document A is more relevant — it addresses endocrine-related cancers (including breast cancer), whereas Document B focuses on PTEN pathway signatures in carcinomas and does not target breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:34.584331Z"}
{"comparison_id":"a56d6dab-0ec1-46c3-a6a8-2304155d178a","query_id":"53","doc_a_id":"19673227","doc_b_id":"11484808","presented_order":["19673227","11484808"],"winner_id":"19673227","reasoning":"Document A is more relevant — it discusses prognostic assays and correlations with disease-free survival in cancer, which relates to prognosis markers like ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:34.584352Z"}
{"comparison_id":"a45dc802-bcea-47b0-99bb-e808d05a47d8","query_id":"53","doc_a_id":"24341590","doc_b_id":"11484808","presented_order":["24341590","11484808"],"winner_id":"11484808","reasoning":"Document B is more relevant — it covers molecular markers and prognostic factors in endocrine-related (including breast) cancer, whereas Document A focuses specifically on CYP2D6 and tamoxifen response.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:34.584362Z"}
{"comparison_id":"51b2629c-70be-4578-98b8-3c1da54f9546","query_id":"53","doc_a_id":"17648235","doc_b_id":"11484808","presented_order":["11484808","17648235"],"winner_id":"11484808","reasoning":"Document A is more relevant — it discusses clinical implications and prognostic/diagnostic markers in endocrine-related cancers, making it more likely to address markers like ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:34.584369Z"}
{"comparison_id":"a3875132-a70e-4c89-9b9f-f2067ba294be","query_id":"53","doc_a_id":"27240667","doc_b_id":"11484808","presented_order":["11484808","27240667"],"winner_id":"11484808","reasoning":"Document A is more relevant — it discusses biomarkers and clinical implications in endocrine-related cancers, which is closer to a claim about ALDH1 as a prognostic marker than population mortality trends.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:34.584377Z"}
{"comparison_id":"c30c8227-2f4c-4e7e-bf86-69374f636c2b","query_id":"53","doc_a_id":"15832146","doc_b_id":"11484808","presented_order":["15832146","11484808"],"winner_id":"11484808","reasoning":"Reason: Neither abstract mentions ALDH1, but the review on ncRNAs and clinical implications in endocrine-related cancers (Document B) is more likely to discuss prognostic biomarkers in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:34.584385Z"}
{"comparison_id":"bc881e4a-5456-44a2-9973-b22a98609c65","query_id":"53","doc_a_id":"31311495","doc_b_id":"11484808","presented_order":["31311495","11484808"],"winner_id":"11484808","reasoning":"Document B is more likely to discuss prognostic biomarkers and clinical correlations; Document A is a cell-line mechanistic study not addressing ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:34.584392Z"}
{"comparison_id":"5d708892-6a70-49eb-abb6-ab8d58b023e2","query_id":"53","doc_a_id":"5649538","doc_b_id":"11484808","presented_order":["11484808","5649538"],"winner_id":"5649538","reasoning":"Document B is more relevant — it focuses on breast cancer and gene expression markers, which is closer to a claim about ALDH1 expression and prognosis than a general review of non-coding RNAs.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:34.584399Z"}
{"comparison_id":"a1e0e4dc-1fd9-41de-8904-101fa679b4dd","query_id":"53","doc_a_id":"1379127","doc_b_id":"11484808","presented_order":["1379127","11484808"],"winner_id":"11484808","reasoning":"Document B is more relevant — it discusses biomarkers and clinical implications in endocrine-related cancers (including breast), which is closer to a claim about a prognostic expression marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:34.584405Z"}
{"comparison_id":"cf46f50a-f9da-494a-b1ff-701417fd11aa","query_id":"53","doc_a_id":"34066665","doc_b_id":"11484808","presented_order":["34066665","11484808"],"winner_id":"34066665","reasoning":"Document A — it reviews molecular mechanisms and clinical implications in breast cancer (including markers linked to therapy resistance and prognosis), so it's more likely to address ALDH1's prognostic relevance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:34.584412Z"}
{"comparison_id":"1f59b37e-4afb-4c1e-b407-bb99b0cc0429","query_id":"53","doc_a_id":"19673227","doc_b_id":"5649538","presented_order":["5649538","19673227"],"winner_id":"19673227","reasoning":"Document B is more relevant — it addresses prognostic/predictive biomarkers and correlations with survival outcomes, whereas A focuses on therapy-sensitivity predictors for dasatinib without prognostic data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:45.725487Z"}
{"comparison_id":"ff16a60f-0439-4d06-9fc8-5e312ef4965d","query_id":"53","doc_a_id":"34066665","doc_b_id":"5649538","presented_order":["5649538","34066665"],"winner_id":"5649538","reasoning":"Document A is slightly more relevant because it focuses on gene expression markers in breast cancer (more likely to address ALDH1 expression) whereas Document B discusses receptor crosstalk and endocrine resistance without emphasis on specific gene expression markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:45.725509Z"}
{"comparison_id":"08a72152-cb97-41bf-8702-9de51acef267","query_id":"53","doc_a_id":"15113221","doc_b_id":"27240667","presented_order":["27240667","15113221"],"winner_id":"15113221","reasoning":"Document B — it links gene expression signatures to poor prognosis in carcinomas, which is more related to the claim about a prognostic gene (ALDH1) than Document A's mortality trends. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:49.883989Z"}
{"comparison_id":"cd727aa7-ec16-4c5f-9ac5-4309724ee9c3","query_id":"53","doc_a_id":"24341590","doc_b_id":"27240667","presented_order":["24341590","27240667"],"winner_id":"24341590","reasoning":"Document A is more directly about factors affecting recurrence and clinical outcomes (prognosis) in breast cancer, whereas B discusses population mortality trends by ER status and age (less directly relevant to ALDH1).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:49.884010Z"}
{"comparison_id":"dd63b27a-4941-4df6-bd04-d12e114beae2","query_id":"53","doc_a_id":"17648235","doc_b_id":"27240667","presented_order":["17648235","27240667"],"winner_id":"17648235","reasoning":"Document A is more relevant — it discusses molecular pathways and tumor cell biology in breast cancer, which is closer to studies linking markers like ALDH1 to prognosis than population-level mortality trends.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:49.884018Z"}
{"comparison_id":"40c295f9-b0cb-4200-a414-694847a71599","query_id":"53","doc_a_id":"1379127","doc_b_id":"27240667","presented_order":["1379127","27240667"],"winner_id":"27240667","reasoning":"Document B is more relevant — it discusses breast cancer prognosis and mortality trends, whereas Document A focuses on calcium-channel proteins and migration mechanisms not directly related to ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:49.884026Z"}
{"comparison_id":"d65eda49-409c-4e57-b529-4f973c824e32","query_id":"53","doc_a_id":"15832146","doc_b_id":"27240667","presented_order":["27240667","15832146"],"winner_id":"27240667","reasoning":"Document A is more relevant because it discusses breast cancer mortality and prognosis trends, whereas Document B focuses on stromal fibroblasts and angiogenesis without addressing prognostic markers like ALDH1.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:49.884034Z"}
{"comparison_id":"ea0c4703-9e75-4d84-baaf-6e2dfd21403a","query_id":"53","doc_a_id":"31311495","doc_b_id":"27240667","presented_order":["31311495","27240667"],"winner_id":"31311495","reasoning":"Document A is more relevant — it discusses molecular markers and cellular behaviors linked to aggressiveness and therapy resistance in breast cancer, which is closer to ALDH1 as a prognostic molecular marker than broad mortality trends.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:49.884043Z"}
{"comparison_id":"247df3b8-b520-4a07-9554-a77e7d538cde","query_id":"53","doc_a_id":"15113221","doc_b_id":"24341590","presented_order":["24341590","15113221"],"winner_id":"24341590","reasoning":"Document A — it directly addresses prognostic outcomes in breast cancer patients (though via CYP2D6/tamoxifen), whereas Document B discusses a general carcinoma PTEN-related signature rather than breast-specific marker expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:56.968866Z"}
{"comparison_id":"4bc28a8e-86f6-4b1d-a844-db5a5b06f08f","query_id":"53","doc_a_id":"31311495","doc_b_id":"24341590","presented_order":["31311495","24341590"],"winner_id":"24341590","reasoning":"Document B is more relevant — it examines the association between a biomarker (CYP2D6) and clinical outcomes/prognosis in breast cancer, whereas A is a cell-line study of tamoxifen resistance mechanisms and does not address prognostic biomarkers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:56.968892Z"}
{"comparison_id":"d955b836-e37c-4b45-a29e-dd90bb9b7589","query_id":"53","doc_a_id":"17648235","doc_b_id":"24341590","presented_order":["24341590","17648235"],"winner_id":"17648235","reasoning":"Document B is more relevant — it addresses breast cancer signaling and tumor cell proliferation (more related to biomarkers and prognosis) while Document A focuses on CYP2D6 pharmacogenetics unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:43:56.968902Z"}
{"comparison_id":"7b0d649d-1f37-40ef-8923-0bca28df5af2","query_id":"53","doc_a_id":"15113221","doc_b_id":"31311495","presented_order":["15113221","31311495"],"winner_id":"15113221","reasoning":"Neither document mentions ALDH1, but Document A directly links a gene expression signature to poor prognosis in carcinomas (more relevant to the prognosis claim) while B addresses tamoxifen resistance mechanisms. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:02.404288Z"}
{"comparison_id":"997ce49b-96ea-4191-b2e4-4590194be38a","query_id":"53","doc_a_id":"1379127","doc_b_id":"15832146","presented_order":["1379127","15832146"],"winner_id":"1379127","reasoning":"Document A is more relevant — it directly links tumor cell migration and metastasis (which relate to poorer prognosis), whereas Document B discusses stromal fibroblasts and angiogenesis without addressing prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:07.217688Z"}
{"comparison_id":"6beaaf2f-dfa9-4b56-9302-9ce4c97a8540","query_id":"53","doc_a_id":"21439640","doc_b_id":"13069283","presented_order":["13069283","21439640"],"winner_id":"21439640","reasoning":"Document B is more relevant — it addresses tumor-progression pathways and prognosis-related biology in breast cancer, whereas A focuses on tamoxifen metabolism/genetics and not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.765855Z"}
{"comparison_id":"d0bb1171-5e6a-438d-9191-4e4cfd4dc3c3","query_id":"53","doc_a_id":"24349992","doc_b_id":"13069283","presented_order":["24349992","13069283"],"winner_id":"24349992","reasoning":"Document A is more relevant — it discusses mechanisms driving tumor aggressiveness and poor outcomes in breast cancer, whereas B focuses on tamoxifen metabolism/genetics and not markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.765876Z"}
{"comparison_id":"f45866fe-a496-402a-975d-d19dd063711d","query_id":"53","doc_a_id":"7795952","doc_b_id":"13069283","presented_order":["7795952","13069283"],"winner_id":"7795952","reasoning":"Document A is more relevant — it discusses a protein linked to poor cancer prognosis (though not ALDH1), whereas Document B focuses on tamoxifen metabolism/genetics and is unrelated to prognostic markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.765885Z"}
{"comparison_id":"f9648457-0975-422b-bf18-93ca6abc7548","query_id":"53","doc_a_id":"2061878","doc_b_id":"13069283","presented_order":["13069283","2061878"],"winner_id":"2061878","reasoning":"Document B is more relevant — it discusses a biomarker (NEAT1) whose expression correlates with poor prognosis in solid tumors, whereas Document A focuses on CYP2D6 and tamoxifen metabolism and does not address prognostic biomarker expression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.765894Z"}
{"comparison_id":"ba1d8f73-5574-4c8a-8297-9c3f1f71261c","query_id":"53","doc_a_id":"13007205","doc_b_id":"13069283","presented_order":["13007205","13069283"],"winner_id":"13007205","reasoning":"Document A is more related to breast cancer biology and tumor progression, which is closer to a claim about prognostic markers than tamoxifen pharmacogenetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.765902Z"}
{"comparison_id":"6e66c385-0281-4638-8afb-e7d33cf2cc75","query_id":"53","doc_a_id":"29366489","doc_b_id":"13069283","presented_order":["13069283","29366489"],"winner_id":"29366489","reasoning":"Document B is more relevant — it discusses tumor markers and prognosis across cancers (potentially including breast cancer), whereas A focuses on tamoxifen metabolism and CYP2D6 genotypes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.765909Z"}
{"comparison_id":"9f4e27f2-45ae-4c4c-b0ee-e0fdd3fe075e","query_id":"53","doc_a_id":"32001951","doc_b_id":"13069283","presented_order":["13069283","32001951"],"winner_id":"32001951","reasoning":"Document B is slightly more relevant because it addresses enzyme expression regulation in breast cancer cells, whereas Document A concerns tamoxifen metabolism genetics and not marker expression.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.765916Z"}
{"comparison_id":"c912b138-0dea-4b73-8c4a-2be83f807617","query_id":"53","doc_a_id":"13030852","doc_b_id":"13069283","presented_order":["13069283","13030852"],"winner_id":"13030852","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it deals with markers linked to metastasis and prognosis in breast cancer, whereas A focuses on tamoxifen metabolism genetics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.765923Z"}
{"comparison_id":"550ae723-5ebf-4e1d-80ac-03d55cb1cddf","query_id":"53","doc_a_id":"4820792","doc_b_id":"13069283","presented_order":["4820792","13069283"],"winner_id":"4820792","reasoning":"Document A is more relevant — it addresses survival pathways and therapy resistance in breast cancer, which relates to prognosis, whereas Document B focuses on tamoxifen metabolism genetics. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.765930Z"}
{"comparison_id":"39718bc9-4401-43c5-a009-780eac1bac43","query_id":"53","doc_a_id":"8037453","doc_b_id":"13069283","presented_order":["8037453","13069283"],"winner_id":"13069283","reasoning":"Document B — it concerns breast cancer (tamoxifen metabolism and outcomes), whereas Document A focuses on bone markers in metastatic cancer and not ALDH1 or general breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.765938Z"}
{"comparison_id":"4f6ba9f1-3c8f-42d1-9814-4b057982aefa","query_id":"53","doc_a_id":"15721252","doc_b_id":"13069283","presented_order":["15721252","13069283"],"winner_id":"15721252","reasoning":"Neither abstract mentions ALDH1. Document A is slightly more relevant because it discusses molecular markers and prognosis/therapy sensitivity in breast cancer, whereas B focuses narrowly on tamoxifen metabolism genetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.765945Z"}
{"comparison_id":"ce7d1e4c-f2fd-4352-8f49-5a8ff4a551ff","query_id":"53","doc_a_id":"16734530","doc_b_id":"13069283","presented_order":["16734530","13069283"],"winner_id":"16734530","reasoning":"Both documents do not mention ALDH1, but Document A discusses tumor molecular associations and nodal involvement (prognostic factors), making it slightly more relevant than B which focuses on drug metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.765952Z"}
{"comparison_id":"9c0ef23a-cb96-4f67-bfb2-eb006c29ee4b","query_id":"53","doc_a_id":"5500086","doc_b_id":"13069283","presented_order":["5500086","13069283"],"winner_id":"5500086","reasoning":"Document A is more relevant — it discusses tumor-intrinsic molecular signatures that correlate with clinical outcomes in breast cancer, which is closer to a prognostic marker question than the tamoxifen pharmacogenetics focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.765960Z"}
{"comparison_id":"33c41901-7ff2-4355-b1ef-e878f4d744d9","query_id":"53","doc_a_id":"17755060","doc_b_id":"13069283","presented_order":["13069283","17755060"],"winner_id":"13069283","reasoning":"Document A is more relevant — it specifically studies breast cancer (even though it doesn't mention ALDH1), whereas B discusses metabolic enzymes and prognosis in cancers generally. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.765968Z"}
{"comparison_id":"fa28e917-2480-4273-9e5d-0085b1a6afb0","query_id":"53","doc_a_id":"19882228","doc_b_id":"13069283","presented_order":["19882228","13069283"],"winner_id":"19882228","reasoning":"Document A is more relevant — it discusses factors linked to poor prognosis in tumors (hypoxia), which is closer to a prognostic biomarker topic than a pharmacogenetics/tamoxifen metabolism study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.765975Z"}
{"comparison_id":"df794d17-6bc7-498c-ac47-3dd6e0d5356a","query_id":"53","doc_a_id":"4999633","doc_b_id":"13069283","presented_order":["4999633","13069283"],"winner_id":"13069283","reasoning":"Neither abstract mentions ALDH1. Document B is slightly more relevant because it addresses clinical prognostic/therapy factors in breast cancer, whereas A is an in vitro signaling study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.765982Z"}
{"comparison_id":"62ad256b-fde9-4f6a-b68c-4829a7f0fb9b","query_id":"53","doc_a_id":"24249915","doc_b_id":"13069283","presented_order":["24249915","13069283"],"winner_id":"24249915","reasoning":"Document A is more relevant — it addresses expression of a marker (ERβ) in breast cancer and its clinical relevance, whereas Document B focuses on tamoxifen metabolism/genetics, not marker expression or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.765990Z"}
{"comparison_id":"010687a5-ccc8-46de-b9e2-90a2cfec0843","query_id":"53","doc_a_id":"9600826","doc_b_id":"13069283","presented_order":["13069283","9600826"],"winner_id":"9600826","reasoning":"Document B is more relevant — it discusses pathways involved in invasion and metastasis (which relate to prognosis), whereas Document A focuses on tamoxifen metabolism genetics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.765997Z"}
{"comparison_id":"df1175ff-3cfd-4a5e-9a11-c9247f43bb89","query_id":"53","doc_a_id":"40127292","doc_b_id":"13069283","presented_order":["13069283","40127292"],"winner_id":"13069283","reasoning":"Document A is more relevant — it specifically studies breast cancer patients (though it focuses on tamoxifen metabolism, not ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.766003Z"}
{"comparison_id":"c4866747-c65a-48ed-b123-7a616f1093bb","query_id":"53","doc_a_id":"219475","doc_b_id":"13069283","presented_order":["13069283","219475"],"winner_id":"219475","reasoning":"Document B is more relevant — it addresses tumor progression and metastasis in mammary tumors, which relates to factors affecting prognosis, whereas Document A focuses on tamoxifen metabolism/genetics. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.766011Z"}
{"comparison_id":"dd815025-8e18-4c12-a98d-6f516bf0a696","query_id":"53","doc_a_id":"5864770","doc_b_id":"13069283","presented_order":["5864770","13069283"],"winner_id":"5864770","reasoning":"Neither document mentions ALDH1, but Document A discusses breast cancer biology and factors affecting prognosis/risk, making it marginally more relevant than B which focuses on tamoxifen metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.766018Z"}
{"comparison_id":"178fc0e2-9c0e-48ad-afd6-4e7a89830193","query_id":"53","doc_a_id":"26231129","doc_b_id":"13069283","presented_order":["13069283","26231129"],"winner_id":"13069283","reasoning":"Document A is more relevant — it specifically studies breast cancer patients, whereas B is a general framework on residual disease in solid tumors and doesn't focus on breast cancer prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.766026Z"}
{"comparison_id":"a1d31f80-7582-4faf-9048-3d564d5878fb","query_id":"53","doc_a_id":"164985","doc_b_id":"13069283","presented_order":["13069283","164985"],"winner_id":"164985","reasoning":"Document B is more relevant — it addresses mechanisms of tumor progression in mammary carcinoma (tumor microenvironment/immune suppression), which is closer to prognostic markers like ALDH1 than a pharmacogenetic study of tamoxifen metabolism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.766033Z"}
{"comparison_id":"4e652777-b080-40c0-8d9f-7dbc9f3e9223","query_id":"53","doc_a_id":"1389264","doc_b_id":"13069283","presented_order":["1389264","13069283"],"winner_id":"1389264","reasoning":"Document A — it addresses tumor biology and biomarkers related to treatment response/prognosis in breast cancer, whereas Document B focuses on tamoxifen pharmacogenetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.766040Z"}
{"comparison_id":"92ae3cfe-2d6c-4d52-a1b5-fd1c8eaf4061","query_id":"53","doc_a_id":"15559582","doc_b_id":"13069283","presented_order":["15559582","13069283"],"winner_id":"13069283","reasoning":"Document B is more relevant — it addresses molecular/clinical factors affecting breast cancer outcomes (tamoxifen metabolism/genotype), whereas A discusses lipids and prolactin without prognosis markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.766047Z"}
{"comparison_id":"e2be5583-6a8c-4c5e-b842-07c732dde90f","query_id":"53","doc_a_id":"24144677","doc_b_id":"13069283","presented_order":["13069283","24144677"],"winner_id":"13069283","reasoning":"Document A is more relevant — it concerns treatment-related factors tied to breast cancer outcomes, whereas Document B addresses genetic susceptibility (risk), not prognosis or biomarker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.766055Z"}
{"comparison_id":"899a5128-8610-4a02-bbbf-86867b7e02e9","query_id":"53","doc_a_id":"67045088","doc_b_id":"13069283","presented_order":["13069283","67045088"],"winner_id":"13069283","reasoning":"Document A is more relevant — it's a clinical study in breast cancer (ties to prognosis/treatment), whereas B is a preclinical immunology/tumor-growth study not related to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.766062Z"}
{"comparison_id":"e8859725-db3e-4479-ada7-802075c89f0e","query_id":"53","doc_a_id":"6550579","doc_b_id":"13069283","presented_order":["13069283","6550579"],"winner_id":"6550579","reasoning":"Neither document mentions ALDH1; both are largely irrelevant. Document B is slightly more related to tumor biology and prognosis/therapy, so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.766071Z"}
{"comparison_id":"b30b105a-7b00-45e5-91c9-8e6b2816b508","query_id":"53","doc_a_id":"23863551","doc_b_id":"13069283","presented_order":["13069283","23863551"],"winner_id":"23863551","reasoning":"Document B is more relevant — neither mentions ALDH1 or prognosis, but B addresses protein expression and its impact on therapeutic outcome, which is closer to a prognosis-related question than A's focus on CYP2D6 tamoxifen metabolism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.766078Z"}
{"comparison_id":"ef52ffaf-375e-490d-96ab-93f4b18b019f","query_id":"53","doc_a_id":"20183360","doc_b_id":"13069283","presented_order":["13069283","20183360"],"winner_id":"20183360","reasoning":"Document B — it addresses molecular drivers of breast cancer aggressiveness and invasion, which is more relevant to prognosis than Document A's focus on tamoxifen metabolism. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.766085Z"}
{"comparison_id":"5b44936c-2e62-43c9-8844-23dacd6645a2","query_id":"53","doc_a_id":"6969753","doc_b_id":"13069283","presented_order":["6969753","13069283"],"winner_id":"13069283","reasoning":"Document B — it directly concerns breast cancer (tamoxifen metabolism in patients), whereas A focuses on invadopodia mechanisms not ALDH1 or clinical prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.766092Z"}
{"comparison_id":"2f12f06d-cbdd-412b-8a3d-1c93b8aa4683","query_id":"53","doc_a_id":"22267225","doc_b_id":"13069283","presented_order":["13069283","22267225"],"winner_id":"13069283","reasoning":"Document A is more relevant — it deals with molecular markers and treatment-related outcomes in breast cancer, whereas Document B is a broad review of chemoprevention not focused on prognostic markers like ALDH1.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.766100Z"}
{"comparison_id":"bc5e6b5a-b7b5-4897-936d-bdc70f708856","query_id":"53","doc_a_id":"8774475","doc_b_id":"13069283","presented_order":["8774475","13069283"],"winner_id":"8774475","reasoning":"Document A is more relevant — it deals with breast cancer biology and tumorigenesis, which is closer to marker expression and prognosis than a pharmacogenetics/metabolism study.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.766108Z"}
{"comparison_id":"80579ca7-ae76-401c-ac33-38c139231178","query_id":"53","doc_a_id":"10279084","doc_b_id":"13069283","presented_order":["10279084","13069283"],"winner_id":"10279084","reasoning":"Document A is more relevant — it discusses molecular alterations observed in breast cancer (MAP kinase phosphatase variants) which is closer to a prognostic biomarker context than a pharmacogenetic tamoxifen metabolism study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.766115Z"}
{"comparison_id":"ac894db7-5dd7-4ef9-9f29-265e7a3009ed","query_id":"53","doc_a_id":"13290521","doc_b_id":"13069283","presented_order":["13290521","13069283"],"winner_id":"13290521","reasoning":"Document A is more relevant — it discusses cancer-related prognostic markers and prognostic applications, whereas Document B focuses on tamoxifen pharmacogenetics unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.766122Z"}
{"comparison_id":"224acb29-a6be-4391-994c-3be30a9450ea","query_id":"53","doc_a_id":"5270265","doc_b_id":"13069283","presented_order":["13069283","5270265"],"winner_id":"5270265","reasoning":"Neither document mentions ALDH1. However, Document B is marginally more relevant because it deals with molecular markers and treatment resistance affecting prognosis in breast cancer, whereas Document A focuses narrowly on tamoxifen metabolism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:21.766128Z"}
{"comparison_id":"663ce3d8-58cd-4b1f-8262-4507a5ce16e4","query_id":"53","doc_a_id":"21439640","doc_b_id":"19882228","presented_order":["21439640","19882228"],"winner_id":"19882228","reasoning":"Document B is more relevant — it discusses tumor biology and factors (hypoxia) linked to poor prognosis, which is closer to mechanisms associated with markers like ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100737Z"}
{"comparison_id":"05b6052a-db3a-4321-bc17-99e9db132a09","query_id":"53","doc_a_id":"24349992","doc_b_id":"19882228","presented_order":["24349992","19882228"],"winner_id":"24349992","reasoning":"Document A is more relevant — it links oxidative stress, stromal changes and tumor aggressiveness (mechanisms related to aldehyde detoxification/ALDH1 biology) to poorer cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100760Z"}
{"comparison_id":"dfea75eb-3e89-495a-943e-5fe1c3c09ced","query_id":"53","doc_a_id":"7795952","doc_b_id":"19882228","presented_order":["7795952","19882228"],"winner_id":"7795952","reasoning":"Document A is more relevant — it discusses a tumor protein linked to poor prognosis and metastatic behavior, which is closer to a claim about a prognostic marker like ALDH1 than a general review of hypoxia.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100770Z"}
{"comparison_id":"3cb5df0f-7629-49df-a238-6ce0ad32fe72","query_id":"53","doc_a_id":"2061878","doc_b_id":"19882228","presented_order":["2061878","19882228"],"winner_id":"2061878","reasoning":"Document A is more relevant — it discusses a specific molecular marker's overexpression correlating with poor prognosis in solid tumors, which is closer to the claim about ALDH1 expression and breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100777Z"}
{"comparison_id":"4a488854-77cd-4b60-94db-c8a1a1c0cdd8","query_id":"53","doc_a_id":"13007205","doc_b_id":"19882228","presented_order":["19882228","13007205"],"winner_id":"13007205","reasoning":"Neither document mentions ALDH1; both are irrelevant. Document B is slightly more relevant because it specifically discusses factors affecting breast cancer progression (invasion), whereas A is a general review of hypoxia. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100785Z"}
{"comparison_id":"c4502742-0483-40ce-b879-de24b27763c5","query_id":"53","doc_a_id":"29366489","doc_b_id":"19882228","presented_order":["29366489","19882228"],"winner_id":"29366489","reasoning":"Document A is more relevant — it discusses a gene's expression as a potential molecular marker tied to cancer prognosis, which is closer to the claim about ALDH1 expression and prognosis than the general hypoxia discussion in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100793Z"}
{"comparison_id":"ebe7d297-cda4-45b0-af0c-02f9773967ce","query_id":"53","doc_a_id":"32001951","doc_b_id":"19882228","presented_order":["32001951","19882228"],"winner_id":"19882228","reasoning":"Document B — it discusses tumor factors linked to poor prognosis (hypoxia), while Document A concerns alkaline phosphatase regulation, unrelated to ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100800Z"}
{"comparison_id":"322b39ec-b6ff-4037-bb6c-39ad45d9fe05","query_id":"53","doc_a_id":"13030852","doc_b_id":"19882228","presented_order":["13030852","19882228"],"winner_id":"19882228","reasoning":"Document B is more relevant — it discusses tumor biology and factors linked to poor prognosis, whereas A concerns alkaline phosphatase assays for metastasis detection and is unrelated to ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100808Z"}
{"comparison_id":"cd467bce-18f9-4629-acb4-f504bdc79ee0","query_id":"53","doc_a_id":"4820792","doc_b_id":"19882228","presented_order":["4820792","19882228"],"winner_id":"4820792","reasoning":"Document A — it specifically addresses breast cancer biology, whereas Document B discusses hypoxia in tumours generally and neither mentions ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100815Z"}
{"comparison_id":"9424e504-9485-425b-95fe-ae55aebea897","query_id":"53","doc_a_id":"15721252","doc_b_id":"19882228","presented_order":["15721252","19882228"],"winner_id":"15721252","reasoning":"Document A is more relevant — it specifically concerns breast cancer molecular markers and treatments, whereas B discusses general tumor hypoxia without addressing ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100822Z"}
{"comparison_id":"2434864a-61ee-4c35-a9b4-76718530f19a","query_id":"53","doc_a_id":"16734530","doc_b_id":"19882228","presented_order":["16734530","19882228"],"winner_id":"16734530","reasoning":"Document A is more relevant — it concerns breast cancer specifically (whereas B discusses general tumour hypoxia) though neither mentions ALDH1 directly.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100829Z"}
{"comparison_id":"4c08b640-5315-4ded-bfe7-522f6cb904e7","query_id":"53","doc_a_id":"5500086","doc_b_id":"19882228","presented_order":["19882228","5500086"],"winner_id":"19882228","reasoning":"Document A is more relevant — it discusses tumor hypoxia and its link to poor prognosis (directly about prognosis), while Document B focuses on type I interferon and chemotherapy response and does not address ALDH1 or prognosis.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100836Z"}
{"comparison_id":"ad387589-6804-4a84-9998-bcefb71c2c4a","query_id":"53","doc_a_id":"5270265","doc_b_id":"19882228","presented_order":["5270265","19882228"],"winner_id":"5270265","reasoning":"Neither abstract mentions ALDH1, but Document A specifically addresses breast cancer mechanisms and treatment outcomes, so it is more directly relevant to a prognosis-related claim in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100843Z"}
{"comparison_id":"b88e2ef2-d71c-422b-ac3b-f972a5a46633","query_id":"53","doc_a_id":"24249915","doc_b_id":"19882228","presented_order":["19882228","24249915"],"winner_id":"19882228","reasoning":"Document A is more relevant — it discusses tumor biology linked to poor prognosis (hypoxia-related pathways), which is more closely related to prognostic markers than Document B's focus on ERβ methylation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100850Z"}
{"comparison_id":"e67a17c4-9ead-46fc-95c5-7a065b880f2e","query_id":"53","doc_a_id":"9600826","doc_b_id":"19882228","presented_order":["9600826","19882228"],"winner_id":"9600826","reasoning":"Document A is more specifically about molecular pathways overexpressed in breast cancer and their link to invasion/angiogenesis (closer to prognosis markers), while Document B is a general review of hypoxia. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100857Z"}
{"comparison_id":"92dda1bf-925c-4931-8ce4-7631d065c4ca","query_id":"53","doc_a_id":"219475","doc_b_id":"19882228","presented_order":["19882228","219475"],"winner_id":"219475","reasoning":"Document B is more relevant — it studies factors affecting metastasis in mammary (breast) tumors, which relates to prognosis, whereas A only discusses hypoxia broadly and does not address breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100864Z"}
{"comparison_id":"7a2ba054-6a13-47be-bb9d-8a9b3849c3f4","query_id":"53","doc_a_id":"5864770","doc_b_id":"19882228","presented_order":["19882228","5864770"],"winner_id":"19882228","reasoning":"Document A is slightly more relevant because it discusses factors linked to poor tumour prognosis, whereas Document B focuses on hormones and risk without addressing prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100871Z"}
{"comparison_id":"095ed97b-4eea-43fd-8850-ad66439ff814","query_id":"53","doc_a_id":"164985","doc_b_id":"19882228","presented_order":["164985","19882228"],"winner_id":"164985","reasoning":"Document A is more relevant — it specifically involves mammary (breast) carcinoma and factors that influence tumor progression, whereas Document B discusses hypoxia in tumors generally and doesn't relate to ALDH1 or breast-specific markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100879Z"}
{"comparison_id":"b23fade4-79e5-4239-bc9a-dbe87d25db95","query_id":"53","doc_a_id":"1389264","doc_b_id":"19882228","presented_order":["1389264","19882228"],"winner_id":"19882228","reasoning":"Document B — it discusses tumor biological factors linked to poor prognosis (hypoxia), which is more related to a claim about biomarkers and prognosis than the therapy-focused xenograft study in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100886Z"}
{"comparison_id":"ead05f9f-5741-4673-87d2-8d03de48f2a8","query_id":"53","doc_a_id":"6550579","doc_b_id":"19882228","presented_order":["19882228","6550579"],"winner_id":"19882228","reasoning":"Document A is more relevant — it discusses factors (hypoxia) linked to poor prognosis in tumors, which is closer to the claim about a prognostic marker than the therapy-focused HER3 paper.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100893Z"}
{"comparison_id":"bd815775-f1d8-4724-b282-9e79e7ce74f9","query_id":"53","doc_a_id":"23863551","doc_b_id":"19882228","presented_order":["19882228","23863551"],"winner_id":"23863551","reasoning":"Reason: Neither document mentions ALDH1, but Document B specifically addresses breast cancer (while A discusses hypoxia and general tumour prognosis), so B is slightly more context-relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100900Z"}
{"comparison_id":"e6489a42-50be-4860-90d8-dc2af43ac327","query_id":"53","doc_a_id":"20183360","doc_b_id":"19882228","presented_order":["20183360","19882228"],"winner_id":"20183360","reasoning":"Document A is more relevant — it deals specifically with molecular factors in breast cancer linked to invasion/prognosis, whereas B discusses general tumor hypoxia not specific to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100907Z"}
{"comparison_id":"d46e5bee-2afe-492e-839e-f99ab2ff3f19","query_id":"53","doc_a_id":"8774475","doc_b_id":"19882228","presented_order":["8774475","19882228"],"winner_id":"8774475","reasoning":"More relevant: Document A — it focuses on mammary (breast) tumorigenesis and factors affecting prognosis, whereas Document B is a general review of hypoxia not specific to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100914Z"}
{"comparison_id":"528b741e-456e-4647-9847-3ecd9f3ae0d7","query_id":"53","doc_a_id":"10279084","doc_b_id":"19882228","presented_order":["19882228","10279084"],"winner_id":"19882228","reasoning":"Document A is more relevant — it discusses factors linked to poor prognosis in tumors, while Document B focuses on a MAP kinase phosphatase splice variant without addressing ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100923Z"}
{"comparison_id":"bf533e43-03dc-40a8-bbbd-d797f5f3c1cd","query_id":"53","doc_a_id":"13290521","doc_b_id":"19882228","presented_order":["13290521","19882228"],"winner_id":"19882228","reasoning":"Document B is more relevant — it discusses tumor factors (hypoxia) linked to poor prognosis in cancer, which is closer to the claim about marker expression and prognosis than a general miRNA review.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:36.100931Z"}
{"comparison_id":"38467f16-78b2-4ba5-8099-44e9e67ad886","query_id":"53","doc_a_id":"24349992","doc_b_id":"16734530","presented_order":["16734530","24349992"],"winner_id":"24349992","reasoning":"Reason: Neither mentions ALDH1, but B discusses mechanisms linked to tumor aggressiveness and poorer outcomes, making it marginally more relevant than A, which focuses on ORAI1 SNPs.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:43.733476Z"}
{"comparison_id":"201648ce-56c5-4865-b5b8-6f344301e0d4","query_id":"53","doc_a_id":"7795952","doc_b_id":"16734530","presented_order":["16734530","7795952"],"winner_id":"7795952","reasoning":"Reason: Document B discusses a protein (fascin) linked to poor cancer prognosis and mechanisms of invasion/metastasis, which is more relevant to a claim about a marker associated with poorer prognosis than Document A’s SNP-focused study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:43.733496Z"}
{"comparison_id":"274ed1b3-bde3-4a99-a3ad-2cf99f2e1656","query_id":"53","doc_a_id":"2061878","doc_b_id":"16734530","presented_order":["2061878","16734530"],"winner_id":"16734530","reasoning":"Document B is more relevant — it studies genetic associations specifically in breast cancer (while A discusses NEAT1 in various tumors, not breast or ALDH1).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:43.733505Z"}
{"comparison_id":"e26aa4f2-dbe9-4981-b405-1f7e3091ea58","query_id":"53","doc_a_id":"13007205","doc_b_id":"16734530","presented_order":["16734530","13007205"],"winner_id":"16734530","reasoning":"Neither document discusses ALDH1 or its association with prognosis. Document A is slightly more relevant because it links genetic markers to breast cancer clinical features (lymph node involvement), which relate to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:43.733513Z"}
{"comparison_id":"96c91859-9fdd-4aff-9cc3-966633e4d339","query_id":"53","doc_a_id":"29366489","doc_b_id":"16734530","presented_order":["16734530","29366489"],"winner_id":"29366489","reasoning":"Reason: Document B discusses a cancer-related marker and its prognostic value, whereas Document A focuses on ORAI1 SNP associations unrelated to ALDH1 or prognosis broadly.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:43.733520Z"}
{"comparison_id":"02068638-442b-4d99-8a50-aee997e19a8c","query_id":"53","doc_a_id":"4820792","doc_b_id":"16734530","presented_order":["4820792","16734530"],"winner_id":"16734530","reasoning":"Document B links genetic variants to clinical features (lymph node involvement) relevant to prognosis, while A focuses on β1 integrin-driven drug resistance and doesn't address ALDH1 or prognosis. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:43.733527Z"}
{"comparison_id":"e10f11b8-eff6-4ca6-a819-57f08acdafc5","query_id":"53","doc_a_id":"15721252","doc_b_id":"16734530","presented_order":["15721252","16734530"],"winner_id":"16734530","reasoning":"Document B — it addresses genetic markers linked to ER+ status and nodal involvement (prognostic), whereas A discusses a CDK4/6 inhibitor and sensitivity markers, not ALDH1 or prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:43.733535Z"}
{"comparison_id":"718f66a5-8d61-4251-b1c0-71e64ab7989e","query_id":"53","doc_a_id":"8774475","doc_b_id":"16734530","presented_order":["8774475","16734530"],"winner_id":"16734530","reasoning":"Reason: Neither abstract discusses ALDH1, but Document B addresses genetic associations with clinical prognostic features (lymph node involvement), making it slightly more relevant to a claim about poor prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:43.733542Z"}
{"comparison_id":"cf0581ad-bdfa-4df5-86fc-038c7ba06df5","query_id":"53","doc_a_id":"5270265","doc_b_id":"16734530","presented_order":["5270265","16734530"],"winner_id":"16734530","reasoning":"Document B is more relevant — it links genetic factors to clinicopathologic features (lymph node involvement) tied to prognosis, whereas A focuses on SRC-mediated trastuzumab resistance. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:43.733549Z"}
{"comparison_id":"883cb3f9-45cb-42da-aaf6-61990d0e97dc","query_id":"53","doc_a_id":"9600826","doc_b_id":"16734530","presented_order":["16734530","9600826"],"winner_id":"16734530","reasoning":"Document A is more relevant — it reports associations between genetic markers and clinical features (estrogen receptor status and lymph node involvement), which relate to prognosis; Document B focuses on a signaling pathway in invasion/angiogenesis without addressing prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:43.733556Z"}
{"comparison_id":"02f7e537-4123-4585-97c4-657e61b82b7e","query_id":"53","doc_a_id":"219475","doc_b_id":"16734530","presented_order":["219475","16734530"],"winner_id":"219475","reasoning":"Document A is more relevant — it addresses tumor progression and metastasis in a breast cancer model (which relates to prognosis), while Document B is limited to ORAI1 SNP associations not related to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:43.733564Z"}
{"comparison_id":"529b860d-efcc-4fe9-b839-87ef28fc3c05","query_id":"53","doc_a_id":"164985","doc_b_id":"16734530","presented_order":["16734530","164985"],"winner_id":"16734530","reasoning":"Document A is more relevant — it directly studies genetic markers and clinical features in breast cancer (linked to prognosis), whereas Document B focuses on macrophage behavior in a tumor model and not on biomarkers or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:43.733571Z"}
{"comparison_id":"a30a195f-3e62-4183-866b-d53e82d97297","query_id":"53","doc_a_id":"23863551","doc_b_id":"16734530","presented_order":["23863551","16734530"],"winner_id":"16734530","reasoning":"Neither mentions ALDH1, but Document B links genetic variants to breast cancer features including lymph node involvement (a prognostic factor), so it's marginally more relevant than A (which focuses on PI3K/HER3 drug-response).  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:43.733578Z"}
{"comparison_id":"eaca40a1-af58-4b79-aa1b-cc57832e9d35","query_id":"53","doc_a_id":"20183360","doc_b_id":"16734530","presented_order":["20183360","16734530"],"winner_id":"20183360","reasoning":"Reason: Document A discusses molecular mechanisms driving invasiveness and metastasis in breast cancer, which is more relevant to prognosis than Document B's focus on ORAI1 SNP associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:43.733585Z"}
{"comparison_id":"513aa0d5-376d-4b04-b983-effc6956eefa","query_id":"53","doc_a_id":"24349992","doc_b_id":"29366489","presented_order":["24349992","29366489"],"winner_id":"29366489","reasoning":"Document B — it discusses a gene whose expression relates to prognosis and could serve as a molecular prognostic marker across cancers, which is more directly related to the claim about a biomarker's expression and prognosis than Document A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:48.793165Z"}
{"comparison_id":"78a2ebf8-e7ad-43b2-82bc-1f81a00657d4","query_id":"53","doc_a_id":"7795952","doc_b_id":"29366489","presented_order":["7795952","29366489"],"winner_id":"7795952","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it discusses a protein linked to poor cancer prognosis and metastasis, which is closer to the claim's focus on prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:48.793187Z"}
{"comparison_id":"fafa58fa-21c2-4005-b2e9-f25d6ea77f82","query_id":"53","doc_a_id":"20183360","doc_b_id":"29366489","presented_order":["20183360","29366489"],"winner_id":"20183360","reasoning":"Document A is more relevant because it specifically addresses molecular mechanisms in breast cancer (invasion and progression), whereas B discusses a tumor suppressor across cancers without breast-specific prognostic data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:48.793196Z"}
{"comparison_id":"4906147e-ed92-4d02-bb77-4d47b51ddf25","query_id":"53","doc_a_id":"219475","doc_b_id":"29366489","presented_order":["29366489","219475"],"winner_id":"29366489","reasoning":"Reason: Document A discusses a molecular marker and prognosis across cancers (relevance to expression–prognosis association), while Document B focuses on immune cells and lung premetastatic niches in mouse mammary tumors and does not address marker expression or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:48.793204Z"}
{"comparison_id":"49cb2110-78db-4738-8b64-d2104b8e8ff2","query_id":"53","doc_a_id":"7795952","doc_b_id":"20183360","presented_order":["20183360","7795952"],"winner_id":"7795952","reasoning":"Neither document mentions ALDH1; Document B discusses a protein (fascin) explicitly linked to poor cancer prognosis, so it is marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:53.291834Z"}
{"comparison_id":"fd1fcd45-e1e7-43b0-99a4-3d7f92f7df98","query_id":"53","doc_a_id":"24349992","doc_b_id":"219475","presented_order":["219475","24349992"],"winner_id":"24349992","reasoning":"Neither abstract mentions ALDH1; both are largely irrelevant. Document B is slightly more relevant because it discusses mechanisms driving aggressive tumor behavior and prognosis in breast cancer, whereas A focuses narrowly on myeloid cells in premetastatic lung.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:44:58.282217Z"}
{"comparison_id":"8e6e8dde-8600-49e4-87d3-a68541cebc79","query_id":"53","doc_a_id":"2061878","doc_b_id":"8774475","presented_order":["8774475","2061878"],"winner_id":"2061878","reasoning":"Document B is more relevant — it discusses a molecular marker (NEAT1) whose expression correlates with poor prognosis in solid tumors, which is closer to the claim about marker expression and prognosis. Document A focuses on Scribble and tumorigenesis mechanisms, not prognostic marker expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:05.324129Z"}
{"comparison_id":"1416c020-6199-4ec7-9bf1-45788516ce24","query_id":"53","doc_a_id":"13007205","doc_b_id":"8774475","presented_order":["13007205","8774475"],"winner_id":"13007205","reasoning":"Document A is slightly more relevant because it addresses mechanisms (increased invasion) related to tumor progression and prognosis, whereas Document B focuses on cell polarity without direct link to prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:05.324149Z"}
{"comparison_id":"502ba089-b7e5-4715-b4d4-6911d1a6c0d6","query_id":"53","doc_a_id":"4820792","doc_b_id":"8774475","presented_order":["4820792","8774475"],"winner_id":"8774475","reasoning":"Document B is more relevant — it addresses molecular changes that promote tumorigenesis and affect cancer progression/outcome, which is closer to a prognostic association than a study focused on therapy resistance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:05.324158Z"}
{"comparison_id":"9e63b6a6-f638-45c1-bd39-25a84cf2d136","query_id":"53","doc_a_id":"15721252","doc_b_id":"8774475","presented_order":["8774475","15721252"],"winner_id":"8774475","reasoning":"Document A is more relevant — it addresses mechanisms of mammary tumorigenesis and cancer progression related to prognosis, whereas B focuses on drug sensitivity markers unrelated to ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:05.324165Z"}
{"comparison_id":"67d64672-8b51-412f-ae7d-04c5445bdc29","query_id":"53","doc_a_id":"23863551","doc_b_id":"8774475","presented_order":["8774475","23863551"],"winner_id":"8774475","reasoning":"Document A is more relevant — it deals with factors influencing mammary tumorigenesis and prognosis, whereas Document B focuses on drug feedback mechanisms and therapy. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:05.324172Z"}
{"comparison_id":"44beb953-079e-4be8-89b9-2e14d060769c","query_id":"53","doc_a_id":"5270265","doc_b_id":"8774475","presented_order":["5270265","8774475"],"winner_id":"8774475","reasoning":"Document B is more relevant — it addresses factors (cell polarity, tumorigenesis) tied to breast cancer progression and prognosis, whereas A focuses on trastuzumab resistance via SRC in HER2+ cases. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:05.324180Z"}
{"comparison_id":"856a5af9-5386-4e00-9a1b-8116eefa606c","query_id":"53","doc_a_id":"9600826","doc_b_id":"8774475","presented_order":["8774475","9600826"],"winner_id":"8774475","reasoning":"Document A is more relevant — it directly addresses mammary tumorigenesis and mechanisms in breast cancer, whereas B focuses on angiogenesis/invasion pathways not related to ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:05.324187Z"}
{"comparison_id":"5270c27a-bde2-4f20-a28f-8335b425b3b4","query_id":"53","doc_a_id":"164985","doc_b_id":"8774475","presented_order":["8774475","164985"],"winner_id":"8774475","reasoning":"Document A is more relevant — it addresses mammary tumorigenesis and cancer cell biology in breast tissue, whereas B focuses on macrophage IL-6 regulation and M2d polarization, which is less directly related to ALDH1 expression or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:05.324194Z"}
{"comparison_id":"3c65a3ea-ec4f-453d-9e2e-a33db4f98377","query_id":"53","doc_a_id":"2061878","doc_b_id":"13007205","presented_order":["13007205","2061878"],"winner_id":"2061878","reasoning":"Document B is more relevant — it discusses a molecular marker whose overexpression correlates with poor prognosis in solid tumors, which is closer to the claim about marker expression and breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:08.393378Z"}
{"comparison_id":"4b77584c-706a-4cc5-8659-58919ef5326f","query_id":"53","doc_a_id":"4820792","doc_b_id":"23863551","presented_order":["23863551","4820792"],"winner_id":"4820792","reasoning":"Neither abstract mentions ALDH1. Document B is slightly more relevant because it addresses survival pathways and therapy resistance (which relate to poor prognosis), whereas A focuses on feedback HER3 upregulation after PI3K inhibition.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:14.691080Z"}
{"comparison_id":"4c285db3-4455-4a2c-ada4-ee8cfd8c0dcb","query_id":"53","doc_a_id":"15721252","doc_b_id":"23863551","presented_order":["23863551","15721252"],"winner_id":"15721252","reasoning":"Document B is more relevant — it discusses molecular markers in breast cancer (predicting therapy response), which is closer to a claim about a prognostic biomarker than Document A's focus on PI3K/HER3 feedback and combination therapy. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:14.691103Z"}
{"comparison_id":"86481fb7-1c59-4c33-8c63-8abf7830dc39","query_id":"53","doc_a_id":"164985","doc_b_id":"23863551","presented_order":["164985","23863551"],"winner_id":"164985","reasoning":"Document A is more relevant — it discusses mechanisms that promote tumor progression in a breast cancer model (4T1), which is closer to prognosis-related factors than Document B's focus on PI3K/HER3 feedback and drug resistance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:14.691112Z"}
{"comparison_id":"09f913ce-6deb-42e0-bb27-6f5dc18931d5","query_id":"53","doc_a_id":"5270265","doc_b_id":"23863551","presented_order":["23863551","5270265"],"winner_id":"5270265","reasoning":"Neither document mentions ALDH1 or directly addresses prognosis. If forced to choose the slightly more relevant one, pick B because it discusses treatment outcomes and resistance pathways that relate to clinical prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:14.691120Z"}
{"comparison_id":"acd2baee-fed0-40f3-85be-5e94096f6f10","query_id":"53","doc_a_id":"9600826","doc_b_id":"23863551","presented_order":["9600826","23863551"],"winner_id":"9600826","reasoning":"Document A is more relevant — it discusses pathways overexpressed in breast cancer that drive invasion and angiogenesis, which relate to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:14.691127Z"}
{"comparison_id":"07f69649-003d-433a-b719-3ca9605b121b","query_id":"53","doc_a_id":"4820792","doc_b_id":"164985","presented_order":["4820792","164985"],"winner_id":"4820792","reasoning":"Neither abstract mentions ALDH1, but Document A deals directly with breast cancer cell survival and therapy resistance (more related to prognosis) whereas Document B focuses on macrophage behavior. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:21.739041Z"}
{"comparison_id":"170d7792-882c-46d4-9eca-dd3f5a50197a","query_id":"53","doc_a_id":"15721252","doc_b_id":"164985","presented_order":["164985","15721252"],"winner_id":"164985","reasoning":"Document A is more relevant — it describes mechanisms that promote breast tumor progression (M2d macrophages supporting tumor growth), which relates to prognosis; Document B focuses on drug sensitivity in ER+ cell lines rather than prognostic markers. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:21.739063Z"}
{"comparison_id":"4986f3c6-4608-4e90-9a7e-7481789d0cfa","query_id":"53","doc_a_id":"9600826","doc_b_id":"164985","presented_order":["9600826","164985"],"winner_id":"9600826","reasoning":"Document A is more relevant — it discusses a molecular pathway overexpressed in breast cancer that promotes invasion, angiogenesis and metastasis, which relates to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:21.739072Z"}
{"comparison_id":"2e508cac-07b8-47ef-b978-0f603e595113","query_id":"53","doc_a_id":"5270265","doc_b_id":"164985","presented_order":["5270265","164985"],"winner_id":"5270265","reasoning":"Reason: Document A deals directly with breast cancer treatment outcomes and factors influencing prognosis, whereas Document B focuses on macrophage behavior and cytokine expression rather than prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:21.739080Z"}
{"comparison_id":"0f621be4-1937-42f5-8cee-df38f1b86382","query_id":"53","doc_a_id":"4820792","doc_b_id":"9600826","presented_order":["9600826","4820792"],"winner_id":"9600826","reasoning":"Document A is more relevant — it discusses pathways linked to invasion, angiogenesis and aggressive breast cancer behavior, which relates to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:27.596252Z"}
{"comparison_id":"bd67d9a6-4084-4a0b-9dbc-65f287c94a4a","query_id":"53","doc_a_id":"5270265","doc_b_id":"9600826","presented_order":["5270265","9600826"],"winner_id":"9600826","reasoning":"Reason: Neither abstract mentions ALDH1, but Document B discusses pathways driving invasion/angiogenesis (which relate to metastasis and prognosis), making it marginally more relevant to a claim about a prognostic marker.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:27.596272Z"}
{"comparison_id":"485f0c90-bdb7-4905-8342-358854c47bab","query_id":"53","doc_a_id":"4820792","doc_b_id":"5270265","presented_order":["5270265","4820792"],"winner_id":"4820792","reasoning":"Document B is more relevant — it addresses alternative survival pathways and therapy resistance in breast cancer, which is more closely related to markers (like ALDH1) linked to poor prognosis than the SRC-targeting focus in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:33.599919Z"}
{"comparison_id":"5b117f8a-34b3-4d75-ac45-86ea7c0c584d","query_id":"53","doc_a_id":"21439640","doc_b_id":"24249915","presented_order":["21439640","24249915"],"winner_id":"24249915","reasoning":"Neither document mentions ALDH1. Both are unrelated, but Document B (ERβ expression changes tied to invasiveness) is marginally more relevant to expression–prognosis relationships in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:40.413720Z"}
{"comparison_id":"3977a503-37fc-4678-aaca-b945639eacbc","query_id":"53","doc_a_id":"32001951","doc_b_id":"24249915","presented_order":["32001951","24249915"],"winner_id":"24249915","reasoning":"Document B is more relevant — it examines expression changes in invasive breast cancer tissue (clinical context), while A is an in vitro study of alkaline phosphatase unrelated to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:40.413740Z"}
{"comparison_id":"e828d490-9501-409f-9982-6d354fa6bf2f","query_id":"53","doc_a_id":"13030852","doc_b_id":"24249915","presented_order":["24249915","13030852"],"winner_id":"24249915","reasoning":"Document A is more relevant — it concerns marker expression changes in breast cancer (ER beta), which is closer to a claim about marker expression and prognosis than Document B's focus on alkaline phosphatase for metastasis detection.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:40.413749Z"}
{"comparison_id":"e5414ebd-95b0-48fd-9919-d5fbd096fa08","query_id":"53","doc_a_id":"5500086","doc_b_id":"24249915","presented_order":["5500086","24249915"],"winner_id":"5500086","reasoning":"Document A is more relevant — it links tumor molecular signatures to clinical outcomes in breast cancer, whereas Document B focuses on ERβ expression and methylation without addressing prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:40.413757Z"}
{"comparison_id":"885f9c0c-08bf-4376-8cca-e12347325574","query_id":"53","doc_a_id":"13290521","doc_b_id":"24249915","presented_order":["24249915","13290521"],"winner_id":"24249915","reasoning":"Document A is more relevant — it directly studies expression changes in breast cancer tissue and biomarkers, whereas Document B is a general review of miR-7 not specific to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:40.413765Z"}
{"comparison_id":"36652ff2-aaf8-4271-9eaf-1fae32c2aad2","query_id":"53","doc_a_id":"5864770","doc_b_id":"24249915","presented_order":["5864770","24249915"],"winner_id":"24249915","reasoning":"Document B — it discusses expression changes of a breast cancer marker (ERβ) and invasive disease, which is more related to expression–prognosis questions than Document A's hormonal risk overview.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:40.413773Z"}
{"comparison_id":"5a5c2088-0bad-400d-ac09-bcbd270c2325","query_id":"53","doc_a_id":"1389264","doc_b_id":"24249915","presented_order":["24249915","1389264"],"winner_id":"24249915","reasoning":"Document A is more relevant — it discusses changes in marker expression in invasive breast cancer and implications for tumor behavior, which is closer to a prognosis-related biomarker than the therapy-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:40.413781Z"}
{"comparison_id":"0dd63bca-cd4d-4fa2-ab0f-9addf6b33325","query_id":"53","doc_a_id":"6550579","doc_b_id":"24249915","presented_order":["24249915","6550579"],"winner_id":"24249915","reasoning":"Document A is more relevant — it discusses expression of a molecular marker in breast cancer (loss of ERβ), which is closer to the claim about a marker (ALDH1) and prognosis; Document B focuses on HER2/HER3-targeted therapy. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:40.413789Z"}
{"comparison_id":"cefc0310-1d90-455c-8b94-86be707bfe9e","query_id":"53","doc_a_id":"10279084","doc_b_id":"24249915","presented_order":["10279084","24249915"],"winner_id":"24249915","reasoning":"Document B is more relevant — it addresses expression changes of a marker (ERβ) in invasive breast cancer and links to disease progression, whereas A concerns a MAP kinase phosphatase splice variant unrelated to ALDH1 or prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:40.413796Z"}
{"comparison_id":"f957255f-f895-489b-b7dc-5fcca9343d34","query_id":"53","doc_a_id":"21439640","doc_b_id":"13290521","presented_order":["21439640","13290521"],"winner_id":"21439640","reasoning":"Document A is more relevant because it directly addresses mechanisms in breast cancer and tumor progression, whereas Document B discusses miR-7 across various tissues and not specifically ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:49.367125Z"}
{"comparison_id":"416c5b3f-8df1-4a46-9420-fcdfc191ddb3","query_id":"53","doc_a_id":"32001951","doc_b_id":"13290521","presented_order":["32001951","13290521"],"winner_id":"13290521","reasoning":"Document B. It discusses biomarkers and prognostic roles in cancer (relevant to claims about prognostic associations), while A focuses on alkaline phosphatase regulation in a cell line and not on ALDH1 or prognosis.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:49.367147Z"}
{"comparison_id":"cd51d076-e7a4-42cf-b773-7171506d3b88","query_id":"53","doc_a_id":"13030852","doc_b_id":"13290521","presented_order":["13290521","13030852"],"winner_id":"13030852","reasoning":"Document B is more relevant — it deals specifically with breast cancer biomarkers and prognosis/monitoring, whereas A discusses miR-7 broadly and does not address breast cancer prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:49.367157Z"}
{"comparison_id":"9c662ac1-f4aa-4472-8f88-28198fee73ea","query_id":"53","doc_a_id":"10279084","doc_b_id":"13290521","presented_order":["13290521","10279084"],"winner_id":"10279084","reasoning":"Document B — it specifically discusses molecular changes in breast cancer context (MAP kinase phosphatase-2 splice variant), whereas Document A is a general review of miR-7 not linked to ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:49.367165Z"}
{"comparison_id":"8bbad6b4-48ec-4627-9ded-97f0f75a4c14","query_id":"53","doc_a_id":"5864770","doc_b_id":"13290521","presented_order":["5864770","13290521"],"winner_id":"5864770","reasoning":"Document A is more relevant because it discusses breast cancer biology specifically, whereas Document B focuses on microRNA-7 across multiple tissues and diseases without specific relation to breast cancer markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:49.367172Z"}
{"comparison_id":"f7482b42-d4a9-4483-a46e-ea41616cab1a","query_id":"53","doc_a_id":"1389264","doc_b_id":"13290521","presented_order":["13290521","1389264"],"winner_id":"1389264","reasoning":"Document B is more relevant — it specifically concerns breast cancer (therapeutic response and biomarkers), whereas Document A is a general review of miR-7 not focused on ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:49.367179Z"}
{"comparison_id":"b8388b67-07b1-4275-9421-80445d7c21b9","query_id":"53","doc_a_id":"6550579","doc_b_id":"13290521","presented_order":["13290521","6550579"],"winner_id":"13290521","reasoning":"Document A is more relevant — it discusses molecular markers and prognostic/diagnostic roles in cancer, which is closer to the claim about ALDH1 as a prognostic marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:49.367186Z"}
{"comparison_id":"20df10de-d403-46b1-8af8-43d71ee5d691","query_id":"53","doc_a_id":"21439640","doc_b_id":"10279084","presented_order":["21439640","10279084"],"winner_id":"21439640","reasoning":"Document A is more relevant — it discusses mechanisms contributing to tumor progression in breast cancer, which relates to prognosis, whereas Document B focuses on a MAPK phosphatase splice variant without linking to prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:54.993655Z"}
{"comparison_id":"ca4f5495-e528-4ca9-9236-6330f20c23d7","query_id":"53","doc_a_id":"13030852","doc_b_id":"10279084","presented_order":["10279084","13030852"],"winner_id":"13030852","reasoning":"Document B is more relevant — it deals with markers tied to metastasis and patient management/prognosis in breast cancer, whereas A describes a MAPK phosphatase splice variant without relation to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:54.993676Z"}
{"comparison_id":"b9480a9a-62ae-4d54-86b6-05349403f872","query_id":"53","doc_a_id":"1389264","doc_b_id":"10279084","presented_order":["10279084","1389264"],"winner_id":"10279084","reasoning":"Doc A is marginally more relevant because it discusses molecular alterations in breast cancer cells, whereas Doc B focuses on therapy for HER2+ brain metastases and not on marker expression or prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:54.993685Z"}
{"comparison_id":"3ca19440-3723-48af-b12f-d711fd4df861","query_id":"53","doc_a_id":"5864770","doc_b_id":"10279084","presented_order":["5864770","10279084"],"winner_id":"10279084","reasoning":"Neither document mentions ALDH1 or directly addresses prognosis. Document B is slightly more relevant because it discusses molecular changes in cancer (including breast cancer), whereas A focuses on hormones and risk rather than molecular prognostic markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:54.993693Z"}
{"comparison_id":"85ebf0a4-8e1a-4fc2-99a0-08f661cc9def","query_id":"53","doc_a_id":"21439640","doc_b_id":"13030852","presented_order":["13030852","21439640"],"winner_id":"21439640","reasoning":"Document B is more relevant — it addresses molecular mechanisms (tumor-promoting pathways) tied to breast cancer progression and prognosis, whereas A focuses on alkaline phosphatase for metastasis detection and not molecular prognostic markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:45:59.615513Z"}
{"comparison_id":"5b467e93-aa1d-4d8c-9d0a-915d55bb34a8","query_id":"53","doc_a_id":"1389264","doc_b_id":"5864770","presented_order":["5864770","1389264"],"winner_id":"1389264","reasoning":"Document B is more relevant. Neither mentions ALDH1, but B addresses treatment response and biomarkers/prognosis in breast cancer, whereas A focuses on hormonal regulation and risk. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:04.528687Z"}
{"comparison_id":"e6b1bd98-2b9a-413c-803e-7133745e5db7","query_id":"53","doc_a_id":"32001951","doc_b_id":"6550579","presented_order":["6550579","32001951"],"winner_id":"32001951","reasoning":"Document B is more relevant — it addresses enzyme expression regulation in breast cancer (though ALP, not ALDH1), whereas Document A focuses on HER2/HER3 targeted therapy. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:14.181723Z"}
{"comparison_id":"a1569235-bd64-4a43-b801-4ddb4de1794e","query_id":"53","doc_a_id":"8037453","doc_b_id":"26231129","presented_order":["8037453","26231129"],"winner_id":"8037453","reasoning":"Document A is more relevant — it discusses prognostic biomarker associations in cancer patients, whereas B is a general framework on residual disease and not about biomarker prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:20.111070Z"}
{"comparison_id":"9a7b2333-b218-4b0b-a54d-7ebdd02c5aa2","query_id":"53","doc_a_id":"17755060","doc_b_id":"26231129","presented_order":["26231129","17755060"],"winner_id":"17755060","reasoning":"Document B is more relevant — it links expression of metabolic enzymes to prognosis in human cancers, which is closer to the claim about a biomarker's association with breast cancer outcome.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:20.111092Z"}
{"comparison_id":"e10566b4-48f1-4388-b4e4-cb0ae0ea88d4","query_id":"53","doc_a_id":"4999633","doc_b_id":"26231129","presented_order":["4999633","26231129"],"winner_id":"4999633","reasoning":"Document A is directly about breast cancer cell biology (MCF-7 cells), whereas B is a broad framework for solid tumors and neither mentions ALDH1; A is therefore slightly more relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:20.111101Z"}
{"comparison_id":"4d35303d-4a0b-426e-b415-e9e4c2fd6949","query_id":"53","doc_a_id":"40127292","doc_b_id":"26231129","presented_order":["26231129","40127292"],"winner_id":"26231129","reasoning":"Document A is slightly more relevant — it addresses residual disease and targeting in solid cancers, which is closer to prognostic markers like ALDH1 in breast cancer than the apoptosis-focused transgenic model discussion in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:20.111109Z"}
{"comparison_id":"a70311f5-787a-4d53-9987-1a139d2438e2","query_id":"53","doc_a_id":"22267225","doc_b_id":"26231129","presented_order":["22267225","26231129"],"winner_id":"26231129","reasoning":"Reason: Document B discusses molecular bases of residual disease and targeting oncogene-driven cancers, which is more likely to address biomarkers (like ALDH1) and prognostic associations than a broad chemoprevention overview.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:20.111117Z"}
{"comparison_id":"cf6ad2e4-eb84-49e3-bd29-af1bc6a63245","query_id":"53","doc_a_id":"15559582","doc_b_id":"26231129","presented_order":["26231129","15559582"],"winner_id":"26231129","reasoning":"Document A is more relevant — it discusses molecular markers and residual disease in solid tumors, which is more likely to address ALDH1 and prognosis than a study about plasma lipids and prolactin. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:20.111125Z"}
{"comparison_id":"9f6a93b8-6d92-43b7-a471-f31d7f764718","query_id":"53","doc_a_id":"24144677","doc_b_id":"26231129","presented_order":["24144677","26231129"],"winner_id":"24144677","reasoning":"Document A is more focused on breast cancer-specific molecular markers and risk, whereas Document B is a general framework about residual disease in solid tumors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:20.111132Z"}
{"comparison_id":"43d20f5e-775d-4012-96ca-c717ef1704db","query_id":"53","doc_a_id":"67045088","doc_b_id":"26231129","presented_order":["26231129","67045088"],"winner_id":"26231129","reasoning":"Document A is more relevant — it discusses molecular basis of residual disease and prognostic/therapeutic markers in solid tumors, whereas Document B focuses on DPP4/IL-33–eosinophil tumor control and not on ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:20.111140Z"}
{"comparison_id":"385cdb9b-05a1-4664-a70c-9ff160e4ba7e","query_id":"53","doc_a_id":"6969753","doc_b_id":"26231129","presented_order":["6969753","26231129"],"winner_id":"26231129","reasoning":"Document B is more relevant — it addresses molecular markers and prognosis/residual disease in solid tumors, while Document A focuses on invadopodia mechanics (cortactin/MT1‑MMP) and not prognostic markers like ALDH1.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:20.111148Z"}
{"comparison_id":"465b7d49-7748-498b-94e2-6203645c35fe","query_id":"53","doc_a_id":"8037453","doc_b_id":"17755060","presented_order":["8037453","17755060"],"winner_id":"17755060","reasoning":"Reason: Document B discusses molecular markers and prognosis in tumorigenesis across human cancers, making it more related to biomarker–prognosis links than Document A, which focuses on bone turnover markers in patients treated with zoledronic acid.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:24.585817Z"}
{"comparison_id":"a8339b5c-23cb-4da1-85f9-0426b0ea7f49","query_id":"53","doc_a_id":"24144677","doc_b_id":"17755060","presented_order":["17755060","24144677"],"winner_id":"17755060","reasoning":"Document A is more relevant — it discusses tumorigenesis and prognosis in cancers, whereas Document B is about ATM mutations and risk, not prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:24.585839Z"}
{"comparison_id":"48a54c40-efe9-4875-840b-61400cf256cf","query_id":"53","doc_a_id":"4999633","doc_b_id":"17755060","presented_order":["4999633","17755060"],"winner_id":"4999633","reasoning":"Document A is more relevant — it concerns breast cancer (MCF-7 cells), whereas Document B addresses metabolic enzymes and prognosis in cancers generally but not breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:24.585847Z"}
{"comparison_id":"00f07fbe-ef41-4961-9801-2e54c38fb01f","query_id":"53","doc_a_id":"8037453","doc_b_id":"24144677","presented_order":["24144677","8037453"],"winner_id":"24144677","reasoning":"Document A is more relevant — it concerns breast cancer specifically (risk/prognosis context), whereas B addresses bone markers in metastatic cancer patients without ALDH1 or direct breast-cancer prognosis data. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:28.232682Z"}
{"comparison_id":"4222d3c8-002a-427f-afcc-8e1e50c2034d","query_id":"53","doc_a_id":"40127292","doc_b_id":"15559582","presented_order":["40127292","15559582"],"winner_id":"40127292","reasoning":"Document A is more relevant — it addresses cancer biology, apoptosis and chemoresistance which are related to biomarkers like ALDH1 and clinical outcome; Document B focuses on lipids/prolactin and not ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:32.992445Z"}
{"comparison_id":"e4db244d-b025-4bc0-a697-0738c25439e7","query_id":"53","doc_a_id":"22267225","doc_b_id":"15559582","presented_order":["22267225","15559582"],"winner_id":"15559582","reasoning":"Document B — it reports biomarker levels and links to invasive/poorly differentiated breast cancer, which is closer to prognosis-related evidence than the general chemoprevention review in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:32.992465Z"}
{"comparison_id":"daf2cd24-4511-4b3d-ab21-80400de0e437","query_id":"53","doc_a_id":"6969753","doc_b_id":"15559582","presented_order":["15559582","6969753"],"winner_id":"15559582","reasoning":"Document A is more relevant — it deals with clinical biomarkers and prognosis in breast cancer, while Document B focuses on cellular mechanisms of invasion and does not relate to prognosis markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:32.992474Z"}
{"comparison_id":"9ed4f5f2-6de1-4260-8d47-5953f208ced1","query_id":"53","doc_a_id":"67045088","doc_b_id":"15559582","presented_order":["15559582","67045088"],"winner_id":"67045088","reasoning":"Neither abstract mentions ALDH1, but Document B discusses tumor growth control and immune-related effects in breast cancer (more directly related to prognosis/mechanisms) whereas A focuses on lipids/prolactin. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:32.992494Z"}
{"comparison_id":"d3d3dc52-896e-43e5-9b01-52c347b80299","query_id":"53","doc_a_id":"40127292","doc_b_id":"67045088","presented_order":["40127292","67045088"],"winner_id":"40127292","reasoning":"Reason: Neither mentions ALDH1, but Document A discusses chemoresistance and cancer models (more directly related to markers linked to prognosis and resistance) while Document B focuses on DPP4/IL-33–eosinophil tumor control.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:39.102738Z"}
{"comparison_id":"10a3e100-3892-4022-b9a8-09a514b05aef","query_id":"53","doc_a_id":"22267225","doc_b_id":"6969753","presented_order":["22267225","6969753"],"winner_id":"22267225","reasoning":"Document A mentions breast cancer and broader clinical outcomes, whereas Document B focuses on invadopodia mechanics (cortactin/MT1‑MMP) and not ALDH1 or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:42.711788Z"}
{"comparison_id":"bf7757c3-b87f-4b2f-92a9-caa91e89161d","query_id":"53","doc_a_id":"8671456","doc_b_id":"31616203","presented_order":["31616203","8671456"],"winner_id":"8671456","reasoning":"Neither document mentions ALDH1 or prognosis directly; Document B is slightly more relevant because it addresses breast cancer tumor growth and survival outcomes, whereas A focuses narrowly on lapatinib for HER2+ brain metastases. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:46.352103Z"}
{"comparison_id":"7e819b0f-c74c-49aa-90d9-8150e3dc3fbb","query_id":"53","doc_a_id":"195680777","doc_b_id":"31616203","presented_order":["195680777","31616203"],"winner_id":"195680777","reasoning":"Document A is more relevant — it addresses prognosis and long-term outcomes in breast cancer broadly, whereas Document B focuses on a specific drug trial for HER2+ brain metastases. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:46.352127Z"}
{"comparison_id":"a213b90f-4379-4f9b-a822-f84c6e5fd661","query_id":"53","doc_a_id":"16691520","doc_b_id":"31616203","presented_order":["31616203","16691520"],"winner_id":"16691520","reasoning":"Document B is more relevant — it addresses genome-wide gene regulation in breast cancer and is more likely to discuss gene expression markers (like ALDH1) and their implications than a clinical trial of lapatinib. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:46.352136Z"}
{"comparison_id":"aa9998a3-51f7-463c-8076-680261c06f11","query_id":"53","doc_a_id":"2015126","doc_b_id":"31616203","presented_order":["31616203","2015126"],"winner_id":"31616203","reasoning":"Document A is slightly more relevant because it discusses breast cancer treatment outcomes and prognosis-related measures, whereas Document B focuses on genetic-risk management rather than tumor biomarkers or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:46.352144Z"}
{"comparison_id":"0f5ab6bc-297b-43fd-8be5-c10b027db64a","query_id":"53","doc_a_id":"8671456","doc_b_id":"195680777","presented_order":["8671456","195680777"],"winner_id":"8671456","reasoning":"Neither document discusses ALDH1 or prognostic biomarkers. Document A is slightly more related because it addresses tumor biology and survival in breast cancer models. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:51.281140Z"}
{"comparison_id":"92309d52-baa5-47ac-bde8-ae490f0b868f","query_id":"53","doc_a_id":"16691520","doc_b_id":"195680777","presented_order":["16691520","195680777"],"winner_id":"16691520","reasoning":"Document A is more relevant — it studies gene regulation and target genes in breast cancer cells, which could include biomarkers like ALDH1 relevant to prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:51.281163Z"}
{"comparison_id":"6c470d9a-f675-417f-9573-56c510165830","query_id":"53","doc_a_id":"8671456","doc_b_id":"16691520","presented_order":["16691520","8671456"],"winner_id":"16691520","reasoning":"Document A is more relevant — it analyzes gene binding and target genes in breast cancer (more likely to address ALDH1 expression and its prognostic relevance), while Document B focuses on a therapeutic virus and not prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:46:55.422383Z"}
{"comparison_id":"72a96f5c-6cf2-4c54-b74b-7b4dc98a9404","query_id":"53","doc_a_id":"20454006","doc_b_id":"878526","presented_order":["878526","20454006"],"winner_id":"878526","reasoning":"Document A is more relevant — it addresses mechanisms of metastasis and prognosis-related processes in breast cancer, whereas Document B focuses on tamoxifen biomarker modulation unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:04.127264Z"}
{"comparison_id":"3fa46b69-7baa-49e3-a68b-bbcd1579b68e","query_id":"53","doc_a_id":"1554348","doc_b_id":"878526","presented_order":["1554348","878526"],"winner_id":"878526","reasoning":"Document B is more relevant — it discusses metastatic behavior and therapeutic implications in breast cancer, which relates to prognosis, whereas Document A focuses on cellular enzyme and stress proteins in MCF-7 cells and not prognosis or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:04.127285Z"}
{"comparison_id":"cd31c6f4-b615-43bb-9712-a6074360b4b5","query_id":"53","doc_a_id":"3329824","doc_b_id":"878526","presented_order":["878526","3329824"],"winner_id":"878526","reasoning":"Document A — it concerns mechanisms of breast cancer metastasis (more related to prognosis) while Document B focuses narrowly on CNS recurrence risk in HER2+ patients and trastuzumab. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:04.127294Z"}
{"comparison_id":"c18a8648-0a90-4e71-a7e4-f3455c5d79b4","query_id":"53","doc_a_id":"25523969","doc_b_id":"878526","presented_order":["25523969","878526"],"winner_id":"878526","reasoning":"Reason: Document B addresses metastasis-initiating breast cancer cells (related to stem-cell markers like ALDH1) and metastatic prognosis, so it's more likely relevant than A, which focuses on miRNA profiles.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:04.127301Z"}
{"comparison_id":"adda7f74-c59d-4fc3-96dc-7bab79a36cb5","query_id":"53","doc_a_id":"4886637","doc_b_id":"878526","presented_order":["4886637","878526"],"winner_id":"878526","reasoning":"Document B is more relevant — it discusses metastasis-initiating breast cancer cells (related to markers like ALDH1), whereas Document A focuses on diabetes/metabolic syndrome and cancer risk.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:04.127309Z"}
{"comparison_id":"06739852-dcfd-48f9-b251-e73106b18e6c","query_id":"53","doc_a_id":"22975806","doc_b_id":"878526","presented_order":["878526","22975806"],"winner_id":"878526","reasoning":"Document A is more relevant — it addresses metastatic behavior and tumor microenvironment factors linked to poor outcomes in breast cancer, whereas Document B focuses on BRCA allele loss unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:04.127317Z"}
{"comparison_id":"61e6b94d-9f18-400e-9a5a-8b7329ce784c","query_id":"53","doc_a_id":"27647593","doc_b_id":"878526","presented_order":["878526","27647593"],"winner_id":"878526","reasoning":"Doc A is more focused on metastatic behavior of breast cancer cells (including metastasis-initiating cells), which is more directly related to prognosis and stem-cell markers like ALDH1 than the metabolic/stromal focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:04.127324Z"}
{"comparison_id":"1702f7a4-7bc5-4687-95b4-2c9f3865bd8c","query_id":"53","doc_a_id":"7875158","doc_b_id":"878526","presented_order":["7875158","878526"],"winner_id":"878526","reasoning":"Document B — it discusses metastasis-initiating breast cancer cells and factors affecting metastatic outcome, which is more closely related to prognosis and stem-like tumor cell behavior than Document A's focus on glucose deprivation and MAPK in drug-resistant cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:04.127332Z"}
{"comparison_id":"74312e7e-de2e-4398-a8fe-750548073140","query_id":"53","doc_a_id":"17163294","doc_b_id":"878526","presented_order":["17163294","878526"],"winner_id":"878526","reasoning":"Document B is more relevant — it addresses mechanisms of breast cancer metastasis and metastasis-initiating cells, which is closer to prognosis-related markers like ALDH1 than metabolic phenotyping of blood plasma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:04.127339Z"}
{"comparison_id":"1e399710-aea0-4488-9895-ecbbcc85de62","query_id":"53","doc_a_id":"11880289","doc_b_id":"878526","presented_order":["878526","11880289"],"winner_id":"878526","reasoning":"Document A is more related to tumor biology and metastatic behavior relevant to prognosis, whereas Document B is about screening outcomes and not biomarker expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:04.127346Z"}
{"comparison_id":"5833789c-256f-452a-9d99-fcd6b7b6c5f6","query_id":"53","doc_a_id":"15600979","doc_b_id":"878526","presented_order":["15600979","878526"],"winner_id":"878526","reasoning":"Neither abstract mentions ALDH1. Document B is marginally more relevant because it addresses mechanisms of metastasis and factors affecting breast cancer prognosis, whereas A focuses on DNA-repair pathway disruption. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:04.127353Z"}
{"comparison_id":"331d419c-5c5d-4cce-9a61-eadec1278cff","query_id":"53","doc_a_id":"23576165","doc_b_id":"878526","presented_order":["878526","23576165"],"winner_id":"878526","reasoning":"Document A is more relevant because it discusses metastasis-initiating breast cancer cells and factors affecting metastatic outcome, which relates to prognosis and cancer stem–like cells (ALDH1 is a stem cell marker); Document B focuses on stromal metabolism, less directly connected.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:04.127361Z"}
{"comparison_id":"e6245586-182a-4b4f-9014-7ad99ee0a251","query_id":"53","doc_a_id":"20454006","doc_b_id":"22975806","presented_order":["22975806","20454006"],"winner_id":"22975806","reasoning":"Document A is more relevant — it addresses breast tumor biology and clinical implications, whereas Document B focuses on a supplement's effect on tamoxifen metabolism and not prognostic biomarkers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:10.683018Z"}
{"comparison_id":"c0c22df3-a1e7-4130-bebd-6e895b17d774","query_id":"53","doc_a_id":"1554348","doc_b_id":"22975806","presented_order":["1554348","22975806"],"winner_id":"1554348","reasoning":"Neither document addresses ALDH1. Document A is slightly more relevant because it studies enzyme expression in breast cancer cells (though it concerns alkaline phosphatase, not ALDH1). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:10.683039Z"}
{"comparison_id":"e9ba9e5c-3a0d-49ac-8238-e7fb290912a1","query_id":"53","doc_a_id":"3329824","doc_b_id":"22975806","presented_order":["22975806","3329824"],"winner_id":"22975806","reasoning":"Document A is marginally more relevant because it discusses breast tumorigenesis and clinical implications, whereas Document B focuses on CNS metastases in HER2-positive patients treated with trastuzumab and does not address ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:10.683048Z"}
{"comparison_id":"711c43db-d34a-4969-87f1-e89743f13442","query_id":"53","doc_a_id":"25523969","doc_b_id":"22975806","presented_order":["25523969","22975806"],"winner_id":"25523969","reasoning":"Document A is more relevant — it discusses molecular markers and immunohistochemical analysis related to metastasis and prognosis, whereas Document B focuses on BRCA allele loss unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:10.683055Z"}
{"comparison_id":"7bc69a0b-7cf1-4f77-aa18-310bad5cf6df","query_id":"53","doc_a_id":"4886637","doc_b_id":"22975806","presented_order":["4886637","22975806"],"winner_id":"22975806","reasoning":"Reason: Document B discusses molecular/genetic features and clinical implications of breast tumorigenesis, which is closer to prognosis-related biomarkers than Document A's focus on diabetes/metabolic risk.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:10.683063Z"}
{"comparison_id":"86312675-8462-45c5-8e16-b24c83c5881f","query_id":"53","doc_a_id":"23576165","doc_b_id":"22975806","presented_order":["22975806","23576165"],"winner_id":"22975806","reasoning":"Document A is more relevant — it directly addresses breast cancer biology and clinical implications, whereas Document B focuses on tumor metabolism generally and not breast-specific prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:10.683070Z"}
{"comparison_id":"918cbadb-14a2-47b4-a457-a7d7c9a69136","query_id":"53","doc_a_id":"27647593","doc_b_id":"22975806","presented_order":["27647593","22975806"],"winner_id":"27647593","reasoning":"Document A is more relevant — it discusses tumor metabolism and microenvironment factors that relate to markers like ALDH1, whereas Document B focuses on BRCA allele loss and is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:10.683078Z"}
{"comparison_id":"e5fdfdc5-735e-4950-8fb3-231a21ded89f","query_id":"53","doc_a_id":"7875158","doc_b_id":"22975806","presented_order":["7875158","22975806"],"winner_id":"22975806","reasoning":"Document B is more relevant — it addresses clinical/tumorigenesis aspects of breast cancer, closer to prognosis-related questions than the cell-stress mechanistic study in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:10.683084Z"}
{"comparison_id":"52b956d8-7b3d-4080-8e1e-67fdaf511847","query_id":"53","doc_a_id":"17163294","doc_b_id":"22975806","presented_order":["17163294","22975806"],"winner_id":"22975806","reasoning":"B is more relevant — it addresses breast cancer biology and prognosis-related tumorigenesis, whereas A is about plasma metabolite classification across cancer types. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:10.683093Z"}
{"comparison_id":"5b6cbdd2-5b22-4ad4-9c3e-a4645f820117","query_id":"53","doc_a_id":"11880289","doc_b_id":"22975806","presented_order":["22975806","11880289"],"winner_id":"22975806","reasoning":"Document A is more relevant — it addresses molecular biology of breast tumorigenesis (closer to marker/prognosis topics) while Document B is a screening trial unrelated to ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:10.683100Z"}
{"comparison_id":"1a761849-a781-4b19-b9da-6eb5dc3b63b0","query_id":"53","doc_a_id":"15600979","doc_b_id":"22975806","presented_order":["15600979","22975806"],"winner_id":"15600979","reasoning":"Neither document discusses ALDH1. Document A is slightly more relevant because it addresses biomarkers/overexpression and prognostic implications for breast cancer biology and therapy, while B focuses specifically on BRCA allele loss patterns. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:10.683107Z"}
{"comparison_id":"d8ae6c6d-fae6-456e-8ec7-ecaa96604633","query_id":"53","doc_a_id":"1554348","doc_b_id":"25523969","presented_order":["1554348","25523969"],"winner_id":"25523969","reasoning":"Document B is more relevant — it analyzes human metastatic cancers and potential prognostic markers, whereas Document A is an in vitro study of alkaline phosphatase and stress proteins in MCF-7 cells and does not address ALDH1 or clinical prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:17.903964Z"}
{"comparison_id":"30a28e57-248f-47c2-8c2b-bfdfb34ac3be","query_id":"53","doc_a_id":"15600979","doc_b_id":"25523969","presented_order":["25523969","15600979"],"winner_id":"15600979","reasoning":"Neither abstract mentions ALDH1. Document B is slightly more relevant because it discusses gene overexpression in the context of breast cancer biology, while A focuses on miRNA profiling of metastatic tumors more generally. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:17.903985Z"}
{"comparison_id":"a11be1d4-3f8b-4136-8b02-c3a8a5584410","query_id":"53","doc_a_id":"27647593","doc_b_id":"25523969","presented_order":["27647593","25523969"],"winner_id":"25523969","reasoning":"Document B is more relevant — it deals with molecular biomarkers and metastatic prognosis, whereas A focuses on stromal metabolism without addressing ALDH1 or prognostic markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:17.903993Z"}
{"comparison_id":"1e18c251-d21c-4886-b4c3-bc95e08da0e5","query_id":"53","doc_a_id":"1554348","doc_b_id":"27647593","presented_order":["1554348","27647593"],"winner_id":"27647593","reasoning":"Document B — it addresses tumor metabolism, stromal interactions and processes (autophagy, metastasis) more related to cancer progression and prognosis than Document A, which focuses on alkaline phosphatase and stress proteins in MCF-7 cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:22.876062Z"}
{"comparison_id":"fc45ba50-4e47-4365-a6a9-d9fdd8b16247","query_id":"53","doc_a_id":"20454006","doc_b_id":"23576165","presented_order":["23576165","20454006"],"winner_id":"20454006","reasoning":"Document B is more relevant — it's a clinical breast cancer study (patient biomarkers and treatment), whereas A discusses general tumor metabolism without linking to ALDH1 or prognosis.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:29.211827Z"}
{"comparison_id":"35ce868b-9556-4506-9e8c-de0cb4098633","query_id":"53","doc_a_id":"3329824","doc_b_id":"23576165","presented_order":["23576165","3329824"],"winner_id":"3329824","reasoning":"Document B is more relevant — it concerns clinical outcomes/prognosis in breast cancer (metastasis risk), while A discusses tumor metabolism and not ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:29.211849Z"}
{"comparison_id":"09c6e5c2-327e-4756-8986-79760e73a31a","query_id":"53","doc_a_id":"4886637","doc_b_id":"23576165","presented_order":["23576165","4886637"],"winner_id":"23576165","reasoning":"Reason: Both documents don't mention ALDH1, but Document A discusses tumor metabolic features and microenvironment relevant to cancer biology and prognosis, making it marginally more relevant than a diabetes/breast cancer risk review.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:29.211859Z"}
{"comparison_id":"da5bf786-8519-43c1-9bb6-9f66d8081610","query_id":"53","doc_a_id":"11880289","doc_b_id":"23576165","presented_order":["11880289","23576165"],"winner_id":"23576165","reasoning":"B is more relevant — it discusses tumor metabolic phenotype and microenvironment, which is closer to ALDH1's role as a metabolic/stemness marker, whereas A is about screening outcomes. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:29.211867Z"}
{"comparison_id":"0a144bc5-e370-4633-963d-058936d840a4","query_id":"53","doc_a_id":"7875158","doc_b_id":"23576165","presented_order":["23576165","7875158"],"winner_id":"7875158","reasoning":"Neither document addresses ALDH1 or clinical prognosis. Document B is slightly more relevant because it studies breast cancer cells and oxidative stress pathways (biologically closer to ALDH1's detoxifying role), whereas A is a general tumor metabolism review.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:29.211874Z"}
{"comparison_id":"cb0e6ed5-bfd7-4049-a0e3-b023a55d9890","query_id":"53","doc_a_id":"17163294","doc_b_id":"23576165","presented_order":["17163294","23576165"],"winner_id":"17163294","reasoning":"Reason: Neither abstract addresses ALDH1 or its prognostic role, but Document A specifically concerns breast cancer (while B is about general tumor metabolism), so A is marginally more related.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:29.211881Z"}
{"comparison_id":"b3a5623f-dd6f-41c1-a960-08d5442e4ab2","query_id":"53","doc_a_id":"20454006","doc_b_id":"3329824","presented_order":["3329824","20454006"],"winner_id":"20454006","reasoning":"Document B is more relevant — it deals with biomarker modulation in breast cancer, whereas A focuses on CNS metastases risk in HER2+ patients and does not address marker expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:32.488626Z"}
{"comparison_id":"3cc77045-d32e-4585-90ce-2d97e6d92146","query_id":"53","doc_a_id":"17163294","doc_b_id":"3329824","presented_order":["3329824","17163294"],"winner_id":"3329824","reasoning":"Document A is more relevant — it directly concerns outcomes in breast cancer (risk of CNS metastases), whereas Document B focuses on metabolite-based cancer type discrimination and not prognosis markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:32.488647Z"}
{"comparison_id":"6ce7ba6a-bfda-4bf1-b9ca-91e841f1cd5f","query_id":"53","doc_a_id":"7875158","doc_b_id":"3329824","presented_order":["3329824","7875158"],"winner_id":"7875158","reasoning":"Document B is slightly more relevant because it addresses cellular mechanisms and drug-resistant breast cancer cells (contexts where ALDH1 is often studied), whereas Document A focuses on CNS metastases after trastuzumab treatment. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:32.488656Z"}
{"comparison_id":"b4e0f9c4-0c44-4c8c-ac03-79d8d2c8eea2","query_id":"53","doc_a_id":"20454006","doc_b_id":"7875158","presented_order":["7875158","20454006"],"winner_id":"20454006","reasoning":"Document B is slightly more relevant — it's a clinical breast cancer study (patient biomarkers/prognosis context) versus Document A which is an in vitro cell-stress study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:35.746508Z"}
{"comparison_id":"ae485f74-385e-4747-9fe3-8bf92c7ff6cc","query_id":"53","doc_a_id":"4886637","doc_b_id":"11880289","presented_order":["11880289","4886637"],"winner_id":"4886637","reasoning":"Reason: Document B discusses breast cancer biology and risk factors (more likely to address prognostic markers) while Document A is about screening age and mortality, unrelated to ALDH1 expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:38.610948Z"}
{"comparison_id":"140a0f85-9a87-48d0-8e09-7ebd4b5bbf45","query_id":"53","doc_a_id":"24205118","doc_b_id":"16390264","presented_order":["16390264","24205118"],"winner_id":"16390264","reasoning":"Document A is more relevant because it concerns breast cancer (even though it doesn't address ALDH1), while Document B studies a different marker in cervical cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103395Z"}
{"comparison_id":"98581b5a-8834-4d33-b3a5-fddf832a27c3","query_id":"53","doc_a_id":"32721137","doc_b_id":"16390264","presented_order":["16390264","32721137"],"winner_id":"16390264","reasoning":"Document A is more relevant — it concerns breast cancer (though not ALDH1 specifically), while B addresses endometrial carcinoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103416Z"}
{"comparison_id":"6d3490fc-1a4a-418c-aa3b-2c7d89f001c1","query_id":"53","doc_a_id":"12358173","doc_b_id":"16390264","presented_order":["16390264","12358173"],"winner_id":"16390264","reasoning":"Document A is more relevant because it concerns breast cancer (patient outcomes), whereas Document B addresses a different marker in lung cancer and does not pertain to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103425Z"}
{"comparison_id":"e3ffb4d4-e7c7-42d2-9e9c-4241e6cb8da5","query_id":"53","doc_a_id":"31591262","doc_b_id":"16390264","presented_order":["31591262","16390264"],"winner_id":"31591262","reasoning":"Document A — it discusses gene expression associated with poor prognosis (though in rectal cancer and different genes, not ALDH1/breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103432Z"}
{"comparison_id":"e4e5466c-d2eb-4a9a-9f84-a4b1fe29b7ba","query_id":"53","doc_a_id":"2140497","doc_b_id":"16390264","presented_order":["16390264","2140497"],"winner_id":"2140497","reasoning":"Document B is more relevant — it addresses biological risk factors for breast cancer, whereas A concerns healthcare access disparities and not molecular prognostic markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103439Z"}
{"comparison_id":"f93febfd-aa79-4c13-bb89-21cccf906887","query_id":"53","doc_a_id":"9486930","doc_b_id":"16390264","presented_order":["9486930","16390264"],"winner_id":"9486930","reasoning":"Document A is more relevant — it discusses a stem-cell related \"self-renewal\" gene signature linked to treatment resistance/prognosis (closely related to markers like ALDH1), whereas Document B deals with health-care access, not molecular prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103446Z"}
{"comparison_id":"ff6d34a5-7592-48ea-85c1-d8d29f4b6227","query_id":"53","doc_a_id":"22521091","doc_b_id":"16390264","presented_order":["16390264","22521091"],"winner_id":"16390264","reasoning":"Document A. It concerns breast cancer (though not molecular markers), whereas B addresses a different cancer (HCC) and a different marker, so A is more relevant to a breast-cancer prognosis claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103453Z"}
{"comparison_id":"6e9c4509-0d77-4813-a380-f8a91a2d5fe6","query_id":"53","doc_a_id":"17021845","doc_b_id":"16390264","presented_order":["16390264","17021845"],"winner_id":"16390264","reasoning":"Document A — it concerns breast cancer (though not ALDH1 specifically), whereas Document B focuses on Nanog in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103459Z"}
{"comparison_id":"1065b7f5-ed13-4f29-aa4c-9c5a228f981a","query_id":"53","doc_a_id":"18340282","doc_b_id":"16390264","presented_order":["18340282","16390264"],"winner_id":"18340282","reasoning":"Document A is more relevant — it deals with genetic/molecular factors in breast cancer, which is closer to a biomarker/prognosis question than Document B's focus on healthcare access. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103466Z"}
{"comparison_id":"ae66159b-0f58-4b04-8002-a23d6ed7802b","query_id":"53","doc_a_id":"1782201","doc_b_id":"16390264","presented_order":["16390264","1782201"],"winner_id":"1782201","reasoning":"Document B — it discusses tumor molecular drivers and progression (more relevant to prognostic biomarker evidence) while A covers socioeconomic access to care, not molecular markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103473Z"}
{"comparison_id":"86187c13-cb7a-42ed-aba7-d3ae7e6ff79a","query_id":"53","doc_a_id":"52180874","doc_b_id":"16390264","presented_order":["16390264","52180874"],"winner_id":"16390264","reasoning":"Document A is more relevant — it specifically concerns breast cancer (where ALDH1's prognostic role would apply), while Document B focuses on PD-1/PD-L1 therapy across cancers and doesn't address ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103480Z"}
{"comparison_id":"4655ecc0-faba-4f64-9b7b-ec9be9414f23","query_id":"53","doc_a_id":"13765757","doc_b_id":"16390264","presented_order":["16390264","13765757"],"winner_id":"13765757","reasoning":"Document B is more relevant — it discusses breast cancer tumor characteristics (hormone-receptor status) related to risk/prognosis, whereas A covers healthcare access and admissions. Neither mentions ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103487Z"}
{"comparison_id":"4c66bd01-ed38-492f-bd78-3b2f05a96772","query_id":"53","doc_a_id":"3222187","doc_b_id":"16390264","presented_order":["3222187","16390264"],"winner_id":"3222187","reasoning":"Document A is more relevant — it's a molecular/genetic study in a breast cancer cohort (though about vitamin D–related genes), closer to biomarker/prognosis context than hospital access data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103494Z"}
{"comparison_id":"b4aa87c2-32da-46a5-8caf-f403e3eaeee2","query_id":"53","doc_a_id":"42106119","doc_b_id":"16390264","presented_order":["42106119","16390264"],"winner_id":"42106119","reasoning":"Document A is more relevant — it discusses stem cell–related proteins and cancer links, which is closer to molecular markers like ALDH1 than a study on healthcare access.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103501Z"}
{"comparison_id":"65cba8b6-e8e2-407b-97c0-67e1342f8b7a","query_id":"53","doc_a_id":"12438901","doc_b_id":"16390264","presented_order":["16390264","12438901"],"winner_id":"12438901","reasoning":"Document B is more relevant — it directly addresses breast cancer outcomes and prognosis, whereas Document A focuses on access to hospital care rather than prognostic biomarkers. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103509Z"}
{"comparison_id":"f62a13a4-6ffa-4478-a7d0-ae95be678f88","query_id":"53","doc_a_id":"3524352","doc_b_id":"16390264","presented_order":["16390264","3524352"],"winner_id":"3524352","reasoning":"Document B is more related to breast cancer prognosis (mortality clusters), while Document A concerns access to care. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103516Z"}
{"comparison_id":"6211ee2d-fc96-4bd8-b534-144d154bb84e","query_id":"53","doc_a_id":"9558539","doc_b_id":"16390264","presented_order":["9558539","16390264"],"winner_id":"16390264","reasoning":"Document B — it concerns breast cancer (though about access to care), whereas A focuses on a colorectal cancer marker (CD44v6) unrelated to ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103523Z"}
{"comparison_id":"e513602b-0318-4633-9718-4aa2a7b7898f","query_id":"53","doc_a_id":"13519661","doc_b_id":"16390264","presented_order":["16390264","13519661"],"winner_id":"13519661","reasoning":"Document B is more relevant because it addresses molecular/genetic aspects of breast cancer, whereas A focuses on socioeconomic patterns of hospital care and not tumor biomarkers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103530Z"}
{"comparison_id":"df2eccd0-b3a1-478c-b8c5-2398f4f138cf","query_id":"53","doc_a_id":"7808055","doc_b_id":"16390264","presented_order":["7808055","16390264"],"winner_id":"16390264","reasoning":"Document B is more relevant because it specifically addresses breast cancer patient outcomes and access to care, whereas Document A focuses on DNA methylation age across tissues and is not about ALDH1 or breast-cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103537Z"}
{"comparison_id":"c4dbf9ca-9a01-44ed-9fb2-6528564c3d11","query_id":"53","doc_a_id":"3756384","doc_b_id":"16390264","presented_order":["16390264","3756384"],"winner_id":"3756384","reasoning":"Document B is more relevant — it discusses a cancer stem cell–like gene signature tied to poor prognosis (conceptually related to ALDH1 as a stem cell marker), whereas A addresses socioeconomic care disparities, not molecular markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103544Z"}
{"comparison_id":"17b661e8-b137-4099-8e0a-70683fbd1fe1","query_id":"53","doc_a_id":"3848469","doc_b_id":"16390264","presented_order":["16390264","3848469"],"winner_id":"16390264","reasoning":"Document A is more relevant — it directly concerns breast cancer outcomes, whereas B studies stemness markers in a lung cancer cell line, not breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103551Z"}
{"comparison_id":"b18e75b2-2c64-4324-a211-b705c9bf21d1","query_id":"53","doc_a_id":"31803596","doc_b_id":"16390264","presented_order":["31803596","16390264"],"winner_id":"16390264","reasoning":"Document B is more relevant — it addresses breast cancer patient outcomes, while Document A concerns oral squamous cell carcinoma and not breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103557Z"}
{"comparison_id":"2eb124b5-37d3-43eb-8618-60368f1961e6","query_id":"53","doc_a_id":"54561709","doc_b_id":"16390264","presented_order":["54561709","16390264"],"winner_id":"54561709","reasoning":"Reason: Neither document addresses ALDH1 expression or its prognostic value; Document A at least concerns breast cancer cell-line molecular variability, making it marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103564Z"}
{"comparison_id":"f550ebfc-32d8-45d5-a9fc-88688623f4b9","query_id":"53","doc_a_id":"3858268","doc_b_id":"16390264","presented_order":["3858268","16390264"],"winner_id":"16390264","reasoning":"Document B is more relevant — it concerns breast cancer patient outcomes (even though not about ALDH1), while A focuses on ovarian cancer stem cells. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103571Z"}
{"comparison_id":"ab994106-476a-4205-be9c-09b13961a311","query_id":"53","doc_a_id":"2374637","doc_b_id":"16390264","presented_order":["2374637","16390264"],"winner_id":"2374637","reasoning":"Document A is more relevant — it concerns methods for analyzing gene expression data, which relates to studying markers like ALDH1 and their prognostic associations. Document B addresses healthcare access, not molecular expression or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103578Z"}
{"comparison_id":"85a5e6f6-6d46-43fa-9c44-4c8676534270","query_id":"53","doc_a_id":"17717391","doc_b_id":"16390264","presented_order":["17717391","16390264"],"winner_id":"16390264","reasoning":"Document B is more relevant — it directly concerns breast cancer patient outcomes, whereas Document A discusses a p16 mouse model unrelated to ALDH1 or prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103585Z"}
{"comparison_id":"71799fa9-845b-4927-b47d-88681c2af6cb","query_id":"53","doc_a_id":"2576811","doc_b_id":"16390264","presented_order":["2576811","16390264"],"winner_id":"16390264","reasoning":"Document B is more relevant — it addresses breast cancer patient outcomes and factors affecting prognosis, whereas Document A focuses on actin assembly in epithelial cells and is unrelated to clinical prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:51.103592Z"}
{"comparison_id":"2e911f3c-9417-400c-93e3-1f9fe20d277b","query_id":"53","doc_a_id":"31591262","doc_b_id":"3222187","presented_order":["31591262","3222187"],"winner_id":"3222187","reasoning":"Neither document addresses ALDH1 expression. Document B is marginally more relevant because it concerns a breast cancer study population, whereas A covers different genes in rectal cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:59.289637Z"}
{"comparison_id":"8470b43b-8e15-4c5a-9eac-27b3e15d1480","query_id":"53","doc_a_id":"2140497","doc_b_id":"3222187","presented_order":["2140497","3222187"],"winner_id":"2140497","reasoning":"Document A is more relevant because it addresses breast cancer characteristics and risk, whereas Document B focuses on vitamin D genetics unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:59.289657Z"}
{"comparison_id":"087cd78f-be8b-4b4f-94b2-1b0f5ef860f5","query_id":"53","doc_a_id":"9486930","doc_b_id":"3222187","presented_order":["3222187","9486930"],"winner_id":"3222187","reasoning":"Document A is more relevant because it concerns breast cancer (population study), while Document B addresses glioblastoma and not breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:59.289665Z"}
{"comparison_id":"344e1359-3729-4a5b-ab71-abcad489a964","query_id":"53","doc_a_id":"18340282","doc_b_id":"3222187","presented_order":["3222187","18340282"],"winner_id":"18340282","reasoning":"Reason: Neither document addresses ALDH1 expression; Document B is more directly about genetics in breast cancer patients, so it's slightly more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:59.289672Z"}
{"comparison_id":"816a6896-2b1b-46df-a48e-a7e2964fa500","query_id":"53","doc_a_id":"1782201","doc_b_id":"3222187","presented_order":["1782201","3222187"],"winner_id":"1782201","reasoning":"Document A is slightly more relevant because it discusses tumor progression and metastasis in carcinomas, whereas Document B focuses on vitamin D genetics and not cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:59.289679Z"}
{"comparison_id":"2a6204a9-4637-410e-9cb0-f201d0226db2","query_id":"53","doc_a_id":"13765757","doc_b_id":"3222187","presented_order":["13765757","3222187"],"winner_id":"13765757","reasoning":"Document A is more relevant — it discusses breast cancer tumor characteristics and risk factors, while Document B concerns vitamin D genetics unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:59.289688Z"}
{"comparison_id":"67b982c5-af12-4ab6-8f62-acf1ee866607","query_id":"53","doc_a_id":"2374637","doc_b_id":"3222187","presented_order":["2374637","3222187"],"winner_id":"2374637","reasoning":"Document A is more relevant — it discusses gene-expression analysis methods applicable to linking gene expression (like ALDH1) with cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:59.289694Z"}
{"comparison_id":"7cad9634-9ef0-4fed-9e1b-bec27f4df646","query_id":"53","doc_a_id":"42106119","doc_b_id":"3222187","presented_order":["42106119","3222187"],"winner_id":"42106119","reasoning":"Document A is more relevant — it deals with stem cell factors and cancer-related proteins, which is closer to ALDH1's role as a stem-cell marker in cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:59.289701Z"}
{"comparison_id":"97b18f88-b6f2-411b-a9c7-abf24cc92fda","query_id":"53","doc_a_id":"12438901","doc_b_id":"3222187","presented_order":["3222187","12438901"],"winner_id":"12438901","reasoning":"Document B — it concerns breast cancer prognosis and long-term outcomes, which is more relevant to a claim about factors associated with prognosis than a genetics/vitamin D study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:59.289708Z"}
{"comparison_id":"8604a115-0885-4132-988e-0e3ba666eb7a","query_id":"53","doc_a_id":"3524352","doc_b_id":"3222187","presented_order":["3222187","3524352"],"winner_id":"3524352","reasoning":"Document B — it discusses breast cancer mortality (related to prognosis), whereas Document A is about vitamin D genetics and unrelated. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:59.289715Z"}
{"comparison_id":"3c786c15-093e-481c-8df3-75641fa58841","query_id":"53","doc_a_id":"13519661","doc_b_id":"3222187","presented_order":["3222187","13519661"],"winner_id":"13519661","reasoning":"Neither document discusses ALDH1 or prognosis; both are irrelevant. Between them, DOCUMENT B is marginally more relevant because it directly addresses breast cancer genetics. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:59.289721Z"}
{"comparison_id":"54d25e17-2c0c-454d-b2e0-a30a621a6309","query_id":"53","doc_a_id":"3756384","doc_b_id":"3222187","presented_order":["3222187","3756384"],"winner_id":"3222187","reasoning":"Document A is more relevant — it concerns breast cancer populations (though not ALDH1 specifically), while B deals with HBV-related liver cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:59.289728Z"}
{"comparison_id":"de5177f4-d738-4a9f-b360-8523d0b4358f","query_id":"53","doc_a_id":"54561709","doc_b_id":"3222187","presented_order":["54561709","3222187"],"winner_id":"54561709","reasoning":"Document A is more relevant — it concerns breast cancer cell line characteristics and functional variability, which is closer to studies of prognostic markers than the vitamin D genetics study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:47:59.289735Z"}
{"comparison_id":"46bae21a-5aa5-45e2-b053-1d5534dbe67a","query_id":"53","doc_a_id":"2140497","doc_b_id":"2374637","presented_order":["2140497","2374637"],"winner_id":"2374637","reasoning":"Reason: Neither document addresses ALDH1 specifically, but Document B (gene expression analysis methods) is more related to assessing gene expression–prognosis associations than Document A (mammographic density/lobular involution).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:05.341311Z"}
{"comparison_id":"9dc536fd-094a-4973-9545-0c2feb334c70","query_id":"53","doc_a_id":"18340282","doc_b_id":"2374637","presented_order":["2374637","18340282"],"winner_id":"2374637","reasoning":"Document A is slightly more relevant because it concerns methods for analyzing gene expression data (which could be used to study ALDH1 expression), whereas Document B focuses on genetic polymorphisms and environmental interactions unrelated to ALDH1 expression or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:05.341331Z"}
{"comparison_id":"95327a29-fc78-40b2-9243-149592b178ff","query_id":"53","doc_a_id":"1782201","doc_b_id":"2374637","presented_order":["2374637","1782201"],"winner_id":"1782201","reasoning":"Document B — it discusses molecular markers linked to tumor progression and prognosis in carcinomas, which is closer to the claim about ALDH1 and breast cancer than the general methods paper in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:05.341339Z"}
{"comparison_id":"d2cc18a9-1940-474d-8780-0dbf2478143f","query_id":"53","doc_a_id":"13765757","doc_b_id":"2374637","presented_order":["13765757","2374637"],"winner_id":"2374637","reasoning":"Document B is more relevant — it discusses a gene-expression analysis method (GSEA) that could be used to study ALDH1 expression and its association with prognosis, whereas A is about reproductive timing and breast cancer risk, not gene expression or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:05.341347Z"}
{"comparison_id":"ef929242-e663-4964-bbc9-c1a126ec7c09","query_id":"53","doc_a_id":"54561709","doc_b_id":"2374637","presented_order":["2374637","54561709"],"winner_id":"54561709","reasoning":"Neither document provides evidence about ALDH1 expression or prognosis, but Document B is marginally more related because it concerns breast-cancer (MCF-7) cell biology that could impact expression studies. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:05.341355Z"}
{"comparison_id":"27c90dfe-53c1-4c0f-9012-881464e8fbd7","query_id":"53","doc_a_id":"42106119","doc_b_id":"2374637","presented_order":["42106119","2374637"],"winner_id":"42106119","reasoning":"Document A is more relevant — it discusses stem cell factors (like Oct4) and links to cancer, which is closer to ALDH1's role as a stem-cell marker in cancer prognosis than a methods paper.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:05.341362Z"}
{"comparison_id":"3dcfe8a4-280a-4422-899a-e3c7ae4f8078","query_id":"53","doc_a_id":"12438901","doc_b_id":"2374637","presented_order":["2374637","12438901"],"winner_id":"2374637","reasoning":"Document A is more relevant — it covers gene expression analysis methods (GSEA) that relate to studying expression markers like ALDH1, whereas Document B is a tamoxifen clinical trial unrelated to ALDH1 expression. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:05.341370Z"}
{"comparison_id":"d21cee02-e504-400a-b0de-bd41d90369ef","query_id":"53","doc_a_id":"3524352","doc_b_id":"2374637","presented_order":["2374637","3524352"],"winner_id":"2374637","reasoning":"Document A is more relevant — it deals with genome-wide expression analysis methods that could address gene expression–prognosis links (whereas B is a geographic mortality study).  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:05.341377Z"}
{"comparison_id":"08449908-d8e5-4ae1-9daa-77511b403616","query_id":"53","doc_a_id":"13519661","doc_b_id":"2374637","presented_order":["2374637","13519661"],"winner_id":"2374637","reasoning":"Document A is more relevant — it discusses gene expression analysis methods (applicable to studying ALDH1 expression and its association with prognosis), whereas Document B focuses on CHEK2 genetic variants unrelated to ALDH1 expression or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:05.341385Z"}
{"comparison_id":"12de0f47-fa59-476d-9a7a-6b90b29f1f88","query_id":"53","doc_a_id":"1782201","doc_b_id":"54561709","presented_order":["1782201","54561709"],"winner_id":"54561709","reasoning":"Document B is more relevant — it concerns breast cancer (MCF-7 cell line) whereas A focuses on integrin/c-Src signaling in pancreatic and other carcinomas, not ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:08.921006Z"}
{"comparison_id":"f3263bc0-cca7-4cbd-a78e-1d6405282399","query_id":"53","doc_a_id":"42106119","doc_b_id":"54561709","presented_order":["42106119","54561709"],"winner_id":"54561709","reasoning":"Document B is more relevant — it concerns breast cancer (MCF-7 cells) and factors affecting cancer research, whereas Document A focuses on Oct4 in embryonic stem cells and not breast cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:08.921026Z"}
{"comparison_id":"6a85db13-dce5-43f7-94ae-c85de28649c3","query_id":"53","doc_a_id":"1782201","doc_b_id":"42106119","presented_order":["42106119","1782201"],"winner_id":"42106119","reasoning":"Doc A is more relevant — it discusses stem cell factors and cancer links (ALDH1 is a stem-cell marker tied to prognosis), whereas Doc B focuses on integrin αvβ3 signaling in pancreatic cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:13.228082Z"}
{"comparison_id":"664e3396-653e-4628-8885-36dec6cb3683","query_id":"53","doc_a_id":"2140497","doc_b_id":"13765757","presented_order":["13765757","2140497"],"winner_id":"2140497","reasoning":"Reason: Neither document mentions ALDH1 or prognosis; both address breast cancer risk. Document B is slightly more relevant because it discusses tissue characteristics and associations with cancer risk (closer to biomarker-related findings).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:17.238823Z"}
{"comparison_id":"2736a6e0-1bc9-4757-b2b6-9ab87e017fa5","query_id":"53","doc_a_id":"18340282","doc_b_id":"13765757","presented_order":["18340282","13765757"],"winner_id":"18340282","reasoning":"Document A is marginally more relevant because it addresses genetic factors in breast cancer (whereas B focuses on reproductive timing); however, neither mentions ALDH1 expression or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:17.238844Z"}
{"comparison_id":"a05975b6-e6c0-4004-a7d6-72e87737c65f","query_id":"53","doc_a_id":"13519661","doc_b_id":"13765757","presented_order":["13519661","13765757"],"winner_id":"13519661","reasoning":"Neither document addresses ALDH1 expression or prognosis in breast cancer. Document A is marginally more relevant because it concerns tumor genetics, whereas Document B deals with reproductive risk factors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:17.238852Z"}
{"comparison_id":"8017cc83-3847-49af-8325-772dab5c18ea","query_id":"53","doc_a_id":"12438901","doc_b_id":"13765757","presented_order":["12438901","13765757"],"winner_id":"12438901","reasoning":"A is more relevant — it addresses prognosis/outcomes in breast cancer, whereas B focuses on risk related to reproductive timing. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:17.238861Z"}
{"comparison_id":"99f5eef1-6322-48c0-8218-51da5310ce62","query_id":"53","doc_a_id":"3524352","doc_b_id":"13765757","presented_order":["13765757","3524352"],"winner_id":"3524352","reasoning":"Document B is more relevant — it discusses breast cancer mortality (prognosis-related outcome), whereas Document A addresses risk factors for developing breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:17.238869Z"}
{"comparison_id":"76f024df-9e44-4869-9c0e-2d26745180ed","query_id":"53","doc_a_id":"2140497","doc_b_id":"13519661","presented_order":["13519661","2140497"],"winner_id":"2140497","reasoning":"Neither abstract mentions ALDH1 or prognosis. Document B is slightly more relevant because it discusses tissue-level breast features related to cancer risk, which is closer to expression-based markers than the CHEK2 germline variation in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:26.791964Z"}
{"comparison_id":"55098426-6c10-440c-98f2-3673af855cda","query_id":"53","doc_a_id":"18340282","doc_b_id":"13519661","presented_order":["18340282","13519661"],"winner_id":"13519661","reasoning":"Neither document addresses ALDH1 expression or breast cancer prognosis; both are irrelevant. Between them, B is marginally more cancer-gene–focused. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:26.791985Z"}
{"comparison_id":"6d9d7c47-087f-457d-aa38-dc71872d46e4","query_id":"53","doc_a_id":"3524352","doc_b_id":"13519661","presented_order":["13519661","3524352"],"winner_id":"13519661","reasoning":"Document A is more relevant — it deals with genetic/molecular factors in breast cancer (risk/prognosis) unlike the geographic mortality study. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:26.791993Z"}
{"comparison_id":"903c6ec0-54d9-4e57-bc25-e06c49579a2b","query_id":"53","doc_a_id":"12438901","doc_b_id":"13519661","presented_order":["12438901","13519661"],"winner_id":"12438901","reasoning":"Doc A discusses breast cancer prognosis and long-term outcomes, which is more relevant to a claim about a prognostic marker than a genetic risk study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:26.792000Z"}
{"comparison_id":"79412542-0c47-4c35-8433-649dc72ae84a","query_id":"53","doc_a_id":"2140497","doc_b_id":"12438901","presented_order":["12438901","2140497"],"winner_id":"12438901","reasoning":"Document A — it reports breast cancer recurrence and mortality (prognosis-related outcomes), whereas Document B addresses risk factors for developing breast cancer, not prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:29.500262Z"}
{"comparison_id":"2ba5a12a-5f9d-47e5-aa09-2c2621ae39e0","query_id":"53","doc_a_id":"18340282","doc_b_id":"3524352","presented_order":["18340282","3524352"],"winner_id":"3524352","reasoning":"Document B is more relevant — it addresses breast cancer mortality (a prognosis measure), while A studies gene–environment risk factors and polymorphisms, not ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:32.720442Z"}
{"comparison_id":"11c7f17e-7fe9-4833-8ce4-c4ed3ea834a7","query_id":"53","doc_a_id":"31591262","doc_b_id":"9486930","presented_order":["9486930","31591262"],"winner_id":"9486930","reasoning":"Document A — it discusses a stem cell-related \"self-renewal\" signature (conceptually related to ALDH1 as a stem cell marker), whereas Document B focuses on different genes in rectal cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:36.488662Z"}
{"comparison_id":"f379383a-21e5-41cd-9ab0-e409c65fbb1c","query_id":"53","doc_a_id":"3756384","doc_b_id":"9486930","presented_order":["3756384","9486930"],"winner_id":"3756384","reasoning":"Document A is more relevant — it discusses a cancer stem cell-like gene signature linked to poorer prognosis (closer in concept to ALDH1 as a stem-cell marker), whereas B focuses on glioblastoma resistance and EGFR/HOX signatures.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:36.488682Z"}
{"comparison_id":"ca0585c3-1bd6-46a6-9742-145fa9d2312e","query_id":"53","doc_a_id":"24205118","doc_b_id":"9558539","presented_order":["9558539","24205118"],"winner_id":"24205118","reasoning":"Document B is more relevant — it addresses clinicopathological and prognostic marker expression associated with poor survival (albeit Bmi-1 in cervical cancer), while A focuses on a different marker in colorectal metastasis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:44.513089Z"}
{"comparison_id":"e49a92bc-ebf5-4c2f-80e0-a995072efd13","query_id":"53","doc_a_id":"32721137","doc_b_id":"9558539","presented_order":["9558539","32721137"],"winner_id":"9558539","reasoning":"Document A is slightly more relevant — it discusses cancer stem cell markers (like CD44v6), which is closer to ALDH1's role as a stem cell marker, whereas B is focused on endometrial genomic profiling unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:44.513108Z"}
{"comparison_id":"0b37dfe8-db19-4d5b-9793-9af9d552f1c4","query_id":"53","doc_a_id":"12358173","doc_b_id":"9558539","presented_order":["12358173","9558539"],"winner_id":"9558539","reasoning":"Document B — it discusses a cancer stem-cell marker (CD44v6) and its role in metastasis, which is conceptually closer to ALDH1's role as a stem-cell/prognostic marker than Document A's focus on PD-ECGF in lung cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:44.513117Z"}
{"comparison_id":"638ef77b-de88-463c-bb8b-daf68bcb10f1","query_id":"53","doc_a_id":"22521091","doc_b_id":"9558539","presented_order":["9558539","22521091"],"winner_id":"9558539","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker and metastasis, which is conceptually closer to ALDH1's role in cancer prognosis than the HCC-specific NRAGE study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:44.513124Z"}
{"comparison_id":"a6351922-bde3-4cd9-b27d-e5de965cfc52","query_id":"53","doc_a_id":"17021845","doc_b_id":"9558539","presented_order":["9558539","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem-cell marker's expression being linked to prognosis, which is closer to the query about marker expression and prognosis than Document A's focus on CD44v6 in colorectal metastasis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:44.513131Z"}
{"comparison_id":"97dc1878-c6d2-4ddd-bec0-a8eca0b61b86","query_id":"53","doc_a_id":"52180874","doc_b_id":"9558539","presented_order":["9558539","52180874"],"winner_id":"9558539","reasoning":"Document A is more relevant — it discusses cancer stem cell markers and their link to metastasis and prognosis (though in colorectal cancer rather than breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:44.513138Z"}
{"comparison_id":"1d10e010-a5cc-47c8-af1b-f6b3dfa4cf00","query_id":"53","doc_a_id":"2576811","doc_b_id":"9558539","presented_order":["9558539","2576811"],"winner_id":"2576811","reasoning":"Document B — it involves breast epithelial cells (breast context), whereas Document A concerns CD44v6 in colorectal cancer, not breast. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:44.513145Z"}
{"comparison_id":"b37fe236-2079-4ade-8c1e-ea87875db5f8","query_id":"53","doc_a_id":"7808055","doc_b_id":"9558539","presented_order":["7808055","9558539"],"winner_id":"9558539","reasoning":"Document B is more relevant — it discusses a cancer stem cell marker (CD44v6) and its link to metastasis/prognosis, which is conceptually closer to ALDH1 as a prognostic stem-cell marker in breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:44.513152Z"}
{"comparison_id":"5ed7723c-e4ad-418c-aa4a-6957a794434d","query_id":"53","doc_a_id":"3848469","doc_b_id":"9558539","presented_order":["3848469","9558539"],"winner_id":"3848469","reasoning":"Document A is more relevant — it discusses stem cell marker expression (likely including ALDH1) and prognosis-related stemness characteristics, whereas Document B focuses on CD44v6 in colorectal cancer, not ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:44.513160Z"}
{"comparison_id":"dce99ba7-a82d-46df-b8a4-a55abab91efc","query_id":"53","doc_a_id":"31803596","doc_b_id":"9558539","presented_order":["9558539","31803596"],"winner_id":"9558539","reasoning":"Document A is slightly more relevant because it discusses cancer stem cell markers and metastasis (ALDH1 is a stem-cell marker linked to prognosis), whereas Document B covers unrelated gene expression in oral carcinoma. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:44.513167Z"}
{"comparison_id":"e25599ee-7b60-4a41-916a-e07815d7133a","query_id":"53","doc_a_id":"3858268","doc_b_id":"9558539","presented_order":["9558539","3858268"],"winner_id":"9558539","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it discusses a cancer stem cell marker as a prognostic/functional biomarker and metastasis, which is conceptually closer to ALDH1's proposed prognostic role. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:44.513175Z"}
{"comparison_id":"55679ebe-fb42-4db8-963c-ee04ea18f5ad","query_id":"53","doc_a_id":"17717391","doc_b_id":"9558539","presented_order":["9558539","17717391"],"winner_id":"9558539","reasoning":"Document A — it discusses cancer stem cell markers (though in colorectal cancer), which is more related to ALDH1 as a stem cell/prognostic marker than Document B's p16 tumor-senescence model.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:44.513181Z"}
{"comparison_id":"a880f579-1bd4-4c33-b1a5-0ee87280bcd1","query_id":"53","doc_a_id":"24205118","doc_b_id":"17021845","presented_order":["24205118","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it studies a stem-cell marker's association with diagnosis and prognosis (similar context to ALDH1) though in a different cancer type. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:48.856279Z"}
{"comparison_id":"7011e2d4-f1d7-46ca-9a5f-88faf9e34d64","query_id":"53","doc_a_id":"3848469","doc_b_id":"17021845","presented_order":["17021845","3848469"],"winner_id":"17021845","reasoning":"Doc A is more relevant — it directly addresses a stem cell marker's association with diagnosis and prognosis, whereas Doc B focuses on EMT and stemness mechanisms. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:48.856299Z"}
{"comparison_id":"65855dc4-9b38-450b-8b26-2c7bb51d7aef","query_id":"53","doc_a_id":"2576811","doc_b_id":"17021845","presented_order":["2576811","17021845"],"winner_id":"2576811","reasoning":"Document A is slightly more relevant because it concerns breast epithelial cells (breast cancer context) whereas Document B addresses lung cancer and a different marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:48.856308Z"}
{"comparison_id":"bd1da673-2c9e-4ceb-b237-940f562a8868","query_id":"53","doc_a_id":"24205118","doc_b_id":"3848469","presented_order":["3848469","24205118"],"winner_id":"3848469","reasoning":"Neither abstract directly studies ALDH1 or breast cancer. Document A is more relevant because it addresses cancer stemness and stem cell markers (the class ALDH1 belongs to) and tumor behavior, while Document B concerns a different marker (Bmi-1) in cervical cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:48:55.210150Z"}
{"comparison_id":"580f3a2c-0ab9-4027-b7af-fb42d33d19be","query_id":"53","doc_a_id":"32721137","doc_b_id":"52180874","presented_order":["52180874","32721137"],"winner_id":"52180874","reasoning":"Document A is marginally more relevant because it addresses biomarker expression and prognosis across multiple cancers, whereas Document B focuses specifically on endometrial carcinoma genomics and PI3K. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:49:00.061937Z"}
{"comparison_id":"55a436c7-96f5-4e51-8a65-cf7fa0b9c647","query_id":"53","doc_a_id":"12358173","doc_b_id":"52180874","presented_order":["12358173","52180874"],"winner_id":"12358173","reasoning":"Document A is more relevant because it addresses tumor-marker expression correlated with prognosis (though in a different marker and cancer type), whereas B concerns immunotherapy efficacy unrelated to ALDH1 or prognosis markers. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:49:00.061957Z"}
{"comparison_id":"e7e2fdf3-5f29-431d-917f-a032a188f46b","query_id":"53","doc_a_id":"22521091","doc_b_id":"52180874","presented_order":["22521091","52180874"],"winner_id":"22521091","reasoning":"Document A is more relevant — it discusses a biomarker whose expression correlates with cancer progression and survival, which is conceptually closer to the claim about ALDH1 expression and prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:49:00.061966Z"}
{"comparison_id":"a6ede86e-cff0-4c19-b303-d5cff15f2df1","query_id":"53","doc_a_id":"17717391","doc_b_id":"52180874","presented_order":["17717391","52180874"],"winner_id":"17717391","reasoning":"Document A is more relevant — it concerns biomarker expression and tumor development/prognosis, whereas Document B addresses immunotherapy efficacy and PD-1/PD-L1, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:49:00.061974Z"}
{"comparison_id":"df03a53b-63d7-4f23-861f-aa079885c99e","query_id":"53","doc_a_id":"7808055","doc_b_id":"52180874","presented_order":["7808055","52180874"],"winner_id":"7808055","reasoning":"Document A is slightly more relevant — it discusses cancer-related molecular measures and prognosis-related findings, whereas Document B focuses on immunotherapy efficacy; neither specifically addresses ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:49:00.061981Z"}
{"comparison_id":"64af0fd4-2008-4997-bafa-c902014e9ffb","query_id":"53","doc_a_id":"31803596","doc_b_id":"52180874","presented_order":["31803596","52180874"],"winner_id":"31803596","reasoning":"Document A is slightly more relevant because it concerns gene expression analysis (ALDH1 is a gene), whereas Document B focuses on PD-1/PD-L1 immunotherapy and not gene expression or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:49:00.061989Z"}
{"comparison_id":"07c093e3-86c7-4791-ba19-0e444d22aa48","query_id":"53","doc_a_id":"3858268","doc_b_id":"52180874","presented_order":["3858268","52180874"],"winner_id":"3858268","reasoning":"Document A is more relevant — it discusses cancer stem cell biology (to which ALDH1 is related), whereas Document B focuses on PD-1/PD-L1 immunotherapy and is unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:49:00.061996Z"}
{"comparison_id":"021a96d8-7b81-45a9-955d-e5971a42f2d2","query_id":"53","doc_a_id":"12358173","doc_b_id":"17717391","presented_order":["17717391","12358173"],"winner_id":"12358173","reasoning":"Document B is more relevant — it links marker expression to tumor prognosis (though in lung cancer, not ALDH1/breast). \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:49:04.365491Z"}
{"comparison_id":"5e70fd11-0db5-44e4-b074-88ca74113064","query_id":"53","doc_a_id":"22521091","doc_b_id":"17717391","presented_order":["22521091","17717391"],"winner_id":"17717391","reasoning":"Document B is more relevant — it discusses in vivo tumor marker expression and monitoring of neoplastic events, which is closer to evaluating prognostic markers than an HCC-specific NRAGE study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:49:04.365511Z"}
{"comparison_id":"e6965f86-63c2-4770-9f3a-28a25846462c","query_id":"53","doc_a_id":"3858268","doc_b_id":"17717391","presented_order":["3858268","17717391"],"winner_id":"3858268","reasoning":"Document A is more relevant — it discusses cancer stem cell markers and therapy (ALDH1 is a CSC marker), whereas B focuses on p16 and aging/tumor visualization. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:49:04.365520Z"}
{"comparison_id":"4811c570-6155-4f01-b19e-664e97e8947a","query_id":"53","doc_a_id":"7808055","doc_b_id":"17717391","presented_order":["7808055","17717391"],"winner_id":"17717391","reasoning":"Document B is more relevant — it discusses a protein marker's expression in tumors and its relation to cancer development/prognosis, whereas A focuses on DNA methylation age across tissues. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:49:04.365527Z"}
{"comparison_id":"fb1f1c88-b4c0-472f-af39-226edefb5106","query_id":"53","doc_a_id":"31803596","doc_b_id":"17717391","presented_order":["31803596","17717391"],"winner_id":"31803596","reasoning":"Document A is more relevant — it involves gene expression analysis in carcinoma (though in oral cancer), which is closer to evaluating expression–prognosis associations than Document B's focus on p16INK4a mouse imaging. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:49:04.365535Z"}
{"comparison_id":"fbb1b124-04f0-4f34-ae63-67405e92cc3c","query_id":"53","doc_a_id":"12358173","doc_b_id":"3858268","presented_order":["12358173","3858268"],"winner_id":"3858268","reasoning":"Document B is more relevant — it addresses cancer stem cell markers and therapeutic implications (closer conceptually to ALDH1 as a stem cell/prognostic marker) whereas A concerns a different factor in lung cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:49:08.632972Z"}
{"comparison_id":"68a7aea6-49e8-4c1d-8f87-12bc8d2bb413","query_id":"53","doc_a_id":"31803596","doc_b_id":"3858268","presented_order":["3858268","31803596"],"winner_id":"3858268","reasoning":"Document A is more relevant — it discusses cancer stem cells (ALDH1 is a known CSC marker), whereas Document B focuses on oral squamous cell carcinoma gene profiling unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:49:08.632992Z"}
{"comparison_id":"3fad2d52-520b-4cc3-ab02-88eab97be34c","query_id":"53","doc_a_id":"12358173","doc_b_id":"31803596","presented_order":["12358173","31803596"],"winner_id":"31803596","reasoning":"Document B — it deals with gene expression profiling and links gene expression patterns to cancer behavior/prognosis, which is closer to an ALDH1–prognosis question than A's focus on a different factor in lung cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:49:12.765496Z"}
{"comparison_id":"d9a92b6b-ec45-4bd8-a12e-da4d1f3987b9","query_id":"53","doc_a_id":"22521091","doc_b_id":"7808055","presented_order":["7808055","22521091"],"winner_id":"22521091","reasoning":"Document B is more relevant — it examines how expression of a gene correlates with cancer progression and survival (though in hepatocellular carcinoma rather than breast cancer), whereas A discusses DNA methylation age and not ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:49:17.327498Z"}
{"comparison_id":"9ce763e5-630a-47e0-be94-35fd633280b1","query_id":"53","doc_a_id":"42731834","doc_b_id":"14726759","presented_order":["42731834","14726759"],"winner_id":"42731834","reasoning":"Document A — it discusses tumor biomarker expression and prognosis in cancer (though a different marker and cancer type), so it's more topically related. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588090Z"}
{"comparison_id":"278a4f6e-c859-4ed1-a4d8-d9986a59b73f","query_id":"53","doc_a_id":"3899896","doc_b_id":"14726759","presented_order":["14726759","3899896"],"winner_id":"3899896","reasoning":"Document B is more relevant — it addresses cancer prognosis, whereas A concerns artery dissection unrelated to cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588112Z"}
{"comparison_id":"29af2d62-40d9-47b2-812d-aeda3ab736aa","query_id":"53","doc_a_id":"10024681","doc_b_id":"14726759","presented_order":["10024681","14726759"],"winner_id":"10024681","reasoning":"Document A is more relevant — it concerns cancer prognostic molecular markers (though in prostate cancer), whereas B is about vascular disease unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588121Z"}
{"comparison_id":"9b1a906b-5af1-4bd5-935e-6368f8602831","query_id":"53","doc_a_id":"52925737","doc_b_id":"14726759","presented_order":["52925737","14726759"],"winner_id":"52925737","reasoning":"Document A is more relevant — it discusses cancer-related expression linked to prognosis (though in gastric cancer, not breast). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588134Z"}
{"comparison_id":"0c587fac-0514-4bb2-a2c0-964e4a37653e","query_id":"53","doc_a_id":"2389574","doc_b_id":"14726759","presented_order":["2389574","14726759"],"winner_id":"2389574","reasoning":"Document A is more relevant — it deals with cancer biomarker expression and prognosis (though in endometrial, not breast, cancer), while B is about vascular disease and unrelated. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588143Z"}
{"comparison_id":"7c3c7e55-ee27-4543-95e7-bdc90862a890","query_id":"53","doc_a_id":"39580129","doc_b_id":"14726759","presented_order":["39580129","14726759"],"winner_id":"39580129","reasoning":"Document A is more relevant — it addresses prognostic biomarker expression in cancer (though different marker and cancer type) while B is about vascular disease unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588161Z"}
{"comparison_id":"e13a9716-724e-466d-8fc6-4acf5655d17f","query_id":"53","doc_a_id":"22963769","doc_b_id":"14726759","presented_order":["14726759","22963769"],"winner_id":"22963769","reasoning":"Document B — it discusses altered protein expression linked to aggressive cancer features, which is more closely related to the query about marker expression and prognosis than a vascular dissection study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588174Z"}
{"comparison_id":"c2060f30-c710-4497-a29b-57d37a447760","query_id":"53","doc_a_id":"654735","doc_b_id":"14726759","presented_order":["14726759","654735"],"winner_id":"654735","reasoning":"Document B is more relevant — it concerns cancer prognostic biomarkers and tumor prognosis, whereas A is about artery dissection and not cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588183Z"}
{"comparison_id":"4f7e50fc-0a14-4a5f-b308-7087c99e22d5","query_id":"53","doc_a_id":"20886584","doc_b_id":"14726759","presented_order":["20886584","14726759"],"winner_id":"20886584","reasoning":"Doc A is more relevant — it concerns breast cancer (though not ALDH1 specifically), while Doc B is about cervicocerebral artery dissection and unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588192Z"}
{"comparison_id":"1e723cfb-6b98-4bf9-b571-b55fa4a76639","query_id":"53","doc_a_id":"38808600","doc_b_id":"14726759","presented_order":["38808600","14726759"],"winner_id":"38808600","reasoning":"Document A is more relevant — it discusses a molecular marker associated with poor prognosis in a cancer context, which is closer to the claim about ALDH1 and breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588201Z"}
{"comparison_id":"e76251e9-1cf8-4245-b148-42e5cc9485e7","query_id":"53","doc_a_id":"15081770","doc_b_id":"14726759","presented_order":["15081770","14726759"],"winner_id":"15081770","reasoning":"Document A — it discusses enzyme expression by tumor cells and prognostic implications in cancers, so it's more related to cancer biomarkers than the artery-dissection study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588210Z"}
{"comparison_id":"0bf4a523-5079-4e65-ac39-c1d7f0794083","query_id":"53","doc_a_id":"8512633","doc_b_id":"14726759","presented_order":["8512633","14726759"],"winner_id":"8512633","reasoning":"Document A is more relevant — it's about cancer and prognosis (though prostate, not breast), whereas Document B concerns vascular disease. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588219Z"}
{"comparison_id":"f06bccbb-3e22-4372-a0db-92136b5aba53","query_id":"53","doc_a_id":"6517763","doc_b_id":"14726759","presented_order":["6517763","14726759"],"winner_id":"6517763","reasoning":"Document A — it involves cancer and gene expression profiling (though in glioblastoma), so it's closer to the topic than the vascular study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588228Z"}
{"comparison_id":"051b05f5-7843-462b-a960-a1a76a8f1f19","query_id":"53","doc_a_id":"3730196","doc_b_id":"14726759","presented_order":["3730196","14726759"],"winner_id":"3730196","reasoning":"Doc A is cancer-related and discusses prognostic biomarkers (though in SCLC), while B is unrelated to cancer; A is therefore more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588237Z"}
{"comparison_id":"f41d5325-b405-4f87-ab67-41f80ff04577","query_id":"53","doc_a_id":"26561572","doc_b_id":"14726759","presented_order":["14726759","26561572"],"winner_id":"26561572","reasoning":"Document B is more relevant — it's cancer-related and discusses molecular markers and prognosis, whereas A is about cervicocerebral artery dissection and unrelated. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588246Z"}
{"comparison_id":"927a3a8f-49f4-4c37-8c9c-ff6fc92cd057","query_id":"53","doc_a_id":"15335331","doc_b_id":"14726759","presented_order":["14726759","15335331"],"winner_id":"15335331","reasoning":"Document B is more relevant because it discusses cancer biomarkers and their association with poor outcomes, whereas Document A is about cervicocerebral artery dissection and unrelated to cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588255Z"}
{"comparison_id":"07bb6802-4613-4b98-add2-8fc91458b321","query_id":"53","doc_a_id":"601033","doc_b_id":"14726759","presented_order":["601033","14726759"],"winner_id":"601033","reasoning":"Document A — it discusses cancer treatment and prognosis-related outcomes, so it's more topically related than the vascular study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588262Z"}
{"comparison_id":"66321486-2fc4-4338-a699-9e59ad10312a","query_id":"53","doc_a_id":"4467129","doc_b_id":"14726759","presented_order":["4467129","14726759"],"winner_id":"4467129","reasoning":"Document A is slightly more relevant because it discusses cancer and prognosis (though in neuroblastoma, not breast cancer), while Document B is about arterial dissection and unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588271Z"}
{"comparison_id":"01cad402-90a8-4bd7-bb0c-a5fb6f872203","query_id":"53","doc_a_id":"38243984","doc_b_id":"14726759","presented_order":["14726759","38243984"],"winner_id":"38243984","reasoning":"Document B — it discusses cancer prognosis and tumor gene/pathway associations (though in pancreatic cancer), which is more related to the claim about a cancer prognostic marker than Document A about arterial dissection.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588279Z"}
{"comparison_id":"5809206d-6c33-425d-a456-e9fe4f4544e6","query_id":"53","doc_a_id":"16806763","doc_b_id":"14726759","presented_order":["16806763","14726759"],"winner_id":"16806763","reasoning":"Document A — it concerns cancer prognosis (though in colorectal cancer) and is more relevant to a claim about prognostic markers in cancer than Document B, which is about arterial dissection. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588288Z"}
{"comparison_id":"3ad7f533-379f-407c-a5ef-20c0caf44598","query_id":"53","doc_a_id":"34189936","doc_b_id":"14726759","presented_order":["14726759","34189936"],"winner_id":"34189936","reasoning":"Document B is slightly more relevant because it concerns cancer biology, whereas Document A is about artery dissection and not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588296Z"}
{"comparison_id":"5b9821ae-7dfb-432c-a995-ba7abe83c3af","query_id":"53","doc_a_id":"16701509","doc_b_id":"14726759","presented_order":["16701509","14726759"],"winner_id":"16701509","reasoning":"Document A is more relevant — it discusses breast cancer (though not ALDH1 specifically), whereas Document B addresses artery dissection unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588304Z"}
{"comparison_id":"917231e6-b175-4369-9ecb-2bf945e5a6f3","query_id":"53","doc_a_id":"37480103","doc_b_id":"14726759","presented_order":["37480103","14726759"],"winner_id":"37480103","reasoning":"Document A is more relevant — it deals with breast cancer (risk/prognosis context), whereas Document B is about artery dissection and unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588312Z"}
{"comparison_id":"35eb8f94-078e-4509-8211-4d0b4e063bda","query_id":"53","doc_a_id":"4489217","doc_b_id":"14726759","presented_order":["4489217","14726759"],"winner_id":"4489217","reasoning":"Document A — it discusses tumor heterogeneity and gene expression in cancer (though not ALDH1 or breast cancer specifically), so it's marginally more related than a vascular study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588320Z"}
{"comparison_id":"c12734ed-17ae-46c7-90b0-a6e5b2889490","query_id":"53","doc_a_id":"7165938","doc_b_id":"14726759","presented_order":["7165938","14726759"],"winner_id":"7165938","reasoning":"Document A is more relevant — it concerns cancer prognosis and biomarkers (though in colorectal cancer), whereas Document B addresses cervicocerebral artery dissection, unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588329Z"}
{"comparison_id":"bbeb74ea-4fb9-46d9-b8bd-f9d72c65ed23","query_id":"53","doc_a_id":"515489","doc_b_id":"14726759","presented_order":["14726759","515489"],"winner_id":"515489","reasoning":"Document B — it discusses molecular markers tied to poor clinical prognosis in cancer (though in HCC), while A is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588338Z"}
{"comparison_id":"56b16ce8-1764-41ab-86f4-bf1d8007ab5c","query_id":"53","doc_a_id":"29124963","doc_b_id":"14726759","presented_order":["14726759","29124963"],"winner_id":"29124963","reasoning":"Document B is more relevant — it deals with cancer prognostic markers and patient outcomes, whereas A is about cervicocerebral artery dissection and unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588346Z"}
{"comparison_id":"b5fe523d-5bb2-4ae4-8345-ea1d967f835d","query_id":"53","doc_a_id":"23304931","doc_b_id":"14726759","presented_order":["23304931","14726759"],"winner_id":"23304931","reasoning":"Document A is more related because it discusses cancer immunophenotypic markers and prognosis, whereas Document B is about vascular dissections unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588355Z"}
{"comparison_id":"c13f9cdc-65b7-4371-88c6-886a537a00bf","query_id":"53","doc_a_id":"19047331","doc_b_id":"14726759","presented_order":["19047331","14726759"],"winner_id":"19047331","reasoning":"Reason: Document A discusses a cancer biomarker and its association with poor clinical outcomes (though in ovarian cancer), whereas Document B is unrelated (vascular disease).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588363Z"}
{"comparison_id":"156b4c67-b4d6-4a13-89cc-233724aab836","query_id":"53","doc_a_id":"11615422","doc_b_id":"14726759","presented_order":["11615422","14726759"],"winner_id":"11615422","reasoning":"Document A is more relevant — it's about cancer genetics and tumor-related gene alterations (whereas B is about vascular disease), so A is closer to the breast cancer/prognosis topic.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588371Z"}
{"comparison_id":"ec782f3b-ef85-433c-9c9e-b3ba0e4862e7","query_id":"53","doc_a_id":"23665162","doc_b_id":"14726759","presented_order":["23665162","14726759"],"winner_id":"23665162","reasoning":"Document A is more relevant — it concerns cancer biomarkers and prognosis, whereas Document B addresses artery dissection unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588380Z"}
{"comparison_id":"c55a3cfa-1bfd-4ff0-bda9-dfc4ce03667a","query_id":"53","doc_a_id":"20280410","doc_b_id":"14726759","presented_order":["20280410","14726759"],"winner_id":"20280410","reasoning":"Document A — it concerns breast cancer (though not ALDH1 specifically), while Document B is about cervicocerebral artery dissection and unrelated to the claim. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588389Z"}
{"comparison_id":"c376a76d-1253-4d74-b763-e81f50673b98","query_id":"53","doc_a_id":"27123743","doc_b_id":"14726759","presented_order":["14726759","27123743"],"winner_id":"27123743","reasoning":"Document B is more relevant because it discusses breast cancer etiology, whereas Document A is about cervicocerebral artery dissection and unrelated to breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588400Z"}
{"comparison_id":"548e7e2b-1966-41c0-b2fa-81adda6bc825","query_id":"53","doc_a_id":"8677721","doc_b_id":"14726759","presented_order":["8677721","14726759"],"winner_id":"8677721","reasoning":"Document A — it's cancer-related (oncogenic signaling and prognosis), whereas B is about cervicocerebral artery dissection and unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588408Z"}
{"comparison_id":"5690a2fb-9c21-4d05-9d17-51f86c0be48b","query_id":"53","doc_a_id":"23830488","doc_b_id":"14726759","presented_order":["14726759","23830488"],"winner_id":"23830488","reasoning":"Document B is more relevant because it addresses gene expression correlations with cancer prognosis, whereas Document A is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588415Z"}
{"comparison_id":"d25c3131-6410-4054-a557-6b873db49a98","query_id":"53","doc_a_id":"38551172","doc_b_id":"14726759","presented_order":["14726759","38551172"],"winner_id":"38551172","reasoning":"Document B is more relevant — it concerns breast cancer, whereas Document A addresses cervicocerebral artery dissection and is unrelated to breast cancer biomarkers or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588424Z"}
{"comparison_id":"72ed3af4-d113-43cc-b24a-a373a62f82f4","query_id":"53","doc_a_id":"21181273","doc_b_id":"14726759","presented_order":["21181273","14726759"],"winner_id":"21181273","reasoning":"Document A — it discusses altered expression of an enzyme linked to tumor progression (cancer-related), whereas Document B is about artery dissection and unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588433Z"}
{"comparison_id":"04b32135-aa1b-4887-8829-7bf563798699","query_id":"53","doc_a_id":"36950726","doc_b_id":"14726759","presented_order":["36950726","14726759"],"winner_id":"36950726","reasoning":"Document A is more relevant because it concerns cancer and changes in expression of molecular markers related to prognosis, whereas Document B addresses arterial dissection unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588441Z"}
{"comparison_id":"48d5b6bc-d0cb-46b9-9a1c-da1f15b4ecba","query_id":"53","doc_a_id":"17088791","doc_b_id":"14726759","presented_order":["17088791","14726759"],"winner_id":"17088791","reasoning":"Document A — it concerns breast cancer genetics and prognosis-related topics, while Document B is unrelated to breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588449Z"}
{"comparison_id":"58ec66b0-109b-4277-90cc-4d54ee2dc2f1","query_id":"53","doc_a_id":"10169908","doc_b_id":"14726759","presented_order":["10169908","14726759"],"winner_id":"10169908","reasoning":"Document A is more relevant because it addresses cancer biology (though in lung cancer and a different protein), while Document B concerns vascular disease unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588457Z"}
{"comparison_id":"40bcca1a-2282-418c-a353-cf2343dc66a3","query_id":"53","doc_a_id":"17450673","doc_b_id":"14726759","presented_order":["14726759","17450673"],"winner_id":"17450673","reasoning":"Reason: Document B concerns breast cancer (risk factors), whereas Document A is about cervicocerebral artery dissection and unrelated to breast cancer biomarkers or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588466Z"}
{"comparison_id":"0b7df8ee-226d-4026-8de2-664527936131","query_id":"53","doc_a_id":"24980622","doc_b_id":"14726759","presented_order":["14726759","24980622"],"winner_id":"24980622","reasoning":"Document B — it relates to cancer biology and biomarker expression, whereas Document A is about cervicocerebral artery dissection and unrelated to cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588475Z"}
{"comparison_id":"34c60a87-9645-4b19-b75e-b6117ca97fbf","query_id":"53","doc_a_id":"5774746","doc_b_id":"14726759","presented_order":["5774746","14726759"],"winner_id":"5774746","reasoning":"Document A is more relevant — it addresses cancer metastasis and links protein expression to poorer survival, whereas B concerns artery dissection and is unrelated to cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588483Z"}
{"comparison_id":"239c2dd1-36a4-4de0-858f-7362b95bf094","query_id":"53","doc_a_id":"5372432","doc_b_id":"14726759","presented_order":["5372432","14726759"],"winner_id":"5372432","reasoning":"Document A is slightly more relevant because it deals with cancer diagnosis and prognosis, whereas Document B is about cervicocerebral artery dissection and unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588491Z"}
{"comparison_id":"14ac06b8-246f-42a9-8660-432c688e5f88","query_id":"53","doc_a_id":"2727303","doc_b_id":"14726759","presented_order":["2727303","14726759"],"winner_id":"2727303","reasoning":"Document A is cancer-related and discusses molecular regulators of malignant behavior, making it more relevant to a claim about cancer biomarkers/prognosis than the vascular study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588500Z"}
{"comparison_id":"fc406de5-60ac-4499-811e-5d6c08b6d847","query_id":"53","doc_a_id":"21502234","doc_b_id":"14726759","presented_order":["21502234","14726759"],"winner_id":"21502234","reasoning":"Document A is more relevant because it concerns cancer prognosis (though a different biomarker and cancer type) whereas Document B is unrelated to cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588541Z"}
{"comparison_id":"290f5bd2-a760-4c89-a11c-51eef05faf61","query_id":"53","doc_a_id":"13831842","doc_b_id":"14726759","presented_order":["13831842","14726759"],"winner_id":"13831842","reasoning":"Document A — it concerns breast cancer (risk factors), so it's more related to prognosis in breast cancer than the artery dissection study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588556Z"}
{"comparison_id":"d2d0b7b2-8e56-4a89-a967-5268b6c6b4be","query_id":"53","doc_a_id":"14471161","doc_b_id":"14726759","presented_order":["14471161","14726759"],"winner_id":"14471161","reasoning":"A is more relevant — it concerns tumor biology and gene expression in cancer, while B addresses artery dissection unrelated to breast cancer or ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588566Z"}
{"comparison_id":"f9f9ec6e-2b6e-4f5c-8270-4d112fefa3ba","query_id":"53","doc_a_id":"13831558","doc_b_id":"14726759","presented_order":["14726759","13831558"],"winner_id":"13831558","reasoning":"Document B is more relevant because it discusses breast cancer (whereas A is about artery dissection) though neither mentions ALDH1 or its prognostic role.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588575Z"}
{"comparison_id":"bc0db2c2-5732-47bc-a2a3-d40ba4fd912b","query_id":"53","doc_a_id":"23577867","doc_b_id":"14726759","presented_order":["23577867","14726759"],"winner_id":"23577867","reasoning":"Document A — it's cancer-related (endometrial) and thus more relevant to a prognosis-breast cancer claim than a vascular study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588584Z"}
{"comparison_id":"edba75f7-a777-45a0-8761-61a993c57add","query_id":"53","doc_a_id":"9239963","doc_b_id":"14726759","presented_order":["9239963","14726759"],"winner_id":"9239963","reasoning":"Reason: Document A discusses cancer-related molecular expression and tumor biology (though in endometrial cancer), making it marginally more relevant to a claim about cancer biomarkers than Document B, which is about artery dissection.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588593Z"}
{"comparison_id":"02b4eb8b-e966-46ec-a549-f7c693c64dbc","query_id":"53","doc_a_id":"25576204","doc_b_id":"14726759","presented_order":["14726759","25576204"],"winner_id":"25576204","reasoning":"Document B is more relevant — it deals with genetic factors and tumorigenesis in cancer, whereas Document A is about cervicocerebral artery dissection and unrelated to cancer markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588602Z"}
{"comparison_id":"01e98939-7002-45cb-96eb-559e3de94d4f","query_id":"53","doc_a_id":"11271123","doc_b_id":"14726759","presented_order":["11271123","14726759"],"winner_id":"11271123","reasoning":"Document A is more relevant — it's a molecular cancer study (though of endometrial, not breast, cancer) and thus more related to biomarker–prognosis associations than a vascular-dissection study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588611Z"}
{"comparison_id":"68431b89-7088-4cc7-a0b0-507a4c1477e2","query_id":"53","doc_a_id":"31439189","doc_b_id":"14726759","presented_order":["31439189","14726759"],"winner_id":"31439189","reasoning":"Document A is more related (discusses cancer stem cell markers and prognosis context), while B is about vascular disease unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588620Z"}
{"comparison_id":"27ea2ab3-3360-4c59-a66d-3040c4eccee5","query_id":"53","doc_a_id":"2272614","doc_b_id":"14726759","presented_order":["14726759","2272614"],"winner_id":"2272614","reasoning":"Document B is more relevant — it concerns cancer molecular expression and prognosis/treatment, whereas A is about cervicocerebral artery dissection and unrelated. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588629Z"}
{"comparison_id":"3110b4a6-e87a-437e-91ad-de3247a1135c","query_id":"53","doc_a_id":"16630996","doc_b_id":"14726759","presented_order":["14726759","16630996"],"winner_id":"16630996","reasoning":"Document B — it discusses molecular markers and cancer prognosis/therapy, so it's marginally more relevant to a claim about a cancer biomarker than a study on artery dissection. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588637Z"}
{"comparison_id":"4fc31397-db5d-4247-ba1c-ed541740cb53","query_id":"53","doc_a_id":"25832301","doc_b_id":"14726759","presented_order":["14726759","25832301"],"winner_id":"25832301","reasoning":"Document B — it's a cancer study discussing marker expression and patient outcomes (though in myeloma, not breast cancer), so it's more related to the query than a vascular disorder study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588645Z"}
{"comparison_id":"a15804b7-603b-48c5-ae14-df0de259c55b","query_id":"53","doc_a_id":"7639744","doc_b_id":"14726759","presented_order":["14726759","7639744"],"winner_id":"7639744","reasoning":"Document B is more relevant because it discusses cancer prognosis (though in lung cancer), while Document A concerns vascular disease unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588653Z"}
{"comparison_id":"bd8f91eb-39a5-45e1-a156-56ca275ce1b6","query_id":"53","doc_a_id":"4828631","doc_b_id":"14726759","presented_order":["4828631","14726759"],"winner_id":"4828631","reasoning":"Document A is more related because it addresses breast cancer outcomes; Document B is unrelated (artery dissection). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588661Z"}
{"comparison_id":"f9943f63-b216-4cad-805d-7b78c5919d60","query_id":"53","doc_a_id":"24349430","doc_b_id":"14726759","presented_order":["24349430","14726759"],"winner_id":"24349430","reasoning":"Document A is more relevant — it concerns cancer biology (though in lung cancer), whereas Document B is about artery dissection and unrelated to cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588669Z"}
{"comparison_id":"4e62c121-caf8-4eca-99e5-5d780032ecf5","query_id":"53","doc_a_id":"1507222","doc_b_id":"14726759","presented_order":["14726759","1507222"],"winner_id":"1507222","reasoning":"Document B — it's about gene expression in a cancer context (whereas A is about artery dissection), so it's marginally more relevant to a claim about a cancer biomarker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588677Z"}
{"comparison_id":"5dd02f54-9faf-4e49-9c28-9666090e677b","query_id":"53","doc_a_id":"7736860","doc_b_id":"14726759","presented_order":["7736860","14726759"],"winner_id":"7736860","reasoning":"Document A is cancer-related and discusses prognostic molecular signaling, making it more relevant to a claim about cancer biomarkers than Document B (vascular disease).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588685Z"}
{"comparison_id":"4604c5c0-9f38-4a16-ad83-03917ac3f6f4","query_id":"53","doc_a_id":"16098747","doc_b_id":"14726759","presented_order":["14726759","16098747"],"winner_id":"16098747","reasoning":"Document B — it concerns breast cancer (risk factors and density), whereas A is about artery dissection and unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588693Z"}
{"comparison_id":"6a46fc64-0fce-4f8f-b3c5-2e974a25ebd3","query_id":"53","doc_a_id":"14672919","doc_b_id":"14726759","presented_order":["14672919","14726759"],"winner_id":"14672919","reasoning":"Document A — it's cancer-related and deals with prognostic markers (though for esophageal cancer), so it's more relevant than a vascular disorder study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588701Z"}
{"comparison_id":"d54664cd-4aa4-411c-9f49-1ab27c7b69a8","query_id":"53","doc_a_id":"5222182","doc_b_id":"14726759","presented_order":["14726759","5222182"],"winner_id":"5222182","reasoning":"Document B is more related to breast cancer (mammographic density and risk factors); Document A is about cervicocerebral artery dissection and unrelated.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588709Z"}
{"comparison_id":"8368ba09-3af1-4524-9c03-9e12f08da8ae","query_id":"53","doc_a_id":"16322674","doc_b_id":"14726759","presented_order":["16322674","14726759"],"winner_id":"16322674","reasoning":"Document A — it concerns breast cancer (risk/prognosis context), while Document B is unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588717Z"}
{"comparison_id":"19c1830a-c631-475f-8ca8-de2ec53292bf","query_id":"53","doc_a_id":"6790197","doc_b_id":"14726759","presented_order":["14726759","6790197"],"winner_id":"6790197","reasoning":"Document B is more relevant — it discusses cancer-associated gene expression and prognostic links, whereas A is unrelated (artery dissection). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588725Z"}
{"comparison_id":"ac559e57-4403-48db-893d-43effd2b541a","query_id":"53","doc_a_id":"5377642","doc_b_id":"14726759","presented_order":["5377642","14726759"],"winner_id":"5377642","reasoning":"Document A is more related to cancer biology (tumor immune regulation), whereas Document B concerns vascular disease unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588733Z"}
{"comparison_id":"f5c636fc-0d52-48d7-80fe-be25b8862f1d","query_id":"53","doc_a_id":"13964633","doc_b_id":"14726759","presented_order":["14726759","13964633"],"winner_id":"13964633","reasoning":"Document B is more related to cancer biology (mechanisms affecting tumor growth), while Document A is unrelated (cerebrovascular disease). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588740Z"}
{"comparison_id":"54479e35-3d00-4ec4-9951-c05617a36d80","query_id":"53","doc_a_id":"3684342","doc_b_id":"14726759","presented_order":["3684342","14726759"],"winner_id":"3684342","reasoning":"Document A is more relevant because it discusses cancer-related expression and reduced survival (prognosis), whereas Document B is about artery dissection and unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588748Z"}
{"comparison_id":"d53ab278-af09-4fa8-9ce2-12a6c0cbf622","query_id":"53","doc_a_id":"39929509","doc_b_id":"14726759","presented_order":["14726759","39929509"],"winner_id":"39929509","reasoning":"Document B — mentions a protein's role in cancers, so it's slightly more related to cancer prognosis than Document A (which is about artery dissection).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588756Z"}
{"comparison_id":"9ef2f673-af03-4bcf-bb49-9368e79f4e38","query_id":"53","doc_a_id":"46617075","doc_b_id":"14726759","presented_order":["46617075","14726759"],"winner_id":"46617075","reasoning":"Document A is more related to cancer biology (oncogenic pathways) while Document B is about vascular disease; neither mentions ALDH1 or breast cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588764Z"}
{"comparison_id":"c156f82a-0df7-4b8a-ac20-9a8c73eafedf","query_id":"53","doc_a_id":"31313782","doc_b_id":"14726759","presented_order":["14726759","31313782"],"winner_id":"31313782","reasoning":"Document B is slightly more relevant because it deals with expression profiles in cancer (though not breast cancer or ALDH1), whereas Document A is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588772Z"}
{"comparison_id":"847a6194-e8a7-48cd-8eee-230012e3c2f8","query_id":"53","doc_a_id":"14180565","doc_b_id":"14726759","presented_order":["14726759","14180565"],"winner_id":"14180565","reasoning":"Document B — it concerns gene expression changes in cancer cells (though glioblastoma, not breast cancer), so it's more related to ALDH1 expression/prognosis than a study on artery dissection.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588781Z"}
{"comparison_id":"d618dee0-e629-4a9e-8873-22b5c37b7366","query_id":"53","doc_a_id":"39758684","doc_b_id":"14726759","presented_order":["39758684","14726759"],"winner_id":"39758684","reasoning":"Document A — it concerns cancer-related molecular overexpression and tumorigenesis, so it's closer to a claim about cancer biomarkers/prognosis than a study on artery dissection.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588789Z"}
{"comparison_id":"d1a07192-b52f-4bf8-9504-128799534e25","query_id":"53","doc_a_id":"641786","doc_b_id":"14726759","presented_order":["14726759","641786"],"winner_id":"641786","reasoning":"Document B is slightly more relevant because it's about cancer biology and prognosis (relapse in leukemia), whereas Document A concerns vascular disease and is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588797Z"}
{"comparison_id":"99c8d6c3-dc57-4a10-aba6-3e51e68374df","query_id":"53","doc_a_id":"33370","doc_b_id":"14726759","presented_order":["14726759","33370"],"winner_id":"33370","reasoning":"Document B is more relevant — it's about cancer stem cell markers and prognosis/tumor growth, which is closer to ALDH1's role in cancer than a vascular study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588805Z"}
{"comparison_id":"fbd942e8-b7e3-4ea8-9555-77021431fa3c","query_id":"53","doc_a_id":"27306942","doc_b_id":"14726759","presented_order":["14726759","27306942"],"winner_id":"27306942","reasoning":"Document B — it links gene expression changes to poor cancer outcomes (though in leukemia rather than breast cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588813Z"}
{"comparison_id":"50f0cc15-0557-4220-abee-1321846ed4d5","query_id":"53","doc_a_id":"3067015","doc_b_id":"14726759","presented_order":["14726759","3067015"],"winner_id":"3067015","reasoning":"B is more relevant — it discusses an aldehyde dehydrogenase (ALDH) gene and clinical outcomes, whereas A is unrelated to ALDH or cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588822Z"}
{"comparison_id":"62b636e3-91fc-4e5a-89f3-bcef83b9c3f2","query_id":"53","doc_a_id":"32852283","doc_b_id":"14726759","presented_order":["14726759","32852283"],"winner_id":"32852283","reasoning":"Document B — it concerns cancer outcomes (tumor growth and survival), whereas Document A is about artery dissection and unrelated to cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588830Z"}
{"comparison_id":"aec4139b-851a-4479-88a2-0647703d7f5f","query_id":"53","doc_a_id":"23557241","doc_b_id":"14726759","presented_order":["23557241","14726759"],"winner_id":"23557241","reasoning":"Document A discusses breast cancer (though not ALDH1 specifically), while Document B is unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588837Z"}
{"comparison_id":"50e1c06e-cac5-41db-b97e-d7e385a58104","query_id":"53","doc_a_id":"9211173","doc_b_id":"14726759","presented_order":["9211173","14726759"],"winner_id":"9211173","reasoning":"Document A is more relevant — it concerns cancer biology and biomarkers, whereas Document B is about cervicocerebral artery dissection and unrelated to breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588845Z"}
{"comparison_id":"06a29325-4f4d-4935-a5ac-3c48e539d7c6","query_id":"53","doc_a_id":"22123421","doc_b_id":"14726759","presented_order":["22123421","14726759"],"winner_id":"22123421","reasoning":"Document A is more relevant — it discusses prognostic biomarkers in cancer (though in NSCLC, not breast cancer), whereas Document B is about artery dissection and unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588853Z"}
{"comparison_id":"b6c8f6e7-25a8-47a5-902b-a1c9eb26ddd1","query_id":"53","doc_a_id":"20738970","doc_b_id":"14726759","presented_order":["20738970","14726759"],"winner_id":"20738970","reasoning":"Document A is more related to cancer biology and prognosis (though in lung cancer, not breast/ALDH1), while Document B concerns vascular disease unrelated to the claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588861Z"}
{"comparison_id":"31fee88e-f659-46f3-a7bd-267b3ffd3b90","query_id":"53","doc_a_id":"9394119","doc_b_id":"14726759","presented_order":["9394119","14726759"],"winner_id":"9394119","reasoning":"Document A is more relevant — it concerns breast cancer genetics and prognosis-related risk factors, whereas Document B is about cervicocerebral artery dissection and unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588868Z"}
{"comparison_id":"53a08e50-3170-45f4-a13d-bb183a612c5a","query_id":"53","doc_a_id":"3210545","doc_b_id":"14726759","presented_order":["3210545","14726759"],"winner_id":"3210545","reasoning":"Document A — it concerns cancer prognosis (though in endometrial cancer), so it's more related than Document B about vascular disease.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588877Z"}
{"comparison_id":"5ecb7dd9-ecc5-4066-9c1c-ab11a62a5704","query_id":"53","doc_a_id":"22007333","doc_b_id":"14726759","presented_order":["22007333","14726759"],"winner_id":"22007333","reasoning":"Document A is more related to breast cancer (risk factors and mammographic density), whereas Document B concerns artery dissection and is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588884Z"}
{"comparison_id":"b477255a-d321-4acf-a8c9-c1f22e84a440","query_id":"53","doc_a_id":"23284774","doc_b_id":"14726759","presented_order":["14726759","23284774"],"winner_id":"23284774","reasoning":"Document B is more relevant because it concerns breast cancer (though it doesn't address ALDH1 specifically), whereas Document A is about cervicocerebral artery dissection and unrelated to breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588893Z"}
{"comparison_id":"165bd5a3-49ca-4238-a73f-6f7c3427a442","query_id":"53","doc_a_id":"6121668","doc_b_id":"14726759","presented_order":["14726759","6121668"],"winner_id":"6121668","reasoning":"Document B — it discusses expression of molecular markers and their prognostic relevance in cancer (though in endometrial, not breast), while A is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588900Z"}
{"comparison_id":"fc53b6c0-f7b1-48d6-bb59-13f975b77693","query_id":"53","doc_a_id":"23509593","doc_b_id":"14726759","presented_order":["14726759","23509593"],"winner_id":"23509593","reasoning":"Document B is slightly more relevant because it deals with gene expression regulation in cancerous tissue (prostate), whereas A is unrelated vascular disease. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588909Z"}
{"comparison_id":"f51d6239-a66b-476c-8ca8-9276819de8f1","query_id":"53","doc_a_id":"26079071","doc_b_id":"14726759","presented_order":["14726759","26079071"],"winner_id":"14726759","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis, so neither is relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588916Z"}
{"comparison_id":"6771f2e3-e067-4ea1-8a4f-55d6d138d8ac","query_id":"53","doc_a_id":"9285396","doc_b_id":"14726759","presented_order":["9285396","14726759"],"winner_id":"9285396","reasoning":"Document A is more relevant — it concerns prognostic biomarkers in cancer (though gastric, not breast), whereas B is unrelated (artery dissection). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588924Z"}
{"comparison_id":"3a514436-c4b0-4aca-b4d1-c63c53b20a01","query_id":"53","doc_a_id":"5386514","doc_b_id":"14726759","presented_order":["5386514","14726759"],"winner_id":"5386514","reasoning":"Document A is more relevant — it discusses tumor immune mechanisms and cancer therapy, whereas Document B concerns artery dissection unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588932Z"}
{"comparison_id":"6e939a99-b205-4a23-b652-b9270fe50706","query_id":"53","doc_a_id":"3710557","doc_b_id":"14726759","presented_order":["14726759","3710557"],"winner_id":"3710557","reasoning":"Document B — it discusses cancer-related signaling and tumorigenesis (though in liver), which is more related to ALDH1 and cancer prognosis than a study on cervicocerebral artery dissection.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588939Z"}
{"comparison_id":"94f999f2-d10a-45c4-be74-f1eceaaa68dc","query_id":"53","doc_a_id":"14664424","doc_b_id":"14726759","presented_order":["14664424","14726759"],"winner_id":"14664424","reasoning":"Document A — it discusses prognostic tumor markers in cancer (although cervical, not breast) and is more related to cancer prognosis than Document B (vascular disease).  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588948Z"}
{"comparison_id":"fad1c68e-bc03-48f1-81b0-1c2e572ec4b0","query_id":"53","doc_a_id":"20754359","doc_b_id":"14726759","presented_order":["14726759","20754359"],"winner_id":"20754359","reasoning":"Document B — it discusses cancer prognosis and treatment, so it's more related to tumor markers and outcomes than a vascular study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588955Z"}
{"comparison_id":"0ac38cd0-b21f-49c4-8a97-0e0940b8ab9b","query_id":"53","doc_a_id":"53211308","doc_b_id":"14726759","presented_order":["53211308","14726759"],"winner_id":"53211308","reasoning":"Document A is more relevant — it discusses cancer biomarkers and mechanisms of cancer progression (though in ovarian cancer), whereas Document B concerns arterial dissection and is unrelated to cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588964Z"}
{"comparison_id":"d0c8aab0-6be9-47a0-8b7a-e2b631938ce9","query_id":"53","doc_a_id":"3355397","doc_b_id":"14726759","presented_order":["14726759","3355397"],"winner_id":"3355397","reasoning":"Document B is more relevant because it addresses cancer-related outcomes, whereas Document A concerns arterial dissection and is unrelated to cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588972Z"}
{"comparison_id":"5aec846b-1b59-4df6-9098-636b87cb3270","query_id":"53","doc_a_id":"25628793","doc_b_id":"14726759","presented_order":["25628793","14726759"],"winner_id":"25628793","reasoning":"Document A is more relevant — it concerns expression of metabolic enzymes in gynecologic tissues (molecular marker research), which is closer to a claim about a biomarker (ALDH1) and cancer prognosis than a vascular-dissection clinical study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588980Z"}
{"comparison_id":"178c1115-fd71-47a7-9bb7-687d91599bd9","query_id":"53","doc_a_id":"36212758","doc_b_id":"14726759","presented_order":["36212758","14726759"],"winner_id":"36212758","reasoning":"Document A — it's a cancer genomics/prognosis study (though in lung cancer), which is more relevant to a claim about cancer prognosis than a vascular disease study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588988Z"}
{"comparison_id":"e4b3d193-d963-4c6f-a302-a0910004d55e","query_id":"53","doc_a_id":"17462437","doc_b_id":"14726759","presented_order":["17462437","14726759"],"winner_id":"17462437","reasoning":"Document A — it's cancer-related (prognostic marker context) whereas B is about vascular disease. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.588995Z"}
{"comparison_id":"50a3162b-409b-4267-8ec5-2881dc00e799","query_id":"53","doc_a_id":"2360905","doc_b_id":"14726759","presented_order":["2360905","14726759"],"winner_id":"2360905","reasoning":"Document A — it discusses gene expression in cancer (though in pediatric gliomas), so it's more related to cancer prognostic markers than the vascular study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589003Z"}
{"comparison_id":"a8fb4bf3-8a97-437e-9a87-1ee84fc4298e","query_id":"53","doc_a_id":"16346504","doc_b_id":"14726759","presented_order":["14726759","16346504"],"winner_id":"16346504","reasoning":"Document B is more relevant — it concerns molecular markers in cancer (though endometrial, not breast), whereas A is about artery dissection and unrelated. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589011Z"}
{"comparison_id":"4563c59e-9f37-4fbe-8a33-657668f1837d","query_id":"53","doc_a_id":"20645538","doc_b_id":"14726759","presented_order":["20645538","14726759"],"winner_id":"20645538","reasoning":"Document A — it discusses prognostic factors in cancer (NSCLC), so it's marginally more related to prognosis in cancer than Document B, which is about artery dissection. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589019Z"}
{"comparison_id":"34052959-a743-4b6a-81ec-a5c7206b0f1f","query_id":"53","doc_a_id":"33638477","doc_b_id":"14726759","presented_order":["14726759","33638477"],"winner_id":"33638477","reasoning":"Document B is more relevant — it concerns oncogenic markers and tumor progression (cancer prognosis-related), whereas A is about artery dissection. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589026Z"}
{"comparison_id":"739ab7da-61cf-4a32-b087-aaa4c2237bdb","query_id":"53","doc_a_id":"3805841","doc_b_id":"14726759","presented_order":["3805841","14726759"],"winner_id":"3805841","reasoning":"Reason: Document A discusses cancer-related mechanisms and links to poor clinical outcomes, making it more topically related than Document B, which concerns artery dissection.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589034Z"}
{"comparison_id":"74ad3b2f-7272-470f-871e-10cfdab7f864","query_id":"53","doc_a_id":"14663842","doc_b_id":"14726759","presented_order":["14726759","14663842"],"winner_id":"14663842","reasoning":"Document B — it discusses cancer-related metabolic changes (IDH1) and is more related to cancer biology than Document A, which covers artery dissection. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589042Z"}
{"comparison_id":"b8d5bb99-065c-467a-9adb-16b99423d45c","query_id":"53","doc_a_id":"4841908","doc_b_id":"14726759","presented_order":["14726759","4841908"],"winner_id":"4841908","reasoning":"Document B is slightly more relevant because it at least addresses disease prognosis and mentions cancer, whereas Document A is unrelated to cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589050Z"}
{"comparison_id":"424d8c2f-9c94-4c71-8187-5f09ba028823","query_id":"53","doc_a_id":"26848994","doc_b_id":"14726759","presented_order":["14726759","26848994"],"winner_id":"26848994","reasoning":"Document B — it discusses cancer biomarkers and prognosis (though in hepatocellular carcinoma), whereas A is about artery dissection and unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589057Z"}
{"comparison_id":"11164eb0-2c72-4654-8a92-e76570da6702","query_id":"53","doc_a_id":"14938990","doc_b_id":"14726759","presented_order":["14938990","14726759"],"winner_id":"14938990","reasoning":"Document A discusses biomarker expression (PD‑1) linked to disease activity/prognosis, which is thematically closer to a claim about marker expression and cancer prognosis than Document B's vascular-dissection study. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589065Z"}
{"comparison_id":"624fa5a9-334a-4479-b98b-b5dc179d5189","query_id":"53","doc_a_id":"32534305","doc_b_id":"14726759","presented_order":["14726759","32534305"],"winner_id":"32534305","reasoning":"Document B is more relevant — it concerns breast cancer (though about diabetes and incidence, not ALDH1), whereas A is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589073Z"}
{"comparison_id":"96394bf8-2c84-49df-b751-c863dac9165f","query_id":"53","doc_a_id":"1780819","doc_b_id":"14726759","presented_order":["1780819","14726759"],"winner_id":"1780819","reasoning":"Document A — it's a cancer-focused study (epigenetics and prognosis), making it more related to a claim about cancer biomarkers/prognosis than Document B, which concerns vascular disease.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589081Z"}
{"comparison_id":"08e842f0-e2b7-4e56-b171-30143e886090","query_id":"53","doc_a_id":"26902591","doc_b_id":"14726759","presented_order":["26902591","14726759"],"winner_id":"26902591","reasoning":"Document A is slightly more relevant because it relates to cancer and prognosis, whereas Document B is about artery dissection unrelated to cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589089Z"}
{"comparison_id":"8efbad64-312d-452e-9aa0-0514e4c1fe71","query_id":"53","doc_a_id":"19368793","doc_b_id":"14726759","presented_order":["14726759","19368793"],"winner_id":"19368793","reasoning":"Document B is slightly more relevant because it concerns cancer biomarkers, whereas Document A is about arterial dissection and not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589096Z"}
{"comparison_id":"068f384d-32df-49f4-9ee5-9320844f9c97","query_id":"53","doc_a_id":"5487448","doc_b_id":"14726759","presented_order":["5487448","14726759"],"winner_id":"5487448","reasoning":"Document A is more relevant — it concerns breast cancer-related factors (mammographic density), while Document B is about arterial dissection and unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589104Z"}
{"comparison_id":"0d3e975b-10da-4ca0-9d78-b0f94bcba402","query_id":"53","doc_a_id":"16180601","doc_b_id":"14726759","presented_order":["14726759","16180601"],"winner_id":"14726759","reasoning":"Neither document discusses ALDH1, breast cancer, or cancer prognosis. Document A is marginally more relevant because it mentions factors linked to poorer prognosis (though in artery dissection, not cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589112Z"}
{"comparison_id":"05c64066-5479-4a4a-9df3-53d123442a28","query_id":"53","doc_a_id":"4959368","doc_b_id":"14726759","presented_order":["14726759","4959368"],"winner_id":"4959368","reasoning":"Document B is more relevant because it deals with cancer-related biomarkers, whereas Document A concerns cervicocerebral artery dissection and is unrelated to cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589121Z"}
{"comparison_id":"bac402cf-6a58-45ba-a287-5dc8589fa71d","query_id":"53","doc_a_id":"38485364","doc_b_id":"14726759","presented_order":["14726759","38485364"],"winner_id":"38485364","reasoning":"Document B is more relevant — it's a cancer biology paper (invasion-related), whereas A is about cervicocerebral artery dissection and unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589128Z"}
{"comparison_id":"c36c5a4b-6459-4af7-ba84-9a682d101de6","query_id":"53","doc_a_id":"3376731","doc_b_id":"14726759","presented_order":["14726759","3376731"],"winner_id":"3376731","reasoning":"Document B is more relevant — it addresses cancer biomarkers and prognosis/treatment resistance, whereas Document A is about cervicocerebral artery dissection and unrelated to cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589136Z"}
{"comparison_id":"4ff6c001-f0bd-4c9e-8660-da7ec06952e4","query_id":"53","doc_a_id":"7228140","doc_b_id":"14726759","presented_order":["14726759","7228140"],"winner_id":"7228140","reasoning":"Document B is more relevant — it concerns cancer molecular subtypes and prognosis (though in pancreatic cancer), whereas A is about artery dissection and unrelated to cancer markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589145Z"}
{"comparison_id":"d937065c-a134-4c92-9398-16b141d32783","query_id":"53","doc_a_id":"5278233","doc_b_id":"14726759","presented_order":["5278233","14726759"],"winner_id":"5278233","reasoning":"Document A is more relevant — it concerns gene-level epigenetic regulation (closer to cancer biomarker context) while Document B is about arterial dissection and unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589153Z"}
{"comparison_id":"872a54f9-3ee3-4bed-b3d3-4d80a7a801f5","query_id":"53","doc_a_id":"29806339","doc_b_id":"14726759","presented_order":["29806339","14726759"],"winner_id":"29806339","reasoning":"Document A is more relevant — it's a cancer study discussing tumor behavior and prognosis-related mechanisms, while Document B concerns artery dissection unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589163Z"}
{"comparison_id":"3b2a88f6-2088-49fc-971a-d4b842c8ab3d","query_id":"53","doc_a_id":"13768432","doc_b_id":"14726759","presented_order":["13768432","14726759"],"winner_id":"13768432","reasoning":"Document A is slightly more relevant because it addresses prognostic biomarkers and outcomes (though for cardiac amyloidosis, not breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589169Z"}
{"comparison_id":"a13a02a9-b906-4db3-a773-3ac7dd0e220c","query_id":"53","doc_a_id":"13205096","doc_b_id":"14726759","presented_order":["14726759","13205096"],"winner_id":"13205096","reasoning":"Document B is more relevant — it deals with gene-expression profiling and prognosis in cancer, whereas A concerns artery dissection and is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589175Z"}
{"comparison_id":"11262400-f359-454f-8b90-223ea63fcfac","query_id":"53","doc_a_id":"36432234","doc_b_id":"14726759","presented_order":["14726759","36432234"],"winner_id":"36432234","reasoning":"Reason: Document B concerns breast cancer biology (tumor growth mechanisms), whereas A is about cervicocerebral artery dissection and unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589182Z"}
{"comparison_id":"6256c3fb-8690-4fde-9e07-f63ba7c7d415","query_id":"53","doc_a_id":"85665741","doc_b_id":"14726759","presented_order":["85665741","14726759"],"winner_id":"85665741","reasoning":"Document A is more related (both concern cancer biology/therapy), whereas B is about vascular disease unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589189Z"}
{"comparison_id":"03946fd3-17d6-4a84-b197-e6ec2eba9f2e","query_id":"53","doc_a_id":"831167","doc_b_id":"14726759","presented_order":["831167","14726759"],"winner_id":"831167","reasoning":"Document A is more relevant — it concerns gene expression and survival prognosis in cancer (though glioblastoma rather than breast), whereas Document B is about artery dissection unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589195Z"}
{"comparison_id":"63331147-9618-4e34-b1a0-541fc3ad7dad","query_id":"53","doc_a_id":"26488879","doc_b_id":"14726759","presented_order":["14726759","26488879"],"winner_id":"14726759","reasoning":"Document A is marginally more relevant because it discusses factors linked to prognosis (even though it's about artery dissection, not breast cancer or ALDH1). \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589202Z"}
{"comparison_id":"02c39025-3eee-469e-a0dc-67e6defcb6af","query_id":"53","doc_a_id":"38784540","doc_b_id":"14726759","presented_order":["38784540","14726759"],"winner_id":"38784540","reasoning":"Document A is more relevant because it addresses breast cancer-related factors, whereas Document B concerns cervicocerebral artery dissection and is unrelated to breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589209Z"}
{"comparison_id":"23a7f43e-5dc9-4740-ad24-53759461a67a","query_id":"53","doc_a_id":"6363093","doc_b_id":"14726759","presented_order":["14726759","6363093"],"winner_id":"6363093","reasoning":"Document B is more relevant — it deals with cancer subclasses and protein expression patterns (closer to biomarkers and prognosis) while A is about artery dissection unrelated to breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589216Z"}
{"comparison_id":"ef10fdb5-1a34-4eae-9de1-44c2f587f683","query_id":"53","doc_a_id":"33677323","doc_b_id":"14726759","presented_order":["14726759","33677323"],"winner_id":"33677323","reasoning":"Document B is more relevant — it concerns cancer biology and links molecular markers to clinical outcomes, whereas Document A is about cervicocerebral artery dissection and unrelated to cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589224Z"}
{"comparison_id":"ddccdfdd-da6a-40df-8783-a33defd254db","query_id":"53","doc_a_id":"4500832","doc_b_id":"14726759","presented_order":["14726759","4500832"],"winner_id":"4500832","reasoning":"Document B is slightly more relevant because it mentions cancer-related topics (though not ALDH1 or breast cancer specifically); Document A is unrelated to cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589230Z"}
{"comparison_id":"e5c769b7-c6be-4727-bfbe-6750cfbeacc3","query_id":"53","doc_a_id":"4387494","doc_b_id":"14726759","presented_order":["4387494","14726759"],"winner_id":"4387494","reasoning":"Document A is slightly more relevant because it deals with cancer biology and molecular markers/treatment, whereas Document B is about vascular disease with no relation to cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589237Z"}
{"comparison_id":"4803d5c4-2820-480d-80d0-99451f194c58","query_id":"53","doc_a_id":"11900630","doc_b_id":"14726759","presented_order":["11900630","14726759"],"winner_id":"11900630","reasoning":"Document A is more related to cancer biology and prognosis/chemoresistance, whereas Document B concerns arterial dissection unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589243Z"}
{"comparison_id":"94942e3d-8cba-40da-a1f3-658696c6fba5","query_id":"53","doc_a_id":"41790911","doc_b_id":"14726759","presented_order":["41790911","14726759"],"winner_id":"41790911","reasoning":"Document A is slightly more relevant because it concerns molecular pathways in human tissue and angiogenesis, which is more related to cancer biology than a vascular disease study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589250Z"}
{"comparison_id":"d8968baa-d486-4f2e-9a50-c704c07c1fc7","query_id":"53","doc_a_id":"42150015","doc_b_id":"14726759","presented_order":["42150015","14726759"],"winner_id":"42150015","reasoning":"Document A is slightly more relevant because it concerns female reproductive biomarkers and breast-cancer–related factors, whereas Document B is about arterial dissection and unrelated to cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589256Z"}
{"comparison_id":"3f5c7f8e-22c3-4d23-b473-f72b85ee775d","query_id":"53","doc_a_id":"23269537","doc_b_id":"14726759","presented_order":["23269537","14726759"],"winner_id":"23269537","reasoning":"Document A is more relevant — it's about gene expression changes in cancer (though not ALDH1 or breast cancer specifically), whereas Document B is about cerebrovascular disease and unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589263Z"}
{"comparison_id":"2f31c56a-0113-471a-aac2-5e34241a01f2","query_id":"53","doc_a_id":"13905670","doc_b_id":"14726759","presented_order":["13905670","14726759"],"winner_id":"13905670","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it deals with a molecular factor linked to disease prognosis, whereas B concerns vascular dissection outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589269Z"}
{"comparison_id":"29a1a80f-a7ef-4fd9-93d6-ad9301825814","query_id":"53","doc_a_id":"25488034","doc_b_id":"14726759","presented_order":["14726759","25488034"],"winner_id":"25488034","reasoning":"Document B is more relevant — it discusses detoxifying enzymes and antioxidant defenses related to cancer biology, whereas A is about cervicocerebral artery dissection and unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589277Z"}
{"comparison_id":"23796621-f14f-4b14-b4c8-169233a27721","query_id":"53","doc_a_id":"9171913","doc_b_id":"14726759","presented_order":["14726759","9171913"],"winner_id":"9171913","reasoning":"Document B is more relevant because it concerns breast cancer (though not ALDH1 or prognosis), while Document A is unrelated. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589283Z"}
{"comparison_id":"74f8978f-47d8-469a-81bc-9543edc02069","query_id":"53","doc_a_id":"21551568","doc_b_id":"14726759","presented_order":["14726759","21551568"],"winner_id":"21551568","reasoning":"Reason: Document B discusses cancer-related molecular markers and tumor progression, so it's more related to prognosis in cancer than Document A, which is about arterial dissection.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589289Z"}
{"comparison_id":"9be68575-9b2a-424c-998d-94f23ec084eb","query_id":"53","doc_a_id":"9095394","doc_b_id":"14726759","presented_order":["14726759","9095394"],"winner_id":"9095394","reasoning":"Document B — it discusses marker expression in cancers (though oral), which is more relevant to a claim about a cancer prognostic marker than Document A about artery dissection.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589296Z"}
{"comparison_id":"9a98bdd0-1118-45e2-9993-0b39f1c2db9a","query_id":"53","doc_a_id":"7028976","doc_b_id":"14726759","presented_order":["14726759","7028976"],"winner_id":"7028976","reasoning":"Document B — it deals with cancer stem cell markers and tumor-initiating cells, which is more related to ALDH1's role in cancer prognosis than a study on artery dissection.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589303Z"}
{"comparison_id":"1a564604-34b5-440e-b1ef-5bd6030cbc6a","query_id":"53","doc_a_id":"46602807","doc_b_id":"14726759","presented_order":["14726759","46602807"],"winner_id":"14726759","reasoning":"Document A is slightly more relevant because it discusses factors linked to prognosis (though in a different disease), while Document B is focused on antibiotic testing and unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589309Z"}
{"comparison_id":"8774c8e1-856b-4a17-a1d7-1d2d9fd75ec6","query_id":"53","doc_a_id":"11968641","doc_b_id":"14726759","presented_order":["11968641","14726759"],"winner_id":"11968641","reasoning":"Document A is more relevant — it discusses cancer biology and tumor behavior, whereas Document B concerns cervicocerebral artery dissection unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589316Z"}
{"comparison_id":"a6811621-d54b-4414-8c67-8de7cb8c4f22","query_id":"53","doc_a_id":"663464","doc_b_id":"14726759","presented_order":["14726759","663464"],"winner_id":"663464","reasoning":"Reason: Neither discusses ALDH1 or breast cancer, but Document B concerns molecular biomarker expression linked to prognosis/mortality, making it marginally more conceptually relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589323Z"}
{"comparison_id":"8e711bc5-caca-469b-890c-31a2ea0ddbf1","query_id":"53","doc_a_id":"26735905","doc_b_id":"14726759","presented_order":["26735905","14726759"],"winner_id":"26735905","reasoning":"Document A is more relevant — it discusses cancer-related tumor biology, whereas Document B covers cervicocerebral artery dissection unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589329Z"}
{"comparison_id":"725b66f9-e5f0-4a21-8c51-f648f546ad01","query_id":"53","doc_a_id":"23934390","doc_b_id":"14726759","presented_order":["23934390","14726759"],"winner_id":"23934390","reasoning":"Doc A is cancer-related (tumor marker/prognosis context), so it's marginally more relevant than a vascular disease study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589336Z"}
{"comparison_id":"0d6dc018-5436-4360-a8c0-da4a314f70b6","query_id":"53","doc_a_id":"2494748","doc_b_id":"14726759","presented_order":["14726759","2494748"],"winner_id":"2494748","reasoning":"Document B is more relevant — it concerns cancer biomarkers and prognosis-related molecular changes, whereas A is about cervicocerebral artery dissection and unrelated to cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589342Z"}
{"comparison_id":"94c00e03-5672-4146-8c8d-2444778202c3","query_id":"53","doc_a_id":"16016673","doc_b_id":"14726759","presented_order":["16016673","14726759"],"winner_id":"16016673","reasoning":"Document A — it concerns cancer biomarker research (though in bladder cancer), whereas Document B is unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589348Z"}
{"comparison_id":"2b842fc7-9b85-49ae-85f2-23ebf46407e2","query_id":"53","doc_a_id":"1976183","doc_b_id":"14726759","presented_order":["14726759","1976183"],"winner_id":"1976183","reasoning":"Document B — it concerns cancer biomarker expression and invasive behavior, so it's more related to prognosis in cancer than the vascular disease study in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589354Z"}
{"comparison_id":"2ecc8478-af9a-4c2c-9834-af76be92c964","query_id":"53","doc_a_id":"33030946","doc_b_id":"14726759","presented_order":["33030946","14726759"],"winner_id":"33030946","reasoning":"Document A is more relevant — it deals with molecular/cellular pathways and hypoxia-related expression in human cells (closer to cancer biology), whereas B is an unrelated vascular study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589360Z"}
{"comparison_id":"7bb38875-eb95-4b53-8e0f-c77b41697e2b","query_id":"53","doc_a_id":"13400643","doc_b_id":"14726759","presented_order":["13400643","14726759"],"winner_id":"13400643","reasoning":"Document A is more relevant because it concerns cancer biology and potential prognostic/therapeutic markers, whereas Document B is about cervicocerebral artery dissection and unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589367Z"}
{"comparison_id":"895d48ab-8c71-426c-9e59-e599d337101a","query_id":"53","doc_a_id":"22901758","doc_b_id":"14726759","presented_order":["14726759","22901758"],"winner_id":"22901758","reasoning":"Reason: Document B discusses molecular markers and their association with prognosis in cancer (glioblastoma), which is closer to the query about a cancer prognostic marker than Document A (vascular disease).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589373Z"}
{"comparison_id":"46668335-6cd5-45a9-b198-7aa59dab685e","query_id":"53","doc_a_id":"17876040","doc_b_id":"14726759","presented_order":["14726759","17876040"],"winner_id":"17876040","reasoning":"Document B — it concerns cancer therapy (though not breast cancer or ALDH1 specifically), whereas Document A is about cervicocerebral artery dissection and unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589379Z"}
{"comparison_id":"11b90695-c837-4389-941f-02b24473840f","query_id":"53","doc_a_id":"23078022","doc_b_id":"14726759","presented_order":["23078022","14726759"],"winner_id":"23078022","reasoning":"Document A — it's a cancer-related molecular study (more relevant to biomarkers/prognosis) whereas B is an unrelated vascular study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589387Z"}
{"comparison_id":"d97a4804-eedb-4196-a76a-17f8b5f47287","query_id":"53","doc_a_id":"14315749","doc_b_id":"14726759","presented_order":["14315749","14726759"],"winner_id":"14315749","reasoning":"Document A — it deals with gene expression and cancer prognosis (albeit colorectal), which is more related to the claim about a cancer marker than Document B about artery dissection.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589393Z"}
{"comparison_id":"6322013d-bb4e-4efd-8ba2-3ec6b9524f47","query_id":"53","doc_a_id":"4729644","doc_b_id":"14726759","presented_order":["4729644","14726759"],"winner_id":"4729644","reasoning":"Document A is more relevant — it's a cancer study discussing tumor markers and prognosis/drug resistance, whereas Document B is about artery dissection and unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589399Z"}
{"comparison_id":"2850011f-6939-4831-afae-1812f690e5e1","query_id":"53","doc_a_id":"38355793","doc_b_id":"14726759","presented_order":["38355793","14726759"],"winner_id":"38355793","reasoning":"Document A is more relevant — it concerns cancer biology (tumor marker expression and prognosis), whereas Document B is about artery dissection and unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589406Z"}
{"comparison_id":"1b58d3ed-521b-4b85-af6d-b3253de9f4e0","query_id":"53","doc_a_id":"7020505","doc_b_id":"14726759","presented_order":["7020505","14726759"],"winner_id":"7020505","reasoning":"Reason: Document A discusses cancer and prognostic genetic markers (more related to prognosis in cancer) while Document B is about artery dissection and unrelated to cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589412Z"}
{"comparison_id":"168c6cfe-55c0-44a4-b630-fad4c8c926db","query_id":"53","doc_a_id":"12903921","doc_b_id":"14726759","presented_order":["12903921","14726759"],"winner_id":"12903921","reasoning":"Document A — it's cancer-related (leukemia) and therefore marginally closer to the query about cancer prognosis than Document B, which concerns vascular dissection. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589419Z"}
{"comparison_id":"5b11c266-38a7-450c-941f-4c18cdf224a4","query_id":"53","doc_a_id":"57783564","doc_b_id":"14726759","presented_order":["14726759","57783564"],"winner_id":"57783564","reasoning":"Document B — it's cancer-related (tumor marker/growth) even though it concerns colon cancer and CDX2 rather than ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589425Z"}
{"comparison_id":"ca82ea12-a83d-41dd-9419-2079170467ae","query_id":"53","doc_a_id":"6807122","doc_b_id":"14726759","presented_order":["14726759","6807122"],"winner_id":"6807122","reasoning":"Document B is more relevant — it discusses tumor biology and mechanisms that relate to cancer progression, whereas Document A is unrelated (vascular disease). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589432Z"}
{"comparison_id":"81970847-0a8f-466c-879d-189ed2712ba0","query_id":"53","doc_a_id":"9648896","doc_b_id":"14726759","presented_order":["9648896","14726759"],"winner_id":"9648896","reasoning":"Document A is more relevant — it's cancer-related (tumor cell behavior and biomarkers), whereas Document B is about artery dissection unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589438Z"}
{"comparison_id":"86fd6037-c763-436d-8ba6-882bc4105ec0","query_id":"53","doc_a_id":"16853734","doc_b_id":"14726759","presented_order":["16853734","14726759"],"winner_id":"16853734","reasoning":"Document A is more relevant — it's cancer-related and discusses protein expression and prognosis-related mechanisms, whereas Document B covers arterial dissection unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589444Z"}
{"comparison_id":"d3acb281-ba8d-4614-ac8d-f499c0310ff8","query_id":"53","doc_a_id":"12074066","doc_b_id":"14726759","presented_order":["12074066","14726759"],"winner_id":"12074066","reasoning":"Reason: Document A addresses cancer (though colorectal) while Document B concerns artery dissection; A is marginally more relevant to a cancer prognosis query.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589451Z"}
{"comparison_id":"d7376559-1428-4bf8-8996-e8f8039de45a","query_id":"53","doc_a_id":"43334921","doc_b_id":"14726759","presented_order":["43334921","14726759"],"winner_id":"43334921","reasoning":"Document A is slightly more relevant because it deals with cancer research (though colorectal), whereas Document B concerns vascular disease unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589457Z"}
{"comparison_id":"3266d660-1684-46f6-aac7-a8989b08b9f6","query_id":"53","doc_a_id":"41293601","doc_b_id":"14726759","presented_order":["41293601","14726759"],"winner_id":"41293601","reasoning":"Document A is more relevant — it discusses tumor biomarkers and cancer subgroups (glioblastoma), which is closer to a cancer prognostic marker than a vascular study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589464Z"}
{"comparison_id":"e364bef4-1f2b-437e-87c1-70df625c4cd3","query_id":"53","doc_a_id":"21414718","doc_b_id":"14726759","presented_order":["21414718","14726759"],"winner_id":"21414718","reasoning":"Document A is more relevant — it concerns cancer biology (though gastric, not breast), whereas Document B is about artery dissection and unrelated to cancer/ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589471Z"}
{"comparison_id":"ecd6213f-1e80-4b3b-a7ca-f7c5168e5d09","query_id":"53","doc_a_id":"25452937","doc_b_id":"14726759","presented_order":["25452937","14726759"],"winner_id":"25452937","reasoning":"Doc A mentions cancer prognosis (though in thyroid cancer), making it marginally more relevant than a vascular study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589477Z"}
{"comparison_id":"50692aac-8651-41bc-af79-79195e2268fb","query_id":"53","doc_a_id":"12145359","doc_b_id":"14726759","presented_order":["14726759","12145359"],"winner_id":"14726759","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document A addresses factors linked to prognosis (though in a different disease), making it slightly more relevant than B which concerns lung cancer risk.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589484Z"}
{"comparison_id":"df4a9589-3971-4382-9b63-aea49b47deac","query_id":"53","doc_a_id":"22478394","doc_b_id":"14726759","presented_order":["14726759","22478394"],"winner_id":"14726759","reasoning":"Document A is slightly more relevant because it discusses factors linked to poorer prognosis (even though not breast cancer), while Document B focuses on liver PPAR-γ expression unrelated to prognosis in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589490Z"}
{"comparison_id":"3ac8bd48-ee93-4244-a552-e9f0fbd00c2f","query_id":"53","doc_a_id":"5884524","doc_b_id":"14726759","presented_order":["5884524","14726759"],"winner_id":"5884524","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant; Document A (about diabetes predicting prognosis) is slightly closer conceptually to a prognostic association. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589496Z"}
{"comparison_id":"cbbff916-f38b-4775-9bc0-bf8461ead6de","query_id":"53","doc_a_id":"24624992","doc_b_id":"14726759","presented_order":["14726759","24624992"],"winner_id":"24624992","reasoning":"Document B is more relevant because it concerns gene expression in cancer cells (leukemia), while Document A is unrelated (artery dissection).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589503Z"}
{"comparison_id":"9dc4376c-48d4-4a19-93fc-dbed3af96817","query_id":"53","doc_a_id":"29190724","doc_b_id":"14726759","presented_order":["14726759","29190724"],"winner_id":"29190724","reasoning":"Document B is more relevant — it discusses cancer-related molecular markers and epigenetics, which is closer to a claim about a cancer biomarker than a study of artery dissection.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589510Z"}
{"comparison_id":"96406080-880f-4b2b-b519-5a1356b6170e","query_id":"53","doc_a_id":"3056682","doc_b_id":"14726759","presented_order":["14726759","3056682"],"winner_id":"14726759","reasoning":"Document A is more relevant — although neither discusses ALDH1 or breast cancer, A at least addresses factors associated with poorer prognosis, whereas B focuses on cardiac troponins and unstable angina.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589516Z"}
{"comparison_id":"5f4198c3-b8c9-491c-abd4-af8d6bad9a3e","query_id":"53","doc_a_id":"1649738","doc_b_id":"14726759","presented_order":["14726759","1649738"],"winner_id":"1649738","reasoning":"Document B — it concerns cancer-related molecular findings, whereas Document A is about artery dissection and unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589523Z"}
{"comparison_id":"2461363e-571c-4af7-b1ef-b97ab0e99036","query_id":"53","doc_a_id":"3590806","doc_b_id":"14726759","presented_order":["3590806","14726759"],"winner_id":"3590806","reasoning":"Document A is more relevant — it's about cancer biology (cancer-initiating cells and pathways), whereas B concerns vascular disease unrelated to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589529Z"}
{"comparison_id":"bcb65fd4-661b-4b61-8681-ab7f4f5e2c99","query_id":"53","doc_a_id":"17671145","doc_b_id":"14726759","presented_order":["17671145","14726759"],"winner_id":"17671145","reasoning":"Reason: Document A is cancer-related (molecular marker and prognosis/therapy context), while Document B is about vascular disease and unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589536Z"}
{"comparison_id":"1992aba8-caa6-4d6b-ad95-7165f5bc6954","query_id":"53","doc_a_id":"9196472","doc_b_id":"14726759","presented_order":["14726759","9196472"],"winner_id":"9196472","reasoning":"Document B — it discusses gene expression and its links to disease susceptibility, which is conceptually closer to a claim about ALDH1 expression and cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589542Z"}
{"comparison_id":"22a455eb-1761-486d-8a50-94be6b274eab","query_id":"53","doc_a_id":"19541444","doc_b_id":"14726759","presented_order":["14726759","19541444"],"winner_id":"19541444","reasoning":"Document B is more relevant — it discusses gene expression and tumorigenesis, which is related to cancer prognosis, whereas Document A concerns artery dissection unrelated to breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589549Z"}
{"comparison_id":"e0a023b0-96b5-4ce8-a622-b3f62000e4d3","query_id":"53","doc_a_id":"24705390","doc_b_id":"14726759","presented_order":["24705390","14726759"],"winner_id":"24705390","reasoning":"Document A is slightly more relevant because it relates to cancer-related mutagenesis, whereas Document B concerns vascular dissections and not cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589555Z"}
{"comparison_id":"710d550c-0794-4b0e-b0fe-85041e1e0d96","query_id":"53","doc_a_id":"5956380","doc_b_id":"14726759","presented_order":["14726759","5956380"],"winner_id":"5956380","reasoning":"Document B is slightly more relevant because it concerns cancer biology (gliomas), whereas A is about artery dissection and unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589561Z"}
{"comparison_id":"579013a4-f42c-424a-ab1e-fcd562c94f88","query_id":"53","doc_a_id":"12337611","doc_b_id":"14726759","presented_order":["12337611","14726759"],"winner_id":"12337611","reasoning":"Document A — it discusses cancer biology and prognosis (neuroblastoma), making it marginally more relevant than Document B, which concerns artery dissection unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589568Z"}
{"comparison_id":"602ddf58-783e-450b-998e-7b5978101a06","query_id":"53","doc_a_id":"38009906","doc_b_id":"14726759","presented_order":["14726759","38009906"],"winner_id":"38009906","reasoning":"Document B — it discusses cancer-related molecular mechanisms (polycomb/INK4a) whereas A is about artery dissection and unrelated to cancer biomarkers or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589574Z"}
{"comparison_id":"852834f3-c50f-4de0-9c28-57464b1568a3","query_id":"53","doc_a_id":"4445629","doc_b_id":"14726759","presented_order":["4445629","14726759"],"winner_id":"4445629","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more related conceptually because it discusses a biomarker associated with prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589581Z"}
{"comparison_id":"a2fb6084-eff8-4a64-8f5b-77b27a8711ed","query_id":"53","doc_a_id":"7046487","doc_b_id":"14726759","presented_order":["7046487","14726759"],"winner_id":"7046487","reasoning":"Document A is more relevant — it discusses cancer-related molecular pathways and tumor-promoting factors, which is closer to ALDH1 and prognosis in breast cancer than a study on artery dissection.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589588Z"}
{"comparison_id":"25a2a85f-5fbb-4a10-ad2f-af9bb6412e74","query_id":"53","doc_a_id":"8702697","doc_b_id":"14726759","presented_order":["14726759","8702697"],"winner_id":"8702697","reasoning":"Document B is slightly more relevant because it discusses cancer prognostic factors and tumor aggressiveness, whereas Document A is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589594Z"}
{"comparison_id":"49267907-7fbc-4206-97e3-c85b1c6ca0af","query_id":"53","doc_a_id":"3559136","doc_b_id":"14726759","presented_order":["3559136","14726759"],"winner_id":"3559136","reasoning":"Reason: Document A concerns tumor biology and breast-cancer–relevant tumor microenvironment mechanisms; Document B is about cervicocerebral artery dissection and unrelated to cancer biomarkers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589601Z"}
{"comparison_id":"08e2f2de-f702-4345-b07e-71a311e760b9","query_id":"53","doc_a_id":"25738896","doc_b_id":"14726759","presented_order":["25738896","14726759"],"winner_id":"14726759","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant only because it addresses prognostic factors (though for artery dissection, not cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589607Z"}
{"comparison_id":"8e4d1746-4cb2-414c-98e1-8752c10768b1","query_id":"53","doc_a_id":"6121555","doc_b_id":"14726759","presented_order":["6121555","14726759"],"winner_id":"6121555","reasoning":"Document A — it's a cancer molecular study (though in glioma), whereas B is about artery dissection and unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589613Z"}
{"comparison_id":"e6f3d4d4-7836-4b18-b077-4597aa47e873","query_id":"53","doc_a_id":"6948886","doc_b_id":"14726759","presented_order":["6948886","14726759"],"winner_id":"6948886","reasoning":"Document A is more relevant — it discusses tumor biology and cancer-related molecular regulation, whereas Document B is about arterial dissection and not cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589620Z"}
{"comparison_id":"e18b7a7f-dd2f-4381-b1fb-650ed46649e4","query_id":"53","doc_a_id":"10699587","doc_b_id":"14726759","presented_order":["10699587","14726759"],"winner_id":"10699587","reasoning":"Document A — it's about cancer prognostic groups (though prostate, not breast), so it's more related to prognosis than the vascular study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589626Z"}
{"comparison_id":"1bdb41e7-b19e-4972-817e-9a6c85334ff0","query_id":"53","doc_a_id":"6171953","doc_b_id":"14726759","presented_order":["14726759","6171953"],"winner_id":"6171953","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses protein expression and disease-related prognosis, whereas A is unrelated (vascular dissection). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589632Z"}
{"comparison_id":"6a5329e9-933b-47a0-b144-afe55989de12","query_id":"53","doc_a_id":"8764879","doc_b_id":"14726759","presented_order":["8764879","14726759"],"winner_id":"8764879","reasoning":"Document A is more relevant — it's cancer-related (AML) and discusses stem-cell markers and prognosis implications, whereas B is about arterial dissection and unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589638Z"}
{"comparison_id":"7b76209e-d846-445c-a296-d026d3fb459c","query_id":"53","doc_a_id":"2359152","doc_b_id":"14726759","presented_order":["2359152","14726759"],"winner_id":"2359152","reasoning":"Doc A is cancer-related and discusses prognostic markers in a hematologic malignancy, making it more relevant than a study on artery dissection. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589644Z"}
{"comparison_id":"57213b02-13ba-412c-b2e3-a8302940b812","query_id":"53","doc_a_id":"67787658","doc_b_id":"14726759","presented_order":["14726759","67787658"],"winner_id":"67787658","reasoning":"Document B is more relevant — it concerns cancer and molecular markers, whereas A is about arterial dissection unrelated to breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589650Z"}
{"comparison_id":"e059b94a-3c5b-4136-986f-741760100390","query_id":"53","doc_a_id":"45764440","doc_b_id":"14726759","presented_order":["45764440","14726759"],"winner_id":"45764440","reasoning":"Document A — it concerns tumor progression and metastasis (cancer context), whereas Document B is about artery dissection and unrelated to cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589656Z"}
{"comparison_id":"b9b1816b-67d2-47a4-a08f-07a109cd48fd","query_id":"53","doc_a_id":"3173489","doc_b_id":"14726759","presented_order":["14726759","3173489"],"winner_id":"14726759","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document A at least discusses factors linked to poorer prognosis (though in cervicocerebral artery dissection), so it's marginally more related to prognosis context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589662Z"}
{"comparison_id":"4957248c-66f0-436a-8224-b7a5b66c9fce","query_id":"53","doc_a_id":"21692235","doc_b_id":"14726759","presented_order":["21692235","14726759"],"winner_id":"21692235","reasoning":"Document A is more relevant — it's about cancer genomics and prognosis (though in glioblastoma), whereas B is about vascular dissections and not cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589669Z"}
{"comparison_id":"56a76692-08f2-4e43-8407-dc070c79ce01","query_id":"53","doc_a_id":"42377686","doc_b_id":"14726759","presented_order":["14726759","42377686"],"winner_id":"42377686","reasoning":"Document B — it discusses prognostic genetic markers in cancer (though in CLL/SLL, not breast cancer), so it's slightly more related than A, which is about artery dissection. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589675Z"}
{"comparison_id":"72cd62c1-20ac-4167-a60e-b12b45aa4e71","query_id":"53","doc_a_id":"35993767","doc_b_id":"14726759","presented_order":["35993767","14726759"],"winner_id":"35993767","reasoning":"Document A is more relevant — it's oncology-focused (tumor biology/metastasis), whereas Document B concerns arterial dissection and is unrelated to cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589681Z"}
{"comparison_id":"6a26785e-2343-4669-962e-a378d043408a","query_id":"53","doc_a_id":"4434951","doc_b_id":"14726759","presented_order":["4434951","14726759"],"winner_id":"4434951","reasoning":"Document A — it concerns gene regulatory/epigenetic changes which are more related to gene expression and cancer biomarkers than the artery-dissection clinical study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589687Z"}
{"comparison_id":"f9281862-9a42-4524-a433-33730cd3b169","query_id":"53","doc_a_id":"16511863","doc_b_id":"14726759","presented_order":["14726759","16511863"],"winner_id":"16511863","reasoning":"Document B is more relevant — it reports a link between elevated expression of a protein and worse disease (hypertrophy), which is analogous to an expression–prognosis association. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589693Z"}
{"comparison_id":"e02a35a6-bb2b-46f4-97f3-3538e7604e7e","query_id":"53","doc_a_id":"10145528","doc_b_id":"14726759","presented_order":["10145528","14726759"],"winner_id":"14726759","reasoning":"Document B is slightly more relevant because it discusses factors linked to prognosis (poorer outcomes), whereas Document A is about ATM polymorphism and not prognosis or ALDH1/breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589700Z"}
{"comparison_id":"4ecf83a0-bc68-450f-b0e6-b48567eccfbd","query_id":"53","doc_a_id":"3619931","doc_b_id":"14726759","presented_order":["3619931","14726759"],"winner_id":"14726759","reasoning":"Document B — mentions factors linked to prognosis (although for artery dissection, not breast cancer), so it's slightly more relevant than A which is unrelated to prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589706Z"}
{"comparison_id":"b9c26cb2-3f4e-4a0f-81ee-295ae74759fa","query_id":"53","doc_a_id":"6766459","doc_b_id":"14726759","presented_order":["6766459","14726759"],"winner_id":"6766459","reasoning":"Document A is more relevant — it discusses molecular gene-expression regulation (closer to tumor biology/markers) while Document B concerns cervicocerebral artery dissection unrelated to breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589713Z"}
{"comparison_id":"b8958122-c58a-4eef-a272-fbbadb50244a","query_id":"53","doc_a_id":"26887439","doc_b_id":"14726759","presented_order":["14726759","26887439"],"winner_id":"26887439","reasoning":"Document B — it's about cancer biology and treatment targets, making it slightly more related to a prognosis-associated marker in cancer, whereas Document A is unrelated (vascular disease). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589720Z"}
{"comparison_id":"da20bdb3-edad-4dc3-88c7-ee946aa24177","query_id":"53","doc_a_id":"26495128","doc_b_id":"14726759","presented_order":["26495128","14726759"],"winner_id":"26495128","reasoning":"Document A is more relevant — it discusses a protein interaction with implications in cancer biology, whereas Document B is about cervicocerebral artery dissection and unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589727Z"}
{"comparison_id":"aa0d4be8-69dc-4767-881f-2d29f15efef0","query_id":"53","doc_a_id":"36310858","doc_b_id":"14726759","presented_order":["14726759","36310858"],"winner_id":"36310858","reasoning":"Document B is more relevant — although neither paper addresses ALDH1 or breast cancer, B concerns cancer biology (tumor biomarkers/regulators), while A is about cerebrovascular disease. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589733Z"}
{"comparison_id":"6730b78c-9860-46a2-825c-467ba280327c","query_id":"53","doc_a_id":"5783785","doc_b_id":"14726759","presented_order":["5783785","14726759"],"winner_id":"5783785","reasoning":"Document A — it's cancer-related (though gastric, not breast) and thus more relevant than a vascular disease study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589739Z"}
{"comparison_id":"9769ac17-70c2-4e18-8fd7-47a3358f8f4b","query_id":"53","doc_a_id":"22059387","doc_b_id":"14726759","presented_order":["14726759","22059387"],"winner_id":"22059387","reasoning":"Document B — it deals with inflammation-mediated carcinogenesis mechanisms, making it marginally more related to cancer prognosis than the vascular study in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589745Z"}
{"comparison_id":"0f839d94-ca45-412f-ad9a-c103800a4efa","query_id":"53","doc_a_id":"5271210","doc_b_id":"14726759","presented_order":["5271210","14726759"],"winner_id":"5271210","reasoning":"Reason: Document A discusses cancer biomarkers and prognosis (though in hepatocellular carcinoma), making it more relevant to a claim about a prognostic biomarker in cancer than Document B, which is unrelated (artery dissection).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589752Z"}
{"comparison_id":"e1d9b1b8-57ff-4034-ac13-b3604688f996","query_id":"53","doc_a_id":"9226649","doc_b_id":"14726759","presented_order":["9226649","14726759"],"winner_id":"9226649","reasoning":"Document A is more relevant — it's about cancer/tumorigenesis mechanisms (though in colon), whereas Document B is about vascular dissection unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.589758Z"}
{"comparison_id":"a9fa7034-ecbb-4eb2-8100-537280a8f907","query_id":"53","doc_a_id":"13283919","doc_b_id":"14726759","presented_order":["13283919","14726759"],"winner_id":"13283919","reasoning":"Document A is slightly more relevant because it discusses molecular/cellular expression and function (closer to biomarker-related topics), whereas Document B concerns vascular disease outcomes unrelated to breast cancer or ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590166Z"}
{"comparison_id":"642753e9-9c57-4c80-96d4-2429404aeeb2","query_id":"53","doc_a_id":"11935250","doc_b_id":"14726759","presented_order":["11935250","14726759"],"winner_id":"11935250","reasoning":"Document A is marginally more relevant because it discusses tissue-specific epigenetic changes (related to cancer biology), while Document B is about artery dissection and unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590175Z"}
{"comparison_id":"e9a9c1bc-31e0-4d69-950a-4c7a8e68c463","query_id":"53","doc_a_id":"15215393","doc_b_id":"14726759","presented_order":["15215393","14726759"],"winner_id":"15215393","reasoning":"Document A is more relevant — it deals with cancer biology and tumor cell epigenetics, whereas B concerns vascular disease; neither directly addresses ALDH1 or breast cancer, but A is closer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590182Z"}
{"comparison_id":"80b66e94-d107-4ece-902d-134e9601a03f","query_id":"53","doc_a_id":"29473081","doc_b_id":"14726759","presented_order":["14726759","29473081"],"winner_id":"29473081","reasoning":"Document B — it discusses cancer biomarker expression linked to survival outcomes (though in multiple myeloma, not breast cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590188Z"}
{"comparison_id":"d48e4f38-5848-4e7b-9aae-b7b6f2a782d7","query_id":"53","doc_a_id":"5123516","doc_b_id":"14726759","presented_order":["14726759","5123516"],"winner_id":"5123516","reasoning":"Document B is more relevant — it discusses cancer biomarkers/targets and tumor prognosis-related biology, whereas Document A concerns vascular disease unrelated to cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590195Z"}
{"comparison_id":"4934567f-de46-4ee6-b1f8-3837eb3e6d8c","query_id":"53","doc_a_id":"26008063","doc_b_id":"14726759","presented_order":["26008063","14726759"],"winner_id":"14726759","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it discusses prognostic associations, while A concerns kidney development and a different gene.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590201Z"}
{"comparison_id":"ca23e719-9420-4e09-bbbf-511bc4e70f0f","query_id":"53","doc_a_id":"22180793","doc_b_id":"14726759","presented_order":["14726759","22180793"],"winner_id":"22180793","reasoning":"Document B is more relevant — it concerns cancer biology (though prostate, not breast), whereas A is about cervicocerebral artery dissection and unrelated to cancer markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590208Z"}
{"comparison_id":"0f30cd4e-6d24-45e6-97ab-07bffdb45f19","query_id":"53","doc_a_id":"33387953","doc_b_id":"14726759","presented_order":["14726759","33387953"],"winner_id":"33387953","reasoning":"Document B is more relevant — it discusses cancer-related molecular markers and mechanisms, whereas A is about cervicocerebral artery dissection and not cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590214Z"}
{"comparison_id":"367e930b-fd92-42bb-83fb-ea4542e6943e","query_id":"53","doc_a_id":"25513319","doc_b_id":"14726759","presented_order":["25513319","14726759"],"winner_id":"25513319","reasoning":"Document A is more relevant — it's about cancer biology and tumor progression (though in prostate cancer), whereas B is a vascular disease study unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590220Z"}
{"comparison_id":"2b77d62c-2591-4f13-85aa-97afee776897","query_id":"53","doc_a_id":"10165723","doc_b_id":"14726759","presented_order":["10165723","14726759"],"winner_id":"10165723","reasoning":"Neither document addresses ALDH1 or breast cancer; however Document A is slightly more relevant because it concerns cancer biology (melanoma) versus a vascular disorder in Document B. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590227Z"}
{"comparison_id":"bbebbd46-9aa5-4dc1-af34-6d4d1d2a73dd","query_id":"53","doc_a_id":"1836154","doc_b_id":"14726759","presented_order":["14726759","1836154"],"winner_id":"1836154","reasoning":"Doc B is cancer-focused and discusses gene expression and prognosis-related biomarkers, making it marginally more relevant than the vascular study in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590233Z"}
{"comparison_id":"219ee218-88b4-4275-9f8a-2c9013280287","query_id":"53","doc_a_id":"18358026","doc_b_id":"14726759","presented_order":["14726759","18358026"],"winner_id":"18358026","reasoning":"Document B is more relevant — it discusses cancer-related molecular mechanisms (epigenetic changes) unlike Document A, which concerns artery dissection and is unrelated to breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590241Z"}
{"comparison_id":"29fe27c8-6eef-427a-8d07-369954f3651c","query_id":"53","doc_a_id":"37204802","doc_b_id":"14726759","presented_order":["14726759","37204802"],"winner_id":"37204802","reasoning":"Document B is more relevant — it discusses a cancer biomarker and prognosis, whereas A is about cervicocerebral artery dissection. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590247Z"}
{"comparison_id":"420fbaa2-27ed-4617-a111-84d0eb6eb0a5","query_id":"53","doc_a_id":"6290112","doc_b_id":"14726759","presented_order":["14726759","6290112"],"winner_id":"14726759","reasoning":"Document A is slightly more relevant because it discusses factors linked to prognosis (though not breast cancer), whereas Document B is about obesity genetics and unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590253Z"}
{"comparison_id":"3811484d-d8d0-44ea-8009-0a6857ab002a","query_id":"53","doc_a_id":"17911973","doc_b_id":"14726759","presented_order":["14726759","17911973"],"winner_id":"17911973","reasoning":"Document B is slightly more relevant because it discusses cancer-related genomic changes, whereas Document A concerns arterial dissection unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590260Z"}
{"comparison_id":"025fb7d4-7a01-4b8c-b468-56b3689c2a56","query_id":"53","doc_a_id":"7975937","doc_b_id":"14726759","presented_order":["7975937","14726759"],"winner_id":"7975937","reasoning":"Document A is more relevant — it discusses cancer biology and tumor prognosis mechanisms, whereas Document B is about artery dissection unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590266Z"}
{"comparison_id":"6201616e-f9f3-458e-ac72-6be1989bd0b7","query_id":"53","doc_a_id":"15928989","doc_b_id":"14726759","presented_order":["14726759","15928989"],"winner_id":"14726759","reasoning":"Document A is slightly more relevant because it discusses factors linked to poorer prognosis (though in artery dissection, not breast cancer); Document B is unrelated to prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590272Z"}
{"comparison_id":"917b6cb3-d637-4950-b8fc-176884227aeb","query_id":"53","doc_a_id":"8385277","doc_b_id":"14726759","presented_order":["8385277","14726759"],"winner_id":"8385277","reasoning":"Document A is more relevant — it's oncology-related and discusses prognostic genomic markers, whereas Document B is about vascular dissection unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590278Z"}
{"comparison_id":"a9bcdd9a-393c-4fd9-852d-3deb834235ec","query_id":"53","doc_a_id":"28334217","doc_b_id":"14726759","presented_order":["14726759","28334217"],"winner_id":"28334217","reasoning":"Reason: Document B concerns cancer biology and tumor prognosis/treatment, while Document A is about artery dissection; neither mentions ALDH1 or breast cancer, but B is more relevant to cancer-related prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590285Z"}
{"comparison_id":"95b958c2-e02b-4488-b349-579c6ca74ae4","query_id":"53","doc_a_id":"7869794","doc_b_id":"14726759","presented_order":["14726759","7869794"],"winner_id":"7869794","reasoning":"Document B is more relevant — it discusses tumor cell interactions and mechanisms in cancer contexts, whereas A is about artery dissection unrelated to breast cancer markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590291Z"}
{"comparison_id":"bbfadd7e-8a3e-4816-ac46-9c3098c119db","query_id":"53","doc_a_id":"864491","doc_b_id":"14726759","presented_order":["864491","14726759"],"winner_id":"864491","reasoning":"Document A — it's oncology-focused (tumor biology/therapy) and thus closer to breast cancer prognosis; Document B is unrelated (cerebrovascular disease).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590298Z"}
{"comparison_id":"277070f2-9dd4-4492-87dd-63b17db4a03d","query_id":"53","doc_a_id":"42782688","doc_b_id":"14726759","presented_order":["42782688","14726759"],"winner_id":"14726759","reasoning":"Neither document addresses ALDH1 or breast cancer. Both are irrelevant; Document B at least discusses “poorer prognosis” (for a different condition). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590304Z"}
{"comparison_id":"b5c0b57e-3cde-42a2-9892-4e97fe4ee909","query_id":"53","doc_a_id":"22703082","doc_b_id":"14726759","presented_order":["22703082","14726759"],"winner_id":"22703082","reasoning":"Document A is more relevant — it discusses cancer-related molecular expression and carcinogenesis, whereas B concerns artery dissection unrelated to cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590310Z"}
{"comparison_id":"3d936ed7-a5d3-4454-abd0-69898f4cc19c","query_id":"53","doc_a_id":"21521236","doc_b_id":"14726759","presented_order":["21521236","14726759"],"winner_id":"21521236","reasoning":"Document A is more relevant because it concerns cancer biology and factors affecting chemosensitivity and prognosis, whereas Document B is unrelated (artery dissection). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590317Z"}
{"comparison_id":"b43097a7-521b-4353-82f2-7f14ab4471ea","query_id":"53","doc_a_id":"3831884","doc_b_id":"14726759","presented_order":["3831884","14726759"],"winner_id":"3831884","reasoning":"Document A is marginally more relevant because it discusses cancer biology (though pancreatic, not breast), whereas Document B concerns vascular disease unrelated to cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590323Z"}
{"comparison_id":"aaa74b35-6ba1-4998-90dc-f9338520c1f8","query_id":"53","doc_a_id":"4325398","doc_b_id":"14726759","presented_order":["4325398","14726759"],"winner_id":"4325398","reasoning":"Document A — it discusses cancer genomic findings (though in pancreatic cancer), which is marginally more related to a claim about cancer biomarkers than a study on artery dissection.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590329Z"}
{"comparison_id":"d7537a29-ac58-46b4-8003-40d680901f37","query_id":"53","doc_a_id":"3504761","doc_b_id":"14726759","presented_order":["3504761","14726759"],"winner_id":"3504761","reasoning":"Document A is more relevant — it discusses tumorigenesis and cancer-related pathways (though not ALDH1 or breast cancer specifically), whereas Document B concerns artery dissection unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590336Z"}
{"comparison_id":"6089ce78-1480-4496-a231-54667ee0c4f1","query_id":"53","doc_a_id":"9791313","doc_b_id":"14726759","presented_order":["14726759","9791313"],"winner_id":"9791313","reasoning":"Document B is more relevant — it discusses cancer-related molecular biology (epigenetic modifiers and tumor suppressors), whereas Document A is about cervicocerebral artery dissection and unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590342Z"}
{"comparison_id":"fd741864-9379-46cb-a7a2-5f9711746c89","query_id":"53","doc_a_id":"5468807","doc_b_id":"14726759","presented_order":["5468807","14726759"],"winner_id":"5468807","reasoning":"Document A is cancer-related (though about ARID1A-mutated ovarian cancer rather than ALDH1 or breast cancer), while Document B concerns vascular disease and is unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590348Z"}
{"comparison_id":"73c95f4a-d4ca-4237-bae4-278acaa47c36","query_id":"53","doc_a_id":"10365787","doc_b_id":"14726759","presented_order":["14726759","10365787"],"winner_id":"10365787","reasoning":"Document B — it discusses cancer-related molecular mechanisms (tumor suppression) whereas Document A is about artery dissection and unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590354Z"}
{"comparison_id":"2753e4a6-2992-4d4c-91a3-da6d3fd4b644","query_id":"53","doc_a_id":"40735046","doc_b_id":"14726759","presented_order":["14726759","40735046"],"winner_id":"40735046","reasoning":"Document B is more relevant — it deals with breast cancer outcomes, whereas Document A is about cervicocerebral artery dissection and is unrelated to breast cancer biology. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590361Z"}
{"comparison_id":"2bd2ee96-1451-427a-a0a1-c97513308455","query_id":"53","doc_a_id":"24783597","doc_b_id":"14726759","presented_order":["14726759","24783597"],"winner_id":"24783597","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. If forced to choose, B is marginally more relevant because it concerns gene expression in disease. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590367Z"}
{"comparison_id":"8529ef32-173d-4486-871c-21b45929c847","query_id":"53","doc_a_id":"1522336","doc_b_id":"14726759","presented_order":["14726759","1522336"],"winner_id":"1522336","reasoning":"Document B is more relevant because it concerns cancer and protein expression, whereas Document A is about cervicocerebral artery dissection and not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590372Z"}
{"comparison_id":"0e3362cd-68f8-457a-8caf-105208ab84e1","query_id":"53","doc_a_id":"24190159","doc_b_id":"14726759","presented_order":["14726759","24190159"],"winner_id":"24190159","reasoning":"Document B is more relevant — it discusses gene expression in cancer (rectal carcinoma), whereas Document A is about artery dissection and unrelated to cancer biomarkers or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590379Z"}
{"comparison_id":"9a809937-1e45-4889-89f9-9c6803b50591","query_id":"53","doc_a_id":"25036988","doc_b_id":"14726759","presented_order":["14726759","25036988"],"winner_id":"25036988","reasoning":"Document B — it's about cancer cell biology (gene expression effects) and thus more related to the claim about a cancer prognostic marker than Document A, which concerns artery dissection. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590385Z"}
{"comparison_id":"9bd003bb-a5f5-4384-972b-16ba0f826751","query_id":"53","doc_a_id":"12685434","doc_b_id":"14726759","presented_order":["14726759","12685434"],"winner_id":"12685434","reasoning":"Document B is more relevant — it's a cancer study about a protein's expression and effect on tumor behavior, whereas A is about artery dissection and unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590392Z"}
{"comparison_id":"b1fb037e-4ec2-41eb-9d87-2ea96fa33ef8","query_id":"53","doc_a_id":"18682109","doc_b_id":"14726759","presented_order":["18682109","14726759"],"winner_id":"18682109","reasoning":"Document A is more relevant — it concerns cancer biology (though in lung cancer), whereas Document B is about artery dissection and unrelated to cancer markers or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590398Z"}
{"comparison_id":"fc8446be-f625-422d-a59a-015230baf14d","query_id":"53","doc_a_id":"2466614","doc_b_id":"14726759","presented_order":["14726759","2466614"],"winner_id":"2466614","reasoning":"Document B — it discusses genome-wide gene expression and molecular pathways (more related to gene expression/prognosis topics) whereas A is about artery dissection and unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590404Z"}
{"comparison_id":"1b590939-ab6a-4282-be22-bc92ce435cfd","query_id":"53","doc_a_id":"14019636","doc_b_id":"14726759","presented_order":["14019636","14726759"],"winner_id":"14019636","reasoning":"Document A is more relevant — it concerns cancer genomics and prognosis-related markers, whereas Document B is about arterial dissection unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590410Z"}
{"comparison_id":"2f3573c8-8714-44e7-b797-118abfd6b962","query_id":"53","doc_a_id":"18988265","doc_b_id":"14726759","presented_order":["18988265","14726759"],"winner_id":"14726759","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; Document B is marginally more relevant because it discusses prognostic factors and outcomes. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590416Z"}
{"comparison_id":"c474b73f-60b1-4273-8e4a-ac9b466b6577","query_id":"53","doc_a_id":"20501163","doc_b_id":"14726759","presented_order":["20501163","14726759"],"winner_id":"20501163","reasoning":"Document A is more relevant — it concerns tumor biology and cancer-related pathways, whereas Document B is about cervicocerebral artery dissection unrelated to cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590422Z"}
{"comparison_id":"94a51bea-3942-4f4e-80ec-b35e25f37a61","query_id":"53","doc_a_id":"22049489","doc_b_id":"14726759","presented_order":["14726759","22049489"],"winner_id":"22049489","reasoning":"Document B — it discusses cancer biology (tumor markers/pathways), whereas A is about arterial dissection and unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590429Z"}
{"comparison_id":"85ca3eee-d571-4b94-ace6-ee24bf733fd2","query_id":"53","doc_a_id":"21063817","doc_b_id":"14726759","presented_order":["21063817","14726759"],"winner_id":"21063817","reasoning":"Document A is more relevant — it concerns marker expression in a carcinoma (cancer) context, while Document B is about cervicocerebral artery dissection and unrelated to cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590435Z"}
{"comparison_id":"26d4f731-48d9-47ff-8a84-1a8c9ad85463","query_id":"53","doc_a_id":"19427410","doc_b_id":"14726759","presented_order":["14726759","19427410"],"winner_id":"19427410","reasoning":"Document B is more relevant — it discusses gene expression (IL-33) and expression changes, which is closer to a claim about marker expression and prognosis than a study of artery dissection. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590441Z"}
{"comparison_id":"ff678ec4-d15f-441a-ac5a-e80a7335ca81","query_id":"53","doc_a_id":"23599024","doc_b_id":"14726759","presented_order":["14726759","23599024"],"winner_id":"23599024","reasoning":"Document B is more relevant — it discusses cancer progression and prognosis (though in lung cancer), whereas Document A is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590447Z"}
{"comparison_id":"43df6692-29eb-4425-870d-f3dc09784419","query_id":"53","doc_a_id":"195689757","doc_b_id":"14726759","presented_order":["14726759","195689757"],"winner_id":"195689757","reasoning":"Reason: Document B discusses cancer metabolic enzymes and metabolic remodeling (ALDH1 is a metabolic enzyme linked to cancer prognosis), so it's more topically related than a study on artery dissection.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590454Z"}
{"comparison_id":"602527dc-d878-4b50-a707-fe4052d510da","query_id":"53","doc_a_id":"36838958","doc_b_id":"14726759","presented_order":["36838958","14726759"],"winner_id":"36838958","reasoning":"Document A is slightly more relevant because it discusses protein expression and regulation at the tissue level (molecular biology), whereas Document B is a clinical vascular study unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590460Z"}
{"comparison_id":"4e7aeee2-6ca0-4138-ba1c-2d46bcb95fd3","query_id":"53","doc_a_id":"15322518","doc_b_id":"14726759","presented_order":["15322518","14726759"],"winner_id":"15322518","reasoning":"Document A is more relevant — it's cancer-related (tumor biology and therapeutic prognosis), whereas B concerns vascular disease unrelated to breast cancer or ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590467Z"}
{"comparison_id":"ab873b08-111c-491b-9c37-055c171eb302","query_id":"53","doc_a_id":"1617327","doc_b_id":"14726759","presented_order":["14726759","1617327"],"winner_id":"1617327","reasoning":"Document B is slightly more relevant because it deals with cancer biology and stem/progenitor cell dysfunction, whereas Document A concerns arterial dissection and is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590473Z"}
{"comparison_id":"6cc8b57a-c59c-4990-8fd2-4fe233d10bb9","query_id":"53","doc_a_id":"11578459","doc_b_id":"14726759","presented_order":["14726759","11578459"],"winner_id":"11578459","reasoning":"Document B — it discusses cancer-related stem cell markers and tumor prognosis mechanisms (though in glioblastoma), which is more related to ALDH1 and prognosis than a study on artery dissection.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590480Z"}
{"comparison_id":"ae867e2a-7a3f-4380-a5e6-80e4561a9e61","query_id":"53","doc_a_id":"9159495","doc_b_id":"14726759","presented_order":["9159495","14726759"],"winner_id":"9159495","reasoning":"Document A is marginally more relevant — it's molecular biology research related to gene expression mechanisms, whereas B concerns cerebrovascular disease unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590487Z"}
{"comparison_id":"aeb6ec51-6aca-4547-abb5-bce9109eb69b","query_id":"53","doc_a_id":"18810195","doc_b_id":"14726759","presented_order":["18810195","14726759"],"winner_id":"18810195","reasoning":"Document A is more relevant — it discusses tumor-associated metabolic changes and prognosis-related mechanisms in cancer, whereas B is an unrelated vascular study. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590493Z"}
{"comparison_id":"dc4517b4-7cef-4ff9-b1a4-b8f95df6103a","query_id":"53","doc_a_id":"1686997","doc_b_id":"14726759","presented_order":["1686997","14726759"],"winner_id":"1686997","reasoning":"Document A is more relevant — it discusses cancer biology and tumor growth mechanisms (potential prognostic/therapeutic targets), whereas Document B is about arterial dissection and unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590500Z"}
{"comparison_id":"b0bddc16-0acf-4543-9ce3-e3a1bca6fc52","query_id":"53","doc_a_id":"28249680","doc_b_id":"14726759","presented_order":["14726759","28249680"],"winner_id":"28249680","reasoning":"Document B is slightly more relevant because it discusses cancer cell biology, whereas Document A concerns cervicocerebral artery dissection and is unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590506Z"}
{"comparison_id":"e34e3625-dc8a-40e4-bc32-dbbb1d6283b7","query_id":"53","doc_a_id":"40349336","doc_b_id":"14726759","presented_order":["14726759","40349336"],"winner_id":"40349336","reasoning":"Document B — it concerns stem cell biology and gene expression affecting stem/progenitor cells, which is more related to ALDH1's role as a stem cell marker than a study on artery dissection.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590530Z"}
{"comparison_id":"6de1fa01-ad51-4645-bd24-89a27d47ea73","query_id":"53","doc_a_id":"16364639","doc_b_id":"14726759","presented_order":["16364639","14726759"],"winner_id":"16364639","reasoning":"Document A is more relevant — it discusses cancer-related molecular markers and oncogenic pathways (though in glioblastoma, not breast cancer), whereas Document B concerns vascular disease unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590544Z"}
{"comparison_id":"6344a788-d0fc-4211-b5a3-f0eaf62eca3e","query_id":"53","doc_a_id":"22483580","doc_b_id":"14726759","presented_order":["22483580","14726759"],"winner_id":"14726759","reasoning":"Neither document discusses ALDH1 or breast cancer; Document B is slightly more relevant because it addresses prognostic factors (though in artery dissection, not cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590553Z"}
{"comparison_id":"2000d37b-5d84-43bb-baf8-8ae6d8206d7f","query_id":"53","doc_a_id":"5573975","doc_b_id":"14726759","presented_order":["5573975","14726759"],"winner_id":"14726759","reasoning":"Document B is slightly more relevant — while neither mentions ALDH1 or breast cancer, B discusses factors linked to prognosis, whereas A is about kidney regeneration and fibrosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590560Z"}
{"comparison_id":"23912a45-268e-4a6b-a64f-79d2d0578457","query_id":"53","doc_a_id":"16201748","doc_b_id":"14726759","presented_order":["14726759","16201748"],"winner_id":"16201748","reasoning":"Document B — it discusses biomarker expression in cancer (PTEN in endometrium), which is more related to biomarker–prognosis questions than Document A about artery dissection. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590566Z"}
{"comparison_id":"3069a8e3-9168-48f0-9f14-ed7077c1004c","query_id":"53","doc_a_id":"2547636","doc_b_id":"14726759","presented_order":["2547636","14726759"],"winner_id":"2547636","reasoning":"Document A is more relevant — it discusses stem cell regulation and carcinogenesis, which is closer to cancer biomarkers like ALDH1 than a vascular-dissection study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590572Z"}
{"comparison_id":"53367d6f-eb9e-4047-b3ff-1240d9a9155d","query_id":"53","doc_a_id":"4312169","doc_b_id":"14726759","presented_order":["14726759","4312169"],"winner_id":"4312169","reasoning":"Document B is more relevant — it's cancer-focused (tumor biomarkers/genetics) though not about ALDH1 or breast cancer; Document A is about artery dissection and unrelated.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590579Z"}
{"comparison_id":"b3ad382a-9d74-4a9f-bac4-efb674564422","query_id":"53","doc_a_id":"6259170","doc_b_id":"14726759","presented_order":["6259170","14726759"],"winner_id":"6259170","reasoning":"Doc A touches on cancer-related pathways (Nrf2, chemoresistance, mitochondrial roles) and is therefore marginally more relevant to biomarkers/prognosis in cancer than Doc B, which is about artery dissection.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590586Z"}
{"comparison_id":"23b5191c-fa7c-4689-97f5-7c0824db7df9","query_id":"53","doc_a_id":"24294572","doc_b_id":"14726759","presented_order":["14726759","24294572"],"winner_id":"24294572","reasoning":"Document B — it deals with cancer-related molecular pathways (more relevant to a claim about a cancer prognostic marker), while Document A is about artery dissection and unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590593Z"}
{"comparison_id":"9aeb0308-9b45-43fc-9542-23b2d3cc502d","query_id":"53","doc_a_id":"5752492","doc_b_id":"14726759","presented_order":["5752492","14726759"],"winner_id":"5752492","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant only because it discusses expression of a molecular marker, whereas B is about vascular dissection.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590600Z"}
{"comparison_id":"140e8995-0a21-4fce-815e-fc507720e0da","query_id":"53","doc_a_id":"30297355","doc_b_id":"14726759","presented_order":["14726759","30297355"],"winner_id":"14726759","reasoning":"Document A is slightly more relevant because it discusses factors linked to prognosis (poorer outcomes), whereas Document B concerns a different gene and tissues unrelated to breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590606Z"}
{"comparison_id":"acc169aa-8d72-421d-b01a-b29422c28625","query_id":"53","doc_a_id":"24347647","doc_b_id":"14726759","presented_order":["14726759","24347647"],"winner_id":"14726759","reasoning":"Document A is slightly more relevant because it discusses factors associated with prognosis (though for artery dissection, not breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590613Z"}
{"comparison_id":"cf00690c-4160-4985-84ba-349f1f1c1aa5","query_id":"53","doc_a_id":"9478135","doc_b_id":"14726759","presented_order":["9478135","14726759"],"winner_id":"9478135","reasoning":"Both documents are irrelevant to ALDH1 or breast cancer; Document A is slightly more relevant because it deals with cancer biology (genetic markers) while B covers vascular disease.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590619Z"}
{"comparison_id":"57d994c4-56e0-4e93-9144-eb660fcf957c","query_id":"53","doc_a_id":"33076846","doc_b_id":"14726759","presented_order":["14726759","33076846"],"winner_id":"33076846","reasoning":"Document B is marginally more relevant because it discusses molecular factors and cancer-related expression, whereas Document A is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590625Z"}
{"comparison_id":"39212d29-7e06-4e87-8a2f-0f297302b263","query_id":"53","doc_a_id":"19644821","doc_b_id":"14726759","presented_order":["19644821","14726759"],"winner_id":"19644821","reasoning":"Document A is more relevant — it concerns cancer biology and prognosis-related findings, whereas Document B is about artery dissection unrelated to cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590632Z"}
{"comparison_id":"eabb15e0-c302-44d7-b328-e494d3c56fb8","query_id":"53","doc_a_id":"5254463","doc_b_id":"14726759","presented_order":["14726759","5254463"],"winner_id":"5254463","reasoning":"Document B is more relevant — it concerns cancer biology and stem-cell-related tumorigenesis, whereas Document A is unrelated (artery dissection). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590638Z"}
{"comparison_id":"c86f483c-ec0d-49e7-b761-20af0700f6e7","query_id":"53","doc_a_id":"4993011","doc_b_id":"14726759","presented_order":["4993011","14726759"],"winner_id":"4993011","reasoning":"Document A — it's cancer-related (though not breast/ALDH1-specific), while B is about artery dissection and unrelated to cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590644Z"}
{"comparison_id":"35e75979-3160-4d24-a7b7-b8073f89a5f8","query_id":"53","doc_a_id":"4457160","doc_b_id":"14726759","presented_order":["14726759","4457160"],"winner_id":"4457160","reasoning":"Document B — it's cancer-related (genomics and prognosis/therapy) while A concerns vascular disease unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590650Z"}
{"comparison_id":"e1062340-ad66-4d66-b063-540dd048bb0c","query_id":"53","doc_a_id":"13398997","doc_b_id":"14726759","presented_order":["13398997","14726759"],"winner_id":"13398997","reasoning":"Document A — it discusses expression of a molecular marker (CTLA-4) and its clinical implications, which is closer in topic to marker expression and prognosis than a vascular disease study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590657Z"}
{"comparison_id":"745c61c5-bf6b-41ad-8361-f14f0bf92243","query_id":"53","doc_a_id":"23887844","doc_b_id":"14726759","presented_order":["23887844","14726759"],"winner_id":"23887844","reasoning":"Document A is more relevant — it concerns cancer cell biology and mechanisms affecting survival/prognosis, whereas B is about artery dissection unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590664Z"}
{"comparison_id":"867a493d-816e-4bf4-8f3e-294d3648509c","query_id":"53","doc_a_id":"6421734","doc_b_id":"14726759","presented_order":["6421734","14726759"],"winner_id":"14726759","reasoning":"Document B is slightly more relevant because it discusses prognostic factors (though for artery dissection, not breast cancer); Document A is unrelated to prognosis or cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590670Z"}
{"comparison_id":"19e011d0-bc79-4176-a01e-92f00a0e5c15","query_id":"53","doc_a_id":"8724666","doc_b_id":"14726759","presented_order":["8724666","14726759"],"winner_id":"8724666","reasoning":"Document A — it's related to cancer biology and metabolic enzymes, so it is closer to a claim about a cancer marker than the vascular study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590676Z"}
{"comparison_id":"8c929c17-8886-45f9-bde0-02ac0264c005","query_id":"53","doc_a_id":"31624828","doc_b_id":"14726759","presented_order":["14726759","31624828"],"winner_id":"31624828","reasoning":"Document B — it discusses cancer-related molecular regulation (p53) and is closer to the topic of cancer biomarkers/prognosis than Document A, which is about artery dissection. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590683Z"}
{"comparison_id":"02bfeb90-621b-4ce7-b27e-d7d418fad566","query_id":"53","doc_a_id":"25344732","doc_b_id":"14726759","presented_order":["14726759","25344732"],"winner_id":"25344732","reasoning":"Document B — it discusses cancer-related gene expression and tumor prognosis, which is closer to the breast cancer/ALDH1 prognosis topic than a vascular dissection study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590689Z"}
{"comparison_id":"49440d43-88a3-47a7-9906-6b51276cb888","query_id":"53","doc_a_id":"10542877","doc_b_id":"14726759","presented_order":["14726759","10542877"],"winner_id":"10542877","reasoning":"Document B is more relevant — it concerns cancer biology/therapy, whereas A is about artery dissection unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590696Z"}
{"comparison_id":"5c81e9f7-662b-447c-97f8-2c1bdb66bd3f","query_id":"53","doc_a_id":"20460020","doc_b_id":"14726759","presented_order":["14726759","20460020"],"winner_id":"20460020","reasoning":"Document B — it's at least about estrogen receptor signaling (more related to cancer biology) while Document A is about arterial dissection and unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590702Z"}
{"comparison_id":"722fd425-19b8-4840-ade2-c9362c2c9b28","query_id":"53","doc_a_id":"25141908","doc_b_id":"14726759","presented_order":["25141908","14726759"],"winner_id":"25141908","reasoning":"Neither document addresses ALDH1 or breast cancer. Both are irrelevant; Document A is marginally closer because it discusses protein expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590708Z"}
{"comparison_id":"ebe120ef-7494-4a7d-82c5-e4d4e4566e8d","query_id":"53","doc_a_id":"30543439","doc_b_id":"14726759","presented_order":["30543439","14726759"],"winner_id":"30543439","reasoning":"Document A is more relevant because it concerns cancer-related molecular biology, while Document B is about artery dissection and unrelated to cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590714Z"}
{"comparison_id":"9f4b6b57-ad46-497c-81f5-7b016d6aa55a","query_id":"53","doc_a_id":"15727984","doc_b_id":"14726759","presented_order":["15727984","14726759"],"winner_id":"15727984","reasoning":"Document A is more relevant — it concerns cancer biology and tumor microenvironment, which is closer to a claim about cancer prognosis than a vascular-dissection study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590721Z"}
{"comparison_id":"d3904fe5-1389-4830-8bf1-0eed582c7958","query_id":"53","doc_a_id":"14972169","doc_b_id":"14726759","presented_order":["14972169","14726759"],"winner_id":"14972169","reasoning":"Document A is slightly more relevant because it addresses molecular enzyme alterations (though not ALDH1 or breast cancer); Document B is unrelated clinical vascular disease. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590727Z"}
{"comparison_id":"ea512d17-b68b-4ffb-adec-910463c1ec04","query_id":"53","doc_a_id":"28644298","doc_b_id":"14726759","presented_order":["28644298","14726759"],"winner_id":"28644298","reasoning":"Document A is slightly more related (cell survival and cancer-related pathways) while B is about vascular disease unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590732Z"}
{"comparison_id":"bb3a9bd8-5c75-41ea-9a7a-8695ad3cb47b","query_id":"53","doc_a_id":"19800147","doc_b_id":"14726759","presented_order":["14726759","19800147"],"winner_id":"19800147","reasoning":"Document B is more relevant because it concerns cancer biology and prognostic markers, whereas Document A is about artery dissection unrelated to breast cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590739Z"}
{"comparison_id":"01f8aff7-39b1-4686-88cf-ec7fd435bc45","query_id":"53","doc_a_id":"4464565","doc_b_id":"14726759","presented_order":["4464565","14726759"],"winner_id":"4464565","reasoning":"Document A is more relevant because it discusses gene expression changes (where ALDH1 expression would fall), whereas Document B concerns artery dissection prognosis unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590745Z"}
{"comparison_id":"8e86b52f-8ac3-426c-a3e4-9c1ed1b24d57","query_id":"53","doc_a_id":"8994465","doc_b_id":"14726759","presented_order":["14726759","8994465"],"winner_id":"8994465","reasoning":"Document B — it concerns cancer cell subpopulations and marker-associated tumor behavior, which is closer to ALDH1/prognosis in breast cancer than a vascular dissection study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590752Z"}
{"comparison_id":"39b265cc-80f5-4e7b-aa3c-db47feadb443","query_id":"53","doc_a_id":"20888849","doc_b_id":"14726759","presented_order":["20888849","14726759"],"winner_id":"20888849","reasoning":"Document A is more relevant — it relates to cancer biology and treatment, whereas Document B is about arterial dissection (unrelated to breast cancer or ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590759Z"}
{"comparison_id":"15ad7e54-98e8-4b0d-94e1-597cf98b66ba","query_id":"53","doc_a_id":"23326722","doc_b_id":"14726759","presented_order":["23326722","14726759"],"winner_id":"23326722","reasoning":"Neither document addresses ALDH1 or breast cancer; however, Document A is cancer-related (lymphoma) while B concerns vascular dissection, so A is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590765Z"}
{"comparison_id":"883947b3-4dbc-4dc6-a3f7-1438e611a287","query_id":"53","doc_a_id":"22890091","doc_b_id":"14726759","presented_order":["22890091","14726759"],"winner_id":"22890091","reasoning":"Document A is slightly more relevant — it deals with protein expression and its relation to cell behavior/prognosis-like outcomes, whereas Document B concerns arterial dissection unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590772Z"}
{"comparison_id":"7e20aafc-acfd-4139-b9f7-4e59d963d3c6","query_id":"53","doc_a_id":"21372171","doc_b_id":"14726759","presented_order":["14726759","21372171"],"winner_id":"14726759","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more related because it addresses prognosis (though for artery dissection, not cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590778Z"}
{"comparison_id":"68170512-6392-4037-a32a-2e513585b1aa","query_id":"53","doc_a_id":"2205779","doc_b_id":"14726759","presented_order":["14726759","2205779"],"winner_id":"2205779","reasoning":"Document B is slightly more relevant because it concerns cancer biomarkers and prognosis, whereas Document A is about artery dissection and unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590784Z"}
{"comparison_id":"b2d773a9-772b-4037-bc1d-333713d8a7c1","query_id":"53","doc_a_id":"17775228","doc_b_id":"14726759","presented_order":["17775228","14726759"],"winner_id":"17775228","reasoning":"Document A is more relevant — it's cancer-related (gene expression/epigenetics) whereas B concerns cerebrovascular disease unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590791Z"}
{"comparison_id":"da3ed73a-524c-4f9b-ba7c-5fd029c91649","query_id":"53","doc_a_id":"41782935","doc_b_id":"14726759","presented_order":["14726759","41782935"],"winner_id":"14726759","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document A at least addresses factors linked to poorer prognosis in a disease, making it marginally more relevant than B (which focuses on Alzheimer's genetics).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590797Z"}
{"comparison_id":"315f9560-d948-431c-aff8-9fed6b5c2422","query_id":"53","doc_a_id":"16627684","doc_b_id":"14726759","presented_order":["14726759","16627684"],"winner_id":"16627684","reasoning":"Document B is more relevant — it discusses cancer-related stem cell biology and tumor suppressors, whereas A concerns artery dissection and is unrelated to cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590803Z"}
{"comparison_id":"2350b094-52b4-4c93-8cdf-998bb8382608","query_id":"53","doc_a_id":"38025907","doc_b_id":"14726759","presented_order":["14726759","38025907"],"winner_id":"38025907","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B discusses tumorigenesis and cancer-related biology, making it marginally closer in topic.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590810Z"}
{"comparison_id":"5f1ecdd6-761b-4b0c-9ca6-93327a035420","query_id":"53","doc_a_id":"19343151","doc_b_id":"14726759","presented_order":["19343151","14726759"],"winner_id":"19343151","reasoning":"Doc A is slightly more relevant because it discusses gene expression as a biomarker (though not ALDH1 or breast cancer); Doc B concerns vascular disease prognosis unrelated to the claim.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590816Z"}
{"comparison_id":"620de06b-ce44-4def-b9eb-6b005d44821c","query_id":"53","doc_a_id":"1727493","doc_b_id":"14726759","presented_order":["1727493","14726759"],"winner_id":"1727493","reasoning":"Document A is more relevant — it concerns cancer biology and tumor markers/therapy (though in ovarian cancer), whereas Document B is about vascular disease unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590822Z"}
{"comparison_id":"45d1db19-4c3f-4903-9d64-7704a39ce8e0","query_id":"53","doc_a_id":"10450725","doc_b_id":"14726759","presented_order":["10450725","14726759"],"winner_id":"10450725","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document A is at least cancer-related (though HCC), so slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590829Z"}
{"comparison_id":"68955463-c92a-431d-b184-1dc2c750a388","query_id":"53","doc_a_id":"3701541","doc_b_id":"14726759","presented_order":["3701541","14726759"],"winner_id":"3701541","reasoning":"Document A is slightly more relevant because it deals with cancer biology (liver cancer), whereas Document B concerns arterial dissection and is unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590835Z"}
{"comparison_id":"bb13dabb-e5a1-4b28-ae9c-f3e63a1578b6","query_id":"53","doc_a_id":"26059876","doc_b_id":"14726759","presented_order":["14726759","26059876"],"winner_id":"26059876","reasoning":"Document B is more relevant because it concerns cancer biology and tumor prognosis mechanisms, whereas A is about cervicocerebral artery dissection and unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590841Z"}
{"comparison_id":"ebf9aa93-46bc-4746-bd1a-f4b774332739","query_id":"53","doc_a_id":"27822315","doc_b_id":"14726759","presented_order":["27822315","14726759"],"winner_id":"27822315","reasoning":"Document A is more relevant — it's a molecular biology study about gene expression and cell differentiation (closer to cancer biology) while Document B is unrelated (vascular disease). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590848Z"}
{"comparison_id":"8b7ea6a4-6546-4b9f-8750-46f5d99811f8","query_id":"53","doc_a_id":"52865789","doc_b_id":"14726759","presented_order":["14726759","52865789"],"winner_id":"14726759","reasoning":"Document A is slightly more relevant because it discusses factors linked to prognosis (even though in artery dissection, not breast cancer); Document B is about IL‑15 and obesity and is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590855Z"}
{"comparison_id":"7e1467de-8a7e-4d17-860e-392c74121d7e","query_id":"53","doc_a_id":"39225849","doc_b_id":"14726759","presented_order":["39225849","14726759"],"winner_id":"39225849","reasoning":"Document A is slightly more related because it discusses cancer-related molecular changes and genomic instability, whereas Document B is about arterial dissection unrelated to cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590861Z"}
{"comparison_id":"458c8ae8-16e1-412c-b434-69dc3c477730","query_id":"53","doc_a_id":"20977638","doc_b_id":"14726759","presented_order":["14726759","20977638"],"winner_id":"20977638","reasoning":"Document B is slightly more relevant because it deals with aldehyde-related oxidative stress pathways (4-HNE) whereas Document A is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590867Z"}
{"comparison_id":"5213ffaf-5911-4e7c-909e-8452c342f90e","query_id":"53","doc_a_id":"32776084","doc_b_id":"14726759","presented_order":["32776084","14726759"],"winner_id":"32776084","reasoning":"Document A is marginally more relevant because it discusses gene expression changes in cells, whereas Document B is about cervicocerebral artery dissection and unrelated to cancer biomarkers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590873Z"}
{"comparison_id":"0f4d44ab-028c-4ab8-89a6-e0ff00b31a3a","query_id":"53","doc_a_id":"1871499","doc_b_id":"14726759","presented_order":["1871499","14726759"],"winner_id":"14726759","reasoning":"Document B — it discusses factors linked to prognosis (though not breast cancer or ALDH1), so it's marginally more relevant than a Huntington's disease epigenetics paper.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590879Z"}
{"comparison_id":"7e51f90c-8a05-4dc9-9812-f37a57a5922e","query_id":"53","doc_a_id":"15491308","doc_b_id":"14726759","presented_order":["15491308","14726759"],"winner_id":"15491308","reasoning":"Document A is slightly closer because it concerns molecular expression and cell growth/biology, whereas Document B is about vascular disease outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590885Z"}
{"comparison_id":"a6e1765c-7755-4de1-b745-852989819f89","query_id":"53","doc_a_id":"41133176","doc_b_id":"14726759","presented_order":["14726759","41133176"],"winner_id":"14726759","reasoning":"Document A is more relevant — it discusses factors linked to poorer prognosis (though in a different disease), whereas B concerns pancreatic antioxidant genes and is unrelated to prognosis or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590892Z"}
{"comparison_id":"fc8f4a0a-e4c9-4f4f-9f31-36b8576b2f17","query_id":"53","doc_a_id":"24285403","doc_b_id":"14726759","presented_order":["14726759","24285403"],"winner_id":"14726759","reasoning":"Document A is slightly more relevant because it discusses factors linked to poorer prognosis (though not breast cancer), whereas Document B concerns cognitive decline and vascular measures. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590898Z"}
{"comparison_id":"c8ec8131-7938-46da-a9f6-3f1d515ffa6f","query_id":"53","doc_a_id":"18938992","doc_b_id":"14726759","presented_order":["18938992","14726759"],"winner_id":"18938992","reasoning":"Document A is marginally more related (covers immune/cancer-related mechanisms), while Document B is about vascular disease; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590904Z"}
{"comparison_id":"a86df8bd-eaf9-4ea1-bffa-8e1c0233437b","query_id":"53","doc_a_id":"3863543","doc_b_id":"14726759","presented_order":["3863543","14726759"],"winner_id":"3863543","reasoning":"Document A is more relevant because it discusses cancer-related biology (stem cell/genotoxic stress and disease progression), whereas Document B is about artery dissection unrelated to cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590911Z"}
{"comparison_id":"6571b82c-76e1-4991-81bc-b3f94c62c98a","query_id":"53","doc_a_id":"23816832","doc_b_id":"14726759","presented_order":["23816832","14726759"],"winner_id":"23816832","reasoning":"Document A is slightly more relevant because it mentions biomarkers and prognosis (though in MS), whereas Document B concerns vascular dissection and is unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590917Z"}
{"comparison_id":"3e49d58a-bf27-4d10-a955-9c413780e8ac","query_id":"53","doc_a_id":"24586989","doc_b_id":"14726759","presented_order":["14726759","24586989"],"winner_id":"14726759","reasoning":"Document A is slightly more relevant because it discusses factors linked to poorer prognosis (though not breast cancer or ALDH1); Document B is about heart-failure genetics and is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590923Z"}
{"comparison_id":"2cb85059-ca45-4a91-90e0-255e4a8612f0","query_id":"53","doc_a_id":"8417211","doc_b_id":"14726759","presented_order":["8417211","14726759"],"winner_id":"8417211","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more related as molecular biology research (protein function) versus B's clinical vascular study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590929Z"}
{"comparison_id":"ad7ed83f-cb93-4694-85bc-930ce94285e9","query_id":"53","doc_a_id":"2919030","doc_b_id":"14726759","presented_order":["14726759","2919030"],"winner_id":"2919030","reasoning":"Document B — it discusses cancer-related cellular mechanisms (metabolism) whereas A is about cervicocerebral artery dissection and unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590935Z"}
{"comparison_id":"9fb475db-7f77-4466-a0b0-aa06742a8fce","query_id":"53","doc_a_id":"22896384","doc_b_id":"14726759","presented_order":["22896384","14726759"],"winner_id":"22896384","reasoning":"Document A is slightly more relevant because it deals with molecular expression and developmental regulators (biological context), whereas Document B is unrelated clinical neurology. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590941Z"}
{"comparison_id":"b614e0a1-4856-4550-8d38-b9d56ba0798e","query_id":"53","doc_a_id":"32372280","doc_b_id":"14726759","presented_order":["32372280","14726759"],"winner_id":"32372280","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses gene expression, whereas Document B concerns vascular dissection prognosis unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590947Z"}
{"comparison_id":"f30e4b2b-1917-499d-9cb7-ae6f2f692755","query_id":"53","doc_a_id":"25022826","doc_b_id":"14726759","presented_order":["25022826","14726759"],"winner_id":"25022826","reasoning":"Document A is more relevant — it's a molecular biology study (gene expression/regulation) whereas Document B concerns vascular disease prognosis unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590954Z"}
{"comparison_id":"8059074d-9369-47f7-9f51-c5b7ecb51f4f","query_id":"53","doc_a_id":"3514072","doc_b_id":"14726759","presented_order":["3514072","14726759"],"winner_id":"14726759","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it concerns prognosis in a human disease, while A is unrelated plant genomics. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590960Z"}
{"comparison_id":"b85af2bf-89f6-4495-9b3e-55d5d56d85df","query_id":"53","doc_a_id":"20179918","doc_b_id":"14726759","presented_order":["14726759","20179918"],"winner_id":"20179918","reasoning":"Document B is more relevant — it concerns gene regulation and molecular biology, which is closer to cancer biomarker context; Document A is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590966Z"}
{"comparison_id":"6d9ece95-046d-440d-b56f-45569b7739d1","query_id":"53","doc_a_id":"19958277","doc_b_id":"14726759","presented_order":["19958277","14726759"],"winner_id":"19958277","reasoning":"Document A is more relevant — it discusses cancer-related molecular biology (genomic stability and cancer risk), whereas Document B concerns artery dissection unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590973Z"}
{"comparison_id":"d6c855fd-02ab-47f8-a781-f46e144f4f3d","query_id":"53","doc_a_id":"12580014","doc_b_id":"14726759","presented_order":["12580014","14726759"],"winner_id":"12580014","reasoning":"Document A is more relevant — it concerns tumor biology and gene expression in cancer cells, whereas Document B is about cervicocerebral artery dissection and unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590979Z"}
{"comparison_id":"71fba5a9-ad80-47c3-bb54-ec111875445c","query_id":"53","doc_a_id":"17412260","doc_b_id":"14726759","presented_order":["17412260","14726759"],"winner_id":"17412260","reasoning":"Document A — it discusses tumor-related senescence and inflammatory signaling relevant to cancer biology, whereas Document B concerns arterial dissection with no relation to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590986Z"}
{"comparison_id":"acce7164-2dba-4007-93cc-e7a92dfc1ccb","query_id":"53","doc_a_id":"11738716","doc_b_id":"14726759","presented_order":["11738716","14726759"],"winner_id":"14726759","reasoning":"Document B is more relevant — it discusses factors linked to poorer prognosis (though in artery dissection, not breast cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590992Z"}
{"comparison_id":"bc8b0701-69d4-457a-a04f-03ba3a96c809","query_id":"53","doc_a_id":"7221410","doc_b_id":"14726759","presented_order":["7221410","14726759"],"winner_id":"7221410","reasoning":"Document A is more similar in topic structure (gene expression linked to disease severity), while Document B concerns artery dissection prognosis unrelated to cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.590998Z"}
{"comparison_id":"6d027d60-d209-4820-b3b2-e89f8ec7dc64","query_id":"53","doc_a_id":"12887068","doc_b_id":"14726759","presented_order":["14726759","12887068"],"winner_id":"12887068","reasoning":"Document B is slightly more relevant because it deals with cancer and stem-cell–like traits, whereas Document A concerns vascular dissection unrelated to cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591004Z"}
{"comparison_id":"1b2121dc-c4a6-4d0c-9282-f68ab32b1db9","query_id":"53","doc_a_id":"5765455","doc_b_id":"14726759","presented_order":["5765455","14726759"],"winner_id":"5765455","reasoning":"Document A — it's cancer-related (genomic instability in leukemia), whereas Document B concerns artery dissection unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591011Z"}
{"comparison_id":"f8e7bd70-31fc-4bc1-9ce2-66c7fdecc969","query_id":"53","doc_a_id":"12462961","doc_b_id":"14726759","presented_order":["14726759","12462961"],"winner_id":"14726759","reasoning":"Document A is slightly more relevant because it discusses prognostic associations (even though for a different disease); Document B concerns transcriptional regulation of an unrelated gene. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591017Z"}
{"comparison_id":"fef5bf78-5cfa-43a6-bd8c-b32ae7505ac6","query_id":"53","doc_a_id":"2829179","doc_b_id":"14726759","presented_order":["2829179","14726759"],"winner_id":"2829179","reasoning":"Document A — it discusses metabolic pathways (more related to ALDH1's metabolic role), while Document B concerns arterial dissection unrelated to breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591023Z"}
{"comparison_id":"2a78e1cb-bfbb-4f7b-afbc-b3e2b5cc4388","query_id":"53","doc_a_id":"28390999","doc_b_id":"14726759","presented_order":["28390999","14726759"],"winner_id":"28390999","reasoning":"Document A is slightly more relevant because it concerns gene expression (though in chicken gonadogenesis, not ALDH1 or breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591029Z"}
{"comparison_id":"3a47ecb3-2577-4723-9e2f-6d47574fb7e2","query_id":"53","doc_a_id":"2356950","doc_b_id":"14726759","presented_order":["2356950","14726759"],"winner_id":"2356950","reasoning":"Neither document provides evidence about ALDH1 in breast cancer, but Document A (molecular study of gene regulation in stem cells) is slightly closer in topic to expression-marker biology than Document B (clinical artery dissection outcomes).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591036Z"}
{"comparison_id":"663882a1-12c9-41d7-a445-2f3591fa53b5","query_id":"53","doc_a_id":"6947286","doc_b_id":"14726759","presented_order":["6947286","14726759"],"winner_id":"14726759","reasoning":"Document B is more relevant — it discusses factors linked to prognosis (though in artery dissection, not breast cancer), whereas Document A is unrelated to ALDH1 or cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591042Z"}
{"comparison_id":"1552043a-97b8-4c00-904e-4e9f6f9cfe70","query_id":"53","doc_a_id":"38028419","doc_b_id":"14726759","presented_order":["14726759","38028419"],"winner_id":"14726759","reasoning":"Document A is marginally more relevant because it discusses factors associated with prognosis (though in artery dissection, not breast cancer), whereas Document B is unrelated to prognosis or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591048Z"}
{"comparison_id":"746ec2c6-bc4d-403d-a435-32f2244014eb","query_id":"53","doc_a_id":"11255504","doc_b_id":"14726759","presented_order":["11255504","14726759"],"winner_id":"11255504","reasoning":"Document A is cancer-related (tumor suppressors, liver cancer), while Document B is about artery dissection; neither mentions ALDH1 or breast cancer, but A is more relevant. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591054Z"}
{"comparison_id":"eb8b0072-3334-4bb6-95b8-c1894d31fb00","query_id":"53","doc_a_id":"13350374","doc_b_id":"14726759","presented_order":["13350374","14726759"],"winner_id":"13350374","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more biologically focused, so choose A.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591060Z"}
{"comparison_id":"690ebf5f-8498-4bc9-a54e-3839430680f4","query_id":"53","doc_a_id":"9641846","doc_b_id":"14726759","presented_order":["9641846","14726759"],"winner_id":"9641846","reasoning":"Document A is more related to cancer biology (cell cycle/differentiation) while Document B concerns vascular disease unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591066Z"}
{"comparison_id":"ffb038e7-ee12-4e2b-86d0-d43434f6a158","query_id":"53","doc_a_id":"34316341","doc_b_id":"14726759","presented_order":["34316341","14726759"],"winner_id":"34316341","reasoning":"Document A is more relevant — it deals with gene expression patterns (IGF2/H19), which is closer to the claim about gene expression and cancer prognosis than Document B's vascular disease study. Neither mentions ALDH1 or breast cancer directly.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591074Z"}
{"comparison_id":"f62bd2c3-5f7f-4dc0-a2cf-f62b55a92225","query_id":"53","doc_a_id":"25748308","doc_b_id":"14726759","presented_order":["14726759","25748308"],"winner_id":"25748308","reasoning":"Document B is more relevant — it discusses protein roles in cancer contexts, whereas A is about artery dissection and unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591080Z"}
{"comparison_id":"1ef946ec-43b4-4949-a54d-56d03da50376","query_id":"53","doc_a_id":"13791206","doc_b_id":"14726759","presented_order":["13791206","14726759"],"winner_id":"13791206","reasoning":"Document A — it relates to DNA repair in BRCA1-deficient cancer cells (breast cancer context) while B is about artery dissection and unrelated to ALDH1 or breast cancer prognosis.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591086Z"}
{"comparison_id":"9e8c187e-917a-4a61-895f-29ca6e469afc","query_id":"53","doc_a_id":"22914228","doc_b_id":"14726759","presented_order":["14726759","22914228"],"winner_id":"22914228","reasoning":"Document B — it's cancer-related (though pancreatic rather than breast), so it's closer to the claim than a vascular disease study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591092Z"}
{"comparison_id":"ff491030-26ae-402f-bc1f-3372312542d9","query_id":"53","doc_a_id":"23513818","doc_b_id":"14726759","presented_order":["14726759","23513818"],"winner_id":"23513818","reasoning":"Document B is more relevant — it discusses molecular regulation of a pro-survival protein (cancer-relevant biology), whereas Document A concerns vascular dissections unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591099Z"}
{"comparison_id":"ed85f877-0b3a-42a6-bd99-14fdb0762df0","query_id":"53","doc_a_id":"5811042","doc_b_id":"14726759","presented_order":["5811042","14726759"],"winner_id":"5811042","reasoning":"Document A is slightly more relevant — it deals with molecular/immune mechanisms in disease context (where markers like ALDH1 would be more likely discussed) whereas Document B is about vascular neurology unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591105Z"}
{"comparison_id":"f2a25b3b-85ef-46f2-a747-1a53ef4d14fc","query_id":"53","doc_a_id":"21602220","doc_b_id":"14726759","presented_order":["14726759","21602220"],"winner_id":"14726759","reasoning":"Document A is slightly more relevant because it addresses clinical prognosis (though for artery dissection, not breast cancer); Document B is unrelated microbiology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591112Z"}
{"comparison_id":"018e53f4-e2bf-4b52-92f2-aa7d949c0dbf","query_id":"53","doc_a_id":"42484543","doc_b_id":"14726759","presented_order":["42484543","14726759"],"winner_id":"42484543","reasoning":"Document A is slightly more relevant because it addresses gene expression profiles (though not ALDH1 or breast cancer), whereas Document B concerns artery dissection unrelated to the claim.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591119Z"}
{"comparison_id":"dfdb0195-8c8a-48b6-97b1-6212bf7db7fe","query_id":"53","doc_a_id":"40901687","doc_b_id":"14726759","presented_order":["14726759","40901687"],"winner_id":"40901687","reasoning":"Document B is more relevant — it discusses molecular pathways and cancer-related cellular responses, whereas A is about cervicocerebral artery dissection and unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591126Z"}
{"comparison_id":"2b662b14-dd09-4946-b00f-6df21c3de90e","query_id":"53","doc_a_id":"1982286","doc_b_id":"14726759","presented_order":["14726759","1982286"],"winner_id":"1982286","reasoning":"Document B — it's cancer-related (oncogenic networks), so marginally more relevant than a vascular study. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591132Z"}
{"comparison_id":"8e7be050-b9ac-4b27-a384-a8ed58f3d6fd","query_id":"53","doc_a_id":"4444861","doc_b_id":"14726759","presented_order":["14726759","4444861"],"winner_id":"4444861","reasoning":"Document B is more relevant—it's about cancer biology and tumor resistance mechanisms, whereas A addresses cervicocerebral artery dissection and is unrelated to breast cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591138Z"}
{"comparison_id":"80fad914-7637-498e-9c9c-0998635477e7","query_id":"53","doc_a_id":"4795303","doc_b_id":"14726759","presented_order":["4795303","14726759"],"winner_id":"4795303","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document A (molecular/cellular study) is marginally closer in topic than a vascular clinical study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591144Z"}
{"comparison_id":"ece80cd3-f628-455a-bfef-755014003afb","query_id":"53","doc_a_id":"14848619","doc_b_id":"14726759","presented_order":["14726759","14848619"],"winner_id":"14848619","reasoning":"Document B is slightly more relevant because it addresses molecular cell-death pathways and hypoxia-related markers that are more connected to cancer biology; Document A concerns vascular dissection and is unrelated. Neither document discusses ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:51:25.591151Z"}
{"comparison_id":"aa3548a5-affd-449b-b5fb-8eccf0a0c81c","query_id":"53","doc_a_id":"42731834","doc_b_id":"25452937","presented_order":["25452937","42731834"],"winner_id":"42731834","reasoning":"Document B is more relevant — it examines how expression of a specific tumor marker (AIM2) relates to patient survival, which is analogous to the claim linking ALDH1 expression and prognosis (even though cancer type and marker differ). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844582Z"}
{"comparison_id":"f10cd92a-4636-4e11-98ad-25512c8cb71d","query_id":"53","doc_a_id":"3899896","doc_b_id":"25452937","presented_order":["3899896","25452937"],"winner_id":"25452937","reasoning":"Document B — it describes a tumor-associated marker linked to decreased survival, which is conceptually closer to a claim about a biomarker (ALDH1) predicting prognosis in cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844616Z"}
{"comparison_id":"26d4f869-7139-4174-9e1a-b344f084334c","query_id":"53","doc_a_id":"10024681","doc_b_id":"25452937","presented_order":["10024681","25452937"],"winner_id":"10024681","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it links gene expression to prognosis (though in prostate cancer), whereas B concerns macrophages in thyroid cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844632Z"}
{"comparison_id":"d64c9e35-d2a6-4efc-a294-08821bae8fa6","query_id":"53","doc_a_id":"52925737","doc_b_id":"25452937","presented_order":["25452937","52925737"],"winner_id":"25452937","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant only because it addresses cancer prognosis/survival (though in thyroid cancer), whereas B focuses on exosomes in gastric cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844642Z"}
{"comparison_id":"15a4a3b4-219c-4e3d-8d72-ce8764ae673a","query_id":"53","doc_a_id":"2389574","doc_b_id":"25452937","presented_order":["25452937","2389574"],"winner_id":"2389574","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it links overexpression of a specific protein to poor prognosis, similar in concept to the claim.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844650Z"}
{"comparison_id":"32dca3db-c1bc-4ee8-ad96-925b0f486552","query_id":"53","doc_a_id":"39580129","doc_b_id":"25452937","presented_order":["39580129","25452937"],"winner_id":"39580129","reasoning":"Reason: Document A examines a molecular marker's expression as a prognostic factor in carcinoma, making it more conceptually similar to a claim about ALDH1 expression and prognosis; Document B concerns immune cell density in thyroid cancer, which is less directly analogous.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844658Z"}
{"comparison_id":"0f15a6a5-1ff5-43e3-8eb6-44e0ec4715d5","query_id":"53","doc_a_id":"22963769","doc_b_id":"25452937","presented_order":["22963769","25452937"],"winner_id":"22963769","reasoning":"Reason: Both documents are unrelated to ALDH1 or breast cancer, but Document A addresses aberrant protein expression correlated with aggressive tumor features, which is conceptually closer to an expression–prognosis association than Document B's focus on macrophage density in thyroid cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844667Z"}
{"comparison_id":"84978939-3165-40b9-b7af-ec111d2b6a4e","query_id":"53","doc_a_id":"654735","doc_b_id":"25452937","presented_order":["654735","25452937"],"winner_id":"654735","reasoning":"Document A is more relevant — it links a molecular marker's expression (miR-21) to poor prognosis in cancer, which is closer to the claim about ALDH1 as a prognostic marker than a study of macrophage density in thyroid cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844675Z"}
{"comparison_id":"b768e943-eed7-4207-8e1f-291b644b929b","query_id":"53","doc_a_id":"20886584","doc_b_id":"25452937","presented_order":["25452937","20886584"],"winner_id":"20886584","reasoning":"Document B — it concerns breast cancer (while A is about thyroid cancer) though neither addresses ALDH1; B is therefore more relevant. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844682Z"}
{"comparison_id":"1f9b92e1-f00a-40fd-a809-b22e529f64e3","query_id":"53","doc_a_id":"38808600","doc_b_id":"25452937","presented_order":["38808600","25452937"],"winner_id":"38808600","reasoning":"Document A is more relevant — it discusses a specific molecular marker (integrin α5β1) being associated with poor prognosis (analogous to ALDH1 as a prognostic marker), whereas Document B focuses on tumor-associated macrophages in thyroid cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844690Z"}
{"comparison_id":"164d3a19-7589-475a-b769-3a067664179b","query_id":"53","doc_a_id":"15081770","doc_b_id":"25452937","presented_order":["15081770","25452937"],"winner_id":"25452937","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it links a tumor-associated factor (macrophage density) to poorer survival, which is closer to the claim about expression and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844697Z"}
{"comparison_id":"a8330c87-23e5-43e7-a58a-6988ef69acbf","query_id":"53","doc_a_id":"8512633","doc_b_id":"25452937","presented_order":["8512633","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it reports an association between a tumor marker (TAM density) and patient survival (prognosis), which is conceptually closer to the claim about a marker (ALDH1) and breast cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844705Z"}
{"comparison_id":"0f270eed-4ab5-4129-b113-c744709c4799","query_id":"53","doc_a_id":"6517763","doc_b_id":"25452937","presented_order":["6517763","25452937"],"winner_id":"6517763","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A deals with molecular expression patterns linked to prognosis (in glioblastoma), so it is marginally more relevant than B, which studies macrophages in thyroid cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844713Z"}
{"comparison_id":"43893c01-e56b-446c-a6ea-5cc57e5ec053","query_id":"53","doc_a_id":"3730196","doc_b_id":"25452937","presented_order":["25452937","3730196"],"winner_id":"3730196","reasoning":"Document B is more relevant — although neither paper studies ALDH1 or breast cancer, B addresses a molecular biomarker (lncRNA) linked to prognosis/chemoresistance, which is closer in scope to an expression–prognosis claim than A's tumor‑associated macrophage study in thyroid cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844722Z"}
{"comparison_id":"807db67d-7152-4942-8468-32dc8f7d9b7c","query_id":"53","doc_a_id":"26561572","doc_b_id":"25452937","presented_order":["25452937","26561572"],"winner_id":"26561572","reasoning":"Both documents are unrelated to ALDH1 in breast cancer; however, B is slightly more relevant because it discusses molecular markers and their association with prognosis (though in lung cancer), whereas A concerns macrophages in thyroid cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844729Z"}
{"comparison_id":"20b21a26-4f07-4311-83a0-8d4a7b23f137","query_id":"53","doc_a_id":"15335331","doc_b_id":"25452937","presented_order":["15335331","25452937"],"winner_id":"15335331","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it links marker expression and EMT to poorer outcomes (a mechanism related to ALDH1-associated prognosis), while B concerns thyroid cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844736Z"}
{"comparison_id":"dc110b0a-77a3-4fd3-a8c3-990f5ca602d6","query_id":"53","doc_a_id":"601033","doc_b_id":"25452937","presented_order":["601033","25452937"],"winner_id":"25452937","reasoning":"Document B — it discusses a tumor-associated marker linked to worse survival in cancer (similar to ALDH1 as a prognostic marker), while A concerns viral reactivation in ATLL and is unrelated. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844743Z"}
{"comparison_id":"c2f817fa-8fc7-469c-a914-a2a8d19c3df5","query_id":"53","doc_a_id":"4467129","doc_b_id":"25452937","presented_order":["4467129","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it reports a tumor marker (TAM density) associated with decreased survival in cancer, which is closer to the claim about a marker (ALDH1) and prognosis than Document A's mechanistic neuroblastoma study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844750Z"}
{"comparison_id":"8ab9490c-69ee-4a6e-be92-0895924f95da","query_id":"53","doc_a_id":"38243984","doc_b_id":"25452937","presented_order":["38243984","25452937"],"winner_id":"38243984","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it addresses gene-expression markers linked to prognosis in cancer generally, whereas B focuses narrowly on tumor-associated macrophages in thyroid cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844757Z"}
{"comparison_id":"887fb004-9bf1-4bcc-9ab7-35e7ad1ef674","query_id":"53","doc_a_id":"16806763","doc_b_id":"25452937","presented_order":["16806763","25452937"],"winner_id":"16806763","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A discusses a molecular expression signature linked to prognosis (closer in concept to ALDH1 expression as a prognostic marker) while Document B focuses on macrophages in thyroid cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844764Z"}
{"comparison_id":"83a9276c-b960-43c1-8de0-f5b99999373a","query_id":"53","doc_a_id":"34189936","doc_b_id":"25452937","presented_order":["34189936","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it addresses a marker's association with survival/prognosis in cancer (though in thyroid, not breast), whereas A concerns a different gene and a different cancer type.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844771Z"}
{"comparison_id":"338a0f90-8626-4c22-ab04-c3c44dce49c2","query_id":"53","doc_a_id":"16701509","doc_b_id":"25452937","presented_order":["16701509","25452937"],"winner_id":"16701509","reasoning":"Reason: Document A concerns breast cancer (though about risk rather than ALDH1 or prognosis), while Document B concerns thyroid cancer and is unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844777Z"}
{"comparison_id":"eae8ed91-27ef-4c7e-af32-665fa2710d4b","query_id":"53","doc_a_id":"37480103","doc_b_id":"25452937","presented_order":["25452937","37480103"],"winner_id":"37480103","reasoning":"Document B — it concerns breast cancer (though about risk, not ALDH1/prognosis), whereas A is about thyroid cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844784Z"}
{"comparison_id":"718d4011-e1a9-4b57-9a66-3aec3091e63e","query_id":"53","doc_a_id":"4489217","doc_b_id":"25452937","presented_order":["4489217","25452937"],"winner_id":"4489217","reasoning":"Document A is slightly more relevant because it discusses intratumor gene expression heterogeneity and its impact on tumor behavior and prognosis, whereas Document B focuses on macrophages in thyroid cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844790Z"}
{"comparison_id":"d65ba922-83b8-49c4-bef3-74f7835ce64c","query_id":"53","doc_a_id":"7165938","doc_b_id":"25452937","presented_order":["7165938","25452937"],"winner_id":"7165938","reasoning":"Document A is more relevant — it discusses how tumor gene expression (Bmal1) relates to prognosis and therapy, which is conceptually closer to a claim about ALDH1 expression and breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844797Z"}
{"comparison_id":"e22de787-1d1b-41b8-9a26-626fa2220f43","query_id":"53","doc_a_id":"515489","doc_b_id":"25452937","presented_order":["25452937","515489"],"winner_id":"515489","reasoning":"Document B is more relevant — it discusses cancer stem cell–like properties and associations with poor prognosis, which is conceptually closer to ALDH1 (a stem cell marker) and prognosis than a study about macrophages in thyroid cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844805Z"}
{"comparison_id":"4274ec76-1035-4886-bc1f-208b072493d4","query_id":"53","doc_a_id":"29124963","doc_b_id":"25452937","presented_order":["29124963","25452937"],"winner_id":"25452937","reasoning":"Document B is slightly more relevant — it reports a biomarker (TAM density) associated with decreased survival (poorer prognosis), which is conceptually similar to the claim about ALDH1 and prognosis, whereas A reports a different marker in lung cancer linked to better outcome.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844812Z"}
{"comparison_id":"f088f59c-01e2-4aca-bbd1-0283e1a33c2d","query_id":"53","doc_a_id":"23304931","doc_b_id":"25452937","presented_order":["25452937","23304931"],"winner_id":"23304931","reasoning":"Reason: Document B examines immunophenotypic marker expression and associations with survival (marker–prognosis relationship), which is more directly analogous to an ALDH1–prognosis claim than Document A's focus on macrophage density in thyroid cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844820Z"}
{"comparison_id":"75da736a-2595-4a9a-bdef-52d3966d164c","query_id":"53","doc_a_id":"19047331","doc_b_id":"25452937","presented_order":["25452937","19047331"],"winner_id":"19047331","reasoning":"Document B is more relevant — it discusses a molecular marker (miR551b-3p/STAT3) tied to cancer growth and poor clinical outcome, which is conceptually closer to ALDH1 as a prognostic molecular marker than Document A's focus on macrophage density in thyroid cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844829Z"}
{"comparison_id":"74aa28ae-f136-4bce-8e6d-733d13c595db","query_id":"53","doc_a_id":"11615422","doc_b_id":"25452937","presented_order":["25452937","11615422"],"winner_id":"25452937","reasoning":"Document A is more relevant because it discusses a marker associated with decreased survival in cancer (though in thyroid cancer), whereas Document B deals with PAX5 breakpoints in leukemia and is less related to prognosis markers in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844837Z"}
{"comparison_id":"b6943983-74d5-47f3-9723-3189617dd704","query_id":"53","doc_a_id":"23665162","doc_b_id":"25452937","presented_order":["23665162","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant because it links a tumor marker's expression/density to patient survival (prognosis) in cancer, whereas A concerns methylation and HCC risk rather than marker expression or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844844Z"}
{"comparison_id":"2a88b386-3e27-475b-9188-b4dc8d0f4a73","query_id":"53","doc_a_id":"20280410","doc_b_id":"25452937","presented_order":["20280410","25452937"],"winner_id":"20280410","reasoning":"Document A — it concerns breast cancer (though not ALDH1 specifically), while Document B is about thyroid cancer and thus less relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844850Z"}
{"comparison_id":"e3275289-7958-44b8-8ac0-5eb2b87dc701","query_id":"53","doc_a_id":"27123743","doc_b_id":"25452937","presented_order":["25452937","27123743"],"winner_id":"27123743","reasoning":"Document B — it concerns breast cancer (risk/etiology), whereas A is about thyroid cancer; neither mentions ALDH1 but B is more relevant to breast cancer prognosis topics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844857Z"}
{"comparison_id":"ee7dff91-4e53-4fbe-aa97-7b3ad4a61a48","query_id":"53","doc_a_id":"8677721","doc_b_id":"25452937","presented_order":["8677721","25452937"],"winner_id":"25452937","reasoning":"Document B — it reports an association between a tumor marker (TAM density) and survival/prognosis, which is conceptually closer to the claim about ALDH1 and breast cancer than Document A's molecular HCC study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844864Z"}
{"comparison_id":"52baa5fb-8c14-497e-bc66-0c46f1fe6a68","query_id":"53","doc_a_id":"23830488","doc_b_id":"25452937","presented_order":["25452937","23830488"],"winner_id":"25452937","reasoning":"Both documents are unrelated to ALDH1 or breast cancer, but A discusses tumor-associated factors linked to decreased survival (prognosis), so it's slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844871Z"}
{"comparison_id":"db01c392-cdba-4365-99d6-a3d02af1b5e7","query_id":"53","doc_a_id":"38551172","doc_b_id":"25452937","presented_order":["25452937","38551172"],"winner_id":"38551172","reasoning":"Document B is more relevant — it concerns breast cancer (though about risk factors) while Document A is about thyroid cancer, so B is closer to the query topic.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844879Z"}
{"comparison_id":"689f426f-9ed5-4776-901e-6fc17b6ec74e","query_id":"53","doc_a_id":"21181273","doc_b_id":"25452937","presented_order":["21181273","25452937"],"winner_id":"21181273","reasoning":"Document A is more relevant — it deals with expression of an enzyme linked to tumor progression (similar to a claim about a marker's expression and prognosis), whereas Document B concerns macrophages in thyroid cancer rather than marker expression in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844888Z"}
{"comparison_id":"701d29d3-1376-4f09-a456-d6decd3367f3","query_id":"53","doc_a_id":"36950726","doc_b_id":"25452937","presented_order":["36950726","25452937"],"winner_id":"36950726","reasoning":"Both documents are not about ALDH1 or breast cancer; Document A is slightly more relevant because it discusses protein expression levels linked to cancer progression (though in melanoma, not breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844894Z"}
{"comparison_id":"6fdadcd5-3006-4dc7-8f13-51fc166c7ac1","query_id":"53","doc_a_id":"17088791","doc_b_id":"25452937","presented_order":["25452937","17088791"],"winner_id":"17088791","reasoning":"Document B is more relevant because it concerns breast cancer (genetic susceptibility), whereas Document A discusses thyroid cancer; neither mentions ALDH1 but B is closer to the query topic.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844901Z"}
{"comparison_id":"617bbad8-ca20-4fd7-9680-30db092869b9","query_id":"53","doc_a_id":"10169908","doc_b_id":"25452937","presented_order":["10169908","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it addresses an association between a tumor-related marker and patient survival (though in thyroid cancer rather than breast). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844907Z"}
{"comparison_id":"85fdcba5-8640-4d40-a274-e7e35aacbd50","query_id":"53","doc_a_id":"17450673","doc_b_id":"25452937","presented_order":["17450673","25452937"],"winner_id":"17450673","reasoning":"Document A is more relevant — it concerns breast cancer (though about risk rather than ALDH1 or prognosis), while B is about thyroid cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844914Z"}
{"comparison_id":"b2d9fd56-c08c-4af8-845d-14e7ce7a25c5","query_id":"53","doc_a_id":"24980622","doc_b_id":"25452937","presented_order":["25452937","24980622"],"winner_id":"25452937","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. Document A is slightly closer to cancer prognosis topics (thyroid), whereas B focuses on hypoxia in colorectal liver metastases.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844921Z"}
{"comparison_id":"2d42df44-1e05-4c02-b6d5-b69cd20dfccb","query_id":"53","doc_a_id":"5774746","doc_b_id":"25452937","presented_order":["25452937","5774746"],"winner_id":"5774746","reasoning":"Reason: Document B discusses tumor protein expression that correlates with worse survival and metastasis, which is conceptually closer to an expression–prognosis association than Document A (which is about macrophage density in thyroid cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844928Z"}
{"comparison_id":"ffa22586-2645-41f1-89c9-87d4d3fbef4c","query_id":"53","doc_a_id":"5372432","doc_b_id":"25452937","presented_order":["25452937","5372432"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant — it discusses a tumor-associated marker linked to decreased survival (though in thyroid cancer, not breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844934Z"}
{"comparison_id":"d5a33c40-f5d6-4f73-b8e5-4f894b875369","query_id":"53","doc_a_id":"2727303","doc_b_id":"25452937","presented_order":["25452937","2727303"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant because it deals with marker expression linked to decreased survival/prognosis (though in thyroid cancer, not ALDH1/breast). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844941Z"}
{"comparison_id":"4c144923-b6c6-4f56-942d-afbe357e4949","query_id":"53","doc_a_id":"21502234","doc_b_id":"25452937","presented_order":["21502234","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — both documents are about biomarkers and prognosis in cancers, but B specifically links marker density/expression to decreased survival, which is closer in theme to the ALDH1–breast cancer prognosis claim.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844948Z"}
{"comparison_id":"f56eb0de-9da4-40b2-b014-418f85fa854c","query_id":"53","doc_a_id":"13831842","doc_b_id":"25452937","presented_order":["13831842","25452937"],"winner_id":"13831842","reasoning":"Reason: Document A addresses breast cancer (though about risk factors), while Document B concerns thyroid cancer; A is therefore more relevant to a claim about prognosis in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844955Z"}
{"comparison_id":"38355dba-e297-43fe-a399-79047968c726","query_id":"53","doc_a_id":"14471161","doc_b_id":"25452937","presented_order":["25452937","14471161"],"winner_id":"25452937","reasoning":"Document A is more relevant — it discusses an association with decreased survival (prognosis) in cancer, whereas Document B focuses on meal timing and tumor growth in pancreatic cancer without addressing prognostic markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844962Z"}
{"comparison_id":"07d6c0aa-6d46-44bd-9815-2f0fb1c953b0","query_id":"53","doc_a_id":"13831558","doc_b_id":"25452937","presented_order":["13831558","25452937"],"winner_id":"13831558","reasoning":"Document A is more relevant — it concerns breast cancer (same disease as the claim), whereas Document B deals with thyroid cancer and is less applicable. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844968Z"}
{"comparison_id":"e3ce5341-fd6c-4722-8285-11c18cefc43a","query_id":"53","doc_a_id":"23577867","doc_b_id":"25452937","presented_order":["25452937","23577867"],"winner_id":"25452937","reasoning":"Document A relates tumor-associated marker density to decreased survival (prognosis), whereas Document B concerns risk factors for endometrial cancer, not prognosis or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844975Z"}
{"comparison_id":"49c4315a-ce77-4f7b-b49e-df03a5a7713b","query_id":"53","doc_a_id":"9239963","doc_b_id":"25452937","presented_order":["9239963","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it links a tumor-associated marker to decreased survival (prognosis), whereas Document A concerns steroidogenic regulation in endometrial cells, not prognosis or ALDH1/breast cancer.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.844995Z"}
{"comparison_id":"a64125a4-b364-406f-ac19-154c11920e0a","query_id":"53","doc_a_id":"25576204","doc_b_id":"25452937","presented_order":["25576204","25452937"],"winner_id":"25576204","reasoning":"Document A is more relevant — it addresses a molecular/genetic factor promoting tumorigenesis (more closely related to biomarker–prognosis links), whereas B focuses on macrophages in thyroid cancer, not breast-cancer biomarkers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845002Z"}
{"comparison_id":"5ae692ba-9b84-427b-87ac-97cfcbb5cf36","query_id":"53","doc_a_id":"11271123","doc_b_id":"25452937","presented_order":["25452937","11271123"],"winner_id":"11271123","reasoning":"Document B is more relevant — it addresses molecular marker analysis in cancer (though in endometrial, not breast), which is closer to the ALDH1–prognosis claim than a thyroid TAM study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845009Z"}
{"comparison_id":"9aea3803-6da4-4907-9fa0-4b7b773bfb2f","query_id":"53","doc_a_id":"31439189","doc_b_id":"25452937","presented_order":["25452937","31439189"],"winner_id":"25452937","reasoning":"A is more relevant — it links a biomarker to patient survival (prognosis), whereas B studies stem-cell markers in prostate cell lines without prognosis data. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845015Z"}
{"comparison_id":"c7a7b7a3-b89b-4a06-95da-cadcebf734c0","query_id":"53","doc_a_id":"2272614","doc_b_id":"25452937","presented_order":["25452937","2272614"],"winner_id":"25452937","reasoning":"Document A is more relevant because it discusses an association between a biomarker and patient survival (prognosis) in cancer, whereas Document B concerns drug resistance mechanisms in lung cancer unrelated to ALDH1 or prognosis in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845023Z"}
{"comparison_id":"1239535c-b906-4cc6-97c3-ac1f62569deb","query_id":"53","doc_a_id":"16630996","doc_b_id":"25452937","presented_order":["16630996","25452937"],"winner_id":"25452937","reasoning":"Document B — it addresses associations with decreased survival (prognosis), whereas A focuses on gemcitabine transport/metabolism in pancreatic cancer, not prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845029Z"}
{"comparison_id":"bac3a382-be35-40ee-bae4-a47594feddcf","query_id":"53","doc_a_id":"25832301","doc_b_id":"25452937","presented_order":["25452937","25832301"],"winner_id":"25452937","reasoning":"Document A is more relevant because it addresses a marker associated with decreased survival (prognosis) in cancer, whereas Document B concerns a different protein and cancer type with improved outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845036Z"}
{"comparison_id":"9c3e1a21-54ec-4ab1-b100-106625354ebb","query_id":"53","doc_a_id":"7639744","doc_b_id":"25452937","presented_order":["7639744","25452937"],"winner_id":"25452937","reasoning":"Document B — it discusses an association between a tumor-related biomarker (TAM density) and cancer prognosis, so it's marginally closer to the ALDH1–breast cancer prognosis claim than a smoking–lung cancer survival study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845043Z"}
{"comparison_id":"caee9a5f-8ca4-4760-92bc-af1cd873cb0e","query_id":"53","doc_a_id":"4828631","doc_b_id":"25452937","presented_order":["25452937","4828631"],"winner_id":"4828631","reasoning":"Document B is more relevant — it at least addresses breast cancer (even though it concerns BMI and risk, not ALDH1 or prognosis). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845064Z"}
{"comparison_id":"56f9d01e-9845-408b-845c-583b5896aec0","query_id":"53","doc_a_id":"24349430","doc_b_id":"25452937","presented_order":["24349430","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it addresses an association between a tumor marker (TAM density) and survival/prognosis in cancer, which is conceptually closer to the query about ALDH1 and prognosis than Document A's mechanistic lung cell study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845082Z"}
{"comparison_id":"dfab45c1-bdb1-4faf-9ee5-f128b454abbc","query_id":"53","doc_a_id":"1507222","doc_b_id":"25452937","presented_order":["25452937","1507222"],"winner_id":"25452937","reasoning":"Document A — it discusses an association between a tumor-related marker and decreased survival (prognosis), which is closer in topic than Document B's focus on metabolic proteins in cachexia. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845091Z"}
{"comparison_id":"194977ce-48ce-4acd-a9e2-2be549c7279e","query_id":"53","doc_a_id":"7736860","doc_b_id":"25452937","presented_order":["25452937","7736860"],"winner_id":"7736860","reasoning":"Document B is more relevant — it links overexpression of a specific molecule to reduced survival in a cancer type, which is conceptually closer to a claim about ALDH1 expression and prognosis than a study of macrophage density in thyroid cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845100Z"}
{"comparison_id":"ee4b3371-c472-48ec-a6a7-aa60ad28f7b4","query_id":"53","doc_a_id":"16098747","doc_b_id":"25452937","presented_order":["25452937","16098747"],"winner_id":"16098747","reasoning":"Document B is more relevant because it concerns breast cancer (where ALDH1 prognostic association would apply), while Document A addresses thyroid cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845108Z"}
{"comparison_id":"2c72938b-103a-45c9-8eb9-c9c32cceaae2","query_id":"53","doc_a_id":"14672919","doc_b_id":"25452937","presented_order":["14672919","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it links a tumor biomarker (TAM density) to prognosis in cancer, which is conceptually closer to the query about ALDH1 and prognosis, whereas Document A concerns platelet measures in esophageal cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845116Z"}
{"comparison_id":"23b1da9c-504b-4c74-9ca3-0fed9c697804","query_id":"53","doc_a_id":"5222182","doc_b_id":"25452937","presented_order":["25452937","5222182"],"winner_id":"5222182","reasoning":"Document B — it concerns breast-related findings (mammographic density) whereas Document A is about thyroid cancer, so B is more relevant to a breast cancer prognosis claim.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845126Z"}
{"comparison_id":"8ca0a703-0460-47e2-8a3b-9e27587a9466","query_id":"53","doc_a_id":"16322674","doc_b_id":"25452937","presented_order":["25452937","16322674"],"winner_id":"16322674","reasoning":"Document B — it concerns breast cancer (though risk rather than prognosis or ALDH1), whereas A is about thyroid cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845133Z"}
{"comparison_id":"6f01d8ef-ed8c-439b-85a7-016a2e2b3625","query_id":"53","doc_a_id":"6790197","doc_b_id":"25452937","presented_order":["6790197","25452937"],"winner_id":"6790197","reasoning":"Document A is more relevant — it concerns cancer-related gene expression alterations and prognosis associations (though in prostate, not breast), whereas B addresses macrophages in thyroid cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845140Z"}
{"comparison_id":"b49d314c-107d-43bf-92bc-3440fad9d001","query_id":"53","doc_a_id":"5377642","doc_b_id":"25452937","presented_order":["25452937","5377642"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant because it reports an association between a tumor-associated marker (TAM density) and patient survival, which is conceptually similar to the claim about ALDH1 and prognosis; Document B focuses on T cell PD-1 regulation and immune exhaustion, not prognosis markers in tumors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845148Z"}
{"comparison_id":"1c525573-22ac-4acf-9513-df98472bb10c","query_id":"53","doc_a_id":"13964633","doc_b_id":"25452937","presented_order":["25452937","13964633"],"winner_id":"13964633","reasoning":"Document B is slightly more relevant because it concerns gene expression and tumor growth mechanisms, whereas Document A is about macrophages in thyroid cancer and unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845155Z"}
{"comparison_id":"5941bc92-3c6f-4267-afc8-69e07d88adb9","query_id":"53","doc_a_id":"3684342","doc_b_id":"25452937","presented_order":["25452937","3684342"],"winner_id":"25452937","reasoning":"Document A — it addresses associations between tumor markers and patient survival (prognosis), whereas Document B is focused on LIN28B-driven lung cancer and is less related to prognosis markers in breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845162Z"}
{"comparison_id":"4226f5e8-1900-4281-a95e-c4947c152d88","query_id":"53","doc_a_id":"39929509","doc_b_id":"25452937","presented_order":["25452937","39929509"],"winner_id":"25452937","reasoning":"Doc A links a tumor-associated marker to decreased survival (a prognosis association), making it more relevant to a claim about marker expression and prognosis than Doc B, which is a molecular binding study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845169Z"}
{"comparison_id":"ea04c80a-998d-45b6-bf6c-6857ceabd878","query_id":"53","doc_a_id":"46617075","doc_b_id":"25452937","presented_order":["46617075","25452937"],"winner_id":"25452937","reasoning":"Document B — it addresses an association between a tumor-related marker (TAM density) and patient survival, which is conceptually closer to the claim about ALDH1 expression and prognosis than the Rb-p16 lung cancer review.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845176Z"}
{"comparison_id":"8b224a56-297a-4e94-b3fc-d859128562f2","query_id":"53","doc_a_id":"31313782","doc_b_id":"25452937","presented_order":["25452937","31313782"],"winner_id":"25452937","reasoning":"Document A — it discusses tumor-marker expression associated with survival (prognosis) in cancer, which is closer to the claim about ALDH1 and breast cancer than the TLR expression study in non-small cell lung cancer/IPF.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845183Z"}
{"comparison_id":"a4caaa46-e1df-4bb7-b2cb-c1ca5d0ecdaf","query_id":"53","doc_a_id":"14180565","doc_b_id":"25452937","presented_order":["25452937","14180565"],"winner_id":"25452937","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document A is slightly more relevant because it addresses cancer prognosis and survival, while Document B focuses on gene modulation in glioblastoma cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845190Z"}
{"comparison_id":"65b466db-2e55-47ba-9725-ebfb14bf4061","query_id":"53","doc_a_id":"39758684","doc_b_id":"25452937","presented_order":["25452937","39758684"],"winner_id":"25452937","reasoning":"Document A is more relevant — it links a tumor-associated factor to decreased survival (prognosis), whereas B is a mechanistic study unrelated to prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845198Z"}
{"comparison_id":"b83a122a-30df-4640-8796-a28336dfc288","query_id":"53","doc_a_id":"641786","doc_b_id":"25452937","presented_order":["641786","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant—both documents are off-topic, but B discusses a prognostic marker linked to survival in cancer, whereas A concerns NT5C2 mutations in childhood ALL unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845205Z"}
{"comparison_id":"abd1528a-3254-4979-a12c-b9e34c4cc3a9","query_id":"53","doc_a_id":"33370","doc_b_id":"25452937","presented_order":["33370","25452937"],"winner_id":"25452937","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it discusses an association between a tumor-related marker (TAM density) and decreased survival, i.e., prognostic correlation.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845211Z"}
{"comparison_id":"cb1b3824-9a5d-4ad7-a75c-7370f3e795c9","query_id":"53","doc_a_id":"27306942","doc_b_id":"25452937","presented_order":["25452937","27306942"],"winner_id":"27306942","reasoning":"Document B — it discusses a gene expression change (CRLF2) linked to poor outcome, which is more conceptually similar to a claim about ALDH1 expression and prognosis than A (which concerns macrophages in thyroid cancer).\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845218Z"}
{"comparison_id":"3deb6d49-c0b8-404e-87b8-796254b99e4f","query_id":"53","doc_a_id":"3067015","doc_b_id":"25452937","presented_order":["25452937","3067015"],"winner_id":"3067015","reasoning":"Document B is slightly more relevant because it discusses an ALDH family gene (ALDH2), whereas Document A is about macrophages in thyroid cancer and unrelated to ALDH or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845225Z"}
{"comparison_id":"37b71f41-9e34-4170-9709-ec844660c2cb","query_id":"53","doc_a_id":"32852283","doc_b_id":"25452937","presented_order":["25452937","32852283"],"winner_id":"25452937","reasoning":"Document A is more relevant — it addresses associations between a tumor feature and decreased survival (prognosis), whereas Document B discusses drug effects in lung cancer unrelated to prognostic markers in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845232Z"}
{"comparison_id":"d6b8173f-2760-40f4-b707-35c358ba9cfe","query_id":"53","doc_a_id":"23557241","doc_b_id":"25452937","presented_order":["23557241","25452937"],"winner_id":"23557241","reasoning":"Document A is about breast cancer (risk factors), whereas Document B concerns thyroid cancer; A is therefore more relevant to a claim about prognosis in breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845238Z"}
{"comparison_id":"326cc0b7-22b5-46c0-ab85-ff2199e363a7","query_id":"53","doc_a_id":"9211173","doc_b_id":"25452937","presented_order":["25452937","9211173"],"winner_id":"25452937","reasoning":"Neither discusses ALDH1 or breast cancer. Document A at least addresses an association with decreased survival (prognosis), so it is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845245Z"}
{"comparison_id":"ab220179-48ce-4dc6-957e-44586442bc3a","query_id":"53","doc_a_id":"22123421","doc_b_id":"25452937","presented_order":["22123421","25452937"],"winner_id":"25452937","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B discusses a tumor-associated biomarker linked to prognosis in cancer, making it marginally more relevant than Document A (which addresses a platelet ratio in lung cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845252Z"}
{"comparison_id":"5789a403-d4a9-403a-9e4b-622561ddb767","query_id":"53","doc_a_id":"20738970","doc_b_id":"25452937","presented_order":["20738970","25452937"],"winner_id":"25452937","reasoning":"Doc B is more relevant because it addresses tumor marker density associated with decreased survival (prognosis) in cancer, whereas Doc A concerns Etk in small cell lung cancer apoptosis and not prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845259Z"}
{"comparison_id":"fd248b2b-74a8-4004-9efb-71db0683d7d9","query_id":"53","doc_a_id":"9394119","doc_b_id":"25452937","presented_order":["9394119","25452937"],"winner_id":"9394119","reasoning":"Document A is more relevant because it concerns breast cancer genetics and risk, whereas Document B focuses on macrophages in thyroid cancer, unrelated to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845266Z"}
{"comparison_id":"ac43a704-4e22-4871-97d3-fb66a0c7fc2c","query_id":"53","doc_a_id":"3210545","doc_b_id":"25452937","presented_order":["3210545","25452937"],"winner_id":"3210545","reasoning":"Reason: Document A discusses gene overexpression linked to poorer prognosis (though in endometrial cancer), which is conceptually closer to an expression–prognosis claim than Document B's focus on macrophage density in thyroid cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845273Z"}
{"comparison_id":"6dbb9c8a-2b15-42d3-aa51-1946b6529f42","query_id":"53","doc_a_id":"22007333","doc_b_id":"25452937","presented_order":["25452937","22007333"],"winner_id":"22007333","reasoning":"Document B — it concerns breast cancer risk factors (mammographic density), whereas A is about thyroid cancer and thus less relevant to ALDH1 and breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845279Z"}
{"comparison_id":"d49a0cc4-f24b-4043-b7a8-59a4234a3bfe","query_id":"53","doc_a_id":"23284774","doc_b_id":"25452937","presented_order":["23284774","25452937"],"winner_id":"23284774","reasoning":"Document A is more relevant — it concerns breast cancer (though psychosocial), whereas Document B addresses thyroid cancer and different biomarkers. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845286Z"}
{"comparison_id":"b58f905a-d54e-4d18-9dba-d371cae2ad5d","query_id":"53","doc_a_id":"6121668","doc_b_id":"25452937","presented_order":["6121668","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it reports a biomarker (TAM density) associated with decreased survival (prognosis), which is conceptually closer to the query about a marker's association with poorer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845293Z"}
{"comparison_id":"216fc428-66ea-461c-a6ce-fcad4b8ee42b","query_id":"53","doc_a_id":"23509593","doc_b_id":"25452937","presented_order":["23509593","25452937"],"winner_id":"25452937","reasoning":"Document B is slightly more relevant because it discusses cancer prognosis (although in thyroid cancer), whereas Document A concerns androgen regulation in prostate stromal cells and is unrelated to prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845300Z"}
{"comparison_id":"7cd090ed-0562-4b68-80a3-2389696976aa","query_id":"53","doc_a_id":"9285396","doc_b_id":"25452937","presented_order":["25452937","9285396"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant — it relates a tumor-associated marker to survival (like ALDH1 would), whereas Document B concerns a blood parameter in gastric cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845307Z"}
{"comparison_id":"4cd1c64a-6dee-479d-9d6f-427f30ed6e5c","query_id":"53","doc_a_id":"5386514","doc_b_id":"25452937","presented_order":["25452937","5386514"],"winner_id":"25452937","reasoning":"Document A — it discusses marker density linked to decreased survival (prognosis), whereas B covers immune mechanisms and not prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845313Z"}
{"comparison_id":"6880eee0-1573-48db-9173-4b573b4a5e51","query_id":"53","doc_a_id":"3710557","doc_b_id":"25452937","presented_order":["25452937","3710557"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant because it discusses cancer prognosis associations (though in thyroid cancer, not breast cancer or ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845320Z"}
{"comparison_id":"a0acf4f2-81de-46c6-bc08-82c18b0d9e52","query_id":"53","doc_a_id":"14664424","doc_b_id":"25452937","presented_order":["14664424","25452937"],"winner_id":"14664424","reasoning":"Document A is about prognostic tumor markers and survival outcomes (closer to the claim's topic of marker-associated prognosis), while B focuses on macrophages in thyroid cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845326Z"}
{"comparison_id":"b47a22da-d479-4c7d-8bd5-796e6270e961","query_id":"53","doc_a_id":"20754359","doc_b_id":"25452937","presented_order":["20754359","25452937"],"winner_id":"25452937","reasoning":"Document B is slightly more relevant — it relates to cancer biomarkers and prognosis (though in thyroid cancer), whereas A is about ATLL treatment and not prognostic markers for breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845333Z"}
{"comparison_id":"f9fc98ed-6bad-4964-ac9c-3bbc70e3b09a","query_id":"53","doc_a_id":"53211308","doc_b_id":"25452937","presented_order":["25452937","53211308"],"winner_id":"25452937","reasoning":"Document A is more relevant — it discusses a tumor marker's association with decreased survival (prognosis), albeit in thyroid cancer rather than breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845339Z"}
{"comparison_id":"db2b40f5-46da-4966-92ab-78f3b4e37a3c","query_id":"53","doc_a_id":"3355397","doc_b_id":"25452937","presented_order":["3355397","25452937"],"winner_id":"25452937","reasoning":"Document B — it addresses an association between a biological marker (TAM density) and decreased survival (prognosis), which is more conceptually related to ALDH1–prognosis links than a drug–cancer incidence study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845346Z"}
{"comparison_id":"6e21f720-a60b-4a01-8388-3c282ccbcbfe","query_id":"53","doc_a_id":"25628793","doc_b_id":"25452937","presented_order":["25628793","25452937"],"winner_id":"25452937","reasoning":"B is more relevant — it studies a marker's association with cancer prognosis (though different marker/cancer), whereas A concerns enzyme expression in endometriosis, not cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845353Z"}
{"comparison_id":"1fcaf7c7-64a3-48d6-88dc-8a389f2b753a","query_id":"53","doc_a_id":"36212758","doc_b_id":"25452937","presented_order":["25452937","36212758"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant because it discusses a marker associated with decreased survival (prognosis) in cancer, whereas Document B focuses on genomic profiles in non-small cell lung cancer unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845360Z"}
{"comparison_id":"4bbdb524-fbde-4ef1-ba7f-d445e5d64dfd","query_id":"53","doc_a_id":"17462437","doc_b_id":"25452937","presented_order":["17462437","25452937"],"winner_id":"17462437","reasoning":"Document A — it addresses the prognostic value of a molecular marker in cancer (like ALDH1), whereas B concerns immune cell density in a different cancer type. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845367Z"}
{"comparison_id":"6439369a-3f03-4977-a2a9-cd5ea90ec8f5","query_id":"53","doc_a_id":"2360905","doc_b_id":"25452937","presented_order":["2360905","25452937"],"winner_id":"25452937","reasoning":"Reason: Neither abstract addresses ALDH1 or breast cancer, but Document B discusses prognostic markers in cancer (tumor-associated macrophages and survival), making it slightly more relevant than Document A which focuses on pediatric gliomas.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845374Z"}
{"comparison_id":"dda74f5b-715b-47c9-b42e-21bea2b0d025","query_id":"53","doc_a_id":"16346504","doc_b_id":"25452937","presented_order":["16346504","25452937"],"winner_id":"16346504","reasoning":"Document A is marginally more relevant because it discusses gene expression changes tied to cancer behavior, whereas B addresses immune cell density in a different cancer type. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845381Z"}
{"comparison_id":"695f2a5e-71b0-4351-a9a9-462516eb2b85","query_id":"53","doc_a_id":"20645538","doc_b_id":"25452937","presented_order":["20645538","25452937"],"winner_id":"25452937","reasoning":"Both documents are unrelated to ALDH1 or breast cancer, but Document B addresses a tumor marker's association with prognosis (like ALDH1 would), while Document A concerns pleural effusion in lung cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845387Z"}
{"comparison_id":"b905256b-f8c6-4b4e-9400-06d08b329804","query_id":"53","doc_a_id":"33638477","doc_b_id":"25452937","presented_order":["25452937","33638477"],"winner_id":"25452937","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document A addresses an association between a tumor-related marker and decreased survival (prognosis), making it marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845394Z"}
{"comparison_id":"392e2286-1708-4289-96e7-8782c7614446","query_id":"53","doc_a_id":"3805841","doc_b_id":"25452937","presented_order":["25452937","3805841"],"winner_id":"25452937","reasoning":"Document A is more relevant — it studies marker expression linked to survival (prognosis), albeit in thyroid cancer, which is closer in topic than B's circadian/MYC mechanism in neuroblastoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845400Z"}
{"comparison_id":"f853f07f-afb8-4853-bfb8-71b4cfb9a9cb","query_id":"53","doc_a_id":"14663842","doc_b_id":"25452937","presented_order":["25452937","14663842"],"winner_id":"25452937","reasoning":"Doc A is more relevant — it addresses an association between a biological marker and patient survival (prognosis), whereas Doc B discusses metabolic effects of IDH1 mutations not prognosis or ALDH1/breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845407Z"}
{"comparison_id":"7266bfa4-738b-4a0c-8c0f-92f9c6784ea8","query_id":"53","doc_a_id":"4841908","doc_b_id":"25452937","presented_order":["4841908","25452937"],"winner_id":"25452937","reasoning":"Document B. Reason: It addresses cancer prognosis (though in thyroid cancer), while Document A does not relate to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845413Z"}
{"comparison_id":"a8f1bdaa-b2e8-47f7-9d83-5e1d1d79c8e1","query_id":"53","doc_a_id":"26848994","doc_b_id":"25452937","presented_order":["25452937","26848994"],"winner_id":"26848994","reasoning":"Document B is slightly more relevant — it links expression of a molecular marker to patient survival (though in HCC, not breast cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845419Z"}
{"comparison_id":"61d69456-90db-4021-93ad-3f2807be6e95","query_id":"53","doc_a_id":"14938990","doc_b_id":"25452937","presented_order":["14938990","25452937"],"winner_id":"25452937","reasoning":"Document B — it concerns cancer prognosis (decreased survival) whereas Document A is about PD-1 in SLE, so B is slightly more relevant to a claim about cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845425Z"}
{"comparison_id":"0ca8d87f-554d-47aa-b00d-5aabe1d1ae14","query_id":"53","doc_a_id":"32534305","doc_b_id":"25452937","presented_order":["25452937","32534305"],"winner_id":"32534305","reasoning":"Document B is more relevant — it involves breast cancer (though it addresses diabetes and incidence rather than ALDH1 or prognosis), whereas A is about thyroid cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845432Z"}
{"comparison_id":"462b6860-188c-4d02-8598-03752a146982","query_id":"53","doc_a_id":"1780819","doc_b_id":"25452937","presented_order":["25452937","1780819"],"winner_id":"25452937","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it addresses expression/density of a tumor marker being associated with prognosis in cancer, while B focuses on HAND2 methylation in endometrial cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845440Z"}
{"comparison_id":"c748ce6c-1106-4a1d-a2ce-200fdc8f7038","query_id":"53","doc_a_id":"26902591","doc_b_id":"25452937","presented_order":["26902591","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant because it links a tumor marker's (TAM) density with survival/prognosis, whereas Document A discusses adipose browning and cachexia unrelated to prognostic markers in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845446Z"}
{"comparison_id":"85eff0e6-11e1-4866-9172-6b5c454879ac","query_id":"53","doc_a_id":"19368793","doc_b_id":"25452937","presented_order":["25452937","19368793"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant because it discusses associations between a tumor-related marker and patient survival (prognosis), whereas Document B concerns miRNA biomarkers in hepatocellular carcinoma and not prognosis or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845453Z"}
{"comparison_id":"d60d71aa-f252-431e-bfab-e48222d66575","query_id":"53","doc_a_id":"5487448","doc_b_id":"25452937","presented_order":["25452937","5487448"],"winner_id":"5487448","reasoning":"Document B is more relevant — it concerns breast cancer risk factors (mammographic density), whereas Document A concerns thyroid cancer and tumor-associated macrophages. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845460Z"}
{"comparison_id":"3b498989-7006-43a9-b734-f1f74befbed2","query_id":"53","doc_a_id":"4959368","doc_b_id":"25452937","presented_order":["25452937","4959368"],"winner_id":"25452937","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A discusses a marker's association with prognosis in cancer (thyroid), making it slightly more relevant than Document B (pancreatic metabolic changes).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845466Z"}
{"comparison_id":"370e9eba-5097-4f74-b784-6b4d896cffb0","query_id":"53","doc_a_id":"38485364","doc_b_id":"25452937","presented_order":["25452937","38485364"],"winner_id":"25452937","reasoning":"Document A — it discusses an association with decreased survival/prognosis (though in thyroid cancer), which is closer to the claim about prognosis than Document B's mechanistic focus. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845473Z"}
{"comparison_id":"924a65b3-6a30-442e-b94d-810857373184","query_id":"53","doc_a_id":"3376731","doc_b_id":"25452937","presented_order":["25452937","3376731"],"winner_id":"25452937","reasoning":"Document A is more relevant — it discusses a marker-associated change in survival/prognosis in cancer (albeit thyroid, not breast), whereas Document B focuses on IL6-mediated chemoresistance in esophageal cancer and not prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845480Z"}
{"comparison_id":"86b1c59c-9b92-4b61-8bf6-342ff8ff1dbf","query_id":"53","doc_a_id":"7228140","doc_b_id":"25452937","presented_order":["25452937","7228140"],"winner_id":"7228140","reasoning":"Reason: Neither mentions ALDH1 or breast cancer, but Document B discusses tumor gene-expression subtypes and prognosis (more related to marker–prognosis associations) while A is about TAMs in thyroid cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845488Z"}
{"comparison_id":"d9483107-e2bf-4481-8c5d-2e475220827e","query_id":"53","doc_a_id":"5278233","doc_b_id":"25452937","presented_order":["25452937","5278233"],"winner_id":"25452937","reasoning":"Document A is more relevant — it addresses cancer prognosis (though in thyroid cancer) whereas Document B concerns imprinting in Beckwith-Wiedemann syndrome, unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845494Z"}
{"comparison_id":"35079648-75f9-4756-ab89-a23f30f44e88","query_id":"53","doc_a_id":"29806339","doc_b_id":"25452937","presented_order":["29806339","25452937"],"winner_id":"29806339","reasoning":"Document A is more relevant — it concerns tumor cell molecular mechanisms and prognosis-related therapeutic effects, whereas Document B focuses on macrophages in thyroid cancer (not breast cancer or ALDH1).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845501Z"}
{"comparison_id":"fadf8c35-8798-493a-9e71-58a134defca4","query_id":"53","doc_a_id":"13768432","doc_b_id":"25452937","presented_order":["13768432","25452937"],"winner_id":"25452937","reasoning":"Document B — it discusses cancer prognosis and tumor markers, which is more related to ALDH1 and breast cancer prognosis than a cardiac imaging study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845508Z"}
{"comparison_id":"1232f7f5-0e66-418c-a94f-e45ee5d8e888","query_id":"53","doc_a_id":"13205096","doc_b_id":"25452937","presented_order":["13205096","25452937"],"winner_id":"13205096","reasoning":"Document A — it addresses gene-expression profiling and prognostic markers (though in AML), which is closer to the claim about a molecular marker and prognosis than Document B on macrophages in thyroid cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845515Z"}
{"comparison_id":"c03a3060-cba4-4696-939f-7cf3e9fe8591","query_id":"53","doc_a_id":"36432234","doc_b_id":"25452937","presented_order":["25452937","36432234"],"winner_id":"36432234","reasoning":"Document B is more relevant — it concerns breast cancer biology, whereas Document A discusses thyroid cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845521Z"}
{"comparison_id":"7eccf684-49c6-464b-9e0d-e3f8fd7e8c9f","query_id":"53","doc_a_id":"85665741","doc_b_id":"25452937","presented_order":["85665741","25452937"],"winner_id":"25452937","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B discusses a biomarker's association with prognosis in cancer, making it marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845528Z"}
{"comparison_id":"fd61b7d9-a7cb-4061-9158-8a2091fd3c2a","query_id":"53","doc_a_id":"831167","doc_b_id":"25452937","presented_order":["831167","25452937"],"winner_id":"831167","reasoning":"Document A is more relevant — it deals with gene expression and survival prognosis (though in glioblastoma rather than breast cancer), while B concerns macrophages in thyroid cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845535Z"}
{"comparison_id":"e59c243c-7b86-4e7a-8a7f-5f869ddc83fe","query_id":"53","doc_a_id":"38784540","doc_b_id":"25452937","presented_order":["25452937","38784540"],"winner_id":"38784540","reasoning":"Reason: Document B concerns breast cancer (risk factors and mammographic density), so it's more topically related to the claim about prognosis in breast cancer than Document A, which addresses thyroid cancer and tumor-associated macrophages.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845541Z"}
{"comparison_id":"7cd18d7e-80c3-4934-ae61-58d7f0bc67bd","query_id":"53","doc_a_id":"6363093","doc_b_id":"25452937","presented_order":["6363093","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it links marker density to patient survival in a cancer type (though thyroid rather than breast), which is closer to the claim about expression tied to prognosis than a GBM subclassing study. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845548Z"}
{"comparison_id":"4f3f4600-f9d8-4cdc-a117-20466f50e311","query_id":"53","doc_a_id":"33677323","doc_b_id":"25452937","presented_order":["25452937","33677323"],"winner_id":"33677323","reasoning":"Document B is more relevant — it links a molecular marker's expression to clinical outcome (poor prognosis) in cancer, which is closer to the claim about ALDH1 and prognosis than a study of macrophage density in thyroid cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845555Z"}
{"comparison_id":"d0cf7696-9f99-46f6-9b26-2b24cfa079ab","query_id":"53","doc_a_id":"4500832","doc_b_id":"25452937","presented_order":["4500832","25452937"],"winner_id":"25452937","reasoning":"Document B — it discusses a tumor marker's association with prognosis in cancer (though thyroid, not breast), so it's more related to the claim about a marker predicting poorer cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845562Z"}
{"comparison_id":"960b40cc-7de0-42fb-83c5-82324fc405e7","query_id":"53","doc_a_id":"4387494","doc_b_id":"25452937","presented_order":["25452937","4387494"],"winner_id":"25452937","reasoning":"Document A is more relevant — it addresses associations between tumor markers and patient survival (though in thyroid cancer rather than breast). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845569Z"}
{"comparison_id":"4ac11680-671d-4523-8cbb-9b96b3eeddff","query_id":"53","doc_a_id":"11900630","doc_b_id":"25452937","presented_order":["25452937","11900630"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant because it addresses cancer prognosis (though in thyroid cancer), whereas Document B concerns bcl-2 in hematopoietic cells and chemotherapy resistance. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845576Z"}
{"comparison_id":"ad802ade-6872-4360-a1a2-37bc762b3d5d","query_id":"53","doc_a_id":"41790911","doc_b_id":"25452937","presented_order":["25452937","41790911"],"winner_id":"25452937","reasoning":"Document A is more relevant — it deals with cancer prognosis and survival associations (though in thyroid cancer), while Document B concerns adipose angiogenesis in obesity and is unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845583Z"}
{"comparison_id":"4948a33f-2924-4110-adc6-aa2a48800e00","query_id":"53","doc_a_id":"42150015","doc_b_id":"25452937","presented_order":["42150015","25452937"],"winner_id":"25452937","reasoning":"Document B — it discusses tumor markers linked to cancer prognosis (though in thyroid cancer), which is more relevant to a claim about cancer prognosis than Document A's study on anti-Müllerian hormone. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845589Z"}
{"comparison_id":"b4048070-898a-4ac9-bca1-b91d2b9e9c2f","query_id":"53","doc_a_id":"23269537","doc_b_id":"25452937","presented_order":["25452937","23269537"],"winner_id":"25452937","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it links a tumor-associated marker to patient survival (though in thyroid cancer and a different marker). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845596Z"}
{"comparison_id":"8b03bf01-a8b7-4f7f-943f-3e151c461908","query_id":"53","doc_a_id":"13905670","doc_b_id":"25452937","presented_order":["13905670","25452937"],"winner_id":"25452937","reasoning":"Document B — it concerns tumor-associated factors and cancer prognosis (though in thyroid cancer), whereas Document A is about a FOXO3 SNP in inflammatory/infectious diseases and not cancer/ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845603Z"}
{"comparison_id":"28650bf9-8a69-4465-9272-5ae6a47e18bd","query_id":"53","doc_a_id":"25488034","doc_b_id":"25452937","presented_order":["25452937","25488034"],"winner_id":"25488034","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B discusses cancer-related detoxifying enzymes and therapy resistance (more related to ALDH1's enzymatic/chemo-resistance role) while Document A focuses on macrophages in thyroid cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845610Z"}
{"comparison_id":"057175b0-d056-4730-9780-7759612e228b","query_id":"53","doc_a_id":"9171913","doc_b_id":"25452937","presented_order":["25452937","9171913"],"winner_id":"9171913","reasoning":"Document B — it concerns breast cancer (though not ALDH1 or prognosis), while Document A addresses thyroid cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845617Z"}
{"comparison_id":"c78c3008-2a61-4ad9-a984-4ba868f10201","query_id":"53","doc_a_id":"21551568","doc_b_id":"25452937","presented_order":["25452937","21551568"],"winner_id":"25452937","reasoning":"Document A is more relevant — it reports a marker (TAM density) being associated with decreased survival, which parallels the query about a marker (ALDH1) and prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845624Z"}
{"comparison_id":"731b6918-977c-4453-8ce7-c184eae73ddb","query_id":"53","doc_a_id":"9095394","doc_b_id":"25452937","presented_order":["25452937","9095394"],"winner_id":"25452937","reasoning":"Document A is more relevant because it discusses a molecular/cellular marker associated with poorer survival in cancer (though in thyroid rather than breast), whereas Document B concerns keratin expression in oral neoplasms without prognosis linkage.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845631Z"}
{"comparison_id":"528eae0c-2a2e-4678-918f-5297a977323d","query_id":"53","doc_a_id":"7028976","doc_b_id":"25452937","presented_order":["25452937","7028976"],"winner_id":"25452937","reasoning":"Document A is more relevant — it discusses an association with decreased survival (prognosis), whereas Document B focuses on EGFR in glioblastoma and not prognosis in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845638Z"}
{"comparison_id":"29d96a89-fbfa-4901-84c4-a2e84db85439","query_id":"53","doc_a_id":"11968641","doc_b_id":"25452937","presented_order":["25452937","11968641"],"winner_id":"25452937","reasoning":"Document A is more relevant — it discusses a marker (TAM density) associated with decreased survival/prognosis, whereas Document B focuses on circadian clock effects in non-breast cancers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845645Z"}
{"comparison_id":"572e75d1-1303-4bcc-922b-e1a80fa0db69","query_id":"53","doc_a_id":"663464","doc_b_id":"25452937","presented_order":["663464","25452937"],"winner_id":"25452937","reasoning":"Document B — it addresses tumor markers and cancer prognosis (though in thyroid cancer), so it's closer to the query about cancer marker-associated prognosis than Document A on aging/microRNAs.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845651Z"}
{"comparison_id":"02653e15-975b-4dc7-80cd-e9588602e015","query_id":"53","doc_a_id":"26735905","doc_b_id":"25452937","presented_order":["25452937","26735905"],"winner_id":"25452937","reasoning":"Document A is more relevant — it addresses associations with cancer patient survival/prognosis (though in thyroid cancer), whereas B focuses on stromal metabolism in prostate tumorigenesis and not prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845658Z"}
{"comparison_id":"8fcc9e35-a85f-4449-b8d0-d00d44c06215","query_id":"53","doc_a_id":"23934390","doc_b_id":"25452937","presented_order":["23934390","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it discusses a biomarker (TAM density) linked to survival/prognosis, whereas A focuses on miR-203 in NSCLC without prognostic data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845664Z"}
{"comparison_id":"8005fccf-3ddd-4b23-8541-965ffb4295cf","query_id":"53","doc_a_id":"2494748","doc_b_id":"25452937","presented_order":["25452937","2494748"],"winner_id":"25452937","reasoning":"Document A is more relevant — it addresses cancer prognosis (survival associations), whereas Document B concerns methylation in gastric carcinoma and not prognosis or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845671Z"}
{"comparison_id":"b9d36b75-9dcf-4982-a061-0c20512085ca","query_id":"53","doc_a_id":"16016673","doc_b_id":"25452937","presented_order":["16016673","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it links a biomarker's increased presence to poorer survival in cancer, which is conceptually closer to the claim about ALDH1 and prognosis than Document A's focus on bladder cancer detection markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845678Z"}
{"comparison_id":"8c755443-875a-4b76-9e81-41baa064e9e6","query_id":"53","doc_a_id":"1976183","doc_b_id":"25452937","presented_order":["25452937","1976183"],"winner_id":"25452937","reasoning":"Document A is more relevant — it links a tumor-related marker to decreased survival (prognosis), whereas B concerns a miRNA in oral cancer without a prognostic focus. Neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845684Z"}
{"comparison_id":"2e1993d9-ed0d-4a7d-bcb5-8cc3c4181236","query_id":"53","doc_a_id":"33030946","doc_b_id":"25452937","presented_order":["33030946","25452937"],"winner_id":"25452937","reasoning":"Document B — it concerns tumor-associated macrophages and cancer prognosis (though in thyroid cancer), which is closer to a claim about cancer prognostic markers than Document A about COMMD1 and osteoclastogenesis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845691Z"}
{"comparison_id":"e382e653-47ff-425b-8156-e867d0099ae6","query_id":"53","doc_a_id":"13400643","doc_b_id":"25452937","presented_order":["25452937","13400643"],"winner_id":"13400643","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is marginally more relevant because it addresses cancer growth and potential prognostic/therapeutic targets, whereas A concerns macrophages in thyroid cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845698Z"}
{"comparison_id":"20ce56bc-95d3-4706-8338-7ccf3e9b79c8","query_id":"53","doc_a_id":"22901758","doc_b_id":"25452937","presented_order":["25452937","22901758"],"winner_id":"22901758","reasoning":"Document B. It addresses tumor-initiating (stem-like) cells and survival correlations, which is conceptually closer to ALDH1 (a cancer stem-cell marker) and prognosis than Document A's focus on macrophages in thyroid cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845704Z"}
{"comparison_id":"0e982ebf-5ecb-45f8-84aa-a6f477c2575c","query_id":"53","doc_a_id":"17876040","doc_b_id":"25452937","presented_order":["25452937","17876040"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant because it discusses tumor markers and prognosis in cancer (though in thyroid cancer), whereas Document B focuses on a drug for AML and is unrelated to prognosis markers. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845711Z"}
{"comparison_id":"7f879a5e-24c4-4664-ab83-eb8c47145ff1","query_id":"53","doc_a_id":"23078022","doc_b_id":"25452937","presented_order":["23078022","25452937"],"winner_id":"23078022","reasoning":"Document A is more relevant — it discusses molecular oncogenic signaling in carcinomas (closer to breast cancer biomarkers) whereas B focuses on macrophages in thyroid cancer, which is less related to ALDH1 and breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845718Z"}
{"comparison_id":"37b47789-3481-4719-a827-1662c5ed8a9a","query_id":"53","doc_a_id":"14315749","doc_b_id":"25452937","presented_order":["14315749","25452937"],"winner_id":"14315749","reasoning":"Neither document mentions ALDH1 or breast cancer; both are only tangentially related. Document A is slightly more relevant because it reports tumor gene expression associated with poorer differentiation and metastasis (conceptually closer to a marker–prognosis link) whereas B focuses on macrophage density in thyroid cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845725Z"}
{"comparison_id":"6b5cdfe2-a9c8-4592-92cf-8e4667418840","query_id":"53","doc_a_id":"4729644","doc_b_id":"25452937","presented_order":["4729644","25452937"],"winner_id":"25452937","reasoning":"Document B — it discusses an association between a tumor feature (TAM density) and patient survival (prognosis), whereas A concerns lncRNA-driven drug resistance in nasopharyngeal carcinoma and not prognosis in breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845732Z"}
{"comparison_id":"2c51fb65-191e-4480-a3e7-c36a8032e658","query_id":"53","doc_a_id":"38355793","doc_b_id":"25452937","presented_order":["38355793","25452937"],"winner_id":"25452937","reasoning":"Document B. It discusses a marker's (TAMs) association with survival in cancer, which is conceptually closer to a claim about a biomarker (ALDH1) and prognosis than Document A about A20 in glioma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845739Z"}
{"comparison_id":"6887f8fe-26b9-4ef5-bdc6-948a6a2b9231","query_id":"53","doc_a_id":"7020505","doc_b_id":"25452937","presented_order":["25452937","7020505"],"winner_id":"25452937","reasoning":"Reason: Neither abstract addresses ALDH1 or breast cancer, but Document A discusses a tumor-associated marker linked to decreased survival in cancer, making it slightly more relevant to a prognosis-related claim than Document B (CLL genetics).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845746Z"}
{"comparison_id":"392f9d53-568f-4ac3-99e5-ed5c4c614b80","query_id":"53","doc_a_id":"12903921","doc_b_id":"25452937","presented_order":["25452937","12903921"],"winner_id":"25452937","reasoning":"Document A — it concerns associations between tumor features and patient survival (prognosis) in cancer, whereas Document B is an animal leukemia oxidative-stress study unrelated to cancer prognosis in humans.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845752Z"}
{"comparison_id":"88f54c82-f8eb-4729-b704-223dc237dc7a","query_id":"53","doc_a_id":"57783564","doc_b_id":"25452937","presented_order":["25452937","57783564"],"winner_id":"25452937","reasoning":"Doc A is slightly more relevant because it addresses cancer prognosis (though in thyroid cancer), whereas Doc B concerns CDX2 in colon cancer and is unrelated to prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845759Z"}
{"comparison_id":"37a9970c-31aa-417f-a7c5-4f81ad2e0234","query_id":"53","doc_a_id":"6807122","doc_b_id":"25452937","presented_order":["6807122","25452937"],"winner_id":"6807122","reasoning":"Document A is slightly more relevant because it discusses tumor progression mechanisms (EndMT and carcinoma-associated fibroblasts) that relate to prognosis across carcinomas, whereas Document B concerns macrophages in thyroid cancer specifically. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845765Z"}
{"comparison_id":"4593cc90-4882-480c-b990-bbc798f27574","query_id":"53","doc_a_id":"9648896","doc_b_id":"25452937","presented_order":["25452937","9648896"],"winner_id":"25452937","reasoning":"Both documents are unrelated to ALDH1 in breast cancer, but A discusses an association with decreased survival (prognosis) in cancer, making it slightly more relevant than B which focuses on lung CAF/miR-1 mechanisms. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845772Z"}
{"comparison_id":"41c6c2a6-7d5f-48a6-a849-b64c9dba6538","query_id":"53","doc_a_id":"16853734","doc_b_id":"25452937","presented_order":["16853734","25452937"],"winner_id":"25452937","reasoning":"Document B — it addresses associations between a tumor-related marker and patient survival (prognosis), making it closer in topic than A which concerns MMP1-driven MSC migration in glioma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845779Z"}
{"comparison_id":"378818db-1a91-4407-b56f-fb36cb73fc95","query_id":"53","doc_a_id":"12074066","doc_b_id":"25452937","presented_order":["25452937","12074066"],"winner_id":"25452937","reasoning":"Document A is more relevant — it concerns cancer prognosis and survival (though in thyroid cancer, not breast or ALDH1), whereas Document B is about vitamin D and colorectal cancer prevention.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845785Z"}
{"comparison_id":"254bf66c-8eae-4121-97f0-317e4f4ddb2c","query_id":"53","doc_a_id":"43334921","doc_b_id":"25452937","presented_order":["25452937","43334921"],"winner_id":"25452937","reasoning":"Document A is more relevant — it addresses cancer-associated markers and survival/prognosis (though in thyroid cancer), whereas Document B concerns aspirin/NSAID use and colorectal cancer risk, not prognostic markers. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845792Z"}
{"comparison_id":"b85ea5ae-4975-41c5-adb9-267600266601","query_id":"53","doc_a_id":"41293601","doc_b_id":"25452937","presented_order":["41293601","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it addresses associations between biomarker levels and cancer prognosis (survival), which is closer to the query about ALDH1 and prognosis than Document A's focus on glioblastoma mutations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845799Z"}
{"comparison_id":"c1b40875-0332-4731-8473-0780000d2bb0","query_id":"53","doc_a_id":"21414718","doc_b_id":"25452937","presented_order":["25452937","21414718"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant because it reports an association between a tumor-associated factor and patient survival (prognostic outcome), whereas Document B focuses on a molecular interaction in gastric cancer unrelated to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845806Z"}
{"comparison_id":"43b8cc40-357d-4e16-b493-e0e1bb035ce0","query_id":"53","doc_a_id":"14848619","doc_b_id":"25452937","presented_order":["25452937","14848619"],"winner_id":"25452937","reasoning":"Document A is more relevant — it discusses a marker's association with survival/prognosis in cancer (though different marker and cancer type). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845812Z"}
{"comparison_id":"8e680258-6aed-4abf-8ea3-c15c67662102","query_id":"53","doc_a_id":"5884524","doc_b_id":"25452937","presented_order":["5884524","25452937"],"winner_id":"25452937","reasoning":"Document B — it discusses tumor-associated markers and their association with decreased cancer survival (though in thyroid cancer), whereas Document A concerns diabetes and cardiac outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845818Z"}
{"comparison_id":"0be3d51a-0807-468e-ae8c-9bdb985b677c","query_id":"53","doc_a_id":"24624992","doc_b_id":"25452937","presented_order":["24624992","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it concerns tumor-marker density associated with survival outcomes in cancer, whereas Document A is about IEX-1 in leukemia cell lines and unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845825Z"}
{"comparison_id":"918fd86e-f3b2-4a5f-870f-1701d22360d8","query_id":"53","doc_a_id":"29190724","doc_b_id":"25452937","presented_order":["25452937","29190724"],"winner_id":"29190724","reasoning":"Neither document discusses ALDH1 or breast cancer; Document B is marginally more relevant because it covers molecular markers/epigenetics, whereas A is about immune cells in thyroid cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845832Z"}
{"comparison_id":"fbb6558a-0b14-43b6-917f-323671bc58de","query_id":"53","doc_a_id":"1649738","doc_b_id":"25452937","presented_order":["1649738","25452937"],"winner_id":"25452937","reasoning":"Reason: Document B discusses a marker (TAM density) associated with cancer prognosis, making it more thematically relevant to a prognostic biomarker claim than Document A, which focuses on genetic variants and therapy-induced second malignancies in Hodgkin's lymphoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845838Z"}
{"comparison_id":"c216c10d-7844-4333-8ef8-661901444a75","query_id":"53","doc_a_id":"3590806","doc_b_id":"25452937","presented_order":["3590806","25452937"],"winner_id":"3590806","reasoning":"Document A — it discusses cancer-initiating (stem-like) cells and stem-cell–related pathways, which is closer to ALDH1's role as a cancer stem cell marker than Document B's focus on macrophages in thyroid cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845845Z"}
{"comparison_id":"72cb2fd0-9eee-4b73-bb23-68a730ffd171","query_id":"53","doc_a_id":"17671145","doc_b_id":"25452937","presented_order":["25452937","17671145"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant because it discusses associations between a molecular/cellular marker and cancer prognosis (survival), whereas Document B focuses on a different pathway in prostate cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845852Z"}
{"comparison_id":"a4355549-070e-4e84-af24-3421c97d37f7","query_id":"53","doc_a_id":"9196472","doc_b_id":"25452937","presented_order":["9196472","25452937"],"winner_id":"25452937","reasoning":"Document B — it discusses cancer prognosis (decreased survival) whereas Document A is about monocyte transcriptomes and atherosclerosis, so B is slightly more relevant. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845858Z"}
{"comparison_id":"36fd756d-5dbe-428d-85cc-cba3e096aaa6","query_id":"53","doc_a_id":"19541444","doc_b_id":"25452937","presented_order":["19541444","25452937"],"winner_id":"19541444","reasoning":"Document A is more related — it discusses gene expression and tumorigenesis, whereas Document B concerns macrophages in thyroid cancer, not gene expression or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845865Z"}
{"comparison_id":"99d43b5f-e3fb-484a-b1b0-103b5d5bf66b","query_id":"53","doc_a_id":"24705390","doc_b_id":"25452937","presented_order":["24705390","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it relates to cancer prognosis and tumor biomarkers, whereas A concerns H. pylori–induced gastric mutations unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845872Z"}
{"comparison_id":"1e44b81e-87b3-4dba-a78f-ca00b84de225","query_id":"53","doc_a_id":"5956380","doc_b_id":"25452937","presented_order":["5956380","25452937"],"winner_id":"25452937","reasoning":"Document B — it discusses an association between a tumor feature (TAM density) and patient prognosis, which is conceptually closer to the claim about ALDH1 and breast cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845878Z"}
{"comparison_id":"b5b54060-b6ae-4b7b-be27-4ebe390a230b","query_id":"53","doc_a_id":"12337611","doc_b_id":"25452937","presented_order":["12337611","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it examines an association between a tumor-related factor (TAM density) and patient survival, whereas Document A focuses on LIN28B-driven neuroblastoma mechanisms unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845885Z"}
{"comparison_id":"43b19b4e-94ac-4fc3-bc0a-2aa15f411a5c","query_id":"53","doc_a_id":"38009906","doc_b_id":"25452937","presented_order":["25452937","38009906"],"winner_id":"25452937","reasoning":"Document A is more relevant — it addresses associations between a tumor-associated factor and patient survival (prognosis), whereas Document B focuses on molecular transcriptional silencing without linking to prognosis or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845892Z"}
{"comparison_id":"62c03a2d-f198-4a04-9900-04259abe2a1a","query_id":"53","doc_a_id":"4445629","doc_b_id":"25452937","presented_order":["25452937","4445629"],"winner_id":"25452937","reasoning":"Document A is more relevant — it concerns cancer prognosis (though in thyroid cancer and not ALDH1/breast cancer), while Document B is about cardiovascular disease.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845899Z"}
{"comparison_id":"8cbb4ee5-c73b-4526-8210-35419b065f4c","query_id":"53","doc_a_id":"7046487","doc_b_id":"25452937","presented_order":["7046487","25452937"],"winner_id":"7046487","reasoning":"Document A is more relevant — it discusses cancer-related molecular pathways and tumor-promoting factors broadly, whereas Document B focuses on tumor-associated macrophages in thyroid cancer (not breast or ALDH1). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845906Z"}
{"comparison_id":"4cf0982e-8a29-4ccb-ae6c-b6ffa119f149","query_id":"53","doc_a_id":"8702697","doc_b_id":"25452937","presented_order":["25452937","8702697"],"winner_id":"25452937","reasoning":"Document A is more relevant — it links a biomarker's expression (TAM density) with poorer survival, which is conceptually similar to ALDH1 expression linked to prognosis (even though it's a different cancer). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845913Z"}
{"comparison_id":"fb0ac027-82d4-46d9-8be8-d0ba18ae034b","query_id":"53","doc_a_id":"3559136","doc_b_id":"25452937","presented_order":["25452937","3559136"],"winner_id":"25452937","reasoning":"Reason: Document A discusses a biomarker's association with decreased survival (prognosis), whereas Document B focuses on therapy resistance mechanisms; A is therefore marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845919Z"}
{"comparison_id":"d4c9b5d5-230c-4fcc-bbee-644fd1638966","query_id":"53","doc_a_id":"6121555","doc_b_id":"25452937","presented_order":["25452937","6121555"],"winner_id":"25452937","reasoning":"Doc A is more relevant because it addresses cancer prognosis/survival associations, while Doc B focuses on a molecular pathway in glioma unrelated to breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845925Z"}
{"comparison_id":"2c89b6ca-a078-4b1e-ae52-df5ba5f6b434","query_id":"53","doc_a_id":"6948886","doc_b_id":"25452937","presented_order":["6948886","25452937"],"winner_id":"6948886","reasoning":"Document A is more relevant because it addresses tumorigenicity and molecular markers involved in cancer biology (though in glioblastoma), which is closer to ALDH1's role in cancer prognosis than a thyroid-TAMs study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845932Z"}
{"comparison_id":"a1ff37a6-5266-4672-bd9c-1f9673d98316","query_id":"53","doc_a_id":"10699587","doc_b_id":"25452937","presented_order":["25452937","10699587"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant because it links a biological marker (tumor-associated macrophages) to prognosis in cancer, whereas Document B concerns prostate radiotherapy prognostic groups. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845939Z"}
{"comparison_id":"82724528-c6d5-468a-a515-863d90460210","query_id":"53","doc_a_id":"6171953","doc_b_id":"25452937","presented_order":["6171953","25452937"],"winner_id":"25452937","reasoning":"Document B — it discusses associations between tumor features and survival in cancer (though in thyroid cancer), which is closer to the claim about prognosis than Document A's focus on Sirtuin-1 and inflammation.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845946Z"}
{"comparison_id":"d935fc2a-62ca-4956-a060-358222783494","query_id":"53","doc_a_id":"8764879","doc_b_id":"25452937","presented_order":["8764879","25452937"],"winner_id":"25452937","reasoning":"Document B — it addresses cancer prognosis/survival (though in thyroid cancer), whereas Document A concerns AML stem-cell biology and not prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845952Z"}
{"comparison_id":"2598f3fd-cf69-4100-8beb-8a192ec0dd3f","query_id":"53","doc_a_id":"2359152","doc_b_id":"25452937","presented_order":["2359152","25452937"],"winner_id":"25452937","reasoning":"Reason: Neither abstract addresses ALDH1 or breast cancer, but Document B discusses a tumor-marker (TAMs) association with prognosis in cancer, making it marginally more relevant than a myelodysplastic syndromes genetics study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845959Z"}
{"comparison_id":"6ab75b35-2509-4cf0-b43c-a9ac81d4b119","query_id":"53","doc_a_id":"67787658","doc_b_id":"25452937","presented_order":["25452937","67787658"],"winner_id":"25452937","reasoning":"Document A is more relevant — it links a tumor-associated marker to decreased survival (prognosis), whereas Document B concerns miRNAs and chemoresistance in glioblastoma, unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845965Z"}
{"comparison_id":"b89b0fc7-2dea-4dff-84d7-cf8116fc98b6","query_id":"53","doc_a_id":"45764440","doc_b_id":"25452937","presented_order":["25452937","45764440"],"winner_id":"25452937","reasoning":"Document A is more relevant because it directly addresses associations with decreased survival (prognosis), albeit in a different cancer type; Document B focuses on Src inhibition in pancreatic cancer and not prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845972Z"}
{"comparison_id":"30769b9b-687a-4fda-ac1b-af423290cfaf","query_id":"53","doc_a_id":"21692235","doc_b_id":"25452937","presented_order":["25452937","21692235"],"winner_id":"21692235","reasoning":"Reason: Both documents are about other cancers and do not mention ALDH1 or breast cancer; Document B is slightly more relevant because it addresses gene expression patterns and prognosis in cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845978Z"}
{"comparison_id":"69e86482-cf3f-4479-a9bb-9688e2e7d1c9","query_id":"53","doc_a_id":"42377686","doc_b_id":"25452937","presented_order":["25452937","42377686"],"winner_id":"25452937","reasoning":"Document A is more relevant because it discusses a biomarker (tumor-associated macrophage density) linked to prognosis in a solid tumor, which is closer in topic to ALDH1 and breast cancer than genetic lesions in leukemia. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845985Z"}
{"comparison_id":"e80269c4-3264-4475-a374-eb79baf47bb5","query_id":"53","doc_a_id":"35993767","doc_b_id":"25452937","presented_order":["35993767","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it reports an association between a tumor component's density and decreased survival, which is conceptually closer to a claim about a marker (ALDH1) being linked to poorer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845991Z"}
{"comparison_id":"5e92f82f-06b9-4b54-bc11-46c099e49082","query_id":"53","doc_a_id":"4434951","doc_b_id":"25452937","presented_order":["25452937","4434951"],"winner_id":"25452937","reasoning":"Document A is more relevant because it addresses cancer prognosis and survival (though in thyroid cancer), while Document B is unrelated to cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.845998Z"}
{"comparison_id":"b64d89b2-feee-4946-b0b1-6e5d5b5d3c5b","query_id":"53","doc_a_id":"16511863","doc_b_id":"25452937","presented_order":["16511863","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it concerns cancer prognostic markers and survival associations (though in thyroid cancer, not breast/ALDH1). \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846004Z"}
{"comparison_id":"7673de87-e83a-48d7-86e6-a135e6cbae47","query_id":"53","doc_a_id":"6766459","doc_b_id":"25452937","presented_order":["25452937","6766459"],"winner_id":"25452937","reasoning":"Document A is about cancer prognosis (though thyroid, not breast) and discusses markers linked to decreased survival, making it marginally more relevant than Document B which is about fever/immune regulation.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846011Z"}
{"comparison_id":"86803cde-d0e8-4c3c-99e3-e4fa34971ae4","query_id":"53","doc_a_id":"26887439","doc_b_id":"25452937","presented_order":["25452937","26887439"],"winner_id":"25452937","reasoning":"Document A is more relevant because it discusses a marker's association with decreased survival (prognosis), whereas Document B focuses on survivin in K-Ras-transformed cells and not on ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846017Z"}
{"comparison_id":"e655d0cf-4a38-4d45-969f-fe06c60f1d33","query_id":"53","doc_a_id":"26495128","doc_b_id":"25452937","presented_order":["26495128","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it reports an association between a tumor marker and decreased survival (prognosis) in cancer, whereas A discusses ribosomal protein function without prognosis data. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846025Z"}
{"comparison_id":"84bbcc56-c4b3-4e53-b4ca-7a71d525c7f1","query_id":"53","doc_a_id":"36310858","doc_b_id":"25452937","presented_order":["25452937","36310858"],"winner_id":"25452937","reasoning":"Document A is more relevant — it discusses associations between a molecular/cellular marker (TAM density) and decreased survival (prognosis) in cancer, which is closer to the claim about ALDH1 expression and prognosis than the mechanistic KRAS–YAP study in PDAC.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846032Z"}
{"comparison_id":"2131958b-6031-4da6-babf-6c8af1f810dc","query_id":"53","doc_a_id":"5783785","doc_b_id":"25452937","presented_order":["25452937","5783785"],"winner_id":"25452937","reasoning":"Document A is more relevant — it addresses an association with decreased survival (prognosis), while Document B focuses on miRNA and methylation in gastric cancer unrelated to prognosis in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846039Z"}
{"comparison_id":"f819038f-aab2-423c-9cfd-185637f85313","query_id":"53","doc_a_id":"22059387","doc_b_id":"25452937","presented_order":["25452937","22059387"],"winner_id":"25452937","reasoning":"Document A is more relevant — it addresses cancer prognosis and marker association (though in thyroid cancer), whereas Document B discusses infection-mediated DNA damage in hamsters unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846046Z"}
{"comparison_id":"a185cdb1-549b-4e5f-84e4-63bc08c7959b","query_id":"53","doc_a_id":"5271210","doc_b_id":"25452937","presented_order":["5271210","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it directly links a biological marker (tumor-associated macrophage density) to prognosis/survival, which is conceptually similar to the claim about ALDH1 and breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846053Z"}
{"comparison_id":"c478c15d-3b09-469f-a775-cab0d566629f","query_id":"53","doc_a_id":"9226649","doc_b_id":"25452937","presented_order":["25452937","9226649"],"winner_id":"25452937","reasoning":"Document A is more relevant — it discusses association of a marker with decreased survival (prognosis), whereas Document B concerns inflammasome roles in colon tumorigenesis not prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846059Z"}
{"comparison_id":"0706547f-0582-4023-9584-5ab401635907","query_id":"53","doc_a_id":"13283919","doc_b_id":"25452937","presented_order":["25452937","13283919"],"winner_id":"25452937","reasoning":"Both documents are irrelevant to ALDH1 in breast cancer, but Document A discusses cancer prognosis (albeit in thyroid cancer), so it's marginally more related.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846066Z"}
{"comparison_id":"9a48acc9-d952-4336-9647-d559eef12a88","query_id":"53","doc_a_id":"11935250","doc_b_id":"25452937","presented_order":["25452937","11935250"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant because it discusses cancer prognosis (though in thyroid cancer, not breast) while Document B concerns age-related methylation in mice and is unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846073Z"}
{"comparison_id":"65899f98-3f3a-4b65-9862-f5f1e8184220","query_id":"53","doc_a_id":"15215393","doc_b_id":"25452937","presented_order":["15215393","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it reports an association between a tumor-related marker (TAM density) and survival in cancer, which is conceptually similar to a study linking ALDH1 expression to prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846080Z"}
{"comparison_id":"5d921e27-4a03-4a55-a6d4-ad6fed56f1a9","query_id":"53","doc_a_id":"29473081","doc_b_id":"25452937","presented_order":["29473081","25452937"],"winner_id":"29473081","reasoning":"Reason: Document A reports that high expression of a specific enzyme (a molecular marker) is linked to poor survival in cancer, which is more analogous to ALDH1 expression and prognosis than Document B's focus on immune-cell density in thyroid cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846086Z"}
{"comparison_id":"a2e3df94-474f-4c2e-a4a8-cd82d1458a39","query_id":"53","doc_a_id":"5123516","doc_b_id":"25452937","presented_order":["5123516","25452937"],"winner_id":"25452937","reasoning":"Document B — it addresses an association between a tumor marker (TAM density) and survival/prognosis, which is conceptually closer to the claim about ALDH1 and prognosis than a GBM therapeutic-target paper. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846093Z"}
{"comparison_id":"bf75d207-316b-4c3b-9539-6f99bd430192","query_id":"53","doc_a_id":"22180793","doc_b_id":"25452937","presented_order":["25452937","22180793"],"winner_id":"25452937","reasoning":"Document A — it discusses associations between a tumor marker and patient survival (prognosis), which is closer to the claim about ALDH1 and breast cancer prognosis than Document B's focus on prostate therapy. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846100Z"}
{"comparison_id":"68b5bdde-97d4-4a2b-9e55-b504ca2790b9","query_id":"53","doc_a_id":"33387953","doc_b_id":"25452937","presented_order":["33387953","25452937"],"winner_id":"33387953","reasoning":"Document A — it discusses cancer-related molecular alterations and treatment resistance across cancers, which is closer to markers affecting prognosis than a thyroid-specific TAMs study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846107Z"}
{"comparison_id":"bc455ca6-8eb6-4d54-99fd-b36101ea7908","query_id":"53","doc_a_id":"25513319","doc_b_id":"25452937","presented_order":["25452937","25513319"],"winner_id":"25452937","reasoning":"Document A is more relevant — it addresses an association between a tumor-related factor and decreased survival (prognosis), which is closer to the claim about ALDH1 and breast cancer prognosis than the prostate metabolism study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846114Z"}
{"comparison_id":"1f7f207c-a02d-4397-90fa-71da1972fc0d","query_id":"53","doc_a_id":"10165723","doc_b_id":"25452937","presented_order":["25452937","10165723"],"winner_id":"25452937","reasoning":"Document A is more relevant — it links a tumor-associated marker to decreased survival/prognosis (though in thyroid cancer), which is closer to the claim about ALDH1 and breast cancer than a melanoma methylation study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846122Z"}
{"comparison_id":"a93b1e32-9dc2-4b64-b468-999072288e9f","query_id":"53","doc_a_id":"1836154","doc_b_id":"25452937","presented_order":["25452937","1836154"],"winner_id":"25452937","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A discusses a marker's association with prognosis in a cancer type (thyroid), making it slightly more relevant than a glioblastoma genomic study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846128Z"}
{"comparison_id":"9c053182-84af-4fc2-977a-afd653ef2384","query_id":"53","doc_a_id":"18358026","doc_b_id":"25452937","presented_order":["25452937","18358026"],"winner_id":"18358026","reasoning":"Document B is more relevant — it addresses cancer-related molecular changes (epigenetic regulation of gene expression) that could relate to biomarkers like ALDH1, while A focuses on TAMs in thyroid cancer (different marker and tissue). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846135Z"}
{"comparison_id":"b3e70bc5-63f4-44d5-a8c2-f1653451d863","query_id":"53","doc_a_id":"37204802","doc_b_id":"25452937","presented_order":["25452937","37204802"],"winner_id":"25452937","reasoning":"Document A is more relevant — it discusses an association between a biomarker (TAM density) and patient prognosis (decreased survival), which is closer in topic to a claim about marker expression and prognosis than a mechanistic colon cancer study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846633Z"}
{"comparison_id":"29173fb5-4379-4f61-9f53-4152164e1e74","query_id":"53","doc_a_id":"17911973","doc_b_id":"25452937","presented_order":["25452937","17911973"],"winner_id":"25452937","reasoning":"Document A is more relevant — it discusses an association between a tumor marker and patient survival in cancer (though in thyroid rather than breast), whereas Document B concerns retrotransposons and not prognosis markers. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846641Z"}
{"comparison_id":"83b486ae-0a6d-40f5-80a4-b8b18ceb6684","query_id":"53","doc_a_id":"7975937","doc_b_id":"25452937","presented_order":["7975937","25452937"],"winner_id":"7975937","reasoning":"Document A is marginally more relevant — it discusses mechanisms of tumor progression across cancer types (more general cancer context), while Document B is specific to thyroid cancer. Neither mentions ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846647Z"}
{"comparison_id":"18441832-de82-42af-910d-c93149c8b239","query_id":"53","doc_a_id":"8385277","doc_b_id":"25452937","presented_order":["8385277","25452937"],"winner_id":"25452937","reasoning":"Reason: Document B discusses a biomarker's association with prognosis in cancer (though in thyroid, not breast), whereas Document A concerns Fanconi anemia and leukemia genomic abnormalities unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846654Z"}
{"comparison_id":"b61f41ac-861e-4802-9897-1b1e70b48b7a","query_id":"53","doc_a_id":"28334217","doc_b_id":"25452937","presented_order":["28334217","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it examines an association between a tumor-related marker (TAM density) and patient survival/prognosis, which is conceptually similar to the claim about ALDH1 and breast cancer; Document A focuses on GLS inhibition and tumor growth in other cancer types. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846661Z"}
{"comparison_id":"4837b51c-59f3-45fd-b4ec-a8425142549c","query_id":"53","doc_a_id":"7869794","doc_b_id":"25452937","presented_order":["25452937","7869794"],"winner_id":"25452937","reasoning":"Document A — it discusses an association between a tumor feature and decreased survival (prognosis), which is closer to the claim about ALDH1 and breast cancer than the neutrophil signaling study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846668Z"}
{"comparison_id":"588d62e9-a3e7-42d9-9912-442ab96aff6d","query_id":"53","doc_a_id":"864491","doc_b_id":"25452937","presented_order":["25452937","864491"],"winner_id":"864491","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document B is slightly more relevant because it deals with tumor biology and therapies in human tumor xenografts (including breast cancer models), whereas A concerns thyroid cancer macrophages.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846674Z"}
{"comparison_id":"5860df75-8dbe-4117-a1be-fec752e88b5f","query_id":"53","doc_a_id":"22703082","doc_b_id":"25452937","presented_order":["25452937","22703082"],"winner_id":"25452937","reasoning":"Document A. It discusses an association between a tumor marker (TAM density) and decreased survival in cancer, which is closer to the query about marker expression and prognosis than Document B about H. pylori and gastric mutations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846680Z"}
{"comparison_id":"e0372da0-4af1-4879-8889-542815d5fe6e","query_id":"53","doc_a_id":"21521236","doc_b_id":"25452937","presented_order":["21521236","25452937"],"winner_id":"21521236","reasoning":"Document A is more relevant because it addresses molecular markers and chemosensitivity in cancer biology, whereas Document B focuses on macrophages in thyroid cancer (unrelated cancer type). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846686Z"}
{"comparison_id":"264f00c6-ca3f-4cb1-b3b3-d1a9f49d99d6","query_id":"53","doc_a_id":"3831884","doc_b_id":"25452937","presented_order":["25452937","3831884"],"winner_id":"25452937","reasoning":"Reason: Document A discusses tumor marker density associated with decreased survival (prognosis) in cancer, which is closer to the claim about ALDH1 and breast cancer prognosis than Document B's metabolic study in pancreatic cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846693Z"}
{"comparison_id":"257850b9-a0d3-4964-a2e4-b910af51b5f0","query_id":"53","doc_a_id":"4325398","doc_b_id":"25452937","presented_order":["25452937","4325398"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant because it discusses a marker's association with prognosis/survival in cancer (though in thyroid, not breast), whereas Document B focuses on pancreatic genomic mutations unrelated to ALDH1 or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846699Z"}
{"comparison_id":"63bf2b20-97a2-431f-926d-4896991b8acf","query_id":"53","doc_a_id":"3504761","doc_b_id":"25452937","presented_order":["3504761","25452937"],"winner_id":"25452937","reasoning":"Reason: Document B discusses an association between a tumor marker (TAM density) and decreased survival in cancer, which is conceptually closer to a claim about a marker (ALDH1) and prognosis than Document A (focused on hepatic metabolism/tumorigenesis).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846705Z"}
{"comparison_id":"a1f10885-4b5a-4bed-aa92-96effddbca6f","query_id":"53","doc_a_id":"9791313","doc_b_id":"25452937","presented_order":["9791313","25452937"],"winner_id":"25452937","reasoning":"Reason: Both documents don't address ALDH1 or breast cancer, but Document B discusses an association between a tumor marker (TAM density) and poorer prognosis, making it more analogous to the claim than Document A's focus on SETD2 and renal cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846711Z"}
{"comparison_id":"06dd1b49-f496-43dd-bceb-4f8065a40a62","query_id":"53","doc_a_id":"5468807","doc_b_id":"25452937","presented_order":["25452937","5468807"],"winner_id":"25452937","reasoning":"Document A is more relevant — it discusses an association between a biological marker and patient survival (prognosis) in cancer, which is conceptually closer to the ALDH1–prognosis claim than Document B's therapeutic study in ARID1A‑mutated ovarian cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846718Z"}
{"comparison_id":"33729a57-da7b-4ac4-ab2d-34a71c65d120","query_id":"53","doc_a_id":"10365787","doc_b_id":"25452937","presented_order":["25452937","10365787"],"winner_id":"25452937","reasoning":"Reason: Document A discusses marker expression and patient survival (though in thyroid cancer), so it is slightly more relevant to a prognosis claim than Document B, which focuses on a cell-cycle cofactor and genomic stability with no link to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846724Z"}
{"comparison_id":"e2bc4dcb-33ca-487c-9094-f6443dac3e8f","query_id":"53","doc_a_id":"40735046","doc_b_id":"25452937","presented_order":["25452937","40735046"],"winner_id":"40735046","reasoning":"Document B is more relevant because it addresses breast cancer outcomes (though it doesn't discuss ALDH1), while A is about thyroid cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846731Z"}
{"comparison_id":"3fb44d52-0c7c-4ae7-b626-3ac6ff16a572","query_id":"53","doc_a_id":"24783597","doc_b_id":"25452937","presented_order":["25452937","24783597"],"winner_id":"25452937","reasoning":"Document A — it discusses tumor-associated markers and prognosis in cancer (though thyroid, not breast), so it's more relevant than an IBD/IL-17F study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846737Z"}
{"comparison_id":"34cbee5f-dd23-4a78-bdab-d710b6064ae4","query_id":"53","doc_a_id":"1522336","doc_b_id":"25452937","presented_order":["25452937","1522336"],"winner_id":"25452937","reasoning":"Document A — it discusses associations with survival/prognosis (though in thyroid cancer), which is closer to the query about prognosis than Document B's in vitro statin effects. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846743Z"}
{"comparison_id":"4f2ce094-e8f0-4dd9-87e7-24d9fe30d843","query_id":"53","doc_a_id":"24190159","doc_b_id":"25452937","presented_order":["25452937","24190159"],"winner_id":"25452937","reasoning":"Reason: Document A discusses an association between a marker's increased density and decreased survival (prognosis), making it more relevant to a prognosis-related claim than Document B, which focuses on mutated KRAS and gene overexpression in rectal cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846749Z"}
{"comparison_id":"1a4910af-7bd3-4f45-bdf8-232f5dee0613","query_id":"53","doc_a_id":"25036988","doc_b_id":"25452937","presented_order":["25036988","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it addresses an association between a tumor marker and patient survival (prognosis), whereas Document A focuses on lamin B1 effects in colon cancer cells without prognosis data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846755Z"}
{"comparison_id":"defc0f45-167f-481c-ac01-2850a9bc8732","query_id":"53","doc_a_id":"12685434","doc_b_id":"25452937","presented_order":["25452937","12685434"],"winner_id":"25452937","reasoning":"Document A is more relevant — it discusses an association with survival/prognosis (though in thyroid cancer), whereas B is a mechanistic glioblastoma study unrelated to prognosis in breast cancer.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846762Z"}
{"comparison_id":"b288fecd-5fed-4ce6-ae7c-c7a23c01c91a","query_id":"53","doc_a_id":"18682109","doc_b_id":"25452937","presented_order":["18682109","25452937"],"winner_id":"25452937","reasoning":"Document B — it links a tumor marker's expression/density to decreased survival (prognosis), whereas A deals with RB loss and histologic transformation in lung cancer, not prognosis markers in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846768Z"}
{"comparison_id":"b30426f8-82d9-495b-a24d-d453ae053fad","query_id":"53","doc_a_id":"2466614","doc_b_id":"25452937","presented_order":["2466614","25452937"],"winner_id":"25452937","reasoning":"Document B — it discusses cancer prognosis (though in thyroid cancer), whereas Document A is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846773Z"}
{"comparison_id":"70eb2dda-b6df-478d-bf62-0ff1959806cb","query_id":"53","doc_a_id":"14019636","doc_b_id":"25452937","presented_order":["14019636","25452937"],"winner_id":"25452937","reasoning":"Document B is slightly more relevant because it addresses a marker (tumor-associated macrophage density) linked to cancer prognosis, whereas Document A focuses on rDNA copy number and DNA damage sensitivity without discussing prognosis markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846779Z"}
{"comparison_id":"7027c6a1-5209-4a95-87e2-e478af665346","query_id":"53","doc_a_id":"20501163","doc_b_id":"25452937","presented_order":["25452937","20501163"],"winner_id":"25452937","reasoning":"Document A is more relevant — it discusses tumor-associated factors linked to decreased survival (prognosis) in cancer, while Document B focuses on metabolic/immune effects of IL-6, not prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846786Z"}
{"comparison_id":"37105a9a-afc3-453d-8f03-39da054cf7bc","query_id":"53","doc_a_id":"22049489","doc_b_id":"25452937","presented_order":["25452937","22049489"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant because it addresses cancer prognosis (survival outcomes), whereas Document B focuses on molecular mechanisms in gastric cancer without prognosis data. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846792Z"}
{"comparison_id":"4554f61e-5f98-4f41-a8d6-6c6b07c12263","query_id":"53","doc_a_id":"21063817","doc_b_id":"25452937","presented_order":["21063817","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it links a tumor-associated marker (TAM density) to survival/prognosis in cancer, whereas A addresses keratin expression in oral lesions not prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846798Z"}
{"comparison_id":"4bf3f113-2438-46d9-8ac9-dd3cfc4b5ae1","query_id":"53","doc_a_id":"19427410","doc_b_id":"25452937","presented_order":["25452937","19427410"],"winner_id":"25452937","reasoning":"Document A — it discusses cancer prognosis (though in thyroid cancer), which is slightly closer to the claim about prognostic markers in cancer than Document B's adipocyte IL-33 study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846804Z"}
{"comparison_id":"67541fcf-b281-47c3-93bd-c5ceabd121e2","query_id":"53","doc_a_id":"23599024","doc_b_id":"25452937","presented_order":["25452937","23599024"],"winner_id":"25452937","reasoning":"Neither document mentions ALDH1 or breast cancer, but Document A addresses association with prognosis (survival) in cancer, making it marginally more relevant. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846810Z"}
{"comparison_id":"c7a338d1-bd43-49f1-8941-05b3b19fb3b8","query_id":"53","doc_a_id":"195689757","doc_b_id":"25452937","presented_order":["195689757","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it discusses an association between a tumor marker (TAM density) and decreased survival (prognosis), whereas A focuses on metabolic remodeling in glioblastoma, unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846816Z"}
{"comparison_id":"53d2037f-413d-4ba3-aa12-44b9c3d26abd","query_id":"53","doc_a_id":"36838958","doc_b_id":"25452937","presented_order":["25452937","36838958"],"winner_id":"25452937","reasoning":"Document A is more relevant — it discusses cancer-related survival and prognosis (though in thyroid cancer), while Document B concerns adipose tissue metabolism unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846823Z"}
{"comparison_id":"0c4761d2-13f1-424f-8b78-5e260ad8c945","query_id":"53","doc_a_id":"15322518","doc_b_id":"25452937","presented_order":["15322518","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it examines an association between a tumor-related marker (TAM density) and patient survival, which aligns with the query about marker expression and prognosis; Document A focuses on targeted therapy in rhabdoid tumors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846829Z"}
{"comparison_id":"1e8b183c-baa8-4623-bcc6-efebf4127e9e","query_id":"53","doc_a_id":"1617327","doc_b_id":"25452937","presented_order":["1617327","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it concerns tumor-associated markers and their association with cancer prognosis (though in thyroid cancer), whereas Document A concerns stromal dysfunction causing myelodysplasia/leukemia and is unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846836Z"}
{"comparison_id":"6af263dd-4fb7-4996-a125-0f3cf261e1f2","query_id":"53","doc_a_id":"11578459","doc_b_id":"25452937","presented_order":["25452937","11578459"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant because it discusses associations between a biomarker (TAM density) and patient prognosis/survival, whereas Document B focuses on genetic/epigenetic mechanisms in glioblastoma unrelated to prognosis in breast cancer.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846842Z"}
{"comparison_id":"498f1eab-6394-466d-9100-7470fbfc4eac","query_id":"53","doc_a_id":"9159495","doc_b_id":"25452937","presented_order":["25452937","9159495"],"winner_id":"25452937","reasoning":"Document A is more relevant because it discusses cancer prognosis and survival (though in thyroid cancer), whereas Document B is about miRNA regulation in C. elegans aging and not cancer-related.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846848Z"}
{"comparison_id":"53942c72-d684-4953-a39a-974763475ee1","query_id":"53","doc_a_id":"18810195","doc_b_id":"25452937","presented_order":["18810195","25452937"],"winner_id":"25452937","reasoning":"Document B — it addresses associations between tumor features and patient survival (prognosis), whereas Document A focuses on PGAM1 phosphorylation and metabolic effects, not prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846854Z"}
{"comparison_id":"3fd7feca-7893-40ee-b4c4-e5f9fa4a7b69","query_id":"53","doc_a_id":"1686997","doc_b_id":"25452937","presented_order":["25452937","1686997"],"winner_id":"25452937","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it examines an association between a biomarker and patient survival (though in thyroid cancer), which is conceptually similar to the claim. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846860Z"}
{"comparison_id":"802c6a2b-4032-4ac1-bd90-eca875bdb414","query_id":"53","doc_a_id":"28249680","doc_b_id":"25452937","presented_order":["28249680","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it reports an association between a tumor biomarker (TAM density) and decreased survival, which is analogous to the claim about a biomarker (ALDH1) and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846867Z"}
{"comparison_id":"a3df6eb1-886c-445d-89d9-680b2e3e05e5","query_id":"53","doc_a_id":"40349336","doc_b_id":"25452937","presented_order":["25452937","40349336"],"winner_id":"25452937","reasoning":"Document A is more relevant — it addresses a biomarker's association with survival in cancer (though thyroid, not breast), whereas B is about gene deletion and aging in mice, unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846873Z"}
{"comparison_id":"da8d5238-2812-426a-bc5c-37db4b9aebfc","query_id":"53","doc_a_id":"16364639","doc_b_id":"25452937","presented_order":["16364639","25452937"],"winner_id":"25452937","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document B addresses an association between a tumor marker (TAM density) and poorer survival, making it more analogous to the prognosis claim than Document A (glioblastoma microRNA network).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846880Z"}
{"comparison_id":"d92ca4e1-e192-4f1f-ab8d-290eb906add0","query_id":"53","doc_a_id":"16201748","doc_b_id":"25452937","presented_order":["25452937","16201748"],"winner_id":"25452937","reasoning":"Document A is more relevant — it links marker levels to survival/prognosis (even though in thyroid cancer), which is closer to the query about marker expression and prognosis in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846886Z"}
{"comparison_id":"13e90e43-1d2d-4c2e-b3e1-3c0228d653f7","query_id":"53","doc_a_id":"2547636","doc_b_id":"25452937","presented_order":["2547636","25452937"],"winner_id":"25452937","reasoning":"B is more relevant — it addresses a cancer-associated marker linked to survival/prognosis, whereas A discusses circadian regulation of epidermal stem cells unrelated to prognosis or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846892Z"}
{"comparison_id":"1c6820a3-795d-4c29-b665-b44f006ef18c","query_id":"53","doc_a_id":"4312169","doc_b_id":"25452937","presented_order":["4312169","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it links a biomarker (TAM density) to prognosis in cancer, whereas A concerns pediatric glioblastoma genetics unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846898Z"}
{"comparison_id":"9d5a6cfc-decf-42c4-9bef-4b282b5fd30d","query_id":"53","doc_a_id":"6259170","doc_b_id":"25452937","presented_order":["25452937","6259170"],"winner_id":"25452937","reasoning":"Reason: Document A discusses an association between a tumor marker's expression/density and decreased survival in cancer (though thyroid, not breast), while Document B covers Nrf2-mitochondria biology unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846905Z"}
{"comparison_id":"2db27850-a4cf-4dc2-a926-e1e3292a900c","query_id":"53","doc_a_id":"24294572","doc_b_id":"25452937","presented_order":["25452937","24294572"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant because it discusses associations with decreased survival in cancer (though in thyroid, not breast), whereas Document B focuses on PTEN lipid signaling and not prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846911Z"}
{"comparison_id":"6e4651f3-ebcf-4f33-8cb2-0b7caa11b1b6","query_id":"53","doc_a_id":"5752492","doc_b_id":"25452937","presented_order":["25452937","5752492"],"winner_id":"25452937","reasoning":"Document A is more relevant — it addresses cancer prognosis and survival associations, whereas Document B concerns HIV immune responses unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846917Z"}
{"comparison_id":"1a0bd85c-5505-41ab-a729-068147ed9a75","query_id":"53","doc_a_id":"9478135","doc_b_id":"25452937","presented_order":["9478135","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it deals with a marker (TAM density) associated with poorer prognosis in a cancer type, which is conceptually closer to ALDH1 as a prognostic marker in breast cancer than the leukemia genetics in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846924Z"}
{"comparison_id":"4f80d7f3-fee2-4c92-b100-534c3f145111","query_id":"53","doc_a_id":"33076846","doc_b_id":"25452937","presented_order":["33076846","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it deals with tumor marker density and associations with cancer prognosis, whereas A focuses on megakaryocyte biology unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846930Z"}
{"comparison_id":"661d3afa-f8fb-48c6-9cda-3db1dd1c21c4","query_id":"53","doc_a_id":"19644821","doc_b_id":"25452937","presented_order":["19644821","25452937"],"winner_id":"19644821","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses an oncogenic marker (Lin28b) and cancer prognosis/maintenance, whereas Document B concerns macrophages in thyroid cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846937Z"}
{"comparison_id":"23e411d2-86e2-4546-ad9b-50562eaeae04","query_id":"53","doc_a_id":"5254463","doc_b_id":"25452937","presented_order":["25452937","5254463"],"winner_id":"25452937","reasoning":"Doc A is more relevant because it directly links a biological marker's (TAM) expression/density to patient survival, whereas Doc B is a mechanistic mouse intestine study unrelated to marker-prognosis associations in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846943Z"}
{"comparison_id":"9cdb9d92-91a3-4bef-8900-7050b63c6ef2","query_id":"53","doc_a_id":"4993011","doc_b_id":"25452937","presented_order":["4993011","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it discusses an association between a tumor marker (TAM density) and decreased survival (prognosis), which is conceptually closer to a claim about a marker's association with prognosis than Document A's molecular/therapeutic focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846950Z"}
{"comparison_id":"e87d807b-d77b-4c9b-acbd-c9f6465bbf29","query_id":"53","doc_a_id":"4457160","doc_b_id":"25452937","presented_order":["4457160","25452937"],"winner_id":"25452937","reasoning":"Document B — it addresses an association between a tumor marker (TAM density) and poorer survival, which is more similar to the claim about ALDH1 and prognosis than the pancreatic genomics focus in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846956Z"}
{"comparison_id":"6284cda9-871f-4e22-b957-50a42583a197","query_id":"53","doc_a_id":"13398997","doc_b_id":"25452937","presented_order":["13398997","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it addresses tumor-associated factors and survival/prognosis in cancer (though in thyroid cancer), whereas Document A is about CTLA-4 in Th17 cells in transplant immunology. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846963Z"}
{"comparison_id":"d407b8a2-1746-48f4-9c38-a6c8e98f6305","query_id":"53","doc_a_id":"23887844","doc_b_id":"25452937","presented_order":["25452937","23887844"],"winner_id":"25452937","reasoning":"Reason: Document A addresses associations with patient survival (prognosis) in cancer, whereas Document B discusses metabolic mechanisms without prognosis or ALDH1 relevance.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846969Z"}
{"comparison_id":"cb66f310-12e7-4c26-aebc-96dd32bb1adf","query_id":"53","doc_a_id":"8724666","doc_b_id":"25452937","presented_order":["25452937","8724666"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant because it addresses marker expression associated with prognosis in a cancer context (decreased survival), whereas B concerns metabolic dependencies in hematopoiesis/leukemia unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846975Z"}
{"comparison_id":"a036671b-f094-4952-b147-88d7c6eeeb77","query_id":"53","doc_a_id":"31624828","doc_b_id":"25452937","presented_order":["31624828","25452937"],"winner_id":"31624828","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant only because it addresses tumor molecular biology, whereas B concerns macrophages in thyroid cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846981Z"}
{"comparison_id":"418c5edf-d8cc-4096-aefe-fb25d25fc3a8","query_id":"53","doc_a_id":"25344732","doc_b_id":"25452937","presented_order":["25344732","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it reports an association between a biological marker (TAM density) and survival (poor prognosis), whereas A concerns PHC3 loss in osteosarcoma, unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846987Z"}
{"comparison_id":"fee05f49-d5f9-4603-9078-06a247cfeccd","query_id":"53","doc_a_id":"10542877","doc_b_id":"25452937","presented_order":["10542877","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it addresses the relationship between a tumor marker's density (TAMs) and patient survival/prognosis, which is conceptually similar to the claim about ALDH1 and prognosis, whereas Document A discusses a STAT3 inhibitor and treatment activity.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.846994Z"}
{"comparison_id":"a0d5f48e-364e-490e-b8be-475339956507","query_id":"53","doc_a_id":"20460020","doc_b_id":"25452937","presented_order":["25452937","20460020"],"winner_id":"25452937","reasoning":"Document A is more relevant — it discusses cancer prognosis and decreased survival (though in thyroid cancer), whereas B concerns macrophage activation in wound healing, not cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847000Z"}
{"comparison_id":"5169ec5b-65d0-410d-8df9-8532060385ce","query_id":"53","doc_a_id":"25141908","doc_b_id":"25452937","presented_order":["25141908","25452937"],"winner_id":"25452937","reasoning":"Document B — discusses tumor marker density and survival in cancer (though thyroid, not breast), so it's more relevant than a virology paper. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847006Z"}
{"comparison_id":"d59383a0-921c-49b4-8376-093d1a4f072d","query_id":"53","doc_a_id":"30543439","doc_b_id":"25452937","presented_order":["30543439","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it links a biological marker (TAM density) to patient survival/prognosis in cancer, whereas Document A discusses enzymatic functions unrelated to prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847012Z"}
{"comparison_id":"5d6e84ed-0eca-4e3a-8d3d-9ed73b1d6d54","query_id":"53","doc_a_id":"15727984","doc_b_id":"25452937","presented_order":["15727984","25452937"],"winner_id":"25452937","reasoning":"Document B — it relates to tumor marker density and survival associations (prognostic link), which is closer to the claim about ALDH1 and prognosis than Document A's NSCLC secretome focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847018Z"}
{"comparison_id":"ba8e6de6-9497-4db3-adff-74de15bc1f6d","query_id":"53","doc_a_id":"14972169","doc_b_id":"25452937","presented_order":["14972169","25452937"],"winner_id":"25452937","reasoning":"Document B — it concerns cancer prognosis (tumor-associated factors and survival), which is closer to the query about prognostic markers in cancer than Document A's embryology/GAPDH study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847025Z"}
{"comparison_id":"df0b58e4-85ff-44ff-b2b2-3974408fad27","query_id":"53","doc_a_id":"28644298","doc_b_id":"25452937","presented_order":["28644298","25452937"],"winner_id":"25452937","reasoning":"Document B — it concerns cancer prognosis and factors linked to decreased survival (though in thyroid cancer), so it's marginally closer to the query about prognostic markers than Document A on EBV/NF-kappa B in lymphoid cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847031Z"}
{"comparison_id":"4c6026cd-7038-4338-94bd-768fb6b1fb62","query_id":"53","doc_a_id":"19800147","doc_b_id":"25452937","presented_order":["19800147","25452937"],"winner_id":"25452937","reasoning":"Document B — it addresses an association with decreased survival (prognosis), which is closer to the query about prognostic markers than Document A's molecular mechanism in colon cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847037Z"}
{"comparison_id":"fd97a533-895a-4155-a6fa-a88cc7766cbb","query_id":"53","doc_a_id":"4464565","doc_b_id":"25452937","presented_order":["25452937","4464565"],"winner_id":"25452937","reasoning":"Document A is more relevant because it addresses cancer prognosis and survival associations (though in thyroid cancer and with TAMs rather than ALDH1), whereas Document B studies cocoa polyphenols in colon cells and is unrelated to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847044Z"}
{"comparison_id":"8a9c6419-6a91-45b6-a714-f83009a98faa","query_id":"53","doc_a_id":"8994465","doc_b_id":"25452937","presented_order":["25452937","8994465"],"winner_id":"8994465","reasoning":"Document B is more relevant — it discusses cancer cell subpopulations and marker-associated tumor behavior (analogous to ALDH1 as a stem-cell marker), whereas A concerns macrophages in thyroid cancer and is unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847050Z"}
{"comparison_id":"a6300ceb-463a-4455-8113-17c5dc35db14","query_id":"53","doc_a_id":"20888849","doc_b_id":"25452937","presented_order":["20888849","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it addresses an association between a tumor-related marker (tumor-associated macrophages) and prognosis/survival, which is conceptually closer to the claim about ALDH1 and prognosis than a study on drug delivery in pancreatic cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847069Z"}
{"comparison_id":"cad0baf4-d353-4b9a-8119-7021c2f827c9","query_id":"53","doc_a_id":"23326722","doc_b_id":"25452937","presented_order":["23326722","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it discusses a tumor marker's association with prognosis in cancer (though in thyroid, not breast or ALDH1), whereas A is about T-cell lymphoma demographics. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847086Z"}
{"comparison_id":"4a2b32fa-114f-4003-bc99-28d0cf2a7cac","query_id":"53","doc_a_id":"22890091","doc_b_id":"25452937","presented_order":["25452937","22890091"],"winner_id":"25452937","reasoning":"Document A — it discusses tumor-associated factors linked to decreased survival in cancer (though thyroid, not breast), making it slightly more relevant than a study on leukocyte bcl-2/Fas. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847095Z"}
{"comparison_id":"0a5e8a5b-3791-462f-9fbf-00c7a9bf9e6f","query_id":"53","doc_a_id":"2205779","doc_b_id":"25452937","presented_order":["25452937","2205779"],"winner_id":"25452937","reasoning":"Document A — it discusses cancer prognosis (decreased survival), which is more related to the query about prognostic markers than Document B about gastric cancer miRNAs. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847103Z"}
{"comparison_id":"023a1209-90c9-4078-9f3c-35425390c780","query_id":"53","doc_a_id":"17775228","doc_b_id":"25452937","presented_order":["17775228","25452937"],"winner_id":"25452937","reasoning":"Document B — it discusses a tumor-associated factor linked to worse survival (similar concept of marker expression and prognosis), whereas A focuses on imprinting in colorectal cancer unrelated to ALDH1 or prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847110Z"}
{"comparison_id":"02559920-c748-4da4-924c-59ccce35fe30","query_id":"53","doc_a_id":"16627684","doc_b_id":"25452937","presented_order":["25452937","16627684"],"winner_id":"25452937","reasoning":"Document A is more relevant — it discusses a biomarker's association with cancer prognosis (though in thyroid cancer), whereas Document B concerns neural stem cell regulation in mice and is unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847117Z"}
{"comparison_id":"969bdd7f-19f1-40cd-b7c8-a7f052fb05c1","query_id":"53","doc_a_id":"38025907","doc_b_id":"25452937","presented_order":["38025907","25452937"],"winner_id":"25452937","reasoning":"Document B — it concerns tumor-related markers and prognosis in cancer (though thyroid, not breast), so it's more relevant than Document A which is about liver disease/NAFLD.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847123Z"}
{"comparison_id":"5292afe8-2d90-46d0-a150-a8e656f6acc3","query_id":"53","doc_a_id":"19343151","doc_b_id":"25452937","presented_order":["25452937","19343151"],"winner_id":"25452937","reasoning":"Document A is more relevant because it addresses cancer marker expression linked to survival/prognosis (albeit in thyroid cancer), whereas Document B concerns skin aging biomarkers unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847130Z"}
{"comparison_id":"980ec3ef-97ac-4488-940f-f01fb8bbe2dc","query_id":"53","doc_a_id":"1727493","doc_b_id":"25452937","presented_order":["1727493","25452937"],"winner_id":"25452937","reasoning":"Reason: Both documents concern cancer but B discusses a marker (TAM density) associated with decreased survival, making it more relevant to a prognosis-related claim than A, which focuses on drug resistance in ovarian cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847136Z"}
{"comparison_id":"7502ee4f-e47c-468e-b8eb-0745b218c7d4","query_id":"53","doc_a_id":"10450725","doc_b_id":"25452937","presented_order":["10450725","25452937"],"winner_id":"25452937","reasoning":"Document B — it concerns a marker's association with survival in cancer (though thyroid, not breast), whereas A focuses on drug effects in liver cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847142Z"}
{"comparison_id":"8431bd1d-2a6e-4048-901f-e3c7edcf3f7d","query_id":"53","doc_a_id":"3701541","doc_b_id":"25452937","presented_order":["3701541","25452937"],"winner_id":"25452937","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it examines an association between a tumor marker and survival in cancer, whereas A focuses on liver fibrosis/VDR signaling. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847149Z"}
{"comparison_id":"72d7fc13-0f67-47ff-bfd5-63323947ac66","query_id":"53","doc_a_id":"26059876","doc_b_id":"25452937","presented_order":["25452937","26059876"],"winner_id":"25452937","reasoning":"Document A — it discusses cancer prognosis and survival (though in thyroid cancer), which is closer to the query about ALDH1 and breast cancer prognosis than the molecular colorectal study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847157Z"}
{"comparison_id":"c7df1962-a3ac-4281-bf9d-c369782ef653","query_id":"53","doc_a_id":"27822315","doc_b_id":"25452937","presented_order":["27822315","25452937"],"winner_id":"27822315","reasoning":"Document A is more relevant — it addresses stem cell differentiation and related regulators (closer to ALDH1 as a stem/progenitor marker), whereas Document B concerns macrophages in thyroid cancer, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847164Z"}
{"comparison_id":"5674a264-f2b6-4fad-99f7-d41ce7f841e6","query_id":"53","doc_a_id":"39225849","doc_b_id":"25452937","presented_order":["25452937","39225849"],"winner_id":"25452937","reasoning":"Document A — it discusses cancer prognosis (decreased survival), making it more relevant than Document B which concerns DNA repair mechanisms unrelated to prognosis or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847170Z"}
{"comparison_id":"fda57658-5e93-494d-b76b-d9a34a13d72a","query_id":"53","doc_a_id":"20977638","doc_b_id":"25452937","presented_order":["20977638","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it discusses tumor markers and survival in cancer, whereas Document A concerns embryonic oxidative stress unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847177Z"}
{"comparison_id":"5fb8eabb-f95a-4829-8dee-90d41fcac5e1","query_id":"53","doc_a_id":"32776084","doc_b_id":"25452937","presented_order":["25452937","32776084"],"winner_id":"25452937","reasoning":"Document A is more relevant — it addresses cancer prognosis and survival associations (though in thyroid cancer), whereas Document B is about stem cell imprinting and not prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847183Z"}
{"comparison_id":"d46dea13-c887-447a-8472-a1e63a1b290a","query_id":"53","doc_a_id":"15491308","doc_b_id":"25452937","presented_order":["15491308","25452937"],"winner_id":"25452937","reasoning":"Document B — it discusses tumor-associated macrophages and cancer survival (prognosis), so it's closer in topic to ALDH1's prognostic association than Document A, which focuses on MSC senescence. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847189Z"}
{"comparison_id":"6c36e5c5-a3fa-4632-97a8-51c7aca7f21f","query_id":"53","doc_a_id":"18938992","doc_b_id":"25452937","presented_order":["25452937","18938992"],"winner_id":"25452937","reasoning":"Document A is more relevant — it discusses tumor marker density and survival associations in cancer (prognosis), whereas Document B covers viral immune evasion in B cells unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847196Z"}
{"comparison_id":"2f70d6d6-6425-49f5-af2f-decea258696e","query_id":"53","doc_a_id":"3863543","doc_b_id":"25452937","presented_order":["25452937","3863543"],"winner_id":"25452937","reasoning":"Document A is more relevant — it addresses associations between a tumor marker and decreased survival (prognosis) in cancer, which is closer to the claim about ALDH1 and breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847203Z"}
{"comparison_id":"f99ea61c-9f63-4785-9468-4c96a7d89506","query_id":"53","doc_a_id":"23816832","doc_b_id":"25452937","presented_order":["23816832","25452937"],"winner_id":"25452937","reasoning":"Document B — it discusses cancer prognosis and biomarkers (though in thyroid cancer), whereas Document A is about CSF analysis in multiple sclerosis. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847209Z"}
{"comparison_id":"e7052da2-0114-4a4d-a362-5a37be69d455","query_id":"53","doc_a_id":"8417211","doc_b_id":"25452937","presented_order":["8417211","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it relates to cancer prognosis (though in thyroid cancer) while Document A is about HP1 phosphorylation in Drosophila and not cancer-related.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847215Z"}
{"comparison_id":"aa28e9ae-9aa7-4a24-a494-2b941edf9f3d","query_id":"53","doc_a_id":"2919030","doc_b_id":"25452937","presented_order":["2919030","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it addresses associations between a tumor marker and patient survival (prognosis) in cancer, whereas A discusses SOD1 and metabolism without linking ALDH1 or prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847222Z"}
{"comparison_id":"4fe26b98-272c-42d3-b813-72d5ca86eef0","query_id":"53","doc_a_id":"22896384","doc_b_id":"25452937","presented_order":["25452937","22896384"],"winner_id":"25452937","reasoning":"Document A is more relevant because it addresses cancer prognosis (survival associations), whereas Document B is about developmental transcription factors unrelated to cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847228Z"}
{"comparison_id":"efcc100b-d1c0-4e1e-94ad-6b201ed4dacc","query_id":"53","doc_a_id":"32372280","doc_b_id":"25452937","presented_order":["25452937","32372280"],"winner_id":"25452937","reasoning":"Document A is more relevant — it concerns tumor markers and cancer prognosis (though in thyroid cancer), whereas Document B concerns glaucoma and is unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847234Z"}
{"comparison_id":"e42c10f0-296c-405e-9632-b87711d3da99","query_id":"53","doc_a_id":"25022826","doc_b_id":"25452937","presented_order":["25452937","25022826"],"winner_id":"25452937","reasoning":"Document A is more relevant because it discusses cancer prognosis and survival associations (though in thyroid cancer), whereas Document B is about MSC osteogenic differentiation and unrelated. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847240Z"}
{"comparison_id":"aa64fa75-b36c-41f1-89eb-b53d0e48f93c","query_id":"53","doc_a_id":"20179918","doc_b_id":"25452937","presented_order":["25452937","20179918"],"winner_id":"25452937","reasoning":"Document A is slightly more relevant because it discusses cancer prognosis (though in thyroid cancer), while Document B concerns stem cell transcriptional regulation and is unrelated to prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847247Z"}
{"comparison_id":"42bd4d60-ebba-4420-8d28-3ed569b7c080","query_id":"53","doc_a_id":"19958277","doc_b_id":"25452937","presented_order":["19958277","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it reports an association between a tumor marker and decreased survival (prognosis) in cancer (though in thyroid, not breast). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847253Z"}
{"comparison_id":"326f7f43-eb16-49c7-b6e6-8f2af5497593","query_id":"53","doc_a_id":"12580014","doc_b_id":"25452937","presented_order":["25452937","12580014"],"winner_id":"25452937","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document A concerns tumor-associated markers linked to decreased survival (poorer prognosis), making it marginally more relevant than B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847259Z"}
{"comparison_id":"90fdf334-839d-400b-9585-e44d1b1a8ed1","query_id":"53","doc_a_id":"17412260","doc_b_id":"25452937","presented_order":["17412260","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it addresses an association between a tumor-related marker and patient survival (prognosis), whereas A focuses on inflammasome-driven senescence mechanisms not prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847266Z"}
{"comparison_id":"00cd8031-07dd-42c5-8073-9eca0aa1042e","query_id":"53","doc_a_id":"7221410","doc_b_id":"25452937","presented_order":["7221410","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it concerns cancer prognosis (though in thyroid cancer) while Document A addresses Alzheimer's disease and is unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847272Z"}
{"comparison_id":"d44a83aa-5da0-465a-8154-37d42703be39","query_id":"53","doc_a_id":"12887068","doc_b_id":"25452937","presented_order":["25452937","12887068"],"winner_id":"25452937","reasoning":"Document A is more relevant — it discusses marker expression associated with survival in cancer (though in thyroid cancer rather than breast). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847279Z"}
{"comparison_id":"3c63636c-cfcd-4fc5-b277-418fe4a99016","query_id":"53","doc_a_id":"5765455","doc_b_id":"25452937","presented_order":["25452937","5765455"],"winner_id":"25452937","reasoning":"Document A — it discusses cancer prognosis (survival) whereas Document B focuses on genomic instability in myeloid leukemia and not prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847285Z"}
{"comparison_id":"3b51e16d-69ea-4eb7-a60a-509061a4b29d","query_id":"53","doc_a_id":"2829179","doc_b_id":"25452937","presented_order":["2829179","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant because it addresses cancer prognosis and survival associations (though in thyroid cancer), whereas Document A concerns pre-eclampsia and is unrelated to cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847291Z"}
{"comparison_id":"7b86720b-8576-4cde-aef4-9dd778daf80c","query_id":"53","doc_a_id":"28390999","doc_b_id":"25452937","presented_order":["28390999","25452937"],"winner_id":"25452937","reasoning":"Document B — it concerns cancer prognosis associations (though in thyroid cancer), whereas A is about chicken gonad development and unrelated to cancer.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847297Z"}
{"comparison_id":"c1696fcf-8f79-40eb-aa37-f4e18c5d4fde","query_id":"53","doc_a_id":"2356950","doc_b_id":"25452937","presented_order":["2356950","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant because it concerns cancer prognosis (though in thyroid cancer), whereas Document A is about neural stem cell regulation and unrelated to cancer biomarkers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847304Z"}
{"comparison_id":"90fb5fda-620a-48e1-bc04-fa5ed82f7ffc","query_id":"53","doc_a_id":"11255504","doc_b_id":"25452937","presented_order":["25452937","11255504"],"winner_id":"25452937","reasoning":"Document A is more relevant because it addresses associations between a molecular/cellular marker and patient prognosis (decreased survival), whereas Document B focuses on liver tumor suppressors unrelated to prognosis markers.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847310Z"}
{"comparison_id":"f57b74e8-db4f-465b-be4a-adcae03ff82f","query_id":"53","doc_a_id":"13350374","doc_b_id":"25452937","presented_order":["13350374","25452937"],"winner_id":"25452937","reasoning":"Document B — it concerns a marker (TAM density) associated with worse cancer survival, which is more analogous to a claim about ALDH1 and cancer prognosis than Document A on aging. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847316Z"}
{"comparison_id":"292752c1-9202-41f5-b273-80eff67fc633","query_id":"53","doc_a_id":"9641846","doc_b_id":"25452937","presented_order":["9641846","25452937"],"winner_id":"9641846","reasoning":"Document A is more related to cancer cell differentiation and cell-cycle pathways (closer to topics around ALDH1 and tumor prognosis) while Document B focuses on macrophages in thyroid cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847323Z"}
{"comparison_id":"2d8f127b-fbde-4761-9691-3e96a6fdf5b7","query_id":"53","doc_a_id":"34316341","doc_b_id":"25452937","presented_order":["34316341","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it discusses cancer prognosis and tumor markers (TAM density) whereas Document A is about developmental gene imprinting unrelated to cancer prognosis. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847330Z"}
{"comparison_id":"e6e26e27-1ead-4b9d-a544-81bbca163366","query_id":"53","doc_a_id":"25748308","doc_b_id":"25452937","presented_order":["25452937","25748308"],"winner_id":"25748308","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; Document B at least discusses a protein's roles in cancers generally, so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847336Z"}
{"comparison_id":"b1a22f00-939e-4f29-a644-aac8f3771eec","query_id":"53","doc_a_id":"13791206","doc_b_id":"25452937","presented_order":["25452937","13791206"],"winner_id":"13791206","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis; Document B is marginally more relevant because it concerns BRCA1-related DNA repair mechanisms tied to breast cancer, whereas A is about thyroid cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847342Z"}
{"comparison_id":"de8c7a5b-d793-4396-b2e2-c47acb077bf3","query_id":"53","doc_a_id":"22914228","doc_b_id":"25452937","presented_order":["22914228","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it examines an association between a tumor feature (TAM density) and patient survival, which is conceptually closer to a claim about a biomarker's prognostic value than a metabolic proteomics study in pancreatic cells. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847349Z"}
{"comparison_id":"69c33aff-0836-4c43-a36c-a7552aa5a5c1","query_id":"53","doc_a_id":"23513818","doc_b_id":"25452937","presented_order":["23513818","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it addresses an association between a tumor feature and patient survival (prognosis), whereas A describes molecular regulation of Mcl-1 without linking to prognosis or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847355Z"}
{"comparison_id":"897d90f2-bb19-43d5-b7ee-a8487aa278bb","query_id":"53","doc_a_id":"5811042","doc_b_id":"25452937","presented_order":["25452937","5811042"],"winner_id":"25452937","reasoning":"Document A is more relevant — it deals with cancer prognosis and survival associations (though in thyroid cancer), whereas Document B is about T-cell regulation and autoinflammatory disease unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847361Z"}
{"comparison_id":"4379ac9e-a0f1-4639-a26c-7cfff8162157","query_id":"53","doc_a_id":"42484543","doc_b_id":"25452937","presented_order":["25452937","42484543"],"winner_id":"25452937","reasoning":"Reason: Document A deals with tumor markers and cancer prognosis (though in thyroid cancer), which is closer to the query about prognostic markers in cancer than Document B's embryonic stem cell transcriptome.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847367Z"}
{"comparison_id":"ded3069d-0a78-4d86-9107-bcae4ec00146","query_id":"53","doc_a_id":"40901687","doc_b_id":"25452937","presented_order":["40901687","25452937"],"winner_id":"25452937","reasoning":"Document B — it examines an association between a tumor feature and patient survival (prognosis), while Document A focuses on a molecular DNA damage pathway unrelated to ALDH1 or clinical prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847373Z"}
{"comparison_id":"d529364e-01aa-4277-8536-6211e7a64b4f","query_id":"53","doc_a_id":"1982286","doc_b_id":"25452937","presented_order":["1982286","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it addresses marker expression associated with prognosis (decreased survival) in cancer, whereas A concerns transcriptional networks in T-ALL unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847379Z"}
{"comparison_id":"f55bc694-c20a-4a33-ba0e-18a5232a8a01","query_id":"53","doc_a_id":"4444861","doc_b_id":"25452937","presented_order":["4444861","25452937"],"winner_id":"4444861","reasoning":"Document A is more relevant — it concerns mechanisms in BRCA-deficient (breast) tumors, whereas Document B focuses on thyroid cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847385Z"}
{"comparison_id":"cbab68df-22fb-4bd8-ad9c-5ed5c318c114","query_id":"53","doc_a_id":"4795303","doc_b_id":"25452937","presented_order":["4795303","25452937"],"winner_id":"25452937","reasoning":"Document B is more relevant — it addresses cancer prognosis (though in thyroid cancer), while Document A is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:53:34.847391Z"}
{"comparison_id":"e1113f24-8c7d-495e-8911-0ee2adb82724","query_id":"53","doc_a_id":"42731834","doc_b_id":"9394119","presented_order":["42731834","9394119"],"winner_id":"9394119","reasoning":"Document B — it concerns breast cancer (though different biomarkers), while Document A is about colorectal cancer and an unrelated marker. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827442Z"}
{"comparison_id":"a57f59ad-43e5-4096-b337-1566a8ffbb0d","query_id":"53","doc_a_id":"10024681","doc_b_id":"9394119","presented_order":["9394119","10024681"],"winner_id":"9394119","reasoning":"Reason: Document A concerns breast cancer (though about BRCA mutations rather than ALDH1), while Document B is about prostate cancer and so is less relevant to the breast cancer prognosis claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827464Z"}
{"comparison_id":"979e8955-1949-4c21-a979-3c0530bc6616","query_id":"53","doc_a_id":"2389574","doc_b_id":"9394119","presented_order":["9394119","2389574"],"winner_id":"9394119","reasoning":"Document A — it concerns breast cancer (though about BRCA mutations, not ALDH1), while Document B is about endometrial cancer and thus less relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827473Z"}
{"comparison_id":"e3da308f-32a7-4beb-8a2e-366ae26e9cb9","query_id":"53","doc_a_id":"39580129","doc_b_id":"9394119","presented_order":["9394119","39580129"],"winner_id":"9394119","reasoning":"Document A is more relevant — it concerns breast cancer (though not ALDH1 specifically), while Document B addresses a different marker in colorectal cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827480Z"}
{"comparison_id":"b7c502d4-1ef3-4540-9dba-4a90ba4ba747","query_id":"53","doc_a_id":"22963769","doc_b_id":"9394119","presented_order":["22963769","9394119"],"winner_id":"9394119","reasoning":"Document B — it concerns breast cancer (BRCA mutation risks), whereas A is about oral cancer and unrelated to ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827487Z"}
{"comparison_id":"8f32628b-8307-4bce-b01e-91d7a4dc6494","query_id":"53","doc_a_id":"654735","doc_b_id":"9394119","presented_order":["9394119","654735"],"winner_id":"9394119","reasoning":"Document A is more relevant — it concerns breast cancer (while Document B is about glioma), so A is more likely to address prognostic markers in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827493Z"}
{"comparison_id":"da7c1619-6bd5-4324-985a-e924cccdf7e0","query_id":"53","doc_a_id":"20886584","doc_b_id":"9394119","presented_order":["9394119","20886584"],"winner_id":"9394119","reasoning":"Document A is more relevant — it deals with breast cancer genetic factors and risk associations, which are closer to prognosis than Document B's focus on treatment neurotoxicity. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827501Z"}
{"comparison_id":"42829796-8ba3-4782-9a71-3a084797f843","query_id":"53","doc_a_id":"38808600","doc_b_id":"9394119","presented_order":["38808600","9394119"],"winner_id":"9394119","reasoning":"Document B — it concerns breast cancer (mutation-associated risk), whereas A is about glioma imaging and is unrelated to breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827507Z"}
{"comparison_id":"db0d1479-ab86-461d-927f-90e4d5cf8d01","query_id":"53","doc_a_id":"6517763","doc_b_id":"9394119","presented_order":["6517763","9394119"],"winner_id":"9394119","reasoning":"Document B is more relevant — it concerns breast cancer risk and genetics, whereas Document A studies glioblastoma; neither mentions ALDH1 but B is closer to the breast cancer context.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827515Z"}
{"comparison_id":"5ac76adb-e803-4d70-86f4-f14132c42488","query_id":"53","doc_a_id":"3730196","doc_b_id":"9394119","presented_order":["3730196","9394119"],"winner_id":"9394119","reasoning":"Document B is more relevant because it addresses breast cancer (risk/prognosis-related genetics), while Document A concerns small cell lung cancer and a different biomarker; neither mentions ALDH1, but B is closer to the query topic.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827523Z"}
{"comparison_id":"6e637ceb-e600-425e-b165-f1cb222ee20a","query_id":"53","doc_a_id":"26561572","doc_b_id":"9394119","presented_order":["9394119","26561572"],"winner_id":"9394119","reasoning":"Document A — it concerns breast cancer (while B is about lung cancer), so A is more relevant to a claim about prognosis in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827529Z"}
{"comparison_id":"183b066d-96eb-4d74-9548-ec8e3e5a414e","query_id":"53","doc_a_id":"15335331","doc_b_id":"9394119","presented_order":["9394119","15335331"],"winner_id":"9394119","reasoning":"Document A — it concerns breast cancer (while B addresses oral cancer) and is therefore more relevant to a prognostic marker in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827536Z"}
{"comparison_id":"078dc60b-809b-47cf-bfa0-a9ff5b8dfb7d","query_id":"53","doc_a_id":"38243984","doc_b_id":"9394119","presented_order":["38243984","9394119"],"winner_id":"9394119","reasoning":"Document B — it concerns breast cancer (BRCA mutation risks), so it's more related to prognosis in breast cancer than Document A, which focuses on pancreatic cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827544Z"}
{"comparison_id":"1ed13587-711d-4c98-a8b4-28bfcda3af56","query_id":"53","doc_a_id":"16806763","doc_b_id":"9394119","presented_order":["16806763","9394119"],"winner_id":"9394119","reasoning":"Document B is more relevant — it deals with breast cancer (though not ALDH1), while Document A is about colorectal cancer and thus less relevant. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827551Z"}
{"comparison_id":"faa76407-01b3-4856-916a-298c0d74fbae","query_id":"53","doc_a_id":"16701509","doc_b_id":"9394119","presented_order":["9394119","16701509"],"winner_id":"9394119","reasoning":"Document A is more relevant — both abstracts deal with molecular/genetic factors and cancer risk/prognosis, whereas B addresses metabolic (HDL) risk; neither mentions ALDH1, but A is closer in topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827558Z"}
{"comparison_id":"79faa9a1-184a-41b0-a355-4a0cd1e9c29e","query_id":"53","doc_a_id":"37480103","doc_b_id":"9394119","presented_order":["37480103","9394119"],"winner_id":"9394119","reasoning":"Document B is more relevant because it discusses molecular/genetic factors linked to breast cancer risk, whereas Document A concerns pregnancy/placental factors unrelated to ALDH1 expression or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827566Z"}
{"comparison_id":"2c4c3b92-53fc-40bd-9f22-ab7396fb1367","query_id":"53","doc_a_id":"4489217","doc_b_id":"9394119","presented_order":["9394119","4489217"],"winner_id":"9394119","reasoning":"Document A is more relevant because it focuses on genetic factors in breast cancer, whereas Document B studies intratumor heterogeneity in renal carcinoma, not breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827573Z"}
{"comparison_id":"0e277b71-69ee-4c84-82ab-1394f8d8be2d","query_id":"53","doc_a_id":"7165938","doc_b_id":"9394119","presented_order":["7165938","9394119"],"winner_id":"9394119","reasoning":"Document B is more relevant — it concerns breast cancer (though about BRCA mutations rather than ALDH1), whereas Document A is about colorectal cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827579Z"}
{"comparison_id":"5b7b4784-b2a8-47e5-8cde-9925ad923c4f","query_id":"53","doc_a_id":"515489","doc_b_id":"9394119","presented_order":["515489","9394119"],"winner_id":"9394119","reasoning":"Document B — it concerns breast cancer (BRCA mutation risks), whereas A is about hepatocellular carcinoma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827586Z"}
{"comparison_id":"ec5adea5-fa55-4ff6-8b20-a0e133b93e88","query_id":"53","doc_a_id":"23304931","doc_b_id":"9394119","presented_order":["9394119","23304931"],"winner_id":"9394119","reasoning":"Document A is more relevant — it deals with breast cancer risk factors, whereas Document B concerns AIDS-related DLBCL (not breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827593Z"}
{"comparison_id":"9663f075-24ce-4634-abaa-96f4635c0d40","query_id":"53","doc_a_id":"19047331","doc_b_id":"9394119","presented_order":["9394119","19047331"],"winner_id":"9394119","reasoning":"Document A is more relevant — it addresses breast cancer (while B focuses on ovarian cancer); neither mentions ALDH1 but A is closer to the query. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827599Z"}
{"comparison_id":"0c545747-d3e5-4cbc-b2f8-f1f155d6dca6","query_id":"53","doc_a_id":"20280410","doc_b_id":"9394119","presented_order":["20280410","9394119"],"winner_id":"9394119","reasoning":"Neither document mentions ALDH1 or directly addresses prognosis in breast cancer; both are irrelevant. Document B is slightly more related to cancer risk/prognosis (mutation–outcome associations), so pick B.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827606Z"}
{"comparison_id":"3a511f2b-08e7-49f3-9e76-95da58e47c66","query_id":"53","doc_a_id":"27123743","doc_b_id":"9394119","presented_order":["9394119","27123743"],"winner_id":"27123743","reasoning":"Document B is slightly more relevant — it discusses stem-cell–related mechanisms and growth-factor effects in breast cancer etiology, which is closer to biomarker/prognosis topics than BRCA mutation-location risk. It does not, however, provide evidence about ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827614Z"}
{"comparison_id":"293f1f4b-f4b4-4645-9745-519c5e1b7840","query_id":"53","doc_a_id":"38551172","doc_b_id":"9394119","presented_order":["9394119","38551172"],"winner_id":"9394119","reasoning":"Doc A is more related to molecular/genetic markers and cancer prognosis, whereas Doc B focuses on mammographic density and vitamin D unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827621Z"}
{"comparison_id":"ffc3d3f5-5ec4-428e-8de5-ddb47a010740","query_id":"53","doc_a_id":"21181273","doc_b_id":"9394119","presented_order":["9394119","21181273"],"winner_id":"9394119","reasoning":"Document A is more relevant because it concerns breast cancer, while Document B concerns colorectal cancer and is unrelated to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827627Z"}
{"comparison_id":"a827b101-b9bf-44db-a584-f6e7e4b0f4fb","query_id":"53","doc_a_id":"36950726","doc_b_id":"9394119","presented_order":["9394119","36950726"],"winner_id":"9394119","reasoning":"Document A is more relevant because it concerns breast cancer (where ALDH1 prognostic links would apply), while Document B is about melanoma and unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827634Z"}
{"comparison_id":"66a623c3-6303-47db-bf15-dc1bb7ce9301","query_id":"53","doc_a_id":"17088791","doc_b_id":"9394119","presented_order":["17088791","9394119"],"winner_id":"17088791","reasoning":"Neither document discusses ALDH1 or prognosis; both focus on BRCA variants. If forced to choose, A is marginally more relevant because it addresses breast cancer susceptibility in the general population rather than specific mutation-location risk.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827641Z"}
{"comparison_id":"ced41d43-2ee6-4209-9bc5-1adf3f24b6b2","query_id":"53","doc_a_id":"17450673","doc_b_id":"9394119","presented_order":["17450673","9394119"],"winner_id":"9394119","reasoning":"Document B is more relevant because it addresses molecular/genetic factors tied to breast cancer risk and prognosis, whereas Document A focuses on perinatal factors and general risk. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827648Z"}
{"comparison_id":"7bd28c2f-c94a-491c-b967-ee9ea7315fc9","query_id":"53","doc_a_id":"5774746","doc_b_id":"9394119","presented_order":["9394119","5774746"],"winner_id":"9394119","reasoning":"Document A is more relevant — it concerns breast cancer (though not ALDH1 specifically), whereas Document B focuses on inflammation/metastasis in colorectal cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827656Z"}
{"comparison_id":"d872edbc-cf31-4f1c-936f-cc4a579ad2c6","query_id":"53","doc_a_id":"13831842","doc_b_id":"9394119","presented_order":["9394119","13831842"],"winner_id":"9394119","reasoning":"Document A is slightly more relevant because it deals with molecular/genetic markers (BRCA1/2) and cancer risk, closer in subject matter to a molecular marker (ALDH1) and prognosis than epidemiologic factors like height/weight.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827663Z"}
{"comparison_id":"ccb6a9c2-908c-40fa-9e7f-730839f4583b","query_id":"53","doc_a_id":"13831558","doc_b_id":"9394119","presented_order":["13831558","9394119"],"winner_id":"9394119","reasoning":"Neither document discusses ALDH1 expression. Both are irrelevant, but Document B is marginally more related to cancer biomarkers/genetics, so it's slightly more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827669Z"}
{"comparison_id":"fb8deeb9-c8fe-4fcd-80be-fb8b59806765","query_id":"53","doc_a_id":"25576204","doc_b_id":"9394119","presented_order":["25576204","9394119"],"winner_id":"25576204","reasoning":"Document A is slightly more related (discusses tumorigenesis/tumor suppression) while neither mentions ALDH1 or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827676Z"}
{"comparison_id":"4fb5270a-66cb-4e36-8a2b-3feb7a5b596a","query_id":"53","doc_a_id":"11271123","doc_b_id":"9394119","presented_order":["9394119","11271123"],"winner_id":"9394119","reasoning":"Document A is more relevant because it concerns breast cancer (while Document B addresses endometrial cancer), making A closer to the query about prognosis in breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827683Z"}
{"comparison_id":"86aee44d-9941-4b4b-a71b-45286bec3ee6","query_id":"53","doc_a_id":"4828631","doc_b_id":"9394119","presented_order":["4828631","9394119"],"winner_id":"9394119","reasoning":"Document B is more relevant — it specifically addresses breast cancer and molecular/genetic factors related to risk, which is closer to biomarker-associated outcomes than a broad BMI–cancer risk study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827690Z"}
{"comparison_id":"c9262f2b-7910-4b3d-abac-c6a9c8203562","query_id":"53","doc_a_id":"7736860","doc_b_id":"9394119","presented_order":["7736860","9394119"],"winner_id":"9394119","reasoning":"Document B is more relevant — it concerns breast cancer (BRCA mutation risks), while Document A discusses STIM1 in cervical cancer, which is unrelated to ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827697Z"}
{"comparison_id":"00fe9bde-3cdf-416e-8e74-f2e8769e72d6","query_id":"53","doc_a_id":"16098747","doc_b_id":"9394119","presented_order":["16098747","9394119"],"winner_id":"9394119","reasoning":"Neither document discusses ALDH1 expression. Document B is slightly more relevant because it addresses molecular/genetic factors linked to breast cancer risk and outcomes, whereas A focuses on breast density epidemiology. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827704Z"}
{"comparison_id":"a814ee66-f21d-47af-9047-0f85bf6aadc9","query_id":"53","doc_a_id":"5222182","doc_b_id":"9394119","presented_order":["5222182","9394119"],"winner_id":"9394119","reasoning":"Document B is more relevant — it deals directly with breast cancer genetics and tumor-related risk factors, which is closer to a molecular prognostic marker than a study of mammographic density.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827711Z"}
{"comparison_id":"d0a89b39-006f-403d-8696-1c317f7eeaf2","query_id":"53","doc_a_id":"16322674","doc_b_id":"9394119","presented_order":["16322674","9394119"],"winner_id":"16322674","reasoning":"Document A is slightly more relevant because it concerns breast cancer epidemiology, whereas Document B focuses narrowly on BRCA1/2 mutation risks and neither mentions ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827718Z"}
{"comparison_id":"684dbd4b-8ec9-468b-bf05-1af03589e49a","query_id":"53","doc_a_id":"6790197","doc_b_id":"9394119","presented_order":["9394119","6790197"],"winner_id":"9394119","reasoning":"Document A — it concerns breast cancer (BRCA mutation-related risk) and is therefore more relevant than Document B, which concerns prostate cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827725Z"}
{"comparison_id":"8c85d33e-1cbf-473e-ad10-465533910b5f","query_id":"53","doc_a_id":"13964633","doc_b_id":"9394119","presented_order":["9394119","13964633"],"winner_id":"9394119","reasoning":"Document A is more relevant because it directly concerns breast cancer (genetic risk and outcomes), whereas Document B focuses on microRNA modulation by versican 3'UTR without direct relevance to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827732Z"}
{"comparison_id":"0d94344c-330a-464e-8ec0-2bba742d7ca0","query_id":"53","doc_a_id":"27306942","doc_b_id":"9394119","presented_order":["9394119","27306942"],"winner_id":"9394119","reasoning":"Document A is more relevant — it concerns breast cancer genetic risk/prognosis, whereas B addresses pediatric acute lymphoblastic leukemia unrelated to ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827740Z"}
{"comparison_id":"53c90ef8-d7a8-4e37-92ae-286f356dcebe","query_id":"53","doc_a_id":"3067015","doc_b_id":"9394119","presented_order":["9394119","3067015"],"winner_id":"3067015","reasoning":"Document B is slightly more relevant because it discusses an ALDH family gene (ALDH2), whereas Document A focuses on BRCA mutations unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827747Z"}
{"comparison_id":"2a7b847b-f1a7-4077-87de-ea8f7b967c4b","query_id":"53","doc_a_id":"23557241","doc_b_id":"9394119","presented_order":["9394119","23557241"],"winner_id":"9394119","reasoning":"Document A is more closely related to breast cancer biology (genetic factors affecting cancer risk/prognosis), while Document B focuses on prenatal risk factors not tumor markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827754Z"}
{"comparison_id":"d8cccb6c-c5ae-4058-b533-11c08d3aa06e","query_id":"53","doc_a_id":"4444861","doc_b_id":"9394119","presented_order":["4444861","9394119"],"winner_id":"4444861","reasoning":"Document A is more relevant — it addresses tumor biology and factors affecting treatment resistance and outcomes in breast cancer, which is closer to prognosis-related evidence than mutation-risk data in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827762Z"}
{"comparison_id":"36dda720-7591-4b1f-be18-f9f3aaf56d7f","query_id":"53","doc_a_id":"3210545","doc_b_id":"9394119","presented_order":["3210545","9394119"],"winner_id":"9394119","reasoning":"Document B — it deals with breast cancer risk (BRCA1/2), whereas Document A is about KRAS in endometrial cancer and is unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827769Z"}
{"comparison_id":"019e6289-59ea-4457-a1ad-42addbc9dedd","query_id":"53","doc_a_id":"22007333","doc_b_id":"9394119","presented_order":["22007333","9394119"],"winner_id":"9394119","reasoning":"Document B is more relevant — it addresses molecular/genetic factors and cancer risk, which is closer to a biomarker/prognosis question; Document A focuses on reproductive factors and mammographic density. (Neither directly addresses ALDH1.)\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827776Z"}
{"comparison_id":"9f2c0640-2d64-43a5-ab3a-d2c8a902b166","query_id":"53","doc_a_id":"23284774","doc_b_id":"9394119","presented_order":["9394119","23284774"],"winner_id":"9394119","reasoning":"Reason: Document A addresses molecular/genetic factors related to breast cancer risk, making it closer to a biomarker/prognosis topic than Document B's psychosocial focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827783Z"}
{"comparison_id":"9e275f98-ff50-4987-933e-5e12cefa692e","query_id":"53","doc_a_id":"14664424","doc_b_id":"9394119","presented_order":["9394119","14664424"],"winner_id":"9394119","reasoning":"Document A is more relevant because it concerns breast cancer (BRCA mutation risks), whereas Document B addresses cervical cancer markers; neither mentions ALDH1 but A is closer to the query topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827812Z"}
{"comparison_id":"ba0a5939-197b-46de-bc24-15e5fef26734","query_id":"53","doc_a_id":"17462437","doc_b_id":"9394119","presented_order":["17462437","9394119"],"winner_id":"9394119","reasoning":"Document B — it concerns breast cancer (BRCA mutation risks) and is more relevant to a claim about prognosis in breast cancer than Document A, which is about lung cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827827Z"}
{"comparison_id":"226b19d2-443e-4ccf-a96a-ec62d60b34e5","query_id":"53","doc_a_id":"16346504","doc_b_id":"9394119","presented_order":["9394119","16346504"],"winner_id":"9394119","reasoning":"Doc A is more relevant — it concerns breast cancer (though not ALDH1 specifically), while Doc B is about endometrial cancer and unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827836Z"}
{"comparison_id":"40bdc6de-00e3-4582-a359-7c890f8fb929","query_id":"53","doc_a_id":"26848994","doc_b_id":"9394119","presented_order":["9394119","26848994"],"winner_id":"9394119","reasoning":"Document A is more relevant — it concerns breast cancer (though not ALDH1 specifically), while Document B addresses hepatocellular carcinoma. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827844Z"}
{"comparison_id":"e10672ea-21fa-4334-90b6-9743a70a25fd","query_id":"53","doc_a_id":"32534305","doc_b_id":"9394119","presented_order":["32534305","9394119"],"winner_id":"9394119","reasoning":"Both documents are irrelevant to ALDH1 expression and prognosis, but Document B is slightly closer because it deals with tumor genetics/biology rather than only epidemiologic incidence.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827852Z"}
{"comparison_id":"4ce5f3a9-b533-42dd-9f08-fc7ecd90dcfe","query_id":"53","doc_a_id":"5487448","doc_b_id":"9394119","presented_order":["9394119","5487448"],"winner_id":"9394119","reasoning":"Document A is slightly more relevant because it addresses molecular/genetic factors related to breast cancer risk and outcomes, whereas Document B focuses on birth weight and mammographic density. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827859Z"}
{"comparison_id":"a32ef40d-4b3d-4ecb-a821-d3ef3b7af5ba","query_id":"53","doc_a_id":"7228140","doc_b_id":"9394119","presented_order":["9394119","7228140"],"winner_id":"7228140","reasoning":"Document B — it deals with gene-expression–based tumor subtypes and prognosis (though in pancreatic cancer), which is more related to expression–prognosis links than a study of BRCA mutation locations. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827866Z"}
{"comparison_id":"6b8bc749-3699-4089-a1ce-9509e7c252ac","query_id":"53","doc_a_id":"29806339","doc_b_id":"9394119","presented_order":["29806339","9394119"],"winner_id":"29806339","reasoning":"Neither paper mentions ALDH1. Document A is slightly more relevant because it addresses tumor behavior and treatment/prognosis, while B focuses on BRCA mutation risk. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827873Z"}
{"comparison_id":"ae50b6c3-b1ca-4ccd-88fb-a0a0bf6fb1d3","query_id":"53","doc_a_id":"13205096","doc_b_id":"9394119","presented_order":["13205096","9394119"],"winner_id":"9394119","reasoning":"Document B — it concerns breast cancer-specific genetic risk, whereas A is about leukemia. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827879Z"}
{"comparison_id":"5b2aa9d6-9fbb-442d-860d-ccaca643df6a","query_id":"53","doc_a_id":"36432234","doc_b_id":"9394119","presented_order":["36432234","9394119"],"winner_id":"36432234","reasoning":"Document A is slightly more relevant — it concerns expression-driven biology in breast cancer (hormone receptor signaling), whereas B focuses on inherited BRCA mutation risk rather than prognostic biomarkers.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827887Z"}
{"comparison_id":"8e0369c0-87be-419d-9efe-9ac52ec627f4","query_id":"53","doc_a_id":"831167","doc_b_id":"9394119","presented_order":["9394119","831167"],"winner_id":"9394119","reasoning":"Document A is more relevant — it concerns breast cancer (where ALDH1 prognosis would apply), while Document B addresses glioblastoma. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827893Z"}
{"comparison_id":"7c25948b-cdca-4f19-b53e-493398e7235e","query_id":"53","doc_a_id":"38784540","doc_b_id":"9394119","presented_order":["38784540","9394119"],"winner_id":"9394119","reasoning":"Document B is more relevant — it addresses molecular/genetic factors linked to breast cancer risk/prognosis, whereas A focuses on life-course factors and mammographic density, not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827901Z"}
{"comparison_id":"13ae13e1-9ba6-4efe-9919-511c2af2a730","query_id":"53","doc_a_id":"33677323","doc_b_id":"9394119","presented_order":["9394119","33677323"],"winner_id":"9394119","reasoning":"Document A is more related (breast cancer-focused), while Document B concerns hematopoietic malignancies unrelated to ALDH1 in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827907Z"}
{"comparison_id":"4cece893-2a66-405e-9c8c-941ac1a2c36b","query_id":"53","doc_a_id":"25488034","doc_b_id":"9394119","presented_order":["25488034","9394119"],"winner_id":"25488034","reasoning":"Document A — it discusses detoxifying enzymes and oxidative-stress–related enzyme systems (closer to ALDH1's enzymatic/prognostic context) while B focuses on BRCA mutation locations unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827914Z"}
{"comparison_id":"8e8d200c-3c3e-40dc-872c-6faa76034a97","query_id":"53","doc_a_id":"9171913","doc_b_id":"9394119","presented_order":["9171913","9394119"],"winner_id":"9394119","reasoning":"Neither document discusses ALDH1 or prognosis. Document B is slightly more relevant because it deals with molecular/genetic markers and cancer risk, whereas A focuses on blood lipids.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827921Z"}
{"comparison_id":"13eb3a30-cd1a-40ad-a297-2a49cb6a9462","query_id":"53","doc_a_id":"13400643","doc_b_id":"9394119","presented_order":["9394119","13400643"],"winner_id":"9394119","reasoning":"Document A is more related to breast cancer outcomes (mutation-associated cancer risk) while Document B discusses a general cancer-targeting small molecule not specific to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827928Z"}
{"comparison_id":"21917555-9647-4bcf-88c1-9ccb8e63e2a4","query_id":"53","doc_a_id":"22901758","doc_b_id":"9394119","presented_order":["22901758","9394119"],"winner_id":"9394119","reasoning":"Document B — it concerns breast cancer (BRCA mutation risks), whereas Document A is about glioblastoma; neither mentions ALDH1 but B is more directly related to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827935Z"}
{"comparison_id":"2c93d36c-53c9-49c8-8045-f0db7d3d5ad6","query_id":"53","doc_a_id":"23078022","doc_b_id":"9394119","presented_order":["23078022","9394119"],"winner_id":"23078022","reasoning":"Document A is more related to tumor biology and factors that influence cancer behavior and prognosis, whereas Document B focuses on inherited mutation risk. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827941Z"}
{"comparison_id":"d412cfca-d5b4-42e4-bf0b-f22fc587436e","query_id":"53","doc_a_id":"14315749","doc_b_id":"9394119","presented_order":["9394119","14315749"],"winner_id":"9394119","reasoning":"Document A is more relevant — it concerns breast cancer (BRCA mutation risks), whereas Document B studies colorectal cancer and doesn't address ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827949Z"}
{"comparison_id":"522d94b3-974d-4f7b-b6f0-54e23cde8fc9","query_id":"53","doc_a_id":"6807122","doc_b_id":"9394119","presented_order":["9394119","6807122"],"winner_id":"6807122","reasoning":"Neither abstract mentions ALDH1 or directly addresses prognosis; Document B is marginally more relevant because it deals with tumor progression mechanisms that could relate to prognostic markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827956Z"}
{"comparison_id":"a159a549-9699-4c0f-b7d4-d4bd26bffb90","query_id":"53","doc_a_id":"29190724","doc_b_id":"9394119","presented_order":["29190724","9394119"],"winner_id":"9394119","reasoning":"Document B — it concerns breast cancer risk factors (BRCA1/2) and is more related to breast cancer prognosis than a paper on gastric cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827962Z"}
{"comparison_id":"398e7ccb-1ed6-416a-8fa4-fb16deeeedb8","query_id":"53","doc_a_id":"3590806","doc_b_id":"9394119","presented_order":["9394119","3590806"],"winner_id":"9394119","reasoning":"Document A is more relevant because it concerns breast cancer, whereas Document B studies colorectal cancer and is unrelated to breast cancer biomarkers or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827969Z"}
{"comparison_id":"ae80de6f-30ce-4180-b556-89cf6ba787e0","query_id":"53","doc_a_id":"19541444","doc_b_id":"9394119","presented_order":["19541444","9394119"],"winner_id":"19541444","reasoning":"Document A is slightly more relevant because it discusses gene expression and tumorigenesis (related to prognostic markers), while Document B focuses on BRCA mutation locations and cancer risk rather than expression markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827976Z"}
{"comparison_id":"85743d2f-04db-4efc-b056-bd3aeeeeb94b","query_id":"53","doc_a_id":"7046487","doc_b_id":"9394119","presented_order":["7046487","9394119"],"winner_id":"7046487","reasoning":"Document A is more relevant — it discusses cancer-related molecular pathways and tumor-promoting factors, which is closer to biomarker/prognosis topics than a BRCA mutation–risk study. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827983Z"}
{"comparison_id":"67a96c52-84c0-4eed-b07d-ca045b2a3f98","query_id":"53","doc_a_id":"6948886","doc_b_id":"9394119","presented_order":["9394119","6948886"],"winner_id":"9394119","reasoning":"Document A — it concerns breast cancer (BRCA mutations) while Document B is about glioblastoma and unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827989Z"}
{"comparison_id":"a82a9500-b83f-4e35-b4bb-ea2efa2efd22","query_id":"53","doc_a_id":"21692235","doc_b_id":"9394119","presented_order":["21692235","9394119"],"winner_id":"9394119","reasoning":"Document B is more relevant — it concerns breast cancer, whereas A focuses on glioblastoma and unrelated genes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.827997Z"}
{"comparison_id":"f037d99b-5ce3-4c36-9a36-d12c9db2fc6d","query_id":"53","doc_a_id":"29473081","doc_b_id":"9394119","presented_order":["9394119","29473081"],"winner_id":"9394119","reasoning":"Document A — it concerns breast cancer risk (BRCA1/2) while Document B is about multiple myeloma and unrelated genes, so A is more relevant to a claim about breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.828003Z"}
{"comparison_id":"7bc87f0c-1c5f-4b2b-8291-907a67fecce6","query_id":"53","doc_a_id":"33387953","doc_b_id":"9394119","presented_order":["9394119","33387953"],"winner_id":"9394119","reasoning":"Document A is more relevant — it concerns breast cancer specifically, while Document B addresses G protein mutations in various cancers and not breast cancer prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.828010Z"}
{"comparison_id":"eec88dfe-1329-40bb-8140-a347a6b41f73","query_id":"53","doc_a_id":"18358026","doc_b_id":"9394119","presented_order":["9394119","18358026"],"winner_id":"9394119","reasoning":"Document A is more directly about breast cancer (BRCA mutation risks) while Document B discusses general oxidative damage and DNA methylation mechanisms not specific to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.828017Z"}
{"comparison_id":"ad0b69fd-9872-42a7-afc0-fa2d8bec4aee","query_id":"53","doc_a_id":"7975937","doc_b_id":"9394119","presented_order":["7975937","9394119"],"winner_id":"9394119","reasoning":"Document B is more relevant because it directly addresses breast cancer, whereas Document A focuses on COX-mediated immune evasion in melanoma/other cancers and not on ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.828024Z"}
{"comparison_id":"fb345203-f721-4e1f-b37c-4b5c78ed9509","query_id":"53","doc_a_id":"864491","doc_b_id":"9394119","presented_order":["9394119","864491"],"winner_id":"9394119","reasoning":"Document A — it deals directly with breast cancer risk and genetics, so it's more related to breast cancer prognosis than a CDK4/6 inhibitor xenograft study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.828031Z"}
{"comparison_id":"5b3c58d7-c45a-4e9d-b4d3-675e1e8345ea","query_id":"53","doc_a_id":"21521236","doc_b_id":"9394119","presented_order":["9394119","21521236"],"winner_id":"9394119","reasoning":"Document A is more relevant — it concerns breast cancer risk and prognosis-related genetics, while Document B focuses on p53/NEAT1 and replication stress not related to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.828039Z"}
{"comparison_id":"06fd0bba-fe73-4c20-8ce5-76e2bec8b5df","query_id":"53","doc_a_id":"40735046","doc_b_id":"9394119","presented_order":["40735046","9394119"],"winner_id":"40735046","reasoning":"Document A is more relevant — it addresses breast cancer outcomes (mortality/prognosis), whereas Document B focuses on BRCA mutation-associated risk rather than prognosis or biomarker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.828047Z"}
{"comparison_id":"5aafaef8-7551-4363-9aee-f95f9ba8b738","query_id":"53","doc_a_id":"19644821","doc_b_id":"9394119","presented_order":["19644821","9394119"],"winner_id":"9394119","reasoning":"Document B is more relevant — it concerns breast cancer risk which is closer to prognosis in breast cancer than a liver cancer study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.828054Z"}
{"comparison_id":"79e1003c-4f2f-4cc7-868e-115b52769d3a","query_id":"53","doc_a_id":"31624828","doc_b_id":"9394119","presented_order":["9394119","31624828"],"winner_id":"9394119","reasoning":"Document A is more relevant — it deals directly with breast cancer risk and genetics, whereas Document B focuses on p53-mediated apoptotic cell clearance and not breast cancer prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.828064Z"}
{"comparison_id":"2423fa77-d6ea-4d90-a6da-3ba9f35f6bf1","query_id":"53","doc_a_id":"8994465","doc_b_id":"9394119","presented_order":["8994465","9394119"],"winner_id":"9394119","reasoning":"Document B — it concerns breast cancer (though not ALDH1 specifically), while A is about melanoma. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.828072Z"}
{"comparison_id":"8e0926fb-a494-40fa-b145-2e1c2e4e3874","query_id":"53","doc_a_id":"27822315","doc_b_id":"9394119","presented_order":["9394119","27822315"],"winner_id":"9394119","reasoning":"Document A is more relevant — it concerns breast cancer (albeit BRCA mutations) while Document B is about steroidogenic differentiation unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.828078Z"}
{"comparison_id":"8a488efc-7140-4441-8479-fae648b24284","query_id":"53","doc_a_id":"9641846","doc_b_id":"9394119","presented_order":["9641846","9394119"],"winner_id":"9394119","reasoning":"Document B is more relevant — it directly concerns breast cancer risk, while A is about Rb-family function in cell cycle/differentiation with no link to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.828085Z"}
{"comparison_id":"c36e7159-e3a1-4c06-9bd7-1dec0e754ca4","query_id":"53","doc_a_id":"25748308","doc_b_id":"9394119","presented_order":["9394119","25748308"],"winner_id":"9394119","reasoning":"Document A is more relevant — it directly concerns breast cancer (though not ALDH1), while B discusses GAPDH and is unrelated to breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.828092Z"}
{"comparison_id":"f78ec56b-3836-4d13-b566-35d70793113b","query_id":"53","doc_a_id":"13791206","doc_b_id":"9394119","presented_order":["9394119","13791206"],"winner_id":"9394119","reasoning":"Reason: Neither document mentions ALDH1, but Document A addresses clinical outcomes and risk in breast cancer, making it marginally more relevant to a prognosis-related claim than Document B, which focuses on DNA repair mechanisms in BRCA1-deficient cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:08.828099Z"}
{"comparison_id":"0b775105-3352-499e-a75f-3c2ac109ed6f","query_id":"53","doc_a_id":"27123743","doc_b_id":"29806339","presented_order":["29806339","27123743"],"winner_id":"29806339","reasoning":"Document A is more relevant — it addresses tumor biology and factors influencing tumor behavior and therapy, whereas Document B discusses birthweight and epidemiologic risk, not tumor markers or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:23.712195Z"}
{"comparison_id":"40b0d662-f723-46a1-b1aa-5f4f385b7b1f","query_id":"53","doc_a_id":"17088791","doc_b_id":"29806339","presented_order":["17088791","29806339"],"winner_id":"17088791","reasoning":"Document A is more relevant — it directly discusses breast cancer (while Document B focuses on mitotic exit mechanisms and tumor regression generally, not prognosis markers like ALDH1).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:23.712216Z"}
{"comparison_id":"f1745475-7e17-4a29-b1b2-80b7d474d5ef","query_id":"53","doc_a_id":"25576204","doc_b_id":"29806339","presented_order":["25576204","29806339"],"winner_id":"25576204","reasoning":"Document A is slightly more relevant — it discusses genes and tumorigenesis related to cancer prognosis, whereas B focuses on mitotic exit as a therapeutic target and not prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:23.712224Z"}
{"comparison_id":"b6b7b089-dedd-4677-81dd-1e67e2b81377","query_id":"53","doc_a_id":"16322674","doc_b_id":"29806339","presented_order":["29806339","16322674"],"winner_id":"29806339","reasoning":"Neither mentions ALDH1; Document A is slightly more relevant because it addresses tumor biology and factors affecting tumor fate/prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:23.712232Z"}
{"comparison_id":"7e80a0e3-8688-4581-a48c-d7a20fe6ef50","query_id":"53","doc_a_id":"3067015","doc_b_id":"29806339","presented_order":["29806339","3067015"],"winner_id":"29806339","reasoning":"Document A is more relevant — it concerns tumor biology and cancer prognosis mechanisms, whereas Document B focuses on ALDH2, alcohol metabolism, and blood pressure, not ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:23.712240Z"}
{"comparison_id":"e0ac0232-0834-4e2c-93c3-419888f6b37c","query_id":"53","doc_a_id":"4444861","doc_b_id":"29806339","presented_order":["4444861","29806339"],"winner_id":"4444861","reasoning":"Doc A is marginally more relevant because it discusses BRCA-deficient tumors (breast cancer context) and factors affecting tumor outcome/chemoresistance, whereas Doc B focuses on mitotic exit mechanisms without breast cancer/ALDH1 relevance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:23.712247Z"}
{"comparison_id":"2d47ec55-0263-40b8-a236-d1b2d3fcd958","query_id":"53","doc_a_id":"7228140","doc_b_id":"29806339","presented_order":["29806339","7228140"],"winner_id":"7228140","reasoning":"Document B is more relevant — it addresses cancer prognostic subtypes (poor-prognosis 'basal-like') whereas Document A focuses on mitotic exit mechanisms and therapy, neither mentions ALDH1 or prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:23.712254Z"}
{"comparison_id":"e7abf512-5e7d-4c82-9630-e01d63a0526a","query_id":"53","doc_a_id":"40735046","doc_b_id":"29806339","presented_order":["40735046","29806339"],"winner_id":"29806339","reasoning":"Neither document mentions ALDH1 or directly addresses breast cancer prognosis. Document B is slightly more relevant because it discusses tumor biology and therapeutic targets, whereas A concerns screening outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:23.712261Z"}
{"comparison_id":"05f3edb9-7807-42b8-9bf3-63849203727f","query_id":"53","doc_a_id":"36432234","doc_b_id":"29806339","presented_order":["29806339","36432234"],"winner_id":"29806339","reasoning":"Neither abstract mentions ALDH1; Document A is slightly more relevant because it addresses tumor regression and factors affecting tumor cell fate (more directly related to prognosis). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:23.712268Z"}
{"comparison_id":"2cf33945-22ca-4f8a-be7e-dc528160ae15","query_id":"53","doc_a_id":"25488034","doc_b_id":"29806339","presented_order":["25488034","29806339"],"winner_id":"25488034","reasoning":"Document A — it discusses enzyme-based detoxification and cancer-related enzyme regulation, which is closer to a claim about ALDH1 expression and prognosis than Document B's focus on mitotic exit mechanisms. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:23.712276Z"}
{"comparison_id":"503cd955-2274-482a-89ca-4b6ab0dca2c5","query_id":"53","doc_a_id":"23078022","doc_b_id":"29806339","presented_order":["23078022","29806339"],"winner_id":"23078022","reasoning":"Document A is slightly more related because it discusses an oncoprotein and signaling relevant to carcinomas (including breast cancer), whereas B focuses on mitotic exit mechanisms and therapy. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:23.712283Z"}
{"comparison_id":"20915b39-1f0f-4121-b32e-607573a50dce","query_id":"53","doc_a_id":"6807122","doc_b_id":"29806339","presented_order":["6807122","29806339"],"winner_id":"6807122","reasoning":"Document A is slightly more relevant — it addresses tumor progression and stromal changes tied to cancer outcomes, whereas Document B focuses on mitotic-exit mechanisms and therapy, not prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:23.712290Z"}
{"comparison_id":"76ede3f6-893d-4225-b402-fdac65335c26","query_id":"53","doc_a_id":"19541444","doc_b_id":"29806339","presented_order":["29806339","19541444"],"winner_id":"19541444","reasoning":"Document B is more relevant—it's about a cancer-related gene and tumorigenesis (more directly connected to prognostic markers) while A focuses on mitotic exit mechanisms unrelated to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:23.712298Z"}
{"comparison_id":"dfaebced-782e-42b3-b36f-3c01b16ca7ce","query_id":"53","doc_a_id":"7046487","doc_b_id":"29806339","presented_order":["29806339","7046487"],"winner_id":"7046487","reasoning":"Document B — it addresses cancer-related molecular pathways and tumor-promoting functions relevant to prognosis, whereas A focuses on mitotic exit mechanisms and therapy. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:23.712305Z"}
{"comparison_id":"2f942ec1-ed02-465d-9602-4d2120ddcdea","query_id":"53","doc_a_id":"17088791","doc_b_id":"25488034","presented_order":["25488034","17088791"],"winner_id":"25488034","reasoning":"Document A is slightly more related (discusses detoxifying enzymes/oxidative stress pathways that are closer to ALDH1's function), while Document B focuses on BRCA1 variants unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:28.522166Z"}
{"comparison_id":"e540b4f3-e3f6-47e5-ab74-7f91119881c6","query_id":"53","doc_a_id":"25576204","doc_b_id":"25488034","presented_order":["25488034","25576204"],"winner_id":"25488034","reasoning":"Document A is slightly more relevant because it discusses enzyme systems and oxidative-stress–related detoxifying enzymes in cancer, which is closer to ALDH1 (an enzyme) than a paper focused on autophagy gene beclin 1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:28.522188Z"}
{"comparison_id":"ef5a88e4-42c8-46ae-9812-be2b5e8022c2","query_id":"53","doc_a_id":"4444861","doc_b_id":"25488034","presented_order":["4444861","25488034"],"winner_id":"25488034","reasoning":"Document B is more relevant — it discusses detoxifying enzymes and mechanisms of chemoresistance/oxidative stress that are conceptually closer to ALDH1's role than the BRCA/replication-fork focus of Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:28.522197Z"}
{"comparison_id":"60962652-87d7-4320-9894-41ded630114e","query_id":"53","doc_a_id":"7228140","doc_b_id":"25488034","presented_order":["7228140","25488034"],"winner_id":"7228140","reasoning":"Document A is more relevant — it addresses tumor molecular subtypes and prognosis in cancer (even though it's PDAC rather than breast), whereas Document B discusses glutathione metabolism not directly related to ALDH1 expression or breast-cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:28.522204Z"}
{"comparison_id":"823cf303-71e0-4bae-b2e2-a6d9b90f0747","query_id":"53","doc_a_id":"7046487","doc_b_id":"25488034","presented_order":["7046487","25488034"],"winner_id":"25488034","reasoning":"Document B — it discusses cellular detoxification and chemoresistance mechanisms related to oxidative-stress–handling enzymes, which is closer to ALDH1’s role in tumor cell survival and prognosis than a general NF-κB review. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:28.522212Z"}
{"comparison_id":"44a604b3-f2c3-44f0-b24a-537973d96cd5","query_id":"53","doc_a_id":"23078022","doc_b_id":"25488034","presented_order":["23078022","25488034"],"winner_id":"25488034","reasoning":"Document B is more relevant — it discusses detoxification/chemo-resistance pathways (glutathione enzymes) that are mechanistically closer to ALDH1's role in cancer prognosis, whereas Document A focuses on MUC1/NF-κB signaling unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:28.522220Z"}
{"comparison_id":"b490d33a-227f-463b-82bf-201eeef56816","query_id":"53","doc_a_id":"6807122","doc_b_id":"25488034","presented_order":["25488034","6807122"],"winner_id":"25488034","reasoning":"Document A is slightly more relevant — it discusses enzymes and cancer chemoresistance/oxidative-stress pathways, which is closer to ALDH1 (an enzyme linked to tumor biology and prognosis) than a paper on endothelial-to-mesenchymal transition.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:28.522227Z"}
{"comparison_id":"a7dbc0ae-2e05-4854-80e5-d4a23fd5535f","query_id":"53","doc_a_id":"19541444","doc_b_id":"25488034","presented_order":["25488034","19541444"],"winner_id":"25488034","reasoning":"Document A is more relevant — it discusses detoxification enzymes and oxidative stress, a closer functional context to ALDH1 than the MEG3-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:28.522234Z"}
{"comparison_id":"b473722e-0e81-4aed-91b9-f0f7ee973722","query_id":"53","doc_a_id":"17088791","doc_b_id":"7046487","presented_order":["7046487","17088791"],"winner_id":"7046487","reasoning":"Document A is more relevant — it discusses tumor-promoting pathways and prognosis-related biology in cancer, which is closer to ALDH1's role as a prognostic marker than a study of BRCA1 susceptibility variants.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:34.386508Z"}
{"comparison_id":"1eaca0a9-70de-40a6-9082-c0eda518949e","query_id":"53","doc_a_id":"25576204","doc_b_id":"7046487","presented_order":["7046487","25576204"],"winner_id":"7046487","reasoning":"Document A is more relevant — it discusses cancer-related signaling and tumor-promoting factors broadly, which is closer to prognosis-related markers than the beclin 1 autophagy genetic study in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:34.386529Z"}
{"comparison_id":"a3826b66-19fc-45f9-8388-db102dff17ac","query_id":"53","doc_a_id":"4444861","doc_b_id":"7046487","presented_order":["7046487","4444861"],"winner_id":"7046487","reasoning":"Document A is more relevant — it discusses tumor-promoting factors and cancer biology broadly, whereas Document B focuses on BRCA-specific chemoresistance mechanisms unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:34.386538Z"}
{"comparison_id":"693f7bc0-c349-41b6-9d67-c49b2a49287b","query_id":"53","doc_a_id":"19541444","doc_b_id":"7046487","presented_order":["19541444","7046487"],"winner_id":"7046487","reasoning":"Reason: Neither mentions ALDH1 or breast cancer specifically, but Document B discusses tumor-promoting pathways (NF-κB) more directly related to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:34.386546Z"}
{"comparison_id":"c570f6ce-7c6b-4a1c-94d0-aa0978a03824","query_id":"53","doc_a_id":"23078022","doc_b_id":"7046487","presented_order":["23078022","7046487"],"winner_id":"7046487","reasoning":"Document B is more relevant — although neither discusses ALDH1 or breast cancer prognosis directly, B's broad review of NF-κB's role in tumor promotion is more likely to relate to prognostic markers than the MUC1-specific mechanistic study in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:34.386553Z"}
{"comparison_id":"23bc592c-1acc-45bd-b4b2-8656bce6d2df","query_id":"53","doc_a_id":"6807122","doc_b_id":"7046487","presented_order":["7046487","6807122"],"winner_id":"7046487","reasoning":"Neither document mentions ALDH1 or breast cancer prognosis. Document A is slightly more relevant because it discusses tumor-promoting pathways (NF-κB) linked to cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:34.386560Z"}
{"comparison_id":"3a5140fd-77b4-440f-8207-0f16afb38de9","query_id":"53","doc_a_id":"17088791","doc_b_id":"4444861","presented_order":["17088791","4444861"],"winner_id":"17088791","reasoning":"Reason: Neither abstract mentions ALDH1 or prognosis, but Document A concerns breast cancer susceptibility in a population context and is therefore slightly more related than Document B's focus on replication-fork–mediated chemoresistance mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:40.081299Z"}
{"comparison_id":"388d40a1-3196-43ac-ad38-d77750b8faec","query_id":"53","doc_a_id":"25576204","doc_b_id":"4444861","presented_order":["4444861","25576204"],"winner_id":"25576204","reasoning":"Document B is more relevant — it addresses tumorigenesis and cancer-related gene effects, which is closer to prognosis in breast cancer than the BRCA-focused chemoresistance mechanisms in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:40.081320Z"}
{"comparison_id":"10616901-a9cd-4a1b-9a7d-ba49953e2384","query_id":"53","doc_a_id":"6807122","doc_b_id":"4444861","presented_order":["4444861","6807122"],"winner_id":"4444861","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it deals with chemoresistance in BRCA‑deficient breast tumors, which is more directly related to prognosis than the EndMT/fibroblast focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:40.081329Z"}
{"comparison_id":"bc22679d-1493-435c-b9ca-d05429a32b72","query_id":"53","doc_a_id":"19541444","doc_b_id":"4444861","presented_order":["4444861","19541444"],"winner_id":"4444861","reasoning":"Document A is more relevant — it concerns mechanisms in BRCA-deficient breast cancers and treatment resistance, which relates to prognosis more directly than a general review of MEG3.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:40.081337Z"}
{"comparison_id":"f9d9cb21-63a2-4386-bb56-cd9aa09257fb","query_id":"53","doc_a_id":"23078022","doc_b_id":"4444861","presented_order":["4444861","23078022"],"winner_id":"4444861","reasoning":"Document A is more relevant — it discusses mechanisms in BRCA-deficient tumors (breast cancer context) and chemoresistance, which relate to prognosis; Document B focuses on MUC1/NF-κB signaling and not ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:40.081344Z"}
{"comparison_id":"7d49d3bd-952b-460e-b130-7b7c37d50174","query_id":"53","doc_a_id":"17088791","doc_b_id":"25576204","presented_order":["25576204","17088791"],"winner_id":"25576204","reasoning":"Neither abstract mentions ALDH1, but Document A addresses tumorigenesis and factors affecting tumor progression (more related to prognosis) while B focuses on BRCA1 susceptibility. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:43.704033Z"}
{"comparison_id":"a1cefd81-903e-4bff-bce3-f25f135d6390","query_id":"53","doc_a_id":"6807122","doc_b_id":"19541444","presented_order":["19541444","6807122"],"winner_id":"19541444","reasoning":"Document A discusses gene expression changes and cancer prognosis-related biology (tumor suppressor gene expression), which is closer to a claim about a molecular marker and prognosis than Document B's focus on EndMT/CAF formation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:52.933904Z"}
{"comparison_id":"d3f800f9-eb0d-4b18-ba58-bb60883e5b6b","query_id":"53","doc_a_id":"23078022","doc_b_id":"19541444","presented_order":["23078022","19541444"],"winner_id":"23078022","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer prognosis, but Document A discusses an oncoprotein and cancer-signaling pathways (more related to mechanisms affecting prognosis) while B focuses on an imprinted noncoding gene and epigenetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:52.933924Z"}
{"comparison_id":"5fd97b11-bd1e-41fa-8be3-2d383cccac6d","query_id":"53","doc_a_id":"27123743","doc_b_id":"3067015","presented_order":["3067015","27123743"],"winner_id":"27123743","reasoning":"Document B — it concerns breast cancer etiology and is therefore more relevant to a claim about prognosis in breast cancer, whereas Document A addresses ALDH2 and blood pressure unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:55.991718Z"}
{"comparison_id":"2254334d-253f-45d9-9631-38bb764af2a9","query_id":"53","doc_a_id":"16322674","doc_b_id":"3067015","presented_order":["16322674","3067015"],"winner_id":"3067015","reasoning":"Reason: Document B discusses an ALDH family gene (ALDH2), which is at least related to the ALDH gene family; Document A is unrelated to ALDH or molecular markers. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:55.991739Z"}
{"comparison_id":"09e41eba-ad70-475b-b97c-20cfd447c1b7","query_id":"53","doc_a_id":"36432234","doc_b_id":"3067015","presented_order":["36432234","3067015"],"winner_id":"36432234","reasoning":"Document A is more relevant — it concerns breast cancer biology (though not ALDH1 specifically), whereas Document B is about ALDH2 and blood pressure unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:55.991749Z"}
{"comparison_id":"d8fe3f67-3a8e-48fb-9ec9-a2d16c9165cb","query_id":"53","doc_a_id":"40735046","doc_b_id":"3067015","presented_order":["3067015","40735046"],"winner_id":"40735046","reasoning":"Document B is more relevant — it concerns breast cancer outcomes (mortality), whereas Document A deals with ALDH2 and blood pressure, unrelated to breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:54:55.991756Z"}
{"comparison_id":"e1fb2741-cac3-4d79-80e5-7f76dc3f914f","query_id":"53","doc_a_id":"27123743","doc_b_id":"36432234","presented_order":["27123743","36432234"],"winner_id":"27123743","reasoning":"Reason: Document A discusses breast cancer etiology and mechanisms involving stem cells and growth factors, which is more related to markers like ALDH1 than Document B's focus on a specific ER agonist.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:00.681129Z"}
{"comparison_id":"3867a46e-20e0-4c97-b819-4f0da5b423f3","query_id":"53","doc_a_id":"40735046","doc_b_id":"36432234","presented_order":["40735046","36432234"],"winner_id":"36432234","reasoning":"Document B — it discusses molecular behavior of breast cancer cells (relevant to biomarkers/prognosis) whereas A is about screening outcomes and not molecular markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:00.681152Z"}
{"comparison_id":"b19cae54-a157-4256-9d0c-194833c2d6f3","query_id":"53","doc_a_id":"42731834","doc_b_id":"13964633","presented_order":["42731834","13964633"],"winner_id":"42731834","reasoning":"Document A is more relevant — it reports a link between marker expression and patient survival (though in colorectal cancer), which is closer to a prognosis association than the molecular miRNA/3'UTR focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136239Z"}
{"comparison_id":"3e1e2884-085a-482f-a3ca-c4e453a388ed","query_id":"53","doc_a_id":"10024681","doc_b_id":"13964633","presented_order":["10024681","13964633"],"winner_id":"10024681","reasoning":"Document A discusses a link between a molecular marker and poorer prognosis in cancer (though in prostate, not breast), while Document B does not address prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136261Z"}
{"comparison_id":"bd547cd4-7811-4501-a0cf-d8f6fa24dbd5","query_id":"53","doc_a_id":"2389574","doc_b_id":"13964633","presented_order":["13964633","2389574"],"winner_id":"2389574","reasoning":"Document B is more relevant — it studies expression of a protein as a prognostic marker associated with poor survival (though in endometrial cancer), whereas A addresses miRNA/3'UTR effects, not marker expression or prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136270Z"}
{"comparison_id":"2d08b6ea-d73d-4a53-bc8f-84b1030d0c9a","query_id":"53","doc_a_id":"39580129","doc_b_id":"13964633","presented_order":["13964633","39580129"],"winner_id":"39580129","reasoning":"Document B — it addresses a prognostic biomarker (though in colorectal cancer), whereas Document A discusses miRNA modulation and tumor growth but not prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136278Z"}
{"comparison_id":"6f5b83fc-110a-492c-8db6-a3922f60f046","query_id":"53","doc_a_id":"22963769","doc_b_id":"13964633","presented_order":["22963769","13964633"],"winner_id":"22963769","reasoning":"Document A is more relevant — it links protein expression and altered localization to aggressive clinicopathological features and poorer outcomes in cancer (even though it's oral SCC rather than breast). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136285Z"}
{"comparison_id":"a702bfa4-0736-4501-b810-8e1d3a59e0e7","query_id":"53","doc_a_id":"654735","doc_b_id":"13964633","presented_order":["654735","13964633"],"winner_id":"13964633","reasoning":"B is more relevant — it addresses cancer-related molecular regulation affecting tumor growth, whereas A is specific to glioma miR-21 in cerebrospinal fluid. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136292Z"}
{"comparison_id":"ea23aed3-8a80-4c2b-b371-58b5155f9b36","query_id":"53","doc_a_id":"20886584","doc_b_id":"13964633","presented_order":["20886584","13964633"],"winner_id":"20886584","reasoning":"Document A is more relevant because it specifically concerns breast cancer (even though about treatment toxicity), whereas Document B addresses miRNA/3'UTR mechanisms not tied to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136299Z"}
{"comparison_id":"5732bf9f-794f-407b-949c-d90602fdab62","query_id":"53","doc_a_id":"38808600","doc_b_id":"13964633","presented_order":["13964633","38808600"],"winner_id":"13964633","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is marginally more relevant because it discusses cancer-related molecular expression and effects on tumor growth, whereas Document B focuses on glioma imaging. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136306Z"}
{"comparison_id":"d11e3093-773e-45f1-b9c7-e769052a2d7c","query_id":"53","doc_a_id":"6517763","doc_b_id":"13964633","presented_order":["13964633","6517763"],"winner_id":"13964633","reasoning":"Document A is more relevant — it discusses tumor growth and cancer-related molecular mechanisms, whereas Document B is specific to glioblastoma and not about breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136313Z"}
{"comparison_id":"e8eedd64-46f4-4455-91b1-b267661753e3","query_id":"53","doc_a_id":"3730196","doc_b_id":"13964633","presented_order":["13964633","3730196"],"winner_id":"13964633","reasoning":"Document A is slightly more relevant because it deals with cancer-related molecular expression and tumor prognosis mechanisms, whereas Document B focuses on chemoresistance in small cell lung cancer (not breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136321Z"}
{"comparison_id":"de4ef794-86eb-48cd-a605-1a1dc5492016","query_id":"53","doc_a_id":"26561572","doc_b_id":"13964633","presented_order":["26561572","13964633"],"winner_id":"26561572","reasoning":"Document A is more relevant — it reports a multivariate analysis of prognostic factors in cancer, while B focuses on miRNA mechanism and not prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136328Z"}
{"comparison_id":"cba2cc5c-46e3-4a4a-a173-44bc68315642","query_id":"53","doc_a_id":"15335331","doc_b_id":"13964633","presented_order":["13964633","15335331"],"winner_id":"15335331","reasoning":"Document B — it links marker expression to poor clinical outcomes (though in oral SCC, not breast cancer), so it's slightly more relevant than A, which focuses on miRNA/3'UTR mechanisms rather than prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136335Z"}
{"comparison_id":"fcee2019-c37f-41a6-a615-92d18cbc3e67","query_id":"53","doc_a_id":"38243984","doc_b_id":"13964633","presented_order":["38243984","13964633"],"winner_id":"38243984","reasoning":"Document A is slightly more relevant—while neither mentions ALDH1 or breast cancer, A discusses tumor engraftment and factors predicting poor prognosis in cancer, whereas B focuses on versican 3'UTR and miRNA modulation without prognostic context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136342Z"}
{"comparison_id":"111cbe98-2dbb-447d-8ccf-71c0b2915b70","query_id":"53","doc_a_id":"16806763","doc_b_id":"13964633","presented_order":["16806763","13964633"],"winner_id":"16806763","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document A concerns prognostic biomarkers in cancer (albeit colorectal), making it slightly more relevant to a claim about expression and prognosis than Document B, which focuses on microRNA modulation by a 3'UTR.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136350Z"}
{"comparison_id":"e6b9df0f-bacb-4417-bbb2-b1514bd97ee8","query_id":"53","doc_a_id":"16701509","doc_b_id":"13964633","presented_order":["13964633","16701509"],"winner_id":"13964633","reasoning":"Doc A is more relevant — it discusses molecular mechanisms affecting tumor growth and cancer-related markers, which is closer to prognosis than Document B's focus on HDL and breast cancer risk. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136357Z"}
{"comparison_id":"4dce350c-68d9-46f2-9d1e-3c41c2be9e93","query_id":"53","doc_a_id":"37480103","doc_b_id":"13964633","presented_order":["13964633","37480103"],"winner_id":"13964633","reasoning":"Document A is more relevant — it addresses molecular mechanisms and tumor biology, which is closer to a claim about a molecular marker (ALDH1) and prognosis than an epidemiologic pregnancy study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136364Z"}
{"comparison_id":"7e9b4119-68ac-4045-98b0-176625536e93","query_id":"53","doc_a_id":"4489217","doc_b_id":"13964633","presented_order":["4489217","13964633"],"winner_id":"4489217","reasoning":"Document A is more relevant — it discusses intratumor heterogeneity and gene expression variation (concepts related to markers like ALDH1), whereas Document B focuses on versican 3'UTR and miRNA regulation without linking to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136372Z"}
{"comparison_id":"8e63c472-2388-4465-92b2-f0e94581f727","query_id":"53","doc_a_id":"7165938","doc_b_id":"13964633","presented_order":["7165938","13964633"],"winner_id":"7165938","reasoning":"Document A is slightly more relevant because it discusses a gene's expression tied to prognosis and survival (though in colorectal cancer), whereas B focuses on miRNA regulation via a 3'UTR and not prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136379Z"}
{"comparison_id":"96e24a24-8932-4c2d-b023-1eadbf952e57","query_id":"53","doc_a_id":"515489","doc_b_id":"13964633","presented_order":["13964633","515489"],"winner_id":"515489","reasoning":"Document B — it links a factor (lncRNA PVT1) to stem cell–like properties and poor prognosis (albeit in HCC), which is closer to ALDH1’s role as a stem-cell marker and prognostic marker than Document A's microRNA/versican focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136386Z"}
{"comparison_id":"66c0e659-d612-42ba-8fc8-d907c23090b9","query_id":"53","doc_a_id":"23304931","doc_b_id":"13964633","presented_order":["23304931","13964633"],"winner_id":"13964633","reasoning":"Document B is more relevant — it addresses cancer-related molecular mechanisms and tumor growth, whereas A focuses on AIDS-related DLBCL, unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136393Z"}
{"comparison_id":"5c46df6e-fc11-40e0-b3ee-67240540e21d","query_id":"53","doc_a_id":"19047331","doc_b_id":"13964633","presented_order":["19047331","13964633"],"winner_id":"19047331","reasoning":"Document A is more relevant — it discusses a molecular marker linked to poor clinical outcomes in cancer (though ovarian rather than breast), whereas B focuses on 3'UTR/miRNA modulation without discussion of prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136400Z"}
{"comparison_id":"016ac782-ffdf-4df5-8719-eedc77df8fd9","query_id":"53","doc_a_id":"20280410","doc_b_id":"13964633","presented_order":["13964633","20280410"],"winner_id":"20280410","reasoning":"Reason: Document B directly concerns breast cancer (genetic risk), while Document A addresses microRNA modulation and tumor growth generally but doesn't involve breast cancer prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136407Z"}
{"comparison_id":"4a886c2b-192f-44ef-9153-170f19e390b1","query_id":"53","doc_a_id":"38551172","doc_b_id":"13964633","presented_order":["38551172","13964633"],"winner_id":"38551172","reasoning":"Document A — it deals with breast cancer (though not ALDH1 specifically), so it's more topically relevant than Document B. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136414Z"}
{"comparison_id":"004e285e-4a3e-4f64-b357-7cf03779af44","query_id":"53","doc_a_id":"21181273","doc_b_id":"13964633","presented_order":["13964633","21181273"],"winner_id":"13964633","reasoning":"Document A is more relevant — it deals with gene expression affecting tumor growth and cancer-related pathways, whereas Document B is specific to colorectal cancer and not related to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136422Z"}
{"comparison_id":"ac705a8c-74f4-49ac-8a0b-458d1b0dced3","query_id":"53","doc_a_id":"36950726","doc_b_id":"13964633","presented_order":["13964633","36950726"],"winner_id":"13964633","reasoning":"Document A is more relevant — it discusses mechanisms affecting tumor growth and cancer-related pathways, whereas Document B is about melanoma epigenetics unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136429Z"}
{"comparison_id":"b8184b93-d697-4566-a43b-d38afb6e02f2","query_id":"53","doc_a_id":"17450673","doc_b_id":"13964633","presented_order":["13964633","17450673"],"winner_id":"13964633","reasoning":"Document A is more relevant — it deals with molecular mechanisms and tumor biology, which is closer to evidence about biomarkers and prognosis than an epidemiologic perinatal risk review.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136436Z"}
{"comparison_id":"90a44f9f-fde7-4f1c-b645-0e09d566199b","query_id":"53","doc_a_id":"5774746","doc_b_id":"13964633","presented_order":["13964633","5774746"],"winner_id":"13964633","reasoning":"Document A is marginally more relevant—both lack ALDH1 or breast-cancer data, but A discusses gene expression and tumor-growth mechanisms generally, whereas B focuses on SAA/S100A4 in colorectal cancer metastasis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136443Z"}
{"comparison_id":"de59f237-79c4-4c31-a5a3-f3520670986e","query_id":"53","doc_a_id":"13831842","doc_b_id":"13964633","presented_order":["13831842","13964633"],"winner_id":"13964633","reasoning":"Neither document mentions ALDH1 or breast cancer prognosis. Document B is marginally more relevant because it addresses molecular mechanisms affecting tumor growth, whereas A is epidemiological. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136450Z"}
{"comparison_id":"ae9484bb-05dd-4b52-9a0f-4bf5a5c39bf9","query_id":"53","doc_a_id":"13831558","doc_b_id":"13964633","presented_order":["13964633","13831558"],"winner_id":"13964633","reasoning":"Document A is more relevant — it discusses molecular tumor biology and factors influencing tumor growth/prognosis, whereas B addresses mammographic density and detection risk, not molecular prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136458Z"}
{"comparison_id":"16e03fbd-9528-4dd7-9906-4ea4376dd395","query_id":"53","doc_a_id":"11271123","doc_b_id":"13964633","presented_order":["13964633","11271123"],"winner_id":"13964633","reasoning":"Reason: Document A concerns cancer-related molecular mechanisms and tumor growth, making it marginally more relevant to a breast cancer prognostic marker than Document B, which focuses on endometrial cancer and different molecular alterations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136465Z"}
{"comparison_id":"223f8905-59e2-43cc-9734-9e98741836aa","query_id":"53","doc_a_id":"4828631","doc_b_id":"13964633","presented_order":["4828631","13964633"],"winner_id":"4828631","reasoning":"Document A is more relevant because it addresses breast cancer (though not ALDH1 specifically), while Document B discusses versican 3'UTR/miRNA without relation to breast cancer prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136472Z"}
{"comparison_id":"09eea3e9-4d27-4c25-9f5a-58cba0b7794d","query_id":"53","doc_a_id":"7736860","doc_b_id":"13964633","presented_order":["7736860","13964633"],"winner_id":"13964633","reasoning":"Document B is slightly more relevant because it discusses mechanisms affecting tumor growth and molecular markers, whereas Document A is specific to STIM1 in cervical cancer and unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136479Z"}
{"comparison_id":"aec6d9b0-a1a2-4bff-a879-387d2bc99820","query_id":"53","doc_a_id":"16098747","doc_b_id":"13964633","presented_order":["16098747","13964633"],"winner_id":"13964633","reasoning":"Document B — it discusses molecular mechanisms affecting tumor growth, which is closer to a claim about a molecular marker (ALDH1) and prognosis than an epidemiologic breast-density study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136486Z"}
{"comparison_id":"b3d21fbe-e9ee-469d-a7c9-764288a82fed","query_id":"53","doc_a_id":"5222182","doc_b_id":"13964633","presented_order":["13964633","5222182"],"winner_id":"13964633","reasoning":"Document A is more related to tumor biology and molecular markers affecting cancer growth, whereas Document B focuses on mammographic density risk factors not prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136492Z"}
{"comparison_id":"93a7b8cd-a44d-4799-866e-719fa64550df","query_id":"53","doc_a_id":"6790197","doc_b_id":"13964633","presented_order":["13964633","6790197"],"winner_id":"6790197","reasoning":"Document B is more relevant — it links gene expression patterns to patient relapse/prognosis (though in prostate cancer), whereas A discusses versican/miRNA effects on tumor growth and does not address prognosis or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136499Z"}
{"comparison_id":"bb7232e2-9553-44e7-98f0-121465bc279d","query_id":"53","doc_a_id":"13791206","doc_b_id":"13964633","presented_order":["13791206","13964633"],"winner_id":"13964633","reasoning":"Neither document mentions ALDH1 or directly addresses prognostic markers in breast cancer; both are irrelevant. Document B is marginally more related because it discusses tumor growth and molecular markers affecting prognosis, while A focuses on DNA repair mechanisms in BRCA1-deficient cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136506Z"}
{"comparison_id":"fb8e54d7-c1eb-46b9-b623-811315dd63b2","query_id":"53","doc_a_id":"27306942","doc_b_id":"13964633","presented_order":["13964633","27306942"],"winner_id":"13964633","reasoning":"Document A is more relevant — it discusses mechanisms affecting tumor growth and cancer-related markers, whereas Document B concerns pediatric B‑cell leukemia unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136513Z"}
{"comparison_id":"176c758f-03d7-436a-b71d-db1b4d5ca644","query_id":"53","doc_a_id":"23557241","doc_b_id":"13964633","presented_order":["23557241","13964633"],"winner_id":"13964633","reasoning":"Document B — it discusses molecular mechanisms affecting tumor growth and prognosis-related pathways, making it more relevant than an epidemiologic review of intrauterine factors. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136519Z"}
{"comparison_id":"db6c6b12-5e41-4e0f-85bd-50f5cf20cff3","query_id":"53","doc_a_id":"3210545","doc_b_id":"13964633","presented_order":["13964633","3210545"],"winner_id":"13964633","reasoning":"Document A is slightly more relevant because it discusses tumor-related molecular mechanisms and effects on tumor growth, whereas Document B focuses on KRAS in endometrial cancer (different gene and cancer type).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136526Z"}
{"comparison_id":"a5f62093-c477-43c5-8d8d-d0ac86701aa2","query_id":"53","doc_a_id":"22007333","doc_b_id":"13964633","presented_order":["22007333","13964633"],"winner_id":"13964633","reasoning":"Document B is closer—it addresses molecular regulators of tumor behavior and prognosis-related pathways, while A concerns reproductive factors and mammographic density, not ALDH1 or prognosis.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136533Z"}
{"comparison_id":"f447c29a-92f2-4840-8770-113ed6e29200","query_id":"53","doc_a_id":"23284774","doc_b_id":"13964633","presented_order":["13964633","23284774"],"winner_id":"13964633","reasoning":"Document A is more relevant — it addresses molecular mechanisms and tumor biology related to cancer prognosis, whereas B focuses on psychosocial issues unrelated to ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136540Z"}
{"comparison_id":"dfb4c455-ece0-4265-bbc0-8f8287d430ff","query_id":"53","doc_a_id":"14664424","doc_b_id":"13964633","presented_order":["13964633","14664424"],"winner_id":"13964633","reasoning":"Document A is more related to cancer biology and mechanisms affecting tumor behavior, whereas Document B focuses on prognostic markers in cervical (not breast) cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136547Z"}
{"comparison_id":"6158ff8a-0ef3-49c2-a886-a83ddbe05b64","query_id":"53","doc_a_id":"17462437","doc_b_id":"13964633","presented_order":["13964633","17462437"],"winner_id":"13964633","reasoning":"Document A is more relevant — it addresses cancer-related molecular markers and tumor growth mechanisms, whereas Document B concerns KRAS in lung cancer (unrelated to ALDH1 or breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136554Z"}
{"comparison_id":"22d35a03-098b-4fe6-9b07-05f1e8372cbc","query_id":"53","doc_a_id":"16346504","doc_b_id":"13964633","presented_order":["16346504","13964633"],"winner_id":"13964633","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it addresses cancer-related gene regulation and tumor growth broadly, whereas A is specific to endometrial cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136561Z"}
{"comparison_id":"03708f07-38eb-4f57-8bae-88f230fd1758","query_id":"53","doc_a_id":"26848994","doc_b_id":"13964633","presented_order":["13964633","26848994"],"winner_id":"13964633","reasoning":"Document A is slightly more relevant — it addresses tumor growth and molecular regulation that could relate to cancer prognosis, while Document B is specific to hepatocellular carcinoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136567Z"}
{"comparison_id":"ea8c6e74-c7ab-4943-a177-5b7d43acd3d5","query_id":"53","doc_a_id":"32534305","doc_b_id":"13964633","presented_order":["32534305","13964633"],"winner_id":"13964633","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer prognosis; Document B is more related to tumor molecular markers and mechanisms than Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136574Z"}
{"comparison_id":"30c96341-d06a-46e7-8b32-f43b523dc66f","query_id":"53","doc_a_id":"5487448","doc_b_id":"13964633","presented_order":["5487448","13964633"],"winner_id":"5487448","reasoning":"Document A is more relevant — it discusses breast cancer risk factors (mammographic density) while Document B focuses on versican 3'UTR/miRNA mechanisms unrelated to ALDH1 or breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136580Z"}
{"comparison_id":"2e6ca66a-c74a-459a-a716-d7a62bd3040b","query_id":"53","doc_a_id":"13205096","doc_b_id":"13964633","presented_order":["13205096","13964633"],"winner_id":"13964633","reasoning":"Neither document mentions ALDH1 or breast cancer, but Document B discusses tumor-related molecular mechanisms potentially more applicable across cancers than Document A's AML-specific prognostic profiling.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136587Z"}
{"comparison_id":"88f2be8d-8896-48c6-80e1-4c477d2ad47c","query_id":"53","doc_a_id":"831167","doc_b_id":"13964633","presented_order":["13964633","831167"],"winner_id":"831167","reasoning":"Document B is more relevant — it addresses survival prognosis (though in glioblastoma) and gene–survival associations, which is closer to the claim about expression linked to prognosis than Document A's mechanistic microRNA/versican study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136594Z"}
{"comparison_id":"12716b7e-c4e3-436e-b9be-9d2203be19f5","query_id":"53","doc_a_id":"38784540","doc_b_id":"13964633","presented_order":["38784540","13964633"],"winner_id":"38784540","reasoning":"Document A is more relevant because it deals directly with breast cancer clinical factors; Document B covers molecular miRNA/versican mechanisms unrelated to ALDH1 or breast prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136602Z"}
{"comparison_id":"64e82f85-fc6e-4767-b1f4-446f7d60492c","query_id":"53","doc_a_id":"33677323","doc_b_id":"13964633","presented_order":["33677323","13964633"],"winner_id":"33677323","reasoning":"Document A is more relevant — it discusses a molecular marker's expression correlating with poor clinical outcomes (though in hematopoietic malignancies rather than breast cancer), whereas Document B focuses on 3'UTR-mediated miRNA modulation without prognosis data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136609Z"}
{"comparison_id":"6ce515f1-85d7-4f32-b48c-9b6543628bd5","query_id":"53","doc_a_id":"9171913","doc_b_id":"13964633","presented_order":["9171913","13964633"],"winner_id":"13964633","reasoning":"Document B is more relevant — although neither mentions ALDH1 or prognosis, B discusses molecular tumor biology and mechanisms affecting tumor behavior, which is marginally closer to a claim about a prognostic tumor marker.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136616Z"}
{"comparison_id":"1666fce0-cfbc-42b4-bf38-83fcbec21108","query_id":"53","doc_a_id":"13400643","doc_b_id":"13964633","presented_order":["13964633","13400643"],"winner_id":"13964633","reasoning":"Neither paper mentions ALDH1 or breast cancer prognosis; both are irrelevant. Document A is slightly more relevant only because it discusses mechanisms affecting tumor growth. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136623Z"}
{"comparison_id":"5f5f7a5a-e5c0-4be8-acc4-a32884f72b8a","query_id":"53","doc_a_id":"22901758","doc_b_id":"13964633","presented_order":["13964633","22901758"],"winner_id":"22901758","reasoning":"Document B is slightly more relevant because it discusses tumor signaling linked to patient survival (prognosis), whereas Document A focuses on microRNA modulation without addressing prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136630Z"}
{"comparison_id":"607bc3e5-b2cf-482e-a439-f53eb0301faa","query_id":"53","doc_a_id":"14315749","doc_b_id":"13964633","presented_order":["14315749","13964633"],"winner_id":"14315749","reasoning":"Document A is slightly more relevant because it links gene expression to tumor differentiation and metastasis (prognostic factors), whereas Document B focuses on microRNA modulation and tumor growth mechanisms without prognostic data. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136637Z"}
{"comparison_id":"61dba1e8-3102-4c97-9e25-09cd15190d30","query_id":"53","doc_a_id":"29190724","doc_b_id":"13964633","presented_order":["29190724","13964633"],"winner_id":"13964633","reasoning":"Document B. It discusses gene expression and tumor growth regulation mechanisms relevant to cancer prognosis, whereas Document A focuses specifically on DNA methylation in gastric cancer (not breast). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136644Z"}
{"comparison_id":"70be734f-2b30-4053-a0f6-e5b06be8ea52","query_id":"53","doc_a_id":"3590806","doc_b_id":"13964633","presented_order":["13964633","3590806"],"winner_id":"3590806","reasoning":"Document B is more relevant — it addresses cancer-initiating (stem-like) cells and pathways tied to tumor self-renewal, which is conceptually closer to ALDH1 as a stem cell/prognostic marker than Document A's focus on versican 3'UTR and microRNA. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136651Z"}
{"comparison_id":"c456f7aa-6ecb-42c9-81c9-dde22d9ef923","query_id":"53","doc_a_id":"6948886","doc_b_id":"13964633","presented_order":["13964633","6948886"],"winner_id":"13964633","reasoning":"Document A is more relevant — it addresses cancer-related molecular mechanisms and tumor growth (potentially applicable to breast cancer), whereas B is specific to glioblastoma and epigenetic reprogramming. Neither mentions ALDH1 or breast cancer directly.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136659Z"}
{"comparison_id":"f1509c8d-4cb0-47f6-b44a-527d62505516","query_id":"53","doc_a_id":"21692235","doc_b_id":"13964633","presented_order":["21692235","13964633"],"winner_id":"13964633","reasoning":"Document B is more relevant — it addresses cancer-related gene expression and prognosis-related mechanisms, whereas A is specific to glioblastoma subtypes and unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136666Z"}
{"comparison_id":"8b6e1c4d-8139-4f06-9306-8ebfde6720e3","query_id":"53","doc_a_id":"29473081","doc_b_id":"13964633","presented_order":["29473081","13964633"],"winner_id":"13964633","reasoning":"Document B is more generally related to cancer growth mechanisms (microRNA/oncogene regulation), while Document A is specific to multiple myeloma and unrelated to breast cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136673Z"}
{"comparison_id":"68d0789a-8e0b-4f30-ade3-0fa5120371c4","query_id":"53","doc_a_id":"33387953","doc_b_id":"13964633","presented_order":["13964633","33387953"],"winner_id":"13964633","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer prognosis, but Document A discusses tumor growth regulation and molecular factors that could relate to prognostic markers, making it slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136680Z"}
{"comparison_id":"1812075f-568e-4e9e-917b-6e761a894e1d","query_id":"53","doc_a_id":"18358026","doc_b_id":"13964633","presented_order":["18358026","13964633"],"winner_id":"18358026","reasoning":"Neither abstract mentions ALDH1 or breast cancer prognosis; Document A is marginally more relevant because it addresses cancer-related gene expression/methylation mechanisms that could affect marker expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136687Z"}
{"comparison_id":"156aafbd-fc0c-4923-9f0e-8be6f5e9f8b8","query_id":"53","doc_a_id":"7975937","doc_b_id":"13964633","presented_order":["13964633","7975937"],"winner_id":"13964633","reasoning":"Document A is more focused on tumor-intrinsic molecular mechanisms affecting tumor growth (more likely to relate to biomarkers/prognosis), whereas Document B centers on COX-mediated immune evasion in melanoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136694Z"}
{"comparison_id":"d5f9e184-3287-4af5-9de8-6dd40f35eebb","query_id":"53","doc_a_id":"864491","doc_b_id":"13964633","presented_order":["864491","13964633"],"winner_id":"864491","reasoning":"Neither document addresses ALDH1 expression or breast cancer prognosis, so neither is truly relevant. Document A is marginally more related to cancer outcomes (tumor response) than B, which focuses on microRNA/3'UTR mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136700Z"}
{"comparison_id":"649b14e4-8525-4216-9d8b-d2274fac9a99","query_id":"53","doc_a_id":"21521236","doc_b_id":"13964633","presented_order":["13964633","21521236"],"winner_id":"21521236","reasoning":"Document B is more relevant — it addresses chemosensitivity and response to DNA-damaging therapy, which relate more directly to prognosis and treatment outcomes in breast cancer than the miRNA/3'UTR mechanisms in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136707Z"}
{"comparison_id":"86e81286-0a18-42d2-96f2-3702598b2d7d","query_id":"53","doc_a_id":"19644821","doc_b_id":"13964633","presented_order":["13964633","19644821"],"winner_id":"13964633","reasoning":"Neither document directly addresses ALDH1 or breast cancer; Document A deals with tumor-related regulatory mechanisms that are more generally relevant to cancer prognosis, while Document B is specific to liver cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136715Z"}
{"comparison_id":"83177be5-12f2-493a-93bb-4a702dbdc74e","query_id":"53","doc_a_id":"31624828","doc_b_id":"13964633","presented_order":["13964633","31624828"],"winner_id":"13964633","reasoning":"Document A is slightly more relevant because it discusses mechanisms affecting tumor growth and cancer-related gene regulation, while Document B focuses on apoptotic cell clearance unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136722Z"}
{"comparison_id":"cca9938b-23bc-4807-8441-0c87e62db0e3","query_id":"53","doc_a_id":"8994465","doc_b_id":"13964633","presented_order":["8994465","13964633"],"winner_id":"13964633","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis. Document B is slightly more related to cancer biology generally (microRNA/tumor growth), while A focuses specifically on melanoma cells. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136729Z"}
{"comparison_id":"903b93bb-f528-432f-b4d8-339697c2116b","query_id":"53","doc_a_id":"27822315","doc_b_id":"13964633","presented_order":["13964633","27822315"],"winner_id":"13964633","reasoning":"Document A is more relevant — it addresses cancer-related molecular mechanisms and tumor growth, while B concerns steroidogenic differentiation unrelated to ALDH1 or breast cancer prognosis.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136735Z"}
{"comparison_id":"8102ce27-603f-4739-98d4-48202aae64e3","query_id":"53","doc_a_id":"9641846","doc_b_id":"13964633","presented_order":["13964633","9641846"],"winner_id":"13964633","reasoning":"Document A is more related to cancer-associated markers and tumor growth pathways (Rb1/PTEN) than Document B, which focuses on developmental Rb knockout and cell-cycle independence. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136742Z"}
{"comparison_id":"b7441853-75d9-4a66-a896-9ede41c5265b","query_id":"53","doc_a_id":"25748308","doc_b_id":"13964633","presented_order":["13964633","25748308"],"winner_id":"13964633","reasoning":"Document A is more relevant — it discusses tumor growth and cancer-related molecular mechanisms, while Document B is a general review of GAPDH; neither mentions ALDH1 but A is closer to cancer prognosis context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:34.136749Z"}
{"comparison_id":"a86804fc-a35a-45cd-a2cc-ec0ffc08851f","query_id":"53","doc_a_id":"42731834","doc_b_id":"19047331","presented_order":["42731834","19047331"],"winner_id":"42731834","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is marginally more relevant because it links tumor gene expression to patient prognosis (though in colorectal cancer and a different gene), whereas B focuses on a microRNA/STAT3 mechanism in ovarian cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820274Z"}
{"comparison_id":"53a1879d-6210-4358-9e80-a01a8bf6df92","query_id":"53","doc_a_id":"10024681","doc_b_id":"19047331","presented_order":["19047331","10024681"],"winner_id":"19047331","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it deals with cancer prognostic biomarkers and poor clinical outcomes (though in ovarian cancer), whereas B focuses on prostate cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820295Z"}
{"comparison_id":"e589b1a4-94f0-4b1f-b541-79527718ca5e","query_id":"53","doc_a_id":"2389574","doc_b_id":"19047331","presented_order":["19047331","2389574"],"winner_id":"2389574","reasoning":"Reason: Both documents study markers in other cancers, but B concerns prognostic marker expression and clinical outcomes (like prognosis and metastasis), making it slightly more relevant than A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820303Z"}
{"comparison_id":"df65bcc4-4774-4801-8d9d-029169d0c634","query_id":"53","doc_a_id":"39580129","doc_b_id":"19047331","presented_order":["39580129","19047331"],"winner_id":"39580129","reasoning":"Document A is more relevant — it reports that elevated expression of a marker is an independent predictor of poor prognosis in cancer, which is closer in topic (expression linked to prognosis) than Document B's mechanistic ovarian-cancer study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820313Z"}
{"comparison_id":"4ee61b90-20fa-4352-922d-c91837b367ba","query_id":"53","doc_a_id":"22963769","doc_b_id":"19047331","presented_order":["19047331","22963769"],"winner_id":"19047331","reasoning":"Document A is more relevant — it links expression of a molecular marker to poor clinical outcomes in cancer (though ovarian rather than breast), whereas B concerns adhesion proteins in oral cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820320Z"}
{"comparison_id":"fbf7ffe6-c0d0-4893-ba72-41ea6f3b1997","query_id":"53","doc_a_id":"20886584","doc_b_id":"19047331","presented_order":["19047331","20886584"],"winner_id":"20886584","reasoning":"Document B — it concerns breast cancer clinical outcomes/markers, while A is about ovarian cancer; neither mentions ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820328Z"}
{"comparison_id":"bc2d476c-7335-4d90-8055-304c22c7850b","query_id":"53","doc_a_id":"26561572","doc_b_id":"19047331","presented_order":["26561572","19047331"],"winner_id":"19047331","reasoning":"Document B — it discusses a molecular marker whose upregulation is linked to poor clinical outcome in cancer, so it's slightly more relevant than a lung-fusion study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820335Z"}
{"comparison_id":"f8cf62d5-1263-4d66-a5f5-15ca06201c3a","query_id":"53","doc_a_id":"15335331","doc_b_id":"19047331","presented_order":["15335331","19047331"],"winner_id":"15335331","reasoning":"Document A is slightly more relevant because it links marker expression to poor clinical outcomes (though in oral cancer, not breast, and not ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820342Z"}
{"comparison_id":"797e78d3-b6d6-4957-9e22-83b98f115432","query_id":"53","doc_a_id":"38243984","doc_b_id":"19047331","presented_order":["19047331","38243984"],"winner_id":"19047331","reasoning":"Document A — it discusses a molecular marker linked to worse clinical outcomes (though in ovarian cancer), making it slightly more relevant than Document B, which focuses on pancreatic xenografts and drug resistance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820349Z"}
{"comparison_id":"95b81e3d-2d1b-460e-83b1-a7f6698f59f9","query_id":"53","doc_a_id":"16806763","doc_b_id":"19047331","presented_order":["16806763","19047331"],"winner_id":"16806763","reasoning":"Neither document mentions ALDH1 or breast cancer, so both are irrelevant. Document A is slightly more relevant only because it addresses prognostic markers in cancer generally.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820356Z"}
{"comparison_id":"b8fb4268-66e1-4769-a381-5c5a62bf7e28","query_id":"53","doc_a_id":"4489217","doc_b_id":"19047331","presented_order":["4489217","19047331"],"winner_id":"4489217","reasoning":"Document A is more relevant — it discusses intratumor heterogeneity and gene expression implications in cancer (though in renal carcinoma), which is closer to a prognosis–biomarker claim than Document B's ovarian/STAT3-specific study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820363Z"}
{"comparison_id":"5ca241f3-d5c5-4733-a9d1-4439f0a76120","query_id":"53","doc_a_id":"7165938","doc_b_id":"19047331","presented_order":["19047331","7165938"],"winner_id":"19047331","reasoning":"Document A is slightly more relevant because it discusses cancer prognosis and factors driving poor clinical outcomes (though in ovarian cancer), whereas Document B focuses on colorectal cancer treatment sensitivity and improved survival.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820370Z"}
{"comparison_id":"3bf4b23a-1364-4a45-a9fa-f87ff69f688b","query_id":"53","doc_a_id":"515489","doc_b_id":"19047331","presented_order":["515489","19047331"],"winner_id":"515489","reasoning":"Neither document studies ALDH1 or breast cancer. Document A is slightly more relevant because it links stem cell–like properties and poor prognosis (though in hepatocellular carcinoma), while B concerns ovarian cancer and STAT3/miRNA.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820378Z"}
{"comparison_id":"6ea86df6-2a6c-459b-9f0a-b7da38f61248","query_id":"53","doc_a_id":"21521236","doc_b_id":"19047331","presented_order":["21521236","19047331"],"winner_id":"21521236","reasoning":"Document A is more relevant — it concerns cancer-related molecular markers and chemosensitivity (more likely translatable to breast cancer contexts) while Document B focuses on ovarian cancer-specific miRNA/STAT3. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820385Z"}
{"comparison_id":"1fcb483a-d2a8-4bdf-a5e3-7a7886988957","query_id":"53","doc_a_id":"20280410","doc_b_id":"19047331","presented_order":["20280410","19047331"],"winner_id":"20280410","reasoning":"Document A is more relevant — it discusses breast cancer (though not ALDH1 specifically), while Document B is about ovarian cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820391Z"}
{"comparison_id":"804c14a6-076b-43ca-9ebf-5f1c5b38eab3","query_id":"53","doc_a_id":"38551172","doc_b_id":"19047331","presented_order":["19047331","38551172"],"winner_id":"38551172","reasoning":"Document B — it concerns breast cancer (risk factors), whereas A discusses ovarian cancer and is unrelated to ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820399Z"}
{"comparison_id":"079c1f1e-def1-4f79-8222-86edd6409d01","query_id":"53","doc_a_id":"4828631","doc_b_id":"19047331","presented_order":["4828631","19047331"],"winner_id":"4828631","reasoning":"Document A is more relevant — it discusses breast cancer (though not ALDH1 specifically), while Document B covers ovarian cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820406Z"}
{"comparison_id":"7fe9cd91-ab13-444f-9575-469969dc5888","query_id":"53","doc_a_id":"6790197","doc_b_id":"19047331","presented_order":["6790197","19047331"],"winner_id":"6790197","reasoning":"Document A is slightly more relevant because it addresses cancer gene expression and prognosis associations (though in prostate, not breast); Document B focuses on miRNA/STAT3 in ovarian cancer and is less related to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820413Z"}
{"comparison_id":"4bbb6f9c-6487-4501-828f-fad1c2d52c45","query_id":"53","doc_a_id":"5487448","doc_b_id":"19047331","presented_order":["5487448","19047331"],"winner_id":"5487448","reasoning":"Document A is more relevant because it addresses breast cancer risk factors (mammographic density), whereas Document B focuses on ovarian cancer and STAT3. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820422Z"}
{"comparison_id":"423aefc2-0255-4b13-9065-fe236810870c","query_id":"53","doc_a_id":"831167","doc_b_id":"19047331","presented_order":["831167","19047331"],"winner_id":"831167","reasoning":"Document A is more relevant — it deals with gene expression and survival prognosis (though in glioblastoma, not breast cancer). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820428Z"}
{"comparison_id":"71a4d1c2-2cd4-4ac8-832d-2dbe601b92b8","query_id":"53","doc_a_id":"38784540","doc_b_id":"19047331","presented_order":["19047331","38784540"],"winner_id":"38784540","reasoning":"Document B is more relevant — it concerns breast cancer (risk factors and mammographic density), whereas Document A focuses on ovarian cancer and STAT3, not ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820435Z"}
{"comparison_id":"1ed84143-8bdc-43c8-8972-8f55f961f936","query_id":"53","doc_a_id":"33677323","doc_b_id":"19047331","presented_order":["19047331","33677323"],"winner_id":"19047331","reasoning":"Document A is slightly more relevant because it concerns solid tumor biology and poor clinical outcomes in epithelial cancer (ovarian), which is closer to breast cancer than hematopoietic malignancies.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820442Z"}
{"comparison_id":"b49642d7-5c7d-4f84-94ca-e08cdaecb2ce","query_id":"53","doc_a_id":"22901758","doc_b_id":"19047331","presented_order":["19047331","22901758"],"winner_id":"22901758","reasoning":"Document B — neither abstract mentions ALDH1 or breast cancer, but B discusses tumor-initiating (stem-like) cells and their link to prognosis, which is conceptually closer to ALDH1 as a cancer stem-cell marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820449Z"}
{"comparison_id":"ea6e5a48-0861-458b-8ed3-c46667a98ab5","query_id":"53","doc_a_id":"14315749","doc_b_id":"19047331","presented_order":["14315749","19047331"],"winner_id":"14315749","reasoning":"Document A is slightly more relevant — it discusses gene expression correlated with worse tumor features (poor differentiation, lymph node metastasis), which is closer to a prognosis-related claim than Document B's focus on a microRNA/STAT3 mechanism in ovarian cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820457Z"}
{"comparison_id":"db6fa27b-1028-4140-84ff-3026316740de","query_id":"53","doc_a_id":"3590806","doc_b_id":"19047331","presented_order":["3590806","19047331"],"winner_id":"3590806","reasoning":"Document A — discusses cancer-initiating (stem-like) cells and pathways related to stemness, which is conceptually closer to ALDH1 (a stemness marker); Document B focuses on ovarian STAT3 unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820464Z"}
{"comparison_id":"34c1856d-c392-4cd5-ad5a-25b3694bb316","query_id":"53","doc_a_id":"18358026","doc_b_id":"19047331","presented_order":["19047331","18358026"],"winner_id":"19047331","reasoning":"Doc A discusses gene expression linked to worse clinical outcomes in cancer (though in ovarian cancer), making it marginally more relevant than Doc B, which focuses on oxidative DNA methylation mechanisms unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820471Z"}
{"comparison_id":"92a42d3b-6341-4d0c-83f3-b0941f4ab806","query_id":"53","doc_a_id":"864491","doc_b_id":"19047331","presented_order":["19047331","864491"],"winner_id":"864491","reasoning":"Neither document mentions ALDH1 or directly studies breast cancer. Document B is slightly more relevant because it addresses antitumor activity in human tumor xenografts (more broadly applicable to cancer prognosis/treatment), whereas A is specific to ovarian cancer and a microRNA–STAT3 mechanism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:47.820479Z"}
{"comparison_id":"6f708275-6b8e-4bb5-8fd2-1ca946cf3bc2","query_id":"53","doc_a_id":"42731834","doc_b_id":"20280410","presented_order":["42731834","20280410"],"winner_id":"20280410","reasoning":"Document B is more relevant — neither mentions ALDH1, but B concerns breast cancer (though about BRCA2 and risk), while A addresses colorectal cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.342861Z"}
{"comparison_id":"a3c95932-7c0c-4686-8292-2ff1d6e16a7c","query_id":"53","doc_a_id":"2389574","doc_b_id":"20280410","presented_order":["20280410","2389574"],"winner_id":"20280410","reasoning":"Document A is more relevant — it concerns breast cancer (though a different marker and about risk), while B is about endometrial cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.342884Z"}
{"comparison_id":"ce15f434-2c33-40ff-b25c-1c843a8baf46","query_id":"53","doc_a_id":"39580129","doc_b_id":"20280410","presented_order":["20280410","39580129"],"winner_id":"20280410","reasoning":"Document A — it concerns breast cancer specifically, while B addresses colorectal cancer; neither mentions ALDH1 but A is more topically related. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.342893Z"}
{"comparison_id":"bb8ff51b-b18d-45d1-ae23-b2dce33d40c9","query_id":"53","doc_a_id":"20886584","doc_b_id":"20280410","presented_order":["20886584","20280410"],"winner_id":"20280410","reasoning":"Document B is more relevant — it addresses a genetic factor associated with breast cancer (though not ALDH1 or prognosis directly), whereas A focuses on taxane neurotoxicity. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.342902Z"}
{"comparison_id":"92ea647b-7088-4944-9c35-095192cd724a","query_id":"53","doc_a_id":"15335331","doc_b_id":"20280410","presented_order":["15335331","20280410"],"winner_id":"20280410","reasoning":"Document B — it concerns breast cancer (risk) while Document A is about oral cancer, so B is more relevant to a claim about breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.342912Z"}
{"comparison_id":"0fabd696-98ae-4b47-a0d9-73fdaeba9995","query_id":"53","doc_a_id":"16806763","doc_b_id":"20280410","presented_order":["16806763","20280410"],"winner_id":"20280410","reasoning":"Document B is more relevant — it concerns breast cancer (though about a BRCA2 variant and risk), whereas Document A is about colorectal cancer.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.342921Z"}
{"comparison_id":"e5666d36-ba9b-4667-9514-9b3bcdad64cf","query_id":"53","doc_a_id":"4489217","doc_b_id":"20280410","presented_order":["20280410","4489217"],"winner_id":"4489217","reasoning":"Document B is more relevant — it discusses tumor gene expression and prognosis-related heterogeneity, which is closer to a claim about a prognostic marker than Document A's BRCA2/prenatal viability topic.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.342929Z"}
{"comparison_id":"45b4f658-e6e5-46dd-919f-47406f5f41cb","query_id":"53","doc_a_id":"515489","doc_b_id":"20280410","presented_order":["515489","20280410"],"winner_id":"20280410","reasoning":"Document B is more relevant — it concerns breast cancer (risk factors), whereas A is about lncRNA in hepatocellular carcinoma and not breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.342937Z"}
{"comparison_id":"6176a0e3-690b-4aa3-a3d9-79bb75bc4a2a","query_id":"53","doc_a_id":"21521236","doc_b_id":"20280410","presented_order":["20280410","21521236"],"winner_id":"20280410","reasoning":"Document A is more relevant — it directly addresses breast cancer (risk/prognosis-related genetics), whereas Document B discusses p53/NEAT1 and replication stress without reference to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.342946Z"}
{"comparison_id":"212afd46-b604-4b1f-92ae-24d27e6fd813","query_id":"53","doc_a_id":"864491","doc_b_id":"20280410","presented_order":["20280410","864491"],"winner_id":"20280410","reasoning":"Document A is more relevant — it explicitly concerns breast cancer (though it doesn't mention ALDH1), whereas B discusses a CDK4/6 inhibitor in tumor xenografts without direct link to breast cancer prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.342954Z"}
{"comparison_id":"9745d18b-70a1-478e-a43a-64cf2316599a","query_id":"53","doc_a_id":"38551172","doc_b_id":"20280410","presented_order":["20280410","38551172"],"winner_id":"20280410","reasoning":"Neither document discusses ALDH1 or prognosis directly, but Document A mentions a genetic association with breast cancer (molecular link) so is slightly more relevant than Document B, which focuses on mammographic density and vitamin D. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.342963Z"}
{"comparison_id":"5ca2744f-910e-4843-8030-f9ec4f103ef6","query_id":"53","doc_a_id":"4828631","doc_b_id":"20280410","presented_order":["20280410","4828631"],"winner_id":"20280410","reasoning":"Reason: Document A directly concerns breast cancer (genetic risk), while Document B addresses BMI and multiple cancers and only briefly mentions breast cancer risk. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.342972Z"}
{"comparison_id":"0302931e-a95c-4f33-bfc3-63ea7b4cd015","query_id":"53","doc_a_id":"6790197","doc_b_id":"20280410","presented_order":["6790197","20280410"],"winner_id":"20280410","reasoning":"Document B — it concerns breast cancer genetics, whereas Document A is about prostate cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.342980Z"}
{"comparison_id":"5afa7589-8218-4be5-8e20-48e868f15718","query_id":"53","doc_a_id":"5487448","doc_b_id":"20280410","presented_order":["5487448","20280410"],"winner_id":"20280410","reasoning":"Reason: Neither document mentions ALDH1 or prognosis, but B deals with a molecular genetic association with breast cancer (closer in topic) while A concerns birth weight and mammographic density.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.342989Z"}
{"comparison_id":"4e5c4bcf-ee18-4dc4-9455-28f835e78d18","query_id":"53","doc_a_id":"831167","doc_b_id":"20280410","presented_order":["831167","20280410"],"winner_id":"20280410","reasoning":"Document B is more relevant because it concerns breast cancer (where ALDH1 prognostic associations would apply); Document A studies glioblastoma and is unrelated. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.342996Z"}
{"comparison_id":"dfef25a9-ff35-4535-bbfe-00ca79be799e","query_id":"53","doc_a_id":"38784540","doc_b_id":"20280410","presented_order":["38784540","20280410"],"winner_id":"20280410","reasoning":"Neither abstract mentions ALDH1 or prognosis. Document B is marginally more relevant because it deals with a molecular/genetic association with breast cancer risk, whereas A addresses epidemiologic risk factors and mammographic density.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.343005Z"}
{"comparison_id":"086e1d62-c1dd-4c76-b7f5-a6e80a5b20e1","query_id":"53","doc_a_id":"22901758","doc_b_id":"20280410","presented_order":["22901758","20280410"],"winner_id":"20280410","reasoning":"Document B is more relevant — it concerns breast cancer (genetic risk), while A discusses glioblastoma; neither mentions ALDH1 but B is closer to the query topic.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.343013Z"}
{"comparison_id":"000f30e3-872a-4792-9265-912694faf248","query_id":"53","doc_a_id":"14315749","doc_b_id":"20280410","presented_order":["20280410","14315749"],"winner_id":"20280410","reasoning":"Document A is more relevant — it concerns breast cancer (though not ALDH1), whereas B is about a different gene in colorectal cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.343020Z"}
{"comparison_id":"9863d7df-cbe5-4fdb-9025-a402e17aa6d5","query_id":"53","doc_a_id":"3590806","doc_b_id":"20280410","presented_order":["3590806","20280410"],"winner_id":"20280410","reasoning":"Document B is more relevant because it concerns breast cancer (genetic risk/prognosis context), whereas Document A is about colorectal cancer and unrelated to ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:55:56.343029Z"}
{"comparison_id":"0faf202a-bf28-4bf8-adc1-e456a9210d82","query_id":"53","doc_a_id":"42731834","doc_b_id":"864491","presented_order":["864491","42731834"],"winner_id":"864491","reasoning":"Document A is more related to cancer biology and therapeutic biomarkers (and its agent is used in breast cancer), while Document B concerns AIM2 in colorectal cancer, unrelated to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:05.985523Z"}
{"comparison_id":"fdb48966-849f-432a-9d44-23703e253695","query_id":"53","doc_a_id":"2389574","doc_b_id":"864491","presented_order":["2389574","864491"],"winner_id":"2389574","reasoning":"Document A is slightly more relevant — it discusses a biomarker's association with poor prognosis (though in endometrial, not breast, cancer). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:05.985546Z"}
{"comparison_id":"164cf0e8-1f74-4afb-95c0-35720340f259","query_id":"53","doc_a_id":"39580129","doc_b_id":"864491","presented_order":["864491","39580129"],"winner_id":"39580129","reasoning":"Document B — it addresses expression of a biomarker as an adverse prognostic factor, which is conceptually closer to the query about ALDH1 and prognosis; Document A is a drug/therapy study. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:05.985555Z"}
{"comparison_id":"ee97194c-51fc-4778-8220-3840bdefb7c5","query_id":"53","doc_a_id":"20886584","doc_b_id":"864491","presented_order":["20886584","864491"],"winner_id":"20886584","reasoning":"Document A is more relevant — it deals with a breast cancer clinical trial and patient outcomes, whereas B is preclinical work on a CDK4/6 inhibitor unrelated to ALDH1 or prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:05.985563Z"}
{"comparison_id":"612140ac-7b05-48b7-8fe2-c780ee9dc2fa","query_id":"53","doc_a_id":"15335331","doc_b_id":"864491","presented_order":["15335331","864491"],"winner_id":"15335331","reasoning":"Document A is more relevant — it links marker expression to poorer outcomes (though in a different cancer), whereas B concerns a CDK4/6 inhibitor unrelated to marker prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:05.985570Z"}
{"comparison_id":"9f980661-ffbc-4972-a025-0276fc840c7d","query_id":"53","doc_a_id":"16806763","doc_b_id":"864491","presented_order":["16806763","864491"],"winner_id":"16806763","reasoning":"Document A — it discusses prognostic biomarkers/signature (though in colorectal cancer), so it's more related to a claim about marker expression and prognosis than a drug inhibition xenograft study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:05.985576Z"}
{"comparison_id":"319e80e5-bafd-439d-99f6-87a8438848a2","query_id":"53","doc_a_id":"515489","doc_b_id":"864491","presented_order":["515489","864491"],"winner_id":"515489","reasoning":"Document A — it links a marker promoting stem cell–like properties with poor prognosis (though in HCC rather than breast cancer), so it's more relevant to a prognosis–ALDH1/stemness claim than Document B. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:05.985583Z"}
{"comparison_id":"5b6f94f6-9494-47b4-8452-156732d74449","query_id":"53","doc_a_id":"21521236","doc_b_id":"864491","presented_order":["864491","21521236"],"winner_id":"864491","reasoning":"Neither document mentions ALDH1 or breast cancer prognosis. Document A is marginally more relevant because it discusses tumor response and antitumor activity, which is closer to prognosis than the molecular paraspeckle/chemosensitivity focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:05.985591Z"}
{"comparison_id":"8797d715-1d7d-4067-895b-b8cf9b153fc8","query_id":"53","doc_a_id":"3590806","doc_b_id":"864491","presented_order":["3590806","864491"],"winner_id":"3590806","reasoning":"Document A is slightly more relevant — it addresses cancer-initiating (stem-like) cells and pathways involved in tumor self-renewal, which is conceptually closer to ALDH1 as a stem-cell/prognostic marker than a paper on CDK4/6 inhibition.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:05.985598Z"}
{"comparison_id":"8c473b86-e724-42cf-9f79-a3db5e05148a","query_id":"53","doc_a_id":"38551172","doc_b_id":"864491","presented_order":["38551172","864491"],"winner_id":"38551172","reasoning":"Document A is more relevant — it directly concerns breast cancer (risk factors and outcomes), whereas Document B focuses on a CDK4/6 inhibitor in tumor xenografts and does not address ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:05.985606Z"}
{"comparison_id":"8d170c80-cd4f-4922-a8af-912a8815db10","query_id":"53","doc_a_id":"4828631","doc_b_id":"864491","presented_order":["864491","4828631"],"winner_id":"4828631","reasoning":"Document B is more relevant — it specifically discusses breast cancer (even though for risk, not prognosis), while Document A focuses on a CDK4/6 inhibitor and tumor xenografts unrelated to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:05.985613Z"}
{"comparison_id":"7e358bae-d590-4777-80f8-1d9c24d91d37","query_id":"53","doc_a_id":"6790197","doc_b_id":"864491","presented_order":["864491","6790197"],"winner_id":"864491","reasoning":"Document A is slightly more relevant because it concerns tumor markers and treatment in human tumor xenografts (potentially including breast cancer), whereas Document B focuses on prostate cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:05.985620Z"}
{"comparison_id":"aa69d3d8-cebc-4d77-9679-e4b4e3860c97","query_id":"53","doc_a_id":"5487448","doc_b_id":"864491","presented_order":["5487448","864491"],"winner_id":"864491","reasoning":"Document B is more relevant — it concerns tumor biology and therapeutic response, which is closer to prognosis-related biomarkers than a study on birth weight and mammographic density.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:05.985627Z"}
{"comparison_id":"5d18d2f2-f450-48df-bda8-be0823ecd897","query_id":"53","doc_a_id":"831167","doc_b_id":"864491","presented_order":["831167","864491"],"winner_id":"831167","reasoning":"Document A is more relevant — it addresses gene expression associations with survival prognosis (though in glioblastoma), whereas B focuses on a CDK4/6 inhibitor and not prognostic gene expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:05.985634Z"}
{"comparison_id":"458eb02d-64ea-4509-9bc1-affcd90e9809","query_id":"53","doc_a_id":"38784540","doc_b_id":"864491","presented_order":["864491","38784540"],"winner_id":"864491","reasoning":"Reason: Document A addresses tumor biology and therapeutic response in cancer models, which is closer to biomarker/prognosis relevance than Document B's focus on epidemiologic risk factors and mammographic density.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:05.985641Z"}
{"comparison_id":"249e1d9c-341a-4daa-8a8e-b6ba5cac2e76","query_id":"53","doc_a_id":"22901758","doc_b_id":"864491","presented_order":["22901758","864491"],"winner_id":"22901758","reasoning":"Document A — it links molecular expression to shorter patient survival (prognosis), whereas Document B describes a therapeutic inhibitor without addressing ALDH1 or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:05.985648Z"}
{"comparison_id":"3510b0a0-4d7e-41b0-b261-a759d9d68401","query_id":"53","doc_a_id":"14315749","doc_b_id":"864491","presented_order":["14315749","864491"],"winner_id":"864491","reasoning":"Neither document mentions ALDH1 or breast cancer prognosis; both are irrelevant. Document B is slightly more related to cancer biology/treatment (general tumor models) than A, which is limited to colorectal cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:05.985655Z"}
{"comparison_id":"03252aaf-c261-4020-9e7c-e468bbaf7cc3","query_id":"53","doc_a_id":"2389574","doc_b_id":"515489","presented_order":["515489","2389574"],"winner_id":"515489","reasoning":"Document A is more relevant — it links stem cell–like properties and poor prognosis (conceptually closer to ALDH1 as a stem cell marker) while B concerns a different marker and cancer type. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:11.922033Z"}
{"comparison_id":"6775215d-d4d2-4eca-b040-309e35b44ec4","query_id":"53","doc_a_id":"39580129","doc_b_id":"515489","presented_order":["515489","39580129"],"winner_id":"515489","reasoning":"Reason: Neither paper studies ALDH1 or breast cancer, but Document A discusses cancer stem cell–like properties and links marker-related biology to poor prognosis (closer conceptually).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:11.922055Z"}
{"comparison_id":"d56437b0-55a7-4323-9768-14060973d29d","query_id":"53","doc_a_id":"20886584","doc_b_id":"515489","presented_order":["515489","20886584"],"winner_id":"20886584","reasoning":"Document B is more relevant — it addresses breast cancer (while A is about hepatocellular carcinoma); neither mentions ALDH1, but B is closer to the query topic. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:11.922063Z"}
{"comparison_id":"748bf7d2-3e38-4f07-8ace-9b827997be05","query_id":"53","doc_a_id":"15335331","doc_b_id":"515489","presented_order":["515489","15335331"],"winner_id":"515489","reasoning":"Reason: Document A discusses stem cell–like properties and poor prognosis in cancer (though in HCC), which is more closely related to ALDH1's role as a cancer stem cell marker than Document B's focus on macrophages in oral cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:11.922071Z"}
{"comparison_id":"069061ce-d1d6-4157-abb9-7c7feb0658e2","query_id":"53","doc_a_id":"16806763","doc_b_id":"515489","presented_order":["16806763","515489"],"winner_id":"515489","reasoning":"Document B — it discusses tumor stem cell–like properties and association with poor prognosis (closer to ALDH1's role as a stem cell marker), whereas A concerns an lncRNA signature in colorectal cancer, not breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:11.922078Z"}
{"comparison_id":"6464fc8a-273b-4c9e-9dcc-f0b1b97cbbb3","query_id":"53","doc_a_id":"22901758","doc_b_id":"515489","presented_order":["22901758","515489"],"winner_id":"22901758","reasoning":"Neither document reports on ALDH1 or breast cancer. Document A is slightly more related conceptually because it discusses tumor-initiating (stem-like) cells and prognosis, whereas B focuses on lncRNA in hepatocellular carcinoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:11.922086Z"}
{"comparison_id":"749ddee6-8e32-4aa6-9341-591bf5128280","query_id":"53","doc_a_id":"3590806","doc_b_id":"515489","presented_order":["515489","3590806"],"winner_id":"515489","reasoning":"Both documents are unrelated to ALDH1 or breast cancer, but A discusses stem cell–like properties and prognosis (albeit in HCC), making it slightly closer in topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:11.922093Z"}
{"comparison_id":"0f7950de-6d21-4e27-bbc0-ce029f68872f","query_id":"53","doc_a_id":"38551172","doc_b_id":"515489","presented_order":["515489","38551172"],"winner_id":"38551172","reasoning":"Document B — it concerns breast cancer (though not ALDH1 specifically), whereas Document A is about hepatocellular carcinoma. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:11.922100Z"}
{"comparison_id":"78221a19-2c63-41d2-9fd2-916d3546a445","query_id":"53","doc_a_id":"4828631","doc_b_id":"515489","presented_order":["515489","4828631"],"winner_id":"4828631","reasoning":"Document B is more relevant because it addresses breast cancer (though not ALDH1), while Document A focuses on hepatocellular carcinoma. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:11.922107Z"}
{"comparison_id":"5305697f-e507-4a04-a9a5-f297d44cb6b8","query_id":"53","doc_a_id":"831167","doc_b_id":"515489","presented_order":["515489","831167"],"winner_id":"515489","reasoning":"Document A is more relevant — it links stem cell–like properties and poorer prognosis (though in HCC), which is closer to an ALDH1–breast cancer stem cell/prognosis claim than B’s glioblastoma network study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:11.922114Z"}
{"comparison_id":"1e411227-8f24-40e5-a31f-8ef4c72444f7","query_id":"53","doc_a_id":"20886584","doc_b_id":"22901758","presented_order":["20886584","22901758"],"winner_id":"20886584","reasoning":"Document A — it concerns breast cancer (though on treatment toxicity), while B is about glioblastoma and unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:15.816442Z"}
{"comparison_id":"6639dedf-8c35-4fe2-a63e-51bbbfdcae37","query_id":"53","doc_a_id":"4828631","doc_b_id":"22901758","presented_order":["22901758","4828631"],"winner_id":"4828631","reasoning":"Document B is more relevant because it concerns breast cancer (even though it addresses BMI and risk rather than ALDH1), while Document A is about glioblastoma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:15.816464Z"}
{"comparison_id":"a0f39821-06dc-43a8-8d66-c20efa4bf29e","query_id":"53","doc_a_id":"38551172","doc_b_id":"22901758","presented_order":["38551172","22901758"],"winner_id":"38551172","reasoning":"Document A is about breast cancer risk factors (more related to prognosis in breast cancer), whereas Document B concerns glioblastoma and unrelated pathways. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:15.816473Z"}
{"comparison_id":"af1267c9-0622-420f-a1b0-476e6bcfcc42","query_id":"53","doc_a_id":"20886584","doc_b_id":"4828631","presented_order":["4828631","20886584"],"winner_id":"4828631","reasoning":"Document A is more relevant — it discusses breast cancer (though not ALDH1 specifically), whereas Document B focuses on chemotherapy neurotoxicity genetics. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:19.105303Z"}
{"comparison_id":"c5890698-1c7c-4c4a-86ca-6ca2188a48ed","query_id":"53","doc_a_id":"38551172","doc_b_id":"4828631","presented_order":["38551172","4828631"],"winner_id":"38551172","reasoning":"Document A is more relevant — it concerns breast cancer risk and characteristics, whereas Document B focuses on BMI and multiple cancers without addressing molecular markers or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:19.105324Z"}
{"comparison_id":"3611b45d-5e48-4652-bdae-4130e7578d78","query_id":"53","doc_a_id":"2389574","doc_b_id":"15335331","presented_order":["15335331","2389574"],"winner_id":"15335331","reasoning":"Document A is more relevant — it links molecular markers to poor outcomes and EMT in cancer, which is closer to the claim about a prognostic marker than a study of stathmin in endometrial cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:26.592840Z"}
{"comparison_id":"8e55be9b-df62-491b-93ca-330685b07350","query_id":"53","doc_a_id":"39580129","doc_b_id":"15335331","presented_order":["15335331","39580129"],"winner_id":"39580129","reasoning":"Document B — it reports that elevated expression of a specific biomarker (miR-24-3p) predicts poorer survival, so it is more closely related to a claim about a biomarker (ALDH1) and prognosis than Document A, which focuses on TAMs and EMT in oral cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:26.592864Z"}
{"comparison_id":"435a6b35-d30f-47b9-90ce-a041d752c50d","query_id":"53","doc_a_id":"831167","doc_b_id":"15335331","presented_order":["15335331","831167"],"winner_id":"831167","reasoning":"Document B is more relevant — it examines gene-expression associations with survival prognosis (though in glioblastoma), which is closer to assessing ALDH1 expression's prognostic value than a study on macrophages in oral squamous cell carcinoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:26.592875Z"}
{"comparison_id":"d68cdb50-bbfa-46e1-8f96-97c4b0c14b73","query_id":"53","doc_a_id":"16806763","doc_b_id":"15335331","presented_order":["15335331","16806763"],"winner_id":"15335331","reasoning":"Document A is more relevant — it discusses marker expression and association with poor outcomes through EMT in cancer (though in OSCC, not breast cancer), whereas Document B focuses on lncRNA signatures in colorectal cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:26.592883Z"}
{"comparison_id":"b5d659f1-6ead-4073-97e1-8db5ee301485","query_id":"53","doc_a_id":"3590806","doc_b_id":"15335331","presented_order":["3590806","15335331"],"winner_id":"3590806","reasoning":"Document A. It discusses cancer-initiating (stem-like) cells and signaling relevant to stemness, which is conceptually closer to ALDH1 (a cancer stem cell marker) and prognosis than Document B's focus on macrophages in oral cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:26.592893Z"}
{"comparison_id":"f58acc88-340b-4b72-ac11-aba250f04395","query_id":"53","doc_a_id":"39580129","doc_b_id":"831167","presented_order":["39580129","831167"],"winner_id":"831167","reasoning":"Document B is more relevant — it deals with associations between gene expression and survival prognosis (though in glioblastoma), whereas A focuses on a microRNA in colorectal cancer and not gene expression in breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:30.927696Z"}
{"comparison_id":"a5f578a0-5458-4f28-b2b5-21eda6375317","query_id":"53","doc_a_id":"3590806","doc_b_id":"831167","presented_order":["3590806","831167"],"winner_id":"831167","reasoning":"Document B is more relevant — it addresses survival prognosis and gene–survival associations (though in glioblastoma), which is closer to the claim about expression correlating with prognosis than a colorectal cancer molecular study. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:30.927716Z"}
{"comparison_id":"a6bc6ddf-e720-4eda-8fec-d5a358975467","query_id":"53","doc_a_id":"39580129","doc_b_id":"3590806","presented_order":["3590806","39580129"],"winner_id":"39580129","reasoning":"Document B is more relevant — it concerns a molecular marker as an adverse prognostic factor (though in colorectal cancer rather than breast), while Document A focuses on NRIP2 and Wnt signaling in colorectal cancer-initiating cells and not prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:35.069660Z"}
{"comparison_id":"99ab6c92-d2e1-487a-bb8e-4fc184bd144a","query_id":"53","doc_a_id":"2389574","doc_b_id":"16806763","presented_order":["2389574","16806763"],"winner_id":"2389574","reasoning":"Document A is more relevant — it discusses expression of a specific protein linked to poor prognosis (though in endometrial, not breast, cancer), whereas Document B concerns lncRNA signatures in colorectal cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:37.656116Z"}
{"comparison_id":"91e95a44-52f6-45ac-86fe-d90771232a7e","query_id":"53","doc_a_id":"42731834","doc_b_id":"6790197","presented_order":["6790197","42731834"],"winner_id":"42731834","reasoning":"Reason: Document B directly examines tumor-gene expression correlated with patient survival (a prognostic association), while Document A focuses on prostate biopsy expression patterns and methods rather than prognosis-related biomarker expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:41.952018Z"}
{"comparison_id":"d2bf8b35-2fab-4aee-b4a6-8842b088544d","query_id":"53","doc_a_id":"21521236","doc_b_id":"6790197","presented_order":["6790197","21521236"],"winner_id":"6790197","reasoning":"Document A is marginally more relevant because it addresses gene-expression changes associated with cancer prognosis (though in prostate cancer), whereas Document B focuses on NEAT1 and chemosensitivity without addressing ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:41.952039Z"}
{"comparison_id":"15192472-f893-4683-9f32-0c45f2eabb64","query_id":"53","doc_a_id":"14315749","doc_b_id":"6790197","presented_order":["6790197","14315749"],"winner_id":"14315749","reasoning":"Document B — it links a specific gene’s higher expression to worse tumor features (poor differentiation, lymph node metastasis), which is more analogous to \"expression associated with poorer prognosis\" than Document A. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:41.952050Z"}
{"comparison_id":"e0cce6cf-9e65-4927-b1ad-5960221acf03","query_id":"53","doc_a_id":"5487448","doc_b_id":"6790197","presented_order":["5487448","6790197"],"winner_id":"5487448","reasoning":"Document A is more relevant because it concerns breast cancer risk factors, whereas Document B is about prostate cancer gene expression and unrelated to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:41.952057Z"}
{"comparison_id":"fea84ed9-ace1-4d9f-a3b8-5636f8612196","query_id":"53","doc_a_id":"38784540","doc_b_id":"6790197","presented_order":["38784540","6790197"],"winner_id":"38784540","reasoning":"Document A is more relevant because it concerns breast cancer-related factors (breast density), whereas Document B focuses on prostate cancer gene expression and is unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:41.952065Z"}
{"comparison_id":"a81a7fce-2e9d-4c45-b13b-5ad6da9193b9","query_id":"53","doc_a_id":"42731834","doc_b_id":"14315749","presented_order":["14315749","42731834"],"winner_id":"42731834","reasoning":"Document B — it links reduced tumor-cell expression to poorer survival (a prognosis-related finding), which is more directly relevant to the claim about expression affecting prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:46.129948Z"}
{"comparison_id":"6af86357-e033-46f3-b080-d623ae582bf4","query_id":"53","doc_a_id":"38784540","doc_b_id":"14315749","presented_order":["14315749","38784540"],"winner_id":"38784540","reasoning":"Document B — it concerns breast cancer risk factors and breast tissue (though not ALDH1), while Document A is about a different gene in colorectal cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:46.129970Z"}
{"comparison_id":"c6897367-57db-469b-8187-0d82e0f11028","query_id":"53","doc_a_id":"5487448","doc_b_id":"14315749","presented_order":["14315749","5487448"],"winner_id":"5487448","reasoning":"B — Document B relates to breast cancer (risk factors), while A concerns colorectal cancer; neither mentions ALDH1 or prognosis, but B is more topically relevant. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:46.129978Z"}
{"comparison_id":"4c8953e4-7657-422a-8597-f190b6da9a0a","query_id":"53","doc_a_id":"42731834","doc_b_id":"38784540","presented_order":["42731834","38784540"],"winner_id":"38784540","reasoning":"Document B — it concerns breast cancer-related risk factors and breast tissue, whereas A discusses AIM2 in colorectal cancer and is unrelated to ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:52.624781Z"}
{"comparison_id":"506104a2-74d6-4c91-972e-db7cffedb4a1","query_id":"53","doc_a_id":"5487448","doc_b_id":"38784540","presented_order":["5487448","38784540"],"winner_id":"5487448","reasoning":"Neither document discusses ALDH1 expression or prognosis. Document A is marginally more relevant because it directly links mammographic density to breast cancer risk, whereas B focuses on life-course correlates of density. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:52.624802Z"}
{"comparison_id":"beb5fe3e-5510-42f2-b637-0e4d6674b28f","query_id":"53","doc_a_id":"10024681","doc_b_id":"38243984","presented_order":["38243984","10024681"],"winner_id":"10024681","reasoning":"Document B is more relevant — it links gene expression changes to prognosis (though in prostate cancer), whereas A concerns pancreatic tumor engraftment and drug resistance, not expression–prognosis relationships. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:58.668848Z"}
{"comparison_id":"3a96d457-6475-4bdf-80b8-85fd428ce0a2","query_id":"53","doc_a_id":"22963769","doc_b_id":"38243984","presented_order":["38243984","22963769"],"winner_id":"38243984","reasoning":"Document A is slightly more relevant because it discusses factors associated with poor survival in cancer (though in pancreatic cancer), whereas Document B focuses on desmosomal proteins in oral cancer and not prognosis markers like ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:58.668872Z"}
{"comparison_id":"3ea3607e-d768-4024-b31a-3d4b59558ba2","query_id":"53","doc_a_id":"26561572","doc_b_id":"38243984","presented_order":["38243984","26561572"],"winner_id":"26561572","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it deals with cancer biomarker fusions and multivariate prognosis analysis, whereas A focuses on pancreatic xenografts and drug resistance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:58.668881Z"}
{"comparison_id":"28e6830b-4454-4b3c-894d-e7c0f4a73333","query_id":"53","doc_a_id":"18358026","doc_b_id":"38243984","presented_order":["18358026","38243984"],"winner_id":"18358026","reasoning":"Document A is somewhat more relevant because it discusses cancer-related gene expression and epigenetic changes that could affect markers like ALDH1, whereas Document B concerns pancreatic cancer and xenografts.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:58.668888Z"}
{"comparison_id":"fc709d2e-1bec-4de2-98c5-6dfbbaaf857b","query_id":"53","doc_a_id":"7165938","doc_b_id":"38243984","presented_order":["7165938","38243984"],"winner_id":"7165938","reasoning":"Document A is more relevant — it links gene expression to patient survival and prognosis (though in colorectal cancer, not breast, and does not mention ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:58.668897Z"}
{"comparison_id":"70582444-a9f2-4994-98de-484a1709aab1","query_id":"53","doc_a_id":"33677323","doc_b_id":"38243984","presented_order":["38243984","33677323"],"winner_id":"33677323","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but B is slightly more relevant because it links expression of a molecular marker to poor clinical outcomes and stem-cell–related behavior.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:56:58.668903Z"}
{"comparison_id":"51eba1bf-805f-43f8-a5e1-b081d9ca388f","query_id":"53","doc_a_id":"10024681","doc_b_id":"18358026","presented_order":["18358026","10024681"],"winner_id":"18358026","reasoning":"Reason: Document A discusses cancer-related epigenetic mechanisms that could pertain to gene expression in cancers generally, whereas Document B is specific to prostate cancer and unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:03.080953Z"}
{"comparison_id":"21fab9ef-498d-44e3-b5f3-bd9044ac1278","query_id":"53","doc_a_id":"26561572","doc_b_id":"18358026","presented_order":["26561572","18358026"],"winner_id":"18358026","reasoning":"Document B is slightly more relevant: it discusses cancer-related molecular mechanisms (epigenetic changes) that could relate to prognostic markers, whereas A focuses on kinase fusions in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:03.080977Z"}
{"comparison_id":"90794533-591c-4bf8-8f7b-b93877251306","query_id":"53","doc_a_id":"33677323","doc_b_id":"18358026","presented_order":["18358026","33677323"],"winner_id":"18358026","reasoning":"Document A is more relevant — it discusses cancer-related epigenetic mechanisms that could relate to prognostic markers, whereas Document B focuses on miR-22 in hematologic malignancies, not breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:03.080991Z"}
{"comparison_id":"c4ad024a-9ade-49d0-87a5-6ae6a5397170","query_id":"53","doc_a_id":"7165938","doc_b_id":"18358026","presented_order":["7165938","18358026"],"winner_id":"7165938","reasoning":"Document A is more relevant — it discusses prognostic biomarkers and patient survival in cancer (though colorectal), whereas B focuses on oxidative‑damage–driven DNA methylation mechanisms without prognostic or ALDH1/breast cancer content.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:03.080998Z"}
{"comparison_id":"be0558d0-9d99-4fa6-a483-dfb1ed616f1d","query_id":"53","doc_a_id":"10024681","doc_b_id":"26561572","presented_order":["10024681","26561572"],"winner_id":"10024681","reasoning":"Document A is slightly more relevant because it discusses biomarker expression linked to prognosis (though in prostate cancer), while Document B focuses on kinase fusions in lung cancer and does not address ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:06.801167Z"}
{"comparison_id":"4a4c20cf-9eff-4708-812e-aab760704371","query_id":"53","doc_a_id":"33677323","doc_b_id":"26561572","presented_order":["26561572","33677323"],"winner_id":"33677323","reasoning":"Document B is more relevant — it relates marker expression levels to clinical outcomes (poor prognosis), whereas A is about kinase fusions in lung cancer and not prognostic marker expression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:06.801190Z"}
{"comparison_id":"c2ef22cb-949a-4143-b614-c755266f8f44","query_id":"53","doc_a_id":"10024681","doc_b_id":"33677323","presented_order":["33677323","10024681"],"winner_id":"10024681","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; Document B is slightly closer because it addresses a biomarker linked to poorer prognosis in a solid tumor.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:10.116122Z"}
{"comparison_id":"e85da79a-c605-408a-8d65-644bcf211a3b","query_id":"53","doc_a_id":"654735","doc_b_id":"22007333","presented_order":["654735","22007333"],"winner_id":"22007333","reasoning":"Document B is more relevant — it addresses breast cancer–related factors (mammographic density and risk), whereas Document A concerns glioma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.348927Z"}
{"comparison_id":"af4aa1c8-1b16-4e99-9848-6446d8d970e5","query_id":"53","doc_a_id":"38808600","doc_b_id":"22007333","presented_order":["22007333","38808600"],"winner_id":"22007333","reasoning":"Document A is more relevant — it concerns breast cancer-related factors (mammographic density and risk), while Document B is about glioma imaging and unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.348947Z"}
{"comparison_id":"f9127408-c6f5-4dfe-8289-2059456313a9","query_id":"53","doc_a_id":"6517763","doc_b_id":"22007333","presented_order":["22007333","6517763"],"winner_id":"22007333","reasoning":"Reason: Document A concerns breast cancer–related factors (mammographic density and risk), while Document B focuses on glioblastoma and is unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.348955Z"}
{"comparison_id":"c623dfe8-2860-4dbd-9765-44eb810c80bf","query_id":"53","doc_a_id":"3730196","doc_b_id":"22007333","presented_order":["3730196","22007333"],"winner_id":"3730196","reasoning":"Document A — it discusses biomarker expression linked to prognosis (though in lung cancer), which is more related to the claim about a biomarker's prognostic association than Document B's focus on reproductive factors and mammographic density. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.348963Z"}
{"comparison_id":"d8fe23fe-a1b1-495a-b48c-4425b00d4dfd","query_id":"53","doc_a_id":"16701509","doc_b_id":"22007333","presented_order":["16701509","22007333"],"winner_id":"16701509","reasoning":"Neither document mentions ALDH1 or prognosis. Document A is marginally more relevant because it addresses breast cancer risk/outcomes (clinical association), while B focuses on mammographic density and reproductive factors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.348972Z"}
{"comparison_id":"5dbd3229-8eeb-43a4-8c9c-fd6857da2ee7","query_id":"53","doc_a_id":"37480103","doc_b_id":"22007333","presented_order":["22007333","37480103"],"winner_id":"37480103","reasoning":"Document B is more directly about breast cancer risk and characteristics related to cancer outcomes; Document A focuses on mammographic density and reproductive factors. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.348979Z"}
{"comparison_id":"6ec27898-e5b5-4da5-86eb-ccbd4cde0f44","query_id":"53","doc_a_id":"23304931","doc_b_id":"22007333","presented_order":["22007333","23304931"],"winner_id":"22007333","reasoning":"Document A is more relevant — it concerns breast cancer risk factors (breast tissue/mammographic findings), while Document B addresses lymphoma in HIV patients and not breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.348986Z"}
{"comparison_id":"ec7caf79-0b6a-4a4a-8e6a-5e7684e1408d","query_id":"53","doc_a_id":"21181273","doc_b_id":"22007333","presented_order":["21181273","22007333"],"winner_id":"22007333","reasoning":"Document B — it concerns breast cancer-related factors (mammographic density and risk), whereas Document A is about colorectal cancer and unrelated to ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.348994Z"}
{"comparison_id":"64ef1c9d-d076-4030-bdf7-4b23863db24c","query_id":"53","doc_a_id":"36950726","doc_b_id":"22007333","presented_order":["36950726","22007333"],"winner_id":"22007333","reasoning":"Document B — it relates to breast cancer risk factors (mammographic density), whereas A is about melanoma and unrelated to breast cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349001Z"}
{"comparison_id":"e05f694b-60f6-4eba-87e3-e50f12037b17","query_id":"53","doc_a_id":"17450673","doc_b_id":"22007333","presented_order":["22007333","17450673"],"winner_id":"22007333","reasoning":"Neither abstract mentions ALDH1 or prognosis; both are unrelated. Document A is marginally more relevant because it discusses breast imaging and factors linked to breast cancer characteristics, whereas B focuses on perinatal risk. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349008Z"}
{"comparison_id":"4e15c9fe-4052-4362-a7c0-706318a589ee","query_id":"53","doc_a_id":"5774746","doc_b_id":"22007333","presented_order":["22007333","5774746"],"winner_id":"5774746","reasoning":"Document B is more relevant — it discusses tumor protein expression linked to metastasis and reduced survival (prognosis), whereas Document A only concerns mammographic density and reproductive factors. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349015Z"}
{"comparison_id":"07e91bd6-1883-4798-934e-d9e0bdf2b895","query_id":"53","doc_a_id":"13831842","doc_b_id":"22007333","presented_order":["22007333","13831842"],"winner_id":"22007333","reasoning":"Neither document discusses ALDH1 or prognosis. Document A is slightly more relevant because it addresses breast tissue characteristics and factors potentially linked to tumor biology, whereas B focuses on height/weight and population risk.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349024Z"}
{"comparison_id":"0b6b71e6-33ca-4005-a2d4-6119aab9be36","query_id":"53","doc_a_id":"13831558","doc_b_id":"22007333","presented_order":["13831558","22007333"],"winner_id":"13831558","reasoning":"Neither document mentions ALDH1. Both are irrelevant, but Document A is marginally more relevant because it addresses breast cancer risk/detection (closer to clinical outcomes) versus Document B's focus on reproductive factors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349031Z"}
{"comparison_id":"7efcc912-ba79-4671-a594-298efde9b43a","query_id":"53","doc_a_id":"11271123","doc_b_id":"22007333","presented_order":["11271123","22007333"],"winner_id":"22007333","reasoning":"Document B is more relevant — it concerns breast-related factors (mammographic density and breast cancer risk), whereas Document A deals with endometrial cancer and is unrelated to ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349038Z"}
{"comparison_id":"e2144a19-0154-42df-88d1-e9637578719f","query_id":"53","doc_a_id":"7736860","doc_b_id":"22007333","presented_order":["7736860","22007333"],"winner_id":"22007333","reasoning":"Document B is more related to breast cancer (mammographic density and risk factors); Document A concerns STIM1 in cervical cancer and is not relevant to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349046Z"}
{"comparison_id":"6c081041-7025-49de-9d3a-650d3e80ec3f","query_id":"53","doc_a_id":"16098747","doc_b_id":"22007333","presented_order":["16098747","22007333"],"winner_id":"16098747","reasoning":"Neither document addresses ALDH1 expression or prognosis. If forced to choose, ANSWER: A — it discusses breast cancer risk factors (marginally more related).","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349053Z"}
{"comparison_id":"a3c075ab-7f93-45cb-bb74-af5f6c7f14ed","query_id":"53","doc_a_id":"5222182","doc_b_id":"22007333","presented_order":["5222182","22007333"],"winner_id":"22007333","reasoning":"Document B is slightly more relevant because it links mammographic density to breast cancer risk factors, whereas Document A focuses more narrowly on predictors like weight without discussing cancer outcomes.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349060Z"}
{"comparison_id":"f33cc29f-26f5-4982-a903-d1e23df172fe","query_id":"53","doc_a_id":"13791206","doc_b_id":"22007333","presented_order":["13791206","22007333"],"winner_id":"22007333","reasoning":"Document B is more relevant — it relates to breast cancer risk factors and breast tissue characteristics, whereas Document A focuses on DNA repair in BRCA1-deficient cells and not on ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349067Z"}
{"comparison_id":"4b222376-b023-4f1e-b418-fa0d3175ce2b","query_id":"53","doc_a_id":"27306942","doc_b_id":"22007333","presented_order":["22007333","27306942"],"winner_id":"22007333","reasoning":"Document A — it relates to breast cancer risk factors and mammographic density, whereas Document B is about pediatric leukemia and unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349074Z"}
{"comparison_id":"7477aec1-8a7c-4808-899a-a46f210985d5","query_id":"53","doc_a_id":"23557241","doc_b_id":"22007333","presented_order":["22007333","23557241"],"winner_id":"22007333","reasoning":"Neither document mentions ALDH1 or prognosis. Document A is marginally more relevant because it addresses breast-cancer–related factors (mammographic density), whereas B focuses on in‑utero risk factors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349081Z"}
{"comparison_id":"86a2d017-3ba6-4c36-a2fd-66e02b54dd07","query_id":"53","doc_a_id":"3210545","doc_b_id":"22007333","presented_order":["22007333","3210545"],"winner_id":"22007333","reasoning":"Document A is more relevant — it concerns breast-related risk factors and mammographic density, whereas Document B covers KRAS in endometrial cancer, not breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349088Z"}
{"comparison_id":"fd818243-ea2c-4372-ae23-95b5c5d39a9d","query_id":"53","doc_a_id":"25748308","doc_b_id":"22007333","presented_order":["22007333","25748308"],"winner_id":"22007333","reasoning":"Document A is more relevant — it concerns breast cancer-related factors (mammographic density and risk), whereas Document B discusses GAPDH and general disease roles not specific to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349095Z"}
{"comparison_id":"42625f35-ca33-4cd2-8598-58fe96bb6a4e","query_id":"53","doc_a_id":"23284774","doc_b_id":"22007333","presented_order":["23284774","22007333"],"winner_id":"22007333","reasoning":"Document B is more relevant — it deals with breast cancer–related biological risk factors, whereas Document A focuses on psychosocial needs and is unrelated to molecular markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349103Z"}
{"comparison_id":"99fbd999-6575-4c3e-a27a-c33c7dd3e54b","query_id":"53","doc_a_id":"14664424","doc_b_id":"22007333","presented_order":["22007333","14664424"],"winner_id":"22007333","reasoning":"Document A is more relevant — it concerns breast cancer risk factors and mammographic density, whereas Document B focuses on biomarkers for cervical cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349110Z"}
{"comparison_id":"4fffb5ec-2b1a-4dbd-a741-32b616ad0ffc","query_id":"53","doc_a_id":"17462437","doc_b_id":"22007333","presented_order":["17462437","22007333"],"winner_id":"22007333","reasoning":"Document B is more relevant — it concerns breast cancer–related risk factors, while A deals with KRAS in lung cancer and is unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349118Z"}
{"comparison_id":"84fec309-756f-45d2-ade3-c7b036a53f23","query_id":"53","doc_a_id":"16346504","doc_b_id":"22007333","presented_order":["16346504","22007333"],"winner_id":"22007333","reasoning":"Document B — it relates to breast cancer risk and breast tissue measures, whereas A concerns endometrial cancer mechanisms unrelated to ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349125Z"}
{"comparison_id":"aea29826-8e38-4624-bc73-8dd4d9d85ca8","query_id":"53","doc_a_id":"26848994","doc_b_id":"22007333","presented_order":["22007333","26848994"],"winner_id":"22007333","reasoning":"Document A is more relevant because it concerns breast cancer–related factors, whereas Document B discusses hepatocellular carcinoma (unrelated to ALDH1 in breast cancer).\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349131Z"}
{"comparison_id":"1f883e9b-c2d6-45b2-8014-488965034e4f","query_id":"53","doc_a_id":"32534305","doc_b_id":"22007333","presented_order":["22007333","32534305"],"winner_id":"32534305","reasoning":"Document B is more relevant — it deals with clinical breast cancer outcomes and risk by subtype (closer to prognosis) whereas A focuses on mammographic density and reproductive factors. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349138Z"}
{"comparison_id":"cd224af6-a43d-4cc4-ad60-bc9464d1ef6d","query_id":"53","doc_a_id":"13205096","doc_b_id":"22007333","presented_order":["13205096","22007333"],"winner_id":"22007333","reasoning":"Document B is more relevant — it concerns breast cancer–related factors (mammographic density and risk), whereas A is about gene-expression in acute myeloid leukemia, unrelated to breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349145Z"}
{"comparison_id":"4fe1d5ce-e180-4f2d-a8f3-a55fc90db46b","query_id":"53","doc_a_id":"9171913","doc_b_id":"22007333","presented_order":["22007333","9171913"],"winner_id":"22007333","reasoning":"Document A — it discusses factors linked to breast cancer risk and mechanisms (more related to prognosis markers) while Document B addresses blood lipids and cancer risk and neither mentions ALDH1 or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349153Z"}
{"comparison_id":"f246daeb-1288-454a-b156-f5bdd6f4f115","query_id":"53","doc_a_id":"13400643","doc_b_id":"22007333","presented_order":["13400643","22007333"],"winner_id":"13400643","reasoning":"Document A is more relevant — it addresses molecular cancer biology and therapeutic impact on tumor growth/prognosis, whereas Document B focuses on reproductive factors and mammographic density, not ALDH1 or prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349160Z"}
{"comparison_id":"632eb487-670b-4b17-abc0-4092a856075d","query_id":"53","doc_a_id":"29190724","doc_b_id":"22007333","presented_order":["22007333","29190724"],"winner_id":"22007333","reasoning":"Document A is more relevant because it concerns breast cancer-related factors (mammographic density and risks), whereas Document B discusses gastric cancer methylation and is unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349168Z"}
{"comparison_id":"6ad10d68-8449-40d7-8bdb-7892ce970be8","query_id":"53","doc_a_id":"6948886","doc_b_id":"22007333","presented_order":["22007333","6948886"],"winner_id":"22007333","reasoning":"Document A — it concerns breast cancer risk factors and mammographic density, which is more related to the query about prognosis in breast cancer than a glioblastoma epigenetics study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349175Z"}
{"comparison_id":"b53046ca-8fea-4897-8fc0-7de5af8c70ed","query_id":"53","doc_a_id":"21692235","doc_b_id":"22007333","presented_order":["22007333","21692235"],"winner_id":"22007333","reasoning":"Document A is more relevant — it concerns breast cancer–related factors (mammographic density) while Document B concerns glioblastoma, unrelated to breast cancer markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349182Z"}
{"comparison_id":"c1bc17ba-f20b-4800-afda-b5c808ade82a","query_id":"53","doc_a_id":"29473081","doc_b_id":"22007333","presented_order":["22007333","29473081"],"winner_id":"22007333","reasoning":"Document A is more relevant — it concerns breast cancer-related factors (mammographic density and reproductive history), whereas Document B is about multiple myeloma and unrelated to breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349189Z"}
{"comparison_id":"7619c672-9a49-4628-9a61-103268f4b9d9","query_id":"53","doc_a_id":"33387953","doc_b_id":"22007333","presented_order":["22007333","33387953"],"winner_id":"33387953","reasoning":"Document B is more relevant — it addresses molecular alterations in cancers and their impact on transformation and therapy resistance, which is closer to prognostic markers than A's focus on reproductive factors and mammographic density.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349196Z"}
{"comparison_id":"56664183-09a4-4556-8eb3-9c2c63753c85","query_id":"53","doc_a_id":"7975937","doc_b_id":"22007333","presented_order":["7975937","22007333"],"winner_id":"22007333","reasoning":"Document B is more relevant — it concerns breast cancer risk factors (mammographic density), whereas Document A focuses on COX-driven immune evasion in melanoma/other cancers and not breast cancer prognosis or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349203Z"}
{"comparison_id":"e2f7f283-a177-475e-a335-e649ad5248cc","query_id":"53","doc_a_id":"19644821","doc_b_id":"22007333","presented_order":["19644821","22007333"],"winner_id":"22007333","reasoning":"Document B is more relevant because it concerns breast cancer–related factors (mammographic density and reproductive history), whereas Document A is about Lin28b in liver cancer and unrelated to breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349210Z"}
{"comparison_id":"fce77399-d789-4d07-a55c-9f237b707613","query_id":"53","doc_a_id":"31624828","doc_b_id":"22007333","presented_order":["31624828","22007333"],"winner_id":"22007333","reasoning":"Document B is more relevant — it concerns breast cancer risk factors and mammographic density, whereas A discusses p53 and apoptotic cell clearance unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349217Z"}
{"comparison_id":"b965048b-cc02-4223-bf36-f5cf65c9a958","query_id":"53","doc_a_id":"8994465","doc_b_id":"22007333","presented_order":["8994465","22007333"],"winner_id":"22007333","reasoning":"Reason: Document B relates to breast cancer risk factors and mammographic density, so it's more relevant to breast cancer prognosis than Document A, which focuses on melanoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349223Z"}
{"comparison_id":"ffc2754f-503f-4723-9a8e-9ea138fa2c91","query_id":"53","doc_a_id":"27822315","doc_b_id":"22007333","presented_order":["22007333","27822315"],"winner_id":"22007333","reasoning":"Document A is more relevant — it addresses breast-related factors (mammographic density and reproductive history) linked to breast cancer risk, whereas B discusses steroidogenic regulation unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349230Z"}
{"comparison_id":"b5cd816c-23b1-4264-8530-f716ae6f7386","query_id":"53","doc_a_id":"9641846","doc_b_id":"22007333","presented_order":["9641846","22007333"],"winner_id":"9641846","reasoning":"Reason: Neither document mentions ALDH1, but Document A addresses cancer cell cycle/differentiation pathways (more related to molecular markers and prognosis) while Document B focuses on reproductive factors and mammographic density.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:29.349237Z"}
{"comparison_id":"a3b709e0-d3de-41b6-a53d-6153ef790027","query_id":"53","doc_a_id":"3730196","doc_b_id":"13831558","presented_order":["13831558","3730196"],"winner_id":"13831558","reasoning":"Document A is more relevant — it discusses breast cancer (risk/prognosis context), while Document B concerns small cell lung cancer and does not address ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:36.647413Z"}
{"comparison_id":"f22d79dc-1c9b-4208-b772-cf3ffb20aa06","query_id":"53","doc_a_id":"16701509","doc_b_id":"13831558","presented_order":["16701509","13831558"],"winner_id":"16701509","reasoning":"Document A — it examines a biomarker and breast cancer outcomes (risk), whereas B addresses mammographic density/detection; neither mentions ALDH1 or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:36.647434Z"}
{"comparison_id":"68617652-033e-4415-bc9e-e1ae75402e94","query_id":"53","doc_a_id":"37480103","doc_b_id":"13831558","presented_order":["37480103","13831558"],"winner_id":"13831558","reasoning":"Document B is slightly more related because it addresses breast cancer risk and detection, whereas Document A focuses on pregnancy/placental factors unrelated to tumor markers or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:36.647443Z"}
{"comparison_id":"edc39868-77d3-42f5-bf58-dceb1ed858c3","query_id":"53","doc_a_id":"5774746","doc_b_id":"13831558","presented_order":["13831558","5774746"],"winner_id":"13831558","reasoning":"Document A is more relevant — it discusses breast cancer risk and detection, whereas Document B focuses on inflammation/metastasis in colorectal carcinoma and does not pertain to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:36.647451Z"}
{"comparison_id":"ac5300ca-09fc-49fe-bf58-783ec10fe371","query_id":"53","doc_a_id":"9641846","doc_b_id":"13831558","presented_order":["13831558","9641846"],"winner_id":"13831558","reasoning":"Document A is more relevant — it concerns breast cancer risk and detection, whereas Document B discusses Rb-family cell-cycle biology not specific to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:36.647458Z"}
{"comparison_id":"3e75f270-ceaf-45d0-ba25-9bf3892b74f7","query_id":"53","doc_a_id":"16098747","doc_b_id":"13831558","presented_order":["13831558","16098747"],"winner_id":"13831558","reasoning":"Document A is slightly more relevant — it addresses breast cancer risk and detection/outcomes, whereas B focuses narrowly on density risk factors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:36.647466Z"}
{"comparison_id":"910c16c1-2e9c-4c3b-b3a9-3a9da07a6f8b","query_id":"53","doc_a_id":"32534305","doc_b_id":"13831558","presented_order":["32534305","13831558"],"winner_id":"32534305","reasoning":"Neither document mentions ALDH1 or prognosis. Document A is slightly more relevant because it addresses breast cancer incidence and subtypes, whereas B focuses on mammographic density and detection.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:36.647473Z"}
{"comparison_id":"d14c13db-8ab2-4a8a-b127-876622fa644c","query_id":"53","doc_a_id":"13400643","doc_b_id":"13831558","presented_order":["13831558","13400643"],"winner_id":"13400643","reasoning":"Neither document mentions ALDH1 or directly addresses prognosis in breast cancer. Document B is slightly more relevant because it discusses molecular cancer behavior and effects on tumor burden/survival, while A only covers mammographic density and detection.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:36.647482Z"}
{"comparison_id":"4baabda0-1868-4fa3-853c-66ef5d41d903","query_id":"53","doc_a_id":"33387953","doc_b_id":"13831558","presented_order":["13831558","33387953"],"winner_id":"13831558","reasoning":"Document A is more relevant — it discusses breast cancer risk/detection (closer to prognosis context) while Document B focuses on G protein mutations across cancers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:36.647489Z"}
{"comparison_id":"b7c50697-9044-4e0c-9dc6-83ae4add5779","query_id":"53","doc_a_id":"16701509","doc_b_id":"32534305","presented_order":["16701509","32534305"],"winner_id":"32534305","reasoning":"Document B is marginally more relevant — neither mentions ALDH1 or prognosis, but B addresses breast cancer incidence and subtypes (closer to clinical outcomes). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:42.951272Z"}
{"comparison_id":"da784de7-1c03-48d8-9746-279c1439fdae","query_id":"53","doc_a_id":"13400643","doc_b_id":"32534305","presented_order":["13400643","32534305"],"winner_id":"13400643","reasoning":"Document A is more related to molecular markers and cancer prognosis/therapy, while Document B is about diabetes and breast cancer incidence (unrelated to ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:42.951293Z"}
{"comparison_id":"e9643a15-b0ac-4fc7-8e17-947289b6a39c","query_id":"53","doc_a_id":"3730196","doc_b_id":"5774746","presented_order":["3730196","5774746"],"winner_id":"5774746","reasoning":"Document B — it discusses tumor markers and survival correlations (metastasis and reduced survival), which is conceptually closer to prognosis, whereas A is specific to SCLC and chemoresistance and does not address prognosis in breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:47.187806Z"}
{"comparison_id":"a49f7531-df7f-4ce8-959e-a3cc91a8cf77","query_id":"53","doc_a_id":"37480103","doc_b_id":"5774746","presented_order":["37480103","5774746"],"winner_id":"5774746","reasoning":"Document B is slightly more relevant because it discusses tumor progression and associations with reduced survival (prognosis), whereas Document A concerns pregnancy-related breast cancer risk, not prognostic markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:47.187829Z"}
{"comparison_id":"3d50085d-2f0e-4f39-bd66-7f1f7d0deeeb","query_id":"53","doc_a_id":"33387953","doc_b_id":"5774746","presented_order":["5774746","33387953"],"winner_id":"5774746","reasoning":"Document A is more relevant — it discusses a protein whose expression correlates with reduced survival and metastasis (though in colorectal cancer), which is closer to a prognosis-related claim than Document B's focus on G protein mutations and drug resistance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:47.187838Z"}
{"comparison_id":"6133309b-6ba5-48ab-8505-e259e481145d","query_id":"53","doc_a_id":"9641846","doc_b_id":"5774746","presented_order":["5774746","9641846"],"winner_id":"5774746","reasoning":"Document A is more relevant — it discusses protein expression correlated with reduced patient survival (prognosis), while Document B concerns Rb-family biology and differentiation not prognosis or ALDH1/breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:47.187846Z"}
{"comparison_id":"b2144e91-b552-4658-94e2-c199618f75b2","query_id":"53","doc_a_id":"16098747","doc_b_id":"5774746","presented_order":["16098747","5774746"],"winner_id":"16098747","reasoning":"Document A is about breast cancer (though not ALDH1), while B discusses inflammation/metastasis in other cancers; A is therefore more topically related. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:47.187852Z"}
{"comparison_id":"34bf1001-f39a-4e39-ab87-10141becca03","query_id":"53","doc_a_id":"3730196","doc_b_id":"37480103","presented_order":["37480103","3730196"],"winner_id":"37480103","reasoning":"Document A is more relevant because it addresses breast cancer (risk/prognosis context), while Document B concerns small cell lung cancer and unrelated molecular markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:51.924976Z"}
{"comparison_id":"940270c9-8ba4-45e5-8a97-03cc837ce2d6","query_id":"53","doc_a_id":"9641846","doc_b_id":"37480103","presented_order":["9641846","37480103"],"winner_id":"37480103","reasoning":"Document B is more relevant — it deals directly with breast cancer (albeit risk, not ALDH1 or prognosis); Document A is unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:51.925055Z"}
{"comparison_id":"b0b6ae2e-17b9-40cb-bc4a-3ee708d5638c","query_id":"53","doc_a_id":"33387953","doc_b_id":"37480103","presented_order":["37480103","33387953"],"winner_id":"37480103","reasoning":"Document A — it directly concerns breast cancer (risk/prognosis context) while Document B discusses unrelated G protein mutations across cancers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:51.925069Z"}
{"comparison_id":"95877a6a-0434-44cb-b705-40391ca30703","query_id":"53","doc_a_id":"3730196","doc_b_id":"9641846","presented_order":["9641846","3730196"],"winner_id":"3730196","reasoning":"Document B is more relevant — it discusses a biomarker and prognosis in cancer (though in SCLC, not breast cancer), whereas A is a basic Rb-family cell-cycle study unrelated to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:55.159171Z"}
{"comparison_id":"01b1582f-a9eb-47b0-971c-534fd16797b2","query_id":"53","doc_a_id":"33387953","doc_b_id":"9641846","presented_order":["33387953","9641846"],"winner_id":"33387953","reasoning":"Document A is more relevant — it discusses cancer-related signaling and therapeutic resistance, whereas Document B focuses on Rb-dependent cell cycle/differentiation in embryos and is less related to breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:55.159192Z"}
{"comparison_id":"c569594c-c640-439b-8b05-bbf9341bc950","query_id":"53","doc_a_id":"3730196","doc_b_id":"33387953","presented_order":["33387953","3730196"],"winner_id":"33387953","reasoning":"Neither document mentions ALDH1 or breast cancer, but Document A discusses oncogenic alterations across multiple cancer types and therapy resistance, making it slightly more relevant than B which is specific to small cell lung cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:57:58.942102Z"}
{"comparison_id":"d300e08c-bee5-4e3f-a914-c8d7d4d05a33","query_id":"53","doc_a_id":"654735","doc_b_id":"25748308","presented_order":["654735","25748308"],"winner_id":"25748308","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B mentions cancer-related functions of a metabolic enzyme (GAPDH), so it's slightly more relevant than A (glioma-specific miR-21).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422342Z"}
{"comparison_id":"04cbac94-f4b5-44b1-b629-b768adceb0b6","query_id":"53","doc_a_id":"38808600","doc_b_id":"25748308","presented_order":["38808600","25748308"],"winner_id":"25748308","reasoning":"Document B. It discusses molecular enzyme involvement in cancers generally (more related to biomarker/prognosis topics) while A is specific to an imaging probe for glioma integrin α5β1 and not relevant to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422365Z"}
{"comparison_id":"e556ec4a-7d8a-4250-9430-edfb03a864c5","query_id":"53","doc_a_id":"6517763","doc_b_id":"25748308","presented_order":["25748308","6517763"],"winner_id":"6517763","reasoning":"Document B is more relevant — it deals with tumor gene expression and associations with patient prognosis, which is closer to the claim about marker expression and breast cancer outcome. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422375Z"}
{"comparison_id":"0be8fac2-e0c8-43b9-a773-c46f375678bd","query_id":"53","doc_a_id":"23304931","doc_b_id":"25748308","presented_order":["23304931","25748308"],"winner_id":"23304931","reasoning":"Document A is slightly more relevant because it discusses immunophenotypic markers and their association with prognosis in a cancer setting, whereas Document B is a general review of GAPDH not related to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422383Z"}
{"comparison_id":"003eb879-57df-4a9d-9d57-68dc5d126718","query_id":"53","doc_a_id":"21181273","doc_b_id":"25748308","presented_order":["21181273","25748308"],"winner_id":"21181273","reasoning":"Document A is slightly more relevant because it discusses altered enzyme expression linked to tumor progression in a specific cancer, whereas B is a general review of GAPDH functions not tied to prognosis in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422391Z"}
{"comparison_id":"c04a402a-32ec-474f-94d7-07646a8c6d46","query_id":"53","doc_a_id":"36950726","doc_b_id":"25748308","presented_order":["36950726","25748308"],"winner_id":"25748308","reasoning":"Document B is more relevant — it discusses protein roles in cancer broadly, whereas A focuses specifically on melanoma epigenetic markers unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422399Z"}
{"comparison_id":"0d2b0cdc-75c4-4a94-b1b5-a7bf16e84945","query_id":"53","doc_a_id":"17450673","doc_b_id":"25748308","presented_order":["25748308","17450673"],"winner_id":"25748308","reasoning":"Document A is more relevant — it discusses a cancer-related protein and molecular roles in cancers, closer to marker expression and prognosis than a paper on perinatal risk factors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422406Z"}
{"comparison_id":"ba08e261-9e81-4058-842a-82593fe46e33","query_id":"53","doc_a_id":"13831842","doc_b_id":"25748308","presented_order":["25748308","13831842"],"winner_id":"13831842","reasoning":"Document B is more relevant — it addresses breast cancer (though not ALDH1 specifically), whereas Document A discusses GAPDH and not breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422414Z"}
{"comparison_id":"22e387c6-5e8a-417a-a0c0-825ee52dc579","query_id":"53","doc_a_id":"11271123","doc_b_id":"25748308","presented_order":["25748308","11271123"],"winner_id":"25748308","reasoning":"Document A is more relevant — it discusses roles of a protein (GAPDH) in cancer contexts, whereas Document B focuses specifically on molecular features of endometrial cancer (not breast cancer or ALDH1). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422421Z"}
{"comparison_id":"f2f5b11a-97aa-4c3d-9f9f-9b58de51ce9d","query_id":"53","doc_a_id":"7736860","doc_b_id":"25748308","presented_order":["7736860","25748308"],"winner_id":"25748308","reasoning":"Document B is slightly more relevant because it discusses protein roles in cancers generally, whereas Document A focuses on STIM1 in cervical cancer only. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422429Z"}
{"comparison_id":"14829e6c-3248-4477-b859-8718328cd2b6","query_id":"53","doc_a_id":"5222182","doc_b_id":"25748308","presented_order":["5222182","25748308"],"winner_id":"5222182","reasoning":"Reason: Neither document mentions ALDH1, but Document A deals directly with breast-cancer–related measures (mammographic density), making it more relevant than Document B's general review of GAPDH.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422436Z"}
{"comparison_id":"61858df3-b95a-4b0a-b617-f6f702a561aa","query_id":"53","doc_a_id":"13791206","doc_b_id":"25748308","presented_order":["13791206","25748308"],"winner_id":"13791206","reasoning":"Document A is more relevant because it addresses BRCA1-deficient cells and DNA-repair mechanisms tied to breast cancer, whereas Document B discusses GAPDH functions broadly and does not pertain to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422443Z"}
{"comparison_id":"afd3de69-3ab0-4a45-87fd-b2122d0ea188","query_id":"53","doc_a_id":"27306942","doc_b_id":"25748308","presented_order":["27306942","25748308"],"winner_id":"25748308","reasoning":"Document B. It discusses enzyme roles and involvement in cancers (albeit GAPDH, not ALDH1), so it's marginally more relevant to a claim about enzyme expression and cancer prognosis than a paper focused on CRLF2 in pediatric ALL.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422451Z"}
{"comparison_id":"65a772a6-c798-41ee-8d48-fe1a4b10c92e","query_id":"53","doc_a_id":"23557241","doc_b_id":"25748308","presented_order":["23557241","25748308"],"winner_id":"23557241","reasoning":"Document A is more relevant because it directly addresses breast cancer (risk/prognosis-related factors), whereas B concerns GAPDH and not ALDH1 or breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422457Z"}
{"comparison_id":"35e35eae-b11f-4b82-a042-85e1efa0d2a5","query_id":"53","doc_a_id":"3210545","doc_b_id":"25748308","presented_order":["25748308","3210545"],"winner_id":"25748308","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A at least discusses a protein's roles in cancers generally, while B focuses on KRAS in endometrial cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422464Z"}
{"comparison_id":"cacc399c-39bd-4a6e-be59-b87c217c35c7","query_id":"53","doc_a_id":"27822315","doc_b_id":"25748308","presented_order":["25748308","27822315"],"winner_id":"25748308","reasoning":"Doc A is slightly more relevant because it discusses roles of a cancer-related protein and mentions cancers, whereas Doc B focuses on steroidogenic differentiation and Leydig cells (unrelated to ALDH1 or breast cancer prognosis).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422472Z"}
{"comparison_id":"b824c6f3-3e68-4357-a9ea-2698cf827146","query_id":"53","doc_a_id":"23284774","doc_b_id":"25748308","presented_order":["23284774","25748308"],"winner_id":"23284774","reasoning":"Document A — it specifically concerns breast cancer (even if psychosocial), whereas Document B discusses GAPDH and not ALDH1 or breast-cancer prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422478Z"}
{"comparison_id":"aba87b6a-550f-4dc6-87a6-1019ff959782","query_id":"53","doc_a_id":"14664424","doc_b_id":"25748308","presented_order":["25748308","14664424"],"winner_id":"25748308","reasoning":"Document A is more broadly about protein expression and roles in cancer (whereas B focuses on cervical cancer markers unrelated to ALDH1 or breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422484Z"}
{"comparison_id":"7e32ec5f-d973-482a-a6b3-590673bf04e0","query_id":"53","doc_a_id":"17462437","doc_b_id":"25748308","presented_order":["17462437","25748308"],"winner_id":"25748308","reasoning":"Doc B is marginally more related because it discusses enzyme functions in cancer contexts; Document A focuses on KRAS in lung cancer and is unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422491Z"}
{"comparison_id":"baf90558-6bf8-4f6b-9224-76acad459250","query_id":"53","doc_a_id":"16346504","doc_b_id":"25748308","presented_order":["16346504","25748308"],"winner_id":"16346504","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly closer only because it addresses gene expression and cancer biology (though in endometrial, not breast) — ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422498Z"}
{"comparison_id":"4e0dc204-b410-4e15-bf08-e9991425f28c","query_id":"53","doc_a_id":"26848994","doc_b_id":"25748308","presented_order":["25748308","26848994"],"winner_id":"26848994","reasoning":"Document B — it links expression of a molecule to poor patient survival (though in HCC rather than breast cancer), whereas A discusses GAPDH functions without linking a marker to prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422505Z"}
{"comparison_id":"10b01432-cfc1-49c4-add6-767d68c01da9","query_id":"53","doc_a_id":"13205096","doc_b_id":"25748308","presented_order":["13205096","25748308"],"winner_id":"13205096","reasoning":"Document A — it discusses gene-expression profiling and prognostic markers (though in AML rather than breast cancer), which is closer to the query's focus on marker expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422513Z"}
{"comparison_id":"e98a6a45-49ed-4dd4-9275-366e7e7660da","query_id":"53","doc_a_id":"9171913","doc_b_id":"25748308","presented_order":["25748308","9171913"],"winner_id":"9171913","reasoning":"Neither abstract mentions ALDH1 or prognosis. Document B is marginally more relevant because it specifically concerns breast cancer (though about risk, not ALDH1 expression or prognosis).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422520Z"}
{"comparison_id":"fbd61012-5e64-4c10-b88e-c0d6cc78b2d4","query_id":"53","doc_a_id":"29190724","doc_b_id":"25748308","presented_order":["25748308","29190724"],"winner_id":"25748308","reasoning":"Document A is more relevant — it discusses a metabolic enzyme's roles in cancer (closer to ALDH1 expression and cancer prognosis) while B focuses on methylation in gastric cancer, a different mechanism and cancer type.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422528Z"}
{"comparison_id":"11381214-cf26-42ea-8e9b-d0f458b526d3","query_id":"53","doc_a_id":"6948886","doc_b_id":"25748308","presented_order":["6948886","25748308"],"winner_id":"25748308","reasoning":"Reason: Neither discusses ALDH1 or breast cancer, but Document B addresses enzyme roles and cancer relevance generally, making it marginally more pertinent than a glioblastoma-specific epigenetics paper.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422535Z"}
{"comparison_id":"5fc8aa4a-4c28-4763-95cb-5300d9f78651","query_id":"53","doc_a_id":"21692235","doc_b_id":"25748308","presented_order":["25748308","21692235"],"winner_id":"25748308","reasoning":"Neither abstract addresses ALDH1 or breast cancer prognosis directly. Document A discusses protein roles in cancer generally, so it is marginally more relevant than a glioblastoma-specific genomic study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422542Z"}
{"comparison_id":"b6528148-3f5e-43ec-9815-88e08748a495","query_id":"53","doc_a_id":"29473081","doc_b_id":"25748308","presented_order":["29473081","25748308"],"winner_id":"25748308","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; Document B discusses protein roles in cancers generally, making it slightly more relevant than a multiple myeloma-specific study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422549Z"}
{"comparison_id":"8fff290d-0383-49ae-a1b7-c77d7d48b3da","query_id":"53","doc_a_id":"7975937","doc_b_id":"25748308","presented_order":["25748308","7975937"],"winner_id":"25748308","reasoning":"Document A is slightly more relevant because it at least discusses cancer-related proteins and disease contexts; Document B focuses on COX/prostaglandin-mediated immune evasion in melanoma and does not address ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422556Z"}
{"comparison_id":"559b5fd4-ceea-4725-b296-ee020109243a","query_id":"53","doc_a_id":"19644821","doc_b_id":"25748308","presented_order":["19644821","25748308"],"winner_id":"25748308","reasoning":"Document B is slightly more relevant because it discusses a protein's role across cancers generally, whereas A focuses on Lin28b in murine liver cancer and not breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422563Z"}
{"comparison_id":"7d1417f1-37ab-45ab-be3d-d6a6990f71ab","query_id":"53","doc_a_id":"31624828","doc_b_id":"25748308","presented_order":["31624828","25748308"],"winner_id":"25748308","reasoning":"Doc B discusses roles of a protein in cancers and disease contexts, making it more related to a cancer prognosis claim than Doc A, which focuses on p53-mediated apoptotic cell clearance. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422569Z"}
{"comparison_id":"869dfc27-ff03-40df-a93b-6028673117b3","query_id":"53","doc_a_id":"8994465","doc_b_id":"25748308","presented_order":["8994465","25748308"],"winner_id":"8994465","reasoning":"Document A. It discusses cancer cell subpopulations and marker-driven tumor maintenance (stem-like cells), which is conceptually closer to ALDH1's role in cancer prognosis than a general review of GAPDH.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:14.422576Z"}
{"comparison_id":"489a7a59-6c1a-4b31-b156-7ccc8204b89a","query_id":"53","doc_a_id":"6517763","doc_b_id":"23557241","presented_order":["6517763","23557241"],"winner_id":"23557241","reasoning":"Document B is more relevant — it concerns breast cancer (though about risk factors, not ALDH1/prognosis). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:20.111599Z"}
{"comparison_id":"494ffaf2-534c-46d7-98a0-ccc195233bcf","query_id":"53","doc_a_id":"23304931","doc_b_id":"23557241","presented_order":["23304931","23557241"],"winner_id":"23557241","reasoning":"Document B is more relevant — it concerns breast cancer (though about risk rather than ALDH1 or prognosis), while A deals with AIDS-related lymphoma, not breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:20.111620Z"}
{"comparison_id":"822e9ce7-d3b6-4c74-a2af-d5f244135afc","query_id":"53","doc_a_id":"21181273","doc_b_id":"23557241","presented_order":["21181273","23557241"],"winner_id":"23557241","reasoning":"Document B — it concerns breast cancer (though about risk factors), whereas A is about colorectal cancer and unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:20.111629Z"}
{"comparison_id":"77b2ba4e-41fc-43ac-8f3a-8ca13cb38af5","query_id":"53","doc_a_id":"13831842","doc_b_id":"23557241","presented_order":["23557241","13831842"],"winner_id":"23557241","reasoning":"Neither document mentions ALDH1 expression or breast cancer prognosis. Document A is slightly more relevant only because it discusses biological/in-utero mechanisms influencing breast cancer risk.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:20.111637Z"}
{"comparison_id":"a70fa0ef-8168-4386-a864-2623b75f0a62","query_id":"53","doc_a_id":"5222182","doc_b_id":"23557241","presented_order":["5222182","23557241"],"winner_id":"5222182","reasoning":"Document A is slightly more relevant because it deals with breast tissue characteristics linked to cancer, whereas Document B focuses on prenatal risk factors; neither discusses ALDH1 or prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:20.111645Z"}
{"comparison_id":"1f66af20-0626-4dd3-9be1-176b647c0846","query_id":"53","doc_a_id":"13791206","doc_b_id":"23557241","presented_order":["23557241","13791206"],"winner_id":"23557241","reasoning":"Document A is more relevant — it discusses breast cancer risk factors, whereas Document B focuses on DNA-repair mechanisms in BRCA1-deficient cells unrelated to ALDH1 expression or clinical prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:20.111653Z"}
{"comparison_id":"4e8919c7-ee75-44db-b7bb-8fa5a10f70a4","query_id":"53","doc_a_id":"8994465","doc_b_id":"23557241","presented_order":["23557241","8994465"],"winner_id":"23557241","reasoning":"Document A — it concerns breast cancer (though not ALDH1 specifically), whereas B is about melanoma and unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:20.111660Z"}
{"comparison_id":"9c912c50-222d-42de-8397-f7e48270911b","query_id":"53","doc_a_id":"23284774","doc_b_id":"23557241","presented_order":["23557241","23284774"],"winner_id":"23557241","reasoning":"Document A is marginally more relevant because it addresses biological risk factors for breast cancer, whereas Document B focuses on psychosocial needs and is unrelated to molecular markers or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:20.111667Z"}
{"comparison_id":"75aa93f1-c2d3-402e-b094-2e08b27587b7","query_id":"53","doc_a_id":"16346504","doc_b_id":"23557241","presented_order":["16346504","23557241"],"winner_id":"23557241","reasoning":"Document B — it relates to breast cancer (though about risk, not ALDH1/prognosis), while A concerns endometrial cancer and is unrelated. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:20.111674Z"}
{"comparison_id":"f979c460-79c4-4879-86dd-867511dffe86","query_id":"53","doc_a_id":"26848994","doc_b_id":"23557241","presented_order":["26848994","23557241"],"winner_id":"23557241","reasoning":"Document B — it concerns breast cancer (though about risk rather than prognosis), whereas A is about hepatocellular carcinoma and is less directly relevant. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:20.111681Z"}
{"comparison_id":"7879f4fa-e4a9-4fdf-bedf-881598f12e58","query_id":"53","doc_a_id":"13205096","doc_b_id":"23557241","presented_order":["23557241","13205096"],"winner_id":"23557241","reasoning":"Document A is more relevant because it concerns breast cancer (though not ALDH1 specifically), while B addresses gene expression in AML, a different disease.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:20.111688Z"}
{"comparison_id":"331f0f42-6983-4db1-a400-f01095acecfb","query_id":"53","doc_a_id":"9171913","doc_b_id":"23557241","presented_order":["23557241","9171913"],"winner_id":"23557241","reasoning":"Document A — it's a broader breast cancer risk review (more likely to address prognostic biomarkers) while Document B focuses narrowly on blood lipids; neither directly addresses ALDH1 or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:20.111695Z"}
{"comparison_id":"e211f016-91c9-48ac-b92e-eab478522672","query_id":"53","doc_a_id":"6517763","doc_b_id":"8994465","presented_order":["8994465","6517763"],"winner_id":"8994465","reasoning":"Document A is more relevant — it discusses a cancer stem-like subpopulation and marker-driven tumor maintenance, which is conceptually closer to ALDH1's role in cancer prognosis than the glioblastoma survival study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:24.323783Z"}
{"comparison_id":"6ef60e03-526c-4eeb-ac04-79f5e8f74a2f","query_id":"53","doc_a_id":"23304931","doc_b_id":"8994465","presented_order":["8994465","23304931"],"winner_id":"8994465","reasoning":"Document A is slightly more relevant because it deals with cancer stem‑cell markers and tumor subpopulations, which is conceptually closer to ALDH1's role than the lymphoma-focused immunophenotype study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:24.323804Z"}
{"comparison_id":"fbf28788-518d-47d4-bb8c-714e4aea9b45","query_id":"53","doc_a_id":"21181273","doc_b_id":"8994465","presented_order":["21181273","8994465"],"winner_id":"8994465","reasoning":"Document B is more relevant — it discusses a cancer cell marker and tumor-maintaining subpopulation (conceptually closer to marker–prognosis associations), whereas A is about a different enzyme in colorectal cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:24.323813Z"}
{"comparison_id":"7cbf9ea0-4c4b-4aa4-8a6e-5a320ffff8e0","query_id":"53","doc_a_id":"13831842","doc_b_id":"8994465","presented_order":["13831842","8994465"],"winner_id":"13831842","reasoning":"Document A — it concerns breast cancer specifically (whereas B is about melanoma) even though neither mentions ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:24.323820Z"}
{"comparison_id":"3c496e8f-31c3-45ed-81ea-a90e08ed1837","query_id":"53","doc_a_id":"13791206","doc_b_id":"8994465","presented_order":["8994465","13791206"],"winner_id":"13791206","reasoning":"Document B is more relevant — it deals with BRCA1-related DNA repair in a breast-cancer–relevant context, whereas A is about melanoma and JARID1B. Neither mentions ALDH1 or prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:24.323828Z"}
{"comparison_id":"7a3d47ae-8809-4ff1-b1f1-7e34cc7733b1","query_id":"53","doc_a_id":"9171913","doc_b_id":"8994465","presented_order":["9171913","8994465"],"winner_id":"9171913","reasoning":"Document A is more relevant — it concerns breast cancer (even though not ALDH1 or prognosis), while Document B is about melanoma and a different marker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:24.323835Z"}
{"comparison_id":"963c6cdb-081d-4667-b184-89bace31ce29","query_id":"53","doc_a_id":"23284774","doc_b_id":"8994465","presented_order":["8994465","23284774"],"winner_id":"23284774","reasoning":"Document B is more relevant — it concerns breast cancer (even though psychosocial), while Document A addresses melanoma and a different marker, so neither directly addresses ALDH1 but B is closer in topic.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:24.323842Z"}
{"comparison_id":"e65d8bef-af5e-4097-8856-9e92d4b54b84","query_id":"53","doc_a_id":"16346504","doc_b_id":"8994465","presented_order":["16346504","8994465"],"winner_id":"8994465","reasoning":"Reason: Document B discusses cancer stem cell–like markers and tumor maintenance, which is conceptually closer to ALDH1's role as a stem-cell marker and prognosis than Document A (endometrial GAS5/PTEN study).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:24.323850Z"}
{"comparison_id":"f661852c-47be-4e52-ae9d-5f6357df296b","query_id":"53","doc_a_id":"26848994","doc_b_id":"8994465","presented_order":["26848994","8994465"],"winner_id":"26848994","reasoning":"Document A is slightly more relevant — it discusses a molecular marker whose up-regulation is linked to poor patient survival (though in HCC, not breast cancer). Document B focuses on melanoma cell cycling and JARID1B, not prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:24.323857Z"}
{"comparison_id":"4185f39c-eda5-408e-ab04-ad7508de7982","query_id":"53","doc_a_id":"13205096","doc_b_id":"8994465","presented_order":["13205096","8994465"],"winner_id":"8994465","reasoning":"Document B — it discusses cancer stem-like cell markers and their link to tumor maintenance/prognosis, which is closer to ALDH1's role than an AML gene-expression study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:24.323864Z"}
{"comparison_id":"a0195e90-f9b2-4f7d-a144-4a11af55c674","query_id":"53","doc_a_id":"13831842","doc_b_id":"9171913","presented_order":["9171913","13831842"],"winner_id":"9171913","reasoning":"Neither document mentions ALDH1 expression or breast cancer prognosis; both are about risk factors. They are equally irrelevant, but if one must be chosen: ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:28.778296Z"}
{"comparison_id":"85191fb2-5a9e-4074-8fcf-b31165ad8ce8","query_id":"53","doc_a_id":"13791206","doc_b_id":"9171913","presented_order":["13791206","9171913"],"winner_id":"13791206","reasoning":"Document A is more relevant — it discusses molecular factors in breast cancer biology (DNA repair/BRCA1), whereas Document B addresses blood lipids and cancer risk, not molecular markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:28.778319Z"}
{"comparison_id":"79ce6773-97c1-4325-8041-a0e66025383b","query_id":"53","doc_a_id":"26848994","doc_b_id":"9171913","presented_order":["9171913","26848994"],"winner_id":"9171913","reasoning":"Document A is more relevant because it concerns breast cancer specifically, whereas Document B focuses on hepatocellular carcinoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:28.778327Z"}
{"comparison_id":"4948a3ae-d30e-4cf4-a4a0-626ec4c6490f","query_id":"53","doc_a_id":"23284774","doc_b_id":"9171913","presented_order":["9171913","23284774"],"winner_id":"9171913","reasoning":"Document A is more relevant — it addresses biological/clinical factors related to breast cancer, whereas Document B focuses on psychosocial needs and not molecular markers or prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:28.778334Z"}
{"comparison_id":"c81a2e96-5dc8-4122-acfc-38a1524766de","query_id":"53","doc_a_id":"13831842","doc_b_id":"26848994","presented_order":["26848994","13831842"],"winner_id":"13831842","reasoning":"Relevant document: B — it concerns breast cancer (though not ALDH1 or prognosis) while A concerns a different cancer (HCC). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:31.901070Z"}
{"comparison_id":"ebc6c58c-8b2d-4530-966b-3f96e754a540","query_id":"53","doc_a_id":"23284774","doc_b_id":"26848994","presented_order":["23284774","26848994"],"winner_id":"23284774","reasoning":"Document A — it concerns breast cancer (though psychosocial aspects), while Document B is about hepatocellular carcinoma and unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:31.901090Z"}
{"comparison_id":"ff441685-59cf-458e-b552-89e074e695f6","query_id":"53","doc_a_id":"13831842","doc_b_id":"23284774","presented_order":["23284774","13831842"],"winner_id":"23284774","reasoning":"Document A — it concerns breast cancer patient outcomes and care (more related to prognosis) while Document B addresses risk factors for developing breast cancer, not prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:35.523396Z"}
{"comparison_id":"d3c85fa8-b550-4588-9ebd-3750c453265a","query_id":"53","doc_a_id":"6517763","doc_b_id":"21181273","presented_order":["6517763","21181273"],"winner_id":"6517763","reasoning":"Document A is more relevant because it examines tumor gene expression patterns and associations with patient survival (prognosis), whereas Document B focuses on a different enzyme in colorectal cancer without linking expression to prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:39.785902Z"}
{"comparison_id":"bccd1164-d75b-4ef9-aaf7-d9ba2fca9de4","query_id":"53","doc_a_id":"23304931","doc_b_id":"21181273","presented_order":["21181273","23304931"],"winner_id":"21181273","reasoning":"Document A is more relevant — it discusses altered expression of an enzyme in cancer and links expression changes to tumor progression, whereas Document B concerns lymphoma markers in AIDS patients, unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:39.785928Z"}
{"comparison_id":"40156639-1593-4eca-88dc-318fb052164a","query_id":"53","doc_a_id":"13205096","doc_b_id":"21181273","presented_order":["13205096","21181273"],"winner_id":"13205096","reasoning":"Document A — it discusses gene-expression profiling and prognostic markers in cancer (though in AML, not breast cancer), so it's marginally more relevant than B which addresses a different enzyme in colorectal cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:39.785939Z"}
{"comparison_id":"a4b0de44-1c50-4a24-a532-b7be6798f22f","query_id":"53","doc_a_id":"16346504","doc_b_id":"21181273","presented_order":["21181273","16346504"],"winner_id":"21181273","reasoning":"Neither document addresses ALDH1 or breast cancer, but Document A discusses enzyme expression changes linked to tumor progression (more conceptually related to prognostic expression markers) while B focuses on lncRNA/PTEN in endometrial cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:39.785948Z"}
{"comparison_id":"87999c38-f4d6-433e-80b7-739f45890558","query_id":"53","doc_a_id":"6517763","doc_b_id":"13205096","presented_order":["6517763","13205096"],"winner_id":"13205096","reasoning":"Document B is more relevant — it focuses on gene-expression profiling to identify prognostic markers/subclasses and predictors of overall survival, which is conceptually closer to a claim about a gene's expression (ALDH1) and prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:43.419445Z"}
{"comparison_id":"854bab36-53d8-41ed-9558-ed3077bc54af","query_id":"53","doc_a_id":"23304931","doc_b_id":"16346504","presented_order":["16346504","23304931"],"winner_id":"23304931","reasoning":"Document B is more relevant — it examines associations between marker expression and patient outcomes (prognosis), which is closer to the claim about ALDH1 expression and prognosis, even though it studies a different cancer type.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:48.138677Z"}
{"comparison_id":"92c8e280-f7fd-4717-812e-6cec334a0c3a","query_id":"53","doc_a_id":"654735","doc_b_id":"27822315","presented_order":["27822315","654735"],"winner_id":"27822315","reasoning":"Document A is slightly more relevant because it discusses stem-cell-related gene regulation and enzyme expression, which is more related to ALDH1 (a stem cell marker) than Document B's glioma/miR-21 focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:58.198006Z"}
{"comparison_id":"2791949c-bd05-46a8-8f1a-23a85dc8e3f9","query_id":"53","doc_a_id":"38808600","doc_b_id":"27822315","presented_order":["38808600","27822315"],"winner_id":"38808600","reasoning":"Document A is slightly more relevant because it discusses cancer marker expression and prognosis (though in glioma, not breast cancer or ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:58.198026Z"}
{"comparison_id":"45a5e641-7a29-4879-ab67-1cffe539931e","query_id":"53","doc_a_id":"36950726","doc_b_id":"27822315","presented_order":["27822315","36950726"],"winner_id":"27822315","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A mentions mesenchymal stem cells and differentiation (stem-cell–related), so it's marginally more related to ALDH1's stem-cell context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:58.198036Z"}
{"comparison_id":"ec72d352-c390-43ac-ab13-ba8fdbf856aa","query_id":"53","doc_a_id":"17450673","doc_b_id":"27822315","presented_order":["17450673","27822315"],"winner_id":"17450673","reasoning":"Document A is about breast cancer (risk factors) while Document B concerns LRH-1 and steroidogenesis unrelated to breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:58.198043Z"}
{"comparison_id":"7ae015dc-29a1-4d4a-aec2-6d6255cb25df","query_id":"53","doc_a_id":"11271123","doc_b_id":"27822315","presented_order":["27822315","11271123"],"winner_id":"11271123","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer prognosis; Document B is about cancer molecular markers (endometrial), so marginally closer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:58.198050Z"}
{"comparison_id":"80584463-30dc-41ad-972a-a61e5deadaa4","query_id":"53","doc_a_id":"7736860","doc_b_id":"27822315","presented_order":["7736860","27822315"],"winner_id":"7736860","reasoning":"Document A — it discusses cancer progression and survival associations (though in cervical cancer), which is more related to prognosis in cancer than Document B's focus on steroidogenic differentiation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:58.198057Z"}
{"comparison_id":"bcbc64ca-d458-4f46-9c33-1e0fa0fecbf3","query_id":"53","doc_a_id":"27306942","doc_b_id":"27822315","presented_order":["27306942","27822315"],"winner_id":"27306942","reasoning":"Document A — it links gene expression changes to poor clinical outcome (though in leukemia), which is conceptually closer to a statement about marker expression and prognosis than Document B's focus on steroidogenic differentiation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:58.198065Z"}
{"comparison_id":"0b4150e8-b1fe-4e24-8e02-05eae159b209","query_id":"53","doc_a_id":"3210545","doc_b_id":"27822315","presented_order":["3210545","27822315"],"winner_id":"3210545","reasoning":"Neither abstract addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses gene expression associated with prognosis in a cancer context, whereas B focuses on steroidogenic differentiation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:58.198072Z"}
{"comparison_id":"2979ae96-f25e-4cbf-b227-a47b5835086b","query_id":"53","doc_a_id":"31624828","doc_b_id":"27822315","presented_order":["31624828","27822315"],"winner_id":"31624828","reasoning":"Document A is slightly more relevant because it concerns a tumor suppressor (p53) and cancer-related processes, whereas Document B focuses on steroidogenic differentiation unrelated to breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:58.198080Z"}
{"comparison_id":"a41d3e82-08d2-42b3-8dd6-17bba8b190dd","query_id":"53","doc_a_id":"14664424","doc_b_id":"27822315","presented_order":["14664424","27822315"],"winner_id":"14664424","reasoning":"Document A — it deals with prognostic tumor markers in cancer (though cervical, not breast) and prognosis associations, which is closer to the query than Document B's steroidogenesis focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:58.198086Z"}
{"comparison_id":"c5ba2aa7-8c66-47d6-9faa-8cc4998799df","query_id":"53","doc_a_id":"17462437","doc_b_id":"27822315","presented_order":["17462437","27822315"],"winner_id":"17462437","reasoning":"Document A is slightly more relevant because it discusses prognostic markers in cancer, whereas Document B focuses on steroidogenic differentiation unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:58.198093Z"}
{"comparison_id":"7ab01dbf-95de-4424-888d-3fdfc69114b7","query_id":"53","doc_a_id":"29190724","doc_b_id":"27822315","presented_order":["27822315","29190724"],"winner_id":"27822315","reasoning":"Document A is slightly more relevant because it discusses stem-cell–related differentiation (ALDH1 is a stem cell marker), whereas Document B focuses on DNA methylation in gastric cancer and not breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:58.198100Z"}
{"comparison_id":"177db3d1-b050-4561-afb3-55fa62dbfd04","query_id":"53","doc_a_id":"6948886","doc_b_id":"27822315","presented_order":["27822315","6948886"],"winner_id":"27822315","reasoning":"Document A is slightly more relevant because it discusses stem cell differentiation and steroidogenic enzyme regulation, which is closer to cancer stem cell markers like ALDH1 than a glioblastoma-specific epigenetics study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:58.198108Z"}
{"comparison_id":"9546cd8d-dd0b-49eb-828f-0d87230f06e7","query_id":"53","doc_a_id":"21692235","doc_b_id":"27822315","presented_order":["27822315","21692235"],"winner_id":"27822315","reasoning":"Document A is slightly more relevant because it discusses stem cell differentiation and steroidogenic enzyme regulation (ALDH1 is a stem/progenitor cell marker), whereas Document B is about glioblastoma subtypes and unrelated to breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:58.198115Z"}
{"comparison_id":"57494a59-7285-447f-b585-bbe664520a56","query_id":"53","doc_a_id":"29473081","doc_b_id":"27822315","presented_order":["29473081","27822315"],"winner_id":"29473081","reasoning":"Document A is more relevant — it links gene expression to poor survival in a cancer, which is closer to the claim about ALDH1 and breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:58.198122Z"}
{"comparison_id":"59dae6af-862e-4f36-834e-2521fba7c3e3","query_id":"53","doc_a_id":"7975937","doc_b_id":"27822315","presented_order":["7975937","27822315"],"winner_id":"7975937","reasoning":"Document A is more relevant—it's about cancer biology and tumor behavior (potentially across cancer types), whereas Document B focuses on steroidogenic differentiation unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:58.198129Z"}
{"comparison_id":"fe2b1cfc-e1f0-44af-89cc-c59226982fc0","query_id":"53","doc_a_id":"19644821","doc_b_id":"27822315","presented_order":["19644821","27822315"],"winner_id":"19644821","reasoning":"Document A is more cancer-relevant (discusses tumor maintenance and survival effects), while B concerns steroidogenic differentiation unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:58:58.198135Z"}
{"comparison_id":"7825a6ee-2d85-4a35-ad40-796a6d5b1a64","query_id":"53","doc_a_id":"38808600","doc_b_id":"3210545","presented_order":["3210545","38808600"],"winner_id":"3210545","reasoning":"Document A is more relevant — it discusses a molecular marker associated with prognosis in cancer (though endometrial, not breast), whereas B concerns an imaging probe for glioma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:03.872583Z"}
{"comparison_id":"c00f58ef-ffb4-43bb-85b7-2091d2b6bcd0","query_id":"53","doc_a_id":"17450673","doc_b_id":"3210545","presented_order":["3210545","17450673"],"winner_id":"17450673","reasoning":"Document B is more relevant — it concerns breast cancer (though not ALDH1 specifically), whereas Document A discusses KRAS in endometrial cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:03.872606Z"}
{"comparison_id":"2f8e8a14-a816-4bc8-83ea-32a2f4e07efe","query_id":"53","doc_a_id":"11271123","doc_b_id":"3210545","presented_order":["3210545","11271123"],"winner_id":"3210545","reasoning":"Document A — it links gene overexpression with poorer outcomes (expression tied to prognosis), making it more relevant than the purely mutation/alteration survey in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:03.872616Z"}
{"comparison_id":"c1dc1f61-f6cd-4643-9c9c-d81ae0a5213e","query_id":"53","doc_a_id":"7736860","doc_b_id":"3210545","presented_order":["3210545","7736860"],"winner_id":"3210545","reasoning":"Neither document is relevant — neither mentions ALDH1 or breast cancer. Document A is slightly more relevant only in that it examines a marker (KRAS) linked to prognosis in cancer, but it concerns endometrial cancer and not ALDH1/breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:03.872626Z"}
{"comparison_id":"42ef1054-40ec-4ef2-9cfd-c62a06de5d3d","query_id":"53","doc_a_id":"27306942","doc_b_id":"3210545","presented_order":["3210545","27306942"],"winner_id":"3210545","reasoning":"Document A is more relevant — it discusses gene expression linked to aggressive cancer and poor outcomes (though in endometrial, not breast). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:03.872634Z"}
{"comparison_id":"296d0a60-3a2e-42a2-937d-8a7ed206b3af","query_id":"53","doc_a_id":"19644821","doc_b_id":"3210545","presented_order":["3210545","19644821"],"winner_id":"3210545","reasoning":"Document A is more relevant — it discusses gene overexpression linked to poor prognosis in cancer, which is conceptually closer to ALDH1 expression and prognosis than a mouse liver-cancer model of Lin28b. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:03.872643Z"}
{"comparison_id":"055ebb2f-5285-468f-bcb4-83cd2babad62","query_id":"53","doc_a_id":"31624828","doc_b_id":"3210545","presented_order":["31624828","3210545"],"winner_id":"31624828","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it discusses tumor biology (p53) broadly, whereas B focuses on KRAS in endometrial cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:03.872654Z"}
{"comparison_id":"05f17398-8960-42ce-aee9-154b91dee2f0","query_id":"53","doc_a_id":"14664424","doc_b_id":"3210545","presented_order":["3210545","14664424"],"winner_id":"14664424","reasoning":"Document B is more relevant — it assesses prognostic tumor markers in cancer (though in cervical cancer), which is conceptually closer to ALDH1 as a prognostic marker than a KRAS/endometrial cancer study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:03.872663Z"}
{"comparison_id":"38cef7dd-d9f7-4c0c-b184-1c739c57c000","query_id":"53","doc_a_id":"17462437","doc_b_id":"3210545","presented_order":["17462437","3210545"],"winner_id":"3210545","reasoning":"Document B — it links gene overexpression (not just mutation) to poor outcomes, which is conceptually closer to a claim about protein expression affecting prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:03.872671Z"}
{"comparison_id":"86983420-97f7-42e7-b427-741086578be3","query_id":"53","doc_a_id":"29473081","doc_b_id":"3210545","presented_order":["29473081","3210545"],"winner_id":"3210545","reasoning":"Neither document mentions ALDH1 or breast cancer; both are unrelated. Document B is slightly more relevant because it discusses gene overexpression linked to poor prognosis in a solid tumor.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:03.872679Z"}
{"comparison_id":"6769a6a4-cf4b-45b6-a492-5e8cc04fa2f7","query_id":"53","doc_a_id":"7975937","doc_b_id":"3210545","presented_order":["3210545","7975937"],"winner_id":"7975937","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant only because it discusses tumor biology across multiple cancer types, whereas A focuses specifically on KRAS in endometrial cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:03.872687Z"}
{"comparison_id":"172d9875-5bee-4330-8729-088cc5aedc67","query_id":"53","doc_a_id":"17450673","doc_b_id":"31624828","presented_order":["17450673","31624828"],"winner_id":"17450673","reasoning":"Document A is more relevant — it addresses breast cancer (risk factors), while Document B is about p53-mediated apoptotic cell clearance and not specific to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:08.000385Z"}
{"comparison_id":"76f9341f-4850-411d-86d6-3a3af8867849","query_id":"53","doc_a_id":"7975937","doc_b_id":"31624828","presented_order":["31624828","7975937"],"winner_id":"7975937","reasoning":"Neither abstract addresses ALDH1 or breast cancer specifically; both are unrelated. Document B is slightly more relevant because it concerns tumor behavior across cancer types, whereas A focuses narrowly on p53-mediated apoptotic clearance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:08.000406Z"}
{"comparison_id":"98a4dbe4-7aed-4a85-95e7-07873cb7458d","query_id":"53","doc_a_id":"14664424","doc_b_id":"31624828","presented_order":["31624828","14664424"],"winner_id":"14664424","reasoning":"Document B is more relevant — it evaluates prognostic markers in cancer (though in cervical cancer), while Document A focuses on p53 and apoptotic cell clearance and does not address ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:08.000415Z"}
{"comparison_id":"36bf0d35-fe0f-4501-aaa5-5a4da842c010","query_id":"53","doc_a_id":"17450673","doc_b_id":"7975937","presented_order":["17450673","7975937"],"winner_id":"17450673","reasoning":"Document A is more relevant — it addresses breast cancer specifically (even though it doesn't mention ALDH1 or prognosis). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:13.520564Z"}
{"comparison_id":"1e5b603e-0ea8-4c4c-b18a-f80d5a093266","query_id":"53","doc_a_id":"14664424","doc_b_id":"7975937","presented_order":["14664424","7975937"],"winner_id":"14664424","reasoning":"Document A is more relevant — it assesses prognostic tumor markers (aligns with the query about marker expression and prognosis), while B focuses on COX-mediated immune evasion rather than marker expression or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:13.520584Z"}
{"comparison_id":"611b5aab-f184-4cf3-8f66-a30e252fb891","query_id":"53","doc_a_id":"17450673","doc_b_id":"14664424","presented_order":["14664424","17450673"],"winner_id":"17450673","reasoning":"Document B — it addresses breast cancer (though not ALDH1 specifically), while Document A concerns cervical cancer and is unrelated to breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:15.713291Z"}
{"comparison_id":"84c1cfd5-b5da-4452-95ae-21eed495d773","query_id":"53","doc_a_id":"38808600","doc_b_id":"27306942","presented_order":["38808600","27306942"],"winner_id":"38808600","reasoning":"Document A is slightly more relevant because it discusses a cancer biomarker linked to prognosis (though in glioma), whereas Document B concerns genetic rearrangements in leukemia; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:19.184695Z"}
{"comparison_id":"b6a30899-b30f-4ac9-b808-cc3ffa07808a","query_id":"53","doc_a_id":"11271123","doc_b_id":"27306942","presented_order":["27306942","11271123"],"winner_id":"11271123","reasoning":"Neither document mentions ALDH1 or breast cancer. If forced to choose, B is slightly more relevant because it deals with molecular markers in a solid tumor type (endometrial cancer) rather than pediatric leukemia.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:19.184719Z"}
{"comparison_id":"c22cac17-8119-4dd7-ab8b-aba5f6995f4d","query_id":"53","doc_a_id":"7736860","doc_b_id":"27306942","presented_order":["7736860","27306942"],"winner_id":"7736860","reasoning":"Document A is more relevant because it discusses cancer progression and survival outcomes (though in cervical cancer), whereas Document B concerns rearrangements in pediatric leukemia and is unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:19.184730Z"}
{"comparison_id":"452adbdf-a707-4511-ac8d-4fa97c6d2c76","query_id":"53","doc_a_id":"29473081","doc_b_id":"27306942","presented_order":["27306942","29473081"],"winner_id":"29473081","reasoning":"Document B. It links high expression of a specific marker to poor survival (analogous to ALDH1 expression linked to prognosis), whereas A concerns CRLF2 in pediatric B-ALL and is less related to marker expression/prognosis in solid tumors like breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:19.184740Z"}
{"comparison_id":"4f6be8d4-8aee-4082-9a2a-c7a8f46e603c","query_id":"53","doc_a_id":"19644821","doc_b_id":"27306942","presented_order":["27306942","19644821"],"winner_id":"27306942","reasoning":"Document A. It discusses a gene expression change associated with poor outcome (albeit in pediatric B-ALL, not breast cancer), whereas B is about Lin28b in murine liver cancer and is less related to the query. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:19.184749Z"}
{"comparison_id":"e5ce4be6-4392-4d1d-8b8c-aa447db1cc5e","query_id":"53","doc_a_id":"17462437","doc_b_id":"27306942","presented_order":["27306942","17462437"],"winner_id":"27306942","reasoning":"Document A — it reports a gene's elevated expression being linked to poor outcome (similar claim about expression and prognosis), while B concerns KRAS mutations in lung cancer rather than expression in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:19.184761Z"}
{"comparison_id":"4a7115ff-fee7-44d9-988e-609c7b27cae1","query_id":"53","doc_a_id":"38808600","doc_b_id":"11271123","presented_order":["38808600","11271123"],"winner_id":"38808600","reasoning":"Document A is closer: it discusses a protein marker tied to prognosis (albeit integrin α5β1 in glioma), while B covers endometrial genomic alterations and doesn't address ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:23.289920Z"}
{"comparison_id":"08e67967-2e6f-4d3a-87df-1cb27029955e","query_id":"53","doc_a_id":"29473081","doc_b_id":"11271123","presented_order":["29473081","11271123"],"winner_id":"29473081","reasoning":"Document A is more relevant — it links expression of a molecular marker to poor survival (though in multiple myeloma), which is closer in topic (biomarker expression associated with prognosis) than the endometrial molecular profiling in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:23.289943Z"}
{"comparison_id":"f82c459f-a78f-4b5a-9334-bdca644b0c09","query_id":"53","doc_a_id":"7736860","doc_b_id":"11271123","presented_order":["11271123","7736860"],"winner_id":"7736860","reasoning":"Document B is more relevant — it discusses overexpression of a molecule linked to reduced survival/prognosis in cancer, which is conceptually closer to the claim about ALDH1 and breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:23.289952Z"}
{"comparison_id":"fa37f51e-a19b-4fd5-a520-5be876f93b17","query_id":"53","doc_a_id":"38808600","doc_b_id":"29473081","presented_order":["29473081","38808600"],"winner_id":"29473081","reasoning":"Document A is more relevant — it reports a gene whose high expression is linked to poor survival in cancer (though in multiple myeloma, not breast cancer), whereas Document B is about an imaging probe for glioma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:28.480637Z"}
{"comparison_id":"e7f8e528-a75f-4811-84a2-7f3661bee676","query_id":"53","doc_a_id":"7736860","doc_b_id":"29473081","presented_order":["29473081","7736860"],"winner_id":"7736860","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it concerns an epithelial cancer (cervical) and links marker overexpression to poorer prognosis, which is more analogous to the claim.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:28.480658Z"}
{"comparison_id":"299d2f76-8151-4fcd-9d2f-95b9fc03cdd1","query_id":"53","doc_a_id":"19644821","doc_b_id":"17462437","presented_order":["17462437","19644821"],"winner_id":"17462437","reasoning":"Document A — it addresses prognostic value of a molecular marker in cancer (though in NSCLC), whereas B is a mechanistic liver-cancer study unrelated to prognosis markers in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:31.575411Z"}
{"comparison_id":"b9f2de4c-1bcc-4cb5-9b10-215bf48401e2","query_id":"53","doc_a_id":"654735","doc_b_id":"29190724","presented_order":["29190724","654735"],"winner_id":"29190724","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A at least concerns gene alterations in cancer (epigenetics), making it marginally more related than a glioma/miR-21 study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:36.000863Z"}
{"comparison_id":"51d40103-8ac2-412f-a963-996d0c3a7f97","query_id":"53","doc_a_id":"36950726","doc_b_id":"29190724","presented_order":["29190724","36950726"],"winner_id":"29190724","reasoning":"Neither document addresses ALDH1 or breast cancer specifically. Document A is marginally more relevant because it discusses cancer-related epigenetic markers broadly, while B focuses on melanoma-specific changes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:36.000883Z"}
{"comparison_id":"be6c537a-a3ff-400f-bc73-db7f7fef312f","query_id":"53","doc_a_id":"21692235","doc_b_id":"29190724","presented_order":["21692235","29190724"],"winner_id":"21692235","reasoning":"Document A is more relevant because it discusses cancer biomarker-associated subtypes and prognosis (even though in glioblastoma), whereas B focuses on DNA methylation in gastric cancer and is less related to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:36.000892Z"}
{"comparison_id":"e0bd180f-ef34-4815-80df-73bd729a026a","query_id":"53","doc_a_id":"6948886","doc_b_id":"29190724","presented_order":["29190724","6948886"],"winner_id":"29190724","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A (gene methylation in cancer) is marginally closer due to its broader focus on cancer epigenetics, whereas B is specific to glioblastoma and LSD1/MYC. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:36.000899Z"}
{"comparison_id":"9a420d0a-a08b-466a-bcca-5ae98ad9d8b0","query_id":"53","doc_a_id":"654735","doc_b_id":"36950726","presented_order":["36950726","654735"],"winner_id":"654735","reasoning":"Document B is more relevant — it links a molecular expression level (miR-21) to prognosis and recurrence in cancer, which is conceptually similar to associating ALDH1 expression with breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:40.888689Z"}
{"comparison_id":"ba2ffcde-78c4-4f44-9b43-50f108b44fa2","query_id":"53","doc_a_id":"6948886","doc_b_id":"36950726","presented_order":["36950726","6948886"],"winner_id":"36950726","reasoning":"Neither document addresses ALDH1 or breast cancer directly. Document A discusses altered protein expression linked to tumor progression (more analogous to prognosis), while B focuses on glioblastoma epigenetic reprogramming. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:59:40.888710Z"}
{"comparison_id":"730c8e08-0f31-4de0-9fc4-6f7ede7323de","query_id":"53","doc_a_id":"3899896","doc_b_id":"4434951","presented_order":["3899896","4434951"],"winner_id":"3899896","reasoning":"Document A is slightly more relevant because it discusses a prognostic biomarker associated with poor cancer outcomes (though in rectal, not breast, cancer). Document B is unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135609Z"}
{"comparison_id":"76488edf-c1ca-43ce-862f-610e3ec5d262","query_id":"53","doc_a_id":"52925737","doc_b_id":"4434951","presented_order":["4434951","52925737"],"winner_id":"52925737","reasoning":"Document B — it discusses cancer prognosis and tumor biology (though in gastric cancer), whereas A is unrelated to cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135631Z"}
{"comparison_id":"afd1baca-c5ee-4dee-ab88-020f2cbeaa22","query_id":"53","doc_a_id":"15081770","doc_b_id":"4434951","presented_order":["4434951","15081770"],"winner_id":"15081770","reasoning":"Document B — it discusses tumor enzyme expression and prognostic associations, which is conceptually related to ALDH1 and cancer prognosis; Document A concerns mouse epigenetics/aging and is unrelated. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135640Z"}
{"comparison_id":"4be0e9b6-4773-408a-9929-949eecdede30","query_id":"53","doc_a_id":"8512633","doc_b_id":"4434951","presented_order":["8512633","4434951"],"winner_id":"8512633","reasoning":"Document A — it's about cancer prognosis (though in prostate cancer), whereas Document B concerns aging epigenetics in mice and is unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135646Z"}
{"comparison_id":"1795e1c3-6d87-4ec0-a106-edeb27bf1745","query_id":"53","doc_a_id":"601033","doc_b_id":"4434951","presented_order":["4434951","601033"],"winner_id":"4434951","reasoning":"Reason: Document A discusses gene regulatory changes and gene expression-related epigenetic modifications, which is closer to a claim about a gene marker (ALDH1) and prognosis than Document B, which focuses on HTLV and T-cell leukemia unrelated to breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135654Z"}
{"comparison_id":"78902f24-df1c-49f3-a5cf-6859ec72f2ae","query_id":"53","doc_a_id":"4467129","doc_b_id":"4434951","presented_order":["4467129","4434951"],"winner_id":"4467129","reasoning":"Document A is more relevant because it discusses cancer-related molecular markers and links to prognosis (though in neuroblastoma rather than breast cancer). \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135661Z"}
{"comparison_id":"17b53ecb-9b26-48a8-88f6-248efcc917bb","query_id":"53","doc_a_id":"34189936","doc_b_id":"4434951","presented_order":["34189936","4434951"],"winner_id":"34189936","reasoning":"Document A is slightly more relevant because it concerns gene expression in cancer (though in mesothelioma, not breast cancer); Document B is about aging and epigenetics in mice and unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135669Z"}
{"comparison_id":"b141c2a0-2375-4c06-88d8-58e2f640bd39","query_id":"53","doc_a_id":"29124963","doc_b_id":"4434951","presented_order":["4434951","29124963"],"winner_id":"29124963","reasoning":"Document B is more relevant — it concerns prognostic markers in human cancer (though in lung, not breast), whereas A focuses on mouse aging and epigenetics unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135677Z"}
{"comparison_id":"b64c45e6-f6d5-4b82-a60f-c5f50c18d04d","query_id":"53","doc_a_id":"11615422","doc_b_id":"4434951","presented_order":["4434951","11615422"],"winner_id":"11615422","reasoning":"Document B — it's about cancer genetics (though a different gene and cancer type), so it's more relevant to a prognosis-related claim than Document A on mouse aging. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135683Z"}
{"comparison_id":"b800a4b3-7420-4d1f-bfb7-f597336f5bf0","query_id":"53","doc_a_id":"23665162","doc_b_id":"4434951","presented_order":["23665162","4434951"],"winner_id":"23665162","reasoning":"Document A — it's a human cancer study (though on HCC and methylation rather than ALDH1/breast cancer) and thus closer in domain than Document B, which concerns mouse aging and epigenetics. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135690Z"}
{"comparison_id":"0ad11a13-ecfd-4c0d-a950-4b48692fd31a","query_id":"53","doc_a_id":"8677721","doc_b_id":"4434951","presented_order":["4434951","8677721"],"winner_id":"8677721","reasoning":"Document B — it concerns cancer biology (tumor growth mechanisms), which is closer to a claim about cancer prognosis than Document A's mouse aging/epigenetics study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135697Z"}
{"comparison_id":"94738874-e670-4886-bdb9-943baf6416ba","query_id":"53","doc_a_id":"23830488","doc_b_id":"4434951","presented_order":["4434951","23830488"],"winner_id":"23830488","reasoning":"Document B is more relevant — it concerns gene expression correlations with cancer prognosis (though in colorectal, not breast, and not ALDH1). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135703Z"}
{"comparison_id":"4afedff3-995e-44f2-8a2f-829a55611f0f","query_id":"53","doc_a_id":"10169908","doc_b_id":"4434951","presented_order":["10169908","4434951"],"winner_id":"10169908","reasoning":"Doc A is more relevant — it concerns cancer-related protein expression and prognosis/therapeutic relevance, whereas Doc B is about aging/epigenetics in mice and unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135710Z"}
{"comparison_id":"aefea9a7-d592-48be-8c96-b94cef1f6cbe","query_id":"53","doc_a_id":"24980622","doc_b_id":"4434951","presented_order":["24980622","4434951"],"winner_id":"24980622","reasoning":"Document A is slightly more relevant because it concerns cancer biology and tumor markers, whereas B is about aging in mice; neither directly addresses ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135717Z"}
{"comparison_id":"ae861269-cbd1-4fea-96a1-e6bf528822cc","query_id":"53","doc_a_id":"5372432","doc_b_id":"4434951","presented_order":["4434951","5372432"],"winner_id":"4434951","reasoning":"Document A is more biologically related (gene regulation/epigenetics) and thus more likely to be relevant to molecular markers like ALDH1 than a study about geographic access to care.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135726Z"}
{"comparison_id":"efa030bb-1bf2-466c-8f25-71ec868fc717","query_id":"53","doc_a_id":"2727303","doc_b_id":"4434951","presented_order":["4434951","2727303"],"winner_id":"2727303","reasoning":"Document B is more relevant because it addresses mechanisms of malignant cell behavior in cancer (where ALDH1 is a cancer marker), whereas Document A focuses on mouse aging and epigenetics unrelated to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135733Z"}
{"comparison_id":"a7ba752a-13a5-4c4b-9ef8-2529ba5c401f","query_id":"53","doc_a_id":"21502234","doc_b_id":"4434951","presented_order":["21502234","4434951"],"winner_id":"21502234","reasoning":"Document A is more relevant because it addresses cancer prognosis and clinical outcomes (though in endometrial cancer), whereas Document B discusses aging and epigenetics in mice and is unrelated to breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135741Z"}
{"comparison_id":"15e08785-e795-4074-a71c-391d390f2c72","query_id":"53","doc_a_id":"14471161","doc_b_id":"4434951","presented_order":["4434951","14471161"],"winner_id":"14471161","reasoning":"B is more relevant — it addresses tumor gene expression and cancer-related interventions, whereas A focuses on aging epigenetics unrelated to cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135748Z"}
{"comparison_id":"8ec6f3f2-d5a0-4952-9249-fe4e842d2786","query_id":"53","doc_a_id":"23577867","doc_b_id":"4434951","presented_order":["23577867","4434951"],"winner_id":"23577867","reasoning":"Document A — it's a cancer biomarker study (though about endometrial cancer), whereas B concerns mouse aging/epigenetics and is unrelated to cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135756Z"}
{"comparison_id":"60078bce-62f7-4731-b8c1-22cd344cf853","query_id":"53","doc_a_id":"9239963","doc_b_id":"4434951","presented_order":["4434951","9239963"],"winner_id":"9239963","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document B relates to cancer cell biology whereas Document A is about aging/epigenetics in mice, so B is marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135763Z"}
{"comparison_id":"9b0fdd97-29f8-46f7-a07e-03966308c513","query_id":"53","doc_a_id":"31439189","doc_b_id":"4434951","presented_order":["4434951","31439189"],"winner_id":"31439189","reasoning":"Document B — it discusses cancer stem cell markers (closer to ALDH1's role) whereas A is about mouse epigenetic aging and irrelevant to breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135771Z"}
{"comparison_id":"cc963fe5-af12-4fdf-9f54-3f774ebed3ec","query_id":"53","doc_a_id":"2272614","doc_b_id":"4434951","presented_order":["4434951","2272614"],"winner_id":"2272614","reasoning":"Document B is more relevant because it concerns how gene expression levels affect cancer outcomes (treatment resistance/prognosis) whereas Document A focuses on mouse aging and epigenetics unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135778Z"}
{"comparison_id":"061b0edd-b248-4c81-a0c6-e26ee3b07396","query_id":"53","doc_a_id":"16630996","doc_b_id":"4434951","presented_order":["16630996","4434951"],"winner_id":"16630996","reasoning":"Document A is more related because it discusses cancer and molecular markers, whereas Document B concerns aging and epigenetics in mice, not cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135786Z"}
{"comparison_id":"5be539ab-deca-4ab4-8a01-771a7ab7eb29","query_id":"53","doc_a_id":"25832301","doc_b_id":"4434951","presented_order":["4434951","25832301"],"winner_id":"25832301","reasoning":"Document B is more relevant — it addresses gene expression and cancer outcomes (though in multiple myeloma and for TSPAN7, not ALDH1 or breast cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135793Z"}
{"comparison_id":"39ccfa52-5566-4c85-9e5d-47a29ede5009","query_id":"53","doc_a_id":"7639744","doc_b_id":"4434951","presented_order":["4434951","7639744"],"winner_id":"7639744","reasoning":"Document B is more relevant — it deals with cancer prognosis (though in lung cancer), whereas Document A is about aging/epigenetics in mice and not cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135800Z"}
{"comparison_id":"c359e819-6eac-45fe-9eab-799c37f4112a","query_id":"53","doc_a_id":"24349430","doc_b_id":"4434951","presented_order":["4434951","24349430"],"winner_id":"24349430","reasoning":"Reason: Document B deals with cancer cell biology (though in lung cancer), which is closer to a claim about a cancer prognostic marker than Document A's aging/epigenetics focus.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135810Z"}
{"comparison_id":"1f017e02-9cf5-47c3-977f-a7f848fcb8a7","query_id":"53","doc_a_id":"1507222","doc_b_id":"4434951","presented_order":["1507222","4434951"],"winner_id":"1507222","reasoning":"Document A is slightly more relevant because it discusses cancer-related gene expression, whereas Document B focuses on aging interventions unrelated to cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135817Z"}
{"comparison_id":"32ea7cf8-b3d0-42e5-afbe-18feaff43a07","query_id":"53","doc_a_id":"14672919","doc_b_id":"4434951","presented_order":["14672919","4434951"],"winner_id":"14672919","reasoning":"Document A is more relevant — it deals with prognostic markers in cancer (though a different cancer type), whereas Document B is about mouse aging and epigenetics and not cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135824Z"}
{"comparison_id":"74c624bb-713c-4fe4-a95b-ef099a87cea1","query_id":"53","doc_a_id":"5377642","doc_b_id":"4434951","presented_order":["4434951","5377642"],"winner_id":"5377642","reasoning":"Document B is more relevant because it concerns tumor biology and immune regulation in cancer, whereas Document A focuses on aging-related epigenetic changes in mice unrelated to breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135831Z"}
{"comparison_id":"8a37cb6b-f6c0-4a01-bae1-85d5bc5f9dc0","query_id":"53","doc_a_id":"3684342","doc_b_id":"4434951","presented_order":["3684342","4434951"],"winner_id":"3684342","reasoning":"Document A is more relevant because it concerns cancer tumorigenesis and survival outcomes (though in lung cancer), while Document B focuses on aging-related epigenetic changes unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135838Z"}
{"comparison_id":"0b76c40d-7c76-4d18-a883-550680612868","query_id":"53","doc_a_id":"39929509","doc_b_id":"4434951","presented_order":["4434951","39929509"],"winner_id":"39929509","reasoning":"Document B — it discusses a cancer-related protein (WT1) and mRNA interactions, which is closer to cancer prognosis topics than Document A's aging/epigenetics mouse lifespan study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135845Z"}
{"comparison_id":"d27a3b41-86dc-478d-8c49-240de3e3f830","query_id":"53","doc_a_id":"46617075","doc_b_id":"4434951","presented_order":["4434951","46617075"],"winner_id":"46617075","reasoning":"Document B — it discusses cancer-related regulatory pathways (albeit in lung cancer) and is more relevant to cancer prognosis than Document A, which is about aging interventions in mice.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135852Z"}
{"comparison_id":"e5063b4d-5286-4317-999e-f324c76bbe96","query_id":"53","doc_a_id":"31313782","doc_b_id":"4434951","presented_order":["4434951","31313782"],"winner_id":"31313782","reasoning":"Document B — it deals with expression profiles in cancer (though lung, not breast) and is more related to tumor marker–prognosis context than the aging/epigenetics study in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135859Z"}
{"comparison_id":"f6848693-d2f3-489a-bbf5-2eb4443e9eee","query_id":"53","doc_a_id":"14180565","doc_b_id":"4434951","presented_order":["14180565","4434951"],"winner_id":"14180565","reasoning":"Document A is more relevant — it concerns cancer and gene expression modulation (though in glioblastoma), whereas Document B focuses on aging/epigenetics in mice and is unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135866Z"}
{"comparison_id":"925a5164-f9ec-4a7c-a3ea-81f33ce9786d","query_id":"53","doc_a_id":"39758684","doc_b_id":"4434951","presented_order":["39758684","4434951"],"winner_id":"39758684","reasoning":"Document A is more relevant — it addresses tumorigenesis and cancer-related molecular changes, whereas B focuses on aging and epigenetics in mice unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135874Z"}
{"comparison_id":"639870e1-9b1b-46fa-925f-b0d016b03972","query_id":"53","doc_a_id":"641786","doc_b_id":"4434951","presented_order":["641786","4434951"],"winner_id":"641786","reasoning":"Reason: Document A discusses cancer-related mutations and links to prognosis/relapse, which is more related to a prognosis claim in breast cancer than Document B's aging/epigenetics mouse study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135880Z"}
{"comparison_id":"0d53d6de-5c5d-49c8-9632-7e1149f3ef07","query_id":"53","doc_a_id":"33370","doc_b_id":"4434951","presented_order":["4434951","33370"],"winner_id":"33370","reasoning":"Document B — it concerns cancer stem cell biology and tumor prognosis relevance, whereas A is about mouse aging epigenetics. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135887Z"}
{"comparison_id":"0f0169ce-19ae-469f-ac0e-fc2e1f3f40f6","query_id":"53","doc_a_id":"32852283","doc_b_id":"4434951","presented_order":["4434951","32852283"],"winner_id":"32852283","reasoning":"Document B is slightly more relevant because it deals with tumor growth and survival in cancer, whereas Document A focuses on aging-related epigenetic changes unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135894Z"}
{"comparison_id":"5c59ef4b-28da-4701-afa5-8663a8db4d23","query_id":"53","doc_a_id":"9211173","doc_b_id":"4434951","presented_order":["9211173","4434951"],"winner_id":"9211173","reasoning":"Document A is more related because it discusses cancer biomarkers and tumor prognosis contexts, whereas Document B concerns aging interventions in mice and is unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135901Z"}
{"comparison_id":"ae0bc0c7-ca9e-4163-bec2-cbc20d61ccc3","query_id":"53","doc_a_id":"22123421","doc_b_id":"4434951","presented_order":["4434951","22123421"],"winner_id":"22123421","reasoning":"Document B is more relevant — it deals with prognostic biomarkers in cancer, whereas Document A focuses on aging/epigenetics in mice and is unrelated to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135907Z"}
{"comparison_id":"019bfa0b-5d26-4b97-8f72-13d8970122cf","query_id":"53","doc_a_id":"20738970","doc_b_id":"4434951","presented_order":["20738970","4434951"],"winner_id":"20738970","reasoning":"Document A — it's cancer-related (though about lung cancer) and therefore marginally more relevant than a mouse aging/epigenetics study. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135914Z"}
{"comparison_id":"580544ce-b29e-476b-9d0b-4b186c26d217","query_id":"53","doc_a_id":"6121668","doc_b_id":"4434951","presented_order":["4434951","6121668"],"winner_id":"6121668","reasoning":"Document B — it concerns cancer and prognostic markers (though in endometrial cancer), which is closer to a claim about ALDH1 and breast cancer than a mouse aging/epigenetics study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135921Z"}
{"comparison_id":"1537b6a9-f261-4ddf-bb27-12dfb639063e","query_id":"53","doc_a_id":"23509593","doc_b_id":"4434951","presented_order":["23509593","4434951"],"winner_id":"23509593","reasoning":"Doc A is slightly more relevant because it discusses gene expression regulation in cancerous tissue (though prostate and STIM1, not ALDH1 or breast); Document B concerns aging/epigenetics in mice and is unrelated to the claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135928Z"}
{"comparison_id":"a91d934d-7b3b-4ed8-9cf7-9ec9b52f7f86","query_id":"53","doc_a_id":"9285396","doc_b_id":"4434951","presented_order":["4434951","9285396"],"winner_id":"9285396","reasoning":"Document B — it concerns prognostic markers in cancer (though gastric, not breast), while A is about mouse epigenetics unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135935Z"}
{"comparison_id":"4cd79023-8a36-411e-aecf-e4f2140f620b","query_id":"53","doc_a_id":"5386514","doc_b_id":"4434951","presented_order":["5386514","4434951"],"winner_id":"5386514","reasoning":"Document A — it deals with tumor immune responses and cancer therapy, which is closer to a prognostic marker in cancer than a mouse aging/epigenetics study. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135942Z"}
{"comparison_id":"869f2856-1e1f-464d-982c-d7d5c1f3a44e","query_id":"53","doc_a_id":"3710557","doc_b_id":"4434951","presented_order":["3710557","4434951"],"winner_id":"3710557","reasoning":"Document A is slightly more relevant because it discusses cancer/tumorigenesis (though in liver), whereas Document B focuses on aging epigenetics in mice unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135949Z"}
{"comparison_id":"6bd4cc1e-441c-415b-b372-0ab39c5d97bc","query_id":"53","doc_a_id":"20754359","doc_b_id":"4434951","presented_order":["20754359","4434951"],"winner_id":"20754359","reasoning":"Document A — it discusses cancer prognosis (though for ATLL, not breast cancer), so it's marginally more relevant than Document B which is about mouse aging. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135955Z"}
{"comparison_id":"78c8ae99-0d50-449d-b859-d374422c7437","query_id":"53","doc_a_id":"53211308","doc_b_id":"4434951","presented_order":["53211308","4434951"],"winner_id":"53211308","reasoning":"Document A is more relevant — it deals with cancer biomarkers and mechanisms of cancer progression, whereas Document B focuses on mouse aging and epigenetics unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135963Z"}
{"comparison_id":"dee7ebc1-a7b0-48cd-b35d-092975ce1cd5","query_id":"53","doc_a_id":"3355397","doc_b_id":"4434951","presented_order":["4434951","3355397"],"winner_id":"3355397","reasoning":"Document B is slightly more relevant because it addresses cancer risk in humans, whereas Document A concerns mouse aging and epigenetics not breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135970Z"}
{"comparison_id":"8fa38f0f-729e-455f-a6ec-5ed49a73301b","query_id":"53","doc_a_id":"25628793","doc_b_id":"4434951","presented_order":["25628793","4434951"],"winner_id":"25628793","reasoning":"Document A is slightly more relevant because it discusses altered expression of metabolic enzymes in human reproductive tissues, whereas Document B focuses on mouse epigenetic changes with lifespan interventions (unrelated to ALDH1 or breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135978Z"}
{"comparison_id":"cfaa5d9b-0ede-4434-985f-b02d16e0a27e","query_id":"53","doc_a_id":"36212758","doc_b_id":"4434951","presented_order":["4434951","36212758"],"winner_id":"36212758","reasoning":"Document B — it concerns cancer genomic profiles and prognosis (though in lung cancer), whereas A is about mouse aging and epigenetics and unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135985Z"}
{"comparison_id":"0dfc90e2-294c-452d-89da-29c55e0f1dc2","query_id":"53","doc_a_id":"2360905","doc_b_id":"4434951","presented_order":["4434951","2360905"],"winner_id":"2360905","reasoning":"Document B — it concerns cancer molecular profiling and gene expression (though in gliomas), so it's closer to a claim about cancer biomarkers than Document A, which is about mouse aging/epigenetics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135992Z"}
{"comparison_id":"818ce36d-aa1b-4d45-82d8-e80fd48100b1","query_id":"53","doc_a_id":"20645538","doc_b_id":"4434951","presented_order":["4434951","20645538"],"winner_id":"20645538","reasoning":"Document B — it concerns prognostic factors in cancer (though in lung cancer, not breast), so it's marginally more relevant than an aging/epigenetics mouse study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.135999Z"}
{"comparison_id":"8ce53478-b9b2-484a-9f8c-ebc763967224","query_id":"53","doc_a_id":"33638477","doc_b_id":"4434951","presented_order":["4434951","33638477"],"winner_id":"33638477","reasoning":"B is more relevant — it addresses cancer progression and oncogenic markers, whereas A concerns aging-related epigenetics in mice and is unrelated to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136006Z"}
{"comparison_id":"dd5cea9f-6478-4811-9ce9-db7ce03dff7a","query_id":"53","doc_a_id":"3805841","doc_b_id":"4434951","presented_order":["3805841","4434951"],"winner_id":"3805841","reasoning":"Reason: Document A discusses cancer-related gene expression and links to poor clinical outcomes, making it more relevant to prognosis in cancer than Document B, which concerns aging interventions in mice.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136013Z"}
{"comparison_id":"98c2305c-ae93-413d-886d-371e6816423d","query_id":"53","doc_a_id":"14663842","doc_b_id":"4434951","presented_order":["4434951","14663842"],"winner_id":"14663842","reasoning":"Document B is more relevant because it concerns cancer-related metabolic enzymes (though IDH1, not ALDH1), whereas Document A focuses on aging/epigenetics in mice and is unrelated to breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136020Z"}
{"comparison_id":"5e717376-24de-4fbf-aef7-29e0370c03d8","query_id":"53","doc_a_id":"4841908","doc_b_id":"4434951","presented_order":["4841908","4434951"],"winner_id":"4841908","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A at least mentions cancer, whereas Document B focuses on mouse epigenetics and longevity.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136027Z"}
{"comparison_id":"f9ea3db1-768f-496f-b429-18547cc4bbe5","query_id":"53","doc_a_id":"14938990","doc_b_id":"4434951","presented_order":["14938990","4434951"],"winner_id":"14938990","reasoning":"Document A — it discusses a gene's expression being associated with disease activity (analogous to an expression–prognosis association), whereas Document B is about aging epigenetics in mice and not expression–prognosis relationships in cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136034Z"}
{"comparison_id":"a22926d5-c05b-45c7-9951-43a01d4c48fe","query_id":"53","doc_a_id":"1780819","doc_b_id":"4434951","presented_order":["1780819","4434951"],"winner_id":"1780819","reasoning":"Reason: Document A concerns cancer biology and biomarkers (though in endometrial cancer), which is closer to a breast cancer prognosis claim than Document B's mouse aging/epigenetics focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136041Z"}
{"comparison_id":"681314d0-8f8e-4dbb-b546-aae2886b70fa","query_id":"53","doc_a_id":"26902591","doc_b_id":"4434951","presented_order":["4434951","26902591"],"winner_id":"26902591","reasoning":"Document B is more relevant — it addresses cancer-related biology (cachexia) whereas Document A focuses on aging and epigenetic changes in mice, not cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136048Z"}
{"comparison_id":"7a26827e-f6f2-49e6-8993-561cdeb7d546","query_id":"53","doc_a_id":"19368793","doc_b_id":"4434951","presented_order":["4434951","19368793"],"winner_id":"19368793","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it concerns cancer (hepatocellular carcinoma) rather than aging epigenetics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136055Z"}
{"comparison_id":"a3f41bb1-15d5-4dbf-995b-698daf39b1d7","query_id":"53","doc_a_id":"4959368","doc_b_id":"4434951","presented_order":["4959368","4434951"],"winner_id":"4959368","reasoning":"Document A is slightly more relevant because it addresses cancer (though pancreatic, not breast or ALDH1), while Document B concerns aging/epigenetics unrelated to breast cancer prognosis.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136061Z"}
{"comparison_id":"6f153fbb-3eb3-4b4f-8e96-80296fceeae6","query_id":"53","doc_a_id":"38485364","doc_b_id":"4434951","presented_order":["38485364","4434951"],"winner_id":"38485364","reasoning":"Document A is more relevant — it addresses cancer cell invasion and proteins involved in cancer progression (closer to prognosis in breast cancer) while B is about aging epigenetics in mice and unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136069Z"}
{"comparison_id":"550bdf3b-c043-4ddb-953a-dbacf3787308","query_id":"53","doc_a_id":"3376731","doc_b_id":"4434951","presented_order":["4434951","3376731"],"winner_id":"3376731","reasoning":"Document B — it concerns cancer biology and treatment resistance, which is more related to prognosis than Document A's aging/epigenetics topic.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136077Z"}
{"comparison_id":"b115e7de-8f35-43f3-8698-e4a2b2ea2dfc","query_id":"53","doc_a_id":"5278233","doc_b_id":"4434951","presented_order":["4434951","5278233"],"winner_id":"4434951","reasoning":"Document A is more relevant — it addresses epigenetic regulation and aging, which is closer to cancer prognosis context than the Beckwith-Wiedemann imprinting focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136084Z"}
{"comparison_id":"c5d0b3f5-0b98-494b-9fed-e677e42a501b","query_id":"53","doc_a_id":"13768432","doc_b_id":"4434951","presented_order":["13768432","4434951"],"winner_id":"4434951","reasoning":"Document B is slightly more relevant because it deals with gene regulation and expression-level changes, whereas Document A concerns cardiac imaging in amyloidosis and is unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136091Z"}
{"comparison_id":"01b89489-4790-49f1-9f7e-e89a9a2f0aed","query_id":"53","doc_a_id":"85665741","doc_b_id":"4434951","presented_order":["85665741","4434951"],"winner_id":"85665741","reasoning":"Doc A is more relevant — it deals with cancer molecular markers and targeted therapy (though in NSCLC, not breast cancer). Document B concerns aging/epigenetics in mice and is less related. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136098Z"}
{"comparison_id":"a85a2795-cd36-4ead-a4ac-216b74168215","query_id":"53","doc_a_id":"6363093","doc_b_id":"4434951","presented_order":["6363093","4434951"],"winner_id":"6363093","reasoning":"Both documents are irrelevant to ALDH1 expression in breast cancer, but Document A is slightly more related because it discusses cancer subclasses and protein expression patterns (whereas B focuses on mouse aging/epigenetics). \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136105Z"}
{"comparison_id":"3d686c64-867a-474e-af4a-1eb68ac9698f","query_id":"53","doc_a_id":"4500832","doc_b_id":"4434951","presented_order":["4434951","4500832"],"winner_id":"4434951","reasoning":"Neither document directly addresses ALDH1 or breast cancer. Document A is marginally more relevant because it deals with gene regulatory/epigenetic changes and gene expression, whereas Document B focuses on a dietary form of vitamin E.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136112Z"}
{"comparison_id":"19f7c7d4-d942-4b44-9bba-caa1bc90695c","query_id":"53","doc_a_id":"4387494","doc_b_id":"4434951","presented_order":["4434951","4387494"],"winner_id":"4387494","reasoning":"Neither abstract mentions ALDH1 or breast cancer, but B is cancer-focused (AML) while A concerns aging in mice; therefore B is marginally more relevant.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136119Z"}
{"comparison_id":"4f0d1212-2f6a-40bf-a1f9-6eb92231384d","query_id":"53","doc_a_id":"11900630","doc_b_id":"4434951","presented_order":["11900630","4434951"],"winner_id":"11900630","reasoning":"Document A is slightly more relevant because it discusses cancer-related gene overexpression and treatment resistance, whereas Document B focuses on aging and epigenetics unrelated to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136125Z"}
{"comparison_id":"abb4675e-ed37-4a1e-9bd1-ea9811a0600a","query_id":"53","doc_a_id":"41790911","doc_b_id":"4434951","presented_order":["4434951","41790911"],"winner_id":"4434951","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it deals with gene regulatory/epigenetic changes affecting gene expression, whereas B focuses on WNT5A-mediated adipose angiogenesis in obesity. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136132Z"}
{"comparison_id":"d2ba943d-4c8e-4c1e-80bd-1fbfa3d492d9","query_id":"53","doc_a_id":"42150015","doc_b_id":"4434951","presented_order":["4434951","42150015"],"winner_id":"4434951","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns gene regulatory regions and expression changes, whereas Document B focuses on reproductive hormone (AMH) determinants. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136140Z"}
{"comparison_id":"148dfb75-d6b0-4724-a5ba-13926ea396d8","query_id":"53","doc_a_id":"23269537","doc_b_id":"4434951","presented_order":["4434951","23269537"],"winner_id":"23269537","reasoning":"Document B is more relevant — it concerns gene expression changes in malignancy (cancer), whereas A addresses mouse aging/epigenetics unrelated to breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136146Z"}
{"comparison_id":"80549ecf-1fe8-43fb-acbe-f46171424a1a","query_id":"53","doc_a_id":"13905670","doc_b_id":"4434951","presented_order":["4434951","13905670"],"winner_id":"13905670","reasoning":"Document B is more relevant — it addresses links between molecular variation and disease prognosis in humans, whereas A is about mouse aging epigenetics and not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136153Z"}
{"comparison_id":"8ee4ff4c-beeb-43a3-b0c9-92f0dfa6b298","query_id":"53","doc_a_id":"21551568","doc_b_id":"4434951","presented_order":["21551568","4434951"],"winner_id":"21551568","reasoning":"Document A is more relevant because it addresses cancer-related genetic alterations, whereas Document B concerns aging interventions in mice and is unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136160Z"}
{"comparison_id":"249e6278-18a3-4acc-a07d-71a78c9f38a0","query_id":"53","doc_a_id":"9095394","doc_b_id":"4434951","presented_order":["4434951","9095394"],"winner_id":"9095394","reasoning":"Document B — it deals with tumor marker expression and associations with tumor behavior, which is more relevant to a claim about biomarker prognostic value in cancer than Document A's aging/epigenetics study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136167Z"}
{"comparison_id":"dc668916-3803-4527-a50c-f1abb4c3a6bf","query_id":"53","doc_a_id":"7028976","doc_b_id":"4434951","presented_order":["4434951","7028976"],"winner_id":"7028976","reasoning":"Doc B is about tumor markers and tumor-initiating cells (though in GBM), which is more related to cancer marker–prognosis questions than Doc A's mouse aging/epigenetics study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136174Z"}
{"comparison_id":"533d48fe-cc50-4216-afdc-3fdb3e2baed5","query_id":"53","doc_a_id":"11968641","doc_b_id":"4434951","presented_order":["11968641","4434951"],"winner_id":"11968641","reasoning":"Doc A is slightly more relevant because it discusses cancer biology (though not breast cancer or ALDH1), whereas Doc B is about aging/epigenetics in mice and unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136181Z"}
{"comparison_id":"b26ff0cd-4572-4780-901a-d102775a2988","query_id":"53","doc_a_id":"663464","doc_b_id":"4434951","presented_order":["663464","4434951"],"winner_id":"663464","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it's a human study linking molecular markers to disease outcomes, whereas B focuses on mouse epigenetic effects of lifespan interventions. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136188Z"}
{"comparison_id":"a201d1be-6799-4707-8c5c-e49a7e105988","query_id":"53","doc_a_id":"26735905","doc_b_id":"4434951","presented_order":["26735905","4434951"],"winner_id":"26735905","reasoning":"Document A is more relevant — it discusses tumor microenvironment and cancer-related signaling pathways (though in prostate cancer), which is closer to a claim about cancer prognosis than an aging/epigenetics study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136195Z"}
{"comparison_id":"819a2cf9-ff54-4f21-abd4-315d4ce959a4","query_id":"53","doc_a_id":"23934390","doc_b_id":"4434951","presented_order":["4434951","23934390"],"winner_id":"23934390","reasoning":"Document B is more relevant — it's a cancer study (though in NSCLC rather than breast cancer), while A is about mouse aging/epigenetics and unrelated to ALDH1 or cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136202Z"}
{"comparison_id":"64f05c23-f9d7-468f-a7b0-92d7c9085f60","query_id":"53","doc_a_id":"2494748","doc_b_id":"4434951","presented_order":["2494748","4434951"],"winner_id":"2494748","reasoning":"Document A is cancer-focused and discusses molecular markers in tumor progression, making it closer to a prognosis-related query than an aging/epigenetics mouse study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136208Z"}
{"comparison_id":"def78dff-135c-48b6-87f4-14ec11ff1f94","query_id":"53","doc_a_id":"16016673","doc_b_id":"4434951","presented_order":["16016673","4434951"],"winner_id":"16016673","reasoning":"Document A is more relevant because it deals with cancer biomarkers and clinical detection, whereas Document B focuses on age-related epigenetic changes in mice unrelated to ALDH1 or breast cancer prognosis.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136215Z"}
{"comparison_id":"780f00be-895c-4af3-9e68-ead72d526808","query_id":"53","doc_a_id":"1976183","doc_b_id":"4434951","presented_order":["1976183","4434951"],"winner_id":"1976183","reasoning":"Document A is more relevant — it discusses biomarker expression linked to cancer invasion/prognosis (albeit in oral cancer), whereas Document B concerns aging/epigenetics in mice and is unrelated to cancer prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136249Z"}
{"comparison_id":"cec84a15-86f4-48c3-949b-3871f755871f","query_id":"53","doc_a_id":"33030946","doc_b_id":"4434951","presented_order":["4434951","33030946"],"winner_id":"4434951","reasoning":"Document A — it addresses gene regulatory and epigenetic changes that can affect gene expression, making it marginally more relevant to a claim about a gene marker's prognostic association than Document B, which focuses on macrophage/osteoclast biology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136262Z"}
{"comparison_id":"766ac620-1dc2-45fc-bbef-71dc74717ddf","query_id":"53","doc_a_id":"17876040","doc_b_id":"4434951","presented_order":["17876040","4434951"],"winner_id":"17876040","reasoning":"Document A is slightly more relevant because it discusses cancer therapy (though not breast cancer or ALDH1), while Document B focuses on aging and epigenetics in mice unrelated to breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136271Z"}
{"comparison_id":"057c7c5c-c457-4657-9ece-dc56f6485d0c","query_id":"53","doc_a_id":"4729644","doc_b_id":"4434951","presented_order":["4729644","4434951"],"winner_id":"4729644","reasoning":"Reason: Document A deals with cancer-related molecular markers and therapy resistance (more likely to discuss tumor markers like ALDH1) whereas Document B addresses mouse aging/epigenetics unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136279Z"}
{"comparison_id":"3ae7885e-27f6-45fb-bd8d-4503018b5d81","query_id":"53","doc_a_id":"38355793","doc_b_id":"4434951","presented_order":["4434951","38355793"],"winner_id":"38355793","reasoning":"Document B is more relevant — it addresses gene overexpression and prognosis-related effects in cancer, whereas A focuses on aging epigenetics in mice and is unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136287Z"}
{"comparison_id":"84bfcb02-e2c9-45d2-8634-b11c75a9e8b4","query_id":"53","doc_a_id":"7020505","doc_b_id":"4434951","presented_order":["4434951","7020505"],"winner_id":"7020505","reasoning":"Document B — it discusses cancer prognostic factors and genetic markers, which is closer to the claim about prognosis in cancer than Document A's mouse epigenetics/longevity focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136294Z"}
{"comparison_id":"de0a2b83-928d-44d0-a9fd-7e8ce2313f4c","query_id":"53","doc_a_id":"12903921","doc_b_id":"4434951","presented_order":["12903921","4434951"],"winner_id":"12903921","reasoning":"Document A is slightly more relevant because it concerns cancer-related biological changes (albeit in leukemia), whereas Document B focuses on aging/epigenetics in mice, not cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136301Z"}
{"comparison_id":"78f128c6-1ead-456d-a459-808594206617","query_id":"53","doc_a_id":"57783564","doc_b_id":"4434951","presented_order":["57783564","4434951"],"winner_id":"57783564","reasoning":"Doc A is more relevant because it concerns cancer biology (tumor proliferation/pathways), whereas Doc B addresses aging/epigenetics in mice and not cancer or ALDH1/breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136312Z"}
{"comparison_id":"018fcd16-93f0-470a-b759-63ab1e5a06b7","query_id":"53","doc_a_id":"9648896","doc_b_id":"4434951","presented_order":["4434951","9648896"],"winner_id":"9648896","reasoning":"Document B is more relevant because it deals with cancer biology (cell proliferation and chemoresistance), while Document A focuses on mouse aging and epigenetics unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136322Z"}
{"comparison_id":"351dd70f-de00-4f65-af8a-dcfca7ce0bfc","query_id":"53","doc_a_id":"16853734","doc_b_id":"4434951","presented_order":["4434951","16853734"],"winner_id":"16853734","reasoning":"Document B is slightly more relevant because it addresses cancer-related molecular expression and tumor cell behavior, whereas Document A concerns aging/epigenetics in mice and not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136333Z"}
{"comparison_id":"d9ebef27-f460-456c-ab24-9b6293ca6b9d","query_id":"53","doc_a_id":"12074066","doc_b_id":"4434951","presented_order":["4434951","12074066"],"winner_id":"4434951","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A (epigenetic regulation at gene regions) is marginally more related to gene expression and cancer biology than Document B (vitamin D and colorectal cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136345Z"}
{"comparison_id":"a71e39e5-e0e1-4274-96b6-2de9d472a901","query_id":"53","doc_a_id":"43334921","doc_b_id":"4434951","presented_order":["4434951","43334921"],"winner_id":"43334921","reasoning":"Document B is more relevant — it addresses cancer-related clinical outcomes, whereas A focuses on mouse aging/epigenetics unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136356Z"}
{"comparison_id":"ce5198cd-3439-4aed-9f81-2ac048568087","query_id":"53","doc_a_id":"41293601","doc_b_id":"4434951","presented_order":["41293601","4434951"],"winner_id":"41293601","reasoning":"Document A is slightly more relevant because it addresses cancer-related molecular markers, whereas Document B concerns aging interventions in mice and not cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136366Z"}
{"comparison_id":"b84477a4-ab77-4a08-b339-d81bed218962","query_id":"53","doc_a_id":"21414718","doc_b_id":"4434951","presented_order":["21414718","4434951"],"winner_id":"21414718","reasoning":"Document A is more relevant because it concerns cancer biology (tumor cell mobility/invasion), whereas Document B is about mouse aging/epigenetics and not cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136376Z"}
{"comparison_id":"8e065497-3649-4d12-834e-c66a21dadac0","query_id":"53","doc_a_id":"14848619","doc_b_id":"4434951","presented_order":["14848619","4434951"],"winner_id":"14848619","reasoning":"Document A is slightly more relevant — it discusses molecular pathways of cell survival/death that are more closely related to cancer biology; neither document mentions ALDH1 or breast cancer prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136383Z"}
{"comparison_id":"ff395015-ae0a-4c79-b3b2-d0b7abe6d7f1","query_id":"53","doc_a_id":"5884524","doc_b_id":"4434951","presented_order":["4434951","5884524"],"winner_id":"4434951","reasoning":"Document A is slightly more relevant because it concerns gene regulation and epigenetic changes (closer to gene expression topics), while Document B deals with diabetes and cardiovascular outcomes unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136390Z"}
{"comparison_id":"71548483-4060-4be5-9e90-126d472aaff3","query_id":"53","doc_a_id":"24624992","doc_b_id":"4434951","presented_order":["4434951","24624992"],"winner_id":"24624992","reasoning":"Document B — it concerns gene expression in cancer cells (though in leukemia), which is marginally more related to the claim about gene expression and cancer prognosis than the aging/epigenetics study in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136397Z"}
{"comparison_id":"9fc0fbfa-e4ac-4b74-8690-31df966eaed7","query_id":"53","doc_a_id":"1649738","doc_b_id":"4434951","presented_order":["1649738","4434951"],"winner_id":"1649738","reasoning":"Neither document addresses ALDH1 or breast cancer; Document A is slightly more related because it concerns cancer genetics and therapy-induced malignancies. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136404Z"}
{"comparison_id":"e5945dde-1d8b-464f-8bc9-13e7849b780a","query_id":"53","doc_a_id":"17671145","doc_b_id":"4434951","presented_order":["4434951","17671145"],"winner_id":"17671145","reasoning":"Reason: Document B addresses cancer-related molecular markers and prognosis/therapy, whereas Document A concerns aging epigenetics in mice and is unrelated to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136411Z"}
{"comparison_id":"15e04830-2421-41cb-9429-6f14507cd3f8","query_id":"53","doc_a_id":"9196472","doc_b_id":"4434951","presented_order":["4434951","9196472"],"winner_id":"9196472","reasoning":"Document B is more relevant because it studies human gene expression and disease associations (transcriptome data), which is closer to assessing biomarkers like ALDH1 in cancer prognosis than a mouse aging-epigenetics study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136418Z"}
{"comparison_id":"9cd6cc65-8e8d-4750-8e2f-4315f43f0aff","query_id":"53","doc_a_id":"24705390","doc_b_id":"4434951","presented_order":["24705390","4434951"],"winner_id":"4434951","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is marginally more related because it concerns gene regulation/epigenetic changes affecting gene expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136425Z"}
{"comparison_id":"34ea6a85-b2ee-4fa8-abb4-e6212bc4487a","query_id":"53","doc_a_id":"5956380","doc_b_id":"4434951","presented_order":["4434951","5956380"],"winner_id":"5956380","reasoning":"Document B is more relevant — it is a cancer study (though in brainstem gliomas and not breast cancer or ALDH1), whereas A concerns aging interventions in mice and is unrelated to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136433Z"}
{"comparison_id":"f6225793-64ab-476a-8092-04684eb1f148","query_id":"53","doc_a_id":"12337611","doc_b_id":"4434951","presented_order":["4434951","12337611"],"winner_id":"12337611","reasoning":"Document B — it concerns cancer and poor outcomes (though in neuroblastoma), making it more related to prognosis than Document A on aging epigenetics. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136440Z"}
{"comparison_id":"675662db-566f-4f4c-94dd-657059099a58","query_id":"53","doc_a_id":"38009906","doc_b_id":"4434951","presented_order":["38009906","4434951"],"winner_id":"38009906","reasoning":"Document A is more related to cancer biology and gene expression regulation, whereas Document B concerns aging interventions in mice and is unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136447Z"}
{"comparison_id":"e50cead6-d035-4d7d-9f2c-2beb682be2e3","query_id":"53","doc_a_id":"4445629","doc_b_id":"4434951","presented_order":["4434951","4445629"],"winner_id":"4434951","reasoning":"Document A is more related (it deals with gene regulation/epigenetics, which is more relevant to gene expression and cancer prognosis than a cardiology biomarker study).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136453Z"}
{"comparison_id":"56f13729-a6a8-4471-9f4a-d58af7071dc8","query_id":"53","doc_a_id":"8702697","doc_b_id":"4434951","presented_order":["8702697","4434951"],"winner_id":"8702697","reasoning":"Doc A discusses cancer cell aggressiveness and EMT, so it's marginally more relevant to prognostic markers in cancer than Doc B's aging/epigenetics focus. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136461Z"}
{"comparison_id":"87376ed5-eb06-463d-bb8b-e501e1db664f","query_id":"53","doc_a_id":"3559136","doc_b_id":"4434951","presented_order":["3559136","4434951"],"winner_id":"3559136","reasoning":"Document A is more related to cancer biology and tumor microenvironment (closer to prognosis markers) while Document B is about aging in mice and unrelated to breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136469Z"}
{"comparison_id":"4c2b1523-bd75-4df4-9800-d0660aef45ec","query_id":"53","doc_a_id":"6121555","doc_b_id":"4434951","presented_order":["4434951","6121555"],"winner_id":"6121555","reasoning":"Document B — it's cancer-related (tumorigenic pathways), whereas A is about aging/epigenetics in mice and not cancer-focused. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136476Z"}
{"comparison_id":"1bd96139-96e3-46a5-9279-cbe42a46bda7","query_id":"53","doc_a_id":"10699587","doc_b_id":"4434951","presented_order":["4434951","10699587"],"winner_id":"10699587","reasoning":"Document B is more relevant — it concerns prognostic factors and survival in cancer (though prostate, not breast), whereas A addresses mouse epigenetics and aging unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136483Z"}
{"comparison_id":"70b96de7-3473-4143-b03c-00be6a5c361f","query_id":"53","doc_a_id":"6171953","doc_b_id":"4434951","presented_order":["6171953","4434951"],"winner_id":"6171953","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document A (human disease/inflammation) is marginally more related than Document B (mouse aging/epigenetics).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136489Z"}
{"comparison_id":"cd495b17-d280-4cc9-8fba-fa631ba61e3d","query_id":"53","doc_a_id":"8764879","doc_b_id":"4434951","presented_order":["8764879","4434951"],"winner_id":"8764879","reasoning":"Document A is more relevant — it's about cancer stem cell markers and prognosis-related mechanisms, whereas B concerns aging and epigenetics in mice, not breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136496Z"}
{"comparison_id":"1374684f-7949-4d53-b5a7-96c96dffeacd","query_id":"53","doc_a_id":"2359152","doc_b_id":"4434951","presented_order":["2359152","4434951"],"winner_id":"2359152","reasoning":"Document A is more relevant — it deals with prognostic markers and risk stratification in a human hematologic malignancy, which is closer to a claim about biomarker-associated prognosis than Document B's mouse aging/epigenetics study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136503Z"}
{"comparison_id":"26fcbf88-629f-4819-86a8-32b902ebba07","query_id":"53","doc_a_id":"67787658","doc_b_id":"4434951","presented_order":["4434951","67787658"],"winner_id":"67787658","reasoning":"Both are irrelevant to ALDH1 in breast cancer, but Document B is cancer-focused (glioblastoma) whereas A is about mouse aging—so B is marginally more related.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136509Z"}
{"comparison_id":"fa312d75-afa5-4046-ab98-61ce1a2309e0","query_id":"53","doc_a_id":"45764440","doc_b_id":"4434951","presented_order":["4434951","45764440"],"winner_id":"45764440","reasoning":"Document B — it concerns cancer progression and molecular markers in a tumor model, whereas Document A addresses aging/epigenetics in mice and is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136516Z"}
{"comparison_id":"34fac61f-dd07-4c79-866a-664d59911c9a","query_id":"53","doc_a_id":"42377686","doc_b_id":"4434951","presented_order":["4434951","42377686"],"winner_id":"42377686","reasoning":"Document B — it discusses cancer prognostic markers and poor prognosis associations (though in CLL/SLL, not breast cancer), so it's closer in topic than A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136523Z"}
{"comparison_id":"ee2bf1d5-9abd-4931-8ce9-69f3afaeddaf","query_id":"53","doc_a_id":"35993767","doc_b_id":"4434951","presented_order":["4434951","35993767"],"winner_id":"35993767","reasoning":"Document B is more relevant — it concerns cancer biology and mechanisms of tumor progression, whereas A covers mouse aging/epigenetics unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136529Z"}
{"comparison_id":"60b05f3f-396a-4bb1-b80a-db6a5c6d2ce9","query_id":"53","doc_a_id":"4795303","doc_b_id":"4434951","presented_order":["4795303","4434951"],"winner_id":"4795303","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document A is slightly more relevant because it discusses protein expression effects in cells, whereas B is about age-related epigenetics in mice.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136536Z"}
{"comparison_id":"38e01cd1-0384-4882-954d-78e237be2afe","query_id":"53","doc_a_id":"16511863","doc_b_id":"4434951","presented_order":["4434951","16511863"],"winner_id":"4434951","reasoning":"Document A is slightly more related because it concerns gene regulatory changes and gene expression, whereas Document B focuses on cardiac hypertrophy unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136543Z"}
{"comparison_id":"3b90fb0c-c55f-464b-98ba-62fae1c4dc5f","query_id":"53","doc_a_id":"6766459","doc_b_id":"4434951","presented_order":["6766459","4434951"],"winner_id":"6766459","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document A is marginally more relevant because it concerns regulation of gene expression (thermomiRs), whereas B focuses on mouse aging and epigenetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136550Z"}
{"comparison_id":"dacedf9f-78bb-43de-9221-a484a31c1a17","query_id":"53","doc_a_id":"26887439","doc_b_id":"4434951","presented_order":["26887439","4434951"],"winner_id":"26887439","reasoning":"Document A is more relevant — it's about cancer cell survival/mechanisms (though not ALDH1 or breast cancer specifically), whereas Document B concerns aging epigenetics in mice and is unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136558Z"}
{"comparison_id":"4291ed2b-da58-4228-a292-dd714953287f","query_id":"53","doc_a_id":"26495128","doc_b_id":"4434951","presented_order":["4434951","26495128"],"winner_id":"26495128","reasoning":"Document B — it discusses a protein's role in cell proliferation and cancer implications, which is more related to cancer prognosis than Document A's aging/epigenetics focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136565Z"}
{"comparison_id":"b537a43e-50b1-43d1-a2d7-f15a704128e0","query_id":"53","doc_a_id":"36310858","doc_b_id":"4434951","presented_order":["36310858","4434951"],"winner_id":"36310858","reasoning":"Document A — discusses cancer progression mechanisms (though in pancreatic cancer), while Document B concerns aging/epigenetics in mice and is unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136573Z"}
{"comparison_id":"ebea6575-286b-4b3f-adf3-10c07e9cce6d","query_id":"53","doc_a_id":"5783785","doc_b_id":"4434951","presented_order":["4434951","5783785"],"winner_id":"5783785","reasoning":"Document B is more relevant — it addresses cancer-related molecular markers and tumor progression, whereas Document A focuses on mouse aging/epigenetics unrelated to breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136579Z"}
{"comparison_id":"6608479e-3a4c-4ce7-ba0b-e257386fb05f","query_id":"53","doc_a_id":"22059387","doc_b_id":"4434951","presented_order":["4434951","22059387"],"winner_id":"22059387","reasoning":"Document B is slightly more relevant because it addresses mechanisms of inflammation-mediated carcinogenesis, whereas Document A focuses on aging-related epigenetic changes in mice; neither mentions ALDH1 or breast cancer specifically.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136587Z"}
{"comparison_id":"3b162aa7-93cc-4737-8801-b2394e54c13c","query_id":"53","doc_a_id":"5271210","doc_b_id":"4434951","presented_order":["5271210","4434951"],"winner_id":"5271210","reasoning":"Document A is more relevant — it discusses cancer biomarkers and prognosis (though for HCC), which is closer to a claim about ALDH1 and breast cancer than a mouse aging/epigenetics study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136594Z"}
{"comparison_id":"eddcfb3b-dfd8-4ff6-9b82-eaf2c88b1a3b","query_id":"53","doc_a_id":"9226649","doc_b_id":"4434951","presented_order":["4434951","9226649"],"winner_id":"9226649","reasoning":"Document B is slightly more relevant because it concerns mechanisms of tumorigenesis, whereas Document A focuses on aging epigenetics in mice and not cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136600Z"}
{"comparison_id":"38c8aafd-07ee-44cb-ba44-e52884d004f1","query_id":"53","doc_a_id":"13283919","doc_b_id":"4434951","presented_order":["4434951","13283919"],"winner_id":"4434951","reasoning":"Neither document addresses ALDH1 or breast cancer; however, Document A is marginally more relevant because it deals with gene regulatory/epigenetic changes related to gene expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136607Z"}
{"comparison_id":"fdddb9a8-8136-4249-8ea4-aaba6b9eed9f","query_id":"53","doc_a_id":"11935250","doc_b_id":"4434951","presented_order":["11935250","4434951"],"winner_id":"4434951","reasoning":"Neither paper addresses ALDH1 or breast cancer. Document B is marginally more relevant because it discusses epigenetic regulation at gene regulatory regions (which can affect gene expression). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136614Z"}
{"comparison_id":"20f63f55-f045-4000-ba2d-c984a7e64d86","query_id":"53","doc_a_id":"15215393","doc_b_id":"4434951","presented_order":["15215393","4434951"],"winner_id":"15215393","reasoning":"Document A is more relevant — it concerns cancer cell biology (therapeutic response in tumors), whereas Document B addresses aging in mice; neither directly discusses ALDH1 or breast cancer, but A is closer in topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136621Z"}
{"comparison_id":"ac941266-2914-4d17-a9e9-02fb4f1d8149","query_id":"53","doc_a_id":"5123516","doc_b_id":"4434951","presented_order":["4434951","5123516"],"winner_id":"5123516","reasoning":"Document B is more relevant — it concerns cancer biology and tumor markers (glioblastoma), whereas Document A addresses mouse aging/epigenetics and is unrelated to cancer biomarkers or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136628Z"}
{"comparison_id":"6d3a4b2f-5216-4848-af9a-a816209c4af4","query_id":"53","doc_a_id":"22180793","doc_b_id":"4434951","presented_order":["22180793","4434951"],"winner_id":"22180793","reasoning":"Document A is more relevant because it addresses cancer progression and biomarkers (though in prostate cancer), while Document B concerns mouse aging/epigenetics and neither discusses ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136649Z"}
{"comparison_id":"b55808ae-54dd-4202-bba4-febbe876ff1f","query_id":"53","doc_a_id":"25513319","doc_b_id":"4434951","presented_order":["25513319","4434951"],"winner_id":"25513319","reasoning":"Document A is more relevant — it concerns cancer biology and tumor progression (though in prostate cancer), whereas Document B focuses on aging/epigenetics in mice and not cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136663Z"}
{"comparison_id":"845cbd67-8b66-4323-a0b9-44d98cfebf74","query_id":"53","doc_a_id":"10165723","doc_b_id":"4434951","presented_order":["10165723","4434951"],"winner_id":"10165723","reasoning":"Document A is more relevant — it addresses cancer progression and prognosis (albeit in melanoma), whereas B focuses on mouse aging and epigenetics unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136672Z"}
{"comparison_id":"aa37355e-2a13-4c86-93a7-633774c1f53b","query_id":"53","doc_a_id":"1836154","doc_b_id":"4434951","presented_order":["1836154","4434951"],"winner_id":"1836154","reasoning":"Document A is cancer-focused and discusses gene expression in human tumors, making it more relevant to a claim about a cancer marker than a mouse aging/epigenetics study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136679Z"}
{"comparison_id":"b922bf21-3418-4184-b7bc-8cbd3ceaef2f","query_id":"53","doc_a_id":"37204802","doc_b_id":"4434951","presented_order":["37204802","4434951"],"winner_id":"37204802","reasoning":"Document A — it concerns cancer biology and biomarkers, making it slightly more relevant to a claim about a cancer prognostic marker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136687Z"}
{"comparison_id":"37839947-c272-49b2-88cc-ac3a04c6ed52","query_id":"53","doc_a_id":"17911973","doc_b_id":"4434951","presented_order":["17911973","4434951"],"winner_id":"17911973","reasoning":"Document A mentions cancer-related genomic changes (though not ALDH1 or breast cancer specifically), while Document B is about mouse aging/epigenetics and is unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136694Z"}
{"comparison_id":"1b0fed97-c9a5-4c1a-9ce3-d9ae91beee0c","query_id":"53","doc_a_id":"8385277","doc_b_id":"4434951","presented_order":["4434951","8385277"],"winner_id":"4434951","reasoning":"Reason: Neither directly addresses ALDH1 or breast cancer, but A deals with gene regulatory/epigenetic changes (more relevant to expression/prognosis) while B focuses on Fanconi anemia and leukemia.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136701Z"}
{"comparison_id":"bf4ac80b-9c2b-4f5f-8e07-4f5a69d9a02e","query_id":"53","doc_a_id":"28334217","doc_b_id":"4434951","presented_order":["28334217","4434951"],"winner_id":"28334217","reasoning":"Neither document mentions ALDH1 or breast cancer; however, Document A is cancer-focused (tumorigenesis/treatment) while Document B is about aging/epigenetics. So A is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136708Z"}
{"comparison_id":"24cc5097-875c-4dd2-af57-b48e78a7e179","query_id":"53","doc_a_id":"7869794","doc_b_id":"4434951","presented_order":["4434951","7869794"],"winner_id":"7869794","reasoning":"Document B is slightly more relevant because it deals with tumor cell–immune interactions and cancer cell apoptosis, whereas Document A focuses on mouse epigenetic aging interventions unrelated to breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136716Z"}
{"comparison_id":"34d4c2bb-8b48-46a7-b444-b315d5216875","query_id":"53","doc_a_id":"22703082","doc_b_id":"4434951","presented_order":["22703082","4434951"],"winner_id":"22703082","reasoning":"Document A is more cancer-relevant (discusses mechanisms of carcinogenesis), while B is about aging/epigenetics in mice; neither addresses ALDH1 or breast cancer directly.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136722Z"}
{"comparison_id":"d7f5aee7-cfbf-4398-b699-731326c223a0","query_id":"53","doc_a_id":"3831884","doc_b_id":"4434951","presented_order":["3831884","4434951"],"winner_id":"3831884","reasoning":"Document A is slightly more relevant because it addresses cancer-related biology (though in pancreatic cancer), whereas Document B focuses on aging/epigenetics in mice and is farther from the breast cancer/ALDH1 prognosis topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136729Z"}
{"comparison_id":"19dcae15-1d7d-4d24-9075-521e370f4f18","query_id":"53","doc_a_id":"4325398","doc_b_id":"4434951","presented_order":["4325398","4434951"],"winner_id":"4325398","reasoning":"Document A is more relevant — it concerns cancer genomics (though pancreatic, not breast), while Document B is about aging interventions in mice and unrelated to cancer prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136736Z"}
{"comparison_id":"a9823ba6-ca19-4f44-a6cd-d302d16daeef","query_id":"53","doc_a_id":"3504761","doc_b_id":"4434951","presented_order":["3504761","4434951"],"winner_id":"3504761","reasoning":"Document A is slightly more relevant because it addresses tumorigenesis/cancer-related mechanisms, whereas Document B focuses on aging/epigenetics; neither mentions ALDH1 or breast cancer specifically.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136743Z"}
{"comparison_id":"b88d7bee-1937-4d48-89e0-f14157718a8a","query_id":"53","doc_a_id":"9791313","doc_b_id":"4434951","presented_order":["9791313","4434951"],"winner_id":"9791313","reasoning":"Reason: Document A discusses cancer-related epigenetics/tumor suppressors, making it closer to a claim about prognostic markers in cancer than Document B, which focuses on aging interventions in mice.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136749Z"}
{"comparison_id":"70b426a0-9460-483a-ba18-12c3bd57772a","query_id":"53","doc_a_id":"5468807","doc_b_id":"4434951","presented_order":["5468807","4434951"],"winner_id":"5468807","reasoning":"Document A is slightly more relevant because it discusses cancer biology and therapeutic outcomes, whereas Document B is about aging interventions in mice and is unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136756Z"}
{"comparison_id":"2b185c24-cb3d-4ecf-acc7-2b641d3e0f26","query_id":"53","doc_a_id":"10365787","doc_b_id":"4434951","presented_order":["4434951","10365787"],"winner_id":"10365787","reasoning":"Document B is more relevant — it addresses cancer-related mechanisms (tumour suppression/genomic stability), whereas A focuses on aging/epigenetics in mice and is unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136763Z"}
{"comparison_id":"fed85652-1885-453d-8614-6295fa9e6596","query_id":"53","doc_a_id":"24783597","doc_b_id":"4434951","presented_order":["24783597","4434951"],"winner_id":"24783597","reasoning":"Document A is slightly more relevant because it discusses protein expression associated with disease activity (though in IBD, not breast cancer); neither document addresses ALDH1 or breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136772Z"}
{"comparison_id":"c33dfe04-6eae-4046-a490-d78d3a403dd8","query_id":"53","doc_a_id":"1522336","doc_b_id":"4434951","presented_order":["1522336","4434951"],"winner_id":"1522336","reasoning":"Document A is slightly more relevant because it concerns cancer-related tumor biology, whereas Document B addresses aging and epigenetics in mice unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136780Z"}
{"comparison_id":"3f8ed8d5-0121-47b6-9ee1-b05fa38d76c8","query_id":"53","doc_a_id":"24190159","doc_b_id":"4434951","presented_order":["24190159","4434951"],"winner_id":"24190159","reasoning":"Document A — it's cancer-related (gene expression in carcinomas), whereas Document B is about mouse aging/epigenetics and not related to cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136787Z"}
{"comparison_id":"b5778561-73db-4cf8-809e-0ab77a650d31","query_id":"53","doc_a_id":"25036988","doc_b_id":"4434951","presented_order":["4434951","25036988"],"winner_id":"25036988","reasoning":"Document B is more relevant because it addresses cancer-related molecular changes (though in colon cancer), whereas Document A concerns aging interventions in mice and not cancer markers or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136794Z"}
{"comparison_id":"cf010673-a365-4aeb-8652-9db6f9e9c3f5","query_id":"53","doc_a_id":"12685434","doc_b_id":"4434951","presented_order":["12685434","4434951"],"winner_id":"12685434","reasoning":"Reason: Document A concerns cancer-related gene expression and tumor invasion, making it more relevant to a prognostic cancer marker than Document B, which addresses aging and epigenetics in mice.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136800Z"}
{"comparison_id":"30deae9e-780f-4768-8cfb-028de44a085d","query_id":"53","doc_a_id":"18682109","doc_b_id":"4434951","presented_order":["18682109","4434951"],"winner_id":"18682109","reasoning":"Document A is more relevant — it discusses cancer and molecular marker changes, whereas Document B concerns aging and epigenetics in mice unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136807Z"}
{"comparison_id":"830e17a6-86e1-4582-860d-e311f5403987","query_id":"53","doc_a_id":"2466614","doc_b_id":"4434951","presented_order":["2466614","4434951"],"winner_id":"2466614","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A mentions genome-wide expression changes (marginally closer to a claim about gene expression), so it's slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136814Z"}
{"comparison_id":"aa52623e-853a-4243-84be-3aaefffadf98","query_id":"53","doc_a_id":"14019636","doc_b_id":"4434951","presented_order":["14019636","4434951"],"winner_id":"14019636","reasoning":"Reason: Document A discusses cancer-related genomic changes and cancer sensitivity, making it marginally more relevant to a prognosis-related cancer claim than Document B, which focuses on mouse aging interventions.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136820Z"}
{"comparison_id":"6ef1d589-9478-4235-931d-1e8496ca11f5","query_id":"53","doc_a_id":"20501163","doc_b_id":"4434951","presented_order":["4434951","20501163"],"winner_id":"20501163","reasoning":"Document B is more relevant — it addresses tumor biology and factors affecting cancer progression, whereas A focuses on aging-related epigenetics in mice. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136827Z"}
{"comparison_id":"8d427a29-6a16-4343-93e6-7133d92cdd4d","query_id":"53","doc_a_id":"22049489","doc_b_id":"4434951","presented_order":["4434951","22049489"],"winner_id":"22049489","reasoning":"Reason: Document B deals with cancer-related molecular markers and prognosis-related pathways, while Document A concerns aging/epigenetics in mice and is unrelated to cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136834Z"}
{"comparison_id":"d8115264-0f1b-4c5c-893d-598ccb0fac21","query_id":"53","doc_a_id":"21063817","doc_b_id":"4434951","presented_order":["4434951","21063817"],"winner_id":"21063817","reasoning":"Document B is more relevant — it deals with cancer-related marker expression (though in oral carcinoma, not breast), whereas A discusses mouse aging and epigenetics unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136841Z"}
{"comparison_id":"a02dd8e1-ce2b-46ed-9c62-56e98b8e1582","query_id":"53","doc_a_id":"19427410","doc_b_id":"4434951","presented_order":["4434951","19427410"],"winner_id":"19427410","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is marginally more relevant because it deals with human gene expression, whereas A is about mouse aging interventions.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136848Z"}
{"comparison_id":"ba075615-3ef9-4ea9-9c72-541eee4d088d","query_id":"53","doc_a_id":"23599024","doc_b_id":"4434951","presented_order":["4434951","23599024"],"winner_id":"23599024","reasoning":"Document B is more relevant — it deals with cancer biology and tumor progression, whereas Document A concerns aging and epigenetics in mice and is unrelated to cancer prognosis or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136855Z"}
{"comparison_id":"f69254c6-7ed0-429f-a97a-85c9b70c93cf","query_id":"53","doc_a_id":"195689757","doc_b_id":"4434951","presented_order":["4434951","195689757"],"winner_id":"195689757","reasoning":"Document B — it discusses cancer metabolic enzymes (more related to ALDH1's role in cancer) while A focuses on mouse aging/epigenetics, not breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136862Z"}
{"comparison_id":"d267aaf7-26d2-438c-9d7c-4e0c852db8e3","query_id":"53","doc_a_id":"36838958","doc_b_id":"4434951","presented_order":["36838958","4434951"],"winner_id":"4434951","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses gene regulatory/epigenetic changes, whereas A concerns adipose thermogenesis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136868Z"}
{"comparison_id":"53a7d5b5-9abd-474f-a241-4f4e0aa61b6e","query_id":"53","doc_a_id":"15322518","doc_b_id":"4434951","presented_order":["4434951","15322518"],"winner_id":"15322518","reasoning":"Both documents do not address ALDH1 or breast cancer; Document B is slightly more relevant because it concerns cancer biology (therapeutic targets and prognosis-related pathways) whereas A focuses on aging epigenetics in mice. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136875Z"}
{"comparison_id":"906a779d-5457-4efe-8fe0-2dd10c21cc4b","query_id":"53","doc_a_id":"1617327","doc_b_id":"4434951","presented_order":["1617327","4434951"],"winner_id":"1617327","reasoning":"Document A is slightly more relevant because it deals with cancer-related biology (stromal-driven oncogenesis), whereas Document B focuses on aging/epigenetics and lifespan interventions, not cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136882Z"}
{"comparison_id":"52e1a66b-65b8-4134-8528-d7675de97ac4","query_id":"53","doc_a_id":"11578459","doc_b_id":"4434951","presented_order":["4434951","11578459"],"winner_id":"11578459","reasoning":"Document B — it concerns cancer and stem-cell–related markers (more relevant to ALDH1/breast cancer context) while A is about mouse aging interventions. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136888Z"}
{"comparison_id":"106786d9-80af-49da-b578-70e030863c66","query_id":"53","doc_a_id":"9159495","doc_b_id":"4434951","presented_order":["9159495","4434951"],"winner_id":"4434951","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it concerns mammalian (mouse) gene regulation and epigenetic changes, which is closer to studies of gene expression in human disease.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136895Z"}
{"comparison_id":"08e4366e-cb3a-43b9-8eb3-4baa8114b133","query_id":"53","doc_a_id":"18810195","doc_b_id":"4434951","presented_order":["4434951","18810195"],"winner_id":"18810195","reasoning":"Document B — it discusses mechanisms in human tumors and cancer cell metabolism, which is more related to cancer prognosis than the aging/epigenetics focus of Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136902Z"}
{"comparison_id":"274981b2-1fd9-45f2-8a21-65cd04eef404","query_id":"53","doc_a_id":"1686997","doc_b_id":"4434951","presented_order":["1686997","4434951"],"winner_id":"1686997","reasoning":"Reason: Document A discusses cancer growth mechanisms and potential prognostic/therapeutic targets, making it more related to breast cancer prognosis than Document B, which focuses on aging and epigenetics in mice.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136909Z"}
{"comparison_id":"424964b7-53cf-4750-9c8c-96a27743fcf7","query_id":"53","doc_a_id":"28249680","doc_b_id":"4434951","presented_order":["28249680","4434951"],"winner_id":"28249680","reasoning":"Document A is more relevant — it discusses cancer cell biology and therapeutics, whereas Document B covers mouse aging/epigenetics unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136916Z"}
{"comparison_id":"60d1b729-5bad-4883-bb2d-f43de14ef938","query_id":"53","doc_a_id":"40349336","doc_b_id":"4434951","presented_order":["4434951","40349336"],"winner_id":"40349336","reasoning":"Document B — it discusses stem and progenitor cell biology, which is more directly related to ALDH1 (a stem cell/cancer stem cell marker) than Document A on aging epigenetics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136923Z"}
{"comparison_id":"0fa549cd-ca5f-4691-b861-555367796eed","query_id":"53","doc_a_id":"16364639","doc_b_id":"4434951","presented_order":["4434951","16364639"],"winner_id":"16364639","reasoning":"Document B — it concerns cancer-related molecular networks (though in glioblastoma), whereas Document A is about aging in mice and epigenetics, not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136930Z"}
{"comparison_id":"cae3757c-e2c3-45bb-9cf5-9e276081dcfa","query_id":"53","doc_a_id":"16201748","doc_b_id":"4434951","presented_order":["4434951","16201748"],"winner_id":"16201748","reasoning":"Document B — it discusses protein expression in cancer tissues and its diagnostic/prognostic relevance, which is closer to the query about marker expression and prognosis than the aging/epigenetics study in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136937Z"}
{"comparison_id":"139b37d0-e997-497c-9777-24b473031cfe","query_id":"53","doc_a_id":"2547636","doc_b_id":"4434951","presented_order":["2547636","4434951"],"winner_id":"2547636","reasoning":"Document A is slightly more relevant because it discusses stem cell function and links to carcinogenesis, which is nearer to cancer prognosis than mouse aging epigenetics. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136943Z"}
{"comparison_id":"b48dc4ad-85f3-4525-af79-96fab7af1ea0","query_id":"53","doc_a_id":"4312169","doc_b_id":"4434951","presented_order":["4434951","4312169"],"winner_id":"4312169","reasoning":"Document B is more relevant because it addresses tumor genetics and cancer biology, whereas Document A focuses on mouse aging and epigenetics unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136974Z"}
{"comparison_id":"a7cbd87a-465e-43e6-a473-90281c5b2bfa","query_id":"53","doc_a_id":"6259170","doc_b_id":"4434951","presented_order":["4434951","6259170"],"winner_id":"6259170","reasoning":"Document B is more relevant — it discusses cancer-related pathways (Nrf2, chemoresistance, growth advantages) that relate to tumor behavior, whereas A focuses on mouse aging epigenetics unrelated to breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136987Z"}
{"comparison_id":"72edcb6e-ac42-4b80-b0d7-08dd784962b8","query_id":"53","doc_a_id":"24294572","doc_b_id":"4434951","presented_order":["4434951","24294572"],"winner_id":"24294572","reasoning":"Document B is more relevant — it concerns cancer signaling pathways and tumor behavior, which is closer to prognosis in breast cancer than the ageing/epigenetics focus of A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.136995Z"}
{"comparison_id":"32184c8c-81e6-4e98-a0fa-777620c53822","query_id":"53","doc_a_id":"5752492","doc_b_id":"4434951","presented_order":["4434951","5752492"],"winner_id":"4434951","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it deals with gene regulatory/epigenetic changes (closer to cancer biology) while B focuses on HIV immune activation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137002Z"}
{"comparison_id":"953e1006-4ee8-4020-8494-05ff8ab9269f","query_id":"53","doc_a_id":"9478135","doc_b_id":"4434951","presented_order":["4434951","9478135"],"winner_id":"4434951","reasoning":"Neither document directly addresses ALDH1 or breast cancer prognosis; Document A is slightly more relevant because it discusses gene regulatory and epigenetic changes affecting gene expression. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137008Z"}
{"comparison_id":"4dbc66bc-da26-4fdc-b688-251663303681","query_id":"53","doc_a_id":"33076846","doc_b_id":"4434951","presented_order":["4434951","33076846"],"winner_id":"33076846","reasoning":"Document B — it discusses factors overexpressed in cancer (though not ALDH1 or breast cancer specifically), while A concerns aging epigenetics in mice and is unrelated to the claim. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137015Z"}
{"comparison_id":"7819b30f-278c-4e24-b355-7de5347fb4dc","query_id":"53","doc_a_id":"5254463","doc_b_id":"4434951","presented_order":["5254463","4434951"],"winner_id":"5254463","reasoning":"Reason: Both abstracts are unrelated to ALDH1 or breast cancer, but Document A deals with tumorigenesis and stem cells (more closely cancer-related) whereas B focuses on aging epigenetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137022Z"}
{"comparison_id":"f177ce9f-81d4-48a8-9414-37e10ba685b0","query_id":"53","doc_a_id":"4993011","doc_b_id":"4434951","presented_order":["4434951","4993011"],"winner_id":"4993011","reasoning":"Document B — it concerns cancer biology and mechanisms in tumors, which is more related to a claim about a prognostic cancer marker than the mouse aging/epigenetics study in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137045Z"}
{"comparison_id":"98874278-5729-448c-a3ba-67d4cc924162","query_id":"53","doc_a_id":"4457160","doc_b_id":"4434951","presented_order":["4457160","4434951"],"winner_id":"4457160","reasoning":"Document A is more relevant — it concerns cancer genomics and prognosis-related findings, whereas Document B is about aging interventions in mice and unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137052Z"}
{"comparison_id":"2a691467-a67d-45c7-8e05-cfa9b16d77dd","query_id":"53","doc_a_id":"13398997","doc_b_id":"4434951","presented_order":["4434951","13398997"],"winner_id":"4434951","reasoning":"Neither document discusses ALDH1 or breast cancer directly, but Document A's focus on gene-regulatory epigenetic changes is marginally more related to gene expression and cancer biomarkers than Document B's transplant immunology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137060Z"}
{"comparison_id":"ac45b890-b827-4725-ba6e-6a7e40fd91a0","query_id":"53","doc_a_id":"23887844","doc_b_id":"4434951","presented_order":["4434951","23887844"],"winner_id":"23887844","reasoning":"Reason: Document B discusses mechanisms in cancer cells (apoptosis inhibition), making it slightly more relevant to a claim about a cancer prognostic marker; Document A is unrelated (mouse aging/epigenetics).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137067Z"}
{"comparison_id":"21cde72f-95e6-4254-80a0-cc40dc9ff8d2","query_id":"53","doc_a_id":"8724666","doc_b_id":"4434951","presented_order":["4434951","8724666"],"winner_id":"8724666","reasoning":"Document B is more relevant — it concerns cancer cell metabolic features and leukemogenesis, which is closer to tumor biology and prognostic markers like ALDH1 than an aging/epigenetics study in mice.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137074Z"}
{"comparison_id":"1c09d640-3dae-4101-b8df-0de7121933db","query_id":"53","doc_a_id":"25344732","doc_b_id":"4434951","presented_order":["4434951","25344732"],"winner_id":"25344732","reasoning":"Document B is more relevant — it concerns gene expression changes in tumors and cancer biology, whereas A is about aging-related epigenetic changes in mice and not cancer-specific.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137080Z"}
{"comparison_id":"37b4ad2e-7712-468d-9e59-91e3fb4f2a29","query_id":"53","doc_a_id":"10542877","doc_b_id":"4434951","presented_order":["4434951","10542877"],"winner_id":"10542877","reasoning":"Document B is slightly more relevant because it discusses cancer therapeutics, whereas Document A is about aging and epigenetics in mice, unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137087Z"}
{"comparison_id":"70b0b1d5-eb81-406a-b28c-e0814a1b644c","query_id":"53","doc_a_id":"20460020","doc_b_id":"4434951","presented_order":["20460020","4434951"],"winner_id":"4434951","reasoning":"Document B is more relevant — it addresses gene regulation and expression changes (epigenetics), which is closer to questions about ALDH1 expression than the wound-healing/macrophage focus of Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137094Z"}
{"comparison_id":"c75a9125-fc74-4583-9928-32af2daf7e79","query_id":"53","doc_a_id":"25141908","doc_b_id":"4434951","presented_order":["4434951","25141908"],"winner_id":"4434951","reasoning":"Document A is slightly more relevant — it deals with gene regulatory changes and expression-related mechanisms, whereas Document B is focused on cytomegalovirus biology and IL-10 homologs, not cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137101Z"}
{"comparison_id":"eb1845ad-ad5f-4e0c-8191-8bfc01591950","query_id":"53","doc_a_id":"30543439","doc_b_id":"4434951","presented_order":["4434951","30543439"],"winner_id":"30543439","reasoning":"Document B — it concerns cancer cell enzymes and survival, which is closer to a prognosis-related topic than the aging/epigenetics focus of A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137107Z"}
{"comparison_id":"6a956199-aa17-41c6-ba82-04bb211550fd","query_id":"53","doc_a_id":"15727984","doc_b_id":"4434951","presented_order":["4434951","15727984"],"winner_id":"15727984","reasoning":"Reason: Both abstracts don't address ALDH1 or breast cancer, but Document B is cancer-related (tumor microenvironment), making it marginally more relevant than an aging/epigenetics mouse lifespan study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137114Z"}
{"comparison_id":"476033ff-50ee-4f19-bc81-2e15b543cea4","query_id":"53","doc_a_id":"14972169","doc_b_id":"4434951","presented_order":["4434951","14972169"],"winner_id":"4434951","reasoning":"Document A is more relevant — it addresses gene regulatory and expression-related epigenetic changes that could relate to markers like ALDH1, whereas Document B focuses on embryonic oxidative damage and GAPDH, unrelated to breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137121Z"}
{"comparison_id":"be2a745b-6fec-4d19-9a13-4b03f75b864b","query_id":"53","doc_a_id":"28644298","doc_b_id":"4434951","presented_order":["28644298","4434951"],"winner_id":"28644298","reasoning":"Neither abstract mentions ALDH1 or breast cancer; both are largely irrelevant. Document A is marginally more related because it concerns cancer-related cell survival and gene expression, whereas B is about aging epigenetics in mice. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137128Z"}
{"comparison_id":"9d0b63af-4a64-42ae-94a1-80994c49598c","query_id":"53","doc_a_id":"19800147","doc_b_id":"4434951","presented_order":["4434951","19800147"],"winner_id":"19800147","reasoning":"Document B — it's cancer-related (though colon cancer), while A is about mouse aging/epigenetics and unrelated to cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137134Z"}
{"comparison_id":"3bec2222-c162-4d9e-aac9-ea1cbc8f7fa2","query_id":"53","doc_a_id":"4464565","doc_b_id":"4434951","presented_order":["4464565","4434951"],"winner_id":"4464565","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A concerns changes in gene expression (human cells), making it slightly more related to expression–prognosis links than Document B's mouse aging/epigenetics focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137141Z"}
{"comparison_id":"e46f10a3-a4f1-4ec0-b1e8-c3de040e02c9","query_id":"53","doc_a_id":"20888849","doc_b_id":"4434951","presented_order":["4434951","20888849"],"winner_id":"20888849","reasoning":"Document B—it's cancer-related (though in pancreatic cancer), while A is about aging/epigenetics in mice and not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137147Z"}
{"comparison_id":"646c6ebd-22ff-4cff-9cfb-1987bade7deb","query_id":"53","doc_a_id":"23326722","doc_b_id":"4434951","presented_order":["4434951","23326722"],"winner_id":"23326722","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it concerns clinical prognosis in human cancer, whereas A focuses on mouse epigenetics and longevity.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137153Z"}
{"comparison_id":"f87d2ca4-9a2a-4adb-9433-e7cdc104cb18","query_id":"53","doc_a_id":"22890091","doc_b_id":"4434951","presented_order":["4434951","22890091"],"winner_id":"22890091","reasoning":"Document B — it addresses differential expression of apoptosis-related proteins (more closely related to cancer biomarkers/prognosis) while Document A is about mouse epigenetic aging and unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137160Z"}
{"comparison_id":"483a73c4-0d82-413a-b02e-69ef61e8b08a","query_id":"53","doc_a_id":"2205779","doc_b_id":"4434951","presented_order":["4434951","2205779"],"winner_id":"2205779","reasoning":"Document B — it concerns cancer biomarkers (though for gastric rather than breast cancer), so it's more relevant than Document A's mouse-aging epigenetics focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137167Z"}
{"comparison_id":"e3b15f3c-62f4-4a29-94c2-fbb1e14ab138","query_id":"53","doc_a_id":"17775228","doc_b_id":"4434951","presented_order":["4434951","17775228"],"winner_id":"17775228","reasoning":"Document B is more relevant because it addresses gene expression and cancer-related epigenetic changes (though in colorectal cancer), whereas Document A concerns aging interventions in mice and is unrelated to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137174Z"}
{"comparison_id":"01a6c4d8-c7b2-403f-9b9b-32beb2f4e08f","query_id":"53","doc_a_id":"16627684","doc_b_id":"4434951","presented_order":["16627684","4434951"],"winner_id":"16627684","reasoning":"Reason: Document A discusses stem cell biology and factors linked to tumor suppression/self-renewal, which is more related to ALDH1 as a cancer stem-cell marker than Document B's focus on lifespan and epigenetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137181Z"}
{"comparison_id":"4fb2fd6f-9935-470b-a82e-9e2834807df9","query_id":"53","doc_a_id":"38025907","doc_b_id":"4434951","presented_order":["4434951","38025907"],"winner_id":"4434951","reasoning":"Document A is slightly more related because it discusses gene regulatory regions and expression changes, which is closer to ALDH1 expression and prognosis than a study on engineered FGF19 in liver disease.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137187Z"}
{"comparison_id":"84f4b09e-273b-4b19-8d60-2fe2d21f86d8","query_id":"53","doc_a_id":"19343151","doc_b_id":"4434951","presented_order":["4434951","19343151"],"winner_id":"19343151","reasoning":"Neither document addresses ALDH1 or breast cancer; Document B is slightly more relevant because it discusses biomarker expression in human tissue. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137193Z"}
{"comparison_id":"9242d77e-bf73-44ee-a9c4-d4302075134b","query_id":"53","doc_a_id":"1727493","doc_b_id":"4434951","presented_order":["1727493","4434951"],"winner_id":"1727493","reasoning":"Document A is slightly more relevant because it concerns cancer biology (though ovarian, not breast, and doesn't mention ALDH1); Document B concerns aging in mice and is unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137199Z"}
{"comparison_id":"5b4cdfef-c3a1-4e39-bbba-8988ae9e6e65","query_id":"53","doc_a_id":"10450725","doc_b_id":"4434951","presented_order":["4434951","10450725"],"winner_id":"10450725","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B concerns cancer biology (though in hepatocellular carcinoma) and is therefore marginally more related than an aging-epigenetics mouse study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137206Z"}
{"comparison_id":"4a16955c-2657-4e36-87fd-e04acfe04be1","query_id":"53","doc_a_id":"3701541","doc_b_id":"4434951","presented_order":["3701541","4434951"],"winner_id":"3701541","reasoning":"Document A is slightly more relevant because it discusses cancer-related pathways (though in liver, not breast), whereas Document B focuses on aging/epigenetics in mice and is unrelated to cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137212Z"}
{"comparison_id":"fb2d44d0-99be-4e60-b4b0-c5c2b4112bec","query_id":"53","doc_a_id":"26059876","doc_b_id":"4434951","presented_order":["26059876","4434951"],"winner_id":"26059876","reasoning":"Document A is more relevant — it deals with cancer-related molecular mechanisms, whereas Document B is about aging/epigenetics in mice and not cancer-specific.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137218Z"}
{"comparison_id":"5ebdfa39-1133-419e-a857-4ecd208c7e88","query_id":"53","doc_a_id":"39225849","doc_b_id":"4434951","presented_order":["4434951","39225849"],"winner_id":"39225849","reasoning":"Document B — it concerns genomic instability and precancerous states, which is more related to cancer prognosis than Document A's aging/epigenetics focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137225Z"}
{"comparison_id":"97e1213c-ed23-4867-8944-e9087c250511","query_id":"53","doc_a_id":"20977638","doc_b_id":"4434951","presented_order":["20977638","4434951"],"winner_id":"4434951","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document B is slightly more related to gene expression/regulation (though not breast cancer), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137231Z"}
{"comparison_id":"cf6a499d-02e3-4545-b98f-a187f4e1ee98","query_id":"53","doc_a_id":"32776084","doc_b_id":"4434951","presented_order":["32776084","4434951"],"winner_id":"32776084","reasoning":"Document A is slightly more relevant because it concerns stem cell gene expression (ALDH1 is a stem/progenitor cell marker related to cancer prognosis), whereas Document B addresses aging interventions with no link to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137238Z"}
{"comparison_id":"787ca7fc-d025-4cfd-96d3-dc6f8ab72ca8","query_id":"53","doc_a_id":"15491308","doc_b_id":"4434951","presented_order":["15491308","4434951"],"winner_id":"15491308","reasoning":"Neither abstract addresses ALDH1 or breast cancer directly. Document A is slightly more relevant because it concerns stem cell biology (ALDH1 is a stem/progenitor marker), whereas B focuses on aging epigenetics in mice.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137245Z"}
{"comparison_id":"d31d0a4e-468b-403b-8620-43b2a4df6681","query_id":"53","doc_a_id":"18938992","doc_b_id":"4434951","presented_order":["18938992","4434951"],"winner_id":"18938992","reasoning":"Both documents are irrelevant to the claim (neither mentions ALDH1, breast cancer, or prognosis). Document A is slightly more relevant because it concerns cancer-related immune biology, whereas B is about mouse aging/epigenetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137690Z"}
{"comparison_id":"1e6a593c-0b51-4781-8432-f14ea2959e42","query_id":"53","doc_a_id":"3863543","doc_b_id":"4434951","presented_order":["3863543","4434951"],"winner_id":"3863543","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant only because it discusses prognostic markers and disease evolution (though in pre‑leukemia, not breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137699Z"}
{"comparison_id":"b71169f8-94c5-46ac-b077-b8af8336c44c","query_id":"53","doc_a_id":"23816832","doc_b_id":"4434951","presented_order":["4434951","23816832"],"winner_id":"4434951","reasoning":"Neither document directly addresses ALDH1 or breast cancer, but Document A (epigenetic regulation and gene regions) is marginally more related to cancer biology than Document B (CSF analysis in multiple sclerosis).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137705Z"}
{"comparison_id":"d0c8449c-6de2-457f-aa6b-f3816db9854b","query_id":"53","doc_a_id":"8417211","doc_b_id":"4434951","presented_order":["8417211","4434951"],"winner_id":"8417211","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document A is marginally more relevant because it concerns gene expression regulation, whereas Document B discusses mouse aging interventions. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137712Z"}
{"comparison_id":"e6305827-790e-4dbe-9630-04ce89670e15","query_id":"53","doc_a_id":"2919030","doc_b_id":"4434951","presented_order":["2919030","4434951"],"winner_id":"2919030","reasoning":"Document A is slightly more relevant because it discusses mechanisms observed in mammalian cells and cancer metabolism, whereas Document B focuses on mouse aging and epigenetics unrelated to breast cancer biomarkers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137718Z"}
{"comparison_id":"ba56c7cf-1e6c-4867-a284-29881e6f252a","query_id":"53","doc_a_id":"22896384","doc_b_id":"4434951","presented_order":["22896384","4434951"],"winner_id":"4434951","reasoning":"Neither document addresses ALDH1 or breast cancer. Doc B is marginally more relevant because it deals with gene regulatory/epigenetic changes that could affect gene expression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137724Z"}
{"comparison_id":"abb5c5b7-4ca6-40e2-9aa6-e8a231d59772","query_id":"53","doc_a_id":"32372280","doc_b_id":"4434951","presented_order":["4434951","32372280"],"winner_id":"4434951","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document A is marginally more relevant because it deals with gene regulatory changes and expression-related biology, whereas Document B focuses specifically on a glaucoma gene.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137731Z"}
{"comparison_id":"4cac23c6-9ee2-4162-8e90-490b98276f40","query_id":"53","doc_a_id":"25022826","doc_b_id":"4434951","presented_order":["25022826","4434951"],"winner_id":"25022826","reasoning":"Reason: Document A deals with gene regulation and human cell differentiation, which is more related to cancer biomarkers and human gene expression than the aging/epigenetics mouse study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137736Z"}
{"comparison_id":"fec66e62-b19a-43fc-811e-0c66506e6e62","query_id":"53","doc_a_id":"20179918","doc_b_id":"4434951","presented_order":["4434951","20179918"],"winner_id":"20179918","reasoning":"Document B — it concerns gene regulation and transcription factors related to cell pluripotency, which is closer to cancer-related gene expression than the aging/epigenetics mouse study in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137743Z"}
{"comparison_id":"e1a9cba9-39ce-4400-b268-adb17d21ee4b","query_id":"53","doc_a_id":"19958277","doc_b_id":"4434951","presented_order":["19958277","4434951"],"winner_id":"19958277","reasoning":"Reason: Doc A mentions links between helicase mutations and cancer risk, making it marginally more related to cancer prognosis than Doc B, which focuses on aging interventions in mice.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137748Z"}
{"comparison_id":"e9906716-7473-45c0-bf97-76428b1542b7","query_id":"53","doc_a_id":"12580014","doc_b_id":"4434951","presented_order":["4434951","12580014"],"winner_id":"12580014","reasoning":"Document B is slightly more relevant because it concerns gene expression and tumor biology, whereas Document A focuses on aging-related epigenetic changes unrelated to cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137754Z"}
{"comparison_id":"bb5464b7-454f-40c3-9603-cef914d7c5a0","query_id":"53","doc_a_id":"17412260","doc_b_id":"4434951","presented_order":["17412260","4434951"],"winner_id":"17412260","reasoning":"Document A is more related to cancer biology and tumor behavior (senescence, paracrine effects) while Document B concerns aging interventions in mice, so A is more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137761Z"}
{"comparison_id":"612c659d-150c-4bb2-8fc5-70888f97a62d","query_id":"53","doc_a_id":"7221410","doc_b_id":"4434951","presented_order":["4434951","7221410"],"winner_id":"4434951","reasoning":"Document A is marginally more relevant because it addresses gene regulatory and expression changes (epigenetics), which is closer to the topic of gene expression in cancer than an Alzheimer's-focused study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137767Z"}
{"comparison_id":"80360573-fdd1-45a1-b95b-765d6932815b","query_id":"53","doc_a_id":"12887068","doc_b_id":"4434951","presented_order":["12887068","4434951"],"winner_id":"12887068","reasoning":"Document A is slightly more relevant because it deals with cancer biology and tumor stem-cell states, whereas Document B focuses on aging and epigenetics in mice; neither mentions ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137773Z"}
{"comparison_id":"82e45dc8-06b4-4bae-9124-23986f4c1d4a","query_id":"53","doc_a_id":"5765455","doc_b_id":"4434951","presented_order":["5765455","4434951"],"winner_id":"5765455","reasoning":"Document A is more relevant because it concerns cancer biology (albeit leukemia) and mechanisms of tumor progression, whereas Document B focuses on aging and epigenetics in mice and is unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137780Z"}
{"comparison_id":"ddd74e5d-c4bc-4116-ba6d-fdfbd592e25e","query_id":"53","doc_a_id":"2829179","doc_b_id":"4434951","presented_order":["4434951","2829179"],"winner_id":"4434951","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer; Document A (epigenetic regulation) is marginally more related to gene expression than Document B (pre-eclampsia).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137786Z"}
{"comparison_id":"6f765487-2cbd-4b29-9eb4-300fb0cc3b23","query_id":"53","doc_a_id":"28390999","doc_b_id":"4434951","presented_order":["4434951","28390999"],"winner_id":"28390999","reasoning":"Reason: Document B deals with gene expression studies (though in chicken gonadogenesis), which is closer to the claim about a specific gene's expression and prognosis than Document A's focus on mouse epigenetic aging interventions.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137792Z"}
{"comparison_id":"8bada436-010b-440b-b163-da8101e22942","query_id":"53","doc_a_id":"2356950","doc_b_id":"4434951","presented_order":["4434951","2356950"],"winner_id":"2356950","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document B is slightly more relevant because it addresses stem cell proliferation/differentiation (ALDH1 is a cancer stem cell marker), whereas A focuses on aging-related epigenetic changes in mice.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137801Z"}
{"comparison_id":"19058d6d-c3a8-4833-999e-c407ba415ede","query_id":"53","doc_a_id":"11255504","doc_b_id":"4434951","presented_order":["4434951","11255504"],"winner_id":"11255504","reasoning":"Document B is more relevant — it concerns cancer biology (tumor suppressors), whereas Document A addresses aging/epigenetics in mice and not cancer prognosis. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137808Z"}
{"comparison_id":"b15ec7c1-17d5-4252-88f9-2866b9ea0471","query_id":"53","doc_a_id":"13350374","doc_b_id":"4434951","presented_order":["4434951","13350374"],"winner_id":"4434951","reasoning":"Document A is slightly more relevant because it discusses gene regulatory regions and expression changes, which is marginally closer to a claim about a biomarker's prognostic significance than an aging-phenotype study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137815Z"}
{"comparison_id":"98acdce9-ee2d-4d3f-aea8-6a994d11e5a0","query_id":"53","doc_a_id":"34316341","doc_b_id":"4434951","presented_order":["34316341","4434951"],"winner_id":"4434951","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it deals with gene-regulatory epigenetic changes that can affect gene expression, whereas Document A focuses on developmental imprinting of IGF2/H19.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137822Z"}
{"comparison_id":"c97d1836-0589-421c-9ab5-a882bbaaf38d","query_id":"53","doc_a_id":"22914228","doc_b_id":"4434951","presented_order":["22914228","4434951"],"winner_id":"22914228","reasoning":"Reason: Document A studies cancer-related proteomics (though in pancreatic cancer), which is closer to ALDH1 and prognosis in cancer than Document B's aging/epigenetics focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137828Z"}
{"comparison_id":"45f82770-ed01-4b93-9f16-9cd1c532a36d","query_id":"53","doc_a_id":"23513818","doc_b_id":"4434951","presented_order":["4434951","23513818"],"winner_id":"23513818","reasoning":"Document B is slightly more relevant because it concerns regulation of cancer-related proteins (Mcl-1) which is more closely related to tumor biology than an aging/epigenetics study in mice. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137834Z"}
{"comparison_id":"7b6a3864-4df3-4581-ba03-42b0975e4dd4","query_id":"53","doc_a_id":"5811042","doc_b_id":"4434951","presented_order":["4434951","5811042"],"winner_id":"4434951","reasoning":"Document A is slightly more relevant — it deals with gene regulatory regions and epigenetic control of gene expression, which is more related to expression–prognosis questions than the immunology focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137840Z"}
{"comparison_id":"e2d335a9-71ce-49d7-b6e7-024b47d308a6","query_id":"53","doc_a_id":"42484543","doc_b_id":"4434951","presented_order":["4434951","42484543"],"winner_id":"42484543","reasoning":"Reason: Document B deals with gene expression profiling in human stem cells, which is closer to gene expression markers like ALDH1 than Document A's focus on mouse aging and epigenetics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137846Z"}
{"comparison_id":"b0740b77-c133-45bf-9191-2f90f841354e","query_id":"53","doc_a_id":"40901687","doc_b_id":"4434951","presented_order":["4434951","40901687"],"winner_id":"40901687","reasoning":"Document B is slightly more relevant because it deals with DNA damage response and apoptosis pathways linked to cancer biology, whereas Document A focuses on mouse aging and epigenetics unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137853Z"}
{"comparison_id":"b8d3bf11-595b-44d1-9969-0e052978d87f","query_id":"53","doc_a_id":"1982286","doc_b_id":"4434951","presented_order":["1982286","4434951"],"winner_id":"1982286","reasoning":"Document A is cancer-focused (oncogenic networks and tumor suppressors), so slightly more related to a prognosis claim in cancer than Document B which is about aging in mice. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:01:10.137858Z"}
{"comparison_id":"491c9a4b-1f2f-4288-8d7b-d5f946d5867f","query_id":"53","doc_a_id":"3899896","doc_b_id":"2359152","presented_order":["2359152","3899896"],"winner_id":"3899896","reasoning":"Neither document discusses ALDH1 or breast cancer, but Document B addresses a prognostic biomarker in cancer (RDW linked to poor prognosis), making it slightly more relevant than A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556441Z"}
{"comparison_id":"dfe8f86e-6800-4c39-b74a-adb4ff705a82","query_id":"53","doc_a_id":"52925737","doc_b_id":"2359152","presented_order":["2359152","52925737"],"winner_id":"52925737","reasoning":"Document B is more relevant — it links a molecular marker's expression to poor prognosis in a cancer type, which is closer to the claim about marker expression and prognosis than Document A's MDS genetic profiling. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556464Z"}
{"comparison_id":"7df3c914-3b21-4c31-affa-da218c901447","query_id":"53","doc_a_id":"15081770","doc_b_id":"2359152","presented_order":["15081770","2359152"],"winner_id":"15081770","reasoning":"Document A is more relevant — it discusses expression of a tumor-associated enzyme and its prognostic implications in cancer, whereas Document B concerns genetic lesions in myelodysplastic syndromes (unrelated to breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556474Z"}
{"comparison_id":"943f87c8-9341-4ffb-ad1d-f9786c2f94d6","query_id":"53","doc_a_id":"8512633","doc_b_id":"2359152","presented_order":["2359152","8512633"],"winner_id":"2359152","reasoning":"Document A — it discusses prognostic models and outcomes (though in MDS, not breast cancer), so it's slightly more related to prognosis than Document B. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556481Z"}
{"comparison_id":"04e69d90-ca37-4224-a3cb-b8ffb10bfa0b","query_id":"53","doc_a_id":"4467129","doc_b_id":"2359152","presented_order":["2359152","4467129"],"winner_id":"4467129","reasoning":"Document B — it discusses molecular markers and prognosis in cancer (though neuroblastoma), whereas A is about genetic lesions in MDS and not relevant to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556489Z"}
{"comparison_id":"3d622eaa-e5ee-4615-a3d6-35c551db8ecc","query_id":"53","doc_a_id":"34189936","doc_b_id":"2359152","presented_order":["34189936","2359152"],"winner_id":"2359152","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B concerns prognostic associations and risk stratification in cancer, making it slightly more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556497Z"}
{"comparison_id":"f3669b1d-2d6c-4d67-aa51-5d5e55199a6a","query_id":"53","doc_a_id":"29124963","doc_b_id":"2359152","presented_order":["2359152","29124963"],"winner_id":"29124963","reasoning":"Both documents are irrelevant to ALDH1 in breast cancer, but Document B is slightly more relevant because it addresses prognostic significance of a molecular alteration in a solid tumor, whereas A concerns genetic lesions in a hematologic disorder. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556504Z"}
{"comparison_id":"eeb66649-23ab-483f-b845-d62193a80159","query_id":"53","doc_a_id":"11615422","doc_b_id":"2359152","presented_order":["11615422","2359152"],"winner_id":"2359152","reasoning":"Document B is more relevant — it addresses prognostic associations in cancer (genetic lesions and risk models), whereas Document A focuses on PAX5 breakpoints in leukemia and not prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556512Z"}
{"comparison_id":"dba6e64c-08da-4b78-b6fb-1076b51de671","query_id":"53","doc_a_id":"23665162","doc_b_id":"2359152","presented_order":["23665162","2359152"],"winner_id":"2359152","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it concerns prognostic genetic profiling in cancer, whereas A deals with methylation and risk of hepatocellular carcinoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556519Z"}
{"comparison_id":"9999dda6-78dc-4ac6-a2dd-7e7f4d583c87","query_id":"53","doc_a_id":"8677721","doc_b_id":"2359152","presented_order":["2359152","8677721"],"winner_id":"2359152","reasoning":"Document A — it discusses prognostic models (though in MDS, not breast cancer), whereas Document B is mechanistic HCC work and unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556526Z"}
{"comparison_id":"ebe5c78f-1b42-431c-8c0f-47186f8f6858","query_id":"53","doc_a_id":"23830488","doc_b_id":"2359152","presented_order":["23830488","2359152"],"winner_id":"23830488","reasoning":"Document A is slightly more relevant because it links gene expression to metastasis and patient outcomes (though in colorectal, not breast, and not ALDH1).  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556533Z"}
{"comparison_id":"57bb71c7-d34d-4e68-b743-7f52e2810d81","query_id":"53","doc_a_id":"10169908","doc_b_id":"2359152","presented_order":["2359152","10169908"],"winner_id":"2359152","reasoning":"Document A is slightly more relevant because it discusses prognostic modeling in cancer (though in MDS, not breast), whereas Document B focuses on a glutamine transporter in lung cancer unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556540Z"}
{"comparison_id":"c2dd20fc-da76-495f-a825-5736eb90648b","query_id":"53","doc_a_id":"24980622","doc_b_id":"2359152","presented_order":["2359152","24980622"],"winner_id":"24980622","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it deals with marker expression in solid tumor metastases rather than hematologic malignancy.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556548Z"}
{"comparison_id":"3dc94bf6-7bd1-456d-97e2-6774a9f58b48","query_id":"53","doc_a_id":"2727303","doc_b_id":"2359152","presented_order":["2727303","2359152"],"winner_id":"2727303","reasoning":"Document A is more relevant — it discusses mechanisms of cancer progression, while Document B concerns genetic lesions in myelodysplastic syndromes (not breast cancer). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556555Z"}
{"comparison_id":"1b027a13-be26-41ff-8882-ac9d9b9a2177","query_id":"53","doc_a_id":"21502234","doc_b_id":"2359152","presented_order":["21502234","2359152"],"winner_id":"21502234","reasoning":"Document A is slightly more relevant because it addresses cancer prognosis and survival outcomes (though in endometrial cancer), whereas Document B concerns genetic lesions in a hematologic disorder (MDS) and not breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556562Z"}
{"comparison_id":"d6eabf3c-e480-4f50-85a8-4a620a2485b2","query_id":"53","doc_a_id":"14471161","doc_b_id":"2359152","presented_order":["14471161","2359152"],"winner_id":"2359152","reasoning":"Document B is more related — it addresses prognostic markers and genetic lesions in cancer (though in MDS rather than breast cancer), whereas A focuses on meal timing effects in pancreatic tumors and not prognosis. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556570Z"}
{"comparison_id":"2196a00b-1e3c-4097-b6a1-9c0b4e07b456","query_id":"53","doc_a_id":"23577867","doc_b_id":"2359152","presented_order":["2359152","23577867"],"winner_id":"2359152","reasoning":"Document A is more relevant — it discusses prognostic models in a cancer context (though MDS, not breast cancer), whereas B concerns endometrial cancer risk factors unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556577Z"}
{"comparison_id":"a0de15dd-93b8-4136-b07d-6ff153449974","query_id":"53","doc_a_id":"9239963","doc_b_id":"2359152","presented_order":["2359152","9239963"],"winner_id":"9239963","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it concerns cancer cell biology, whereas A focuses on myelodysplastic syndromes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556584Z"}
{"comparison_id":"831fbc4f-af4f-4925-b9b7-d15a120619c2","query_id":"53","doc_a_id":"31439189","doc_b_id":"2359152","presented_order":["2359152","31439189"],"winner_id":"31439189","reasoning":"Reason: Document B discusses stem cell markers in cancer cells (closer to ALDH1's role as a stemness marker), while Document A is about genetic lesions in myelodysplastic syndromes and unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556591Z"}
{"comparison_id":"2f252e61-b8c9-4a61-859d-1aa0a10028ee","query_id":"53","doc_a_id":"2272614","doc_b_id":"2359152","presented_order":["2359152","2272614"],"winner_id":"2359152","reasoning":"Neither document addresses ALDH1 or breast cancer; however, Document A discusses prognostic models (though in MDS), making it marginally more relevant to a prognosis-related query. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556599Z"}
{"comparison_id":"9c93c045-7329-4477-9d85-45672513411b","query_id":"53","doc_a_id":"16630996","doc_b_id":"2359152","presented_order":["2359152","16630996"],"winner_id":"16630996","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses gene expression markers in cancer (though in pancreatic cancer and about drug resistance), whereas A is about genetic lesions in MDS.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556606Z"}
{"comparison_id":"5e24611c-d7bd-4ef6-a538-ca08cc11a938","query_id":"53","doc_a_id":"25832301","doc_b_id":"2359152","presented_order":["25832301","2359152"],"winner_id":"25832301","reasoning":"Reason: Document A discusses expression of a specific protein and its association with tumor outcome, which is closer to the query about marker expression and prognosis than Document B (genetic lesions in MDS).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556613Z"}
{"comparison_id":"03dd2c18-76f9-4b63-ac0a-f8838aeafffa","query_id":"53","doc_a_id":"7639744","doc_b_id":"2359152","presented_order":["7639744","2359152"],"winner_id":"7639744","reasoning":"Document A — it addresses cancer prognosis (though in lung cancer), which is closer to the claim about prognosis in breast cancer than the MDS genetic study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556620Z"}
{"comparison_id":"7ebf27ef-5bc8-4315-83fc-963267096aac","query_id":"53","doc_a_id":"24349430","doc_b_id":"2359152","presented_order":["2359152","24349430"],"winner_id":"2359152","reasoning":"Neither document addresses ALDH1 or breast cancer directly. Document A discusses prognostic associations (albeit in MDS), making it marginally more relevant than B, which concerns Orai1 in lung cancer cell proliferation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556627Z"}
{"comparison_id":"fc4b9164-66b9-4876-ac8c-90193e6af72a","query_id":"53","doc_a_id":"1507222","doc_b_id":"2359152","presented_order":["2359152","1507222"],"winner_id":"2359152","reasoning":"Document A is slightly more relevant because it concerns prognostic biomarkers in cancer (though in MDS, not breast cancer), whereas Document B addresses UCPs in cancer cachexia and not prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556634Z"}
{"comparison_id":"a4ba591a-0f56-4bcf-a3d1-739830dcabd5","query_id":"53","doc_a_id":"14672919","doc_b_id":"2359152","presented_order":["14672919","2359152"],"winner_id":"14672919","reasoning":"Document A is slightly more relevant because it discusses prognostic markers in a solid carcinoma (cancer prognosis), whereas Document B focuses on genetic lesions in a hematologic disorder (MDS). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556641Z"}
{"comparison_id":"c4807fe1-b6ca-4a48-83c1-540e5426b1ca","query_id":"53","doc_a_id":"5377642","doc_b_id":"2359152","presented_order":["5377642","2359152"],"winner_id":"5377642","reasoning":"Document A is more related to tumor biology and factors influencing tumor immunity/prognosis, whereas Document B concerns genetic lesions in MDS (a different disease). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556648Z"}
{"comparison_id":"7fa76940-a0fd-404e-b13c-267ef09738dc","query_id":"53","doc_a_id":"3684342","doc_b_id":"2359152","presented_order":["2359152","3684342"],"winner_id":"3684342","reasoning":"Document B is slightly more relevant because it addresses marker expression and impact on tumor prognosis in a solid tumor model and uses TCGA expression analysis; Document A concerns myelodysplastic syndromes, unrelated to breast cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556655Z"}
{"comparison_id":"ca2fde19-1541-4aeb-bc43-15845ef02e42","query_id":"53","doc_a_id":"39929509","doc_b_id":"2359152","presented_order":["2359152","39929509"],"winner_id":"39929509","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it discusses cancer-related protein interactions, whereas A focuses on myelodysplastic syndromes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556662Z"}
{"comparison_id":"286550ca-0ffb-4abf-91ff-c7ad736ee8b4","query_id":"53","doc_a_id":"46617075","doc_b_id":"2359152","presented_order":["2359152","46617075"],"winner_id":"46617075","reasoning":"Document B is slightly more relevant because it discusses solid-tumor regulatory pathways, whereas Document A concerns hematologic (MDS) genetics; neither directly addresses ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556669Z"}
{"comparison_id":"43d1f984-bee5-4031-8190-8ab86f8afa9b","query_id":"53","doc_a_id":"31313782","doc_b_id":"2359152","presented_order":["31313782","2359152"],"winner_id":"2359152","reasoning":"Neither document directly addresses ALDH1 or breast cancer. B is slightly more relevant because it deals with molecular markers and prognosis (albeit in MDS), while A focuses on TLRs in lung disease.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556676Z"}
{"comparison_id":"c1d08ce6-0588-4471-b49b-e28f6a11fed1","query_id":"53","doc_a_id":"14180565","doc_b_id":"2359152","presented_order":["14180565","2359152"],"winner_id":"2359152","reasoning":"Document B — it discusses prognostic models and genetic lesions (prognosis-related content), which is slightly closer to the claim about prognosis than a glioblastoma gene-expression study. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556683Z"}
{"comparison_id":"9afa444b-3e4e-4a51-a43e-3657a1c39fbb","query_id":"53","doc_a_id":"39758684","doc_b_id":"2359152","presented_order":["39758684","2359152"],"winner_id":"39758684","reasoning":"Document A discusses effects of protein overexpression on tumorigenesis, which is more closely related to cancer prognosis than Document B's focus on myelodysplastic syndromes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556689Z"}
{"comparison_id":"f46e7636-f540-4165-9c06-d0662e7d7bcb","query_id":"53","doc_a_id":"641786","doc_b_id":"2359152","presented_order":["2359152","641786"],"winner_id":"2359152","reasoning":"Document A — it discusses prognostic modeling in cancer (though in MDS, not breast cancer), so it's marginally more relevant than a study on relapse mutations in childhood ALL.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556697Z"}
{"comparison_id":"305e680d-c75b-4e40-af7c-172ead247e1e","query_id":"53","doc_a_id":"33370","doc_b_id":"2359152","presented_order":["33370","2359152"],"winner_id":"33370","reasoning":"Document A — discusses cancer stem cells and tumor growth (closer to marker-driven prognosis in solid tumors) while Document B concerns genetic lesions in MDS, a hematologic disease. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556704Z"}
{"comparison_id":"3b135726-b8dc-4512-a86f-1ea4c134fa37","query_id":"53","doc_a_id":"32852283","doc_b_id":"2359152","presented_order":["32852283","2359152"],"winner_id":"2359152","reasoning":"Document B — it discusses genetic markers and prognostic models (conceptually closer to biomarker–prognosis relationships) while A concerns a drug effect in lung cancer, not prognosis biomarkers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556711Z"}
{"comparison_id":"3a41ff2f-9298-477a-86eb-d38af6f27920","query_id":"53","doc_a_id":"9211173","doc_b_id":"2359152","presented_order":["9211173","2359152"],"winner_id":"9211173","reasoning":"Document A is more relevant — it discusses cancer biomarker expression and prognosis/early detection, whereas Document B concerns genetic lesions in myelodysplastic syndromes unrelated to breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556718Z"}
{"comparison_id":"c5079bfb-999a-46de-bc12-53aa88a571e8","query_id":"53","doc_a_id":"22123421","doc_b_id":"2359152","presented_order":["22123421","2359152"],"winner_id":"22123421","reasoning":"Document A is more relevant — it addresses a biomarker's association with prognosis in cancer (though in NSCLC), whereas Document B concerns genetic profiling in myelodysplastic syndromes and is not related to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556725Z"}
{"comparison_id":"7a485da4-f93e-4b1a-86dd-a87b6db6d694","query_id":"53","doc_a_id":"20738970","doc_b_id":"2359152","presented_order":["20738970","2359152"],"winner_id":"2359152","reasoning":"Document B — it addresses prognostic associations in cancer (development of prognostic models), making it slightly closer to a claim about prognosis than Document A, which focuses on apoptosis in small cell lung cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556732Z"}
{"comparison_id":"3c1c9b60-ac51-4a50-8b21-c8dd14ec55f6","query_id":"53","doc_a_id":"6121668","doc_b_id":"2359152","presented_order":["2359152","6121668"],"winner_id":"6121668","reasoning":"Document B is slightly more relevant — it examines marker expression and links to prognosis in a carcinoma (though not breast cancer or ALDH1). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556739Z"}
{"comparison_id":"9038a56a-0fd0-4f89-9baa-b71f736a0791","query_id":"53","doc_a_id":"23509593","doc_b_id":"2359152","presented_order":["23509593","2359152"],"winner_id":"2359152","reasoning":"Document B is slightly more relevant because it addresses associations between molecular markers and prognosis (even though it's in MDS, not breast cancer or ALDH1). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556746Z"}
{"comparison_id":"960a3292-f910-45a1-be40-cf7359d4c7e1","query_id":"53","doc_a_id":"9285396","doc_b_id":"2359152","presented_order":["9285396","2359152"],"winner_id":"9285396","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A, which discusses a prognostic marker in cancer (gastric), is marginally more related to prognosis in cancer than the MDS genetics study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556753Z"}
{"comparison_id":"caf153a9-241d-41a1-9c10-2bb6bc91d079","query_id":"53","doc_a_id":"5386514","doc_b_id":"2359152","presented_order":["2359152","5386514"],"winner_id":"5386514","reasoning":"Document B is slightly more relevant because it deals with tumor biology and anticancer responses, whereas Document A focuses on genetic lesions in myelodysplastic syndromes, unrelated to breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556760Z"}
{"comparison_id":"4b292dad-fe2c-4315-800a-f70fef8a9601","query_id":"53","doc_a_id":"3710557","doc_b_id":"2359152","presented_order":["2359152","3710557"],"winner_id":"2359152","reasoning":"Document A is more relevant — it discusses prognostic models and biomarkers in cancer (though in MDS, not breast cancer), whereas B focuses on liver β-catenin signaling unrelated to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556767Z"}
{"comparison_id":"800770d3-0896-48b3-93a5-53fc3cbeff8e","query_id":"53","doc_a_id":"20754359","doc_b_id":"2359152","presented_order":["20754359","2359152"],"winner_id":"20754359","reasoning":"Document A is slightly more relevant — it discusses cancer prognosis (though in ATLL, not breast cancer); Document B focuses on genetic lesions in MDS. Neither mentions ALDH1 or breast cancer, so neither provides direct evidence.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556774Z"}
{"comparison_id":"6b5cc827-d8fc-42af-8fe5-72386d808c6a","query_id":"53","doc_a_id":"53211308","doc_b_id":"2359152","presented_order":["53211308","2359152"],"winner_id":"53211308","reasoning":"Document A is more relevant — it discusses cancer biomarker expression and tumor progression (though in ovarian cancer), while B covers genetic lesions in MDS, not breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556781Z"}
{"comparison_id":"f1db9016-beab-4c37-a157-4d3a79c9ba9b","query_id":"53","doc_a_id":"3355397","doc_b_id":"2359152","presented_order":["3355397","2359152"],"winner_id":"2359152","reasoning":"Document B is more relevant — it deals with cancer-associated biomarkers and prognostic modeling (though in MDS, not breast cancer), whereas A is about drug use and cancer incidence unrelated to ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556788Z"}
{"comparison_id":"7d57a7d2-8991-4e5b-8a93-294853a9d8f8","query_id":"53","doc_a_id":"25628793","doc_b_id":"2359152","presented_order":["2359152","25628793"],"winner_id":"2359152","reasoning":"Document A is more relevant — it concerns prognosis and molecular markers in a malignancy (though MDS, not breast cancer), whereas Document B addresses CYP enzymes in endometriosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556795Z"}
{"comparison_id":"e34b9287-87b7-4150-9c5f-f449e49b57f8","query_id":"53","doc_a_id":"36212758","doc_b_id":"2359152","presented_order":["36212758","2359152"],"winner_id":"36212758","reasoning":"Document A is slightly more relevant because it discusses cancer prognostic patterns and pathway activation related to recurrence risk, whereas Document B focuses on myelodysplastic syndromes genetics unrelated to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556802Z"}
{"comparison_id":"ccda3b07-3d8a-47ce-9098-30cd953f30e4","query_id":"53","doc_a_id":"2360905","doc_b_id":"2359152","presented_order":["2359152","2360905"],"winner_id":"2359152","reasoning":"Document A is slightly more relevant because it addresses prognostic associations and models (though in MDS, not breast cancer); Document B focuses on pediatric glioma genomics. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556810Z"}
{"comparison_id":"a271e6b8-eebe-44aa-8af4-ba18c8c66090","query_id":"53","doc_a_id":"20645538","doc_b_id":"2359152","presented_order":["2359152","20645538"],"winner_id":"20645538","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it examines a prognostic factor in cancer, whereas A focuses on genetic lesions in myelodysplastic syndromes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556818Z"}
{"comparison_id":"eb3517b6-000b-4f9c-9d41-f406ca55aae1","query_id":"53","doc_a_id":"33638477","doc_b_id":"2359152","presented_order":["33638477","2359152"],"winner_id":"33638477","reasoning":"Document A discusses tumor progression and factors affecting proliferation/metastasis in cancers, which is more related to prognosis in cancer than Document B's focus on MDS genetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556825Z"}
{"comparison_id":"de8a9fa1-e30c-4971-a44e-a3a459e59a1d","query_id":"53","doc_a_id":"3805841","doc_b_id":"2359152","presented_order":["2359152","3805841"],"winner_id":"3805841","reasoning":"Document B — it discusses cancer-related mechanisms and links to poor clinical outcomes, which is closer to a claim about prognostic markers in cancer than Document A's focus on myelodysplastic syndromes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556832Z"}
{"comparison_id":"51f1369e-1f4d-4889-a563-cb71e0424247","query_id":"53","doc_a_id":"14663842","doc_b_id":"2359152","presented_order":["2359152","14663842"],"winner_id":"2359152","reasoning":"Document A is marginally more relevant because it addresses prognostic associations (though in MDS), whereas Document B concerns IDH1 metabolic effects unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556863Z"}
{"comparison_id":"cea7e242-d5ad-4ef4-891d-9b03efbc8312","query_id":"53","doc_a_id":"4841908","doc_b_id":"2359152","presented_order":["4841908","2359152"],"winner_id":"2359152","reasoning":"Document B — neither abstract mentions ALDH1 or breast cancer, but B addresses prognostic markers/models (albeit in MDS), making it marginally more relevant to a prognosis-related claim.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556878Z"}
{"comparison_id":"88645d46-b234-4875-86e4-1d502d2e46fb","query_id":"53","doc_a_id":"14938990","doc_b_id":"2359152","presented_order":["14938990","2359152"],"winner_id":"2359152","reasoning":"Neither document mentions ALDH1 or breast cancer; Document B is slightly more relevant because it addresses cancer prognostic markers (though in MDS, not breast cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556887Z"}
{"comparison_id":"9744821d-9935-4ba6-a70d-5f25c962e605","query_id":"53","doc_a_id":"1780819","doc_b_id":"2359152","presented_order":["1780819","2359152"],"winner_id":"1780819","reasoning":"Document A is more relevant because it deals with cancer biomarkers and prognosis (though in endometrial cancer), whereas Document B concerns genetic lesions in myelodysplastic syndromes, unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556895Z"}
{"comparison_id":"921cf1d0-4ef5-45bb-a953-97452db70b65","query_id":"53","doc_a_id":"26902591","doc_b_id":"2359152","presented_order":["26902591","2359152"],"winner_id":"26902591","reasoning":"Document A is slightly more relevant because it addresses solid-tumor cancer biology, whereas Document B concerns hematologic (MDS) genetics and neither mentions ALDH1 or breast cancer specifically.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556902Z"}
{"comparison_id":"89730287-098d-4845-a7ab-c2dfec930bb7","query_id":"53","doc_a_id":"19368793","doc_b_id":"2359152","presented_order":["2359152","19368793"],"winner_id":"2359152","reasoning":"Neither document mentions ALDH1 or breast cancer, but Document A deals with cancer prognostic modeling (though in MDS), so it is slightly more related to the prognosis aspect of the query.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556910Z"}
{"comparison_id":"2580bb10-7a46-443a-b6f3-d8c1e60b9ad6","query_id":"53","doc_a_id":"4959368","doc_b_id":"2359152","presented_order":["2359152","4959368"],"winner_id":"2359152","reasoning":"Document A is slightly more relevant because it discusses prognostic models and prognosis in cancer (though in MDS, not breast cancer); Document B concerns metabolic markers in pancreatic cancer and is less related. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556917Z"}
{"comparison_id":"718cebd2-9aa9-4d19-aec4-e552870f5741","query_id":"53","doc_a_id":"38485364","doc_b_id":"2359152","presented_order":["38485364","2359152"],"winner_id":"38485364","reasoning":"Document A is more related to cancer biology and invasion mechanisms, whereas Document B concerns genetic lesions in myelodysplastic syndromes (unrelated to breast cancer or ALDH1). \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556924Z"}
{"comparison_id":"e1309bb0-7da7-4e38-b5eb-a226066cfc52","query_id":"53","doc_a_id":"3376731","doc_b_id":"2359152","presented_order":["2359152","3376731"],"winner_id":"3376731","reasoning":"Document B is more relevant — it deals with cancer biology and prognosis/therapy (though in ESCC), whereas A is about myelodysplastic syndromes and unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556931Z"}
{"comparison_id":"bf7cfcf2-532e-4a2d-a291-5320d5c28c2f","query_id":"53","doc_a_id":"85665741","doc_b_id":"2359152","presented_order":["2359152","85665741"],"winner_id":"2359152","reasoning":"Neither document discusses ALDH1 or breast cancer, but Document A addresses prognostic markers and models (though in MDS), making it slightly more related to prognosis than Document B about BRAF in NSCLC.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556939Z"}
{"comparison_id":"4d881f01-a928-4378-8320-474bde025356","query_id":"53","doc_a_id":"6363093","doc_b_id":"2359152","presented_order":["2359152","6363093"],"winner_id":"2359152","reasoning":"Document A is slightly more relevant because it discusses prognostic models (though in MDS, not breast cancer); Document B concerns glioblastoma pathways and is unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556947Z"}
{"comparison_id":"36e627cc-67e8-4478-8e8d-8b6e05eea4b8","query_id":"53","doc_a_id":"4387494","doc_b_id":"2359152","presented_order":["4387494","2359152"],"winner_id":"2359152","reasoning":"Neither document is relevant to ALDH1 in breast cancer. Document B is slightly more related because it addresses prognostic markers/models, whereas A focuses on an AML drug.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556969Z"}
{"comparison_id":"f6537439-9829-478f-bc11-c95f90baf634","query_id":"53","doc_a_id":"11900630","doc_b_id":"2359152","presented_order":["11900630","2359152"],"winner_id":"2359152","reasoning":"Neither abstract discusses ALDH1 or breast cancer; Document B is slightly more related because it addresses prognostic models in cancer patients (though in MDS, not breast cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556985Z"}
{"comparison_id":"44ada0f5-80b5-4a6b-8763-6461bb515910","query_id":"53","doc_a_id":"23269537","doc_b_id":"2359152","presented_order":["2359152","23269537"],"winner_id":"23269537","reasoning":"Document B is more relevant — it addresses gene expression changes in cancer (epigenetic regulation of an oncogene), whereas A concerns MDS genetics unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.556994Z"}
{"comparison_id":"6590069b-9121-434f-88b9-e3580e5f8ff1","query_id":"53","doc_a_id":"13905670","doc_b_id":"2359152","presented_order":["2359152","13905670"],"winner_id":"2359152","reasoning":"Both documents are irrelevant to ALDH1 in breast cancer, but Document A is slightly more related because it addresses cancer prognostic models (though in myelodysplastic syndromes, not breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557003Z"}
{"comparison_id":"b5f83b93-3fba-4372-bbef-8453ecfb6111","query_id":"53","doc_a_id":"21551568","doc_b_id":"2359152","presented_order":["2359152","21551568"],"winner_id":"21551568","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B discusses tumor genetic alterations and tumor progression (solid tumors), making it slightly more related than a study of myelodysplastic syndromes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557010Z"}
{"comparison_id":"9166013b-b188-4418-ae63-496bebd80489","query_id":"53","doc_a_id":"9095394","doc_b_id":"2359152","presented_order":["9095394","2359152"],"winner_id":"9095394","reasoning":"Document A — it discusses expression of tissue markers and their relation to tumor behavior, which is conceptually closer to a claim about a marker's prognostic significance in cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557018Z"}
{"comparison_id":"fd7ff73c-7f9e-4e15-bea4-2cd8db6da507","query_id":"53","doc_a_id":"7028976","doc_b_id":"2359152","presented_order":["2359152","7028976"],"winner_id":"7028976","reasoning":"Document B is more relevant — it discusses tumor-initiating (cancer stem) cell markers and prognosis-related biology, which is closer to ALDH1's role in cancer stemness than a study on myelodysplastic syndromes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557045Z"}
{"comparison_id":"03adbadd-abf1-458c-b8fa-b8402a541f4f","query_id":"53","doc_a_id":"11968641","doc_b_id":"2359152","presented_order":["2359152","11968641"],"winner_id":"11968641","reasoning":"Document B is slightly more relevant because it addresses tumor growth and cancer progression (though not breast cancer or ALDH1); Document A is about myelodysplastic syndromes and unrelated.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557058Z"}
{"comparison_id":"2ae25cd2-009e-493f-9b18-4a2b0c5d196d","query_id":"53","doc_a_id":"663464","doc_b_id":"2359152","presented_order":["2359152","663464"],"winner_id":"2359152","reasoning":"Both abstracts are unrelated to ALDH1 or breast cancer, but Document A addresses genetic lesions and prognostic models in a malignancy (MDS), making it slightly more relevant to prognosis than Document B's aging/microRNA focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557068Z"}
{"comparison_id":"085f84aa-ff77-4e16-933f-b52d17376830","query_id":"53","doc_a_id":"26735905","doc_b_id":"2359152","presented_order":["26735905","2359152"],"winner_id":"26735905","reasoning":"Document A is more relevant — it discusses tumor biology and stromal factors affecting epithelial cancers, whereas Document B covers genetic lesions in myelodysplastic syndromes (unrelated to breast cancer or ALDH1).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557076Z"}
{"comparison_id":"6a3d36b8-8cf4-4a75-9bcf-b9c076fd5992","query_id":"53","doc_a_id":"23934390","doc_b_id":"2359152","presented_order":["23934390","2359152"],"winner_id":"23934390","reasoning":"Document A is more relevant — it addresses tumor markers and pathways in a solid tumor (though NSCLC), whereas Document B focuses on genetic profiling in a hematologic malignancy (MDS) unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557085Z"}
{"comparison_id":"62c15eb0-e2b9-4828-a951-20436282d539","query_id":"53","doc_a_id":"2494748","doc_b_id":"2359152","presented_order":["2494748","2359152"],"winner_id":"2494748","reasoning":"Both documents do not address ALDH1 or breast cancer, but Document A discusses biomarker changes in a solid carcinoma context (gastric), making it marginally closer to breast cancer prognosis than the hematologic focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557093Z"}
{"comparison_id":"5620b087-5beb-43d4-a33d-287fe9107d0e","query_id":"53","doc_a_id":"16016673","doc_b_id":"2359152","presented_order":["16016673","2359152"],"winner_id":"2359152","reasoning":"Document B is more relevant — it deals with prognostic associations of molecular markers (though in MDS, not breast cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557100Z"}
{"comparison_id":"858a346d-d1b5-4e88-86d4-dfe80398df2e","query_id":"53","doc_a_id":"1976183","doc_b_id":"2359152","presented_order":["2359152","1976183"],"winner_id":"2359152","reasoning":"Document A — it discusses prognostic associations and models (though in MDS rather than breast cancer), whereas B focuses on a molecular mechanism in oral cancer without prognosis data. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557107Z"}
{"comparison_id":"cd4c99fb-0f06-4e71-8fca-363decbd2370","query_id":"53","doc_a_id":"17876040","doc_b_id":"2359152","presented_order":["2359152","17876040"],"winner_id":"2359152","reasoning":"Reason: Neither paper addresses ALDH1 or breast cancer, but Document A discusses prognostic associations (though in MDS), so it's slightly more related to the claim about prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557114Z"}
{"comparison_id":"a942cfda-0177-40bb-95aa-b0a6bc6328eb","query_id":"53","doc_a_id":"4729644","doc_b_id":"2359152","presented_order":["2359152","4729644"],"winner_id":"4729644","reasoning":"Document B is marginally more relevant because it discusses molecular markers and tumor behavior in cancer, whereas Document A concerns genetic lesions in myelodysplastic syndromes (a different disease). Neither document addresses ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557122Z"}
{"comparison_id":"bddc251d-9cb8-43fe-86d6-c779b51c8825","query_id":"53","doc_a_id":"38355793","doc_b_id":"2359152","presented_order":["38355793","2359152"],"winner_id":"2359152","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it deals with prognostic associations (though in MDS, not breast cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557129Z"}
{"comparison_id":"0c84dc01-3527-4234-99e9-4e5a1217e0b7","query_id":"53","doc_a_id":"7020505","doc_b_id":"2359152","presented_order":["2359152","7020505"],"winner_id":"2359152","reasoning":"Document A is marginally more relevant: although neither mentions ALDH1 or breast cancer, A discusses prognostic models and risk stratification, which is closer to a prognosis-related claim than B. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557137Z"}
{"comparison_id":"ac152f47-0a55-476a-984d-c6e41447adcf","query_id":"53","doc_a_id":"12903921","doc_b_id":"2359152","presented_order":["12903921","2359152"],"winner_id":"2359152","reasoning":"Document B is more relevant — it deals with prognostic markers in human cancer (hematologic malignancy), whereas A is an animal study of oxidative stress in leukemia and neither mentions ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557145Z"}
{"comparison_id":"44f81b02-bd72-461a-91ce-d11bf8c19ee4","query_id":"53","doc_a_id":"57783564","doc_b_id":"2359152","presented_order":["57783564","2359152"],"winner_id":"2359152","reasoning":"Document B — it discusses prognostic models and risk stratification (though in MDS, not breast cancer), whereas A focuses on colon cancer molecular mechanisms and not prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557152Z"}
{"comparison_id":"89dee119-67c1-4a99-9456-ba8a16f0865a","query_id":"53","doc_a_id":"9648896","doc_b_id":"2359152","presented_order":["2359152","9648896"],"winner_id":"9648896","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document B deals with cancer cell signaling and prognosis-related processes (proliferation/chemoresistance), making it slightly more relevant than Document A, which concerns myelodysplastic syndromes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557159Z"}
{"comparison_id":"dbf120b2-98d3-46e2-9948-331beb6021f7","query_id":"53","doc_a_id":"16853734","doc_b_id":"2359152","presented_order":["16853734","2359152"],"winner_id":"2359152","reasoning":"Document B is slightly more relevant because it addresses prognostic markers/models in cancer, whereas A is focused on MMP1-mediated MSC migration in glioma; neither mentions ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557167Z"}
{"comparison_id":"488a8895-40dc-482a-bf77-8c26c6461492","query_id":"53","doc_a_id":"43334921","doc_b_id":"2359152","presented_order":["2359152","43334921"],"winner_id":"43334921","reasoning":"Document B is more relevant — it addresses cancer risk and biomarkers, whereas A focuses on myelodysplastic syndromes, not breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557173Z"}
{"comparison_id":"8851be46-eae9-4ac5-a7e0-44a344f96032","query_id":"53","doc_a_id":"41293601","doc_b_id":"2359152","presented_order":["41293601","2359152"],"winner_id":"2359152","reasoning":"Both documents are irrelevant to ALDH1 expression in breast cancer (neither mentions ALDH1 or breast cancer). ANSWER: B — slightly more relevant because it addresses prognostic models and genetic markers in a cancer cohort, whereas A focuses on glioblastoma-specific mutations.","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557181Z"}
{"comparison_id":"77fbc825-6d45-4ca2-bba5-2fe6e1b3b98f","query_id":"53","doc_a_id":"21414718","doc_b_id":"2359152","presented_order":["21414718","2359152"],"winner_id":"21414718","reasoning":"Document A is slightly more relevant because it addresses cancer-related protein expression and tumor cell behavior (though in gastric cancer), whereas Document B concerns genetic lesions in myelodysplastic syndromes (hematologic), not breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557187Z"}
{"comparison_id":"9ffb10a6-8205-47dd-8641-09694b18fb9c","query_id":"53","doc_a_id":"14848619","doc_b_id":"2359152","presented_order":["14848619","2359152"],"winner_id":"2359152","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is slightly more related because it addresses prognostic biomarkers in cancer, whereas A focuses on hypoxic cell death mechanisms.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557194Z"}
{"comparison_id":"854f1894-3a8d-413e-88c5-74f00e165a9c","query_id":"53","doc_a_id":"24624992","doc_b_id":"2359152","presented_order":["24624992","2359152"],"winner_id":"2359152","reasoning":"Document B is slightly more relevant because it addresses genetic markers and prognostic models (related to prognosis), whereas Document A focuses on IEX-1 regulation in leukemia cell lines and not prognosis. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557201Z"}
{"comparison_id":"31ed0dd6-d7dc-48eb-8cae-a105f98df81f","query_id":"53","doc_a_id":"1649738","doc_b_id":"2359152","presented_order":["2359152","1649738"],"winner_id":"1649738","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document B discusses gene expression changes linked to cancer risk/outcomes, making it slightly more related to an expression–prognosis claim than Document A (which concerns genetic lesions in myelodysplastic syndromes).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557208Z"}
{"comparison_id":"610da82c-0a02-450a-93c1-4a736b07c6f6","query_id":"53","doc_a_id":"17671145","doc_b_id":"2359152","presented_order":["2359152","17671145"],"winner_id":"2359152","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses prognostic markers/models (though in myelodysplastic syndromes, not breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557215Z"}
{"comparison_id":"a00bbf2e-8b52-423e-b8eb-d3b49c72acbf","query_id":"53","doc_a_id":"9196472","doc_b_id":"2359152","presented_order":["2359152","9196472"],"winner_id":"9196472","reasoning":"Document B is more relevant — it deals with gene expression and its links to disease susceptibility, which is marginally closer to a claim about expression (ALDH1) and prognosis than a genetic-mutation study in MDS.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557221Z"}
{"comparison_id":"4c00d708-0b14-4a15-9be5-f7dd8e887e6d","query_id":"53","doc_a_id":"5956380","doc_b_id":"2359152","presented_order":["5956380","2359152"],"winner_id":"2359152","reasoning":"Document B is more relevant — it addresses genetic markers and prognostic models (though in MDS, not breast cancer), whereas A focuses on PPM1D mutations in brainstem gliomas.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557228Z"}
{"comparison_id":"f136bc4b-9310-4396-9cf4-f19f21761d6b","query_id":"53","doc_a_id":"12337611","doc_b_id":"2359152","presented_order":["12337611","2359152"],"winner_id":"12337611","reasoning":"Neither document addresses ALDH1 or breast cancer. Both are irrelevant, but A is marginally more related because it discusses cancer prognosis (neuroblastoma) rather than hematologic disease.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557235Z"}
{"comparison_id":"135c3b1b-a435-47be-803c-942e464082fb","query_id":"53","doc_a_id":"38009906","doc_b_id":"2359152","presented_order":["2359152","38009906"],"winner_id":"38009906","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it deals with cancer-related gene regulation, whereas A focuses on myelodysplastic syndromes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557242Z"}
{"comparison_id":"c8926ce1-6ec5-4f90-bbb5-892bedc6e82a","query_id":"53","doc_a_id":"8702697","doc_b_id":"2359152","presented_order":["8702697","2359152"],"winner_id":"8702697","reasoning":"Document A is more related to cancer biology and tumor aggressiveness (though in prostate cancer), whereas Document B is about hematologic malignancy genetics and is unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557254Z"}
{"comparison_id":"7fa82c31-0b2e-443f-9142-4ce4171760d4","query_id":"53","doc_a_id":"3559136","doc_b_id":"2359152","presented_order":["3559136","2359152"],"winner_id":"3559136","reasoning":"Document A is more relevant — it concerns tumor biology and therapeutic response in solid tumors (more likely to discuss markers like ALDH1 and breast cancer context) while Document B is focused on myelodysplastic syndromes, not breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557261Z"}
{"comparison_id":"048cc544-b4e5-4fb6-831a-e32d55d32633","query_id":"53","doc_a_id":"6121555","doc_b_id":"2359152","presented_order":["2359152","6121555"],"winner_id":"6121555","reasoning":"Document B is more relevant — it addresses tumor biology and molecular markers in cancer cells, whereas A focuses on genetic lesions in myelodysplastic syndromes (not breast cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557269Z"}
{"comparison_id":"3c1b8ebb-8179-4e6f-a234-0eaab5e9ff10","query_id":"53","doc_a_id":"10699587","doc_b_id":"2359152","presented_order":["2359152","10699587"],"winner_id":"2359152","reasoning":"Document A is about genetic lesions and prognostic modeling (biomarker–prognosis associations), which is slightly closer to the claim about a biomarker and prognosis than Document B's prostate radiotherapy subgrouping. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557276Z"}
{"comparison_id":"1ee6225f-6d1d-4e01-b003-9e640e90d1e3","query_id":"53","doc_a_id":"6171953","doc_b_id":"2359152","presented_order":["6171953","2359152"],"winner_id":"2359152","reasoning":"Document B — it discusses prognostic markers and modeling in a cancer context (though MDS, not breast cancer), so it's slightly more related to the claim than Document A on Sirtuin-1 and inflammation.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557284Z"}
{"comparison_id":"389ba768-17e4-4a17-91d7-b22133fc529a","query_id":"53","doc_a_id":"8764879","doc_b_id":"2359152","presented_order":["2359152","8764879"],"winner_id":"2359152","reasoning":"Neither document discusses ALDH1 or breast cancer; however, Document A addresses prognostic models and genetic lesions (general prognosis context), making it marginally more related than B, which focuses on leukemia stem-cell mechanisms. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557295Z"}
{"comparison_id":"b65665bc-1d5e-42d0-afa1-d2b7281d0bf9","query_id":"53","doc_a_id":"1982286","doc_b_id":"2359152","presented_order":["2359152","1982286"],"winner_id":"2359152","reasoning":"Document A is slightly more relevant because it discusses prognostic models and associations with patient outcomes (though in MDS, not breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557302Z"}
{"comparison_id":"889d2fbd-c436-4769-9057-f0030e853e8e","query_id":"53","doc_a_id":"67787658","doc_b_id":"2359152","presented_order":["2359152","67787658"],"winner_id":"2359152","reasoning":"Document A is slightly more relevant because it addresses prognosis in a cancer cohort (though not breast cancer), whereas Document B focuses on glioblastoma drug resistance mechanisms. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557309Z"}
{"comparison_id":"020288ef-01f1-4fbf-a59a-1ae026008768","query_id":"53","doc_a_id":"45764440","doc_b_id":"2359152","presented_order":["45764440","2359152"],"winner_id":"45764440","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A discusses tumor progression/metastasis in a carcinoma model, making it slightly more relevant than a myelodysplastic syndromes genetic study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557316Z"}
{"comparison_id":"bc9ff6fa-22d8-4872-9485-27dd7d22aeb0","query_id":"53","doc_a_id":"42377686","doc_b_id":"2359152","presented_order":["2359152","42377686"],"winner_id":"42377686","reasoning":"Neither paper addresses ALDH1 or breast cancer; both are irrelevant. Document B is marginally more relevant because it discusses prognostic associations (though in CLL, not breast cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557322Z"}
{"comparison_id":"a49d98f5-32b5-4190-b631-87126d7b367f","query_id":"53","doc_a_id":"35993767","doc_b_id":"2359152","presented_order":["35993767","2359152"],"winner_id":"2359152","reasoning":"Document B is more relevant — it deals with prognostic associations and risk stratification (though in MDS, not breast cancer), whereas A concerns CAF-driven metastasis in hepatocellular carcinoma. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557329Z"}
{"comparison_id":"d5122242-a82c-4c27-b78b-ce63e9a20ad6","query_id":"53","doc_a_id":"4795303","doc_b_id":"2359152","presented_order":["4795303","2359152"],"winner_id":"2359152","reasoning":"Document B — it addresses cancer-related genetic markers and prognosis (though in MDS, not breast cancer), so it's closer in topic than the neuroprotection study in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557336Z"}
{"comparison_id":"150830a8-f2fe-449f-a622-966d514c0b73","query_id":"53","doc_a_id":"6766459","doc_b_id":"2359152","presented_order":["2359152","6766459"],"winner_id":"2359152","reasoning":"Document A — it deals with prognostic markers in a cancer cohort (MDS), which is closer to a prognosis-related claim than a fever/miRNA study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557343Z"}
{"comparison_id":"b8b9b030-db47-43b9-9c7f-a50523b34745","query_id":"53","doc_a_id":"26887439","doc_b_id":"2359152","presented_order":["2359152","26887439"],"winner_id":"2359152","reasoning":"Document A is slightly more relevant because it deals with prognostic associations and risk stratification (though in a different cancer), whereas B focuses on survivin in K-Ras-transformed cells and not prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557350Z"}
{"comparison_id":"053a8214-cc51-4baf-82c8-d45960226ab0","query_id":"53","doc_a_id":"26495128","doc_b_id":"2359152","presented_order":["26495128","2359152"],"winner_id":"26495128","reasoning":"Doc A mentions cancer-related protein function and implications for tumor biology, while Doc B concerns genetic lesions in myelodysplastic syndromes (not breast cancer), so A is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557357Z"}
{"comparison_id":"04359139-d1bb-4b9f-afd2-0e4050c62068","query_id":"53","doc_a_id":"36310858","doc_b_id":"2359152","presented_order":["2359152","36310858"],"winner_id":"36310858","reasoning":"Both documents are irrelevant to ALDH1 in breast cancer, but B is slightly more related because it addresses solid-tumor cancer progression mechanisms while A focuses on hematologic (MDS) genetics. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557364Z"}
{"comparison_id":"9ca8f772-8d4e-45ef-906c-b38d01a5e67f","query_id":"53","doc_a_id":"5783785","doc_b_id":"2359152","presented_order":["2359152","5783785"],"winner_id":"2359152","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it deals with prognostic modeling in cancer, whereas B focuses on miRNA in gastric cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557371Z"}
{"comparison_id":"6565102c-33a0-4edd-930f-a2bdabbbae19","query_id":"53","doc_a_id":"22059387","doc_b_id":"2359152","presented_order":["22059387","2359152"],"winner_id":"22059387","reasoning":"Document A is marginally more relevant because it concerns mechanisms of carcinogenesis (solid tumor biology), whereas Document B focuses on genetic lesions in myelodysplastic syndromes; neither directly addresses ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557379Z"}
{"comparison_id":"4d6c3bc8-9d42-433f-b5c4-7fa31f207f25","query_id":"53","doc_a_id":"5271210","doc_b_id":"2359152","presented_order":["5271210","2359152"],"winner_id":"5271210","reasoning":"Document A is more relevant — it discusses prognostic biomarkers in cancer (though HCC), closer to the claim about a biomarker's prognostic value than a study of genetic lesions in MDS.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557386Z"}
{"comparison_id":"48f92811-fdd4-4184-a5b0-a5c4ec02035b","query_id":"53","doc_a_id":"9226649","doc_b_id":"2359152","presented_order":["2359152","9226649"],"winner_id":"2359152","reasoning":"Reason: Document A discusses prognosis and prognostic models (though in myelodysplastic syndromes), which is closer to the claim about prognosis than Document B's focus on colon inflammation and caspase-1/NLRC4 mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557394Z"}
{"comparison_id":"b66c9f34-74eb-4f72-98ad-a531ef86cc49","query_id":"53","doc_a_id":"15215393","doc_b_id":"2359152","presented_order":["2359152","15215393"],"winner_id":"2359152","reasoning":"Document A is slightly more relevant because it concerns prognostic associations in a cancer cohort (though a different cancer), whereas B focuses on glioblastoma treatment mechanisms and not prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557402Z"}
{"comparison_id":"4d93fb58-af29-4a3f-93bb-b2c35c9c5360","query_id":"53","doc_a_id":"5123516","doc_b_id":"2359152","presented_order":["5123516","2359152"],"winner_id":"5123516","reasoning":"Document A is more relevant. Neither discusses ALDH1 or breast cancer, but A concerns a solid tumor marker and tumorigenicity (cancer prognosis/therapy context), whereas B is about genetic lesions in a hematologic disorder (MDS).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557409Z"}
{"comparison_id":"e7bf486a-13cc-4580-9228-82cceccd60e6","query_id":"53","doc_a_id":"22180793","doc_b_id":"2359152","presented_order":["2359152","22180793"],"winner_id":"22180793","reasoning":"Document B is slightly more relevant because it addresses cancer progression and therapeutic markers, whereas Document A is about genetic lesions in myelodysplastic syndromes and neither discusses ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557416Z"}
{"comparison_id":"4790264c-4c7c-4113-8d44-271b9fb66fe1","query_id":"53","doc_a_id":"25513319","doc_b_id":"2359152","presented_order":["2359152","25513319"],"winner_id":"25513319","reasoning":"Document B is more relevant — it concerns cancer biology and factors linked to tumor progression/metastasis, whereas Document A discusses genetic lesions in myelodysplastic syndromes (not breast cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557423Z"}
{"comparison_id":"1b577bee-5914-49d1-9a64-c2d597b639a9","query_id":"53","doc_a_id":"10165723","doc_b_id":"2359152","presented_order":["10165723","2359152"],"winner_id":"10165723","reasoning":"Document A — it discusses biomarker methylation patterns linked to cancer prognosis, which is closer to a claim about a prognostic marker in breast cancer than a genetic survey of myelodysplastic syndromes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557432Z"}
{"comparison_id":"d1e1b376-ba2f-40b1-b23e-6717b804d463","query_id":"53","doc_a_id":"1836154","doc_b_id":"2359152","presented_order":["1836154","2359152"],"winner_id":"1836154","reasoning":"Document A is slightly more relevant—it's about gene expression analyses in cancer (though glioblastoma, not breast cancer). \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557439Z"}
{"comparison_id":"fd1c9993-6d8b-4f39-b869-f749296093d5","query_id":"53","doc_a_id":"37204802","doc_b_id":"2359152","presented_order":["2359152","37204802"],"winner_id":"37204802","reasoning":"Document B is more relevant — it discusses a cancer biomarker and prognosis-related mechanism, whereas A is about genetic lesions in myelodysplastic syndromes (not breast cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557446Z"}
{"comparison_id":"0138fa03-f86e-4026-9621-8687b9317e6a","query_id":"53","doc_a_id":"17911973","doc_b_id":"2359152","presented_order":["2359152","17911973"],"winner_id":"2359152","reasoning":"Both documents are irrelevant to ALDH1 and breast cancer, but Document A is slightly more relevant because it discusses prognostic associations in a cancer cohort, whereas B focuses on retrotransposons and mutagenesis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557453Z"}
{"comparison_id":"e2d90393-94a9-4604-bc75-954ff8294540","query_id":"53","doc_a_id":"28334217","doc_b_id":"2359152","presented_order":["2359152","28334217"],"winner_id":"2359152","reasoning":"Document A — it discusses genetic markers and prognostic models (albeit in MDS rather than breast cancer), making it marginally more relevant to a claim about a biomarker's association with prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557460Z"}
{"comparison_id":"85066188-ebbc-4e12-8f0c-187fd5295726","query_id":"53","doc_a_id":"7869794","doc_b_id":"2359152","presented_order":["7869794","2359152"],"winner_id":"2359152","reasoning":"Document B is more relevant — it addresses prognostic associations and biomarker-based risk models in cancer (MDS), whereas A focuses on neutrophil Ca2+ signaling in ADCC and not prognosis or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557467Z"}
{"comparison_id":"64c1f838-01b1-465c-9152-0f5cdab1d577","query_id":"53","doc_a_id":"22703082","doc_b_id":"2359152","presented_order":["2359152","22703082"],"winner_id":"2359152","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it addresses prognostic modeling in a malignancy, whereas Document B concerns H. pylori–induced AID expression in gastric epithelium. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557474Z"}
{"comparison_id":"03bb47d5-8d2a-4fa8-ac6d-fa73941c4787","query_id":"53","doc_a_id":"3831884","doc_b_id":"2359152","presented_order":["3831884","2359152"],"winner_id":"2359152","reasoning":"Document B is slightly more relevant because it addresses associations between molecular markers and prognosis (though in MDS, not breast cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557481Z"}
{"comparison_id":"27cec73e-f762-496f-9dee-007ebe512040","query_id":"53","doc_a_id":"4325398","doc_b_id":"2359152","presented_order":["2359152","4325398"],"winner_id":"2359152","reasoning":"Document A — it discusses prognostic models (though in MDS), so it's slightly closer to the claim about prognosis than Document B, which focuses on pancreatic cancer genomics. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557488Z"}
{"comparison_id":"ad5602bc-7897-42d9-a319-b0d61717eb46","query_id":"53","doc_a_id":"3504761","doc_b_id":"2359152","presented_order":["3504761","2359152"],"winner_id":"2359152","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it deals with prognostic markers/models, whereas A focuses on liver metabolism and tumorigenesis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557495Z"}
{"comparison_id":"b64fa58e-b8ca-410a-bb36-732908ca891a","query_id":"53","doc_a_id":"9791313","doc_b_id":"2359152","presented_order":["9791313","2359152"],"winner_id":"9791313","reasoning":"Document A is more cancer-related (discusses tumor suppressors and prognosis), while Document B focuses on myelodysplastic syndromes unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557502Z"}
{"comparison_id":"ea420e1e-1501-41ec-8ff7-8fdc77eaf92a","query_id":"53","doc_a_id":"5468807","doc_b_id":"2359152","presented_order":["2359152","5468807"],"winner_id":"5468807","reasoning":"Document B is more relevant — it discusses cancer biology and effects on tumor survival/prognosis, whereas A covers myelodysplastic syndromes unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557509Z"}
{"comparison_id":"d80d68de-c4a8-44d4-9a1f-445b4e129fd9","query_id":"53","doc_a_id":"10365787","doc_b_id":"2359152","presented_order":["10365787","2359152"],"winner_id":"2359152","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses prognostic models (though in MDS, not breast cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557516Z"}
{"comparison_id":"4df77867-3491-4ee0-8594-7d657143a1dc","query_id":"53","doc_a_id":"24783597","doc_b_id":"2359152","presented_order":["2359152","24783597"],"winner_id":"2359152","reasoning":"Document A is more relevant — it deals with cancer prognostic markers and risk stratification (though in MDS, not breast cancer), while Document B concerns IBD immunology and is unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557523Z"}
{"comparison_id":"58aa336d-b859-4d56-9df1-34ca962a9a51","query_id":"53","doc_a_id":"1522336","doc_b_id":"2359152","presented_order":["1522336","2359152"],"winner_id":"2359152","reasoning":"Document B is slightly more relevant because it concerns prognostic markers and genetic profiling, whereas Document A focuses on statin effects in head and neck cancer and neither mentions ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557530Z"}
{"comparison_id":"ee586f8f-15b3-4848-90c5-edbb966c484a","query_id":"53","doc_a_id":"24190159","doc_b_id":"2359152","presented_order":["2359152","24190159"],"winner_id":"2359152","reasoning":"Document A — it discusses prognostic associations (though in MDS, not breast cancer), making it marginally more relevant than Document B which focuses on KRAS in rectal cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557537Z"}
{"comparison_id":"f547a148-9815-4641-9b09-1cc48d825d74","query_id":"53","doc_a_id":"25036988","doc_b_id":"2359152","presented_order":["25036988","2359152"],"winner_id":"2359152","reasoning":"Document B is slightly more relevant because it addresses prognostic associations in cancer (though in MDS, not breast cancer or ALDH1). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557544Z"}
{"comparison_id":"49988c5c-53e8-4410-b59d-c58ba63481dc","query_id":"53","doc_a_id":"12685434","doc_b_id":"2359152","presented_order":["12685434","2359152"],"winner_id":"12685434","reasoning":"Document A is slightly more relevant because it concerns protein expression and cancer invasion (though in glioblastoma, not breast cancer). Neither document addresses ALDH1 or breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557552Z"}
{"comparison_id":"2fd61b16-db0a-40cc-bb97-90289ff30950","query_id":"53","doc_a_id":"18682109","doc_b_id":"2359152","presented_order":["2359152","18682109"],"winner_id":"2359152","reasoning":"Document A is slightly more relevant because it addresses prognostic associations and risk stratification (even though in a different cancer type), whereas Document B focuses on transformation in lung cancer and RB loss. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557559Z"}
{"comparison_id":"8a0d0984-2247-4d62-a2ac-d9bc183501f7","query_id":"53","doc_a_id":"2466614","doc_b_id":"2359152","presented_order":["2359152","2466614"],"winner_id":"2359152","reasoning":"Document A is slightly more relevant because it discusses prognostic associations and models (even though it's in MDS, not breast cancer), whereas Document B focuses on aging in mice and is unrelated to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557566Z"}
{"comparison_id":"6c5d0636-adf7-42a5-b2f5-05ffec340e1c","query_id":"53","doc_a_id":"14019636","doc_b_id":"2359152","presented_order":["14019636","2359152"],"winner_id":"14019636","reasoning":"Document A is more relevant — it discusses cancer genomic features and prognosis-related indicators, whereas Document B focuses on myelodysplastic syndromes (a hematologic disease), not breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557573Z"}
{"comparison_id":"7f776eef-547d-4471-8468-6141a8de9e55","query_id":"53","doc_a_id":"20501163","doc_b_id":"2359152","presented_order":["2359152","20501163"],"winner_id":"20501163","reasoning":"Document B — it concerns tumor biology and mechanisms affecting cancer outcomes, which is more related to prognosis in cancer than a study of myelodysplastic syndromes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557581Z"}
{"comparison_id":"c3f904a1-159b-46b2-80a0-4df57c5b77c6","query_id":"53","doc_a_id":"22049489","doc_b_id":"2359152","presented_order":["22049489","2359152"],"winner_id":"22049489","reasoning":"Neither document provides evidence about ALDH1 or breast cancer prognosis. Document A is slightly more related (cancer biology) but still not relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557588Z"}
{"comparison_id":"f37aa2fb-ea34-4cc5-b46c-ce19ab2b56f0","query_id":"53","doc_a_id":"21063817","doc_b_id":"2359152","presented_order":["21063817","2359152"],"winner_id":"21063817","reasoning":"Document A is slightly more relevant because it concerns expression of protein markers in an epithelial cancer, whereas Document B is about genetic lesions in a hematologic disorder (MDS). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557595Z"}
{"comparison_id":"fcb43961-49a1-45b2-8001-b758d46a1f0e","query_id":"53","doc_a_id":"19427410","doc_b_id":"2359152","presented_order":["2359152","19427410"],"winner_id":"2359152","reasoning":"Document A — it discusses prognostic models (though in MDS, not breast cancer), so it's marginally more related to prognosis than Document B. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557602Z"}
{"comparison_id":"270a32b3-79d1-44ad-9a77-40b1b62b9d6e","query_id":"53","doc_a_id":"23599024","doc_b_id":"2359152","presented_order":["2359152","23599024"],"winner_id":"23599024","reasoning":"Document B is more relevant because it addresses cancer progression mechanisms (though in lung cancer), whereas Document A focuses on genetic lesions in myelodysplastic syndromes, unrelated to breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557609Z"}
{"comparison_id":"570c0b08-6a36-426e-93c8-3b7c128c5018","query_id":"53","doc_a_id":"195689757","doc_b_id":"2359152","presented_order":["2359152","195689757"],"winner_id":"195689757","reasoning":"Neither document directly addresses ALDH1 in breast cancer, but B is slightly more relevant because it discusses metabolic enzymes in cancer (ALDH1 is a metabolic enzyme), whereas A focuses on genetic lesions in myelodysplastic syndromes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557616Z"}
{"comparison_id":"fa0fb4bd-ac3b-4c62-b46e-ec708368de93","query_id":"53","doc_a_id":"15322518","doc_b_id":"2359152","presented_order":["15322518","2359152"],"winner_id":"2359152","reasoning":"Document B is slightly more relevant because it addresses associations between molecular markers and prognosis (though in MDS, not breast cancer), whereas Document A focuses on RTK targeting in rhabdoid tumors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557624Z"}
{"comparison_id":"b7e1f3e8-9086-409e-a2ad-c34a3c168bd6","query_id":"53","doc_a_id":"1617327","doc_b_id":"2359152","presented_order":["1617327","2359152"],"winner_id":"2359152","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it deals with prognostic associations (though in MDS, not breast cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557630Z"}
{"comparison_id":"6e38a258-4397-41fd-a7af-4c3050e4aca1","query_id":"53","doc_a_id":"11578459","doc_b_id":"2359152","presented_order":["2359152","11578459"],"winner_id":"11578459","reasoning":"Document B — it discusses a stem cell–related expression signature in cancer, which is closer to ALDH1 (a stem cell marker) and prognosis than Document A's unrelated MDS genetics. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557638Z"}
{"comparison_id":"43380c24-cd3f-4e0f-aa45-6e34835268c2","query_id":"53","doc_a_id":"18810195","doc_b_id":"2359152","presented_order":["2359152","18810195"],"winner_id":"18810195","reasoning":"Document B is slightly more relevant because it discusses a cancer-related molecular mechanism, whereas Document A focuses on myelodysplastic syndromes (not breast cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557644Z"}
{"comparison_id":"61159558-b863-4dad-a991-747418c41e93","query_id":"53","doc_a_id":"1686997","doc_b_id":"2359152","presented_order":["1686997","2359152"],"winner_id":"1686997","reasoning":"Document A — it's about cancer metabolism and tumor growth (more related to cancer prognosis) while Document B concerns genetic lesions in myelodysplastic syndromes, a different disease. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557651Z"}
{"comparison_id":"ce4d9672-9a8f-4172-bd2f-d379c936bb4d","query_id":"53","doc_a_id":"28249680","doc_b_id":"2359152","presented_order":["28249680","2359152"],"winner_id":"28249680","reasoning":"Document A — it discusses mechanisms in epithelial cancer cells (more relevant to breast cancer context) while Document B focuses on genetic lesions in myelodysplastic syndromes (hematologic disease). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557659Z"}
{"comparison_id":"ea50b727-50f9-4ece-84f8-0e6c1701bb8e","query_id":"53","doc_a_id":"40349336","doc_b_id":"2359152","presented_order":["40349336","2359152"],"winner_id":"40349336","reasoning":"Document A is slightly more relevant because it concerns stem cell biology (ALDH1 is a stem/progenitor cell marker), while Document B focuses on genetic lesions in myelodysplastic syndromes unrelated to breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557666Z"}
{"comparison_id":"74024ea1-adc3-4e4f-b1a2-a818026c56d9","query_id":"53","doc_a_id":"16364639","doc_b_id":"2359152","presented_order":["16364639","2359152"],"winner_id":"16364639","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer directly, but Document A discusses cancer-related gene regulation and oncogenic pathways (more general tumor relevance) while Document B focuses on genetic lesions in myelodysplastic syndromes (hematologic cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557673Z"}
{"comparison_id":"89cbb9c6-26aa-45ec-a3c1-c0a72ad27d16","query_id":"53","doc_a_id":"16201748","doc_b_id":"2359152","presented_order":["2359152","16201748"],"winner_id":"16201748","reasoning":"Document B — it discusses expression of a diagnostic/prognostic marker in epithelial cancer tissues, which is more conceptually related to ALDH1 expression in breast cancer than a genomic study of myelodysplastic syndromes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557680Z"}
{"comparison_id":"112840ce-4277-47d8-8477-b7653b8010ba","query_id":"53","doc_a_id":"2547636","doc_b_id":"2359152","presented_order":["2359152","2547636"],"winner_id":"2547636","reasoning":"Document B is more relevant — it discusses stem cell regulation and links to carcinogenesis, which is closer to ALDH1 (a cancer stem-cell marker) and prognosis in cancers than a study of MDS genetics. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557688Z"}
{"comparison_id":"bba17b3d-d774-4fff-b27a-08317b4e4584","query_id":"53","doc_a_id":"4312169","doc_b_id":"2359152","presented_order":["2359152","4312169"],"winner_id":"2359152","reasoning":"A is more relevant — neither mentions ALDH1 or breast cancer, but A discusses prognostic associations in cancer (albeit MDS), making it marginally closer to the query. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557695Z"}
{"comparison_id":"026295b4-366d-4bc3-8e49-be16b895da8e","query_id":"53","doc_a_id":"6259170","doc_b_id":"2359152","presented_order":["6259170","2359152"],"winner_id":"6259170","reasoning":"Document A — it discusses cancer-related pathways (Nrf2, oxidative stress, chemoresistance) that are more related to tumor biology than the MDS-focused genetic study in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557702Z"}
{"comparison_id":"af1031a0-2604-4e70-b7cd-e316370f007e","query_id":"53","doc_a_id":"24294572","doc_b_id":"2359152","presented_order":["24294572","2359152"],"winner_id":"24294572","reasoning":"Neither document mentions ALDH1 or breast cancer prognosis, but Document A discusses cancer-related signaling (more broadly relevant than MDS genetics). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557708Z"}
{"comparison_id":"0c4a78d9-a7c2-45b9-9175-bdddf4c22439","query_id":"53","doc_a_id":"33076846","doc_b_id":"2359152","presented_order":["33076846","2359152"],"winner_id":"2359152","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses prognostic markers in cancer (myelodysplastic syndromes), whereas A focuses on megakaryocyte biology.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557716Z"}
{"comparison_id":"64e9a86f-c55b-43e3-ae5e-064aaf2c851b","query_id":"53","doc_a_id":"5254463","doc_b_id":"2359152","presented_order":["5254463","2359152"],"winner_id":"5254463","reasoning":"Document A is slightly more related because it discusses stem cells and tumorigenesis (ALDH1 is a stem-cell marker), whereas Document B concerns genetic lesions in MDS and not breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557722Z"}
{"comparison_id":"bdc12166-05ff-4f7d-8c9c-febaa23e743f","query_id":"53","doc_a_id":"4993011","doc_b_id":"2359152","presented_order":["4993011","2359152"],"winner_id":"4993011","reasoning":"Document A — it discusses cancer-related molecular changes (more generally relevant to breast cancer prognosis) while Document B focuses on myelodysplastic syndromes, not breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557730Z"}
{"comparison_id":"0acef6a3-1e4a-43d4-a5df-2e2a2ec57548","query_id":"53","doc_a_id":"4457160","doc_b_id":"2359152","presented_order":["4457160","2359152"],"winner_id":"4457160","reasoning":"Document A is slightly more relevant because it concerns solid tumor cancer genomics and prognosis/therapy, whereas Document B focuses on hematologic MDS and not breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557736Z"}
{"comparison_id":"dc0246b7-967c-4bc2-9ba4-f38de37c96d9","query_id":"53","doc_a_id":"23887844","doc_b_id":"2359152","presented_order":["23887844","2359152"],"winner_id":"23887844","reasoning":"Document A, because it discusses mechanisms in cancer cells relevant to tumor behavior and prognosis, while Document B focuses on genetic lesions in MDS (not breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557743Z"}
{"comparison_id":"f7da6d7f-b73b-48eb-9566-4c6cef3fe1e1","query_id":"53","doc_a_id":"8724666","doc_b_id":"2359152","presented_order":["8724666","2359152"],"winner_id":"2359152","reasoning":"Neither document addresses ALDH1 or breast cancer directly. Document B is slightly more relevant because it deals with prognostic markers and risk stratification, whereas A focuses on leukemia metabolism. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557751Z"}
{"comparison_id":"ad220faf-f467-4fbc-a666-bbd54ca0485d","query_id":"53","doc_a_id":"25344732","doc_b_id":"2359152","presented_order":["25344732","2359152"],"winner_id":"25344732","reasoning":"Reason: Document A discusses protein expression changes in solid tumors (cancer-related expression), which is more related to breast cancer prognostic expression than Document B's focus on genetic lesions in a blood disorder (MDS).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557758Z"}
{"comparison_id":"6544d227-b38d-467e-bd10-640056a3e75e","query_id":"53","doc_a_id":"10542877","doc_b_id":"2359152","presented_order":["2359152","10542877"],"winner_id":"2359152","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant because it addresses prognostic associations (though in MDS, not breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557765Z"}
{"comparison_id":"eea3e046-9ecc-4aaa-9fa5-50d5fc8a781f","query_id":"53","doc_a_id":"30543439","doc_b_id":"2359152","presented_order":["30543439","2359152"],"winner_id":"2359152","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it concerns prognostic associations in cancer patients (albeit in MDS, not breast cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557771Z"}
{"comparison_id":"05b2592b-d56b-4e66-8f68-22134196083d","query_id":"53","doc_a_id":"15727984","doc_b_id":"2359152","presented_order":["15727984","2359152"],"winner_id":"15727984","reasoning":"Document A is slightly more relevant because it studies tumor biology in a solid cancer microenvironment (though it's lung cancer), whereas Document B focuses on genetic lesions in a hematologic disorder; neither addresses ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557779Z"}
{"comparison_id":"e35c1744-ca60-43ba-8aca-cef43a9601f3","query_id":"53","doc_a_id":"28644298","doc_b_id":"2359152","presented_order":["2359152","28644298"],"winner_id":"2359152","reasoning":"Document A is more relevant—it's about associations between molecular markers and prognosis/risk stratification (even though in MDS, it's closer to prognostic evidence than B). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557786Z"}
{"comparison_id":"ab76043d-4798-4dc6-81a1-220bd1f2f7ef","query_id":"53","doc_a_id":"19800147","doc_b_id":"2359152","presented_order":["2359152","19800147"],"winner_id":"2359152","reasoning":"Document A is more relevant because it addresses prognosis and prognostic models (though in MDS), whereas Document B focuses on exosomal miRNA in colon cancer and is unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557793Z"}
{"comparison_id":"010912dc-5b66-4091-85a0-8d724d39915c","query_id":"53","doc_a_id":"4464565","doc_b_id":"2359152","presented_order":["4464565","2359152"],"winner_id":"2359152","reasoning":"Document B is more relevant — it deals with genetic lesions and prognostic models in cancer, which is conceptually closer to a claim about gene expression and prognosis (even though it concerns MDS, not breast cancer). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557800Z"}
{"comparison_id":"9c855f5a-4bc6-4479-8df2-5dc2aade392e","query_id":"53","doc_a_id":"20888849","doc_b_id":"2359152","presented_order":["2359152","20888849"],"winner_id":"2359152","reasoning":"Document A is marginally more relevant because it discusses prognostic associations (though in MDS, not breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557807Z"}
{"comparison_id":"7c714c6a-1cd8-414b-9901-93668d5f10ad","query_id":"53","doc_a_id":"23326722","doc_b_id":"2359152","presented_order":["23326722","2359152"],"winner_id":"2359152","reasoning":"Document B is slightly more relevant because it addresses molecular markers and prognosis in cancer, whereas Document A discusses clinical features of a specific lymphoma unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557814Z"}
{"comparison_id":"05d035ce-dd51-4376-aa2e-a77cce25d597","query_id":"53","doc_a_id":"22890091","doc_b_id":"2359152","presented_order":["2359152","22890091"],"winner_id":"2359152","reasoning":"Document A is slightly more relevant because it discusses prognostic associations (though in MDS, not breast cancer); Document B focuses on leukocyte apoptosis and bcl-2, unrelated to prognosis in cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557821Z"}
{"comparison_id":"60efd2d8-e7f6-4fea-a2d6-25ca17894abd","query_id":"53","doc_a_id":"2205779","doc_b_id":"2359152","presented_order":["2205779","2359152"],"winner_id":"2359152","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it deals with prognostic markers/models (though in MDS, not breast cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557828Z"}
{"comparison_id":"80221af5-ec93-476c-b273-b0b655835800","query_id":"53","doc_a_id":"17775228","doc_b_id":"2359152","presented_order":["2359152","17775228"],"winner_id":"17775228","reasoning":"Document B is slightly more relevant because it discusses gene expression and epigenetic changes in a solid tumor context, whereas Document A concerns genetic lesions in a hematologic disorder unrelated to breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557835Z"}
{"comparison_id":"9328cdaf-0312-4473-abb0-51377a0f0cf5","query_id":"53","doc_a_id":"16627684","doc_b_id":"2359152","presented_order":["16627684","2359152"],"winner_id":"2359152","reasoning":"Document B is slightly more relevant because it addresses prognosis and prognostic models (albeit in MDS), whereas A concerns neural stem cells and aging. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557841Z"}
{"comparison_id":"d4125c7b-36ff-4982-9b62-d9210ad22e3b","query_id":"53","doc_a_id":"19343151","doc_b_id":"2359152","presented_order":["2359152","19343151"],"winner_id":"2359152","reasoning":"Document A — it discusses genetic lesions and prognostic models in a cancer context (though in MDS, not breast cancer), whereas Document B concerns skin aging and is unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557849Z"}
{"comparison_id":"ff96eba4-24fe-4f43-bae3-17cb9b2a381d","query_id":"53","doc_a_id":"1727493","doc_b_id":"2359152","presented_order":["1727493","2359152"],"winner_id":"1727493","reasoning":"Document A is slightly more relevant because it deals with cancer biology and treatment resistance (closer to breast cancer prognosis) while Document B is about hematologic (MDS) genetics and less related. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557855Z"}
{"comparison_id":"2dc6fe2a-ea13-4640-a766-b5e484bafdc0","query_id":"53","doc_a_id":"10450725","doc_b_id":"2359152","presented_order":["10450725","2359152"],"winner_id":"2359152","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it deals with prognostic models in a cancer-related context, whereas A focuses on a treatment effect in hepatocellular carcinoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557863Z"}
{"comparison_id":"e7b07819-0e8c-4b07-9f53-0e4001d9b568","query_id":"53","doc_a_id":"3701541","doc_b_id":"2359152","presented_order":["2359152","3701541"],"winner_id":"2359152","reasoning":"Document A is more relevant — it discusses prognostic models and cancer genetic lesions (though in MDS, not breast cancer), which is closer to a claim about prognosis than Doc B's liver-specific mechanistic study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557870Z"}
{"comparison_id":"b71a15fc-d7e8-4137-b683-9ae50fd81668","query_id":"53","doc_a_id":"26059876","doc_b_id":"2359152","presented_order":["2359152","26059876"],"winner_id":"2359152","reasoning":"Document A is more relevant — it concerns prognostic associations in cancer (even though in MDS rather than breast cancer), whereas B focuses on Ku70 and colorectal tumorigenesis without prognostic data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557877Z"}
{"comparison_id":"e12d503e-e08a-48b3-a206-953e862b4d2d","query_id":"53","doc_a_id":"39225849","doc_b_id":"2359152","presented_order":["39225849","2359152"],"winner_id":"2359152","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it addresses prognostic associations (though in MDS, not breast cancer); A is purely mechanistic about BLM deficiency. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557885Z"}
{"comparison_id":"68566f3b-b345-45ce-b212-9a0ecca30f4c","query_id":"53","doc_a_id":"32776084","doc_b_id":"2359152","presented_order":["2359152","32776084"],"winner_id":"2359152","reasoning":"Reason: Document A discusses prognostic models in a human hematologic cancer, making it marginally closer to the claim about prognosis in cancer than Document B, which studies imprinted genes in mouse embryonic stem cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557892Z"}
{"comparison_id":"61e77545-c62a-4c0d-a220-7485d267f65d","query_id":"53","doc_a_id":"15491308","doc_b_id":"2359152","presented_order":["2359152","15491308"],"winner_id":"2359152","reasoning":"Document A is marginally more relevant — it discusses prognostic markers in a cancer cohort (though in MDS, not breast cancer), while Document B focuses on SIRT1 in mesenchymal stem cells and does not address ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557900Z"}
{"comparison_id":"a0831bf1-6eb6-4683-b2ad-a22c1f0d9ab2","query_id":"53","doc_a_id":"18938992","doc_b_id":"2359152","presented_order":["2359152","18938992"],"winner_id":"2359152","reasoning":"Document A is slightly more relevant because it discusses prognosis and prognostic models in cancer, whereas Document B focuses on EBV effects in B lymphocytes; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557907Z"}
{"comparison_id":"25fab3a7-ddda-4058-bc65-676cf1236eb0","query_id":"53","doc_a_id":"3863543","doc_b_id":"2359152","presented_order":["3863543","2359152"],"winner_id":"2359152","reasoning":"Neither abstract discusses ALDH1 or breast cancer. Document B is marginally more relevant because it focuses on genetic markers and prognostic models, which is closer to a prognosis–biomarker relationship. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557914Z"}
{"comparison_id":"f2f4af45-79c7-4267-8613-1b60b773271c","query_id":"53","doc_a_id":"8417211","doc_b_id":"2359152","presented_order":["2359152","8417211"],"winner_id":"2359152","reasoning":"Document A — it addresses prognostic associations (albeit in MDS, not breast cancer), whereas Document B is an unrelated Drosophila HP1 mechanistic study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557921Z"}
{"comparison_id":"209f8544-b77a-44a9-b828-843936a855fe","query_id":"53","doc_a_id":"2919030","doc_b_id":"2359152","presented_order":["2359152","2919030"],"winner_id":"2919030","reasoning":"Document B is slightly more relevant because it discusses cancer-related metabolic mechanisms in mammalian cells; Document A is about myelodysplastic syndromes, not breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557928Z"}
{"comparison_id":"3c951ef5-af00-4780-9b35-54cf67ac4e89","query_id":"53","doc_a_id":"25022826","doc_b_id":"2359152","presented_order":["25022826","2359152"],"winner_id":"2359152","reasoning":"Document B — it discusses prognostic associations and risk models (though in MDS, not breast cancer), so it's closer to the claim's prognosis focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557935Z"}
{"comparison_id":"4e28c601-1d4c-41b1-a071-4ac117c6aa26","query_id":"53","doc_a_id":"20179918","doc_b_id":"2359152","presented_order":["2359152","20179918"],"winner_id":"20179918","reasoning":"Document B is slightly more relevant because it concerns transcriptional regulation of stemness-related genes (more related to ALDH1's role as a stem cell marker) while Document A concerns MDS genetics unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557941Z"}
{"comparison_id":"4c8e0072-6d3b-4432-8086-f0a9db7d3976","query_id":"53","doc_a_id":"19958277","doc_b_id":"2359152","presented_order":["19958277","2359152"],"winner_id":"19958277","reasoning":"Document A is marginally more relevant — it discusses cancer-related genomic maintenance broadly, whereas Document B focuses specifically on myelodysplastic syndromes and not breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557948Z"}
{"comparison_id":"eb266b12-55a2-41bc-88f9-f4f24ea8f183","query_id":"53","doc_a_id":"12580014","doc_b_id":"2359152","presented_order":["12580014","2359152"],"winner_id":"2359152","reasoning":"Document B is more relevant — it addresses prognostic associations (though in MDS, not breast cancer), whereas Document A concerns keratin/Aire in skin tumors and does not discuss ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557955Z"}
{"comparison_id":"00b26e17-cd28-40e4-b52b-c2b8a4f7d314","query_id":"53","doc_a_id":"17412260","doc_b_id":"2359152","presented_order":["2359152","17412260"],"winner_id":"17412260","reasoning":"Document B is more relevant — it addresses tumor-related processes (senescence, paracrine signaling) that are more likely to relate to cancer prognosis than Document A, which focuses on myelodysplastic syndromes unrelated to breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557964Z"}
{"comparison_id":"3475cf9e-3da8-46f9-86b1-add82e36cffa","query_id":"53","doc_a_id":"12887068","doc_b_id":"2359152","presented_order":["12887068","2359152"],"winner_id":"12887068","reasoning":"Document A is more relevant — it discusses stem cell–like tumor states (ALDH1 is a stem-cell marker), while Document B concerns genetic lesions in MDS unrelated to breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557971Z"}
{"comparison_id":"5a0eee43-385b-4e34-ab00-ccab46267df3","query_id":"53","doc_a_id":"5765455","doc_b_id":"2359152","presented_order":["5765455","2359152"],"winner_id":"2359152","reasoning":"Document B — it discusses prognostic models and risk stratification (though in MDS, not breast cancer), so it's marginally more related to the claim's prognosis aspect.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557977Z"}
{"comparison_id":"f1d348b1-f492-446c-abf4-f7601682d206","query_id":"53","doc_a_id":"28390999","doc_b_id":"2359152","presented_order":["28390999","2359152"],"winner_id":"2359152","reasoning":"Document B — it addresses prognostic genetic markers in cancer (though in MDS), whereas A is about chicken gonad development and unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557984Z"}
{"comparison_id":"4d59455c-dd46-43e8-8ba6-a1a1a1ab88f9","query_id":"53","doc_a_id":"2356950","doc_b_id":"2359152","presented_order":["2356950","2359152"],"winner_id":"2359152","reasoning":"Document B is slightly more relevant because it discusses prognostic models and associations of biomarkers with patient outcomes, whereas Document A focuses on neural stem cells and miR-184. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557991Z"}
{"comparison_id":"68e6a0c6-3acd-4273-a8e8-3ce083167359","query_id":"53","doc_a_id":"11255504","doc_b_id":"2359152","presented_order":["11255504","2359152"],"winner_id":"11255504","reasoning":"Document A is slightly more relevant because it concerns cancer biology (tumor suppressor roles), whereas Document B focuses on genetic lesions in a blood disorder (MDS) unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.557998Z"}
{"comparison_id":"38354298-69a1-4c42-9998-d06bff3dc5a8","query_id":"53","doc_a_id":"22914228","doc_b_id":"2359152","presented_order":["22914228","2359152"],"winner_id":"22914228","reasoning":"Document A — it's a proteomic study of a solid tumor cancer (pancreatic) and thus closer in topic to breast cancer marker expression than a hematologic-genetics study of MDS.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.558006Z"}
{"comparison_id":"652138d4-1962-475e-a6ca-88469b39028d","query_id":"53","doc_a_id":"23513818","doc_b_id":"2359152","presented_order":["23513818","2359152"],"winner_id":"23513818","reasoning":"Document A is more related to cancer biology and protein expression/turnover, whereas Document B focuses on genetics of myelodysplastic syndromes (unrelated to ALDH1 or breast cancer prognosis).\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.558013Z"}
{"comparison_id":"d5a2ab4f-b752-4403-858b-977c1ce99b29","query_id":"53","doc_a_id":"42484543","doc_b_id":"2359152","presented_order":["2359152","42484543"],"winner_id":"42484543","reasoning":"Reason: Neither abstract addresses ALDH1 or breast cancer, but Document B (stem cell transcriptome) is marginally more relevant because it concerns gene expression and stemness markers, which relate conceptually to ALDH1's role as a stem/progenitor marker.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.558021Z"}
{"comparison_id":"69df4049-eb5f-4167-aff8-a1ed4fac54cf","query_id":"53","doc_a_id":"40901687","doc_b_id":"2359152","presented_order":["2359152","40901687"],"winner_id":"2359152","reasoning":"Doc A discusses prognostic associations in a cancer cohort and development of prognostic models, whereas Doc B is a mechanistic DNA-damage study unrelated to prognosis or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:02:39.558028Z"}
{"comparison_id":"dc68afeb-187b-4585-9c3d-11b8ebda469b","query_id":"53","doc_a_id":"3899896","doc_b_id":"38009906","presented_order":["3899896","38009906"],"winner_id":"38009906","reasoning":"Document B is more relevant — it discusses molecular cancer gene regulation (epigenetic/transcriptional mechanisms) which is closer to studies of marker expression and prognosis than Document A's RDW findings in rectal cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763574Z"}
{"comparison_id":"a5097d41-086d-478d-93c0-888effd7da77","query_id":"53","doc_a_id":"52925737","doc_b_id":"38009906","presented_order":["38009906","52925737"],"winner_id":"52925737","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses marker expression linked to prognosis in cancer, whereas A focuses on ANRIL/CBX7 transcriptional silencing.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763595Z"}
{"comparison_id":"7164d799-1f2a-4f48-be3a-5e87bd5eb65e","query_id":"53","doc_a_id":"15081770","doc_b_id":"38009906","presented_order":["15081770","38009906"],"winner_id":"15081770","reasoning":"Document A is slightly more relevant because it discusses expression of a protein as a prognostic factor in cancer, whereas Document B focuses on epigenetic silencing mechanisms unrelated to ALDH1 or breast cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763604Z"}
{"comparison_id":"61e483c5-ce29-4a4a-add1-563844fa896d","query_id":"53","doc_a_id":"4467129","doc_b_id":"38009906","presented_order":["4467129","38009906"],"winner_id":"4467129","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses prognostic associations in cancer (though in neuroblastoma), whereas B focuses on chromatin silencing unrelated to ALDH1/breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763612Z"}
{"comparison_id":"21fc5f33-fa9a-4134-b664-1a8304d591f3","query_id":"53","doc_a_id":"29124963","doc_b_id":"38009906","presented_order":["29124963","38009906"],"winner_id":"38009906","reasoning":"Document B — it discusses molecular cancer mechanisms and tumor-suppressor regulation (more related to biomarkers/prognosis) while A is a lung-specific translocation study unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763619Z"}
{"comparison_id":"9d062c51-27e5-4d39-b449-2ec74c583046","query_id":"53","doc_a_id":"23830488","doc_b_id":"38009906","presented_order":["23830488","38009906"],"winner_id":"23830488","reasoning":"Document A is more relevant — it concerns correlations between gene expression and patient outcomes/prognosis (though in colorectal cancer), whereas Document B covers epigenetic silencing mechanisms unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763627Z"}
{"comparison_id":"3ea25036-2a7a-4954-881a-7bdbc886ec1c","query_id":"53","doc_a_id":"24980622","doc_b_id":"38009906","presented_order":["38009906","24980622"],"winner_id":"38009906","reasoning":"Document A is more relevant — it discusses cancer-related gene expression and regulation (though not ALDH1 specifically), while B focuses on colorectal liver metastases and hypoxia markers unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763634Z"}
{"comparison_id":"dfaa1d3c-38da-409f-aacf-e0cbd5ea0738","query_id":"53","doc_a_id":"2727303","doc_b_id":"38009906","presented_order":["38009906","2727303"],"winner_id":"2727303","reasoning":"Document B — it concerns cancer cell malignant behavior and therapy-relevant biomarkers, whereas A focuses on ANRIL/CBX7-mediated silencing of INK4a with no link to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763642Z"}
{"comparison_id":"1136cb4f-7cd8-454a-b1ab-a4d7e12d39e9","query_id":"53","doc_a_id":"21502234","doc_b_id":"38009906","presented_order":["21502234","38009906"],"winner_id":"38009906","reasoning":"Document B is slightly more relevant because it addresses cancer-related molecular mechanisms, whereas Document A focuses on mismatch repair in endometrial cancer, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763648Z"}
{"comparison_id":"a72c7341-564f-4a38-986e-1accb01e8256","query_id":"53","doc_a_id":"9239963","doc_b_id":"38009906","presented_order":["38009906","9239963"],"winner_id":"38009906","reasoning":"Document A — it discusses molecular cancer biology and tumor suppressor regulation, which is more related to cancer prognosis than Document B's focus on endometrial steroidogenesis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763655Z"}
{"comparison_id":"7030c672-ef24-4397-a98c-7acc38ecb2b3","query_id":"53","doc_a_id":"31439189","doc_b_id":"38009906","presented_order":["38009906","31439189"],"winner_id":"31439189","reasoning":"Document B is more relevant — it discusses stem cell markers and clonogenicity in cancer cell lines (closer to ALDH1 as a stem-cell marker) while A focuses on ANRIL/CBX7 regulation of INK4 unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763663Z"}
{"comparison_id":"cb0ee9f2-6d69-4ceb-a0d6-6f3d834be92f","query_id":"53","doc_a_id":"16630996","doc_b_id":"38009906","presented_order":["38009906","16630996"],"winner_id":"38009906","reasoning":"Document A is more relevant — it deals with cancer-related gene expression and tumor suppressor regulation, whereas B focuses on gemcitabine transport/metabolism in pancreatic cancer, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763671Z"}
{"comparison_id":"3fe67f64-e0f8-48d9-90f0-1797a4c20f9a","query_id":"53","doc_a_id":"25832301","doc_b_id":"38009906","presented_order":["25832301","38009906"],"winner_id":"38009906","reasoning":"Document B is more relevant — it addresses cancer-related molecular markers and tumor suppressor regulation, whereas A is specific to multiple myeloma and TSPAN7, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763678Z"}
{"comparison_id":"eb36016a-b945-442c-9f89-5c99f4312e88","query_id":"53","doc_a_id":"7639744","doc_b_id":"38009906","presented_order":["38009906","7639744"],"winner_id":"38009906","reasoning":"Document A is slightly more relevant because it deals with molecular markers and cancer biology, whereas Document B focuses on smoking cessation and lung cancer; however, neither discusses ALDH1 or breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763685Z"}
{"comparison_id":"c824103e-f3a0-4c51-a314-f504e6a26b8b","query_id":"53","doc_a_id":"14672919","doc_b_id":"38009906","presented_order":["14672919","38009906"],"winner_id":"14672919","reasoning":"Document A is more relevant because it addresses prognostic markers in cancer (though for esophageal cancer), whereas Document B focuses on molecular silencing unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763693Z"}
{"comparison_id":"3961e68e-519f-4cb0-acd7-5611a10ea377","query_id":"53","doc_a_id":"5377642","doc_b_id":"38009906","presented_order":["5377642","38009906"],"winner_id":"38009906","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis. Document B is slightly more relevant because it addresses tumor-cell epigenetic regulation, whereas A focuses on T cell PD-1 regulation.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763700Z"}
{"comparison_id":"7bd35e56-a8bd-42dc-b4be-e54c75acfe28","query_id":"53","doc_a_id":"3684342","doc_b_id":"38009906","presented_order":["38009906","3684342"],"winner_id":"38009906","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it deals with cancer-related transcriptional regulation and tumor suppressors, whereas B is specific to lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763707Z"}
{"comparison_id":"24e8ab45-3ef9-42c3-8515-2a0b75b099d8","query_id":"53","doc_a_id":"39929509","doc_b_id":"38009906","presented_order":["38009906","39929509"],"winner_id":"39929509","reasoning":"Document B — it at least discusses WT1's role in cancers generally, whereas A focuses on ANRIL/CBX7 and a prostate-related locus; neither mentions ALDH1 or breast cancer but B is marginally more related to cancer biology. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763715Z"}
{"comparison_id":"fe00ef4a-1f4e-4d8b-8023-15d3de30194a","query_id":"53","doc_a_id":"46617075","doc_b_id":"38009906","presented_order":["38009906","46617075"],"winner_id":"38009906","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more generally related to cancer biology (gene regulation) than B, which is specific to lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763722Z"}
{"comparison_id":"0d9da450-0509-4c37-9a32-230689da8c3f","query_id":"53","doc_a_id":"39758684","doc_b_id":"38009906","presented_order":["39758684","38009906"],"winner_id":"38009906","reasoning":"Neither abstract mentions ALDH1 or breast cancer, so both are irrelevant. Document B is slightly more related to cancer gene regulation, so is marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763729Z"}
{"comparison_id":"926bb424-bec8-4ca4-99f3-263433052f81","query_id":"53","doc_a_id":"33370","doc_b_id":"38009906","presented_order":["38009906","33370"],"winner_id":"33370","reasoning":"Document B — it discusses cancer stem cell survival and tumor growth (ALDH1 is a stem-cell marker), whereas Document A focuses on ANRIL/CBX7 and INK4a silencing unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763736Z"}
{"comparison_id":"ee36bf13-be79-4c11-9336-65cbf658ec07","query_id":"53","doc_a_id":"9211173","doc_b_id":"38009906","presented_order":["38009906","9211173"],"winner_id":"38009906","reasoning":"Document A is slightly more relevant — it deals with cancer-related transcriptional regulation and tumor suppressor pathways (more generalizable to breast cancer prognosis) while B focuses specifically on ARID1A in ovarian carcinoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763744Z"}
{"comparison_id":"c72965b6-6fe7-43fa-9602-a8dd840dc654","query_id":"53","doc_a_id":"22123421","doc_b_id":"38009906","presented_order":["38009906","22123421"],"winner_id":"38009906","reasoning":"Document A is more relevant — it discusses cancer-related molecular markers and gene regulation, whereas B concerns platelet measures in lung cancer unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763752Z"}
{"comparison_id":"bca425f6-4526-4e5c-891c-848b8db543ac","query_id":"53","doc_a_id":"6121668","doc_b_id":"38009906","presented_order":["6121668","38009906"],"winner_id":"6121668","reasoning":"Document A — it discusses expression of markers and their (lack of) link to prognosis/overall survival, which is closer to the claim about prognostic association than Document B's mechanistic study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763760Z"}
{"comparison_id":"527c7f63-2765-461f-9f47-d42ebd4b7ef3","query_id":"53","doc_a_id":"9285396","doc_b_id":"38009906","presented_order":["38009906","9285396"],"winner_id":"9285396","reasoning":"Document B is slightly more relevant because it addresses prognostic markers in cancer (though in gastric cancer), whereas Document A discusses a molecular mechanism unrelated to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763767Z"}
{"comparison_id":"4744913b-7bb4-4fa1-9e62-63afbccb765f","query_id":"53","doc_a_id":"5386514","doc_b_id":"38009906","presented_order":["38009906","5386514"],"winner_id":"38009906","reasoning":"Reason: Document A discusses molecular mechanisms in tumorigenesis and tumor suppressor regulation, making it slightly more relevant to a prognostic biomarker claim than Document B's focus on inflammasome-driven antitumor immunity.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763775Z"}
{"comparison_id":"d1625ead-dbbc-436b-b7f7-228eee486b4f","query_id":"53","doc_a_id":"20754359","doc_b_id":"38009906","presented_order":["20754359","38009906"],"winner_id":"38009906","reasoning":"Document B — it discusses molecular oncology mechanisms relevant to cancer biology, whereas A focuses on adult T‑cell leukemia/lymphoma clinical course and therapy and neither mentions ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763782Z"}
{"comparison_id":"ebace912-bbde-446c-b5ae-243c8596749c","query_id":"53","doc_a_id":"53211308","doc_b_id":"38009906","presented_order":["38009906","53211308"],"winner_id":"38009906","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. Document A is slightly more relevant because it deals with cancer-related molecular mechanisms, whereas B concerns ovarian cancer biomarkers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763790Z"}
{"comparison_id":"ab0b4ac8-ff25-4bd7-9cb5-db4550332424","query_id":"53","doc_a_id":"36212758","doc_b_id":"38009906","presented_order":["38009906","36212758"],"winner_id":"38009906","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it covers general cancer-related molecular mechanisms, while B is specific to lung cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763801Z"}
{"comparison_id":"31bd0bfa-2b02-48aa-8c9a-4eb918d4bfb0","query_id":"53","doc_a_id":"20645538","doc_b_id":"38009906","presented_order":["38009906","20645538"],"winner_id":"38009906","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more related (cancer molecular biology) than B (lung clinical study).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763808Z"}
{"comparison_id":"e3e6459a-ebba-4130-a63f-802f4560f26f","query_id":"53","doc_a_id":"33638477","doc_b_id":"38009906","presented_order":["38009906","33638477"],"winner_id":"33638477","reasoning":"Neither document mentions ALDH1 or breast cancer. If forced to choose, B is marginally more relevant because it deals with tumor progression and prognosis-related features.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763815Z"}
{"comparison_id":"dd1c00d4-c99a-4605-a63e-e5fc00b5473b","query_id":"53","doc_a_id":"3805841","doc_b_id":"38009906","presented_order":["38009906","3805841"],"winner_id":"38009906","reasoning":"Document A is slightly more relevant—it's about cancer-related molecular markers and tumor suppressor regulation, which is closer to prognostic marker biology than the circadian/metabolism focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763823Z"}
{"comparison_id":"fca46ab0-9b00-4f17-8dc3-6698e46a2ab5","query_id":"53","doc_a_id":"1780819","doc_b_id":"38009906","presented_order":["38009906","1780819"],"winner_id":"38009906","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Both are irrelevant; Document A is slightly more related to cancer gene expression/pathways. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763830Z"}
{"comparison_id":"347278f2-7c4a-47be-b3e2-3cb756550be5","query_id":"53","doc_a_id":"26902591","doc_b_id":"38009906","presented_order":["26902591","38009906"],"winner_id":"38009906","reasoning":"Document B is more relevant — it discusses molecular mechanisms in cancer (gene silencing and tumor suppressor regulation), which is closer to markers and prognosis than a study on adipose browning and cachexia. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763837Z"}
{"comparison_id":"0a3ec1a1-4f40-4ae5-ade3-5d2f5045904c","query_id":"53","doc_a_id":"38485364","doc_b_id":"38009906","presented_order":["38485364","38009906"],"winner_id":"38485364","reasoning":"Document A is more relevant — it discusses cancer cell invasion and factors linked to aggressive cancer behavior, whereas Document B focuses on noncoding RNA-mediated silencing unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763845Z"}
{"comparison_id":"d21cbeee-8e33-45a5-b7a7-113ca79ef29d","query_id":"53","doc_a_id":"3376731","doc_b_id":"38009906","presented_order":["3376731","38009906"],"winner_id":"38009906","reasoning":"Document B is more relevant — neither mentions ALDH1 or breast cancer, but B discusses molecular regulation of tumor suppressors with broader implications for cancer prognosis, whereas A is specific to IL6-driven chemoresistance in esophageal cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763853Z"}
{"comparison_id":"9ee7796e-2b4d-422f-bef0-f6cc8df93c0e","query_id":"53","doc_a_id":"23269537","doc_b_id":"38009906","presented_order":["23269537","38009906"],"winner_id":"38009906","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document B is slightly more relevant because it concerns transcriptional silencing of a tumor suppressor locus and broader cancer biology, whereas A focuses on cyclin D1 in B-cell malignancy. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763861Z"}
{"comparison_id":"bee79c2f-2849-4318-befc-4cc7500404e6","query_id":"53","doc_a_id":"21551568","doc_b_id":"38009906","presented_order":["38009906","21551568"],"winner_id":"38009906","reasoning":"Document A — it discusses gene expression and cancer-related transcriptional regulation (more relevant to a claim about a cancer biomarker) while Document B focuses specifically on thyroid cancer pathways. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763868Z"}
{"comparison_id":"92bba197-fe8b-4c4e-8f5d-44f98ff5b729","query_id":"53","doc_a_id":"9095394","doc_b_id":"38009906","presented_order":["9095394","38009906"],"winner_id":"9095394","reasoning":"Document A is more relevant — it discusses expression of protein markers in epithelial cancers and their links to tumor differentiation/invasiveness, which is closer to a claim about a biomarker (ALDH1) and prognosis than Document B's epigenetic/ANRIL mechanism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763876Z"}
{"comparison_id":"99f20913-7743-443c-b5db-7e42b27c7c2a","query_id":"53","doc_a_id":"7028976","doc_b_id":"38009906","presented_order":["38009906","7028976"],"winner_id":"38009906","reasoning":"Document A is slightly more relevant — it addresses cancer-related molecular markers and transcriptional regulation (potentially related to prognosis), whereas Document B is specific to EGFR in glioblastoma and not breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763883Z"}
{"comparison_id":"5bcf4c97-7128-40bd-a328-03e49082ae3b","query_id":"53","doc_a_id":"11968641","doc_b_id":"38009906","presented_order":["11968641","38009906"],"winner_id":"38009906","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document B is slightly more relevant because it addresses molecular markers and tumor-suppressor regulation in cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763890Z"}
{"comparison_id":"a08f6968-86ca-4443-a021-6b2e60fa7e61","query_id":"53","doc_a_id":"26735905","doc_b_id":"38009906","presented_order":["38009906","26735905"],"winner_id":"26735905","reasoning":"Document B is slightly more relevant because it addresses mechanisms that influence tumor progression and the tumor microenvironment, whereas A focuses on a chromatin-silencing mechanism unrelated to ALDH1 or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763897Z"}
{"comparison_id":"1c21f5d5-6431-4f6c-9f17-5a7ceb7cbc98","query_id":"53","doc_a_id":"23934390","doc_b_id":"38009906","presented_order":["23934390","38009906"],"winner_id":"38009906","reasoning":"Neither paper examines ALDH1 or breast cancer; however, Document B discusses tumor‑suppressor regulation and epigenetic mechanisms linked to cancer prognosis, so it is slightly more relevant. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763904Z"}
{"comparison_id":"7c955265-94cc-4e5b-b163-2e11625af598","query_id":"53","doc_a_id":"2494748","doc_b_id":"38009906","presented_order":["2494748","38009906"],"winner_id":"38009906","reasoning":"Document B is more relevant — it discusses cancer-related molecular regulation (polycomb/lncRNA) which is closer to markers and prognosis in cancer, whereas A focuses on gastric carcinoma methylation unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763911Z"}
{"comparison_id":"56b44806-7bb0-4ca7-b12a-0926a217a87b","query_id":"53","doc_a_id":"4729644","doc_b_id":"38009906","presented_order":["38009906","4729644"],"winner_id":"38009906","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns cancer-related gene regulation, whereas B focuses on NEAT1 in nasopharyngeal carcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763918Z"}
{"comparison_id":"354ea30d-4285-4c7b-a515-f34b35a26b7e","query_id":"53","doc_a_id":"9648896","doc_b_id":"38009906","presented_order":["9648896","38009906"],"winner_id":"9648896","reasoning":"Document A is more relevant — it discusses cancer cell proliferation and chemoresistance (processes linked to markers like ALDH1 and prognosis), while Document B focuses on polycomb-mediated silencing unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763950Z"}
{"comparison_id":"14b9237f-894d-44dc-8225-7e4aeab968eb","query_id":"53","doc_a_id":"43334921","doc_b_id":"38009906","presented_order":["43334921","38009906"],"winner_id":"38009906","reasoning":"Document B is more relevant — it addresses molecular mechanisms and cancer-related gene regulation (closer to marker/prognosis studies) while A is an epidemiologic colorectal cancer/NSAID paper. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763963Z"}
{"comparison_id":"8d7115b4-d150-4daf-bb10-061c3feae763","query_id":"53","doc_a_id":"21414718","doc_b_id":"38009906","presented_order":["21414718","38009906"],"winner_id":"38009906","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document B discusses cancer-relevant gene regulation and tumor suppressor silencing, making it marginally more relevant than Document A, which focuses on gastric cancer mobility.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763972Z"}
{"comparison_id":"8a25d79b-60bf-4694-9c51-7d29a9098073","query_id":"53","doc_a_id":"1649738","doc_b_id":"38009906","presented_order":["38009906","1649738"],"winner_id":"38009906","reasoning":"Document A is slightly more relevant because it discusses cancer-related gene regulation and expression, whereas Document B concerns genetic risk for secondary malignancies after Hodgkin's lymphoma and not gene expression in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763980Z"}
{"comparison_id":"8b12602b-96ff-4217-a8ad-53ded6381e58","query_id":"53","doc_a_id":"9196472","doc_b_id":"38009906","presented_order":["9196472","38009906"],"winner_id":"38009906","reasoning":"Document B — it discusses cancer-related pathways (tumor suppressor locus and cell senescence), so it's more relevant to a prognosis-related claim in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763988Z"}
{"comparison_id":"b41c0dd7-d4eb-46fc-885c-94dcb93fb566","query_id":"53","doc_a_id":"12337611","doc_b_id":"38009906","presented_order":["12337611","38009906"],"winner_id":"38009906","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it discusses cancer-related transcriptional regulation of a tumor suppressor locus, whereas A is specific to LIN28B in neuroblastoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.763996Z"}
{"comparison_id":"e4581a6f-786c-4e72-8a43-f92bbf0549c7","query_id":"53","doc_a_id":"42484543","doc_b_id":"38009906","presented_order":["42484543","38009906"],"winner_id":"38009906","reasoning":"Document B — it concerns cancer-related epigenetic regulation (tumor suppressor locus silencing), whereas A is about embryonic stem cell transcriptomes. Neither document mentions ALDH1 or breast cancer prognosis, but B is more cancer-relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764004Z"}
{"comparison_id":"08681bd1-1356-4cba-9146-1152eb68f235","query_id":"53","doc_a_id":"8702697","doc_b_id":"38009906","presented_order":["38009906","8702697"],"winner_id":"38009906","reasoning":"Neither document addresses ALDH1 or breast cancer; Document A is slightly more generally cancer-related (epigenetic regulation/tumor suppressors) while B is specific to prostate CAFs. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764012Z"}
{"comparison_id":"6ee22775-70be-4633-9ae1-6ee6f41158a7","query_id":"53","doc_a_id":"3559136","doc_b_id":"38009906","presented_order":["38009906","3559136"],"winner_id":"3559136","reasoning":"Document B is more relevant — it addresses tumor microenvironment and treatment response (closer to prognosis context), whereas A focuses on ANRIL/CBX7-mediated INK4a silencing and not ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764020Z"}
{"comparison_id":"6a8089df-1ebf-49a5-b4ac-d25e09377b19","query_id":"53","doc_a_id":"6121555","doc_b_id":"38009906","presented_order":["6121555","38009906"],"winner_id":"38009906","reasoning":"Document B — it discusses cancer-related molecular mechanisms (polycomb-mediated silencing) which is more generally relevant to cancer prognosis than a glioma-specific SPHK1/apoptosis study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764027Z"}
{"comparison_id":"e84b1ca6-8e85-41c4-b9bd-c26504a380d4","query_id":"53","doc_a_id":"45764440","doc_b_id":"38009906","presented_order":["38009906","45764440"],"winner_id":"38009906","reasoning":"Neither abstract mentions ALDH1 or breast cancer prognosis. Document A is marginally more relevant because it addresses cancer-related gene regulation, whereas B focuses on Src in pancreatic cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764034Z"}
{"comparison_id":"b48cd0d4-32b0-4aac-951c-9c2959cc937b","query_id":"53","doc_a_id":"42377686","doc_b_id":"38009906","presented_order":["42377686","38009906"],"winner_id":"38009906","reasoning":"Document B — it addresses cancer-related molecular markers and tumor suppression mechanisms (more related to cancer prognosis) whereas A is specific to CLL/SLL cytogenetics and not breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764042Z"}
{"comparison_id":"1d6e1cfb-c78d-40b5-88e4-85ec22c32b3b","query_id":"53","doc_a_id":"26495128","doc_b_id":"38009906","presented_order":["38009906","26495128"],"winner_id":"38009906","reasoning":"Document A is slightly more relevant because it discusses cancer-related transcriptional regulation and tumor suppressor pathways, which are closer to prognosis in cancer than ribosomal biogenesis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764049Z"}
{"comparison_id":"67b79257-b4dc-4384-8c67-57d0269f79df","query_id":"53","doc_a_id":"36310858","doc_b_id":"38009906","presented_order":["36310858","38009906"],"winner_id":"38009906","reasoning":"Document B is slightly more relevant — it addresses cancer-related regulatory mechanisms (tumor suppressor silencing) that could relate to prognostic markers, whereas A is specific to KRAS-driven pancreatic cancer. Neither document mentions ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764056Z"}
{"comparison_id":"874fcad4-cb5c-4292-9076-647003ba05c1","query_id":"53","doc_a_id":"22059387","doc_b_id":"38009906","presented_order":["22059387","38009906"],"winner_id":"38009906","reasoning":"Document B is more relevant — it addresses molecular mechanisms of cancer-related gene regulation (epigenetic silencing of tumor suppressors), which is closer to biomarkers and prognosis in human cancers than the infection-driven cholangiocarcinoma model in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764063Z"}
{"comparison_id":"c4ce10d8-a9dd-4a80-9aae-5f65014656cf","query_id":"53","doc_a_id":"5271210","doc_b_id":"38009906","presented_order":["38009906","5271210"],"winner_id":"5271210","reasoning":"Document B is marginally more relevant — it discusses biomarkers and prognosis in cancer (though for HCC, not breast cancer), while A focuses on ANRIL/CBX7 transcriptional silencing unrelated to ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764070Z"}
{"comparison_id":"0d5f3441-5466-4594-b730-cf43038db991","query_id":"53","doc_a_id":"5123516","doc_b_id":"38009906","presented_order":["5123516","38009906"],"winner_id":"38009906","reasoning":"Document B — it discusses gene expression and cancer-related transcriptional regulation, which is marginally more related to biomarkers and prognosis than a glioblastoma-targeting study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764078Z"}
{"comparison_id":"dc0a05c8-440f-4e90-be58-b6da75c406f3","query_id":"53","doc_a_id":"22180793","doc_b_id":"38009906","presented_order":["38009906","22180793"],"winner_id":"38009906","reasoning":"Document A is more relevant — though neither mentions ALDH1 or breast cancer, A discusses tumor-suppressor regulation and cancer-related epigenetics, which is more related to prognostic markers than B’s prostate-specific therapy focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764085Z"}
{"comparison_id":"ad40a55d-55f1-4a5e-8551-f64e75d33c9b","query_id":"53","doc_a_id":"25513319","doc_b_id":"38009906","presented_order":["38009906","25513319"],"winner_id":"38009906","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. Document A is marginally more related to cancer molecular mechanisms, so:\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764092Z"}
{"comparison_id":"fb868477-841e-415a-96c3-0de61548e04c","query_id":"53","doc_a_id":"10165723","doc_b_id":"38009906","presented_order":["38009906","10165723"],"winner_id":"38009906","reasoning":"Document A is slightly more relevant — it addresses cancer-related gene regulation and tumor suppressor pathways, whereas Document B focuses on methylation in melanoma; neither mentions ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764099Z"}
{"comparison_id":"f072d1bc-0c27-4562-af2f-f765f2cfa8e2","query_id":"53","doc_a_id":"1836154","doc_b_id":"38009906","presented_order":["1836154","38009906"],"winner_id":"38009906","reasoning":"Document B is more relevant — it addresses cancer-related gene regulation and tumor suppressor pathways that are more likely to relate to biomarkers and prognosis across cancers, whereas A focuses specifically on glioblastoma genomics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764106Z"}
{"comparison_id":"a0e22bbe-3694-43d0-b904-13de13e21f3a","query_id":"53","doc_a_id":"37204802","doc_b_id":"38009906","presented_order":["37204802","38009906"],"winner_id":"38009906","reasoning":"Neither document mentions ALDH1 or breast cancer, but Document B discusses cancer-related transcriptional regulation and tumor suppressors, making it slightly more relevant. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764113Z"}
{"comparison_id":"7f1e53ef-4b46-4b86-abb3-41f5740c72c1","query_id":"53","doc_a_id":"9791313","doc_b_id":"38009906","presented_order":["38009906","9791313"],"winner_id":"9791313","reasoning":"Document B is more relevant — it discusses epigenetic modifiers and cancer development broadly, whereas A focuses on ANRIL/CBX7 and INK4a with no relation to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764120Z"}
{"comparison_id":"24af8166-0c28-4d1f-b546-10e9e42d9f30","query_id":"53","doc_a_id":"5468807","doc_b_id":"38009906","presented_order":["5468807","38009906"],"winner_id":"38009906","reasoning":"Both documents are not directly about ALDH1 or breast cancer prognosis. Document B is slightly more relevant because it discusses mechanisms of tumor suppression and cell senescence that can relate to cancer prognosis, whereas A focuses on ARID1A-mutated ovarian cancer therapy.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764128Z"}
{"comparison_id":"44d165e2-9d84-4c4d-840f-ec4c55c84118","query_id":"53","doc_a_id":"12685434","doc_b_id":"38009906","presented_order":["12685434","38009906"],"winner_id":"38009906","reasoning":"Neither document discusses ALDH1 or breast cancer; Document B is slightly more relevant because it concerns cancer-related gene regulation and tumor suppressors, whereas A is specific to glioblastoma invasion.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764135Z"}
{"comparison_id":"8053f2bd-7ab7-4627-a2d2-60a014d4fe78","query_id":"53","doc_a_id":"14019636","doc_b_id":"38009906","presented_order":["14019636","38009906"],"winner_id":"38009906","reasoning":"Document B is slightly more relevant — it concerns gene expression and cancer-related transcriptional regulation, which is closer to a claim about a specific cancer marker's prognostic significance than a study of rDNA copy number. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764142Z"}
{"comparison_id":"a445635c-5736-4569-94f1-d66971b1f189","query_id":"53","doc_a_id":"20501163","doc_b_id":"38009906","presented_order":["20501163","38009906"],"winner_id":"38009906","reasoning":"Neither document mentions ALDH1 or breast cancer prognosis; Document B is slightly more related because it discusses cancer-related molecular markers and transcriptional regulation. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764149Z"}
{"comparison_id":"b0efe66e-effa-443c-8138-23a8d06013e4","query_id":"53","doc_a_id":"22049489","doc_b_id":"38009906","presented_order":["22049489","38009906"],"winner_id":"38009906","reasoning":"Neither document mentions ALDH1 or breast cancer; Document B is slightly more relevant because it addresses tumor-suppressor regulation and epigenetic mechanisms that can relate broadly to cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764156Z"}
{"comparison_id":"57255a7d-5905-4f26-954e-0ab7407e8a51","query_id":"53","doc_a_id":"21063817","doc_b_id":"38009906","presented_order":["38009906","21063817"],"winner_id":"38009906","reasoning":"Document A is more relevant — it addresses molecular factors in cancer biology (tumor suppressor regulation), whereas Document B concerns keratins in oral squamous carcinoma, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764163Z"}
{"comparison_id":"c7a7fc41-9b21-4b27-a55b-7dd0df411edc","query_id":"53","doc_a_id":"23599024","doc_b_id":"38009906","presented_order":["38009906","23599024"],"winner_id":"23599024","reasoning":"Document B — it discusses cancer progression and prognosis-related effects (though in lung cancer), whereas Document A focuses on noncoding RNA/CBX7 epigenetics unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764170Z"}
{"comparison_id":"e5d1d26e-33a9-4fcb-8351-e03fabdf5c35","query_id":"53","doc_a_id":"195689757","doc_b_id":"38009906","presented_order":["195689757","38009906"],"winner_id":"195689757","reasoning":"Document A is more relevant — it discusses metabolic enzymes in cancer (ALDH1 is a metabolic enzyme/marker), while Document B focuses on ANRIL/CBX7 epigenetic silencing unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764177Z"}
{"comparison_id":"c4b9ca80-60e9-435c-91bd-ac71d2581492","query_id":"53","doc_a_id":"11578459","doc_b_id":"38009906","presented_order":["11578459","38009906"],"winner_id":"11578459","reasoning":"Document A is slightly more relevant because it discusses a stem cell–related transcriptional program in cancer (closer to ALDH1 as a stem-cell marker), whereas B focuses on ANRIL/CBX7-mediated silencing unrelated to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764185Z"}
{"comparison_id":"797fb26e-f472-4de1-9f02-cf5f030751a5","query_id":"53","doc_a_id":"18810195","doc_b_id":"38009906","presented_order":["38009906","18810195"],"winner_id":"18810195","reasoning":"Neither document mentions ALDH1 or breast cancer prognosis. Document B is marginally more relevant because it discusses tumor-associated enzyme alterations in human cancers, whereas A focuses on ANRIL/CBX7 silencing of the INK4 locus with prostate implications. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764191Z"}
{"comparison_id":"8bf2506b-4bd7-4f81-99d5-144395f355e9","query_id":"53","doc_a_id":"1686997","doc_b_id":"38009906","presented_order":["1686997","38009906"],"winner_id":"1686997","reasoning":"Document A is slightly more relevant because it discusses a metabolic enzyme implicated in tumor growth, whereas Document B focuses on noncoding RNA/polycomb silencing unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764198Z"}
{"comparison_id":"418f7ed2-d15c-4b87-b92e-94b83fa462e6","query_id":"53","doc_a_id":"28249680","doc_b_id":"38009906","presented_order":["28249680","38009906"],"winner_id":"28249680","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer prognosis, but Document A discusses epithelial cancer cell biology (more directly related to cancer prognosis) whereas Document B focuses on ANRIL/CBX7-mediated silencing with prostate implications.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764205Z"}
{"comparison_id":"a6ae23d4-a225-4685-8bb2-b8c242320963","query_id":"53","doc_a_id":"40349336","doc_b_id":"38009906","presented_order":["38009906","40349336"],"winner_id":"40349336","reasoning":"Document B is more relevant — it concerns stem/progenitor cell biology, which relates to ALDH1 as a stem cell marker; Document A focuses on ANRIL/CBX7 and INK4a silencing (unrelated). \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764212Z"}
{"comparison_id":"82062f2f-ae94-485e-9e51-94b6904a99fb","query_id":"53","doc_a_id":"16364639","doc_b_id":"38009906","presented_order":["38009906","16364639"],"winner_id":"38009906","reasoning":"Document A is more relevant — it addresses cancer-related molecular regulation (epigenetic control of tumor suppressors), whereas Document B is specific to glioblastoma and does not concern breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764219Z"}
{"comparison_id":"6ad30ef2-c5e2-4d00-83c9-780971824e2d","query_id":"53","doc_a_id":"16201748","doc_b_id":"38009906","presented_order":["38009906","16201748"],"winner_id":"38009906","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document A is about ANRIL/CBX7 and INK4a silencing; Document B is about PTEN in endometrium. More relevant: A (both are irrelevant, but A deals with cancer-related molecular mechanisms). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764226Z"}
{"comparison_id":"dcf05850-055f-4594-92f7-d8b9b23b29b1","query_id":"53","doc_a_id":"2547636","doc_b_id":"38009906","presented_order":["2547636","38009906"],"winner_id":"38009906","reasoning":"Document B is more relevant — it concerns cancer-related gene regulation and tumor suppressors, whereas A is about epidermal circadian rhythms not linked to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764233Z"}
{"comparison_id":"8a440ac8-4b82-4ec4-97d5-59e0bba43f33","query_id":"53","doc_a_id":"6259170","doc_b_id":"38009906","presented_order":["38009906","6259170"],"winner_id":"38009906","reasoning":"Document A is more related to cancer-related molecular mechanisms (tumor suppressor regulation) while Document B focuses on Nrf2/mitochondria and oxidative stress — neither mentions ALDH1 or breast cancer, but A is closer in topic. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764240Z"}
{"comparison_id":"15169b2e-f206-43a2-a9d5-d0c8b839ae56","query_id":"53","doc_a_id":"24294572","doc_b_id":"38009906","presented_order":["24294572","38009906"],"winner_id":"24294572","reasoning":"Document A is slightly more relevant — it discusses cancer signaling and tumor behavior (growth/motility) which relate to prognosis; Document B focuses on ANRIL/CBX7 and INK4 silencing (not breast or ALDH1).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764248Z"}
{"comparison_id":"0caeccb8-ca8e-4d0a-a62a-177b54e2a795","query_id":"53","doc_a_id":"5254463","doc_b_id":"38009906","presented_order":["5254463","38009906"],"winner_id":"5254463","reasoning":"Document A is slightly more relevant because it addresses stem cells and tumorigenesis (ALDH1 is a cancer stem cell marker), whereas Document B focuses on noncoding RNA/epigenetic silencing unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764255Z"}
{"comparison_id":"c84173e8-d45d-49a2-8399-4b8d68e23d5e","query_id":"53","doc_a_id":"4993011","doc_b_id":"38009906","presented_order":["4993011","38009906"],"winner_id":"38009906","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Both are irrelevant; B is marginally more related because it deals with gene expression/regulation in cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764262Z"}
{"comparison_id":"adc332b8-fd84-4164-9993-d4c116563bec","query_id":"53","doc_a_id":"4457160","doc_b_id":"38009906","presented_order":["38009906","4457160"],"winner_id":"4457160","reasoning":"Document B — it discusses clinical/genomic factors linked to patient outcomes and therapy response, which is closer to a prognosis-related claim than Document A's molecular silencing study. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764270Z"}
{"comparison_id":"826083dc-17ab-4e62-8b90-d28731df3093","query_id":"53","doc_a_id":"23887844","doc_b_id":"38009906","presented_order":["23887844","38009906"],"winner_id":"23887844","reasoning":"Document A is slightly more relevant because it addresses mechanisms of cancer cell survival and metabolism, which are more directly related to tumor behavior and prognosis than the epigenetic ANRIL/CBX7 focus in Document B.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764277Z"}
{"comparison_id":"ed744fae-4887-45f1-a14f-49eb8a87d4e7","query_id":"53","doc_a_id":"25344732","doc_b_id":"38009906","presented_order":["38009906","25344732"],"winner_id":"38009906","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document A is slightly more relevant because it discusses cancer-related gene regulation and tumor suppressor silencing, while Document B focuses specifically on PHC3 loss in osteosarcoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764285Z"}
{"comparison_id":"96bc8d1d-2107-40c6-aebd-065557dc62c9","query_id":"53","doc_a_id":"15727984","doc_b_id":"38009906","presented_order":["38009906","15727984"],"winner_id":"38009906","reasoning":"Document A is more relevant — it discusses molecular markers and tumor-suppressor regulation in cancer, which is closer to biomarker/prognosis context than a lung cancer secretome study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764291Z"}
{"comparison_id":"1350346c-9bac-4059-b067-fea0acc87c60","query_id":"53","doc_a_id":"17775228","doc_b_id":"38009906","presented_order":["38009906","17775228"],"winner_id":"38009906","reasoning":"Document A — it discusses cancer-related transcriptional regulation and tumor suppressor pathways, which is marginally closer to the breast cancer/prognosis topic than a colorectal imprinting study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764298Z"}
{"comparison_id":"fcd49607-4706-4e96-be73-59be83b482bc","query_id":"53","doc_a_id":"1727493","doc_b_id":"38009906","presented_order":["1727493","38009906"],"winner_id":"38009906","reasoning":"Document B — it discusses gene-expression regulation of a tumor suppressor locus relevant to cancer behavior and prognosis, whereas A is specific to miR21-mediated paclitaxel resistance in ovarian cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764305Z"}
{"comparison_id":"97bedbb8-f72b-4306-8044-59372dd97169","query_id":"53","doc_a_id":"2919030","doc_b_id":"38009906","presented_order":["38009906","2919030"],"winner_id":"38009906","reasoning":"Document A is more relevant — it deals with cancer-related gene regulation and tumor suppressor pathways, whereas B focuses on yeast/mammalian metabolism not related to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764312Z"}
{"comparison_id":"11178dbf-c7f9-47f0-b3cf-1794f25ab1e4","query_id":"53","doc_a_id":"20179918","doc_b_id":"38009906","presented_order":["20179918","38009906"],"winner_id":"38009906","reasoning":"Document B is more relevant — it addresses cancer-related mechanisms (tumor suppressor silencing and implications for cancer), whereas A focuses on stem cell transcriptional regulation without cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764320Z"}
{"comparison_id":"395b9511-a8cf-47c6-8ef3-946abfbdaf24","query_id":"53","doc_a_id":"19958277","doc_b_id":"38009906","presented_order":["19958277","38009906"],"winner_id":"38009906","reasoning":"Neither document mentions ALDH1 or breast cancer. Both are irrelevant, but Document B is slightly more related to cancer progression mechanisms (tumor suppressor silencing and cell senescence), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764327Z"}
{"comparison_id":"b04374da-86a0-4dd1-b46e-42197cedc6e3","query_id":"53","doc_a_id":"17412260","doc_b_id":"38009906","presented_order":["38009906","17412260"],"winner_id":"38009906","reasoning":"Neither paper mentions ALDH1 or breast cancer. Document A is marginally more relevant because it deals with cancer-related molecular regulation and cell senescence, which are closer to prognosis topics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764334Z"}
{"comparison_id":"79a9e4a4-1152-423e-b738-c583f0bac452","query_id":"53","doc_a_id":"12887068","doc_b_id":"38009906","presented_order":["12887068","38009906"],"winner_id":"38009906","reasoning":"Document B is more relevant — it discusses cancer-related epigenetic regulation and tumor suppressor silencing, which is closer to breast cancer prognosis mechanisms than a pediatric glioma stem-cell model.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764341Z"}
{"comparison_id":"d0383e29-f86c-438f-83d1-acd43ecb169d","query_id":"53","doc_a_id":"11255504","doc_b_id":"38009906","presented_order":["38009906","11255504"],"winner_id":"38009906","reasoning":"Document A is slightly more relevant — it discusses cancer-related molecular markers and tumor suppressor regulation (though it doesn't address ALDH1 or breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764347Z"}
{"comparison_id":"7c0f3c68-2d73-4801-92e8-dd8d17c2fc25","query_id":"53","doc_a_id":"22914228","doc_b_id":"38009906","presented_order":["38009906","22914228"],"winner_id":"38009906","reasoning":"Document A is slightly more relevant because it discusses cancer-related gene regulation, whereas Document B focuses on pancreatic cancer metabolism unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764354Z"}
{"comparison_id":"751871b7-7c4b-417d-9fa6-3df613ec8c2f","query_id":"53","doc_a_id":"23513818","doc_b_id":"38009906","presented_order":["23513818","38009906"],"winner_id":"38009906","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis, so neither is relevant. However, Document B (on ANRIL/CBX7) is slightly more cancer-prognosis–related than A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:34.764360Z"}
{"comparison_id":"fac9c420-674f-4627-b9fe-b3f97eca2c2e","query_id":"53","doc_a_id":"52925737","doc_b_id":"26735905","presented_order":["26735905","52925737"],"winner_id":"52925737","reasoning":"Document B is more relevant — although neither mentions ALDH1 or breast cancer, B at least discusses a marker (HMGB1) linked to poor prognosis, whereas A focuses on p62 and prostate cancer tumorigenesis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299369Z"}
{"comparison_id":"2e1d15c1-352c-4d09-b309-f327434b097b","query_id":"53","doc_a_id":"15081770","doc_b_id":"26735905","presented_order":["26735905","15081770"],"winner_id":"15081770","reasoning":"Document B is more relevant — it discusses expression of an enzyme by tumor cells and its potential as a prognostic factor, which is closer to the query about a biomarker (ALDH1) and prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299389Z"}
{"comparison_id":"24324c23-5f3a-4c9d-8f03-0c304fee0a45","query_id":"53","doc_a_id":"4467129","doc_b_id":"26735905","presented_order":["4467129","26735905"],"winner_id":"26735905","reasoning":"Document B — it discusses tumorigenesis and tumor microenvironment mechanisms (more general cancer relevance) while A is specific to neuroblastoma microRNA disruption. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299397Z"}
{"comparison_id":"cdaa8e51-5ed6-4363-b886-2cd607350a92","query_id":"53","doc_a_id":"23830488","doc_b_id":"26735905","presented_order":["23830488","26735905"],"winner_id":"23830488","reasoning":"Document A is more relevant — it examines associations between gene expression and patient prognosis/outcomes (though in colorectal cancer), whereas B focuses on stromal metabolism and prostate tumorigenesis, not prognostic expression markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299405Z"}
{"comparison_id":"8d13cfed-7923-434f-b00f-025fd9954e89","query_id":"53","doc_a_id":"2727303","doc_b_id":"26735905","presented_order":["2727303","26735905"],"winner_id":"2727303","reasoning":"Document A is slightly more related to tumor cell behavior (potentially applicable across cancers) while Document B focuses on prostate stromal fibroblasts, so neither addresses ALDH1 in breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299413Z"}
{"comparison_id":"ab5c9aa6-fa4e-4356-aa4d-a5e0f547b0b3","query_id":"53","doc_a_id":"31439189","doc_b_id":"26735905","presented_order":["31439189","26735905"],"winner_id":"31439189","reasoning":"Document A — it discusses stem-cell markers in cancer cell lines (closer to ALDH1's role as a stem/progenitor marker), whereas Document B focuses on stromal p62/mTORC1 signaling in prostate tumorigenesis, which is less related to ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299420Z"}
{"comparison_id":"90c7732b-cdc7-4625-bccd-73ad8cdcfc26","query_id":"53","doc_a_id":"14672919","doc_b_id":"26735905","presented_order":["26735905","14672919"],"winner_id":"14672919","reasoning":"Document B. It addresses prognostic markers in cancer (postoperative prognosis), which is closer to the claim about prognosis than A's mechanistic prostate tumorigenesis study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299427Z"}
{"comparison_id":"68eb0c3f-3f30-4992-bd50-2dff0aa35f52","query_id":"53","doc_a_id":"39929509","doc_b_id":"26735905","presented_order":["39929509","26735905"],"winner_id":"39929509","reasoning":"Document A is slightly more relevant — it discusses a cancer-related gene/protein interaction, whereas Document B focuses on prostate stromal metabolism unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299434Z"}
{"comparison_id":"182c1026-93c9-4ee8-8cdf-c6001f48c80b","query_id":"53","doc_a_id":"33370","doc_b_id":"26735905","presented_order":["26735905","33370"],"winner_id":"33370","reasoning":"Document B is slightly more relevant because it addresses cancer stem cell biology (ALDH1 is a stem-cell marker), whereas Document A focuses on stromal fibroblasts and prostate cancer unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299441Z"}
{"comparison_id":"b9eacee8-5463-4efe-bd92-f0307b6d2a83","query_id":"53","doc_a_id":"6121668","doc_b_id":"26735905","presented_order":["6121668","26735905"],"winner_id":"6121668","reasoning":"Document A is more relevant because it addresses expression of molecular markers and their link to prognosis in a carcinoma (though a different marker and tissue), whereas B focuses on stromal metabolism in prostate cancer and not prognosis markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299448Z"}
{"comparison_id":"b7ac0227-0f3e-4f39-b7fb-61a875ac5bd4","query_id":"53","doc_a_id":"9285396","doc_b_id":"26735905","presented_order":["26735905","9285396"],"winner_id":"9285396","reasoning":"Document B is more relevant — it concerns prognostic marker associations in cancer (though in gastric cancer), while A focuses on stromal fibroblast signaling in prostate tumorigenesis and not prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299456Z"}
{"comparison_id":"fffb711a-7e35-41b2-ab71-cf3dfd18927e","query_id":"53","doc_a_id":"33638477","doc_b_id":"26735905","presented_order":["26735905","33638477"],"winner_id":"33638477","reasoning":"B is more relevant — it addresses factors that drive tumor progression, metastasis and prognosis across cancers, whereas A focuses on stromal fibroblast metabolism in prostate cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299464Z"}
{"comparison_id":"cd349e82-5385-4bc3-957a-4ac22e11e838","query_id":"53","doc_a_id":"38485364","doc_b_id":"26735905","presented_order":["26735905","38485364"],"winner_id":"26735905","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant because it addresses tumorigenesis and the tumor microenvironment, which relate broadly to prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299471Z"}
{"comparison_id":"ee3808f8-c41b-43dc-93de-df653280b2ac","query_id":"53","doc_a_id":"9095394","doc_b_id":"26735905","presented_order":["9095394","26735905"],"winner_id":"26735905","reasoning":"Document B is more relevant — although neither mentions ALDH1 or breast cancer, B discusses tumorigenic mechanisms in the tumor microenvironment (more general cancer-prognosis relevance) while A is limited to keratin expression in oral squamous neoplasms.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299479Z"}
{"comparison_id":"b45d6a27-639d-4880-9355-ecac69fbc6f8","query_id":"53","doc_a_id":"23887844","doc_b_id":"26735905","presented_order":["23887844","26735905"],"winner_id":"23887844","reasoning":"Reason: Neither discusses ALDH1 or breast cancer, but A addresses cancer cell metabolism broadly while B focuses on stromal signaling in prostate cancer, so A is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299486Z"}
{"comparison_id":"a17e2535-bce1-4354-86a3-70d9ccff84c6","query_id":"53","doc_a_id":"9648896","doc_b_id":"26735905","presented_order":["26735905","9648896"],"winner_id":"9648896","reasoning":"Neither abstract mentions ALDH1 or breast cancer, but Document B (CAF paracrine effects on proliferation and chemoresistance) is somewhat more related to prognostic/treatment-relevant tumor biology. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299493Z"}
{"comparison_id":"2298ec91-51a5-43fd-bbc6-5f1b040d68d5","query_id":"53","doc_a_id":"3559136","doc_b_id":"26735905","presented_order":["3559136","26735905"],"winner_id":"3559136","reasoning":"Document A is more relevant — it addresses tumor microenvironment and treatment effects in cancer broadly, while Document B focuses on stromal changes in prostate cancer specifically, so A is marginally closer to a breast cancer prognosis question.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299501Z"}
{"comparison_id":"d28c00ad-7102-4df4-8c56-229c6d966412","query_id":"53","doc_a_id":"5271210","doc_b_id":"26735905","presented_order":["26735905","5271210"],"winner_id":"5271210","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it discusses biomarkers and prognosis (though in hepatocellular carcinoma, not breast cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299508Z"}
{"comparison_id":"5a9a4762-7159-4ce7-9ba4-25e72ce92478","query_id":"53","doc_a_id":"9791313","doc_b_id":"26735905","presented_order":["9791313","26735905"],"winner_id":"26735905","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are largely irrelevant; Document B is marginally more relevant because it addresses tumorigenic mechanisms in the tumor microenvironment that could generalize across cancers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299516Z"}
{"comparison_id":"cb5eaf5b-00cd-44d6-a1aa-c9b344c1521c","query_id":"53","doc_a_id":"23599024","doc_b_id":"26735905","presented_order":["23599024","26735905"],"winner_id":"26735905","reasoning":"Neither document addresses ALDH1 or breast cancer specifically; Document B is slightly more relevant because it discusses tumorigenic mechanisms in epithelial cancers and the tumor microenvironment, which is more conceptually related to prognosis than a lung-specific SP-B study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299523Z"}
{"comparison_id":"55636d2d-bdd6-4c6f-8681-3fc90c3be412","query_id":"53","doc_a_id":"195689757","doc_b_id":"26735905","presented_order":["26735905","195689757"],"winner_id":"195689757","reasoning":"Neither document directly addresses ALDH1 or breast cancer. Document B is slightly more relevant because it discusses metabolic remodeling and metabolic enzymes (ALDH1 is a metabolic enzyme), whereas A focuses on p62/mTORC1 in prostate stromal fibroblasts.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299531Z"}
{"comparison_id":"4461a892-cafb-4988-802f-4c9c51f03648","query_id":"53","doc_a_id":"11578459","doc_b_id":"26735905","presented_order":["11578459","26735905"],"winner_id":"11578459","reasoning":"Document A is slightly more relevant because it discusses a stem cell–related expression signature (closer to ALDH1's role as a cancer stem cell marker), whereas Document B focuses on stromal metabolism and prostate cancer rather than ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299539Z"}
{"comparison_id":"cec75144-56ed-4679-9afa-143cdb4a393b","query_id":"53","doc_a_id":"18810195","doc_b_id":"26735905","presented_order":["18810195","26735905"],"winner_id":"18810195","reasoning":"Document A is marginally more relevant — it addresses metabolic enzyme changes in human tumors broadly, whereas B focuses on stromal signaling in prostate cancer; neither mentions ALDH1 or breast cancer prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299546Z"}
{"comparison_id":"a2ef87d4-bb5e-4ca2-acd8-ebdfaef68fd4","query_id":"53","doc_a_id":"1686997","doc_b_id":"26735905","presented_order":["26735905","1686997"],"winner_id":"1686997","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer; Document B addresses a general tumor growth mechanism (potentially more broadly relevant) while A is specific to prostate stromal fibroblasts.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299553Z"}
{"comparison_id":"bb4cfeb1-9b7a-4452-8811-bbe7df14c969","query_id":"53","doc_a_id":"28249680","doc_b_id":"26735905","presented_order":["28249680","26735905"],"winner_id":"28249680","reasoning":"Document A is slightly more relevant because it discusses cancer cell death mechanisms and therapy resistance, which is closer to prognosis implications than stromal metabolism in prostate cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299561Z"}
{"comparison_id":"7ec0f59c-702e-4de1-a0f6-dae36f9340f0","query_id":"53","doc_a_id":"40349336","doc_b_id":"26735905","presented_order":["26735905","40349336"],"winner_id":"26735905","reasoning":"Document A — it discusses tumorigenesis and tumor microenvironment signaling (though in prostate cancer), making it marginally more related to cancer prognosis than the aging/stem-cell focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299568Z"}
{"comparison_id":"84b5dc2a-b717-4f9d-9f63-e4e17038ea59","query_id":"53","doc_a_id":"24294572","doc_b_id":"26735905","presented_order":["24294572","26735905"],"winner_id":"24294572","reasoning":"Document A is more relevant — it addresses cancer signaling mechanisms broadly, whereas Document B focuses on stromal effects in prostate cancer (not breast cancer or ALDH1). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299575Z"}
{"comparison_id":"5795caca-bc6c-4e60-b786-0514ac757986","query_id":"53","doc_a_id":"5254463","doc_b_id":"26735905","presented_order":["5254463","26735905"],"winner_id":"5254463","reasoning":"Document A is more relevant — it discusses stem cells and tumorigenesis (ALDH1 is a stem-cell marker), whereas B focuses on stromal fibroblasts in prostate cancer, not breast or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299583Z"}
{"comparison_id":"9ccc1824-1217-4f70-98b8-36bb6db0465a","query_id":"53","doc_a_id":"4457160","doc_b_id":"26735905","presented_order":["4457160","26735905"],"winner_id":"26735905","reasoning":"Document B is more relevant — while neither mentions ALDH1 or breast cancer, B addresses tumor-associated metabolic and prognostic pathways in cancer biology, whereas A is focused on pancreatic genomic rearrangements. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:03:52.299590Z"}
{"comparison_id":"66339bce-cfbc-4be8-9e36-d5ac1c14b940","query_id":"53","doc_a_id":"52925737","doc_b_id":"33638477","presented_order":["52925737","33638477"],"winner_id":"52925737","reasoning":"Reason: Document A mentions association with poor prognosis (though in gastric cancer) and tumor markers, so it's slightly closer to a prognosis-related claim than Document B which focuses on BCL9 in other cancers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.141857Z"}
{"comparison_id":"d90eae67-e681-4be1-a762-493c4b47d609","query_id":"53","doc_a_id":"15081770","doc_b_id":"33638477","presented_order":["15081770","33638477"],"winner_id":"15081770","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it addresses expression of a potential prognostic marker in cancers, whereas B focuses on a different oncogene and tumor types.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.141879Z"}
{"comparison_id":"23081d3e-c2cc-4b40-a869-e39734c34077","query_id":"53","doc_a_id":"23830488","doc_b_id":"33638477","presented_order":["33638477","23830488"],"winner_id":"33638477","reasoning":"Document A is marginally more relevant because it discusses genes linked to tumor progression and prognosis across cancers, while Document B is specific to circadian genes in colorectal cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.141887Z"}
{"comparison_id":"25fdd4fc-b2b1-42f6-929d-f83c6103966c","query_id":"53","doc_a_id":"2727303","doc_b_id":"33638477","presented_order":["2727303","33638477"],"winner_id":"2727303","reasoning":"Document A is slightly more relevant — it discusses mechanisms promoting malignant cell behaviors (which relate to prognosis) while B focuses on BCL9 in other cancers (multiple myeloma, colon). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.141896Z"}
{"comparison_id":"760dc82c-a21e-411c-ad11-132255e5e33e","query_id":"53","doc_a_id":"31439189","doc_b_id":"33638477","presented_order":["31439189","33638477"],"winner_id":"31439189","reasoning":"Document A is slightly more relevant because it discusses stem cell markers (though in prostate cancer), whereas Document B focuses on BCL9 in other cancers and neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.141903Z"}
{"comparison_id":"3d4adfaa-16ca-4a23-9c41-ce150a66ef06","query_id":"53","doc_a_id":"14672919","doc_b_id":"33638477","presented_order":["14672919","33638477"],"winner_id":"14672919","reasoning":"Reason: Document A addresses prognostic markers in cancer (postoperative prognosis), which is more directly related to a claim about marker expression and prognosis than Document B's focus on a specific oncogene and tumor biology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.141910Z"}
{"comparison_id":"c43915ed-630d-426f-b6be-f90aecc06b9f","query_id":"53","doc_a_id":"39929509","doc_b_id":"33638477","presented_order":["39929509","33638477"],"winner_id":"33638477","reasoning":"Document B — it discusses oncogenic factors that drive tumor progression and metastasis (more directly related to prognosis in cancers), whereas Document A focuses on WT1 binding ACTN1 mRNA in kidney development/cancer contexts and is less relevant to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.141918Z"}
{"comparison_id":"24bca93a-9364-4788-91c4-65c999707348","query_id":"53","doc_a_id":"33370","doc_b_id":"33638477","presented_order":["33370","33638477"],"winner_id":"33638477","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis. Document B is marginally more relevant because it addresses tumor progression mechanisms across multiple cancer types, whereas A focuses specifically on glioma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.141925Z"}
{"comparison_id":"9651c8d6-4f48-45f6-8843-9287998e3e17","query_id":"53","doc_a_id":"6121668","doc_b_id":"33638477","presented_order":["6121668","33638477"],"winner_id":"6121668","reasoning":"Document A is slightly more relevant — although neither mentions ALDH1 or breast cancer, A discusses associations with prognostic factors and overall survival. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.141932Z"}
{"comparison_id":"12774f90-2f09-4d84-bf75-f18ff627b840","query_id":"53","doc_a_id":"9285396","doc_b_id":"33638477","presented_order":["33638477","9285396"],"winner_id":"9285396","reasoning":"Document B is more relevant — it examines associations between a biomarker and cancer prognosis (though in gastric cancer), whereas A focuses on BCL9 in other cancers and doesn't address prognostic marker expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.141939Z"}
{"comparison_id":"c598bad9-cf33-4a90-b91a-5a32df03d18a","query_id":"53","doc_a_id":"5254463","doc_b_id":"33638477","presented_order":["33638477","5254463"],"winner_id":"33638477","reasoning":"Document A is more relevant: it addresses tumor progression and factors linked to proliferation, metastasis, and prognosis across cancers, which is closer to a claim about biomarker-associated prognosis than a mouse-intestine polyp study.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.141947Z"}
{"comparison_id":"5d89a3ce-603b-452f-9093-8c18dfa94cbd","query_id":"53","doc_a_id":"23887844","doc_b_id":"33638477","presented_order":["23887844","33638477"],"winner_id":"33638477","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer prognosis, but Document B addresses tumor progression and factors affecting metastasis and growth, which is more related to prognosis than Document A's metabolic/apoptosis focus. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.141954Z"}
{"comparison_id":"0667d748-56d1-476b-9893-3941fff518c5","query_id":"53","doc_a_id":"9648896","doc_b_id":"33638477","presented_order":["33638477","9648896"],"winner_id":"33638477","reasoning":"Document A is more relevant because it addresses tumor progression and prognosis-related cancer biology, whereas Document B focuses on lung cancer CAFs and mir-1, not breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.141962Z"}
{"comparison_id":"e1004b93-cd19-4356-a5c6-baedeb95141c","query_id":"53","doc_a_id":"3559136","doc_b_id":"33638477","presented_order":["33638477","3559136"],"winner_id":"33638477","reasoning":"Document A is slightly more relevant because it addresses tumor progression, proliferation, and metastasis (factors related to prognosis), whereas Document B focuses on immune microenvironment and therapy resistance. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.141970Z"}
{"comparison_id":"0c272504-97d8-434d-b8bc-3488c7cb06fa","query_id":"53","doc_a_id":"5271210","doc_b_id":"33638477","presented_order":["5271210","33638477"],"winner_id":"33638477","reasoning":"Document B is more relevant — it addresses tumor progression and prognostic factors across cancers, whereas A focuses on miRNAs in hepatocellular (liver) cancer, not breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.141977Z"}
{"comparison_id":"1dbc6aea-4e59-4092-ae15-f82fe94de436","query_id":"53","doc_a_id":"195689757","doc_b_id":"33638477","presented_order":["33638477","195689757"],"winner_id":"33638477","reasoning":"Document A is more relevant — it discusses genes driving tumor progression, metastasis and prognosis in epithelial cancers, which is closer to the query about prognostic markers in breast cancer than a GBM metabolism review.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.141985Z"}
{"comparison_id":"88cc3043-cb01-4e3c-9c50-3e50cfa12f77","query_id":"53","doc_a_id":"11578459","doc_b_id":"33638477","presented_order":["11578459","33638477"],"winner_id":"11578459","reasoning":"Document A is slightly more relevant because it discusses a stem cell–related expression signature (closer to ALDH1 as a stem cell marker), whereas Document B focuses on BCL9 in other cancers and does not relate to stem cell markers or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.141993Z"}
{"comparison_id":"babcb199-9f49-439c-a42d-d4a3248eddd8","query_id":"53","doc_a_id":"18810195","doc_b_id":"33638477","presented_order":["18810195","33638477"],"winner_id":"18810195","reasoning":"Document A is more relevant — it addresses tumor metabolic markers and general cancer cell behavior in human tumors, while Document B focuses on BCL9 in myeloma and colon cancer rather than breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.142000Z"}
{"comparison_id":"e02dfde8-f6d8-4237-a1d8-cbea9d10ec36","query_id":"53","doc_a_id":"1686997","doc_b_id":"33638477","presented_order":["33638477","1686997"],"winner_id":"33638477","reasoning":"Document A is more relevant because it addresses tumor progression, metastasis, and poor outcomes in cancers, which is closer to a prognosis-related claim than the metabolic enzyme focus in Document B.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.142008Z"}
{"comparison_id":"83768e25-9b6e-4391-bc28-19d093442d66","query_id":"53","doc_a_id":"28249680","doc_b_id":"33638477","presented_order":["28249680","33638477"],"winner_id":"33638477","reasoning":"Document B is more relevant — it discusses an oncogene that affects tumor progression and prognosis-related behaviors (growth, metastasis), whereas A focuses on apoptosis mechanisms unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.142015Z"}
{"comparison_id":"0f0edb69-0927-4c44-af7a-b322761a8dc0","query_id":"53","doc_a_id":"24294572","doc_b_id":"33638477","presented_order":["24294572","33638477"],"winner_id":"33638477","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document B is slightly more relevant because it links an oncogene to tumor progression and metastasis (factors tied to prognosis), whereas A focuses on PI lipid phosphatase signaling.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:08.142022Z"}
{"comparison_id":"324ab75b-ce1e-4071-abeb-23c601f02431","query_id":"53","doc_a_id":"52925737","doc_b_id":"14672919","presented_order":["14672919","52925737"],"winner_id":"14672919","reasoning":"Document A is more relevant — it addresses prognostic markers in cancer, whereas B discusses exosome signaling in gastric cancer not related to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:13.593597Z"}
{"comparison_id":"baa754d4-db44-4d46-8528-5eefb153e899","query_id":"53","doc_a_id":"15081770","doc_b_id":"14672919","presented_order":["14672919","15081770"],"winner_id":"15081770","reasoning":"Document B — it discusses tumor cell protein expression as a prognostic factor, which is more similar to the ALDH1–breast cancer claim than a platelet-count study in esophageal cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:13.593618Z"}
{"comparison_id":"04913d4f-f15c-45ad-bbec-e5c34fa55e4d","query_id":"53","doc_a_id":"2727303","doc_b_id":"14672919","presented_order":["2727303","14672919"],"winner_id":"2727303","reasoning":"Document A is more relevant — it addresses molecular cancer markers and mechanisms, whereas Document B concerns platelet measures in esophageal cancer (unrelated to ALDH1 or breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:13.593627Z"}
{"comparison_id":"ec4c5593-6515-4412-a58f-d838bbab96d3","query_id":"53","doc_a_id":"31439189","doc_b_id":"14672919","presented_order":["31439189","14672919"],"winner_id":"31439189","reasoning":"Document A is marginally more relevant because it addresses cancer stem-cell markers (closer to ALDH1's role), whereas Document B concerns platelet metrics in esophageal cancer and is unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:13.593635Z"}
{"comparison_id":"a340926f-f12d-46bc-a66f-986bcdebfec3","query_id":"53","doc_a_id":"18810195","doc_b_id":"14672919","presented_order":["14672919","18810195"],"winner_id":"14672919","reasoning":"Document A is more relevant — it addresses prognostic markers in cancer (though in esophageal cancer), whereas Document B focuses on a biochemical mechanism (PGAM1 phosphorylation) not related to ALDH1 or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:13.593642Z"}
{"comparison_id":"c6c25642-c90b-4a64-ad72-a060488fb9f3","query_id":"53","doc_a_id":"6121668","doc_b_id":"14672919","presented_order":["6121668","14672919"],"winner_id":"6121668","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant since it discusses tumor marker expression in carcinoma, whereas B concerns platelet indices in esophageal cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:13.593649Z"}
{"comparison_id":"c1db2bea-ae0c-4b84-8737-9fd617d7adc7","query_id":"53","doc_a_id":"9285396","doc_b_id":"14672919","presented_order":["9285396","14672919"],"winner_id":"9285396","reasoning":"Document A is slightly more relevant — both documents study prognostic markers and survival outcomes, but A discusses associations with disease-free and overall survival (though in gastric cancer), which is closer in topic to the claim about prognosis in cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:13.593658Z"}
{"comparison_id":"58df9fcf-01f3-4757-bceb-eaa0e07bd0eb","query_id":"53","doc_a_id":"11578459","doc_b_id":"14672919","presented_order":["14672919","11578459"],"winner_id":"11578459","reasoning":"Document B — it deals with stem cell–related tumor biology which is conceptually closer to ALDH1 (a stem cell marker), whereas A focuses on platelet metrics in esophageal cancer and is unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:13.593665Z"}
{"comparison_id":"c5dc3928-a67e-4ab7-85a2-2d8e63ed7e7c","query_id":"53","doc_a_id":"15081770","doc_b_id":"31439189","presented_order":["15081770","31439189"],"winner_id":"15081770","reasoning":"Document A is more relevant — it discusses expression of a tumor-associated enzyme and its link to prognosis in cancers, whereas Document B concerns prostate cell lines and stem-cell markers unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:22.160806Z"}
{"comparison_id":"23c878be-21e1-4c01-bb75-cf8437c0d215","query_id":"53","doc_a_id":"2727303","doc_b_id":"31439189","presented_order":["31439189","2727303"],"winner_id":"31439189","reasoning":"Document A is more relevant — it addresses cancer stem cell markers (similar to ALDH1) and their association with clonogenicity/prognosis, whereas B focuses on HDAC6/STIM1 signaling unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:22.160826Z"}
{"comparison_id":"39e896b1-55d8-4fcd-a82e-72ca595ac67e","query_id":"53","doc_a_id":"11578459","doc_b_id":"31439189","presented_order":["31439189","11578459"],"winner_id":"31439189","reasoning":"Document A is more relevant — it discusses stem-cell markers in cancer cell lines (though in prostate), which is closer to ALDH1's role as a cancer stem cell marker than the glioblastoma HOX-signature study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:22.160834Z"}
{"comparison_id":"5889e743-2558-4e82-aa3f-b3121f213d10","query_id":"53","doc_a_id":"6121668","doc_b_id":"31439189","presented_order":["6121668","31439189"],"winner_id":"6121668","reasoning":"Document A is more relevant — it examines marker expression and ties to overall survival/prognosis (though in endometrial cancer), whereas B studies stem-cell markers in prostate cell lines and doesn't address prognosis or breast cancer.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:22.160842Z"}
{"comparison_id":"14e77c09-b20d-416c-938f-1725cab821ef","query_id":"53","doc_a_id":"9285396","doc_b_id":"31439189","presented_order":["9285396","31439189"],"winner_id":"31439189","reasoning":"Document B — it discusses cancer stem cell markers and stem-like properties (more conceptually related to ALDH1 as a stemness/prognostic marker) whereas A is unrelated (RDW in gastric cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:22.160849Z"}
{"comparison_id":"95fdb710-f0f3-41a3-8da7-baaca78057ba","query_id":"53","doc_a_id":"15081770","doc_b_id":"6121668","presented_order":["15081770","6121668"],"winner_id":"15081770","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document A discusses a potential prognostic marker in cancer contexts (closer to the claim about prognosis) while B is specific to endometrial carcinoma and survival-negative.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:28.012991Z"}
{"comparison_id":"dd05c7a8-8e18-473b-9da0-1ff5b0f801f0","query_id":"53","doc_a_id":"2727303","doc_b_id":"11578459","presented_order":["2727303","11578459"],"winner_id":"11578459","reasoning":"Document B — it addresses stem cell–related expression patterns linked to tumor aggressiveness, which is closer to ALDH1 (a stem-cell marker) and prognosis than Document A's focus on HDAC6/SOCE signaling. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:32.985051Z"}
{"comparison_id":"de6d20d2-41bf-456a-b6be-98d901ad1b88","query_id":"53","doc_a_id":"9285396","doc_b_id":"11578459","presented_order":["11578459","9285396"],"winner_id":"9285396","reasoning":"Document B is more relevant — it concerns prognostic markers in cancer (though in gastric, not breast), whereas A discusses molecular alterations in glioblastoma unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:32.985074Z"}
{"comparison_id":"3e10e293-3e2a-436e-a860-17b39a41af5e","query_id":"53","doc_a_id":"52925737","doc_b_id":"18810195","presented_order":["52925737","18810195"],"winner_id":"52925737","reasoning":"Document A at least mentions an association with poor prognosis (albeit in gastric cancer); Document B focuses on PGAM1 metabolism and does not address ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:37.006843Z"}
{"comparison_id":"b528d682-83aa-4754-879a-f85be7839a6d","query_id":"53","doc_a_id":"23830488","doc_b_id":"9648896","presented_order":["23830488","9648896"],"winner_id":"23830488","reasoning":"Document A is somewhat more relevant because it discusses gene expression correlations with metastasis and patient outcomes (prognosis), whereas Document B focuses on CAFs and lung cancer chemoresistance. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:56.386951Z"}
{"comparison_id":"0db17b6f-11b8-47b2-9a24-62c995c28fe8","query_id":"53","doc_a_id":"39929509","doc_b_id":"9648896","presented_order":["39929509","9648896"],"winner_id":"9648896","reasoning":"Document B is more relevant—although it's about lung cancer, it addresses tumor biology (CAF effects on proliferation/chemoresistance) while Document A concerns WT1 binding in kidney development and is unrelated to cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:56.386974Z"}
{"comparison_id":"9e38b08d-48ca-4b8f-b175-5d9955b237de","query_id":"53","doc_a_id":"33370","doc_b_id":"9648896","presented_order":["9648896","33370"],"winner_id":"33370","reasoning":"Document B is more relevant — it deals with cancer stem cells and tumor survival mechanisms, which are conceptually closer to ALDH1 (a stem cell marker) and prognosis than a study on CAFs in lung cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:56.386983Z"}
{"comparison_id":"59fd9272-e835-4e9f-8df3-c9faf3b74fef","query_id":"53","doc_a_id":"5254463","doc_b_id":"9648896","presented_order":["5254463","9648896"],"winner_id":"5254463","reasoning":"Document A is slightly more relevant because it addresses tumorigenesis and stem cell biology (ALDH1 is a stem cell marker), whereas Document B focuses on CAFs and lung cancer without relation to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:56.386991Z"}
{"comparison_id":"ec20e28b-dafa-4afe-a682-3bc87f1c9408","query_id":"53","doc_a_id":"23887844","doc_b_id":"9648896","presented_order":["9648896","23887844"],"winner_id":"23887844","reasoning":"Document B is more relevant. Neither mentions ALDH1 or breast cancer, but B discusses cancer cell survival mechanisms more generally, which is marginally closer to prognosis-related biology than A's lung-CAF/mir-1 focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:56.387000Z"}
{"comparison_id":"7ed5a790-9633-473f-afd4-925ba0c1b806","query_id":"53","doc_a_id":"24294572","doc_b_id":"9648896","presented_order":["24294572","9648896"],"winner_id":"24294572","reasoning":"Document A is more relevant — it discusses tumor signaling and mechanisms linked to cancer progression, which is closer to prognosis-related biomarkers than a lung-cancer CAF/microRNA study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:56.387007Z"}
{"comparison_id":"6be23098-c3e3-43e6-ac00-90c7a5350505","query_id":"53","doc_a_id":"3559136","doc_b_id":"9648896","presented_order":["3559136","9648896"],"winner_id":"3559136","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document A addresses tumor biology more generally, while B is specific to lung cancer, so A is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:56.387013Z"}
{"comparison_id":"9e079969-cbfb-4114-b917-25614ca200d8","query_id":"53","doc_a_id":"5271210","doc_b_id":"9648896","presented_order":["5271210","9648896"],"winner_id":"5271210","reasoning":"Document A — it discusses biomarkers and prognosis (though in HCC), which is closer to the claim about prognosis than Document B's focus on lung CAFs and chemoresistance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:56.387020Z"}
{"comparison_id":"3a7cb9ec-3268-4aef-aa79-fe2dd9f92955","query_id":"53","doc_a_id":"195689757","doc_b_id":"9648896","presented_order":["195689757","9648896"],"winner_id":"195689757","reasoning":"Document A is slightly more relevant because it discusses altered metabolism and metabolic enzymes in cancer, which is conceptually closer to ALDH1 (a metabolic enzyme) than the lung-CAF/microRNA topic in Document B. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:56.387028Z"}
{"comparison_id":"c634dfb4-542c-4f99-8b3e-e0d56a178290","query_id":"53","doc_a_id":"1686997","doc_b_id":"9648896","presented_order":["1686997","9648896"],"winner_id":"1686997","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer prognosis, but Document A concerns tumor growth/metabolic markers and is marginally closer in topic than the lung cancer/CAF study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:56.387035Z"}
{"comparison_id":"95eceace-a60c-48ae-91d9-ac1290168fd8","query_id":"53","doc_a_id":"28249680","doc_b_id":"9648896","presented_order":["28249680","9648896"],"winner_id":"28249680","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer prognosis, but Document A discusses mechanisms of apoptosis resistance in epithelial cancers (more generally relevant to prognostic markers) while Document B focuses specifically on CAF/miR-1 effects in lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:04:56.387042Z"}
{"comparison_id":"9cdaccfd-3cc3-4bdf-b552-65360ae6544d","query_id":"53","doc_a_id":"23830488","doc_b_id":"24294572","presented_order":["24294572","23830488"],"winner_id":"24294572","reasoning":"Document A is marginally more relevant — both abstracts don't mention ALDH1 or breast cancer, but A discusses cancer signaling and tumor biology, making it closer in topic than a colorectal/circadian study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:03.474276Z"}
{"comparison_id":"9efd7c99-c26d-40e8-bb39-91c36a066d79","query_id":"53","doc_a_id":"33370","doc_b_id":"24294572","presented_order":["24294572","33370"],"winner_id":"33370","reasoning":"More relevant: Document B — it addresses cancer stem cell markers and tumorigenic potential (ALDH1 is a cancer stem cell marker), whereas A focuses on PI lipid signaling unrelated to ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:03.474297Z"}
{"comparison_id":"2ecf6d5c-1d7a-45b9-bad0-61434825b006","query_id":"53","doc_a_id":"5254463","doc_b_id":"24294572","presented_order":["5254463","24294572"],"winner_id":"5254463","reasoning":"Document A is more relevant — it discusses stem cells and tumorigenesis (ALDH1 is a stem-cell marker), whereas Document B focuses on PTEN/PI lipid signaling without connection to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:03.474306Z"}
{"comparison_id":"39397f9b-c805-42e8-8403-3172ba959afb","query_id":"53","doc_a_id":"23887844","doc_b_id":"24294572","presented_order":["23887844","24294572"],"winner_id":"24294572","reasoning":"Document B is more relevant — it addresses cancer signaling and factors affecting tumor growth/progression, which is closer to prognosis than the metabolic mechanism in Document A. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:03.474313Z"}
{"comparison_id":"35784229-80aa-4962-a40a-b58df7502f70","query_id":"53","doc_a_id":"28249680","doc_b_id":"24294572","presented_order":["24294572","28249680"],"winner_id":"24294572","reasoning":"Document A is more relevant because it discusses cancer signaling and factors affecting tumor growth/progression, which is closer to prognosis-related markers than a paper on proteasome-induced cell death. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:03.474321Z"}
{"comparison_id":"848e5da1-49c8-4161-a5f6-60387dbe5194","query_id":"53","doc_a_id":"3559136","doc_b_id":"24294572","presented_order":["24294572","3559136"],"winner_id":"24294572","reasoning":"Neither abstract mentions ALDH1 or breast cancer prognosis. Document A is slightly more relevant because it addresses tumor signaling and growth, which is closer to prognostic markers than the therapy-focused CAF study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:03.474329Z"}
{"comparison_id":"aa1cc645-fcbd-412f-bcc4-34d8ffeaf272","query_id":"53","doc_a_id":"5271210","doc_b_id":"24294572","presented_order":["5271210","24294572"],"winner_id":"24294572","reasoning":"Document B is more relevant — it discusses cancer signaling and tumor suppressor loss affecting tumor behavior, which is closer to prognosis-related mechanisms than A's focus on miRNAs in hepatocellular carcinoma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:03.474336Z"}
{"comparison_id":"04d2fb2f-db79-48b5-8fde-e8ebddea7258","query_id":"53","doc_a_id":"195689757","doc_b_id":"24294572","presented_order":["24294572","195689757"],"winner_id":"24294572","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it addresses cancer signaling and tumor behavior generally, whereas B is specific to glioblastoma metabolism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:03.474344Z"}
{"comparison_id":"b5539d8a-da4c-448b-b277-393b142605fd","query_id":"53","doc_a_id":"1686997","doc_b_id":"24294572","presented_order":["24294572","1686997"],"winner_id":"24294572","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis; both are irrelevant. Document A is marginally more related to cancer signaling and progression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:03.474351Z"}
{"comparison_id":"e7ababfe-ca72-4319-8141-2a87bcfb6286","query_id":"53","doc_a_id":"33370","doc_b_id":"5254463","presented_order":["5254463","33370"],"winner_id":"33370","reasoning":"Document B is more relevant — it addresses cancer stem cells and their impact on tumor survival/prognosis, which is conceptually related to ALDH1 as a stem-cell marker in breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:07.792092Z"}
{"comparison_id":"f8508415-dded-4a13-bde2-f3598feb567c","query_id":"53","doc_a_id":"23830488","doc_b_id":"3559136","presented_order":["3559136","23830488"],"winner_id":"3559136","reasoning":"Document A is more likely relevant because it discusses tumor biology and microenvironment interactions (potentially across cancers), whereas Document B focuses on circadian genes in colorectal cancer only. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:13.882909Z"}
{"comparison_id":"83d8ba4b-8cd7-4526-a57c-9ddd3ea8f788","query_id":"53","doc_a_id":"23887844","doc_b_id":"3559136","presented_order":["3559136","23887844"],"winner_id":"3559136","reasoning":"Document A is more related to tumor biology and factors affecting tumor progression and therapy response, which are relevant to prognosis; Document B focuses on metabolic apoptosis mechanisms not specific to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:13.882930Z"}
{"comparison_id":"736c77a7-d795-46e1-acbd-82c5de5f03d1","query_id":"53","doc_a_id":"28249680","doc_b_id":"3559136","presented_order":["28249680","3559136"],"winner_id":"28249680","reasoning":"Neither document addresses ALDH1 expression or breast cancer prognosis. Document A is marginally more relevant because it discusses epithelial cancer cell biology (potentially including breast cancer), while B focuses on stromal/immune interactions unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:13.882939Z"}
{"comparison_id":"8255cf22-b45c-4c83-bebd-49d36cc9742a","query_id":"53","doc_a_id":"1686997","doc_b_id":"3559136","presented_order":["3559136","1686997"],"winner_id":"3559136","reasoning":"Document A. It discusses tumor biology and factors affecting tumor progression/therapy, making it slightly more relevant to a prognosis-related claim than Document B, which focuses on a metabolic enzyme (6PGD) unrelated to ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:13.882947Z"}
{"comparison_id":"50121a7b-52c8-44d7-b944-ddad2b266461","query_id":"53","doc_a_id":"5271210","doc_b_id":"3559136","presented_order":["3559136","5271210"],"winner_id":"3559136","reasoning":"Document A — it discusses tumor biology and therapy in solid tumors (more likely related to breast cancer contexts) while Document B focuses on hepatocellular carcinoma, so A is closer to the query.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:13.882957Z"}
{"comparison_id":"548395dc-f2ea-422f-a7b1-f9101cde13f8","query_id":"53","doc_a_id":"195689757","doc_b_id":"3559136","presented_order":["3559136","195689757"],"winner_id":"3559136","reasoning":"Document A is more relevant — it concerns cancer tumor biology and therapy contexts (more likely related to breast cancer prognosis markers) while Document B focuses on glioblastoma metabolism, not breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:13.882965Z"}
{"comparison_id":"1c710675-42e2-47b7-ac6b-2c46a4db53e8","query_id":"53","doc_a_id":"23830488","doc_b_id":"1686997","presented_order":["1686997","23830488"],"winner_id":"23830488","reasoning":"Document B — it examines gene expression correlations with metastasis and patient outcomes (i.e., prognosis), which is conceptually closer to a claim about marker expression and prognosis than Document A's mechanistic study of 6PGD. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:18.786537Z"}
{"comparison_id":"f933d9d4-0528-460d-aa00-9b546e676e2f","query_id":"53","doc_a_id":"23887844","doc_b_id":"1686997","presented_order":["1686997","23887844"],"winner_id":"1686997","reasoning":"Document A is slightly more relevant because it directly addresses an enzyme's role in tumor growth and cancer prognosis implications, whereas Document B focuses on metabolic inhibition of apoptosis without linking to prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:18.786558Z"}
{"comparison_id":"bb86e9b4-50b2-4b71-9fad-488a811a23d5","query_id":"53","doc_a_id":"195689757","doc_b_id":"1686997","presented_order":["1686997","195689757"],"winner_id":"1686997","reasoning":"Document A is more relevant — it addresses metabolic enzymes linked to tumor growth and prognosis-related pathways, whereas B is focused specifically on glioblastoma metabolism. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:18.786567Z"}
{"comparison_id":"22b8cd16-0c20-4be0-b6a0-dd6ad0d9547f","query_id":"53","doc_a_id":"5271210","doc_b_id":"1686997","presented_order":["1686997","5271210"],"winner_id":"1686997","reasoning":"Document A is slightly more relevant because it discusses a cancer-associated enzyme and tumor growth, whereas Document B focuses on microRNAs in hepatocellular carcinoma (unrelated cancer type). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:18.786575Z"}
{"comparison_id":"85b95cf8-4d49-4088-a310-befddf743940","query_id":"53","doc_a_id":"23887844","doc_b_id":"195689757","presented_order":["23887844","195689757"],"winner_id":"23887844","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer prognosis; Document A is slightly more relevant because it discusses cancer cell biology more generally rather than being specific to glioblastoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:22.496796Z"}
{"comparison_id":"231cd583-bf97-414b-95f0-169897f32724","query_id":"53","doc_a_id":"5271210","doc_b_id":"195689757","presented_order":["195689757","5271210"],"winner_id":"195689757","reasoning":"Document A is slightly more relevant because it discusses metabolic enzymes in cancer (ALDH1 is a metabolic enzyme), whereas Document B focuses on miRNAs in liver cancer, not related to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:22.496817Z"}
{"comparison_id":"71ad5b80-1ee5-4c6f-9ae1-8ca298581d2f","query_id":"53","doc_a_id":"4467129","doc_b_id":"9791313","presented_order":["4467129","9791313"],"winner_id":"4467129","reasoning":"Document A — it discusses molecular expression linked to poor prognosis in cancer (though in neuroblastoma rather than breast). Document B focuses on SETD2 and renal cancer, which is less relevant to ALDH1/breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:28.491957Z"}
{"comparison_id":"769cf77b-2e35-44b7-a5c9-f83823331318","query_id":"53","doc_a_id":"38485364","doc_b_id":"9791313","presented_order":["9791313","38485364"],"winner_id":"38485364","reasoning":"Document B is slightly more relevant because it discusses cancer cell invasiveness and mechanisms that could relate to prognostic markers, whereas Document A focuses on SETD2 and renal cancer unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:28.491979Z"}
{"comparison_id":"9a7c0f2e-e13f-4cbe-92c4-367a65ec8c32","query_id":"53","doc_a_id":"9095394","doc_b_id":"9791313","presented_order":["9095394","9791313"],"winner_id":"9095394","reasoning":"Document A is slightly more relevant because it discusses marker expression patterns in cancer tissues (though not ALDH1 or breast cancer specifically), while Document B focuses on SETD2 and renal cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:28.491988Z"}
{"comparison_id":"cf7f1a47-067f-44f0-a2a1-72dbabc9b5c1","query_id":"53","doc_a_id":"4457160","doc_b_id":"9791313","presented_order":["9791313","4457160"],"winner_id":"9791313","reasoning":"Document A is slightly more relevant because it discusses tumor suppressors and cancer prognostic factors generally; Document B focuses specifically on pancreatic cancer genomics. Neither directly addresses ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:28.491996Z"}
{"comparison_id":"812e5e88-df62-4899-8ab7-477bf2b79bfb","query_id":"53","doc_a_id":"23599024","doc_b_id":"9791313","presented_order":["9791313","23599024"],"winner_id":"9791313","reasoning":"Document A is more relevant — it discusses cancer-related molecular markers and tumor suppressor function, whereas Document B focuses specifically on lung cancer and surfactant protein B, unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:28.492004Z"}
{"comparison_id":"fb609c8d-9622-4a98-89ac-d51bf1181637","query_id":"53","doc_a_id":"40349336","doc_b_id":"9791313","presented_order":["9791313","40349336"],"winner_id":"9791313","reasoning":"Document A is more relevant — it discusses cancer biology and prognosis-related factors (though not ALDH1 specifically), whereas Document B focuses on ATR deletion and aging in mice. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:28.492012Z"}
{"comparison_id":"f0ef3c6a-789f-4987-82f5-d728651bede5","query_id":"53","doc_a_id":"4467129","doc_b_id":"38485364","presented_order":["38485364","4467129"],"winner_id":"4467129","reasoning":"Document B is more relevant — it discusses molecular markers linked to poor prognosis (though in neuroblastoma), whereas A focuses on Tks5 and invasion without addressing prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:34.142984Z"}
{"comparison_id":"1621247f-2e11-456c-b5ce-36929fd93378","query_id":"53","doc_a_id":"9095394","doc_b_id":"38485364","presented_order":["38485364","9095394"],"winner_id":"9095394","reasoning":"Document B — it examines marker expression correlated with tumor aggressiveness (though in oral cancer), which is closer to an expression–prognosis link than Document A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:34.143005Z"}
{"comparison_id":"02404570-0398-411f-be7a-9278e24c5148","query_id":"53","doc_a_id":"4467129","doc_b_id":"9095394","presented_order":["4467129","9095394"],"winner_id":"4467129","reasoning":"Document A is more relevant — it discusses molecular marker disruption linked to poor prognosis in cancer (although in neuroblastoma rather than breast cancer), whereas B focuses on keratins in oral squamous neoplasms without prognosis data for breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:38.150899Z"}
{"comparison_id":"b61ba7b1-d5b3-4faf-a0c4-f048798cff23","query_id":"53","doc_a_id":"4457160","doc_b_id":"23599024","presented_order":["4457160","23599024"],"winner_id":"23599024","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it examines how altered protein expression affects cancer progression and prognosis, whereas A focuses on pancreatic cancer genomics. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:44.266104Z"}
{"comparison_id":"1a788549-9389-4f27-bfd2-18f0a97e2728","query_id":"53","doc_a_id":"40349336","doc_b_id":"23599024","presented_order":["40349336","23599024"],"winner_id":"40349336","reasoning":"Document A — it discusses stem/progenitor cell biology (ALDH1 is a stem cell marker), whereas Document B concerns surfactant protein and lung cancer unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:05:44.266126Z"}
{"comparison_id":"4d0e7937-5452-45c8-875d-56b409dc96cb","query_id":"53","doc_a_id":"3899896","doc_b_id":"42484543","presented_order":["3899896","42484543"],"winner_id":"42484543","reasoning":"Document B is more relevant — it deals with gene expression profiles and stem-cell–related markers (closer to ALDH1 expression) while Document A is unrelated (RDW in rectal cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462387Z"}
{"comparison_id":"5079d5f6-3eb2-4dd9-a13e-603fbecf908c","query_id":"53","doc_a_id":"29124963","doc_b_id":"42484543","presented_order":["42484543","29124963"],"winner_id":"42484543","reasoning":"Document A is slightly more related because it discusses stem-cell–associated gene expression, whereas Document B concerns a lung cancer fusion unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462408Z"}
{"comparison_id":"6872c847-e9e7-4c7b-9d51-217567d45ce9","query_id":"53","doc_a_id":"24980622","doc_b_id":"42484543","presented_order":["24980622","42484543"],"winner_id":"24980622","reasoning":"Document A — it concerns cancer tissue marker expression in tumors/metastases, whereas B is about embryonic stem cell transcriptomes and is unrelated to cancer markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462417Z"}
{"comparison_id":"88a521b3-5ecc-4cb5-8cf0-12f549fc0545","query_id":"53","doc_a_id":"21502234","doc_b_id":"42484543","presented_order":["42484543","21502234"],"winner_id":"42484543","reasoning":"Document A is marginally more relevant because it deals with gene expression and stem cell markers, whereas Document B focuses on mismatch repair in endometrial cancer; however, neither directly addresses ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462426Z"}
{"comparison_id":"f78d247d-ccc5-4897-bcc6-ee3e67b33b93","query_id":"53","doc_a_id":"9239963","doc_b_id":"42484543","presented_order":["9239963","42484543"],"winner_id":"9239963","reasoning":"Document A is more relevant because it concerns cancer-related gene expression and tumor biology, whereas Document B focuses on embryonic stem cell transcriptomes and not cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462434Z"}
{"comparison_id":"a6e66cb5-7a4f-4d3d-8984-3cd4dfb33469","query_id":"53","doc_a_id":"16630996","doc_b_id":"42484543","presented_order":["42484543","16630996"],"winner_id":"16630996","reasoning":"Document B — it's about cancer and molecular markers, whereas A covers embryonic stem cells and not cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462445Z"}
{"comparison_id":"e3bf3bcc-0604-4045-bb41-f9c2ac98ef61","query_id":"53","doc_a_id":"25832301","doc_b_id":"42484543","presented_order":["42484543","25832301"],"winner_id":"42484543","reasoning":"Document A — it discusses stem cell transcriptome and stemness-related genes (closer to ALDH1's role as a stem-cell marker), while Document B is about TSPAN7 in multiple myeloma and unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462454Z"}
{"comparison_id":"b255e278-b1a8-4df6-a539-1ca9283b7a75","query_id":"53","doc_a_id":"7639744","doc_b_id":"42484543","presented_order":["42484543","7639744"],"winner_id":"42484543","reasoning":"Document A is slightly more relevant: it discusses gene expression profiles (molecular markers) whereas Document B concerns smoking cessation and lung cancer prognosis, unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462461Z"}
{"comparison_id":"856d8aa2-d494-4ea8-a2aa-44cf158f9e79","query_id":"53","doc_a_id":"5377642","doc_b_id":"42484543","presented_order":["5377642","42484543"],"winner_id":"5377642","reasoning":"Reason: Document A concerns tumor biology and immune regulation in cancer, whereas Document B addresses embryonic stem cell transcriptomes and is unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462468Z"}
{"comparison_id":"ef95e53d-8bdb-4287-8f6c-18e1a61ec8b5","query_id":"53","doc_a_id":"3684342","doc_b_id":"42484543","presented_order":["42484543","3684342"],"winner_id":"42484543","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A discusses stem-cell transcriptional programs (POU5F1, SOX2) related to cellular \"stemness,\" making it marginally more relevant to ALDH1 (a stemness marker) than Document B (lung-specific LIN28B tumor model).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462475Z"}
{"comparison_id":"4c8ea7eb-b774-4d27-8583-2a338bb0556c","query_id":"53","doc_a_id":"46617075","doc_b_id":"42484543","presented_order":["46617075","42484543"],"winner_id":"46617075","reasoning":"Both documents are irrelevant to ALDH1 and breast cancer; Document A is slightly more relevant because it concerns cancer biology (lung cancer) versus embryonic stem cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462482Z"}
{"comparison_id":"faa2b77b-c398-4305-b1c0-49f8fc3d6e9b","query_id":"53","doc_a_id":"39758684","doc_b_id":"42484543","presented_order":["39758684","42484543"],"winner_id":"39758684","reasoning":"Document A is slightly more relevant because it discusses tumorigenesis and factors driving cancer progression, whereas Document B focuses on embryonic stem cell transcriptomes unrelated to cancer prognosis.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462489Z"}
{"comparison_id":"3e50c0d7-5dd0-4516-9ac6-20fca282f921","query_id":"53","doc_a_id":"9211173","doc_b_id":"42484543","presented_order":["42484543","9211173"],"winner_id":"42484543","reasoning":"Document A is more relevant — it concerns gene expression/transcriptome profiling (which could include ALDH1-related expression), whereas Document B focuses on ARID1A mutations in ovarian cancer, not ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462497Z"}
{"comparison_id":"8026599e-b6db-4149-8b9f-1b0e9cc0c5f9","query_id":"53","doc_a_id":"22123421","doc_b_id":"42484543","presented_order":["22123421","42484543"],"winner_id":"22123421","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it addresses prognostic markers in cancer, whereas B is about embryonic stem cell transcriptomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462504Z"}
{"comparison_id":"eec0eaac-870c-451d-9624-dca5abd895fb","query_id":"53","doc_a_id":"5386514","doc_b_id":"42484543","presented_order":["5386514","42484543"],"winner_id":"5386514","reasoning":"Document A is slightly more relevant because it relates to tumor biology and cancer immune response, whereas Document B concerns embryonic stem cell transcriptomes and not cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462512Z"}
{"comparison_id":"3a16fb91-e26a-4577-8ab9-c7b1eab01217","query_id":"53","doc_a_id":"20754359","doc_b_id":"42484543","presented_order":["42484543","20754359"],"winner_id":"42484543","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis; both are irrelevant. Document A is slightly more related because it concerns gene expression profiling and stem-cell markers, which is closer to studies of ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462519Z"}
{"comparison_id":"c0b75cb2-23c4-4c76-89e3-8519bdcbbf11","query_id":"53","doc_a_id":"53211308","doc_b_id":"42484543","presented_order":["53211308","42484543"],"winner_id":"53211308","reasoning":"Document A is slightly more relevant because it concerns cancer biology, whereas Document B focuses on embryonic stem cell transcriptomes and neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462527Z"}
{"comparison_id":"8c6ead74-1f58-42de-9d31-eeac087c30a3","query_id":"53","doc_a_id":"36212758","doc_b_id":"42484543","presented_order":["42484543","36212758"],"winner_id":"36212758","reasoning":"Document B — it discusses cancer genomic profiles and associations with prognosis (though in lung cancer), which is more related to the claim about prognostic markers than a stem-cell transcriptome study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462534Z"}
{"comparison_id":"0e159d07-fd52-4e62-8c5d-dc2dd4c51ebb","query_id":"53","doc_a_id":"20645538","doc_b_id":"42484543","presented_order":["20645538","42484543"],"winner_id":"20645538","reasoning":"Document A is more relevant — it deals with prognostic factors in cancer (though NSCLC, not breast cancer), whereas B covers embryonic stem cell transcriptomes unrelated to cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462542Z"}
{"comparison_id":"92464df7-b52f-4c0f-bf26-a4f947153932","query_id":"53","doc_a_id":"3805841","doc_b_id":"42484543","presented_order":["42484543","3805841"],"winner_id":"3805841","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer prognosis; Document B discusses cancer-related poor outcomes (though in neuroblastoma), so it's slightly more related than Document A (embryonic stem cell transcriptome).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462549Z"}
{"comparison_id":"4eee748b-b063-4341-923b-14cdf8660031","query_id":"53","doc_a_id":"1780819","doc_b_id":"42484543","presented_order":["1780819","42484543"],"winner_id":"1780819","reasoning":"Document A is more relevant — it concerns cancer biology and clinical associations, whereas B is about embryonic stem cell transcriptomes unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462556Z"}
{"comparison_id":"24fe7177-9614-4c00-9ab1-7889fb9b91ec","query_id":"53","doc_a_id":"26902591","doc_b_id":"42484543","presented_order":["26902591","42484543"],"winner_id":"26902591","reasoning":"Document A is more relevant — it discusses cancer-related biology (cachexia) while Document B is focused on embryonic stem cells and unrelated to cancer prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462563Z"}
{"comparison_id":"878821fb-08f9-45eb-ab09-71461c8656f2","query_id":"53","doc_a_id":"3376731","doc_b_id":"42484543","presented_order":["3376731","42484543"],"winner_id":"42484543","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B (stem cell transcriptome) is slightly closer conceptually because ALDH1 is a stemness marker, whereas Document A concerns IL6/CXCR7 in esophageal cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462571Z"}
{"comparison_id":"6c5167eb-387d-4037-a02e-322f1de1ccda","query_id":"53","doc_a_id":"23269537","doc_b_id":"42484543","presented_order":["23269537","42484543"],"winner_id":"23269537","reasoning":"Document A is slightly more relevant because it concerns cancer-related gene expression, whereas Document B focuses on embryonic stem cells and pluripotency. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462578Z"}
{"comparison_id":"63066901-c313-4f57-83d3-7c873033f565","query_id":"53","doc_a_id":"21551568","doc_b_id":"42484543","presented_order":["42484543","21551568"],"winner_id":"42484543","reasoning":"Document A is slightly more relevant because it deals with stem cell-related gene expression (ALDH1 is a stemness marker), whereas Document B focuses on PI3K/Akt alterations in thyroid cancer, not breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462585Z"}
{"comparison_id":"bb2a2095-7e53-459f-8d74-0a920ecbadd5","query_id":"53","doc_a_id":"7028976","doc_b_id":"42484543","presented_order":["42484543","7028976"],"winner_id":"7028976","reasoning":"Document B is more relevant because it addresses cancer stem cell markers and tumorigenic potential, whereas Document A focuses on embryonic stem cell transcriptomes unrelated to cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462592Z"}
{"comparison_id":"ae129f76-aeeb-4da3-9fc0-e6a8ff6b4cb3","query_id":"53","doc_a_id":"11968641","doc_b_id":"42484543","presented_order":["11968641","42484543"],"winner_id":"11968641","reasoning":"Document A is slightly more relevant because it deals with cancer cell biology and tumor growth, whereas Document B focuses on embryonic stem cell transcriptomes and is unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462599Z"}
{"comparison_id":"ffb47be7-8ef8-4751-9da0-8ab63a60b033","query_id":"53","doc_a_id":"23934390","doc_b_id":"42484543","presented_order":["23934390","42484543"],"winner_id":"42484543","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document B is slightly more related (gene expression profiling) but still not relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462605Z"}
{"comparison_id":"f55cfd91-1b47-4f90-a43e-94ce19b59380","query_id":"53","doc_a_id":"2494748","doc_b_id":"42484543","presented_order":["42484543","2494748"],"winner_id":"42484543","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns stem cell gene expression (ALDH1 is a stem-cell marker), while B focuses on CpG methylation in gastric carcinoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462613Z"}
{"comparison_id":"874d350d-419e-4160-a988-ca79d74c24ee","query_id":"53","doc_a_id":"4729644","doc_b_id":"42484543","presented_order":["4729644","42484543"],"winner_id":"4729644","reasoning":"Neither document discusses ALDH1 or breast cancer; however, Document A is cancer-related (tumor growth/drug resistance) while Document B concerns embryonic stem cells, so A is slightly more relevant. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462620Z"}
{"comparison_id":"0dda3f7e-c0fb-41f5-8646-3ecf50bb7666","query_id":"53","doc_a_id":"43334921","doc_b_id":"42484543","presented_order":["43334921","42484543"],"winner_id":"42484543","reasoning":"Document B is slightly more relevant because it addresses gene expression profiles (though in embryonic stem cells), whereas Document A concerns aspirin/NSAID use and colorectal cancer risk, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462627Z"}
{"comparison_id":"1280957a-fc61-407a-8519-53105826171b","query_id":"53","doc_a_id":"21414718","doc_b_id":"42484543","presented_order":["21414718","42484543"],"winner_id":"21414718","reasoning":"Document A is slightly more relevant because it concerns cancer biology (though gastric, not breast) while Document B concerns embryonic stem cells and not cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462634Z"}
{"comparison_id":"be69700f-7a33-4529-b0fb-0e705eeeeda6","query_id":"53","doc_a_id":"1649738","doc_b_id":"42484543","presented_order":["1649738","42484543"],"winner_id":"42484543","reasoning":"Document B is slightly more relevant because it profiles stem-cell–associated gene expression (which relates to markers like ALDH1), whereas Document A concerns PRDM1 and therapy-induced second malignancies after Hodgkin's lymphoma and not breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462642Z"}
{"comparison_id":"3bbc5ebc-c1fd-4ad8-bb62-993dda0ac70e","query_id":"53","doc_a_id":"9196472","doc_b_id":"42484543","presented_order":["42484543","9196472"],"winner_id":"42484543","reasoning":"Document A is more relevant — it concerns stem cell transcriptomes and genes related to pluripotency and differentiation, which is closer to ALDH1's role as a stem/cancer stem cell marker than a monocyte transcriptome study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462649Z"}
{"comparison_id":"786e9164-b7a6-458c-9ad8-8fc08e7644b7","query_id":"53","doc_a_id":"12337611","doc_b_id":"42484543","presented_order":["42484543","12337611"],"winner_id":"42484543","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns stem-cell–related gene expression (contextually closer to ALDH1 as a stem cell marker), whereas B is about LIN28B in neuroblastoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462657Z"}
{"comparison_id":"7612c790-15ab-45be-aafb-173069dbf5e4","query_id":"53","doc_a_id":"23513818","doc_b_id":"42484543","presented_order":["42484543","23513818"],"winner_id":"42484543","reasoning":"Document A is more relevant — it concerns transcriptome/gene expression profiling (which could address ALDH1 expression), whereas Document B focuses on Mcl-1 ubiquitination unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462664Z"}
{"comparison_id":"dd25138e-b588-4746-94ee-596f15c1baf8","query_id":"53","doc_a_id":"8702697","doc_b_id":"42484543","presented_order":["42484543","8702697"],"winner_id":"42484543","reasoning":"Document A is more relevant — it addresses stem cell gene expression and markers tied to stemness, which is conceptually closer to ALDH1 as a cancer stem cell/prognostic marker than a prostate-specific miR-205 study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462671Z"}
{"comparison_id":"d93fdd40-6ae7-42e0-8084-cc697dc90eda","query_id":"53","doc_a_id":"6121555","doc_b_id":"42484543","presented_order":["42484543","6121555"],"winner_id":"42484543","reasoning":"Document A is more relevant — it addresses stem cell transcriptomes (ALDH1 is a stem/progenitor marker), while Document B focuses on SPHK1 in glioma apoptosis and is unrelated to breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462678Z"}
{"comparison_id":"4e250eb3-9469-435a-bb70-f1528b986bb5","query_id":"53","doc_a_id":"45764440","doc_b_id":"42484543","presented_order":["45764440","42484543"],"winner_id":"45764440","reasoning":"Document A is more relevant — it discusses tumor progression and metastasis (cancer prognosis-related topics), whereas B is about embryonic stem cell transcriptomes and unrelated to cancer prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462685Z"}
{"comparison_id":"be7831f6-3198-4d77-bdc3-21ea3c3d32c1","query_id":"53","doc_a_id":"42377686","doc_b_id":"42484543","presented_order":["42377686","42484543"],"winner_id":"42377686","reasoning":"Document A — it discusses cancer prognosis (though in CLL/SLL rather than breast cancer), whereas Document B concerns embryonic stem cell transcriptomes and is unrelated to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462691Z"}
{"comparison_id":"a2c017af-dbc3-44dd-a30a-600be6bbb2af","query_id":"53","doc_a_id":"26495128","doc_b_id":"42484543","presented_order":["26495128","42484543"],"winner_id":"26495128","reasoning":"Document A is marginally more relevant because it discusses cancer-related cell proliferation, whereas Document B focuses on embryonic stem cells and not cancer or prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462698Z"}
{"comparison_id":"b82c1444-c57f-4d99-81cd-e3a1087c6824","query_id":"53","doc_a_id":"36310858","doc_b_id":"42484543","presented_order":["42484543","36310858"],"winner_id":"42484543","reasoning":"Document A is marginally more relevant because it discusses stem-cell–related gene expression (ALDH1 is a stem/progenitor marker), whereas Document B focuses on YAP in pancreatic cancer unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462705Z"}
{"comparison_id":"50311bad-86b4-4d9b-a928-b2da27ad2579","query_id":"53","doc_a_id":"22059387","doc_b_id":"42484543","presented_order":["22059387","42484543"],"winner_id":"42484543","reasoning":"Document B — it concerns stem cell gene expression (more related to ALDH1 as a stem-cell marker) while Document A is about parasite-induced cholangiocarcinoma and unrelated mechanisms. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462721Z"}
{"comparison_id":"12c92357-27eb-4511-98cf-307151900a98","query_id":"53","doc_a_id":"5123516","doc_b_id":"42484543","presented_order":["42484543","5123516"],"winner_id":"5123516","reasoning":"Document B is more relevant — it concerns cancer biology and tumor markers, whereas A is about embryonic stem cell transcriptomes and unrelated to cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462729Z"}
{"comparison_id":"1d40f320-9b1d-499a-bbe7-de578592b0d0","query_id":"53","doc_a_id":"22180793","doc_b_id":"42484543","presented_order":["22180793","42484543"],"winner_id":"42484543","reasoning":"Document B is slightly more relevant because it deals with gene expression profiling (transcriptome) which relates to expression–prognosis associations; Document A focuses on N-cadherin in prostate cancer, not gene expression in breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462736Z"}
{"comparison_id":"b5fb68f5-42d8-4ddf-9f70-eb2fd2c86014","query_id":"53","doc_a_id":"25513319","doc_b_id":"42484543","presented_order":["25513319","42484543"],"winner_id":"25513319","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns cancer prognosis/metastasis (though in prostate cancer), while B is about embryonic stem cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462743Z"}
{"comparison_id":"8a77681b-2809-4796-a7b7-a33db41d7394","query_id":"53","doc_a_id":"10165723","doc_b_id":"42484543","presented_order":["42484543","10165723"],"winner_id":"42484543","reasoning":"Document A is slightly more relevant — it concerns stem cell gene expression (ALDH1 is a stemness marker), whereas Document B addresses methylation in melanoma, not breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462750Z"}
{"comparison_id":"e7d0961c-2aa0-4336-8370-ddc910ef088b","query_id":"53","doc_a_id":"1836154","doc_b_id":"42484543","presented_order":["1836154","42484543"],"winner_id":"1836154","reasoning":"Document A — it's a cancer genomics study (though on glioblastoma) and thus marginally more related to cancer prognosis than an embryonic stem cell transcriptome paper.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462757Z"}
{"comparison_id":"cd1d0c59-fae0-4044-a54f-944cde33cfbf","query_id":"53","doc_a_id":"37204802","doc_b_id":"42484543","presented_order":["42484543","37204802"],"winner_id":"37204802","reasoning":"Document B — it discusses cancer biomarkers and prognosis-related findings, making it more relevant than an embryonic stem cell transcriptome study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462763Z"}
{"comparison_id":"85c79b20-4185-4248-be1e-c5e5b733aec6","query_id":"53","doc_a_id":"5468807","doc_b_id":"42484543","presented_order":["5468807","42484543"],"winner_id":"5468807","reasoning":"Document A is slightly more relevant because it addresses cancer prognosis and therapy, whereas Document B concerns embryonic stem cell transcriptomes and is unrelated to cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462771Z"}
{"comparison_id":"4d3606fc-9013-445d-aaab-25f766303e09","query_id":"53","doc_a_id":"12685434","doc_b_id":"42484543","presented_order":["42484543","12685434"],"winner_id":"42484543","reasoning":"Document A is more relevant — it discusses stem-cell–related gene expression (closer to ALDH1 as a stem-cell marker), whereas Document B concerns GBP1 in glioblastoma and not breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462778Z"}
{"comparison_id":"47bffb62-ec20-4c42-8f94-33a262fb409b","query_id":"53","doc_a_id":"14019636","doc_b_id":"42484543","presented_order":["14019636","42484543"],"winner_id":"14019636","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis directly. Document A is marginally more relevant because it concerns cancer genomic features and prognosis-related pathways, whereas Document B is about embryonic stem cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462785Z"}
{"comparison_id":"fc8ce0bb-9eb1-4a3d-bda6-dff8e3bb524c","query_id":"53","doc_a_id":"20501163","doc_b_id":"42484543","presented_order":["20501163","42484543"],"winner_id":"20501163","reasoning":"Document A is more related to tumor biology and cancer prognosis/treatment, while Document B concerns embryonic stem cells and is not relevant to breast cancer markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462792Z"}
{"comparison_id":"89feab73-39c8-4c23-82d3-14d99ba0553d","query_id":"53","doc_a_id":"22049489","doc_b_id":"42484543","presented_order":["42484543","22049489"],"winner_id":"42484543","reasoning":"Reason: Document A discusses stem cell transcriptome and pluripotency-related genes, which is closer to ALDH1's role as a stemness marker in cancer; Document B focuses on gastric cancer miRNA/RUNX1 and is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462799Z"}
{"comparison_id":"72dd2817-8a70-4560-ba23-7b5d2ff7be67","query_id":"53","doc_a_id":"21063817","doc_b_id":"42484543","presented_order":["42484543","21063817"],"winner_id":"21063817","reasoning":"Document B is more relevant — it concerns aberrant protein expression in cancer (though oral, not breast) and links marker expression to disease prognosis/diagnosis, which is conceptually closer to the query about ALDH1 in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462825Z"}
{"comparison_id":"bc815707-6937-47d8-9cd8-a3ceba6c60ea","query_id":"53","doc_a_id":"16364639","doc_b_id":"42484543","presented_order":["42484543","16364639"],"winner_id":"16364639","reasoning":"Document B is more relevant — it addresses cancer-related molecular pathways, whereas Document A focuses on embryonic stem cell transcriptomes and not cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462841Z"}
{"comparison_id":"ee7412ce-300a-4f9d-9181-429e2b6419b8","query_id":"53","doc_a_id":"16201748","doc_b_id":"42484543","presented_order":["42484543","16201748"],"winner_id":"16201748","reasoning":"Document B — it discusses marker expression in cancer tissues and prognosis, whereas A is about embryonic stem cells. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462851Z"}
{"comparison_id":"43b9ca1c-c1b1-4dcb-8a65-bfd871d949c6","query_id":"53","doc_a_id":"2547636","doc_b_id":"42484543","presented_order":["2547636","42484543"],"winner_id":"2547636","reasoning":"Document A is more relevant — it discusses stem cell function and links circadian disruption to carcinogenesis, which is closer to ALDH1's role as a cancer stem cell marker in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462858Z"}
{"comparison_id":"749f1227-b7e7-4292-a3c9-e5ef0c64fd89","query_id":"53","doc_a_id":"6259170","doc_b_id":"42484543","presented_order":["42484543","6259170"],"winner_id":"6259170","reasoning":"Reason: Document B discusses cancer-related pathways (Nrf2, chemoresistance) and cell survival, which is closer to prognosis in cancer than Document A's focus on embryonic stem cell transcriptomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462866Z"}
{"comparison_id":"4a1e234e-87ee-4af1-bbd6-88dae5d919c1","query_id":"53","doc_a_id":"4993011","doc_b_id":"42484543","presented_order":["42484543","4993011"],"winner_id":"4993011","reasoning":"Document B is more relevant — it discusses cancer-related molecular changes, whereas Document A focuses on embryonic stem cell transcriptomes and doesn't address cancer markers or prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462873Z"}
{"comparison_id":"35185338-01ae-45f9-a954-0df16b601656","query_id":"53","doc_a_id":"25344732","doc_b_id":"42484543","presented_order":["42484543","25344732"],"winner_id":"25344732","reasoning":"Document B is more relevant — both docs don't address ALDH1 or breast cancer, but B discusses tumor-associated expression changes (cancer context), while A is about embryonic stem cells. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462880Z"}
{"comparison_id":"f28746c3-954b-46b4-8b02-df6977086c71","query_id":"53","doc_a_id":"15727984","doc_b_id":"42484543","presented_order":["15727984","42484543"],"winner_id":"42484543","reasoning":"Document B is slightly more relevant because it deals with gene expression and stem cell markers (contextually closer to ALDH1 as a stem/progenitor marker), whereas Document A focuses on lung cancer secreted proteins unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462887Z"}
{"comparison_id":"3029c120-fe14-4145-8493-b6d582ddeba1","query_id":"53","doc_a_id":"17775228","doc_b_id":"42484543","presented_order":["17775228","42484543"],"winner_id":"17775228","reasoning":"Document A is marginally more relevant because it deals with cancer-related molecular changes, whereas Document B focuses on embryonic stem cell transcriptomes; neither discusses ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462894Z"}
{"comparison_id":"50fe02d8-7ea0-4f91-8ff8-083823b51d30","query_id":"53","doc_a_id":"1727493","doc_b_id":"42484543","presented_order":["42484543","1727493"],"winner_id":"42484543","reasoning":"Neither document directly addresses ALDH1 or breast cancer prognosis. Document A is marginally more relevant because it covers stem-cell gene expression (ALDH1 is a stem-cell marker), while Document B concerns miR21 in ovarian cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462902Z"}
{"comparison_id":"860188f7-629a-4928-8d38-ab516eaea4f3","query_id":"53","doc_a_id":"2919030","doc_b_id":"42484543","presented_order":["2919030","42484543"],"winner_id":"42484543","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document B is slightly more relevant because it deals with human gene expression profiling (potentially including ALDH1), whereas A focuses on SOD1 and metabolism. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462909Z"}
{"comparison_id":"a63a1bc6-bbaa-4f63-8512-a24c3da5ddf8","query_id":"53","doc_a_id":"20179918","doc_b_id":"42484543","presented_order":["42484543","20179918"],"winner_id":"42484543","reasoning":"Neither document addresses ALDH1 or breast cancer. Both are irrelevant; Document A is slightly more relevant only because it covers broad gene expression profiling (where ALDH family genes might appear), while B is narrowly about STAT3 regulation of SALL4 in ESCs.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462916Z"}
{"comparison_id":"2c9e1372-3dce-4643-90f8-da9b78f20740","query_id":"53","doc_a_id":"19958277","doc_b_id":"42484543","presented_order":["19958277","42484543"],"winner_id":"19958277","reasoning":"Reason: Document A discusses links between genetic factors and cancer risk, making it marginally more relevant to a prognosis-related cancer claim than Document B, which focuses on embryonic stem cell transcriptomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462923Z"}
{"comparison_id":"634e9f21-5684-4f5d-9a73-04f03ae320ba","query_id":"53","doc_a_id":"17412260","doc_b_id":"42484543","presented_order":["17412260","42484543"],"winner_id":"17412260","reasoning":"Document A is more related to tumor biology and mechanisms that could affect cancer prognosis, whereas Document B focuses on embryonic stem cell transcriptomes and is unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462930Z"}
{"comparison_id":"28587e28-c136-42ce-84b4-547d43154f53","query_id":"53","doc_a_id":"12887068","doc_b_id":"42484543","presented_order":["42484543","12887068"],"winner_id":"42484543","reasoning":"Document A is slightly more relevant — it discusses stem cell transcriptomes and gene expression profiles (more related to stem-cell marker ALDH1) whereas B focuses specifically on a glioma model. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462937Z"}
{"comparison_id":"d561ff49-49ee-46e6-8206-f97292edcb64","query_id":"53","doc_a_id":"11255504","doc_b_id":"42484543","presented_order":["42484543","11255504"],"winner_id":"11255504","reasoning":"Document B is more relevant — it addresses cancer biology (tumorigenesis), whereas Document A focuses on embryonic stem cell transcriptomes; however, neither mentions ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462944Z"}
{"comparison_id":"9a8e4bd7-a212-446d-8532-2b3553e0b426","query_id":"53","doc_a_id":"22914228","doc_b_id":"42484543","presented_order":["22914228","42484543"],"winner_id":"22914228","reasoning":"Document A is more relevant — it's a cancer proteomic study (more likely to address enzyme markers like ALDH1) while Document B concerns embryonic stem cells and not breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:20.462951Z"}
{"comparison_id":"a646c7c0-5525-48af-b61b-1c3f95f641e8","query_id":"53","doc_a_id":"24980622","doc_b_id":"42377686","presented_order":["42377686","24980622"],"winner_id":"42377686","reasoning":"Document A is slightly more relevant because it discusses associations between genetic alterations and prognosis in cancer (though in CLL/SLL, not breast cancer). Document B concerns hypoxia in colorectal liver metastases and is unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001017Z"}
{"comparison_id":"affd40e7-e7ec-4332-b75c-f1f4676f5420","query_id":"53","doc_a_id":"9239963","doc_b_id":"42377686","presented_order":["9239963","42377686"],"winner_id":"42377686","reasoning":"Document B is more relevant — it discusses prognostic associations in cancer (though in CLL/SLL, not breast), whereas A focuses on steroidogenesis in endometrial cancer and not prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001040Z"}
{"comparison_id":"afc90187-3457-43a0-b198-2823a4a1cc0f","query_id":"53","doc_a_id":"16630996","doc_b_id":"42377686","presented_order":["16630996","42377686"],"winner_id":"16630996","reasoning":"Document A is more relevant — it discusses cancer-related molecular marker expression and prognosis/therapy response, which is closer to a claim about ALDH1 expression and breast cancer prognosis than a study of chromosomal deletions in CLL.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001050Z"}
{"comparison_id":"81948e1e-867f-4fe7-ab71-8550186c92d2","query_id":"53","doc_a_id":"5377642","doc_b_id":"42377686","presented_order":["42377686","5377642"],"winner_id":"42377686","reasoning":"Document A — it discusses associations with poor prognosis in a cancer context (though not breast cancer), whereas Document B focuses on T-cell PD-1 regulation unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001062Z"}
{"comparison_id":"3c6f2e4d-ec28-4d75-90e4-4e942b26bcf7","query_id":"53","doc_a_id":"46617075","doc_b_id":"42377686","presented_order":["42377686","46617075"],"winner_id":"42377686","reasoning":"Document A is slightly more relevant — it discusses associations between molecular alterations and poor prognosis (though in CLL, not breast cancer), while B concerns lung cancer pathways and not prognosis markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001069Z"}
{"comparison_id":"1d8d739e-fc0e-46b9-827e-7f6322fa7656","query_id":"53","doc_a_id":"39758684","doc_b_id":"42377686","presented_order":["39758684","42377686"],"winner_id":"39758684","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it addresses tumorigenesis broadly, while B focuses on CLL/SLL genetics. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001076Z"}
{"comparison_id":"c6143b9b-145e-4051-9060-6a0ee2b48d33","query_id":"53","doc_a_id":"22123421","doc_b_id":"42377686","presented_order":["42377686","22123421"],"winner_id":"22123421","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it addresses the prognostic impact of a biomarker in a solid tumor, whereas A concerns genetic deletions in CLL/SLL.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001083Z"}
{"comparison_id":"b328b7e8-605b-4535-aed0-4c4a556c4a9d","query_id":"53","doc_a_id":"5386514","doc_b_id":"42377686","presented_order":["42377686","5386514"],"winner_id":"5386514","reasoning":"Document B is more relevant — it relates to tumor biology and immune responses in cancer, whereas Document A concerns chromosomal deletions in CLL/SLL, unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001090Z"}
{"comparison_id":"c7c2dc42-6236-4f07-8cdd-10415d7c8310","query_id":"53","doc_a_id":"53211308","doc_b_id":"42377686","presented_order":["42377686","53211308"],"winner_id":"53211308","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it concerns a cancer biomarker and tumor progression, whereas A deals with genetic lesions in leukemia. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001097Z"}
{"comparison_id":"4bff6ed0-3a6a-4cba-a88d-17d17fdc2187","query_id":"53","doc_a_id":"36212758","doc_b_id":"42377686","presented_order":["42377686","36212758"],"winner_id":"36212758","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document B is slightly more comparable because it addresses prognosis in a solid tumor (NSCLC) rather than a hematologic malignancy.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001104Z"}
{"comparison_id":"78d4938e-43fa-43ce-af41-50f7691a9df9","query_id":"53","doc_a_id":"20645538","doc_b_id":"42377686","presented_order":["42377686","20645538"],"winner_id":"42377686","reasoning":"Both documents are unrelated to ALDH1 or breast cancer. Document A is slightly more relevant because it discusses molecular/genetic markers associated with prognosis, whereas B deals with pleural effusion in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001112Z"}
{"comparison_id":"e0222582-e628-4912-bc76-8cf08cf66cb1","query_id":"53","doc_a_id":"3805841","doc_b_id":"42377686","presented_order":["3805841","42377686"],"winner_id":"3805841","reasoning":"Document A is more relevant — it discusses cancer metabolism and poor clinical outcomes, which is closer to a claim about a metabolic marker (ALDH1) and prognosis than a leukemia-specific genetic study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001119Z"}
{"comparison_id":"64739bf6-d581-41ad-b412-4b1746e06bfc","query_id":"53","doc_a_id":"1780819","doc_b_id":"42377686","presented_order":["42377686","1780819"],"winner_id":"1780819","reasoning":"Document B — it deals with cancer biomarker expression and prognosis/diagnosis in a solid tumor (endometrial cancer), which is more related to breast cancer biomarker prognostic studies than a CLL genetics paper.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001127Z"}
{"comparison_id":"e18cefaf-f683-43aa-ae50-9797c662d284","query_id":"53","doc_a_id":"26902591","doc_b_id":"42377686","presented_order":["42377686","26902591"],"winner_id":"42377686","reasoning":"Document A is slightly more relevant because it discusses molecular markers associated with prognosis (though in CLL/SLL, not breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001133Z"}
{"comparison_id":"8eca7e78-2ccd-4543-9724-4cc194401b21","query_id":"53","doc_a_id":"23269537","doc_b_id":"42377686","presented_order":["42377686","23269537"],"winner_id":"42377686","reasoning":"Document A — it mentions an association with poor prognosis (though in CLL/SLL rather than breast cancer), whereas B focuses on cyclin D1 regulation in B-cell malignancies and doesn't address prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001141Z"}
{"comparison_id":"e7127979-9563-4eb8-a1aa-7ee202100547","query_id":"53","doc_a_id":"7028976","doc_b_id":"42377686","presented_order":["7028976","42377686"],"winner_id":"7028976","reasoning":"Neither document addresses ALDH1 or breast cancer; Document A is slightly more relevant because it discusses marker expression in tumor-initiating (cancer stem) cells, whereas B concerns CLL genetics. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001148Z"}
{"comparison_id":"48dad4af-2c77-48fa-a319-a5af3108a4a2","query_id":"53","doc_a_id":"11968641","doc_b_id":"42377686","presented_order":["42377686","11968641"],"winner_id":"42377686","reasoning":"Document A is more relevant — it discusses molecular markers associated with prognosis (though in leukemia rather than breast cancer), whereas Document B covers circadian clock effects on melanoma/colon tumors and not prognosis or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001155Z"}
{"comparison_id":"1039d193-fffd-4944-8f0f-2df88c005239","query_id":"53","doc_a_id":"4729644","doc_b_id":"42377686","presented_order":["42377686","4729644"],"winner_id":"42377686","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is marginally more relevant because it deals with prognostic markers in cancer (mentions poor prognosis), whereas B focuses on lncRNA-mediated drug resistance in nasopharyngeal carcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001162Z"}
{"comparison_id":"db5ca4aa-5755-4736-9cb4-f8297827c179","query_id":"53","doc_a_id":"21414718","doc_b_id":"42377686","presented_order":["21414718","42377686"],"winner_id":"42377686","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it discusses biomarkers associated with prognosis, whereas A focuses on a gastric cancer protein interaction. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001170Z"}
{"comparison_id":"11b4b54d-9242-46cb-af62-0e70cb4972d7","query_id":"53","doc_a_id":"45764440","doc_b_id":"42377686","presented_order":["42377686","45764440"],"winner_id":"42377686","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it mentions associations with poor prognosis in a cancer context (although in CLL, not breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001177Z"}
{"comparison_id":"132f8131-ee2c-4ae4-a019-bd5ac50e454b","query_id":"53","doc_a_id":"22914228","doc_b_id":"42377686","presented_order":["22914228","42377686"],"winner_id":"22914228","reasoning":"Reason: Document A deals with cancer proteomics and metabolic enzyme expression (more related to ALDH1's role), while Document B concerns chromosomal deletions in leukemia, unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001185Z"}
{"comparison_id":"d3f17406-f265-4ede-bb86-403b286d36ec","query_id":"53","doc_a_id":"26495128","doc_b_id":"42377686","presented_order":["42377686","26495128"],"winner_id":"42377686","reasoning":"Document A discusses associations with genetic changes and poor prognosis (albeit in CLL rather than breast cancer), whereas B is mechanistic cell biology without prognostic data. A is therefore more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001192Z"}
{"comparison_id":"c933f307-0473-44c0-9e4b-d7c7793f51a0","query_id":"53","doc_a_id":"5123516","doc_b_id":"42377686","presented_order":["42377686","5123516"],"winner_id":"42377686","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A at least concerns prognosis in a cancer context, so it is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001199Z"}
{"comparison_id":"b7e4046f-4d6f-4d7a-9d9e-fd79142d5f4c","query_id":"53","doc_a_id":"25513319","doc_b_id":"42377686","presented_order":["42377686","25513319"],"winner_id":"42377686","reasoning":"Neither document addresses ALDH1 expression or breast cancer. Document A mentions poor prognosis (though in CLL/SLL), so it's slightly closer on the prognosis aspect.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001205Z"}
{"comparison_id":"d2281a77-03ea-4b1d-87ba-7a808163355a","query_id":"53","doc_a_id":"1836154","doc_b_id":"42377686","presented_order":["1836154","42377686"],"winner_id":"1836154","reasoning":"Document A — it discusses gene expression and prognosis links in cancer (though glioblastoma), which is closer to the query about ALDH1 expression and breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001212Z"}
{"comparison_id":"279d0375-680d-4e1f-a86b-4c8544254c1c","query_id":"53","doc_a_id":"37204802","doc_b_id":"42377686","presented_order":["42377686","37204802"],"winner_id":"37204802","reasoning":"Both documents are irrelevant to ALDH1 in breast cancer, but B is slightly more related because it discusses a biomarker associated with aggressive cancer prognosis. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001219Z"}
{"comparison_id":"381f7e7e-9aee-4cd3-a57c-f08c7a33173f","query_id":"53","doc_a_id":"5468807","doc_b_id":"42377686","presented_order":["5468807","42377686"],"winner_id":"42377686","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it discusses associations with prognosis in a cancer context, whereas A focuses on ovarian cancer therapy. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001226Z"}
{"comparison_id":"c675bcb7-0220-4613-a77f-8dac99e2cd49","query_id":"53","doc_a_id":"14019636","doc_b_id":"42377686","presented_order":["42377686","14019636"],"winner_id":"42377686","reasoning":"Document A — it discusses an association with poor prognosis (though in CLL/SLL, not breast cancer), so it's marginally more relevant than Document B which doesn't address prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001234Z"}
{"comparison_id":"6b25066b-39a8-4971-8e20-f3a6a885d534","query_id":"53","doc_a_id":"20501163","doc_b_id":"42377686","presented_order":["42377686","20501163"],"winner_id":"20501163","reasoning":"Document B is more relevant — it addresses tumor biology and host-tumor interactions, while A concerns chromosomal deletions in CLL/SLL (unrelated to ALDH1 or breast cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001241Z"}
{"comparison_id":"e2eaa6e4-0007-4fa3-b0be-23fcc1cfaf49","query_id":"53","doc_a_id":"21063817","doc_b_id":"42377686","presented_order":["42377686","21063817"],"winner_id":"21063817","reasoning":"Document B is more relevant — it discusses expression of protein markers in epithelial cancers, whereas Document A concerns chromosomal deletions in CLL (a hematologic malignancy), not marker expression in breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001248Z"}
{"comparison_id":"d046580d-a174-4c45-a12a-9fdfc63efcef","query_id":"53","doc_a_id":"16364639","doc_b_id":"42377686","presented_order":["16364639","42377686"],"winner_id":"16364639","reasoning":"Document A is marginally more relevant — it concerns molecular oncogenic pathways and gene expression in cancer, whereas Document B is specific to chromosomal deletions in CLL/SLL and unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001256Z"}
{"comparison_id":"523b1af3-5174-43bb-bdfd-7e89026c576c","query_id":"53","doc_a_id":"16201748","doc_b_id":"42377686","presented_order":["16201748","42377686"],"winner_id":"42377686","reasoning":"Document B is more relevant — it discusses an association between a genetic alteration and poorer prognosis in cancer, whereas Document A concerns PTEN in endometrium and not breast cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001264Z"}
{"comparison_id":"a97464a6-d5ba-4597-baae-526d18777c8b","query_id":"53","doc_a_id":"2547636","doc_b_id":"42377686","presented_order":["2547636","42377686"],"winner_id":"42377686","reasoning":"Document B is slightly more relevant because it discusses prognostic markers in cancer (though in CLL/SLL, not breast cancer); Document A does not address prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001271Z"}
{"comparison_id":"20a163aa-de14-46de-8165-6eb1ea428626","query_id":"53","doc_a_id":"6259170","doc_b_id":"42377686","presented_order":["42377686","6259170"],"winner_id":"6259170","reasoning":"Document B is more relevant. Neither mentions ALDH1 or breast cancer, but B discusses cancer-related pathways (Nrf2, chemoresistance) that are closer to prognostic markers than A's focus on CLL chromosomal deletions.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001278Z"}
{"comparison_id":"5397ab98-b85e-4231-9914-ee0557dca374","query_id":"53","doc_a_id":"4993011","doc_b_id":"42377686","presented_order":["4993011","42377686"],"winner_id":"42377686","reasoning":"Reason: Document B discusses associations with poor prognosis (though in CLL/SLL), while Document A doesn't address prognosis or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001284Z"}
{"comparison_id":"531081c2-ef2e-4a73-88fe-19aa18840404","query_id":"53","doc_a_id":"25344732","doc_b_id":"42377686","presented_order":["42377686","25344732"],"winner_id":"42377686","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A at least discusses cancer prognosis (though in CLL/SLL), so it's slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001291Z"}
{"comparison_id":"dd91c545-e92e-4bde-b171-06ce1932076a","query_id":"53","doc_a_id":"17775228","doc_b_id":"42377686","presented_order":["17775228","42377686"],"winner_id":"42377686","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses prognostic associations in cancer, whereas A concerns imprinting in colorectal cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001298Z"}
{"comparison_id":"64a4b590-6f38-4440-a045-575e05b3f3f2","query_id":"53","doc_a_id":"19958277","doc_b_id":"42377686","presented_order":["19958277","42377686"],"winner_id":"42377686","reasoning":"Document B mentions associations with poor prognosis in a cancer context (even though it's CLL/SLL, not breast cancer), while Document A is general about helicases and genomic stability. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001305Z"}
{"comparison_id":"136329ac-54e8-4c18-9fb9-2692b71ec00c","query_id":"53","doc_a_id":"17412260","doc_b_id":"42377686","presented_order":["42377686","17412260"],"winner_id":"17412260","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer prognosis, but Document B deals with tumor-related senescence pathways (more generally cancer-relevant) while Document A is specific to CLL genetics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001312Z"}
{"comparison_id":"abaf0eed-2a73-4fec-90e0-b00a1bf69cb6","query_id":"53","doc_a_id":"11255504","doc_b_id":"42377686","presented_order":["42377686","11255504"],"winner_id":"42377686","reasoning":"Document A is slightly more relevant because it discusses associations with poor prognosis (though in CLL), while Document B covers liver cancer genetics unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:41.001319Z"}
{"comparison_id":"09ed5e7f-c270-4038-b968-9c51bc71ef7e","query_id":"53","doc_a_id":"16630996","doc_b_id":"7028976","presented_order":["16630996","7028976"],"winner_id":"7028976","reasoning":"Both documents are not about ALDH1 or breast cancer, but B is more relevant because it addresses marker expression in tumor-initiating (cancer stem) cells, a context closer to ALDH1's role in prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:49.058969Z"}
{"comparison_id":"c91d434b-c211-409b-9335-7847ade8a608","query_id":"53","doc_a_id":"39758684","doc_b_id":"7028976","presented_order":["39758684","7028976"],"winner_id":"39758684","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer, but Document A discusses mechanisms of tumorigenesis broadly, making it slightly more relevant than Document B which focuses on EGFR in glioblastoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:49.058990Z"}
{"comparison_id":"b21b42e1-f056-42b4-b8d3-8271feecf627","query_id":"53","doc_a_id":"22123421","doc_b_id":"7028976","presented_order":["7028976","22123421"],"winner_id":"7028976","reasoning":"Document A is more relevant — it discusses tumor-initiating/cancer stem cell markers (EGFR) and tumorigenesis, which is conceptually closer to ALDH1's role in cancer prognosis than a platelet ratio study in lung cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:49.059000Z"}
{"comparison_id":"504c7042-48ac-463e-aef1-fedf4564e841","query_id":"53","doc_a_id":"5386514","doc_b_id":"7028976","presented_order":["5386514","7028976"],"winner_id":"7028976","reasoning":"Neither document mentions ALDH1 or breast cancer; Document B is slightly more relevant because it discusses tumor-initiating cell markers and prognosis/therapeutic implications (though in glioblastoma, not breast cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:49.059007Z"}
{"comparison_id":"c8eff25a-f826-48bf-a4d2-f4ecd4c9b458","query_id":"53","doc_a_id":"53211308","doc_b_id":"7028976","presented_order":["7028976","53211308"],"winner_id":"53211308","reasoning":"Document B is more relevant because it addresses cancer biomarker expression and clinical implications, whereas Document A focuses on EGFR in glioblastoma, not breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:49.059015Z"}
{"comparison_id":"3d5b1339-2143-4422-a27e-0a8e8d56ee16","query_id":"53","doc_a_id":"36212758","doc_b_id":"7028976","presented_order":["7028976","36212758"],"winner_id":"7028976","reasoning":"Document A — it discusses tumor-initiating/cancer stem cell markers and their prognostic/functional relevance, which is more related to ALDH1's role than a genomic study in lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:49.059022Z"}
{"comparison_id":"7ad15280-efcb-48c3-9372-d96a23a19c5a","query_id":"53","doc_a_id":"3805841","doc_b_id":"7028976","presented_order":["3805841","7028976"],"winner_id":"7028976","reasoning":"Document B — it addresses tumor-initiating cell markers (analogous to ALDH1 as a stem-cell marker), whereas A discusses MYC/circadian disruption in neuroblastoma and not markers or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:49.059030Z"}
{"comparison_id":"ddf07423-a268-4e3d-a824-a761a21b94e6","query_id":"53","doc_a_id":"1780819","doc_b_id":"7028976","presented_order":["7028976","1780819"],"winner_id":"7028976","reasoning":"Document A — it discusses tumor-initiating (cancer stem) cells, which is conceptually closer to ALDH1 as a stem-cell marker; Document B focuses on HAND2 methylation in endometrial cancer, unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:49.059037Z"}
{"comparison_id":"be771c3a-4911-4113-846c-673110f29b46","query_id":"53","doc_a_id":"17412260","doc_b_id":"7028976","presented_order":["7028976","17412260"],"winner_id":"17412260","reasoning":"Document B is more relevant — it deals with cancer-related cellular programs (senescence/SASP) that can influence tumor behavior, whereas A is specific to EGFR in glioblastoma and not related to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:49.059044Z"}
{"comparison_id":"62adedc4-cb17-4f6a-b9ee-809fd28804c6","query_id":"53","doc_a_id":"22914228","doc_b_id":"7028976","presented_order":["22914228","7028976"],"winner_id":"7028976","reasoning":"Document B — it concerns tumor‑initiating cell markers and prognosis-related biology (though in GBM), which is closer to ALDH1 as a stem-cell/prognostic marker than a metabolic proteomics study in pancreatic cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:49.059052Z"}
{"comparison_id":"136fe10d-79cb-4e53-bc52-55751b194b8c","query_id":"53","doc_a_id":"1836154","doc_b_id":"7028976","presented_order":["7028976","1836154"],"winner_id":"7028976","reasoning":"Neither abstract addresses ALDH1 or breast cancer. Document A is slightly more relevant because it studies marker expression in tumor-initiating (cancer stem) cells, which is conceptually closer to ALDH1's role. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:49.059059Z"}
{"comparison_id":"26b5d9ca-1541-40f0-ad42-82dfcece3882","query_id":"53","doc_a_id":"37204802","doc_b_id":"7028976","presented_order":["7028976","37204802"],"winner_id":"7028976","reasoning":"Document A is slightly more relevant because it discusses expression of a tumor-initiating cell marker (EGFR) and tumor-initiating cell biology, which is closer to marker-prognosis relationships than Document B's focus on a colon-specific enzymatic regulator of p53.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:49.059067Z"}
{"comparison_id":"c92910fc-b65b-4ffe-8dd3-d796b73be6b9","query_id":"53","doc_a_id":"20501163","doc_b_id":"7028976","presented_order":["20501163","7028976"],"winner_id":"7028976","reasoning":"Document B — it discusses tumor-initiating cell markers and their clinical implications (though in GBM), which is more closely related to marker-expression/prognosis questions than Document A's metabolic/IL-6 immunology focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:49.059074Z"}
{"comparison_id":"d8d5a6b2-f829-4420-82b6-d68aebee1beb","query_id":"53","doc_a_id":"21063817","doc_b_id":"7028976","presented_order":["7028976","21063817"],"winner_id":"7028976","reasoning":"Document A is more relevant — it discusses tumor-initiating (cancer stem) cell markers and their clinical implications, which is conceptually closer to ALDH1 as a stem-cell marker linked to prognosis than keratin changes in oral cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:49.059082Z"}
{"comparison_id":"2521da55-2843-4fcd-901a-6df2eef07a4e","query_id":"53","doc_a_id":"16364639","doc_b_id":"7028976","presented_order":["16364639","7028976"],"winner_id":"7028976","reasoning":"Document B is more relevant because it deals with tumor-initiating cell markers and their clinical impact, which is closer to ALDH1's role as a stem-cell/prognostic marker than the microRNA network focus of Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:49.059089Z"}
{"comparison_id":"7f3bd5aa-d691-4fec-9236-29124045fd53","query_id":"53","doc_a_id":"6259170","doc_b_id":"7028976","presented_order":["7028976","6259170"],"winner_id":"7028976","reasoning":"Document A is more relevant — it addresses tumor-initiating cell markers and their clinical implications in cancer (though in GBM rather than breast), whereas B focuses on Keap1–Nrf2/mitochondria signaling unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:49.059096Z"}
{"comparison_id":"e7df0120-eeb6-47e2-a203-66e0eeb86313","query_id":"53","doc_a_id":"39758684","doc_b_id":"53211308","presented_order":["39758684","53211308"],"winner_id":"39758684","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer; Document A is at least related to general tumorigenesis mechanisms, making it slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:53.260542Z"}
{"comparison_id":"949a96c9-32f3-42d0-8e6d-333ee7598fd2","query_id":"53","doc_a_id":"17412260","doc_b_id":"53211308","presented_order":["17412260","53211308"],"winner_id":"17412260","reasoning":"Document A is marginally more relevant because it discusses tumor biology and in vivo processes affecting cancer outcomes, whereas Document B is specific to ovarian cancer biomarkers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:53.260566Z"}
{"comparison_id":"d7129df8-b065-49cc-a0a5-466b021167d7","query_id":"53","doc_a_id":"39758684","doc_b_id":"17412260","presented_order":["17412260","39758684"],"winner_id":"17412260","reasoning":"Neither document mentions ALDH1 or directly addresses breast cancer prognosis, but Document A is marginally more relevant because it discusses tumor-related senescence and signaling pathways that can influence tumor behavior and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:06:57.437997Z"}
{"comparison_id":"190e5592-6112-4be7-916d-9efb79ea4087","query_id":"53","doc_a_id":"16630996","doc_b_id":"22914228","presented_order":["16630996","22914228"],"winner_id":"16630996","reasoning":"Document A — it discusses molecular markers and their association with clinical outcomes (chemoresistance), which is closer to a claim about marker expression and prognosis than the metabolic proteomics focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:04.705958Z"}
{"comparison_id":"5ea62cb7-f53e-436d-86a5-4b4071295806","query_id":"53","doc_a_id":"22123421","doc_b_id":"22914228","presented_order":["22123421","22914228"],"winner_id":"22123421","reasoning":"Document A is more relevant — it addresses prognostic biomarkers and survival outcomes in cancer (though different cancer type), whereas Document B focuses on metabolic proteomics in pancreatic cancer cells and not prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:04.705979Z"}
{"comparison_id":"569d211a-cf56-419f-9ecb-60a7cc2a1d51","query_id":"53","doc_a_id":"5386514","doc_b_id":"22914228","presented_order":["22914228","5386514"],"winner_id":"5386514","reasoning":"Document B — it addresses tumor-related immune mechanisms (general cancer relevance), whereas A is specific to pancreatic cancer metabolism and doesn't relate to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:04.705989Z"}
{"comparison_id":"860538cf-1f47-49c4-ae03-eb0a7d2a7f41","query_id":"53","doc_a_id":"36212758","doc_b_id":"22914228","presented_order":["22914228","36212758"],"winner_id":"36212758","reasoning":"Document B is more relevant — it addresses prognostic genomic profiles and survival associations in cancer, which is closer to a claim about marker expression and prognosis than a pancreatic metabolism study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:04.705996Z"}
{"comparison_id":"b6ca5b90-3f9f-401d-90cd-46a181429ed7","query_id":"53","doc_a_id":"3805841","doc_b_id":"22914228","presented_order":["22914228","3805841"],"winner_id":"3805841","reasoning":"Document B — it discusses links between oncogenic signaling, metabolism, and poor clinical outcomes in cancers, which is somewhat closer to prognosis-related claims than a proteomic study in pancreatic cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:04.706004Z"}
{"comparison_id":"81db4f40-a006-4eda-975a-5581642d2cfe","query_id":"53","doc_a_id":"1780819","doc_b_id":"22914228","presented_order":["22914228","1780819"],"winner_id":"1780819","reasoning":"Document B — it addresses gene expression and prognostic/diagnostic implications in cancer, whereas A focuses on pancreatic metabolism unrelated to ALDH1 or breast cancer.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:04.706011Z"}
{"comparison_id":"bbfd3078-ce17-43de-bceb-54bfd63dc731","query_id":"53","doc_a_id":"6259170","doc_b_id":"22914228","presented_order":["22914228","6259170"],"winner_id":"6259170","reasoning":"Neither document directly addresses ALDH1 or breast cancer, but Document B is more related because it discusses stress-response pathways (Keap1–Nrf2) involved in chemoresistance and cellular homeostasis that can connect to ALDH1-mediated stemness. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:04.706018Z"}
{"comparison_id":"035109df-dc5b-492f-9c18-428c14bd06d7","query_id":"53","doc_a_id":"1836154","doc_b_id":"22914228","presented_order":["1836154","22914228"],"winner_id":"1836154","reasoning":"Document A is slightly more relevant because it discusses cancer-related gene expression and prognosis-related molecular markers (though in glioblastoma, not breast cancer). Document B focuses on pancreatic cell metabolism and is less related to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:04.706027Z"}
{"comparison_id":"01ac1765-a652-4510-8dea-aa1bad922754","query_id":"53","doc_a_id":"37204802","doc_b_id":"22914228","presented_order":["22914228","37204802"],"winner_id":"22914228","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more related (proteomics/metabolism vs. colon-specific molecular mechanism in B).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:04.706035Z"}
{"comparison_id":"522157d9-7d0f-49f6-97b8-032c468df3ae","query_id":"53","doc_a_id":"20501163","doc_b_id":"22914228","presented_order":["22914228","20501163"],"winner_id":"22914228","reasoning":"Document A is a proteomic study of cancer protein expression (potentially including markers like ALDH1), while Document B focuses on IL-6–driven host metabolism and immunity, so A is more relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:04.706042Z"}
{"comparison_id":"321e7766-88ca-4dfd-be06-fd67cc945898","query_id":"53","doc_a_id":"21063817","doc_b_id":"22914228","presented_order":["22914228","21063817"],"winner_id":"21063817","reasoning":"Document B is more relevant — it addresses differential protein expression as a diagnostic/prognostic marker in epithelial cancers, which is conceptually closer to ALDH1 expression and prognosis in breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:04.706050Z"}
{"comparison_id":"ee4f0489-4fe5-45f5-a775-ff32ec725e83","query_id":"53","doc_a_id":"16364639","doc_b_id":"22914228","presented_order":["22914228","16364639"],"winner_id":"22914228","reasoning":"Document A is slightly more relevant because it is a proteomic study of cancer metabolism (may include metabolic enzymes like ALDH1), whereas Document B focuses on microRNA networks in glioblastoma and not metabolic enzyme expression; neither directly addresses ALDH1 in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:04.706057Z"}
{"comparison_id":"459a5141-0583-4fad-bd4c-ef330215ee2f","query_id":"53","doc_a_id":"16630996","doc_b_id":"3805841","presented_order":["3805841","16630996"],"winner_id":"16630996","reasoning":"Document B is slightly more relevant because it discusses molecular expression markers linked to cancer treatment outcomes, whereas A focuses on MYC-driven circadian disruption in neuroblastoma, not biomarker–prognosis links in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:10.675327Z"}
{"comparison_id":"8e5388b5-f564-4c3e-a2a5-e6e5d74a6805","query_id":"53","doc_a_id":"22123421","doc_b_id":"3805841","presented_order":["22123421","3805841"],"winner_id":"3805841","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document B discusses molecular oncogenic alterations linked to poor clinical outcomes, making it slightly more relevant to a prognostic biomarker claim than a platelet ratio study in lung cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:10.675350Z"}
{"comparison_id":"0f7e3eab-dcae-4c7f-9b24-a0020da385f6","query_id":"53","doc_a_id":"5386514","doc_b_id":"3805841","presented_order":["5386514","3805841"],"winner_id":"5386514","reasoning":"Document A is marginally more relevant because it discusses tumor-related immune responses and chemotherapy effects broadly, while Document B focuses on MYC and neuroblastoma (not breast cancer). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:10.675359Z"}
{"comparison_id":"6e59c842-6ca1-4b93-9c71-dee05525fc2a","query_id":"53","doc_a_id":"36212758","doc_b_id":"3805841","presented_order":["3805841","36212758"],"winner_id":"36212758","reasoning":"Document B is more relevant — it addresses cancer prognostic genomic profiles and survival associations, whereas A focuses on MYC-driven circadian/metabolic disruption in neuroblastoma, not breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:10.675367Z"}
{"comparison_id":"6df9ab44-fb87-4e6f-ac54-cafa9e4a5a3c","query_id":"53","doc_a_id":"21063817","doc_b_id":"3805841","presented_order":["3805841","21063817"],"winner_id":"3805841","reasoning":"Document A is slightly more relevant because it discusses cancer prognosis and mechanisms linked to poor clinical outcomes; Document B focuses on keratin changes in oral squamous carcinoma, unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:10.675374Z"}
{"comparison_id":"a4877674-bc50-4250-897d-21960400115a","query_id":"53","doc_a_id":"1780819","doc_b_id":"3805841","presented_order":["1780819","3805841"],"winner_id":"3805841","reasoning":"B — Document B discusses oncogene-driven disruption linked to poor clinical outcomes in cancer, whereas A focuses on HAND2 in endometrial cancer unrelated to ALDH1 or breast cancer.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:10.675381Z"}
{"comparison_id":"c0986e46-124f-4a22-97a7-82112cacaeb6","query_id":"53","doc_a_id":"6259170","doc_b_id":"3805841","presented_order":["3805841","6259170"],"winner_id":"6259170","reasoning":"Document B — it discusses chemoresistance and cytoprotective/detoxification pathways (more related to ALDH1’s role in chemoresistance/prognosis) while A focuses on MYC and circadian disruption in neuroblastoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:10.675389Z"}
{"comparison_id":"6519cda9-70a1-4d4c-b6f5-4f94ad633711","query_id":"53","doc_a_id":"1836154","doc_b_id":"3805841","presented_order":["1836154","3805841"],"winner_id":"3805841","reasoning":"Neither abstract addresses ALDH1 or breast cancer specifically; both are irrelevant. Document B is slightly more related insofar as it discusses cancer prognosis and metabolic markers, while A focuses on glioblastoma genomics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:10.675396Z"}
{"comparison_id":"92c34951-4ff0-4526-8b78-b5aea89ae9d1","query_id":"53","doc_a_id":"16630996","doc_b_id":"5386514","presented_order":["16630996","5386514"],"winner_id":"5386514","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document B relates to tumor biology and immune response, making it marginally more relevant than Document A, which focuses on pancreatic gemcitabine transport genes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:18.396557Z"}
{"comparison_id":"d22c4947-0026-4558-8a3d-f611da574fb1","query_id":"53","doc_a_id":"6259170","doc_b_id":"5386514","presented_order":["6259170","5386514"],"winner_id":"6259170","reasoning":"Document A is more related — it discusses cancer-related pathways and chemoresistance (Nrf2/mitochondria) which is closer to ALDH1's role as a marker of tumor aggressiveness than B's immune-inflammasome focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:18.396579Z"}
{"comparison_id":"87479a06-f03d-465d-9b2b-4e4b97b2ff4b","query_id":"53","doc_a_id":"36212758","doc_b_id":"5386514","presented_order":["36212758","5386514"],"winner_id":"36212758","reasoning":"Document A is more relevant — it discusses prognostic genomic profiles and recurrence risk in cancer (though in NSCLC rather than breast), while B focuses on immune mechanisms unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:18.396588Z"}
{"comparison_id":"3ee6e7ae-cccb-4ba0-aaa5-395e3b81354c","query_id":"53","doc_a_id":"6259170","doc_b_id":"36212758","presented_order":["36212758","6259170"],"winner_id":"36212758","reasoning":"Neither document addresses ALDH1 or breast cancer; Document A is marginally more relevant because it discusses cancer prognosis (though in lung cancer), whereas Document B focuses on Nrf2/mitochondria. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:23.368275Z"}
{"comparison_id":"b2108567-e4d6-4d78-85b3-14d5172e6739","query_id":"53","doc_a_id":"22123421","doc_b_id":"21063817","presented_order":["22123421","21063817"],"winner_id":"21063817","reasoning":"Document B — it discusses biomarker expression patterns in epithelial cancers (molecular marker relevance), which is closer to a claim about ALDH1 expression in breast cancer than a platelet ratio study in NSCLC.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:27.936137Z"}
{"comparison_id":"4676ab49-dd4a-4d37-be37-924b3cbd505b","query_id":"53","doc_a_id":"1836154","doc_b_id":"21063817","presented_order":["21063817","1836154"],"winner_id":"1836154","reasoning":"Document B — it discusses cancer genomic markers and prognosis (though in glioblastoma), whereas Document A is limited to keratins in oral cancer; neither addresses ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:27.936158Z"}
{"comparison_id":"1a999330-5199-4781-bb4e-36c7d917ea93","query_id":"53","doc_a_id":"1780819","doc_b_id":"21063817","presented_order":["21063817","1780819"],"winner_id":"1780819","reasoning":"Document B is slightly more relevant — it addresses a molecular marker (epigenetic silencing) associated with cancer prognosis/response, whereas A is about keratins in oral cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:27.936166Z"}
{"comparison_id":"7c22999b-2f2b-4089-9892-f3f6b81ac41f","query_id":"53","doc_a_id":"1836154","doc_b_id":"1780819","presented_order":["1780819","1836154"],"winner_id":"1780819","reasoning":"Document A is somewhat more relevant because it discusses cancer biomarker expression and clinical prognosis/response (though in endometrial, not breast); Document B focuses on glioblastoma genomics. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:32.058934Z"}
{"comparison_id":"950e2957-a1dd-46e8-952c-3d11ee77d63a","query_id":"53","doc_a_id":"37204802","doc_b_id":"20501163","presented_order":["37204802","20501163"],"winner_id":"37204802","reasoning":"Document A is slightly more relevant because it discusses a biomarker linked to aggressive cancer/prognosis (though in colon cancer), while Document B focuses on metabolism and immune suppression without addressing biomarkers or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:37.014786Z"}
{"comparison_id":"a5efbe63-7e4c-4811-9800-27d3a082f577","query_id":"53","doc_a_id":"16364639","doc_b_id":"20501163","presented_order":["16364639","20501163"],"winner_id":"20501163","reasoning":"Document B — it addresses tumor-driven factors (IL-6) that affect tumor progression, immune suppression, and therapy outcomes, which is more broadly related to prognosis than A’s glioblastoma-specific microRNA network. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:37.014807Z"}
{"comparison_id":"300225b0-8a2e-49b8-ba36-fef63fd90563","query_id":"53","doc_a_id":"24980622","doc_b_id":"26495128","presented_order":["24980622","26495128"],"winner_id":"26495128","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document B discusses a protein involved in cancer cell proliferation (more relevant to tumor biology) whereas Document A concerns hypoxia in colorectal liver metastases.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841090Z"}
{"comparison_id":"e485d08b-7cd3-45e5-b084-f1e13aceac44","query_id":"53","doc_a_id":"9239963","doc_b_id":"26495128","presented_order":["26495128","9239963"],"winner_id":"26495128","reasoning":"Document A — it discusses proteins involved in cell proliferation and cancer implications, which is closer to a prognostic marker context than an endometrial steroidogenesis study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841113Z"}
{"comparison_id":"7f48067e-7e75-4dc6-a5ab-1c6b4a2a9152","query_id":"53","doc_a_id":"5377642","doc_b_id":"26495128","presented_order":["5377642","26495128"],"winner_id":"26495128","reasoning":"Document B is more relevant—it's about tumor cell proliferation and cancer-related proteins, which is closer to tumor marker/prognosis context than A's focus on T cell PD‑1 regulation.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841122Z"}
{"comparison_id":"068e76cc-959a-40ef-97d5-aa01479b5304","query_id":"53","doc_a_id":"46617075","doc_b_id":"26495128","presented_order":["46617075","26495128"],"winner_id":"26495128","reasoning":"Neither document mentions ALDH1 or breast cancer; Document B is marginally more relevant because it discusses proteins and proliferation with implications for cancer generally, while A focuses on lung-specific Rb-p16 pathways.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841129Z"}
{"comparison_id":"a10d64a0-976c-4159-8b9f-fd3d70a0880a","query_id":"53","doc_a_id":"20645538","doc_b_id":"26495128","presented_order":["20645538","26495128"],"winner_id":"26495128","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B discusses molecular cancer-related proteins and proliferation (more biologically related) while Document A focuses on pleural effusion in NSCLC (unrelated disease/marker).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841137Z"}
{"comparison_id":"f139b55d-0366-479f-98a2-d73198fa9443","query_id":"53","doc_a_id":"26902591","doc_b_id":"26495128","presented_order":["26495128","26902591"],"winner_id":"26495128","reasoning":"Document A is more relevant — it discusses cancer-related molecular mechanisms and cell proliferation, while Document B addresses adipose browning and cachexia, not tumor markers or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841144Z"}
{"comparison_id":"1f31dd5c-e6f0-42f8-b76a-851fd77c3390","query_id":"53","doc_a_id":"23269537","doc_b_id":"26495128","presented_order":["23269537","26495128"],"winner_id":"23269537","reasoning":"Document A is more relevant — it discusses gene expression changes associated with malignancy (though in B-cell cancer), which is closer to the query about marker expression and prognosis than the ribosomal/proliferation focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841152Z"}
{"comparison_id":"ef536a20-55a1-4e2e-9ac3-b9faad70acdc","query_id":"53","doc_a_id":"11968641","doc_b_id":"26495128","presented_order":["11968641","26495128"],"winner_id":"26495128","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer prognosis, but Document B at least addresses cancer-related protein alterations and implications for tumor biology, making it slightly more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841159Z"}
{"comparison_id":"982c8fbc-48be-4bb0-95e1-12a4f69cd2fd","query_id":"53","doc_a_id":"4729644","doc_b_id":"26495128","presented_order":["4729644","26495128"],"winner_id":"26495128","reasoning":"Document B is more generally related to cancer biology (cell proliferation and cancer-related nucleolar proteins), whereas Document A focuses on NEAT1-mediated cisplatin resistance in nasopharyngeal carcinoma, unrelated to ALDH1 or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841166Z"}
{"comparison_id":"83881563-6e1a-4e71-ba2d-246b06f76e10","query_id":"53","doc_a_id":"21414718","doc_b_id":"26495128","presented_order":["21414718","26495128"],"winner_id":"26495128","reasoning":"Document B is slightly more relevant — it discusses a protein interaction with implications for cancer biology and cell proliferation, which is closer to prognostic biomarker context than a gastric-cancer–specific mobility study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841174Z"}
{"comparison_id":"7f244a5b-e26a-4025-aad3-2956bd9730a8","query_id":"53","doc_a_id":"45764440","doc_b_id":"26495128","presented_order":["45764440","26495128"],"winner_id":"45764440","reasoning":"Reason: Document A discusses tumor progression and metastasis (directly related to prognosis), while Document B focuses on ribosome biogenesis and proliferation without linking to prognosis or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841181Z"}
{"comparison_id":"0afd325b-326b-412c-8465-6bfe37b33b78","query_id":"53","doc_a_id":"11255504","doc_b_id":"26495128","presented_order":["11255504","26495128"],"winner_id":"26495128","reasoning":"Document B is more relevant — it discusses proteins involved in cancer-related cell proliferation, whereas Document A focuses on liver-specific tumor suppressors unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841188Z"}
{"comparison_id":"99617da0-05c0-46e1-9b63-7bf4c28a3376","query_id":"53","doc_a_id":"5123516","doc_b_id":"26495128","presented_order":["26495128","5123516"],"winner_id":"26495128","reasoning":"Document A is slightly more relevant because it discusses proteins and mechanisms related to cancer biology, whereas Document B focuses on glioblastoma and a receptor unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841195Z"}
{"comparison_id":"712158a1-c7c5-4807-928b-72eceb8d2ec2","query_id":"53","doc_a_id":"25513319","doc_b_id":"26495128","presented_order":["25513319","26495128"],"winner_id":"25513319","reasoning":"Document A is slightly more relevant because it addresses cancer survival and metastasis (clinical outcomes), whereas Document B focuses on ribosome biogenesis and cell proliferation without linking to prognosis or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841203Z"}
{"comparison_id":"17d189ae-f028-4bc9-a1a8-4c58bd66c94f","query_id":"53","doc_a_id":"5468807","doc_b_id":"26495128","presented_order":["26495128","5468807"],"winner_id":"26495128","reasoning":"Document A is slightly more relevant because it discusses proteins involved in cell proliferation and potential cancer implications, whereas Document B focuses specifically on ARID1A-mutated ovarian cancer and HDAC6. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841210Z"}
{"comparison_id":"5dfdbc3f-e37c-4867-ab46-37612b0c8ac1","query_id":"53","doc_a_id":"14019636","doc_b_id":"26495128","presented_order":["26495128","14019636"],"winner_id":"26495128","reasoning":"Document A is slightly more relevant — it discusses proteins and mechanisms implicated in cancer biology (cell proliferation), which is closer to prognostic markers than rDNA copy-number variation focused on DNA-damage sensitivity.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841218Z"}
{"comparison_id":"b28c6bda-e324-448c-abe9-0cc6b8acc9de","query_id":"53","doc_a_id":"16201748","doc_b_id":"26495128","presented_order":["16201748","26495128"],"winner_id":"16201748","reasoning":"Document A is slightly more relevant because it reports how altered marker expression correlates with progression to carcinoma, which is analogous to linking expression with prognosis; Document B is mechanistic and not about marker expression or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841225Z"}
{"comparison_id":"7609f377-267f-4901-a415-1fea9f002447","query_id":"53","doc_a_id":"2547636","doc_b_id":"26495128","presented_order":["26495128","2547636"],"winner_id":"2547636","reasoning":"Neither document mentions ALDH1 or breast cancer directly; Document B is slightly more relevant because it addresses stem cell function and carcinogenesis, which is closer to ALDH1's role as a stem-cell marker. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841233Z"}
{"comparison_id":"24e1732b-ca0d-441d-a9d3-642e15730312","query_id":"53","doc_a_id":"4993011","doc_b_id":"26495128","presented_order":["4993011","26495128"],"winner_id":"26495128","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it discusses a protein's role in cell proliferation and cancer implications, whereas A focuses on ATRX-driven rDNA instability and a specific therapeutic sensitivity.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841240Z"}
{"comparison_id":"2276084d-1129-4f03-8c18-f70bbd7ab8cf","query_id":"53","doc_a_id":"25344732","doc_b_id":"26495128","presented_order":["26495128","25344732"],"winner_id":"26495128","reasoning":"Document A. Neither abstract mentions ALDH1 or breast cancer, but A's focus on proteins tied to cell proliferation and cancer is slightly more relevant than B's osteosarcoma-specific finding.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841247Z"}
{"comparison_id":"49701a7e-a719-4f2e-9c5f-e22a7c673fc6","query_id":"53","doc_a_id":"17775228","doc_b_id":"26495128","presented_order":["26495128","17775228"],"winner_id":"26495128","reasoning":"Document A — it discusses a protein's role in cancer-related processes (cell proliferation, ribosome biogenesis) and potential cancer implications, which is closer to breast cancer prognosis than a colorectal imprinting study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841254Z"}
{"comparison_id":"c8e3baa9-9e42-48f2-889f-a7b2ad529ef5","query_id":"53","doc_a_id":"19958277","doc_b_id":"26495128","presented_order":["26495128","19958277"],"winner_id":"26495128","reasoning":"Neither document discusses ALDH1 or breast cancer; Document A is marginally more relevant because it at least mentions potential implications in cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:46.841261Z"}
{"comparison_id":"1fc069c4-994e-4ec9-b0c5-1f161b5b5e2b","query_id":"53","doc_a_id":"23269537","doc_b_id":"25513319","presented_order":["25513319","23269537"],"winner_id":"23269537","reasoning":"Neither document addresses ALDH1 or breast cancer; both are unrelated. Document B is marginally more relevant because it deals with gene expression changes in cancer (whereas A is specific to prostate metabolic reprogramming).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:53.452539Z"}
{"comparison_id":"e6d34321-f82e-469d-9b4a-6645727a5854","query_id":"53","doc_a_id":"45764440","doc_b_id":"25513319","presented_order":["45764440","25513319"],"winner_id":"25513319","reasoning":"Neither document addresses ALDH1 or breast cancer. Both focus on SRC family proteins in non-breast cancers; Document B is marginally more relevant because it discusses a coactivator elevated in many tumors (broader tumor context). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:53.452559Z"}
{"comparison_id":"753386c2-9c3d-497d-9533-0f42e7dee626","query_id":"53","doc_a_id":"2547636","doc_b_id":"25513319","presented_order":["25513319","2547636"],"winner_id":"25513319","reasoning":"Document A is more relevant — it's cancer-related (tumor survival/metastasis), whereas Document B concerns epidermal stem cell circadian rhythms and not cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:53.452570Z"}
{"comparison_id":"c8163091-ebb8-4e16-b9c3-47cc7c35d33a","query_id":"53","doc_a_id":"16201748","doc_b_id":"25513319","presented_order":["16201748","25513319"],"winner_id":"25513319","reasoning":"Reason: Document B discusses a cancer-related protein linked to tumor survival and metastasis (prognosis-related concepts), making it slightly more relevant than Document A, which focuses on PTEN in endometrial tissue.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:53.452578Z"}
{"comparison_id":"be198a8d-ebe9-4b7f-a603-a186d6b761d4","query_id":"53","doc_a_id":"45764440","doc_b_id":"2547636","presented_order":["2547636","45764440"],"winner_id":"2547636","reasoning":"Document A is slightly more relevant because it discusses stem cell function (ALDH1 is a stem cell marker), whereas Document B concerns Src in pancreatic cancer, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:57.309904Z"}
{"comparison_id":"6211ff9b-0815-4361-bf04-fd79828d1a8c","query_id":"53","doc_a_id":"16201748","doc_b_id":"2547636","presented_order":["2547636","16201748"],"winner_id":"2547636","reasoning":"Document A is more relevant — although neither mentions ALDH1 or breast cancer, A discusses stem cell function and carcinogenesis which is more conceptually related to ALDH1 (a stem cell marker) than B's focus on PTEN in endometrium.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:07:57.309925Z"}
{"comparison_id":"eecab04a-fbb5-4587-9eac-e09b9dfe5c65","query_id":"53","doc_a_id":"45764440","doc_b_id":"16201748","presented_order":["45764440","16201748"],"winner_id":"16201748","reasoning":"Document B — it examines expression of a molecular marker (PTEN) and its association with disease state, which is conceptually closer to a claim about marker expression and prognosis than Document A's therapeutic Src inhibition in pancreatic cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:01.413672Z"}
{"comparison_id":"8ecb5cb6-b318-40e1-9f41-aa9892273680","query_id":"53","doc_a_id":"24980622","doc_b_id":"21414718","presented_order":["21414718","24980622"],"winner_id":"24980622","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. If forced to choose the closer match, Document B is marginally more relevant because it discusses tumor marker expression and prognostic marker reliability.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:11.689591Z"}
{"comparison_id":"b945ee51-49b7-42b3-bf8a-aa109de17d23","query_id":"53","doc_a_id":"9239963","doc_b_id":"21414718","presented_order":["21414718","9239963"],"winner_id":"9239963","reasoning":"Document B is more relevant—both are unrelated to ALDH1 and breast cancer, but B deals with hormone-related cancer biology (estradiol production), which is closer to breast cancer context than a gastric cancer mobility study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:11.689614Z"}
{"comparison_id":"64c061dd-2848-4efb-b731-f43eeb20e85a","query_id":"53","doc_a_id":"5377642","doc_b_id":"21414718","presented_order":["5377642","21414718"],"winner_id":"21414718","reasoning":"Neither document addresses ALDH1 or breast cancer specifically. Document B is slightly more relevant because it concerns a protein that promotes cancer cell mobility (potentially linked to prognosis), whereas A focuses on T cell PD‑1 regulation.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:11.689623Z"}
{"comparison_id":"4c46c9cc-d74d-457a-bf18-5987fcd25e52","query_id":"53","doc_a_id":"46617075","doc_b_id":"21414718","presented_order":["21414718","46617075"],"winner_id":"21414718","reasoning":"Reason: Neither discusses ALDH1 or breast cancer prognosis, but Document A is a molecular cancer study (cell mobility/metastasis) and thus slightly closer in topic than a lung-specific Rb pathway review.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:11.689631Z"}
{"comparison_id":"d9bf9309-f71f-44ac-a8cc-b2dad8fef5df","query_id":"53","doc_a_id":"20645538","doc_b_id":"21414718","presented_order":["20645538","21414718"],"winner_id":"20645538","reasoning":"Document A is more relevant — it discusses prognostic impact in cancer (though NSCLC), whereas B focuses on a molecular interaction in gastric cancer unrelated to prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:11.689639Z"}
{"comparison_id":"ee403425-351d-4898-8345-4cf228d1f345","query_id":"53","doc_a_id":"26902591","doc_b_id":"21414718","presented_order":["26902591","21414718"],"winner_id":"26902591","reasoning":"Document A is slightly more relevant because it addresses cancer-related biology (though not ALDH1 or breast cancer specifically), whereas Document B is specific to gastric cancer and unrelated to ALDH1/breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:11.689646Z"}
{"comparison_id":"82b46b43-1aef-4af5-9f64-ca24980360a2","query_id":"53","doc_a_id":"11968641","doc_b_id":"21414718","presented_order":["21414718","11968641"],"winner_id":"11968641","reasoning":"Reason: Neither mentions ALDH1 or breast cancer, but Document B discusses cancer cell behavior and treatment effects more generally, making it slightly more relevant than A which is specific to gastric cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:11.689653Z"}
{"comparison_id":"8c7fdf9e-3538-4520-84c8-8b49f1def432","query_id":"53","doc_a_id":"4729644","doc_b_id":"21414718","presented_order":["21414718","4729644"],"winner_id":"21414718","reasoning":"Neither document addresses ALDH1, breast cancer, or prognosis. Document A is marginally more relevant because it discusses cancer cell mobility and metastasis (related to prognosis), whereas Document B focuses on lncRNA-mediated drug resistance in nasopharyngeal carcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:11.689660Z"}
{"comparison_id":"79228ae2-99d3-4ac3-bde2-9221d90cd45b","query_id":"53","doc_a_id":"19958277","doc_b_id":"21414718","presented_order":["19958277","21414718"],"winner_id":"19958277","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular biology, whereas Document B focuses on gastric cancer-specific proteins not related to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:11.689667Z"}
{"comparison_id":"5dd5fa24-d65a-485e-a0c3-2d61a971747c","query_id":"53","doc_a_id":"11255504","doc_b_id":"21414718","presented_order":["21414718","11255504"],"winner_id":"21414718","reasoning":"Document A is slightly more relevant because it discusses cancer cell behavior (mobility/metastasis) related to prognosis, whereas Document B focuses on liver-specific tumor suppressors unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:11.689674Z"}
{"comparison_id":"9a662693-46a3-4335-acb1-73492d3c013e","query_id":"53","doc_a_id":"5123516","doc_b_id":"21414718","presented_order":["21414718","5123516"],"winner_id":"21414718","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses cancer cell mobility/metastasis (which relates to prognosis), whereas B focuses on glioblastoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:11.689681Z"}
{"comparison_id":"5478b516-0dca-402a-acd0-fa3ccf4663fb","query_id":"53","doc_a_id":"5468807","doc_b_id":"21414718","presented_order":["5468807","21414718"],"winner_id":"5468807","reasoning":"Neither document mentions ALDH1 or breast cancer; however, Document A at least discusses survival/prognosis in a cancer context, so it's slightly more related.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:11.689689Z"}
{"comparison_id":"e802fee7-578e-471c-91f6-506617aef5b6","query_id":"53","doc_a_id":"14019636","doc_b_id":"21414718","presented_order":["14019636","21414718"],"winner_id":"21414718","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document B concerns cancer cell mobility and metastasis (more related to prognosis) while A focuses on rDNA copy number and DNA-damage sensitivity.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:11.689696Z"}
{"comparison_id":"85932431-ce56-4ef3-b783-b0cd3994078d","query_id":"53","doc_a_id":"4993011","doc_b_id":"21414718","presented_order":["21414718","4993011"],"winner_id":"21414718","reasoning":"Neither document mentions ALDH1 or breast cancer, but Document A concerns tumor cell mobility (related to prognosis/metastasis) while B focuses on ATRX-driven rDNA instability—less directly related. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:11.689704Z"}
{"comparison_id":"cb5b2dd3-dd00-4dbf-b421-951b42cfa230","query_id":"53","doc_a_id":"25344732","doc_b_id":"21414718","presented_order":["21414718","25344732"],"winner_id":"25344732","reasoning":"Reason: Document B discusses altered expression of a protein in tumors and its potential role in tumorigenesis, which is closer to a claim about expression and prognosis than Document A's gastric cell mobility focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:11.689711Z"}
{"comparison_id":"c0a3451b-2724-4962-a6b1-9c49333d8129","query_id":"53","doc_a_id":"17775228","doc_b_id":"21414718","presented_order":["17775228","21414718"],"winner_id":"21414718","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is marginally more relevant because it addresses a protein promoting cancer cell mobility (implications for prognosis), whereas A focuses on imprinting in colorectal cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:11.689719Z"}
{"comparison_id":"1eb3c1b6-6734-4f8a-921d-f184e1aacece","query_id":"53","doc_a_id":"24980622","doc_b_id":"26902591","presented_order":["24980622","26902591"],"winner_id":"24980622","reasoning":"Document A is slightly more relevant — it discusses tumor marker expression and prognostic biomarkers in cancer metastases, which is closer to the claim about ALDH1 as a prognostic marker than the cachexia/adipose focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:16.782326Z"}
{"comparison_id":"c3de3559-ee75-4566-a50f-369c9b788d1f","query_id":"53","doc_a_id":"9239963","doc_b_id":"26902591","presented_order":["9239963","26902591"],"winner_id":"9239963","reasoning":"Document A is more relevant — it discusses hormone-related cancer biology and tumor cell expression, which is closer to breast cancer biomarker/prognosis context than cachexia-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:16.782347Z"}
{"comparison_id":"5592bada-85c2-440a-8116-5b20a2007e9d","query_id":"53","doc_a_id":"20645538","doc_b_id":"26902591","presented_order":["26902591","20645538"],"winner_id":"20645538","reasoning":"Document B is more relevant — it addresses prognostic impact in cancer (though in NSCLC, not breast), whereas A focuses on adipose tissue changes in cachexia and not prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:16.782356Z"}
{"comparison_id":"c8204cec-03c4-4324-9b68-3b8f3342158d","query_id":"53","doc_a_id":"25344732","doc_b_id":"26902591","presented_order":["26902591","25344732"],"winner_id":"25344732","reasoning":"Document B is slightly more relevant because it discusses gene expression changes in tumors, whereas Document A concerns fat browning in cancer cachexia unrelated to tumor marker expression or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:16.782364Z"}
{"comparison_id":"819a460e-3bcb-4180-a48b-9b28393acdbc","query_id":"53","doc_a_id":"11968641","doc_b_id":"26902591","presented_order":["26902591","11968641"],"winner_id":"11968641","reasoning":"Document B is more relevant — it discusses tumor growth and intrinsic cancer-cell mechanisms (more directly related to prognosis) while A focuses on adipose browning and cachexia, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:16.782372Z"}
{"comparison_id":"d2e27218-1aba-4422-8578-51856711c765","query_id":"53","doc_a_id":"19958277","doc_b_id":"26902591","presented_order":["19958277","26902591"],"winner_id":"19958277","reasoning":"Document A is slightly more relevant because it discusses molecular/genetic factors linked to cancer risk, whereas Document B focuses on cachexia and adipose tissue changes unrelated to breast cancer prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:16.782379Z"}
{"comparison_id":"c080b1ba-1d31-4196-95e7-c8af381ff189","query_id":"53","doc_a_id":"5468807","doc_b_id":"26902591","presented_order":["26902591","5468807"],"winner_id":"26902591","reasoning":"Document A is slightly more related to general cancer biology, whereas Document B focuses specifically on ARID1A-mutated ovarian cancer and HDAC6, so A is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:16.782386Z"}
{"comparison_id":"fae92c81-823e-4184-94e9-bf14e93d835c","query_id":"53","doc_a_id":"24980622","doc_b_id":"20645538","presented_order":["24980622","20645538"],"winner_id":"24980622","reasoning":"Neither document addresses ALDH1 or breast cancer; Document A is slightly more relevant because it discusses tumor marker expression in cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:24.457327Z"}
{"comparison_id":"60a7da0e-3345-4f76-b295-42504dc1f880","query_id":"53","doc_a_id":"9239963","doc_b_id":"20645538","presented_order":["9239963","20645538"],"winner_id":"9239963","reasoning":"Document A is more relevant — it discusses gene expression in tumor cells (expression-related biology), whereas B concerns pleural effusion in lung cancer and does not address marker expression or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:24.457349Z"}
{"comparison_id":"e50e7e07-1c08-496c-b457-e938dc601b06","query_id":"53","doc_a_id":"19958277","doc_b_id":"20645538","presented_order":["20645538","19958277"],"winner_id":"20645538","reasoning":"Document A is slightly more relevant because it addresses prognostic factors in cancer (though in lung cancer rather than breast). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:24.457357Z"}
{"comparison_id":"6dec2580-d0cf-47d3-96cd-bf94d2b64320","query_id":"53","doc_a_id":"25344732","doc_b_id":"20645538","presented_order":["20645538","25344732"],"winner_id":"20645538","reasoning":"Document A is more relevant — it addresses prognostic factors in cancer (though in NSCLC, not breast cancer), whereas Document B discusses gene loss in osteosarcoma without prognostic data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:24.457365Z"}
{"comparison_id":"682fc79b-eb5b-4e3e-9428-2065dcfc1d02","query_id":"53","doc_a_id":"11968641","doc_b_id":"20645538","presented_order":["11968641","20645538"],"winner_id":"20645538","reasoning":"Document B — it addresses prognostic factors in cancer (survival impact), whereas A discusses circadian clock effects on tumor growth in non-breast cancers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:24.457372Z"}
{"comparison_id":"3d955368-eaf5-4d18-8bfe-6af8dc0a8706","query_id":"53","doc_a_id":"24980622","doc_b_id":"9239963","presented_order":["9239963","24980622"],"winner_id":"9239963","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document A concerns gene expression in cancer cells (closer to marker–prognosis context) while Document B focuses on hypoxia in colorectal liver metastases.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:28.721302Z"}
{"comparison_id":"88ef3c92-0842-456d-9213-b75d0fe99741","query_id":"53","doc_a_id":"19958277","doc_b_id":"25344732","presented_order":["25344732","19958277"],"winner_id":"19958277","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is marginally more relevant because it discusses cancer-related genomic stability broadly, whereas A focuses on osteosarcoma-specific loss of PHC3.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:34.045993Z"}
{"comparison_id":"f6936caf-931a-405c-bf1e-0d9dd2c0fc97","query_id":"53","doc_a_id":"11968641","doc_b_id":"25344732","presented_order":["11968641","25344732"],"winner_id":"11968641","reasoning":"Neither document mentions ALDH1 or breast cancer, so both are irrelevant. Document A is marginally more relevant because it addresses tumor biology and growth across cancer types, whereas B is specific to PHC3 loss in osteosarcoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:34.046013Z"}
{"comparison_id":"43bf6a92-f0c2-4ce9-8c08-6ff3e10cb606","query_id":"53","doc_a_id":"19958277","doc_b_id":"11968641","presented_order":["19958277","11968641"],"winner_id":"19958277","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it addresses cancer-related genomic factors, whereas B focuses specifically on circadian effects in melanoma and colon carcinoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:38.099122Z"}
{"comparison_id":"6fbd59fe-4306-4749-b89a-b691ee7ddb4f","query_id":"53","doc_a_id":"5377642","doc_b_id":"11255504","presented_order":["11255504","5377642"],"winner_id":"11255504","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant because it concerns cancer gene roles and prognosis, whereas B focuses on T cell epigenetics. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:43.529229Z"}
{"comparison_id":"b7a8eb30-c296-4df0-8ef6-54a265e69d7d","query_id":"53","doc_a_id":"46617075","doc_b_id":"11255504","presented_order":["46617075","11255504"],"winner_id":"46617075","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:43.529250Z"}
{"comparison_id":"59d4092d-d092-4d4b-a018-afbeed55241b","query_id":"53","doc_a_id":"4729644","doc_b_id":"11255504","presented_order":["4729644","11255504"],"winner_id":"4729644","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses cancer molecular mechanisms/markers, while B focuses on liver cancer genetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:43.529258Z"}
{"comparison_id":"fc64a0f9-41a4-4b25-8db4-9d918ab91032","query_id":"53","doc_a_id":"17775228","doc_b_id":"11255504","presented_order":["17775228","11255504"],"winner_id":"17775228","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant, but Document A is marginally more relevant because it deals with cancer-related gene expression/epigenetics, whereas B focuses on liver-specific tumor suppressors. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:43.529266Z"}
{"comparison_id":"51219a34-76b8-4471-aac8-6c6d9253c983","query_id":"53","doc_a_id":"5123516","doc_b_id":"11255504","presented_order":["5123516","11255504"],"winner_id":"5123516","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it addresses cancer marker expression and tumorigenicity, whereas B focuses on liver-specific mutagenesis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:43.529273Z"}
{"comparison_id":"d347bb3f-8ffd-46af-8473-00770a9c0235","query_id":"53","doc_a_id":"14019636","doc_b_id":"11255504","presented_order":["11255504","14019636"],"winner_id":"14019636","reasoning":"Document B is slightly more relevant — it addresses molecular alterations and potential prognostic indicators across cancers, whereas A is focused on a liver-specific tumor suppressor unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:43.529283Z"}
{"comparison_id":"3008789e-3f32-4c02-82b1-c4e98a923ef1","query_id":"53","doc_a_id":"4993011","doc_b_id":"11255504","presented_order":["4993011","11255504"],"winner_id":"4993011","reasoning":"Neither document addresses ALDH1 or breast cancer specifically; Document A is slightly more relevant because it discusses cancer biology generally, while B focuses on liver cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:43.529289Z"}
{"comparison_id":"0ca6d4f1-fdae-4abb-9127-62c18780aeee","query_id":"53","doc_a_id":"46617075","doc_b_id":"17775228","presented_order":["46617075","17775228"],"winner_id":"46617075","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses cancer regulatory pathways and prognosis context (though in lung cancer), whereas Document B is focused on imprinting in colorectal cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:48.246048Z"}
{"comparison_id":"d3d634ca-c7ab-4a28-b735-41adec72c16d","query_id":"53","doc_a_id":"4729644","doc_b_id":"17775228","presented_order":["17775228","4729644"],"winner_id":"4729644","reasoning":"Reason: Neither paper addresses ALDH1 or breast cancer, but Document B links gene expression to tumor growth and treatment resistance (clinical outcome), making it marginally more relevant than A, which is about imprinting in colorectal cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:48.246069Z"}
{"comparison_id":"309d0601-507f-479d-b54b-659339aea933","query_id":"53","doc_a_id":"4993011","doc_b_id":"17775228","presented_order":["17775228","4993011"],"winner_id":"4993011","reasoning":"Neither document mentions ALDH1 or breast cancer. Both are irrelevant; Document B is slightly more relevant only because it addresses cancer-related mechanisms broadly. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:48.246077Z"}
{"comparison_id":"372bb50c-8f66-4b4c-9d83-869b2db1af06","query_id":"53","doc_a_id":"5123516","doc_b_id":"17775228","presented_order":["17775228","5123516"],"winner_id":"5123516","reasoning":"Document B is slightly more relevant because it addresses tumorigenicity and cancer prognosis-related biology, whereas Document A concerns imprinting in colorectal cancer and is less related to breast cancer markers. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:48.246084Z"}
{"comparison_id":"1fd053c5-3589-4aec-aeff-b886fbc00bba","query_id":"53","doc_a_id":"14019636","doc_b_id":"17775228","presented_order":["17775228","14019636"],"winner_id":"14019636","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is slightly more generally about cancer biology, so marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:48.246091Z"}
{"comparison_id":"287ed9f6-b54b-4d18-9417-3673e4c7684a","query_id":"53","doc_a_id":"46617075","doc_b_id":"4993011","presented_order":["46617075","4993011"],"winner_id":"4993011","reasoning":"Neither document addresses ALDH1 or breast cancer. Both are irrelevant; if forced to choose, B is marginally more relevant because it discusses molecular alterations in cancers generally, whereas A is specific to lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:53.715914Z"}
{"comparison_id":"3de54960-c1a1-4ba0-91ea-e86ca7e6bc9f","query_id":"53","doc_a_id":"4729644","doc_b_id":"4993011","presented_order":["4993011","4729644"],"winner_id":"4729644","reasoning":"Document B is slightly more relevant because it addresses tumor markers, drug resistance, and tumor growth (clinical outcomes) whereas A focuses on ATRX-related rDNA instability and therapy sensitivity, unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:53.715935Z"}
{"comparison_id":"b3c1d305-1883-4439-bd85-1a7b37f337fa","query_id":"53","doc_a_id":"14019636","doc_b_id":"4993011","presented_order":["14019636","4993011"],"winner_id":"14019636","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis. Both are irrelevant; Document A is marginally more relevant because it broadly links genomic changes to cancer sensitivity and potential prognostic indicators, whereas B focuses on ATRX-specific mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:53.715944Z"}
{"comparison_id":"8a0d169d-0628-4cc5-ab30-24f51d09fb39","query_id":"53","doc_a_id":"5123516","doc_b_id":"4993011","presented_order":["5123516","4993011"],"winner_id":"5123516","reasoning":"Document A is more relevant — it discusses expression of a tumor-associated marker linked to aggressive behavior and prognosis, whereas Document B focuses on ATRX-related rDNA instability and therapy sensitivity, not marker expression or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:53.715954Z"}
{"comparison_id":"11002d95-5430-4e72-8e64-1e82a71b5bae","query_id":"53","doc_a_id":"4729644","doc_b_id":"14019636","presented_order":["14019636","4729644"],"winner_id":"14019636","reasoning":"Neither document is relevant — neither mentions ALDH1 or breast cancer. If one must be chosen, A is marginally more relevant because it addresses cancer genomic markers broadly, whereas B concerns nasopharyngeal carcinoma specifically.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:57.555494Z"}
{"comparison_id":"4c1ffd12-db74-4cc1-a190-02effe5c0d4d","query_id":"53","doc_a_id":"5123516","doc_b_id":"14019636","presented_order":["14019636","5123516"],"winner_id":"14019636","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more generally cancer-related (rDNA and prognosis/sensitivity), while B is specific to glioblastoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:08:57.555515Z"}
{"comparison_id":"b63f1516-8a5c-41e0-a0e7-ab88b4352fbb","query_id":"53","doc_a_id":"4729644","doc_b_id":"5123516","presented_order":["5123516","4729644"],"winner_id":"4729644","reasoning":"Document B — neither abstract mentions ALDH1 or breast cancer, but B discusses cancer-related biomarkers and prognosis/therapy relevance (drug resistance), making it slightly more related than A, which focuses on glioblastoma EphA3. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:03.121810Z"}
{"comparison_id":"13ffef72-1beb-4992-aa15-f13d18b26da3","query_id":"53","doc_a_id":"3899896","doc_b_id":"9196472","presented_order":["9196472","3899896"],"winner_id":"9196472","reasoning":"Document A is slightly more relevant because it discusses gene expression and disease associations, while Document B concerns RDW in rectal cancer and is unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553054Z"}
{"comparison_id":"b6c02807-ff25-4bb2-bf2a-06423a5e2eba","query_id":"53","doc_a_id":"29124963","doc_b_id":"9196472","presented_order":["29124963","9196472"],"winner_id":"9196472","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document B discusses gene expression associations (transcriptome) which is marginally closer to a claim about a gene's prognostic expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553077Z"}
{"comparison_id":"61214e25-8e65-4e50-ba83-77cd88eb2b15","query_id":"53","doc_a_id":"21502234","doc_b_id":"9196472","presented_order":["9196472","21502234"],"winner_id":"21502234","reasoning":"Document B is more relevant — it discusses mismatch repair status and clinical outcomes in cancer (though endometrial), which is closer to a claim about a biomarker and prognosis than a monocyte transcriptome study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553090Z"}
{"comparison_id":"746008f6-bcde-4ada-b689-d8e3e81fc773","query_id":"53","doc_a_id":"25832301","doc_b_id":"9196472","presented_order":["9196472","25832301"],"winner_id":"9196472","reasoning":"Document A is more relevant — it concerns gene expression and disease susceptibility broadly, which is closer to a claim about expression (ALDH1) and cancer prognosis than a myeloma-specific study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553099Z"}
{"comparison_id":"670d6e8a-8725-4fca-86ea-05ad519f9152","query_id":"53","doc_a_id":"7639744","doc_b_id":"9196472","presented_order":["9196472","7639744"],"winner_id":"9196472","reasoning":"Document A — it discusses gene expression and disease associations (more relevant to ALDH1 expression and cancer prognosis) while Document B focuses on smoking cessation and lung cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553108Z"}
{"comparison_id":"474d67a4-e147-45ab-8e5a-1644d8c3c84a","query_id":"53","doc_a_id":"3684342","doc_b_id":"9196472","presented_order":["3684342","9196472"],"winner_id":"3684342","reasoning":"Document A — it deals with tumorigenesis and survival in cancer (though lung, not breast), so it's closer to the query about ALDH1 and prognosis than a monocyte transcriptome study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553117Z"}
{"comparison_id":"834c7074-41b8-41a3-b31e-facb15db43f6","query_id":"53","doc_a_id":"9211173","doc_b_id":"9196472","presented_order":["9196472","9211173"],"winner_id":"9211173","reasoning":"Document B — it discusses cancer-related mutations and biomarkers, which is more relevant to a claim about a cancer prognostic marker than a monocyte transcriptome study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553125Z"}
{"comparison_id":"7b9d5628-9ea5-463c-aa9d-9ce056c724c6","query_id":"53","doc_a_id":"20754359","doc_b_id":"9196472","presented_order":["9196472","20754359"],"winner_id":"9196472","reasoning":"Document A is more relevant — it concerns gene expression and disease associations (transcriptome analysis), which is closer to the claim about ALDH1 expression and cancer prognosis than a paper on T-cell leukemia therapy.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553134Z"}
{"comparison_id":"b43d1122-879c-46af-814e-da2a245c63a0","query_id":"53","doc_a_id":"3376731","doc_b_id":"9196472","presented_order":["3376731","9196472"],"winner_id":"3376731","reasoning":"Doc A is more relevant because it concerns cancer biology and treatment outcomes (though in esophageal cancer), whereas Doc B focuses on monocyte transcriptomes and atherosclerosis rather than breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553143Z"}
{"comparison_id":"a9907550-7cc3-4dcf-9e7e-063962b89ff6","query_id":"53","doc_a_id":"21551568","doc_b_id":"9196472","presented_order":["9196472","21551568"],"winner_id":"9196472","reasoning":"Document A — it discusses gene expression and disease associations (more generally relevant to expression–prognosis links) while Document B focuses on thyroid cancer pathways, not breast cancer or ALDH1.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553151Z"}
{"comparison_id":"f14f82a0-c6cf-455b-ba41-a970a6b05247","query_id":"53","doc_a_id":"23934390","doc_b_id":"9196472","presented_order":["23934390","9196472"],"winner_id":"23934390","reasoning":"Document A is more cancer-focused (gene expression affecting tumor behavior), whereas B concerns monocyte transcriptomes and atherosclerosis—not breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553159Z"}
{"comparison_id":"ccb42ca6-ac9f-45c3-96e3-71fb0c458426","query_id":"53","doc_a_id":"2494748","doc_b_id":"9196472","presented_order":["9196472","2494748"],"winner_id":"9196472","reasoning":"Document A is more relevant — it deals with gene expression/transcriptome data (generalizable to expression–prognosis links), whereas B focuses on CpG methylation in gastric cancer, not breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553168Z"}
{"comparison_id":"68404691-07e5-43b9-99c6-880e62448afc","query_id":"53","doc_a_id":"43334921","doc_b_id":"9196472","presented_order":["9196472","43334921"],"winner_id":"9196472","reasoning":"Document A is more relevant — it addresses gene expression and disease associations (though not breast cancer specifically), while B focuses on aspirin/NSAID use and colorectal cancer genetics. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553176Z"}
{"comparison_id":"e54cb3cb-f7e2-473e-97f3-825c90f1e8cc","query_id":"53","doc_a_id":"1649738","doc_b_id":"9196472","presented_order":["1649738","9196472"],"winner_id":"9196472","reasoning":"Reason: Document B discusses gene expression associations with disease susceptibility (transcriptome-level links), which is more relevant to a claim about gene expression and prognosis than Document A's focus on PRDM1 variants in Hodgkin's lymphoma survivors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553185Z"}
{"comparison_id":"46ca9ae5-5d3f-4b36-8838-ac2564c7b5ce","query_id":"53","doc_a_id":"12887068","doc_b_id":"9196472","presented_order":["12887068","9196472"],"winner_id":"9196472","reasoning":"Neither paper addresses ALDH1 or breast cancer. Document B is marginally more relevant because it concerns gene expression associations with disease susceptibility, while A focuses on glioma modeling.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553194Z"}
{"comparison_id":"ef21df9f-f29c-42bb-8f02-e6fff1c582d5","query_id":"53","doc_a_id":"12337611","doc_b_id":"9196472","presented_order":["9196472","12337611"],"winner_id":"9196472","reasoning":"Document A is slightly more relevant — it discusses gene expression associations with disease susceptibility, whereas Document B is specific to neuroblastoma and LIN28B. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553202Z"}
{"comparison_id":"518201b4-54db-4a06-99a9-fd6a43114255","query_id":"53","doc_a_id":"23513818","doc_b_id":"9196472","presented_order":["9196472","23513818"],"winner_id":"23513818","reasoning":"Document B is slightly more relevant because it discusses regulation of a pro-survival protein (Mcl-1) implicated in cancer biology, whereas Document A focuses on monocyte transcriptomes and atherosclerosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553210Z"}
{"comparison_id":"6aa5db88-f5bb-49fd-9051-0013603c41c0","query_id":"53","doc_a_id":"8702697","doc_b_id":"9196472","presented_order":["8702697","9196472"],"winner_id":"8702697","reasoning":"Document A is more relevant — it deals with cancer biology and tumor aggressiveness (though in prostate cancer), while B focuses on monocyte transcriptomes and atherosclerosis, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553219Z"}
{"comparison_id":"ec471486-2cec-4daa-9dc2-478bf279b38e","query_id":"53","doc_a_id":"6121555","doc_b_id":"9196472","presented_order":["9196472","6121555"],"winner_id":"6121555","reasoning":"Document B is more relevant because it addresses cancer-related molecular expression and prognosis mechanisms (though in glioma, not breast cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553227Z"}
{"comparison_id":"799958dc-f326-49e2-8b7e-3e6e4a2077bb","query_id":"53","doc_a_id":"36310858","doc_b_id":"9196472","presented_order":["9196472","36310858"],"winner_id":"36310858","reasoning":"Document B is more relevant — it deals with cancer-related transcriptional regulation and tumor progression, whereas A focuses on monocyte transcriptomes and atherosclerosis; neither mentions ALDH1 or breast cancer, but B is closer to the cancer context.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553236Z"}
{"comparison_id":"f254405a-23ed-4891-8540-1561f7de27bf","query_id":"53","doc_a_id":"22059387","doc_b_id":"9196472","presented_order":["9196472","22059387"],"winner_id":"9196472","reasoning":"Document A is more relevant — it concerns gene expression and transcriptome analysis (closer to ALDH1 expression and its disease associations) while Document B focuses on infection-driven DNA damage in hamsters unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553246Z"}
{"comparison_id":"0fc496a2-effb-4a45-9034-4023d1403e7b","query_id":"53","doc_a_id":"22180793","doc_b_id":"9196472","presented_order":["9196472","22180793"],"winner_id":"9196472","reasoning":"Document A is more relevant — it discusses gene expression and disease associations, which is closer to the claim about ALDH1 expression and prognosis in cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553254Z"}
{"comparison_id":"7036c975-50af-4808-bb71-c620cba94f23","query_id":"53","doc_a_id":"10165723","doc_b_id":"9196472","presented_order":["10165723","9196472"],"winner_id":"10165723","reasoning":"Document A is about cancer progression and prognosis (though in melanoma), so it's more related to a claim about prognostic markers in cancer than Document B, which focuses on monocyte transcriptomics and atherosclerosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553263Z"}
{"comparison_id":"20e0a96e-365d-4f03-8bbd-cf78601d50b3","query_id":"53","doc_a_id":"12685434","doc_b_id":"9196472","presented_order":["12685434","9196472"],"winner_id":"9196472","reasoning":"Document B — it addresses gene expression and disease associations broadly, whereas A focuses on GBP1 in glioblastoma, not ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553271Z"}
{"comparison_id":"e206f5f0-40ad-436e-b5f5-d2369df10d7f","query_id":"53","doc_a_id":"22049489","doc_b_id":"9196472","presented_order":["9196472","22049489"],"winner_id":"22049489","reasoning":"Document B is more relevant because it addresses cancer-related molecular markers and prognosis pathways, whereas Document A focuses on monocyte transcriptomes and atherosclerosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553278Z"}
{"comparison_id":"f021fd48-9b8f-457e-9c27-01b1270247c0","query_id":"53","doc_a_id":"15727984","doc_b_id":"9196472","presented_order":["15727984","9196472"],"winner_id":"9196472","reasoning":"Document B — it addresses gene expression associations and disease susceptibility (more relevant to an expression–prognosis claim) while A focuses on lung cancer secreted proteins, not ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553287Z"}
{"comparison_id":"6cb46f27-7570-4deb-ad43-5a0ba7d55f49","query_id":"53","doc_a_id":"1727493","doc_b_id":"9196472","presented_order":["9196472","1727493"],"winner_id":"1727493","reasoning":"Document B is more relevant — it addresses cancer-related molecular markers and therapy response (though in ovarian cancer), which is closer to a claim about a cancer biomarker and prognosis than a monocyte transcriptome study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553297Z"}
{"comparison_id":"f17fcd81-f5a8-4776-a764-5d7ab382622f","query_id":"53","doc_a_id":"2919030","doc_b_id":"9196472","presented_order":["9196472","2919030"],"winner_id":"2919030","reasoning":"Document B is slightly more relevant because it discusses cancer-related metabolic mechanisms, whereas A focuses on monocyte expression and atherosclerosis rather than cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553304Z"}
{"comparison_id":"d577e466-6451-429d-ad47-09542ef15da8","query_id":"53","doc_a_id":"20179918","doc_b_id":"9196472","presented_order":["9196472","20179918"],"winner_id":"9196472","reasoning":"Document A is slightly more relevant because it discusses gene expression patterns and associations with disease susceptibility, whereas Document B focuses on STAT3 regulation of SALL4 in embryonic stem cells and is unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:14.553313Z"}
{"comparison_id":"502a3b64-bd99-47de-8df3-89d5d4378cfd","query_id":"53","doc_a_id":"21502234","doc_b_id":"8702697","presented_order":["21502234","8702697"],"winner_id":"8702697","reasoning":"Neither document addresses ALDH1 or breast cancer directly, but Document B (miR-205 in prostate cancer) is slightly more relevant because it deals with tumor aggressiveness and EMT pathways that relate broadly to prognostic markers, whereas Document A is limited to MMR status in endometrial cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:24.707555Z"}
{"comparison_id":"81b82435-fe08-42e3-ad2e-df5542627b64","query_id":"53","doc_a_id":"3684342","doc_b_id":"8702697","presented_order":["3684342","8702697"],"winner_id":"3684342","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document A is slightly more relevant because it discusses tumorigenesis and reduced survival (prognosis), whereas B focuses on prostate CAFs and miR-205.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:24.707575Z"}
{"comparison_id":"936ef165-ee9b-4e62-87b4-69feccd82361","query_id":"53","doc_a_id":"9211173","doc_b_id":"8702697","presented_order":["9211173","8702697"],"winner_id":"9211173","reasoning":"Document A is slightly more relevant because it discusses cancer biomarkers and prognosis-related genetic changes (though in ovarian cancer), whereas Document B concerns miR-205 in prostate cancer and tumor–stroma interactions. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:24.707587Z"}
{"comparison_id":"d8f22c0f-71ff-4d5e-bdaf-bcbef49189b6","query_id":"53","doc_a_id":"3376731","doc_b_id":"8702697","presented_order":["3376731","8702697"],"winner_id":"8702697","reasoning":"Neither document mentions ALDH1 or breast cancer, so both are irrelevant. Document B is slightly more related to prognosis (tumor aggressiveness/metastasis), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:24.707594Z"}
{"comparison_id":"8d49fd77-e5c6-4897-8338-98db9c531277","query_id":"53","doc_a_id":"23934390","doc_b_id":"8702697","presented_order":["23934390","8702697"],"winner_id":"8702697","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B discusses EMT and tumor aggressiveness (more directly related to prognosis) while A is about NSCLC proliferation only.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:24.707601Z"}
{"comparison_id":"326c3840-be9d-4e4b-9deb-c4e19cd16dd4","query_id":"53","doc_a_id":"23513818","doc_b_id":"8702697","presented_order":["8702697","23513818"],"winner_id":"23513818","reasoning":"Document B — it discusses molecular regulation of a pro-survival protein (Mcl-1) relevant to cancer prognosis broadly; Document A is specific to prostate cancer and unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:24.707607Z"}
{"comparison_id":"8ed2521e-7176-45b2-856f-3cb974cb01db","query_id":"53","doc_a_id":"2919030","doc_b_id":"8702697","presented_order":["2919030","8702697"],"winner_id":"8702697","reasoning":"Document B is more relevant — it addresses cancer aggressiveness and tumor-stroma interactions (closer to prognosis-related cancer biology) while A discusses SOD1-driven metabolic regulation in yeast/mammalian cells, not ALDH1 or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:24.707615Z"}
{"comparison_id":"fde1ef0a-c6d2-4eaa-b675-670bf0eb3cc5","query_id":"53","doc_a_id":"6121555","doc_b_id":"8702697","presented_order":["6121555","8702697"],"winner_id":"8702697","reasoning":"Document B is slightly more relevant because it addresses cancer aggressiveness and EMT-related mechanisms affecting prognosis, whereas Document A focuses on apoptosis pathways in glioma. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:24.707622Z"}
{"comparison_id":"db051b92-d4cb-41b6-bd24-af412fd2fd8d","query_id":"53","doc_a_id":"36310858","doc_b_id":"8702697","presented_order":["36310858","8702697"],"winner_id":"8702697","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document B is marginally more related because it deals with tumor aggressiveness and EMT, topics sometimes linked to stem-cell markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:24.707629Z"}
{"comparison_id":"8909e430-f346-43e5-a8ed-37b9d1a8a05f","query_id":"53","doc_a_id":"10165723","doc_b_id":"8702697","presented_order":["8702697","10165723"],"winner_id":"10165723","reasoning":"Reason: Document B discusses molecular markers predicting cancer progression and outcomes, so it's more relevant to a prognosis-related claim than Document A, which focuses on miR-205 effects in prostate cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:24.707636Z"}
{"comparison_id":"cc17496c-36a7-4988-9506-26acc3e3126f","query_id":"53","doc_a_id":"22049489","doc_b_id":"8702697","presented_order":["22049489","8702697"],"winner_id":"22049489","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant; Document A is marginally more relevant only because it addresses cancer-related molecular markers and prognosis-related pathways. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:24.707643Z"}
{"comparison_id":"0398953c-c29f-44db-9cbd-8321ac54d99d","query_id":"53","doc_a_id":"1727493","doc_b_id":"8702697","presented_order":["1727493","8702697"],"winner_id":"1727493","reasoning":"Both documents are irrelevant to ALDH1 or breast cancer, but A is marginally closer because it deals with tumor–stroma interactions and therapy resistance. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:24.707651Z"}
{"comparison_id":"d98379a9-6afd-41ad-b713-00b290dbd8ae","query_id":"53","doc_a_id":"3684342","doc_b_id":"23513818","presented_order":["3684342","23513818"],"winner_id":"3684342","reasoning":"Document A is slightly more relevant because it relates cancer gene expression to tumor progression and decreased survival, whereas Document B focuses on molecular regulation of Mcl-1 without connection to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:30.624138Z"}
{"comparison_id":"e37f8a46-db70-49b2-8452-5b485c9099c8","query_id":"53","doc_a_id":"9211173","doc_b_id":"23513818","presented_order":["23513818","9211173"],"winner_id":"23513818","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document A is marginally more relevant because it deals with cancer-related protein regulation, whereas Document B focuses on ARID1A in ovarian cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:30.624158Z"}
{"comparison_id":"6b95ce8a-f194-4c57-97a0-d31d2079ed82","query_id":"53","doc_a_id":"1727493","doc_b_id":"23513818","presented_order":["23513818","1727493"],"winner_id":"23513818","reasoning":"Document A is more relevant — it discusses cancer-related protein expression/regulation (Mcl-1) which is closer to prognostic biomarker topics than a study on exosomal miR21 in ovarian cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:30.624170Z"}
{"comparison_id":"8f5ec2b0-fd62-48fc-8327-c40c9ca6aff0","query_id":"53","doc_a_id":"10165723","doc_b_id":"23513818","presented_order":["10165723","23513818"],"winner_id":"10165723","reasoning":"Document A is about cancer prognosis (though in melanoma), while Document B deals with a specific protein degradation pathway unrelated to ALDH1 or clinical prognosis; A is therefore slightly more relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:30.624177Z"}
{"comparison_id":"6bc8b4d3-88a7-48d8-912b-4c24a980df29","query_id":"53","doc_a_id":"22049489","doc_b_id":"23513818","presented_order":["23513818","22049489"],"winner_id":"23513818","reasoning":"Neither document mentions ALDH1 or breast cancer; both are unrelated. Document A is marginally more relevant because it discusses cancer-related protein regulation, whereas B is specific to gastric cancer pathways. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:30.624184Z"}
{"comparison_id":"94812a32-f476-421f-85da-e91253d006a0","query_id":"53","doc_a_id":"3684342","doc_b_id":"10165723","presented_order":["10165723","3684342"],"winner_id":"10165723","reasoning":"Document A is slightly more relevant because it discusses cancer progression and prognostic indicators, whereas Document B focuses on LIN28B in lung cancer unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:33.450931Z"}
{"comparison_id":"db161531-f774-4879-9d91-ee85ddbf65af","query_id":"53","doc_a_id":"9211173","doc_b_id":"1727493","presented_order":["9211173","1727493"],"winner_id":"9211173","reasoning":"Doc A mentions a cancer biomarker and tumor progression/early detection roles (more related to prognosis), while Doc B focuses on miR21-mediated drug resistance in ovarian cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:37.917734Z"}
{"comparison_id":"48583f57-2724-42d6-825a-1b2aca571a92","query_id":"53","doc_a_id":"22049489","doc_b_id":"1727493","presented_order":["22049489","1727493"],"winner_id":"22049489","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular expression and tumor behavior, which is closer to prognostic marker studies than the drug-resistance focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:37.917753Z"}
{"comparison_id":"46eae3e0-343a-4bea-87aa-934e6cde2d9a","query_id":"53","doc_a_id":"9211173","doc_b_id":"22049489","presented_order":["9211173","22049489"],"winner_id":"9211173","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it deals with cancer biomarkers and a gynecologic malignancy, whereas Document B focuses on a gastric cancer miRNA pathway.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:42.994877Z"}
{"comparison_id":"9440daaf-b32e-44d8-9b78-e7e3a446f245","query_id":"53","doc_a_id":"21502234","doc_b_id":"23934390","presented_order":["23934390","21502234"],"winner_id":"21502234","reasoning":"Document B — it discusses prognostic associations (MMR status and clinical outcomes), so it's slightly closer to the claim about a prognostic marker, even though it's in a different cancer type. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:53.408068Z"}
{"comparison_id":"7b3ad414-a282-4f04-9109-48a620c1bfe2","query_id":"53","doc_a_id":"3376731","doc_b_id":"23934390","presented_order":["3376731","23934390"],"winner_id":"3376731","reasoning":"Neither paper addresses ALDH1 or breast cancer; however, Document A (tumor chemoresistance pathways) is slightly more related to prognosis mechanisms than Document B (miRNA in NSCLC). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:53.408090Z"}
{"comparison_id":"9ead03fd-8da9-4f35-9559-cbc634c3e238","query_id":"53","doc_a_id":"36310858","doc_b_id":"23934390","presented_order":["36310858","23934390"],"winner_id":"23934390","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it deals with cancer proliferation and a stemness-related factor (Bmi1), whereas A focuses on KRAS/YAP in pancreatic cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:53.408100Z"}
{"comparison_id":"3ffd579e-35d3-4e6a-bd58-513801fc7741","query_id":"53","doc_a_id":"2919030","doc_b_id":"23934390","presented_order":["23934390","2919030"],"winner_id":"23934390","reasoning":"Neither document addresses ALDH1 or breast cancer directly. Document A is at least a cancer-focused study (NSCLC), so it's marginally more relevant than B, which is a yeast/mammalian metabolism paper not tied to breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:53.408107Z"}
{"comparison_id":"0d1ab08a-e5f3-4cf3-a4cf-543871fa80dc","query_id":"53","doc_a_id":"6121555","doc_b_id":"23934390","presented_order":["23934390","6121555"],"winner_id":"23934390","reasoning":"Neither document addresses ALDH1 or breast cancer directly; Document A is slightly more relevant because it deals with cancer proliferation and a stemness-related gene (Bmi1), whereas Document B focuses on glioma apoptosis pathways. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:53.408115Z"}
{"comparison_id":"5c1007b1-f63a-4935-af06-b94fb07fa5fd","query_id":"53","doc_a_id":"21502234","doc_b_id":"3376731","presented_order":["3376731","21502234"],"winner_id":"3376731","reasoning":"Document A is somewhat closer—addresses tumor biology and chemoresistance relevant to markers like ALDH1—whereas B focuses on MMR in endometrial cancer, unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:09:58.683875Z"}
{"comparison_id":"d66a2b26-4a9f-4f09-a08a-2629d17896d9","query_id":"53","doc_a_id":"36310858","doc_b_id":"2919030","presented_order":["2919030","36310858"],"winner_id":"2919030","reasoning":"Document A is slightly more relevant — it discusses cancer-related biology in mammalian cells (metabolic pathways) that could be tangentially related to prognostic markers, whereas Document B is specific to YAP in pancreatic cancer and not breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:06.263925Z"}
{"comparison_id":"f4e84a13-6949-49af-a3dc-37bb3554f775","query_id":"53","doc_a_id":"6121555","doc_b_id":"2919030","presented_order":["2919030","6121555"],"winner_id":"6121555","reasoning":"Neither paper addresses ALDH1 or breast cancer specifically. Both are irrelevant, but Document B is slightly more relevant because it studies a cancer-associated pathway affecting tumor cell survival. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:06.263948Z"}
{"comparison_id":"5994e83c-d9d3-4e95-bdd7-dc451299e179","query_id":"53","doc_a_id":"3899896","doc_b_id":"43334921","presented_order":["43334921","3899896"],"winner_id":"3899896","reasoning":"Document B — it addresses prognostic factors in cancer (poor prognosis), whereas Document A concerns NSAID use and colorectal cancer risk rather than prognosis or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:15.019022Z"}
{"comparison_id":"e6685aeb-5eea-4fc5-b97b-c266be6d04e0","query_id":"53","doc_a_id":"29124963","doc_b_id":"43334921","presented_order":["43334921","29124963"],"winner_id":"29124963","reasoning":"Reason: Document B concerns prognostic markers and survival in cancer patients (though lung adenocarcinoma), making it conceptually closer to a claim about a prognostic marker than Document A, which addresses NSAID use and colorectal cancer risk.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:15.019042Z"}
{"comparison_id":"3f457209-e0f4-4652-8961-1ca70fc171a7","query_id":"53","doc_a_id":"25832301","doc_b_id":"43334921","presented_order":["25832301","43334921"],"winner_id":"25832301","reasoning":"Document A — it discusses gene expression and tumor outcomes (though in multiple myeloma, not breast cancer), so it's more topically similar than B, which concerns NSAID use and colorectal cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:15.019051Z"}
{"comparison_id":"8cb1943b-46cb-468e-8f3e-b74c509562c8","query_id":"53","doc_a_id":"7639744","doc_b_id":"43334921","presented_order":["7639744","43334921"],"winner_id":"7639744","reasoning":"Document A is slightly more relevant because it addresses cancer prognosis and survival outcomes (though in lung cancer), whereas Document B concerns colorectal cancer risk and drug use. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:15.019058Z"}
{"comparison_id":"e9a06fd0-4143-4f7d-a8d6-6949c9abf1b4","query_id":"53","doc_a_id":"20754359","doc_b_id":"43334921","presented_order":["20754359","43334921"],"winner_id":"20754359","reasoning":"Reason: Both documents are unrelated to ALDH1 or breast cancer, but Document A discusses cancer prognosis (albeit in ATLL), making it slightly more relevant than Document B which focuses on NSAIDs and colorectal cancer risk.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:15.019066Z"}
{"comparison_id":"c27fabb2-b7a6-4b0f-b955-3b30f6046954","query_id":"53","doc_a_id":"21551568","doc_b_id":"43334921","presented_order":["21551568","43334921"],"winner_id":"21551568","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular alterations and tumor progression (though in thyroid cancer), while Document B is specific to colorectal cancer and drug use. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:15.019073Z"}
{"comparison_id":"6f8dc7d8-beff-46f3-ad94-af88ec264a75","query_id":"53","doc_a_id":"2494748","doc_b_id":"43334921","presented_order":["43334921","2494748"],"winner_id":"2494748","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document B covers molecular tumor markers and epigenetic changes in cancer, making it marginally more related than Document A (which focuses on aspirin/NSAID use and colorectal cancer genetics).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:15.019080Z"}
{"comparison_id":"34c5a8d8-c72e-495f-9f9c-0cf25492e2a2","query_id":"53","doc_a_id":"20179918","doc_b_id":"43334921","presented_order":["43334921","20179918"],"winner_id":"20179918","reasoning":"Document B is more relevant — it addresses stem-cell–related gene regulation (SALL4/STAT3), which is conceptually closer to ALDH1 as a stemness marker in cancer; Document A concerns NSAID use and colorectal cancer and is unrelated.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:15.019088Z"}
{"comparison_id":"046f2fe6-b0dc-4f32-b5a0-2c06aca9c143","query_id":"53","doc_a_id":"1649738","doc_b_id":"43334921","presented_order":["1649738","43334921"],"winner_id":"1649738","reasoning":"Document A is slightly more relevant because it addresses gene expression changes in cancer etiology, whereas Document B focuses on NSAID use and colorectal cancer risk, not breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:15.019095Z"}
{"comparison_id":"f0f2fd72-3af3-4bab-9f28-f0ec1e3ee2b8","query_id":"53","doc_a_id":"12887068","doc_b_id":"43334921","presented_order":["43334921","12887068"],"winner_id":"12887068","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document B is slightly more related conceptually because it involves stem-cell–like tumor biology, whereas A focuses on NSAID use and colorectal cancer genetics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:15.019102Z"}
{"comparison_id":"bb218422-2e21-4662-9fa7-3ba04149cc11","query_id":"53","doc_a_id":"12337611","doc_b_id":"43334921","presented_order":["43334921","12337611"],"winner_id":"12337611","reasoning":"Document B is more relevant — it discusses cancer biology and associations with poor outcome, whereas Document A concerns aspirin/NSAID use and colorectal cancer risk unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:15.019110Z"}
{"comparison_id":"cea96104-c47b-4307-b107-f5f1b783c5c7","query_id":"53","doc_a_id":"22059387","doc_b_id":"43334921","presented_order":["22059387","43334921"],"winner_id":"22059387","reasoning":"Document A is slightly more relevant because it deals with molecular markers and mechanisms in carcinogenesis (though not breast cancer or ALDH1 specifically). Document B focuses on aspirin/NSAID use and colorectal cancer genetics, which is less related to the query.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:15.019116Z"}
{"comparison_id":"625efc1a-3e3c-4db4-8597-01849c07a593","query_id":"53","doc_a_id":"22180793","doc_b_id":"43334921","presented_order":["22180793","43334921"],"winner_id":"22180793","reasoning":"Document A is slightly more relevant because it discusses cancer biomarkers and tumor progression (though in prostate cancer), whereas Document B concerns NSAID use and colorectal cancer risk, which is less related to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:15.019124Z"}
{"comparison_id":"568d0428-f475-4ee1-b752-b84eb4dd72c7","query_id":"53","doc_a_id":"12685434","doc_b_id":"43334921","presented_order":["43334921","12685434"],"winner_id":"12685434","reasoning":"Reason: Document B concerns protein expression linked to tumor invasion and prognosis-related biology, making it more relevant to a claim about a cancer marker than Document A, which focuses on NSAID use and colorectal cancer risk.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:15.019131Z"}
{"comparison_id":"4e24e47e-c711-4e5a-be73-60a81b38135c","query_id":"53","doc_a_id":"15727984","doc_b_id":"43334921","presented_order":["15727984","43334921"],"winner_id":"15727984","reasoning":"Document A is slightly more relevant because it concerns tumor biology and factors affecting tumorigenicity (though it does not address ALDH1 or breast cancer specifically). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:15.019138Z"}
{"comparison_id":"739799bc-6b7e-4dfa-ac30-cdd0f914dab8","query_id":"53","doc_a_id":"3899896","doc_b_id":"20179918","presented_order":["20179918","3899896"],"winner_id":"20179918","reasoning":"Document A is more relevant — it concerns transcriptional regulation of stemness genes (SALL4/STAT3), which is closer to ALDH1 and cancer stem cell prognostic markers than a study about RDW in rectal cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:26.046355Z"}
{"comparison_id":"2fab5cec-8b57-4ba2-ba2b-fa6ed6e29cab","query_id":"53","doc_a_id":"29124963","doc_b_id":"20179918","presented_order":["20179918","29124963"],"winner_id":"20179918","reasoning":"Document A is slightly more relevant because it concerns regulation of stemness-related genes (SALL4/STAT3), which is conceptually closer to ALDH1 as a cancer stem cell marker; Document B is about an unrelated lung cancer fusion.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:26.046377Z"}
{"comparison_id":"211110d5-f7d0-4605-9fb0-61768085062a","query_id":"53","doc_a_id":"25832301","doc_b_id":"20179918","presented_order":["25832301","20179918"],"winner_id":"20179918","reasoning":"Neither document provides evidence about ALDH1 or breast cancer prognosis, but Document B is slightly closer conceptually (stemness/gene regulation) than Document A (multiple myeloma/TSPAN7).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:26.046386Z"}
{"comparison_id":"8013da76-ce23-4a33-b134-ebf12eff341d","query_id":"53","doc_a_id":"7639744","doc_b_id":"20179918","presented_order":["7639744","20179918"],"winner_id":"20179918","reasoning":"Document B is slightly more relevant because it concerns stem-cell–related gene regulation (SALL4/STAT3), which is closer to topics like ALDH1 (a stemness marker) than a lung-cancer/smoking prognosis review. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:26.046394Z"}
{"comparison_id":"f327f252-f154-49ff-8964-9e2a7ea2a3c7","query_id":"53","doc_a_id":"20754359","doc_b_id":"20179918","presented_order":["20179918","20754359"],"winner_id":"20179918","reasoning":"Document A — it discusses stem-cell–related gene regulation (SALL4/STAT3), which is closer to ALDH1's role as a stem-cell marker in cancer; Document B is about ATLL and unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:26.046421Z"}
{"comparison_id":"33d4bea4-8535-4915-bc5a-ec7f43487d9a","query_id":"53","doc_a_id":"21551568","doc_b_id":"20179918","presented_order":["20179918","21551568"],"winner_id":"20179918","reasoning":"Document A is slightly more related because it discusses transcriptional regulation of stemness factors (more relevant to cancer stem cell markers like ALDH1) while Document B focuses on PI3K/Akt alterations in thyroid cancer, unrelated to ALDH1 or breast cancer.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:26.046434Z"}
{"comparison_id":"5e967980-e0d9-4d97-9c41-9aa0f8306416","query_id":"53","doc_a_id":"2494748","doc_b_id":"20179918","presented_order":["20179918","2494748"],"winner_id":"20179918","reasoning":"Document A is more relevant — it addresses transcriptional regulation of pluripotency/self-renewal (stemness), which is conceptually related to ALDH1 as a cancer stem cell marker, whereas B concerns gastric methylation unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:26.046443Z"}
{"comparison_id":"c983be9b-d217-4bf9-b376-f82fe4c82eb2","query_id":"53","doc_a_id":"15727984","doc_b_id":"20179918","presented_order":["20179918","15727984"],"winner_id":"20179918","reasoning":"Document A is more relevant — it deals with regulation of stemness/pluripotency factors (SALL4/STAT3), which is conceptually closer to ALDH1 as a cancer stem–cell marker; Document B is about lung cancer secreted proteins and not related to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:26.046451Z"}
{"comparison_id":"39ed683b-85eb-487b-9bdf-5ded6b1157f8","query_id":"53","doc_a_id":"1649738","doc_b_id":"20179918","presented_order":["20179918","1649738"],"winner_id":"20179918","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. Document A is slightly more related conceptually (stem cell/pluripotency factors) but still not evidence for the claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:26.046458Z"}
{"comparison_id":"54588a31-af6a-4210-93ce-c2b242310996","query_id":"53","doc_a_id":"12887068","doc_b_id":"20179918","presented_order":["20179918","12887068"],"winner_id":"20179918","reasoning":"Document A is more relevant — it discusses stem-cell–related gene regulation (SALL4/STAT3), which is closer to ALDH1's role as a stemness marker than a pediatric glioma model. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:26.046465Z"}
{"comparison_id":"03f9716e-a534-4e9a-abab-26fed2e0a44a","query_id":"53","doc_a_id":"12337611","doc_b_id":"20179918","presented_order":["12337611","20179918"],"winner_id":"12337611","reasoning":"Both documents are unrelated to ALDH1 or breast cancer, but Document A discusses cancer prognosis (neuroblastoma) while B is about stem cell transcriptional regulation, so A is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:26.046473Z"}
{"comparison_id":"ff72350f-041c-414f-99ea-9f531eae46dc","query_id":"53","doc_a_id":"22059387","doc_b_id":"20179918","presented_order":["20179918","22059387"],"winner_id":"20179918","reasoning":"Document A is more relevant — it discusses stemness-related gene regulation (SALL4/STAT3), which is closer to cancer stem cell markers like ALDH1 than the inflammation/cholangiocarcinoma focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:26.046481Z"}
{"comparison_id":"3a217a72-14a1-433d-ba97-2acac4e0a551","query_id":"53","doc_a_id":"22180793","doc_b_id":"20179918","presented_order":["20179918","22180793"],"winner_id":"20179918","reasoning":"Document A is more relevant — it discusses transcriptional regulation of a stemness-associated gene (SALL4), which is closer to ALDH1 and prognosis in breast cancer than Document B's prostate cancer/N-cadherin focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:26.046493Z"}
{"comparison_id":"b4179e8c-12cc-4fad-bf9d-da380c1b2c90","query_id":"53","doc_a_id":"12685434","doc_b_id":"20179918","presented_order":["20179918","12685434"],"winner_id":"20179918","reasoning":"Document A is more relevant — it concerns regulation of a stemness-associated gene (SALL4), which is more closely related to ALDH1's role as a cancer stem cell marker and prognosis than glioblastoma invasion.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:26.046505Z"}
{"comparison_id":"7ad38cf5-a38a-4fc6-aff5-ad529ce227ee","query_id":"53","doc_a_id":"3899896","doc_b_id":"2494748","presented_order":["2494748","3899896"],"winner_id":"2494748","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it addresses molecular cancer markers (CpG methylation), whereas B concerns RDW in rectal cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:37.268958Z"}
{"comparison_id":"a1646418-2a7d-4813-88eb-3c258c13980c","query_id":"53","doc_a_id":"29124963","doc_b_id":"2494748","presented_order":["29124963","2494748"],"winner_id":"29124963","reasoning":"Document A is slightly more relevant because it discusses a prognostic biomarker in cancer (though in lung adenocarcinoma), whereas Document B concerns methylation in gastric carcinoma and neither addresses ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:37.268979Z"}
{"comparison_id":"9836f0b6-159b-494d-8c58-7353b7cc3ed4","query_id":"53","doc_a_id":"25832301","doc_b_id":"2494748","presented_order":["2494748","25832301"],"winner_id":"25832301","reasoning":"Document B is more relevant — it addresses protein expression levels and their association with tumor outcomes (though in multiple myeloma), which is closer to a claim about marker expression and prognosis than a study of CpG methylation in gastric cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:37.268991Z"}
{"comparison_id":"c3c7fb04-4363-49cf-a6a3-b0287b374318","query_id":"53","doc_a_id":"7639744","doc_b_id":"2494748","presented_order":["7639744","2494748"],"winner_id":"2494748","reasoning":"Document B is more relevant — it deals with molecular biomarkers and cancer prognosis, which is closer to a claim about ALDH1 expression and breast cancer prognosis than a study about smoking cessation in lung cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:37.269009Z"}
{"comparison_id":"67d0a550-1e32-4024-95cb-5674b1938a83","query_id":"53","doc_a_id":"20754359","doc_b_id":"2494748","presented_order":["2494748","20754359"],"winner_id":"2494748","reasoning":"Document A — it concerns molecular markers in a solid carcinoma context (epigenetic markers in gastric cancer), which is slightly closer to studies of prognostic tumor markers than a paper on T‑cell leukemia/lymphoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:37.269027Z"}
{"comparison_id":"656134f9-c57c-44a2-bb82-5602c360772c","query_id":"53","doc_a_id":"21551568","doc_b_id":"2494748","presented_order":["2494748","21551568"],"winner_id":"2494748","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; both are unrelated. Document A is slightly more relevant because it discusses molecular markers and progression in carcinoma, whereas B focuses on PI3K/Akt genetic changes in thyroid cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:37.269038Z"}
{"comparison_id":"5b029371-5d2e-4ca6-b6d3-4bf2ef9802c0","query_id":"53","doc_a_id":"12685434","doc_b_id":"2494748","presented_order":["2494748","12685434"],"winner_id":"2494748","reasoning":"Document A is more relevant — both abstracts are unrelated to ALDH1 or breast cancer, but A discusses cancer-related molecular markers, making it slightly closer in topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:37.269047Z"}
{"comparison_id":"32a74788-14e5-4a0c-b179-521503706d9c","query_id":"53","doc_a_id":"15727984","doc_b_id":"2494748","presented_order":["15727984","2494748"],"winner_id":"2494748","reasoning":"Document B is slightly more relevant — it addresses molecular markers and progression in carcinoma (potentially linked to prognosis), whereas A focuses on secreted proteins in a lung cancer model unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:37.269055Z"}
{"comparison_id":"374fe74d-ddb5-4042-87a7-e02cc5bd9b3f","query_id":"53","doc_a_id":"1649738","doc_b_id":"2494748","presented_order":["1649738","2494748"],"winner_id":"2494748","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it studies cancer-associated molecular markers and progression, while A focuses on PRDM1 variants in Hodgkin's survivors. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:37.269062Z"}
{"comparison_id":"6ad95913-7ef5-4749-8cf1-7bf2169a2eb8","query_id":"53","doc_a_id":"12887068","doc_b_id":"2494748","presented_order":["2494748","12887068"],"winner_id":"2494748","reasoning":"Document A — it discusses biomarker methylation patterns in carcinoma progression (more related to cancer prognosis/biomarkers) whereas B is about pediatric glioma modeling. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:37.269070Z"}
{"comparison_id":"89c5e280-eb7f-4b23-ab6b-e363a6442607","query_id":"53","doc_a_id":"22059387","doc_b_id":"2494748","presented_order":["2494748","22059387"],"winner_id":"2494748","reasoning":"Document A. It discusses molecular markers and methylation patterns in human carcinoma (though gastric, not breast), which is closer to the claim about a cancer prognostic marker than Document B's infection-induced hamster model of cholangiocarcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:37.269077Z"}
{"comparison_id":"f9091f24-66dd-4275-b4b8-5e38db024062","query_id":"53","doc_a_id":"22180793","doc_b_id":"2494748","presented_order":["22180793","2494748"],"winner_id":"22180793","reasoning":"Neither document mentions ALDH1 or breast cancer. Both are irrelevant, but A is slightly closer (cancer biology/prognosis context) than B (gastric CpG methylation).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:37.269084Z"}
{"comparison_id":"ad80eb73-3216-41a2-b0a9-e0418597835f","query_id":"53","doc_a_id":"29124963","doc_b_id":"25832301","presented_order":["29124963","25832301"],"winner_id":"25832301","reasoning":"Document B is slightly more relevant because it reports how expression level of a biomarker (TSPAN7) relates to patient outcome, whereas Document A addresses a gene translocation in lung cancer unrelated to marker expression in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:44.535053Z"}
{"comparison_id":"7b0b8ddd-0456-4883-a28a-62527fcde5cc","query_id":"53","doc_a_id":"22180793","doc_b_id":"25832301","presented_order":["25832301","22180793"],"winner_id":"22180793","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document B discusses tumor growth/metastasis (factors closely related to prognosis), so it's slightly more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:44.535076Z"}
{"comparison_id":"2ebdc8b4-19e3-48fc-8a47-e9f3ddea5a10","query_id":"53","doc_a_id":"3899896","doc_b_id":"12685434","presented_order":["12685434","3899896"],"winner_id":"12685434","reasoning":"Document A is marginally more relevant because it discusses a cancer-related protein whose expression affects tumor aggressiveness (similar molecular-prognostic context), whereas Document B concerns a hematologic marker in rectal cancer unrelated to ALDH1 or breast cancer.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:49.317289Z"}
{"comparison_id":"2c740fb4-a123-4d7e-8161-e91904c06a4e","query_id":"53","doc_a_id":"7639744","doc_b_id":"12685434","presented_order":["7639744","12685434"],"winner_id":"12685434","reasoning":"Document B — it's a molecular study of protein expression and cancer invasion (more similar to a marker/prognosis study) whereas A is about smoking cessation and lung cancer survival, which is unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:49.317311Z"}
{"comparison_id":"a7cab15c-8cf6-45a2-92a5-b6db0545177b","query_id":"53","doc_a_id":"20754359","doc_b_id":"12685434","presented_order":["20754359","12685434"],"winner_id":"20754359","reasoning":"Document A is slightly more relevant because it discusses cancer prognosis (though in ATLL, not breast cancer); Document B focuses on glioblastoma invasion mechanisms and not prognosis in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:49.317320Z"}
{"comparison_id":"0bf3175a-5fc1-421d-948c-d736274ff198","query_id":"53","doc_a_id":"21551568","doc_b_id":"12685434","presented_order":["21551568","12685434"],"winner_id":"21551568","reasoning":"Document A is slightly more relevant because it discusses cancer-related genetic alterations and tumor progression (though it concerns thyroid cancer, not breast cancer or ALDH1). Neither document addresses ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:49.317328Z"}
{"comparison_id":"9f308ea1-3fef-4563-8fce-91d2cd04c914","query_id":"53","doc_a_id":"22059387","doc_b_id":"12685434","presented_order":["12685434","22059387"],"winner_id":"12685434","reasoning":"Document A is slightly more relevant because it deals with cancer and marker expression, whereas Document B concerns parasite-induced cholangiocarcinoma in hamsters, unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:49.317336Z"}
{"comparison_id":"f13ed9ff-3a28-4f81-a7ed-fcb796250a89","query_id":"53","doc_a_id":"15727984","doc_b_id":"12685434","presented_order":["15727984","12685434"],"winner_id":"15727984","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses tumor microenvironment and secreted proteins (general cancer prognostic mechanisms), whereas Document B focuses narrowly on glioblastoma invasion.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:49.317343Z"}
{"comparison_id":"781eac19-04f1-45f4-90f5-40e37f60421c","query_id":"53","doc_a_id":"1649738","doc_b_id":"12685434","presented_order":["12685434","1649738"],"winner_id":"1649738","reasoning":"Neither document mentions ALDH1 or breast cancer, so both are irrelevant to the claim. If forced to choose the closer one, B is slightly more related to cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:49.317350Z"}
{"comparison_id":"7b824e2b-d88d-473e-8bc9-b8783a387c72","query_id":"53","doc_a_id":"12887068","doc_b_id":"12685434","presented_order":["12685434","12887068"],"winner_id":"12685434","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it addresses cancer invasion and a potential prognostic effector, whereas B focuses on modeling pediatric gliomas. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:10:49.317358Z"}
{"comparison_id":"461ed3d4-ee7d-42bb-af8a-5b2f604a4b4d","query_id":"53","doc_a_id":"20754359","doc_b_id":"21551568","presented_order":["20754359","21551568"],"winner_id":"20754359","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses cancer prognosis (though in ATLL, not breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:11:06.237002Z"}
{"comparison_id":"4c1f66ff-7ca2-4693-90f0-3c952a0f532b","query_id":"53","doc_a_id":"1649738","doc_b_id":"21551568","presented_order":["21551568","1649738"],"winner_id":"21551568","reasoning":"Document A is more relevant — it addresses cancer-related genetic alterations and tumor progression (though in thyroid), whereas B focuses on genetics of therapy-induced second cancers after Hodgkin's lymphoma; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:11:06.237026Z"}
{"comparison_id":"bf54d7ea-1190-4099-9e51-8e64b616b1a3","query_id":"53","doc_a_id":"15727984","doc_b_id":"21551568","presented_order":["21551568","15727984"],"winner_id":"15727984","reasoning":"Reason: Both are unrelated to ALDH1 or breast cancer, but Document B (tumor microenvironment and secreted factors in lung cancer) is closer in theme (tumor markers/interaction) than Document A (PI3K/Akt alterations in thyroid cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:11:06.237035Z"}
{"comparison_id":"837857b2-84e1-4164-8a6c-3dbe4830df51","query_id":"53","doc_a_id":"20754359","doc_b_id":"15727984","presented_order":["20754359","15727984"],"winner_id":"15727984","reasoning":"Document B — it deals with tumor biology and microenvironment factors in solid tumors, which is closer to breast cancer marker studies than a paper on T‑cell leukemia/lymphoma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:11:10.271255Z"}
{"comparison_id":"3b1fca68-12d2-4e7b-ba0b-a4a4b7181b9f","query_id":"53","doc_a_id":"3899896","doc_b_id":"7639744","presented_order":["7639744","3899896"],"winner_id":"3899896","reasoning":"Document B — it discusses a biomarker (RDW) linked to prognosis in cancer, which is more analogous to the claim about ALDH1 as a prognostic marker than the smoking/lung cancer study in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:11:15.749081Z"}
{"comparison_id":"1c3279a0-59dd-4edc-8563-b05a023bf9ba","query_id":"53","doc_a_id":"12887068","doc_b_id":"7639744","presented_order":["7639744","12887068"],"winner_id":"12887068","reasoning":"Neither abstract addresses ALDH1 or breast cancer. Document B is slightly more relevant because it deals with stem-cell states and tumor stemness, which is conceptually closer to ALDH1 (a stem-cell marker). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:11:15.749102Z"}
{"comparison_id":"57c5d32c-31b9-428c-9aa4-d177eab7aec7","query_id":"53","doc_a_id":"22059387","doc_b_id":"7639744","presented_order":["22059387","7639744"],"winner_id":"7639744","reasoning":"Document B — it addresses cancer prognosis (though in lung cancer), while Document A is about infection-driven DNA damage in hamsters and unrelated to prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:11:15.749111Z"}
{"comparison_id":"3141fe6c-5021-4135-b8d1-93dac056ba9b","query_id":"53","doc_a_id":"3899896","doc_b_id":"12887068","presented_order":["12887068","3899896"],"winner_id":"12887068","reasoning":"Document A — it discusses stem-cell–related cancer biology (more conceptually related to ALDH1 as a stemness marker) while Document B concerns RDW in rectal cancer and is unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:11:20.776437Z"}
{"comparison_id":"40493d13-7157-4408-91ab-c1f5fef7a439","query_id":"53","doc_a_id":"8512633","doc_b_id":"4795303","presented_order":["4795303","8512633"],"winner_id":"8512633","reasoning":"Document B — it concerns prognosis-related molecular markers in cancer (though in prostate cancer), making it more relevant than Document A which is about neuroprotection in PC12 cells. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202286Z"}
{"comparison_id":"150072a7-d3fa-480d-9ed5-1fc7bc038a29","query_id":"53","doc_a_id":"34189936","doc_b_id":"4795303","presented_order":["34189936","4795303"],"winner_id":"34189936","reasoning":"Document A is more relevant because it addresses gene expression in a cancer context (tumor prognostic/therapeutic relevance), whereas Document B concerns neuroprotective effects in PC12 cells unrelated to cancer prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202306Z"}
{"comparison_id":"ff7d658d-e9a1-4ef4-b788-f3033b21baa2","query_id":"53","doc_a_id":"11615422","doc_b_id":"4795303","presented_order":["4795303","11615422"],"winner_id":"11615422","reasoning":"Document B is more relevant — it deals with cancer-related genetic alterations, whereas Document A is about neuroprotective effects in PC12 cells and unrelated to cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202315Z"}
{"comparison_id":"aadb7602-c5b8-4d02-95f8-bcbcff3a6268","query_id":"53","doc_a_id":"23665162","doc_b_id":"4795303","presented_order":["23665162","4795303"],"winner_id":"23665162","reasoning":"Document A is cancer-related and discusses a biomarker linked to cancer risk/prognosis, while B is about neuroprotection and unrelated to cancer or ALDH1. Neither mentions ALDH1 or breast cancer, but A is more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202323Z"}
{"comparison_id":"f8b89d21-f4f9-450b-994e-a6eec9ab3e8e","query_id":"53","doc_a_id":"8677721","doc_b_id":"4795303","presented_order":["8677721","4795303"],"winner_id":"8677721","reasoning":"Document A is slightly more relevant — it concerns cancer biology (though hepatocellular carcinoma, not breast cancer) while Document B is about neuroprotection in PC12 cells; neither mentions ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202330Z"}
{"comparison_id":"cad97c73-25ad-4627-8098-0bc22b222ff7","query_id":"53","doc_a_id":"10169908","doc_b_id":"4795303","presented_order":["4795303","10169908"],"winner_id":"10169908","reasoning":"Document B is slightly more relevant because it addresses cancer-related protein expression and tumor cell survival, whereas A focuses on neuronal protection unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202338Z"}
{"comparison_id":"616772dd-9766-4a1a-a39b-bb7553a9e4e2","query_id":"53","doc_a_id":"14471161","doc_b_id":"4795303","presented_order":["4795303","14471161"],"winner_id":"14471161","reasoning":"Document B is more relevant — it concerns cancer and tumor gene expression, whereas Document A is about neuroprotection in PC12 cells and unrelated to cancer biomarkers or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202345Z"}
{"comparison_id":"29cef7b6-c734-4312-96ad-cfbf440778da","query_id":"53","doc_a_id":"23577867","doc_b_id":"4795303","presented_order":["4795303","23577867"],"winner_id":"23577867","reasoning":"Document B is slightly more relevant because it concerns cancer biomarkers and cancer risk, while Document A deals with neuroprotection in PC12 cells unrelated to breast cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202352Z"}
{"comparison_id":"dd781a77-3a80-4ab5-af6d-59f12bd62b51","query_id":"53","doc_a_id":"2272614","doc_b_id":"4795303","presented_order":["4795303","2272614"],"winner_id":"2272614","reasoning":"Document B — it concerns gene expression in cancer (therapy resistance), which is closer to the claim about a prognostic cancer marker than the neuroprotection study in Document A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202359Z"}
{"comparison_id":"b4a605fa-527c-4a2a-a870-0171d7f8002f","query_id":"53","doc_a_id":"24349430","doc_b_id":"4795303","presented_order":["4795303","24349430"],"winner_id":"24349430","reasoning":"Document B is slightly more relevant because it addresses cancer cell signaling and proliferation (though in lung cancer), whereas Document A is about neuroprotection in PC12 cells and unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202366Z"}
{"comparison_id":"6819a0b4-c893-48e8-aa4c-aaaccbca3889","query_id":"53","doc_a_id":"1507222","doc_b_id":"4795303","presented_order":["1507222","4795303"],"winner_id":"1507222","reasoning":"Document A is slightly more relevant because it deals with cancer-related gene expression (though not ALDH1 or breast cancer specifically). \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202372Z"}
{"comparison_id":"23758b56-10aa-4a1d-a1a0-8d2908116e06","query_id":"53","doc_a_id":"31313782","doc_b_id":"4795303","presented_order":["31313782","4795303"],"winner_id":"31313782","reasoning":"Document A is slightly more relevant because it concerns cancer-related expression profiles, whereas Document B covers neuroprotection in PC12 cells and is unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202379Z"}
{"comparison_id":"7985ad1a-5d83-4c9c-8cff-cc67341f802c","query_id":"53","doc_a_id":"14180565","doc_b_id":"4795303","presented_order":["14180565","4795303"],"winner_id":"14180565","reasoning":"Document A is slightly more relevant because it concerns gene expression changes in cancer cells (glioblastoma), whereas B is about neuroprotection in neuronal cells and unrelated to cancer markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202386Z"}
{"comparison_id":"cd33f482-7f44-4d42-b978-46973b98a7f1","query_id":"53","doc_a_id":"641786","doc_b_id":"4795303","presented_order":["4795303","641786"],"winner_id":"641786","reasoning":"Document B is more relevant — it deals with cancer prognosis/relapse, whereas Document A is about neuroprotection in PC12 cells and unrelated to cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202393Z"}
{"comparison_id":"16b99ce2-6c78-430f-a915-ca4859349dc9","query_id":"53","doc_a_id":"32852283","doc_b_id":"4795303","presented_order":["32852283","4795303"],"winner_id":"32852283","reasoning":"Document A is more relevant — it addresses cancer and survival/prognosis (though in NSCLC), whereas Document B concerns neuroprotection in PC12 cells and is unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202401Z"}
{"comparison_id":"6ddcac60-9457-4886-ae43-e66095250557","query_id":"53","doc_a_id":"20738970","doc_b_id":"4795303","presented_order":["20738970","4795303"],"winner_id":"20738970","reasoning":"Document A is slightly more relevant because it concerns cancer biology and apoptosis markers, whereas Document B is about neuroprotection in PC12 cells and unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202408Z"}
{"comparison_id":"73c2f3e3-2479-45a3-9e7d-921af31ebfb8","query_id":"53","doc_a_id":"23509593","doc_b_id":"4795303","presented_order":["4795303","23509593"],"winner_id":"23509593","reasoning":"Document B. It relates to cancer and gene regulation (prostate stromal cells), whereas A is about neuroprotection in PC12 cells and is unrelated to cancer; neither addresses ALDH1 or breast cancer prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202414Z"}
{"comparison_id":"16c516f1-26d5-4873-8413-9c7f3d6ae7db","query_id":"53","doc_a_id":"3710557","doc_b_id":"4795303","presented_order":["3710557","4795303"],"winner_id":"3710557","reasoning":"Neither document discusses ALDH1 or breast cancer, but Document A (about β-catenin and tumorigenesis) is marginally more relevant due to its cancer focus.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202421Z"}
{"comparison_id":"2f138da5-52ff-4b97-8554-7e7c8a5d8b6f","query_id":"53","doc_a_id":"3355397","doc_b_id":"4795303","presented_order":["4795303","3355397"],"winner_id":"3355397","reasoning":"Document B — it concerns cancer risk and is more related to oncology, whereas Document A is a neuroprotection study unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202427Z"}
{"comparison_id":"fdb7230b-8abd-46c5-841c-ef57de1ce960","query_id":"53","doc_a_id":"25628793","doc_b_id":"4795303","presented_order":["4795303","25628793"],"winner_id":"25628793","reasoning":"Neither is relevant — neither mentions ALDH1 or breast cancer. Document B is marginally closer (both study tissue enzyme expression), so: ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202434Z"}
{"comparison_id":"e3dc4196-9950-463d-a301-0c2fd26957ae","query_id":"53","doc_a_id":"2360905","doc_b_id":"4795303","presented_order":["2360905","4795303"],"winner_id":"2360905","reasoning":"Document A is more relevant — it concerns cancer and gene expression alterations (though in gliomas, not breast cancer), whereas Document B is an unrelated neuroprotection study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202441Z"}
{"comparison_id":"0e26e971-491e-47ff-898b-6c3d9e5539c0","query_id":"53","doc_a_id":"14663842","doc_b_id":"4795303","presented_order":["14663842","4795303"],"winner_id":"14663842","reasoning":"Document A is more relevant — it discusses cancer metabolism (though IDH1, not ALDH1), while Document B is about neuroprotection in PC12 cells and unrelated to breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202449Z"}
{"comparison_id":"b61a492e-770c-46c3-b61e-b85e2f6aeeb9","query_id":"53","doc_a_id":"4841908","doc_b_id":"4795303","presented_order":["4795303","4841908"],"winner_id":"4841908","reasoning":"Document B is slightly more relevant because it addresses biomarkers and links to disease outcomes (mentions cancer), whereas Document A studies neuroprotective effects in PC12 cells unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202456Z"}
{"comparison_id":"f5025477-11c3-4201-b6a9-fdd7f2e491d9","query_id":"53","doc_a_id":"14938990","doc_b_id":"4795303","presented_order":["14938990","4795303"],"winner_id":"14938990","reasoning":"Reason: Document A discusses gene/protein expression linked to disease development/prognosis, which is more related to the claim about biomarker expression and prognosis than Document B's unrelated neuroprotection study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202463Z"}
{"comparison_id":"e7705eaa-3ae0-4a25-bb44-0744293bad3d","query_id":"53","doc_a_id":"19368793","doc_b_id":"4795303","presented_order":["19368793","4795303"],"winner_id":"19368793","reasoning":"Document A is more relevant — it concerns cancer biomarkers (though in HCC), while B addresses neuroprotection unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202469Z"}
{"comparison_id":"d99479cf-73ea-4e57-8d54-b0ff5f6a5c05","query_id":"53","doc_a_id":"4959368","doc_b_id":"4795303","presented_order":["4795303","4959368"],"winner_id":"4959368","reasoning":"Document B — it concerns cancer biology (though pancreatic), while Document A is about neuroprotection in PC12 cells and is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202475Z"}
{"comparison_id":"77617d53-edcc-464b-b43c-ad9fface88e1","query_id":"53","doc_a_id":"85665741","doc_b_id":"4795303","presented_order":["4795303","85665741"],"winner_id":"85665741","reasoning":"Document B — it discusses cancer biology (though in NSCLC), whereas Document A is about neuroprotection in PC12 cells and unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202482Z"}
{"comparison_id":"5e8a7bdb-4d77-4aab-a49d-1ab271d72d58","query_id":"53","doc_a_id":"6363093","doc_b_id":"4795303","presented_order":["6363093","4795303"],"winner_id":"6363093","reasoning":"Document A is more relevant — it addresses cancer and protein expression patterns, while Document B is about neuroprotection in neuronal cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202488Z"}
{"comparison_id":"0028bd40-5ec7-4d17-8e6c-4e1124f6708f","query_id":"53","doc_a_id":"4387494","doc_b_id":"4795303","presented_order":["4387494","4795303"],"winner_id":"4387494","reasoning":"Document A is more relevant — it's cancer-related (though AML, not breast cancer); Document B is about neuroprotection and unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202495Z"}
{"comparison_id":"15f92068-b5ce-4a59-adcc-92911bdf19c4","query_id":"53","doc_a_id":"11900630","doc_b_id":"4795303","presented_order":["4795303","11900630"],"winner_id":"11900630","reasoning":"Document B is more relevant — it concerns cancer and factors affecting tumor cell survival/prognosis (though not ALDH1 or breast cancer specifically). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202502Z"}
{"comparison_id":"a49c1645-feaf-4e39-9c8b-21525a84e2cd","query_id":"53","doc_a_id":"13905670","doc_b_id":"4795303","presented_order":["4795303","13905670"],"winner_id":"13905670","reasoning":"Document B — it addresses genetic variation linked to disease prognosis, which is more related to a claim about gene expression being associated with cancer prognosis than Document A's neuroprotection study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202509Z"}
{"comparison_id":"b2cdda9b-8deb-4dca-ab26-7d9f7ab7a120","query_id":"53","doc_a_id":"663464","doc_b_id":"4795303","presented_order":["4795303","663464"],"winner_id":"663464","reasoning":"Document B is more relevant — it deals with biomarker expression and associations with prognosis/mortality, whereas A is an unrelated neuroprotection study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202516Z"}
{"comparison_id":"f89e0311-61a5-440f-859f-26be00956bc3","query_id":"53","doc_a_id":"16016673","doc_b_id":"4795303","presented_order":["16016673","4795303"],"winner_id":"16016673","reasoning":"Document A is more relevant — it concerns cancer biomarkers and prognosis (though in bladder cancer), while Document B focuses on neuroprotection and is unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202522Z"}
{"comparison_id":"4d1c57ed-3b7a-4718-bacc-df1321e03ff1","query_id":"53","doc_a_id":"1976183","doc_b_id":"4795303","presented_order":["1976183","4795303"],"winner_id":"1976183","reasoning":"Document A — it discusses cancer-related biomarkers and invasive/metastatic behavior, making it more relevant to a prognosis claim than a neuroprotection study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202529Z"}
{"comparison_id":"39e60bf4-e357-4656-9885-31a84b552632","query_id":"53","doc_a_id":"17876040","doc_b_id":"4795303","presented_order":["17876040","4795303"],"winner_id":"17876040","reasoning":"Document A is slightly more relevant because it discusses cancer therapy (oncology), whereas Document B is about neuroprotection in PC12 cells and not cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202535Z"}
{"comparison_id":"13280e11-6313-459b-9518-80595c5773f8","query_id":"53","doc_a_id":"38355793","doc_b_id":"4795303","presented_order":["38355793","4795303"],"winner_id":"38355793","reasoning":"Document A is more relevant because it addresses gene expression in cancer tissues (though in glioma), whereas Document B concerns neuroprotective effects in PC12 cells and not cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202542Z"}
{"comparison_id":"6e0d1213-453b-46d1-8457-9766e0dc74e8","query_id":"53","doc_a_id":"7020505","doc_b_id":"4795303","presented_order":["4795303","7020505"],"winner_id":"7020505","reasoning":"Document B — discusses prognostic markers in cancer (though in CLL), so it's slightly more relevant to a claim about expression and prognosis than Document A, which is unrelated (neuroprotection). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202549Z"}
{"comparison_id":"e4c27888-7ee0-481a-aed8-649ec26320ac","query_id":"53","doc_a_id":"12903921","doc_b_id":"4795303","presented_order":["12903921","4795303"],"winner_id":"12903921","reasoning":"Document A is slightly more relevant because it deals with cancer (leukemia) and oxidative stress, whereas Document B is a neuroprotection study in PC12 cells; neither addresses ALDH1 or breast cancer directly.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202556Z"}
{"comparison_id":"e24f82af-e937-4e1c-9239-9793024ef831","query_id":"53","doc_a_id":"57783564","doc_b_id":"4795303","presented_order":["4795303","57783564"],"winner_id":"57783564","reasoning":"Document B — it concerns cancer biology (though colon cancer), whereas A is about neuroprotection in PC12 cells and unrelated to cancer markers or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202563Z"}
{"comparison_id":"8dd7ec26-f652-4b73-822f-fe086eaab8e7","query_id":"53","doc_a_id":"16853734","doc_b_id":"4795303","presented_order":["16853734","4795303"],"winner_id":"16853734","reasoning":"Document A is slightly more relevant because it addresses cancer-related molecular expression and cell behavior, whereas Document B focuses on neuroprotection in PC12 cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202570Z"}
{"comparison_id":"e8930d2d-76dd-4409-9317-95bffdfde22d","query_id":"53","doc_a_id":"41293601","doc_b_id":"4795303","presented_order":["4795303","41293601"],"winner_id":"41293601","reasoning":"Document B is slightly more relevant because it deals with cancer biomarkers and prognostic subgroups, whereas Document A focuses on neuroprotection in PC12 cells unrelated to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202576Z"}
{"comparison_id":"7e493b10-1133-4f71-ab8d-2963d933defb","query_id":"53","doc_a_id":"14848619","doc_b_id":"4795303","presented_order":["4795303","14848619"],"winner_id":"14848619","reasoning":"Document B. It concerns cell-death pathways and HIF-1α, which are more related to cancer biology than Document A's neuroprotective PC12-cell study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202582Z"}
{"comparison_id":"872cb306-e974-4dd4-a895-c91fca02468a","query_id":"53","doc_a_id":"24624992","doc_b_id":"4795303","presented_order":["24624992","4795303"],"winner_id":"24624992","reasoning":"Document A — it discusses gene expression in cancer cell lines (though leukemia), whereas B is a neuroprotection study in neuronal cells and is less related to breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202589Z"}
{"comparison_id":"c74b6227-2c45-423d-bb4f-229f365378cd","query_id":"53","doc_a_id":"17671145","doc_b_id":"4795303","presented_order":["4795303","17671145"],"winner_id":"17671145","reasoning":"Document B — it's cancer-focused (though prostate) and more likely relevant to prognosis/biomarker discussion than Document A, which is a neuronal/PC12 cell study. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202595Z"}
{"comparison_id":"8074165d-4c28-454f-8610-f40b149bb69d","query_id":"53","doc_a_id":"5956380","doc_b_id":"4795303","presented_order":["4795303","5956380"],"winner_id":"5956380","reasoning":"Document B — it's about cancer genetics (tumors) and thus more related to prognosis in oncology than Document A, which covers neuroprotection in PC12 cells. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202602Z"}
{"comparison_id":"32f9b990-0492-4234-8074-6d1a9477fd69","query_id":"53","doc_a_id":"10699587","doc_b_id":"4795303","presented_order":["10699587","4795303"],"winner_id":"10699587","reasoning":"Document A is more relevant — it discusses prognostic groups in cancer (though prostate, not breast), whereas B is a cell-level neuroprotection study unrelated to cancer prognosis.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202608Z"}
{"comparison_id":"7eac5def-91e7-48d5-a06a-3a48be70790f","query_id":"53","doc_a_id":"6171953","doc_b_id":"4795303","presented_order":["6171953","4795303"],"winner_id":"6171953","reasoning":"Document A is slightly more relevant because it discusses a protein (Sirtuin-1) and disease-related signaling that could be more plausibly connected to cancer prognosis than a study on neuronal protection in PC12 cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202615Z"}
{"comparison_id":"a88ce963-fba4-4bca-8eaa-d6d01d07e858","query_id":"53","doc_a_id":"8764879","doc_b_id":"4795303","presented_order":["4795303","8764879"],"winner_id":"8764879","reasoning":"Reason: Document B is cancer-related (leukemia) and discusses stem-cell markers and prognosis/therapy, whereas Document A is about neuroprotective effects in PC12 cells and is unrelated to cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202622Z"}
{"comparison_id":"0c6f2651-3626-41f3-af9f-34014e37b1fd","query_id":"53","doc_a_id":"1982286","doc_b_id":"4795303","presented_order":["4795303","1982286"],"winner_id":"1982286","reasoning":"Document B is more relevant — it concerns cancer biology and transcriptional regulators, whereas Document A is a neuroprotection study unrelated to cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202629Z"}
{"comparison_id":"84f6f0bd-dd98-4701-8d47-278bbb8a495f","query_id":"53","doc_a_id":"67787658","doc_b_id":"4795303","presented_order":["67787658","4795303"],"winner_id":"67787658","reasoning":"Document A is more relevant — it involves cancer biology (glioblastoma) and cell cycle/prognosis–related mechanisms, whereas B is about neuroprotection in PC12 cells and unrelated to cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202636Z"}
{"comparison_id":"2d67462d-71d6-4123-abf5-67ae34fde629","query_id":"53","doc_a_id":"35993767","doc_b_id":"4795303","presented_order":["4795303","35993767"],"winner_id":"35993767","reasoning":"Document B is more relevant — it discusses cancer (tumor progression/metastasis) whereas A is about neuroprotection in PC12 cells and unrelated to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202668Z"}
{"comparison_id":"26abc32d-fc50-47a9-9a9f-e321aa977df2","query_id":"53","doc_a_id":"40901687","doc_b_id":"4795303","presented_order":["40901687","4795303"],"winner_id":"40901687","reasoning":"Document A is more relevant — it discusses cancer-related DNA damage response mechanisms, whereas B concerns neuroprotection in PC12 cells and does not pertain to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202680Z"}
{"comparison_id":"498b04ee-6308-47c3-8405-8ec12cdc9c2a","query_id":"53","doc_a_id":"6766459","doc_b_id":"4795303","presented_order":["6766459","4795303"],"winner_id":"6766459","reasoning":"Neither document mentions ALDH1 or breast cancer prognosis, so both are irrelevant. If forced to choose, A is marginally more relevant because it concerns human disease immune regulation, whereas B is a neuronal cell study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202689Z"}
{"comparison_id":"4ab28e0b-5b6b-4d8d-a39b-14fc764db593","query_id":"53","doc_a_id":"26887439","doc_b_id":"4795303","presented_order":["26887439","4795303"],"winner_id":"26887439","reasoning":"Document A is slightly more relevant because it addresses cancer-related biomarkers and tumor prognosis contexts, whereas Document B is about neuroprotection in PC12 cells and unrelated to cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202696Z"}
{"comparison_id":"d225702d-be85-4464-bdf5-5741c2d5a932","query_id":"53","doc_a_id":"5783785","doc_b_id":"4795303","presented_order":["5783785","4795303"],"winner_id":"5783785","reasoning":"Doc A is more relevant because it studies cancer biology (though gastric cancer), whereas Doc B addresses neuroprotection in cell models unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202703Z"}
{"comparison_id":"2239b7c4-f335-4abe-bf2d-d94b0b742808","query_id":"53","doc_a_id":"9226649","doc_b_id":"4795303","presented_order":["4795303","9226649"],"winner_id":"9226649","reasoning":"Document B is more relevant — it concerns cancer biology and tumorigenesis, whereas Document A deals with neuroprotection in PC12 cells and is unrelated to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202710Z"}
{"comparison_id":"0088c90c-9fd1-46d8-8495-12018d57a20d","query_id":"53","doc_a_id":"15215393","doc_b_id":"4795303","presented_order":["15215393","4795303"],"winner_id":"15215393","reasoning":"Document A is more relevant — it concerns cancer biology (though glioblastoma, not breast cancer), whereas Document B is about neuroprotection in PC12 cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202717Z"}
{"comparison_id":"4a8f47d2-227f-4cfb-a362-95c407a56b09","query_id":"53","doc_a_id":"17911973","doc_b_id":"4795303","presented_order":["17911973","4795303"],"winner_id":"17911973","reasoning":"Neither document discusses ALDH1 or breast cancer specifically; Document A mentions cancer-related genomic changes (lung), so it's slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202725Z"}
{"comparison_id":"fdd2a67d-beb7-41ea-a273-426ce0851625","query_id":"53","doc_a_id":"28334217","doc_b_id":"4795303","presented_order":["28334217","4795303"],"winner_id":"28334217","reasoning":"Document A is more relevant — it concerns cancer biology and tumor prognosis/therapy, whereas B is about neuroprotection in PC12 cells and unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202731Z"}
{"comparison_id":"45235980-f2f6-401d-abcd-c6d4636f8347","query_id":"53","doc_a_id":"7869794","doc_b_id":"4795303","presented_order":["7869794","4795303"],"winner_id":"7869794","reasoning":"Document A — it concerns tumor cell interactions and cancer-related mechanisms, while Document B is about neuroprotection in PC12 cells and not cancer-related.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202738Z"}
{"comparison_id":"985841c7-f2ba-440f-8cb9-20dd586f2f41","query_id":"53","doc_a_id":"22703082","doc_b_id":"4795303","presented_order":["22703082","4795303"],"winner_id":"22703082","reasoning":"Document A is more relevant — it discusses cancer-related gene expression and carcinogenesis (though in gastric tissue), whereas B is a neuroprotection study unrelated to cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202744Z"}
{"comparison_id":"f0874978-5d1f-4399-aebe-21d7e7ed9f71","query_id":"53","doc_a_id":"3831884","doc_b_id":"4795303","presented_order":["3831884","4795303"],"winner_id":"3831884","reasoning":"Both documents are unrelated to ALDH1 or breast cancer, but Document A discusses cancer biology (pancreatic tumor metabolism) making it slightly more relevant than the neuroprotection study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202751Z"}
{"comparison_id":"5ddb3382-9e00-4f5f-bc4e-baa3fb46d5b1","query_id":"53","doc_a_id":"4325398","doc_b_id":"4795303","presented_order":["4325398","4795303"],"winner_id":"4325398","reasoning":"Document A is more relevant — it's a cancer genomics study (although pancreatic, it's closer to the oncology context of the query). \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202757Z"}
{"comparison_id":"f3696c35-c51c-482e-9466-2f266876586c","query_id":"53","doc_a_id":"3504761","doc_b_id":"4795303","presented_order":["4795303","3504761"],"winner_id":"3504761","reasoning":"Document B is more relevant — it discusses tumorigenesis and cancer-related pathways, whereas Document A focuses on neuronal protection and Nrf2 in PC12 cells, unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202765Z"}
{"comparison_id":"2394e554-8c08-4d46-8a85-fce514a8a065","query_id":"53","doc_a_id":"10365787","doc_b_id":"4795303","presented_order":["10365787","4795303"],"winner_id":"10365787","reasoning":"Document A is slightly more relevant because it discusses tumor suppression and cancer-related pathways, whereas Document B is about neuroprotection in PC12 cells and unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202772Z"}
{"comparison_id":"6c635f0b-b4e4-435d-aa48-c29f8ddebd11","query_id":"53","doc_a_id":"24783597","doc_b_id":"4795303","presented_order":["24783597","4795303"],"winner_id":"24783597","reasoning":"Document A is slightly more relevant — it deals with expression of a molecular marker in human disease and prognosis contexts, whereas Document B is an in vitro neuroprotection study unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202779Z"}
{"comparison_id":"59868b12-eacd-4336-9813-2a7811e0dc57","query_id":"53","doc_a_id":"1522336","doc_b_id":"4795303","presented_order":["4795303","1522336"],"winner_id":"1522336","reasoning":"Document B is more relevant — it concerns cancer and changes in protein expression, while A is a neuroprotection study unrelated to cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202785Z"}
{"comparison_id":"fdbec9aa-c9ad-4a64-830d-98dd29143415","query_id":"53","doc_a_id":"24190159","doc_b_id":"4795303","presented_order":["24190159","4795303"],"winner_id":"24190159","reasoning":"Document A is more relevant — it addresses gene expression changes in carcinoma and links overexpression to clinical outcomes, whereas Document B is a neuroprotection study unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202792Z"}
{"comparison_id":"df604089-ba7a-474f-a2f6-d32a15ca4fad","query_id":"53","doc_a_id":"25036988","doc_b_id":"4795303","presented_order":["4795303","25036988"],"winner_id":"25036988","reasoning":"Document B — it discusses cancer-related molecular changes (though in colon cancer), whereas A is a neuroprotection study unrelated to cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202799Z"}
{"comparison_id":"346da358-d2c8-4e6a-b022-e4353536e1da","query_id":"53","doc_a_id":"18682109","doc_b_id":"4795303","presented_order":["4795303","18682109"],"winner_id":"18682109","reasoning":"Document B is more relevant — it discusses cancer-related molecular markers and prognosis/therapy resistance (though in lung cancer), while A is about neuroprotection in PC12 cells and unrelated to cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202805Z"}
{"comparison_id":"809c22a2-ecab-4f7e-8690-e16cbcae622b","query_id":"53","doc_a_id":"2466614","doc_b_id":"4795303","presented_order":["4795303","2466614"],"winner_id":"2466614","reasoning":"Neither document addresses ALDH1, breast cancer, or prognosis, but B is marginally closer because it deals with genome-wide expression patterns; A is focused on neuronal cell protection. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202812Z"}
{"comparison_id":"63680d17-1790-4c0a-9d53-d6b0a093513d","query_id":"53","doc_a_id":"19427410","doc_b_id":"4795303","presented_order":["19427410","4795303"],"winner_id":"19427410","reasoning":"Neither document addresses ALDH1 or breast cancer. Both are irrelevant; if forced to choose, A is marginally more relevant because it studies human tissue biology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202818Z"}
{"comparison_id":"85797ff4-1d9c-4378-b30d-eadc2a40a4ce","query_id":"53","doc_a_id":"15322518","doc_b_id":"4795303","presented_order":["4795303","15322518"],"winner_id":"15322518","reasoning":"Document B is more relevant — it addresses cancer biology/therapy, whereas Document A is a neuroprotective cell study unrelated to breast cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202825Z"}
{"comparison_id":"b66dc85c-03f9-49df-8f6a-550da4aea022","query_id":"53","doc_a_id":"1617327","doc_b_id":"4795303","presented_order":["1617327","4795303"],"winner_id":"1617327","reasoning":"Document A is more relevant because it addresses cancer-related biology (neoplastic disease mechanisms), whereas Document B concerns neuroprotection and is unrelated to cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202832Z"}
{"comparison_id":"00550e87-a5f8-463d-86e9-e02a1ef1d5a4","query_id":"53","doc_a_id":"4312169","doc_b_id":"4795303","presented_order":["4312169","4795303"],"winner_id":"4312169","reasoning":"Reason: Document A concerns tumor genetics (glioblastoma), making it more related to cancer prognosis than Document B, which focuses on neuroprotection in cell models.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202838Z"}
{"comparison_id":"48fe204b-dbc4-470f-bb64-dd4e26889b40","query_id":"53","doc_a_id":"33076846","doc_b_id":"4795303","presented_order":["4795303","33076846"],"winner_id":"33076846","reasoning":"Document B — it discusses factors linked to cancer biology (whereas A is an unrelated neuroprotection study). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202845Z"}
{"comparison_id":"84ef4ba3-b91c-499d-8123-639749bc2a1d","query_id":"53","doc_a_id":"8724666","doc_b_id":"4795303","presented_order":["8724666","4795303"],"winner_id":"8724666","reasoning":"Neither document mentions ALDH1 or breast cancer, but Document A is slightly more relevant because it addresses cancer and stem-cell biology (leukemia/hematopoiesis), whereas B is about neuronal oxidative stress. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202851Z"}
{"comparison_id":"14e18799-d42e-4252-9d9b-87acb921fbc7","query_id":"53","doc_a_id":"10542877","doc_b_id":"4795303","presented_order":["4795303","10542877"],"winner_id":"10542877","reasoning":"Document B is more relevant — it deals with cancer biology and clinical outcomes, whereas Document A is a neuroprotection study unrelated to cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202858Z"}
{"comparison_id":"95458daa-5be1-42bc-a763-4fcaa531a2a6","query_id":"53","doc_a_id":"30543439","doc_b_id":"4795303","presented_order":["4795303","30543439"],"winner_id":"30543439","reasoning":"Document B — it discusses enzymes in cancer cells (though not ALDH1 or breast cancer), while Document A is about neuronal PC12 cells and Nrf2, so B is marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202865Z"}
{"comparison_id":"0e8c00b1-a753-4d80-b071-183030ce844e","query_id":"53","doc_a_id":"28644298","doc_b_id":"4795303","presented_order":["28644298","4795303"],"winner_id":"28644298","reasoning":"Document A is slightly more related because it addresses cancer cell survival and transcriptional regulation, whereas Document B focuses on neuroprotection in PC12 cells; neither mentions ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202872Z"}
{"comparison_id":"c6caea65-4fbe-4fd8-949a-81a18276fd1f","query_id":"53","doc_a_id":"19800147","doc_b_id":"4795303","presented_order":["19800147","4795303"],"winner_id":"19800147","reasoning":"Document A is cancer-related (tumor progression) and thus more relevant to a prognosis claim in breast cancer than a neuroprotection study. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202878Z"}
{"comparison_id":"79fd6f74-d8ce-47d9-a52f-0c302f0fa159","query_id":"53","doc_a_id":"4464565","doc_b_id":"4795303","presented_order":["4795303","4464565"],"winner_id":"4464565","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it addresses changes in gene expression (whereas A focuses on neuroprotection in PC12 cells).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202884Z"}
{"comparison_id":"8f500de9-79b8-4bae-bba0-f48d5de1c355","query_id":"53","doc_a_id":"20888849","doc_b_id":"4795303","presented_order":["4795303","20888849"],"winner_id":"20888849","reasoning":"Document B — it concerns cancer biology (tumor therapy and microenvironment), whereas A is a neuroprotection study unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202891Z"}
{"comparison_id":"7074841b-04d8-4326-9c8a-29367d528030","query_id":"53","doc_a_id":"23326722","doc_b_id":"4795303","presented_order":["23326722","4795303"],"winner_id":"23326722","reasoning":"Document A — it discusses clinical features and prognosis of a cancer (though not breast cancer or ALDH1), so it's marginally more relevant than a neuroprotection study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202898Z"}
{"comparison_id":"e9ebf244-103c-4bbc-a17f-74214a36dec4","query_id":"53","doc_a_id":"22890091","doc_b_id":"4795303","presented_order":["22890091","4795303"],"winner_id":"22890091","reasoning":"Document A is slightly more relevant because it discusses expression of cell-death–related markers (bcl-2/Fas) and prognosis-related biology, whereas Document B focuses on neuroprotection in PC12 cells and Nrf2 activation. Neither document mentions ALDH1, breast cancer, or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202906Z"}
{"comparison_id":"461d75d4-21db-4c41-ac49-5a605ff1d17b","query_id":"53","doc_a_id":"2205779","doc_b_id":"4795303","presented_order":["4795303","2205779"],"winner_id":"2205779","reasoning":"Document B — it concerns cancer biomarkers (though for gastric cancer), whereas A is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202912Z"}
{"comparison_id":"0aaca34c-f800-401d-9715-31dbd68cf338","query_id":"53","doc_a_id":"16627684","doc_b_id":"4795303","presented_order":["4795303","16627684"],"winner_id":"16627684","reasoning":"Document B — it discusses factors (Hmga2, tumor suppressors p16/p19) related to cell self-renewal and tumor biology, which is closer to prognosis/cancer context than Document A. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202919Z"}
{"comparison_id":"650b8235-5aa3-4258-a446-ea9bd0aa61ff","query_id":"53","doc_a_id":"19343151","doc_b_id":"4795303","presented_order":["4795303","19343151"],"winner_id":"19343151","reasoning":"Document B is more relevant — it deals with gene/protein expression as a biomarker in human tissue, which is closer to the claim about ALDH1 expression and prognosis than a neuronal cell study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202928Z"}
{"comparison_id":"6b5460bb-0f90-4b70-b2d9-9aebbcba16f5","query_id":"53","doc_a_id":"10450725","doc_b_id":"4795303","presented_order":["10450725","4795303"],"winner_id":"10450725","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more related because it concerns cancer (hepatocellular carcinoma) versus B which is neuroprotection.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202936Z"}
{"comparison_id":"f7323153-6062-4dd1-ad64-0bc9c0bd6e38","query_id":"53","doc_a_id":"3701541","doc_b_id":"4795303","presented_order":["4795303","3701541"],"winner_id":"3701541","reasoning":"Document B is more relevant — it addresses cancer-related pathways (though in liver cancer, not breast, and doesn't mention ALDH1), whereas A is about neuroprotection in PC12 cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202943Z"}
{"comparison_id":"347d9e19-1260-4df9-bbb3-4df4323ec03c","query_id":"53","doc_a_id":"26059876","doc_b_id":"4795303","presented_order":["26059876","4795303"],"winner_id":"26059876","reasoning":"A is more relevant — it addresses cancer-related tumorigenesis mechanisms (though in colorectal cancer), while B is a neuroprotection study unrelated to cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202950Z"}
{"comparison_id":"23808e71-4746-4e14-8566-adba4a6d57b6","query_id":"53","doc_a_id":"39225849","doc_b_id":"4795303","presented_order":["4795303","39225849"],"winner_id":"39225849","reasoning":"Document B is more relevant — it concerns cancer-related genomic instability and checkpoint activation, whereas A is about neuroprotection in PC12 cells and unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202956Z"}
{"comparison_id":"25390870-b4b6-4581-b2aa-59563cea89e2","query_id":"53","doc_a_id":"32776084","doc_b_id":"4795303","presented_order":["32776084","4795303"],"winner_id":"32776084","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it addresses gene expression changes in mammalian stem cells, whereas B is a neuronal antioxidant study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202963Z"}
{"comparison_id":"64bf3c93-6a9c-416c-8332-0d530ea362cf","query_id":"53","doc_a_id":"15491308","doc_b_id":"4795303","presented_order":["4795303","15491308"],"winner_id":"15491308","reasoning":"Document B — it concerns stem cell biology (SIRT1 in mesenchymal stem cells), which is more related to ALDH1's role as a stem/cancer‑stem marker and prognosis than the neuroprotective PC12 study in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202969Z"}
{"comparison_id":"8c23a119-4705-44e4-ab57-7b6eb5bda081","query_id":"53","doc_a_id":"18938992","doc_b_id":"4795303","presented_order":["4795303","18938992"],"winner_id":"18938992","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant; B is marginally more related to cancer biology (immune evasion in B cells) whereas A concerns neuroprotection in PC12 cells. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202976Z"}
{"comparison_id":"853b25bb-4f89-4c71-bf56-175716cb4ffd","query_id":"53","doc_a_id":"3863543","doc_b_id":"4795303","presented_order":["3863543","4795303"],"winner_id":"3863543","reasoning":"Document A is more relevant because it addresses cancer progression and disease prognosis (though in hematopoietic/pre-leukemia context), whereas Document B focuses on neuroprotection in PC12 cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202983Z"}
{"comparison_id":"55d79c93-4287-435d-be12-2c338954e372","query_id":"53","doc_a_id":"8417211","doc_b_id":"4795303","presented_order":["8417211","4795303"],"winner_id":"8417211","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; Document A is slightly more relevant because it discusses gene/protein expression and regulation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.202989Z"}
{"comparison_id":"65675419-0744-4d0e-b610-c364475bd553","query_id":"53","doc_a_id":"25022826","doc_b_id":"4795303","presented_order":["4795303","25022826"],"winner_id":"25022826","reasoning":"Document B is more relevant — it concerns stem cell biology and differentiation, which is closer to ALDH1 (a stemness marker) and cancer prognosis than a neuroprotection study in PC12 cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.203003Z"}
{"comparison_id":"9ccdde99-90c8-426d-9238-d44a628afb27","query_id":"53","doc_a_id":"12580014","doc_b_id":"4795303","presented_order":["12580014","4795303"],"winner_id":"12580014","reasoning":"Document A is marginally more relevant because it concerns tumor biology (skin tumors), whereas Document B is unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.203010Z"}
{"comparison_id":"6d9d8f5e-ab5c-4df9-ab2b-fef67de32fd5","query_id":"53","doc_a_id":"5765455","doc_b_id":"4795303","presented_order":["5765455","4795303"],"winner_id":"5765455","reasoning":"Document A — it discusses cancer progression and genomic instability (more related to cancer prognosis) while Document B is about neuroprotection in PC12 cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.203016Z"}
{"comparison_id":"57ad5b24-5b1d-4475-b489-d90399808f18","query_id":"53","doc_a_id":"28390999","doc_b_id":"4795303","presented_order":["28390999","4795303"],"winner_id":"28390999","reasoning":"Neither document discusses ALDH1 or breast cancer, but Document A at least concerns gene expression studies (albeit in chicken gonads), so it's slightly more related to the query's topic of gene expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.203023Z"}
{"comparison_id":"61df09bf-e3ab-4bb3-8c7b-cbc5e605756f","query_id":"53","doc_a_id":"2356950","doc_b_id":"4795303","presented_order":["4795303","2356950"],"winner_id":"2356950","reasoning":"Document B — it deals with stem-cell regulatory mechanisms (more conceptually related to ALDH1 as a stem-cell marker), whereas A is about neuroprotective glycosides and unrelated to cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:02.203030Z"}
{"comparison_id":"5b28782c-1bdf-421f-81ce-7ae1be1c534e","query_id":"53","doc_a_id":"8512633","doc_b_id":"35993767","presented_order":["8512633","35993767"],"winner_id":"8512633","reasoning":"Document A is slightly more relevant because it discusses cancer prognostic associations (though in prostate cancer), whereas Document B focuses on fibroblast-driven metastasis in liver cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.178851Z"}
{"comparison_id":"a0c01a40-705b-4cce-a332-1517352dd8f0","query_id":"53","doc_a_id":"34189936","doc_b_id":"35993767","presented_order":["34189936","35993767"],"winner_id":"34189936","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses gene expression and prognosis in a cancer context, whereas B focuses on CAF-mediated metastasis in liver cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.178872Z"}
{"comparison_id":"4db74a96-4219-46c9-b9cb-4a318a806fd3","query_id":"53","doc_a_id":"11615422","doc_b_id":"35993767","presented_order":["11615422","35993767"],"winner_id":"35993767","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it addresses tumor microenvironment–driven metastasis and prognostic mechanisms, whereas A focuses on PAX5 rearrangements in leukemia.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.178883Z"}
{"comparison_id":"e369ac27-5e00-4d9c-bd1f-51cba0aa17aa","query_id":"53","doc_a_id":"23665162","doc_b_id":"35993767","presented_order":["23665162","35993767"],"winner_id":"35993767","reasoning":"Document B is more relevant — although neither addresses ALDH1 or breast cancer, B discusses mechanisms of tumor metastasis and signaling pathways linked to aggressive behavior, which is closer to prognosis than A's HCC risk biomarker study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.178892Z"}
{"comparison_id":"14d05724-253c-483f-94fa-4e76c6b3c826","query_id":"53","doc_a_id":"8677721","doc_b_id":"35993767","presented_order":["35993767","8677721"],"winner_id":"35993767","reasoning":"Document A is slightly more relevant because it discusses factors promoting cancer metastasis and prognosis-related pathways, whereas Document B focuses narrowly on NDRG1/β-catenin in HCC. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.178900Z"}
{"comparison_id":"2fe43451-00de-49e0-83f7-9a2864f1c9f4","query_id":"53","doc_a_id":"10169908","doc_b_id":"35993767","presented_order":["10169908","35993767"],"winner_id":"10169908","reasoning":"Document A is slightly more relevant because it discusses a cancer-related protein's expression and its link to tumor growth/survival, whereas Document B focuses on fibroblast-driven metastasis in hepatocellular carcinoma, unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.178907Z"}
{"comparison_id":"e69bf5de-e02a-40db-9c09-fd31adaf3789","query_id":"53","doc_a_id":"14471161","doc_b_id":"35993767","presented_order":["35993767","14471161"],"winner_id":"35993767","reasoning":"Document A is slightly more relevant because it addresses cancer metastasis and prognostic pathways (though in HCC, not breast cancer), whereas Document B focuses on meal timing in pancreatic cancer and circadian effects. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.178914Z"}
{"comparison_id":"5124ad7c-0278-4dd2-8d3d-7189d40dc688","query_id":"53","doc_a_id":"23577867","doc_b_id":"35993767","presented_order":["35993767","23577867"],"winner_id":"35993767","reasoning":"Document A — it discusses cancer metastasis mechanisms (though in hepatocellular carcinoma), which is more related to cancer progression than Document B's focus on metabolic markers and endometrial cancer risk. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.178921Z"}
{"comparison_id":"115cd214-1d3b-4590-8173-082141ffa85e","query_id":"53","doc_a_id":"2272614","doc_b_id":"35993767","presented_order":["35993767","2272614"],"winner_id":"35993767","reasoning":"Document A is marginally more related because it deals with cancer progression and metastasis (though in HCC), whereas Document B focuses on lung cancer drug resistance. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.178928Z"}
{"comparison_id":"cfaef24e-69b1-4b5f-9228-4e55855241ae","query_id":"53","doc_a_id":"24349430","doc_b_id":"35993767","presented_order":["35993767","24349430"],"winner_id":"35993767","reasoning":"Document A is more relevant — it addresses tumor metastasis and pathways affecting cancer progression, which is closer to prognosis-related evidence than a lung cell proliferation study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.178935Z"}
{"comparison_id":"343aa0cb-01e2-4dfa-92b8-63b6f292e32f","query_id":"53","doc_a_id":"1507222","doc_b_id":"35993767","presented_order":["1507222","35993767"],"winner_id":"35993767","reasoning":"Document B is more relevant — it addresses cancer progression/metastasis (which relates to prognosis), while A focuses on uncoupling proteins in cachexia unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.178942Z"}
{"comparison_id":"ebf11614-3f5c-4216-9686-fed1ac996c83","query_id":"53","doc_a_id":"31313782","doc_b_id":"35993767","presented_order":["31313782","35993767"],"winner_id":"31313782","reasoning":"Document A is slightly more relevant because it addresses expression profiles of molecular markers in cancer (though not ALDH1 or breast cancer), whereas Document B focuses on CAF-driven metastasis in liver cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.178950Z"}
{"comparison_id":"5832ac90-f9a2-401d-b5d4-d4390e5ec7e5","query_id":"53","doc_a_id":"14180565","doc_b_id":"35993767","presented_order":["35993767","14180565"],"winner_id":"35993767","reasoning":"Document A is more relevant — it discusses cancer metastasis and pathways linked to poor prognosis, whereas Document B focuses on Aloe emodin effects in glioblastoma cells, not breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.178957Z"}
{"comparison_id":"efa81495-925c-483c-88f6-e4c206a80374","query_id":"53","doc_a_id":"641786","doc_b_id":"35993767","presented_order":["35993767","641786"],"winner_id":"35993767","reasoning":"Document A is more related to cancer biology and tumor progression mechanisms, whereas Document B concerns leukemia-specific mutations unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.178965Z"}
{"comparison_id":"00ae6c2c-517d-434a-818e-3defabd74c4b","query_id":"53","doc_a_id":"32852283","doc_b_id":"35993767","presented_order":["32852283","35993767"],"winner_id":"35993767","reasoning":"Neither document mentions ALDH1 or breast cancer; however Document B is slightly more relevant because it discusses tumor-promoting signaling and metastasis (TGF-β/hedgehog) which relate to prognosis, while A focuses on a drug effect in NSCLC. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.178973Z"}
{"comparison_id":"9dc6d78f-3cd7-4e6b-bb0b-bacedc8cf8f9","query_id":"53","doc_a_id":"20738970","doc_b_id":"35993767","presented_order":["20738970","35993767"],"winner_id":"20738970","reasoning":"Document A is slightly more relevant — it discusses expression of a cancer-associated protein and its clinical implications (though in SCLC, not breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.178981Z"}
{"comparison_id":"57d7e6b6-c08c-4561-94ad-2e1eafabf15b","query_id":"53","doc_a_id":"23509593","doc_b_id":"35993767","presented_order":["35993767","23509593"],"winner_id":"35993767","reasoning":"Document A is slightly more relevant because it deals with cancer biology and metastasis mechanisms, whereas Document B pertains to androgen regulation in prostate stromal cells (unrelated to breast cancer or ALDH1). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.178989Z"}
{"comparison_id":"eb300346-c1fd-45a2-bac8-cfcfcef6843d","query_id":"53","doc_a_id":"3710557","doc_b_id":"35993767","presented_order":["3710557","35993767"],"winner_id":"3710557","reasoning":"Neither document mentions ALDH1 or breast cancer, so neither provides relevant evidence. More generally related to cancer signaling is Document A.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.178996Z"}
{"comparison_id":"41b8b487-70a0-43a6-a2aa-6d27a9a67755","query_id":"53","doc_a_id":"3355397","doc_b_id":"35993767","presented_order":["3355397","35993767"],"winner_id":"3355397","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. Document A is marginally more related because it deals with cancer risk across multiple common cancers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179003Z"}
{"comparison_id":"ca8ff236-d075-45dd-b0d6-424c72714442","query_id":"53","doc_a_id":"25628793","doc_b_id":"35993767","presented_order":["35993767","25628793"],"winner_id":"35993767","reasoning":"Document A is slightly more relevant because it addresses cancer-related prognostic mechanisms (metastasis pathways), whereas Document B concerns enzyme expression in endometriosis, unrelated to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179010Z"}
{"comparison_id":"12b52ae2-085f-46bc-99ce-475c8115a15b","query_id":"53","doc_a_id":"2360905","doc_b_id":"35993767","presented_order":["2360905","35993767"],"winner_id":"35993767","reasoning":"Document B — it concerns cancer progression and tumor microenvironment, which is more related to prognosis-related markers than a study on pediatric gliomas. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179017Z"}
{"comparison_id":"0fc74a42-2386-4903-b9eb-e9ab01835702","query_id":"53","doc_a_id":"14663842","doc_b_id":"35993767","presented_order":["14663842","35993767"],"winner_id":"14663842","reasoning":"Document A is slightly more relevant because it discusses a cancer-related metabolic enzyme (IDH1) and tumor metabolic vulnerability, which is closer to ALDH1 (an enzyme linked to cancer prognosis) than Document B's focus on CAF-driven HCC metastasis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179024Z"}
{"comparison_id":"1ab6e052-88bc-41e1-b3ce-6c1bd77abedb","query_id":"53","doc_a_id":"4841908","doc_b_id":"35993767","presented_order":["4841908","35993767"],"winner_id":"35993767","reasoning":"Document B is more relevant because it concerns cancer biology and metastasis, whereas A focuses on metabolomic markers of longevity and explicitly not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179031Z"}
{"comparison_id":"55150f74-77b0-480e-ada8-8fba34c5e496","query_id":"53","doc_a_id":"14938990","doc_b_id":"35993767","presented_order":["14938990","35993767"],"winner_id":"35993767","reasoning":"Document B — it's about cancer (tumor progression/metastasis), whereas A concerns PD-1 in lupus and is unrelated to cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179038Z"}
{"comparison_id":"39516f2a-af98-494d-b9ba-3f7a57817317","query_id":"53","doc_a_id":"19368793","doc_b_id":"35993767","presented_order":["35993767","19368793"],"winner_id":"35993767","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses tumor progression/metastasis (which relates to prognosis), while B focuses on HCC diagnostic miRNAs.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179044Z"}
{"comparison_id":"468c8d22-ea64-44e0-bd28-048189bc3912","query_id":"53","doc_a_id":"4959368","doc_b_id":"35993767","presented_order":["35993767","4959368"],"winner_id":"35993767","reasoning":"Document A is slightly more relevant because it discusses cancer progression and metastasis mechanisms, whereas Document B focuses on metabolic changes in pancreatic cancer unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179052Z"}
{"comparison_id":"0f593c5b-3096-4b8b-b4a0-32d9c36bb0a4","query_id":"53","doc_a_id":"85665741","doc_b_id":"35993767","presented_order":["35993767","85665741"],"winner_id":"35993767","reasoning":"Document A is slightly more related (both concern cancer biology and metastasis), though neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179058Z"}
{"comparison_id":"ff0b2ccc-1318-4c4e-8674-025bd72e81bc","query_id":"53","doc_a_id":"6363093","doc_b_id":"35993767","presented_order":["6363093","35993767"],"winner_id":"35993767","reasoning":"Document B is slightly more relevant — it discusses cancer metastasis mechanisms (linked to prognosis), whereas A is focused on glioblastoma subclasses; neither mentions ALDH1 or breast cancer specifically.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179065Z"}
{"comparison_id":"1c238b6d-9d64-49cb-8c5c-607a488d26bf","query_id":"53","doc_a_id":"4387494","doc_b_id":"35993767","presented_order":["4387494","35993767"],"winner_id":"35993767","reasoning":"Document B is slightly more relevant because it deals with cancer metastasis and tumor microenvironment (which can relate to prognosis), whereas A is specific to AML therapeutics and unrelated. Neither mentions ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179072Z"}
{"comparison_id":"13278cc7-5a27-4539-869f-aae87dd673bf","query_id":"53","doc_a_id":"11900630","doc_b_id":"35993767","presented_order":["11900630","35993767"],"winner_id":"11900630","reasoning":"Document A — it discusses stem-cell-associated chemoresistance (more related to ALDH1 as a stem cell marker), while Document B focuses on CAF-driven hepatocellular carcinoma and is unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179079Z"}
{"comparison_id":"cb0d37dc-9794-46d7-887f-da430e1edf73","query_id":"53","doc_a_id":"13905670","doc_b_id":"35993767","presented_order":["35993767","13905670"],"winner_id":"35993767","reasoning":"Document A is more relevant — it addresses cancer progression/metastasis (though in HCC), whereas Document B concerns a FOXO3 SNP linked to inflammatory/infectious disease outcomes, not cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179086Z"}
{"comparison_id":"0b431bfc-58dd-4287-b465-3882a059e8b3","query_id":"53","doc_a_id":"663464","doc_b_id":"35993767","presented_order":["663464","35993767"],"winner_id":"35993767","reasoning":"Document B is more relevant because it addresses cancer biology and metastasis mechanisms, whereas Document A concerns age-related microRNA expression unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179093Z"}
{"comparison_id":"ad04aea7-84f4-43c0-a341-e2f68fb09e6e","query_id":"53","doc_a_id":"16016673","doc_b_id":"35993767","presented_order":["35993767","16016673"],"winner_id":"35993767","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. Document A is slightly more related to cancer progression mechanisms (metastasis), so it's marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179100Z"}
{"comparison_id":"c8aef669-13fd-4e0f-b0b6-a7724c7a2fa6","query_id":"53","doc_a_id":"1976183","doc_b_id":"35993767","presented_order":["35993767","1976183"],"winner_id":"35993767","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses metastasis and signaling pathways (hedgehog/TGF-β) linked to cancer stemness biology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179107Z"}
{"comparison_id":"dc88dc35-ea74-4db0-bfb7-98d958cf9b9d","query_id":"53","doc_a_id":"17876040","doc_b_id":"35993767","presented_order":["35993767","17876040"],"winner_id":"35993767","reasoning":"Document A is more relevant — it discusses cancer metastasis mechanisms (though in HCC), which is closer to biomarkers and prognosis than a drug development paper on AML.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179114Z"}
{"comparison_id":"9f683d8e-690a-4ccb-b7e4-9b817d22a095","query_id":"53","doc_a_id":"38355793","doc_b_id":"35993767","presented_order":["35993767","38355793"],"winner_id":"38355793","reasoning":"Document B — it addresses protein overexpression and tumor outcome/therapeutic implications, which is closer to a claim about a prognostic marker than Document A's CAF/HCC metastasis focus. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179121Z"}
{"comparison_id":"1353882f-3ed2-4961-853d-2e1f04e60967","query_id":"53","doc_a_id":"7020505","doc_b_id":"35993767","presented_order":["35993767","7020505"],"winner_id":"35993767","reasoning":"Document A is at least about tumor biology and metastasis (though in HCC), while Document B concerns CLL genetics and is unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179128Z"}
{"comparison_id":"0269ee6f-4598-4cbd-b7f2-8b3020d2eb3d","query_id":"53","doc_a_id":"12903921","doc_b_id":"35993767","presented_order":["35993767","12903921"],"winner_id":"35993767","reasoning":"Document A is more relevant — it concerns cancer biology and metastasis pathways (closer to breast cancer prognosis context) while B is about leukemia in rats and oxidative stress, unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179134Z"}
{"comparison_id":"cc6dc6aa-6851-4ddb-abd8-c18c03612fb8","query_id":"53","doc_a_id":"57783564","doc_b_id":"35993767","presented_order":["57783564","35993767"],"winner_id":"35993767","reasoning":"Both documents are irrelevant — neither mentions ALDH1 or breast cancer. If one must be chosen, B is marginally more related because it addresses cancer metastasis, which impacts prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179141Z"}
{"comparison_id":"c0a93bab-adf2-40f7-b833-58cc990d66a4","query_id":"53","doc_a_id":"16853734","doc_b_id":"35993767","presented_order":["35993767","16853734"],"winner_id":"35993767","reasoning":"Both documents do not address ALDH1 or breast cancer. Document A is marginally more relevant because it discusses tumor metastasis mechanisms, whereas B focuses on MSC migration toward glioma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179148Z"}
{"comparison_id":"2a07ca93-a60d-43b1-a65f-45b0fa616d51","query_id":"53","doc_a_id":"41293601","doc_b_id":"35993767","presented_order":["41293601","35993767"],"winner_id":"41293601","reasoning":"Document A is slightly more relevant — it discusses tumor-associated dehydrogenase (IDH1) mutations and cancer prognosis/biology, whereas Document B is limited to CAF-driven pathways in hepatocellular carcinoma and does not relate to ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179156Z"}
{"comparison_id":"a1205d43-22f2-43fd-a54b-8bb0bab2421b","query_id":"53","doc_a_id":"14848619","doc_b_id":"35993767","presented_order":["35993767","14848619"],"winner_id":"35993767","reasoning":"Document A is more relevant — it deals with cancer metastasis mechanisms (though in HCC), which is closer to ALDH1's prognostic role in cancer than the hypoxia/Noxa focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179163Z"}
{"comparison_id":"6be1215b-13da-4dcb-aa79-6c7aafb967e8","query_id":"53","doc_a_id":"24624992","doc_b_id":"35993767","presented_order":["24624992","35993767"],"winner_id":"35993767","reasoning":"Document B is marginally more relevant because it addresses cancer progression/metastasis mechanisms, whereas Document A is limited to retinoic acid responses in leukemia cell lines; however, neither mentions ALDH1 or breast cancer.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179169Z"}
{"comparison_id":"97ab8776-4b3d-43ab-be7d-16ded53d8f95","query_id":"53","doc_a_id":"17671145","doc_b_id":"35993767","presented_order":["35993767","17671145"],"winner_id":"35993767","reasoning":"Neither document addresses ALDH1 or breast cancer; Document A is slightly more relevant only because it discusses cancer metastasis mechanisms (though in hepatocellular carcinoma), while B is prostate-specific.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179176Z"}
{"comparison_id":"32718b11-5c0a-4906-9e68-8feabececd42","query_id":"53","doc_a_id":"5956380","doc_b_id":"35993767","presented_order":["35993767","5956380"],"winner_id":"35993767","reasoning":"Document A is slightly more relevant because it discusses mechanisms of cancer progression/metastasis (though in HCC), whereas Document B focuses on brainstem glioma genetics and is unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179183Z"}
{"comparison_id":"72b2499b-ef88-4e65-b69a-44e7ea8e01f0","query_id":"53","doc_a_id":"10699587","doc_b_id":"35993767","presented_order":["35993767","10699587"],"winner_id":"35993767","reasoning":"Document A is slightly more relevant because it discusses cancer biology and metastasis mechanisms, whereas Document B focuses on prostate cancer prognostic groups unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179190Z"}
{"comparison_id":"6ca93995-43e0-459b-8503-b9b21a2fe1fb","query_id":"53","doc_a_id":"6171953","doc_b_id":"35993767","presented_order":["35993767","6171953"],"winner_id":"35993767","reasoning":"Document A — it discusses cancer-related pathways and metastasis (though in HCC), which is closer to the claim about ALDH1 and cancer prognosis than Document B on SirT1 and inflammation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179196Z"}
{"comparison_id":"b10df7f7-c856-4d4b-b5ca-2cee54573c62","query_id":"53","doc_a_id":"8764879","doc_b_id":"35993767","presented_order":["35993767","8764879"],"winner_id":"35993767","reasoning":"Document A is slightly more relevant because it discusses cancer progression and pathways related to metastasis (though in HCC, not breast cancer); Document B is focused on leukemia and CSF1R, which is less related to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179203Z"}
{"comparison_id":"72857b70-8efc-4b60-9400-4cef13868a8a","query_id":"53","doc_a_id":"1982286","doc_b_id":"35993767","presented_order":["1982286","35993767"],"winner_id":"35993767","reasoning":"Document B is slightly more relevant — it addresses cancer progression/metastasis mechanisms (potentially related to prognosis), while A is specific to T-ALL and RUNX1 and unrelated to breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179210Z"}
{"comparison_id":"5023aab4-4c03-4835-b3db-211f47ab07db","query_id":"53","doc_a_id":"67787658","doc_b_id":"35993767","presented_order":["67787658","35993767"],"winner_id":"35993767","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more related to cancer progression/metastasis (which pertains to prognosis), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179216Z"}
{"comparison_id":"37352355-7e6c-4857-8b00-3930197e678e","query_id":"53","doc_a_id":"2356950","doc_b_id":"35993767","presented_order":["2356950","35993767"],"winner_id":"35993767","reasoning":"Document B is more relevant — it concerns cancer biology (metastasis mechanisms), whereas A is about neural stem cells and miR-184, unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179224Z"}
{"comparison_id":"6e296485-e8f1-4f23-8107-8fe34d494bfe","query_id":"53","doc_a_id":"40901687","doc_b_id":"35993767","presented_order":["35993767","40901687"],"winner_id":"35993767","reasoning":"Document A is more relevant — it discusses cancer metastasis and tumor-promoting processes (closer to prognosis/clinical outcomes) while Document B focuses on a DNA damage signaling mechanism unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179231Z"}
{"comparison_id":"5d826e0f-b78d-4e45-aa70-4185deb194ef","query_id":"53","doc_a_id":"6766459","doc_b_id":"35993767","presented_order":["35993767","6766459"],"winner_id":"35993767","reasoning":"Document A is more relevant — it addresses cancer biology and metastasis pathways (closer to breast cancer prognosis) while B concerns fever/immune regulation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179238Z"}
{"comparison_id":"341e6191-0bd8-4a2b-811b-a9d12dc4e00e","query_id":"53","doc_a_id":"26887439","doc_b_id":"35993767","presented_order":["35993767","26887439"],"winner_id":"35993767","reasoning":"Document A is slightly more relevant—it discusses cancer metastasis mechanisms (which relate to prognosis), whereas Document B focuses on survivin in K-Ras-transformed cells and neither mentions ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179245Z"}
{"comparison_id":"f9a46140-1313-4095-9196-b5178ddd18e1","query_id":"53","doc_a_id":"5783785","doc_b_id":"35993767","presented_order":["5783785","35993767"],"winner_id":"5783785","reasoning":"Document A is slightly more relevant — it discusses cancer biomarker regulation and prognosis-related tumor behavior (though in gastric cancer, not breast, and does not mention ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179252Z"}
{"comparison_id":"6c337795-bc08-43ea-879d-b68d2fcaec22","query_id":"53","doc_a_id":"9226649","doc_b_id":"35993767","presented_order":["9226649","35993767"],"winner_id":"35993767","reasoning":"Document B — it discusses cancer progression and metastasis mechanisms (closer in topic to prognosis-related markers) whereas A is specific to colon inflammasome biology and unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179259Z"}
{"comparison_id":"bff25dc3-66d6-431c-89ec-f9aff4c15a92","query_id":"53","doc_a_id":"15215393","doc_b_id":"35993767","presented_order":["35993767","15215393"],"winner_id":"35993767","reasoning":"Document A — it discusses cancer metastasis and prognosis-related pathways (though in HCC, not breast cancer), so it's slightly closer in topic to ALDH1's prognostic role than a glioblastoma therapy paper.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179266Z"}
{"comparison_id":"42c7cca3-09a3-4eb2-96bb-f40c29e6d31f","query_id":"53","doc_a_id":"17911973","doc_b_id":"35993767","presented_order":["35993767","17911973"],"winner_id":"35993767","reasoning":"Document A is slightly more relevant because it discusses cancer biology and metastasis (though in HCC, not breast cancer), whereas Document B focuses on retrotransposons and genomic mutagenesis unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179273Z"}
{"comparison_id":"66069412-ace8-4221-9a51-21c53db3026f","query_id":"53","doc_a_id":"28334217","doc_b_id":"35993767","presented_order":["35993767","28334217"],"winner_id":"35993767","reasoning":"Document A is more related — it discusses cancer metastasis and prognosis-relevant pathways (though in HCC, not breast cancer), whereas B focuses on glutaminase inhibition in HCC/lymphoma and is less relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179280Z"}
{"comparison_id":"d524aff0-3f40-410d-b95f-e775b57bca9e","query_id":"53","doc_a_id":"7869794","doc_b_id":"35993767","presented_order":["7869794","35993767"],"winner_id":"35993767","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it discusses cancer progression/metastasis (related to prognosis), whereas A focuses on neutrophil Ca2+ signaling during ADCC. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179286Z"}
{"comparison_id":"f22c6d24-8b95-4861-9da2-a0a951bee1bd","query_id":"53","doc_a_id":"22703082","doc_b_id":"35993767","presented_order":["22703082","35993767"],"winner_id":"35993767","reasoning":"Document B is slightly more relevant because it discusses cancer progression and factors affecting metastasis/prognosis, whereas Document A is specific to H. pylori-induced gastric mutations and unrelated to breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179293Z"}
{"comparison_id":"4104f021-7efd-4e28-b105-4d2e31643627","query_id":"53","doc_a_id":"3831884","doc_b_id":"35993767","presented_order":["3831884","35993767"],"winner_id":"35993767","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant, but B is marginally more related because it addresses cancer metastasis (a component of prognosis), whereas A focuses on pancreatic metabolic pathways. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179300Z"}
{"comparison_id":"85f3183c-55bb-42d2-9dee-c46efed236c7","query_id":"53","doc_a_id":"4325398","doc_b_id":"35993767","presented_order":["4325398","35993767"],"winner_id":"4325398","reasoning":"Neither document discusses ALDH1 or breast cancer; neither provides evidence for the claim. Both are irrelevant — if one must be chosen, pick A (both still unrelated). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179307Z"}
{"comparison_id":"ef9dab91-c680-40d9-9d00-42aab2a96d28","query_id":"53","doc_a_id":"3504761","doc_b_id":"35993767","presented_order":["3504761","35993767"],"winner_id":"35993767","reasoning":"Neither document addresses ALDH1 or breast cancer; both are about liver cancer. Document B is slightly more related to cancer progression/metastasis (which affects prognosis), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179314Z"}
{"comparison_id":"152e7dfc-55fb-410d-9799-d5584cbfb159","query_id":"53","doc_a_id":"10365787","doc_b_id":"35993767","presented_order":["35993767","10365787"],"winner_id":"35993767","reasoning":"Document A — it's about cancer metastasis pathways (more related to tumor progression and prognosis) while Document B focuses on cell-cycle regulator Cdh1; neither mentions ALDH1 or breast cancer specifically. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179321Z"}
{"comparison_id":"12aaf7dd-c25a-4927-9ebd-bdd5b736681a","query_id":"53","doc_a_id":"24783597","doc_b_id":"35993767","presented_order":["35993767","24783597"],"winner_id":"35993767","reasoning":"Document A — it deals with cancer biology and metastasis (though in HCC, not breast cancer); Document B is about IBD and is unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179328Z"}
{"comparison_id":"a1dad0b3-b7f8-4a7b-894f-60290fca1894","query_id":"53","doc_a_id":"1522336","doc_b_id":"35993767","presented_order":["35993767","1522336"],"winner_id":"35993767","reasoning":"Both documents are unrelated to ALDH1 or breast cancer, but Document A (cancer metastasis mechanisms) is marginally more relevant than B (statin effects in head and neck cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179334Z"}
{"comparison_id":"900a7b65-5b53-4b64-bf88-3c9008ef52ba","query_id":"53","doc_a_id":"24190159","doc_b_id":"35993767","presented_order":["24190159","35993767"],"winner_id":"24190159","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it discusses gene expression changes in carcinoma (whereas B focuses on CAF-driven pathways in hepatocellular carcinoma).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179341Z"}
{"comparison_id":"43acb0cc-a8db-46f5-9c19-bbfacc57ab93","query_id":"53","doc_a_id":"25036988","doc_b_id":"35993767","presented_order":["35993767","25036988"],"winner_id":"35993767","reasoning":"Document A is slightly more relevant because it deals with cancer progression and metastasis mechanisms, which are closer to prognosis-related topics than Document B's cell-cycle/structural findings in colon cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179348Z"}
{"comparison_id":"0b64166b-ae0d-4ca8-a08c-0fa490c6284b","query_id":"53","doc_a_id":"18682109","doc_b_id":"35993767","presented_order":["35993767","18682109"],"winner_id":"35993767","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it concerns cancer metastasis pathways (vs. lung cancer histologic transformation).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179355Z"}
{"comparison_id":"c581b347-2fe7-460f-9ea1-5e2dca9cf9a2","query_id":"53","doc_a_id":"2466614","doc_b_id":"35993767","presented_order":["35993767","2466614"],"winner_id":"35993767","reasoning":"Doc A is about cancer biology and metastasis (though in HCC), while Document B concerns aging in mice; A is marginally more relevant to a claim about cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179361Z"}
{"comparison_id":"702ab827-5a11-449e-8f84-8823e2b6dfa1","query_id":"53","doc_a_id":"19427410","doc_b_id":"35993767","presented_order":["19427410","35993767"],"winner_id":"35993767","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more related because it concerns cancer metastasis pathways, whereas A is about IL-33 in adipocytes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179368Z"}
{"comparison_id":"6a672b0d-2caf-4c98-9a41-a631a34ab514","query_id":"53","doc_a_id":"15322518","doc_b_id":"35993767","presented_order":["15322518","35993767"],"winner_id":"35993767","reasoning":"Document B is slightly more relevant because it addresses tumor metastasis and pathways affecting cancer progression, which relates more to prognosis than the targeted-therapy focus in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179374Z"}
{"comparison_id":"ad255a84-1e90-4c1b-bba8-f7aadcb093b5","query_id":"53","doc_a_id":"1617327","doc_b_id":"35993767","presented_order":["35993767","1617327"],"winner_id":"35993767","reasoning":"Document A is slightly more relevant because it concerns carcinoma biology and tumor progression, whereas Document B focuses on bone marrow/stromal defects causing leukemia. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179381Z"}
{"comparison_id":"1fc45386-4fe0-4872-9570-9568d0d63fad","query_id":"53","doc_a_id":"4312169","doc_b_id":"35993767","presented_order":["4312169","35993767"],"winner_id":"35993767","reasoning":"Neither document addresses ALDH1 or breast cancer; Document B is slightly more relevant because it concerns carcinoma biology and prognosis-related processes (metastasis), whereas A focuses on pediatric glioblastoma genetics. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179388Z"}
{"comparison_id":"25d2c291-65e5-4b5e-b0d2-d8505671a5ed","query_id":"53","doc_a_id":"33076846","doc_b_id":"35993767","presented_order":["35993767","33076846"],"winner_id":"33076846","reasoning":"Document B is slightly more relevant because it discusses gene expression changes in cancer generally, whereas Document A is specific to chemokine-driven HCC metastasis and unrelated to ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179395Z"}
{"comparison_id":"02b4dede-83f5-4dfe-aa5f-cf611f2bcccd","query_id":"53","doc_a_id":"8724666","doc_b_id":"35993767","presented_order":["8724666","35993767"],"winner_id":"8724666","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document A is marginally more related because it discusses cancer stem/progenitor cell biology, whereas B focuses on CAF-driven hepatocellular carcinoma mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179402Z"}
{"comparison_id":"f186c4d1-1a55-4a55-93ad-423bfb887950","query_id":"53","doc_a_id":"10542877","doc_b_id":"35993767","presented_order":["10542877","35993767"],"winner_id":"35993767","reasoning":"Document B — it addresses cancer metastasis and pathways related to prognosis, which is closer to a biomarker–prognosis claim than a treatment study in other cancers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179408Z"}
{"comparison_id":"e657b598-2479-4519-9fcc-719a99fc8ccd","query_id":"53","doc_a_id":"30543439","doc_b_id":"35993767","presented_order":["35993767","30543439"],"winner_id":"35993767","reasoning":"Document A — it discusses cancer metastasis pathways (more related to prognosis in cancer) while Document B focuses on nucleotide‑sanitizing enzymes unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179415Z"}
{"comparison_id":"0009b0ca-8a12-43cc-a9f0-fd45080feb91","query_id":"53","doc_a_id":"28644298","doc_b_id":"35993767","presented_order":["35993767","28644298"],"winner_id":"35993767","reasoning":"Neither document discusses ALDH1 or breast cancer; Document A is slightly more relevant because it addresses cancer metastasis pathways, whereas B focuses on EBV-infected lymphoid cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179422Z"}
{"comparison_id":"2ca9f097-4ec8-491c-947f-1575453c7c7f","query_id":"53","doc_a_id":"19800147","doc_b_id":"35993767","presented_order":["19800147","35993767"],"winner_id":"35993767","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant to the claim. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179429Z"}
{"comparison_id":"dc0d8568-1d2b-4df5-ad14-2193d78bf105","query_id":"53","doc_a_id":"4464565","doc_b_id":"35993767","presented_order":["4464565","35993767"],"winner_id":"35993767","reasoning":"Document B is more relevant — it deals with cancer biology and metastasis pathways (though in HCC, not breast cancer), whereas A focuses on polyphenol effects in intestinal Caco-2 cells.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179436Z"}
{"comparison_id":"3d9b93ec-e567-4885-8a4f-3af5e8f6dd11","query_id":"53","doc_a_id":"20888849","doc_b_id":"35993767","presented_order":["35993767","20888849"],"winner_id":"35993767","reasoning":"Document A is slightly more relevant — it discusses mechanisms (CAF-driven hedgehog/TGF-β–mediated metastasis) tied to tumor aggressiveness and prognosis, whereas B focuses on drug delivery in pancreatic cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179442Z"}
{"comparison_id":"f391ca90-2818-45fc-95af-01993ae77c6e","query_id":"53","doc_a_id":"23326722","doc_b_id":"35993767","presented_order":["35993767","23326722"],"winner_id":"35993767","reasoning":"Document A is more relevant — it concerns cancer biology and mechanisms of metastasis (whereas B is about adult T‑cell leukaemia/lymphoma); neither directly addresses ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179450Z"}
{"comparison_id":"345bcf5c-0c57-47d5-86f4-03b6d31100ed","query_id":"53","doc_a_id":"22890091","doc_b_id":"35993767","presented_order":["35993767","22890091"],"winner_id":"35993767","reasoning":"Document A — it's cancer-focused (metastasis pathways), whereas Document B is about blood leukocyte apoptosis and unrelated to cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179456Z"}
{"comparison_id":"c7d00137-8571-4259-86f0-b8905b405406","query_id":"53","doc_a_id":"2205779","doc_b_id":"35993767","presented_order":["35993767","2205779"],"winner_id":"35993767","reasoning":"Document A is more relevant — it addresses cancer progression and signaling pathways tied to prognosis, whereas Document B focuses on gastric cancer miRNA biomarkers unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179463Z"}
{"comparison_id":"08379e63-5e04-474b-b080-8c63332f062e","query_id":"53","doc_a_id":"16627684","doc_b_id":"35993767","presented_order":["16627684","35993767"],"winner_id":"16627684","reasoning":"Document A is more relevant — it discusses stem cell self-renewal and tumor-associated pathways, which is closer to ALDH1 as a cancer stem cell marker; Document B focuses on CAF-driven HCC metastasis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179470Z"}
{"comparison_id":"1e83761a-628a-4ac9-914b-47e9ff1fd70e","query_id":"53","doc_a_id":"19343151","doc_b_id":"35993767","presented_order":["19343151","35993767"],"winner_id":"35993767","reasoning":"Document B is more relevant — it addresses cancer biology and metastasis, whereas A deals with skin aging (p16INK4A); neither mentions ALDH1 or breast cancer, but B is closer in topic. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179477Z"}
{"comparison_id":"16adc774-8963-4fc0-9c1b-34233bf3d247","query_id":"53","doc_a_id":"10450725","doc_b_id":"35993767","presented_order":["35993767","10450725"],"winner_id":"35993767","reasoning":"Document A is slightly more relevant because it addresses tumor metastasis and signaling pathways linked to cancer progression, which is closer to prognosis than a drug treatment study in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179483Z"}
{"comparison_id":"d6ecfca5-495b-44fb-94d5-11c2c91f8ec6","query_id":"53","doc_a_id":"3701541","doc_b_id":"35993767","presented_order":["3701541","35993767"],"winner_id":"35993767","reasoning":"Neither document discusses ALDH1 or breast cancer; both are about liver cancer. Document B is slightly more relevant because it addresses cancer metastasis and pathways tied to prognosis, whereas A focuses on fibrosis and VDR signaling. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179490Z"}
{"comparison_id":"8e01983b-36e9-45bf-9ec8-bda7e16852fc","query_id":"53","doc_a_id":"26059876","doc_b_id":"35993767","presented_order":["26059876","35993767"],"winner_id":"35993767","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it discusses cancer metastasis and pathways (hedgehog/TGF-β) linked to stemness, which can relate to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179497Z"}
{"comparison_id":"b5463ad1-d065-4102-a376-5113a07b0530","query_id":"53","doc_a_id":"39225849","doc_b_id":"35993767","presented_order":["35993767","39225849"],"winner_id":"35993767","reasoning":"Document A is marginally more relevant because it addresses cancer progression and metastasis, while Document B focuses on DNA replication stress in BLM-deficient cells without connection to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179504Z"}
{"comparison_id":"be446709-6089-4711-8b5a-f8b79dcbeddf","query_id":"53","doc_a_id":"32776084","doc_b_id":"35993767","presented_order":["32776084","35993767"],"winner_id":"35993767","reasoning":"Document B is more relevant — it concerns cancer biology and metastasis pathways, whereas A deals with embryonic stem cell imprinting unrelated to cancer prognosis. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179510Z"}
{"comparison_id":"941fa0cf-1564-4bc6-b4ff-6d0b319893af","query_id":"53","doc_a_id":"15491308","doc_b_id":"35993767","presented_order":["15491308","35993767"],"winner_id":"35993767","reasoning":"Document B is more relevant because it addresses cancer-related mechanisms (metastasis and tumor microenvironment), whereas Document A discusses MSC senescence unrelated to ALDH1 or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179517Z"}
{"comparison_id":"60040bd9-1b48-4492-8ec1-e1008f5c86d2","query_id":"53","doc_a_id":"18938992","doc_b_id":"35993767","presented_order":["35993767","18938992"],"winner_id":"35993767","reasoning":"Neither abstract addresses ALDH1 or breast cancer. Document A discusses cancer metastasis pathways (though in HCC), so it's marginally more related than Document B's EBV/B‑cell immune evasion topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179523Z"}
{"comparison_id":"385ba262-bd22-476f-8785-b11f3eccd467","query_id":"53","doc_a_id":"3863543","doc_b_id":"35993767","presented_order":["35993767","3863543"],"winner_id":"35993767","reasoning":"Reason: Both documents do not address ALDH1 or breast cancer; Document A discusses cancer metastasis and tumor microenvironment (more related to cancer prognosis) whereas Document B focuses on hematopoietic/pre-leukemic disease.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179530Z"}
{"comparison_id":"3f8aaa44-32ea-4f28-a561-739fb251b244","query_id":"53","doc_a_id":"8417211","doc_b_id":"35993767","presented_order":["8417211","35993767"],"winner_id":"35993767","reasoning":"Document B is more relevant — it concerns cancer progression and metastasis (though in HCC), whereas A is about Drosophila HP1 phosphorylation and unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179537Z"}
{"comparison_id":"e6d27ab9-e795-4f58-bafb-ec47e801e729","query_id":"53","doc_a_id":"25022826","doc_b_id":"35993767","presented_order":["35993767","25022826"],"winner_id":"35993767","reasoning":"Document A is slightly more relevant because it discusses cancer metastasis and tumor biology, whereas Document B concerns osteogenic differentiation of MSCs and is unrelated to cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179543Z"}
{"comparison_id":"ddf6be72-e975-4878-bc1b-ae22adc36549","query_id":"53","doc_a_id":"12580014","doc_b_id":"35993767","presented_order":["35993767","12580014"],"winner_id":"35993767","reasoning":"Document A is slightly more relevant — it addresses tumor metastasis pathways and cancer prognosis–related biology, whereas B focuses on keratin/Aire in skin tumors, not breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179550Z"}
{"comparison_id":"683e5d6e-56c2-41dc-a63d-924f5370363d","query_id":"53","doc_a_id":"5765455","doc_b_id":"35993767","presented_order":["35993767","5765455"],"winner_id":"35993767","reasoning":"Document A is more relevant — it discusses carcinoma progression and metastasis mechanisms, which is closer to a prognostic biomarker context than a leukemia progression study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179557Z"}
{"comparison_id":"38e3959b-a402-48b1-ab67-515ea5dc1ff5","query_id":"53","doc_a_id":"28390999","doc_b_id":"35993767","presented_order":["28390999","35993767"],"winner_id":"35993767","reasoning":"Document B is more related to cancer biology (tumor progression/metastasis) than Document A, which concerns chicken gonad development.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:47.179563Z"}
{"comparison_id":"3094640e-9815-4aca-ab0a-6cf6f1fd617f","query_id":"53","doc_a_id":"8512633","doc_b_id":"11900630","presented_order":["11900630","8512633"],"winner_id":"11900630","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A discusses stem-cell–related chemoresistance and cancer treatment implications, which is slightly more related to ALDH1 (a stem cell marker) than a prostate lncRNA study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:56.900093Z"}
{"comparison_id":"2b1132d8-8d65-4b30-a9be-9f3786389f90","query_id":"53","doc_a_id":"34189936","doc_b_id":"11900630","presented_order":["34189936","11900630"],"winner_id":"11900630","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it concerns cancer treatment resistance and factors affecting prognosis, whereas A is focused on BMAL1 in mesothelioma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:56.900114Z"}
{"comparison_id":"1adf694a-e114-45eb-8bdc-311c2a4d0259","query_id":"53","doc_a_id":"10169908","doc_b_id":"11900630","presented_order":["11900630","10169908"],"winner_id":"11900630","reasoning":"Document A — it discusses gene overexpression affecting cancer cell resistance/prognosis-related outcomes, which is closer to the claim about a marker (ALDH1) and prognosis than Document B's lung-specific metabolism study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:56.900123Z"}
{"comparison_id":"f4f2f5d2-6d4a-4ca6-8976-383ef080c8d1","query_id":"53","doc_a_id":"31313782","doc_b_id":"11900630","presented_order":["11900630","31313782"],"winner_id":"11900630","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document A concerns gene overexpression and cancer treatment resistance (more related to prognostic marker implications) while Document B focuses on TLRs in lung disease.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:56.900131Z"}
{"comparison_id":"5f53df26-fcdf-4995-b9a8-e2e534c92d4c","query_id":"53","doc_a_id":"20738970","doc_b_id":"11900630","presented_order":["11900630","20738970"],"winner_id":"11900630","reasoning":"Document A is slightly more relevant — it discusses stem-cell–related chemoresistance mechanisms (bcl-2 overexpression), which is closer to ALDH1's role as a stem/progenitor marker linked to treatment resistance and prognosis than the SCLC/Etk focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:56.900139Z"}
{"comparison_id":"5f7ba366-243e-4c87-8033-597e8ab3ab29","query_id":"53","doc_a_id":"3710557","doc_b_id":"11900630","presented_order":["11900630","3710557"],"winner_id":"11900630","reasoning":"Document A — it discusses gene expression affecting chemotherapy resistance and prognosis-related mechanisms in cancer, which is marginally more relevant than B's focus on liver-specific β-catenin biology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:56.900147Z"}
{"comparison_id":"043e1a0f-74e2-4940-a889-5a144444f046","query_id":"53","doc_a_id":"3355397","doc_b_id":"11900630","presented_order":["11900630","3355397"],"winner_id":"3355397","reasoning":"Document B — it addresses cancer risk associations (more related to cancer prognosis questions), whereas Document A concerns bcl-2 in hematopoietic cells, unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:56.900155Z"}
{"comparison_id":"e25b096c-cc8d-46da-a7cb-03ec10067b56","query_id":"53","doc_a_id":"14663842","doc_b_id":"11900630","presented_order":["11900630","14663842"],"winner_id":"11900630","reasoning":"Document A is more relevant — it discusses stem-cell–associated chemoresistance and prognosis-related treatment effects, whereas Document B focuses on IDH1 metabolic mutations unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:56.900162Z"}
{"comparison_id":"f75087b4-f12f-4ef3-ab3d-2d7fc74ea9a9","query_id":"53","doc_a_id":"16627684","doc_b_id":"11900630","presented_order":["16627684","11900630"],"winner_id":"11900630","reasoning":"Document B — it concerns stem cells and chemoresistance with implications for cancer prognosis/therapy, whereas A is about neural stem cell aging and tumor suppressors, not cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:56.900169Z"}
{"comparison_id":"aacdc14c-95e1-4438-830a-e6f86b1837b7","query_id":"53","doc_a_id":"38355793","doc_b_id":"11900630","presented_order":["38355793","11900630"],"winner_id":"11900630","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it involves stem cells and chemoresistance—concepts related to ALDH1's role—whereas A is limited to A20 in glioma. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:56.900176Z"}
{"comparison_id":"954d79cf-ed48-4038-b336-8f3d4e1537b1","query_id":"53","doc_a_id":"41293601","doc_b_id":"11900630","presented_order":["41293601","11900630"],"winner_id":"11900630","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer; Document B (stem cell chemoresistance) is marginally closer because it involves stem-cell biology and cancer therapy, whereas A focuses on glioblastoma mutations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:56.900182Z"}
{"comparison_id":"f0c50730-5f41-4d5a-9da1-96559e3d6ace","query_id":"53","doc_a_id":"5783785","doc_b_id":"11900630","presented_order":["5783785","11900630"],"winner_id":"5783785","reasoning":"Document A is slightly more relevant because it discusses tumor progression and prognostic factors in cancer, whereas Document B focuses on bcl-2–mediated chemoresistance in hematopoietic cells, unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:56.900189Z"}
{"comparison_id":"e9b43430-e9ff-4bd4-9644-f69d6391fa27","query_id":"53","doc_a_id":"4325398","doc_b_id":"11900630","presented_order":["4325398","11900630"],"winner_id":"11900630","reasoning":"Document B is slightly more relevant because it discusses stem cell biology and therapy resistance, which is more related to ALDH1 as a stem-cell marker than a pancreatic cancer genomics study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:56.900196Z"}
{"comparison_id":"074cbed7-8f7e-462f-9a15-477b75132b00","query_id":"53","doc_a_id":"24190159","doc_b_id":"11900630","presented_order":["24190159","11900630"],"winner_id":"11900630","reasoning":"Document B is marginally more related because it discusses how expression of a specific gene affects therapy resistance and prognosis-like outcomes, whereas A addresses KRAS-driven gene changes in rectal (not breast) cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:56.900203Z"}
{"comparison_id":"7e3aadc6-de9c-4155-a6b7-62b33f11906f","query_id":"53","doc_a_id":"33076846","doc_b_id":"11900630","presented_order":["33076846","11900630"],"winner_id":"11900630","reasoning":"Document B is slightly more related because it addresses cancer-related gene expression and treatment outcomes, whereas A focuses on megakaryocyte biology unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:56.900210Z"}
{"comparison_id":"24ac6578-bc03-4862-9309-2347d693cfa9","query_id":"53","doc_a_id":"8724666","doc_b_id":"11900630","presented_order":["8724666","11900630"],"winner_id":"11900630","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is slightly more related conceptually (chemoresistance/prognosis) than A, so choose B.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:12:56.900216Z"}
{"comparison_id":"14f1d1ed-a6da-4709-bcee-c9183fb8ac4b","query_id":"53","doc_a_id":"3355397","doc_b_id":"5783785","presented_order":["5783785","3355397"],"winner_id":"3355397","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer prognosis; Document B is somewhat more related because it examines cancer risk associations in humans.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:01.207484Z"}
{"comparison_id":"6b547f77-212e-41b1-9213-cd9eb4e1184f","query_id":"53","doc_a_id":"8512633","doc_b_id":"14663842","presented_order":["14663842","8512633"],"winner_id":"14663842","reasoning":"Document A is slightly more relevant because it discusses cancer-related metabolic enzymes (IDH1), which is closer to ALDH1 (an enzyme) and cancer prognosis than a prostate cancer lncRNA study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:09.836307Z"}
{"comparison_id":"9cadfd4e-f684-4338-bf8b-0e8f9c35b48f","query_id":"53","doc_a_id":"34189936","doc_b_id":"14663842","presented_order":["14663842","34189936"],"winner_id":"14663842","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis. Document A is marginally more relevant because it concerns a cancer-related dehydrogenase (IDH1) and metabolic effects, whereas B focuses on BMAL1 in mesothelioma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:09.836328Z"}
{"comparison_id":"d68abf07-9e0e-4b59-83ae-d4f12d556b75","query_id":"53","doc_a_id":"10169908","doc_b_id":"14663842","presented_order":["10169908","14663842"],"winner_id":"14663842","reasoning":"Neither document addresses ALDH1 or breast cancer; Document B is marginally more relevant because it discusses a cancer-related dehydrogenase (IDH1) and metabolic prognosis-related effects, whereas A focuses on a lung glutamine transporter. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:09.836337Z"}
{"comparison_id":"bd759d18-9dec-4a54-8e7b-ec4173e1c0e9","query_id":"53","doc_a_id":"31313782","doc_b_id":"14663842","presented_order":["31313782","14663842"],"winner_id":"14663842","reasoning":"Document B is slightly more related because it discusses a metabolic enzyme (IDH1) in cancer, whereas Document A focuses on Toll-like receptors in lung disease; neither addresses ALDH1 or breast cancer prognosis directly.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:09.836344Z"}
{"comparison_id":"50361251-9df0-4955-a242-c372aecf6ad0","query_id":"53","doc_a_id":"20738970","doc_b_id":"14663842","presented_order":["14663842","20738970"],"winner_id":"14663842","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses a dehydrogenase (IDH1) and cancer metabolism, which is closer in topic than Etk in small cell lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:09.836351Z"}
{"comparison_id":"b610f063-2a65-4e22-bede-a9909fb68c70","query_id":"53","doc_a_id":"3710557","doc_b_id":"14663842","presented_order":["14663842","3710557"],"winner_id":"14663842","reasoning":"Document A — neither discusses ALDH1 or breast cancer, but A addresses cancer-related metabolic enzymes broadly while B is specific to liver/β-catenin. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:09.836361Z"}
{"comparison_id":"838bf71e-af7b-413a-a724-953e396a45f2","query_id":"53","doc_a_id":"8724666","doc_b_id":"14663842","presented_order":["8724666","14663842"],"winner_id":"14663842","reasoning":"Document B is slightly more relevant because it discusses metabolic enzyme mutations in cancer broadly, whereas A focuses on hematopoiesis and leukemia metabolic dependencies only. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:09.836368Z"}
{"comparison_id":"8058298b-20cf-433b-bb23-cbd508dd0626","query_id":"53","doc_a_id":"16627684","doc_b_id":"14663842","presented_order":["14663842","16627684"],"winner_id":"14663842","reasoning":"Neither paper discusses ALDH1 or breast cancer; Document A discusses cancer metabolism (more related) while B is about neural stem cells. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:09.836375Z"}
{"comparison_id":"9589c046-f756-4804-afd0-b402eef296de","query_id":"53","doc_a_id":"38355793","doc_b_id":"14663842","presented_order":["14663842","38355793"],"winner_id":"14663842","reasoning":"Document A is slightly more relevant — it discusses an enzyme (IDH1) and cancer metabolism, which is more thematically similar to ALDH1 in cancer than Document B's glioma/A20 focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:09.836382Z"}
{"comparison_id":"f0b6d147-5748-4261-9efc-f78335efa534","query_id":"53","doc_a_id":"41293601","doc_b_id":"14663842","presented_order":["14663842","41293601"],"winner_id":"14663842","reasoning":"Both documents are unrelated to ALDH1 or breast cancer, but Document A discusses metabolic enzyme alterations in cancer broadly, making it slightly more relevant than Document B (which focuses on glioblastoma subgroups).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:09.836389Z"}
{"comparison_id":"9b1116ee-7ad9-4c1b-81da-c7cabdf4e256","query_id":"53","doc_a_id":"4325398","doc_b_id":"14663842","presented_order":["14663842","4325398"],"winner_id":"14663842","reasoning":"Document A is more relevant — it discusses a metabolic dehydrogenase (IDH1) and cancer metabolism, which is closer in topic to ALDH1 expression in cancer than the pancreatic genomics focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:09.836396Z"}
{"comparison_id":"213460ef-379f-49a2-8c9f-5e6bf8d9da0e","query_id":"53","doc_a_id":"24190159","doc_b_id":"14663842","presented_order":["24190159","14663842"],"winner_id":"14663842","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more related by discussing an enzyme (IDH1) and metabolic changes in cancer, whereas A focuses on KRAS-driven gene expression in rectal carcinoma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:09.836404Z"}
{"comparison_id":"1ced209f-08cb-44ff-8ce9-ef76d0d745b3","query_id":"53","doc_a_id":"33076846","doc_b_id":"14663842","presented_order":["14663842","33076846"],"winner_id":"14663842","reasoning":"Both documents are not directly relevant (neither mentions ALDH1 or breast cancer prognosis). Document A is slightly more related because it concerns cancer metabolism and an enzyme (IDH1) similar in name/function to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:09.836411Z"}
{"comparison_id":"88e98bfe-3194-4b8b-93cc-2069901c880c","query_id":"53","doc_a_id":"8512633","doc_b_id":"8724666","presented_order":["8512633","8724666"],"winner_id":"8512633","reasoning":"Document A is more relevant — it concerns cancer prognosis (though in prostate cancer), whereas Document B focuses on metabolism in hematopoiesis/leukemia, unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:18.498026Z"}
{"comparison_id":"624e89e4-5f19-456b-a0f2-1b09b6d3ac25","query_id":"53","doc_a_id":"34189936","doc_b_id":"8724666","presented_order":["34189936","8724666"],"winner_id":"34189936","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant because it concerns gene expression as a therapeutic/prognostic factor in cancer (though in mesothelioma, not breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:18.498047Z"}
{"comparison_id":"5cb35684-ca4f-489b-9c75-e8ac46e168f4","query_id":"53","doc_a_id":"10169908","doc_b_id":"8724666","presented_order":["8724666","10169908"],"winner_id":"8724666","reasoning":"Neither document mentions ALDH1 or breast cancer; neither directly addresses the claim. Document A is marginally more relevant because it deals with cancer cell biology (vs. lung-specific transporter in B).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:18.498056Z"}
{"comparison_id":"ab0436c7-a84f-49b7-bf96-8950533cf658","query_id":"53","doc_a_id":"31313782","doc_b_id":"8724666","presented_order":["31313782","8724666"],"winner_id":"31313782","reasoning":"Neither document discusses ALDH1 or breast cancer, so neither is relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:18.498062Z"}
{"comparison_id":"1247bcaf-cb90-40dc-ae46-7a6ccf8fd952","query_id":"53","doc_a_id":"20738970","doc_b_id":"8724666","presented_order":["20738970","8724666"],"winner_id":"20738970","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it addresses tumor protein expression and apoptosis in a solid cancer type, whereas Document B focuses on hematopoiesis/leukemia metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:18.498070Z"}
{"comparison_id":"4f6052e9-3825-42f2-bc31-4aa5034a666f","query_id":"53","doc_a_id":"3710557","doc_b_id":"8724666","presented_order":["8724666","3710557"],"winner_id":"3710557","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is marginally more relevant because it discusses signaling and tumorigenesis generally.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:18.498077Z"}
{"comparison_id":"f66d0027-19d9-4ba9-a68a-f9cc37425b3f","query_id":"53","doc_a_id":"33076846","doc_b_id":"8724666","presented_order":["33076846","8724666"],"winner_id":"33076846","reasoning":"Reason: Neither abstract addresses ALDH1 or breast cancer, but Document A discusses gene expression changes linked to cancerous behavior (overexpression effects), making it slightly more relevant than B, which focuses on leukemia metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:18.498084Z"}
{"comparison_id":"99e509b3-7b7d-4a13-b16f-130f8afe1c4a","query_id":"53","doc_a_id":"16627684","doc_b_id":"8724666","presented_order":["8724666","16627684"],"winner_id":"8724666","reasoning":"Document A is more related to cancer biology and stem/progenitor cell behavior, making it closer to the breast cancer prognosis context than Document B, which concerns neural stem cell aging.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:18.498091Z"}
{"comparison_id":"5524eaf8-38c4-4c2c-b781-ae626760dc1a","query_id":"53","doc_a_id":"38355793","doc_b_id":"8724666","presented_order":["38355793","8724666"],"winner_id":"8724666","reasoning":"Neither document addresses ALDH1 or breast cancer directly, but B is slightly more relevant because it discusses metabolic enzymes in cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:18.498098Z"}
{"comparison_id":"f0e856a8-d231-4ea7-8738-0955db2e592e","query_id":"53","doc_a_id":"41293601","doc_b_id":"8724666","presented_order":["8724666","41293601"],"winner_id":"8724666","reasoning":"Document A is marginally more relevant because it discusses cancer metabolic markers and prognosis-related effects in malignancy, whereas Document B focuses on glioblastoma-specific mutations; neither directly addresses ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:18.498104Z"}
{"comparison_id":"67f988ee-3836-4931-b5b5-ff526933daa5","query_id":"53","doc_a_id":"4325398","doc_b_id":"8724666","presented_order":["8724666","4325398"],"winner_id":"8724666","reasoning":"Neither document addresses ALDH1 or breast cancer; Document A is slightly more relevant because it concerns cancer cell biology, whereas B focuses on pancreatic genomics. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:18.498111Z"}
{"comparison_id":"e5a102d9-88bc-426b-9b57-fa8760a0501f","query_id":"53","doc_a_id":"24190159","doc_b_id":"8724666","presented_order":["8724666","24190159"],"winner_id":"24190159","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it deals with gene expression and prognosis-related findings in carcinomas, whereas A focuses on hematopoiesis/leukemia metabolism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:18.498118Z"}
{"comparison_id":"ec3b5f11-450f-40d8-a4de-de5cc6a05e68","query_id":"53","doc_a_id":"8512633","doc_b_id":"20738970","presented_order":["20738970","8512633"],"winner_id":"20738970","reasoning":"Document A — it discusses protein expression linked to cancer cell survival/prognosis mechanisms (though in lung cancer), whereas B concerns unrelated lncRNAs in prostate cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:24.178795Z"}
{"comparison_id":"e0236b9c-4e16-42bb-a77a-703537b6a1c5","query_id":"53","doc_a_id":"34189936","doc_b_id":"20738970","presented_order":["34189936","20738970"],"winner_id":"34189936","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it addresses cancer prognosis/therapy targets (gene function affecting proliferation/apoptosis), whereas B focuses on apoptosis pathways in small cell lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:24.178817Z"}
{"comparison_id":"e0616465-a4ca-4df2-89d5-2e8055854313","query_id":"53","doc_a_id":"31313782","doc_b_id":"20738970","presented_order":["31313782","20738970"],"winner_id":"31313782","reasoning":"Neither document discusses ALDH1 or breast cancer; both are unrelated. Document A (expression profiles in lung cancer) is slightly more relevant because it addresses gene expression patterns in cancer generally.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:24.178826Z"}
{"comparison_id":"af83ae85-21ad-4753-a9bd-415772d5ee85","query_id":"53","doc_a_id":"24190159","doc_b_id":"20738970","presented_order":["20738970","24190159"],"winner_id":"20738970","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly closer because it discusses protein expression linked to cancer cell survival, whereas B is specific to KRAS in rectal carcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:24.178833Z"}
{"comparison_id":"1cff97aa-3da9-4ed0-8768-5d3179f8c4aa","query_id":"53","doc_a_id":"3710557","doc_b_id":"20738970","presented_order":["20738970","3710557"],"winner_id":"20738970","reasoning":"Document A — it discusses cancer cell protein expression and its association with clinical behavior, whereas B focuses on liver-specific β-catenin biology unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:24.178841Z"}
{"comparison_id":"46bd08cd-c641-44af-8295-1eda21597b5d","query_id":"53","doc_a_id":"33076846","doc_b_id":"20738970","presented_order":["33076846","20738970"],"winner_id":"20738970","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis; both are irrelevant. Document B is slightly more relevant only because it deals with cancer-related protein expression, whereas A focuses on megakaryocyte biology.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:24.178848Z"}
{"comparison_id":"262efad9-17ac-45ad-81dc-3e0cdf7a80d0","query_id":"53","doc_a_id":"34189936","doc_b_id":"31313782","presented_order":["31313782","34189936"],"winner_id":"31313782","reasoning":"Document A — it discusses expression profiles of cancer-related markers (closer to an expression–prognosis question), while Document B focuses on BMAL1 as a therapeutic target in mesothelioma and neither addresses ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:29.938154Z"}
{"comparison_id":"f82e9cbf-875f-47f7-8ff2-6e97bc8333b6","query_id":"53","doc_a_id":"8512633","doc_b_id":"24190159","presented_order":["8512633","24190159"],"winner_id":"8512633","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer. Document A at least discusses associations with prognosis (albeit in prostate cancer), so it's slightly closer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:34.478113Z"}
{"comparison_id":"69573eb8-2472-4d77-b63f-22b9065b37e4","query_id":"53","doc_a_id":"33076846","doc_b_id":"24190159","presented_order":["24190159","33076846"],"winner_id":"24190159","reasoning":"Document A is slightly more relevant — it discusses gene overexpression and cancer prognosis/treatment resistance (though in rectal cancer, not breast, and does not mention ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:34.478134Z"}
{"comparison_id":"730a10ff-8094-4d3c-8af6-3b2f6640a112","query_id":"53","doc_a_id":"3710557","doc_b_id":"24190159","presented_order":["3710557","24190159"],"winner_id":"3710557","reasoning":"Document A is more relevant — it discusses cancer signaling and tumorigenesis (potentially relating to markers of stemness and prognosis), while Document B focuses on KRAS-driven changes in rectal carcinoma unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:34.478143Z"}
{"comparison_id":"20b77fd4-6a61-403e-a126-9d4d4e25713d","query_id":"53","doc_a_id":"8512633","doc_b_id":"3710557","presented_order":["3710557","8512633"],"winner_id":"8512633","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B discusses prognostic associations in cancer (though in prostate), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:39.336009Z"}
{"comparison_id":"c243a31d-6c8b-4db9-b2e8-e6917c4960b4","query_id":"53","doc_a_id":"10169908","doc_b_id":"38355793","presented_order":["38355793","10169908"],"winner_id":"38355793","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant only because it addresses a protein overexpression in cancer (glioma), which is conceptually closer than a metabolism transporter in lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:43.112655Z"}
{"comparison_id":"46b72445-5d42-4521-ba00-32c84602b877","query_id":"53","doc_a_id":"16627684","doc_b_id":"38355793","presented_order":["16627684","38355793"],"winner_id":"38355793","reasoning":"Document B is slightly more relevant because it discusses gene overexpression and cancer prognosis/therapy, whereas Document A concerns neural stem cells in mice and tumor suppressors unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:43.112677Z"}
{"comparison_id":"408baaa5-c292-465c-8009-575e32f2eb1c","query_id":"53","doc_a_id":"4325398","doc_b_id":"38355793","presented_order":["38355793","4325398"],"winner_id":"38355793","reasoning":"Document A is marginally more relevant because it addresses gene expression and cancer prognosis (though in glioma, not breast); Document B focuses on pancreatic cancer genomics unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:43.112686Z"}
{"comparison_id":"aef410cb-dd11-480a-80ce-210c25f0ef0a","query_id":"53","doc_a_id":"41293601","doc_b_id":"38355793","presented_order":["38355793","41293601"],"winner_id":"38355793","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A discusses overexpression of a specific protein and its tumor effects (expression/prognosis theme), making it marginally more related than Document B, which focuses on mutation-defined subgroups.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:43.112694Z"}
{"comparison_id":"3f3682bf-09b1-4e73-b8b4-34c6476dea87","query_id":"53","doc_a_id":"10169908","doc_b_id":"16627684","presented_order":["16627684","10169908"],"winner_id":"16627684","reasoning":"Document A is slightly more relevant because it discusses stem cell-related factors and tumor suppressors, which is closer to ALDH1's role as a cancer stem cell marker than a lung cancer glutamine transporter study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:46.634025Z"}
{"comparison_id":"636c7f41-d054-435c-b2f9-e05a189bc93b","query_id":"53","doc_a_id":"41293601","doc_b_id":"16627684","presented_order":["41293601","16627684"],"winner_id":"41293601","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more cancer-related (glioblastoma tumor biology), so it's marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:46.634046Z"}
{"comparison_id":"6f2bc74f-6a35-43f6-bef6-5d26122d9308","query_id":"53","doc_a_id":"4325398","doc_b_id":"16627684","presented_order":["16627684","4325398"],"winner_id":"16627684","reasoning":"Document A is slightly more relevant — it addresses stem-cell biology and tumor suppressors (more related to ALDH1 as a cancer stem-cell marker) while Document B focuses on pancreatic genomic changes unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:46.634057Z"}
{"comparison_id":"5e1ca036-3f2d-4f3e-b7ab-54e16d0592a5","query_id":"53","doc_a_id":"10169908","doc_b_id":"4325398","presented_order":["10169908","4325398"],"winner_id":"10169908","reasoning":"Document A is more relevant — it discusses protein expression and cancer cell behavior (closer to the claim about a marker's expression and prognosis) whereas Document B focuses on pancreatic genomic aberrations unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:13:50.169731Z"}
{"comparison_id":"60286a70-f049-40f9-825b-3bbdf6cd1068","query_id":"53","doc_a_id":"11615422","doc_b_id":"6766459","presented_order":["6766459","11615422"],"winner_id":"11615422","reasoning":"Document B is more relevant — it deals with cancer genetics/pathogenesis (though in leukemia), whereas Document A is focused on fever/immune microRNA regulation and not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445662Z"}
{"comparison_id":"d2518f3d-1066-4246-bace-5fdfb0e2dc14","query_id":"53","doc_a_id":"23665162","doc_b_id":"6766459","presented_order":["6766459","23665162"],"winner_id":"23665162","reasoning":"Document B — it relates to cancer (hepatocellular carcinoma) whereas Document A concerns fever/immune regulation; neither mentions ALDH1 or breast cancer, but B is more cancer-relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445683Z"}
{"comparison_id":"35414446-82ad-45ac-9c92-48a1c4303f72","query_id":"53","doc_a_id":"8677721","doc_b_id":"6766459","presented_order":["8677721","6766459"],"winner_id":"8677721","reasoning":"Document A — it's cancer-related (tumor progression/biomarkers), whereas Document B concerns fever/immune regulation and is unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445692Z"}
{"comparison_id":"0aba09ef-325e-4f87-9847-f8070357d972","query_id":"53","doc_a_id":"14471161","doc_b_id":"6766459","presented_order":["14471161","6766459"],"winner_id":"14471161","reasoning":"Both documents are unrelated to ALDH1 or breast cancer, but Document A discusses tumor gene expression and cancer growth (albeit in pancreatic cancer), making it slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445701Z"}
{"comparison_id":"7ae7f87e-88af-43b4-87c6-8d6dd9aa66d5","query_id":"53","doc_a_id":"23577867","doc_b_id":"6766459","presented_order":["23577867","6766459"],"winner_id":"23577867","reasoning":"Document A is slightly more relevant because it discusses cancer biomarkers and prognosis-related factors, whereas Document B concerns fever and immune regulation unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445708Z"}
{"comparison_id":"295c62df-b17c-4fe9-8915-8ac8e758edcd","query_id":"53","doc_a_id":"2272614","doc_b_id":"6766459","presented_order":["6766459","2272614"],"winner_id":"2272614","reasoning":"Document B — it discusses gene expression in cancer (though lung, not breast) and is thus slightly closer in topic than Document A, which concerns fever and immune microRNAs. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445715Z"}
{"comparison_id":"daba3e27-b392-4996-86c9-756859fef45b","query_id":"53","doc_a_id":"24349430","doc_b_id":"6766459","presented_order":["6766459","24349430"],"winner_id":"24349430","reasoning":"Document B is slightly more relevant because it deals with cancer cell behavior, whereas Document A concerns fever/immune regulation and not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445722Z"}
{"comparison_id":"0d663409-fe77-43c7-a5e9-60b0d586ba40","query_id":"53","doc_a_id":"1507222","doc_b_id":"6766459","presented_order":["6766459","1507222"],"winner_id":"1507222","reasoning":"Document B — it concerns cancer biology (cachexia in a tumor model), so it's marginally more related to cancer prognosis than Document A, which focuses on fever/immune microRNA regulation. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445729Z"}
{"comparison_id":"ca3c8393-36f4-4265-8b94-9d4b43745ce8","query_id":"53","doc_a_id":"14180565","doc_b_id":"6766459","presented_order":["6766459","14180565"],"winner_id":"14180565","reasoning":"Document B is slightly more relevant because it addresses gene expression changes in cancer cells, whereas Document A concerns fever and immune microRNAs unrelated to ALDH1 or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445736Z"}
{"comparison_id":"e6fb3dcc-a019-468c-913d-0af967c83d81","query_id":"53","doc_a_id":"641786","doc_b_id":"6766459","presented_order":["641786","6766459"],"winner_id":"641786","reasoning":"Document A is marginally more relevant because it concerns cancer and prognosis (relapse), whereas Document B addresses fever/immune regulation and not cancer. Both do not discuss ALDH1 or breast cancer specifically.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445743Z"}
{"comparison_id":"68eff26c-eb26-4fb2-b0ac-42427fa613e5","query_id":"53","doc_a_id":"32852283","doc_b_id":"6766459","presented_order":["32852283","6766459"],"winner_id":"32852283","reasoning":"Document A is more relevant — it discusses tumor growth and survival outcomes (though in NSCLC rather than breast cancer), whereas Document B concerns fever/immune regulation unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445750Z"}
{"comparison_id":"f74a2acc-0b61-4464-9cbf-ff4d77eee1c1","query_id":"53","doc_a_id":"23509593","doc_b_id":"6766459","presented_order":["6766459","23509593"],"winner_id":"23509593","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document B is slightly more related to cancer biology (prostate tissue regulation), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445757Z"}
{"comparison_id":"d7377968-4c3d-4bc8-a8dd-0dc9959e2dfe","query_id":"53","doc_a_id":"25628793","doc_b_id":"6766459","presented_order":["25628793","6766459"],"winner_id":"25628793","reasoning":"Document A is slightly more relevant because it discusses expression of metabolic enzymes in reproductive tissues and hormone-related pathologies, whereas Document B focuses on fever-regulating microRNAs unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445764Z"}
{"comparison_id":"2f8ec88d-3c18-4b10-b152-8677c0635bdd","query_id":"53","doc_a_id":"2360905","doc_b_id":"6766459","presented_order":["6766459","2360905"],"winner_id":"6766459","reasoning":"Document A is slightly more relevant because it deals with gene expression regulation (miRNAs/RBM3) and immune-related pathways, whereas Document B focuses on pediatric glioma genomics unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445771Z"}
{"comparison_id":"3a2cd751-9964-45b7-90aa-6dedcc2fc77c","query_id":"53","doc_a_id":"4841908","doc_b_id":"6766459","presented_order":["6766459","4841908"],"winner_id":"4841908","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis. Document B is slightly more relevant because it addresses disease outcomes and explicitly mentions cancer (though not related to ALDH1), so:\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445777Z"}
{"comparison_id":"aa24079c-2c64-49ff-ab8f-28f067e28174","query_id":"53","doc_a_id":"14938990","doc_b_id":"6766459","presented_order":["14938990","6766459"],"winner_id":"14938990","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it discusses associations between gene/protein expression and disease outcome, while B focuses on fever-related microRNA regulation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445784Z"}
{"comparison_id":"38e8a73e-8d78-4d29-a524-cb20af5748b5","query_id":"53","doc_a_id":"19368793","doc_b_id":"6766459","presented_order":["19368793","6766459"],"winner_id":"19368793","reasoning":"A — it discusses cancer biomarkers (miRNAs) and is cancer-related, while B concerns fever/immune regulation not breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445790Z"}
{"comparison_id":"e6849442-73ae-4af2-bd80-6af5e5ed9df2","query_id":"53","doc_a_id":"4959368","doc_b_id":"6766459","presented_order":["4959368","6766459"],"winner_id":"4959368","reasoning":"Document A is cancer-related (though about pancreatic cancer) while B concerns fever/immune miRNAs and not cancer; A is therefore slightly more relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445797Z"}
{"comparison_id":"aa1cfec2-c70a-441d-8c2b-e9216023fd80","query_id":"53","doc_a_id":"85665741","doc_b_id":"6766459","presented_order":["6766459","85665741"],"winner_id":"6766459","reasoning":"Document A is slightly more relevant — it discusses gene expression regulation (miRNAs/RBM3) which is closer to biomarker expression topics; Document B focuses on BRAF/MEK in NSCLC. Neither mentions ALDH1 or breast cancer specifically.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445804Z"}
{"comparison_id":"1e638767-0faf-417c-b879-5ef1bfae19fa","query_id":"53","doc_a_id":"6363093","doc_b_id":"6766459","presented_order":["6363093","6766459"],"winner_id":"6363093","reasoning":"Neither abstract mentions ALDH1 or breast cancer; however, A is cancer-related (glioblastoma) while B concerns fever/immune miRNAs, so A is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445810Z"}
{"comparison_id":"e8905b18-81f0-4068-89e8-3f4f28cdd1a0","query_id":"53","doc_a_id":"4387494","doc_b_id":"6766459","presented_order":["6766459","4387494"],"winner_id":"4387494","reasoning":"Document B is more relevant — it concerns cancer biology/therapy (AML), whereas Document A is about fever and immune thermomiRs, unrelated to cancer biomarkers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445817Z"}
{"comparison_id":"dc5cea3a-b101-40af-bda2-008e6725da5c","query_id":"53","doc_a_id":"13905670","doc_b_id":"6766459","presented_order":["6766459","13905670"],"winner_id":"13905670","reasoning":"Document B — it discusses links between a genetic variant and disease prognosis/outcomes, so it's more relevant to a claim about marker expression and prognosis (even though neither mentions ALDH1 or breast cancer). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445824Z"}
{"comparison_id":"213db4bb-e4e7-4d2a-b4cd-12bf824548e1","query_id":"53","doc_a_id":"663464","doc_b_id":"6766459","presented_order":["6766459","663464"],"winner_id":"663464","reasoning":"Document B is slightly more relevant because it addresses microRNA expression linked to mortality and age-related disease (prognosis-related outcomes), whereas Document A concerns fever regulation and thermomiRs unrelated to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445831Z"}
{"comparison_id":"c27f2711-9773-4e79-9a25-ebff35287bf1","query_id":"53","doc_a_id":"16016673","doc_b_id":"6766459","presented_order":["16016673","6766459"],"winner_id":"16016673","reasoning":"Document A is slightly more relevant because it addresses cancer biomarkers (though for bladder cancer), whereas Document B discusses fever-regulating miRNAs and is unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445838Z"}
{"comparison_id":"c653b8b7-3d2f-4f7d-914f-67ee09804745","query_id":"53","doc_a_id":"1976183","doc_b_id":"6766459","presented_order":["1976183","6766459"],"winner_id":"1976183","reasoning":"Document A is more relevant — it addresses cancer biomarkers and invasive/prognostic features (though in oral cancer), whereas Document B is about fever/immune regulation unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445845Z"}
{"comparison_id":"86da9d3e-91c7-4d69-aa32-67b7a7bd7c90","query_id":"53","doc_a_id":"17876040","doc_b_id":"6766459","presented_order":["6766459","17876040"],"winner_id":"17876040","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but B is oncology-focused (cancer therapy) while A concerns fever/immune regulation.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445852Z"}
{"comparison_id":"2b266211-5841-48c4-8335-ea7c2d139654","query_id":"53","doc_a_id":"7020505","doc_b_id":"6766459","presented_order":["7020505","6766459"],"winner_id":"7020505","reasoning":"Document A is more relevant — it discusses prognostic biomarkers and genetic factors in cancer (though in CLL), which is closer to a claim about expression linked to prognosis than Document B on fever/thermomiRs. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445858Z"}
{"comparison_id":"11d2bec8-6798-4e48-8615-5dc852b87068","query_id":"53","doc_a_id":"12903921","doc_b_id":"6766459","presented_order":["6766459","12903921"],"winner_id":"6766459","reasoning":"Document A is slightly more relevant because it deals with gene expression and regulatory mechanisms, whereas Document B concerns oxidative stress in a leukemia rat model; neither directly addresses ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445866Z"}
{"comparison_id":"a46b4506-ff1d-4e95-91d2-75bd298cfb9d","query_id":"53","doc_a_id":"57783564","doc_b_id":"6766459","presented_order":["57783564","6766459"],"winner_id":"57783564","reasoning":"Document A is more relevant because it discusses cancer-related expression and tumor progression, whereas Document B focuses on fever and immune microRNA regulation unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445873Z"}
{"comparison_id":"a73ffb0f-7f86-4e1c-9d86-9109657efb32","query_id":"53","doc_a_id":"16853734","doc_b_id":"6766459","presented_order":["16853734","6766459"],"winner_id":"16853734","reasoning":"Document A is slightly more relevant because it relates to cancer biology (tumor cell/microenvironment interactions), whereas Document B concerns fever/immune regulation and is unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445879Z"}
{"comparison_id":"12e38cf7-6ebb-4d76-9473-53cab204d285","query_id":"53","doc_a_id":"14848619","doc_b_id":"6766459","presented_order":["6766459","14848619"],"winner_id":"14848619","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more related because it concerns cancer-relevant cell death pathways, whereas A focuses on fever/immune thermomiRs. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445887Z"}
{"comparison_id":"7060f67c-d12d-468b-a35c-dd5949cd1f20","query_id":"53","doc_a_id":"24624992","doc_b_id":"6766459","presented_order":["6766459","24624992"],"winner_id":"24624992","reasoning":"Document B is more relevant — it deals with gene expression in cancer cells, whereas A focuses on fever/immune regulation unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445894Z"}
{"comparison_id":"72b05079-9434-451d-9c63-c176db48a8ef","query_id":"53","doc_a_id":"17671145","doc_b_id":"6766459","presented_order":["6766459","17671145"],"winner_id":"17671145","reasoning":"Neither document addresses ALDH1 or breast cancer. Both are irrelevant, but Document B is an oncology study (prostate cancer) and thus marginally more related to cancer prognosis than Document A (fever/immune regulation).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445901Z"}
{"comparison_id":"fc0d43eb-8f99-45f0-9aa9-10671a14093a","query_id":"53","doc_a_id":"5956380","doc_b_id":"6766459","presented_order":["6766459","5956380"],"winner_id":"6766459","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document A discusses gene expression/regulation (miRNAs/RBM3) making it marginally more relevant than Document B, which is specific to PPM1D mutations in brainstem gliomas.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445907Z"}
{"comparison_id":"e644cf9b-979b-4d4f-ae29-2f3f2cae9296","query_id":"53","doc_a_id":"10699587","doc_b_id":"6766459","presented_order":["10699587","6766459"],"winner_id":"6766459","reasoning":"Document B — it discusses molecular regulators and biomarkers (microRNAs/RBM3), which is closer to the claim about a molecular marker (ALDH1) and prognosis than a prostate radiotherapy prognostic grouping.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445914Z"}
{"comparison_id":"96de715c-373d-481d-9eec-b2b9b591e275","query_id":"53","doc_a_id":"6171953","doc_b_id":"6766459","presented_order":["6171953","6766459"],"winner_id":"6171953","reasoning":"Neither document discusses ALDH1 or breast cancer, so both are irrelevant. If forced to choose, pick A — it at least covers a protein (Sirtuin‑1) implicated in pathways often studied in cancer, whereas B focuses on fever-related miRNAs.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445922Z"}
{"comparison_id":"b0aeba8f-e584-4a43-b46a-f4f4cb1cfa34","query_id":"53","doc_a_id":"8764879","doc_b_id":"6766459","presented_order":["6766459","8764879"],"winner_id":"8764879","reasoning":"Document B is more relevant — it deals with cancer stem cell markers and prognosis/therapy in leukemia, which is closer to the claim about ALDH1 as a prognostic cancer marker than Document A's fever/immune miRNA study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445929Z"}
{"comparison_id":"470c3793-4b08-4c3d-9d41-73e7a2ae6b8a","query_id":"53","doc_a_id":"1982286","doc_b_id":"6766459","presented_order":["1982286","6766459"],"winner_id":"1982286","reasoning":"Document A — it's cancer-related (though about T-ALL, not breast cancer). Neither document mentions ALDH1 or breast cancer, so neither provides direct evidence. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445936Z"}
{"comparison_id":"634236fe-ea98-4230-998a-8434d4a6b8bd","query_id":"53","doc_a_id":"67787658","doc_b_id":"6766459","presented_order":["67787658","6766459"],"winner_id":"67787658","reasoning":"Document A is more relevant — it concerns cancer-related molecular mechanisms (although in glioblastoma), whereas Document B is about fever/immune regulation and not cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445943Z"}
{"comparison_id":"736e795b-cc8f-4a94-a319-945d127a64ca","query_id":"53","doc_a_id":"2356950","doc_b_id":"6766459","presented_order":["2356950","6766459"],"winner_id":"2356950","reasoning":"Document A is more relevant — it concerns stem cell regulation (miR-184 and neural stem cells), which is conceptually closer to ALDH1 as a stem-cell marker in cancer prognosis, whereas Document B focuses on fever and immune thermomiRs. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445951Z"}
{"comparison_id":"d2924a92-15d1-4208-9e13-e4e7cae0f313","query_id":"53","doc_a_id":"40901687","doc_b_id":"6766459","presented_order":["6766459","40901687"],"winner_id":"40901687","reasoning":"Document B is more relevant — it concerns DNA damage response pathways and cancer-relevant mechanisms, whereas A deals with fever and immune microRNAs unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445957Z"}
{"comparison_id":"04106615-fbd8-4a0e-9abb-da3f2d86e546","query_id":"53","doc_a_id":"28390999","doc_b_id":"6766459","presented_order":["28390999","6766459"],"winner_id":"6766459","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document B is chosen only marginally more relevant because it deals with gene regulation and disease processes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445965Z"}
{"comparison_id":"d9e058bd-0865-4124-8a52-5cd6be917b57","query_id":"53","doc_a_id":"26887439","doc_b_id":"6766459","presented_order":["6766459","26887439"],"winner_id":"26887439","reasoning":"Document B is more relevant — it concerns cancer cell survival and prognosis-related mechanisms, whereas Document A deals with fever/immune microRNAs unrelated to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445972Z"}
{"comparison_id":"227d057a-8a1e-4aed-a94a-02c8768eb88f","query_id":"53","doc_a_id":"9226649","doc_b_id":"6766459","presented_order":["9226649","6766459"],"winner_id":"9226649","reasoning":"Document A is slightly more relevant because it concerns tumorigenesis (cancer), whereas Document B addresses fever/immune regulation unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445978Z"}
{"comparison_id":"3d9417a4-7de5-44fa-aa71-02cc62449b5e","query_id":"53","doc_a_id":"15215393","doc_b_id":"6766459","presented_order":["15215393","6766459"],"winner_id":"15215393","reasoning":"Neither discusses ALDH1 or breast cancer; Document A is marginally more relevant because it addresses cancer biology, whereas B is about fever/immune regulation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445984Z"}
{"comparison_id":"9fc4cc1c-b7b7-4f3b-a108-2dce25315de2","query_id":"53","doc_a_id":"17911973","doc_b_id":"6766459","presented_order":["17911973","6766459"],"winner_id":"17911973","reasoning":"Document A — it discusses cancer-related genomic changes (mentions lung cancer), so it's marginally more relevant to a prognosis claim in breast cancer than Document B, which is about fever/immune regulation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445992Z"}
{"comparison_id":"d839f037-9d6e-4354-8ea2-a8afd056cf4b","query_id":"53","doc_a_id":"28334217","doc_b_id":"6766459","presented_order":["28334217","6766459"],"winner_id":"28334217","reasoning":"Document A is more relevant — it deals with tumor biology and cancer treatment, whereas Document B focuses on fever/immune regulation; neither mentions ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.445999Z"}
{"comparison_id":"74e8dc2c-0c6e-49e5-9181-f73e1ada7a4d","query_id":"53","doc_a_id":"7869794","doc_b_id":"6766459","presented_order":["7869794","6766459"],"winner_id":"7869794","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; however, Document A is slightly more relevant because it discusses tumor cell biology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446006Z"}
{"comparison_id":"3b7d9cf3-c416-441b-aa30-708e7d572cd9","query_id":"53","doc_a_id":"22703082","doc_b_id":"6766459","presented_order":["22703082","6766459"],"winner_id":"22703082","reasoning":"Document A is slightly more relevant because it addresses aberrant gene expression in carcinogenesis (cancer context), whereas B concerns fever/immune regulation unrelated to cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446013Z"}
{"comparison_id":"1bf9d632-050f-4c2b-a3f0-dafb18ac3e59","query_id":"53","doc_a_id":"3831884","doc_b_id":"6766459","presented_order":["6766459","3831884"],"winner_id":"3831884","reasoning":"Document B is more relevant — it discusses cancer biology and tumor prognosis mechanisms (though in pancreatic, not breast), whereas A focuses on fever/immune regulation unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446020Z"}
{"comparison_id":"da7e0b09-a22b-46ab-9fef-882a11b263af","query_id":"53","doc_a_id":"3504761","doc_b_id":"6766459","presented_order":["3504761","6766459"],"winner_id":"3504761","reasoning":"Document A — discusses tumorigenesis (cancer-related pathways), whereas B is about fever/immune miRNAs and unrelated to cancer or ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446027Z"}
{"comparison_id":"69349600-ed21-4f00-a5b7-4df547e03baa","query_id":"53","doc_a_id":"10365787","doc_b_id":"6766459","presented_order":["6766459","10365787"],"winner_id":"10365787","reasoning":"Document B is more relevant — it concerns tumor suppression and genomic stability, which relate to cancer prognosis, whereas A discusses fever and thermomiRs unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446034Z"}
{"comparison_id":"80f99f44-b1c5-41ac-864c-2e4909109e59","query_id":"53","doc_a_id":"24783597","doc_b_id":"6766459","presented_order":["6766459","24783597"],"winner_id":"6766459","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant (discusses regulatory/immune pathways) while B focuses on IBD. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446041Z"}
{"comparison_id":"891a4b80-243c-415b-aee7-d76a291edb40","query_id":"53","doc_a_id":"1522336","doc_b_id":"6766459","presented_order":["1522336","6766459"],"winner_id":"1522336","reasoning":"Document A is slightly more relevant because it relates to cancer biology (though in HNSCC), whereas Document B concerns fever/immune regulation unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446048Z"}
{"comparison_id":"7909f3c6-3541-45d5-a4be-dc883f272604","query_id":"53","doc_a_id":"25036988","doc_b_id":"6766459","presented_order":["6766459","25036988"],"winner_id":"6766459","reasoning":"Neither document mentions ALDH1 or breast cancer, so both are irrelevant. If forced to pick the marginally more related one (gene expression/clinical regulation context), choose A.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446055Z"}
{"comparison_id":"354b32bb-6662-4c8a-b058-ae0e8558d597","query_id":"53","doc_a_id":"18682109","doc_b_id":"6766459","presented_order":["18682109","6766459"],"winner_id":"18682109","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document A is slightly more relevant because it concerns cancer biology, whereas B concerns fever/immune regulation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446061Z"}
{"comparison_id":"54b9ec3f-de18-4c73-81a2-2cd14cdd869b","query_id":"53","doc_a_id":"2466614","doc_b_id":"6766459","presented_order":["6766459","2466614"],"winner_id":"6766459","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is marginally more related because it deals with regulation of gene expression, whereas B focuses on aging in mice. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446068Z"}
{"comparison_id":"456e53fe-929e-4fb3-a71a-f2898dab9c87","query_id":"53","doc_a_id":"19427410","doc_b_id":"6766459","presented_order":["19427410","6766459"],"winner_id":"19427410","reasoning":"Document A is slightly more related (both concern gene expression in human tissues and factors like hypoxia/TNF that are relevant to cancer biology), while Document B concerns fever regulation and thermomiRs unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446075Z"}
{"comparison_id":"d2f2f6ad-6121-4226-9737-9611b90c22fc","query_id":"53","doc_a_id":"15322518","doc_b_id":"6766459","presented_order":["6766459","15322518"],"winner_id":"15322518","reasoning":"Reason: Document B is cancer-focused (therapeutic targets and prognosis-related pathways), while Document A concerns fever/immune microRNAs unrelated to breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446082Z"}
{"comparison_id":"dfa2f9a6-f9ee-433c-875e-e925689fe919","query_id":"53","doc_a_id":"1617327","doc_b_id":"6766459","presented_order":["1617327","6766459"],"winner_id":"1617327","reasoning":"Document A — it concerns cancer-related mechanisms (oncogenesis) whereas Document B addresses fever/immune regulation, so A is marginally more relevant to a claim about cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446089Z"}
{"comparison_id":"7a5c890c-8ef3-4f91-af32-847c132bfbd6","query_id":"53","doc_a_id":"4312169","doc_b_id":"6766459","presented_order":["4312169","6766459"],"winner_id":"4312169","reasoning":"Document A is slightly more relevant because it concerns cancer biology (though glioblastoma, not breast cancer); Document B focuses on fever/thermomiRs and immune regulation, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446096Z"}
{"comparison_id":"544ed1d6-7667-46c2-9652-d54f7ca6297e","query_id":"53","doc_a_id":"10542877","doc_b_id":"6766459","presented_order":["6766459","10542877"],"winner_id":"10542877","reasoning":"Document B — it concerns cancer therapies (though not breast cancer specifically), while Document A is about fever/thermomiRs and unrelated to cancer markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446120Z"}
{"comparison_id":"396f3c89-9f6c-4180-b02a-7222d9cb2d0a","query_id":"53","doc_a_id":"30543439","doc_b_id":"6766459","presented_order":["30543439","6766459"],"winner_id":"30543439","reasoning":"Document A is slightly more relevant because it discusses functions in cancer cells, whereas Document B concerns fever/immune regulation not related to ALDH1 or breast cancer prognosis.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446139Z"}
{"comparison_id":"e3b86615-9b72-4a5d-9876-4c963d8eead8","query_id":"53","doc_a_id":"28644298","doc_b_id":"6766459","presented_order":["28644298","6766459"],"winner_id":"28644298","reasoning":"Document A — it deals with cancer cell survival and transcriptional regulation, making it more tangentially relevant to prognosis than Document B, which focuses on fever/immune miRNAs. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446150Z"}
{"comparison_id":"b852971c-736d-49cb-9b58-15043d035a69","query_id":"53","doc_a_id":"19800147","doc_b_id":"6766459","presented_order":["19800147","6766459"],"winner_id":"19800147","reasoning":"Document A — it discusses cancer progression and prognostic biomarkers (albeit in colon cancer), which is more relevant to a claim about ALDH1 and breast cancer prognosis than Document B's focus on fever/immune regulation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446159Z"}
{"comparison_id":"2cda321f-616b-4d28-a9d7-3e89a7646d19","query_id":"53","doc_a_id":"4464565","doc_b_id":"6766459","presented_order":["6766459","4464565"],"winner_id":"4464565","reasoning":"Document B — it discusses modulation of gene expression in human cells, which is more closely related to a claim about a gene marker (ALDH1) and prognosis than Document A's focus on fever-regulating thermomiRs. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446166Z"}
{"comparison_id":"5b5e05cf-4f7f-4d88-b728-1b47f4fc4ea0","query_id":"53","doc_a_id":"20888849","doc_b_id":"6766459","presented_order":["6766459","20888849"],"winner_id":"6766459","reasoning":"Document A — it discusses gene/miRNA expression and regulation (more related to biomarkers/prognosis) while Document B is specific to pancreatic cancer therapy. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446175Z"}
{"comparison_id":"bdd6ac3c-7515-4b9c-8139-19e87c4fe1b2","query_id":"53","doc_a_id":"23326722","doc_b_id":"6766459","presented_order":["6766459","23326722"],"winner_id":"23326722","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it addresses cancer prognosis (though in T‑cell lymphoma, not breast cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446183Z"}
{"comparison_id":"2dfd0850-4bd3-4d73-b7d0-fe8ac415c79a","query_id":"53","doc_a_id":"22890091","doc_b_id":"6766459","presented_order":["22890091","6766459"],"winner_id":"22890091","reasoning":"Document A is marginally more relevant because it discusses expression of a protein (bcl-2) and cell survival, which is closer to biomarker/prognosis topics than the fever/miRNA focus of Document B. Neither document addresses ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446191Z"}
{"comparison_id":"8220347c-241f-4c84-8652-ae05e366165e","query_id":"53","doc_a_id":"2205779","doc_b_id":"6766459","presented_order":["2205779","6766459"],"winner_id":"2205779","reasoning":"Document A is more relevant — it discusses cancer biomarker expression, whereas Document B focuses on fever-related microRNA regulation and immune genes, unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446198Z"}
{"comparison_id":"6bc077ef-6f86-47b9-b035-a968b7a9ae12","query_id":"53","doc_a_id":"19343151","doc_b_id":"6766459","presented_order":["19343151","6766459"],"winner_id":"19343151","reasoning":"Document A is slightly more relevant because it discusses gene expression biomarkers in human tissue, whereas Document B concerns fever-related miRNAs and immune regulation; neither addresses ALDH1 or breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446205Z"}
{"comparison_id":"c164fcd6-2431-44d1-a054-b90bcd20f65c","query_id":"53","doc_a_id":"10450725","doc_b_id":"6766459","presented_order":["6766459","10450725"],"winner_id":"10450725","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more related because it concerns cancer biology (hepatocellular carcinoma), whereas A is about fever/thermomiRs.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446212Z"}
{"comparison_id":"16426476-dde1-4acb-8d9e-01f3111400cb","query_id":"53","doc_a_id":"3701541","doc_b_id":"6766459","presented_order":["3701541","6766459"],"winner_id":"3701541","reasoning":"Document A is more relevant — it discusses cancer-related signaling and tumor activity (though in liver, not breast or ALDH1), whereas Document B is about fever/immune regulation and thermomiRs, unrelated to cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446219Z"}
{"comparison_id":"c3f01dbf-7e08-4fed-98c4-dd62b3cc0719","query_id":"53","doc_a_id":"26059876","doc_b_id":"6766459","presented_order":["26059876","6766459"],"winner_id":"26059876","reasoning":"Document A is slightly more relevant because it discusses cancer-related mechanisms and tumorigenesis, whereas Document B concerns fever regulation and immune microRNAs unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446226Z"}
{"comparison_id":"6e6f1c00-d93a-43c4-aff1-e68014a88d15","query_id":"53","doc_a_id":"39225849","doc_b_id":"6766459","presented_order":["39225849","6766459"],"winner_id":"39225849","reasoning":"Document A is slightly more relevant because it discusses genomic instability and a precancerous state, whereas Document B is about fever-related microRNAs and immune genes with no cancer link.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446233Z"}
{"comparison_id":"fedd094d-e24d-41d7-9d4e-c0503eb3d911","query_id":"53","doc_a_id":"32776084","doc_b_id":"6766459","presented_order":["32776084","6766459"],"winner_id":"32776084","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns stem cell gene expression (ALDH1 is a stem cell marker), whereas B concerns fever/immune miRNAs.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446240Z"}
{"comparison_id":"28fcd11f-fec7-44bb-8996-8a0df79b4eed","query_id":"53","doc_a_id":"15491308","doc_b_id":"6766459","presented_order":["15491308","6766459"],"winner_id":"15491308","reasoning":"Document A is slightly more relevant because it discusses protein expression and cellular growth dynamics (closer to tumor biology), whereas Document B focuses on fever/immune regulation unrelated to cancer markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446248Z"}
{"comparison_id":"5487d052-9fbb-47cb-b42f-896afc341f90","query_id":"53","doc_a_id":"18938992","doc_b_id":"6766459","presented_order":["6766459","18938992"],"winner_id":"6766459","reasoning":"Neither document mentions ALDH1 or breast cancer; Document A is marginally more relevant because it concerns gene-expression regulation (microRNAs/RBM3), whereas B focuses on viral immune evasion. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446255Z"}
{"comparison_id":"ad9ee625-a826-4ae5-87b1-4bf802957af5","query_id":"53","doc_a_id":"3863543","doc_b_id":"6766459","presented_order":["6766459","3863543"],"winner_id":"3863543","reasoning":"Document B is more relevant — it deals with cancer, genotoxic stress, and prediction of disease evolution, whereas Document A focuses on fever-related microRNAs and immune regulation with no cancer/prognosis content.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446264Z"}
{"comparison_id":"82d08dbc-7da2-4dea-afce-a61337150caa","query_id":"53","doc_a_id":"8417211","doc_b_id":"6766459","presented_order":["6766459","8417211"],"winner_id":"6766459","reasoning":"Document A is more relevant — it's human/clinical immunology-focused, whereas B is a Drosophila epigenetics study unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446271Z"}
{"comparison_id":"54e5b455-e2f6-444f-bd7e-8c8967f6e1f8","query_id":"53","doc_a_id":"25022826","doc_b_id":"6766459","presented_order":["25022826","6766459"],"winner_id":"25022826","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis, but A (gene regulation in stem-like cells) is marginally closer in topic than B (fever/immune thermomiRs).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446279Z"}
{"comparison_id":"1126b084-90de-449d-b683-5e8b14ca5073","query_id":"53","doc_a_id":"12580014","doc_b_id":"6766459","presented_order":["6766459","12580014"],"winner_id":"12580014","reasoning":"Document B. It concerns gene regulation in tumor keratinocytes and cancer-related pathways, which is more relevant to a prognostic cancer marker than Document A's fever/immune regulation topic.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446286Z"}
{"comparison_id":"31c8a92f-176d-40cd-bdec-e4a79fc3d4e9","query_id":"53","doc_a_id":"5765455","doc_b_id":"6766459","presented_order":["5765455","6766459"],"winner_id":"5765455","reasoning":"Document A — it concerns cancer progression and genomic instability (though in leukemia), which is more related to prognostic cancer markers than Document B's focus on fever/thermomiRs.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:24.446293Z"}
{"comparison_id":"e927f0e6-00d0-405d-bda2-5ae3857754a3","query_id":"53","doc_a_id":"11615422","doc_b_id":"40901687","presented_order":["11615422","40901687"],"winner_id":"11615422","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is marginally more relevant because it addresses cancer gene alterations, whereas Document B focuses on a DNA damage–response pathway without ties to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711735Z"}
{"comparison_id":"66fa1926-dce0-482c-80a2-85e6ca62a771","query_id":"53","doc_a_id":"23665162","doc_b_id":"40901687","presented_order":["23665162","40901687"],"winner_id":"23665162","reasoning":"Neither document mentions ALDH1 or breast cancer, so neither is truly relevant. Document A is marginally more relevant because it reports an association study linking a molecular marker with cancer risk, similar in type to the query.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711756Z"}
{"comparison_id":"37c97201-984a-4484-a6cf-647f21be6afa","query_id":"53","doc_a_id":"8677721","doc_b_id":"40901687","presented_order":["8677721","40901687"],"winner_id":"8677721","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document A deals with cancer progression and tumor growth (more related to prognosis) while Document B focuses on a DNA damage signaling mechanism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711765Z"}
{"comparison_id":"7d12114a-17b4-4fc8-a3e3-9371ff7e8f83","query_id":"53","doc_a_id":"14471161","doc_b_id":"40901687","presented_order":["40901687","14471161"],"winner_id":"40901687","reasoning":"Document A is slightly more related because it discusses cancer-relevant DNA damage response pathways, whereas Document B focuses on meal timing effects in pancreatic cancer; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711772Z"}
{"comparison_id":"71bb9c35-85e5-4823-843b-42595485c5b3","query_id":"53","doc_a_id":"23577867","doc_b_id":"40901687","presented_order":["23577867","40901687"],"winner_id":"23577867","reasoning":"Document A is more relevant — it deals with cancer risk and biomarker associations (though in endometrial cancer), whereas Document B focuses on a molecular DNA repair mechanism unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711781Z"}
{"comparison_id":"2e091b58-0530-4af6-84e5-5ddcd4167104","query_id":"53","doc_a_id":"2272614","doc_b_id":"40901687","presented_order":["40901687","2272614"],"winner_id":"40901687","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular pathways (DNA damage response) that could relate to prognosis, whereas Document B focuses on EGFR inhibitor resistance in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711788Z"}
{"comparison_id":"73b66463-7a77-4622-a57c-e1a611cd7996","query_id":"53","doc_a_id":"24349430","doc_b_id":"40901687","presented_order":["40901687","24349430"],"winner_id":"24349430","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Both are irrelevant; B is marginally more relevant only in that it studies cancer cell behavior (though in lung cells), not ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711795Z"}
{"comparison_id":"006e11af-2c5a-4c03-9f92-4f5afa5da8af","query_id":"53","doc_a_id":"1507222","doc_b_id":"40901687","presented_order":["1507222","40901687"],"winner_id":"40901687","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document B is slightly more related to cancer signaling mechanisms. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711802Z"}
{"comparison_id":"1e47197f-e85a-41aa-80e4-810bbfdcff38","query_id":"53","doc_a_id":"14180565","doc_b_id":"40901687","presented_order":["14180565","40901687"],"winner_id":"14180565","reasoning":"Reason: Neither paper addresses ALDH1 or breast cancer. Document A is a gene expression study (more likely to include ALDH1 data) while B focuses on PHD3/HCLK2 DNA-damage signaling unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711809Z"}
{"comparison_id":"58f4e8a3-43b9-4807-ab04-20db34ad5a52","query_id":"53","doc_a_id":"641786","doc_b_id":"40901687","presented_order":["641786","40901687"],"winner_id":"40901687","reasoning":"Neither document mentions ALDH1 or breast cancer, so neither provides evidence for or against the claim. Document B is slightly more related to cancer biology (DNA damage/apoptosis) than A, which is specific to childhood ALL mutations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711817Z"}
{"comparison_id":"b52e8616-f72b-4dcb-abb5-daaa0df91829","query_id":"53","doc_a_id":"32852283","doc_b_id":"40901687","presented_order":["40901687","32852283"],"winner_id":"40901687","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis; both are irrelevant. Document A is slightly more relevant as it addresses cancer-related molecular pathways, while B focuses on NSCLC therapy.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711824Z"}
{"comparison_id":"30d827c0-c0a0-4139-8a0f-8b1626e34fbd","query_id":"53","doc_a_id":"23509593","doc_b_id":"40901687","presented_order":["40901687","23509593"],"winner_id":"40901687","reasoning":"Reason: Document A deals with cancer-related DNA damage response pathways, which is more relevant to prognosis in breast cancer than Document B's focus on androgen regulation in prostate stromal cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711831Z"}
{"comparison_id":"dbd56f77-118f-4579-bc35-b0e169e75383","query_id":"53","doc_a_id":"25628793","doc_b_id":"40901687","presented_order":["25628793","40901687"],"winner_id":"40901687","reasoning":"Document B is more relevant — it addresses cancer-related DNA damage and signaling pathways, whereas Document A focuses on CYP enzymes in endometriosis; neither mentions ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711838Z"}
{"comparison_id":"b91bc82c-734e-4767-a5b5-8b715962612b","query_id":"53","doc_a_id":"4841908","doc_b_id":"40901687","presented_order":["4841908","40901687"],"winner_id":"4841908","reasoning":"Reason: Neither abstract addresses ALDH1 or breast cancer directly, but Document A explicitly mentions cancer (not associated), making it slightly more relevant than B which focuses on PHD3/HCLK2 and DNA damage.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711845Z"}
{"comparison_id":"581c946b-10a9-434c-a5fe-0f985805537f","query_id":"53","doc_a_id":"14938990","doc_b_id":"40901687","presented_order":["40901687","14938990"],"winner_id":"40901687","reasoning":"Document A — it's cancer/DNA damage–related, whereas Document B is about autoimmune disease (SLE), neither mentions ALDH1 or breast cancer, but A is more related. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711852Z"}
{"comparison_id":"561b8dba-6124-40df-b208-f4ede31f1114","query_id":"53","doc_a_id":"19368793","doc_b_id":"40901687","presented_order":["40901687","19368793"],"winner_id":"40901687","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis, but Document A concerns cancer-related DNA damage pathways (more generally relevant) while Document B focuses on HCC miRNAs. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711859Z"}
{"comparison_id":"0a55b0da-648e-4d79-b3e7-789009621f8c","query_id":"53","doc_a_id":"4959368","doc_b_id":"40901687","presented_order":["4959368","40901687"],"winner_id":"40901687","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer; Document B addresses a cancer-related molecular pathway (DNA damage response), making it marginally more relevant than Document A, which focuses on BCAAs and pancreatic cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711867Z"}
{"comparison_id":"6035ac8c-5712-4ca5-bd26-5b05ec9f2038","query_id":"53","doc_a_id":"6363093","doc_b_id":"40901687","presented_order":["6363093","40901687"],"winner_id":"6363093","reasoning":"Document A is slightly more relevant because it concerns cancer subclassification and protein expression patterns, whereas Document B focuses on a specific DNA damage response mechanism unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711874Z"}
{"comparison_id":"a71b1f1c-d6cd-407f-bea1-e80f1dcf06bd","query_id":"53","doc_a_id":"4387494","doc_b_id":"40901687","presented_order":["4387494","40901687"],"winner_id":"40901687","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. If one must be chosen, B is slightly more generally cancer-related (DNA damage response), so:\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711881Z"}
{"comparison_id":"fdd23eec-d9c9-48d5-b81c-9f9a5bab2da6","query_id":"53","doc_a_id":"13905670","doc_b_id":"40901687","presented_order":["40901687","13905670"],"winner_id":"40901687","reasoning":"Document A is more related to cancer biology (DNA damage response and apoptosis) than Document B, which is about inflammatory/infectious disease prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711887Z"}
{"comparison_id":"d46755d5-9582-4ab9-8fa8-1cdb1c496720","query_id":"53","doc_a_id":"663464","doc_b_id":"40901687","presented_order":["40901687","663464"],"winner_id":"40901687","reasoning":"Document A is slightly more relevant — it discusses molecular cancer-related pathways (DNA damage response/therapeutic targets), whereas Document B concerns aging-related microRNAs unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711894Z"}
{"comparison_id":"dd33a993-ce70-4bd8-b03f-e0aaf030a96e","query_id":"53","doc_a_id":"16016673","doc_b_id":"40901687","presented_order":["16016673","40901687"],"winner_id":"16016673","reasoning":"Document A is slightly more relevant because it concerns cancer biomarkers (though for bladder, not breast), whereas Document B focuses on a DNA damage–response mechanism unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711901Z"}
{"comparison_id":"b04afe6d-ae08-4d68-8346-00a0907e6ab3","query_id":"53","doc_a_id":"1976183","doc_b_id":"40901687","presented_order":["40901687","1976183"],"winner_id":"1976183","reasoning":"Document B — it discusses an expression biomarker linked to aggressive cancer behavior (though in oral cancer), which is more related to the claim about marker expression and prognosis than Document A's DNA-damage mechanism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711909Z"}
{"comparison_id":"056bc965-f63a-4560-b09c-53dc5a11984a","query_id":"53","doc_a_id":"17876040","doc_b_id":"40901687","presented_order":["40901687","17876040"],"winner_id":"40901687","reasoning":"Document A — it discusses a cancer-related molecular pathway (DNA damage response) and is closer to tumor biology, whereas Document B is focused on an AML drug and neither mentions ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711915Z"}
{"comparison_id":"e9e31354-685c-4aa5-929f-debb40ba2262","query_id":"53","doc_a_id":"7020505","doc_b_id":"40901687","presented_order":["40901687","7020505"],"winner_id":"40901687","reasoning":"Document A — it relates to cancer-relevant molecular pathways (DNA damage response), whereas Document B focuses on CLL genetics and is unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711922Z"}
{"comparison_id":"5155230f-4bd4-49af-bc30-6fe6786f2fe3","query_id":"53","doc_a_id":"57783564","doc_b_id":"40901687","presented_order":["40901687","57783564"],"winner_id":"40901687","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it addresses cancer-related signaling/DNA damage pathways rather than colon-specific transcriptional regulation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711930Z"}
{"comparison_id":"8b126389-2659-49fc-9d6e-e4e0f8f1341e","query_id":"53","doc_a_id":"16853734","doc_b_id":"40901687","presented_order":["16853734","40901687"],"winner_id":"16853734","reasoning":"Document A is more relevant — it discusses stem cell behavior in cancer (MSC migration), which is tangentially related to ALDH1 as a stem-cell marker; Document B focuses on DNA damage signaling unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711937Z"}
{"comparison_id":"3fbfdab3-7d8c-4926-94e2-2a8c90459316","query_id":"53","doc_a_id":"14848619","doc_b_id":"40901687","presented_order":["40901687","14848619"],"winner_id":"40901687","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is marginally more relevant because it addresses cancer-related DNA damage response and apoptosis, which can relate to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711944Z"}
{"comparison_id":"238c72e4-6952-4748-9b76-64382276b46e","query_id":"53","doc_a_id":"24624992","doc_b_id":"40901687","presented_order":["24624992","40901687"],"winner_id":"24624992","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is marginally closer because it concerns gene expression differences in cancer cells; B focuses on a DNA damage hydroxylation pathway unrelated to the query. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711951Z"}
{"comparison_id":"a318bbf0-a945-4247-b802-acc3d7cdea51","query_id":"53","doc_a_id":"17671145","doc_b_id":"40901687","presented_order":["40901687","17671145"],"winner_id":"40901687","reasoning":"Document A — it discusses a general cancer-relevant DNA damage response pathway (more related to tumor biology) versus Document B which is specific to prostate cancer and androgen receptor. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711958Z"}
{"comparison_id":"17b8638f-0b39-460f-bca4-093f17718d8e","query_id":"53","doc_a_id":"6171953","doc_b_id":"40901687","presented_order":["40901687","6171953"],"winner_id":"40901687","reasoning":"Document A — it addresses cancer-related DNA damage and apoptosis pathways, which is more relevant to cancer prognosis than Document B's focus on nutrient sensing/inflammation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711965Z"}
{"comparison_id":"d031f6c8-21c5-4879-a1e0-21176e6fa80d","query_id":"53","doc_a_id":"8764879","doc_b_id":"40901687","presented_order":["8764879","40901687"],"winner_id":"40901687","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document B is slightly more generally related to cancer-relevant DNA damage pathways, while A is specific to AML/leukemia stem cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711972Z"}
{"comparison_id":"aa64bdd9-6588-4882-a65b-f310e3309ca0","query_id":"53","doc_a_id":"1982286","doc_b_id":"40901687","presented_order":["1982286","40901687"],"winner_id":"40901687","reasoning":"Document B is more relevant — it addresses cancer-related DNA damage/apoptosis pathways that can impact tumor behavior broadly; Document A is specific to T-ALL transcriptional networks and RUNX1.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711979Z"}
{"comparison_id":"5dadc897-1b95-4091-8ed4-65f55d890ad2","query_id":"53","doc_a_id":"67787658","doc_b_id":"40901687","presented_order":["40901687","67787658"],"winner_id":"40901687","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns cancer-related signaling/pathways (DNA damage response) versus Document B which is specific to glioblastoma and chemoresistance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711986Z"}
{"comparison_id":"81829670-f6d4-4be7-b84f-6eb145eb6567","query_id":"53","doc_a_id":"2356950","doc_b_id":"40901687","presented_order":["2356950","40901687"],"winner_id":"40901687","reasoning":"Document B is marginally more relevant because it concerns cancer-related DNA damage response pathways, whereas Document A is about neural stem cell regulation and unrelated to cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711992Z"}
{"comparison_id":"724a0798-ea11-4914-8c54-5ccf51808232","query_id":"53","doc_a_id":"5765455","doc_b_id":"40901687","presented_order":["40901687","5765455"],"winner_id":"40901687","reasoning":"Document A is more relevant — it discusses cancer-related signaling and DNA damage response, whereas Document B focuses on myeloid leukemia progression and ROS; neither addresses ALDH1 or breast cancer prognosis directly. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.711999Z"}
{"comparison_id":"b561a669-dddf-4ca2-8e45-be8af96f6efd","query_id":"53","doc_a_id":"26887439","doc_b_id":"40901687","presented_order":["40901687","26887439"],"winner_id":"26887439","reasoning":"Document B is more relevant — it addresses cancer cell survival and factors affecting tumor cell viability, which is closer to prognosis than A's mechanistic DNA damage–response focus. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712006Z"}
{"comparison_id":"8fe486b7-b170-4415-b786-9efade15f044","query_id":"53","doc_a_id":"9226649","doc_b_id":"40901687","presented_order":["9226649","40901687"],"winner_id":"40901687","reasoning":"Neither document mentions ALDH1 or breast cancer, so both are irrelevant. Document B is marginally more related to cancer biology (DNA damage/prognosis) than A (colitis-associated colorectal tumorigenesis).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712013Z"}
{"comparison_id":"27e8c59f-d47a-403f-b679-163fbe330b29","query_id":"53","doc_a_id":"15215393","doc_b_id":"40901687","presented_order":["40901687","15215393"],"winner_id":"40901687","reasoning":"Document A is slightly more relevant because it addresses cancer-related molecular pathways, whereas Document B focuses on glioblastoma therapy unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712019Z"}
{"comparison_id":"7f0918c1-035b-41b2-a120-0b64b6ae0d49","query_id":"53","doc_a_id":"17911973","doc_b_id":"40901687","presented_order":["17911973","40901687"],"winner_id":"40901687","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it addresses cancer-relevant DNA damage/apoptosis pathways that could affect prognosis, while A focuses on retrotransposons and germline insertions.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712026Z"}
{"comparison_id":"715bdcfa-7986-447c-b4c7-626a954c2b00","query_id":"53","doc_a_id":"28334217","doc_b_id":"40901687","presented_order":["28334217","40901687"],"winner_id":"28334217","reasoning":"Document A is slightly more relevant because it addresses tumor metabolism and treatment effects on cancer progression, whereas Document B focuses on DNA damage signaling unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712033Z"}
{"comparison_id":"78c9da8b-6ebc-4e2c-bd97-5e1de1a0811b","query_id":"53","doc_a_id":"7869794","doc_b_id":"40901687","presented_order":["40901687","7869794"],"winner_id":"40901687","reasoning":"Document A is more relevant — it discusses cancer cell DNA damage response and apoptosis pathways, which are closer to tumor biology and prognosis than neutrophil calcium signaling. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712040Z"}
{"comparison_id":"d764e5e7-3c03-4599-94f0-581de44aee7a","query_id":"53","doc_a_id":"22703082","doc_b_id":"40901687","presented_order":["22703082","40901687"],"winner_id":"40901687","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant, but Document B is slightly more generally related to cancer biology (DNA damage/p53 pathways) than Document A (H. pylori–driven gastric AID expression).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712077Z"}
{"comparison_id":"e6f98fb7-0440-4f38-940b-6ea3a76540ef","query_id":"53","doc_a_id":"3831884","doc_b_id":"40901687","presented_order":["40901687","3831884"],"winner_id":"40901687","reasoning":"Neither document mentions ALDH1 or breast cancer prognosis; both are irrelevant. Document A is marginally more related to cancer biology (DNA damage response), so:\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712091Z"}
{"comparison_id":"f90b3e98-aba9-464b-b294-9eb77da77d03","query_id":"53","doc_a_id":"3504761","doc_b_id":"40901687","presented_order":["3504761","40901687"],"winner_id":"3504761","reasoning":"A is slightly more relevant because it discusses tumorigenesis and cancer-related pathways, whereas B focuses on a DNA damage response mechanism unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712100Z"}
{"comparison_id":"7f44f7dd-c6b9-4440-9f0e-db8cd3dbfc64","query_id":"53","doc_a_id":"10365787","doc_b_id":"40901687","presented_order":["10365787","40901687"],"winner_id":"10365787","reasoning":"Document A is more related to tumor outcome (tumor suppression and susceptibility) while B focuses on a DNA-damage signaling mechanism unrelated to prognosis or ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712108Z"}
{"comparison_id":"d90ceb37-2542-4a18-b47b-d321c36b0b33","query_id":"53","doc_a_id":"1522336","doc_b_id":"40901687","presented_order":["40901687","1522336"],"winner_id":"40901687","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it addresses cancer-related molecular pathways, whereas B focuses on statins in head and neck cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712115Z"}
{"comparison_id":"15bf34d0-98a8-4948-88fe-595ea03a4a31","query_id":"53","doc_a_id":"18682109","doc_b_id":"40901687","presented_order":["18682109","40901687"],"winner_id":"18682109","reasoning":"Document A is marginally more relevant because it discusses cancer progression and prognosis-related changes, while Document B focuses on a DNA damage pathway unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712123Z"}
{"comparison_id":"e94e7bc7-b596-4bb1-8112-d1eaee378302","query_id":"53","doc_a_id":"19427410","doc_b_id":"40901687","presented_order":["19427410","40901687"],"winner_id":"40901687","reasoning":"Document B is more relevant — it addresses cancer-related DNA damage/repair pathways, which are more closely connected to tumor prognosis mechanisms than A's adipocyte/IL-33 focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712130Z"}
{"comparison_id":"64b6a6a5-8baa-4907-8f11-1d2867f991f1","query_id":"53","doc_a_id":"15322518","doc_b_id":"40901687","presented_order":["15322518","40901687"],"winner_id":"15322518","reasoning":"Reason: Document A discusses cancer biology and therapeutic markers/pathways (though in rhabdoid tumors), making it marginally more relevant than Document B, which focuses on a DNA-damage hydroxylation mechanism unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712137Z"}
{"comparison_id":"61fd6979-4e95-4264-a6da-f168dca5e2ba","query_id":"53","doc_a_id":"1617327","doc_b_id":"40901687","presented_order":["40901687","1617327"],"winner_id":"40901687","reasoning":"Neither document mentions ALDH1 or breast cancer; Document A is marginally more relevant because it addresses cancer-related molecular pathways (DNA damage/apoptosis), while B focuses on bone marrow/hematologic disease. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712144Z"}
{"comparison_id":"56fc90ec-c291-4053-b53f-0eaa078fe431","query_id":"53","doc_a_id":"4312169","doc_b_id":"40901687","presented_order":["40901687","4312169"],"winner_id":"40901687","reasoning":"Document A is slightly more relevant — it discusses cancer-related cellular pathways (DNA damage response and apoptosis) that are more generally connected to prognosis and tumor biology, whereas Document B focuses on pediatric glioblastoma genetics unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712152Z"}
{"comparison_id":"bd11919e-d579-4c93-9532-c633dc148fb5","query_id":"53","doc_a_id":"10542877","doc_b_id":"40901687","presented_order":["10542877","40901687"],"winner_id":"10542877","reasoning":"Document A is slightly more relevant because it discusses cancer clinical activity and prognosis-related therapy, whereas Document B focuses on DNA damage signaling unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712159Z"}
{"comparison_id":"85c5be86-cffc-45b4-83b0-b8638e2f3a6d","query_id":"53","doc_a_id":"30543439","doc_b_id":"40901687","presented_order":["40901687","30543439"],"winner_id":"40901687","reasoning":"Document A is more relevant — it discusses cancer-related DNA damage response and apoptosis pathways, which are more directly related to tumor behavior and prognosis than the enzymatic/structural focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712166Z"}
{"comparison_id":"43b3764e-f770-4b7e-bb0c-0e5d630bc6cd","query_id":"53","doc_a_id":"28644298","doc_b_id":"40901687","presented_order":["40901687","28644298"],"winner_id":"40901687","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is marginally more relevant because it addresses cancer-related DNA damage/apoptosis signaling, while B focuses on EBV latency in lymphoid cells. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712173Z"}
{"comparison_id":"0c8a83b9-4f0a-4205-9ad5-f41244aa4a52","query_id":"53","doc_a_id":"19800147","doc_b_id":"40901687","presented_order":["40901687","19800147"],"winner_id":"40901687","reasoning":"Document A is slightly more relevant — it discusses cancer-related signaling and therapeutic implications (whereas Document B focuses specifically on exosomal miR-193a in colon cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712180Z"}
{"comparison_id":"fb72d132-ba5a-4aa0-bfd0-2f450a62ff64","query_id":"53","doc_a_id":"4464565","doc_b_id":"40901687","presented_order":["4464565","40901687"],"winner_id":"4464565","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer, but Document A deals with modulation of gene expression (validated by RT‑PCR/Western blot), making it slightly more relevant to a claim about expression markers than the DNA damage pathway focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712188Z"}
{"comparison_id":"a6ea467a-2759-42f4-b452-8ae5cae53b0c","query_id":"53","doc_a_id":"23326722","doc_b_id":"40901687","presented_order":["40901687","23326722"],"winner_id":"40901687","reasoning":"Document A is marginally more relevant because it addresses cancer-related molecular pathways, whereas B covers clinical features of a different cancer type; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712194Z"}
{"comparison_id":"f955a6ac-a01e-4b13-828f-b7794a5d89cb","query_id":"53","doc_a_id":"22890091","doc_b_id":"40901687","presented_order":["40901687","22890091"],"winner_id":"40901687","reasoning":"Neither abstract mentions ALDH1 or breast cancer; however, A is more cancer-related (DNA damage response and therapeutic implications) while B focuses on normal leukocytes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712201Z"}
{"comparison_id":"ae3c93fe-9ccd-4321-90d3-93f5cf4bb11c","query_id":"53","doc_a_id":"2205779","doc_b_id":"40901687","presented_order":["2205779","40901687"],"winner_id":"40901687","reasoning":"Document B is slightly more related (discusses cancer-relevant molecular pathways and prognosis-related mechanisms), while A focuses on gastric cancer miRNAs. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712209Z"}
{"comparison_id":"291c0c8c-92dc-49f2-9549-c5157b5c645a","query_id":"53","doc_a_id":"19343151","doc_b_id":"40901687","presented_order":["40901687","19343151"],"winner_id":"40901687","reasoning":"Document A is slightly more relevant because it concerns cancer-related DNA damage/apoptosis pathways, whereas Document B is about skin aging biomarkers and unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712216Z"}
{"comparison_id":"0d9d91ac-c000-4731-a7f3-44b2884e1d8a","query_id":"53","doc_a_id":"10450725","doc_b_id":"40901687","presented_order":["10450725","40901687"],"winner_id":"40901687","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document B discusses DNA damage–response pathways relevant across cancers, making it slightly more contextually relevant than a study limited to hepatocellular carcinoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712223Z"}
{"comparison_id":"df2263ee-5a82-40e3-be1c-0ff3d340f118","query_id":"53","doc_a_id":"3701541","doc_b_id":"40901687","presented_order":["40901687","3701541"],"winner_id":"40901687","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant; Document A is marginally more related to cancer biology (DNA damage/apoptosis) but provides no evidence about ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712229Z"}
{"comparison_id":"71bf6494-71d3-4cff-bd83-98cabbf149dd","query_id":"53","doc_a_id":"26059876","doc_b_id":"40901687","presented_order":["26059876","40901687"],"winner_id":"26059876","reasoning":"Document A is slightly more relevant because it discusses tumorigenesis and adenocarcinoma (cancer progression), whereas Document B focuses on a DNA damage signaling mechanism unrelated to ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712236Z"}
{"comparison_id":"ef991f69-17d1-4d82-8ba7-55c1f6d9752d","query_id":"53","doc_a_id":"39225849","doc_b_id":"40901687","presented_order":["39225849","40901687"],"winner_id":"39225849","reasoning":"Neither paper discusses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more related because it mentions a precancerous state and genomic instability, which loosely relates to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712243Z"}
{"comparison_id":"1e097c1d-4533-4836-b607-ddfa6e1437b6","query_id":"53","doc_a_id":"32776084","doc_b_id":"40901687","presented_order":["32776084","40901687"],"winner_id":"40901687","reasoning":"Document B — it addresses cancer-relevant DNA damage and apoptotic pathways (more related to tumor behavior/prognosis) whereas A is about imprinting in mouse ESCs and unrelated to cancer/ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712252Z"}
{"comparison_id":"2b1fc612-eb53-4497-9674-93a8f4812a1f","query_id":"53","doc_a_id":"15491308","doc_b_id":"40901687","presented_order":["40901687","15491308"],"winner_id":"15491308","reasoning":"Document B — neither abstract mentions ALDH1 or breast cancer, but B (stem cell biology) is marginally more related to ALDH1's role as a stem/progenitor cell marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712260Z"}
{"comparison_id":"d7867e79-6b41-447d-817d-634ff7718df5","query_id":"53","doc_a_id":"3863543","doc_b_id":"40901687","presented_order":["40901687","3863543"],"winner_id":"40901687","reasoning":"Document A is slightly more relevant because it addresses DNA damage response pathways in cancer contexts, whereas Document B focuses on hematopoietic stem cell inflammation and pre-leukemia. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712268Z"}
{"comparison_id":"26fbbaa0-3e74-4d2c-927a-21d79886cbfe","query_id":"53","doc_a_id":"25022826","doc_b_id":"40901687","presented_order":["25022826","40901687"],"winner_id":"40901687","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document B is slightly more relevant since DNA damage response pathways are more directly related to cancer biology than MSC osteogenic differentiation.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712275Z"}
{"comparison_id":"e4afe2ab-4ba3-40f2-aa42-4bc2aa6c6b04","query_id":"53","doc_a_id":"12580014","doc_b_id":"40901687","presented_order":["12580014","40901687"],"winner_id":"12580014","reasoning":"Document A is slightly more relevant because it discusses gene expression in tumor epithelial cells, whereas Document B focuses on DNA damage signaling; neither mentions ALDH1 or breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:14:59.712282Z"}
{"comparison_id":"c7148ef9-e8f7-4133-aded-e259cdecbe37","query_id":"53","doc_a_id":"11615422","doc_b_id":"24624992","presented_order":["11615422","24624992"],"winner_id":"11615422","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it deals with cancer gene alterations broadly, while B is specific to leukemia cell lines.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121070Z"}
{"comparison_id":"a911fc4c-f6d2-4416-b1c8-f44d7742d0f3","query_id":"53","doc_a_id":"23665162","doc_b_id":"24624992","presented_order":["24624992","23665162"],"winner_id":"24624992","reasoning":"Document A is marginally more relevant because it discusses gene expression in cancer cells; Document B concerns LINE-1 methylation and hepatocellular carcinoma, which is further from ALDH1 and breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121092Z"}
{"comparison_id":"5ce32d4c-aaae-4fa6-87a4-5809a112ed5f","query_id":"53","doc_a_id":"8677721","doc_b_id":"24624992","presented_order":["8677721","24624992"],"winner_id":"8677721","reasoning":"Document A is slightly more relevant because it discusses cancer progression mechanisms (tumor growth signaling), whereas Document B focuses on retinoic acid responses in leukemia cell lines and is less related to breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121100Z"}
{"comparison_id":"5dcb6fe8-fcb9-467e-b3ed-a94d5455f7f8","query_id":"53","doc_a_id":"23577867","doc_b_id":"24624992","presented_order":["23577867","24624992"],"winner_id":"23577867","reasoning":"Document A is slightly more relevant because it addresses cancer prognosis/risk biomarkers (albeit in endometrial cancer), whereas Document B concerns leukemia cell lines and retinoic acid response. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121108Z"}
{"comparison_id":"c6c723f5-f733-4fdd-872c-fea475878d8d","query_id":"53","doc_a_id":"24349430","doc_b_id":"24624992","presented_order":["24349430","24624992"],"winner_id":"24349430","reasoning":"Neither document mentions ALDH1 or breast cancer, but Document A (lung cancer study) is marginally more related to solid-tumor prognosis than Document B (leukemia). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121114Z"}
{"comparison_id":"16915358-b3e4-48f1-88aa-98c3042ce4c1","query_id":"53","doc_a_id":"14180565","doc_b_id":"24624992","presented_order":["24624992","14180565"],"winner_id":"14180565","reasoning":"Document B is slightly more relevant because it deals with gene expression changes in cancer cells, whereas Document A focuses on a different gene in leukemia cell lines; neither addresses ALDH1 or breast cancer prognosis specifically.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121121Z"}
{"comparison_id":"323c583f-0db0-40cf-be3e-b3b1705d2b69","query_id":"53","doc_a_id":"4841908","doc_b_id":"24624992","presented_order":["4841908","24624992"],"winner_id":"24624992","reasoning":"Document B — it discusses gene expression in cancer cells (though not ALDH1 or breast cancer), while A focuses on longevity/metabolomics and explicitly not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121130Z"}
{"comparison_id":"321040f0-8466-4227-b322-62bf8149dcc0","query_id":"53","doc_a_id":"6363093","doc_b_id":"24624992","presented_order":["6363093","24624992"],"winner_id":"6363093","reasoning":"Document A is slightly more relevant because it deals with cancer subclasses and protein expression patterns (biomarkers) whereas Document B focuses on retinoic acid responses in leukemia cell lines, unrelated to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121137Z"}
{"comparison_id":"61b7ce46-d205-492a-a0f6-f536f96d06c3","query_id":"53","doc_a_id":"16016673","doc_b_id":"24624992","presented_order":["24624992","16016673"],"winner_id":"24624992","reasoning":"Document A is more relevant — it deals with gene expression in cancer cells (though in leukemia), whereas B focuses on bladder cancer methylation markers unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121144Z"}
{"comparison_id":"5105925a-f5d8-4a4a-95c4-c5b043511a37","query_id":"53","doc_a_id":"1976183","doc_b_id":"24624992","presented_order":["1976183","24624992"],"winner_id":"1976183","reasoning":"Document A is slightly more relevant because it addresses cancer biomarker expression and prognosis-related invasive behavior, whereas B concerns leukemia cell lines and retinoic acid responses. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121151Z"}
{"comparison_id":"27c81235-af3a-4f5a-a5e8-d9db241c8030","query_id":"53","doc_a_id":"16853734","doc_b_id":"24624992","presented_order":["16853734","24624992"],"winner_id":"24624992","reasoning":"Document B is marginally more relevant because it addresses gene expression in cancer cells, whereas Document A focuses on MMP1-driven MSC migration toward glioma and not gene expression linked to prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121158Z"}
{"comparison_id":"d6cfff33-b28e-4d07-a989-fddebd3b4918","query_id":"53","doc_a_id":"12580014","doc_b_id":"24624992","presented_order":["12580014","24624992"],"winner_id":"12580014","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant only because it discusses tumor biology, whereas B focuses on leukemia cell lines. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121165Z"}
{"comparison_id":"21408a74-b724-4ba4-819f-4ad1bc115d8b","query_id":"53","doc_a_id":"26887439","doc_b_id":"24624992","presented_order":["24624992","26887439"],"winner_id":"26887439","reasoning":"Neither document mentions ALDH1 or breast cancer, but Document B relates to cancer cell survival/prognostic factors (survivin), making it slightly more relevant. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121172Z"}
{"comparison_id":"c927a316-a510-435b-b3f1-08f3932097a0","query_id":"53","doc_a_id":"28334217","doc_b_id":"24624992","presented_order":["24624992","28334217"],"winner_id":"24624992","reasoning":"Neither document is relevant — neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121178Z"}
{"comparison_id":"8e36d177-b308-481f-83b8-2a9f2bd349e1","query_id":"53","doc_a_id":"3504761","doc_b_id":"24624992","presented_order":["24624992","3504761"],"winner_id":"24624992","reasoning":"Document A — neither document addresses ALDH1 or breast cancer, but A at least concerns gene expression in cancer cells while B focuses on liver metabolism and hepatosteatosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121186Z"}
{"comparison_id":"67017b6d-f79a-4a31-8c14-6558bd381083","query_id":"53","doc_a_id":"10365787","doc_b_id":"24624992","presented_order":["24624992","10365787"],"winner_id":"10365787","reasoning":"Document B is more generally related to cancer prognosis and tumor suppression, whereas A concerns retinoic acid responses in leukemia cell lines and not breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121192Z"}
{"comparison_id":"18750826-0c8e-4318-bfbf-e32b290f2327","query_id":"53","doc_a_id":"18682109","doc_b_id":"24624992","presented_order":["24624992","18682109"],"winner_id":"24624992","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses gene expression and cellular phenotype, whereas B focuses on RB loss in EGFR-mutant lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121199Z"}
{"comparison_id":"ea0980ce-9a5d-4ec9-908a-8a16fa5041ad","query_id":"53","doc_a_id":"15322518","doc_b_id":"24624992","presented_order":["24624992","15322518"],"winner_id":"15322518","reasoning":"Reason: Both abstracts are unrelated to ALDH1 or breast cancer prognosis, but B is at least cancer-focused (therapeutics), whereas A concerns leukemia cell lines.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121206Z"}
{"comparison_id":"94dac889-63d6-4ef9-a4bc-7e3127c9cafc","query_id":"53","doc_a_id":"10542877","doc_b_id":"24624992","presented_order":["24624992","10542877"],"winner_id":"10542877","reasoning":"Document B is slightly more relevant — it deals with cancer clinical activity and prognosis-related therapy, whereas A concerns a different gene and leukemia cell lines, not breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121213Z"}
{"comparison_id":"e62d2ab1-3da0-4858-9577-80ccb6151c31","query_id":"53","doc_a_id":"4464565","doc_b_id":"24624992","presented_order":["4464565","24624992"],"winner_id":"4464565","reasoning":"Neither document directly addresses ALDH1 or breast cancer prognosis, but Document A is slightly more relevant because it examines gene expression changes in a cancer-derived cell line (including oxidative/enzymatic genes), whereas Document B focuses on a different gene in leukemia cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121220Z"}
{"comparison_id":"f45110f5-81f1-4eef-b77d-f58cf7fccc1b","query_id":"53","doc_a_id":"26059876","doc_b_id":"24624992","presented_order":["24624992","26059876"],"winner_id":"26059876","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant only because it concerns tumorigenesis mechanisms, whereas A focuses on leukemia cell line responses to retinoic acid. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121227Z"}
{"comparison_id":"b31820e4-7d00-4775-aa0f-d3d5315c7b25","query_id":"53","doc_a_id":"39225849","doc_b_id":"24624992","presented_order":["39225849","24624992"],"winner_id":"39225849","reasoning":"Document A is slightly more relevant — it discusses cancer-related genomic instability and a precancerous state, whereas Document B is specific to leukemia cell lines and retinoic acid response. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121233Z"}
{"comparison_id":"fc185889-bc81-46ed-ae37-977069d3854e","query_id":"53","doc_a_id":"15491308","doc_b_id":"24624992","presented_order":["24624992","15491308"],"winner_id":"15491308","reasoning":"B is slightly more relevant because it concerns stem-cell biology (ALDH1 is a stem-cell marker), whereas A focuses on leukemia-specific IEX-1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:22.121240Z"}
{"comparison_id":"4ea182ac-e3fb-45a3-bdc6-fc79963ead97","query_id":"53","doc_a_id":"11615422","doc_b_id":"12580014","presented_order":["12580014","11615422"],"winner_id":"12580014","reasoning":"Document A is slightly more related because it discusses gene expression in tumor epithelial cells, whereas Document B focuses on PAX5 rearrangements in leukemia unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:33.213871Z"}
{"comparison_id":"52b1c0a8-8d2e-4aeb-9b5f-7287fe470056","query_id":"53","doc_a_id":"8677721","doc_b_id":"12580014","presented_order":["12580014","8677721"],"winner_id":"8677721","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document B is slightly more relevant because it addresses cancer progression mechanisms, while A is specific to skin keratinocytes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:33.213892Z"}
{"comparison_id":"5df445f0-c48a-43b4-a380-e78d12e546b1","query_id":"53","doc_a_id":"23577867","doc_b_id":"12580014","presented_order":["12580014","23577867"],"winner_id":"12580014","reasoning":"Document A is slightly more relevant because it addresses tumor cell gene expression and tumor development (though in skin, not breast) while Document B concerns metabolic biomarkers and endometrial cancer risk, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:33.213901Z"}
{"comparison_id":"483b9121-c8e9-4b85-b066-c6ef1576f79e","query_id":"53","doc_a_id":"24349430","doc_b_id":"12580014","presented_order":["12580014","24349430"],"winner_id":"12580014","reasoning":"Document A is slightly more relevant because it deals with tumor keratinocyte gene expression and tumor development (cancer-related biology), whereas Document B focuses on calcium signaling in lung cancer cell proliferation; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:33.213909Z"}
{"comparison_id":"b50dadb6-d4bb-4f7b-9f03-86f01f7061fb","query_id":"53","doc_a_id":"14180565","doc_b_id":"12580014","presented_order":["14180565","12580014"],"winner_id":"12580014","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it deals with gene regulation in tumor epithelial cells (skin), which is closer to breast cancer biology than a glioblastoma study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:33.213916Z"}
{"comparison_id":"e93c0837-93a4-4e77-8fe9-153863ba6425","query_id":"53","doc_a_id":"6363093","doc_b_id":"12580014","presented_order":["12580014","6363093"],"winner_id":"12580014","reasoning":"Neither document addresses ALDH1 or breast cancer directly; both are irrelevant. Document A is marginally more relevant because it deals with gene expression in epithelial tumors, whereas B focuses on glioblastoma subclasses. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:33.213924Z"}
{"comparison_id":"7e1d2ff0-3c02-4e4a-ad4f-99f1c6917c00","query_id":"53","doc_a_id":"1976183","doc_b_id":"12580014","presented_order":["12580014","1976183"],"winner_id":"1976183","reasoning":"Document B — it discusses a cancer biomarker linked to invasive behavior and worse outcomes (lymph node metastasis), so it's slightly more relevant than Document A, which is about skin keratin regulation and not cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:33.213934Z"}
{"comparison_id":"9c62a2c9-5e94-4542-b853-5f7e057c8879","query_id":"53","doc_a_id":"15491308","doc_b_id":"12580014","presented_order":["12580014","15491308"],"winner_id":"12580014","reasoning":"Document A is slightly more relevant — it deals with tumor keratinocyte gene expression and tumor development, whereas B focuses on MSC senescence; neither mentions ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:33.213941Z"}
{"comparison_id":"fa1a51cf-929a-43a7-aaac-b110c6d38773","query_id":"53","doc_a_id":"26887439","doc_b_id":"12580014","presented_order":["12580014","26887439"],"winner_id":"26887439","reasoning":"Neither document mentions ALDH1 or breast cancer, so neither provides evidence for the claim. Document B is slightly more relevant only because it concerns a cancer survival marker (survivin) tied to prognosis-related biology. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:33.213948Z"}
{"comparison_id":"53b7abed-241e-46c9-8087-6afa6b52ed73","query_id":"53","doc_a_id":"10365787","doc_b_id":"12580014","presented_order":["10365787","12580014"],"winner_id":"10365787","reasoning":"Document A is more relevant — it discusses tumor suppression and factors affecting tumor development and prognosis broadly, whereas Document B is specific to skin keratinocytes and not related to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:33.213956Z"}
{"comparison_id":"12d589fc-94dd-4e19-bdb5-94a5b682ba36","query_id":"53","doc_a_id":"15322518","doc_b_id":"12580014","presented_order":["12580014","15322518"],"winner_id":"15322518","reasoning":"Neither document mentions ALDH1 or breast cancer. Both are irrelevant, but B is slightly more related to cancer prognosis/therapy topics than A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:33.213964Z"}
{"comparison_id":"e0b9db55-ce55-4271-97fd-1a4db12c8bf5","query_id":"53","doc_a_id":"10542877","doc_b_id":"12580014","presented_order":["10542877","12580014"],"winner_id":"10542877","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document A is marginally more relevant because it addresses cancer biology/therapy broadly, while B focuses specifically on skin keratinocytes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:33.213970Z"}
{"comparison_id":"3150c7d1-503a-4426-8a3a-23bc8680746c","query_id":"53","doc_a_id":"4464565","doc_b_id":"12580014","presented_order":["12580014","4464565"],"winner_id":"12580014","reasoning":"Document A is more relevant because it concerns gene regulation in tumor keratinocytes and tumor development, which is closer to cancer prognosis context than a study of cocoa polyphenols in intestinal Caco-2 cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:33.213977Z"}
{"comparison_id":"8b64af7d-38b4-4f14-ab30-1aa7886efd87","query_id":"53","doc_a_id":"26059876","doc_b_id":"12580014","presented_order":["12580014","26059876"],"winner_id":"12580014","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant because it discusses gene expression in epithelial tumors, whereas B focuses on colorectal homeostasis and Ku70.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:33.213984Z"}
{"comparison_id":"07748d39-764a-4928-8ca8-c573d999024b","query_id":"53","doc_a_id":"39225849","doc_b_id":"12580014","presented_order":["39225849","12580014"],"winner_id":"39225849","reasoning":"Document A is slightly more relevant because it discusses cancer-related genomic instability and precancerous states, whereas Document B is specific to skin tumor keratinocytes; neither addresses ALDH1 or breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:33.213991Z"}
{"comparison_id":"99605a8f-2c94-4a07-8d99-2e78dffac081","query_id":"53","doc_a_id":"8677721","doc_b_id":"10365787","presented_order":["8677721","10365787"],"winner_id":"10365787","reasoning":"Document B is more relevant — it discusses general mechanisms of tumor suppression and genomic stability that relate to cancer prognosis, whereas A focuses specifically on hepatocellular carcinoma signaling not breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:43.028694Z"}
{"comparison_id":"91471bbc-d64c-4db8-b1f4-b88d67c80cb0","query_id":"53","doc_a_id":"1976183","doc_b_id":"10365787","presented_order":["10365787","1976183"],"winner_id":"10365787","reasoning":"Document A is slightly more relevant because it addresses tumor suppression and cancer-related prognosis mechanisms, whereas Document B focuses on microRNA in oral cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:43.028716Z"}
{"comparison_id":"8c4a0901-a8c7-4bd6-a3af-f2978586aa6f","query_id":"53","doc_a_id":"26887439","doc_b_id":"10365787","presented_order":["10365787","26887439"],"winner_id":"10365787","reasoning":"Document A is slightly more relevant because it addresses tumor suppression and genomic stability in cancer broadly, whereas Document B focuses narrowly on survivin in K-Ras-transformed cells (not breast prognosis). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:43.028725Z"}
{"comparison_id":"493cb727-9cb7-4e54-8a68-2560b7b86d9c","query_id":"53","doc_a_id":"39225849","doc_b_id":"10365787","presented_order":["10365787","39225849"],"winner_id":"10365787","reasoning":"Document A is more relevant — it discusses tumor suppression and genomic instability linked to tumor susceptibility, which is closer to prognosis in cancer than the replication-stress focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:43.028733Z"}
{"comparison_id":"2847c955-ddb1-4e02-ae45-fa2a4ae3b2c6","query_id":"53","doc_a_id":"15322518","doc_b_id":"10365787","presented_order":["15322518","10365787"],"winner_id":"10365787","reasoning":"Document B. Reason: Neither abstract mentions ALDH1 or breast cancer, but B addresses general tumor suppression/genomic stability (more broadly related to cancer prognosis) while A is specific to rhabdoid tumors and RTK targeting. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:43.028740Z"}
{"comparison_id":"b1828dbd-ce4d-4866-9ce5-2d54dc81187f","query_id":"53","doc_a_id":"10542877","doc_b_id":"10365787","presented_order":["10365787","10542877"],"winner_id":"10365787","reasoning":"Document A is slightly more relevant — it addresses tumor biology and factors affecting tumor suppression and genomic stability, which are more directly related to prognosis than a therapy-focused paper on other cancer types.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:43.028747Z"}
{"comparison_id":"e82ed4ad-8e93-43fd-8822-7dd9b82c35cf","query_id":"53","doc_a_id":"8677721","doc_b_id":"26887439","presented_order":["26887439","8677721"],"winner_id":"26887439","reasoning":"Document A — it at least discusses cancer survival mechanisms, whereas Document B focuses on hepatocellular carcinoma and β-catenin with no general breast cancer relevance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:49.597149Z"}
{"comparison_id":"1be71f4c-041a-415e-ac61-71a31af248a5","query_id":"53","doc_a_id":"1976183","doc_b_id":"26887439","presented_order":["1976183","26887439"],"winner_id":"1976183","reasoning":"Reason: Document A discusses a biomarker linked to metastasis and prognosis in cancer (though oral cancer), which is closer to a claim about a prognostic marker than Document B's focus on survivin in K-Ras-transformed cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:49.597170Z"}
{"comparison_id":"54b25ffc-dffa-4b8b-80c1-b4f56949517d","query_id":"53","doc_a_id":"10542877","doc_b_id":"26887439","presented_order":["26887439","10542877"],"winner_id":"26887439","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it discusses a cancer-associated marker (survivin) and tumor cell survival/prognosis, whereas B focuses on a STAT3 inhibitor in lymphoma/lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:49.597178Z"}
{"comparison_id":"37855ef8-e747-4383-8e70-6b60f5cb88d5","query_id":"53","doc_a_id":"39225849","doc_b_id":"26887439","presented_order":["39225849","26887439"],"winner_id":"26887439","reasoning":"Document B — it addresses cancer cell survival and factors that affect tumor outcome; Document A focuses on BLM-related replication stress, not prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:49.597186Z"}
{"comparison_id":"9073b464-8745-4e8e-8108-88338a8fc4f7","query_id":"53","doc_a_id":"15322518","doc_b_id":"26887439","presented_order":["15322518","26887439"],"winner_id":"26887439","reasoning":"Document B is more relevant — it addresses cancer cell survival and prognostic-related pathways, whereas A is specific to rhabdoid tumors and RTKs, not prognosis markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:49.597193Z"}
{"comparison_id":"c883b7da-c741-4e6d-ab46-e32fa3231f4b","query_id":"53","doc_a_id":"8677721","doc_b_id":"10542877","presented_order":["8677721","10542877"],"winner_id":"10542877","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it concerns a cancer-related biomarker/therapy, whereas A focuses on NDRG1 in hepatocellular carcinoma mechanistic biology.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:54.598376Z"}
{"comparison_id":"43d86fbe-c96d-403c-9951-bd392b8f6fac","query_id":"53","doc_a_id":"15322518","doc_b_id":"10542877","presented_order":["10542877","15322518"],"winner_id":"10542877","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Both are irrelevant; Document A is marginally more related (general cancer clinical activity).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:54.598396Z"}
{"comparison_id":"0c9fa7fc-f4da-463b-b54d-3e7c5da0148a","query_id":"53","doc_a_id":"39225849","doc_b_id":"10542877","presented_order":["39225849","10542877"],"winner_id":"10542877","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis; both are irrelevant. Document B is slightly more related to cancer clinical outcomes (therapeutics), so it is marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:15:54.598404Z"}
{"comparison_id":"323a9802-37a3-40b0-acd6-45bca3e093e8","query_id":"53","doc_a_id":"8677721","doc_b_id":"15322518","presented_order":["15322518","8677721"],"winner_id":"8677721","reasoning":"Document B. It discusses a molecular tumor-promoting marker and prognosis-related biology, whereas A focuses on RTK targeting in malignant rhabdoid tumors and is unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:01.850148Z"}
{"comparison_id":"d554f073-8dfd-4e73-876c-c58b29775b30","query_id":"53","doc_a_id":"39225849","doc_b_id":"15322518","presented_order":["39225849","15322518"],"winner_id":"39225849","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it addresses cancer-related genomic instability, whereas B focuses on therapy for a different tumor type. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:01.850168Z"}
{"comparison_id":"d8d71fb4-9ca2-41f5-a135-f6d88d562e08","query_id":"53","doc_a_id":"8677721","doc_b_id":"39225849","presented_order":["8677721","39225849"],"winner_id":"8677721","reasoning":"Document A discusses tumor progression and oncogenic signaling (cancer prognosis/targets), while Document B concerns DNA replication stress unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:07.449580Z"}
{"comparison_id":"56862f20-4827-4f8e-b2af-0c613d808055","query_id":"53","doc_a_id":"11615422","doc_b_id":"14180565","presented_order":["11615422","14180565"],"winner_id":"14180565","reasoning":"Document B is marginally more relevant — it concerns gene expression profiling in cancer cells (though in glioblastoma, not breast cancer, and doesn't mention ALDH1). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:18.386747Z"}
{"comparison_id":"81975051-aad4-4b43-96b1-fc8f70ebde3a","query_id":"53","doc_a_id":"23577867","doc_b_id":"14180565","presented_order":["14180565","23577867"],"winner_id":"14180565","reasoning":"Neither document directly addresses ALDH1 or breast cancer. Document A is slightly more relevant because it deals with gene expression changes in cancer cells, whereas Document B concerns metabolic biomarkers and endometrial cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:18.386770Z"}
{"comparison_id":"e044e14b-e0f9-4a34-aff5-70894788e7c1","query_id":"53","doc_a_id":"24349430","doc_b_id":"14180565","presented_order":["14180565","24349430"],"winner_id":"14180565","reasoning":"Neither abstract reports on ALDH1 or breast cancer; both are irrelevant. Of the two, Document A (gene expression profiling) is slightly more related to expression studies.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:18.386779Z"}
{"comparison_id":"d8330935-8aae-4600-bbf3-f4b7280128bb","query_id":"53","doc_a_id":"26059876","doc_b_id":"14180565","presented_order":["26059876","14180565"],"winner_id":"14180565","reasoning":"Document B is slightly more relevant because it profiles gene expression in cancer cells (possible overlap with stem-cell markers like ALDH1), whereas Document A concerns Ku70 in colorectal homeostasis and not gene expression or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:18.386787Z"}
{"comparison_id":"661fa709-c1d3-4a30-8f76-fb091a39bca9","query_id":"53","doc_a_id":"6363093","doc_b_id":"14180565","presented_order":["6363093","14180565"],"winner_id":"6363093","reasoning":"Neither document addresses ALDH1 or breast cancer; both focus on glioblastoma. Document A is slightly more relevant because it discusses protein expression patterns and tumor subclass prognosis, whereas B only covers gene changes after treatment.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:18.386795Z"}
{"comparison_id":"bb3fd09f-a4a3-4d84-af9e-f2d9f32d995e","query_id":"53","doc_a_id":"15491308","doc_b_id":"14180565","presented_order":["15491308","14180565"],"winner_id":"15491308","reasoning":"Doc A is slightly more relevant because it concerns stem cell biology (ALDH1 is a stem/progenitor cell marker), whereas Doc B focuses on gene changes in glioblastoma unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:18.386802Z"}
{"comparison_id":"50cb65e9-c8aa-49c4-a0b8-185e27704dfc","query_id":"53","doc_a_id":"4464565","doc_b_id":"14180565","presented_order":["14180565","4464565"],"winner_id":"14180565","reasoning":"Document A is slightly more relevant because it examines gene expression changes in cancer cells (glioblastoma), whereas Document B studies non-cancer intestinal Caco-2 cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:18.386809Z"}
{"comparison_id":"d84b6e8c-ae70-47d7-a741-6199e8cdf42d","query_id":"53","doc_a_id":"6363093","doc_b_id":"15491308","presented_order":["6363093","15491308"],"winner_id":"6363093","reasoning":"Neither abstract addresses ALDH1 or breast cancer. Document A is slightly more relevant because it deals with cancer molecular markers, whereas B focuses on mesenchymal stem cell aging. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:22.891261Z"}
{"comparison_id":"fc126922-f75d-4b86-83c5-71d38fe53904","query_id":"53","doc_a_id":"11615422","doc_b_id":"24349430","presented_order":["11615422","24349430"],"winner_id":"24349430","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant only because it studies protein expression effects in cancer cells, whereas A focuses on PAX5 in leukemia. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:28.574785Z"}
{"comparison_id":"f7bb80bf-7126-4050-814e-1bd78c347c4f","query_id":"53","doc_a_id":"23577867","doc_b_id":"24349430","presented_order":["23577867","24349430"],"winner_id":"23577867","reasoning":"Document A is slightly more relevant because it deals with cancer biomarkers and clinical outcomes (risk/prognosis), whereas Document B is a mechanistic study in lung cancer cells unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:28.574805Z"}
{"comparison_id":"a10bb0d0-2500-44dd-a5e9-0f25b25bc895","query_id":"53","doc_a_id":"4464565","doc_b_id":"24349430","presented_order":["4464565","24349430"],"winner_id":"24349430","reasoning":"Document B is more relevant — it addresses cancer cell biology and expression of cell-cycle markers, whereas Document A studies gene effects in intestinal Caco-2 cells unrelated to breast cancer.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:28.574816Z"}
{"comparison_id":"1b756b84-825b-48b4-b835-f93c8e644ac3","query_id":"53","doc_a_id":"26059876","doc_b_id":"24349430","presented_order":["24349430","26059876"],"winner_id":"26059876","reasoning":"Document B is more relevant. Reason: neither document addresses ALDH1 or breast cancer, but B discusses tumorigenesis and altered expression of cancer-related proteins (e.g., cyclin D1), making it slightly closer in scope to prognostic marker studies. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:28.574823Z"}
{"comparison_id":"4be63442-5415-4762-9f44-af381927b3ca","query_id":"53","doc_a_id":"23577867","doc_b_id":"26059876","presented_order":["23577867","26059876"],"winner_id":"26059876","reasoning":"Neither document is relevant — neither mentions ALDH1 or breast cancer. If one must be chosen, ANSWER: B (slightly more relevant due to molecular tumorigenesis focus).","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:34.293326Z"}
{"comparison_id":"87a43dc8-ac5b-48a0-aaf7-900001736f80","query_id":"53","doc_a_id":"11615422","doc_b_id":"4464565","presented_order":["11615422","4464565"],"winner_id":"11615422","reasoning":"Document A is marginally more relevant because it deals with cancer-related gene alterations (while neither document mentions ALDH1 or breast cancer); Document B focuses on dietary polyphenols in intestinal cells and is unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:39.680460Z"}
{"comparison_id":"6576acf6-47b9-4bf0-a5c2-fe66bdb40c02","query_id":"53","doc_a_id":"23665162","doc_b_id":"16853734","presented_order":["23665162","16853734"],"winner_id":"16853734","reasoning":"Document B is more relevant — it concerns cancer cell behavior and tumor biology (migration), whereas A is about LINE-1 methylation and hepatocellular carcinoma risk, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:44.348613Z"}
{"comparison_id":"db2c6e2e-05e3-43bd-98df-8fb8632f6831","query_id":"53","doc_a_id":"4841908","doc_b_id":"16853734","presented_order":["4841908","16853734"],"winner_id":"16853734","reasoning":"Reason: Neither mentions ALDH1 or breast cancer, but Document B concerns cancer-related protein expression and tumor cell interactions, making it marginally more relevant than Document A (which does not address cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:44.348635Z"}
{"comparison_id":"1f23baf0-da1c-4bc6-9537-df066786d2bc","query_id":"53","doc_a_id":"16016673","doc_b_id":"16853734","presented_order":["16853734","16016673"],"winner_id":"16016673","reasoning":"Document B is slightly more relevant because it deals with cancer biomarkers (epigenetic markers) related to prognosis/diagnosis, whereas Document A focuses on MMP1 and MSC migration in glioma, unrelated to breast cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:44.348644Z"}
{"comparison_id":"5864340c-8dcc-4fcd-b808-33ce01f0e159","query_id":"53","doc_a_id":"18682109","doc_b_id":"16853734","presented_order":["16853734","18682109"],"winner_id":"16853734","reasoning":"Document A — it involves cancer-related cell migration and stem-cell–related biology (MSCs), which is closer to ALDH1's role as a stem/progenitor marker than the lung cancer–specific RB/transformation topic in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:44.348653Z"}
{"comparison_id":"bbdfac08-d22e-4fba-834e-5e6694b2c330","query_id":"53","doc_a_id":"28334217","doc_b_id":"16853734","presented_order":["28334217","16853734"],"winner_id":"28334217","reasoning":"Document A is slightly more relevant — it addresses cancer progression and survival outcomes, whereas Document B focuses on MSC migration toward glioma, unrelated to prognosis or ALDH1/breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:44.348661Z"}
{"comparison_id":"538ae6a5-fe74-42a8-8559-4fea2213f64e","query_id":"53","doc_a_id":"3504761","doc_b_id":"16853734","presented_order":["3504761","16853734"],"winner_id":"3504761","reasoning":"Document A is slightly more relevant — it discusses tumorigenesis and cancer-related pathways (though in liver, not breast), whereas Document B focuses on MSC migration toward glioma.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:44.348668Z"}
{"comparison_id":"e902f79f-02ec-40c4-9687-348163b8f3d5","query_id":"53","doc_a_id":"16016673","doc_b_id":"28334217","presented_order":["28334217","16016673"],"winner_id":"28334217","reasoning":"Document A is slightly more relevant because it discusses tumor enzyme expression and impact on tumor progression/prognosis, whereas Document B focuses on bladder cancer urine markers unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:48.642377Z"}
{"comparison_id":"a7b007e8-b211-4bd7-b997-1bea6f68d631","query_id":"53","doc_a_id":"3504761","doc_b_id":"28334217","presented_order":["3504761","28334217"],"winner_id":"28334217","reasoning":"Document B — it discusses cancer-specific metabolic pathways and tumorigenesis, so it's marginally closer to the query. Neither document mentions ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:48.642399Z"}
{"comparison_id":"34fded46-6244-4244-84ad-af91f3ae37f2","query_id":"53","doc_a_id":"16016673","doc_b_id":"3504761","presented_order":["3504761","16016673"],"winner_id":"3504761","reasoning":"Document A is slightly more relevant because it addresses cancer-related molecular pathways and tumorigenesis (though in liver), whereas Document B concerns bladder cancer diagnostics rather than breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:53.058381Z"}
{"comparison_id":"c9ce7c71-28a9-433c-9617-20ec7bbe2a3c","query_id":"53","doc_a_id":"23665162","doc_b_id":"4841908","presented_order":["23665162","4841908"],"winner_id":"23665162","reasoning":"Document A — it concerns cancer risk and a biomarker, which is more related to the query about a cancer prognostic marker than Document B, which addresses non-cancer longevity/metabolites.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:57.801717Z"}
{"comparison_id":"0b613f84-4eb6-44a2-a0fb-37cbc660920d","query_id":"53","doc_a_id":"18682109","doc_b_id":"4841908","presented_order":["4841908","18682109"],"winner_id":"4841908","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document A at least discusses associations with disease outcomes (and explicitly notes no cancer link), whereas Document B is specific to lung cancer biology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:16:57.801738Z"}
{"comparison_id":"f54c1ea3-f1d1-42d9-8291-167d59f58f66","query_id":"53","doc_a_id":"14471161","doc_b_id":"2356950","presented_order":["2356950","14471161"],"winner_id":"14471161","reasoning":"Document B is more relevant — it concerns cancer biology and tumor gene expression, whereas Document A is about neural stem cell regulation. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427723Z"}
{"comparison_id":"16ae7b34-e0b5-442d-a948-746e165e3fe6","query_id":"53","doc_a_id":"2272614","doc_b_id":"2356950","presented_order":["2356950","2272614"],"winner_id":"2272614","reasoning":"Document B is more relevant because it discusses cancer-related gene expression and treatment outcomes, whereas Document A concerns neural stem cell regulation unrelated to breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427744Z"}
{"comparison_id":"379c57fe-a9d4-4009-ba66-2ac9787d3f30","query_id":"53","doc_a_id":"1507222","doc_b_id":"2356950","presented_order":["1507222","2356950"],"winner_id":"1507222","reasoning":"Reason: Document A relates to cancer biology (tumor-induced changes), while Document B concerns neural stem cell regulation; neither mentions ALDH1 or breast cancer, but A is more cancer-relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427753Z"}
{"comparison_id":"dd014730-e1a5-4c3a-97db-40b620f3f601","query_id":"53","doc_a_id":"641786","doc_b_id":"2356950","presented_order":["641786","2356950"],"winner_id":"641786","reasoning":"Document A is slightly more relevant because it discusses cancer prognosis/relapse (though in leukemia, not breast cancer); Document B is unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427761Z"}
{"comparison_id":"198e51d4-7344-42b0-99cd-06b254775e98","query_id":"53","doc_a_id":"32852283","doc_b_id":"2356950","presented_order":["32852283","2356950"],"winner_id":"32852283","reasoning":"Document A is more relevant — it covers cancer and survival outcomes (though in NSCLC), whereas Document B concerns neural stem cell epigenetics and is unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427769Z"}
{"comparison_id":"5fff5e62-f01d-44f7-9f60-5df997bcd6aa","query_id":"53","doc_a_id":"23509593","doc_b_id":"2356950","presented_order":["2356950","23509593"],"winner_id":"23509593","reasoning":"Document B is marginally more relevant because it deals with cancer-related tissue and gene regulation, while A concerns neural stem cells and miR-184; neither mentions ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427777Z"}
{"comparison_id":"253b511e-1cb0-4343-8dfb-448d9dcd2dab","query_id":"53","doc_a_id":"25628793","doc_b_id":"2356950","presented_order":["25628793","2356950"],"winner_id":"25628793","reasoning":"Document A is slightly more relevant because it addresses hormone-related enzyme expression in reproductive tissues/cancer contexts; Document B concerns neural stem cell regulation and is unrelated to breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427785Z"}
{"comparison_id":"368ec9ac-be74-4086-b965-be9f6f914f24","query_id":"53","doc_a_id":"14938990","doc_b_id":"2356950","presented_order":["14938990","2356950"],"winner_id":"2356950","reasoning":"Document B — it discusses stem cell regulation (miR-184/MBD1), which is more related to stem-cell–associated markers like ALDH1 than Document A's SLE/PD-1 focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427793Z"}
{"comparison_id":"cc85128c-6cc3-45c7-9db1-f9e30bc94819","query_id":"53","doc_a_id":"19368793","doc_b_id":"2356950","presented_order":["2356950","19368793"],"winner_id":"2356950","reasoning":"Doc A is about stem cell regulation (closer to cancer stem cell markers like ALDH1) while Doc B focuses on miRNAs in liver cancer; A is slightly more relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427801Z"}
{"comparison_id":"e14868cb-f583-4d84-8f3c-bd1e728354de","query_id":"53","doc_a_id":"4959368","doc_b_id":"2356950","presented_order":["2356950","4959368"],"winner_id":"4959368","reasoning":"Document B — it discusses cancer-related biomarkers and prognosis, whereas Document A is about neural stem cells and miR-184. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427810Z"}
{"comparison_id":"ca1f9396-1649-450a-a812-376ecb538fe1","query_id":"53","doc_a_id":"4387494","doc_b_id":"2356950","presented_order":["4387494","2356950"],"winner_id":"4387494","reasoning":"Document A is slightly more relevant because it concerns cancer biology/therapy, while Document B concerns neural stem cells; neither discusses ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427818Z"}
{"comparison_id":"56c537a0-bfff-4732-a81c-c5934050c897","query_id":"53","doc_a_id":"13905670","doc_b_id":"2356950","presented_order":["13905670","2356950"],"winner_id":"13905670","reasoning":"Document A is slightly more relevant because it discusses prognosis in human disease contexts, whereas Document B concerns neural stem cell regulation unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427825Z"}
{"comparison_id":"d12f7101-edf4-4275-8a1f-340e13da9862","query_id":"53","doc_a_id":"663464","doc_b_id":"2356950","presented_order":["663464","2356950"],"winner_id":"663464","reasoning":"Document A is more relevant — it discusses biomarker expression and associations with mortality/prognosis, whereas Document B deals with neural stem cell regulation unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427832Z"}
{"comparison_id":"bc4c1047-7634-4eef-9cea-d3bef4f02227","query_id":"53","doc_a_id":"17876040","doc_b_id":"2356950","presented_order":["17876040","2356950"],"winner_id":"17876040","reasoning":"Document A is marginally more relevant because it discusses cancer (though not breast cancer), whereas Document B concerns neural stem cells and epigenetics unrelated to breast cancer or ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427839Z"}
{"comparison_id":"1e57490f-8602-4d1a-975c-85bb653becf2","query_id":"53","doc_a_id":"7020505","doc_b_id":"2356950","presented_order":["7020505","2356950"],"winner_id":"7020505","reasoning":"Document A — it discusses cancer prognostic markers and prognosis (though in CLL, not breast cancer), so it's closer in topic than the neural stem cell paper.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427846Z"}
{"comparison_id":"c9c9dd07-fcac-4c91-b318-e05a7efa7b82","query_id":"53","doc_a_id":"57783564","doc_b_id":"2356950","presented_order":["2356950","57783564"],"winner_id":"2356950","reasoning":"Document A is slightly more relevant because it concerns stem cell regulation (ALDH1 is a cancer stem cell marker), whereas Document B is about colon cancer-specific signaling. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427853Z"}
{"comparison_id":"4fb73783-d7f1-4bc2-ab55-aa9219749a49","query_id":"53","doc_a_id":"14848619","doc_b_id":"2356950","presented_order":["2356950","14848619"],"winner_id":"2356950","reasoning":"Document A — it discusses stem cell regulation (ALDH1 is a stem-cell–related marker), so it's marginally closer in topic than a paper on hypoxic cell death. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427860Z"}
{"comparison_id":"93e7e943-5c23-4efd-a2f6-c47c1bde8f93","query_id":"53","doc_a_id":"17671145","doc_b_id":"2356950","presented_order":["17671145","2356950"],"winner_id":"17671145","reasoning":"Document A is slightly more relevant because it discusses cancer biology (though in prostate cancer), while Document B concerns neural stem cells and not cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427867Z"}
{"comparison_id":"3eca1b22-659d-4558-8e99-b5d26dc96f46","query_id":"53","doc_a_id":"6171953","doc_b_id":"2356950","presented_order":["2356950","6171953"],"winner_id":"2356950","reasoning":"Document A is slightly more relevant because it addresses stem cell proliferation/differentiation (ALDH1 is a cancer stem cell marker), whereas Document B focuses on nutrient sensing/inflammation unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427874Z"}
{"comparison_id":"944bc234-9fb3-4b17-944d-37ae6dbafa01","query_id":"53","doc_a_id":"8764879","doc_b_id":"2356950","presented_order":["8764879","2356950"],"winner_id":"8764879","reasoning":"Document A is more relevant — it deals with cancer stem cells and prognostic/therapeutic markers in leukemia, which is closer to the cancer/prognosis topic than Document B's neural stem cell epigenetics. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427881Z"}
{"comparison_id":"a86aba8c-4e11-4002-affd-6053274d86de","query_id":"53","doc_a_id":"1982286","doc_b_id":"2356950","presented_order":["1982286","2356950"],"winner_id":"1982286","reasoning":"Document A is marginally more relevant because it deals with cancer-related transcriptional networks and tumor suppressors, whereas Document B concerns neural stem cell regulation and not cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427888Z"}
{"comparison_id":"ad8dd6f0-dd7c-4680-8dea-0f0ffb07b0c2","query_id":"53","doc_a_id":"67787658","doc_b_id":"2356950","presented_order":["67787658","2356950"],"winner_id":"67787658","reasoning":"Document A is slightly more relevant because it addresses cancer-related molecular mechanisms, while Document B focuses on neural stem cell regulation; neither directly discusses ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427895Z"}
{"comparison_id":"efac0eae-adec-4e4e-9ce4-a3f16e5eaa5f","query_id":"53","doc_a_id":"25022826","doc_b_id":"2356950","presented_order":["25022826","2356950"],"winner_id":"25022826","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis; both are irrelevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427901Z"}
{"comparison_id":"74157a35-ad2c-4b8b-bd71-d5ff1d7974f6","query_id":"53","doc_a_id":"5765455","doc_b_id":"2356950","presented_order":["5765455","2356950"],"winner_id":"5765455","reasoning":"Document A is more relevant — it deals with cancer biology (leukemia) and pathways linked to tumor progression, whereas Document B concerns neural stem cell regulation and not cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427908Z"}
{"comparison_id":"525e58c9-e97b-4696-9c76-986b6c7256ad","query_id":"53","doc_a_id":"9226649","doc_b_id":"2356950","presented_order":["9226649","2356950"],"winner_id":"9226649","reasoning":"Reason: Both abstracts do not address ALDH1 or breast cancer, but Document A concerns tumorigenesis (cancer) whereas B is about neural stem cells, so A is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427914Z"}
{"comparison_id":"a5276b48-0978-407c-bd72-d78d50cc7212","query_id":"53","doc_a_id":"15215393","doc_b_id":"2356950","presented_order":["2356950","15215393"],"winner_id":"15215393","reasoning":"Document B — it concerns cancer and an enzyme-related marker/therapy (more closely related to prognosis biomarkers) while Document A is about neural stem cell regulation and unrelated to cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427922Z"}
{"comparison_id":"0284b7df-8249-466b-bb80-fdc4c380bcd3","query_id":"53","doc_a_id":"17911973","doc_b_id":"2356950","presented_order":["2356950","17911973"],"winner_id":"17911973","reasoning":"Document B — it addresses cancer-related genomic changes (though in lung cancer) and is more related to cancer biology than the neural stem cell focus of Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427929Z"}
{"comparison_id":"e67c0e59-dd03-485b-a340-e332f3f4ad16","query_id":"53","doc_a_id":"7869794","doc_b_id":"2356950","presented_order":["2356950","7869794"],"winner_id":"7869794","reasoning":"Document B is slightly more relevant because it discusses tumor cell–immune interactions and cancer-related processes, whereas Document A concerns neural stem cells and miRNA regulation unrelated to cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427936Z"}
{"comparison_id":"4c6804af-eaf3-4d97-be1e-2448c15ca6eb","query_id":"53","doc_a_id":"22703082","doc_b_id":"2356950","presented_order":["2356950","22703082"],"winner_id":"22703082","reasoning":"Document B is more relevant — it deals with cancer-related molecular changes, whereas Document A concerns neural stem cell regulation unrelated to breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427944Z"}
{"comparison_id":"aaca95fd-8a49-4eb7-8c46-41116fec5ec7","query_id":"53","doc_a_id":"3831884","doc_b_id":"2356950","presented_order":["2356950","3831884"],"winner_id":"2356950","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. Document A is slightly closer because it discusses stem cell regulation (ALDH1 is a stem-cell marker), while B focuses on pancreatic metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427951Z"}
{"comparison_id":"4c06a2b9-56ff-4f7d-8ab0-73933cb4aa34","query_id":"53","doc_a_id":"1522336","doc_b_id":"2356950","presented_order":["2356950","1522336"],"winner_id":"1522336","reasoning":"Document B is more relevant because it addresses cancer and protein expression, whereas A concerns neural stem cell regulation unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427957Z"}
{"comparison_id":"ddd8df07-2a23-47b6-ad49-2048e66631ec","query_id":"53","doc_a_id":"19427410","doc_b_id":"2356950","presented_order":["2356950","19427410"],"winner_id":"2356950","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns stem cell regulation (ALDH1 is a stem-cell–associated marker), whereas B focuses on adipocyte IL-33. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427964Z"}
{"comparison_id":"6f2ba3e6-9a58-441f-a29f-3291deae2917","query_id":"53","doc_a_id":"1617327","doc_b_id":"2356950","presented_order":["1617327","2356950"],"winner_id":"1617327","reasoning":"Document A is marginally more relevant because it deals with cancer/oncogenesis, whereas Document B concerns neural stem cell regulation and not cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427971Z"}
{"comparison_id":"167a25f5-dbd4-4dda-af5c-e973edf306cf","query_id":"53","doc_a_id":"4312169","doc_b_id":"2356950","presented_order":["4312169","2356950"],"winner_id":"4312169","reasoning":"Document A is more relevant — it discusses tumor genetics and cancer biology, which is closer to a prognosis-related claim than Document B's neural stem cell focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427977Z"}
{"comparison_id":"93fabecd-7a28-45dc-8aa4-9f1c2c035779","query_id":"53","doc_a_id":"30543439","doc_b_id":"2356950","presented_order":["2356950","30543439"],"winner_id":"30543439","reasoning":"Document B is slightly more relevant because it addresses cancer cell enzymes and survival, whereas Document A concerns neural stem cell regulation and is unrelated to cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427984Z"}
{"comparison_id":"85383681-999a-4550-bcc7-d692d2b20e63","query_id":"53","doc_a_id":"28644298","doc_b_id":"2356950","presented_order":["28644298","2356950"],"winner_id":"28644298","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document A is slightly more related because it deals with cancer-related cell survival pathways, whereas B focuses on neural stem cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427991Z"}
{"comparison_id":"71cb1657-1802-4f65-afe0-98cb768e057d","query_id":"53","doc_a_id":"19800147","doc_b_id":"2356950","presented_order":["19800147","2356950"],"winner_id":"19800147","reasoning":"Document A is more relevant — it concerns cancer progression and tumor biomarkers (though in colon cancer), while Document B focuses on neural stem cells; neither mentions ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.427998Z"}
{"comparison_id":"a3574722-9cfc-425b-8650-90ffcafd3960","query_id":"53","doc_a_id":"23326722","doc_b_id":"2356950","presented_order":["23326722","2356950"],"winner_id":"23326722","reasoning":"Document A is somewhat more relevant because it discusses cancer prognosis (though in T-cell lymphoma, not breast cancer); Document B is about neural stem cell regulation and unrelated molecular markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.428006Z"}
{"comparison_id":"42eb2053-c1c5-4662-9234-4f1ea294e808","query_id":"53","doc_a_id":"22890091","doc_b_id":"2356950","presented_order":["22890091","2356950"],"winner_id":"22890091","reasoning":"Document A is marginally more related because it discusses protein marker expression in human cells, whereas Document B focuses on neural stem cell miRNA regulation; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.428013Z"}
{"comparison_id":"ab3b7e3a-c99e-43ac-8eae-a5ebf094068a","query_id":"53","doc_a_id":"2205779","doc_b_id":"2356950","presented_order":["2205779","2356950"],"winner_id":"2205779","reasoning":"Document A is slightly more relevant because it addresses cancer biomarkers (though for gastric, not breast), whereas Document B concerns neural stem cells and miR-184, unrelated to cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.428020Z"}
{"comparison_id":"06376dba-b6f5-4f87-a83b-761e19ff0812","query_id":"53","doc_a_id":"19343151","doc_b_id":"2356950","presented_order":["19343151","2356950"],"winner_id":"19343151","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document A concerns biomarker expression in human tissue (more related to clinical prognostic markers) while Document B focuses on neural stem cell regulation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.428027Z"}
{"comparison_id":"3cd650ba-72e3-41bb-be1a-dd7358186321","query_id":"53","doc_a_id":"10450725","doc_b_id":"2356950","presented_order":["10450725","2356950"],"winner_id":"10450725","reasoning":"Doc A is cancer-related (though HCC rather than breast) and thus more topically close than Doc B, which concerns neural stem cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.428034Z"}
{"comparison_id":"266219aa-9a4b-4987-b7e6-54210451d613","query_id":"53","doc_a_id":"3701541","doc_b_id":"2356950","presented_order":["2356950","3701541"],"winner_id":"3701541","reasoning":"Document B is more relevant—both miss ALDH1/breast cancer, but B deals with cancer-related signaling and prognosis-relevant processes, whereas A concerns neural stem cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.428041Z"}
{"comparison_id":"a5b6c453-b454-4710-85aa-bb98c7d67068","query_id":"53","doc_a_id":"32776084","doc_b_id":"2356950","presented_order":["2356950","32776084"],"winner_id":"2356950","reasoning":"Document A is slightly more relevant because it deals with stem cell regulation (miR-184/MBD1) whereas Document B concerns imprinting in embryonic stem cell culture; ALDH1 is a stem cell marker linked to cancer prognosis, so A is closer in topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.428048Z"}
{"comparison_id":"5ba75e1e-8b03-4264-bc5e-8dadb78e92c1","query_id":"53","doc_a_id":"3863543","doc_b_id":"2356950","presented_order":["2356950","3863543"],"winner_id":"2356950","reasoning":"Document A is slightly more relevant because it deals with stem cell regulation (ALDH1 is a stem cell marker), while B is specific to hematopoietic pre‑leukemia and unrelated to breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:24.428056Z"}
{"comparison_id":"ec5e1be1-e38a-4497-9965-20234072b173","query_id":"53","doc_a_id":"14471161","doc_b_id":"25022826","presented_order":["14471161","25022826"],"winner_id":"14471161","reasoning":"Document A is slightly more relevant because it discusses cancer tumor biology (though in pancreatic cancer), whereas Document B is about MSC osteogenic differentiation and not cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722102Z"}
{"comparison_id":"71a10f69-57ab-40ae-929d-9e4b8f5fa323","query_id":"53","doc_a_id":"2272614","doc_b_id":"25022826","presented_order":["25022826","2272614"],"winner_id":"2272614","reasoning":"Document B — it relates to cancer biology and treatment response, whereas Document A concerns MSC osteogenic differentiation unrelated to cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722124Z"}
{"comparison_id":"c20b4195-cfb2-41a9-b2ba-b813d45e3b96","query_id":"53","doc_a_id":"1507222","doc_b_id":"25022826","presented_order":["1507222","25022826"],"winner_id":"1507222","reasoning":"Document A is slightly more relevant because it concerns cancer-related gene expression, whereas Document B concerns stem cell osteogenesis with no cancer context. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722132Z"}
{"comparison_id":"7d96ea2d-37f7-4b09-a1e1-13c25e6abc04","query_id":"53","doc_a_id":"641786","doc_b_id":"25022826","presented_order":["25022826","641786"],"winner_id":"25022826","reasoning":"Document A is marginally more relevant because it concerns stem-cell biology and differentiation (ALDH1 is a stem/progenitor cell marker), whereas Document B deals with unrelated leukemia gene mutations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722140Z"}
{"comparison_id":"b3c2d21d-2e24-493e-a65a-866ab59f0582","query_id":"53","doc_a_id":"32852283","doc_b_id":"25022826","presented_order":["32852283","25022826"],"winner_id":"32852283","reasoning":"Document A is slightly more relevant because it concerns cancer biology/tumor prognosis, whereas Document B is about MSC osteogenic differentiation and not cancer-related.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722148Z"}
{"comparison_id":"6be42bcd-97e5-49b9-90b7-70feaa0fcdc8","query_id":"53","doc_a_id":"23509593","doc_b_id":"25022826","presented_order":["25022826","23509593"],"winner_id":"23509593","reasoning":"Document B is more relevant — it concerns gene regulation in prostate tissue (cancer-related context), whereas A focuses on MSC osteogenic differentiation and is not cancer-related.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722155Z"}
{"comparison_id":"02e86de4-790c-4192-ae83-b0d62a74e3a8","query_id":"53","doc_a_id":"25628793","doc_b_id":"25022826","presented_order":["25022826","25628793"],"winner_id":"25022826","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more related as it addresses gene expression and cell differentiation, whereas B focuses on endometriosis estrogen metabolism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722163Z"}
{"comparison_id":"35a9b6f4-686d-4bde-9d8f-e61b32d80142","query_id":"53","doc_a_id":"4959368","doc_b_id":"25022826","presented_order":["25022826","4959368"],"winner_id":"25022826","reasoning":"Document A is slightly more relevant because it discusses gene regulation in human stem cells (related to cancer stem-cell markers like ALDH1), whereas Document B concerns pancreatic cancer and amino acids, not ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722170Z"}
{"comparison_id":"11dd827e-50ee-4f23-bac9-ac4b1445b8d2","query_id":"53","doc_a_id":"4387494","doc_b_id":"25022826","presented_order":["25022826","4387494"],"winner_id":"4387494","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; Document B is marginally more relevant because it deals with cancer biology, whereas A is about MSC osteogenic differentiation. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722177Z"}
{"comparison_id":"22a81e8c-ef93-40d5-a5ed-a358e5cf9100","query_id":"53","doc_a_id":"13905670","doc_b_id":"25022826","presented_order":["25022826","13905670"],"winner_id":"13905670","reasoning":"Document B is slightly more relevant because it discusses links between molecular variation and disease prognosis, whereas Document A focuses on MSC osteogenic differentiation unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722184Z"}
{"comparison_id":"36946ae5-568e-42dd-99bc-80eaddd14686","query_id":"53","doc_a_id":"663464","doc_b_id":"25022826","presented_order":["663464","25022826"],"winner_id":"663464","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A—addressing age-related biomarkers and mortality—is slightly more relevant than Document B, which focuses on MSC osteogenic differentiation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722192Z"}
{"comparison_id":"1e374dbf-499e-4f3b-9af4-53bd9fb663fb","query_id":"53","doc_a_id":"17876040","doc_b_id":"25022826","presented_order":["25022826","17876040"],"winner_id":"17876040","reasoning":"Document B is more relevant — it discusses cancer therapy and clinical outcomes, whereas Document A concerns MSC osteogenic differentiation and is unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722200Z"}
{"comparison_id":"8ee7ccd5-54bf-4498-a36f-4bc2f323468b","query_id":"53","doc_a_id":"7020505","doc_b_id":"25022826","presented_order":["7020505","25022826"],"winner_id":"7020505","reasoning":"Document A — it discusses cancer prognostic markers and prognosis (though in CLL rather than breast cancer), whereas Document B concerns MSC osteogenic differentiation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722207Z"}
{"comparison_id":"66c5b25f-bb8b-41ce-9a8e-7939692bee69","query_id":"53","doc_a_id":"17671145","doc_b_id":"25022826","presented_order":["25022826","17671145"],"winner_id":"25022826","reasoning":"Neither document discusses ALDH1 or breast cancer, so both are irrelevant. If forced to choose, DOCUMENT A is marginally more relevant because it deals with gene expression and human cell differentiation, which is closer to biomarker/prognosis topics than a prostate cancer AR-targeting study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722215Z"}
{"comparison_id":"81ab1bf2-bf18-429e-bed1-b78101b54edf","query_id":"53","doc_a_id":"8764879","doc_b_id":"25022826","presented_order":["8764879","25022826"],"winner_id":"8764879","reasoning":"Document A is more related because it discusses cancer stem cell markers and prognosis/therapy in leukemia, which is closer to ALDH1's role as a stem cell marker in cancer than Document B's focus on MSC osteogenic differentiation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722223Z"}
{"comparison_id":"10f3cc14-39ef-41d0-bc64-1122aaa67419","query_id":"53","doc_a_id":"1982286","doc_b_id":"25022826","presented_order":["1982286","25022826"],"winner_id":"1982286","reasoning":"Document A — it concerns cancer and tumor biology (though in T-ALL), whereas Document B is about MSC osteogenic differentiation and unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722230Z"}
{"comparison_id":"30027fba-23ac-4023-bf70-9134dcdefbfa","query_id":"53","doc_a_id":"67787658","doc_b_id":"25022826","presented_order":["25022826","67787658"],"winner_id":"67787658","reasoning":"Document B is slightly more relevant because it addresses cancer biology (therapy resistance) while Document A focuses on MSC osteogenic differentiation and not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722237Z"}
{"comparison_id":"a3f8cae5-cf2a-4260-849e-be28441329ed","query_id":"53","doc_a_id":"3701541","doc_b_id":"25022826","presented_order":["25022826","3701541"],"winner_id":"25022826","reasoning":"Document A is slightly more related because it discusses stem-cell biology and gene regulation (closer to ALDH1 as a stem-cell marker), while Document B focuses on liver fibrosis/cancer unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722244Z"}
{"comparison_id":"f03d65d6-827c-4c86-addb-533e1ea83c65","query_id":"53","doc_a_id":"5765455","doc_b_id":"25022826","presented_order":["5765455","25022826"],"winner_id":"5765455","reasoning":"Document A is slightly more relevant because it discusses cancer progression mechanisms, whereas Document B concerns MSC osteogenic differentiation; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722251Z"}
{"comparison_id":"0aebf482-4e0d-42c9-83d0-7c2b73262287","query_id":"53","doc_a_id":"9226649","doc_b_id":"25022826","presented_order":["9226649","25022826"],"winner_id":"9226649","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document A discusses tumorigenesis (cancer biology), making it marginally more related than Document B on MSC osteogenesis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722262Z"}
{"comparison_id":"33ae8abf-101c-47cf-a60a-466c1b766a8a","query_id":"53","doc_a_id":"15215393","doc_b_id":"25022826","presented_order":["15215393","25022826"],"winner_id":"15215393","reasoning":"Document A is slightly more relevant because it concerns cancer biology, whereas Document B is about MSC osteogenic differentiation unrelated to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722269Z"}
{"comparison_id":"d8fd6048-b3d0-4091-ad1a-d7df073a6c3f","query_id":"53","doc_a_id":"17911973","doc_b_id":"25022826","presented_order":["17911973","25022826"],"winner_id":"17911973","reasoning":"Document A is more relevant — it discusses cancer-related genomic changes (mentions cancer) while Document B focuses on MSC osteogenic differentiation unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722276Z"}
{"comparison_id":"e2fce70e-a811-4b61-8b4a-cfa4f7d82e12","query_id":"53","doc_a_id":"7869794","doc_b_id":"25022826","presented_order":["7869794","25022826"],"winner_id":"7869794","reasoning":"Reason: Document A discusses tumor cell–related processes (neutrophil interaction and tumor cell apoptosis), which is closer to cancer prognosis than Document B's focus on MSC osteogenic differentiation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722283Z"}
{"comparison_id":"4783cef6-539e-48da-a50f-908cef5ead9c","query_id":"53","doc_a_id":"22703082","doc_b_id":"25022826","presented_order":["25022826","22703082"],"winner_id":"22703082","reasoning":"Document B is more relevant — it deals with cancer-related molecular changes (carcinogenesis/TP53), whereas Document A concerns MSC osteogenic differentiation unrelated to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722291Z"}
{"comparison_id":"0ce8c248-9fd6-4965-8a9b-161f7330fcfb","query_id":"53","doc_a_id":"1522336","doc_b_id":"25022826","presented_order":["25022826","1522336"],"winner_id":"1522336","reasoning":"Document B — it relates to cancer, protein expression, and treatment effects, while Document A concerns MSC osteogenesis unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722298Z"}
{"comparison_id":"302a0bf1-9620-48fc-a03d-34866cf08bfb","query_id":"53","doc_a_id":"1617327","doc_b_id":"25022826","presented_order":["25022826","1617327"],"winner_id":"1617327","reasoning":"Document B is slightly more relevant because it concerns stromal cell dysfunction leading to neoplasia, whereas Document A focuses on MSC osteogenic differentiation without cancer context.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722305Z"}
{"comparison_id":"11aab008-1e28-4e1c-bc6d-08f6ed2a8da4","query_id":"53","doc_a_id":"4312169","doc_b_id":"25022826","presented_order":["4312169","25022826"],"winner_id":"25022826","reasoning":"Neither abstract addresses ALDH1 or breast cancer. Document B is slightly more relevant because it deals with stem-cell differentiation and gene regulation (closer to ALDH1's role as a stemness marker).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722312Z"}
{"comparison_id":"65e81fb9-6656-4ff9-81f7-62c43ce998c6","query_id":"53","doc_a_id":"30543439","doc_b_id":"25022826","presented_order":["25022826","30543439"],"winner_id":"30543439","reasoning":"Document B — it discusses enzymes in cancer cells (oncology context) whereas A is about MSC osteogenic differentiation and not cancer/ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722319Z"}
{"comparison_id":"553fac55-053d-45df-887a-9f28f054f101","query_id":"53","doc_a_id":"28644298","doc_b_id":"25022826","presented_order":["28644298","25022826"],"winner_id":"28644298","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more related because it discusses cancer-related cell survival pathways, while B concerns MSC osteogenic differentiation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722326Z"}
{"comparison_id":"3f4fff8a-2186-43eb-9fcb-601acc282f81","query_id":"53","doc_a_id":"19800147","doc_b_id":"25022826","presented_order":["19800147","25022826"],"winner_id":"19800147","reasoning":"Document A is slightly more relevant because it concerns cancer progression and prognosis (though in colon cancer), whereas B focuses on MSC osteogenic differentiation and is unrelated to cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722333Z"}
{"comparison_id":"c960da83-fd5a-4728-8e96-8e50f5a6e812","query_id":"53","doc_a_id":"23326722","doc_b_id":"25022826","presented_order":["23326722","25022826"],"winner_id":"23326722","reasoning":"Document A is slightly more relevant because it discusses cancer clinical features and prognosis (though not breast cancer or ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722340Z"}
{"comparison_id":"a7563c7e-6656-42ad-ac56-68e9491313f2","query_id":"53","doc_a_id":"22890091","doc_b_id":"25022826","presented_order":["22890091","25022826"],"winner_id":"25022826","reasoning":"Document B — it discusses regulation in human mesenchymal stem cells (related to stemness markers like ALDH1), whereas Document A covers leukocyte bcl-2/Fas expression unrelated to ALDH1 or breast cancer.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722346Z"}
{"comparison_id":"5c02c454-da3a-48ab-a9ea-55494c24fa27","query_id":"53","doc_a_id":"2205779","doc_b_id":"25022826","presented_order":["25022826","2205779"],"winner_id":"25022826","reasoning":"Document A is slightly more relevant because it concerns stem-cell gene regulation (closer to ALDH1's stemness context), whereas Document B focuses on gastric cancer miRNAs; neither addresses ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722353Z"}
{"comparison_id":"66b8eeaf-388c-45f3-b00d-907dd83cd9bf","query_id":"53","doc_a_id":"19343151","doc_b_id":"25022826","presented_order":["25022826","19343151"],"winner_id":"19343151","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. Document B is marginally closer (discusses gene-expression biomarkers in human tissue), but it still does not provide evidence about ALDH1 in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722360Z"}
{"comparison_id":"11fe3396-6670-4748-9e7f-8a8de0e77de8","query_id":"53","doc_a_id":"10450725","doc_b_id":"25022826","presented_order":["10450725","25022826"],"winner_id":"10450725","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer prognosis; Document A is at least about cancer (hepatocellular carcinoma), so marginally more related.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:17:47.722366Z"}
{"comparison_id":"df5a210a-7ce9-4dc3-a686-0e7ce7c85d57","query_id":"53","doc_a_id":"14471161","doc_b_id":"5765455","presented_order":["14471161","5765455"],"winner_id":"14471161","reasoning":"Reason: Document A concerns tumor gene expression and cancer growth, which is more related to markers and prognosis in solid tumors than Document B, which focuses on leukemia mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144032Z"}
{"comparison_id":"837932b1-9fe1-4554-9126-7418b45ad89f","query_id":"53","doc_a_id":"2272614","doc_b_id":"5765455","presented_order":["2272614","5765455"],"winner_id":"2272614","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it discusses how gene expression (NF1) affects cancer treatment/resistance, which is closer to a prognosis association than the leukemia-focused mechanistic study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144053Z"}
{"comparison_id":"549d6410-dad9-4200-8aa5-87f9aa403cff","query_id":"53","doc_a_id":"1507222","doc_b_id":"5765455","presented_order":["1507222","5765455"],"winner_id":"1507222","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it deals with solid tumor (cachexia) biology, whereas B focuses on myeloid leukemia.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144061Z"}
{"comparison_id":"49ad7032-0f87-4acb-8dcc-0100361ae068","query_id":"53","doc_a_id":"32852283","doc_b_id":"5765455","presented_order":["5765455","32852283"],"winner_id":"5765455","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant; however, Document A is slightly more related to cancer progression mechanisms, so it's marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144068Z"}
{"comparison_id":"5d5765f3-99e0-4eff-b9b6-8da69f60b259","query_id":"53","doc_a_id":"23509593","doc_b_id":"5765455","presented_order":["5765455","23509593"],"winner_id":"5765455","reasoning":"Document A — it's cancer-related (genomic instability in leukemia), so slightly more relevant than a prostate/stromal androgen regulation study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144077Z"}
{"comparison_id":"c33fd346-9dc8-4fc5-8639-1bb8694da80e","query_id":"53","doc_a_id":"4387494","doc_b_id":"5765455","presented_order":["4387494","5765455"],"winner_id":"4387494","reasoning":"Neither document addresses ALDH1 or breast cancer (both focus on myeloid leukemias), so neither is relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144084Z"}
{"comparison_id":"e0f3205e-870e-450d-a1eb-6cf7a3f54eae","query_id":"53","doc_a_id":"13905670","doc_b_id":"5765455","presented_order":["13905670","5765455"],"winner_id":"5765455","reasoning":"Document B — it discusses cancer progression mechanisms (genomic instability/ROS) whereas A is about inflammatory/infectious disease genetics; B is therefore slightly more relevant. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144091Z"}
{"comparison_id":"ab102a74-a37c-4fd9-a525-99cff8b70c5c","query_id":"53","doc_a_id":"663464","doc_b_id":"5765455","presented_order":["663464","5765455"],"winner_id":"5765455","reasoning":"Both documents do not discuss ALDH1 or breast cancer, but Document B addresses cancer progression mechanisms (genomic instability), making it marginally more relevant than Document A on aging/microRNAs.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144098Z"}
{"comparison_id":"5b016c91-7dd3-458d-bc98-2498ba2460a5","query_id":"53","doc_a_id":"17876040","doc_b_id":"5765455","presented_order":["5765455","17876040"],"winner_id":"5765455","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it addresses cancer progression mechanisms, whereas B focuses narrowly on an AML drug. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144106Z"}
{"comparison_id":"8ae47e91-a14a-4552-abee-ab2ddd09de1d","query_id":"53","doc_a_id":"7020505","doc_b_id":"5765455","presented_order":["5765455","7020505"],"winner_id":"7020505","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it discusses biomarkers and their association with prognosis (albeit in CLL), whereas A focuses on ROS and progression in myeloid leukemia.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144113Z"}
{"comparison_id":"8da763b5-3b3b-4b1d-933e-5d585cb14fad","query_id":"53","doc_a_id":"8764879","doc_b_id":"5765455","presented_order":["5765455","8764879"],"winner_id":"8764879","reasoning":"Document B is slightly more relevant — it discusses leukemia stem cell potential and markers, which is marginally closer to ALDH1's role as a stem-cell-associated marker; neither document addresses ALDH1 or breast cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144121Z"}
{"comparison_id":"cfb72a84-1b1a-493c-ad81-7d6915cb57b9","query_id":"53","doc_a_id":"1982286","doc_b_id":"5765455","presented_order":["5765455","1982286"],"winner_id":"5765455","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more related (addresses oxidative stress/ROS, which can relate to ALDH function), so more relevant than B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144128Z"}
{"comparison_id":"1f980798-359b-4cae-99b1-9b27969632d6","query_id":"53","doc_a_id":"67787658","doc_b_id":"5765455","presented_order":["67787658","5765455"],"winner_id":"67787658","reasoning":"Neither document mentions ALDH1 or breast cancer, so neither provides evidence for the claim. Document A is slightly more related (cancer biology/mechanisms) than B (myeloid leukemia model).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144135Z"}
{"comparison_id":"f1ddb985-13bc-412d-b8ef-4f4eee44d340","query_id":"53","doc_a_id":"10450725","doc_b_id":"5765455","presented_order":["10450725","5765455"],"winner_id":"10450725","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant to the claim. Document A is slightly more relevant only in that it concerns a solid tumor cancer study (HCC) rather than hematologic malignancy.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144142Z"}
{"comparison_id":"789afdcc-b3b6-4bbc-b7c3-91b0b7a62095","query_id":"53","doc_a_id":"9226649","doc_b_id":"5765455","presented_order":["5765455","9226649"],"winner_id":"9226649","reasoning":"Document B is slightly more related because it addresses mechanisms of epithelial tumorigenesis (solid tumor biology), whereas Document A focuses on myeloid leukemia; neither mentions ALDH1 or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144149Z"}
{"comparison_id":"e7d10fef-bd7c-4350-b036-583d5f05ff66","query_id":"53","doc_a_id":"15215393","doc_b_id":"5765455","presented_order":["5765455","15215393"],"winner_id":"5765455","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses cancer progression and prognosis, whereas B focuses on glioblastoma therapy. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144157Z"}
{"comparison_id":"4e4bec30-cba3-474f-a395-7632da88e565","query_id":"53","doc_a_id":"17911973","doc_b_id":"5765455","presented_order":["5765455","17911973"],"winner_id":"5765455","reasoning":"Document A is marginally more relevant because it discusses cancer progression and prognosis-related mechanisms, whereas Document B focuses on retrotransposons and germline/lung cancer mutagenesis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144163Z"}
{"comparison_id":"5252204f-dd05-4add-adbe-c0e1b206c93f","query_id":"53","doc_a_id":"7869794","doc_b_id":"5765455","presented_order":["7869794","5765455"],"winner_id":"7869794","reasoning":"Document A is slightly more relevant — it discusses tumor cell biology and immune interactions, whereas Document B focuses on myeloid leukemia progression, not breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144171Z"}
{"comparison_id":"4e06bcfa-b324-4078-aee1-42fb49a79245","query_id":"53","doc_a_id":"22703082","doc_b_id":"5765455","presented_order":["22703082","5765455"],"winner_id":"22703082","reasoning":"Document A is slightly more relevant because it deals with carcinogenesis in epithelial tissue (cancer context); neither document mentions ALDH1 or breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144178Z"}
{"comparison_id":"4973c4d6-e3fc-4b92-9738-92b3fc7a1f68","query_id":"53","doc_a_id":"1522336","doc_b_id":"5765455","presented_order":["1522336","5765455"],"winner_id":"1522336","reasoning":"Reason: Both documents do not address ALDH1 or breast cancer directly, but Document A discusses cancer-related protein expression, making it slightly more relevant than Document B (which focuses on ROS and leukemia progression).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144185Z"}
{"comparison_id":"b43ec77c-aad9-492b-82c7-49bbe3274b7f","query_id":"53","doc_a_id":"1617327","doc_b_id":"5765455","presented_order":["5765455","1617327"],"winner_id":"5765455","reasoning":"Reason: Neither paper addresses ALDH1 or breast cancer, but Document A discusses reactive oxygen species and DNA damage (more mechanistic overlap with ALDH1’s role in oxidative metabolism) while B focuses on bone progenitor dysfunction.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144192Z"}
{"comparison_id":"44650941-727f-4f9d-b21f-0debac678c4c","query_id":"53","doc_a_id":"30543439","doc_b_id":"5765455","presented_order":["30543439","5765455"],"winner_id":"5765455","reasoning":"Document B is slightly more relevant because it discusses cancer progression and mechanisms related to prognosis, whereas Document A focuses on unrelated nucleotide sanitizing enzymes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144199Z"}
{"comparison_id":"2fe9a193-47fe-4a5f-862f-02349381ea0d","query_id":"53","doc_a_id":"28644298","doc_b_id":"5765455","presented_order":["28644298","5765455"],"winner_id":"5765455","reasoning":"Document B is more relevant — it discusses cancer progression and mechanisms (genomic instability/ROS) whereas Document A focuses on EBV/NF-κB in lymphoid cells, neither directly about ALDH1 or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144207Z"}
{"comparison_id":"43dfebfc-f823-42d8-a583-d28b8d565f96","query_id":"53","doc_a_id":"19800147","doc_b_id":"5765455","presented_order":["19800147","5765455"],"winner_id":"19800147","reasoning":"Reason: Both are unrelated to ALDH1 or breast cancer, but Document A discusses cancer progression and a tumor-associated marker, making it slightly closer in topic than the leukemia-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144213Z"}
{"comparison_id":"8af3dba1-0bc1-43d6-be08-989c2d09837e","query_id":"53","doc_a_id":"23326722","doc_b_id":"5765455","presented_order":["23326722","5765455"],"winner_id":"5765455","reasoning":"Document B is slightly more relevant — it discusses cancer-related mechanisms (ROS and DNA damage) that are more conceptually related to ALDH1's role in detoxification and tumor progression, whereas A is an unrelated clinical report on T‑cell lymphoma. Neither paper directly addresses ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144220Z"}
{"comparison_id":"b5861a31-28cc-419a-b081-3cfb194b1c4d","query_id":"53","doc_a_id":"19343151","doc_b_id":"5765455","presented_order":["19343151","5765455"],"winner_id":"5765455","reasoning":"B is slightly more relevant because it addresses cancer-related molecular mechanisms, whereas A focuses on skin aging and not cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:05.144227Z"}
{"comparison_id":"cb4c11e3-03f4-4505-968f-5318a7232786","query_id":"53","doc_a_id":"14471161","doc_b_id":"67787658","presented_order":["14471161","67787658"],"winner_id":"14471161","reasoning":"Document A is slightly more relevant because it concerns tumor gene expression and cancer prognosis-related mechanisms, whereas Document B focuses narrowly on glioblastoma chemoresistance and cyclin D. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:15.227400Z"}
{"comparison_id":"434323c5-a960-4499-90eb-d2b9b02d8444","query_id":"53","doc_a_id":"2272614","doc_b_id":"67787658","presented_order":["2272614","67787658"],"winner_id":"2272614","reasoning":"Document A is slightly more relevant because it discusses how gene expression levels affect cancer treatment outcomes, whereas Document B focuses on microRNA-mediated drug resistance in glioblastoma, further from the breast cancer/prognosis topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:15.227423Z"}
{"comparison_id":"e701c654-337b-4cc4-9f15-fe0433e04e29","query_id":"53","doc_a_id":"1507222","doc_b_id":"67787658","presented_order":["1507222","67787658"],"winner_id":"1507222","reasoning":"Document A is slightly more relevant because it reports changes in gene expression in a cancer model, whereas Document B focuses on microRNA-mediated chemoresistance in glioblastoma (unrelated tumor type). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:15.227434Z"}
{"comparison_id":"6c2e9420-46d9-4275-b433-b4c3cbc89bc3","query_id":"53","doc_a_id":"4387494","doc_b_id":"67787658","presented_order":["4387494","67787658"],"winner_id":"4387494","reasoning":"Neither document mentions ALDH1 or breast cancer. Both are irrelevant; Document A is marginally more relevant because it deals with cancer biology/therapy, whereas B focuses on glioblastoma chemoresistance mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:15.227442Z"}
{"comparison_id":"07f9bd89-13c2-46f8-8dc4-da4aaa7d8699","query_id":"53","doc_a_id":"7020505","doc_b_id":"67787658","presented_order":["7020505","67787658"],"winner_id":"67787658","reasoning":"Document B — it's about tumor cell biology and resistance mechanisms (more related to cancer biomarkers) whereas A focuses on CLL-specific chromosomal abnormalities, unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:15.227454Z"}
{"comparison_id":"0b13e1ff-c3ad-4b7d-86cf-a92bc5b149e9","query_id":"53","doc_a_id":"8764879","doc_b_id":"67787658","presented_order":["67787658","8764879"],"winner_id":"8764879","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document B is slightly closer because it deals with cancer stem cell biology, which is more conceptually related to ALDH1 as a stem cell marker.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:15.227463Z"}
{"comparison_id":"b22fc651-4d26-432e-83af-16159fc9a57a","query_id":"53","doc_a_id":"19800147","doc_b_id":"67787658","presented_order":["19800147","67787658"],"winner_id":"19800147","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it concerns cancer progression mechanisms, whereas B focuses on glioblastoma chemoresistance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:15.227471Z"}
{"comparison_id":"5055760e-5758-4428-95ef-37ea0f46109c","query_id":"53","doc_a_id":"10450725","doc_b_id":"67787658","presented_order":["10450725","67787658"],"winner_id":"10450725","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant; Document A is marginally more relevant only because it concerns cancer biology generally. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:15.227507Z"}
{"comparison_id":"7747329a-2290-45e2-a6d5-0aadbc6b0766","query_id":"53","doc_a_id":"9226649","doc_b_id":"67787658","presented_order":["9226649","67787658"],"winner_id":"9226649","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A and B study colon and glioblastoma mechanisms, respectively — no link to ALDH1 prognostic value in breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:15.227545Z"}
{"comparison_id":"9a67b0f7-dc19-4d04-b0e5-277dd8955534","query_id":"53","doc_a_id":"7869794","doc_b_id":"67787658","presented_order":["67787658","7869794"],"winner_id":"67787658","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document A is marginally more relevant because it deals with tumor cell biology, whereas B focuses on neutrophil-mediated ADCC. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:15.227559Z"}
{"comparison_id":"5ce3e44e-af7e-4394-b521-b249360c6203","query_id":"53","doc_a_id":"22703082","doc_b_id":"67787658","presented_order":["22703082","67787658"],"winner_id":"22703082","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is marginally closer since it concerns aberrant gene expression in cancerous epithelium, whereas B focuses on glioblastoma chemoresistance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:15.227570Z"}
{"comparison_id":"a7d61599-494b-4e0d-ac7e-6287357702ab","query_id":"53","doc_a_id":"1522336","doc_b_id":"67787658","presented_order":["1522336","67787658"],"winner_id":"1522336","reasoning":"Document A is marginally more relevant because it concerns cancer and protein expression, whereas Document B focuses on glioblastoma cell-cycle microRNAs unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:15.227578Z"}
{"comparison_id":"8ca3a2e2-23af-4585-9756-27d9148a610c","query_id":"53","doc_a_id":"14471161","doc_b_id":"8764879","presented_order":["14471161","8764879"],"winner_id":"14471161","reasoning":"Document A is more relevant — it deals with tumor gene expression and cancer outcomes, whereas Document B is specific to leukemia (AML) and unrelated to breast cancer or ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:22.090204Z"}
{"comparison_id":"e7a9a03d-0b70-495d-a153-41dbbe77e3cc","query_id":"53","doc_a_id":"2272614","doc_b_id":"8764879","presented_order":["2272614","8764879"],"winner_id":"8764879","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B discusses cancer stem-cell biology and markers in leukemia, making it marginally more conceptually relevant than Document A (which focuses on NF1 and EGFR in lung cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:22.090225Z"}
{"comparison_id":"69b12cfc-bffb-4524-bc3e-68685495778a","query_id":"53","doc_a_id":"1507222","doc_b_id":"8764879","presented_order":["1507222","8764879"],"winner_id":"1507222","reasoning":"Document A is more relevant — it discusses gene expression changes in a solid tumor model (cancer cachexia), whereas Document B focuses on AML/leukemia stem cells, which is unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:22.090234Z"}
{"comparison_id":"b9d9387d-cd04-4db9-8bd7-d0b494676343","query_id":"53","doc_a_id":"4387494","doc_b_id":"8764879","presented_order":["4387494","8764879"],"winner_id":"4387494","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document A at least discusses disease progression and prognosis-related effects, while B focuses on leukemia stem cell mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:22.090241Z"}
{"comparison_id":"2125289f-7b86-4f77-9f51-5fe5534590e2","query_id":"53","doc_a_id":"1522336","doc_b_id":"8764879","presented_order":["8764879","1522336"],"winner_id":"8764879","reasoning":"Neither document addresses ALDH1 expression or breast cancer prognosis. Document A is marginally more relevant because it deals with cancer stem cell–related biology, whereas Document B focuses on statins in head and neck cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:22.090249Z"}
{"comparison_id":"01c63a10-1b27-4f9d-b219-177a36955e2f","query_id":"53","doc_a_id":"19800147","doc_b_id":"8764879","presented_order":["19800147","8764879"],"winner_id":"19800147","reasoning":"Document A is slightly more relevant — it addresses cancer progression mechanisms in a solid tumor context, which is closer to breast cancer prognosis than a leukemia study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:22.090256Z"}
{"comparison_id":"35bc3b6f-a00a-4b42-980b-1daf380d098e","query_id":"53","doc_a_id":"10450725","doc_b_id":"8764879","presented_order":["10450725","8764879"],"winner_id":"10450725","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more related only because it deals with a solid carcinoma rather than leukemia.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:22.090263Z"}
{"comparison_id":"13fa8851-729d-452b-ad08-407f4d423464","query_id":"53","doc_a_id":"9226649","doc_b_id":"8764879","presented_order":["8764879","9226649"],"winner_id":"8764879","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more related because it discusses cancer stem-cell markers/pathways, whereas B focuses on colon inflammasomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:22.090270Z"}
{"comparison_id":"d6fe0b17-c100-45ca-a777-675d188b427b","query_id":"53","doc_a_id":"22703082","doc_b_id":"8764879","presented_order":["8764879","22703082"],"winner_id":"8764879","reasoning":"Neither document addresses ALDH1 or breast cancer; however, A (leukemia stem-cell biology) is slightly more related to cancer stem-cell markers than B (H. pylori–gastric cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:22.090277Z"}
{"comparison_id":"2342ca70-2305-432a-a6d2-e86ab8f13ae5","query_id":"53","doc_a_id":"14471161","doc_b_id":"4387494","presented_order":["4387494","14471161"],"winner_id":"14471161","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses tumor gene expression and prognosis-related tumor biology, whereas A focuses on AML therapy. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:29.206601Z"}
{"comparison_id":"121ee5e1-1965-4c09-a28b-ec18f18018f8","query_id":"53","doc_a_id":"1507222","doc_b_id":"4387494","presented_order":["1507222","4387494"],"winner_id":"1507222","reasoning":"Reason: Both abstracts are not about ALDH1 or breast cancer prognosis, but Document A discusses gene expression changes in a cancer model (more related to expression–prognosis context) while Document B is specific to AML therapy.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:29.206625Z"}
{"comparison_id":"3179fea4-c5c4-4c9e-a4bd-0188ae26136b","query_id":"53","doc_a_id":"10450725","doc_b_id":"4387494","presented_order":["4387494","10450725"],"winner_id":"4387494","reasoning":"Neither document discusses ALDH1 or breast cancer, so both are irrelevant to the claim. If forced to choose, A is marginally more relevant because it addresses cancer biology (albeit in AML), whereas B is limited to HCC.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:29.206633Z"}
{"comparison_id":"7833aa02-d88b-4106-a637-803f1ae4593a","query_id":"53","doc_a_id":"19800147","doc_b_id":"4387494","presented_order":["19800147","4387494"],"winner_id":"19800147","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A discusses solid tumor progression mechanisms (colon cancer), making it marginally more relevant than Document B (acute myeloid leukemia).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:29.206641Z"}
{"comparison_id":"eef23882-3654-4eb7-90e7-881ffbdce624","query_id":"53","doc_a_id":"14471161","doc_b_id":"1507222","presented_order":["1507222","14471161"],"winner_id":"14471161","reasoning":"Document B is more relevant — it deals with tumor gene expression and cancer outcomes (though not breast cancer or ALDH1 specifically). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:35.542929Z"}
{"comparison_id":"985136f1-6981-438b-b9b1-e24bf581dde0","query_id":"53","doc_a_id":"19800147","doc_b_id":"1507222","presented_order":["1507222","19800147"],"winner_id":"19800147","reasoning":"Document B — it concerns tumor progression and biomarkers in human cancer (though colon cancer), whereas A addresses uncoupling proteins in a mouse cachexia model and is less related to prognosis or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:35.542949Z"}
{"comparison_id":"e235ba4b-9d9e-4ce1-970a-6320cebf94f5","query_id":"53","doc_a_id":"14471161","doc_b_id":"19800147","presented_order":["14471161","19800147"],"winner_id":"19800147","reasoning":"Document B — it discusses cancer progression and a molecular marker linked to advanced disease, which is more related to prognosis than Document A's meal-timing/pancreatic growth study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:38.455963Z"}
{"comparison_id":"5f42a275-dfd0-4498-b1ef-747e0218daf3","query_id":"53","doc_a_id":"2272614","doc_b_id":"1522336","presented_order":["2272614","1522336"],"winner_id":"2272614","reasoning":"Document A is more relevant — it discusses gene expression impacts on cancer prognosis/treatment (although in lung cancer and a different gene), which is closer in topic than a statin review in HNSCC.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:43.501194Z"}
{"comparison_id":"81d4d5e0-5d5d-495e-be2a-09a29c7e606f","query_id":"53","doc_a_id":"22703082","doc_b_id":"1522336","presented_order":["22703082","1522336"],"winner_id":"22703082","reasoning":"Document A is more relevant — it discusses aberrant expression of a protein in epithelial cancer, which is closer to biomarker/prognosis issues than B's focus on statin effects in HNSCC.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:43.501216Z"}
{"comparison_id":"8c1535ab-e78e-4d11-8ea1-c0e0d3ca1598","query_id":"53","doc_a_id":"9226649","doc_b_id":"1522336","presented_order":["1522336","9226649"],"winner_id":"1522336","reasoning":"Neither paper addresses ALDH1 or breast cancer directly, but Document A (cancer-related protein expression) is marginally more relevant than Document B (colon inflammasome work). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:43.501225Z"}
{"comparison_id":"c648b27b-106c-436e-b36f-c2dd82743e64","query_id":"53","doc_a_id":"2272614","doc_b_id":"22703082","presented_order":["22703082","2272614"],"winner_id":"22703082","reasoning":"Document A is slightly more relevant because it discusses aberrant expression of a marker in epithelial cancer, whereas B is about drug resistance in lung cancer; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:48.196485Z"}
{"comparison_id":"243707f5-054d-4366-a4b7-33c58863a163","query_id":"53","doc_a_id":"7020505","doc_b_id":"7869794","presented_order":["7869794","7020505"],"winner_id":"7869794","reasoning":"Document A is slightly more relevant because it discusses tumor–immune cell interactions in cancer, whereas Document B focuses on genetic abnormalities in CLL (unrelated to breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:18:52.823427Z"}
{"comparison_id":"39c44d3e-c83a-4c32-a2af-d8674d46ea66","query_id":"53","doc_a_id":"32852283","doc_b_id":"15215393","presented_order":["32852283","15215393"],"winner_id":"32852283","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; Document A at least discusses tumor growth and survival outcomes, which relate to prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:01.404814Z"}
{"comparison_id":"742d347c-3869-461d-bee7-bfece873697b","query_id":"53","doc_a_id":"23509593","doc_b_id":"15215393","presented_order":["15215393","23509593"],"winner_id":"15215393","reasoning":"Document A is slightly more relevant because it addresses cancer biology (epigenetic regulation in tumor cells), whereas Document B concerns androgen regulation in prostate stromal cells; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:01.404835Z"}
{"comparison_id":"6fea477c-1899-4b95-94ca-524621fa8444","query_id":"53","doc_a_id":"13905670","doc_b_id":"15215393","presented_order":["13905670","15215393"],"winner_id":"15215393","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; Document B is marginally more relevant because it concerns cancer biology (glioblastoma) while A focuses on inflammatory/infectious disease prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:01.404844Z"}
{"comparison_id":"64363c5b-2704-499a-bafd-306d5e6a44fe","query_id":"53","doc_a_id":"663464","doc_b_id":"15215393","presented_order":["663464","15215393"],"winner_id":"15215393","reasoning":"Document B — it concerns cancer biology (glioblastoma and therapy) while Document A addresses age-related microRNA in blood and not cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:01.404853Z"}
{"comparison_id":"797c50dc-4939-4af0-9765-58a3a01704e0","query_id":"53","doc_a_id":"17876040","doc_b_id":"15215393","presented_order":["15215393","17876040"],"winner_id":"15215393","reasoning":"Neither paper discusses ALDH1 or breast cancer. Document A is marginally more relevant because it deals with enzyme modulation in cancer (glioblastoma) rather than AML-focused therapy. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:01.404860Z"}
{"comparison_id":"7aaec2b1-0900-4bf2-9d58-7745c0c8e9a6","query_id":"53","doc_a_id":"1982286","doc_b_id":"15215393","presented_order":["15215393","1982286"],"winner_id":"15215393","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant since it addresses a solid tumor cancer context (glioblastoma) rather than a hematologic malignancy.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:01.404867Z"}
{"comparison_id":"e2569b59-9ba6-4dcc-baa3-910087633f41","query_id":"53","doc_a_id":"19343151","doc_b_id":"15215393","presented_order":["19343151","15215393"],"winner_id":"15215393","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it concerns cancer biology, whereas A is about skin aging. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:01.404874Z"}
{"comparison_id":"61b19a4f-49ff-4df4-9447-ae8c7d4cf7aa","query_id":"53","doc_a_id":"17911973","doc_b_id":"15215393","presented_order":["17911973","15215393"],"winner_id":"15215393","reasoning":"Neither document addresses ALDH1 or breast cancer specifically, but Document B deals with cancer biology and therapeutic response (glioblastoma), making it marginally more relevant than A, which focuses on retrotransposons and lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:01.404882Z"}
{"comparison_id":"f97b54a9-02c7-439f-b724-b6ef45e67467","query_id":"53","doc_a_id":"1617327","doc_b_id":"15215393","presented_order":["15215393","1617327"],"winner_id":"15215393","reasoning":"Document A is slightly more relevant because it concerns tumor cell biology and epigenetic regulators related to cancer cell behavior, whereas Document B focuses on bone progenitors and leukemia (not breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:01.404889Z"}
{"comparison_id":"e2ed3e37-4a71-430e-8143-646d4bf08ad0","query_id":"53","doc_a_id":"30543439","doc_b_id":"15215393","presented_order":["30543439","15215393"],"winner_id":"15215393","reasoning":"Document B — it deals with cancer cell behavior and therapy, so is marginally more related to a prognostic marker in cancer; Document A is focused on unrelated nucleotide‑sanitizing enzymes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:01.404896Z"}
{"comparison_id":"7777bf47-e1e6-461b-9ef3-d9afa1919a6b","query_id":"53","doc_a_id":"28644298","doc_b_id":"15215393","presented_order":["15215393","28644298"],"winner_id":"15215393","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it is a cancer study (glioblastoma) and thus closer in topic to cancer prognosis than Document B, which focuses on EBV-infected lymphoid cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:01.404903Z"}
{"comparison_id":"11b3ad57-e7bb-49c5-adeb-83af0d247e0c","query_id":"53","doc_a_id":"23326722","doc_b_id":"15215393","presented_order":["23326722","15215393"],"winner_id":"23326722","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant only because it discusses cancer prognosis (though in T‑cell lymphoma, not breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:01.404910Z"}
{"comparison_id":"838e6b41-c768-4fd6-8a36-633e59abbd9e","query_id":"53","doc_a_id":"32852283","doc_b_id":"23326722","presented_order":["23326722","32852283"],"winner_id":"32852283","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it concerns tumor growth and survival (prognosis-related) in cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:08.938541Z"}
{"comparison_id":"3f222ecd-f09c-4a45-8dad-ce43bc4e0bce","query_id":"53","doc_a_id":"23509593","doc_b_id":"1982286","presented_order":["23509593","1982286"],"winner_id":"1982286","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is slightly more relevant because it addresses cancer-related transcriptional networks and prognostic implications, while A is specific to prostate stromal calcium signaling.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:15.722603Z"}
{"comparison_id":"42863d07-2ba6-477e-8d63-7ae49663e22d","query_id":"53","doc_a_id":"13905670","doc_b_id":"1982286","presented_order":["1982286","13905670"],"winner_id":"1982286","reasoning":"Reason: Document A is cancer-focused (oncogenic/tumor suppressor networks), which is closer to a breast cancer prognosis question than Document B's inflammatory/infectious disease focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:15.722624Z"}
{"comparison_id":"148aaed7-6cc8-4ee0-ae7d-a8ebef8b37ab","query_id":"53","doc_a_id":"663464","doc_b_id":"1982286","presented_order":["1982286","663464"],"winner_id":"1982286","reasoning":"Document A — it's cancer-focused (oncogenic transcriptional networks), whereas Document B concerns aging-related microRNAs in blood, unrelated to breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:15.722636Z"}
{"comparison_id":"d94166fb-0dc3-4a18-ae53-63cf68c6f0cd","query_id":"53","doc_a_id":"17876040","doc_b_id":"1982286","presented_order":["1982286","17876040"],"winner_id":"1982286","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant; Document A is marginally more related to cancer biology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:15.722644Z"}
{"comparison_id":"e763cb73-e4a5-47a3-9d3e-3f0b8c629eed","query_id":"53","doc_a_id":"28644298","doc_b_id":"1982286","presented_order":["1982286","28644298"],"winner_id":"1982286","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns cancer transcriptional networks, whereas B focuses on EBV/NF-κB in lymphoid cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:15.722652Z"}
{"comparison_id":"d1dc70bc-09f5-4ef6-b0a0-ac902b2cd319","query_id":"53","doc_a_id":"19343151","doc_b_id":"1982286","presented_order":["1982286","19343151"],"winner_id":"1982286","reasoning":"Document A is slightly more relevant because it concerns cancer-related transcriptional networks, whereas Document B addresses skin aging not cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:15.722659Z"}
{"comparison_id":"fca10756-e4ec-4219-848a-2d9bb557de6e","query_id":"53","doc_a_id":"17911973","doc_b_id":"1982286","presented_order":["17911973","1982286"],"winner_id":"1982286","reasoning":"Neither document mentions ALDH1 or breast cancer. Both are largely irrelevant, but DOCUMENT B is slightly more related to cancer biology (oncogenic networks), so it's marginally more relevant. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:15.722666Z"}
{"comparison_id":"7e334063-b331-4f74-931c-0fd8bc8818f9","query_id":"53","doc_a_id":"1617327","doc_b_id":"1982286","presented_order":["1617327","1982286"],"winner_id":"1617327","reasoning":"Document A is marginally more relevant because it addresses progenitor/stromal cell dysfunction and niche-induced oncogenesis, which is more related to stem-cell markers like ALDH1 and cancer prognosis than the T-ALL transcriptional focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:15.722674Z"}
{"comparison_id":"2aca7c71-d2dc-4c23-a16a-5fa23728bb8d","query_id":"53","doc_a_id":"30543439","doc_b_id":"1982286","presented_order":["1982286","30543439"],"winner_id":"1982286","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. Document A is slightly more related to cancer biology (transcriptional networks/tumor suppressor) than the biochemical/structural focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:15.722681Z"}
{"comparison_id":"122a971e-88f9-477b-ac93-4a561d5b6271","query_id":"53","doc_a_id":"23509593","doc_b_id":"17876040","presented_order":["17876040","23509593"],"winner_id":"17876040","reasoning":"Document A is slightly more relevant because it discusses cancer therapy and outcomes, whereas Document B focuses on androgen regulation in prostate stromal cells, unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:20.896873Z"}
{"comparison_id":"700809a7-c056-46a6-9ea7-489c9699afbe","query_id":"53","doc_a_id":"13905670","doc_b_id":"17876040","presented_order":["13905670","17876040"],"winner_id":"17876040","reasoning":"Document B — it discusses cancer therapy (though not breast cancer or ALDH1), while Document A concerns inflammatory/infectious diseases unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:20.896897Z"}
{"comparison_id":"fa372c81-228c-46c1-945f-f10166ada7cd","query_id":"53","doc_a_id":"663464","doc_b_id":"17876040","presented_order":["663464","17876040"],"winner_id":"17876040","reasoning":"Document B — it's about cancer therapy/oncology (more related to cancer prognosis/markers) while A concerns aging and microRNA in blood, not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:20.896906Z"}
{"comparison_id":"1ee70c98-5404-4e45-ad13-a2033c26da14","query_id":"53","doc_a_id":"30543439","doc_b_id":"17876040","presented_order":["17876040","30543439"],"winner_id":"17876040","reasoning":"Document A is more relevant — it discusses cancer therapy and patient survival (clinical prognosis), whereas Document B is a molecular enzymology study unrelated to breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:20.896914Z"}
{"comparison_id":"0d07ae0a-5d23-49c3-8ccc-bca0894a5830","query_id":"53","doc_a_id":"28644298","doc_b_id":"17876040","presented_order":["17876040","28644298"],"winner_id":"17876040","reasoning":"Document A is more related to oncology (cancer therapy/prognosis context), while Document B deals with EBV-infected lymphoid cells unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:20.896921Z"}
{"comparison_id":"719469f3-e43a-4d0b-91cc-3aa4f852f46c","query_id":"53","doc_a_id":"19343151","doc_b_id":"17876040","presented_order":["19343151","17876040"],"winner_id":"17876040","reasoning":"Document B — it discusses cancer therapy (though not breast cancer specifically), whereas Document A is about skin aging and unrelated to cancer markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:20.896928Z"}
{"comparison_id":"5088ddde-9897-4258-a43b-d77d992eed6e","query_id":"53","doc_a_id":"17911973","doc_b_id":"17876040","presented_order":["17876040","17911973"],"winner_id":"17876040","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant only because it addresses cancer prognosis/survival, whereas B focuses on retrotransposons and genome mutagenesis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:20.896935Z"}
{"comparison_id":"9026c36f-33e5-49f4-a921-39e0d412e708","query_id":"53","doc_a_id":"23509593","doc_b_id":"30543439","presented_order":["23509593","30543439"],"winner_id":"30543439","reasoning":"Document B is slightly more relevant because it discusses enzymes and cancer cell survival, whereas Document A concerns androgen regulation in prostate stromal cells (unrelated to ALDH1 or breast cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:25.320711Z"}
{"comparison_id":"3ca93d09-f080-42d1-968e-f0374d765998","query_id":"53","doc_a_id":"13905670","doc_b_id":"30543439","presented_order":["13905670","30543439"],"winner_id":"30543439","reasoning":"Document B — it discusses enzymes and effects in cancer cells (related to cancer prognosis), whereas Document A concerns inflammatory/infectious disease prognosis and not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:25.320733Z"}
{"comparison_id":"a96103a7-6807-4e65-8d1b-6090bda3177b","query_id":"53","doc_a_id":"663464","doc_b_id":"30543439","presented_order":["30543439","663464"],"winner_id":"30543439","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document A concerns cancer-related enzymes and cancer cell survival, so it's marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:25.320742Z"}
{"comparison_id":"1994b1d6-0bc9-4c48-87e3-88f5c252d2e8","query_id":"53","doc_a_id":"17911973","doc_b_id":"30543439","presented_order":["17911973","30543439"],"winner_id":"30543439","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer prognosis, but Document B discusses cancer-related enzyme function and cell survival, making it marginally more relevant to cancer prognosis than Document A (which focuses on retrotransposons and lung genomes).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:25.320751Z"}
{"comparison_id":"71b46c6d-b1ce-4f15-a057-6fdf80e54569","query_id":"53","doc_a_id":"28644298","doc_b_id":"30543439","presented_order":["30543439","28644298"],"winner_id":"30543439","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis; both are irrelevant. Document A is marginally more relevant because it addresses enzymes in cancer cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:25.320758Z"}
{"comparison_id":"f264db38-875f-48de-a5b8-acf8760b22bf","query_id":"53","doc_a_id":"19343151","doc_b_id":"30543439","presented_order":["30543439","19343151"],"winner_id":"30543439","reasoning":"Neither abstract addresses ALDH1 or breast cancer prognosis. Document A is slightly more relevant because it discusses cancer-related enzymes, while B is about skin aging. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:25.320765Z"}
{"comparison_id":"956418f1-d743-4b92-b0dd-6444ae52a3c0","query_id":"53","doc_a_id":"23509593","doc_b_id":"663464","presented_order":["23509593","663464"],"winner_id":"23509593","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is marginally more related because it concerns gene expression in cancer-related tissue (prostate), whereas Document B deals with blood microRNAs and aging.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:31.306683Z"}
{"comparison_id":"1a7a3352-2b0b-4247-b38b-27a867f0670b","query_id":"53","doc_a_id":"13905670","doc_b_id":"663464","presented_order":["13905670","663464"],"winner_id":"663464","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document B is slightly more relevant because it deals with biomarkers associated with mortality/prognosis, whereas A concerns a FOXO3A SNP and inflammatory diseases.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:31.306704Z"}
{"comparison_id":"139dd4d0-c637-4833-ae75-181ffabf417f","query_id":"53","doc_a_id":"19343151","doc_b_id":"663464","presented_order":["663464","19343151"],"winner_id":"663464","reasoning":"Document A is slightly more relevant because it discusses biomarkers associated with mortality and disease outcomes, whereas Document B focuses on skin aging markers not linked to cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:31.306713Z"}
{"comparison_id":"dc330c84-ce73-4840-b56f-4dd167ab2fcc","query_id":"53","doc_a_id":"17911973","doc_b_id":"663464","presented_order":["663464","17911973"],"winner_id":"17911973","reasoning":"Document B is slightly more relevant because it addresses cancer-related genomic changes, whereas Document A focuses on age-related microRNAs and non-cancer diseases. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:31.306721Z"}
{"comparison_id":"62acc145-e9fe-4fff-ad31-0b1512cf0f00","query_id":"53","doc_a_id":"28644298","doc_b_id":"663464","presented_order":["28644298","663464"],"winner_id":"28644298","reasoning":"Document A is more relevant — it's about cancer cell survival and transcriptional regulation (though in EBV-infected cells), which is closer to a prognostic marker discussion than a study of age-associated blood microRNAs. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:31.306731Z"}
{"comparison_id":"b76d798f-990f-444f-ba43-40f7e7b14baf","query_id":"53","doc_a_id":"23509593","doc_b_id":"17911973","presented_order":["17911973","23509593"],"winner_id":"17911973","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document A at least addresses cancer-related genomic changes, while Document B concerns androgen regulation in prostate cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:34.910049Z"}
{"comparison_id":"3b5bba0c-98f7-47a8-bac4-6c51550bf5d3","query_id":"53","doc_a_id":"28644298","doc_b_id":"17911973","presented_order":["28644298","17911973"],"winner_id":"28644298","reasoning":"Document A is slightly more relevant because it discusses cancer-related cell survival and transcription pathways, whereas Document B focuses on retrotransposons and germline insertions unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:34.910070Z"}
{"comparison_id":"0804ab87-0be7-422c-b58a-2ceeeac6a3ef","query_id":"53","doc_a_id":"13905670","doc_b_id":"19343151","presented_order":["19343151","13905670"],"winner_id":"13905670","reasoning":"Document B is slightly more relevant because it discusses associations between a molecular marker and disease prognosis, whereas Document A concerns aging in skin and not prognosis or cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:37.815245Z"}
{"comparison_id":"c766cf9e-0b60-4aea-88af-6b33ef0d0e3b","query_id":"53","doc_a_id":"641786","doc_b_id":"17671145","presented_order":["17671145","641786"],"winner_id":"17671145","reasoning":"Document A is slightly more relevant because it addresses gene expression in a solid tumor cancer context, whereas Document B concerns mutations in childhood leukemia and is less related to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:42.396912Z"}
{"comparison_id":"a11b6754-981a-4598-956d-6906506b6c96","query_id":"53","doc_a_id":"25628793","doc_b_id":"17671145","presented_order":["17671145","25628793"],"winner_id":"25628793","reasoning":"Document B is slightly more relevant — neither mentions ALDH1 or breast cancer, but B deals with estrogen-related tissue biology (more related to breast cancer context) while A is about prostate cancer and AR.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:42.396937Z"}
{"comparison_id":"4cf186c9-105c-4e12-8153-fe96df6505e1","query_id":"53","doc_a_id":"4959368","doc_b_id":"17671145","presented_order":["17671145","4959368"],"winner_id":"17671145","reasoning":"Document A — it discusses expression of a molecular driver in cancer (gene expression and prognosis/therapy context), making it marginally more relevant than B, which concerns metabolic biomarkers in pancreatic cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:42.396946Z"}
{"comparison_id":"25688562-5b11-4014-b855-f460776e4605","query_id":"53","doc_a_id":"2205779","doc_b_id":"17671145","presented_order":["2205779","17671145"],"winner_id":"2205779","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it discusses cancer biomarker expression and diagnostic/prognostic potential, whereas B focuses on prostate cancer therapy mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:42.396954Z"}
{"comparison_id":"54f87567-778d-4de6-8a4b-69b5afa46a8f","query_id":"53","doc_a_id":"3701541","doc_b_id":"17671145","presented_order":["17671145","3701541"],"winner_id":"3701541","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document B is marginally closer because it addresses cancer-related cell activity, whereas A is specific to prostate AR signaling. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:42.396962Z"}
{"comparison_id":"4ac55b33-8030-4db9-a1fc-eda692fd0948","query_id":"53","doc_a_id":"4312169","doc_b_id":"17671145","presented_order":["17671145","4312169"],"winner_id":"17671145","reasoning":"Document A is slightly more relevant because it addresses cancer biomarker/therapy relationships (though in prostate, not breast); Document B concerns pediatric glioblastoma genetics and is less related to ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:42.396969Z"}
{"comparison_id":"4438cc6b-c809-456e-b589-f11a7dcd5d7e","query_id":"53","doc_a_id":"22890091","doc_b_id":"17671145","presented_order":["22890091","17671145"],"winner_id":"17671145","reasoning":"Document B is more relevant — it concerns cancer biology and prognostic/therapeutic markers, whereas Document A deals with leukocyte apoptosis unrelated to breast cancer or ALDH1.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:42.396977Z"}
{"comparison_id":"2a818e95-7c46-4bc9-a63b-f4d03146f7ca","query_id":"53","doc_a_id":"25628793","doc_b_id":"2205779","presented_order":["2205779","25628793"],"winner_id":"2205779","reasoning":"Document A is slightly more relevant because it concerns biomarker expression in cancer (though gastric, not breast), whereas Document B is about enzyme expression in endometriosis rather than cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:47.542339Z"}
{"comparison_id":"3d4c333f-bf0d-4e5a-9009-06beec803e16","query_id":"53","doc_a_id":"3701541","doc_b_id":"2205779","presented_order":["3701541","2205779"],"winner_id":"3701541","reasoning":"Neither document mentions ALDH1 or breast cancer. Both are irrelevant, but A is marginally more related because it addresses cancer biology (liver cancer) rather than an unrelated gastric biomarker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:47.542361Z"}
{"comparison_id":"683c66c7-cbac-4d07-9692-473e5711e7a4","query_id":"53","doc_a_id":"641786","doc_b_id":"4959368","presented_order":["4959368","641786"],"winner_id":"4959368","reasoning":"Document A is slightly more relevant because it discusses a biomarker's association with cancer development/prognosis (though in pancreatic cancer), whereas Document B concerns mutations in childhood ALL unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:52.488403Z"}
{"comparison_id":"7497408f-b75d-4354-8b90-3d6ccc0679a0","query_id":"53","doc_a_id":"22890091","doc_b_id":"4959368","presented_order":["4959368","22890091"],"winner_id":"22890091","reasoning":"Document B is more relevant — it discusses differential expression of a protein marker and its link to cell behavior/prognosis, which is conceptually closer to a claim about ALDH1 expression and breast cancer prognosis than a study of BCAAs in pancreatic cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:52.488425Z"}
{"comparison_id":"6bf1fcfc-c4ac-4870-b74a-b4da2b1a3908","query_id":"53","doc_a_id":"4312169","doc_b_id":"4959368","presented_order":["4312169","4959368"],"winner_id":"4312169","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant to the claim. I pick A (also unrelated—glioblastoma study).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:52.488433Z"}
{"comparison_id":"092e6994-36e1-47ce-8d1f-8361d16df7ba","query_id":"53","doc_a_id":"22890091","doc_b_id":"4312169","presented_order":["22890091","4312169"],"winner_id":"4312169","reasoning":"Reason: Both documents don't address ALDH1 or breast cancer, but Document B discusses tumor genetics and cancer biology (glioblastoma), making it slightly more related to cancer prognosis than Document A's leukocyte apoptosis study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:19:56.032887Z"}
{"comparison_id":"45b7fef2-b639-45a8-a150-22bc2ac992ff","query_id":"53","doc_a_id":"14938990","doc_b_id":"6171953","presented_order":["6171953","14938990"],"winner_id":"6171953","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document A is marginally more relevant because it discusses protein expression in a disease context, whereas B is specific to PD-1 in SLE. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:01.081652Z"}
{"comparison_id":"085f4b5a-8b34-496f-9329-5b30f40b68ea","query_id":"53","doc_a_id":"19368793","doc_b_id":"6171953","presented_order":["19368793","6171953"],"winner_id":"19368793","reasoning":"Document A is more related to cancer biomarker expression (though in HCC), while B focuses on inflammation; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:01.081673Z"}
{"comparison_id":"f3688fcc-c0c1-42a9-ac93-7463aaf91e55","query_id":"53","doc_a_id":"57783564","doc_b_id":"6171953","presented_order":["6171953","57783564"],"winner_id":"57783564","reasoning":"B is more relevant — it discusses tumor proliferation and cancer signaling (though in colon cancer), whereas A is about metabolism/inflammation. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:01.081684Z"}
{"comparison_id":"3ec136e6-8f8e-44cd-b7bd-ed31b0249bdb","query_id":"53","doc_a_id":"14848619","doc_b_id":"6171953","presented_order":["6171953","14848619"],"winner_id":"6171953","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. Document A and B do not provide evidence for the claim. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:01.081691Z"}
{"comparison_id":"dbdf0ac9-6b56-432a-bddb-ad36131d2a79","query_id":"53","doc_a_id":"3863543","doc_b_id":"6171953","presented_order":["3863543","6171953"],"winner_id":"3863543","reasoning":"Neither document addresses ALDH1 or breast cancer directly. Document A is slightly more relevant because it discusses stem-cell–related disease progression and prognosis, whereas B focuses on Sirtuin-1 and obesity-related inflammation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:01.081699Z"}
{"comparison_id":"2cbd4807-b5b2-424a-af14-dfe4812c90ba","query_id":"53","doc_a_id":"3831884","doc_b_id":"6171953","presented_order":["6171953","3831884"],"winner_id":"6171953","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis. Document A is slightly more relevant only because it concerns protein expression and disease outcomes generally, whereas Document B focuses on pancreatic cancer metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:01.081706Z"}
{"comparison_id":"104929c6-ba3b-4214-a5fb-deeaf1a4ceac","query_id":"53","doc_a_id":"19427410","doc_b_id":"6171953","presented_order":["6171953","19427410"],"winner_id":"6171953","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it addresses a protein (Sirtuin-1) linked to inflammation and metabolic pathways that are sometimes related to cancer biology, whereas Document B is focused narrowly on adipocyte IL-33.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:01.081713Z"}
{"comparison_id":"94778e26-1ce7-4fd6-b7c9-c04ba615d246","query_id":"53","doc_a_id":"32776084","doc_b_id":"6171953","presented_order":["32776084","6171953"],"winner_id":"6171953","reasoning":"Document B is more relevant — neither discusses ALDH1 or breast cancer prognosis, but B covers disease-related protein regulation (inflammation/energy sensing) which is closer in context than A's embryonic stem cell imprinting study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:01.081721Z"}
{"comparison_id":"807c9ab3-a56b-46e6-b439-e3f8f953474d","query_id":"53","doc_a_id":"19368793","doc_b_id":"57783564","presented_order":["19368793","57783564"],"winner_id":"57783564","reasoning":"Neither document addresses ALDH1 or breast cancer. Both are irrelevant; Document B is marginally more relevant because it discusses cancer-related signaling and tumor formation (general prognostic mechanisms) rather than HCC-specific diagnostics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:09.839821Z"}
{"comparison_id":"7b3500f4-6e9a-4689-a530-975fbace10d6","query_id":"53","doc_a_id":"3863543","doc_b_id":"57783564","presented_order":["3863543","57783564"],"winner_id":"3863543","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it concerns stem-cell–linked genotoxic stress and prediction of disease evolution (prognosis), whereas B focuses on colon cancer signaling mechanisms. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:09.839846Z"}
{"comparison_id":"8a4a3667-f737-496c-a094-5d0c9cd38707","query_id":"53","doc_a_id":"14938990","doc_b_id":"3831884","presented_order":["14938990","3831884"],"winner_id":"3831884","reasoning":"Document B — it concerns cancer biology (tumor metabolism and growth), making it slightly more related to a claim about a cancer prognostic marker; Document A is about PD‑1 in lupus and not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:15.544500Z"}
{"comparison_id":"4802bec7-a7d7-48a6-8dfb-766d7536f295","query_id":"53","doc_a_id":"14848619","doc_b_id":"3831884","presented_order":["3831884","14848619"],"winner_id":"3831884","reasoning":"Both documents are unrelated to ALDH1 in breast cancer, but Document A is slightly more relevant because it discusses cancer metabolism and tumor growth, whereas Document B focuses narrowly on hypoxia-induced cell death.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:15.544520Z"}
{"comparison_id":"3324305a-b51d-4674-8371-1b725a20c658","query_id":"53","doc_a_id":"32776084","doc_b_id":"3831884","presented_order":["3831884","32776084"],"winner_id":"3831884","reasoning":"Neither document addresses ALDH1 or breast cancer; however, Document A is marginally more relevant because it concerns cancer biology (pancreatic cancer) versus embryonic stem cell imprinting. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:15.544529Z"}
{"comparison_id":"3ea5c55a-7fb2-4b24-b1f6-bb11ef5c21a8","query_id":"53","doc_a_id":"19427410","doc_b_id":"3831884","presented_order":["3831884","19427410"],"winner_id":"3831884","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer prognosis, but Document A concerns cancer biology (pancreatic), making it marginally more relevant than an adipocyte/IL-33 study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:15.544537Z"}
{"comparison_id":"bd4889ca-fd2d-4bb8-8563-edfc1f7e9d5e","query_id":"53","doc_a_id":"14938990","doc_b_id":"14848619","presented_order":["14848619","14938990"],"winner_id":"14848619","reasoning":"Document A — it discusses a cancer-related molecular pathway (hypoxic cell death) while Document B concerns PD-1 in SLE, so A is slightly more relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:18.826796Z"}
{"comparison_id":"01f865fd-b153-4ac2-8ff4-3039d2d5cc0d","query_id":"53","doc_a_id":"19427410","doc_b_id":"14848619","presented_order":["14848619","19427410"],"winner_id":"14848619","reasoning":"Document A is slightly more relevant because it addresses a cancer-related molecular pathway (hypoxia-induced cell death), whereas Document B concerns IL-33 in adipocytes and is unrelated to cancer biomarkers or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:18.826817Z"}
{"comparison_id":"ad34f832-20ae-4968-ba07-1c0012f82321","query_id":"53","doc_a_id":"32776084","doc_b_id":"14848619","presented_order":["32776084","14848619"],"winner_id":"14848619","reasoning":"Document B — it discusses cell-death pathways relevant to cancer biology, whereas Document A concerns imprinted gene changes in mouse embryonic stem cells and is unrelated to breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:18.826826Z"}
{"comparison_id":"1374325c-0092-4e30-bb50-3b6afa339814","query_id":"53","doc_a_id":"14938990","doc_b_id":"19427410","presented_order":["19427410","14938990"],"winner_id":"19427410","reasoning":"Neither document addresses ALDH1 or breast cancer, but Document A discusses protein expression in human tissue (closer to biomarker/prognosis context) while Document B is about PD-1 in SLE. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:23.783567Z"}
{"comparison_id":"30ed70fd-64e0-4792-8e47-62aef85b91b8","query_id":"53","doc_a_id":"32776084","doc_b_id":"19427410","presented_order":["32776084","19427410"],"winner_id":"32776084","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document A is marginally closer because it concerns stem cell gene expression, whereas B is about adipocyte IL‑33. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:23.783588Z"}
{"comparison_id":"0bc4a75b-a08c-4f30-a99d-9cdd48692de0","query_id":"53","doc_a_id":"2360905","doc_b_id":"28390999","presented_order":["28390999","2360905"],"winner_id":"2360905","reasoning":"Document B is more relevant — it deals with molecular genetic profiling of human cancers (gene expression in tumors), whereas Document A covers gonad development in chickens and is not cancer-related.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:31.570838Z"}
{"comparison_id":"262ffbd8-2a80-475d-8f9b-386b95b7d21e","query_id":"53","doc_a_id":"85665741","doc_b_id":"28390999","presented_order":["28390999","85665741"],"winner_id":"85665741","reasoning":"Document B is marginally more relevant because it discusses cancer-related molecular markers and prognosis/therapy in human tumors, whereas A concerns chicken gonad development and is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:31.570861Z"}
{"comparison_id":"a316ba87-3ee1-4468-8c3c-8d9efb76ae65","query_id":"53","doc_a_id":"12903921","doc_b_id":"28390999","presented_order":["12903921","28390999"],"winner_id":"12903921","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it addresses cancer-related biology (oxidative stress in leukemia), whereas B concerns chicken gonadogenesis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:31.570870Z"}
{"comparison_id":"57dc88d6-8895-469d-93c0-87c9b5f84236","query_id":"53","doc_a_id":"5956380","doc_b_id":"28390999","presented_order":["5956380","28390999"],"winner_id":"5956380","reasoning":"Document A is more relevant — it concerns somatic mutations in a cancer type (gliomas), whereas Document B is about gene expression during chicken gonad development and unrelated to cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:31.570877Z"}
{"comparison_id":"80f9a487-97da-41e2-8246-c70b4685e05a","query_id":"53","doc_a_id":"10699587","doc_b_id":"28390999","presented_order":["28390999","10699587"],"winner_id":"28390999","reasoning":"Document A is slightly more relevant because it concerns gene expression studies (though in chicken gonadogenesis), whereas B deals with prostate cancer prognosis and not gene expression markers. Neither document provides evidence about ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:31.570884Z"}
{"comparison_id":"265048e0-7d8c-40ce-9ba1-b432080d5aa6","query_id":"53","doc_a_id":"8417211","doc_b_id":"28390999","presented_order":["28390999","8417211"],"winner_id":"28390999","reasoning":"Document A is slightly more relevant because it concerns gene expression studies (whereas B focuses on Drosophila HP1 phosphorylation unrelated to ALDH1 or breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:31.570892Z"}
{"comparison_id":"bb8bd910-6311-469a-b08c-3f1d07e9dd71","query_id":"53","doc_a_id":"24783597","doc_b_id":"28390999","presented_order":["28390999","24783597"],"winner_id":"24783597","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer; Document B (human disease gene expression) is marginally closer in topic than Document A (chicken gonad development).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:31.570899Z"}
{"comparison_id":"50cbafb6-e6c8-4db5-bfbb-5db7021cf48e","query_id":"53","doc_a_id":"25036988","doc_b_id":"28390999","presented_order":["28390999","25036988"],"winner_id":"25036988","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is marginally more relevant because it concerns cancer biology, whereas A is about embryonic gonad development. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:31.570905Z"}
{"comparison_id":"ae21b16d-d147-4f2b-9956-2a6b34c162f7","query_id":"53","doc_a_id":"2466614","doc_b_id":"28390999","presented_order":["2466614","28390999"],"winner_id":"2466614","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; Document A (mouse aging/genome-wide expression) is marginally more relevant than Document B (chicken gonadogenesis).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:31.570912Z"}
{"comparison_id":"58c1b706-6254-436a-9c03-3008cdde9d9c","query_id":"53","doc_a_id":"20888849","doc_b_id":"28390999","presented_order":["28390999","20888849"],"winner_id":"20888849","reasoning":"Document B is slightly more relevant because it concerns cancer biology (though not breast cancer or ALDH1); Document A is about chicken gonad development and is unrelated.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:31.570919Z"}
{"comparison_id":"bc0c4a60-97b5-4062-91c1-fbf9ceb20252","query_id":"53","doc_a_id":"18938992","doc_b_id":"28390999","presented_order":["28390999","18938992"],"winner_id":"28390999","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns gene expression (though in chicken gonadogenesis, not human breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:31.570926Z"}
{"comparison_id":"ca9e4ade-2657-4577-bce1-fab30084344e","query_id":"53","doc_a_id":"2360905","doc_b_id":"5956380","presented_order":["5956380","2360905"],"winner_id":"2360905","reasoning":"Both documents are unrelated to ALDH1 or breast cancer; however, Document B (molecular genetic profiling and gene expression) is marginally more relevant than A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:36.645167Z"}
{"comparison_id":"6821c635-541d-4857-95ef-d1f44e45774f","query_id":"53","doc_a_id":"85665741","doc_b_id":"5956380","presented_order":["85665741","5956380"],"winner_id":"85665741","reasoning":"Document A is slightly more relevant because it discusses cancer prognosis/predictive molecular markers (though in NSCLC), whereas Document B focuses on PPM1D mutations in brainstem gliomas unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:36.645187Z"}
{"comparison_id":"6885f8b3-33dc-4b24-a5ed-39533e3a5526","query_id":"53","doc_a_id":"12903921","doc_b_id":"5956380","presented_order":["5956380","12903921"],"winner_id":"5956380","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant only because it concerns human cancer genomics rather than a rat leukemia model.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:36.645195Z"}
{"comparison_id":"02c3e69c-c46f-423a-810b-1458bd74ac1a","query_id":"53","doc_a_id":"20888849","doc_b_id":"5956380","presented_order":["20888849","5956380"],"winner_id":"20888849","reasoning":"Neither document discusses ALDH1 or breast cancer, but Document A is at least about cancer biology/therapy while B is specific to brainstem gliomas. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:36.645203Z"}
{"comparison_id":"6fc0356e-a9af-4bfe-96ca-837f793b40a7","query_id":"53","doc_a_id":"24783597","doc_b_id":"5956380","presented_order":["5956380","24783597"],"winner_id":"5956380","reasoning":"A is slightly more relevant because it concerns cancer biology (though in gliomas), whereas B addresses inflammatory bowel disease and is unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:36.645210Z"}
{"comparison_id":"9333f2a7-413b-437a-8b41-86eda7bfd280","query_id":"53","doc_a_id":"25036988","doc_b_id":"5956380","presented_order":["25036988","5956380"],"winner_id":"25036988","reasoning":"Document A is slightly more relevant because it discusses cancer cell biology and gene expression effects, whereas Document B focuses on mutations in brainstem gliomas unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:36.645217Z"}
{"comparison_id":"7045c6c1-75fe-42bd-9821-838f2b2c197a","query_id":"53","doc_a_id":"2466614","doc_b_id":"5956380","presented_order":["5956380","2466614"],"winner_id":"5956380","reasoning":"Document A is slightly more relevant because it addresses cancer genetics (though in brain tumors), while Document B concerns aging mechanisms in mice and not cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:36.645224Z"}
{"comparison_id":"635d95e4-d0ad-4bee-86b8-2f469e281098","query_id":"53","doc_a_id":"2360905","doc_b_id":"85665741","presented_order":["85665741","2360905"],"winner_id":"85665741","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. Document A is marginally closer (discusses cancer biomarkers/therapy). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:42.390047Z"}
{"comparison_id":"c86e2b5b-9db0-4f7e-bafc-7d1bd35b6388","query_id":"53","doc_a_id":"25036988","doc_b_id":"85665741","presented_order":["85665741","25036988"],"winner_id":"25036988","reasoning":"Document B is marginally more relevant because it addresses gene expression effects on cancer cell behavior (though in colon cancer), whereas Document A focuses on BRAF mutations in NSCLC and is unrelated to ALDH1 or breast cancer prognosis.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:42.390067Z"}
{"comparison_id":"d96f4ff5-6061-48cf-93c6-e4b3426e00e3","query_id":"53","doc_a_id":"20888849","doc_b_id":"85665741","presented_order":["20888849","85665741"],"winner_id":"20888849","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses cancer treatment resistance and prognosis-related mechanisms (chemoresistance), whereas Document B is specific to BRAF/MEK in NSCLC.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:42.390076Z"}
{"comparison_id":"f147dedb-fa7b-4140-8665-8736770404d8","query_id":"53","doc_a_id":"25036988","doc_b_id":"20888849","presented_order":["20888849","25036988"],"winner_id":"20888849","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. Document A is marginally more related because it discusses cancer therapy and factors affecting outcome, whereas B focuses on lamin B1 in colon cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:48.060428Z"}
{"comparison_id":"7f235dcf-9b37-4289-b490-2b222493b204","query_id":"53","doc_a_id":"12903921","doc_b_id":"24783597","presented_order":["24783597","12903921"],"winner_id":"12903921","reasoning":"Document B is more relevant — it concerns cancer and oxidative/enzymatic changes (more related to ALDH1's role) while Document A deals with IL-17F in IBD, not cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:52.196868Z"}
{"comparison_id":"232691bb-14fa-4e1c-8b65-316ddbf6c9ce","query_id":"53","doc_a_id":"2466614","doc_b_id":"24783597","presented_order":["24783597","2466614"],"winner_id":"2466614","reasoning":"Document B — it discusses genome-wide expression changes (more closely related to gene expression and outcome) while Document A is focused on IBD cytokine findings unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:52.196887Z"}
{"comparison_id":"19c5088c-8c16-478b-9fd0-83442fba16f8","query_id":"53","doc_a_id":"12903921","doc_b_id":"2466614","presented_order":["12903921","2466614"],"winner_id":"2466614","reasoning":"Neither document addresses ALDH1, breast cancer, or prognosis; both are irrelevant. Document B is slightly more relevant only because it discusses genome-wide expression patterns (gene expression), whereas A focuses narrowly on oxidative stress in leukemic rats.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:20:55.812126Z"}
{"comparison_id":"dd69db41-5aaa-4c32-9396-b360d8459e6a","query_id":"53","doc_a_id":"10699587","doc_b_id":"8417211","presented_order":["10699587","8417211"],"winner_id":"10699587","reasoning":"Document A is more relevant — it discusses prognostic groups and cancer survival (though in prostate, not breast), while B is unrelated (Drosophila HP1 phosphorylation). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:07.088381Z"}
{"comparison_id":"4d692d08-7261-4ea9-ae82-58eb576bca7b","query_id":"53","doc_a_id":"18938992","doc_b_id":"8417211","presented_order":["8417211","18938992"],"winner_id":"18938992","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is slightly more related to human disease (immune evasion) than the Drosophila molecular study, so it’s marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:07.088402Z"}
{"comparison_id":"5ff902fe-ff61-4281-ab68-37358b1a510a","query_id":"53","doc_a_id":"10699587","doc_b_id":"18938992","presented_order":["18938992","10699587"],"winner_id":"10699587","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document B is at least about cancer prognosis (though in prostate), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:11.022211Z"}
{"comparison_id":"7b79c941-5c19-4eb0-9fc0-34557d7195a0","query_id":"53","doc_a_id":"601033","doc_b_id":"36838958","presented_order":["601033","36838958"],"winner_id":"601033","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns cancer (leukemia), whereas Document B focuses on adipose tissue metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115539Z"}
{"comparison_id":"d5999bac-8ee9-4deb-8d1a-cf7be3013ff3","query_id":"53","doc_a_id":"5372432","doc_b_id":"36838958","presented_order":["36838958","5372432"],"winner_id":"5372432","reasoning":"Document B is more relevant — it deals with cancer diagnosis/outcomes, whereas A focuses on adipose tissue metabolism unrelated to breast cancer markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115561Z"}
{"comparison_id":"41295d15-fe4d-41cf-859c-9b3bd9bc72d3","query_id":"53","doc_a_id":"5278233","doc_b_id":"36838958","presented_order":["5278233","36838958"],"winner_id":"5278233","reasoning":"Document A is slightly more relevant because it deals with gene expression and epigenetic changes linked to disease (cancer-related imprinting), whereas Document B concerns adipose thermogenesis and not cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115570Z"}
{"comparison_id":"108bd827-f23a-4b93-890d-3ac5b8fd6d7b","query_id":"53","doc_a_id":"13768432","doc_b_id":"36838958","presented_order":["36838958","13768432"],"winner_id":"36838958","reasoning":"Document A — it discusses molecular protein expression and cellular pathways (closer to a gene/protein–prognosis topic), while Document B is specific to cardiac imaging in amyloidosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115578Z"}
{"comparison_id":"09c51198-0819-417f-a2f0-d944b28fed86","query_id":"53","doc_a_id":"4500832","doc_b_id":"36838958","presented_order":["36838958","4500832"],"winner_id":"4500832","reasoning":"Brief reason: Neither document mentions ALDH1 or breast cancer prognosis, but Document B at least discusses cancer-related effects, making it slightly more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115585Z"}
{"comparison_id":"a9a827b1-af8a-4397-9906-606b01043024","query_id":"53","doc_a_id":"41790911","doc_b_id":"36838958","presented_order":["36838958","41790911"],"winner_id":"41790911","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant only because it addresses angiogenesis (a process linked to cancer progression), whereas A focuses on brown fat thermogenesis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115593Z"}
{"comparison_id":"7137a64d-56f7-4cbe-9167-d9fa7e8fcf91","query_id":"53","doc_a_id":"42150015","doc_b_id":"36838958","presented_order":["36838958","42150015"],"winner_id":"42150015","reasoning":"Document B — neither document addresses ALDH1 or breast cancer directly, but B (women's reproductive/lifestyle factors) is marginally closer to breast cancer-related clinical context than A (brown adipose tissue thermogenesis).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115600Z"}
{"comparison_id":"ff5cf82b-6d1b-4c33-8539-de2264cea85d","query_id":"53","doc_a_id":"33030946","doc_b_id":"36838958","presented_order":["36838958","33030946"],"winner_id":"33030946","reasoning":"Both documents are unrelated to ALDH1 or breast cancer, but Document B (hypoxia, signaling and metabolism) is slightly closer to cancer-relevant processes than A. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115607Z"}
{"comparison_id":"a298e69e-c055-469d-a5ad-39f3f6197456","query_id":"53","doc_a_id":"12074066","doc_b_id":"36838958","presented_order":["36838958","12074066"],"winner_id":"36838958","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally closer because it discusses protein expression and molecular pathways. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115614Z"}
{"comparison_id":"fdf85648-7cac-42cc-a6a5-2d479e6ac8f5","query_id":"53","doc_a_id":"5884524","doc_b_id":"36838958","presented_order":["36838958","5884524"],"winner_id":"36838958","reasoning":"Document A is more relevant — it concerns protein expression (though not ALDH1) while Document B is about diabetes and cardiac outcomes, unrelated to protein expression or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115621Z"}
{"comparison_id":"be3e77a3-cb8c-403d-a18c-f23b99c5ea85","query_id":"53","doc_a_id":"24705390","doc_b_id":"36838958","presented_order":["24705390","36838958"],"winner_id":"24705390","reasoning":"Document A is slightly more relevant because it concerns cancer-related molecular changes, whereas Document B is about adipose tissue metabolism unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115629Z"}
{"comparison_id":"e9b49db0-9114-4fef-a776-584e93e40775","query_id":"53","doc_a_id":"4445629","doc_b_id":"36838958","presented_order":["4445629","36838958"],"winner_id":"4445629","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115635Z"}
{"comparison_id":"7c4232e3-77a5-40ac-84db-0e04c9e8c62f","query_id":"53","doc_a_id":"16511863","doc_b_id":"36838958","presented_order":["36838958","16511863"],"winner_id":"36838958","reasoning":"Neither document mentions ALDH1 or breast cancer, so both are irrelevant. Document A is marginally closer because it deals with cellular metabolism and ROS, which are more often discussed in cancer contexts than cardiac hypertrophy.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115643Z"}
{"comparison_id":"848e6d16-5023-4d5f-962f-924027446274","query_id":"53","doc_a_id":"13283919","doc_b_id":"36838958","presented_order":["36838958","13283919"],"winner_id":"36838958","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally closer (deals with protein expression and ROS-related signaling), so ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115650Z"}
{"comparison_id":"ab7e31fe-3c98-43ff-936c-e8031b18a042","query_id":"53","doc_a_id":"11935250","doc_b_id":"36838958","presented_order":["11935250","36838958"],"winner_id":"11935250","reasoning":"Reason: Document A discusses gene-level epigenetic changes, which is closer to expression/prognosis issues than Document B's focus on adipose thermogenesis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115656Z"}
{"comparison_id":"45fec9bd-9252-43dc-9cd3-1daa09e79c13","query_id":"53","doc_a_id":"8385277","doc_b_id":"36838958","presented_order":["8385277","36838958"],"winner_id":"8385277","reasoning":"Document A is more relevant — it discusses cancer-related genomic abnormalities and clinical implications (staging/management), whereas B is about adipose tissue metabolism unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115663Z"}
{"comparison_id":"307ae191-0f95-4e3d-9b51-df9387f2f2fa","query_id":"53","doc_a_id":"5811042","doc_b_id":"36838958","presented_order":["5811042","36838958"],"winner_id":"5811042","reasoning":"Document A is slightly more relevant because it discusses immune-related disease mechanisms, which are closer to cancer biology than a paper on brown adipose tissue metabolism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115670Z"}
{"comparison_id":"c7fe4eb7-625e-45dc-9d4c-a088142e72a8","query_id":"53","doc_a_id":"9159495","doc_b_id":"36838958","presented_order":["36838958","9159495"],"winner_id":"36838958","reasoning":"Document A is marginally more relevant because it concerns mammalian tissue and signaling pathways, whereas Document B is about C. elegans aging; neither discusses ALDH1 or breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115678Z"}
{"comparison_id":"6201c2bc-1a82-4a11-a721-2b00937c1d9e","query_id":"53","doc_a_id":"5752492","doc_b_id":"36838958","presented_order":["5752492","36838958"],"winner_id":"5752492","reasoning":"Document A is slightly more relevant because it discusses protein expression and disease outcomes, whereas Document B focuses on adipose thermogenesis unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115685Z"}
{"comparison_id":"dae164a5-2860-41c5-90c1-61016e7fa4f2","query_id":"53","doc_a_id":"9478135","doc_b_id":"36838958","presented_order":["9478135","36838958"],"winner_id":"9478135","reasoning":"Document A — it relates to cancer genetics (leukemia), while Document B concerns adipose thermogenesis and not cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115692Z"}
{"comparison_id":"b1fc8e33-6eb0-4436-9321-524f83e1e3c1","query_id":"53","doc_a_id":"13398997","doc_b_id":"36838958","presented_order":["13398997","36838958"],"winner_id":"13398997","reasoning":"Document A is slightly more relevant — though neither discusses ALDH1 or breast cancer, A deals with immune markers and clinical outcomes, which is marginally closer than B's adipose/thermogenesis topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115699Z"}
{"comparison_id":"5436e775-3ceb-4fdc-8a36-bb061df1604e","query_id":"53","doc_a_id":"20460020","doc_b_id":"36838958","presented_order":["20460020","36838958"],"winner_id":"20460020","reasoning":"Document A is slightly more relevant because it involves estrogen receptor signaling, which is related to breast cancer biology; Document B concerns brown adipose tissue metabolism and is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115706Z"}
{"comparison_id":"6aecc085-af50-41a0-bff7-07209be56dfb","query_id":"53","doc_a_id":"25141908","doc_b_id":"36838958","presented_order":["36838958","25141908"],"winner_id":"36838958","reasoning":"Document A is slightly more relevant—it's about mammalian protein expression and tissue metabolism, whereas B concerns a viral transcript; neither mentions ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115713Z"}
{"comparison_id":"d94d754d-a8a9-4bbb-b63b-a1ba367b7dfb","query_id":"53","doc_a_id":"14972169","doc_b_id":"36838958","presented_order":["36838958","14972169"],"winner_id":"14972169","reasoning":"Document B — it discusses oxidative stress and aldehyde (4-HNE) protein adducts, which is more conceptually related to ALDH1's role in aldehyde metabolism than Document A's focus on brown fat thermogenesis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115720Z"}
{"comparison_id":"506be3c4-c114-4e11-9dfc-563f24d8653e","query_id":"53","doc_a_id":"38025907","doc_b_id":"36838958","presented_order":["38025907","36838958"],"winner_id":"38025907","reasoning":"Document A is slightly more relevant because it mentions tumorigenesis and cancer-related outcomes, whereas Document B discusses adipose tissue thermogenesis unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115727Z"}
{"comparison_id":"3a8a6093-07a3-4e2c-908c-3c280875ad58","query_id":"53","doc_a_id":"20977638","doc_b_id":"36838958","presented_order":["36838958","20977638"],"winner_id":"20977638","reasoning":"Neither document addresses ALDH1 expression or breast cancer prognosis. Document B is slightly more related (discusses aldehyde (4-HNE) and oxidative stress), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115733Z"}
{"comparison_id":"4f0a965f-32d8-4e30-94ba-b909d994fe6f","query_id":"53","doc_a_id":"23816832","doc_b_id":"36838958","presented_order":["23816832","36838958"],"winner_id":"23816832","reasoning":"Document A is more relevant — it mentions prognosis (though in MS), whereas Document B is unrelated to cancer or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115740Z"}
{"comparison_id":"b8c227b0-7009-4aa0-995a-f081c63e54e7","query_id":"53","doc_a_id":"22896384","doc_b_id":"36838958","presented_order":["22896384","36838958"],"winner_id":"22896384","reasoning":"Document A is slightly more relevant because it concerns transcriptional regulation in epithelial tissues (potentially more related to cancer biology) whereas Document B focuses on brown adipose thermogenesis unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115747Z"}
{"comparison_id":"96444f6c-2f4b-4ea9-bb55-11e2fd632065","query_id":"53","doc_a_id":"32372280","doc_b_id":"36838958","presented_order":["32372280","36838958"],"winner_id":"32372280","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns gene expression changes in disease contexts (mentions tumor necrosis factor-alpha), whereas B focuses on brown fat metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115754Z"}
{"comparison_id":"5a51b2f6-b71c-40ea-861c-74be867b86dc","query_id":"53","doc_a_id":"7221410","doc_b_id":"36838958","presented_order":["7221410","36838958"],"winner_id":"7221410","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is marginally closer because it addresses gene expression and disease prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115761Z"}
{"comparison_id":"6173d7a3-49cf-4897-8cbb-6b160d34eeea","query_id":"53","doc_a_id":"2829179","doc_b_id":"36838958","presented_order":["36838958","2829179"],"winner_id":"2829179","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it addresses clinical/metabolic disease pathways, whereas A focuses on brown adipose thermogenesis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115768Z"}
{"comparison_id":"b9c47159-8d63-4d76-b1bf-6466e1d98cbd","query_id":"53","doc_a_id":"13350374","doc_b_id":"36838958","presented_order":["13350374","36838958"],"winner_id":"13350374","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is marginally more relevant because it discusses mammalian pathology and lifespan/prognosis-related outcomes, whereas B focuses on adipose thermogenesis and ROS. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115775Z"}
{"comparison_id":"edc5bc3a-b6d9-4659-b66b-494178beddb9","query_id":"53","doc_a_id":"34316341","doc_b_id":"36838958","presented_order":["36838958","34316341"],"winner_id":"34316341","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it concerns gene expression patterns, whereas A focuses on adipose thermogenesis unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:28.115781Z"}
{"comparison_id":"65463955-45ad-4cc9-857e-cff97c74dba4","query_id":"53","doc_a_id":"601033","doc_b_id":"5752492","presented_order":["5752492","601033"],"winner_id":"5752492","reasoning":"Document A is slightly more relevant — it discusses expression of a molecular marker and its association with disease progression, whereas Document B focuses on chemotherapy and viral reactivation in ATLL. Neither addresses ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.606977Z"}
{"comparison_id":"b377c916-345a-414b-8d84-0994ea708fb6","query_id":"53","doc_a_id":"5372432","doc_b_id":"5752492","presented_order":["5752492","5372432"],"winner_id":"5372432","reasoning":"Reason: Document B concerns cancer outcomes and prognosis-related measures, while Document A is about PD-1H in HIV and unrelated to cancer biomarkers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.606998Z"}
{"comparison_id":"72c7323f-6ece-426c-bd6e-ff3b6c791de7","query_id":"53","doc_a_id":"5278233","doc_b_id":"5752492","presented_order":["5752492","5278233"],"winner_id":"5278233","reasoning":"Document B is slightly more relevant — it discusses gene expression and epigenetic changes related to a cancer/overgrowth syndrome, whereas A concerns immune activation in HIV and not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607008Z"}
{"comparison_id":"447be049-2bcc-4531-a078-8a51acda90bf","query_id":"53","doc_a_id":"4500832","doc_b_id":"5752492","presented_order":["4500832","5752492"],"winner_id":"4500832","reasoning":"A is slightly more relevant because it mentions cancer contexts (though not breast cancer or ALDH1); B focuses on PD-1H in HIV. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607015Z"}
{"comparison_id":"b3f2e8da-f69a-4bb4-aa6e-76dfd391cab9","query_id":"53","doc_a_id":"41790911","doc_b_id":"5752492","presented_order":["41790911","5752492"],"winner_id":"41790911","reasoning":"Document A is slightly more relevant — it deals with angiogenesis and VEGF pathways, which are more related to cancer biology than the HIV/immune focus of Document B. Neither directly addresses ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607024Z"}
{"comparison_id":"d144be42-de4a-4285-927a-501c04ffa893","query_id":"53","doc_a_id":"42150015","doc_b_id":"5752492","presented_order":["42150015","5752492"],"winner_id":"42150015","reasoning":"Document A is slightly more relevant because it concerns women's reproductive biology, whereas Document B focuses on PD-1H in HIV; neither discusses ALDH1 or breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607032Z"}
{"comparison_id":"250d473c-7971-403e-8326-093700be5c37","query_id":"53","doc_a_id":"33030946","doc_b_id":"5752492","presented_order":["5752492","33030946"],"winner_id":"33030946","reasoning":"Neither document mentions ALDH1 or breast cancer, so both are irrelevant; Document B is marginally more related (hypoxia/metabolism can relate to cancer biology). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607038Z"}
{"comparison_id":"fcfc0818-2ae1-4d8c-a80c-17b31bdacfc9","query_id":"53","doc_a_id":"24705390","doc_b_id":"5752492","presented_order":["5752492","24705390"],"winner_id":"24705390","reasoning":"Document B is slightly more related (covers cancer-related mutagenesis), whereas neither mentions ALDH1 or breast cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607045Z"}
{"comparison_id":"527cfe16-7a10-463e-8d78-3cef72e72d96","query_id":"53","doc_a_id":"4445629","doc_b_id":"5752492","presented_order":["5752492","4445629"],"winner_id":"5752492","reasoning":"Document A is slightly more relevant because it discusses expression of an immune-related protein and its prognostic/functional implications, whereas Document B concerns a cardiovascular marker unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607052Z"}
{"comparison_id":"2be601fb-6830-4176-a494-926689c20a83","query_id":"53","doc_a_id":"11935250","doc_b_id":"5752492","presented_order":["11935250","5752492"],"winner_id":"11935250","reasoning":"Both documents are largely unrelated, but Document A is slightly more relevant because it concerns gene-level/epigenetic changes (potentially affecting gene expression like ALDH1), whereas Document B focuses on PD-1H in HIV. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607059Z"}
{"comparison_id":"2596f256-b78e-4fcc-b3c2-0f92bb34bd61","query_id":"53","doc_a_id":"8385277","doc_b_id":"5752492","presented_order":["5752492","8385277"],"winner_id":"8385277","reasoning":"Document B is slightly more relevant because it addresses cancer-related genomic abnormalities, whereas Document A concerns PD-1H in HIV infection and is unrelated to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607067Z"}
{"comparison_id":"2f53ffe4-cf0d-4e4e-84fd-05f444f0f54d","query_id":"53","doc_a_id":"5811042","doc_b_id":"5752492","presented_order":["5811042","5752492"],"winner_id":"5811042","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant; Document A is marginally more relevant only because it addresses disease-related molecular regulation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607073Z"}
{"comparison_id":"df9de114-e5f1-48f3-876e-5fe371089ab4","query_id":"53","doc_a_id":"34316341","doc_b_id":"5752492","presented_order":["5752492","34316341"],"winner_id":"34316341","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it concerns gene expression patterns, whereas A focuses on PD-1H in HIV.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607080Z"}
{"comparison_id":"42aa64e5-9015-4388-a59d-9526af4482cc","query_id":"53","doc_a_id":"9478135","doc_b_id":"5752492","presented_order":["5752492","9478135"],"winner_id":"9478135","reasoning":"Document B is more relevant — it concerns cancer (leukemia) biology, whereas Document A is about PD-1H in HIV; however neither discusses ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607087Z"}
{"comparison_id":"6041fb47-cc3f-4170-9fb0-bc7d34c2df2c","query_id":"53","doc_a_id":"13398997","doc_b_id":"5752492","presented_order":["5752492","13398997"],"winner_id":"5752492","reasoning":"Both documents are irrelevant — neither mentions ALDH1 or breast cancer. If one must be chosen, DOCUMENT A is marginally closer (discusses expression of a marker and disease outcome), so:\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607095Z"}
{"comparison_id":"8475c53a-626c-43f7-9aad-bd565e04039b","query_id":"53","doc_a_id":"20460020","doc_b_id":"5752492","presented_order":["5752492","20460020"],"winner_id":"20460020","reasoning":"Document B — it involves estrogen receptor biology (relevant to breast cancer pathways), while Document A is about PD-1H in HIV and unrelated. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607101Z"}
{"comparison_id":"883bf496-28fc-41d7-8deb-ed0b5d077f94","query_id":"53","doc_a_id":"14972169","doc_b_id":"5752492","presented_order":["5752492","14972169"],"winner_id":"14972169","reasoning":"Document B — it deals with oxidative stress and aldehyde-related protein modifications (4-HNE), which is closer biologically to ALDH1/aliphatic aldehyde metabolism than the HIV immune topic in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607109Z"}
{"comparison_id":"f4c937b6-4563-4340-b3ab-5681e020547d","query_id":"53","doc_a_id":"38025907","doc_b_id":"5752492","presented_order":["38025907","5752492"],"winner_id":"38025907","reasoning":"Neither document addresses ALDH1 or breast cancer, but Document A is slightly more relevant because it relates to cancer/tumorigenesis biology, while Document B is focused on HIV immunology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607115Z"}
{"comparison_id":"cb76d50c-d60d-4f9b-a65c-dee9abf88109","query_id":"53","doc_a_id":"20977638","doc_b_id":"5752492","presented_order":["5752492","20977638"],"winner_id":"20977638","reasoning":"Document B — it discusses aldehyde (4‑HNE) metabolism/oxidative stress related to aldehyde handling, which is marginally more related to ALDH1 than the HIV/PD‑1H study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607123Z"}
{"comparison_id":"7f2d1294-885f-4eb7-b970-0501290550d4","query_id":"53","doc_a_id":"23816832","doc_b_id":"5752492","presented_order":["23816832","5752492"],"winner_id":"5752492","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document B is slightly closer (immunology-related) but still not relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607129Z"}
{"comparison_id":"f8a6b4b4-ff47-461c-bb6b-1770f0d73ff3","query_id":"53","doc_a_id":"22896384","doc_b_id":"5752492","presented_order":["5752492","22896384"],"winner_id":"5752492","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant because it concerns human disease and immune markers, whereas B is mouse developmental biology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607136Z"}
{"comparison_id":"9d1f2a44-5dea-4d6b-a771-f5081c5fb902","query_id":"53","doc_a_id":"32372280","doc_b_id":"5752492","presented_order":["32372280","5752492"],"winner_id":"32372280","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses gene expression changes (whereas B focuses on immune function in HIV).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607143Z"}
{"comparison_id":"fc7640f5-290f-41a9-a345-ec03b15954f8","query_id":"53","doc_a_id":"7221410","doc_b_id":"5752492","presented_order":["5752492","7221410"],"winner_id":"5752492","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses expression of a disease-related biomarker, whereas Document B focuses on Alzheimer's pathology unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607154Z"}
{"comparison_id":"9295abeb-4db3-4a11-82f6-2743cb10c461","query_id":"53","doc_a_id":"2829179","doc_b_id":"5752492","presented_order":["5752492","2829179"],"winner_id":"5752492","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. Document A is marginally more relevant only because it studies protein expression patterns, whereas B focuses on pre-eclampsia metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607161Z"}
{"comparison_id":"d907949e-058f-449e-b7ce-27bd1c0ca466","query_id":"53","doc_a_id":"13350374","doc_b_id":"5752492","presented_order":["5752492","13350374"],"winner_id":"5752492","reasoning":"Doc A is slightly more relevant because it discusses expression of a specific protein and disease outcomes, whereas Document B concerns circadian clock deficiency in mice and aging, not cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:41.607168Z"}
{"comparison_id":"6f4d1955-786e-41c2-b448-3ff213ca743b","query_id":"53","doc_a_id":"5372432","doc_b_id":"8385277","presented_order":["5372432","8385277"],"winner_id":"5372432","reasoning":"Document A is more related to cancer prognosis/diagnosis context; Document B concerns Fanconi anemia and leukemia and does not relate to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:50.091105Z"}
{"comparison_id":"0af2810c-d571-4c4f-83a9-dd83665cf5e6","query_id":"53","doc_a_id":"5278233","doc_b_id":"8385277","presented_order":["5278233","8385277"],"winner_id":"8385277","reasoning":"Document B — it discusses cancer-related genomic abnormalities and clinical implications (staging/management), making it slightly closer to a prognosis-related query than A, which is about imprinting in Beckwith-Wiedemann syndrome.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:50.091128Z"}
{"comparison_id":"c3a3af7e-7afe-449e-ba4f-184dcd73874f","query_id":"53","doc_a_id":"4500832","doc_b_id":"8385277","presented_order":["4500832","8385277"],"winner_id":"8385277","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it concerns cancer-related genomic abnormalities, whereas A is about vitamin E.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:50.091137Z"}
{"comparison_id":"38ca9b14-84d1-4411-8e9a-726b738cf01d","query_id":"53","doc_a_id":"41790911","doc_b_id":"8385277","presented_order":["8385277","41790911"],"winner_id":"8385277","reasoning":"Document A is more related to cancer/oncogenesis (though not breast cancer or ALDH1 specifically). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:50.091144Z"}
{"comparison_id":"add5f006-d37c-4ca5-95dd-4ff6c450a167","query_id":"53","doc_a_id":"42150015","doc_b_id":"8385277","presented_order":["8385277","42150015"],"winner_id":"42150015","reasoning":"Neither document mentions ALDH1 or breast cancer; Document B (a study of reproductive factors in women) is marginally closer to the breast cancer context than a Fanconi anemia/leukemia genetics paper. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:50.091151Z"}
{"comparison_id":"0cdbdc71-1566-4f9a-a6bd-7263417687fc","query_id":"53","doc_a_id":"33030946","doc_b_id":"8385277","presented_order":["33030946","8385277"],"winner_id":"8385277","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant only because it concerns cancer genomics, whereas A focuses on macrophage/osteoclast biology.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:50.091158Z"}
{"comparison_id":"d5d8b548-b670-4f66-857a-5beb30ec6c6c","query_id":"53","doc_a_id":"24705390","doc_b_id":"8385277","presented_order":["24705390","8385277"],"winner_id":"8385277","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it concerns cancer genomic abnormalities and prognosis, whereas A is about H. pylori–induced gastric mutations in mice. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:50.091165Z"}
{"comparison_id":"3931accc-c6f9-4e66-8933-3859ba495aec","query_id":"53","doc_a_id":"11935250","doc_b_id":"8385277","presented_order":["11935250","8385277"],"winner_id":"11935250","reasoning":"Document A is slightly more relevant because it deals with gene-level epigenetic changes across tissues, which is closer to gene expression in cancer than a study focused on Fanconi anemia and leukemia. Neither document directly addresses ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:50.091173Z"}
{"comparison_id":"2f960331-b4c0-4ecb-b64c-25f616baa6fd","query_id":"53","doc_a_id":"32372280","doc_b_id":"8385277","presented_order":["32372280","8385277"],"winner_id":"8385277","reasoning":"Reason: Document B discusses cancer-related genomic abnormalities and oncogenesis, which is more related to prognosis in cancer than Document A's focus on glaucoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:50.091179Z"}
{"comparison_id":"9fd38eb8-0968-4f4c-b753-29120bca6b65","query_id":"53","doc_a_id":"5811042","doc_b_id":"8385277","presented_order":["5811042","8385277"],"winner_id":"8385277","reasoning":"Document B is more relevant — it deals with cancer-related genomic abnormalities and prognosis/oncogenesis, whereas A concerns T-cell regulation and autoimmune inflammation, unrelated to breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:50.091187Z"}
{"comparison_id":"9940c052-e11b-41d5-aeea-e741c93e0961","query_id":"53","doc_a_id":"34316341","doc_b_id":"8385277","presented_order":["34316341","8385277"],"winner_id":"34316341","reasoning":"Document A is slightly more relevant because it discusses gene expression patterns (though not ALDH1 or breast cancer); Document B concerns Fanconi anemia and leukemia, which is farther from the claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:50.091194Z"}
{"comparison_id":"07d5b39e-937c-41c9-b7ed-c4d502b26f88","query_id":"53","doc_a_id":"9478135","doc_b_id":"8385277","presented_order":["9478135","8385277"],"winner_id":"8385277","reasoning":"Document B is slightly more relevant — it discusses genomic abnormalities with implications for staging and therapeutic management (i.e., prognosis), whereas A focuses narrowly on AML1/FLT3 mutation co-occurrence in AML. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:50.091202Z"}
{"comparison_id":"9faa3fec-6f14-491f-8208-e04494de0996","query_id":"53","doc_a_id":"20460020","doc_b_id":"8385277","presented_order":["8385277","20460020"],"winner_id":"20460020","reasoning":"Document B is slightly more relevant — it involves estrogen receptor α, a factor directly connected to breast cancer biology; Document A concerns Fanconi anemia/myeloid leukemia and is unrelated.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:50.091209Z"}
{"comparison_id":"ee792d5f-721f-4c08-94e8-9ead58ef5624","query_id":"53","doc_a_id":"14972169","doc_b_id":"8385277","presented_order":["14972169","8385277"],"winner_id":"8385277","reasoning":"Document B is slightly more relevant because it concerns cancer-related genomic abnormalities, whereas Document A focuses on embryonic oxidative stress unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:50.091216Z"}
{"comparison_id":"dcb1ba60-b774-44af-80d4-afeff45692b8","query_id":"53","doc_a_id":"38025907","doc_b_id":"8385277","presented_order":["38025907","8385277"],"winner_id":"8385277","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B discusses cancer-associated genomic abnormalities and prognosis-related implications, making it marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:50.091223Z"}
{"comparison_id":"ad9a8f21-c5ab-47ab-b5ea-bd87ac5c7136","query_id":"53","doc_a_id":"20977638","doc_b_id":"8385277","presented_order":["20977638","8385277"],"winner_id":"8385277","reasoning":"B is slightly more relevant because it concerns cancer-related genomic abnormalities and oncogenesis, whereas A addresses embryonic teratogenicity unrelated to breast cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:50.091230Z"}
{"comparison_id":"28791215-0bad-423c-bdda-7d5830c82044","query_id":"53","doc_a_id":"5372432","doc_b_id":"11935250","presented_order":["11935250","5372432"],"winner_id":"11935250","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis. Document A (molecular/epigenetic changes) is slightly more relevant than B (healthcare access) to the biological claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:55.706478Z"}
{"comparison_id":"c8925a2f-9722-42c8-b536-e9bbf4e8f2c9","query_id":"53","doc_a_id":"42150015","doc_b_id":"11935250","presented_order":["11935250","42150015"],"winner_id":"11935250","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis directly. Document A discusses gene-specific DNA methylation and epigenetic deregulation (more related to gene expression), so it's slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:55.706497Z"}
{"comparison_id":"2e9ed982-bb1f-4666-a592-f9d5925a8e58","query_id":"53","doc_a_id":"20460020","doc_b_id":"11935250","presented_order":["11935250","20460020"],"winner_id":"20460020","reasoning":"Document B is marginally more related because it involves estrogen receptor signaling, which is relevant to breast cancer biology; Document A is about age-related methylation in mice and not related to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:55.706506Z"}
{"comparison_id":"b8cb5394-1dc7-405b-b5f5-4fb1b0b9e81d","query_id":"53","doc_a_id":"34316341","doc_b_id":"11935250","presented_order":["34316341","11935250"],"winner_id":"34316341","reasoning":"Neither paper mentions ALDH1 or breast cancer. Document A concerns human gene expression patterns (more directly related to gene expression in humans), whereas B is about age-related methylation in mice, so A is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:21:55.706514Z"}
{"comparison_id":"02756f6a-fa2f-44c0-a368-562bb6400359","query_id":"53","doc_a_id":"20460020","doc_b_id":"34316341","presented_order":["20460020","34316341"],"winner_id":"20460020","reasoning":"Document A is more relevant — though neither mentions ALDH1 or breast cancer, A at least addresses estrogen receptor signaling in tissue biology, which is closer to cancer biology than B's developmental imprinting focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:01.197363Z"}
{"comparison_id":"8affe965-1f9f-48fc-979b-4bfb4bc471ef","query_id":"53","doc_a_id":"5372432","doc_b_id":"42150015","presented_order":["42150015","5372432"],"winner_id":"42150015","reasoning":"Neither abstract addresses ALDH1 or breast cancer prognosis; however, A (a study of a molecular reproductive biomarker in women) is slightly closer in subject matter than B (healthcare access and post-mortem diagnoses).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:06.388317Z"}
{"comparison_id":"c8db7d66-5ba9-4fdc-87ee-7bff43de6d8c","query_id":"53","doc_a_id":"5278233","doc_b_id":"32372280","presented_order":["32372280","5278233"],"winner_id":"32372280","reasoning":"Document A is marginally more relevant — it discusses gene expression changes in disease contexts, whereas Document B is about imprinting in Beckwith-Wiedemann syndrome and unrelated to cancer or ALDH1. Neither mentions ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:11.821479Z"}
{"comparison_id":"259a343f-a095-42d5-84d7-04809e870c98","query_id":"53","doc_a_id":"4500832","doc_b_id":"32372280","presented_order":["4500832","32372280"],"winner_id":"4500832","reasoning":"Document A is slightly more relevant — it mentions cancer context (though not ALDH1 or breast cancer), while B is about glaucoma and an unrelated gene.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:11.821499Z"}
{"comparison_id":"cba6bf98-f6f6-4375-a927-b6c5211dc0e6","query_id":"53","doc_a_id":"41790911","doc_b_id":"32372280","presented_order":["41790911","32372280"],"winner_id":"41790911","reasoning":"Document A is slightly more relevant because it concerns angiogenesis and pathways that are more related to cancer biology, whereas Document B is focused on glaucoma/ocular physiology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:11.821508Z"}
{"comparison_id":"5ab93964-c354-47e5-892e-2e2e479e00da","query_id":"53","doc_a_id":"33030946","doc_b_id":"32372280","presented_order":["32372280","33030946"],"winner_id":"32372280","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. Document A is slightly closer only because it mentions tumor necrosis factor–alpha, whereas B focuses on osteoclastogenesis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:11.821516Z"}
{"comparison_id":"6e2e3c9f-cec7-44e8-b3a5-ece26827c121","query_id":"53","doc_a_id":"24705390","doc_b_id":"32372280","presented_order":["32372280","24705390"],"winner_id":"32372280","reasoning":"Document A is slightly more relevant because it discusses gene expression changes (though not ALDH1 or breast cancer), whereas Document B concerns H. pylori–induced gastric mutations unrelated to gene expression in cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:11.821524Z"}
{"comparison_id":"1a44529b-4adb-4f02-a0a0-94d5264c51b7","query_id":"53","doc_a_id":"20977638","doc_b_id":"32372280","presented_order":["32372280","20977638"],"winner_id":"20977638","reasoning":"Neither document addresses ALDH1 or breast cancer directly; Document B is slightly more relevant because it discusses aldehyde (4-HNE) biology and oxidative stress, which is tangentially related to aldehyde dehydrogenase function. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:11.821532Z"}
{"comparison_id":"d4fb4f08-dafd-49af-ac00-c5f64b747be5","query_id":"53","doc_a_id":"5811042","doc_b_id":"32372280","presented_order":["32372280","5811042"],"winner_id":"5811042","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document B is marginally more relevant because it concerns immune regulation, which can relate to cancer biology.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:11.821539Z"}
{"comparison_id":"ee2ec287-ebd6-469c-8c37-675688972b42","query_id":"53","doc_a_id":"9478135","doc_b_id":"32372280","presented_order":["32372280","9478135"],"winner_id":"9478135","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document B is slightly more relevant since it deals with cancer (leukemia) rather than glaucoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:11.821546Z"}
{"comparison_id":"f88ef73b-dc77-4aa2-ad21-90b53b722ec7","query_id":"53","doc_a_id":"14972169","doc_b_id":"32372280","presented_order":["14972169","32372280"],"winner_id":"14972169","reasoning":"Document A is slightly more relevant because it involves cancer-related pathways (oxidative stress, p53) unlike Document B which is about glaucoma/optineurin. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:11.821553Z"}
{"comparison_id":"4148760f-3a27-455b-b0f1-fca3bf819cdc","query_id":"53","doc_a_id":"38025907","doc_b_id":"32372280","presented_order":["38025907","32372280"],"winner_id":"38025907","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more related because it mentions tumorigenesis (cancer context); Document B is about glaucoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:11.821559Z"}
{"comparison_id":"9e852e94-88b9-42fb-afec-8668dc235922","query_id":"53","doc_a_id":"4500832","doc_b_id":"5811042","presented_order":["5811042","4500832"],"winner_id":"4500832","reasoning":"Neither abstract discusses ALDH1 or breast cancer; Document B briefly touches on cancer (prostate) while A is about T-cell inflammation, so B is slightly more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:17.808394Z"}
{"comparison_id":"0d8a1a3a-64c5-4de2-9f92-f21e240d0512","query_id":"53","doc_a_id":"41790911","doc_b_id":"5811042","presented_order":["5811042","41790911"],"winner_id":"41790911","reasoning":"Document B — it discusses angiogenesis (relevant to tumor biology), while Document A is about T-cell regulation and autoinflammation; neither mentions ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:17.808416Z"}
{"comparison_id":"9e3ed843-1d1e-4f3a-8089-2c054bb4ce8e","query_id":"53","doc_a_id":"20977638","doc_b_id":"5811042","presented_order":["20977638","5811042"],"winner_id":"5811042","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant only because immune regulation can relate to cancer biology, whereas A is about embryonic teratogenicity.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:17.808425Z"}
{"comparison_id":"304e9fa8-5e66-4ce8-ac12-7d851fd5e3be","query_id":"53","doc_a_id":"38025907","doc_b_id":"5811042","presented_order":["5811042","38025907"],"winner_id":"5811042","reasoning":"Neither abstract mentions ALDH1 or breast cancer, so neither is relevant to the claim. If one must be chosen, DOCUMENT A is marginally closer (immunology/disease association) but still not relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:17.808433Z"}
{"comparison_id":"2b9fe254-64f0-48f7-8786-d59f5b0e3c7e","query_id":"53","doc_a_id":"9478135","doc_b_id":"5811042","presented_order":["9478135","5811042"],"winner_id":"9478135","reasoning":"Neither document mentions ALDH1 or breast cancer, but Document A is a cancer genetics study (leukemia) whereas B is immunology; A is therefore slightly more related to cancer prognosis context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:17.808440Z"}
{"comparison_id":"9a5852e0-a6b2-477b-a15d-e2f5bb1b465e","query_id":"53","doc_a_id":"14972169","doc_b_id":"5811042","presented_order":["14972169","5811042"],"winner_id":"14972169","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses enzyme modification/expression in tissues, whereas Document B focuses on T-cell immunoregulation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:17.808446Z"}
{"comparison_id":"7e34e5f1-68d4-43e8-80ae-d9995b8b88b8","query_id":"53","doc_a_id":"4500832","doc_b_id":"41790911","presented_order":["4500832","41790911"],"winner_id":"4500832","reasoning":"Neither document discusses ALDH1 or breast cancer; however, Document A at least mentions cancer-related effects while Document B focuses on adipose angiogenesis in obesity. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:25.307976Z"}
{"comparison_id":"35f29e26-c0d1-4f98-aad5-948f7de672e0","query_id":"53","doc_a_id":"14972169","doc_b_id":"41790911","presented_order":["14972169","41790911"],"winner_id":"14972169","reasoning":"Document A is slightly more relevant — it addresses aldehyde-related oxidative stress (4-HNE adducts), which is mechanistically closer to ALDH1’s role in aldehyde detoxification; neither document mentions ALDH1 or breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:25.307998Z"}
{"comparison_id":"ce9ca27d-c5d5-4c0b-b06a-a17267632960","query_id":"53","doc_a_id":"9478135","doc_b_id":"41790911","presented_order":["9478135","41790911"],"winner_id":"9478135","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns cancer (leukemia) rather than obesity-related angiogenesis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:25.308007Z"}
{"comparison_id":"67ab8833-f8c7-482e-9dab-87311f1d0715","query_id":"53","doc_a_id":"4500832","doc_b_id":"14972169","presented_order":["14972169","4500832"],"winner_id":"14972169","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. If forced to choose one, ANSWER: A (both irrelevant, A is at least a biomedical study).","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:28.375907Z"}
{"comparison_id":"6d920264-ed67-448d-a9ec-b4c1d38d781d","query_id":"53","doc_a_id":"9478135","doc_b_id":"14972169","presented_order":["9478135","14972169"],"winner_id":"9478135","reasoning":"Document A is slightly more relevant because it concerns cancer biology (genetic alterations in leukemia), whereas Document B focuses on embryonic oxidative stress unrelated to cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:28.375928Z"}
{"comparison_id":"c178deb2-379c-4e56-87b9-743ad4bbcf98","query_id":"53","doc_a_id":"20977638","doc_b_id":"38025907","presented_order":["38025907","20977638"],"winner_id":"20977638","reasoning":"Document B is slightly more relevant because it involves aldehyde-related biology (4‑HNE adducts and oxidative aldehyde stress), whereas Document A concerns FGF19 and liver disease unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:33.288730Z"}
{"comparison_id":"54d43369-2e08-4580-adc8-90fc45e47632","query_id":"53","doc_a_id":"5278233","doc_b_id":"33030946","presented_order":["5278233","33030946"],"winner_id":"5278233","reasoning":"Document A is slightly more relevant — it deals with gene expression and epigenetic regulation (potentially related to cancer marker expression), whereas Document B focuses on macrophage/osteoclast biology and rheumatoid arthritis, not breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:38.286692Z"}
{"comparison_id":"bc9928d6-4d03-45fa-9b6c-a951c7abc6d4","query_id":"53","doc_a_id":"24705390","doc_b_id":"33030946","presented_order":["24705390","33030946"],"winner_id":"24705390","reasoning":"Document A is slightly more relevant because it deals with infection-induced gastric mutations/cancer-related processes, whereas Document B concerns macrophage/osteoclast biology unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:38.286712Z"}
{"comparison_id":"d3ed23fd-f57e-426d-af02-a7033f3a0fa2","query_id":"53","doc_a_id":"5278233","doc_b_id":"24705390","presented_order":["24705390","5278233"],"winner_id":"5278233","reasoning":"Document B — it concerns cancer-related epigenetic regulation (imprinting), which is slightly more relevant to prognostic markers in cancer than a mouse gastric infection study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:42.840654Z"}
{"comparison_id":"67ed7a6e-991f-4812-b0b1-ec9a6bbd78f1","query_id":"53","doc_a_id":"601033","doc_b_id":"23816832","presented_order":["601033","23816832"],"winner_id":"601033","reasoning":"Reason: Document A concerns cancer (leukemia) and treatment/prognosis, making it marginally more relevant to a prognostic biomarker in cancer than Document B, which discusses multiple sclerosis and CSF analysis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:48.653568Z"}
{"comparison_id":"a79c7458-4444-4690-8fcc-a23934bce254","query_id":"53","doc_a_id":"4445629","doc_b_id":"23816832","presented_order":["4445629","23816832"],"winner_id":"4445629","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it deals with a prognostic biomarker, which aligns with the claim's focus on prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:48.653590Z"}
{"comparison_id":"ae585593-f1c0-400e-b39c-2b4ea58703ff","query_id":"53","doc_a_id":"13398997","doc_b_id":"23816832","presented_order":["13398997","23816832"],"winner_id":"23816832","reasoning":"Document B — it discusses prognosis and biomarkers (clinical outcome relevance), whereas A is about CTLA-4 in transplant immunology and unrelated to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:48.653601Z"}
{"comparison_id":"478883fb-6e19-4e02-b82c-206d81b7d17d","query_id":"53","doc_a_id":"13350374","doc_b_id":"23816832","presented_order":["23816832","13350374"],"winner_id":"23816832","reasoning":"Document A is slightly more relevant because it discusses biomarkers and prognosis (though in MS), while Document B concerns circadian gene deficiency and aging in mice, unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:48.653609Z"}
{"comparison_id":"ed79b326-ef72-421e-abd5-2be86b8d80a4","query_id":"53","doc_a_id":"22896384","doc_b_id":"23816832","presented_order":["22896384","23816832"],"winner_id":"23816832","reasoning":"Document B is slightly more relevant because it discusses prognosis and biomarker analysis (though in MS, not breast cancer); Document A is unrelated developmental biology. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:48.653616Z"}
{"comparison_id":"640a9867-d24c-4429-b5d1-1db4b83f7b1a","query_id":"53","doc_a_id":"7221410","doc_b_id":"23816832","presented_order":["23816832","7221410"],"winner_id":"23816832","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document A addresses biomarkers and prognosis (albeit in MS), so it's marginally more related to the claim about marker expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:48.653623Z"}
{"comparison_id":"99dc3b3b-2340-4be6-b201-291917d2bbdb","query_id":"53","doc_a_id":"2829179","doc_b_id":"23816832","presented_order":["23816832","2829179"],"winner_id":"2829179","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it covers metabolic pathways (ALDH1 is a metabolic enzyme), whereas A is about CSF analysis in multiple sclerosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:48.653630Z"}
{"comparison_id":"13363fd9-4679-4f89-9fa2-1212d57559a4","query_id":"53","doc_a_id":"601033","doc_b_id":"4445629","presented_order":["4445629","601033"],"winner_id":"601033","reasoning":"Document B — it's cancer-related (though not breast cancer), so it's marginally more relevant than a heart-failure study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:52.330696Z"}
{"comparison_id":"f98bfe19-914a-465c-846e-880143ccba8e","query_id":"53","doc_a_id":"2829179","doc_b_id":"4445629","presented_order":["4445629","2829179"],"winner_id":"2829179","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer prognosis; Document B (metabolic/enzymatic focus) is marginally closer in topic than a heart-failure biomarker study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:52.330717Z"}
{"comparison_id":"e0ab229d-9126-4b9a-a435-0d81a4ef2df2","query_id":"53","doc_a_id":"601033","doc_b_id":"2829179","presented_order":["601033","2829179"],"winner_id":"601033","reasoning":"Document A — it's cancer-related (though neither mentions ALDH1 or breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:54.936066Z"}
{"comparison_id":"f0d80d7e-d86e-4ebf-b605-1b7441735a94","query_id":"53","doc_a_id":"13398997","doc_b_id":"13350374","presented_order":["13398997","13350374"],"winner_id":"13398997","reasoning":"Document A is slightly more relevant — it discusses marker expression and clinical implications in a disease/immunology context, whereas Document B concerns circadian gene knockout and aging unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:59.731733Z"}
{"comparison_id":"9cf05fac-8c73-4fb5-ae5a-80a70c015a79","query_id":"53","doc_a_id":"7221410","doc_b_id":"13350374","presented_order":["7221410","13350374"],"winner_id":"7221410","reasoning":"Document A is more relevant — it reports an association between increased expression of a gene (CD33) and worse disease pathology, which is conceptually similar to the claim about ALDH1 expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:59.731753Z"}
{"comparison_id":"31ab0dc8-c86a-4486-bdc8-fb777ded1a20","query_id":"53","doc_a_id":"22896384","doc_b_id":"13350374","presented_order":["22896384","13350374"],"winner_id":"22896384","reasoning":"Neither document mentions ALDH1, breast cancer, or prognosis; both are irrelevant. Document A is slightly more related to tissue development and transcription factors, so it is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:22:59.731762Z"}
{"comparison_id":"913dafaa-6008-4151-94ab-b8dec846d98f","query_id":"53","doc_a_id":"13398997","doc_b_id":"7221410","presented_order":["13398997","7221410"],"winner_id":"13398997","reasoning":"Document A is marginally more relevant because it discusses expression of an immune-related protein and clinical implications, whereas Document B concerns Alzheimer's disease mechanisms unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:05.765768Z"}
{"comparison_id":"086ed5f7-c7a9-4f2a-b0df-f96e8f2eec4f","query_id":"53","doc_a_id":"22896384","doc_b_id":"7221410","presented_order":["7221410","22896384"],"winner_id":"7221410","reasoning":"Document A is slightly more relevant — it discusses gene expression correlated with disease severity, whereas Document B is about developmental transcription factors unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:05.765792Z"}
{"comparison_id":"7e7e304f-fd65-47f9-aa75-acf7c61d3e24","query_id":"53","doc_a_id":"13768432","doc_b_id":"16511863","presented_order":["16511863","13768432"],"winner_id":"16511863","reasoning":"Document A is more relevant — it discusses expression of a molecular marker (ILK) and disease outcome, which is closer in topic to ALDH1 expression and prognosis than an imaging study in amyloidosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:11.689460Z"}
{"comparison_id":"fcb7b990-e3a9-4843-90fa-e56361746dd3","query_id":"53","doc_a_id":"12074066","doc_b_id":"16511863","presented_order":["12074066","16511863"],"winner_id":"12074066","reasoning":"Document A is more relevant — it concerns cancer (colorectal) and so is closer in topic to breast cancer prognosis than Document B, which is about cardiac hypertrophy. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:11.689482Z"}
{"comparison_id":"16901951-f875-4144-aff4-b297622a71bf","query_id":"53","doc_a_id":"5884524","doc_b_id":"16511863","presented_order":["5884524","16511863"],"winner_id":"16511863","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. Document B is slightly more relevant only because it discusses protein expression in disease contexts, whereas A deals only with diabetes and cardiac outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:11.689491Z"}
{"comparison_id":"40f5b24e-2578-4979-877a-1a7f0628a4f4","query_id":"53","doc_a_id":"25141908","doc_b_id":"16511863","presented_order":["16511863","25141908"],"winner_id":"16511863","reasoning":"Neither abstract mentions ALDH1 or breast cancer, so both are irrelevant; Document A is marginally more relevant because it addresses altered expression of a human protein in disease tissue, whereas B concerns a viral transcript in fibroblasts. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:11.689499Z"}
{"comparison_id":"9264d374-37d6-4024-91a9-56e09cc1e74e","query_id":"53","doc_a_id":"13283919","doc_b_id":"16511863","presented_order":["16511863","13283919"],"winner_id":"16511863","reasoning":"Neither document addresses ALDH1 or breast cancer; however, Document A is slightly more relevant since it involves human disease and gene expression, whereas Document B is a mouse immunology study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:11.689506Z"}
{"comparison_id":"ac33922b-835d-49a0-95b6-4235e3d553a3","query_id":"53","doc_a_id":"9159495","doc_b_id":"16511863","presented_order":["9159495","16511863"],"winner_id":"16511863","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it studies human disease and tissue, whereas A is about miRNA in C. elegans aging. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:11.689513Z"}
{"comparison_id":"710b3a2a-44a0-4788-ad31-59ea2565ea2c","query_id":"53","doc_a_id":"13768432","doc_b_id":"25141908","presented_order":["13768432","25141908"],"winner_id":"13768432","reasoning":"Document A is slightly more relevant because it discusses prognostic biomarkers and outcomes (though in cardiac amyloidosis, not breast cancer); Document B is virology-focused and unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:16.972933Z"}
{"comparison_id":"04fc08b7-b383-4fbf-af1b-882ba1913cc2","query_id":"53","doc_a_id":"5884524","doc_b_id":"25141908","presented_order":["25141908","5884524"],"winner_id":"25141908","reasoning":"Reason: Document A discusses gene/protein expression (though in viral infection), which is more related to a claim about marker expression and prognosis than Document B's cardiology/diabetes outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:16.972955Z"}
{"comparison_id":"2a1de2c2-c5a7-422f-967b-9a3f16470ac2","query_id":"53","doc_a_id":"9159495","doc_b_id":"25141908","presented_order":["25141908","9159495"],"winner_id":"25141908","reasoning":"Neither document addresses ALDH1, breast cancer, or clinical prognosis; both are irrelevant. Document A is marginally closer (human cell context) but still not relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:16.972964Z"}
{"comparison_id":"97215cbd-c7cb-4375-9bca-aa212d7492c2","query_id":"53","doc_a_id":"13283919","doc_b_id":"25141908","presented_order":["25141908","13283919"],"winner_id":"25141908","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant only because it involves gene expression in human cells, whereas B is a mouse mast‑cell study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:16.972974Z"}
{"comparison_id":"afcdecf5-5b29-4b9d-bc0b-be75d99b4da7","query_id":"53","doc_a_id":"5884524","doc_b_id":"9159495","presented_order":["9159495","5884524"],"winner_id":"9159495","reasoning":"Document A is marginally more relevant — it's a molecular biology study (though in C. elegans and about miRNAs, not ALDH1 or breast cancer), whereas Document B concerns diabetes and cardiovascular outcomes, which is unrelated to the claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:23.076807Z"}
{"comparison_id":"1bdf57ac-e370-408f-a1bc-0a31afbad1bd","query_id":"53","doc_a_id":"13283919","doc_b_id":"9159495","presented_order":["9159495","13283919"],"winner_id":"9159495","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. If forced to choose, A is slightly more relevant because it concerns gene expression regulation, whereas B focuses on mast cell function.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:23.076828Z"}
{"comparison_id":"edfcf1b6-9cd8-42ef-949c-554f80dcb994","query_id":"53","doc_a_id":"5884524","doc_b_id":"13283919","presented_order":["5884524","13283919"],"winner_id":"5884524","reasoning":"Document A is more relevant — it addresses \"prognosis\" (though in cardiac disease), whereas Document B concerns mast cell function in mice and not prognosis or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:27.587751Z"}
{"comparison_id":"79ad5282-f726-4aad-aaa9-6edafbbf0686","query_id":"53","doc_a_id":"26079071","doc_b_id":"22483580","presented_order":["22483580","26079071"],"winner_id":"26079071","reasoning":"Document B is more relevant — it's an oncology study (cancer-related), whereas A concerns sleep and bipolar disorder unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189539Z"}
{"comparison_id":"ce6ff3c6-17eb-486b-b540-c24933ad8f44","query_id":"53","doc_a_id":"16180601","doc_b_id":"22483580","presented_order":["16180601","22483580"],"winner_id":"16180601","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A concerns prognosis (stroke outcomes), making it slightly more relevant to a prognosis-related claim than Document B, which concerns sleep and IL-6 in bipolar disorder.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189559Z"}
{"comparison_id":"70eb06fc-a280-4a64-8f0a-d7017e31b2ab","query_id":"53","doc_a_id":"26488879","doc_b_id":"22483580","presented_order":["22483580","26488879"],"winner_id":"22483580","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses human disease and molecular markers (IL-6) versus B which is about H. pylori in gerbils.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189568Z"}
{"comparison_id":"ca0a4d5f-5bdd-444a-b0d3-1174c9b9f574","query_id":"53","doc_a_id":"46602807","doc_b_id":"22483580","presented_order":["46602807","22483580"],"winner_id":"22483580","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B discusses clinical biomarkers and prognosis-related biology, making it slightly more relevant than an antibiotic synergy methods paper.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189576Z"}
{"comparison_id":"6499a9e0-bcaf-406d-a21c-76479b8e7bb9","query_id":"53","doc_a_id":"12145359","doc_b_id":"22483580","presented_order":["12145359","22483580"],"winner_id":"12145359","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant only because it concerns cancer (lung), whereas B is about sleep and IL-6 in bipolar disorder. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189583Z"}
{"comparison_id":"8579cb86-dcc2-491d-af17-c3d06ee2e535","query_id":"53","doc_a_id":"22478394","doc_b_id":"22483580","presented_order":["22483580","22478394"],"winner_id":"22483580","reasoning":"Neither document is relevant — neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189589Z"}
{"comparison_id":"3ceab97a-7a8e-452d-8d78-52b14aea6c13","query_id":"53","doc_a_id":"3056682","doc_b_id":"22483580","presented_order":["3056682","22483580"],"winner_id":"3056682","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. (Document A discusses unstable angina/troponins, Document B discusses IL-6 and sleep.) ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189596Z"}
{"comparison_id":"b0c1b29e-7b64-458a-ae21-d471632244bd","query_id":"53","doc_a_id":"25738896","doc_b_id":"22483580","presented_order":["25738896","22483580"],"winner_id":"25738896","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; Document A is slightly more relevant because it concerns cancer biology (melanoma) while Document B concerns bipolar disorder. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189603Z"}
{"comparison_id":"87725fd7-71ed-40f1-89e5-f2eaf35b72d4","query_id":"53","doc_a_id":"3173489","doc_b_id":"22483580","presented_order":["3173489","22483580"],"winner_id":"3173489","reasoning":"Document A is slightly more relevant because it discusses cancer-related pathways and tumor development, whereas Document B is about sleep and bipolar disorder. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189610Z"}
{"comparison_id":"11a1cad8-0bc6-447e-9c22-2c97947964fb","query_id":"53","doc_a_id":"10145528","doc_b_id":"22483580","presented_order":["10145528","22483580"],"winner_id":"10145528","reasoning":"Document A is marginally closer (genetics/cancer-related topic) whereas B is psychiatric and unrelated; neither mentions ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189616Z"}
{"comparison_id":"d9645488-66bc-4cdb-ba1f-c445f3a29beb","query_id":"53","doc_a_id":"3619931","doc_b_id":"22483580","presented_order":["22483580","3619931"],"winner_id":"22483580","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is marginally more related because it addresses expression of a biological marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189623Z"}
{"comparison_id":"3f507748-8e30-4188-aba9-e61044f40b47","query_id":"53","doc_a_id":"26008063","doc_b_id":"22483580","presented_order":["22483580","26008063"],"winner_id":"26008063","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it concerns gene expression and disease association, whereas A is about sleep and IL-6 in bipolar disorder.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189630Z"}
{"comparison_id":"0fdd5254-b24a-4c0c-85b2-046104fadea9","query_id":"53","doc_a_id":"6290112","doc_b_id":"22483580","presented_order":["22483580","6290112"],"winner_id":"22483580","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns expression of an inflammatory marker in disease, whereas B is unrelated (obesity genetics). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189637Z"}
{"comparison_id":"4ccc58fa-00d6-485b-a782-a66aae73e12d","query_id":"53","doc_a_id":"15928989","doc_b_id":"22483580","presented_order":["22483580","15928989"],"winner_id":"22483580","reasoning":"Document A is slightly more relevant — it discusses a disease biomarker (IL-6) and prognostic implications, whereas Document B is about reproductive biology and pregnancy. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189644Z"}
{"comparison_id":"3dd80542-0510-4f03-b3ec-ff3f037c7e68","query_id":"53","doc_a_id":"42782688","doc_b_id":"22483580","presented_order":["22483580","42782688"],"winner_id":"22483580","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns a clinical biomarker (IL-6) versus B's focus on probiotics and colitis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189651Z"}
{"comparison_id":"06325f7f-0e64-4361-a494-3456c01bfde9","query_id":"53","doc_a_id":"18988265","doc_b_id":"22483580","presented_order":["22483580","18988265"],"winner_id":"22483580","reasoning":"Neither document mentions ALDH1 or breast cancer, so neither is relevant. If forced to choose, A is slightly more relevant because it discusses biomarker/immune marker expression, whereas B addresses COPD exacerbations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189658Z"}
{"comparison_id":"d697ab0b-7891-48ab-a7ab-93b5e63f8c67","query_id":"53","doc_a_id":"21602220","doc_b_id":"22483580","presented_order":["22483580","21602220"],"winner_id":"22483580","reasoning":"Document A is more relevant—it's medical/clinical and discusses biomarkers and prognosis-related immune factors, whereas Document B is about microbial fermentation and unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189665Z"}
{"comparison_id":"8cd33f73-21f8-49db-b375-a8ac3e132d14","query_id":"53","doc_a_id":"5573975","doc_b_id":"22483580","presented_order":["22483580","5573975"],"winner_id":"22483580","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189671Z"}
{"comparison_id":"3b02e56d-a532-4d57-8df3-1648a6e952d3","query_id":"53","doc_a_id":"30297355","doc_b_id":"22483580","presented_order":["30297355","22483580"],"winner_id":"30297355","reasoning":"Reason: Both are unrelated to ALDH1 or breast cancer, but Document A discusses gene expression patterns (more thematically related) while Document B concerns sleep and IL-6 in bipolar disorder.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189678Z"}
{"comparison_id":"e5ed6d77-0344-4df0-8d67-fcb672937f9a","query_id":"53","doc_a_id":"24347647","doc_b_id":"22483580","presented_order":["24347647","22483580"],"winner_id":"24347647","reasoning":"Neither document discusses ALDH1 or breast cancer; Document A is slightly more relevant because it concerns biomedical/age-related pathology, whereas B is psychiatric/IL-6–focused.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189685Z"}
{"comparison_id":"fbdcefde-44a3-4678-a591-c021a6f249c0","query_id":"53","doc_a_id":"6421734","doc_b_id":"22483580","presented_order":["6421734","22483580"],"winner_id":"6421734","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis, so neither is relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189691Z"}
{"comparison_id":"0201f70d-0513-42ee-8f94-583a23def17a","query_id":"53","doc_a_id":"21372171","doc_b_id":"22483580","presented_order":["22483580","21372171"],"winner_id":"21372171","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is marginally more related because it concerns a disease biomarker, whereas A is about sleep and IL-6 in bipolar disorder. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189698Z"}
{"comparison_id":"3b52307e-1001-4f50-b59b-f89a55b8d705","query_id":"53","doc_a_id":"41782935","doc_b_id":"22483580","presented_order":["41782935","22483580"],"winner_id":"41782935","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses genetic biomarkers and prognosis (though for Alzheimer’s), whereas B concerns IL-6 and sleep in bipolar disorder. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189705Z"}
{"comparison_id":"b8919567-a338-40aa-ba16-a1f5a458b2b2","query_id":"53","doc_a_id":"52865789","doc_b_id":"22483580","presented_order":["22483580","52865789"],"winner_id":"22483580","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis, so both are irrelevant. If a choice is required, A is marginally more relevant because it concerns human disease biomarkers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189712Z"}
{"comparison_id":"774aee0d-867a-4fa7-a1f0-b4a603e5af98","query_id":"53","doc_a_id":"1871499","doc_b_id":"22483580","presented_order":["22483580","1871499"],"winner_id":"1871499","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B (epigenetic changes/gene regulation) is marginally closer in topic to gene expression than Document A (sleep and IL-6 in bipolar disorder).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189720Z"}
{"comparison_id":"21f7f19b-2594-4ac1-a0ed-cadcaec9b6f4","query_id":"53","doc_a_id":"41133176","doc_b_id":"22483580","presented_order":["41133176","22483580"],"winner_id":"41133176","reasoning":"Document A is slightly more relevant because it concerns gene expression of enzymes in tissues (whereas B is about IL-6 and sleep in bipolar disorder), though neither discusses ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189727Z"}
{"comparison_id":"d43d00fa-5c9e-4599-ac3e-4760a0ef9f7d","query_id":"53","doc_a_id":"24285403","doc_b_id":"22483580","presented_order":["24285403","22483580"],"winner_id":"22483580","reasoning":"Document B is slightly more relevant because it addresses molecular biomarkers and immune signaling, whereas Document A is an epidemiologic vascular/cognitive study; neither discusses ALDH1 or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189734Z"}
{"comparison_id":"18fa886d-4a1d-4d91-990a-7fc4b9252213","query_id":"53","doc_a_id":"24586989","doc_b_id":"22483580","presented_order":["24586989","22483580"],"winner_id":"24586989","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant; Document A is slightly more related to biomedical genetics than B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189741Z"}
{"comparison_id":"2ea19d94-5f81-4f2b-ad32-7b6e984d55c1","query_id":"53","doc_a_id":"3514072","doc_b_id":"22483580","presented_order":["22483580","3514072"],"winner_id":"22483580","reasoning":"Document A is more relevant — it's about human disease and immune markers (closer to clinical prognosis topics), while Document B is plant genomics and unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189748Z"}
{"comparison_id":"a8ba940d-33b8-4ce1-83f2-410db9b8b1aa","query_id":"53","doc_a_id":"11738716","doc_b_id":"22483580","presented_order":["22483580","11738716"],"winner_id":"22483580","reasoning":"Document A is slightly more relevant because it's human-disease related, while Document B concerns C. elegans lifespan and is unrelated to cancer biomarkers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189755Z"}
{"comparison_id":"9e17f32f-292a-46dc-93df-cdc802582b6d","query_id":"53","doc_a_id":"12462961","doc_b_id":"22483580","presented_order":["12462961","22483580"],"winner_id":"12462961","reasoning":"Document A is slightly more relevant because it concerns gene expression and transcriptional regulation, which is closer to a claim about a gene marker (ALDH1) and prognosis than Document B's topic on IL-6 and sleep in bipolar disorder.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189762Z"}
{"comparison_id":"fb7cc5e4-d3e6-4473-bc5e-70e1f35ad3fe","query_id":"53","doc_a_id":"6947286","doc_b_id":"22483580","presented_order":["22483580","6947286"],"winner_id":"22483580","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant only because it discusses biomarker expression/inflammation, while B focuses on Alzheimer's gene polymorphisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189769Z"}
{"comparison_id":"92aaafed-18ac-429f-9706-e8003b132775","query_id":"53","doc_a_id":"38028419","doc_b_id":"22483580","presented_order":["22483580","38028419"],"winner_id":"38028419","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it deals with molecular pathology/metabolic disease, whereas A is psychiatric (sleep/IL-6). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:48.189776Z"}
{"comparison_id":"d8732306-70f8-4195-aab9-59aaaffc3c18","query_id":"53","doc_a_id":"26079071","doc_b_id":"30297355","presented_order":["26079071","30297355"],"winner_id":"26079071","reasoning":"Document A is cancer-related (clinical outcomes), so it's more likely to be relevant to prognosis/biomarkers than a mouse developmental gene expression study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:58.089499Z"}
{"comparison_id":"6a546076-602f-4e2b-bd34-19fbe6e07c11","query_id":"53","doc_a_id":"16180601","doc_b_id":"30297355","presented_order":["16180601","30297355"],"winner_id":"16180601","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A mentions prognosis (in stroke), so it's marginally more related to the concept of prognosis than B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:58.089519Z"}
{"comparison_id":"b5a52861-0d31-49fa-a869-e1472e94a181","query_id":"53","doc_a_id":"12145359","doc_b_id":"30297355","presented_order":["30297355","12145359"],"winner_id":"30297355","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document A is marginally closer because it discusses gene expression patterns (though in a different gene and tissues). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:58.089528Z"}
{"comparison_id":"96c950c1-1b4e-41d2-a57d-e34a5fc177ac","query_id":"53","doc_a_id":"3056682","doc_b_id":"30297355","presented_order":["3056682","30297355"],"winner_id":"30297355","reasoning":"Document B is more relevant — it deals with gene expression patterns (though in mouse CNS), which is closer to a claim about ALDH1 expression and prognosis than a paper on unstable angina. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:58.089538Z"}
{"comparison_id":"7b5d78be-e714-467b-9d26-57dc9c720beb","query_id":"53","doc_a_id":"25738896","doc_b_id":"30297355","presented_order":["25738896","30297355"],"winner_id":"25738896","reasoning":"Document A — it's cancer-related (melanoma) and thus marginally closer to a claim about cancer prognosis than a developmental Ndp expression study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:58.089545Z"}
{"comparison_id":"b1bc6378-019b-4032-b381-ada00b59c2ed","query_id":"53","doc_a_id":"3173489","doc_b_id":"30297355","presented_order":["3173489","30297355"],"winner_id":"3173489","reasoning":"Document A — discusses cancer-related mechanisms (tumor development), so it's closer to a prognosis/marker topic than Document B. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:58.089552Z"}
{"comparison_id":"238b83d5-fc15-49a8-8219-32e6e5dbb1e1","query_id":"53","doc_a_id":"10145528","doc_b_id":"30297355","presented_order":["10145528","30297355"],"winner_id":"10145528","reasoning":"Document A is marginally more relevant because it concerns human gene variation and cancer-related gene (ATM) analysis, whereas Document B focuses on a mouse developmental gene unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:58.089559Z"}
{"comparison_id":"f6e7d4f4-dea1-47e8-92ef-bdd3b6f29e67","query_id":"53","doc_a_id":"26008063","doc_b_id":"30297355","presented_order":["26008063","30297355"],"winner_id":"26008063","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is marginally closer because it addresses gene expression and a human disease link, whereas B focuses on Ndp expression in CNS tissues.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:58.089566Z"}
{"comparison_id":"dec67a8d-3caf-4eed-9dcb-962e97407a92","query_id":"53","doc_a_id":"38028419","doc_b_id":"30297355","presented_order":["30297355","38028419"],"winner_id":"30297355","reasoning":"Document A is marginally more relevant because it concerns gene expression patterns (though not ALDH1 or breast cancer); Document B focuses on leptin and alcoholic fatty liver disease, which is unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:58.089573Z"}
{"comparison_id":"0e2517a2-d26a-445b-b207-84086c2382c9","query_id":"53","doc_a_id":"24347647","doc_b_id":"30297355","presented_order":["24347647","30297355"],"winner_id":"24347647","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document A's focus on disease phenotypes and metabolism is marginally closer to cancer-related biology than Document B's developmental CNS focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:58.089580Z"}
{"comparison_id":"0cf7929e-4971-47ce-95d7-63676ee59462","query_id":"53","doc_a_id":"6421734","doc_b_id":"30297355","presented_order":["6421734","30297355"],"winner_id":"30297355","reasoning":"Neither document addresses ALDH1 or breast cancer. Both are irrelevant, but B is marginally more related because it reports gene expression studies (whereas A is about GP service experience). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:58.089587Z"}
{"comparison_id":"52a2e2de-71c2-4bdd-b075-f88ab08ad60b","query_id":"53","doc_a_id":"21372171","doc_b_id":"30297355","presented_order":["21372171","30297355"],"winner_id":"21372171","reasoning":"Document A is more relevant — it studies protein biomarker expression in human disease and prognosis contexts, whereas Document B describes developmental gene expression in mouse CNS unrelated to cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:58.089594Z"}
{"comparison_id":"158193d8-eb16-45cd-8fcd-32b1a76ea527","query_id":"53","doc_a_id":"41782935","doc_b_id":"30297355","presented_order":["30297355","41782935"],"winner_id":"30297355","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A at least concerns gene expression studies (though in mouse CNS), so it's slightly more relevant than a review on Alzheimer's genetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:58.089601Z"}
{"comparison_id":"9ce21455-27b6-4556-ad7c-fe86b529a71a","query_id":"53","doc_a_id":"1871499","doc_b_id":"30297355","presented_order":["30297355","1871499"],"winner_id":"30297355","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant because it concerns gene expression studies (whereas B focuses on epigenetic changes in Huntington's disease).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:58.089608Z"}
{"comparison_id":"5c6150cd-e358-49ea-914c-43ace6217068","query_id":"53","doc_a_id":"41133176","doc_b_id":"30297355","presented_order":["41133176","30297355"],"winner_id":"41133176","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is marginally closer since it addresses expression of enzymes in disease tissues. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:58.089615Z"}
{"comparison_id":"4e774d5a-8b14-425f-b55d-842ea0d7cc08","query_id":"53","doc_a_id":"24586989","doc_b_id":"30297355","presented_order":["30297355","24586989"],"winner_id":"30297355","reasoning":"Document A — although neither discusses ALDH1 or breast cancer, A concerns gene expression patterns (more related to a biomarker/prognosis question) while B is about heart-failure receptor polymorphisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:58.089622Z"}
{"comparison_id":"f67b53f4-b9e7-487c-90b9-1c9425b2e487","query_id":"53","doc_a_id":"12462961","doc_b_id":"30297355","presented_order":["12462961","30297355"],"winner_id":"12462961","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses human gene transcription and cancer-related cell lines, whereas B covers developmental expression of a mouse gene. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:23:58.089628Z"}
{"comparison_id":"300f55ef-4683-4db5-b485-db54ea05103d","query_id":"53","doc_a_id":"26079071","doc_b_id":"10145528","presented_order":["26079071","10145528"],"winner_id":"26079071","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A, however, is about cancer treatment and outcomes (though in NSCLC), so it's marginally more relevant than the population genetics focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:06.530730Z"}
{"comparison_id":"37246a90-5d77-4e86-b042-599cc9b087f2","query_id":"53","doc_a_id":"16180601","doc_b_id":"10145528","presented_order":["10145528","16180601"],"winner_id":"10145528","reasoning":"Document A is more relevant — it deals with gene variation related to cancer biology (ATM), whereas Document B concerns stroke/corin and is unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:06.530754Z"}
{"comparison_id":"d676907f-0cb0-4161-9d83-ebb412afca46","query_id":"53","doc_a_id":"25738896","doc_b_id":"10145528","presented_order":["10145528","25738896"],"winner_id":"10145528","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis. Both are irrelevant; Document A is marginally more related because it concerns a cancer-associated gene (ATM), whereas B focuses on melanoma immune responses.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:06.530763Z"}
{"comparison_id":"b966831e-cf69-4eb2-9d66-5750751177af","query_id":"53","doc_a_id":"3173489","doc_b_id":"10145528","presented_order":["3173489","10145528"],"winner_id":"3173489","reasoning":"Document A is marginally more related because it deals with tumor development and prognosis-related biology, whereas Document B focuses on ATM population genetics unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:06.530770Z"}
{"comparison_id":"d4caaefe-8d1d-48d3-a991-c24c50766770","query_id":"53","doc_a_id":"12462961","doc_b_id":"10145528","presented_order":["10145528","12462961"],"winner_id":"12462961","reasoning":"B is slightly more relevant because it concerns regulation of gene expression and epigenetic control, which is closer to a claim about marker expression and prognosis; A focuses on ATM polymorphisms unrelated to ALDH1 or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:06.530777Z"}
{"comparison_id":"8b79759d-947b-490d-ad15-2f15cc141d51","query_id":"53","doc_a_id":"26008063","doc_b_id":"10145528","presented_order":["10145528","26008063"],"winner_id":"10145528","reasoning":"Document A is slightly more related because it concerns cancer-relevant gene variation (ATM), whereas Document B concerns kidney development and is unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:06.530783Z"}
{"comparison_id":"d100dde4-4e60-4dd6-a695-74cfc6fb36c5","query_id":"53","doc_a_id":"24347647","doc_b_id":"10145528","presented_order":["10145528","24347647"],"winner_id":"10145528","reasoning":"Document A is slightly more relevant only in being a human gene study; neither discusses ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:06.530790Z"}
{"comparison_id":"74dcbbd4-8134-460c-aa41-d6b406ca11d1","query_id":"53","doc_a_id":"21372171","doc_b_id":"10145528","presented_order":["10145528","21372171"],"winner_id":"10145528","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis; both are irrelevant. Document A is marginally closer since it concerns a cancer-related gene study rather than peripheral artery disease. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:06.530796Z"}
{"comparison_id":"3d724732-35a4-4086-bb1a-be11da4e0a28","query_id":"53","doc_a_id":"41133176","doc_b_id":"10145528","presented_order":["41133176","10145528"],"winner_id":"41133176","reasoning":"Document A is marginally more relevant because it concerns differential enzyme expression (though in pancreatic islets, not ALDH1 or breast cancer), whereas Document B is about ATM genetic variation unrelated to ALDH1 expression or breast cancer prognosis.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:06.530804Z"}
{"comparison_id":"2db8a4ed-a5e6-4658-ae5b-5ce7943652c7","query_id":"53","doc_a_id":"26079071","doc_b_id":"3173489","presented_order":["3173489","26079071"],"winner_id":"3173489","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document A relates to tumor development and prognosis more generally, while Document B is specific to ROS1-rearranged lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:11.839605Z"}
{"comparison_id":"07b8ce81-7667-4073-b07f-2f976eff5b9c","query_id":"53","doc_a_id":"41133176","doc_b_id":"3173489","presented_order":["3173489","41133176"],"winner_id":"3173489","reasoning":"Document A — it concerns tumor development and cancer-relevant biology, whereas B deals with pancreatic islet antioxidant enzymes unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:11.839630Z"}
{"comparison_id":"6cb0ce56-b036-4f29-a9cb-906e006f3173","query_id":"53","doc_a_id":"12462961","doc_b_id":"3173489","presented_order":["3173489","12462961"],"winner_id":"3173489","reasoning":"Document A is slightly more relevant because it addresses tumor development and cancer-related outcomes (though in lymphomas), whereas B concerns adrenal transcription regulation unrelated to ALDH1 or breast cancer.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:11.839638Z"}
{"comparison_id":"c79b14b9-3ec1-46d4-8a46-d235e8393df8","query_id":"53","doc_a_id":"26079071","doc_b_id":"41133176","presented_order":["41133176","26079071"],"winner_id":"26079071","reasoning":"Document B is more relevant — both documents are unrelated to ALDH1 in breast cancer, but B at least concerns cancer prognosis/treatment, while A is about pancreatic islets and antioxidant enzymes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:19.007669Z"}
{"comparison_id":"218008f2-e6ae-4084-bdfe-c43c0774f70c","query_id":"53","doc_a_id":"12462961","doc_b_id":"41133176","presented_order":["12462961","41133176"],"winner_id":"12462961","reasoning":"Document A is slightly more relevant because it deals with regulation of gene expression and epigenetic control in human tissues, whereas Document B concerns antioxidant enzyme levels in mouse pancreatic islets and is unrelated to breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:19.007691Z"}
{"comparison_id":"772373e1-cb7c-4b04-bf9c-f056e9757c40","query_id":"53","doc_a_id":"26079071","doc_b_id":"12462961","presented_order":["12462961","26079071"],"winner_id":"12462961","reasoning":"Document A is slightly more relevant because it discusses gene expression regulation and epigenetic effects, which is closer to an expression–prognosis topic than a lung cancer drug trial.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:22.596371Z"}
{"comparison_id":"38183e30-236e-4d31-b442-454caa5de414","query_id":"53","doc_a_id":"16180601","doc_b_id":"26008063","presented_order":["26008063","16180601"],"winner_id":"16180601","reasoning":"Document B — it concerns a biomarker predicting clinical prognosis (though in stroke), which is conceptually closer to a claim about a prognostic marker in cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:27.276795Z"}
{"comparison_id":"9243d8d5-1d94-458a-b666-7572c265d740","query_id":"53","doc_a_id":"25738896","doc_b_id":"26008063","presented_order":["26008063","25738896"],"winner_id":"25738896","reasoning":"Document B is more relevant — it's cancer-related (immune response to melanoma), whereas A concerns kidney development and CAKUT. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:27.276816Z"}
{"comparison_id":"6dbfb40f-06aa-425b-8d33-11a36b772d46","query_id":"53","doc_a_id":"21372171","doc_b_id":"26008063","presented_order":["26008063","21372171"],"winner_id":"21372171","reasoning":"Document B is more relevant — it deals with biomarkers and disease prognosis, whereas Document A is about kidney development and congenital anomalies. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:27.276824Z"}
{"comparison_id":"714a018b-537a-4669-9f41-85abfa4d6255","query_id":"53","doc_a_id":"24347647","doc_b_id":"26008063","presented_order":["24347647","26008063"],"winner_id":"24347647","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; Document A (aging/metabolic abnormalities) is slightly more tangentially related to cancer biology than Document B (kidney development).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:27.276832Z"}
{"comparison_id":"2212379d-9fde-4811-aa11-9afd874024c3","query_id":"53","doc_a_id":"16180601","doc_b_id":"25738896","presented_order":["25738896","16180601"],"winner_id":"25738896","reasoning":"Document A — it's cancer-related (immune response to melanoma), so marginally closer to a claim about cancer prognosis than a stroke prognosis study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:30.725791Z"}
{"comparison_id":"ba981329-f663-402a-8fb8-b7899680435c","query_id":"53","doc_a_id":"24347647","doc_b_id":"25738896","presented_order":["24347647","25738896"],"winner_id":"25738896","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is marginally more relevant because it deals with cancer biology (immune response to melanoma) versus metabolic/aging phenotypes in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:30.725812Z"}
{"comparison_id":"a2f5c405-948e-4fce-a8e2-0afa9a2517b5","query_id":"53","doc_a_id":"21372171","doc_b_id":"25738896","presented_order":["25738896","21372171"],"winner_id":"25738896","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns cancer biology (melanoma/immune response), whereas B concerns vascular disease biomarkers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:30.725821Z"}
{"comparison_id":"56874eab-ec96-4805-b807-3e159814fffc","query_id":"53","doc_a_id":"16180601","doc_b_id":"24347647","presented_order":["16180601","24347647"],"winner_id":"16180601","reasoning":"Document A is slightly more relevant because it addresses a biomarker (corin) and clinical prognosis, whereas Document B is about proteasomal activity in aging/metabolism and unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:35.630584Z"}
{"comparison_id":"a5fd0ce3-6e54-45f4-ba8e-63f369d30e61","query_id":"53","doc_a_id":"21372171","doc_b_id":"24347647","presented_order":["21372171","24347647"],"winner_id":"21372171","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document A concerns a clinical biomarker in human disease (closer in topic to tumor biomarker/prognosis) whereas Document B is an animal aging/metabolism study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:35.630603Z"}
{"comparison_id":"264bbde3-6b53-47e4-8c11-e87f0ba1a139","query_id":"53","doc_a_id":"16180601","doc_b_id":"21372171","presented_order":["16180601","21372171"],"winner_id":"16180601","reasoning":"Document A is slightly more relevant because it concerns a biomarker's association with prognosis (though in stroke, not breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:40.569443Z"}
{"comparison_id":"105ad675-c8b3-4981-b080-e9fcc289eb48","query_id":"53","doc_a_id":"12145359","doc_b_id":"6421734","presented_order":["12145359","6421734"],"winner_id":"12145359","reasoning":"Document A is cancer-related (lung cancer risk) and thus marginally more relevant than Document B, which is about GP service experiences; neither directly addresses ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:45.447807Z"}
{"comparison_id":"bae74b4b-05c7-4c3d-b93a-81e3ac32c2d9","query_id":"53","doc_a_id":"3056682","doc_b_id":"6421734","presented_order":["3056682","6421734"],"winner_id":"3056682","reasoning":"Neither document provides evidence about ALDH1 or breast cancer. Document A is slightly more relevant because it discusses a biomarker's association with prognosis, whereas B is about GP service experience. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:45.447827Z"}
{"comparison_id":"7c2079d5-f393-422a-aaed-a9445c4128c7","query_id":"53","doc_a_id":"38028419","doc_b_id":"6421734","presented_order":["38028419","6421734"],"winner_id":"38028419","reasoning":"Document A is marginally more relevant because it is a biomedical study (whereas B is about health services); however, neither discusses ALDH1 or breast cancer prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:45.447836Z"}
{"comparison_id":"1f010ca0-9cfe-4ed8-8bbe-12feeac1ef4e","query_id":"53","doc_a_id":"24586989","doc_b_id":"6421734","presented_order":["6421734","24586989"],"winner_id":"24586989","reasoning":"Document B — it's biomedical research (genetics and prognosis-related analysis), whereas A is about GP service experience and unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:45.447846Z"}
{"comparison_id":"c9632fe9-e6ff-4605-8ead-c9b96b712882","query_id":"53","doc_a_id":"41782935","doc_b_id":"6421734","presented_order":["41782935","6421734"],"winner_id":"41782935","reasoning":"Document A is more related to genetics and prognostic biomarkers (though in Alzheimer's, not breast cancer), while Document B is about patient service experiences and unrelated to molecular prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:45.447853Z"}
{"comparison_id":"f3911dbd-430f-4668-83a1-4c238e2e6696","query_id":"53","doc_a_id":"1871499","doc_b_id":"6421734","presented_order":["6421734","1871499"],"winner_id":"1871499","reasoning":"Document B is marginally more relevant because it concerns molecular/epigenetic biomarkers in disease, whereas Document A is about GP service experience and unrelated to cancer biomarkers. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:45.447860Z"}
{"comparison_id":"bd3278f5-a0c6-4c61-bea8-6a905690dd2b","query_id":"53","doc_a_id":"12145359","doc_b_id":"38028419","presented_order":["38028419","12145359"],"winner_id":"38028419","reasoning":"Document A is slightly more relevant — it's a basic biomedical study (molecular/pathway focus), whereas Document B is an epidemiologic lung-function/lung-cancer study; neither directly addresses ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:50.755900Z"}
{"comparison_id":"e792aaa8-9812-4ccd-9775-f8a05605f33e","query_id":"53","doc_a_id":"3056682","doc_b_id":"38028419","presented_order":["3056682","38028419"],"winner_id":"3056682","reasoning":"Document A — it discusses a biomarker (troponins) predicting clinical prognosis, which is conceptually closer to a claim about biomarker expression and cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:50.755920Z"}
{"comparison_id":"a7d3b1b7-b120-482b-9561-9c02ddf90c9f","query_id":"53","doc_a_id":"1871499","doc_b_id":"38028419","presented_order":["1871499","38028419"],"winner_id":"1871499","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; both are unrelated. Document A is slightly more relevant only in that it concerns molecular/epigenetic markers, but neither provides evidence about ALDH1 prognosis in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:50.755929Z"}
{"comparison_id":"0e43a467-a488-4c2c-8c9b-1bd0c21f69be","query_id":"53","doc_a_id":"24586989","doc_b_id":"38028419","presented_order":["38028419","24586989"],"winner_id":"38028419","reasoning":"Neither document addresses ALDH1 or breast cancer, so both are irrelevant. Document A is marginally more related since it discusses protein expression and disease pathology, whereas B focuses on beta‑adrenergic polymorphisms in heart failure. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:50.755938Z"}
{"comparison_id":"b144a568-1d02-4777-8167-998df1e3f08c","query_id":"53","doc_a_id":"41782935","doc_b_id":"38028419","presented_order":["38028419","41782935"],"winner_id":"41782935","reasoning":"Document B is more relevant — it discusses prognosis (though for Alzheimer's, not breast cancer), whereas Document A is about leptin and alcoholic fatty liver disease in mice and is unrelated.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:50.755945Z"}
{"comparison_id":"16fb9f14-48d9-4f84-9105-3a1e3fcdfce7","query_id":"53","doc_a_id":"3056682","doc_b_id":"1871499","presented_order":["1871499","3056682"],"winner_id":"1871499","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it deals with molecular/epigenetic expression, whereas B is cardiovascular. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:55.804327Z"}
{"comparison_id":"1bdda7d0-b768-464f-9654-6edb8bffb41c","query_id":"53","doc_a_id":"41782935","doc_b_id":"1871499","presented_order":["41782935","1871499"],"winner_id":"41782935","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document A at least addresses prognosis (albeit in Alzheimer's), whereas B focuses on epigenetic changes in Huntington's disease.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:24:55.804347Z"}
{"comparison_id":"574f1ab1-06fe-4834-bed8-2d6d6a4ccf0f","query_id":"53","doc_a_id":"12145359","doc_b_id":"24586989","presented_order":["24586989","12145359"],"winner_id":"12145359","reasoning":"Document B is slightly more relevant because it addresses cancer risk (though lung cancer), whereas Document A concerns heart failure and is unrelated; neither mentions ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:01.465273Z"}
{"comparison_id":"a78900dc-b1ca-4d81-a1e5-d4509d2325ea","query_id":"53","doc_a_id":"26488879","doc_b_id":"18988265","presented_order":["26488879","18988265"],"winner_id":"26488879","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant only because it discusses molecular protein interactions (rather than COPD clinical course).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:09.330975Z"}
{"comparison_id":"58a139eb-c432-44fc-a965-017f0915dfa1","query_id":"53","doc_a_id":"46602807","doc_b_id":"18988265","presented_order":["18988265","46602807"],"winner_id":"18988265","reasoning":"Document A is more relevant — although neither mentions ALDH1 or breast cancer, A deals with prognostic associations in a human disease (whereas B is an antibiotic synergy methods study). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:09.330998Z"}
{"comparison_id":"9f3438c0-9269-4a2f-aaf9-89334113ca36","query_id":"53","doc_a_id":"22478394","doc_b_id":"18988265","presented_order":["22478394","18988265"],"winner_id":"22478394","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it discusses gene expression associations with disease, whereas B is about COPD exacerbations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:09.331007Z"}
{"comparison_id":"d187cb4c-7be6-4f25-8712-b75d84543f8c","query_id":"53","doc_a_id":"3619931","doc_b_id":"18988265","presented_order":["18988265","3619931"],"winner_id":"18988265","reasoning":"Neither document addresses ALDH1 or breast cancer (both are about lung diseases), so both are irrelevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:09.331014Z"}
{"comparison_id":"659f6b3f-9bdf-4e6a-9d9d-90e21b9847b6","query_id":"53","doc_a_id":"6290112","doc_b_id":"18988265","presented_order":["6290112","18988265"],"winner_id":"6290112","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A at least concerns gene copy number/expression and disease association, while B is about COPD exacerbations, so A is slightly more related.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:09.331021Z"}
{"comparison_id":"7e83811a-388e-4a3a-930f-4db32e414a44","query_id":"53","doc_a_id":"15928989","doc_b_id":"18988265","presented_order":["15928989","18988265"],"winner_id":"15928989","reasoning":"Neither document mentions ALDH1 or breast cancer, so neither is relevant to the claim. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:09.331028Z"}
{"comparison_id":"722ed6a8-396b-4026-bfd8-e25855f2e46f","query_id":"53","doc_a_id":"42782688","doc_b_id":"18988265","presented_order":["42782688","18988265"],"winner_id":"42782688","reasoning":"Neither document addresses ALDH1 or breast cancer; Document A is slightly closer because it discusses molecular expression changes in human disease. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:09.331034Z"}
{"comparison_id":"5971a460-179d-401d-9e07-332a341b3e2c","query_id":"53","doc_a_id":"6947286","doc_b_id":"18988265","presented_order":["18988265","6947286"],"winner_id":"6947286","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document B is slightly more relevant because it concerns genetic markers (whereas A is a COPD clinical phenotype).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:09.331041Z"}
{"comparison_id":"a41197b8-cf38-42df-85a3-a2c36055396b","query_id":"53","doc_a_id":"21602220","doc_b_id":"18988265","presented_order":["18988265","21602220"],"winner_id":"18988265","reasoning":"Document A is medical/clinical in human disease (though COPD, not cancer) and thus slightly closer in relevance than a microbial fermentation study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:09.331047Z"}
{"comparison_id":"4385bb22-78d4-4732-a3d2-8e0c336d3e64","query_id":"53","doc_a_id":"5573975","doc_b_id":"18988265","presented_order":["18988265","5573975"],"winner_id":"5573975","reasoning":"Both documents are irrelevant to ALDH1 expression or breast cancer prognosis; Document B is marginally more related (molecular signaling/epithelial biology) than the COPD clinical study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:09.331054Z"}
{"comparison_id":"f22c646b-eab7-4c9c-936e-2bc40c1c03d8","query_id":"53","doc_a_id":"52865789","doc_b_id":"18988265","presented_order":["52865789","18988265"],"winner_id":"52865789","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A, which involves molecular expression changes, is slightly more related in scope than the COPD exacerbation study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:09.331061Z"}
{"comparison_id":"a8085c36-ba45-497c-b31d-486882a8932f","query_id":"53","doc_a_id":"24285403","doc_b_id":"18988265","presented_order":["24285403","18988265"],"winner_id":"24285403","reasoning":"Document A is slightly more relevant: although neither mentions ALDH1 or breast cancer, A discusses a prognostic association of a clinical measure, which is marginally closer to the claim about a biomarker and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:09.331067Z"}
{"comparison_id":"e25f74fe-9f26-4f76-bac5-b78f2050fcb3","query_id":"53","doc_a_id":"3514072","doc_b_id":"18988265","presented_order":["18988265","3514072"],"winner_id":"18988265","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns human disease, while B is plant genomics. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:09.331074Z"}
{"comparison_id":"62be3b7a-218f-45b9-b2d1-1500592424ac","query_id":"53","doc_a_id":"11738716","doc_b_id":"18988265","presented_order":["11738716","18988265"],"winner_id":"11738716","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is marginally closer (biological signaling context) so pick A.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:09.331081Z"}
{"comparison_id":"a3d7a671-f3a4-449c-8875-1c5e583d3fd6","query_id":"53","doc_a_id":"26488879","doc_b_id":"42782688","presented_order":["26488879","42782688"],"winner_id":"42782688","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document B is marginally more relevant because it involves human disease and molecular expression changes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:15.376114Z"}
{"comparison_id":"91645ee0-d6c0-412e-bb37-d144447e84f1","query_id":"53","doc_a_id":"22478394","doc_b_id":"42782688","presented_order":["42782688","22478394"],"winner_id":"22478394","reasoning":"Doc B is slightly more relevant because it addresses gene expression changes in human disease, whereas Doc A focuses on probiotics and intestinal enzyme activity unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:15.376134Z"}
{"comparison_id":"f7e80169-690e-4184-9462-a1ed7827d646","query_id":"53","doc_a_id":"6290112","doc_b_id":"42782688","presented_order":["6290112","42782688"],"winner_id":"6290112","reasoning":"Reason: Neither paper addresses ALDH1 or breast cancer, but Document A discusses gene copy number and expression (more conceptually related to gene-expression–prognosis claims) while B concerns probiotics and colitis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:15.376145Z"}
{"comparison_id":"9cf79319-af22-45cb-8fdc-abc6cfde40e7","query_id":"53","doc_a_id":"15928989","doc_b_id":"42782688","presented_order":["15928989","42782688"],"winner_id":"15928989","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more related to cancer biology (steroid/reproductive tissue pathways) than B, which is about probiotics and colitis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:15.376153Z"}
{"comparison_id":"b4db510f-90d7-48bf-8494-0db831476fb4","query_id":"53","doc_a_id":"11738716","doc_b_id":"42782688","presented_order":["42782688","11738716"],"winner_id":"42782688","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document A is at least about a human disease context, so marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:15.376159Z"}
{"comparison_id":"d64d602c-ebbd-4a82-b266-481300009cb7","query_id":"53","doc_a_id":"6947286","doc_b_id":"42782688","presented_order":["42782688","6947286"],"winner_id":"42782688","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns human disease/inflammation (versus an Alzheimer's genetics study), but neither provides evidence for the claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:15.376166Z"}
{"comparison_id":"8d9245a2-2124-4a5b-9f59-26606f572811","query_id":"53","doc_a_id":"5573975","doc_b_id":"42782688","presented_order":["42782688","5573975"],"winner_id":"42782688","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis; both are irrelevant. Document A is marginally closer because it involves human disease context. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:15.376173Z"}
{"comparison_id":"34fd3907-7648-44fa-af10-454ef569fd49","query_id":"53","doc_a_id":"52865789","doc_b_id":"42782688","presented_order":["52865789","42782688"],"winner_id":"52865789","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant only because it addresses inflammation, which can relate to cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:15.376180Z"}
{"comparison_id":"522713b5-a836-4067-a7e1-dc0ca56df41f","query_id":"53","doc_a_id":"24285403","doc_b_id":"42782688","presented_order":["42782688","24285403"],"winner_id":"42782688","reasoning":"Document A is marginally more related because it discusses expression/activity of an enzyme in a disease context, whereas Document B concerns vascular measures and cognition; neither addresses ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:15.376187Z"}
{"comparison_id":"5aa0b0fb-f548-4297-8bdb-3500eb30994c","query_id":"53","doc_a_id":"22478394","doc_b_id":"6290112","presented_order":["22478394","6290112"],"winner_id":"22478394","reasoning":"Document A is slightly more relevant because it discusses gene expression changes in a disease context, whereas Document B concerns gene copy number and obesity unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:20.693540Z"}
{"comparison_id":"8fd20aff-f323-490a-86ec-552e07018a08","query_id":"53","doc_a_id":"52865789","doc_b_id":"6290112","presented_order":["6290112","52865789"],"winner_id":"6290112","reasoning":"Document A is slightly more relevant because it discusses gene copy number and expression associations with disease, while Document B focuses on IL-15 and obesity mechanisms in mice; neither mentions ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:20.693562Z"}
{"comparison_id":"85fb04ca-ff88-4fcc-b125-dc81ee5fb54a","query_id":"53","doc_a_id":"15928989","doc_b_id":"6290112","presented_order":["6290112","15928989"],"winner_id":"15928989","reasoning":"Neither document mentions ALDH1 or breast cancer, so both are irrelevant to the claim. Document B is marginally more relevant only because it discusses molecular regulation (whereas A is purely about obesity/AMY1).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:20.693571Z"}
{"comparison_id":"3526fe3a-4d49-400f-9c9b-2710ddc1a32b","query_id":"53","doc_a_id":"22478394","doc_b_id":"15928989","presented_order":["22478394","15928989"],"winner_id":"22478394","reasoning":"Document A is slightly more relevant because it discusses gene expression changes in disease contexts, whereas Document B concerns a reproductive receptor unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:25.212547Z"}
{"comparison_id":"85afeb66-0d4e-40c6-8aaf-4a396444a449","query_id":"53","doc_a_id":"26488879","doc_b_id":"6947286","presented_order":["26488879","6947286"],"winner_id":"26488879","reasoning":"Document A is slightly more related because it concerns bacterial factors and tissue inflammation linked to cancer contexts, whereas Document B is about Alzheimer's genetics and not cancer. Neither mentions ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:30.054006Z"}
{"comparison_id":"ff7fbe76-55c3-46f9-abe6-6690f5b1132a","query_id":"53","doc_a_id":"11738716","doc_b_id":"6947286","presented_order":["6947286","11738716"],"winner_id":"6947286","reasoning":"Neither document addresses ALDH1, breast cancer, or prognosis. Both are irrelevant; pick A.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:30.054025Z"}
{"comparison_id":"77892506-a7a3-4b89-b3fd-305e240ab5f9","query_id":"53","doc_a_id":"24285403","doc_b_id":"6947286","presented_order":["24285403","6947286"],"winner_id":"6947286","reasoning":"Neither document addresses ALDH1, breast cancer, or prognosis. Document B is slightly more relevant because it reports a gene–disease association study (both are genetic/biomarker topics), whereas A concerns vascular index and cognition.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:30.054037Z"}
{"comparison_id":"1c002928-a021-4bf2-8a58-be19330a956b","query_id":"53","doc_a_id":"5573975","doc_b_id":"6947286","presented_order":["5573975","6947286"],"winner_id":"5573975","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Both are irrelevant; if forced to choose the closer match, pick A because it concerns epithelial biology and signaling. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:30.054044Z"}
{"comparison_id":"792f7338-35f6-4aa2-b481-8430590955be","query_id":"53","doc_a_id":"26488879","doc_b_id":"5573975","presented_order":["26488879","5573975"],"winner_id":"5573975","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document B is marginally more relevant because it involves mammalian signaling and disease outcomes, whereas A is about bacterial proteins and gastric infection.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:39.013940Z"}
{"comparison_id":"8ea4b4bb-952b-4f02-961b-f7df49e4e2bc","query_id":"53","doc_a_id":"11738716","doc_b_id":"24285403","presented_order":["11738716","24285403"],"winner_id":"11738716","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis. Document A is marginally more relevant because it covers biological signaling, whereas B is about vascular predictors of cognitive decline. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:44.772241Z"}
{"comparison_id":"4bdb1029-a595-4200-9068-8df2c3f7c353","query_id":"53","doc_a_id":"46602807","doc_b_id":"3619931","presented_order":["46602807","3619931"],"winner_id":"3619931","reasoning":"Neither document is relevant — neither mentions ALDH1 or breast cancer. If a choice is required: ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:48.749129Z"}
{"comparison_id":"293f5975-e70d-491a-af62-d3e79b86ecb0","query_id":"53","doc_a_id":"3514072","doc_b_id":"3619931","presented_order":["3514072","3619931"],"winner_id":"3619931","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it concerns mammalian disease and clinical outcomes, whereas A is about rice genomics. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:48.749151Z"}
{"comparison_id":"11f2932e-0d6f-4bbe-b0a0-4d82fbc95b6c","query_id":"53","doc_a_id":"21602220","doc_b_id":"3619931","presented_order":["3619931","21602220"],"winner_id":"3619931","reasoning":"Document A is slightly more relevant because it addresses mammalian disease/clinical biology, whereas Document B is about microbial fermentation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:48.749159Z"}
{"comparison_id":"e73d9fb7-43e2-4411-b544-b6b0c833d15a","query_id":"53","doc_a_id":"46602807","doc_b_id":"3514072","presented_order":["46602807","3514072"],"winner_id":"3514072","reasoning":"Document B is slightly more relevant because it discusses gene regulation and epigenetic control of gene expression, which is more related to ALDH1 expression than an antibiotic synergy study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:52.664356Z"}
{"comparison_id":"3555f6dd-0e6d-4d6e-bedd-4a2993c8feae","query_id":"53","doc_a_id":"21602220","doc_b_id":"3514072","presented_order":["3514072","21602220"],"winner_id":"3514072","reasoning":"Document A is marginally more relevant because it concerns gene regulation and expression/epigenetic mechanisms, whereas Document B covers bacterial fermentation unrelated to cancer biology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:52.664377Z"}
{"comparison_id":"d9ba2f60-8868-43a5-8e82-46e5c9d5f99f","query_id":"53","doc_a_id":"46602807","doc_b_id":"21602220","presented_order":["46602807","21602220"],"winner_id":"46602807","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more medical/clinical in focus, so it's marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:25:56.717307Z"}
{"comparison_id":"81238d27-8451-4a12-952d-f5f06fe636af","query_id":"53","doc_a_id":"27240667","doc_b_id":"4702639","presented_order":["27240667","4702639"],"winner_id":"4702639","reasoning":"Document B. It discusses tumor stemness and markers/drivers of stem-like, therapy‑resistant cells (contextually related to ALDH1, a cancer stem cell marker), whereas A only reports mortality trends by ER status/age and says nothing about ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693368Z"}
{"comparison_id":"459c8d0b-66dd-455f-8e0b-01786804483d","query_id":"53","doc_a_id":"2931832","doc_b_id":"29495185","presented_order":["29495185","2931832"],"winner_id":"29495185","reasoning":"Document A is about molecular predictors of cancer prognosis (which would include markers like ALDH1), while Document B focuses on a platelet-based marker unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693410Z"}
{"comparison_id":"da1b86a3-129a-4082-87c2-2b2492575fc4","query_id":"53","doc_a_id":"11484808","doc_b_id":"22482820","presented_order":["11484808","22482820"],"winner_id":"11484808","reasoning":"Document A is more relevant — it reviews clinical implications and biomarkers in endocrine-related cancers (including breast), which is where associations between markers like ALDH1 and prognosis would be discussed. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693422Z"}
{"comparison_id":"23152d9f-0885-45b6-a630-70f00cc5fce1","query_id":"53","doc_a_id":"17648235","doc_b_id":"7821634","presented_order":["7821634","17648235"],"winner_id":"7821634","reasoning":"Document A is more relevant — it links a molecular marker (DUSP4 deficiency) to poor outcomes in breast cancer, matching the prognosis-focused claim. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693430Z"}
{"comparison_id":"33b247fb-2370-4b25-97fc-ff1676e84ba7","query_id":"53","doc_a_id":"15946643","doc_b_id":"29366489","presented_order":["15946643","29366489"],"winner_id":"15946643","reasoning":"Document A is more relevant — it focuses on breast cancer mechanisms (chemoresistance/metastasis) tied to prognosis, whereas Document B discusses a different tumor suppressor (DLC-1) without relation to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693438Z"}
{"comparison_id":"1eb519a6-c1cc-492f-8036-2380f9a49a1e","query_id":"53","doc_a_id":"12762485","doc_b_id":"20333864","presented_order":["20333864","12762485"],"winner_id":"12762485","reasoning":"Document B is more relevant — it addresses stem-cell–like phenotypes in breast cancer (linked to markers and prognosis), whereas A focuses on stromal/myoepithelial roles in DCIS-to-invasive transition and does not discuss ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693446Z"}
{"comparison_id":"1f83f19a-e432-4df0-a170-c95a0eec8073","query_id":"53","doc_a_id":"4429932","doc_b_id":"7821634","presented_order":["4429932","7821634"],"winner_id":"7821634","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it links expression of a specific gene (DUSP4) to prognosis and chemotherapy resistance in breast cancer, which is conceptually closer to the claim about marker expression and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693454Z"}
{"comparison_id":"ebf82826-4915-4097-9c54-ae10007fe154","query_id":"53","doc_a_id":"24834968","doc_b_id":"27240667","presented_order":["24834968","27240667"],"winner_id":"27240667","reasoning":"Document B is more relevant because it discusses breast cancer mortality and prognosis by tumor characteristics, whereas Document A focuses on chemotherapy response markers and does not address prognosis directly.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693461Z"}
{"comparison_id":"e7be2f95-8342-4e3b-bf71-6363ad9ec286","query_id":"53","doc_a_id":"15946643","doc_b_id":"27240667","presented_order":["15946643","27240667"],"winner_id":"15946643","reasoning":"Document A is more relevant — it addresses molecular mechanisms tied to breast cancer aggressiveness, chemoresistance, and metastasis (more likely to discuss tumor markers like ALDH1) while B is population-level mortality trends unrelated to ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693469Z"}
{"comparison_id":"1d21ec7c-8e6b-4b8d-8f68-7fa9ca277250","query_id":"53","doc_a_id":"3285322","doc_b_id":"7821634","presented_order":["3285322","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it examines a molecular marker (DUSP4) whose low expression correlates with poor outcomes in breast cancer, which is closer to the ALDH1–prognosis question than the BRCA-focused clinical comparison in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693476Z"}
{"comparison_id":"2e38ed98-86e5-40db-8cec-9fc46de478bb","query_id":"53","doc_a_id":"15113221","doc_b_id":"22401720","presented_order":["15113221","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant — it studies prognostic markers in primary breast cancer specifically, whereas A discusses a PTEN-related signature in carcinomas generally and doesn't address breast cancer markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693484Z"}
{"comparison_id":"dfa2e7bf-cbd4-44d0-8515-41e467bba343","query_id":"53","doc_a_id":"19673227","doc_b_id":"21902400","presented_order":["21902400","19673227"],"winner_id":"19673227","reasoning":"Document B — it directly addresses prognostic markers and prediction of disease-free survival/time to progression in epithelial tumors, which is closer to evaluating a biomarker's association with prognosis than the general discussion of hypoxia in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693510Z"}
{"comparison_id":"2e2fcd8c-812d-4391-a13d-e73c6502dd3b","query_id":"53","doc_a_id":"1379127","doc_b_id":"4418878","presented_order":["4418878","1379127"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and their link to cancer prognosis, which relates to ALDH1 expression and prognostic associations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693523Z"}
{"comparison_id":"49301a96-8566-4f6f-acbb-1c3fb6a301ae","query_id":"53","doc_a_id":"20183360","doc_b_id":"20333864","presented_order":["20183360","20333864"],"winner_id":"20333864","reasoning":"Document B — it discusses mechanisms of progression from in situ to invasive breast carcinoma and tumor-promoting cell types, which is more directly related to prognosis than the molecular regulation of fascin in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693533Z"}
{"comparison_id":"44d470a4-6ff9-4cec-9ed8-195fcfecd738","query_id":"53","doc_a_id":"20333864","doc_b_id":"29366489","presented_order":["20333864","29366489"],"winner_id":"20333864","reasoning":"Document A is more relevant — it focuses on breast carcinoma biology and progression, whereas Document B discusses a different tumor suppressor (DLC‑1) not specific to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693540Z"}
{"comparison_id":"911cc4a1-537d-4a38-8940-34076d89b78e","query_id":"53","doc_a_id":"17648235","doc_b_id":"3285322","presented_order":["17648235","3285322"],"winner_id":"3285322","reasoning":"Document B is more relevant — it covers clinical/pathologic features and prognosis-related differences in breast cancer, whereas A focuses on WNT signaling in cell lines and doesn't address prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693547Z"}
{"comparison_id":"6ac8ca3e-acdf-44c8-9650-def3eeacda65","query_id":"53","doc_a_id":"20127522","doc_b_id":"24341590","presented_order":["20127522","24341590"],"winner_id":"20127522","reasoning":"Document A — it discusses a tumor biomarker (CTCs) linked to prognosis in breast cancer, which is closer to ALDH1 as a prognostic marker than a study on CYP2D6 pharmacogenetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693554Z"}
{"comparison_id":"175733a3-0b1f-4fc2-b166-ef6c25903d4e","query_id":"53","doc_a_id":"1866911","doc_b_id":"25973484","presented_order":["25973484","1866911"],"winner_id":"1866911","reasoning":"Document B is more relevant — it discusses breast epithelial progenitor populations and marker-defined cells (stem/progenitor biology) tied to tumor subtype, which is closer to ALDH1 (a stem cell marker) and prognosis than the obesity-focused review in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693562Z"}
{"comparison_id":"5f8ee2c3-ae8c-4058-a717-330c7b34f884","query_id":"53","doc_a_id":"20333864","doc_b_id":"20839751","presented_order":["20333864","20839751"],"winner_id":"20839751","reasoning":"Document B is more relevant — it addresses associations between tumor biomarkers/pathological parameters and prognosis in breast cancer, whereas A focuses on cellular mechanisms of DCIS-to-invasive transition without discussing prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693570Z"}
{"comparison_id":"530f6436-f65f-4694-b4b9-583ad4b954ad","query_id":"53","doc_a_id":"7795952","doc_b_id":"825728","presented_order":["7795952","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it discusses cancer cell stemness and links to patient survival/metastasis, which is closer to ALDH1 (a stem cell marker) and prognosis than A's focus on fascin/filopodia.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693577Z"}
{"comparison_id":"1791ec55-3678-48ac-8a33-923d5d05a00b","query_id":"53","doc_a_id":"22482820","doc_b_id":"24341590","presented_order":["22482820","24341590"],"winner_id":"22482820","reasoning":"Document A is more relevant — it discusses breast cancer classification, drug resistance, and treatment strategies which are more likely to address biomarkers like ALDH1 and prognosis than a CYP2D6/tamoxifen genetics study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693584Z"}
{"comparison_id":"d50a7e79-29ea-4a7b-ac96-4b1e3a59f640","query_id":"53","doc_a_id":"24834968","doc_b_id":"4583180","presented_order":["24834968","4583180"],"winner_id":"24834968","reasoning":"Document A — it concerns biomarkers and prognosis/response in primary breast cancer, making it more relevant to a claim about ALDH1 and breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693591Z"}
{"comparison_id":"a0664cb5-a909-4200-98e7-b5ddc630d361","query_id":"53","doc_a_id":"25732836","doc_b_id":"7795952","presented_order":["7795952","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant — it concerns prognostic markers and outcome prediction in breast cancer, whereas A discusses fascin, not prognostic markers for ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693599Z"}
{"comparison_id":"37a3d217-c7d3-4ec0-9518-f8c386345340","query_id":"53","doc_a_id":"2130391","doc_b_id":"4429932","presented_order":["2130391","4429932"],"winner_id":"4429932","reasoning":"Document B is more relevant — it links a molecular factor (LOX) to poor patient outcomes in breast cancer, whereas A focuses on adipocyte-driven invasion without addressing prognostic biomarkers. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693606Z"}
{"comparison_id":"a4af7eaf-62e4-42e0-bf6f-d11b9169a20f","query_id":"53","doc_a_id":"2014909","doc_b_id":"34066665","presented_order":["34066665","2014909"],"winner_id":"2014909","reasoning":"Document B — it discusses tumor-initiating cells and analyses of primary breast cancers, which is more likely to address markers like ALDH1 and their prognostic significance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693613Z"}
{"comparison_id":"0488da27-ce05-4489-9c0f-c7e1fbffaf82","query_id":"53","doc_a_id":"2014909","doc_b_id":"45638119","presented_order":["45638119","2014909"],"winner_id":"45638119","reasoning":"Doc A directly states that ALDH1 marks mammary stem cells and predicts poor clinical outcome in breast cancer, which directly addresses the claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693621Z"}
{"comparison_id":"f0523acb-29ff-4173-804c-5c00eca18250","query_id":"53","doc_a_id":"24341590","doc_b_id":"7583725","presented_order":["24341590","7583725"],"winner_id":"7583725","reasoning":"Document B is more relevant — it links high expression of a marker (TRPM7) to poor breast cancer outcomes, which is conceptually similar to the ALDH1 prognosis claim.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693628Z"}
{"comparison_id":"54148dd3-1139-4ee4-a350-1f41e42f1c36","query_id":"53","doc_a_id":"29495185","doc_b_id":"5649538","presented_order":["29495185","5649538"],"winner_id":"29495185","reasoning":"Document A is more relevant — it discusses molecular predictors of cancer prognosis (though not ALDH1 specifically), whereas Document B focuses on genomic predictors of dasatinib sensitivity, not prognostic markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693635Z"}
{"comparison_id":"77465f1e-5964-413e-804d-2c8b4fb489ea","query_id":"53","doc_a_id":"24341590","doc_b_id":"34066665","presented_order":["24341590","34066665"],"winner_id":"34066665","reasoning":"Document B — it discusses mechanisms of therapy resistance and prognostic signaling in breast cancer, which is more conceptually related to markers like ALDH1 than a pharmacogenetic tamoxifen study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693642Z"}
{"comparison_id":"65d50416-8360-4e0d-9f7a-840f4118f86d","query_id":"53","doc_a_id":"20333864","doc_b_id":"34066665","presented_order":["34066665","20333864"],"winner_id":"34066665","reasoning":"Document A is more relevant — it covers molecular markers and clinical implications in breast cancer (therapy resistance/prognosis), whereas B focuses on DCIS microenvironment and invasion without prognostic marker discussion.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693649Z"}
{"comparison_id":"e4f52e76-4f0b-4084-b51a-9c9cdb1d4aab","query_id":"53","doc_a_id":"1866911","doc_b_id":"31311495","presented_order":["1866911","31311495"],"winner_id":"31311495","reasoning":"Neither abstract mentions ALDH1. Both are largely irrelevant, but Document B is slightly more relevant because it links molecular changes to increased aggressiveness/therapy resistance (closer to prognosis implications).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693656Z"}
{"comparison_id":"ec6ff454-cd9b-43bd-b6f5-a13ba747ede8","query_id":"53","doc_a_id":"1866911","doc_b_id":"7821634","presented_order":["1866911","7821634"],"winner_id":"1866911","reasoning":"Document A is more related to marker-defined cell populations in breast cancer (progenitor marker expression and tumor origin), which is closer to a claim about ALDH1 as a prognostic marker than Document B's focus on DUSP4 and chemotherapy resistance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693663Z"}
{"comparison_id":"0a2d2ce7-ea30-4f2e-8be7-e3d6dc05ba9c","query_id":"53","doc_a_id":"3285322","doc_b_id":"7583725","presented_order":["3285322","7583725"],"winner_id":"7583725","reasoning":"Document B is more relevant — it addresses how expression of a specific protein (TRPM7) predicts poor outcomes in breast cancer, which is analogous to the ALDH1–prognosis claim. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693671Z"}
{"comparison_id":"dffd85cf-dfe1-4ec9-a15f-fae2d4f747f7","query_id":"53","doc_a_id":"22482820","doc_b_id":"27240667","presented_order":["22482820","27240667"],"winner_id":"22482820","reasoning":"Document A is more relevant — it discusses molecular classification and treatment resistance in breast cancer (more likely to address biomarkers like ALDH1) while B focuses on mortality trends by ER status and age. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693678Z"}
{"comparison_id":"4de8e55a-3932-4a5f-933a-62cc28061b80","query_id":"53","doc_a_id":"15113221","doc_b_id":"2014909","presented_order":["2014909","15113221"],"winner_id":"2014909","reasoning":"Document A is more relevant — it analyzes tumor-initiating cells in primary breast cancers (ALDH1 is a tumor-initiating/cancer stem cell marker), so it’s more likely to address ALDH1 and prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693685Z"}
{"comparison_id":"734ad839-2600-4ba6-85eb-b60e3c87783b","query_id":"53","doc_a_id":"22401720","doc_b_id":"4583180","presented_order":["4583180","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant because it examines expression of biomarkers in primary breast cancer and their association with prognosis, whereas A focuses on SREBP2 and tumor progression mechanisms not specific to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693692Z"}
{"comparison_id":"6cd21da7-b87a-455e-912b-500d2fe0d9ae","query_id":"53","doc_a_id":"15113221","doc_b_id":"34066665","presented_order":["34066665","15113221"],"winner_id":"34066665","reasoning":"Reason: Document A specifically addresses molecular mechanisms and clinical implications in breast cancer (endocrine resistance and outcomes), so it's more directly related to prognosis in breast cancer than Document B, which focuses on PTEN pathway signatures across carcinomas.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693714Z"}
{"comparison_id":"5a53ee4c-3f25-4a3a-8f26-2ca37287315e","query_id":"53","doc_a_id":"34066665","doc_b_id":"4455466","presented_order":["4455466","34066665"],"winner_id":"4455466","reasoning":"Document A is slightly more relevant — it discusses a specific gene's expression level being linked to poor prognosis in breast cancer (though not ALDH1), whereas B reviews ER/HER signaling without addressing marker-prognosis associations. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693726Z"}
{"comparison_id":"0f0fc53c-a012-44a7-ad62-79f70b3836bd","query_id":"53","doc_a_id":"12762485","doc_b_id":"2931832","presented_order":["2931832","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses stem-cell–like phenotypes in breast cancer (linked to poorer differentiation/prognosis), which is more relevant to ALDH1 (a stem cell marker) than Document A's platelet-ratio prognostic study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693735Z"}
{"comparison_id":"7d1a54d5-1897-4e0e-8538-bb1637988733","query_id":"53","doc_a_id":"17648235","doc_b_id":"4583180","presented_order":["17648235","4583180"],"winner_id":"4583180","reasoning":"Document B is more relevant — it links molecular expression changes to reduced patient survival (prognosis), whereas A focuses on WNT signaling and cell proliferation without prognosis data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693743Z"}
{"comparison_id":"b3493250-f8ab-405e-ab00-fa71151406d6","query_id":"53","doc_a_id":"29495185","doc_b_id":"4418878","presented_order":["4418878","29495185"],"winner_id":"4418878","reasoning":"Document A is more focused on gene expression signatures and their links to prognosis and treatment response, which is directly relevant to ALDH1 expression as a prognostic molecular marker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693751Z"}
{"comparison_id":"2d3171ed-8a91-4d44-86ed-de9deef438b1","query_id":"53","doc_a_id":"43385013","doc_b_id":"7795952","presented_order":["43385013","7795952"],"winner_id":"43385013","reasoning":"Doc A is about stem/progenitor properties in breast cell subpopulations (more directly related to ALDH1 as a stem cell marker), while Doc B focuses on fascin/TGFβ unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693758Z"}
{"comparison_id":"272add78-fba1-4d3b-b634-1c5d835618a4","query_id":"53","doc_a_id":"20839751","doc_b_id":"825728","presented_order":["20839751","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it links EMT repression, acquisition of stem-cell properties and patient survival (closer to ALDH1's role as a cancer stem-cell marker). Document A focuses on apoptosis and general prognostic factors and doesn’t address stem-cell markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693766Z"}
{"comparison_id":"069da7ed-8916-4e81-9363-65c131cbce97","query_id":"53","doc_a_id":"20333864","doc_b_id":"313403","presented_order":["313403","20333864"],"winner_id":"313403","reasoning":"Document A is more relevant — it directly addresses prognostic markers and outcomes in breast cancer, whereas B focuses on cellular mechanisms of DCIS-to-invasive transition; neither mentions ALDH1, but A is closer to the prognosis topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693773Z"}
{"comparison_id":"58da6b8f-85d4-4e0a-b8b3-0c10b51819f1","query_id":"53","doc_a_id":"21902400","doc_b_id":"4429932","presented_order":["4429932","21902400"],"winner_id":"4429932","reasoning":"Document A is more relevant because it specifically links a molecular marker (LOX) to poor patient outcomes in breast cancer, whereas Document B discusses hypoxia prognosis more generally and does not address ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693780Z"}
{"comparison_id":"86fb952c-30c6-483b-aed4-2b6a2721bf3d","query_id":"53","doc_a_id":"1866911","doc_b_id":"7583725","presented_order":["7583725","1866911"],"winner_id":"1866911","reasoning":"Neither abstract mentions ALDH1, but Document B discusses progenitor cell markers and origins of breast tumors (more related to stem/progenitor markers like ALDH1) whereas A focuses on TRPM7. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693787Z"}
{"comparison_id":"b1d0890f-4182-4746-a116-effae756af9e","query_id":"53","doc_a_id":"21902400","doc_b_id":"31311495","presented_order":["31311495","21902400"],"winner_id":"31311495","reasoning":"Document A is more directly about breast cancer cell behavior and mechanisms tied to aggressiveness/prognosis, whereas B is a broad review of hypoxia across tumors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693793Z"}
{"comparison_id":"c53b15f6-6dcb-4d4f-abb9-7801d11ac472","query_id":"53","doc_a_id":"11484808","doc_b_id":"22401720","presented_order":["22401720","11484808"],"winner_id":"22401720","reasoning":"Document A is more relevant because it directly studies protein expression and links specific markers to prognosis in primary breast cancer, whereas Document B focuses on non-coding RNAs in endocrine cancers and is less directly related to ALDH1 expression or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693801Z"}
{"comparison_id":"d9b7e183-e128-405a-af6d-95cbc5f1c33d","query_id":"53","doc_a_id":"16086778","doc_b_id":"22401720","presented_order":["22401720","16086778"],"winner_id":"22401720","reasoning":"Document A — it discusses expression of tumor factors and directly links high VEGF expression to poor prognosis in breast cancer, whereas B focuses on Numb/Notch signaling without addressing prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693808Z"}
{"comparison_id":"aa373299-90d0-440e-95c6-4e480fe7db3c","query_id":"53","doc_a_id":"1866911","doc_b_id":"22401720","presented_order":["1866911","22401720"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses breast cancer progenitor cell populations and markers (related to ALDH1 as a stem/progenitor marker), whereas Document B focuses on angiogenic factors unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693815Z"}
{"comparison_id":"5e84910c-2471-4bfc-ba03-4a7024c3fb81","query_id":"53","doc_a_id":"18953920","doc_b_id":"7583725","presented_order":["18953920","7583725"],"winner_id":"18953920","reasoning":"Document A — it links acquisition of stem‑cell markers in mammary cells (of which ALDH1 is a known marker) to increased tumorigenicity/poor prognosis; Document B concerns TRPM7, not ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693823Z"}
{"comparison_id":"053ac96e-40b0-4b96-86c9-8bc7aafa27a2","query_id":"53","doc_a_id":"15113221","doc_b_id":"20839751","presented_order":["20839751","15113221"],"winner_id":"20839751","reasoning":"Document A is more relevant — it discusses prognostic factors in breast cancer specifically, whereas B addresses a PTEN-related signature in carcinomas more generally. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693830Z"}
{"comparison_id":"b45746c6-b18d-47ae-ae36-830c7c85bcb0","query_id":"53","doc_a_id":"20333864","doc_b_id":"4889228","presented_order":["4889228","20333864"],"winner_id":"4889228","reasoning":"Document A is more relevant — it discusses gene expression levels (high TDP43) correlated with poor prognosis in breast cancer, which is directly related to the query about expression-prognosis associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693836Z"}
{"comparison_id":"6e96223f-b48c-4a9f-a10b-fcbab35d085b","query_id":"53","doc_a_id":"20183360","doc_b_id":"25973484","presented_order":["25973484","20183360"],"winner_id":"25973484","reasoning":"Document A is more relevant — it discusses breast cancer prognosis and factors linked to aggressive tumor phenotypes, while Document B focuses on molecular regulation of invasion without addressing prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693843Z"}
{"comparison_id":"5c7e1cfe-4e5a-4faa-b21c-dd36f7c387b9","query_id":"53","doc_a_id":"19673227","doc_b_id":"7583725","presented_order":["7583725","19673227"],"winner_id":"7583725","reasoning":"Document A is more relevant — it links a specific gene expression to poor breast cancer outcomes (similar to the ALDH1 prognosis claim), whereas B concerns CTC chemosensitivity assays not marker prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693851Z"}
{"comparison_id":"966947f9-2ab9-4efc-9497-19df3ba7d7dd","query_id":"53","doc_a_id":"18953920","doc_b_id":"825728","presented_order":["825728","18953920"],"winner_id":"18953920","reasoning":"Document B is more relevant — it discusses EMT producing mammary cells with stem-cell markers and increased tumorigenicity, which relates to ALDH1 as a breast cancer stem-cell marker linked to prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693857Z"}
{"comparison_id":"7caf1025-0a7b-4c10-b1fa-634077e1e4ec","query_id":"53","doc_a_id":"15832146","doc_b_id":"20127522","presented_order":["15832146","20127522"],"winner_id":"20127522","reasoning":"Reason: Both abstracts do not mention ALDH1, but Document B discusses a prognostic biomarker (CTC levels) and links marker expression to poorer outcomes, making it more relevant to a claim about a marker (ALDH1) and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693864Z"}
{"comparison_id":"6735068a-2bd2-4cac-85f9-73ad4ccd21ae","query_id":"53","doc_a_id":"15113221","doc_b_id":"16086778","presented_order":["15113221","16086778"],"winner_id":"16086778","reasoning":"Document B is more relevant — it specifically addresses mechanisms in human breast carcinomas, whereas A discusses a general PTEN-related signature across carcinomas without breast-specific markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693871Z"}
{"comparison_id":"8c307716-0df9-49d9-9603-6ccecad7800a","query_id":"53","doc_a_id":"7821634","doc_b_id":"825728","presented_order":["7821634","825728"],"winner_id":"825728","reasoning":"Document B — it links EMT, stem-cell properties and patient survival (more directly related to ALDH1 as a cancer stem cell marker). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693878Z"}
{"comparison_id":"8b629a18-71f6-44a4-9b28-26be6f0c6b73","query_id":"53","doc_a_id":"15832146","doc_b_id":"15946643","presented_order":["15946643","15832146"],"winner_id":"15946643","reasoning":"Document A is more relevant — it links chemoresistance and metastasis in breast cancer, which is closely related to the poorer prognosis associated with ALDH1 expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693885Z"}
{"comparison_id":"aa32e6d0-4f85-49ae-ba08-50373bafb7c9","query_id":"53","doc_a_id":"4455466","doc_b_id":"45638119","presented_order":["45638119","4455466"],"winner_id":"45638119","reasoning":"Document A is directly about ALDH1 as a marker and predictor of poor prognosis in breast cancer; Document B concerns ZMYND11 instead.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693891Z"}
{"comparison_id":"151c6ce6-6955-488a-ad18-415660cbdfab","query_id":"53","doc_a_id":"22482820","doc_b_id":"313403","presented_order":["313403","22482820"],"winner_id":"313403","reasoning":"Reason: Document A directly addresses prognostic markers and clinical outcomes in breast cancer (though about TAMs), so it is more relevant to a claim about a marker's association with prognosis than Document B, which focuses on therapies.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693898Z"}
{"comparison_id":"5cda8e88-1d5e-4e3f-ad31-d2c163c0f64f","query_id":"53","doc_a_id":"19673227","doc_b_id":"25973484","presented_order":["25973484","19673227"],"winner_id":"25973484","reasoning":"Document A is more relevant — it discusses prognostic factors and aggressive tumor phenotypes in breast cancer, whereas B focuses on CTC chemosensitivity assays and not ALDH1 or prognosis in breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693905Z"}
{"comparison_id":"4edca057-32c8-438e-9c98-3af6e857851d","query_id":"53","doc_a_id":"25973484","doc_b_id":"45638119","presented_order":["45638119","25973484"],"winner_id":"45638119","reasoning":"Document A is directly about ALDH1 as a marker and predictor of poor clinical outcome in breast cancer, while Document B focuses on obesity-related factors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693912Z"}
{"comparison_id":"27bade7a-e0a2-4373-937a-336b8bc4ac98","query_id":"53","doc_a_id":"20127522","doc_b_id":"4889228","presented_order":["4889228","20127522"],"winner_id":"4889228","reasoning":"Document A is more relevant — it examines expression of a specific gene in breast cancer and its association with prognosis, which is conceptually closer to a claim about ALDH1 expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693919Z"}
{"comparison_id":"4b91173e-65a2-492f-99e3-ce43c308e1b7","query_id":"53","doc_a_id":"20839751","doc_b_id":"4702639","presented_order":["4702639","20839751"],"winner_id":"4702639","reasoning":"Document A is more relevant — it discusses tumour stemness markers and their association with aggressive, therapy‑resistant phenotypes, which is closer to ALDH1 (a stem-cell marker) and prognosis than Document B's focus on apoptosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693926Z"}
{"comparison_id":"7125f65c-013e-486e-b53a-6f30440b7968","query_id":"53","doc_a_id":"22482820","doc_b_id":"825728","presented_order":["825728","22482820"],"winner_id":"825728","reasoning":"Document A is more relevant — it discusses cancer stem-cell properties and links to patient survival/metastasis, which is closer to evidence about ALDH1 (a stem-cell marker) and prognosis than a therapy overview.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693934Z"}
{"comparison_id":"f74e7b24-15f2-4f44-a38b-738dff09ffb1","query_id":"53","doc_a_id":"21902400","doc_b_id":"8963413","presented_order":["8963413","21902400"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses biomarker expression and clinical outcomes in breast cancer, whereas B addresses tumor hypoxia generally and not breast cancer biomarkers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693940Z"}
{"comparison_id":"116046c0-b4fe-42c4-b448-a3b799096289","query_id":"53","doc_a_id":"3285322","doc_b_id":"34066665","presented_order":["34066665","3285322"],"winner_id":"34066665","reasoning":"Document A is more relevant — it reviews molecular markers and clinical implications for prognosis and therapy resistance in breast cancer, whereas Document B focuses on BRCA mutation status and clinicopathologic features.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693947Z"}
{"comparison_id":"bff918e0-43b8-4d37-b82f-6dd28b92e76d","query_id":"53","doc_a_id":"12762485","doc_b_id":"4418878","presented_order":["4418878","12762485"],"winner_id":"12762485","reasoning":"Reason: Document B discusses a stem-cell–like phenotype in breast cancer (associated with worse features), which is directly relevant to ALDH1 as a stem cell marker; Document A is more general about pathway signatures. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693954Z"}
{"comparison_id":"8137ae5b-80a8-41fc-a780-0d45420565cf","query_id":"53","doc_a_id":"34066665","doc_b_id":"45638119","presented_order":["34066665","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 as a marker and its correlation with poor prognosis in breast cancer, while Document A covers ER/HER signaling and therapy resistance without mentioning ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693961Z"}
{"comparison_id":"e4f74407-c4d5-4b5e-b1cd-9f3e78356c63","query_id":"53","doc_a_id":"27240667","doc_b_id":"5649538","presented_order":["5649538","27240667"],"winner_id":"5649538","reasoning":"Document A is more relevant — it deals with gene expression markers in breast cancer (where ALDH1 would be categorized), whereas B focuses on population mortality by ER status and age and doesn't address specific molecular markers. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693969Z"}
{"comparison_id":"ff89cef6-ae59-4fee-925a-8537e347e6ac","query_id":"53","doc_a_id":"21033230","doc_b_id":"4429932","presented_order":["4429932","21033230"],"winner_id":"21033230","reasoning":"B is more relevant — it discusses molecular markers in breast cancer and their association with survival, whereas A focuses on LOX, not marker expression like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693975Z"}
{"comparison_id":"4743eac4-374f-4367-88b4-86c61b718700","query_id":"53","doc_a_id":"2931832","doc_b_id":"7583725","presented_order":["2931832","7583725"],"winner_id":"7583725","reasoning":"Document B — it discusses a tumor cell protein whose expression predicts poor outcomes in breast cancer, which is more analogous to a claim about ALDH1 expression and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693983Z"}
{"comparison_id":"b61c65f7-53dd-4348-8fca-bb94bb6a600a","query_id":"53","doc_a_id":"20839751","doc_b_id":"7795952","presented_order":["7795952","20839751"],"winner_id":"7795952","reasoning":"Document A is more relevant — it discusses overexpression of a specific protein linked to poor cancer prognosis, which is closer to a claim about marker expression and prognosis than Document B's focus on apoptosis indices. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693990Z"}
{"comparison_id":"0a1a38ad-5f81-47fa-add0-db14ffde5432","query_id":"53","doc_a_id":"12762485","doc_b_id":"15946643","presented_order":["15946643","12762485"],"winner_id":"12762485","reasoning":"Document B is more relevant — it discusses a stem cell phenotype in breast cancer (linked to prognosis-related markers), which is directly related to ALDH1 as a stem-cell-associated prognostic marker. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.693997Z"}
{"comparison_id":"b7896717-546c-4897-92a3-cccabd93dfb4","query_id":"53","doc_a_id":"17648235","doc_b_id":"4429932","presented_order":["17648235","4429932"],"winner_id":"4429932","reasoning":"Document B — it discusses factors associated with poor patient outcomes in breast cancer (though not ALDH1 specifically), whereas A focuses on WNT signaling and cell proliferation without prognosis data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694004Z"}
{"comparison_id":"deb90090-ecc3-4c99-b96a-5e617b9deca2","query_id":"53","doc_a_id":"29366489","doc_b_id":"7821634","presented_order":["29366489","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it specifically addresses prognosis and chemotherapy response in breast cancer, whereas A discusses a tumor suppressor in various cancers but not breast cancer prognosis or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694012Z"}
{"comparison_id":"95416eb8-832b-4af5-bae9-baf45a96b380","query_id":"53","doc_a_id":"24834968","doc_b_id":"25973484","presented_order":["24834968","25973484"],"winner_id":"24834968","reasoning":"Document A is more focused on tumor biological markers and prognosis/response in breast cancer, making it more relevant to a claim about ALDH1 expression than Document B, which deals with obesity. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694019Z"}
{"comparison_id":"240b696a-6f8e-4326-a25e-d90ec12f9f35","query_id":"53","doc_a_id":"1171121","doc_b_id":"22482820","presented_order":["1171121","22482820"],"winner_id":"1171121","reasoning":"Document A is more relevant — it directly studies prognostic factors in breast cancer (though it covers MVD and p53 rather than ALDH1), whereas B focuses on therapy strategies.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694026Z"}
{"comparison_id":"56ffd5cd-6e26-4803-83d9-86e4ce2c614c","query_id":"53","doc_a_id":"27240667","doc_b_id":"313403","presented_order":["313403","27240667"],"winner_id":"313403","reasoning":"Doc A is more relevant because it discusses a prognostic marker (TAM infiltration) in breast cancer, which is closer to the claim about ALDH1 as a prognostic marker.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694033Z"}
{"comparison_id":"0957804a-c829-4d8a-ae6e-417821fca9f9","query_id":"53","doc_a_id":"11484808","doc_b_id":"12762485","presented_order":["12762485","11484808"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses a stem cell phenotype in breast cancer (which relates to markers like ALDH1) and prognosis-related features, while B focuses on non-coding RNAs in endocrine cancers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694040Z"}
{"comparison_id":"80c642c8-0b44-4220-8857-11524f34d35d","query_id":"53","doc_a_id":"18953920","doc_b_id":"313403","presented_order":["313403","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses acquisition of stem-cell markers/properties in mammary cells (ALDH1 is a stem cell marker), which is more directly related to ALDH1's role than Document A about tumor-associated macrophages.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694048Z"}
{"comparison_id":"d11ab30f-0697-46f2-b898-d16842a1f437","query_id":"53","doc_a_id":"19358586","doc_b_id":"45638119","presented_order":["19358586","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 as a marker and predictor of poor prognosis in breast cancer, while Document A does not mention ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694054Z"}
{"comparison_id":"bd9a0994-c7ef-44a6-a367-162069feadb8","query_id":"53","doc_a_id":"15113221","doc_b_id":"15946643","presented_order":["15946643","15113221"],"winner_id":"15946643","reasoning":"Document A is more relevant — it specifically addresses breast cancer (where ALDH1 prognostic data would apply), while Document B discusses a general PTEN-related signature in carcinomas and is less directly related to ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694062Z"}
{"comparison_id":"9960ca15-4b49-4cc8-9ed7-7718d8512c88","query_id":"53","doc_a_id":"19673227","doc_b_id":"4583180","presented_order":["19673227","4583180"],"winner_id":"19673227","reasoning":"Document A — it discusses prognostic measures (disease-free survival/time to progression) and chemotherapy response in tumor patients, which is more directly related to prognosis than Document B's focus on SREBP2 and cholesterol biosynthesis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694069Z"}
{"comparison_id":"42f31774-c3a3-431c-a05f-52f0cfb28214","query_id":"53","doc_a_id":"15832146","doc_b_id":"20839751","presented_order":["20839751","15832146"],"winner_id":"20839751","reasoning":"Document A is more relevant because it discusses prognostic factors in breast cancer (even though it doesn't mention ALDH1), whereas Document B focuses on stromal fibroblasts and angiogenesis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694076Z"}
{"comparison_id":"b792b3a2-b23a-4f17-8e4b-ef9998938c92","query_id":"53","doc_a_id":"20333864","doc_b_id":"7583725","presented_order":["7583725","20333864"],"winner_id":"7583725","reasoning":"Document A is more relevant — it discusses a molecular marker (TRPM7) whose high expression predicts poor outcome in breast cancer, which is conceptually closer to a claim about ALDH1 expression and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694082Z"}
{"comparison_id":"50453202-f29b-403d-87b3-84cfbed43edc","query_id":"53","doc_a_id":"27240667","doc_b_id":"4429932","presented_order":["4429932","27240667"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses a molecular marker (LOX) linked to poor patient outcomes in breast cancer, which is closer to the claim about ALDH1 and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694098Z"}
{"comparison_id":"e800e9e4-eaf1-446a-ae0c-6057fd7d7916","query_id":"53","doc_a_id":"15832146","doc_b_id":"5649538","presented_order":["5649538","15832146"],"winner_id":"5649538","reasoning":"Document A is more relevant — it deals with gene expression markers in breast cancer (closer to ALDH1 expression) while B focuses on stromal fibroblasts and SDF-1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694118Z"}
{"comparison_id":"a385fbb6-31ea-483f-86ed-45e177d99493","query_id":"53","doc_a_id":"4702639","doc_b_id":"8963413","presented_order":["8963413","4702639"],"winner_id":"4702639","reasoning":"Document B is more relevant — it discusses tumour stemness markers and stem-like properties (similar context to ALDH1, a cancer stem cell marker linked to prognosis), whereas A focuses on PD-L1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694127Z"}
{"comparison_id":"771ed4d5-cb82-4558-821e-16fd7fcc36a3","query_id":"53","doc_a_id":"16086778","doc_b_id":"7795952","presented_order":["7795952","16086778"],"winner_id":"16086778","reasoning":"Neither document mentions ALDH1, but Document B focuses specifically on mechanisms in human breast carcinogenesis, so it's more relevant to a claim about prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694135Z"}
{"comparison_id":"ab43d906-ba98-4489-84af-b500d292cc30","query_id":"53","doc_a_id":"31311495","doc_b_id":"8963413","presented_order":["31311495","8963413"],"winner_id":"8963413","reasoning":"Document B — it discusses expression of a prognostic biomarker and clinical outcomes in breast cancer, so it's more relevant to a claim about marker expression and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694142Z"}
{"comparison_id":"f9538622-17ea-45a5-bf02-11e34268f384","query_id":"53","doc_a_id":"29366489","doc_b_id":"4583180","presented_order":["4583180","29366489"],"winner_id":"29366489","reasoning":"Document B — it discusses tumor-suppressor expression and the use of molecular markers for cancer prognosis, which is more directly related to a claim about marker expression (ALDH1) and prognosis than Document A's focus on SREBP2 and cholesterol metabolism. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694149Z"}
{"comparison_id":"dd0a2f85-3f64-48a4-b0c6-45d16752b89b","query_id":"53","doc_a_id":"12762485","doc_b_id":"5649538","presented_order":["5649538","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses a stem cell phenotype in breast cancer (linked to poor differentiation and higher proliferation), which is more relevant to ALDH1 (a stem cell marker) than Document A about dasatinib predictors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694156Z"}
{"comparison_id":"7036875e-9d06-489f-8218-2830e9fa532f","query_id":"53","doc_a_id":"17648235","doc_b_id":"825728","presented_order":["825728","17648235"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT regulation to acquisition of stem cell properties and patient survival, which is closer to ALDH1 (a stem cell marker) and prognosis than Document B's focus on WNT signaling. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694163Z"}
{"comparison_id":"66febeeb-3579-42a6-af55-eeb4fe223d07","query_id":"53","doc_a_id":"22401720","doc_b_id":"24341590","presented_order":["24341590","22401720"],"winner_id":"22401720","reasoning":"Reason: Document B discusses expression of tumor biomarkers and their relation to prognosis in breast cancer, so it's more relevant to a claim about a prognostic marker (ALDH1) than Document A, which focuses on CYP2D6 pharmacogenetics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694171Z"}
{"comparison_id":"33de88cc-b0da-4e5c-bde0-d6ba12d7bb34","query_id":"53","doc_a_id":"20333864","doc_b_id":"22401720","presented_order":["20333864","22401720"],"winner_id":"22401720","reasoning":"Reason: Document B discusses tumor marker expression and links expression levels to prognosis in breast cancer, making it more relevant to a claim about a biomarker's prognostic association.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694177Z"}
{"comparison_id":"7c5563b4-fb56-42be-b1c3-19967058b9dd","query_id":"53","doc_a_id":"19673227","doc_b_id":"7795952","presented_order":["7795952","19673227"],"winner_id":"7795952","reasoning":"Document A is more relevant — it discusses a protein's expression linked to poor cancer prognosis, which is closer to the claim about a marker (ALDH1) and prognosis than the chemosensitivity/CTC assay in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694185Z"}
{"comparison_id":"dcb79ed9-02a0-4864-a8b1-a093902b5fcd","query_id":"53","doc_a_id":"20183360","doc_b_id":"22482820","presented_order":["20183360","22482820"],"winner_id":"22482820","reasoning":"Reason: Neither abstract mentions ALDH1, but the review on treatment/classification (B) is more likely to address prognostic markers and clinical outcomes than the mechanistic study (A).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694192Z"}
{"comparison_id":"2d699bf8-56f6-4886-ae28-aec022e7c198","query_id":"53","doc_a_id":"29366489","doc_b_id":"34066665","presented_order":["34066665","29366489"],"winner_id":"34066665","reasoning":"Reason: Document A focuses on breast cancer mechanisms and treatment implications, so it's more directly related to breast cancer prognosis than Document B, which discusses a different tumor suppressor across cancers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694199Z"}
{"comparison_id":"9abd56a6-f1e1-426a-8941-94839ce1d1ea","query_id":"53","doc_a_id":"4702639","doc_b_id":"7795952","presented_order":["4702639","7795952"],"winner_id":"4702639","reasoning":"Reason: Document A discusses markers and drivers of tumour stem-like properties (stemness), which is more directly relevant to ALDH1 (a stem-cell marker) and prognosis than Document B's focus on fascin and cell motility.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694205Z"}
{"comparison_id":"2f3e9613-13c8-4ba2-bba5-07fb81ec7ec8","query_id":"53","doc_a_id":"24834968","doc_b_id":"4418878","presented_order":["24834968","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures that link pathway deregulation to prognosis and could encompass markers like ALDH1, while A focuses on HER-2/neu and chemo response, not ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694212Z"}
{"comparison_id":"43a24eed-a23b-4274-9cfc-a1972372b152","query_id":"53","doc_a_id":"24834968","doc_b_id":"31311495","presented_order":["24834968","31311495"],"winner_id":"31311495","reasoning":"B — Document B discusses mechanisms (tamoxifen resistance, EMT-like behavior, increased aggressiveness) related to poorer prognosis, whereas A focuses on HER2 and chemo response and does not address prognostic markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694219Z"}
{"comparison_id":"80b7ec39-bd76-46d3-b54e-1dd909e9ce7c","query_id":"53","doc_a_id":"1171121","doc_b_id":"15946643","presented_order":["15946643","1171121"],"winner_id":"15946643","reasoning":"Document A is more relevant — it addresses mechanisms (chemoresistance and metastasis) tied to poorer breast cancer outcomes, whereas Document B focuses on microvessel density and p53 and does not relate to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694226Z"}
{"comparison_id":"bccaaf10-7826-4479-902f-42e82796f090","query_id":"53","doc_a_id":"17648235","doc_b_id":"2014909","presented_order":["2014909","17648235"],"winner_id":"2014909","reasoning":"Document A is more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers (ALDH1 is a marker of tumor-initiating cells linked to prognosis), whereas B focuses on WNT signaling and proliferation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694233Z"}
{"comparison_id":"3032f0fe-5447-4cca-bfd7-b6511d4db188","query_id":"53","doc_a_id":"16086778","doc_b_id":"19358586","presented_order":["16086778","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it discusses molecular markers linked to poor survival in breast cancer (a prognostic association), whereas A focuses on Numb/Notch signaling without prognostic marker data. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694240Z"}
{"comparison_id":"0c91414b-5a1b-482b-919e-989607f7e319","query_id":"53","doc_a_id":"16086778","doc_b_id":"7583725","presented_order":["16086778","7583725"],"winner_id":"7583725","reasoning":"Document B is more relevant — it links expression level (TRPM7) to patient outcome (poor prognosis), which is closer to the claim about marker expression and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694247Z"}
{"comparison_id":"a19204e5-82f0-4a28-a4c5-dd2102ef6bde","query_id":"53","doc_a_id":"4429932","doc_b_id":"8963413","presented_order":["4429932","8963413"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses a molecular marker (LOX) linked to poor outcomes in breast cancer, which is closer to the claim about a biomarker associated with prognosis than Document B about PD-L1 (which notes better outcomes in breast). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694254Z"}
{"comparison_id":"9f43498f-e0f8-4f30-981d-ac784af583d5","query_id":"53","doc_a_id":"17648235","doc_b_id":"20839751","presented_order":["17648235","20839751"],"winner_id":"20839751","reasoning":"Reason: Document B discusses associations between molecular/pathological markers and prognosis in breast cancer, which is more relevant to a claim about a prognostic marker than Document A's focus on WNT signaling and cell proliferation.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694262Z"}
{"comparison_id":"e746c8ca-a2d5-4e17-b51c-d3d5e445203d","query_id":"53","doc_a_id":"20333864","doc_b_id":"21033230","presented_order":["21033230","20333864"],"winner_id":"21033230","reasoning":"Document A is more relevant — it addresses molecular markers on circulating tumor cells and their correlation with survival/prognosis in breast cancer, whereas B focuses on cellular interactions in DCIS-to-invasive transition without prognostic marker discussion.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694270Z"}
{"comparison_id":"cc018ac5-522f-4055-bace-d943fd64addc","query_id":"53","doc_a_id":"24341590","doc_b_id":"29495185","presented_order":["29495185","24341590"],"winner_id":"29495185","reasoning":"Document A is more relevant — it discusses molecular predictors of cancer prognosis (broadly applicable to markers like ALDH1), whereas Document B focuses specifically on CYP2D6/tamoxifen pharmacogenetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694276Z"}
{"comparison_id":"be20003f-707b-424c-8a6a-26b198f35bc8","query_id":"53","doc_a_id":"22401720","doc_b_id":"31311495","presented_order":["22401720","31311495"],"winner_id":"22401720","reasoning":"Document A is more relevant — it discusses biomarkers linked to prognosis in breast cancer (e.g., VEGF), whereas Document B focuses on tamoxifen resistance and EMT without prognosis markers.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694283Z"}
{"comparison_id":"4a8194ba-2861-46ac-bc67-d18461d434e7","query_id":"53","doc_a_id":"19358586","doc_b_id":"7795952","presented_order":["19358586","7795952"],"winner_id":"19358586","reasoning":"Document A is more relevant — it discusses protein signatures linked to poor survival in breast cancer specifically, whereas B focuses on fascin and TGFβ in tumor invasion without specific mention of breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694290Z"}
{"comparison_id":"dab2c476-950f-4f4a-b5bc-139d2a3f08e6","query_id":"53","doc_a_id":"21033230","doc_b_id":"4889228","presented_order":["4889228","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it discusses prognostic molecular markers in breast cancer (though neither document mentions ALDH1 specifically). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694297Z"}
{"comparison_id":"5482c484-55bb-4ae5-8732-f099a75cfcd3","query_id":"53","doc_a_id":"22401720","doc_b_id":"4429932","presented_order":["4429932","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant — it examines expression of breast cancer markers and links specific factor expression (e.g., VEGF) to prognosis, matching the query's focus on expression–prognosis associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694304Z"}
{"comparison_id":"984f4bbc-bdfc-48d5-adfd-34d5462ece58","query_id":"53","doc_a_id":"15113221","doc_b_id":"4583180","presented_order":["4583180","15113221"],"winner_id":"15113221","reasoning":"Document B — it discusses a gene-expression signature linked to poor prognosis in carcinomas (more relevant to a prognostic marker claim) while A focuses on SREBP2/cholesterol metabolism. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694311Z"}
{"comparison_id":"3bd99f88-932a-4fd3-b459-e6504c67e867","query_id":"53","doc_a_id":"15113221","doc_b_id":"20127522","presented_order":["15113221","20127522"],"winner_id":"15113221","reasoning":"Document A is more relevant — it discusses a gene expression signature linked to prognosis in carcinomas, which is closer to ALDH1 expression as a prognostic molecular marker. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694318Z"}
{"comparison_id":"fd2d7500-5ad8-4e84-bf55-698d52d329d8","query_id":"53","doc_a_id":"34066665","doc_b_id":"8963413","presented_order":["8963413","34066665"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses expression of a molecular marker (PD-L1) and its association with clinical outcomes in breast cancer, which is closer to the claim about a biomarker (ALDH1) and prognosis than the mechanistic review in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694325Z"}
{"comparison_id":"690842c0-7f8f-4a1c-8947-e420d5b08b9a","query_id":"53","doc_a_id":"22401720","doc_b_id":"29366489","presented_order":["29366489","22401720"],"winner_id":"22401720","reasoning":"Document B — it examines markers linked to prognosis in primary breast cancer (though not ALDH1), whereas A discusses DLC-1 in various cancers generally. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694332Z"}
{"comparison_id":"3b524778-d793-4114-9239-407884ab83a9","query_id":"53","doc_a_id":"3285322","doc_b_id":"4583180","presented_order":["4583180","3285322"],"winner_id":"4583180","reasoning":"Document A is more relevant — it links gene expression to reduced survival/prognosis in cancer, whereas B focuses on BRCA status and tumor features without addressing ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694339Z"}
{"comparison_id":"7d53c923-51e7-4279-9f21-118323ebaa02","query_id":"53","doc_a_id":"31311495","doc_b_id":"7795952","presented_order":["31311495","7795952"],"winner_id":"31311495","reasoning":"Document A is more relevant — it specifically discusses breast cancer (MCF7) and changes linked to increased aggressiveness/progression, whereas B focuses on fascin in spindle-shaped tumor cells without breast-cancer specificity or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694346Z"}
{"comparison_id":"57c49c15-fb94-4b70-bd85-0278e407e8b1","query_id":"53","doc_a_id":"1379127","doc_b_id":"21902400","presented_order":["1379127","21902400"],"winner_id":"1379127","reasoning":"Document A is more relevant — it addresses breast cancer behavior (migration/metastasis) directly, which is closer to prognosis in breast cancer than Document B's general discussion of hypoxia.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694354Z"}
{"comparison_id":"6b1d5f8a-c856-4e49-b46a-10860b33fa6b","query_id":"53","doc_a_id":"20127522","doc_b_id":"4418878","presented_order":["20127522","4418878"],"winner_id":"4418878","reasoning":"B is more relevant—it discusses gene expression signatures and prognosis, which pertains to biomarkers like ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694360Z"}
{"comparison_id":"4e0797d9-6ea2-408b-9e39-8272f76b2e36","query_id":"53","doc_a_id":"12762485","doc_b_id":"1379127","presented_order":["12762485","1379127"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses a \"stem cell phenotype\" in breast cancer (related to ALDH1 as a stem cell marker) and its association with more aggressive features, whereas Document B is about calcium channels and metastasis unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694367Z"}
{"comparison_id":"1e1c47cf-c034-41be-ae11-c7fb27940b79","query_id":"53","doc_a_id":"11484808","doc_b_id":"20127522","presented_order":["20127522","11484808"],"winner_id":"20127522","reasoning":"Document A is more relevant — it addresses prognostic markers and outcomes in breast cancer, whereas B is a general review of ncRNAs in endocrine cancers and does not focus on breast cancer prognosis markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694375Z"}
{"comparison_id":"4e9dbc61-6557-47a6-ab27-2c719e4bbcf1","query_id":"53","doc_a_id":"2130391","doc_b_id":"7821634","presented_order":["7821634","2130391"],"winner_id":"7821634","reasoning":"Document A is more relevant — it discusses factors linked to poor outcomes in breast cancer (drug resistance and prognosis), whereas Document B focuses on adipocyte-mediated invasion without direct prognosis data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694382Z"}
{"comparison_id":"1156cb56-a30c-4e33-964c-1abee1f575d1","query_id":"53","doc_a_id":"2931832","doc_b_id":"7795952","presented_order":["2931832","7795952"],"winner_id":"7795952","reasoning":"Document B is more relevant — it discusses a protein's overexpression being linked to poor cancer prognosis and invasiveness, which is conceptually closer to a claim about ALDH1 expression and prognosis than a platelet ratio biomarker.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694389Z"}
{"comparison_id":"a3294659-533b-40b8-8db6-221118830ce7","query_id":"53","doc_a_id":"15832146","doc_b_id":"21033230","presented_order":["21033230","15832146"],"winner_id":"21033230","reasoning":"Doc A discusses molecular profiling of tumor cells and correlations with overall survival (prognostic markers), making it more relevant to a claim about a marker's association with prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694396Z"}
{"comparison_id":"61d22b6a-e66f-4660-a254-1e3fd244cb2c","query_id":"53","doc_a_id":"15113221","doc_b_id":"3285322","presented_order":["3285322","15113221"],"winner_id":"15113221","reasoning":"Document B is more relevant — it deals with a gene expression signature associated with poor prognosis in carcinoma (related to expression–prognosis links), whereas A focuses on BRCA mutation clinical features, not expression markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694404Z"}
{"comparison_id":"860899f7-726b-437e-be1b-0b5dc46a0365","query_id":"53","doc_a_id":"20333864","doc_b_id":"25973484","presented_order":["20333864","25973484"],"winner_id":"20333864","reasoning":"Document A — it discusses cellular and molecular mechanisms of tumor progression relevant to markers linked to invasive behavior, whereas B focuses on obesity-related epidemiology and not ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694410Z"}
{"comparison_id":"8b6a67a0-a409-4aba-b284-d7ec476f03b6","query_id":"53","doc_a_id":"18953920","doc_b_id":"19673227","presented_order":["18953920","19673227"],"winner_id":"18953920","reasoning":"Document A — it links breast epithelial cells acquiring stem-cell markers (like ALDH1) with increased tumorigenicity, which is relevant to ALDH1-related prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694417Z"}
{"comparison_id":"66b977b2-777a-4971-a150-70f123e3b6af","query_id":"53","doc_a_id":"11484808","doc_b_id":"45638119","presented_order":["11484808","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly reports that ALDH1 marks mammary stem cells and correlates with poor prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694423Z"}
{"comparison_id":"3dddec64-9786-4750-86d0-7a650dc80aa6","query_id":"53","doc_a_id":"22482820","doc_b_id":"45638119","presented_order":["22482820","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 as a marker and its correlation with poor prognosis in breast cancer; Document A does not address ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694430Z"}
{"comparison_id":"80e41cfa-6eee-4321-8248-072b26d21f3f","query_id":"53","doc_a_id":"18953920","doc_b_id":"2931832","presented_order":["18953920","2931832"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses breast cancer stem-cell markers and increased tumorigenic potential (closely related to ALDH1 as a stem-cell marker and prognosis), while B focuses on platelet indices unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694437Z"}
{"comparison_id":"f27db59e-5940-43cb-8684-7d722255fec2","query_id":"53","doc_a_id":"1171121","doc_b_id":"21902400","presented_order":["21902400","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it specifically studies prognostic biomarkers in breast cancer, whereas A discusses hypoxia generally across solid tumors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694444Z"}
{"comparison_id":"655aa402-b9eb-4aa6-a6b0-7f084c22d7ab","query_id":"53","doc_a_id":"12762485","doc_b_id":"29366489","presented_order":["29366489","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses stem-cell–like phenotypes and prognostic features in breast cancer, which is more relevant to ALDH1 (a stem cell marker) than a paper about DLC-1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694451Z"}
{"comparison_id":"4b96b6fa-b25a-4c7d-905b-0acf742687b3","query_id":"53","doc_a_id":"24834968","doc_b_id":"5649538","presented_order":["5649538","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it evaluates biological markers as predictors of treatment response and prognosis in breast cancer, whereas A focuses on dasatinib sensitivity predictors. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694458Z"}
{"comparison_id":"a0919c17-136e-4640-9ace-adeadafee0da","query_id":"53","doc_a_id":"4418878","doc_b_id":"45638119","presented_order":["45638119","4418878"],"winner_id":"45638119","reasoning":"Document A directly states ALDH1 is a marker of mammary stem cells and predicts poor clinical outcome in breast cancer, matching the claim. Document B is general about pathway signatures and doesn't address ALDH1 or its prognostic value.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694466Z"}
{"comparison_id":"0152e318-486d-4d01-8168-0515a9252814","query_id":"53","doc_a_id":"7583725","doc_b_id":"8963413","presented_order":["7583725","8963413"],"winner_id":"7583725","reasoning":"Document A is more relevant — it discusses a molecular marker (TRPM7) whose expression predicts poor outcomes in breast cancer, which is conceptually closer to the ALDH1 prognosis claim than the PD-L1-focused paper. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694473Z"}
{"comparison_id":"e84e08a9-2220-4f15-8924-4abcaa35a1df","query_id":"53","doc_a_id":"27240667","doc_b_id":"8963413","presented_order":["27240667","8963413"],"winner_id":"27240667","reasoning":"Document A is more relevant — it addresses breast cancer prognosis directly, whereas Document B focuses on PD-L1 (a different biomarker) across cancers and does not pertain to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694480Z"}
{"comparison_id":"e0123050-861a-4863-9eec-58f8207e7dac","query_id":"53","doc_a_id":"19358586","doc_b_id":"2931832","presented_order":["2931832","19358586"],"winner_id":"19358586","reasoning":"Document B — it discusses molecular/protein signatures tied to prognosis in breast cancer, so it's more closely related to a claim about a molecular marker (ALDH1) than a platelet-based prognostic study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694487Z"}
{"comparison_id":"fbaf3976-b1b5-42a1-a741-55f3d54064e9","query_id":"53","doc_a_id":"19673227","doc_b_id":"22401720","presented_order":["19673227","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant — it examines prognostic molecular markers in primary breast cancer, while A addresses chemosensitivity of circulating tumor cells and not breast cancer prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694494Z"}
{"comparison_id":"ff0e549e-f4d3-4025-9bc2-621fc29f0f58","query_id":"53","doc_a_id":"4889228","doc_b_id":"7583725","presented_order":["4889228","7583725"],"winner_id":"7583725","reasoning":"Document B is more relevant — it reports that high expression of a specific molecule (TRPM7) predicts poor outcomes in breast cancer, which is the same type of evidence needed for the ALDH1 prognosis claim.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694502Z"}
{"comparison_id":"2d10b616-b791-4f47-af2a-6155e0f4253c","query_id":"53","doc_a_id":"22401720","doc_b_id":"7795952","presented_order":["7795952","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant — it studies prognostic markers in primary human breast cancer (even though neither document mentions ALDH1). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694508Z"}
{"comparison_id":"1f706923-93cb-4142-8edd-67200a1acc89","query_id":"53","doc_a_id":"4418878","doc_b_id":"8963413","presented_order":["4418878","8963413"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and their link to prognosis in cancers (including breast), which pertains to markers like ALDH1; Document B focuses on PD-L1, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694515Z"}
{"comparison_id":"e3f95623-8899-4ea8-94ef-a860151a2652","query_id":"53","doc_a_id":"20333864","doc_b_id":"29495185","presented_order":["20333864","29495185"],"winner_id":"29495185","reasoning":"Document B is more relevant — it discusses molecular predictors of treatment response and survival (i.e., markers linked to prognosis), whereas A focuses on cellular/molecular mechanisms of DCIS invasion without addressing prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694523Z"}
{"comparison_id":"03f1e7ac-7ee3-440f-b45d-dc19f6fd431f","query_id":"53","doc_a_id":"16086778","doc_b_id":"313403","presented_order":["313403","16086778"],"winner_id":"313403","reasoning":"Doc A is more relevant — it addresses a prognostic marker (TAM infiltration) linked to worse outcomes in breast cancer, which is closer to a claim about markers associated with prognosis than Doc B's mechanistic Notch/Numb study. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694531Z"}
{"comparison_id":"d2d7e1cb-e327-4911-b4ab-7725bf5dd532","query_id":"53","doc_a_id":"24341590","doc_b_id":"7795952","presented_order":["7795952","24341590"],"winner_id":"7795952","reasoning":"Document A is more relevant — it discusses a protein whose expression is linked to poor cancer prognosis and tumor invasiveness, which is thematically closer to ALDH1 expression and prognosis than the tamoxifen/CYP2D6 pharmacogenetics study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694538Z"}
{"comparison_id":"12754aac-18a4-4be3-b5a7-80d24cc603f0","query_id":"53","doc_a_id":"16086778","doc_b_id":"4889228","presented_order":["4889228","16086778"],"winner_id":"4889228","reasoning":"Reason: Document A directly reports that high expression of a gene (TDP43) correlates with poor prognosis in breast cancer, which is the same type of association asked about. Document B focuses on Numb/Notch signaling and tumorigenesis but not on marker expression linked to prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694546Z"}
{"comparison_id":"115417da-a182-4c0e-94b4-c8b75443715a","query_id":"53","doc_a_id":"22401720","doc_b_id":"825728","presented_order":["22401720","825728"],"winner_id":"22401720","reasoning":"Document A is more directly about prognosis in breast cancer (though not ALDH1 specifically). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694553Z"}
{"comparison_id":"0a9cb56b-ede4-4555-8e33-5f14f58e91b8","query_id":"53","doc_a_id":"25973484","doc_b_id":"2931832","presented_order":["25973484","2931832"],"winner_id":"2931832","reasoning":"Document B — it evaluates a prognostic biomarker in breast cancer, so it is more directly related to claims about marker expression and prognosis (Document A focuses on obesity). Neither mentions ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694560Z"}
{"comparison_id":"07d3f273-4540-47ba-95cc-32e662094e88","query_id":"53","doc_a_id":"20839751","doc_b_id":"4889228","presented_order":["4889228","20839751"],"winner_id":"4889228","reasoning":"Document A is more relevant — it reports that expression of a molecular marker (TDP43) correlates with poor prognosis in breast cancer, which is conceptually closer to the claim about ALDH1 than Document B's focus on apoptotic index. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694568Z"}
{"comparison_id":"4ac5d3d3-0652-45b1-89b6-5820f417e497","query_id":"53","doc_a_id":"20839751","doc_b_id":"21902400","presented_order":["20839751","21902400"],"winner_id":"20839751","reasoning":"Document A is more relevant because it discusses prognostic factors specifically in breast cancer, whereas Document B addresses tumor hypoxia broadly without focus on breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694575Z"}
{"comparison_id":"48fa8984-9ae1-43fb-8b8c-e97beb1cd557","query_id":"53","doc_a_id":"2931832","doc_b_id":"3285322","presented_order":["3285322","2931832"],"winner_id":"2931832","reasoning":"Document B — it examines a prognostic biomarker in breast cancer (like the query's focus on ALDH1 as a prognostic marker), whereas Document A focuses on BRCA mutation status and tumor features. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694582Z"}
{"comparison_id":"310bcd47-6a08-4531-a1a4-b7cee12f2980","query_id":"53","doc_a_id":"19673227","doc_b_id":"22482820","presented_order":["19673227","22482820"],"winner_id":"19673227","reasoning":"Document A is more focused on prognostic biomarkers and survival outcomes, which is closer to assessing whether a marker like ALDH1 predicts poorer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694589Z"}
{"comparison_id":"3428d511-682f-4c59-af9e-27b101fc7118","query_id":"53","doc_a_id":"12762485","doc_b_id":"22401720","presented_order":["12762485","22401720"],"winner_id":"12762485","reasoning":"Document A is more relevant — it links a stem cell phenotype in breast cancer (ALDH1 is a stem cell marker) with more aggressive features and poorer differentiation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694596Z"}
{"comparison_id":"fb57c535-517a-4130-a9c8-ff7a9a01fc4b","query_id":"53","doc_a_id":"1171121","doc_b_id":"27240667","presented_order":["1171121","27240667"],"winner_id":"1171121","reasoning":"Document A is more relevant — it discusses tumor biomarker status and prognostic associations in breast cancer, which is conceptually closer to ALDH1's prognostic role. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694603Z"}
{"comparison_id":"9f07d3b3-4d4e-46e5-89ef-e2f0f34624a4","query_id":"53","doc_a_id":"11484808","doc_b_id":"7583725","presented_order":["7583725","11484808"],"winner_id":"7583725","reasoning":"Document A directly reports that high expression of a specific protein predicts poor outcomes in breast cancer, which is more relevant to a claim about marker expression and prognosis than a general review of ncRNAs.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694610Z"}
{"comparison_id":"21f97e1a-d792-4d73-b825-c8b30abb678f","query_id":"53","doc_a_id":"3285322","doc_b_id":"4889228","presented_order":["4889228","3285322"],"winner_id":"4889228","reasoning":"Document A is more relevant because it discusses a specific protein's expression being correlated with prognosis in breast cancer, which is closer to the claim about a marker (ALDH1) and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694617Z"}
{"comparison_id":"c0aca30a-a79a-43d6-8ecf-df6f912eaca0","query_id":"53","doc_a_id":"21033230","doc_b_id":"25973484","presented_order":["25973484","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it addresses molecular markers and their association with prognosis in breast cancer, whereas A focuses on obesity and epidemiology without molecular marker data. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694625Z"}
{"comparison_id":"f705bad8-7c34-471e-9f10-dc645935c821","query_id":"53","doc_a_id":"19673227","doc_b_id":"31311495","presented_order":["19673227","31311495"],"winner_id":"31311495","reasoning":"B — Document B deals specifically with breast cancer cell behavior and factors tied to aggressiveness/prognosis, whereas A is a general chemosensitivity/CTC assay across epithelial tumors and not breast‑specific.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694632Z"}
{"comparison_id":"aaf76910-365a-457b-9e34-54d63cda92af","query_id":"53","doc_a_id":"22401720","doc_b_id":"2931832","presented_order":["2931832","22401720"],"winner_id":"22401720","reasoning":"Document B — it examines expression of tumor biomarkers and links high expression (e.g., VEGF) to poor prognosis, which is more contextually similar to an ALDH1 expression–prognosis claim.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694639Z"}
{"comparison_id":"9ef0be5b-a888-4b4b-af47-2d4d09addb27","query_id":"53","doc_a_id":"29366489","doc_b_id":"3285322","presented_order":["29366489","3285322"],"winner_id":"3285322","reasoning":"Document B is more relevant — it discusses clinical and pathological prognostic features in breast cancer, whereas Document A is about the DLC-1 tumor suppressor and not specific to ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694646Z"}
{"comparison_id":"5478d0e7-1bba-4359-b946-b69fd77dc416","query_id":"53","doc_a_id":"20333864","doc_b_id":"4429932","presented_order":["4429932","20333864"],"winner_id":"4429932","reasoning":"Doc A discusses a specific molecule (LOX) being associated with poor patient outcomes in breast cancer, which is directly about molecular expression and prognosis; Document B focuses on cell interactions in DCIS progression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694653Z"}
{"comparison_id":"9514a4d6-16a1-4821-a853-63d9f64a755a","query_id":"53","doc_a_id":"1171121","doc_b_id":"31311495","presented_order":["1171121","31311495"],"winner_id":"1171121","reasoning":"Document A is more relevant — it discusses prognostic factors in breast cancer (though it doesn't mention ALDH1), whereas Document B focuses on tamoxifen resistance mechanisms. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694660Z"}
{"comparison_id":"4ad79be3-b22b-428e-adff-cf993464b898","query_id":"53","doc_a_id":"21902400","doc_b_id":"29495185","presented_order":["29495185","21902400"],"winner_id":"29495185","reasoning":"Document A is more relevant — it discusses molecular predictors of cancer prognosis (like markers such as ALDH1), whereas Document B focuses on tumor hypoxia unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694667Z"}
{"comparison_id":"9daec6a1-f036-48a5-b37e-746afedf8a61","query_id":"53","doc_a_id":"24341590","doc_b_id":"7821634","presented_order":["7821634","24341590"],"winner_id":"7821634","reasoning":"Document A is more relevant — it discusses a molecular marker whose expression level correlates with prognosis in breast cancer, whereas Document B focuses on CYP2D6 pharmacogenetics in tamoxifen-treated patients.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694674Z"}
{"comparison_id":"74f4a79c-0871-44d4-ae67-1c3946f4b14f","query_id":"53","doc_a_id":"1866911","doc_b_id":"2931832","presented_order":["2931832","1866911"],"winner_id":"1866911","reasoning":"Document B is more relevant — it discusses breast cell populations and markers related to tumor progenitors (closer to ALDH1's role as a stem/progenitor marker), while A focuses on platelet metrics unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694682Z"}
{"comparison_id":"9e4b36f3-909a-48b0-8d2c-71b4d17927ea","query_id":"53","doc_a_id":"24341590","doc_b_id":"24834968","presented_order":["24341590","24834968"],"winner_id":"24834968","reasoning":"Reason: Neither abstract mentions ALDH1, but Document B evaluates multiple biological markers in breast cancer (more relevant to marker–prognosis questions) while Document A focuses on CYP2D6 pharmacogenetics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694689Z"}
{"comparison_id":"5655f7f8-2fa4-4f03-beb3-105bb7558702","query_id":"53","doc_a_id":"2130391","doc_b_id":"313403","presented_order":["313403","2130391"],"winner_id":"313403","reasoning":"Document A is more relevant — it directly addresses prognostic factors and links tumor characteristics to clinical outcome, whereas B focuses on adipocytes and invasion rather than prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694696Z"}
{"comparison_id":"e234d7f7-fc61-45ff-862b-094c08de5df5","query_id":"53","doc_a_id":"15113221","doc_b_id":"43385013","presented_order":["15113221","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it discusses stem cell/progenitor properties in breast cells (related to ALDH1 as a stem cell marker), whereas A focuses on PTEN pathway signatures unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694703Z"}
{"comparison_id":"f3eba31d-3b95-4ac6-83d9-f80cd2e30a5c","query_id":"53","doc_a_id":"24834968","doc_b_id":"43385013","presented_order":["24834968","43385013"],"winner_id":"43385013","reasoning":"Document B — it addresses stem cell/progenitor properties and epithelial/mesenchymal subpopulations in breast cells (closer to ALDH1-related stem cell marker biology), while A focuses on HER2/Ki67 and chemotherapy response. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694711Z"}
{"comparison_id":"fd314588-4b6b-4e34-8626-53ccef5b7a9f","query_id":"53","doc_a_id":"313403","doc_b_id":"45638119","presented_order":["45638119","313403"],"winner_id":"45638119","reasoning":"Document A directly states that ALDH1 is a marker of malignant mammary stem cells and predicts poor clinical outcome in breast cancer, matching the claim. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694717Z"}
{"comparison_id":"c09278f9-bb0d-4455-8ce5-a54fd0e361c7","query_id":"53","doc_a_id":"20127522","doc_b_id":"313403","presented_order":["313403","20127522"],"winner_id":"313403","reasoning":"Document A is more relevant — it deals with a tumor-associated marker (TAM infiltration) linked to poor prognosis in breast cancer, which is closer to the claim about a prognostic biomarker than the CTC treatment-monitoring focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694725Z"}
{"comparison_id":"a1fdf2ff-9975-4fc1-b8d4-bc29f6d19002","query_id":"53","doc_a_id":"4455466","doc_b_id":"5649538","presented_order":["4455466","5649538"],"winner_id":"4455466","reasoning":"Document A is more relevant — it discusses gene expression linked to prognosis in breast cancer (though not ALDH1 specifically), whereas B focuses on dasatinib sensitivity markers. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694731Z"}
{"comparison_id":"27934839-7bc8-4329-ae8e-623eeef0d091","query_id":"53","doc_a_id":"4702639","doc_b_id":"4889228","presented_order":["4702639","4889228"],"winner_id":"4889228","reasoning":"Document B is more relevant — it directly links high expression of a gene to poor prognosis in breast cancer (TNBC). Document A focuses on integrin-driven stemness and drug resistance but does not address prognosis or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694739Z"}
{"comparison_id":"6f8fd27d-222a-48f9-aa82-1133a9a46a84","query_id":"53","doc_a_id":"15113221","doc_b_id":"7795952","presented_order":["7795952","15113221"],"winner_id":"7795952","reasoning":"Document A is more relevant — it discusses a specific protein marker (fascin) whose expression is linked to poor cancer prognosis, which is conceptually closer to the claim about ALDH1 expression and prognosis than the pathway-focused study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694746Z"}
{"comparison_id":"bcda3697-50f9-43e0-8bce-52854e82b963","query_id":"53","doc_a_id":"11484808","doc_b_id":"15946643","presented_order":["11484808","15946643"],"winner_id":"15946643","reasoning":"Document B is more focused on breast cancer biology and clinical outcomes (chemoresistance/metastasis), making it likelier to address biomarkers like ALDH1; Document A is a broad ncRNA review not specific to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694753Z"}
{"comparison_id":"c673dbb8-394f-4585-bfa2-5a12d80b4403","query_id":"53","doc_a_id":"29495185","doc_b_id":"4455466","presented_order":["4455466","29495185"],"winner_id":"4455466","reasoning":"Document A links gene expression levels to prognosis in breast cancer (low ZMYND11 expression → poor prognosis), providing direct evidence of an expression–prognosis relationship; Document B is a general review without specific data on ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694761Z"}
{"comparison_id":"d0ebf05b-2bb2-4039-bedf-cc163fc57770","query_id":"53","doc_a_id":"19673227","doc_b_id":"4418878","presented_order":["4418878","19673227"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and their link to cancer prognosis, which directly relates to biomarker expression like ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694768Z"}
{"comparison_id":"b407e3c7-f1b1-4542-8331-19fd26d7d6a7","query_id":"53","doc_a_id":"21033230","doc_b_id":"31311495","presented_order":["31311495","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it addresses prognostic markers and associations with overall survival in breast cancer, whereas A focuses on tamoxifen resistance mechanisms without prognostic marker data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694775Z"}
{"comparison_id":"d0d5d09c-d484-45d7-8203-ebe1a032ebf9","query_id":"53","doc_a_id":"1379127","doc_b_id":"20333864","presented_order":["20333864","1379127"],"winner_id":"20333864","reasoning":"Document A is more relevant — it discusses factors influencing progression from in situ to invasive breast cancer and tumor behavior, which relates to prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694782Z"}
{"comparison_id":"f20aaa68-f13a-4126-88d4-4bae5ee88e9f","query_id":"53","doc_a_id":"20333864","doc_b_id":"7821634","presented_order":["7821634","20333864"],"winner_id":"7821634","reasoning":"Document A — it discusses prognostic correlations in breast cancer (links low DUSP4 with poor outcomes), whereas Document B focuses on cellular mechanisms of invasion and not prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694789Z"}
{"comparison_id":"e9a10703-17d2-46e5-9851-f79ca57cd52a","query_id":"53","doc_a_id":"15113221","doc_b_id":"24834968","presented_order":["15113221","24834968"],"winner_id":"15113221","reasoning":"Document A is more relevant — it discusses a gene expression signature linked to poor prognosis in carcinomas (closer to the claim about a prognostic marker), whereas Document B focuses on chemo response predictors and not prognosis or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694796Z"}
{"comparison_id":"eea54eaf-9f02-4cac-ade5-3b6e6dd2d2f3","query_id":"53","doc_a_id":"1171121","doc_b_id":"45638119","presented_order":["45638119","1171121"],"winner_id":"45638119","reasoning":"Document A directly links ALDH1 expression with poor clinical outcome in breast cancer, while Document B discusses microvessel density and p53 without mentioning ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694803Z"}
{"comparison_id":"750b54f2-8291-4bce-a526-a30382436873","query_id":"53","doc_a_id":"29366489","doc_b_id":"8963413","presented_order":["8963413","29366489"],"winner_id":"8963413","reasoning":"Doc A — it discusses expression of a marker and its association with clinical outcomes in breast cancer, making it more directly relevant to a claim about marker expression and prognosis than Document B, which focuses on a different tumor suppressor.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694811Z"}
{"comparison_id":"35aad9f4-0aee-4ac7-addf-837ce27ef1d6","query_id":"53","doc_a_id":"12762485","doc_b_id":"4702639","presented_order":["4702639","12762485"],"winner_id":"4702639","reasoning":"Document A is more relevant — it addresses tumor \"stemness\" markers and mechanisms tied to stem-like phenotype, which is directly related to ALDH1 as a cancer stem cell marker. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694818Z"}
{"comparison_id":"9473d80c-b3f6-428a-822b-ad176079e8c5","query_id":"53","doc_a_id":"27240667","doc_b_id":"29495185","presented_order":["29495185","27240667"],"winner_id":"29495185","reasoning":"Document A is more relevant — it discusses molecular predictors of cancer prognosis (which would include markers like ALDH1), whereas Document B focuses on mortality trends by ER status and age.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694826Z"}
{"comparison_id":"fb950c4e-2953-4755-96bc-5f8dfa8137af","query_id":"53","doc_a_id":"21033230","doc_b_id":"29366489","presented_order":["29366489","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it addresses prognostic molecular markers in metastatic breast cancer, while A discusses DLC-1 unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694833Z"}
{"comparison_id":"af7f3b9d-9b53-4f0b-ac02-1f5c3e87d99a","query_id":"53","doc_a_id":"15113221","doc_b_id":"15832146","presented_order":["15832146","15113221"],"winner_id":"15113221","reasoning":"Doc B is more relevant because it addresses gene expression signatures linked to poor prognosis in carcinomas, whereas Doc A focuses on fibroblast-mediated tumor growth/angiogenesis without linking ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694839Z"}
{"comparison_id":"dab11cab-0d79-4cc6-9d71-1be5fc772377","query_id":"53","doc_a_id":"17648235","doc_b_id":"1866911","presented_order":["1866911","17648235"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses progenitor/stem-like cell populations and markers related to breast cancer origin, which is more directly related to ALDH1 (a stem/progenitor marker) than Document B's focus on WNT signaling.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694846Z"}
{"comparison_id":"3ca95e04-9074-4846-bb44-01169f1550f6","query_id":"53","doc_a_id":"15113221","doc_b_id":"2931832","presented_order":["15113221","2931832"],"winner_id":"15113221","reasoning":"Document A is more relevant — it discusses a gene expression signature linked to poor prognosis in carcinoma, which is closer to the claim about a prognostic gene/protein marker than a platelet-based biomarker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694854Z"}
{"comparison_id":"1d357002-ce68-4f03-ae1e-f34a87076a69","query_id":"53","doc_a_id":"2014909","doc_b_id":"4429932","presented_order":["2014909","4429932"],"winner_id":"2014909","reasoning":"Document A — it analyzes primary breast cancers and tumor-initiating cells (ALDH1 is a marker of tumor-initiating/stem-like cells) and is therefore more likely to address prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694860Z"}
{"comparison_id":"9be84b31-63b7-4611-9e9a-6cbcfa14f93f","query_id":"53","doc_a_id":"15946643","doc_b_id":"20839751","presented_order":["20839751","15946643"],"winner_id":"15946643","reasoning":"Reason: Neither mentions ALDH1, but Document B discusses mechanisms (chemoresistance and metastasis) more directly related to prognosis in breast cancer than Document A's focus on apoptotic index.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694867Z"}
{"comparison_id":"b51a19e0-072a-4a90-91f7-904e9a7852a8","query_id":"53","doc_a_id":"1866911","doc_b_id":"22482820","presented_order":["1866911","22482820"],"winner_id":"1866911","reasoning":"Document A is more relevant — it addresses breast epithelial progenitor populations and marker expression linked to tumor subtype/prognosis, which is closer to ALDH1's role as a stem/progenitor marker. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694874Z"}
{"comparison_id":"7d9c7d3e-3a59-4731-bbcc-e821c8429dc9","query_id":"53","doc_a_id":"1379127","doc_b_id":"15113221","presented_order":["1379127","15113221"],"winner_id":"1379127","reasoning":"Reason: Document A specifically concerns breast tumor behavior (migration/metastasis), so it's more directly related to breast cancer prognosis than Document B, which discusses a general PTEN-related signature across carcinomas.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694881Z"}
{"comparison_id":"46f058bd-269d-4dad-80a2-4c15baa2445d","query_id":"53","doc_a_id":"20127522","doc_b_id":"7821634","presented_order":["7821634","20127522"],"winner_id":"7821634","reasoning":"Document A is more relevant — it discusses a tumor biomarker whose expression correlates with poor outcomes in breast cancer, whereas Document B focuses on circulating tumor cells rather than ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694889Z"}
{"comparison_id":"17d55f83-eccc-4bfb-8f69-ed4de49578a9","query_id":"53","doc_a_id":"12762485","doc_b_id":"22482820","presented_order":["12762485","22482820"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses a stem-cell–like phenotype in breast cancer (linked to markers like ALDH1) and associations with worse features (p53+, ER/PgR–, high proliferation). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694896Z"}
{"comparison_id":"a0fe2eff-9032-4a70-a3a9-1e72fafc4f74","query_id":"53","doc_a_id":"16086778","doc_b_id":"31311495","presented_order":["16086778","31311495"],"winner_id":"16086778","reasoning":"Document A addresses mechanisms of breast cancer progression and factors affecting tumor behavior/prognosis (Numb/Notch), while Document B focuses on tamoxifen resistance and EMT in cell lines. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694903Z"}
{"comparison_id":"01c6401b-07e0-4061-b687-eba9aa50b7e4","query_id":"53","doc_a_id":"20839751","doc_b_id":"45638119","presented_order":["20839751","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 and states it predicts poor clinical outcome in breast cancer, while Document A does not mention ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694910Z"}
{"comparison_id":"26cb99cc-c3f9-4ad5-a8b9-68dcf66274fc","query_id":"53","doc_a_id":"22482820","doc_b_id":"5649538","presented_order":["5649538","22482820"],"winner_id":"22482820","reasoning":"Document B is more relevant — a review of therapies and resistance is more likely to discuss biomarkers (like ALDH1) and their prognostic significance than a technical paper on dasatinib genomic predictors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694917Z"}
{"comparison_id":"0632c68b-9103-4954-9a28-052751c08f52","query_id":"53","doc_a_id":"1379127","doc_b_id":"4889228","presented_order":["4889228","1379127"],"winner_id":"4889228","reasoning":"Document A — it discusses gene expression that correlates with prognosis in breast cancer, whereas Document B focuses on calcium channels and metastasis and does not address prognostic marker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.694924Z"}
{"comparison_id":"cbb02073-2f4d-4739-8d86-983520775e25","query_id":"53","doc_a_id":"15113221","doc_b_id":"313403","presented_order":["313403","15113221"],"winner_id":"313403","reasoning":"Document A is more relevant — it addresses prognostic markers specifically in breast cancer, whereas Document B discusses a PTEN-related signature across carcinomas but not breast-specific markers like ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695856Z"}
{"comparison_id":"d3da080e-f3d3-4dfc-bd35-aa87e2744c39","query_id":"53","doc_a_id":"22482820","doc_b_id":"7583725","presented_order":["22482820","7583725"],"winner_id":"7583725","reasoning":"Document B is more relevant — it directly discusses how expression of a specific molecule (TRPM7) correlates with prognosis in breast cancer, which is conceptually closer to a claim about ALDH1 expression and prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695887Z"}
{"comparison_id":"f5819be8-5aa7-4d40-aa23-3c0796044f1d","query_id":"53","doc_a_id":"19358586","doc_b_id":"20333864","presented_order":["20333864","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it directly discusses molecular signatures linked to poor survival in breast cancer, whereas A focuses on cellular mechanisms of DCIS-to-invasive transition without prognosis data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695895Z"}
{"comparison_id":"a14ef6fa-338c-4f30-ae22-0f57d9ab64ec","query_id":"53","doc_a_id":"1171121","doc_b_id":"16086778","presented_order":["16086778","1171121"],"winner_id":"1171121","reasoning":"Document B — it discusses prognostic biomarkers in breast cancer (MVD and p53), so it's more aligned with a claim about a prognostic marker like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695903Z"}
{"comparison_id":"0d39692e-9720-48ca-b65a-91e067573244","query_id":"53","doc_a_id":"1379127","doc_b_id":"22401720","presented_order":["22401720","1379127"],"winner_id":"22401720","reasoning":"Document A — it discusses expression of markers in primary breast cancer and links a marker (VEGF) to poor prognosis, which is more directly related to prognosis than Document B's focus on migration/metastasis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695910Z"}
{"comparison_id":"489a929c-5e20-4650-a43b-58476d502b71","query_id":"53","doc_a_id":"1171121","doc_b_id":"34066665","presented_order":["34066665","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it deals directly with prognostic factors in breast cancer, whereas A discusses receptor crosstalk and therapy resistance without focusing on prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695916Z"}
{"comparison_id":"710b579c-9e0f-458b-a9ee-e08224972c09","query_id":"53","doc_a_id":"22482820","doc_b_id":"8963413","presented_order":["8963413","22482820"],"winner_id":"8963413","reasoning":"Document A — it discusses expression of a tumor marker (PD-L1) and its association with clinical outcomes, which is more relevant to a claim about marker expression and prognosis than a treatment/combinations overview.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695923Z"}
{"comparison_id":"36225b08-2e4a-45f8-bad2-2efff89693a5","query_id":"53","doc_a_id":"19358586","doc_b_id":"24834968","presented_order":["19358586","24834968"],"winner_id":"19358586","reasoning":"Document A is more relevant — it discusses proteomic signatures linked to poor survival in breast cancer (prognosis-related), whereas B focuses on chemotherapy response predictors, not prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695929Z"}
{"comparison_id":"32685dbb-58ad-45ef-b98d-ee4dc0df7063","query_id":"53","doc_a_id":"2130391","doc_b_id":"2931832","presented_order":["2931832","2130391"],"winner_id":"2931832","reasoning":"Document A is more relevant — it addresses prognostic biomarkers and survival in breast cancer, which is closer to the claim about ALDH1 and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695935Z"}
{"comparison_id":"29efae59-904b-499b-abf4-4f3d27a4f49d","query_id":"53","doc_a_id":"1171121","doc_b_id":"25973484","presented_order":["25973484","1171121"],"winner_id":"1171121","reasoning":"Document B — it discusses prognostic biomarkers in breast cancer (MVD and p53), so it's more relevant to a claim about a prognostic marker than Document A about obesity. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695942Z"}
{"comparison_id":"b91710e5-cc61-4557-823b-7ef845de9932","query_id":"53","doc_a_id":"21033230","doc_b_id":"34066665","presented_order":["21033230","34066665"],"winner_id":"21033230","reasoning":"Document A is more relevant — it discusses prognostic markers and survival correlations in metastatic breast cancer, whereas Document B focuses on ER–HER signaling and endocrine resistance, not prognostic marker expression like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695948Z"}
{"comparison_id":"6d9897d4-333b-4845-95de-dffc54c20769","query_id":"53","doc_a_id":"17648235","doc_b_id":"34066665","presented_order":["17648235","34066665"],"winner_id":"34066665","reasoning":"Document B is more relevant — it addresses clinical implications and therapy resistance in breast cancer, which relates more directly to prognosis than the cell-signaling focus of Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695955Z"}
{"comparison_id":"4324a4c1-99fa-4879-b8c8-4a0990547280","query_id":"53","doc_a_id":"1171121","doc_b_id":"20127522","presented_order":["20127522","1171121"],"winner_id":"1171121","reasoning":"Neither abstract mentions ALDH1. Document B is slightly more relevant because it examines molecular/protein markers (p53) and prognostic associations, whereas A focuses on circulating tumor cell counts. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695962Z"}
{"comparison_id":"36b332ad-bc2c-47d6-a36e-67db75dba0bf","query_id":"53","doc_a_id":"19673227","doc_b_id":"4889228","presented_order":["19673227","4889228"],"winner_id":"4889228","reasoning":"Reason: Document B discusses a specific molecular marker whose high expression correlates with poor prognosis in triple-negative breast cancer, which is conceptually closer to the claim about ALDH1 expression and prognosis than the general chemosensitivity CTC study in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695968Z"}
{"comparison_id":"b6b4a0e6-40f3-433f-a76c-3f241d63d23a","query_id":"53","doc_a_id":"29495185","doc_b_id":"825728","presented_order":["29495185","825728"],"winner_id":"29495185","reasoning":"Reason: Document A discusses molecular predictors of cancer prognosis broadly, which is more directly relevant to a claim about ALDH1 as a prognostic marker; Document B focuses on Prrx1/EMT and metastasis, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695975Z"}
{"comparison_id":"48dd09bb-a337-4404-9658-341cc637876b","query_id":"53","doc_a_id":"20127522","doc_b_id":"20183360","presented_order":["20127522","20183360"],"winner_id":"20127522","reasoning":"Document A is more relevant — it addresses prognostic markers and survival outcomes in breast cancer, whereas Document B focuses on molecular mechanisms of invasion not prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695981Z"}
{"comparison_id":"cfa8dfc1-4aac-4963-8597-c7747e32660e","query_id":"53","doc_a_id":"24341590","doc_b_id":"45638119","presented_order":["45638119","24341590"],"winner_id":"45638119","reasoning":"Document A is directly about ALDH1 as a marker and predictor of poor clinical outcome in breast cancer, matching the query. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695987Z"}
{"comparison_id":"7ced5eed-6eae-4e7a-82c8-cd396bd45c57","query_id":"53","doc_a_id":"4455466","doc_b_id":"4583180","presented_order":["4583180","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it discusses gene expression linked to prognosis in breast cancer (though a different marker), whereas A focuses on SREBP2 and tumor metabolism and does not address prognostic markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695993Z"}
{"comparison_id":"c234b31e-8a50-4a9f-b9c7-6628d19c1766","query_id":"53","doc_a_id":"4418878","doc_b_id":"825728","presented_order":["4418878","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it links EMT, stem cell properties, and patient survival (topics closely related to ALDH1 as a breast cancer stem cell/prognostic marker).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.695999Z"}
{"comparison_id":"91802026-20c8-46e7-a12d-6c97f4bc99fa","query_id":"53","doc_a_id":"29495185","doc_b_id":"4702639","presented_order":["4702639","29495185"],"winner_id":"29495185","reasoning":"Document B is more relevant — it covers molecular predictors of cancer prognosis (the domain that would include ALDH1 associations), whereas A focuses on integrin αvβ3–driven stemness and drug resistance, not ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696006Z"}
{"comparison_id":"773a2c1f-4e09-459c-9d1b-4dce6323bb2d","query_id":"53","doc_a_id":"1379127","doc_b_id":"7795952","presented_order":["7795952","1379127"],"winner_id":"7795952","reasoning":"Document A is more relevant — it explicitly mentions a protein linked to poor cancer prognosis, which is closer to the claim about marker expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696012Z"}
{"comparison_id":"e9f74021-3a26-47e3-a34d-b055e96c7ae1","query_id":"53","doc_a_id":"4583180","doc_b_id":"8963413","presented_order":["8963413","4583180"],"winner_id":"8963413","reasoning":"Document A — it discusses cancer biomarker expression and clinical outcomes specifically mentioning breast cancer, so it's more directly relevant to a prognosis-related claim in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696018Z"}
{"comparison_id":"560a2e19-4eaf-4422-9e1e-7a622c4e31dc","query_id":"53","doc_a_id":"5649538","doc_b_id":"7583725","presented_order":["7583725","5649538"],"winner_id":"7583725","reasoning":"Doc A. It directly links a gene's expression (TRPM7) to poor outcomes in breast cancer, which is conceptually similar to the claim about ALDH1 and prognosis; Doc B is about drug-sensitivity markers for dasatinib.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696024Z"}
{"comparison_id":"0b7c4dbc-39cb-415d-a378-fa6475aa31d4","query_id":"53","doc_a_id":"20183360","doc_b_id":"43385013","presented_order":["20183360","43385013"],"winner_id":"43385013","reasoning":"Document B — it discusses stem-cell/progenitor properties in breast cell subpopulations (ALDH1 is a stem cell marker), so it's more relevant to a claim about ALDH1 and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696030Z"}
{"comparison_id":"3a823463-7477-4bdb-a44e-7e6e45d5e187","query_id":"53","doc_a_id":"19673227","doc_b_id":"20127522","presented_order":["19673227","20127522"],"winner_id":"20127522","reasoning":"Document B — it specifically links a measurable marker to poorer prognosis in metastatic breast cancer, making it more directly relevant to the claim about prognostic markers in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696037Z"}
{"comparison_id":"9a23d4e8-5028-47ab-a5ac-aff92462481a","query_id":"53","doc_a_id":"20183360","doc_b_id":"20839751","presented_order":["20183360","20839751"],"winner_id":"20839751","reasoning":"Document B — it discusses relationships between molecular/pathological markers and prognosis in breast cancer, making it more relevant to a claim about marker (ALDH1) and prognosis, whereas A focuses on GATA3/Smad4 invasion mechanisms and not prognosis markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696043Z"}
{"comparison_id":"d9d669ca-89b2-4192-959b-1d81076a7222","query_id":"53","doc_a_id":"17648235","doc_b_id":"22482820","presented_order":["17648235","22482820"],"winner_id":"22482820","reasoning":"Document B is more likely to discuss biomarkers and clinical outcomes (classification and treatment challenges) relevant to prognosis; Document A focuses on WNT signaling mechanisms, not prognostic markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696050Z"}
{"comparison_id":"b65af26e-de6e-4c85-aad6-160911d0096d","query_id":"53","doc_a_id":"1171121","doc_b_id":"4455466","presented_order":["1171121","4455466"],"winner_id":"4455466","reasoning":"Document B. It discusses gene/protein expression levels linked to prognosis in breast cancer (low ZMYND11 linked to poor outcome), so it's more closely related to the claim about marker expression and prognosis than Document A, which focuses on MVD and p53.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696056Z"}
{"comparison_id":"3b243a81-de37-48bb-8bc0-c2e544a82c59","query_id":"53","doc_a_id":"1866911","doc_b_id":"4429932","presented_order":["1866911","4429932"],"winner_id":"1866911","reasoning":"Document A is more relevant—it discusses breast cancer progenitor cell populations and marker-defined origins (closer in context to ALDH1 as a stem/progenitor marker), whereas B focuses on LOX/hypoxia unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696083Z"}
{"comparison_id":"d6c35e5a-3ad5-4f29-9cdd-7dcdf70b06b7","query_id":"53","doc_a_id":"34066665","doc_b_id":"4583180","presented_order":["4583180","34066665"],"winner_id":"34066665","reasoning":"Reason: Document B focuses specifically on breast cancer biology and clinical outcomes, so it's more likely to address markers linked to prognosis than Document A, which discusses general tumor cholesterol metabolism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696095Z"}
{"comparison_id":"3756c5a2-db4d-4450-b0be-13a895822ee7","query_id":"53","doc_a_id":"24834968","doc_b_id":"7583725","presented_order":["7583725","24834968"],"winner_id":"7583725","reasoning":"Document A is more relevant — it reports that high expression of a molecular marker (TRPM7) predicts poor outcomes in breast cancer, which is conceptually closer to the claim about marker expression and prognosis than Document B's focus on chemotherapy response predictors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696103Z"}
{"comparison_id":"59c492dc-96f9-4b96-9d8c-3ef064cd6389","query_id":"53","doc_a_id":"27240667","doc_b_id":"7821634","presented_order":["27240667","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it discusses a molecular marker (DUSP4) linked to poor outcomes and treatment resistance in breast cancer, whereas A covers population mortality trends by ER status/age and not molecular markers. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696110Z"}
{"comparison_id":"77a58724-a155-4255-98a9-d1fc61eb12cc","query_id":"53","doc_a_id":"31311495","doc_b_id":"7821634","presented_order":["31311495","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it specifically links a molecular marker (DUSP4) to poor outcomes and chemoresistance in breast cancer, whereas A focuses on EMT and beta-catenin in tamoxifen-resistant cells without addressing prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696117Z"}
{"comparison_id":"4995c42f-69b1-4cc8-af99-6b69d82d3c69","query_id":"53","doc_a_id":"1866911","doc_b_id":"34066665","presented_order":["34066665","1866911"],"winner_id":"1866911","reasoning":"Document B is more relevant — it discusses breast epithelial progenitor cell populations and markers linked to tumor origin, which is closer to ALDH1 (a stem/progenitor marker) and prognosis than a review focused on ER–HER signaling. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696123Z"}
{"comparison_id":"91a64419-5bd9-4256-856c-49fb0ca59737","query_id":"53","doc_a_id":"18953920","doc_b_id":"22401720","presented_order":["18953920","22401720"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses acquisition of stem-cell markers and increased tumorigenic potential in mammary epithelial cells, which relates to ALDH1 as a breast cancer stem-cell marker; Document B focuses on angiogenic factors (VEGF) and not ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696130Z"}
{"comparison_id":"2c1885e2-3aab-40ab-8f2d-ff9f565f9f5e","query_id":"53","doc_a_id":"20333864","doc_b_id":"2931832","presented_order":["20333864","2931832"],"winner_id":"2931832","reasoning":"Document B is more relevant — it directly studies prognostic biomarkers in breast cancer, whereas A focuses on cellular mechanisms of DCIS-to-invasive transition and not prognosis markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696137Z"}
{"comparison_id":"504eebdd-e20e-496d-98fa-acaf1291c5ce","query_id":"53","doc_a_id":"1379127","doc_b_id":"31311495","presented_order":["1379127","31311495"],"winner_id":"31311495","reasoning":"Document B is more relevant — it discusses therapy resistance, EMT-like changes and increased tumor aggressiveness (factors tied to poorer prognosis), whereas A focuses on calcium channels and metastasis without linking to markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696143Z"}
{"comparison_id":"b4a100ff-54aa-47f5-9e1f-1549119a54f7","query_id":"53","doc_a_id":"20333864","doc_b_id":"2130391","presented_order":["20333864","2130391"],"winner_id":"20333864","reasoning":"Document A is more relevant — it addresses mechanisms of progression from in situ to invasive breast carcinoma (directly related to prognosis), while B focuses narrowly on adipocyte-induced invasion without linking to prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696150Z"}
{"comparison_id":"da69c494-fc83-4d3d-a342-9f5d0db1fb15","query_id":"53","doc_a_id":"20127522","doc_b_id":"3285322","presented_order":["3285322","20127522"],"winner_id":"3285322","reasoning":"Document A is more relevant — it addresses tumor clinical/pathologic features and prognosis in breast cancer, which is closer to ALDH1 prognostic associations than the CTC-focused study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696157Z"}
{"comparison_id":"5c09e3db-7c05-411e-9563-725f569e45d9","query_id":"53","doc_a_id":"17648235","doc_b_id":"25732836","presented_order":["17648235","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant — it directly addresses prognostic markers and outcome prediction in breast cancer, whereas Document A focuses on WNT signaling mechanisms, not prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696163Z"}
{"comparison_id":"06b92873-288e-41d4-ad3d-e5092e00ac82","query_id":"53","doc_a_id":"15113221","doc_b_id":"7821634","presented_order":["15113221","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it specifically studies breast cancer and links a molecular marker (DUSP4 deficiency) to poor outcomes, whereas A addresses PTEN-related signatures across carcinomas more generally.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696170Z"}
{"comparison_id":"59443c5f-1db2-4d8a-9897-28b8c2866c4b","query_id":"53","doc_a_id":"22401720","doc_b_id":"7583725","presented_order":["7583725","22401720"],"winner_id":"7583725","reasoning":"Document A is more directly about a specific protein's expression predicting poor outcomes in breast cancer, which parallels the claim about ALDH1 and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696177Z"}
{"comparison_id":"861b98f3-103c-495f-bd8c-27eb08e29d1d","query_id":"53","doc_a_id":"4583180","doc_b_id":"825728","presented_order":["4583180","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it links EMT/ stem-cell properties to patient survival and metastasis, which is closer to ALDH1's role as a cancer stem-cell marker associated with prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696183Z"}
{"comparison_id":"b9d3740e-111c-4670-871e-ca9903ee5bf7","query_id":"53","doc_a_id":"11484808","doc_b_id":"3285322","presented_order":["3285322","11484808"],"winner_id":"3285322","reasoning":"Document A is more relevant — it discusses clinical and pathologic characteristics and prognosis in breast cancer, whereas Document B focuses on non-coding RNAs and not ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696189Z"}
{"comparison_id":"f72f7b24-9243-4833-a1b6-d49436eefabf","query_id":"53","doc_a_id":"19358586","doc_b_id":"27240667","presented_order":["27240667","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it discusses molecular expression signatures linked to poor survival in breast cancer, which is closer to the claim about a marker (ALDH1) and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696195Z"}
{"comparison_id":"35b6c3cd-4a9d-46d2-8b93-4fc31982f504","query_id":"53","doc_a_id":"5649538","doc_b_id":"7821634","presented_order":["5649538","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it discusses gene expression linked to poor outcomes in breast cancer (a prognostic association), whereas A focuses on predictors of dasatinib sensitivity.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696201Z"}
{"comparison_id":"91d9fa7d-d105-4a66-a0ce-c3b39705928e","query_id":"53","doc_a_id":"15113221","doc_b_id":"4429932","presented_order":["4429932","15113221"],"winner_id":"4429932","reasoning":"Document A is more relevant — it specifically mentions poor outcomes in breast cancer, whereas B discusses PTEN-related signatures in carcinomas overall and not breast-specific or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696207Z"}
{"comparison_id":"d01f6918-132f-4f25-814a-06b1eaf8bfa3","query_id":"53","doc_a_id":"45638119","doc_b_id":"825728","presented_order":["825728","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 as a marker and predictor of poor prognosis in breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696213Z"}
{"comparison_id":"0017f9ed-c476-4ae2-9de4-11eea8eba53a","query_id":"53","doc_a_id":"15832146","doc_b_id":"7821634","presented_order":["7821634","15832146"],"winner_id":"7821634","reasoning":"Document A discusses a molecular marker (DUSP4) whose low expression correlates with poor outcomes in breast cancer, so it's more relevant to a claim about prognostic expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696219Z"}
{"comparison_id":"c4cc6d9f-92e9-42ac-8887-2f2c54846317","query_id":"53","doc_a_id":"20183360","doc_b_id":"24341590","presented_order":["20183360","24341590"],"winner_id":"20183360","reasoning":"Document A is more relevant — it addresses molecular mechanisms of breast cancer invasiveness and progression (which relate to prognosis), whereas Document B focuses on CYP2D6/tamoxifen pharmacogenetics unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696226Z"}
{"comparison_id":"7f1d9414-d475-4361-818d-44629ab7f3d5","query_id":"53","doc_a_id":"15113221","doc_b_id":"19673227","presented_order":["15113221","19673227"],"winner_id":"15113221","reasoning":"Document A is more relevant because it discusses a gene expression signature linked to poor prognosis in carcinomas, which is closer to the claim about a specific marker's expression and prognosis than Document B's focus on CTC chemosensitivity.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696232Z"}
{"comparison_id":"6e1efa6a-5654-4b22-b20a-23c712efa3b7","query_id":"53","doc_a_id":"17648235","doc_b_id":"4889228","presented_order":["4889228","17648235"],"winner_id":"4889228","reasoning":"Document A is more relevant — it links gene expression levels to prognosis in breast cancer, whereas B focuses on WNT signaling and proliferation without prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696238Z"}
{"comparison_id":"c21b4dcd-0341-44fc-b040-16570e804296","query_id":"53","doc_a_id":"17648235","doc_b_id":"29495185","presented_order":["29495185","17648235"],"winner_id":"29495185","reasoning":"Doc A is more relevant — it addresses molecular predictors of cancer prognosis, whereas Doc B focuses on WNT signaling and proliferation without mention of ALDH1 or clinical prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696245Z"}
{"comparison_id":"ba72152a-0913-4c4c-a819-f11f588f0b54","query_id":"53","doc_a_id":"20333864","doc_b_id":"4455466","presented_order":["4455466","20333864"],"winner_id":"4455466","reasoning":"Document A is more relevant — it discusses associations with prognosis in breast cancer (though not ALDH1 specifically), while B focuses on cellular mechanisms of invasion. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696251Z"}
{"comparison_id":"cbbef29f-a7b5-4d80-9984-32bd60737a7d","query_id":"53","doc_a_id":"31311495","doc_b_id":"7583725","presented_order":["7583725","31311495"],"winner_id":"7583725","reasoning":"Document A — it discusses a specific gene's expression predicting poor outcomes in breast cancer, which is conceptually closer to ALDH1's prognostic association. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696257Z"}
{"comparison_id":"db4c1030-815e-479b-bbc2-cdc1006484e3","query_id":"53","doc_a_id":"20127522","doc_b_id":"4702639","presented_order":["20127522","4702639"],"winner_id":"4702639","reasoning":"Document B. It addresses tumour stemness and stem-cell–associated markers/pathways, which is conceptually closer to ALDH1 (a stemness marker) than Document A's focus on circulating tumor cells and CTC counts.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696264Z"}
{"comparison_id":"b9181483-1fe4-4734-89ff-b64eb2c150e6","query_id":"53","doc_a_id":"12762485","doc_b_id":"3285322","presented_order":["12762485","3285322"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses a stem cell phenotype and associations with more aggressive, less differentiated tumors, which relates to ALDH1 as a cancer stem cell marker. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696271Z"}
{"comparison_id":"77ef0cda-3619-404d-b9e1-79ef5c3f5f45","query_id":"53","doc_a_id":"21902400","doc_b_id":"7821634","presented_order":["21902400","7821634"],"winner_id":"7821634","reasoning":"Document B — it discusses markers linked to poor outcomes in breast cancer (DUSP4), so it's more directly related to prognostic markers in breast cancer than the general hypoxia-focused Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696278Z"}
{"comparison_id":"24fb5d02-5d37-4944-b172-f8a3035e5b4f","query_id":"53","doc_a_id":"1171121","doc_b_id":"19673227","presented_order":["1171121","19673227"],"winner_id":"1171121","reasoning":"Document A is more relevant — it discusses prognostic factors in breast cancer, whereas Document B focuses on chemosensitivity of circulating tumor cells across cancers. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696284Z"}
{"comparison_id":"60520e25-5a76-4be0-8411-7ccafe7c91d0","query_id":"53","doc_a_id":"15113221","doc_b_id":"825728","presented_order":["825728","15113221"],"winner_id":"825728","reasoning":"Document A is more relevant — it links epithelial–mesenchymal transition, acquisition of stem-cell properties, and patient survival, which relates to ALDH1 as a stem-cell marker in breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696291Z"}
{"comparison_id":"c4a0435e-f1a8-433a-979e-629e797bb96b","query_id":"53","doc_a_id":"12762485","doc_b_id":"1866911","presented_order":["1866911","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses a stem cell phenotype and associations with markers and poorer features (p53 positivity, ER/PgR negativity, higher proliferation), which is more relevant to a claim about ALDH1 (a stem cell marker) and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696298Z"}
{"comparison_id":"de07e402-9f4f-434e-8a57-af02569375c0","query_id":"53","doc_a_id":"2130391","doc_b_id":"8963413","presented_order":["2130391","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — it discusses biomarker expression and associations with clinical outcomes in cancer (including breast), which relates to the claim about a marker's prognostic significance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696304Z"}
{"comparison_id":"bf6fe7a0-e063-4883-af59-b6e396fd553b","query_id":"53","doc_a_id":"20839751","doc_b_id":"29366489","presented_order":["20839751","29366489"],"winner_id":"20839751","reasoning":"Document A is more relevant — it discusses prognostic markers and outcomes in breast cancer (though not ALDH1 specifically). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696312Z"}
{"comparison_id":"aa8a359d-b3c4-4205-81ad-78701aa078ca","query_id":"53","doc_a_id":"313403","doc_b_id":"4583180","presented_order":["4583180","313403"],"winner_id":"313403","reasoning":"Document B — it directly addresses factors linked to prognosis in breast cancer (though not ALDH1), whereas A discusses SREBP2 and general tumor progression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696320Z"}
{"comparison_id":"c0d5e14c-ac52-4912-9a90-de3e0d9c714d","query_id":"53","doc_a_id":"15832146","doc_b_id":"7583725","presented_order":["7583725","15832146"],"winner_id":"7583725","reasoning":"Document A is more relevant — it links expression of a molecular marker to patient outcomes in breast cancer, matching the prognostic focus of the query. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696326Z"}
{"comparison_id":"02d1d3b1-d5f9-4916-b576-11b9e14fcd70","query_id":"53","doc_a_id":"20839751","doc_b_id":"25973484","presented_order":["25973484","20839751"],"winner_id":"20839751","reasoning":"Reason: Document B discusses prognostic markers and pathological parameters in breast cancer (closer to evaluating a biomarker's prognostic significance) while Document A focuses on obesity-related risk and not marker expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696333Z"}
{"comparison_id":"9bb04f8f-b408-46a9-967f-2bfad23981b3","query_id":"53","doc_a_id":"15946643","doc_b_id":"17648235","presented_order":["15946643","17648235"],"winner_id":"15946643","reasoning":"Document A is more relevant — it addresses chemoresistance and metastasis, which relate to prognosis in breast cancer, whereas Document B focuses on WNT-driven proliferation without prognostic context. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696340Z"}
{"comparison_id":"8d2552b9-6bbb-421b-9d5d-ca8afdb95973","query_id":"53","doc_a_id":"17648235","doc_b_id":"4455466","presented_order":["4455466","17648235"],"winner_id":"4455466","reasoning":"Document A is more relevant because it discusses expression of a specific gene linked to prognosis in breast cancer, whereas Document B focuses on WNT signaling without addressing prognostic marker expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696346Z"}
{"comparison_id":"d3021c3d-90f7-4f32-997c-b694fcec25ab","query_id":"53","doc_a_id":"20183360","doc_b_id":"5649538","presented_order":["5649538","20183360"],"winner_id":"5649538","reasoning":"Document A is more relevant — it addresses genomic markers and clinical outcomes in breast cancer, which is closer to an association between a marker like ALDH1 and prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696352Z"}
{"comparison_id":"c645be2d-a7bc-4f8f-9fa7-02ea862c76af","query_id":"53","doc_a_id":"16086778","doc_b_id":"2931832","presented_order":["16086778","2931832"],"winner_id":"16086778","reasoning":"Document A is more relevant — it addresses molecular markers and pathways in breast cancer prognosis, whereas Document B concerns a platelet-based prognostic metric unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696359Z"}
{"comparison_id":"7e8e0a67-edbf-4e0c-af24-088626c33874","query_id":"53","doc_a_id":"1171121","doc_b_id":"825728","presented_order":["1171121","825728"],"winner_id":"825728","reasoning":"Document B — it discusses cancer stem cell properties and links to patient survival, which is more related to ALDH1's role as a stem-cell marker; Document A focuses on MVD and p53 without relation to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696366Z"}
{"comparison_id":"77a58539-29f9-44df-a195-dc13273063a8","query_id":"53","doc_a_id":"31311495","doc_b_id":"4889228","presented_order":["31311495","4889228"],"winner_id":"4889228","reasoning":"Document B is more relevant — it discusses factors correlated with poor prognosis in triple-negative breast cancer, whereas Document A focuses on tamoxifen resistance and EMT mechanisms without prognosis markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696372Z"}
{"comparison_id":"f0b87791-590b-473e-8031-e84383c8aae4","query_id":"53","doc_a_id":"12762485","doc_b_id":"34066665","presented_order":["34066665","12762485"],"winner_id":"12762485","reasoning":"Document B is more relevant — it addresses stem-cell–like phenotypes in breast cancer (which relate to ALDH1 as a stem cell marker) and links those phenotypes to aggressive features and prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696378Z"}
{"comparison_id":"6997c1fe-9f07-46f6-92ae-c76c9fe4cade","query_id":"53","doc_a_id":"2931832","doc_b_id":"4429932","presented_order":["2931832","4429932"],"winner_id":"2931832","reasoning":"Document A is more relevant — it reports an association between a biomarker and prognosis in breast cancer, which is closer to the query about a prognostic biomarker (ALDH1) than Document B's focus on LOX and metastasis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696385Z"}
{"comparison_id":"48f0761f-666d-4a3d-8508-8936348dc44f","query_id":"53","doc_a_id":"16086778","doc_b_id":"7821634","presented_order":["16086778","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant because it links a molecular marker (DUSP4) to poor outcomes/prognosis in breast cancer, whereas A focuses on Numb/Notch signaling without prognostic data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696391Z"}
{"comparison_id":"c3ef46d7-057f-4699-aa9a-079d296931d7","query_id":"53","doc_a_id":"34066665","doc_b_id":"4889228","presented_order":["4889228","34066665"],"winner_id":"4889228","reasoning":"Document A is more relevant — it directly discusses a protein whose expression correlates with poor prognosis in breast cancer, whereas B focuses on ER/HER signaling and therapy resistance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696398Z"}
{"comparison_id":"92399ec3-a80c-4272-9a21-2bc55918276d","query_id":"53","doc_a_id":"19673227","doc_b_id":"825728","presented_order":["825728","19673227"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT repression, acquisition of stem-cell-like properties, and patient survival (stemness markers like ALDH1 relate to prognosis), whereas Document B focuses on CTC chemosensitivity assays and chemotherapy prediction.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696404Z"}
{"comparison_id":"be0b0be8-4fdf-4dbe-aeb8-62c940ad4d6d","query_id":"53","doc_a_id":"1171121","doc_b_id":"17648235","presented_order":["1171121","17648235"],"winner_id":"1171121","reasoning":"Document A is more focused on prognostic factors in breast cancer (MVD and p53) vs Document B which addresses WNT signaling and cell proliferation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696410Z"}
{"comparison_id":"9d1d0d85-67d1-453e-b6a0-68a92907f315","query_id":"53","doc_a_id":"4583180","doc_b_id":"7821634","presented_order":["4583180","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it discusses markers linked to prognosis in breast cancer (poor outcomes), whereas A focuses on SREBP2 and general tumor progression not ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696416Z"}
{"comparison_id":"03ae7783-fc9f-4ce5-b98e-ed36db24656e","query_id":"53","doc_a_id":"29495185","doc_b_id":"7583725","presented_order":["7583725","29495185"],"winner_id":"7583725","reasoning":"Doc A is more relevant — it reports a specific tumor-marker's expression predicting poor outcomes in breast cancer, matching the claim's focus on marker-associated prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696423Z"}
{"comparison_id":"83787cf4-c850-4c1f-96bf-d8631c102401","query_id":"53","doc_a_id":"24341590","doc_b_id":"4418878","presented_order":["24341590","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant because it addresses gene expression signatures and their link to prognosis in cancers, which relates to assessing ALDH1 expression as a prognostic marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696429Z"}
{"comparison_id":"054754b6-e4a2-4f8c-960f-3a1aaa7f885b","query_id":"53","doc_a_id":"1379127","doc_b_id":"43385013","presented_order":["1379127","43385013"],"winner_id":"43385013","reasoning":"Document B — it addresses stem cell/progenitor properties in breast cell subpopulations (relevant to ALDH1 as a stem-cell marker and prognosis), whereas Document A focuses on calcium channels unrelated to ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696436Z"}
{"comparison_id":"d6a6cccb-d2d3-4140-afd7-ef42a33aaca7","query_id":"53","doc_a_id":"2931832","doc_b_id":"4418878","presented_order":["2931832","4418878"],"winner_id":"4418878","reasoning":"Doc B is more relevant — it discusses gene expression signatures and their links to prognosis, which relates to assessing markers like ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696442Z"}
{"comparison_id":"de7bcb16-9ade-465d-a642-90456a084de5","query_id":"53","doc_a_id":"20127522","doc_b_id":"7583725","presented_order":["20127522","7583725"],"winner_id":"7583725","reasoning":"Document B — it discusses how expression of a specific gene (TRPM7) predicts poor outcomes in breast cancer, which is more directly analogous to the claim about ALDH1 expression and prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696448Z"}
{"comparison_id":"c35fa64e-0765-4b83-bd33-641550d768cc","query_id":"53","doc_a_id":"1171121","doc_b_id":"29495185","presented_order":["29495185","1171121"],"winner_id":"1171121","reasoning":"Neither abstract mentions ALDH1. Document B is slightly more relevant because it reports specific prognostic markers in a breast cancer cohort (closer in scope to the claim) while A is a broad overview. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696455Z"}
{"comparison_id":"625ae6aa-d5af-418e-8418-5b86936f20d9","query_id":"53","doc_a_id":"19673227","doc_b_id":"20183360","presented_order":["19673227","20183360"],"winner_id":"19673227","reasoning":"Document A is more relevant — it discusses prognostic value and disease-free survival, which relates to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696461Z"}
{"comparison_id":"10ddc170-cd57-4dfd-a176-08c5eb3f8a1a","query_id":"53","doc_a_id":"18953920","doc_b_id":"4418878","presented_order":["18953920","4418878"],"winner_id":"18953920","reasoning":"Document A is more relevant — it links EMT to acquisition of stem-cell markers and increased tumorigenic potential in mammary cells (closer to ALDH1 stem-cell marker and prognosis). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696467Z"}
{"comparison_id":"039fb2ec-917b-44f2-9662-9074bc8a7d44","query_id":"53","doc_a_id":"45638119","doc_b_id":"4889228","presented_order":["45638119","4889228"],"winner_id":"45638119","reasoning":"Document A directly states ALDH1 is a marker of mammary stem cells and predicts poor clinical outcome in breast cancer, matching the claim. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696473Z"}
{"comparison_id":"da302e65-ed97-4d29-9a26-0864a03a0115","query_id":"53","doc_a_id":"20127522","doc_b_id":"25973484","presented_order":["25973484","20127522"],"winner_id":"20127522","reasoning":"Document B — it deals with a tumor biomarker (CTCs) linked to prognosis, making it more relevant to a claim about a biomarker (ALDH1) and outcome.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696479Z"}
{"comparison_id":"20e5630a-c6a8-4414-94e3-d1e360ad1a5f","query_id":"53","doc_a_id":"20839751","doc_b_id":"22401720","presented_order":["20839751","22401720"],"winner_id":"22401720","reasoning":"Neither abstract mentions ALDH1; both are irrelevant. If forced to choose, B is slightly more relevant because it discusses expression of tumor markers linked to prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696486Z"}
{"comparison_id":"02447139-74cc-4085-b61a-8ce848780274","query_id":"53","doc_a_id":"12762485","doc_b_id":"4455466","presented_order":["4455466","12762485"],"winner_id":"12762485","reasoning":"Document B is more relevant — it discusses a stem-cell phenotype and its association with poorer prognostic features in breast cancer, which relates to ALDH1 as a stem-cell marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696492Z"}
{"comparison_id":"0fb8f887-77fe-431c-9c54-0a0d2415cbe5","query_id":"53","doc_a_id":"17648235","doc_b_id":"313403","presented_order":["313403","17648235"],"winner_id":"313403","reasoning":"Document A is more relevant — it addresses prognostic markers and links immune infiltration to poorer outcomes in breast cancer, which is closer to the claim about ALDH1 and prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696498Z"}
{"comparison_id":"ed66ad70-95e1-4b64-93be-a92af21e3137","query_id":"53","doc_a_id":"21902400","doc_b_id":"24834968","presented_order":["21902400","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it discusses biological markers in primary breast cancer and their association with treatment response/prognosis, whereas A focuses on tumor hypoxia broadly and not breast cancer markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696505Z"}
{"comparison_id":"64d90284-1394-4b69-9ed1-34dc0838c9ff","query_id":"53","doc_a_id":"27240667","doc_b_id":"4455466","presented_order":["27240667","4455466"],"winner_id":"4455466","reasoning":"Document B — it discusses how expression level of a specific gene is linked to breast cancer prognosis, which is conceptually closer to the ALDH1 expression–prognosis claim than Document A's general mortality trends. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696511Z"}
{"comparison_id":"8701e086-78da-414a-a872-44de481ef49d","query_id":"53","doc_a_id":"20183360","doc_b_id":"21033230","presented_order":["20183360","21033230"],"winner_id":"21033230","reasoning":"Document B — it addresses prognostic markers and survival in breast cancer (clinical association), whereas Document A focuses on GATA3/Smad4 signaling and invasion mechanisms, not prognosis markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696518Z"}
{"comparison_id":"41c84f94-7d62-4d73-943b-373da555c697","query_id":"53","doc_a_id":"27240667","doc_b_id":"29366489","presented_order":["29366489","27240667"],"winner_id":"29366489","reasoning":"Document A — it discusses tumor suppressors and the use of molecular markers for cancer prognosis, which is closer to the claim about a prognostic biomarker than B's focus on mortality trends by ER status and age. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696525Z"}
{"comparison_id":"e427ffdc-223c-457d-b207-63aeafd62610","query_id":"53","doc_a_id":"1866911","doc_b_id":"20183360","presented_order":["20183360","1866911"],"winner_id":"1866911","reasoning":"Document B is more relevant — it addresses breast epithelial progenitor populations and markers linked to tumor origin and prognosis, which relates to ALDH1 as a stem/progenitor marker. Document A focuses on GATA3/Smad4 signaling and invasion, not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696532Z"}
{"comparison_id":"737b0102-44a9-4352-90c2-b27ae5bfb71e","query_id":"53","doc_a_id":"1866911","doc_b_id":"20333864","presented_order":["20333864","1866911"],"winner_id":"1866911","reasoning":"Document B is more relevant — it discusses progenitor cell populations and marker expression linked to tumor behavior, which is closer to ALDH1's role as a stem/progenitor marker and its prognostic implications.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696539Z"}
{"comparison_id":"831369e9-7df5-40bc-856f-f634d99e8ff3","query_id":"53","doc_a_id":"19358586","doc_b_id":"34066665","presented_order":["34066665","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it discusses molecular markers and a protein signature linked to poor survival in breast cancer, which is closer to prognosis-related evidence than Document A's focus on ER/HER signaling and therapy resistance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696545Z"}
{"comparison_id":"4e555a10-dfc8-4207-b12f-f4c890700875","query_id":"53","doc_a_id":"2130391","doc_b_id":"4418878","presented_order":["2130391","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures and their link to prognosis, which pertains to marker expression like ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696552Z"}
{"comparison_id":"07b89671-6b38-40b1-838d-0821a67dfcba","query_id":"53","doc_a_id":"15832146","doc_b_id":"16086778","presented_order":["16086778","15832146"],"winner_id":"16086778","reasoning":"Document A is more relevant — it addresses tumor cell–intrinsic signaling and markers of tumor behavior, closer to a claim about a tumor cell marker's prognostic significance than the stromal/angiogenesis focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696558Z"}
{"comparison_id":"f43a24d7-cb51-456f-ace7-f0c95b12e0d4","query_id":"53","doc_a_id":"17648235","doc_b_id":"5649538","presented_order":["17648235","5649538"],"winner_id":"5649538","reasoning":"B is more relevant — it deals with gene expression markers in breast cancer (potentially including prognostic markers), whereas A focuses on WNT signaling mechanisms unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696565Z"}
{"comparison_id":"12d83027-67a1-4767-859a-c256a92fe90e","query_id":"53","doc_a_id":"2014909","doc_b_id":"20333864","presented_order":["20333864","2014909"],"winner_id":"2014909","reasoning":"Document B — it addresses tumor-initiating cells and primary breast cancers, which is more likely to relate to ALDH1 as a stem-cell/prognostic marker. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696571Z"}
{"comparison_id":"d3c82dc3-76bc-4179-a0ba-b14557c4eef3","query_id":"53","doc_a_id":"20839751","doc_b_id":"29495185","presented_order":["20839751","29495185"],"winner_id":"29495185","reasoning":"B is more relevant — it discusses molecular predictors of prognosis (even if general), while A focuses on apoptosis and not ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696577Z"}
{"comparison_id":"4b544ff2-3b0b-42de-a9c2-c8857d9855a9","query_id":"53","doc_a_id":"15113221","doc_b_id":"21033230","presented_order":["21033230","15113221"],"winner_id":"21033230","reasoning":"Document A is more relevant — it specifically studies molecular markers and prognostic associations in metastatic breast cancer, whereas B addresses PTEN-related signatures across carcinomas generally. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696584Z"}
{"comparison_id":"6a1d6ac9-0108-4888-b06d-b9685c2d60b7","query_id":"53","doc_a_id":"1866911","doc_b_id":"29495185","presented_order":["29495185","1866911"],"winner_id":"1866911","reasoning":"Document B is more relevant — it discusses specific breast cancer cell populations and marker expression related to tumor biology, which is closer to evidence about ALDH1 as a prognostic marker than the general overview in A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696591Z"}
{"comparison_id":"710b28d6-be6c-4d99-b776-543e2d9d16bc","query_id":"53","doc_a_id":"1866911","doc_b_id":"19358586","presented_order":["19358586","1866911"],"winner_id":"1866911","reasoning":"Document B is more relevant — it discusses aberrant luminal progenitor cells and cellular markers linked to breast cancer subtypes and prognosis, which relates to ALDH1 as a stem/progenitor marker. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696597Z"}
{"comparison_id":"be496289-6485-4740-a5f1-ef3d3bf21700","query_id":"53","doc_a_id":"19673227","doc_b_id":"8963413","presented_order":["8963413","19673227"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses expression of a tumor marker and its association with clinical outcomes in breast cancer, whereas Document B focuses on CTC chemosensitivity assays rather than marker expression or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696604Z"}
{"comparison_id":"14f72490-408c-445f-aba9-d812292d2074","query_id":"53","doc_a_id":"22482820","doc_b_id":"7795952","presented_order":["7795952","22482820"],"winner_id":"7795952","reasoning":"Reason: Document A discusses a specific protein's expression being linked to poor cancer prognosis, which is closer to a claim about a biomarker (ALDH1) and prognosis than the therapy-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696611Z"}
{"comparison_id":"6d07c1dd-e568-4c67-9631-60a069228157","query_id":"53","doc_a_id":"20127522","doc_b_id":"2130391","presented_order":["20127522","2130391"],"winner_id":"20127522","reasoning":"Doc A is more relevant — it addresses markers correlated with poorer prognosis in breast cancer (CTC levels and progression-free survival), whereas Doc B focuses on adipocytes and invasion without prognosis markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696618Z"}
{"comparison_id":"56b7eca7-ce0f-4b7a-98ad-1ce7faa44c3c","query_id":"53","doc_a_id":"17648235","doc_b_id":"4418878","presented_order":["4418878","17648235"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and their link to prognosis in cancers, which pertains to markers like ALDH1 and their association with outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696625Z"}
{"comparison_id":"4f80ca2f-1dd2-46a7-96ec-2cf524146115","query_id":"53","doc_a_id":"20127522","doc_b_id":"31311495","presented_order":["31311495","20127522"],"winner_id":"20127522","reasoning":"Document B is more relevant — it addresses a biomarker (CTCs) linked to prognosis in breast cancer, which is conceptually closer to the claim about ALDH1 as a prognostic marker.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696631Z"}
{"comparison_id":"a3253351-de23-4cc6-805c-a13b7c4926dc","query_id":"53","doc_a_id":"4455466","doc_b_id":"7583725","presented_order":["7583725","4455466"],"winner_id":"7583725","reasoning":"Document A is more relevant — it reports that high expression of a marker (TRPM7) predicts poor outcomes in breast cancer, which matches the claim pattern that marker expression (like ALDH1) is linked to poorer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696637Z"}
{"comparison_id":"315ddcde-268c-4761-81cf-a11f50925e56","query_id":"53","doc_a_id":"29495185","doc_b_id":"31311495","presented_order":["31311495","29495185"],"winner_id":"29495185","reasoning":"Document B is more relevant — it addresses molecular predictors of cancer prognosis, while A describes tamoxifen-resistance mechanisms in cell lines and does not discuss ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696644Z"}
{"comparison_id":"2abc2a9f-8f3f-403e-a294-aa9552034008","query_id":"53","doc_a_id":"1866911","doc_b_id":"20127522","presented_order":["1866911","20127522"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses progenitor cell populations and marker expression related to tumor biology, which is closer to ALDH1 as a prognostic marker than CTC enumeration.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696650Z"}
{"comparison_id":"68e69938-79f8-490f-aba8-f7be0b18cca9","query_id":"53","doc_a_id":"20333864","doc_b_id":"4702639","presented_order":["4702639","20333864"],"winner_id":"4702639","reasoning":"Document A — it discusses tumour stemness and stem-cell–related pathways/markers tied to therapy resistance and prognosis, which is more directly related to ALDH1's role as a cancer stem cell marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696656Z"}
{"comparison_id":"97d4f70f-303b-4f0c-973a-58f0f39b9812","query_id":"53","doc_a_id":"1379127","doc_b_id":"20839751","presented_order":["20839751","1379127"],"winner_id":"20839751","reasoning":"Document A is more relevant because it discusses prognostic factors and outcomes in breast cancer, whereas Document B focuses on calcium channels and metastasis unrelated to ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696662Z"}
{"comparison_id":"76e899d5-639b-4003-8756-b8b39217d63c","query_id":"53","doc_a_id":"15946643","doc_b_id":"19358586","presented_order":["15946643","19358586"],"winner_id":"19358586","reasoning":"Document B — it discusses markers/signatures tied to poor survival in breast cancer, which is closer to a prognosis question. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696668Z"}
{"comparison_id":"a450bc0a-bb99-4c20-a52a-12789957e025","query_id":"53","doc_a_id":"25973484","doc_b_id":"313403","presented_order":["25973484","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it addresses prognostic biomarkers in breast cancer (like TAM density predicting poor outcome), whereas A discusses obesity-related risk factors and not biomarkers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696675Z"}
{"comparison_id":"240921f0-a324-4065-82b0-1d2e33d08c55","query_id":"53","doc_a_id":"15946643","doc_b_id":"4418878","presented_order":["15946643","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures and prognosis across cancers, which relates to assessing markers like ALDH1 for prognostic association.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696681Z"}
{"comparison_id":"9dd5b3d3-5534-4c34-8738-a81bf5ee5eb0","query_id":"53","doc_a_id":"24341590","doc_b_id":"825728","presented_order":["825728","24341590"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT, acquisition of stem-cell properties, and patient survival (ALDH1 is a cancer stem cell marker). Document B concerns CYP2D6/tamoxifen and is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696688Z"}
{"comparison_id":"8d56108b-ff99-425b-9785-31394f94f4b6","query_id":"53","doc_a_id":"25732836","doc_b_id":"27240667","presented_order":["27240667","25732836"],"winner_id":"25732836","reasoning":"Document B — it addresses prognostic biomarkers in breast cancer (CTCs and imaging), so it's more related to the claim about a biomarker (ALDH1) and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696694Z"}
{"comparison_id":"042a82f0-7700-42e8-927e-43463dd1b787","query_id":"53","doc_a_id":"20127522","doc_b_id":"21033230","presented_order":["20127522","21033230"],"winner_id":"21033230","reasoning":"Reason: Document B addresses molecular profiling of tumor cells and the prognostic value of expressed markers, which is closer to a claim about a specific marker's (ALDH1) prognostic association than Document A's focus on CTC counts alone.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696700Z"}
{"comparison_id":"15feb827-406e-4a0b-9955-8a03d10b6baf","query_id":"53","doc_a_id":"11484808","doc_b_id":"43385013","presented_order":["43385013","11484808"],"winner_id":"43385013","reasoning":"Document A is more relevant — it discusses stem cell/progenitor properties in breast cell subpopulations (ALDH1 is a stem cell marker), whereas Document B focuses on ncRNAs in endocrine cancers and is less directly related to ALDH1/prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696707Z"}
{"comparison_id":"4496cbff-fd21-4703-a401-6afbe41be68c","query_id":"53","doc_a_id":"7795952","doc_b_id":"8963413","presented_order":["7795952","8963413"],"winner_id":"8963413","reasoning":"Document B — it discusses expression of a tumor biomarker and its association with clinical outcomes in breast cancer, which is more related to the query than Document A (about fascin). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696713Z"}
{"comparison_id":"f3cd8c15-5520-40aa-bbfd-5b82f450cbe3","query_id":"53","doc_a_id":"17648235","doc_b_id":"45638119","presented_order":["17648235","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 as a marker and its correlation with poor prognosis in breast cancer, while Document A focuses on WNT signaling. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696719Z"}
{"comparison_id":"2c9b3070-44e0-4be6-b502-d3b097563ae8","query_id":"53","doc_a_id":"29495185","doc_b_id":"34066665","presented_order":["29495185","34066665"],"winner_id":"29495185","reasoning":"Document A is more relevant because it discusses molecular predictors of cancer prognosis, which relates to biomarkers like ALDH1 and their association with outcomes.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696725Z"}
{"comparison_id":"47ac9518-e639-4526-b361-31f012f26997","query_id":"53","doc_a_id":"2014909","doc_b_id":"22482820","presented_order":["2014909","22482820"],"winner_id":"2014909","reasoning":"Document A is more focused on tumor-initiating cells and analyses of primary breast cancers (ALDH1 is a tumor-initiating cell marker and prognosis biomarker). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696731Z"}
{"comparison_id":"faf94c41-911f-42bc-9006-4be9fe346181","query_id":"53","doc_a_id":"11484808","doc_b_id":"313403","presented_order":["313403","11484808"],"winner_id":"313403","reasoning":"Document A is more relevant — it directly addresses prognostic markers and survival outcomes in breast cancer, whereas B is a broad review of ncRNAs in endocrine cancers and doesn't focus on breast prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696737Z"}
{"comparison_id":"35e46ad6-6403-4e7d-8b98-94f11f57ab62","query_id":"53","doc_a_id":"12762485","doc_b_id":"15832146","presented_order":["15832146","12762485"],"winner_id":"12762485","reasoning":"Document B is more relevant — it discusses stem cell phenotypes in breast cancer (which relate to ALDH1 as a stem cell marker) and their clinical correlations. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696744Z"}
{"comparison_id":"2e9e6fea-9e0c-4f30-a14b-febc2cca914f","query_id":"53","doc_a_id":"21902400","doc_b_id":"4889228","presented_order":["4889228","21902400"],"winner_id":"4889228","reasoning":"Document A is more relevant because it discusses expression of a molecular marker correlated with prognosis specifically in breast cancer, whereas Document B covers hypoxia broadly and does not address ALDH1 or breast-specific prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696750Z"}
{"comparison_id":"3aca1a83-0e19-4e79-bea5-7a329d213694","query_id":"53","doc_a_id":"22401720","doc_b_id":"4889228","presented_order":["4889228","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant — it studies expression of tumor markers and their correlations with prognosis in breast cancer, which is closer to the claim about ALDH1 expression and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696756Z"}
{"comparison_id":"5cf3e29b-e406-41d6-97b0-5abfd94ba3ae","query_id":"53","doc_a_id":"21033230","doc_b_id":"5649538","presented_order":["5649538","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it discusses molecular profiling of tumor cells and links marker expression to survival/prognosis, whereas A focuses on predictors of dasatinib sensitivity.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696762Z"}
{"comparison_id":"78fd40eb-a557-426c-a667-e6476376c49a","query_id":"53","doc_a_id":"20183360","doc_b_id":"21902400","presented_order":["20183360","21902400"],"winner_id":"20183360","reasoning":"Document A is more focused on molecular mechanisms of breast cancer invasion and markers relevant to prognosis, so it's closer to the claim about ALDH1 and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696768Z"}
{"comparison_id":"cb6166ed-e3a1-4135-84a0-332307b55fa1","query_id":"53","doc_a_id":"20333864","doc_b_id":"7795952","presented_order":["20333864","7795952"],"winner_id":"20333864","reasoning":"Document A — it specifically addresses breast carcinoma progression (DCIS to invasive), so it's more directly relevant to prognosis in breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696774Z"}
{"comparison_id":"3daa6e7b-0274-43f3-9fe9-d80c39db1546","query_id":"53","doc_a_id":"15113221","doc_b_id":"29366489","presented_order":["29366489","15113221"],"winner_id":"15113221","reasoning":"Document B — it discusses a gene expression signature linked to poor prognosis in carcinomas, which is more related to the claim about expression markers (like ALDH1) and prognosis than Document A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696781Z"}
{"comparison_id":"543db0a5-5b7f-4e05-829e-3ce6e8f696a3","query_id":"53","doc_a_id":"18953920","doc_b_id":"7795952","presented_order":["7795952","18953920"],"winner_id":"18953920","reasoning":"Document B is more relevant — it links EMT to acquisition of stem-cell markers (like ALDH1) and increased tumorigenic potential in mammary epithelial cells, which relates to prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696787Z"}
{"comparison_id":"3b2db768-eb39-4377-80e2-95f3e847c02e","query_id":"53","doc_a_id":"34066665","doc_b_id":"43385013","presented_order":["43385013","34066665"],"winner_id":"43385013","reasoning":"Document A is more relevant — it addresses stem cell/progenitor properties in breast cell subpopulations (ALDH1 is a stem cell marker), whereas B focuses on ER/HER signaling and endocrine resistance, not ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696794Z"}
{"comparison_id":"2ea33cbe-4d74-46e7-8781-2dacd918f973","query_id":"53","doc_a_id":"24834968","doc_b_id":"4702639","presented_order":["24834968","4702639"],"winner_id":"24834968","reasoning":"Document A is more relevant — it concerns biomarkers and prognosis/response in primary breast cancer, whereas B focuses on an integrin–KRAS pathway and drug resistance not specific to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696800Z"}
{"comparison_id":"cf25ecf6-a26c-4343-99e2-f2948a25dfee","query_id":"53","doc_a_id":"15832146","doc_b_id":"313403","presented_order":["313403","15832146"],"winner_id":"313403","reasoning":"Document A is more relevant — it directly addresses factors predicting poor prognosis in breast cancer (clinical outcomes), whereas Document B focuses on fibroblast-mediated tumor growth mechanisms without prognosis data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696807Z"}
{"comparison_id":"cb1190aa-f0d4-4e8c-8dfa-7138b112d946","query_id":"53","doc_a_id":"2931832","doc_b_id":"4583180","presented_order":["2931832","4583180"],"winner_id":"2931832","reasoning":"Document A is about a prognostic biomarker in breast cancer (closer to the claim), while Document B addresses SREBP2 and tumor progression broadly. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696813Z"}
{"comparison_id":"9cacce6e-002f-4583-b588-14bb729e193c","query_id":"53","doc_a_id":"16086778","doc_b_id":"45638119","presented_order":["16086778","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 as a marker and predictor of poor prognosis in breast cancer, while Document A addresses Numb/Notch and is unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696819Z"}
{"comparison_id":"d5951e89-a47d-476e-b2a7-d6aa0c48337d","query_id":"53","doc_a_id":"17648235","doc_b_id":"21902400","presented_order":["17648235","21902400"],"winner_id":"21902400","reasoning":"Document B — it discusses prognostic indicators and factors affecting prognosis in tumors, which is more related to a claim about a marker (ALDH1) and prognosis than Document A's focus on WNT signaling. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696826Z"}
{"comparison_id":"518cf948-0751-41a5-bcce-093e98c6e66a","query_id":"53","doc_a_id":"20183360","doc_b_id":"8963413","presented_order":["8963413","20183360"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses expression of a biomarker and its association with clinical outcomes in breast cancer, which is the topic of the claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696832Z"}
{"comparison_id":"acba661c-a5f6-43e7-9d30-7496beb9b2a3","query_id":"53","doc_a_id":"45638119","doc_b_id":"4702639","presented_order":["45638119","4702639"],"winner_id":"45638119","reasoning":"Document A directly states that ALDH1 is a marker of mammary stem cells and predicts poor clinical outcome in breast cancer; Document B discusses integrin αvβ3 and is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696839Z"}
{"comparison_id":"95483563-b9f5-45e4-b7fe-28570e7445c5","query_id":"53","doc_a_id":"24834968","doc_b_id":"45638119","presented_order":["45638119","24834968"],"winner_id":"45638119","reasoning":"Document A directly reports that ALDH1 marks malignant mammary stem cells and predicts poor clinical outcome in breast cancer, while Document B does not discuss ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696845Z"}
{"comparison_id":"94847e89-ead8-4b87-8a16-b16b9f7c0f40","query_id":"53","doc_a_id":"22482820","doc_b_id":"4429932","presented_order":["4429932","22482820"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses factors associated with poor patient outcomes in breast cancer (though not ALDH1 specifically), while Document B focuses on treatment strategies without addressing prognosis markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696851Z"}
{"comparison_id":"4a295335-61c7-4192-a5eb-756b27d21785","query_id":"53","doc_a_id":"2014909","doc_b_id":"24834968","presented_order":["2014909","24834968"],"winner_id":"2014909","reasoning":"Document A is more relevant — it analyzes tumor-initiating cells and primary breast cancers (more likely to address stem-cell markers like ALDH1), whereas Document B focuses on HER-2/neu and chemo response without ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696858Z"}
{"comparison_id":"da8de1ae-5c9b-4523-afdf-359bbd23d8de","query_id":"53","doc_a_id":"11484808","doc_b_id":"21902400","presented_order":["21902400","11484808"],"winner_id":"21902400","reasoning":"Document A is more relevant — it discusses prognostic markers and clinical outcomes in cancer, which relates to claims about markers like ALDH1 and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696864Z"}
{"comparison_id":"ddbcf937-116b-4ddc-9162-a71d77b04f1b","query_id":"53","doc_a_id":"20183360","doc_b_id":"825728","presented_order":["20183360","825728"],"winner_id":"825728","reasoning":"Document B — it discusses EMT, acquisition of stem-cell properties, and links to patient survival/metastasis, which is more relevant to ALDH1 (a cancer stem-cell marker associated with prognosis). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696871Z"}
{"comparison_id":"3226263d-8868-4982-b6ca-232100bf3739","query_id":"53","doc_a_id":"2931832","doc_b_id":"45638119","presented_order":["45638119","2931832"],"winner_id":"45638119","reasoning":"Document A is directly about ALDH1 as a marker and predictor of poor clinical outcome in breast cancer, matching the claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696878Z"}
{"comparison_id":"60a3d6b6-f475-4b15-a39f-2994033452cf","query_id":"53","doc_a_id":"20127522","doc_b_id":"22401720","presented_order":["22401720","20127522"],"winner_id":"22401720","reasoning":"Document A is more relevant — it examines tumor marker expression and links high expression of a specific protein (VEGF) to poor prognosis, which is closer to the claim about ALDH1 expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696884Z"}
{"comparison_id":"4a831b4a-7b4b-474f-9ae2-80104d5ce8bb","query_id":"53","doc_a_id":"18953920","doc_b_id":"20333864","presented_order":["20333864","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses EMT producing cells with stem-cell markers (like ALDH1) and increased tumorigenic potential, which relates to prognosis. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696891Z"}
{"comparison_id":"652bb07b-f67d-4190-bf34-47b71242f568","query_id":"53","doc_a_id":"19358586","doc_b_id":"3285322","presented_order":["19358586","3285322"],"winner_id":"19358586","reasoning":"Document A — it directly discusses protein-expression signatures linked to poor survival in breast cancer, whereas B focuses on BRCA mutation clinical features and not marker expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696897Z"}
{"comparison_id":"0e5096ce-f08e-46da-aedc-a68fb4fa2e32","query_id":"53","doc_a_id":"19673227","doc_b_id":"25732836","presented_order":["25732836","19673227"],"winner_id":"25732836","reasoning":"Document A is more directly about prognostic markers and outcomes in metastatic breast cancer, so it's more relevant to a claim about ALDH1 and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696903Z"}
{"comparison_id":"bc3cdf15-a78f-4b1f-a2ba-62e7c8517bdf","query_id":"53","doc_a_id":"1866911","doc_b_id":"5649538","presented_order":["1866911","5649538"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses breast epithelial cell populations and markers related to tumor origin, which is closer to ALDH1 as a cancer stem/progenitor marker than a study on dasatinib predictors. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696910Z"}
{"comparison_id":"6e3dd3d6-1197-47ab-ae96-c04ccef0f5f3","query_id":"53","doc_a_id":"16086778","doc_b_id":"5649538","presented_order":["5649538","16086778"],"winner_id":"5649538","reasoning":"Document A is more relevant — it deals with gene expression markers in breast cancer (potentially relating to prognostic markers), whereas Document B focuses on Numb/Notch signaling not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696916Z"}
{"comparison_id":"5aed47dc-cc96-4aed-81df-e066685604f4","query_id":"53","doc_a_id":"4418878","doc_b_id":"5649538","presented_order":["4418878","5649538"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures tied to cancer prognosis, which aligns with evaluating ALDH1 expression as a prognostic marker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696922Z"}
{"comparison_id":"73bcd2cc-51ae-4078-b60d-a4123d382bb7","query_id":"53","doc_a_id":"19358586","doc_b_id":"4418878","presented_order":["4418878","19358586"],"winner_id":"4418878","reasoning":"Reason: Document A discusses gene expression signatures and their association with prognosis in cancers, making it more relevant to a claim about a specific marker's prognostic association than Document B, which focuses on a different protein/miRNA signature.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696929Z"}
{"comparison_id":"4fdb310e-c683-410d-9c38-62ba1e557b7c","query_id":"53","doc_a_id":"1379127","doc_b_id":"4429932","presented_order":["1379127","4429932"],"winner_id":"4429932","reasoning":"Document B is more relevant — it discusses a molecular factor (LOX) tied to poor patient outcomes in breast cancer, which is conceptually closer to a claim about a marker (ALDH1) and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696935Z"}
{"comparison_id":"573c394b-6c63-4915-b7f4-000875e8d1e7","query_id":"53","doc_a_id":"15946643","doc_b_id":"45638119","presented_order":["15946643","45638119"],"winner_id":"45638119","reasoning":"Document B — it explicitly reports that ALDH1 marks mammary stem cells and predicts poor clinical outcome in breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696941Z"}
{"comparison_id":"bb08213b-dfb0-4482-ac84-8918bade6b83","query_id":"53","doc_a_id":"18953920","doc_b_id":"3285322","presented_order":["18953920","3285322"],"winner_id":"18953920","reasoning":"Document A is more relevant — it links EMT to acquisition of stem-cell markers (like ALDH1) and increased tumorigenicity, which bears on prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696947Z"}
{"comparison_id":"b7bf177e-5b7c-47ca-af0d-2c95279e8d3e","query_id":"53","doc_a_id":"15832146","doc_b_id":"20333864","presented_order":["20333864","15832146"],"winner_id":"20333864","reasoning":"Neither abstract mentions ALDH1. Both are largely unrelated to ALDH1-prognosis associations, but Document A (discussing factors controlling progression from in situ to invasive carcinoma) is slightly more relevant to prognosis than Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696953Z"}
{"comparison_id":"87056f98-c9a6-496e-9044-0cc792d6a401","query_id":"53","doc_a_id":"19358586","doc_b_id":"2130391","presented_order":["19358586","2130391"],"winner_id":"19358586","reasoning":"Document A is more relevant — it discusses protein signatures linked to poor survival in breast cancer, whereas Document B focuses on adipocyte-driven invasion and not prognostic markers like ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696960Z"}
{"comparison_id":"b5c047cc-af43-4bc9-854b-c58f0ad47d6d","query_id":"53","doc_a_id":"20127522","doc_b_id":"24834968","presented_order":["20127522","24834968"],"winner_id":"20127522","reasoning":"Document A is more relevant — it discusses a marker (CTC levels) associated with poorer progression-free survival in breast cancer, which is directly related to prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696966Z"}
{"comparison_id":"3106f8da-df3f-45b3-bfc2-801ff502a61a","query_id":"53","doc_a_id":"1171121","doc_b_id":"20183360","presented_order":["20183360","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it studies prognostic factors in breast cancer, while A focuses on GATA3/Smad4 signaling and invasion and does not address ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696972Z"}
{"comparison_id":"f01378fc-1d77-45ba-badb-beca590aba5d","query_id":"53","doc_a_id":"20183360","doc_b_id":"4455466","presented_order":["20183360","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it discusses how expression levels of a gene correlate with prognosis in breast cancer, which is the same type of biomarker–prognosis association as the query. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696978Z"}
{"comparison_id":"1205ed1f-cf8c-4808-91c7-48cf7dd132f6","query_id":"53","doc_a_id":"2014909","doc_b_id":"7821634","presented_order":["2014909","7821634"],"winner_id":"2014909","reasoning":"Document A is more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers (where ALDH1 is a known stem-cell/tumor-initiating marker), whereas Document B focuses on DUSP4 and chemotherapy resistance without mentioning ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.696985Z"}
{"comparison_id":"a0866ebf-b26c-4280-a41a-96ad68fe9cd2","query_id":"53","doc_a_id":"18953920","doc_b_id":"29366489","presented_order":["29366489","18953920"],"winner_id":"18953920","reasoning":"Document B — it links EMT to acquisition of stem-cell markers and increased tumorigenic potential in mammary cells, which is relevant to ALDH1 as a breast cancer stem-cell marker associated with poor prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697010Z"}
{"comparison_id":"8d201267-94b1-4f27-8d0b-1d00a3321862","query_id":"53","doc_a_id":"20333864","doc_b_id":"27240667","presented_order":["27240667","20333864"],"winner_id":"27240667","reasoning":"Document A is more relevant — it deals with breast cancer prognosis/mortality trends, whereas Document B focuses on cellular mechanisms of invasion and does not address prognosis markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697023Z"}
{"comparison_id":"dfa20d0d-e82b-413a-a120-8a9da3a6ce06","query_id":"53","doc_a_id":"15113221","doc_b_id":"4889228","presented_order":["15113221","4889228"],"winner_id":"4889228","reasoning":"Reason: Document B specifically addresses factors linked to prognosis in triple-negative breast cancer, while Document A discusses PTEN-related signatures in carcinomas generally and is less directly about breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697032Z"}
{"comparison_id":"b237fe15-f018-45e2-ae4c-c124eaef77df","query_id":"53","doc_a_id":"21902400","doc_b_id":"4702639","presented_order":["4702639","21902400"],"winner_id":"4702639","reasoning":"Document A is more relevant — it discusses markers and drivers of tumor stemness (like cancer stem cell markers) and prognosis/therapy resistance, which is conceptually closer to ALDH1's role as a stem-cell marker linked to poor breast cancer outcome.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697040Z"}
{"comparison_id":"76984075-5191-48cd-9dd0-ea29c54d9809","query_id":"53","doc_a_id":"16086778","doc_b_id":"27240667","presented_order":["27240667","16086778"],"winner_id":"16086778","reasoning":"Document B — it discusses a specific molecular mechanism relevant to breast cancer biology and prognosis, whereas A covers broad mortality trends by ER status and age. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697047Z"}
{"comparison_id":"2fcef616-9b47-41ba-8930-c8e05508bb6b","query_id":"53","doc_a_id":"20839751","doc_b_id":"4418878","presented_order":["20839751","4418878"],"winner_id":"20839751","reasoning":"Document A is more directly about prognostic factors in breast cancer (even though it doesn't mention ALDH1), while Document B is a general methods paper on pathway signatures. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697053Z"}
{"comparison_id":"79a6e059-d2b1-492c-a4da-22e7cc5c75fd","query_id":"53","doc_a_id":"21902400","doc_b_id":"4418878","presented_order":["4418878","21902400"],"winner_id":"4418878","reasoning":"Document A — it discusses gene expression signatures and their links to prognosis in cancers, which is directly relevant to ALDH1 expression as a prognostic marker. Document B focuses on hypoxia, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697060Z"}
{"comparison_id":"5734bb45-c9ac-477b-9923-074ee28ec823","query_id":"53","doc_a_id":"29366489","doc_b_id":"4702639","presented_order":["29366489","4702639"],"winner_id":"4702639","reasoning":"Document B — it discusses tumor stemness markers and therapy resistance (closer to ALDH1's role as a stem-cell/prognostic marker) while Document A is about DLC-1 tumor suppression unrelated to ALDH1 or prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697067Z"}
{"comparison_id":"c7e84bcb-a5d4-440f-aca3-0732ca0fa59d","query_id":"53","doc_a_id":"25973484","doc_b_id":"7795952","presented_order":["7795952","25973484"],"winner_id":"25973484","reasoning":"Document B is more relevant — it discusses breast cancer prognosis factors (though it doesn't mention ALDH1), whereas A focuses on fascin and TGFβ in tumor cells. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697073Z"}
{"comparison_id":"ab171784-afa3-486c-bc94-d2149f8dd7ae","query_id":"53","doc_a_id":"24834968","doc_b_id":"7795952","presented_order":["24834968","7795952"],"winner_id":"24834968","reasoning":"Document A is more relevant — it discusses biological markers and prognosis/response in breast cancer (whereas B focuses on fascin/TGFβ in tumor invasion but not breast cancer markers).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697080Z"}
{"comparison_id":"d88a7382-0f2b-440d-adc0-dcbbe1720c90","query_id":"53","doc_a_id":"18953920","doc_b_id":"4455466","presented_order":["18953920","4455466"],"winner_id":"18953920","reasoning":"Document A — it links acquisition of stem-cell markers in mammary cells (which includes markers like ALDH1) to increased tumorigenicity, whereas Document B discusses a different gene (ZMYND11) and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697086Z"}
{"comparison_id":"a463c1f6-429e-4ace-a98f-fce7a58f6e7d","query_id":"53","doc_a_id":"22401720","doc_b_id":"27240667","presented_order":["27240667","22401720"],"winner_id":"22401720","reasoning":"Document B — it discusses tumor marker expression and links high expression of a marker (VEGF) to poor prognosis; Document A addresses mortality trends by ER status/age and not molecular marker expression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697094Z"}
{"comparison_id":"2be5b905-5921-4e46-a64d-46e9457d78e3","query_id":"53","doc_a_id":"5649538","doc_b_id":"825728","presented_order":["5649538","825728"],"winner_id":"825728","reasoning":"Document B — it addresses EMT, cancer stem-cell properties and links to patient survival, which is more relevant to prognosis and stem-cell markers like ALDH1 than a drug-sensitivity predictor study. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697101Z"}
{"comparison_id":"f170bf92-3b94-4356-834e-353d2b2f1cb1","query_id":"53","doc_a_id":"1379127","doc_b_id":"15946643","presented_order":["15946643","1379127"],"winner_id":"15946643","reasoning":"Document A is more relevant — it addresses chemoresistance and metastatic networks (closely tied to prognostic markers like ALDH1), whereas B focuses on calcium channels and cell migration without linking to prognosis or biomarkers. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697108Z"}
{"comparison_id":"ebbfedf7-a72e-4a80-bdc7-6865d0a61ff4","query_id":"53","doc_a_id":"15113221","doc_b_id":"18953920","presented_order":["18953920","15113221"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses acquisition of stem-cell markers and increased tumorigenic potential in mammary epithelial cells, which relates to ALDH1 as a breast cancer stem-cell marker and prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697115Z"}
{"comparison_id":"cff50c8e-01bb-40f1-a2ca-6282a701cedf","query_id":"53","doc_a_id":"2130391","doc_b_id":"3285322","presented_order":["3285322","2130391"],"winner_id":"3285322","reasoning":"Doc A — it discusses clinical/pathologic features and prognosis-related differences in breast cancer (grade, subtype, treatment response), which is more directly related to prognostic markers than the adipocyte/invasion focus of Doc B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697121Z"}
{"comparison_id":"fcb9469e-b420-4899-b119-277ecd55a125","query_id":"53","doc_a_id":"11484808","doc_b_id":"825728","presented_order":["11484808","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it links EMT, acquisition of stem-cell properties, and patient survival/metastasis (topics closely related to ALDH1 as a stemness/prognostic marker).  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697128Z"}
{"comparison_id":"567dc3fc-4a8d-4251-bf91-0a551fe72086","query_id":"53","doc_a_id":"19673227","doc_b_id":"24834968","presented_order":["19673227","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it specifically evaluates biological markers in primary breast cancer, whereas A discusses a general chemosensitivity assay across epithelial tumors without focus on breast cancer markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697135Z"}
{"comparison_id":"1a92e922-4dfb-44ed-aa89-3f4b657d90b6","query_id":"53","doc_a_id":"20183360","doc_b_id":"313403","presented_order":["20183360","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it addresses factors linked to prognosis in breast cancer (unfavorable clinical outcome), whereas A focuses on molecular regulation of invasion without prognostic association.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697141Z"}
{"comparison_id":"aea276e6-541a-468d-ae3e-3c0ec7f0b2a6","query_id":"53","doc_a_id":"27240667","doc_b_id":"43385013","presented_order":["27240667","43385013"],"winner_id":"43385013","reasoning":"Document B — it addresses epithelial/mesenchymal subpopulations and stem/progenitor properties (relevant to ALDH1 as a stem cell marker), while A discusses mortality by ER status and age and does not mention ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697148Z"}
{"comparison_id":"83867594-7e62-47f4-a4a9-d108e759f572","query_id":"53","doc_a_id":"17648235","doc_b_id":"8963413","presented_order":["17648235","8963413"],"winner_id":"8963413","reasoning":"Document B — it discusses biomarker expression and clinical outcomes in cancers (including breast), which is directly relevant to a claim about a marker's association with prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697154Z"}
{"comparison_id":"ab5d82f4-a13d-4b8b-ab1d-dcb76dc26400","query_id":"53","doc_a_id":"15113221","doc_b_id":"4702639","presented_order":["15113221","4702639"],"winner_id":"4702639","reasoning":"B — Document B discusses tumor stemness and markers/drivers of stem-like properties (which ALDH1 is a known cancer stem cell marker), so it's more closely related to ALDH1's prognostic role than Document A's PTEN-focused signature. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697161Z"}
{"comparison_id":"c4ca3fce-17f4-48aa-9200-4e3a022ee683","query_id":"53","doc_a_id":"12762485","doc_b_id":"4583180","presented_order":["4583180","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses stem-cell–like phenotypes in breast cancer (linked to worse/proliferative features), which relates to ALDH1 as a stem cell marker; Document A is unrelated. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697167Z"}
{"comparison_id":"8745fd64-ce57-4e5b-9571-2710d31cfb9e","query_id":"53","doc_a_id":"20127522","doc_b_id":"8963413","presented_order":["8963413","20127522"],"winner_id":"20127522","reasoning":"Reason: Document B discusses a biomarker (CTCs) linked to poorer prognosis in breast cancer, which is more directly related to the query about a prognostic biomarker. Document A focuses on PD-L1 and not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697173Z"}
{"comparison_id":"d2485c9f-573f-4571-8baf-148a0d51cbad","query_id":"53","doc_a_id":"21902400","doc_b_id":"2931832","presented_order":["21902400","2931832"],"winner_id":"2931832","reasoning":"Document B — it directly studies prognostic biomarkers in breast cancer, whereas Document A discusses hypoxia generally and is less specific to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697179Z"}
{"comparison_id":"afe6bd05-407b-4214-9822-94d59875db7f","query_id":"53","doc_a_id":"11484808","doc_b_id":"25732836","presented_order":["11484808","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant — it directly studies prognostic markers in breast cancer, whereas Document A focuses on non-coding RNAs in endocrine cancers and is less likely to address ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697186Z"}
{"comparison_id":"f95dce8b-155f-4da6-a6e5-71230c24a23a","query_id":"53","doc_a_id":"17648235","doc_b_id":"7795952","presented_order":["17648235","7795952"],"winner_id":"7795952","reasoning":"Document B is more relevant — it discusses a protein (fascin) linked to poor cancer prognosis, whereas Document A focuses on WNT signaling without prognosis markers like ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697192Z"}
{"comparison_id":"13b17021-38b8-4912-b342-fb0e12f282ff","query_id":"53","doc_a_id":"21033230","doc_b_id":"2931832","presented_order":["21033230","2931832"],"winner_id":"21033230","reasoning":"Document A is more relevant — it discusses molecular marker profiling in breast cancer and prognostic associations, whereas Document B addresses platelet indices unrelated to ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697199Z"}
{"comparison_id":"b2a2ef01-baeb-481a-b9ed-17c573162f23","query_id":"53","doc_a_id":"313403","doc_b_id":"34066665","presented_order":["34066665","313403"],"winner_id":"313403","reasoning":"Document B — it investigates a biomarker (TAM infiltration) tied to prognosis in breast cancer, which is more directly relevant to a claim about ALDH1 as a prognostic marker than Document A's focus on ER/HER signaling and therapy resistance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697205Z"}
{"comparison_id":"521f07b5-4e36-46ea-9dfd-665f337821ad","query_id":"53","doc_a_id":"19673227","doc_b_id":"27240667","presented_order":["19673227","27240667"],"winner_id":"19673227","reasoning":"Document A is more relevant — it addresses prognostic biomarkers and survival outcomes (chemosensitivity of circulating tumor cells), which relates to associations between marker expression and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697212Z"}
{"comparison_id":"5d849b03-8801-4c6a-92cc-27d338729dbe","query_id":"53","doc_a_id":"2014909","doc_b_id":"21902400","presented_order":["2014909","21902400"],"winner_id":"2014909","reasoning":"Document A is more relevant — it discusses tumor-initiating cells in primary breast cancers (ALDH1 is a marker of such cells), whereas Document B discusses hypoxia broadly and doesn't address ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697219Z"}
{"comparison_id":"cadfc8dd-3589-4d11-8fc3-0819e342cb54","query_id":"53","doc_a_id":"31311495","doc_b_id":"4583180","presented_order":["4583180","31311495"],"winner_id":"31311495","reasoning":"Reason: Neither abstract mentions ALDH1, but Document B specifically concerns breast cancer cell behavior and factors tied to aggressiveness/prognosis, so it's slightly more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697225Z"}
{"comparison_id":"f9a3a464-4207-4120-b80b-a17403c33ef1","query_id":"53","doc_a_id":"16086778","doc_b_id":"29366489","presented_order":["16086778","29366489"],"winner_id":"16086778","reasoning":"Document A is more relevant because it specifically addresses mechanisms in breast cancer, whereas Document B discusses a tumor suppressor in other cancers without breast-specific focus. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697231Z"}
{"comparison_id":"b3b4d29b-b22b-45e7-89b2-947f899dadf4","query_id":"53","doc_a_id":"12762485","doc_b_id":"313403","presented_order":["313403","12762485"],"winner_id":"12762485","reasoning":"Document B is more relevant — it discusses a stem-cell phenotype in breast cancer (linked to poorer features like higher proliferation and ER/PgR negativity), which is conceptually related to ALDH1 as a stem-cell marker. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697237Z"}
{"comparison_id":"8bc7bfa6-d7a4-428e-9c4a-ebe98017f4dc","query_id":"53","doc_a_id":"20127522","doc_b_id":"2014909","presented_order":["20127522","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — although neither abstract mentions ALDH1 explicitly, B discusses tumor-initiating cells and analyses of primary breast cancers (closer to ALDH1's role as a cancer stem-cell marker and prognosis) while A only addresses circulating tumor cells. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697244Z"}
{"comparison_id":"8ea8e2c8-ca50-4039-96bb-aa5354a06f51","query_id":"53","doc_a_id":"20183360","doc_b_id":"7821634","presented_order":["7821634","20183360"],"winner_id":"7821634","reasoning":"Document A — it discusses correlations with poor outcomes in breast cancer (prognosis), whereas Document B focuses on molecular regulation of invasion without linking to prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697250Z"}
{"comparison_id":"a411724c-b85b-48f2-9c47-322b9b9a5103","query_id":"53","doc_a_id":"2014909","doc_b_id":"825728","presented_order":["825728","2014909"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT/stem-cell properties to patient survival and metastasis (ALDH1 is a stem-cell marker), whereas B focuses on mTOR and immune recruitment not ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697257Z"}
{"comparison_id":"8e646329-d40e-4385-84a4-5c51c2a60b6d","query_id":"53","doc_a_id":"25973484","doc_b_id":"7583725","presented_order":["25973484","7583725"],"winner_id":"7583725","reasoning":"B is more relevant — it links expression of a specific protein to poor breast cancer outcomes, matching the claim's focus on marker expression and prognosis.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697263Z"}
{"comparison_id":"ac80932c-2fe7-48cd-994b-dcdcce772ebf","query_id":"53","doc_a_id":"1171121","doc_b_id":"4583180","presented_order":["1171121","4583180"],"winner_id":"1171121","reasoning":"Document A is more relevant because it discusses prognostic factors in breast cancer, whereas Document B addresses SREBP2 and tumor metabolism without linking to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697270Z"}
{"comparison_id":"e31e670b-95cb-443a-be54-fc554d517e6f","query_id":"53","doc_a_id":"1866911","doc_b_id":"29366489","presented_order":["1866911","29366489"],"winner_id":"1866911","reasoning":"Reason: Document A addresses breast cancer biology directly (cell populations linked to tumor types), while Document B discusses a general tumor suppressor across cancers and does not focus on breast cancer. Neither mentions ALDH1, but A is more relevant to the breast cancer prognosis context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697276Z"}
{"comparison_id":"019df19b-2837-4e50-976c-1cdd927b1b54","query_id":"53","doc_a_id":"4889228","doc_b_id":"7821634","presented_order":["4889228","7821634"],"winner_id":"7821634","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it deals with treatment resistance and poor outcomes in residual/basal-like breast cancer—topics more closely related to ALDH1's reported role in prognosis than the splicing-factor focus of A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697283Z"}
{"comparison_id":"9ef3cb7e-07e0-4d83-8bab-66dc64107de1","query_id":"53","doc_a_id":"4418878","doc_b_id":"7821634","presented_order":["4418878","7821634"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and their association with cancer prognosis, which is closer to the ALDH1 prognostic claim than the DUSP4/drug-resistance focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697290Z"}
{"comparison_id":"e4a4df47-6a4f-4d0d-973b-2685dbbbe922","query_id":"53","doc_a_id":"20183360","doc_b_id":"4583180","presented_order":["20183360","4583180"],"winner_id":"20183360","reasoning":"Document A is more relevant because it specifically addresses mechanisms in breast cancer, while Document B discusses general tumor progression without breast-specific or ALDH1 information.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697296Z"}
{"comparison_id":"ea0a6804-9428-4b0f-9137-e8cd26d1b97b","query_id":"53","doc_a_id":"19358586","doc_b_id":"31311495","presented_order":["31311495","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it discusses molecular markers linked to poor survival in breast cancer, which is closer to prognosis-related evidence than Document A's focus on tamoxifen resistance mechanisms.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697303Z"}
{"comparison_id":"6b3e7984-a407-44a3-98c2-fde4724218a2","query_id":"53","doc_a_id":"2130391","doc_b_id":"29495185","presented_order":["2130391","29495185"],"winner_id":"29495185","reasoning":"Reason: Document B discusses molecular predictors of cancer prognosis, which is directly relevant to a biomarker association like ALDH1 and breast cancer; Document A focuses on adipocytes and invasion, not ALDH1 or prognostic markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697309Z"}
{"comparison_id":"20375632-062f-405a-9362-b502f94f9a5b","query_id":"53","doc_a_id":"2130391","doc_b_id":"21902400","presented_order":["2130391","21902400"],"winner_id":"2130391","reasoning":"Document A — discusses breast cancer tumor microenvironment and progression, making it more directly relevant to a claim about a breast cancer prognostic marker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697316Z"}
{"comparison_id":"3362d5c0-31a9-4ee4-9470-25aa5ed75ca8","query_id":"53","doc_a_id":"1379127","doc_b_id":"18953920","presented_order":["18953920","1379127"],"winner_id":"18953920","reasoning":"Document A is more relevant — it links EMT to acquisition of stem-cell markers (like ALDH1) and increased tumorigenic potential, which relates to ALDH1's association with poor prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697366Z"}
{"comparison_id":"f8ea87d6-5841-49ca-9fc2-6b56d2920dbd","query_id":"53","doc_a_id":"20839751","doc_b_id":"24834968","presented_order":["24834968","20839751"],"winner_id":"20839751","reasoning":"Document B is more relevant — it discusses associations between a biological marker (apoptotic index) and prognosis in breast cancer, whereas Document A focuses on HER-2/neu and chemotherapy response.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697373Z"}
{"comparison_id":"69ce4e37-df67-4ab7-a391-c77d570cfbae","query_id":"53","doc_a_id":"24341590","doc_b_id":"4429932","presented_order":["4429932","24341590"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses a marker (LOX) linked to poor outcomes in breast cancer, whereas Document B focuses on CYP2D6 and tamoxifen response, not prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697381Z"}
{"comparison_id":"cc7f8d9c-6fbf-4d56-92ff-5e77a3e4bc89","query_id":"53","doc_a_id":"1171121","doc_b_id":"4418878","presented_order":["1171121","4418878"],"winner_id":"4418878","reasoning":"Document B — it discusses gene expression signatures and prognosis in cancers, which is more directly related to biomarker prognostic associations than Document A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697387Z"}
{"comparison_id":"983ca484-a610-4478-b60e-4b27dcd4a8c2","query_id":"53","doc_a_id":"1379127","doc_b_id":"4583180","presented_order":["4583180","1379127"],"winner_id":"1379127","reasoning":"Document B is more relevant — it specifically addresses breast tumor cell behavior (migration/metastasis), which is directly related to prognosis, whereas Document A is a general tumor progression study not specific to breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697394Z"}
{"comparison_id":"c25b0063-c0ca-48ee-9694-81dabe5f87fe","query_id":"53","doc_a_id":"1866911","doc_b_id":"21902400","presented_order":["21902400","1866911"],"winner_id":"1866911","reasoning":"Document B — it discusses breast epithelial progenitor populations and cellular markers related to breast cancer biology, so it's more closely related to ALDH1 (a stem/progenitor marker) than the hypoxia-focused Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697401Z"}
{"comparison_id":"a9cf6afc-6485-4e72-8da4-d7fd466ef38a","query_id":"53","doc_a_id":"2130391","doc_b_id":"45638119","presented_order":["45638119","2130391"],"winner_id":"45638119","reasoning":"Document A directly reports that ALDH1 is a marker and predictor of poor clinical outcome in breast cancer, matching the claim. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697407Z"}
{"comparison_id":"e06c5273-ef67-412d-bb89-c2087a36305f","query_id":"53","doc_a_id":"15832146","doc_b_id":"29366489","presented_order":["29366489","15832146"],"winner_id":"15832146","reasoning":"Document B is more relevant — it concerns mechanisms in invasive human breast carcinomas, while Document A discusses DLC-1 in various cancers but not breast-specific prognosis markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697414Z"}
{"comparison_id":"f96712df-2c8a-4562-85a7-8d59264da058","query_id":"53","doc_a_id":"17648235","doc_b_id":"2931832","presented_order":["17648235","2931832"],"winner_id":"2931832","reasoning":"Document B is more relevant — it directly studies prognostic biomarkers in breast cancer (though not ALDH1), whereas A focuses on WNT signaling and cell proliferation. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697420Z"}
{"comparison_id":"696679e7-1a86-42d4-ba96-81ba45637b34","query_id":"53","doc_a_id":"15946643","doc_b_id":"7795952","presented_order":["7795952","15946643"],"winner_id":"15946643","reasoning":"Document B — it specifically addresses mechanisms in breast cancer related to metastasis and treatment resistance (factors tied to prognosis), while A focuses on fascin/TGFβ without mention of breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697427Z"}
{"comparison_id":"db626aeb-2494-4999-b95f-de5583317cb7","query_id":"53","doc_a_id":"4455466","doc_b_id":"825728","presented_order":["825728","4455466"],"winner_id":"825728","reasoning":"Document A — it links acquisition of stem-cell properties to patient survival, which is conceptually related to ALDH1 (a cancer stem-cell marker) and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697433Z"}
{"comparison_id":"17ae4173-8da6-4728-a9de-08c5851c13bf","query_id":"53","doc_a_id":"15946643","doc_b_id":"24341590","presented_order":["24341590","15946643"],"winner_id":"15946643","reasoning":"Document B is more relevant — it addresses mechanisms (chemoresistance and metastasis) linked to poor prognosis in breast cancer, which is conceptually closer to ALDH1's role than a study on CYP2D6/tamoxifen pharmacogenetics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697439Z"}
{"comparison_id":"8e27637d-9b0e-4d64-8881-e7e3a9344776","query_id":"53","doc_a_id":"24834968","doc_b_id":"2931832","presented_order":["24834968","2931832"],"winner_id":"24834968","reasoning":"Document A is slightly more relevant because it discusses biological markers in breast cancer (even though it doesn't mention ALDH1 specifically), whereas Document B focuses on a platelet-based prognostic marker unrelated to ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697446Z"}
{"comparison_id":"1fd2494f-d8ce-4d4a-9bab-9ef362bd85b0","query_id":"53","doc_a_id":"22401720","doc_b_id":"4455466","presented_order":["4455466","22401720"],"winner_id":"4455466","reasoning":"Reason: Neither document mentions ALDH1; Document A discusses a gene whose expression is linked to breast cancer prognosis (more directly relevant to a marker–prognosis claim).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697452Z"}
{"comparison_id":"abe90daa-1b62-4da1-948c-35c355b8f10a","query_id":"53","doc_a_id":"25973484","doc_b_id":"27240667","presented_order":["27240667","25973484"],"winner_id":"27240667","reasoning":"Document A is more focused on breast cancer prognosis/mortality, so it's more relevant to a claim about a marker being associated with poorer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697458Z"}
{"comparison_id":"a6abad06-a4b4-4f89-bde0-1c3dfaf6e9d1","query_id":"53","doc_a_id":"45638119","doc_b_id":"4583180","presented_order":["4583180","45638119"],"winner_id":"45638119","reasoning":"Document B directly reports that ALDH1 correlates with poor prognosis in breast cancer; Document A is unrelated. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697464Z"}
{"comparison_id":"64b1ad43-9625-4086-a0a6-e5196ca2a2ab","query_id":"53","doc_a_id":"4429932","doc_b_id":"4455466","presented_order":["4429932","4455466"],"winner_id":"4455466","reasoning":"Reason: Neither document mentions ALDH1, but Document B discusses gene expression tied to prognosis in breast cancer, so it's more topically similar.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697471Z"}
{"comparison_id":"4eabaaf4-4132-4de5-a7bb-05afc7a56878","query_id":"53","doc_a_id":"7795952","doc_b_id":"7821634","presented_order":["7795952","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it specifically discusses prognosis and poor outcomes in breast cancer, whereas A focuses on fascin and tumor cell invasion without addressing breast cancer prognosis or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697477Z"}
{"comparison_id":"527c71b2-5e98-41c5-b3a5-ccfb91f7598c","query_id":"53","doc_a_id":"20183360","doc_b_id":"29495185","presented_order":["20183360","29495185"],"winner_id":"29495185","reasoning":"Document B is more relevant — it discusses molecular predictors of cancer prognosis, which is the category containing ALDH1 as a prognostic marker. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697484Z"}
{"comparison_id":"4cd97e18-5437-4bf7-abea-e233a8489677","query_id":"53","doc_a_id":"29366489","doc_b_id":"4889228","presented_order":["29366489","4889228"],"winner_id":"4889228","reasoning":"Document B — it directly concerns breast cancer prognosis (TNBC) while Document A discusses a tumor suppressor more broadly and is less specific to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697490Z"}
{"comparison_id":"110cb4a8-5ae6-467e-a4bb-bd0202587bbc","query_id":"53","doc_a_id":"24834968","doc_b_id":"29366489","presented_order":["24834968","29366489"],"winner_id":"24834968","reasoning":"Reason: Document A discusses biomarkers in primary breast cancer (though not ALDH1), while Document B focuses on a different tumor suppressor across cancers. Document A is therefore more contextually relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697496Z"}
{"comparison_id":"934b7c0c-9c65-4717-9cb5-64eb6a0d48d3","query_id":"53","doc_a_id":"15832146","doc_b_id":"19673227","presented_order":["15832146","19673227"],"winner_id":"15832146","reasoning":"Document A is more relevant — it concerns mechanisms in invasive breast carcinomas and tumor progression, which is closer to prognosis in breast cancer (Document B focuses on CTC chemosensitivity across epithelial tumors). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697522Z"}
{"comparison_id":"a99f885a-d740-49ac-841b-5a857f0898bc","query_id":"53","doc_a_id":"12762485","doc_b_id":"16086778","presented_order":["12762485","16086778"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses a stem-cell phenotype in breast cancer (linked to worse markers like ER/PgR negativity and higher proliferation), which relates to ALDH1 as a stem-cell marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697534Z"}
{"comparison_id":"cd9f52d4-638b-4dce-b35f-a53782bf086a","query_id":"53","doc_a_id":"31311495","doc_b_id":"43385013","presented_order":["31311495","43385013"],"winner_id":"43385013","reasoning":"Document B — it addresses stem cell/progenitor properties in breast cell subpopulations (ALDH1 is a stem cell marker), so it's more directly related to ALDH1's prognostic implications than Document A, which focuses on tamoxifen resistance and beta-catenin/EMT.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697543Z"}
{"comparison_id":"d3b8a1d8-0432-4128-9d34-5f498f66f866","query_id":"53","doc_a_id":"15832146","doc_b_id":"1866911","presented_order":["1866911","15832146"],"winner_id":"1866911","reasoning":"Document A is more relevant — it concerns progenitor/cell-of-origin biology of breast tumors (stem/progenitor markers), which relates to ALDH1 expression and prognosis, whereas B focuses on stromal fibroblasts and SDF‑1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697550Z"}
{"comparison_id":"95ebe86d-00fe-4fea-b28d-cd5b617420c0","query_id":"53","doc_a_id":"19358586","doc_b_id":"4583180","presented_order":["19358586","4583180"],"winner_id":"19358586","reasoning":"Document A — it discusses prognostic protein signatures and survival in breast cancer, so it's more directly relevant to an assertion about markers associated with prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697557Z"}
{"comparison_id":"d8f906df-46a9-47d2-a333-424b8e58a8e8","query_id":"53","doc_a_id":"21033230","doc_b_id":"45638119","presented_order":["45638119","21033230"],"winner_id":"45638119","reasoning":"Document A directly reports that ALDH1 predicts poor clinical outcome in breast cancer; Document B does not mention ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697563Z"}
{"comparison_id":"39d3cad8-7520-4194-8f4e-f9e27259aa99","query_id":"53","doc_a_id":"15832146","doc_b_id":"45638119","presented_order":["15832146","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 as a marker and its correlation with poor prognosis in breast cancer, while Document A discusses stromal fibroblasts and SDF-1/CXCL12 unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697570Z"}
{"comparison_id":"7eb1a924-6af1-452d-af79-b59e410a0f7b","query_id":"53","doc_a_id":"1379127","doc_b_id":"825728","presented_order":["825728","1379127"],"winner_id":"825728","reasoning":"Document A — it links EMT regulation, acquisition of stem-cell properties, and patient survival/metastasis, which is more related to ALDH1 (a cancer stem-cell marker) and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697577Z"}
{"comparison_id":"fe8a770e-5e57-4829-88a2-4c775683b8f4","query_id":"53","doc_a_id":"19673227","doc_b_id":"2931832","presented_order":["19673227","2931832"],"winner_id":"2931832","reasoning":"Reason: Document B directly studies a prognostic biomarker in breast cancer, while Document A discusses CTC chemosensitivity across tumor types without addressing ALDH1 or breast-specific biomarker expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697584Z"}
{"comparison_id":"4f39131e-34e4-4a67-88a7-b185ed9f3fa2","query_id":"53","doc_a_id":"22401720","doc_b_id":"3285322","presented_order":["3285322","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant — it examines tumor marker expression and links marker levels to prognosis in breast cancer, which is closer to the ALDH1–prognosis claim than a BRCA mutation comparison.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697591Z"}
{"comparison_id":"bae2aa07-52c9-46ab-bf03-82717fd21ac3","query_id":"53","doc_a_id":"27240667","doc_b_id":"7795952","presented_order":["27240667","7795952"],"winner_id":"7795952","reasoning":"Document B is more relevant — it discusses overexpression of a specific protein linked to poor cancer prognosis, which is conceptually closer to a claim about ALDH1 expression and prognosis than general mortality trends. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697597Z"}
{"comparison_id":"da82ca7c-19d0-4494-9ffc-c9ee1f38028e","query_id":"53","doc_a_id":"15113221","doc_b_id":"17648235","presented_order":["17648235","15113221"],"winner_id":"15113221","reasoning":"Document B is more relevant — it links a gene expression signature to poor prognosis in carcinomas, which is closer to the claim about marker expression and prognosis than Document A's focus on WNT signaling mechanisms. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697604Z"}
{"comparison_id":"f6761672-7691-4812-9470-3af2f5a0e036","query_id":"53","doc_a_id":"4455466","doc_b_id":"7821634","presented_order":["4455466","7821634"],"winner_id":"4455466","reasoning":"Document A is more relevant — it directly discusses a gene whose low expression is associated with poor prognosis in breast cancer, which is conceptually closer to the ALDH1–prognosis association than Document B's focus on chemotherapy resistance/DUSP4.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697611Z"}
{"comparison_id":"dbd82e07-680b-4a21-a286-621ca2def681","query_id":"53","doc_a_id":"22401720","doc_b_id":"4418878","presented_order":["22401720","4418878"],"winner_id":"22401720","reasoning":"Document A is more focused on biomarker expression and associations with prognosis specifically in breast cancer, whereas B is a general methods paper on pathway signatures and not specific to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697618Z"}
{"comparison_id":"60742b7c-856d-46e6-b688-bdd9e6006c40","query_id":"53","doc_a_id":"20183360","doc_b_id":"4702639","presented_order":["20183360","4702639"],"winner_id":"4702639","reasoning":"Document B — it discusses tumour stemness markers and resistance (related to cancer stem cell markers like ALDH1), whereas Document A focuses on GATA3/Smad4-driven invasion without ALDH1 or stemness. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697625Z"}
{"comparison_id":"e60b03e9-eb22-4490-83d8-e2b5fa566726","query_id":"53","doc_a_id":"1171121","doc_b_id":"20333864","presented_order":["1171121","20333864"],"winner_id":"1171121","reasoning":"Document A is more relevant — it discusses prognostic factors and survival outcomes in breast cancer, whereas Document B focuses on cellular mechanisms of DCIS to invasive transition and not prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697632Z"}
{"comparison_id":"2b3d8369-8d91-468c-b667-8e4782257630","query_id":"53","doc_a_id":"34066665","doc_b_id":"4702639","presented_order":["34066665","4702639"],"winner_id":"4702639","reasoning":"Document B is more relevant — it addresses tumor \"stemness\" markers and therapy resistance, which is the context where ALDH1 (a stem-cell marker linked to prognosis) would be discussed. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697638Z"}
{"comparison_id":"7e85cc7c-0da8-4e0f-ba14-e5be7a379115","query_id":"53","doc_a_id":"27240667","doc_b_id":"7583725","presented_order":["27240667","7583725"],"winner_id":"7583725","reasoning":"Document B is more relevant — it links expression of a molecular marker (TRPM7) to poor outcome in breast cancer, which is analogous to the claim about ALDH1 expression and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697645Z"}
{"comparison_id":"ce6dae12-6a77-4740-9d98-563f85cc4b42","query_id":"53","doc_a_id":"12762485","doc_b_id":"24834968","presented_order":["12762485","24834968"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses a stem-cell-like phenotype in breast cancer (linked to markers such as ALDH1) and prognosis-related features, whereas Document B focuses on HER2/Ki67 and chemo response. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697652Z"}
{"comparison_id":"64dad25a-06e2-43ac-97c1-bfaaf454997a","query_id":"53","doc_a_id":"2014909","doc_b_id":"8963413","presented_order":["2014909","8963413"],"winner_id":"2014909","reasoning":"Document A is more relevant — it analyzes tumor-initiating cells in primary breast cancers (where ALDH1 is a common marker), whereas Document B focuses on PD-L1 and clinical outcomes, not ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697660Z"}
{"comparison_id":"a0ba6b30-b9f5-4057-9219-561992036695","query_id":"53","doc_a_id":"11484808","doc_b_id":"1866911","presented_order":["11484808","1866911"],"winner_id":"1866911","reasoning":"Document B is more focused on breast epithelial progenitor populations and markers linked to tumor origin and aggressiveness, making it more likely to address ALDH1's prognostic relevance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697666Z"}
{"comparison_id":"78626849-2810-42c3-85a8-17ee91745876","query_id":"53","doc_a_id":"15113221","doc_b_id":"20333864","presented_order":["20333864","15113221"],"winner_id":"20333864","reasoning":"Document A is focused on breast carcinoma biology (DCIS to invasive), whereas Document B discusses PTEN-related signatures across carcinomas and does not pertain to ALDH1; neither mentions ALDH1, but A is more directly about breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697673Z"}
{"comparison_id":"873b205e-8aa7-4e51-ada3-19b693462aac","query_id":"53","doc_a_id":"22401720","doc_b_id":"34066665","presented_order":["22401720","34066665"],"winner_id":"22401720","reasoning":"Document A — it examines expression of tumor markers in primary breast cancer and links marker levels to prognosis, so it's more relevant to a claim about ALDH1 as a prognostic marker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697680Z"}
{"comparison_id":"bc943a3f-051a-4351-9a85-4806e3d2a077","query_id":"53","doc_a_id":"3285322","doc_b_id":"43385013","presented_order":["43385013","3285322"],"winner_id":"43385013","reasoning":"Document A is more relevant — it examines stem cell/progenitor properties in breast cells (ALDH1 is a stem cell marker), whereas Document B focuses on BRCA mutation clinicopathologic features and not stem cell markers or prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697686Z"}
{"comparison_id":"1731e176-3a1a-49bb-bd97-5d72be47cb79","query_id":"53","doc_a_id":"34066665","doc_b_id":"4418878","presented_order":["34066665","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it covers gene expression signatures linked to prognosis, so it's likelier to address ALDH1 expression and its prognostic significance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697692Z"}
{"comparison_id":"1748ce32-ad4b-4256-8229-a740d79de365","query_id":"53","doc_a_id":"18953920","doc_b_id":"34066665","presented_order":["34066665","18953920"],"winner_id":"18953920","reasoning":"Document B is more relevant — it discusses EMT generating cells with stem-cell markers and increased tumorigenicity (ALDH1 is a known stem-cell marker linked to prognosis).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697699Z"}
{"comparison_id":"4795e3ae-957b-4e1d-a0c1-d7b90eaf5d50","query_id":"53","doc_a_id":"25732836","doc_b_id":"29366489","presented_order":["29366489","25732836"],"winner_id":"25732836","reasoning":"B — It discusses prognostic markers in breast cancer (CTCs and PET/CT), so it's more directly related to prognosis in breast cancer than a paper about DLC-1 in various cancers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697705Z"}
{"comparison_id":"de6c5de2-dbe6-4e40-a44a-6ce2a781ffd3","query_id":"53","doc_a_id":"17648235","doc_b_id":"20333864","presented_order":["20333864","17648235"],"winner_id":"20333864","reasoning":"Document A is more relevant: it discusses factors influencing tumor progression from in situ to invasive disease and prognosis-related mechanisms, whereas Document B focuses on WNT signaling and proliferation without addressing prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697712Z"}
{"comparison_id":"430c766b-091a-4cb0-916a-eef0348f5f89","query_id":"53","doc_a_id":"4429932","doc_b_id":"825728","presented_order":["825728","4429932"],"winner_id":"825728","reasoning":"Doc A — it links EMT, acquisition of stem-cell properties and patient survival (relevant to ALDH1 as a breast cancer stem-cell prognostic marker), while B focuses on LOX/hypoxia without relating to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697718Z"}
{"comparison_id":"652357ff-8555-4509-ad81-2cf27183ec7e","query_id":"53","doc_a_id":"11484808","doc_b_id":"18953920","presented_order":["18953920","11484808"],"winner_id":"18953920","reasoning":"Document A is about EMT generating cells with stem-cell markers and increased tumorigenicity (relevant to ALDH1 as a stem-cell marker linked to poor prognosis). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697725Z"}
{"comparison_id":"41c66557-35ea-460e-b8fb-07276133ca23","query_id":"53","doc_a_id":"18953920","doc_b_id":"4702639","presented_order":["18953920","4702639"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses breast/mammary epithelial cells acquiring stem-cell markers and increased tumorigenic potential, which relates to marker expression (like ALDH1) and poorer prognosis in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697732Z"}
{"comparison_id":"bcc9bd84-10e0-4ffe-884c-8cae2d255d17","query_id":"53","doc_a_id":"29495185","doc_b_id":"4583180","presented_order":["29495185","4583180"],"winner_id":"29495185","reasoning":"Document A is more relevant — it discusses molecular predictors of cancer prognosis (broadly related to markers like ALDH1), while Document B focuses on SREBP2 and tumor metabolism unrelated to ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697738Z"}
{"comparison_id":"12bf42dd-47ae-4dad-bd70-5b6eabef0971","query_id":"53","doc_a_id":"1379127","doc_b_id":"1866911","presented_order":["1866911","1379127"],"winner_id":"1866911","reasoning":"Doc A is more relevant — it discusses luminal progenitor cells and marker-defined tumor-origin populations (related to stem/progenitor markers like ALDH1), whereas Doc B focuses on calcium-entry proteins unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697745Z"}
{"comparison_id":"50ba82b8-3c58-4662-91c5-eea2720f7113","query_id":"53","doc_a_id":"2014909","doc_b_id":"4702639","presented_order":["4702639","2014909"],"winner_id":"2014909","reasoning":"Document B. It analyzes tumor-initiating cells and primary breast cancers/patient-derived xenografts, which is more directly relevant to prognostic stem-cell markers like ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697751Z"}
{"comparison_id":"a2f97095-e7ea-42c2-9bca-b0fd59a64a05","query_id":"53","doc_a_id":"2014909","doc_b_id":"27240667","presented_order":["27240667","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers, which is closer to studies linking ALDH1 (a cancer stem cell marker) to prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697758Z"}
{"comparison_id":"2b511578-64ac-47d1-91fe-19de4c74aa11","query_id":"53","doc_a_id":"16086778","doc_b_id":"34066665","presented_order":["34066665","16086778"],"winner_id":"16086778","reasoning":"Document B. It addresses molecular mechanisms (Numb/Notch) linked to tumor proliferation and pathways tied to cancer stem–like behavior, which is more directly related to markers like ALDH1 and prognosis than the ER–HER signaling focus of Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697765Z"}
{"comparison_id":"dc31abad-0977-4a3e-a1c5-b55a119ee795","query_id":"53","doc_a_id":"1171121","doc_b_id":"15832146","presented_order":["15832146","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant because it addresses prognostic markers in breast cancer, whereas Document A focuses on stromal fibroblasts and angiogenesis mechanisms unrelated to ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697771Z"}
{"comparison_id":"81cbf81a-6785-419b-a2eb-b66af793c2f3","query_id":"53","doc_a_id":"1379127","doc_b_id":"24834968","presented_order":["24834968","1379127"],"winner_id":"24834968","reasoning":"Document A is more relevant — it discusses biological markers and their association with treatment response/prognosis in breast cancer, while Document B focuses on calcium channels and metastasis, not marker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697778Z"}
{"comparison_id":"185c4b57-cc9e-4932-a133-798bdaf9fecd","query_id":"53","doc_a_id":"31311495","doc_b_id":"313403","presented_order":["31311495","313403"],"winner_id":"313403","reasoning":"Document B — it directly concerns prognostic markers and clinical outcomes in breast cancer, whereas Document A discusses tamoxifen resistance mechanisms without addressing prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697784Z"}
{"comparison_id":"21dd3017-667f-4f41-bda7-66c483d0197f","query_id":"53","doc_a_id":"17648235","doc_b_id":"7583725","presented_order":["7583725","17648235"],"winner_id":"7583725","reasoning":"Document A — it discusses a specific gene's expression predicting poor outcomes in breast cancer, which is more directly related to prognosis than Document B's focus on WNT signaling and proliferation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697790Z"}
{"comparison_id":"1e7015d5-cc35-4994-b95b-f677fc2ca12b","query_id":"53","doc_a_id":"24341590","doc_b_id":"4889228","presented_order":["24341590","4889228"],"winner_id":"4889228","reasoning":"Document B — it discusses expression of a marker (TDP43) linked to prognosis in breast cancer, which is more relevant to a claim about a marker's association with prognosis than Document A about CYP2D6/tamoxifen metabolism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697797Z"}
{"comparison_id":"b190e53c-a28e-43ec-ab0e-544c692eab98","query_id":"53","doc_a_id":"4429932","doc_b_id":"45638119","presented_order":["4429932","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 and states it predicts poor clinical outcome in breast cancer, matching the query.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697803Z"}
{"comparison_id":"2279afe9-8e3d-45c2-b7d2-1652492487d7","query_id":"53","doc_a_id":"16086778","doc_b_id":"4418878","presented_order":["16086778","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures and their links to prognosis in cancers, which relates to assessing markers like ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697809Z"}
{"comparison_id":"e9b98417-6cd6-4fa3-80f2-3d5f3096f177","query_id":"53","doc_a_id":"19358586","doc_b_id":"24341590","presented_order":["19358586","24341590"],"winner_id":"19358586","reasoning":"Document A is more relevant — it discusses protein biomarkers and a signature linked to poor survival in breast cancer, whereas Document B focuses on CYP2D6 pharmacogenetics and tamoxifen response. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697815Z"}
{"comparison_id":"89b2a73c-10d2-4a0d-bd69-1b42c6aeda55","query_id":"53","doc_a_id":"25732836","doc_b_id":"5649538","presented_order":["25732836","5649538"],"winner_id":"25732836","reasoning":"Document A is more relevant — it deals with prognostic markers/outcome prediction in breast cancer, whereas Document B focuses on genomic predictors for dasatinib sensitivity. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697821Z"}
{"comparison_id":"faf636c7-f21a-4b7d-a614-547b1aaeb8d5","query_id":"53","doc_a_id":"15832146","doc_b_id":"21902400","presented_order":["15832146","21902400"],"winner_id":"21902400","reasoning":"Document B is more relevant because it discusses prognostic indicators and clinical outcome in cancer, whereas Document A focuses on stromal fibroblasts and SDF-1/CXCL12 without addressing ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697827Z"}
{"comparison_id":"aef8d74d-ff5a-41fa-9524-ec302fd33e43","query_id":"53","doc_a_id":"1171121","doc_b_id":"3285322","presented_order":["1171121","3285322"],"winner_id":"1171121","reasoning":"Document A is more relevant — it investigates prognostic markers in breast cancer, whereas Document B focuses on BRCA mutation characteristics not prognosis markers like ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697833Z"}
{"comparison_id":"56890c9b-0143-4088-b462-0eb2d5dbf77b","query_id":"53","doc_a_id":"21902400","doc_b_id":"825728","presented_order":["825728","21902400"],"winner_id":"825728","reasoning":"Document A is more relevant — it discusses acquisition of cancer stem cell properties and links to patient survival/metastasis, which relates to ALDH1 as a stem-cell/prognostic marker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697840Z"}
{"comparison_id":"977551ab-d28f-4cb3-814e-1b0467169635","query_id":"53","doc_a_id":"313403","doc_b_id":"3285322","presented_order":["3285322","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it addresses a tumor biomarker (TAM infiltration) linked to prognosis, whereas Document A focuses on BRCA mutation clinical characteristics and not prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697847Z"}
{"comparison_id":"fc79e68f-c800-4ab4-9867-6eadd7af98ab","query_id":"53","doc_a_id":"15946643","doc_b_id":"20333864","presented_order":["20333864","15946643"],"winner_id":"15946643","reasoning":"Document B is more relevant — it addresses mechanisms (chemoresistance and metastasis) that relate to poorer prognosis in breast cancer, whereas A focuses on cell-type roles in DCIS-to-invasive transition without linking ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697854Z"}
{"comparison_id":"860d19fa-222f-4e8d-a37f-193efb7f3425","query_id":"53","doc_a_id":"1171121","doc_b_id":"7583725","presented_order":["1171121","7583725"],"winner_id":"1171121","reasoning":"Neither abstract mentions ALDH1, so neither directly supports or refutes the claim. Document A is slightly more relevant because it examines prognostic markers and survival in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697860Z"}
{"comparison_id":"7a3a0afb-7b21-42d8-bda0-e8c55ba43df1","query_id":"53","doc_a_id":"18953920","doc_b_id":"21033230","presented_order":["21033230","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses acquisition of stem-cell markers and increased tumorigenicity in mammary cells (more directly related to ALDH1 as a stem-cell/prognostic marker). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697866Z"}
{"comparison_id":"a82fef1e-bfc0-4493-9ff6-3a6f170cc370","query_id":"53","doc_a_id":"24341590","doc_b_id":"313403","presented_order":["313403","24341590"],"winner_id":"313403","reasoning":"Reason: Document A examines a tumor biomarker (TAM density) linked to poor prognosis in breast cancer, which is more similar to the claim about ALDH1 as a prognostic marker than Document B, which focuses on CYP2D6 pharmacogenetics and tamoxifen response.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697873Z"}
{"comparison_id":"c466eb93-d8d3-4fca-88ad-a7c383a0d7cc","query_id":"53","doc_a_id":"20127522","doc_b_id":"4429932","presented_order":["20127522","4429932"],"winner_id":"4429932","reasoning":"Document B is more relevant — it discusses a specific molecular marker (LOX) linked to poor outcomes in breast cancer, which is closer to the query about a molecular marker (ALDH1) and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697879Z"}
{"comparison_id":"39951758-2e5a-4eb5-b1da-ab7957736d8a","query_id":"53","doc_a_id":"20839751","doc_b_id":"2931832","presented_order":["2931832","20839751"],"winner_id":"20839751","reasoning":"Document B is more relevant — it discusses tumor cell markers and their association with prognosis, whereas Document A concerns platelet indices unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697885Z"}
{"comparison_id":"58844824-e1b2-4d12-a4b9-5e4bff8339c0","query_id":"53","doc_a_id":"4702639","doc_b_id":"825728","presented_order":["4702639","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it links regulation of stem-like/EMT states to patient survival and metastasis, which relates to prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697891Z"}
{"comparison_id":"9b411443-0849-4d6e-b873-53a448832e62","query_id":"53","doc_a_id":"16086778","doc_b_id":"825728","presented_order":["16086778","825728"],"winner_id":"825728","reasoning":"Reason: Document B links EMT/stem-cell properties to patient survival and metastasis (more aligned with ALDH1 as a stem-cell prognostic marker), while A focuses on Numb/Notch regulation without addressing ALDH1 or stemness.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697898Z"}
{"comparison_id":"2f644569-a7c8-47dc-a2e4-0b0ad11b487e","query_id":"53","doc_a_id":"21902400","doc_b_id":"24341590","presented_order":["24341590","21902400"],"winner_id":"21902400","reasoning":"Document B is more relevant — it discusses tumor microenvironmental factors (hypoxia) linked to prognosis, which is closer to markers like ALDH1 than a CYP2D6/tamoxifen pharmacogenetics study.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697904Z"}
{"comparison_id":"08319eda-6a0f-45ec-a40e-9851efb98196","query_id":"53","doc_a_id":"4418878","doc_b_id":"4583180","presented_order":["4583180","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures and their link to prognosis and cancer subtypes, which is directly related to evaluating markers like ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697911Z"}
{"comparison_id":"2186a350-86cd-45a1-b6dd-4b1b65507f3b","query_id":"53","doc_a_id":"24341590","doc_b_id":"29366489","presented_order":["29366489","24341590"],"winner_id":"24341590","reasoning":"Document B is more relevant — it directly addresses prognostic outcomes in breast cancer, whereas A discusses a different tumor suppressor unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697917Z"}
{"comparison_id":"c982486b-21c4-418a-b27c-131fdd7872e2","query_id":"53","doc_a_id":"4583180","doc_b_id":"7583725","presented_order":["7583725","4583180"],"winner_id":"7583725","reasoning":"Doc A is about a marker (TRPM7) predicting poor outcomes specifically in breast cancer, so it's more relevant to a claim about prognosis in breast cancer than Doc B, which addresses general tumor progression mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697924Z"}
{"comparison_id":"c98dd73f-7993-4b65-acf2-655bab3c8839","query_id":"53","doc_a_id":"20183360","doc_b_id":"34066665","presented_order":["34066665","20183360"],"winner_id":"34066665","reasoning":"Document A — it discusses clinical implications and therapy resistance in breast cancer, which is more directly related to prognosis than the molecular invasion focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697930Z"}
{"comparison_id":"821de974-639d-4fbc-88da-f4586484d943","query_id":"53","doc_a_id":"21902400","doc_b_id":"22401720","presented_order":["22401720","21902400"],"winner_id":"22401720","reasoning":"Document A — it discusses prognostic molecular markers in primary breast cancer (links marker expression to outcome), so it's more relevant to a claim about ALDH1 and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697936Z"}
{"comparison_id":"8921ca21-9bde-4c99-b71d-7d4a8641ce71","query_id":"53","doc_a_id":"25973484","doc_b_id":"7821634","presented_order":["7821634","25973484"],"winner_id":"7821634","reasoning":"Document A is more relevant — it discusses tumor marker expression (DUSP4) linked to poor outcomes and chemotherapy resistance, which is closer to the claim about a prognostic biomarker than the obesity-focused review.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697942Z"}
{"comparison_id":"4d07609e-96d9-40f7-9c30-9fef94d5c3fe","query_id":"53","doc_a_id":"15832146","doc_b_id":"20183360","presented_order":["15832146","20183360"],"winner_id":"15832146","reasoning":"Document A is more directly about factors that drive tumor growth and progression (which relate to prognosis), while Document B focuses on a specific transcriptional mechanism of invasion without addressing prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697949Z"}
{"comparison_id":"fd2cccae-aa39-4261-862c-0cabaa6a29da","query_id":"53","doc_a_id":"25973484","doc_b_id":"31311495","presented_order":["31311495","25973484"],"winner_id":"25973484","reasoning":"Document B is more relevant — it discusses factors linked to breast cancer prognosis, while A focuses on tamoxifen resistance mechanisms and EMT without addressing prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697955Z"}
{"comparison_id":"62e7c994-a9a7-45f4-be49-6e58c8e5694d","query_id":"53","doc_a_id":"313403","doc_b_id":"825728","presented_order":["825728","313403"],"winner_id":"825728","reasoning":"Document A is more relevant — it links acquisition of stem-cell properties and patient survival (related to markers like ALDH1), while B discusses macrophage infiltration unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697961Z"}
{"comparison_id":"4de6d8bb-733c-47ac-8b02-b6c638127bb2","query_id":"53","doc_a_id":"20183360","doc_b_id":"4889228","presented_order":["4889228","20183360"],"winner_id":"4889228","reasoning":"Document A is more relevant — it discusses gene expression correlated with prognosis in breast cancer, whereas Document B focuses on signaling and invasion without prognosis data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697968Z"}
{"comparison_id":"632c4d98-05a7-4b74-902e-b61ae5898d79","query_id":"53","doc_a_id":"16086778","doc_b_id":"20183360","presented_order":["20183360","16086778"],"winner_id":"20183360","reasoning":"Document A is slightly more relevant because it addresses mechanisms of tumor invasion and progression (which relate to prognosis), whereas Document B focuses on Numb/Notch regulation of carcinogenesis without linking to prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697974Z"}
{"comparison_id":"07362293-3dd9-4cc5-b4cb-eece01ee5b74","query_id":"53","doc_a_id":"11484808","doc_b_id":"4702639","presented_order":["11484808","4702639"],"winner_id":"4702639","reasoning":"Document B is more relevant — it addresses tumour stemness markers and clinical outcomes (drug resistance), which is closer to ALDH1's role as a stem-cell/prognostic marker than a review focused on non-coding RNAs.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697981Z"}
{"comparison_id":"a982b98c-3137-401b-976c-4ca273761a2f","query_id":"53","doc_a_id":"18953920","doc_b_id":"2014909","presented_order":["18953920","2014909"],"winner_id":"18953920","reasoning":"Document A is more relevant — it links EMT to acquisition of stem-cell markers and increased tumorigenicity in mammary epithelial cells, which directly relates to ALDH1 as a breast cancer stem-cell marker and its prognostic implications.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697988Z"}
{"comparison_id":"251dd486-a5ad-4842-b199-ef707eab4a50","query_id":"53","doc_a_id":"3285322","doc_b_id":"8963413","presented_order":["3285322","8963413"],"winner_id":"3285322","reasoning":"Neither document mentions ALDH1. Document A is more breast-cancer specific (clinical/pathologic features), so it's slightly more relevant to a prognosis-related claim in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.697994Z"}
{"comparison_id":"60333c60-cb02-448c-b4c7-891ff840bcd9","query_id":"53","doc_a_id":"15113221","doc_b_id":"8963413","presented_order":["8963413","15113221"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses expression markers and clinical outcomes specifically in breast cancer, whereas B focuses on PTEN pathway signatures in carcinomas generally. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698001Z"}
{"comparison_id":"f50e488f-ffc0-456c-bee1-fd2e48b0ff2b","query_id":"53","doc_a_id":"1171121","doc_b_id":"2130391","presented_order":["1171121","2130391"],"winner_id":"1171121","reasoning":"Document A is more relevant because it examines prognostic factors in breast cancer, whereas Document B focuses on adipocytes and invasion rather than prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698007Z"}
{"comparison_id":"700749db-2006-4b96-b0e2-506e3fdfb9c6","query_id":"53","doc_a_id":"15946643","doc_b_id":"1866911","presented_order":["1866911","15946643"],"winner_id":"1866911","reasoning":"Document A is more relevant — it concerns progenitor/stem-like cell populations in breast cancer (markers and tumor origin), which is closer to ALDH1 (a stem/progenitor marker) and prognosis than the CXCL1/chemoresistance signaling focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698014Z"}
{"comparison_id":"51c09a92-031e-4d5e-b152-703cf115f6e5","query_id":"53","doc_a_id":"21033230","doc_b_id":"825728","presented_order":["21033230","825728"],"winner_id":"21033230","reasoning":"Document A is more directly about prognostic markers in metastatic breast cancer, whereas Document B focuses on EMT/ Prrx1 and metastasis mechanisms. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698020Z"}
{"comparison_id":"5fc6f609-4053-4fdb-a552-5c399d28dc4a","query_id":"53","doc_a_id":"18953920","doc_b_id":"20839751","presented_order":["18953920","20839751"],"winner_id":"18953920","reasoning":"Document A discusses acquisition of stem-cell markers and increased tumorigenic potential in mammary cells, which is directly relevant to ALDH1 (a stem-cell marker) and prognosis. Document B focuses on apoptosis and not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698027Z"}
{"comparison_id":"ac7ada15-0609-4a7b-b398-905f3e064110","query_id":"53","doc_a_id":"15946643","doc_b_id":"825728","presented_order":["825728","15946643"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT/stem-cell properties to patient survival, which is closer to evidence about ALDH1 (a stem-cell marker) and prognosis than the CXCL1 chemoresistance focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698034Z"}
{"comparison_id":"235f273a-c5a9-4711-96c3-a953f4de8126","query_id":"53","doc_a_id":"18953920","doc_b_id":"5649538","presented_order":["5649538","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses EMT creating cells with stem-cell markers (including markers like ALDH1) and increased tumorigenicity, which is directly relevant to ALDH1's prognostic role in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698041Z"}
{"comparison_id":"7fee72c7-4988-4423-b6d5-4be817c42991","query_id":"53","doc_a_id":"29366489","doc_b_id":"29495185","presented_order":["29495185","29366489"],"winner_id":"29495185","reasoning":"Document A is more relevant — it discusses molecular predictors of cancer prognosis generally, which is directly related to ALDH1 as a prognostic marker; Document B focuses on a different gene (DLC-1).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698048Z"}
{"comparison_id":"2a747d7f-e01a-4f10-96e3-18d743d673f1","query_id":"53","doc_a_id":"16086778","doc_b_id":"29495185","presented_order":["29495185","16086778"],"winner_id":"29495185","reasoning":"Document A is more relevant — it addresses molecular predictors of prognosis in cancer (including breast cancer), which is the topic of the query, whereas Document B focuses specifically on Numb/Notch signaling without discussing ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698055Z"}
{"comparison_id":"9205a6cf-bad6-4e41-a91d-13ffab7e485b","query_id":"53","doc_a_id":"11484808","doc_b_id":"24834968","presented_order":["11484808","24834968"],"winner_id":"24834968","reasoning":"Document B — it directly evaluates biological markers in primary breast cancer (predictive/prognostic markers), whereas Document A focuses on non-coding RNAs and not ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698062Z"}
{"comparison_id":"13483d37-2e98-45e4-9f57-1462d3d887a6","query_id":"53","doc_a_id":"21902400","doc_b_id":"25973484","presented_order":["21902400","25973484"],"winner_id":"21902400","reasoning":"Document A is more relevant — it discusses tumor microenvironment and prognostic factors affecting clinical outcome, which is closer to a claim about a prognostic marker like ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698068Z"}
{"comparison_id":"a9827527-7a5f-455e-83fa-4d9f2e910a62","query_id":"53","doc_a_id":"21033230","doc_b_id":"8963413","presented_order":["21033230","8963413"],"winner_id":"21033230","reasoning":"Document A — it discusses molecular prognostic markers in breast cancer (CTC profiling), so it's more directly related to prognostic marker expression in breast cancer than the PD-L1–focused review. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698075Z"}
{"comparison_id":"96c6ae6d-cc1a-4b7d-b845-c0f70a469d0f","query_id":"53","doc_a_id":"2014909","doc_b_id":"4455466","presented_order":["4455466","2014909"],"winner_id":"4455466","reasoning":"Reason: Neither abstract mentions ALDH1, but Document A specifically discusses a marker whose expression level is linked to poor breast cancer prognosis, making it marginally more relevant than B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698082Z"}
{"comparison_id":"bf38b632-8ad8-491e-8a76-807908f2c436","query_id":"53","doc_a_id":"20333864","doc_b_id":"43385013","presented_order":["20333864","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it addresses stem cell/progenitor properties in breast cell subpopulations (where ALDH1 is commonly discussed as a stem cell marker), while Document A focuses on stromal/myoepithelial regulation of DCIS-to-invasive transition and not on ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698088Z"}
{"comparison_id":"bb0d9d39-2ebf-48d9-9c08-8ae2ed407995","query_id":"53","doc_a_id":"17648235","doc_b_id":"22401720","presented_order":["17648235","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant — it examines expression of markers in primary breast cancer and relates them to prognosis, whereas A focuses on WNT signaling without prognosis or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698095Z"}
{"comparison_id":"245ff6da-dec9-4f37-9729-946a6b672f87","query_id":"53","doc_a_id":"15946643","doc_b_id":"5649538","presented_order":["5649538","15946643"],"winner_id":"15946643","reasoning":"Document B — it addresses mechanisms linking chemoresistance and metastasis (topics closely related to prognosis and stem-cell–like features), so it's more likely to discuss markers like ALDH1 than the dasatinib-sensitivity focus of A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698102Z"}
{"comparison_id":"3f87dd10-e6d4-4e32-8736-8ef139321ec5","query_id":"53","doc_a_id":"29366489","doc_b_id":"43385013","presented_order":["29366489","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it addresses stem cell/progenitor properties and epithelial/mesenchymal subpopulations in breast cells, which relates to ALDH1 as a stem cell marker linked to prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698108Z"}
{"comparison_id":"8de3376e-6416-4bcb-8495-9f1eadb8364f","query_id":"53","doc_a_id":"2931832","doc_b_id":"825728","presented_order":["825728","2931832"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT repression, cancer cell stemness, and patient survival (closer to ALDH1 as a cancer stem cell marker), while B addresses a platelet-based prognostic marker unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698115Z"}
{"comparison_id":"8fa702b5-212e-4c4c-a8df-7b4ab2136759","query_id":"53","doc_a_id":"15832146","doc_b_id":"2014909","presented_order":["15832146","2014909"],"winner_id":"2014909","reasoning":"Reason: Document B discusses tumor-initiating cells and analyses of primary breast cancers, making it more relevant to markers (like ALDH1) linked to prognosis than Document A, which focuses on stromal fibroblasts and SDF-1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698122Z"}
{"comparison_id":"e8387503-6366-4885-8e9e-055edfd58b03","query_id":"53","doc_a_id":"29495185","doc_b_id":"4889228","presented_order":["4889228","29495185"],"winner_id":"29495185","reasoning":"Document B is more relevant — it discusses molecular predictors of cancer prognosis (the category ALDH1 would fall into), whereas A focuses on TDP43/SRSF3 in TNBC and does not address ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698128Z"}
{"comparison_id":"f7f0836e-6b39-4684-b0f9-748a2398dc78","query_id":"53","doc_a_id":"16086778","doc_b_id":"2130391","presented_order":["2130391","16086778"],"winner_id":"2130391","reasoning":"Document A is slightly more relevant — it discusses tumor invasion and progression (clinical outcomes related to prognosis), whereas Document B focuses on Numb/Notch signaling without addressing prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698135Z"}
{"comparison_id":"0a4c92c3-a932-4d72-a465-b61908dcc19b","query_id":"53","doc_a_id":"19358586","doc_b_id":"29366489","presented_order":["29366489","19358586"],"winner_id":"19358586","reasoning":"Document B — it discusses prognostic protein signatures and survival in breast cancer, whereas Document A is about DLC-1 in liver/other cancers and not about breast cancer prognosis or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698142Z"}
{"comparison_id":"d0b22f9c-8597-459a-971d-06d04b00f4b6","query_id":"53","doc_a_id":"21033230","doc_b_id":"24834968","presented_order":["24834968","21033230"],"winner_id":"21033230","reasoning":"Document B discusses molecular markers in breast cancer and links marker-positive circulating tumor cells to shorter overall survival, so it's more relevant to a claim about marker expression and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698148Z"}
{"comparison_id":"30080ab3-3b98-4bd0-8d83-3d1436c65477","query_id":"53","doc_a_id":"21033230","doc_b_id":"3285322","presented_order":["21033230","3285322"],"winner_id":"21033230","reasoning":"Document A is more relevant — it discusses molecular markers and prognostic value of circulating tumor cells, which is closer to ALDH1 as a prognostic biomarker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698155Z"}
{"comparison_id":"5929938c-3b63-4c02-b227-135bc110030d","query_id":"53","doc_a_id":"17648235","doc_b_id":"21033230","presented_order":["17648235","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it addresses molecular markers on circulating tumor cells and their association with overall survival, which relates to prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698162Z"}
{"comparison_id":"8eb49706-48fc-4808-9be8-a756737555ab","query_id":"53","doc_a_id":"24341590","doc_b_id":"25732836","presented_order":["24341590","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant — it concerns prognostic markers in breast cancer (CTCs/PET) while Document A focuses on CYP2D6 pharmacogenetics related to tamoxifen, not ALDH1.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698168Z"}
{"comparison_id":"2f3d2756-efc5-4855-a2ac-a867ecdde535","query_id":"53","doc_a_id":"20333864","doc_b_id":"825728","presented_order":["20333864","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it links EMT regulation, acquisition of stem-cell properties, and patient survival, which relates to ALDH1 as a stem-cell marker associated with prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698175Z"}
{"comparison_id":"5e1438bc-50c3-4b3e-a4b4-33d7a766bd31","query_id":"53","doc_a_id":"1866911","doc_b_id":"21033230","presented_order":["21033230","1866911"],"winner_id":"21033230","reasoning":"Document A is more relevant — it addresses prognostic markers and survival in metastatic breast cancer, while Document B focuses on cell-of-origin biology and not prognosis or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698181Z"}
{"comparison_id":"ddd0b694-c0a4-4df6-a221-6149ad905b4b","query_id":"53","doc_a_id":"20839751","doc_b_id":"4429932","presented_order":["4429932","20839751"],"winner_id":"4429932","reasoning":"Document A — it reports a specific molecular marker (LOX) whose expression is associated with poor breast cancer outcomes, which is more analogous to a claim about ALDH1 expression and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698188Z"}
{"comparison_id":"70bd3da3-90fe-4a40-93cf-5b113577754e","query_id":"53","doc_a_id":"22482820","doc_b_id":"2931832","presented_order":["22482820","2931832"],"winner_id":"2931832","reasoning":"Document B is more relevant — it directly investigates prognostic biomarkers and survival outcomes in breast cancer, whereas A is a therapy-focused overview and does not address prognostic marker expression. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698195Z"}
{"comparison_id":"1870a431-b738-400e-b93e-f4fc319dd537","query_id":"53","doc_a_id":"15832146","doc_b_id":"7795952","presented_order":["15832146","7795952"],"winner_id":"15832146","reasoning":"Document A is more relevant — it specifically addresses invasive human breast carcinomas and factors promoting tumor progression, whereas B discusses fascin in spindle-shaped tumor cells without focus on breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698202Z"}
{"comparison_id":"8b767c50-5f29-4352-9f80-91b8645b9356","query_id":"53","doc_a_id":"15832146","doc_b_id":"4583180","presented_order":["4583180","15832146"],"winner_id":"4583180","reasoning":"Neither abstract mentions ALDH1, but Document A discusses gene expression linked to reduced survival (prognosis), so it's slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698208Z"}
{"comparison_id":"fbf5a625-b3fd-4196-8532-e1dcfca5b964","query_id":"53","doc_a_id":"7583725","doc_b_id":"7795952","presented_order":["7583725","7795952"],"winner_id":"7583725","reasoning":"Document A is more relevant — it specifically links high expression to poor outcomes in breast cancer, whereas B discusses prognosis more generally without focusing on breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698214Z"}
{"comparison_id":"a3e066d0-51dd-4144-876f-1edfd1a1ea5b","query_id":"53","doc_a_id":"15113221","doc_b_id":"5649538","presented_order":["5649538","15113221"],"winner_id":"15113221","reasoning":"Document B is more relevant — it links a gene expression signature to poor prognosis in carcinomas, which is closer to the claim about prognostic gene expression than drug-sensitivity predictors in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698221Z"}
{"comparison_id":"fc36e5b5-7285-4043-8865-a92fc7e4638c","query_id":"53","doc_a_id":"15946643","doc_b_id":"2014909","presented_order":["15946643","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — it discusses tumor-initiating cells and primary breast cancer analyses, which relate to markers like ALDH1 and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698227Z"}
{"comparison_id":"2eef4841-d7fc-4abd-8ed4-e179d2deb898","query_id":"53","doc_a_id":"3285322","doc_b_id":"4455466","presented_order":["4455466","3285322"],"winner_id":"4455466","reasoning":"Document A is more relevant — it links gene expression levels to breast cancer prognosis, whereas B focuses on BRCA mutation clinical features and doesn't address marker expression like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698234Z"}
{"comparison_id":"ed7b7bd5-6604-4bed-a8e6-76043e69d3ef","query_id":"53","doc_a_id":"29495185","doc_b_id":"7795952","presented_order":["29495185","7795952"],"winner_id":"29495185","reasoning":"Reason: Document A discusses molecular predictors of cancer prognosis (relevant to ALDH1 as a prognostic marker), while Document B focuses on a different protein (fascin) unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698240Z"}
{"comparison_id":"2369360b-2bd1-41f9-ab6b-7e2aaf1bf105","query_id":"53","doc_a_id":"20839751","doc_b_id":"21033230","presented_order":["21033230","20839751"],"winner_id":"21033230","reasoning":"Document A is more relevant — it discusses molecular marker profiling and prognostic value in breast cancer (though not ALDH1 specifically), whereas Document B focuses on apoptosis metrics unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698246Z"}
{"comparison_id":"660447d4-74ab-448b-9913-f6698131aa1b","query_id":"53","doc_a_id":"15946643","doc_b_id":"8963413","presented_order":["8963413","15946643"],"winner_id":"15946643","reasoning":"Document B is more relevant — it discusses mechanisms (chemoresistance and metastasis) that relate to poorer prognosis in breast cancer, whereas Document A focuses on PD-L1 and not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698253Z"}
{"comparison_id":"39ee29c7-2605-43a6-8000-17a65aa19c01","query_id":"53","doc_a_id":"43385013","doc_b_id":"5649538","presented_order":["43385013","5649538"],"winner_id":"43385013","reasoning":"Document A is more relevant — it discusses stem cell/progenitor properties in breast cell subpopulations (ALDH1 is a breast cancer stem cell marker), whereas Document B focuses on dasatinib genomic predictors unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698259Z"}
{"comparison_id":"476f535f-b8c7-4609-a7c4-fa580953e342","query_id":"53","doc_a_id":"21902400","doc_b_id":"4455466","presented_order":["21902400","4455466"],"winner_id":"4455466","reasoning":"Document B — it links expression of a molecular marker to breast cancer prognosis, whereas A discusses hypoxia and not marker expression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698265Z"}
{"comparison_id":"6159e508-ed7d-4beb-b532-b3ef28af9011","query_id":"53","doc_a_id":"4429932","doc_b_id":"7583725","presented_order":["4429932","7583725"],"winner_id":"7583725","reasoning":"Document B is more relevant — it describes a protein whose high expression predicts poor outcomes in breast cancer, which is the same type of prognostic association claimed for ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698272Z"}
{"comparison_id":"e4ce0f23-73bf-4997-a13f-e0de7ec29b8d","query_id":"53","doc_a_id":"17648235","doc_b_id":"29366489","presented_order":["17648235","29366489"],"winner_id":"29366489","reasoning":"Document B — it discusses tumor-suppressor markers and prognosis relevance, whereas A focuses on WNT signaling mechanisms not prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698278Z"}
{"comparison_id":"f396e441-3126-46cd-a387-0e1a757c71f1","query_id":"53","doc_a_id":"2014909","doc_b_id":"3285322","presented_order":["2014909","3285322"],"winner_id":"2014909","reasoning":"Document A — it examines tumor-initiating cells and analyses of primary breast cancers (more likely to address ALDH1 as a stem-cell/prognostic marker). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698284Z"}
{"comparison_id":"55303701-0c2c-4266-8868-64264e333d84","query_id":"53","doc_a_id":"4429932","doc_b_id":"4702639","presented_order":["4702639","4429932"],"winner_id":"4702639","reasoning":"Document A is more relevant — it addresses tumor stemness and stem-cell markers/drivers, which is related to ALDH1 as a cancer stem cell marker; Document B focuses on LOX and hypoxia/metastasis without discussing stem-cell markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698291Z"}
{"comparison_id":"da7bf38f-747f-4afe-b2c4-066d0dec79b2","query_id":"53","doc_a_id":"12762485","doc_b_id":"31311495","presented_order":["12762485","31311495"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses stem cell–like phenotypes and prognostic markers in breast cancer, which is closer to ALDH1 (a stem cell marker) than the tamoxifen/EMT focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698297Z"}
{"comparison_id":"ab47112d-b75a-411f-8dbe-657e99b94109","query_id":"53","doc_a_id":"20127522","doc_b_id":"2931832","presented_order":["20127522","2931832"],"winner_id":"20127522","reasoning":"Document A is more relevant — it addresses a tumor-cell–related biomarker and its association with poorer prognosis, which is more closely related to ALDH1 (a tumor cell marker) than a platelet-based marker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698303Z"}
{"comparison_id":"33b0278e-ae0d-4dba-bc55-ed7d1184fded","query_id":"53","doc_a_id":"17648235","doc_b_id":"24834968","presented_order":["17648235","24834968"],"winner_id":"24834968","reasoning":"Document B — it evaluates clinical/biomarker associations in breast cancer (prognosis/response), so it's more relevant to a claim about ALDH1 as a prognostic marker.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698310Z"}
{"comparison_id":"b8f17eca-53fb-468c-a4a3-48d14dbf9ff2","query_id":"53","doc_a_id":"19358586","doc_b_id":"4889228","presented_order":["19358586","4889228"],"winner_id":"4889228","reasoning":"Document B is more relevant — it discusses a protein whose expression level correlates with prognosis in breast cancer, matching the query's focus on marker expression and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698320Z"}
{"comparison_id":"8d4984d5-d98e-44df-908d-935854d60ed1","query_id":"53","doc_a_id":"1171121","doc_b_id":"19358586","presented_order":["1171121","19358586"],"winner_id":"1171121","reasoning":"Document A directly addresses prognostic factors and survival outcomes in breast cancer, making it more relevant to a claim about marker-associated prognosis. Document B focuses on a different molecular signature and therapeutic miRNAs.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698326Z"}
{"comparison_id":"e2479c20-b434-475c-b762-21a262753fd3","query_id":"53","doc_a_id":"1379127","doc_b_id":"20127522","presented_order":["1379127","20127522"],"winner_id":"20127522","reasoning":"Document B is more relevant — it addresses prognostic biomarkers in breast cancer (CTC levels and survival), which is conceptually closer to a claim about ALDH1 as a prognostic marker than Document A’s focus on calcium channels and metastasis mechanisms.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698333Z"}
{"comparison_id":"1ac9e868-7620-4a5a-b822-5163764dfce8","query_id":"53","doc_a_id":"25973484","doc_b_id":"4418878","presented_order":["25973484","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures and their links to prognosis, which relates to ALDH1 expression as a prognostic biomarker.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698339Z"}
{"comparison_id":"50352c37-62b0-4033-960d-414f36c7a5f6","query_id":"53","doc_a_id":"12762485","doc_b_id":"19673227","presented_order":["19673227","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses a stem-cell phenotype in breast cancer linked to more aggressive features and worse differentiation, which is directly relevant to ALDH1 as a stem-cell/prognostic marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698346Z"}
{"comparison_id":"c9711536-ddc4-4033-a34f-25f5eebe024f","query_id":"53","doc_a_id":"15832146","doc_b_id":"31311495","presented_order":["15832146","31311495"],"winner_id":"31311495","reasoning":"Document B — it discusses tumor cell aggressiveness and therapy resistance (factors tied to prognosis), whereas Document A focuses on stromal fibroblasts and CXCL12 without linking to tumor cell markers like ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698352Z"}
{"comparison_id":"626c6872-77d1-4d5d-b8ef-84aef1d6af04","query_id":"53","doc_a_id":"20839751","doc_b_id":"24341590","presented_order":["24341590","20839751"],"winner_id":"20839751","reasoning":"Document B is more relevant — it examines associations between a molecular/pathological marker (apoptotic index) and prognosis in breast cancer, which is closer to the claim about ALDH1 as a prognostic marker. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698359Z"}
{"comparison_id":"3b69d9b5-39ff-4eb7-abe4-9700c786353e","query_id":"53","doc_a_id":"3285322","doc_b_id":"4418878","presented_order":["4418878","3285322"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and their links to cancer prognosis, which is directly related to associations like ALDH1 expression and outcome.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698365Z"}
{"comparison_id":"abef6834-1670-4377-b562-41b737978ec9","query_id":"53","doc_a_id":"2931832","doc_b_id":"4455466","presented_order":["4455466","2931832"],"winner_id":"4455466","reasoning":"Document A is more relevant because it discusses how the expression level of a specific gene is linked to prognosis in breast cancer, whereas Document B covers a platelet-derived prognostic marker unrelated to gene expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698371Z"}
{"comparison_id":"381da160-2383-43c8-a048-5d1a1027274b","query_id":"53","doc_a_id":"19673227","doc_b_id":"4702639","presented_order":["19673227","4702639"],"winner_id":"4702639","reasoning":"Document B is more relevant — it discusses tumor stemness markers and therapy resistance (which relate to prognosis), whereas A focuses on a chemosensitivity assay of circulating tumor cells without addressing ALDH1 or stemness markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698378Z"}
{"comparison_id":"151cf09e-13ba-4eed-81a8-c2ee04c367f2","query_id":"53","doc_a_id":"19358586","doc_b_id":"25973484","presented_order":["19358586","25973484"],"winner_id":"19358586","reasoning":"Document A — it discusses molecular markers and a protein signature linked to poor survival in breast cancer, which is more relevant to a claim about a prognostic biomarker than the obesity-focused review in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698384Z"}
{"comparison_id":"76fea806-86ca-4289-bf8f-be980d017652","query_id":"53","doc_a_id":"29366489","doc_b_id":"4455466","presented_order":["29366489","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it discusses gene expression linked to prognosis in breast cancer (though not ALDH1). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698390Z"}
{"comparison_id":"7cbe5d6b-ba6b-427d-80ce-04e953ab7d67","query_id":"53","doc_a_id":"3285322","doc_b_id":"4429932","presented_order":["3285322","4429932"],"winner_id":"3285322","reasoning":"Document A is more relevant — it discusses clinical/pathologic prognostic features in breast cancer, whereas Document B focuses on LOX and hypoxia-related metastasis, not ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698397Z"}
{"comparison_id":"bfb575e5-f520-4679-a1fe-e1309307fd82","query_id":"53","doc_a_id":"20839751","doc_b_id":"7821634","presented_order":["20839751","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it links a specific molecular marker's expression level (DUSP4) to tumor behavior and poor outcomes, which is analogous to assessing ALDH1's prognostic association.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698403Z"}
{"comparison_id":"44afcf82-07c0-4156-b79e-1f64c6095f5a","query_id":"53","doc_a_id":"24834968","doc_b_id":"825728","presented_order":["825728","24834968"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT, acquisition of stem-cell properties and patient survival, which is closer to ALDH1 (a stem-cell marker) and prognosis than Document B's focus on HER2 and chemotherapy response. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698410Z"}
{"comparison_id":"4792327d-77e3-4ad7-9c09-aa5a6c8bdfb0","query_id":"53","doc_a_id":"31311495","doc_b_id":"45638119","presented_order":["31311495","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 as a marker and predictor of poor clinical outcome in breast cancer, matching the query. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698416Z"}
{"comparison_id":"c8755139-4e82-46c8-804d-3957dff3152e","query_id":"53","doc_a_id":"19673227","doc_b_id":"21033230","presented_order":["21033230","19673227"],"winner_id":"21033230","reasoning":"Document A is more relevant — it specifically studies prognostic markers in metastatic breast cancer, whereas B addresses chemosensitivity of CTCs across epithelial tumors generally.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698422Z"}
{"comparison_id":"3751283e-cae2-40cc-bb99-fef06fd061d0","query_id":"53","doc_a_id":"2130391","doc_b_id":"4583180","presented_order":["4583180","2130391"],"winner_id":"4583180","reasoning":"Document A is more relevant — it links tumor molecular changes to reduced survival (prognosis), whereas B focuses on adipocytes and invasion without addressing prognosis directly.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698428Z"}
{"comparison_id":"03bf0e92-2232-43f0-aac4-b0ae20e5f5db","query_id":"53","doc_a_id":"31311495","doc_b_id":"4455466","presented_order":["31311495","4455466"],"winner_id":"4455466","reasoning":"Document B — it discusses gene expression linked to prognosis in breast cancer (even though not ALDH1), while A focuses on tamoxifen resistance mechanisms without prognosis data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698435Z"}
{"comparison_id":"db19939a-0690-4a9c-9442-0d256fcc6653","query_id":"53","doc_a_id":"1866911","doc_b_id":"2130391","presented_order":["1866911","2130391"],"winner_id":"1866911","reasoning":"Document A is more relevant — it addresses progenitor/stem-like cell populations and markers related to breast tumor biology, which is closer to ALDH1 (a stem/progenitor marker) than the adipocyte-focused study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698442Z"}
{"comparison_id":"b65c9c86-c6de-4fc3-b71d-ee062ad7e0d3","query_id":"53","doc_a_id":"1171121","doc_b_id":"22401720","presented_order":["1171121","22401720"],"winner_id":"22401720","reasoning":"Document B — it examines expression of molecular markers in breast cancer and links marker levels (e.g., VEGF) to prognosis, whereas A focuses on MVD and p53 without addressing marker expression like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698448Z"}
{"comparison_id":"1bd44edb-3796-428e-9283-4f84b32708d7","query_id":"53","doc_a_id":"19673227","doc_b_id":"4429932","presented_order":["4429932","19673227"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses a molecular marker (LOX) linked to poor outcomes in breast cancer, which is closer to the claim about a biomarker predicting prognosis than the CTC chemosensitivity assay in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698455Z"}
{"comparison_id":"66e53ee0-adb4-4530-9443-1ddd83198053","query_id":"53","doc_a_id":"825728","doc_b_id":"8963413","presented_order":["8963413","825728"],"winner_id":"825728","reasoning":"Document B — it links EMT/stem-cell properties to metastatic behavior and patient survival, which is more relevant to ALDH1 (a stemness marker) and prognosis than a PD-L1–focused paper.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698462Z"}
{"comparison_id":"8c5ed07f-ee45-4aee-924b-eadfa5f68e26","query_id":"53","doc_a_id":"16086778","doc_b_id":"20127522","presented_order":["20127522","16086778"],"winner_id":"20127522","reasoning":"Document A is more focused on prognostic markers in breast cancer (CTC levels and survival), making it slightly more relevant to a claim about a prognostic biomarker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698468Z"}
{"comparison_id":"1d5bfa22-e2c3-4551-8be2-54760d02e165","query_id":"53","doc_a_id":"1379127","doc_b_id":"4455466","presented_order":["1379127","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it discusses gene expression levels linked to prognosis in breast cancer (though a different gene), while A focuses on calcium-entry proteins unrelated to prognostic marker expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698474Z"}
{"comparison_id":"b98607c0-3b3b-4d30-934e-b509d25b75b2","query_id":"53","doc_a_id":"22482820","doc_b_id":"4702639","presented_order":["22482820","4702639"],"winner_id":"4702639","reasoning":"Neither document mentions ALDH1. Document B is more related because it addresses tumour stemness and stem-cell markers linked to poor outcome and therapy resistance, whereas A focuses on combination therapy delivery strategies. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698480Z"}
{"comparison_id":"e52a6827-ccf5-4829-9e7f-f721a59da088","query_id":"53","doc_a_id":"1171121","doc_b_id":"7795952","presented_order":["7795952","1171121"],"winner_id":"1171121","reasoning":"Document B — it addresses prognostic factors in breast cancer specifically, whereas A discusses fascin in tumor invasion but not breast-cancer prognostic markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698486Z"}
{"comparison_id":"0afe7faf-915a-4d67-a71d-c73c74aa966c","query_id":"53","doc_a_id":"12762485","doc_b_id":"21033230","presented_order":["21033230","12762485"],"winner_id":"12762485","reasoning":"Doc B — it links a stem-cell phenotype in breast cancer (associated with poorer differentiation and higher proliferation) to prognosis, which is more relevant to ALDH1's stemness/prognostic role. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698492Z"}
{"comparison_id":"cdceb43f-8835-4540-85ca-a23c528e0571","query_id":"53","doc_a_id":"12762485","doc_b_id":"2130391","presented_order":["12762485","2130391"],"winner_id":"12762485","reasoning":"Document A — it discusses stem-cell–like phenotypes and prognostic markers in breast cancer (more directly related to ALDH1 as a stem cell marker); Document B is about adipocytes and invasion. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698499Z"}
{"comparison_id":"0f0693ab-e3cb-4754-8c20-c000a3bb33ce","query_id":"53","doc_a_id":"19358586","doc_b_id":"29495185","presented_order":["29495185","19358586"],"winner_id":"29495185","reasoning":"Document A broadly covers molecular predictors of cancer prognosis (more likely to mention markers like ALDH1), while Document B focuses on a specific p27/Myc/phospho-Rb/miRNA signature unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698505Z"}
{"comparison_id":"7060cd94-e3c1-41c0-a86a-1215578e6c49","query_id":"53","doc_a_id":"31311495","doc_b_id":"4429932","presented_order":["31311495","4429932"],"winner_id":"4429932","reasoning":"Document B is more relevant — it discusses factors (LOX) linked to poor patient outcomes in breast cancer, which relates to prognosis, whereas Document A focuses on tamoxifen resistance and EMT without addressing prognosis markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698512Z"}
{"comparison_id":"2cd5c3c9-7dec-4caa-a22b-286bbc277756","query_id":"53","doc_a_id":"4429932","doc_b_id":"5649538","presented_order":["4429932","5649538"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses a molecular marker (LOX) associated with poor outcomes in breast cancer, which is closer to the claim about a prognostic marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698518Z"}
{"comparison_id":"2ba3a73e-214c-4108-ad6d-da5400707b8e","query_id":"53","doc_a_id":"22482820","doc_b_id":"4418878","presented_order":["22482820","4418878"],"winner_id":"4418878","reasoning":"Reason: Document B addresses gene expression signatures and their links to cancer subtype classification and prognosis, which is directly relevant to a claim about ALDH1 (a gene expression marker) and prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698524Z"}
{"comparison_id":"01fcfc75-c56a-4e3c-a53a-f5c5194ee06f","query_id":"53","doc_a_id":"18953920","doc_b_id":"24834968","presented_order":["18953920","24834968"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses acquisition of stem-cell markers and increased tumorigenic potential in breast epithelial cells, which relates to markers like ALDH1 and prognosis. Document B addresses HER-2/neu and chemo response, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698530Z"}
{"comparison_id":"27283f01-1b3e-4f60-b18f-86bb6984f470","query_id":"53","doc_a_id":"15832146","doc_b_id":"8963413","presented_order":["15832146","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant because it discusses biomarker expression (PD-L1) and its association with clinical outcomes in breast cancer, which is closer to the query about ALDH1 as a prognostic biomarker.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698568Z"}
{"comparison_id":"1940abca-d5a6-4197-89a6-a657506ec31d","query_id":"53","doc_a_id":"16086778","doc_b_id":"1866911","presented_order":["16086778","1866911"],"winner_id":"1866911","reasoning":"Document B is more relevant — it discusses luminal progenitor cell populations and markers related to stem/progenitor phenotypes in breast cancer, which is closer to ALDH1 (a stem/progenitor marker) than Document A's focus on Numb/Notch signaling.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698576Z"}
{"comparison_id":"8103843b-8dae-4f1a-a3e7-5895cc142ba8","query_id":"53","doc_a_id":"24341590","doc_b_id":"43385013","presented_order":["43385013","24341590"],"winner_id":"43385013","reasoning":"Document A is more relevant — it addresses breast epithelial/mesenchymal subpopulations and stem cell/progenitor markers (context where ALDH1 is typically discussed), while B concerns CYP2D6/tamoxifen pharmacogenetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698582Z"}
{"comparison_id":"25f1f784-4f8b-4600-83ce-69bd28fac531","query_id":"53","doc_a_id":"20333864","doc_b_id":"24341590","presented_order":["20333864","24341590"],"winner_id":"20333864","reasoning":"Document A is more relevant — it addresses molecular features of breast tumor progression and prognosis-related processes (invasion), whereas Document B focuses on CYP2D6 pharmacogenetics unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698589Z"}
{"comparison_id":"169dcbe6-7ec8-4bb0-b432-95dc0dc3f1a1","query_id":"53","doc_a_id":"2130391","doc_b_id":"22401720","presented_order":["2130391","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant — it examines expression of molecular markers in breast cancer and their relation to prognosis (e.g., VEGF linked to poor outcome), which is conceptually closer to an ALDH1–prognosis question.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698595Z"}
{"comparison_id":"423c16f3-e092-47e2-9179-0bb284f7d406","query_id":"53","doc_a_id":"15832146","doc_b_id":"43385013","presented_order":["43385013","15832146"],"winner_id":"43385013","reasoning":"Document A is more relevant — it addresses breast epithelial/mesenchymal subpopulations and stem cell/progenitor properties (related to ALDH1 as a stem cell marker), whereas B focuses on CAFs and SDF-1/CXCL12. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698601Z"}
{"comparison_id":"899e2dec-4828-492c-adca-6d7997741a7d","query_id":"53","doc_a_id":"24834968","doc_b_id":"313403","presented_order":["24834968","313403"],"winner_id":"313403","reasoning":"Document B — it addresses a biomarker (TAM infiltration) linked to poorer prognosis in breast cancer, which is closer to the query about a prognostic marker (ALDH1). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698607Z"}
{"comparison_id":"3a2af0ae-7ff6-4dc0-819c-62f7acc4faef","query_id":"53","doc_a_id":"21033230","doc_b_id":"29495185","presented_order":["21033230","29495185"],"winner_id":"21033230","reasoning":"Document A is more specifically about molecular markers and prognostic value in breast cancer (CTC profiling), so it's more relevant to a claim about a molecular marker like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698613Z"}
{"comparison_id":"350418ca-6060-4aa9-aecb-1ae735ce6496","query_id":"53","doc_a_id":"20333864","doc_b_id":"8963413","presented_order":["20333864","8963413"],"winner_id":"20333864","reasoning":"Reason: Document A specifically discusses mechanisms in breast carcinoma progression, so it's more directly related to prognosis in breast cancer than Document B, which focuses on PD-L1 across cancers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698620Z"}
{"comparison_id":"59694678-5833-4f7f-9db3-ae7b326563f2","query_id":"53","doc_a_id":"18953920","doc_b_id":"31311495","presented_order":["18953920","31311495"],"winner_id":"18953920","reasoning":"Document A is more relevant — it links EMT to acquisition of stem-cell markers and increased tumorigenicity, which relates to ALDH1 as a stem-cell marker associated with poor prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698626Z"}
{"comparison_id":"531b4c45-9801-463a-8892-b07ee59d7b0e","query_id":"53","doc_a_id":"12762485","doc_b_id":"25973484","presented_order":["25973484","12762485"],"winner_id":"12762485","reasoning":"Document B — discusses stem-cell–like phenotype (linked to poor differentiation and higher proliferation), which is more relevant to ALDH1 (a stem cell marker) than Document A about obesity. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698633Z"}
{"comparison_id":"8d34fd2d-380c-47c8-963b-e83ddf9a15f5","query_id":"53","doc_a_id":"11484808","doc_b_id":"2931832","presented_order":["2931832","11484808"],"winner_id":"2931832","reasoning":"Document A is more relevant because it addresses prognostic biomarkers specifically in breast cancer, while Document B focuses on non-coding RNAs in endocrine cancers and does not pertain to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698639Z"}
{"comparison_id":"d2fbeafa-9bd4-44e5-9d56-a82ac5761afd","query_id":"53","doc_a_id":"15832146","doc_b_id":"2931832","presented_order":["15832146","2931832"],"winner_id":"2931832","reasoning":"Document B is more relevant — it directly studies prognostic biomarkers in breast cancer, whereas A focuses on stromal fibroblasts and tumor biology rather than prognostic marker expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698646Z"}
{"comparison_id":"dd9f5690-48d9-44a6-b773-b58118b65a82","query_id":"53","doc_a_id":"29366489","doc_b_id":"45638119","presented_order":["45638119","29366489"],"winner_id":"45638119","reasoning":"Document A is directly about ALDH1 as a marker in human mammary (breast) cancer and states it predicts poor clinical outcome; Document B is unrelated (DLC‑1). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698651Z"}
{"comparison_id":"a01a4e1a-eb55-4eb2-b553-68489cef1641","query_id":"53","doc_a_id":"22401720","doc_b_id":"22482820","presented_order":["22482820","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant — it examines expression of tumor markers in breast cancer and their links to prognosis (e.g., VEGF and poor outcome), whereas A focuses on combination therapies and drug delivery. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698658Z"}
{"comparison_id":"b7069b98-0fc5-4a37-abd2-a0d7dba40d13","query_id":"53","doc_a_id":"313403","doc_b_id":"5649538","presented_order":["313403","5649538"],"winner_id":"313403","reasoning":"Document A is about a prognostic marker in breast cancer (TAM density) and therefore more relevant to a claim about a marker's association with prognosis; Document B concerns therapy selection markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698664Z"}
{"comparison_id":"c7e90be7-33e5-4747-8dea-2bcdfd6e7c6d","query_id":"53","doc_a_id":"4583180","doc_b_id":"4702639","presented_order":["4702639","4583180"],"winner_id":"4702639","reasoning":"Document A is more relevant — it addresses tumour stemness and markers linked to stem-like properties (which relate to ALDH1 as a CSC marker), whereas Document B focuses on SREBP2 and cholesterol metabolism unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698671Z"}
{"comparison_id":"9098cd43-a027-4e8e-bed2-89812657ca93","query_id":"53","doc_a_id":"15946643","doc_b_id":"4889228","presented_order":["4889228","15946643"],"winner_id":"4889228","reasoning":"Document A is more relevant — it discusses a specific gene's expression correlating with poor prognosis in breast cancer, which is the same type of evidence sought about ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698678Z"}
{"comparison_id":"7fc4bc17-88aa-4b77-b5e6-aa72316d1292","query_id":"53","doc_a_id":"1866911","doc_b_id":"4889228","presented_order":["4889228","1866911"],"winner_id":"1866911","reasoning":"Document B is more relevant — it concerns breast cancer cell populations and marker expression (progenitor markers), which is closer to ALDH1's role as a prognostic marker than Document A's focus on splicing factors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698684Z"}
{"comparison_id":"e9ef2571-2568-4d28-9f46-54d1c0984dce","query_id":"53","doc_a_id":"2014909","doc_b_id":"4889228","presented_order":["2014909","4889228"],"winner_id":"2014909","reasoning":"Document A is marginally more relevant — it analyzes tumor-initiating cells in primary breast cancers (ALDH1 is a cancer stem cell marker), whereas Document B concerns TDP43 in TNBC and does not relate to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698691Z"}
{"comparison_id":"b0e84630-edf6-4be3-bd48-6aad9f370b20","query_id":"53","doc_a_id":"31311495","doc_b_id":"34066665","presented_order":["31311495","34066665"],"winner_id":"34066665","reasoning":"Document B — it's a clinical review on ER/HER signaling and endocrine resistance, so it's more likely to discuss prognostic biomarkers like ALDH1 than the MCF7-focused mechanistic study in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698697Z"}
{"comparison_id":"4bb2bd9a-e0c7-4595-b3f3-6e24b317758c","query_id":"53","doc_a_id":"19673227","doc_b_id":"45638119","presented_order":["19673227","45638119"],"winner_id":"45638119","reasoning":"Doc B directly studies ALDH1 in breast tissue and links its expression to poor clinical outcome; Doc A is about CTC chemosensitivity and unrelated to ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698703Z"}
{"comparison_id":"a672f73f-3075-4d6b-bcca-62574cbbc0ba","query_id":"53","doc_a_id":"1866911","doc_b_id":"45638119","presented_order":["45638119","1866911"],"winner_id":"45638119","reasoning":"Doc A directly reports that ALDH1 is a marker and predictor of poor clinical outcome in breast cancer, matching the claim. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698708Z"}
{"comparison_id":"0f3b1ac8-4af4-4c15-8e63-5019ff974372","query_id":"53","doc_a_id":"2130391","doc_b_id":"24834968","presented_order":["2130391","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it addresses biological markers and prognosis/response in breast cancer, whereas A focuses on adipocytes and invasion without biomarker data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698715Z"}
{"comparison_id":"73776bfc-0fd8-4971-accf-3e1ec36d6fac","query_id":"53","doc_a_id":"2130391","doc_b_id":"22482820","presented_order":["22482820","2130391"],"winner_id":"2130391","reasoning":"Document B is more relevant — it discusses factors (invasion, tumor progression, lymph node involvement) tied to prognosis in breast cancer, which is closer to the claim about ALDH1 and poor prognosis. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698721Z"}
{"comparison_id":"6e6d9a96-021f-4c07-bf2f-b3428133d3b9","query_id":"53","doc_a_id":"1866911","doc_b_id":"27240667","presented_order":["1866911","27240667"],"winner_id":"1866911","reasoning":"Document A is more focused on cellular markers and tumor origins in breast cancer (relevant to marker–prognosis associations); Document B is epidemiological mortality trends and not about molecular markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698727Z"}
{"comparison_id":"6341fb28-24eb-4a3c-a735-842859c4807a","query_id":"53","doc_a_id":"5649538","doc_b_id":"7795952","presented_order":["7795952","5649538"],"winner_id":"7795952","reasoning":"Doc A discusses a protein whose overexpression is linked to poor cancer prognosis, so it's more directly relevant to a claim about marker expression and prognosis than Doc B's focus on drug-sensitivity predictors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698734Z"}
{"comparison_id":"fd051d83-d90c-4a2d-ab9a-6b8850982624","query_id":"53","doc_a_id":"12762485","doc_b_id":"825728","presented_order":["12762485","825728"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses stem-cell–like phenotypes and prognostic markers in breast cancer, whereas B focuses on Prrx1 and metastatic colonization mechanisms not specific to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698740Z"}
{"comparison_id":"3614dd1c-b446-4509-a2c6-62e88289054d","query_id":"53","doc_a_id":"11484808","doc_b_id":"2014909","presented_order":["11484808","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — it analyzes tumor-initiating cells and primary breast cancers, which is more likely to address ALDH1 (a tumor-initiating cell marker) and its prognostic significance than a review focused on non-coding RNAs.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698747Z"}
{"comparison_id":"381fd3d2-bbbe-4be4-81a5-4fdd98803e15","query_id":"53","doc_a_id":"20127522","doc_b_id":"4455466","presented_order":["4455466","20127522"],"winner_id":"4455466","reasoning":"Document A is more relevant — it discusses a molecular marker's expression level being linked to breast cancer prognosis, similar to ALDH1 expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698753Z"}
{"comparison_id":"f5f1f618-297c-46b0-bf2e-cd7fa35353cc","query_id":"53","doc_a_id":"15113221","doc_b_id":"21902400","presented_order":["21902400","15113221"],"winner_id":"15113221","reasoning":"Document B is slightly more relevant — it discusses gene expression signatures linked to poor prognosis in carcinomas, which is closer to the claim about a prognostic biomarker than the general hypoxia review.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698760Z"}
{"comparison_id":"baa1b980-140f-4fd9-8e97-c50c21faa28c","query_id":"53","doc_a_id":"11484808","doc_b_id":"7821634","presented_order":["7821634","11484808"],"winner_id":"7821634","reasoning":"Document A is more relevant — it discusses factors tied to poor outcomes in breast cancer (though not ALDH1 specifically), while B focuses on ncRNAs in endocrine cancers generally.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698766Z"}
{"comparison_id":"98b7d731-4606-47cb-92e7-f979ef3b8f63","query_id":"53","doc_a_id":"20127522","doc_b_id":"34066665","presented_order":["34066665","20127522"],"winner_id":"34066665","reasoning":"Document A is more relevant — it discusses molecular markers and signaling pathways in breast cancer and their clinical/prognostic implications, which is closer to ALDH1 expression and prognosis than CTC enumeration.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698773Z"}
{"comparison_id":"0820e86a-9cf7-48df-97ca-ea6612081d3d","query_id":"53","doc_a_id":"20333864","doc_b_id":"4418878","presented_order":["20333864","4418878"],"winner_id":"4418878","reasoning":"Reason: Document B discusses gene expression signatures and their links to prognosis in cancers, which is more directly relevant to a claim about ALDH1 expression (a gene marker) being associated with breast cancer prognosis. Document A focuses on cellular interactions in DCIS progression and doesn't mention ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698780Z"}
{"comparison_id":"a4e53056-7a76-4cc4-9c07-5758ef887ccc","query_id":"53","doc_a_id":"16086778","doc_b_id":"4455466","presented_order":["4455466","16086778"],"winner_id":"4455466","reasoning":"Document A discusses a gene whose expression level is linked to prognosis in breast cancer, matching the query's focus on marker expression and outcome; Document B focuses on Numb/Notch signaling without linking expression to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698786Z"}
{"comparison_id":"e5a10571-f050-4253-ae72-81a843800760","query_id":"53","doc_a_id":"1171121","doc_b_id":"7821634","presented_order":["1171121","7821634"],"winner_id":"7821634","reasoning":"Neither abstract mentions ALDH1. Document B is more relevant because it addresses molecular markers linked to poor outcomes and chemotherapy resistance in breast cancer, which is closer to the claim's topic than Document A (which focuses on MVD and p53). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698793Z"}
{"comparison_id":"e776f3ea-ee4e-4bae-bbaf-5b00e2b69384","query_id":"53","doc_a_id":"12762485","doc_b_id":"19358586","presented_order":["19358586","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses a stem-cell phenotype (linked to poor differentiation, higher proliferation, ER/PgR negativity) which is more directly related to ALDH1 as a stem-cell marker than Document A. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698800Z"}
{"comparison_id":"7a1c43fd-9c8c-4e98-bc7d-d8a89411355c","query_id":"53","doc_a_id":"20127522","doc_b_id":"20333864","presented_order":["20333864","20127522"],"winner_id":"20333864","reasoning":"Doc A — it addresses molecular mechanisms and markers involved in breast tumor progression (more relevant to marker-linked prognosis); Doc B focuses on circulating tumor cells and treatment monitoring.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698807Z"}
{"comparison_id":"777a8f04-7a7f-46a9-9f68-f7e60c6e7f6a","query_id":"53","doc_a_id":"16086778","doc_b_id":"4429932","presented_order":["4429932","16086778"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses a molecular marker (LOX) being associated with poor outcomes in breast cancer, which is closer to the prognosis-focused claim than Document B's signaling/regulation study. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698814Z"}
{"comparison_id":"6d8ce669-8afe-4ed3-b714-3c04e7823466","query_id":"53","doc_a_id":"19358586","doc_b_id":"19673227","presented_order":["19358586","19673227"],"winner_id":"19358586","reasoning":"Document A is more relevant because it discusses a protein signature linked to poor survival in breast cancer, whereas Document B focuses on CTC chemosensitivity and does not address prognostic markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698820Z"}
{"comparison_id":"e97009c6-042d-459c-8392-a0a60e1e489c","query_id":"53","doc_a_id":"11484808","doc_b_id":"4429932","presented_order":["4429932","11484808"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses expression of a cancer-associated enzyme linked to poor outcomes in breast cancer, whereas Document B focuses on ncRNAs in endocrine cancers and is less directly related.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698827Z"}
{"comparison_id":"a3fc339b-45b4-40c3-a9b2-f0d0f1902169","query_id":"53","doc_a_id":"12762485","doc_b_id":"20183360","presented_order":["20183360","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses stem‑cell phenotypes and clinical correlations (markers, prognosis-related features), which is more directly relevant to ALDH1 as a stem-cell marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698833Z"}
{"comparison_id":"692fad53-6f93-41c8-86b7-3221cc7c8ba2","query_id":"53","doc_a_id":"15113221","doc_b_id":"25732836","presented_order":["25732836","15113221"],"winner_id":"15113221","reasoning":"Document B is more relevant — it discusses a gene expression signature associated with poor prognosis, which is closer to an expression-based prognostic marker like ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698839Z"}
{"comparison_id":"377f81ed-16a5-4cb5-b052-ea1c758e5a4e","query_id":"53","doc_a_id":"19673227","doc_b_id":"7821634","presented_order":["7821634","19673227"],"winner_id":"7821634","reasoning":"Document A is more relevant — it directly addresses prognosis in breast cancer (residual/basal-like tumors and outcomes), whereas Document B discusses a general CTC chemosensitivity assay across epithelial tumors and not ALDH1 or breast-cancer-specific prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698846Z"}
{"comparison_id":"33deb465-6520-426f-a48b-305d6b1c1316","query_id":"53","doc_a_id":"21902400","doc_b_id":"5649538","presented_order":["21902400","5649538"],"winner_id":"5649538","reasoning":"Document B is more relevant — it deals with gene expression markers in breast cancer, which is directly related to claims about expression (like ALDH1) and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698853Z"}
{"comparison_id":"43ab55eb-9680-4165-bbc0-fc593fe1d7e4","query_id":"53","doc_a_id":"29495185","doc_b_id":"3285322","presented_order":["3285322","29495185"],"winner_id":"29495185","reasoning":"Document B — it discusses molecular predictors of cancer prognosis (the category ALDH1 falls into), while Document A focuses on BRCA mutation clinical features and not ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698859Z"}
{"comparison_id":"6e662bee-7a2f-4d86-8450-4f20d3edfb98","query_id":"53","doc_a_id":"15946643","doc_b_id":"34066665","presented_order":["15946643","34066665"],"winner_id":"15946643","reasoning":"Document A is more relevant — it addresses chemoresistance and metastasis in breast cancer and is more likely to discuss stem-cell–related markers (like ALDH1) and prognosis, whereas Document B focuses on ER/HER signaling and endocrine resistance without relating to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698866Z"}
{"comparison_id":"b1e59ffb-57ad-4150-b910-4fb8a9d80fa9","query_id":"53","doc_a_id":"1866911","doc_b_id":"4455466","presented_order":["1866911","4455466"],"winner_id":"4455466","reasoning":"Document B — it links gene expression to prognosis in breast cancer (though not ALDH1); Document A does not address prognosis or ALDH1.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698872Z"}
{"comparison_id":"b3ecf92a-0e79-4ad3-895b-93d849768d03","query_id":"53","doc_a_id":"4455466","doc_b_id":"7795952","presented_order":["7795952","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it directly discusses a molecular marker (ZMYND11) whose expression level is linked to prognosis in breast cancer, whereas Document A focuses on fascin and TGFβ without breast-specific prognostic data. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698878Z"}
{"comparison_id":"6225347f-6bf4-4cff-8d99-cd31cb2c2256","query_id":"53","doc_a_id":"15946643","doc_b_id":"2931832","presented_order":["15946643","2931832"],"winner_id":"15946643","reasoning":"Document A is more related to molecular markers and mechanisms of breast cancer aggressiveness and prognosis (chemoresistance/metastasis), whereas Document B focuses on a platelet-based prognostic metric unrelated to ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698885Z"}
{"comparison_id":"74813537-aa1d-4ed9-9649-13fc783cf6c7","query_id":"53","doc_a_id":"24834968","doc_b_id":"4889228","presented_order":["4889228","24834968"],"winner_id":"4889228","reasoning":"Document A — it discusses a marker whose high expression correlates with poor prognosis in breast cancer (TNBC), which is conceptually closer to the ALDH1 prognosis claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698891Z"}
{"comparison_id":"cd7a80ea-911f-4abf-8b6a-6985816b1593","query_id":"53","doc_a_id":"1171121","doc_b_id":"24834968","presented_order":["24834968","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it addresses prognostic biomarkers and survival associations in breast cancer, while Document A focuses on HER2 and chemotherapy response. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698898Z"}
{"comparison_id":"50ef24bb-eb67-43d8-a056-59d22aa8b76b","query_id":"53","doc_a_id":"15832146","doc_b_id":"25973484","presented_order":["25973484","15832146"],"winner_id":"25973484","reasoning":"Document A is more relevant — it discusses factors tied to breast cancer prognosis and aggressive tumor phenotypes, which relate to the claim about markers linked to poorer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698904Z"}
{"comparison_id":"758ac7ad-2dbb-492e-bdd9-0e3d206875c7","query_id":"53","doc_a_id":"18953920","doc_b_id":"24341590","presented_order":["24341590","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses acquisition of stem-cell markers and tumorigenic potential in mammary cells (closely related to ALDH1 as a breast cancer stem-cell marker), whereas A is about CYP2D6/tamoxifen. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698911Z"}
{"comparison_id":"c3314ff4-b4eb-4363-9026-3fd50dad5b5d","query_id":"53","doc_a_id":"19358586","doc_b_id":"20183360","presented_order":["20183360","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — although neither mentions ALDH1, B directly links a protein signature to poor survival in breast cancer, whereas A focuses on invasion mechanisms without prognosis data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698917Z"}
{"comparison_id":"488d8186-62ae-418d-9752-efacabce9fbc","query_id":"53","doc_a_id":"29366489","doc_b_id":"4429932","presented_order":["29366489","4429932"],"winner_id":"4429932","reasoning":"Document B is more relevant — it directly links a molecular marker (LOX) to poor outcomes in breast cancer, whereas A discusses DLC-1 generally and not prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698923Z"}
{"comparison_id":"108a5e80-2e6b-4ccd-bf05-c4e9538e4744","query_id":"53","doc_a_id":"12762485","doc_b_id":"4889228","presented_order":["4889228","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses stem-cell phenotypes and prognostic associations in breast cancer, which is more relevant to ALDH1 (a stem-cell marker) than Document A about TDP43. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698929Z"}
{"comparison_id":"e80b2c94-78c2-481a-85e2-4c9fd9d9cb6d","query_id":"53","doc_a_id":"2014909","doc_b_id":"4583180","presented_order":["2014909","4583180"],"winner_id":"2014909","reasoning":"Document A — it analyzes primary breast cancers and tumor-initiating cells (which are often linked to ALDH1), so it's more likely to provide evidence about ALDH1 and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698936Z"}
{"comparison_id":"3eecbefa-a370-4538-9af6-f285c8597b0b","query_id":"53","doc_a_id":"2130391","doc_b_id":"25732836","presented_order":["25732836","2130391"],"winner_id":"25732836","reasoning":"Document A focuses on prognostic markers and outcome prediction in breast cancer, which is more directly relevant to a claim about prognosis; Document B addresses tumor-adipocyte interactions and invasion. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698942Z"}
{"comparison_id":"4e5f6d3a-3f5b-4d39-8aee-811b0fc9683b","query_id":"53","doc_a_id":"25973484","doc_b_id":"4429932","presented_order":["25973484","4429932"],"winner_id":"4429932","reasoning":"Document B is more relevant — it discusses a molecular marker (LOX) linked to poor outcomes and metastasis in breast cancer, which is closer to the claim about a molecular prognostic marker (ALDH1) than the obesity-focused Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698948Z"}
{"comparison_id":"5558ed6f-50bb-4eae-b924-ede6693f2ebe","query_id":"53","doc_a_id":"15832146","doc_b_id":"3285322","presented_order":["3285322","15832146"],"winner_id":"3285322","reasoning":"Document A is more relevant — it addresses clinical/pathologic tumor features (grade, triple-negative status) tied to prognosis, which is closer to linking a marker like ALDH1 to outcomes than a paper on stromal SDF-1 signaling.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698955Z"}
{"comparison_id":"c965e78d-33d6-4713-a7e1-efbe68d30ce3","query_id":"53","doc_a_id":"15946643","doc_b_id":"20127522","presented_order":["20127522","15946643"],"winner_id":"20127522","reasoning":"Document A is more relevant — it concerns a biomarker's association with poorer prognosis in breast cancer, which is closer to the claim about ALDH1 and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698961Z"}
{"comparison_id":"430764a8-e9e5-4dfe-95c9-7e6fd4cb2078","query_id":"53","doc_a_id":"15832146","doc_b_id":"22482820","presented_order":["15832146","22482820"],"winner_id":"22482820","reasoning":"Document B is more relevant — it addresses breast cancer classification and treatment challenges broadly, which is likelier to discuss prognostic markers like ALDH1 than a paper focused narrowly on stromal fibroblasts and SDF-1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698968Z"}
{"comparison_id":"3df36e85-f8a5-4215-9e5a-e7ce06798358","query_id":"53","doc_a_id":"2931832","doc_b_id":"5649538","presented_order":["5649538","2931832"],"winner_id":"5649538","reasoning":"Reason: Document A discusses gene expression markers in breast cancer (more related to ALDH1 as a molecular marker), while Document B focuses on platelet-based prognostic measures unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698974Z"}
{"comparison_id":"5848f673-27c2-4f64-8e8e-c4bffe8e4615","query_id":"53","doc_a_id":"19673227","doc_b_id":"43385013","presented_order":["43385013","19673227"],"winner_id":"43385013","reasoning":"Document A is more relevant — it concerns breast epithelial/mesenchymal subpopulations and stem/progenitor properties (ALDH1 is a stem cell marker), whereas Document B focuses on CTC chemosensitivity across epithelial tumors and not breast stem cell markers or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698981Z"}
{"comparison_id":"42f1c212-4ca3-4db3-ba97-f3c1cc489d74","query_id":"53","doc_a_id":"27240667","doc_b_id":"2931832","presented_order":["2931832","27240667"],"winner_id":"2931832","reasoning":"Document A is more relevant — it evaluates a prognostic biomarker in breast cancer, which is closer to the claim about ALDH1 as a prognostic marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698987Z"}
{"comparison_id":"85ea7b88-3d6d-4a66-b415-53d4a9700e98","query_id":"53","doc_a_id":"22482820","doc_b_id":"29495185","presented_order":["29495185","22482820"],"winner_id":"29495185","reasoning":"Document A is more relevant — it addresses molecular predictors of recurrence and survival (prognostic markers) in cancer, which pertains to ALDH1's association with breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.698993Z"}
{"comparison_id":"c9ac9d54-0b3b-4f6c-9fb0-43a12e78db02","query_id":"53","doc_a_id":"19358586","doc_b_id":"4455466","presented_order":["4455466","19358586"],"winner_id":"4455466","reasoning":"DOCUMENT A is more relevant — it discusses how expression level of a marker is linked to prognosis in breast cancer, which is closer to the claim about ALDH1 expression and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699000Z"}
{"comparison_id":"1a289a7a-4899-44b6-9b06-b85b1c33b466","query_id":"53","doc_a_id":"19358586","doc_b_id":"8963413","presented_order":["8963413","19358586"],"winner_id":"8963413","reasoning":"Document A is slightly more relevant because it discusses marker expression (PD-L1) and its association with clinical outcomes in breast cancer, whereas Document B focuses on a different molecular signature and miRNAs without addressing prognostic marker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699006Z"}
{"comparison_id":"87acba56-6ec5-4781-8359-5a421daca5c2","query_id":"53","doc_a_id":"20183360","doc_b_id":"31311495","presented_order":["31311495","20183360"],"winner_id":"31311495","reasoning":"Document A — it discusses EMT-like behavior and increased aggressiveness/tumor progression in breast cancer, which is more directly related to markers (like ALDH1) linked to poorer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699012Z"}
{"comparison_id":"cf5833e7-bc6f-405d-b185-d5355c2a5e92","query_id":"53","doc_a_id":"15113221","doc_b_id":"22482820","presented_order":["15113221","22482820"],"winner_id":"15113221","reasoning":"Document A is more focused on gene expression signatures linked to poor prognosis, which is directly relevant to a claim about a prognostic marker; Document B focuses on treatment strategies. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699018Z"}
{"comparison_id":"15ab8629-cd88-43c5-be4f-ab17a0a66cbd","query_id":"53","doc_a_id":"18953920","doc_b_id":"4889228","presented_order":["4889228","18953920"],"winner_id":"18953920","reasoning":"Document B is more relevant — it links EMT to acquisition of stem-cell markers and increased tumorigenicity (ALDH1 is a known breast cancer stem-cell marker), while Document A focuses on TDP43/SRSF3 and doesn't mention ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699024Z"}
{"comparison_id":"fb87c750-725b-4397-bbaf-0d07aace11fc","query_id":"53","doc_a_id":"1379127","doc_b_id":"25732836","presented_order":["1379127","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant — it addresses prognostic markers in breast cancer, whereas A focuses on calcium-entry proteins and metastasis mechanisms. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699031Z"}
{"comparison_id":"d4a38086-e7b0-4ed9-b91c-dbcc6377de69","query_id":"53","doc_a_id":"31311495","doc_b_id":"4418878","presented_order":["31311495","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it addresses gene expression signatures and their link to prognosis in cancers, which is directly related to assessing ALDH1 expression and clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699037Z"}
{"comparison_id":"57895d4d-f327-4f7e-be79-f9eec10c810f","query_id":"53","doc_a_id":"4418878","doc_b_id":"4429932","presented_order":["4429932","4418878"],"winner_id":"4429932","reasoning":"Document A is more relevant because it specifically links a molecular marker (LOX) to poor patient outcomes in breast cancer, whereas Document B discusses general pathway signatures without addressing specific prognosis markers like ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699043Z"}
{"comparison_id":"60850f11-3fe4-49ab-93d6-b669fd453108","query_id":"53","doc_a_id":"15832146","doc_b_id":"18953920","presented_order":["15832146","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses acquisition of stem-cell markers and increased tumorigenic potential in mammary cells, which is directly relevant to ALDH1 as a stem-cell/prognostic marker.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699049Z"}
{"comparison_id":"55387224-58ee-4c58-b18a-736e6cf2bab3","query_id":"53","doc_a_id":"4889228","doc_b_id":"5649538","presented_order":["5649538","4889228"],"winner_id":"4889228","reasoning":"Document B is more relevant — it discusses gene expression associated with poor prognosis in breast cancer (TDP43 in TNBC), whereas Document A focuses on dasatinib sensitivity predictors and does not address prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699056Z"}
{"comparison_id":"1325f191-7b2c-4c44-997f-3454d67936ea","query_id":"53","doc_a_id":"16086778","doc_b_id":"8963413","presented_order":["8963413","16086778"],"winner_id":"8963413","reasoning":"Document A is more relevant because it discusses biomarker expression and clinical outcomes in breast cancer (though for PD-L1, not ALDH1), whereas Document B focuses on Numb/Notch signaling mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699062Z"}
{"comparison_id":"a7234491-0632-48ce-ba17-43edd61f383e","query_id":"53","doc_a_id":"29366489","doc_b_id":"5649538","presented_order":["5649538","29366489"],"winner_id":"5649538","reasoning":"Document A is more relevant because it addresses gene expression profiling in breast cancer, whereas Document B discusses a different gene (DLC-1) and is not breast-specific. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699068Z"}
{"comparison_id":"16c52df0-dddf-46bb-876a-4b18c263e3bb","query_id":"53","doc_a_id":"2130391","doc_b_id":"43385013","presented_order":["43385013","2130391"],"winner_id":"43385013","reasoning":"Document A is more relevant — it discusses stem cell/progenitor properties and epithelial/mesenchymal subpopulations in breast tissue, which relates to markers like ALDH1 and prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699074Z"}
{"comparison_id":"386ec1c0-c990-419c-9cb2-7418e41f91fc","query_id":"53","doc_a_id":"15832146","doc_b_id":"4455466","presented_order":["4455466","15832146"],"winner_id":"4455466","reasoning":"Document A is more relevant — it discusses expression of a molecular marker (though ZMYND11, not ALDH1) linked to poor breast cancer prognosis, whereas B focuses on fibroblasts and SDF-1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699081Z"}
{"comparison_id":"8e05d57b-8a18-46d9-9a31-54b7fc66e6e5","query_id":"53","doc_a_id":"18953920","doc_b_id":"20183360","presented_order":["18953920","20183360"],"winner_id":"18953920","reasoning":"Doc A — it discusses acquisition of stem-cell markers and increased tumorigenic potential in mammary epithelial cells, which is directly related to ALDH1 as a breast cancer stem-cell marker linked to prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699087Z"}
{"comparison_id":"984f1adf-d4f0-455c-92c7-00d18c4f1e5c","query_id":"53","doc_a_id":"24341590","doc_b_id":"5649538","presented_order":["24341590","5649538"],"winner_id":"5649538","reasoning":"Document B is more relevant — it deals with gene expression–based markers in breast cancer, which is closer to ALDH1 expression and prognosis than a study on CYP2D6 pharmacogenetics. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699093Z"}
{"comparison_id":"f4915305-6992-4d1b-bf21-41dd2522ec37","query_id":"53","doc_a_id":"15946643","doc_b_id":"3285322","presented_order":["3285322","15946643"],"winner_id":"3285322","reasoning":"Document A is more relevant — it discusses clinical/pathologic features and prognosis-related tumor characteristics in breast cancer (grade, subtype), while Document B focuses on CXCL1 signaling and chemoresistance without addressing ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699100Z"}
{"comparison_id":"9fa4d668-c565-4cfa-8cf0-0c2ca003286b","query_id":"53","doc_a_id":"24341590","doc_b_id":"8963413","presented_order":["24341590","8963413"],"winner_id":"8963413","reasoning":"Document B — it discusses biomarker expression (PD-L1) and its link to clinical outcomes in breast cancer, making it more relevant to a claim about ALDH1 expression and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699106Z"}
{"comparison_id":"7df7e3a9-47f3-4d6b-8ad2-d1cf00890cdd","query_id":"53","doc_a_id":"19673227","doc_b_id":"29495185","presented_order":["29495185","19673227"],"winner_id":"29495185","reasoning":"Document A is more relevant — it discusses molecular predictors of cancer prognosis (the category ALDH1 would fall into), whereas B focuses on chemosensitivity of circulating tumor cells, not ALDH1 or prognosis in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699113Z"}
{"comparison_id":"de2db147-c9ec-4446-bc99-65204151b138","query_id":"53","doc_a_id":"20127522","doc_b_id":"27240667","presented_order":["20127522","27240667"],"winner_id":"20127522","reasoning":"Document A is more relevant — it links a tumor biomarker (CTC levels) to prognosis in breast cancer, which is closer to evidence about ALDH1 expression and outcome than mortality trends by ER status. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699119Z"}
{"comparison_id":"6984a007-8946-4bb5-be6b-6842a4babc45","query_id":"53","doc_a_id":"1379127","doc_b_id":"5649538","presented_order":["5649538","1379127"],"winner_id":"5649538","reasoning":"Document A is more relevant — it addresses gene expression markers and patient selection/prognosis in breast cancer, whereas Document B focuses on calcium-entry proteins and metastasis, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699126Z"}
{"comparison_id":"ef095fe6-94c8-45d8-819d-f5ccd48a1b7d","query_id":"53","doc_a_id":"2130391","doc_b_id":"4702639","presented_order":["2130391","4702639"],"winner_id":"4702639","reasoning":"Document B — it addresses tumour stemness and stem-like markers/behavior relevant to ALDH1’s role as a cancer stem cell marker and prognosis, whereas A focuses on adipocytes and invasion. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699132Z"}
{"comparison_id":"a1b0b6f6-cd02-4799-b27f-c7d1c5af6c85","query_id":"53","doc_a_id":"18953920","doc_b_id":"4583180","presented_order":["18953920","4583180"],"winner_id":"18953920","reasoning":"Document A discusses stem-cell markers in mammary epithelial cells (relevant to ALDH1 as a breast cancer stem cell marker and prognosis), while B focuses on SREBP2 and pH unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699138Z"}
{"comparison_id":"636af8d8-43fa-4bb6-9d69-411175d02403","query_id":"53","doc_a_id":"2130391","doc_b_id":"4889228","presented_order":["4889228","2130391"],"winner_id":"4889228","reasoning":"Document A is more relevant — it links expression of a specific protein to prognosis in breast cancer, matching the claim's structure about a marker and outcome; Document B focuses on adipocytes and invasion, not marker–prognosis associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699145Z"}
{"comparison_id":"599e870f-6e99-4707-ab36-fcbfdcfb710c","query_id":"53","doc_a_id":"20183360","doc_b_id":"3285322","presented_order":["20183360","3285322"],"winner_id":"20183360","reasoning":"DOCUMENT A is more relevant — it addresses molecular drivers of invasiveness in breast cancer, which is closer to biomarker expression and prognosis than the BRCA-focused clinical study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699152Z"}
{"comparison_id":"0396bce5-38d0-4e33-a5bf-ba003c3dd78d","query_id":"53","doc_a_id":"15946643","doc_b_id":"20183360","presented_order":["20183360","15946643"],"winner_id":"15946643","reasoning":"Document B — it addresses chemoresistance and metastasis (key drivers of poor prognosis) and is thus more related to ALDH1's association with worse breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699158Z"}
{"comparison_id":"c59a4a77-855c-427d-91ca-ff11fc529960","query_id":"53","doc_a_id":"2931832","doc_b_id":"4702639","presented_order":["4702639","2931832"],"winner_id":"2931832","reasoning":"Document B — it directly addresses prognostic factors in breast cancer, whereas A focuses on integrin-driven stemness and drug resistance without mention of ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699164Z"}
{"comparison_id":"eccfefe9-e024-44f8-ac85-ab93601b02db","query_id":"53","doc_a_id":"21033230","doc_b_id":"27240667","presented_order":["27240667","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it discusses molecular markers and their prognostic value in breast cancer, whereas A only covers mortality trends by ER status and age. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699171Z"}
{"comparison_id":"316d9301-c184-48bb-bda0-690db4e3d948","query_id":"53","doc_a_id":"12762485","doc_b_id":"20839751","presented_order":["20839751","12762485"],"winner_id":"12762485","reasoning":"Document B — it links a stem-cell phenotype (which ALDH1 marks) to ER/PgR negativity and higher proliferative activity associated with worse outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699177Z"}
{"comparison_id":"0e5e1c6c-de7c-4e06-a76f-54ff01a4860b","query_id":"53","doc_a_id":"34066665","doc_b_id":"7795952","presented_order":["7795952","34066665"],"winner_id":"7795952","reasoning":"Neither mentions ALDH1, but Document A discusses a protein linked to poor prognosis and metastasis (more directly about prognosis), so it's marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699183Z"}
{"comparison_id":"24017655-de99-4b6d-a4b1-d965ebc5fafb","query_id":"53","doc_a_id":"43385013","doc_b_id":"4583180","presented_order":["43385013","4583180"],"winner_id":"43385013","reasoning":"Document A is more relevant — it concerns breast epithelial/mesenchymal subpopulations and stem/progenitor properties (where ALDH1 is a commonly discussed marker), whereas Document B focuses on SREBP2 and cholesterol metabolism unrelated to ALDH1/breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699189Z"}
{"comparison_id":"8c4b3627-09bf-4b9e-bf0a-292ea7ce14b8","query_id":"53","doc_a_id":"34066665","doc_b_id":"7583725","presented_order":["7583725","34066665"],"winner_id":"7583725","reasoning":"Document A is more relevant — it directly links expression of a specific protein to poor outcomes in breast cancer, matching the claim's structure about marker expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699196Z"}
{"comparison_id":"c5027dfd-5f31-4038-82cd-9853ec8e9e9f","query_id":"53","doc_a_id":"1866911","doc_b_id":"7795952","presented_order":["1866911","7795952"],"winner_id":"1866911","reasoning":"Document A is more relevant — it addresses breast cancer cell populations and progenitor markers (stem/progenitor context), which is closer to ALDH1's role as a stem cell/prognostic marker. Document B focuses on fascin/TGFβ-driven invasion, unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699203Z"}
{"comparison_id":"51e2ad39-ddb7-4649-873c-48de1e83857e","query_id":"53","doc_a_id":"16086778","doc_b_id":"17648235","presented_order":["16086778","17648235"],"winner_id":"16086778","reasoning":"Reason: Document A discusses dysregulation of a pathway (Numb/Notch) directly tied to human breast carcinogenesis and tumor behavior, which is more relevant to clinical prognosis than the cell-line-focused signaling findings in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699210Z"}
{"comparison_id":"ae4a6c94-3fd2-4a9e-86bf-97a1769c124a","query_id":"53","doc_a_id":"11484808","doc_b_id":"19358586","presented_order":["11484808","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant because it explicitly links a molecular signature to poor survival in breast cancer, whereas A is a general review of ncRNAs in endocrine cancers and does not specifically address ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699216Z"}
{"comparison_id":"b9216d0b-a916-488f-8a9d-dc93ec734cdb","query_id":"53","doc_a_id":"15832146","doc_b_id":"22401720","presented_order":["15832146","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant — it studies expression of tumor markers and links high expression (VEGF) to poor prognosis in breast cancer, which is closer to the claim about marker expression and prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699223Z"}
{"comparison_id":"44573bc4-017c-444a-af57-41ff29b32777","query_id":"53","doc_a_id":"16086778","doc_b_id":"43385013","presented_order":["16086778","43385013"],"winner_id":"43385013","reasoning":"Reason: Document B discusses stem cell/progenitor properties in breast cell subpopulations (context where ALDH1 is a relevant marker), whereas Document A focuses on Numb/Notch regulation without relation to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699229Z"}
{"comparison_id":"3839a00c-dbd7-4f2c-8967-f473b00026e3","query_id":"53","doc_a_id":"31311495","doc_b_id":"5649538","presented_order":["31311495","5649538"],"winner_id":"5649538","reasoning":"Document B is more relevant because it focuses on gene expression markers in breast cancer (potentially including prognostic markers), whereas Document A discusses tamoxifen resistance mechanisms unrelated to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699236Z"}
{"comparison_id":"0a5ea75a-45fb-4ad1-8124-05be459b66eb","query_id":"53","doc_a_id":"2130391","doc_b_id":"4455466","presented_order":["2130391","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it discusses gene expression levels linked to prognosis in breast cancer (though a different marker), while A focuses on adipocytes and invasion without prognostic marker data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699243Z"}
{"comparison_id":"bb44bf91-fb38-475a-8d5e-c62c4fb85bce","query_id":"53","doc_a_id":"22401720","doc_b_id":"25973484","presented_order":["25973484","22401720"],"winner_id":"22401720","reasoning":"Document B — it discusses molecular expression in tumors and links expression (e.g., VEGF) to prognosis, so it's closer to the claim about a marker's expression and outcome.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699249Z"}
{"comparison_id":"f6332899-8466-4ae1-831f-342c6205e9bc","query_id":"53","doc_a_id":"20839751","doc_b_id":"7583725","presented_order":["7583725","20839751"],"winner_id":"7583725","reasoning":"Document A is more relevant — it reports that high expression of a specific protein (TRPM7) predicts poor outcomes in breast cancer, which is directly analogous to the claim about ALDH1 expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699256Z"}
{"comparison_id":"fa405a38-c889-4d6b-90e3-f1e1e26130ea","query_id":"53","doc_a_id":"20183360","doc_b_id":"24834968","presented_order":["20183360","24834968"],"winner_id":"20183360","reasoning":"Document A — it addresses mechanisms of breast cancer invasiveness and progression (more related to prognosis) while Document B focuses on chemo-response markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699262Z"}
{"comparison_id":"a4dd7bb6-4b53-4983-ab34-245113968ae8","query_id":"53","doc_a_id":"19358586","doc_b_id":"20839751","presented_order":["20839751","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it examines molecular/protein expression signatures linked to poor survival in breast cancer, whereas A discusses apoptotic index rather than specific marker expression like ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699269Z"}
{"comparison_id":"03fb71cb-8419-4621-a1f8-ff4b585e3c0c","query_id":"53","doc_a_id":"4429932","doc_b_id":"4583180","presented_order":["4429932","4583180"],"winner_id":"4429932","reasoning":"Document A is more relevant because it specifically mentions poor patient outcomes in breast cancer, whereas Document B discusses general tumor progression and survival without breast-cancer-specific prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699275Z"}
{"comparison_id":"f616627e-628a-4926-9397-35a3404b8b32","query_id":"53","doc_a_id":"45638119","doc_b_id":"7821634","presented_order":["7821634","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 as a marker and predictor of poor clinical outcome in breast cancer, matching the query.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699281Z"}
{"comparison_id":"d98efa27-161f-42c8-8365-b0cf02a167e9","query_id":"53","doc_a_id":"25973484","doc_b_id":"825728","presented_order":["825728","25973484"],"winner_id":"825728","reasoning":"Document A is more relevant — it discusses cancer stem-cell properties and links a molecular factor to patient survival/metastasis, which is closer to an ALDH1 prognostic association than the obesity-focused review in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699288Z"}
{"comparison_id":"f765660b-8fad-43c5-8d3f-8f6992dc1b4c","query_id":"53","doc_a_id":"25732836","doc_b_id":"34066665","presented_order":["34066665","25732836"],"winner_id":"34066665","reasoning":"Document A is more likely to discuss molecular markers linked to prognosis (like ALDH1) and their clinical implications in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699293Z"}
{"comparison_id":"06bfb326-a376-4958-9dd5-cfcac323c789","query_id":"53","doc_a_id":"24834968","doc_b_id":"34066665","presented_order":["34066665","24834968"],"winner_id":"24834968","reasoning":"Document B discusses evaluation of biological markers as predictors of treatment response/prognosis in breast cancer, so it's more directly related to a claim about marker-associated prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699300Z"}
{"comparison_id":"55323738-2c46-4ca3-a2d7-8e2bef7b758c","query_id":"53","doc_a_id":"20333864","doc_b_id":"24834968","presented_order":["20333864","24834968"],"winner_id":"24834968","reasoning":"Neither abstract mentions ALDH1. Document B is slightly more relevant because it evaluates biological markers as predictors in breast cancer, whereas A focuses on cellular mechanisms of DCIS invasion. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699306Z"}
{"comparison_id":"3f862134-b269-4ccf-85cf-6c43eddae2bb","query_id":"53","doc_a_id":"1866911","doc_b_id":"4583180","presented_order":["1866911","4583180"],"winner_id":"1866911","reasoning":"Document A is more relevant because it addresses breast cancer cell populations and tumor origins, whereas Document B discusses a general tumor progression pathway without focus on breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699312Z"}
{"comparison_id":"a950f32b-c169-4ef7-9bc3-a7ded0e3eaa1","query_id":"53","doc_a_id":"27240667","doc_b_id":"4418878","presented_order":["27240667","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures and their link to prognosis, which relates to whether expression of a marker like ALDH1 associates with breast cancer outcome.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699318Z"}
{"comparison_id":"3f7c19fc-d323-46e8-96bb-b99912cf5aec","query_id":"53","doc_a_id":"17648235","doc_b_id":"20127522","presented_order":["20127522","17648235"],"winner_id":"20127522","reasoning":"Document A is more relevant because it discusses a biomarker (CTCs) linked to prognosis in breast cancer, whereas Document B focuses on WNT signaling without addressing prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699324Z"}
{"comparison_id":"e74a11d8-253b-46f9-bf81-a947f93b21c5","query_id":"53","doc_a_id":"17648235","doc_b_id":"20183360","presented_order":["20183360","17648235"],"winner_id":"20183360","reasoning":"Document A is slightly more relevant — it addresses mechanisms of breast cancer invasiveness and progression (which relate to prognosis), whereas Document B focuses on WNT-driven proliferation; neither mentions ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699331Z"}
{"comparison_id":"6eb7258a-f337-4b59-b510-3f60c8b5cb7b","query_id":"53","doc_a_id":"34066665","doc_b_id":"7821634","presented_order":["34066665","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it links specific molecular marker expression changes to tumor proliferation and poor outcomes in breast cancer, which is closer to the claim about a marker (ALDH1) being associated with prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699337Z"}
{"comparison_id":"3fa6e3cd-c5e9-4bca-bbbe-2cae851e71d0","query_id":"53","doc_a_id":"19673227","doc_b_id":"313403","presented_order":["19673227","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it discusses a tumor marker (TAM infiltration) linked to poorer prognosis in breast cancer, whereas Document A deals with CTC chemosensitivity profiling and not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699343Z"}
{"comparison_id":"d400e121-a585-4a2d-9eb4-c3af91e139d3","query_id":"53","doc_a_id":"17648235","doc_b_id":"4702639","presented_order":["4702639","17648235"],"winner_id":"4702639","reasoning":"Document A. It discusses tumor stemness and stem-cell markers/drivers (integrin αvβ3) and links stem-like properties to poor clinical behavior, which is more directly relevant to ALDH1 as a stem-cell marker associated with prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699350Z"}
{"comparison_id":"e59c0419-d6ca-41bf-8115-da75c06bd683","query_id":"53","doc_a_id":"21902400","doc_b_id":"313403","presented_order":["313403","21902400"],"winner_id":"313403","reasoning":"Document A is more relevant — it specifically addresses prognostic markers in breast cancer (albeit TAMs, not ALDH1), whereas B discusses hypoxia across cancers generally. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699356Z"}
{"comparison_id":"3b6ec049-1acc-4cc1-ab89-461268268bb8","query_id":"53","doc_a_id":"19673227","doc_b_id":"2014909","presented_order":["2014909","19673227"],"winner_id":"2014909","reasoning":"Document A is more relevant — it analyzes primary breast cancers and tumor-initiating cells (commonly associated with ALDH1) and links pathways to tumor progression; Document B focuses on CTC chemosensitivity and not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699362Z"}
{"comparison_id":"611c5243-dfd3-48f9-b6d0-5168ff2f86b9","query_id":"53","doc_a_id":"20839751","doc_b_id":"31311495","presented_order":["20839751","31311495"],"winner_id":"20839751","reasoning":"Document A is more related to prognosis factors in breast cancer (even though neither mentions ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699368Z"}
{"comparison_id":"5cafa6ad-7e77-43e8-9074-aa9ad3344c78","query_id":"53","doc_a_id":"15832146","doc_b_id":"825728","presented_order":["15832146","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it links EMT regulation, acquisition of stem-cell properties and patient survival (prognosis), whereas A focuses on CAFs and SDF-1/CXCL12 without addressing ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699374Z"}
{"comparison_id":"5bc2b0e5-04d4-4ced-b70f-8392c5b9ebe2","query_id":"53","doc_a_id":"3285322","doc_b_id":"45638119","presented_order":["45638119","3285322"],"winner_id":"45638119","reasoning":"Document A directly reports that ALDH1 marks mammary stem cells and predicts poor clinical outcome in breast cancer; Document B is about BRCA mutation characteristics and unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699380Z"}
{"comparison_id":"5d3c106c-1581-40e2-9f92-bc31a5c25e90","query_id":"53","doc_a_id":"1379127","doc_b_id":"29366489","presented_order":["1379127","29366489"],"winner_id":"1379127","reasoning":"Document A is more relevant because it specifically addresses breast cancer biology (metastasis/prognosis-related processes), while Document B discusses a general tumor suppressor in various cancers and does not focus on breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699387Z"}
{"comparison_id":"88aeb036-8f89-422e-b035-d09519e5b0bc","query_id":"53","doc_a_id":"15946643","doc_b_id":"19673227","presented_order":["19673227","15946643"],"winner_id":"15946643","reasoning":"Document B — it addresses breast cancer prognosis-related biology (chemoresistance and metastasis), so it's more relevant to a claim about markers linked to poorer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699393Z"}
{"comparison_id":"29660a37-0bf6-46c0-946e-b0a3f0ed6556","query_id":"53","doc_a_id":"15832146","doc_b_id":"25732836","presented_order":["25732836","15832146"],"winner_id":"25732836","reasoning":"Document A — it addresses prognostic markers and overall survival in metastatic breast cancer, so it's more related to prognosis than Document B. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699399Z"}
{"comparison_id":"404bec8f-0932-43b4-ae01-56cfed46abc2","query_id":"53","doc_a_id":"15946643","doc_b_id":"25973484","presented_order":["15946643","25973484"],"winner_id":"15946643","reasoning":"Document A is more focused on breast cancer biology (chemoresistance and metastasis), which is more directly relevant to biomarkers tied to prognosis like ALDH1; Document B addresses obesity-related risk and outcomes, not marker expression. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699405Z"}
{"comparison_id":"6f8780f4-c2d6-44c3-9840-5e849857d07d","query_id":"53","doc_a_id":"21033230","doc_b_id":"7795952","presented_order":["7795952","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it specifically addresses prognostic molecular markers and survival in metastatic breast cancer, whereas A discusses fascin and invasion without linking ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699412Z"}
{"comparison_id":"7907ed3f-7900-4c45-af57-5c9709409b72","query_id":"53","doc_a_id":"11484808","doc_b_id":"7795952","presented_order":["11484808","7795952"],"winner_id":"11484808","reasoning":"Document A is more likely to discuss biomarkers and clinical prognostic markers in endocrine-related (including breast) cancers, whereas Document B focuses on fascin and TGFβ, unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699419Z"}
{"comparison_id":"9a6a9da2-7eee-4638-85d7-789ae7351a89","query_id":"53","doc_a_id":"1379127","doc_b_id":"24341590","presented_order":["24341590","1379127"],"winner_id":"24341590","reasoning":"Document A is more relevant — it examines a molecular/genetic factor (CYP2D6) linked to recurrence and outcomes in breast cancer, which is closer to the claim about a biomarker (ALDH1) and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699425Z"}
{"comparison_id":"9ed89ea6-6794-42f8-a87d-b509e2affb4b","query_id":"53","doc_a_id":"20127522","doc_b_id":"4583180","presented_order":["4583180","20127522"],"winner_id":"20127522","reasoning":"Document B — it discusses a prognostic marker and survival in breast cancer (CTC levels linked to poorer progression), which is more directly related to the claim about a prognostic biomarker than Document A's SREBP2/tumor progression mechanism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699432Z"}
{"comparison_id":"93a3df11-e442-44f4-8149-385145385e3b","query_id":"53","doc_a_id":"31311495","doc_b_id":"3285322","presented_order":["31311495","3285322"],"winner_id":"3285322","reasoning":"Document B — it deals with clinical and pathologic characteristics (which relate to prognosis), whereas A is an in vitro mechanistic study unrelated to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699439Z"}
{"comparison_id":"b4c70ba2-6941-4e12-9df9-4e7477373d73","query_id":"53","doc_a_id":"45638119","doc_b_id":"7795952","presented_order":["7795952","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly reports that ALDH1 marks mammary (including malignant) stem cells and correlates with poor prognosis in breast cancer.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699445Z"}
{"comparison_id":"e9cbe869-fc74-433c-9ae6-3f443376f1a1","query_id":"53","doc_a_id":"19673227","doc_b_id":"3285322","presented_order":["3285322","19673227"],"winner_id":"3285322","reasoning":"Document A is more relevant — it concerns prognostic/pathologic features in breast cancer, whereas Document B focuses on chemosensitivity assays of circulating tumor cells across epithelial tumors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699451Z"}
{"comparison_id":"d69ac6b1-f332-4afd-8a17-e44cda38ffe2","query_id":"53","doc_a_id":"1866911","doc_b_id":"24834968","presented_order":["24834968","1866911"],"winner_id":"1866911","reasoning":"Document B — it discusses progenitor/stem-like cell populations in breast cancer (more related to ALDH1 as a stem/progenitor marker). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699457Z"}
{"comparison_id":"21f8473a-5bf5-48c6-933e-6cf3d0ff6428","query_id":"53","doc_a_id":"1379127","doc_b_id":"2014909","presented_order":["2014909","1379127"],"winner_id":"2014909","reasoning":"Document A is more relevant — it analyzes primary breast cancers and tumor-initiating cells (ALDH1 is a marker of tumor-initiating/cancer stem cells) and thus is more likely to bear on prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699463Z"}
{"comparison_id":"ae30ae0b-a524-4257-80e5-c4137a324625","query_id":"53","doc_a_id":"27240667","doc_b_id":"3285322","presented_order":["3285322","27240667"],"winner_id":"3285322","reasoning":"Document A is slightly more relevant because it discusses tumor biological features (triple-negative, high grade) linked to worse prognosis, which is closer to a marker-prognosis claim than broad mortality trends. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699469Z"}
{"comparison_id":"8868e201-bae5-4363-8c1b-25e240229373","query_id":"53","doc_a_id":"16086778","doc_b_id":"4702639","presented_order":["16086778","4702639"],"winner_id":"4702639","reasoning":"Document B is more relevant — it addresses tumor stemness markers and their link to aggressive, treatment‑resistant behavior, which is conceptually closer to ALDH1's role as a stem-cell marker tied to poor prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699476Z"}
{"comparison_id":"6be94983-e71c-4991-bb30-e2a562307fcb","query_id":"53","doc_a_id":"31311495","doc_b_id":"825728","presented_order":["825728","31311495"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT, acquisition of stem-cell properties and patient survival (closely related to ALDH1 as a stem-cell/prognostic marker), while B focuses on tamoxifen resistance mechanisms. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699482Z"}
{"comparison_id":"94dec7e9-b98f-43ca-bd28-f756eef074f6","query_id":"53","doc_a_id":"1866911","doc_b_id":"24341590","presented_order":["24341590","1866911"],"winner_id":"1866911","reasoning":"Document B is more relevant — it discusses progenitor cell markers and tumor cell origins (closer to ALDH1 as a stem/progenitor marker) whereas A focuses on CYP2D6 pharmacogenetics and tamoxifen response.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699488Z"}
{"comparison_id":"d844a9b2-e55b-41a2-ae48-a3857ab5a74a","query_id":"53","doc_a_id":"1379127","doc_b_id":"4702639","presented_order":["4702639","1379127"],"winner_id":"4702639","reasoning":"Document A is more relevant — it discusses tumour stemness and stem-cell–associated markers/drivers, which relates to ALDH1 as a cancer stem cell marker linked to prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699495Z"}
{"comparison_id":"4c49308e-8008-4ea4-b697-1da02d985e9e","query_id":"53","doc_a_id":"12762485","doc_b_id":"27240667","presented_order":["27240667","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses a stem-cell phenotype in breast cancer linked to poor prognostic features (p53+, ER/PgR-, high proliferation), which is more relevant to ALDH1 (a stem-cell marker) than A's general mortality trends.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699501Z"}
{"comparison_id":"eb10e5c6-c5f4-4067-98ce-763773a43ecb","query_id":"53","doc_a_id":"11484808","doc_b_id":"25973484","presented_order":["25973484","11484808"],"winner_id":"25973484","reasoning":"Document A is more relevant — it discusses breast cancer prognosis and factors linked to aggressive tumors, whereas Document B focuses on non-coding RNAs in endocrine cancers and not prognosis markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699526Z"}
{"comparison_id":"504ecf10-585d-45c4-9979-4cc049b8e5b0","query_id":"53","doc_a_id":"2014909","doc_b_id":"7795952","presented_order":["2014909","7795952"],"winner_id":"2014909","reasoning":"Document A is more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers, which relate to stem-cell markers like ALDH1 and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699538Z"}
{"comparison_id":"55a4c59f-76ca-4fbf-94d1-54061dcf1183","query_id":"53","doc_a_id":"27240667","doc_b_id":"4583180","presented_order":["4583180","27240667"],"winner_id":"27240667","reasoning":"Reason: Document B discusses breast cancer prognosis/mortality directly, while Document A addresses SREBP2 and general tumor progression not ALDH1 or breast-specific prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699546Z"}
{"comparison_id":"b0df5e7d-960f-4bc2-b70c-1835dcc09458","query_id":"53","doc_a_id":"15946643","doc_b_id":"29495185","presented_order":["15946643","29495185"],"winner_id":"29495185","reasoning":"Document B is more relevant because it addresses molecular predictors of treatment response and survival (biomarkers like ALDH1), while Document A focuses on CXCL1-mediated chemoresistance and metastasis unrelated to ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699553Z"}
{"comparison_id":"ed180107-cbe8-4626-ac0e-b52b4d040c6c","query_id":"53","doc_a_id":"12762485","doc_b_id":"7821634","presented_order":["12762485","7821634"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses a stem-cell phenotype in breast cancer (which relates to markers like ALDH1) and its association with poorer prognostic features, whereas Document B focuses on DUSP4 and chemo resistance without addressing ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699560Z"}
{"comparison_id":"6e4d631e-0b41-41ac-8565-0786713cd1d0","query_id":"53","doc_a_id":"25973484","doc_b_id":"34066665","presented_order":["25973484","34066665"],"winner_id":"34066665","reasoning":"Document B — it discusses molecular signaling and markers related to breast cancer prognosis/therapy resistance, making it slightly more relevant to a claim about a molecular marker like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699567Z"}
{"comparison_id":"d27d9dfa-6916-4c58-ae30-6ee235729abf","query_id":"53","doc_a_id":"25973484","doc_b_id":"29495185","presented_order":["25973484","29495185"],"winner_id":"29495185","reasoning":"Document B is more relevant — it discusses molecular predictors of treatment response and survival, which pertains to tumor markers like ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699573Z"}
{"comparison_id":"61b0f5e5-5ef5-48ee-bb37-f6d044fbeca2","query_id":"53","doc_a_id":"1379127","doc_b_id":"3285322","presented_order":["1379127","3285322"],"winner_id":"3285322","reasoning":"Document B is more relevant — it addresses clinical and pathologic features and prognosis-related differences in breast cancer, whereas A focuses on calcium channels and metastasis mechanisms unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699580Z"}
{"comparison_id":"8e4b31e8-1a92-4658-ab6a-128d02124189","query_id":"53","doc_a_id":"12762485","doc_b_id":"15113221","presented_order":["12762485","15113221"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses a stem-cell phenotype in breast cancer (which relates to ALDH1 as a stem cell marker) and its association with poor prognostic features. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699587Z"}
{"comparison_id":"b17ce77a-f94f-4a8b-8c14-16959ff54e50","query_id":"53","doc_a_id":"19673227","doc_b_id":"4455466","presented_order":["4455466","19673227"],"winner_id":"4455466","reasoning":"Document A is more relevant — it discusses gene expression linked to prognosis in breast cancer (though not ALDH1), whereas Document B concerns chemosensitivity of circulating tumor cells and not expression-based prognosis.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699593Z"}
{"comparison_id":"a84b3951-1062-43af-84a0-527b8384272d","query_id":"53","doc_a_id":"20333864","doc_b_id":"5649538","presented_order":["5649538","20333864"],"winner_id":"5649538","reasoning":"Document A is more relevant — it deals with gene expression markers in breast cancer (more likely to address markers like ALDH1) while B focuses on stromal cell roles in DCIS-to-invasive transition.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699600Z"}
{"comparison_id":"42eff1a4-5e24-42c4-a08c-79fac7b84a8b","query_id":"53","doc_a_id":"4889228","doc_b_id":"7795952","presented_order":["7795952","4889228"],"winner_id":"4889228","reasoning":"Document B is more relevant — it directly studies expression linked to prognosis in triple-negative breast cancer, whereas Document A discusses fascin in tumor cells and does not address breast cancer ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699606Z"}
{"comparison_id":"b9af968f-7340-483d-b534-33bc6a083190","query_id":"53","doc_a_id":"11484808","doc_b_id":"29495185","presented_order":["11484808","29495185"],"winner_id":"29495185","reasoning":"Document B focuses on molecular predictors of prognosis and survival (more directly relevant to biomarkers like ALDH1), while A is specific to non-coding RNAs rather than ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699612Z"}
{"comparison_id":"841afde4-f937-4bc5-bbff-014c525e942f","query_id":"53","doc_a_id":"2130391","doc_b_id":"825728","presented_order":["2130391","825728"],"winner_id":"825728","reasoning":"Reason: Document B discusses cancer cell stemness and links to patient survival, which is more directly related to ALDH1 (a cancer stem cell marker) and prognosis than Document A's focus on adipocytes and invasion.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699618Z"}
{"comparison_id":"25089498-7d29-472a-afa8-d2a5f0519318","query_id":"53","doc_a_id":"15832146","doc_b_id":"17648235","presented_order":["15832146","17648235"],"winner_id":"17648235","reasoning":"Neither abstract mentions ALDH1, but Document B (WNT signaling) is marginally more related to tumor cell–intrinsic pathways and stemness/proliferation relevant to ALDH1's role. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699624Z"}
{"comparison_id":"f854bffc-2b30-4d4c-b251-4124c42a32a1","query_id":"53","doc_a_id":"22482820","doc_b_id":"4583180","presented_order":["4583180","22482820"],"winner_id":"22482820","reasoning":"Reason: Document B focuses on breast cancer specifically (treatment, classification, prognosis-related challenges), making it more likely to address biomarkers like ALDH1 than Document A, which centers on SREBP2 and general tumor progression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699631Z"}
{"comparison_id":"0976140b-22f7-47c4-9d73-682869e4f89d","query_id":"53","doc_a_id":"20127522","doc_b_id":"5649538","presented_order":["5649538","20127522"],"winner_id":"20127522","reasoning":"Document B is more relevant — it links a biomarker (CTC levels) to prognosis in breast cancer, while A focuses on predictors of dasatinib sensitivity, not prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699637Z"}
{"comparison_id":"3ca31a82-b86f-4b6f-ba9c-9355cfa0b70b","query_id":"53","doc_a_id":"15832146","doc_b_id":"24341590","presented_order":["24341590","15832146"],"winner_id":"24341590","reasoning":"Neither document discusses ALDH1. Document A is slightly more relevant because it directly addresses prognosis/recurrence in breast cancer, whereas B focuses on stromal fibroblast–mediated tumor growth.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699643Z"}
{"comparison_id":"eecab51a-f828-4daa-90af-bc927eb3498e","query_id":"53","doc_a_id":"21033230","doc_b_id":"22482820","presented_order":["22482820","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it focuses on molecular markers and prognostic value in breast cancer (predicting survival), whereas A discusses treatment delivery strategies and not prognostic markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699650Z"}
{"comparison_id":"46c20397-5e19-4773-94d9-70381aac8a45","query_id":"53","doc_a_id":"1379127","doc_b_id":"21033230","presented_order":["1379127","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it discusses molecular markers in circulating tumor cells and their association with prognosis in metastatic breast cancer, which is closer to ALDH1 prognostic associations than the calcium-channel focus of Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699657Z"}
{"comparison_id":"b7591093-087c-4589-ae01-fde1646b1911","query_id":"53","doc_a_id":"1379127","doc_b_id":"29495185","presented_order":["1379127","29495185"],"winner_id":"29495185","reasoning":"Document B is more relevant — it discusses molecular predictors of cancer prognosis, which relates to the claim about ALDH1 as a prognostic marker. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699663Z"}
{"comparison_id":"21696adc-0e1c-4a40-a73e-388e55565c20","query_id":"53","doc_a_id":"5649538","doc_b_id":"8963413","presented_order":["5649538","8963413"],"winner_id":"8963413","reasoning":"Reason: Document B discusses expression of a molecular marker (PD-L1) and its association with clinical outcomes in breast cancer, which is more closely related to the prognostic question than Document A's focus on dasatinib sensitivity predictors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699670Z"}
{"comparison_id":"1b93b0b5-2b4e-4e16-b8e0-95b337f2a434","query_id":"53","doc_a_id":"19358586","doc_b_id":"4429932","presented_order":["19358586","4429932"],"winner_id":"19358586","reasoning":"Document A is more relevant — it discusses molecular expression signatures linked to poor survival in breast cancer, whereas Document B focuses on LOX and metastasis without addressing marker expression like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699677Z"}
{"comparison_id":"2a09c100-a034-4351-9d74-3789265d3ed2","query_id":"53","doc_a_id":"29495185","doc_b_id":"7821634","presented_order":["29495185","7821634"],"winner_id":"29495185","reasoning":"Document A is more relevant because it discusses molecular predictors of cancer prognosis broadly, while Document B focuses specifically on DUSP4 and chemotherapy resistance without mentioning ALDH1.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699683Z"}
{"comparison_id":"4b2ed857-e8ae-4386-bd40-7271007311a7","query_id":"53","doc_a_id":"17648235","doc_b_id":"18953920","presented_order":["18953920","17648235"],"winner_id":"18953920","reasoning":"Document A is more relevant — it links acquisition of stem-cell markers in mammary cells and increased tumorigenic potential, which relates to ALDH1 as a breast cancer stem-cell marker and poor prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699690Z"}
{"comparison_id":"b1dd4f6e-b398-4859-9cf5-6e81110273a3","query_id":"53","doc_a_id":"4455466","doc_b_id":"4889228","presented_order":["4889228","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it discusses gene expression levels tied to breast cancer prognosis, whereas A focuses on TDP43/SRSF3 in TNBC and does not address prognostic markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699696Z"}
{"comparison_id":"5a54183d-3f66-4b9d-a26b-58bd1aa683d5","query_id":"53","doc_a_id":"12762485","doc_b_id":"17648235","presented_order":["17648235","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses a stem cell phenotype and associated poor-prognosis features (p53 positivity, ER/PgR negativity, high proliferation), which is more relevant to ALDH1 as a stem cell/prognostic marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699702Z"}
{"comparison_id":"8004f61b-fc82-4d24-94c7-c224d7d32671","query_id":"53","doc_a_id":"15832146","doc_b_id":"4429932","presented_order":["4429932","15832146"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses a molecular marker (LOX) being associated with poor outcomes in breast cancer, which is closer to the prognosis-related claim. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699708Z"}
{"comparison_id":"e105fa82-daa9-4abf-a78f-663f0c28f24d","query_id":"53","doc_a_id":"12762485","doc_b_id":"21902400","presented_order":["12762485","21902400"],"winner_id":"12762485","reasoning":"Document A — it discusses a stem-cell phenotype in breast cancer (linked to poor differentiation, ER/PgR negativity and higher proliferation), which is more directly relevant to ALDH1 as a stem-cell/prognostic marker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699749Z"}
{"comparison_id":"6d5dba8a-b0c0-48c4-875b-c961c0e47c53","query_id":"53","doc_a_id":"20839751","doc_b_id":"2130391","presented_order":["2130391","20839751"],"winner_id":"20839751","reasoning":"Document B is more relevant — it discusses biomarker expression (apoptotic index) and its relationship to prognosis in breast cancer, whereas A focuses on adipocytes and invasion rather than prognostic markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699756Z"}
{"comparison_id":"621a3221-5fe1-4809-b0b4-e1be92af3e86","query_id":"53","doc_a_id":"2014909","doc_b_id":"20183360","presented_order":["2014909","20183360"],"winner_id":"2014909","reasoning":"Document A is more relevant — it analyzes primary breast cancers and tumor-initiating cells (commonly linked to ALDH1 as a stem-cell/prognostic marker), whereas B focuses on GATA3/Smad4-mediated invasion without relevance to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699762Z"}
{"comparison_id":"9b118055-0913-4835-8b59-c021f0aaf980","query_id":"53","doc_a_id":"18953920","doc_b_id":"22482820","presented_order":["22482820","18953920"],"winner_id":"18953920","reasoning":"Document B — it links EMT to acquisition of stem-cell markers and increased tumorigenicity, which is more relevant to ALDH1 (a breast cancer stem-cell marker) and prognosis than a therapy-focused overview. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699769Z"}
{"comparison_id":"026fd74c-0a57-4838-b4c8-fe5a49f1537b","query_id":"53","doc_a_id":"1379127","doc_b_id":"45638119","presented_order":["45638119","1379127"],"winner_id":"45638119","reasoning":"Doc A directly states ALDH1 is a marker of mammary stem cells and predicts poor clinical outcome in breast cancer, matching the claim. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699774Z"}
{"comparison_id":"c0c02490-f151-4153-8237-ff4cae99adc2","query_id":"53","doc_a_id":"22482820","doc_b_id":"43385013","presented_order":["22482820","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it examines stem cell/progenitor properties in breast cell subpopulations and is more likely to discuss stem cell markers like ALDH1 and their clinical implications, whereas Document A focuses on combination therapies and drug delivery. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699781Z"}
{"comparison_id":"5b9aaf85-9c61-4965-9be4-dcbf8592438c","query_id":"53","doc_a_id":"21902400","doc_b_id":"7795952","presented_order":["21902400","7795952"],"winner_id":"7795952","reasoning":"Document B — it describes a specific protein marker (fascin) being linked to poor cancer prognosis, which is more analogous to a claim about ALDH1 expression and prognosis than the general discussion of hypoxia in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699788Z"}
{"comparison_id":"87990f2c-3451-4f31-a7dd-d37f05ab3e3b","query_id":"53","doc_a_id":"15946643","doc_b_id":"43385013","presented_order":["15946643","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it discusses epithelial/mesenchymal subpopulations and stem cell/progenitor properties in breast cells, which relates to ALDH1 as a stem cell marker and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699795Z"}
{"comparison_id":"85129383-62c3-4a1c-b4c5-e1c3e2f92230","query_id":"53","doc_a_id":"29366489","doc_b_id":"7583725","presented_order":["7583725","29366489"],"winner_id":"7583725","reasoning":"Document A is more relevant — it links expression of a specific protein to prognosis in breast cancer, which is conceptually closer to the claim about ALDH1 expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699801Z"}
{"comparison_id":"8fe9b4f9-d4e1-4e36-a0e5-3c50a38687e6","query_id":"53","doc_a_id":"21033230","doc_b_id":"22401720","presented_order":["22401720","21033230"],"winner_id":"22401720","reasoning":"Document A is more relevant — it examines expression of markers in primary breast tumors and links marker expression to prognosis, which is closer to the claim about ALDH1 tissue expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699807Z"}
{"comparison_id":"74da9e6a-4955-4d57-9072-a59e28e1cbce","query_id":"53","doc_a_id":"4583180","doc_b_id":"7795952","presented_order":["7795952","4583180"],"winner_id":"7795952","reasoning":"Document A is more relevant because it discusses a specific protein whose overexpression is linked to poor cancer prognosis and metastasis, which is analogous to the claim about ALDH1 expression and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699813Z"}
{"comparison_id":"71e8a395-5bbe-40f9-9e11-cf917b341850","query_id":"53","doc_a_id":"17648235","doc_b_id":"31311495","presented_order":["17648235","31311495"],"winner_id":"31311495","reasoning":"Document B is more relevant — it discusses tamoxifen resistance and EMT-like behavior leading to increased aggressiveness, which more directly relates to poorer prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699819Z"}
{"comparison_id":"b9fd7260-6e5e-44d2-a662-ca95189cb7b0","query_id":"53","doc_a_id":"20333864","doc_b_id":"3285322","presented_order":["3285322","20333864"],"winner_id":"20333864","reasoning":"Document B is more relevant — it addresses molecular and cellular mechanisms of tumor progression and invasion (contexts where ALDH1 as a stemness/prognostic marker would be discussed) while A focuses on BRCA mutation clinical features without molecular markers. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699826Z"}
{"comparison_id":"8e12e637-736b-4683-9aec-3b125e930fa6","query_id":"53","doc_a_id":"22482820","doc_b_id":"3285322","presented_order":["3285322","22482820"],"winner_id":"3285322","reasoning":"Document A is more relevant — it discusses clinical and pathologic features and prognosis-related tumor characteristics (e.g., high grade, triple-negative) in breast cancer patients, which is closer to a claim about a prognostic marker like ALDH1 than a paper on therapy delivery. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699833Z"}
{"comparison_id":"770ccb03-b29b-4763-af57-6c2043d69d3d","query_id":"53","doc_a_id":"29366489","doc_b_id":"31311495","presented_order":["31311495","29366489"],"winner_id":"31311495","reasoning":"Document A is more relevant — it discusses breast cancer cell behavior and factors linked to aggressiveness/prognosis, whereas B is about a different tumor suppressor across cancers and doesn't relate to breast cancer prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699839Z"}
{"comparison_id":"b255016b-a0d5-4e32-91bc-38daa4b6f90f","query_id":"53","doc_a_id":"12762485","doc_b_id":"8963413","presented_order":["12762485","8963413"],"winner_id":"12762485","reasoning":"Document A — it discusses stem-cell–like phenotypes and markers linked to poorer differentiation and higher proliferation in breast cancer, which is more relevant to ALDH1 (a stem cell marker) than the PD-L1–focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699846Z"}
{"comparison_id":"ffd073ae-22d4-4882-b677-2f72eb2d1279","query_id":"53","doc_a_id":"22482820","doc_b_id":"7821634","presented_order":["22482820","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it discusses molecular markers in residual breast cancer and their association with poor outcomes, while Document A focuses on combination therapies and does not address prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699853Z"}
{"comparison_id":"4cc6ef58-d413-458c-9762-4bdb3e716fa1","query_id":"53","doc_a_id":"11484808","doc_b_id":"20333864","presented_order":["20333864","11484808"],"winner_id":"20333864","reasoning":"Document A is more directly about breast cancer progression and prognosis-related biology, whereas Document B focuses on non-coding RNAs across endocrine cancers (less directly tied to ALDH1).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699859Z"}
{"comparison_id":"358c2abb-ed35-4204-a8e4-e01c9bb9f977","query_id":"53","doc_a_id":"29495185","doc_b_id":"8963413","presented_order":["8963413","29495185"],"winner_id":"29495185","reasoning":"Document B — it discusses molecular predictors of prognosis in cancer (more likely to cover markers like ALDH1), whereas Document A focuses specifically on PD-L1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699865Z"}
{"comparison_id":"a927a47e-d6fb-4507-9df4-3cfab490045c","query_id":"53","doc_a_id":"21033230","doc_b_id":"2130391","presented_order":["21033230","2130391"],"winner_id":"21033230","reasoning":"Document A is more relevant — it concerns molecular profiling of circulating tumor cells and prognostic markers in metastatic breast cancer, which relates to associations between marker expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699872Z"}
{"comparison_id":"d9ebb2bc-54c1-487b-b7a1-211bcf053b43","query_id":"53","doc_a_id":"21902400","doc_b_id":"34066665","presented_order":["34066665","21902400"],"winner_id":"34066665","reasoning":"Document A is more relevant — it focuses on breast cancer molecular markers and therapy resistance, which is closer to ALDH1's prognostic role in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699878Z"}
{"comparison_id":"fc05ff61-872f-466d-8d86-4a8e30bed5c6","query_id":"53","doc_a_id":"2014909","doc_b_id":"5649538","presented_order":["2014909","5649538"],"winner_id":"2014909","reasoning":"Document A is more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers, which likely relate to ALDH1 (a stem-cell/tumor-initiating marker) and prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699884Z"}
{"comparison_id":"d808fa0b-e1fe-47d2-b6f2-cc15a268c476","query_id":"53","doc_a_id":"2130391","doc_b_id":"7583725","presented_order":["7583725","2130391"],"winner_id":"7583725","reasoning":"Doc A discusses a specific molecular marker whose high expression predicts poor outcomes in breast cancer, which is more directly relevant to a claim about expression being associated with prognosis. Document B focuses on adipocyte effects on invasion without linking expression markers or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699891Z"}
{"comparison_id":"440cd3e5-f183-4797-9650-951e40f3a05d","query_id":"53","doc_a_id":"24341590","doc_b_id":"2931832","presented_order":["2931832","24341590"],"winner_id":"2931832","reasoning":"Document A is more relevant — it addresses prognostic biomarkers and their association with disease-free survival in breast cancer, which is conceptually closer to a claim about ALDH1 and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699898Z"}
{"comparison_id":"80a2f854-1b45-45da-905d-42232503a58d","query_id":"53","doc_a_id":"1379127","doc_b_id":"8963413","presented_order":["1379127","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — it discusses expression of a biomarker and its association with clinical outcomes in breast cancer, whereas Document A focuses on calcium entry proteins and metastasis without addressing prognostic marker expression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699905Z"}
{"comparison_id":"cbed616c-7db1-4719-a0c0-3bc2f5270dc3","query_id":"53","doc_a_id":"19673227","doc_b_id":"29366489","presented_order":["29366489","19673227"],"winner_id":"29366489","reasoning":"Neither abstract mentions ALDH1 or breast cancer; Document A discusses a gene's expression as a prognostic marker, so it's slightly more relevant to a claim about marker expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699911Z"}
{"comparison_id":"b6271899-4d17-44ac-b549-addd787fcd67","query_id":"53","doc_a_id":"24341590","doc_b_id":"4455466","presented_order":["24341590","4455466"],"winner_id":"4455466","reasoning":"Document B — it discusses gene expression levels (low ZMYND11) being linked to poor breast cancer prognosis, which is conceptually relevant to a claim about ALDH1 expression and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699917Z"}
{"comparison_id":"b11f7881-b48c-4365-bc7e-928f4b69596a","query_id":"53","doc_a_id":"1171121","doc_b_id":"21033230","presented_order":["21033230","1171121"],"winner_id":"21033230","reasoning":"Document A is more relevant — it discusses molecular profiling and prognostic markers in breast cancer (though it doesn't mention ALDH1 specifically), while Document B focuses on microvessel density and p53. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699924Z"}
{"comparison_id":"c921fafe-0ab2-46ed-bbd0-e9c61e56a75b","query_id":"53","doc_a_id":"20333864","doc_b_id":"45638119","presented_order":["45638119","20333864"],"winner_id":"45638119","reasoning":"Document A explicitly reports that ALDH1 marks mammary stem cells and predicts poor clinical outcome in breast cancer; Document B does not discuss ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699930Z"}
{"comparison_id":"73b90073-bf87-4bbb-aaf5-51cf1e9c1ae6","query_id":"53","doc_a_id":"22482820","doc_b_id":"29366489","presented_order":["29366489","22482820"],"winner_id":"22482820","reasoning":"Document B is more relevant — it specifically discusses breast cancer (classification and treatment), while Document A focuses on the DLC-1 gene in liver/other cancers, not ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699937Z"}
{"comparison_id":"316b6cd4-ae38-40be-abd5-93859a7bd4cc","query_id":"53","doc_a_id":"15832146","doc_b_id":"4889228","presented_order":["15832146","4889228"],"winner_id":"4889228","reasoning":"Document B is more relevant — it discusses a molecular marker (TDP43) whose expression correlates with poor prognosis in breast cancer, whereas A focuses on stromal fibroblasts and SDF-1/CXCL12 without prognostic marker data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699943Z"}
{"comparison_id":"7234aa6e-1625-4c0b-81e7-72a7a07dc0cc","query_id":"53","doc_a_id":"19358586","doc_b_id":"825728","presented_order":["825728","19358586"],"winner_id":"825728","reasoning":"Document A links EMT, acquisition of stem-cell properties and patient survival—closer to ALDH1 (a cancer stem cell marker) and prognosis than Document B's focus on a p27/Myc/miRNA signature.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699949Z"}
{"comparison_id":"a18da9f3-64d5-40d5-b601-c940a6ffaae8","query_id":"53","doc_a_id":"15113221","doc_b_id":"4455466","presented_order":["15113221","4455466"],"winner_id":"4455466","reasoning":"Document B — it discusses a specific gene's expression level being linked to prognosis in breast cancer, which is more directly related to the claim about expression-prognosis association.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699956Z"}
{"comparison_id":"78c4a1e6-867c-49e4-9e1b-1069c8632b70","query_id":"53","doc_a_id":"31311495","doc_b_id":"4702639","presented_order":["31311495","4702639"],"winner_id":"4702639","reasoning":"Document B — it addresses tumour stemness and markers of stem-like cells (which ALDH1 is a known marker), so it's more relevant to a claim about ALDH1 and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699962Z"}
{"comparison_id":"d19c3f00-b684-4aac-8948-ef2bce92dd1a","query_id":"53","doc_a_id":"18953920","doc_b_id":"19358586","presented_order":["18953920","19358586"],"winner_id":"18953920","reasoning":"Document A is more relevant — it links EMT to acquisition of stem-cell markers and increased tumorigenic potential in mammary cells (ALDH1 is a breast cancer stem-cell marker). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699969Z"}
{"comparison_id":"e9c923b7-fde5-4dac-b1c9-f76e497d91aa","query_id":"53","doc_a_id":"16086778","doc_b_id":"21033230","presented_order":["16086778","21033230"],"winner_id":"21033230","reasoning":"Document B is more focused on prognostic biomarkers and survival correlations in breast cancer, while A discusses Numb/Notch signaling mechanisms and not prognosis or ALDH1.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699975Z"}
{"comparison_id":"c6aaa5ec-58fa-4ef7-9560-a752848750af","query_id":"53","doc_a_id":"15946643","doc_b_id":"31311495","presented_order":["31311495","15946643"],"winner_id":"15946643","reasoning":"Document B — it addresses chemoresistance and metastasis (drivers of poor prognosis), which is more directly related to ALDH1's reported association with worse outcomes than Document A's narrow focus on tamoxifen-driven EMT. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699982Z"}
{"comparison_id":"f1b8b4b9-9cd9-417a-87d7-34c7e0d6d674","query_id":"53","doc_a_id":"11484808","doc_b_id":"1171121","presented_order":["11484808","1171121"],"winner_id":"11484808","reasoning":"Document A is slightly more relevant because it discusses biomarkers and clinical implications in endocrine-related cancers, whereas Document B focuses specifically on MVD and p53 without addressing ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699989Z"}
{"comparison_id":"ed0db8e3-1ca0-4cbc-a73e-67901ed170c9","query_id":"53","doc_a_id":"24834968","doc_b_id":"29495185","presented_order":["29495185","24834968"],"winner_id":"29495185","reasoning":"Document A is more relevant — it discusses molecular predictors of cancer prognosis generally, whereas Document B focuses on HER-2/neu and chemotherapy response, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.699995Z"}
{"comparison_id":"7aeef2a8-521b-4c3f-a7c2-ccc6c68780b6","query_id":"53","doc_a_id":"21033230","doc_b_id":"4455466","presented_order":["4455466","21033230"],"winner_id":"4455466","reasoning":"Document A is more relevant — it reports that low expression of a specific gene is associated with poor prognosis in breast cancer, which is closer in topic to the claim about marker expression and prognosis (although it does not mention ALDH1). \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700001Z"}
{"comparison_id":"3a5d570e-fb18-4d14-97af-d6b1ee22e1e2","query_id":"53","doc_a_id":"20183360","doc_b_id":"27240667","presented_order":["20183360","27240667"],"winner_id":"20183360","reasoning":"Document A is more relevant — it addresses molecular markers and mechanisms of breast cancer progression (invasion) which is closer to studies on prognostic biomarkers like ALDH1, whereas B covers population mortality trends unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700008Z"}
{"comparison_id":"d233b6b8-4739-477b-a570-e519f711deaf","query_id":"53","doc_a_id":"21033230","doc_b_id":"21902400","presented_order":["21033230","21902400"],"winner_id":"21033230","reasoning":"Document A is more relevant — it addresses molecular markers in metastatic breast cancer and their prognostic value, whereas B discusses hypoxia generally without breast cancer markers like ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700014Z"}
{"comparison_id":"f943a514-dc52-4005-ad02-a9369c0686da","query_id":"53","doc_a_id":"1171121","doc_b_id":"12762485","presented_order":["12762485","1171121"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses a stem-cell phenotype in breast cancer linked to worse features (p53+, ER/PgR−, higher proliferation), which relates to ALDH1 as a stem cell marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700021Z"}
{"comparison_id":"7e007470-0c7d-4cc7-8058-c3c2f6f4a3e2","query_id":"53","doc_a_id":"4583180","doc_b_id":"5649538","presented_order":["5649538","4583180"],"winner_id":"5649538","reasoning":"Document A — it's focused on breast cancer samples (more likely to address prognostic markers), while B discusses SREBP2 and tumor progression more generally. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700027Z"}
{"comparison_id":"5c0d11be-375f-42fb-8956-b942cb5175de","query_id":"53","doc_a_id":"16086778","doc_b_id":"18953920","presented_order":["18953920","16086778"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses acquisition of stem-cell markers in mammary epithelial cells and increased tumorigenic potential, which relates to ALDH1 as a breast cancer stem-cell marker linked to prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700034Z"}
{"comparison_id":"bd95588c-b890-46da-9f26-dae791430b84","query_id":"53","doc_a_id":"18953920","doc_b_id":"2130391","presented_order":["2130391","18953920"],"winner_id":"18953920","reasoning":"Document B is more relevant — it links EMT to acquisition of stem-cell markers and tumorigenic potential (ALDH1 is a breast cancer stem-cell marker), whereas A discusses adipocytes and invasion without ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700040Z"}
{"comparison_id":"caba9cfc-a581-428a-a307-87ad27914b52","query_id":"53","doc_a_id":"34066665","doc_b_id":"4429932","presented_order":["4429932","34066665"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses factors associated with poor patient outcomes in breast cancer (prognosis), whereas B focuses on receptor signaling and endocrine resistance not directly about prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700047Z"}
{"comparison_id":"9978221e-5636-471a-b4be-44366466221e","query_id":"53","doc_a_id":"21902400","doc_b_id":"43385013","presented_order":["21902400","43385013"],"winner_id":"43385013","reasoning":"Document B — it discusses breast epithelial/mesenchymal subpopulations and stem cell/progenitor properties (more relevant to ALDH1 as a stem cell marker), whereas A is about hypoxia broadly. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700053Z"}
{"comparison_id":"4966d042-0292-40cf-bce2-e80ada7d949c","query_id":"53","doc_a_id":"24341590","doc_b_id":"25973484","presented_order":["24341590","25973484"],"winner_id":"25973484","reasoning":"Document B — it discusses factors linked to breast cancer prognosis and tumor aggressiveness, which is closer to the claim about prognostic markers than Document A's focus on CYP2D6-tamoxifen pharmacogenetics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700060Z"}
{"comparison_id":"c6eccfbb-8973-4702-bc68-e7c6145e5ae2","query_id":"53","doc_a_id":"20183360","doc_b_id":"4429932","presented_order":["20183360","4429932"],"winner_id":"4429932","reasoning":"Reason: Document B discusses a marker (LOX) linked to poor patient outcomes in breast cancer, so it's more relevant to prognosis than Document A, which focuses on GATA3 and invasion mechanisms.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700066Z"}
{"comparison_id":"4df427b7-d99d-4cf4-872f-b506b96a622b","query_id":"53","doc_a_id":"1171121","doc_b_id":"24341590","presented_order":["1171121","24341590"],"winner_id":"1171121","reasoning":"Document A is more relevant — it addresses prognostic factors in breast cancer (MVD and p53), whereas Document B focuses on CYP2D6 pharmacogenetics and tamoxifen response, not general prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700072Z"}
{"comparison_id":"4340e5d1-9f2d-4c57-9b65-81ab19b304c4","query_id":"53","doc_a_id":"2014909","doc_b_id":"29366489","presented_order":["29366489","2014909"],"winner_id":"2014909","reasoning":"Document B — it discusses tumor-initiating cells and analyses of primary breast cancers (more likely to relate to ALDH1 as a stem-cell/prognostic marker). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700079Z"}
{"comparison_id":"5457c5dc-afdd-418a-83f5-3b3ab1c09c35","query_id":"53","doc_a_id":"7583725","doc_b_id":"7821634","presented_order":["7821634","7583725"],"winner_id":"7583725","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it directly links a marker's high expression to poor breast‑cancer outcomes, similar to the claim's form. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700085Z"}
{"comparison_id":"1d1f64c5-7084-4647-8b64-cd5743fb7d2b","query_id":"53","doc_a_id":"20127522","doc_b_id":"29366489","presented_order":["20127522","29366489"],"winner_id":"20127522","reasoning":"Document A is more relevant — it discusses a prognostic marker (circulating tumor cells) specifically in breast cancer, whereas Document B addresses a different tumor suppressor gene in varied cancers. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700092Z"}
{"comparison_id":"bc1cea95-54b5-436a-9bc5-0b02952264d2","query_id":"53","doc_a_id":"2931832","doc_b_id":"34066665","presented_order":["34066665","2931832"],"winner_id":"2931832","reasoning":"Document B is more relevant — it directly studies prognostic biomarkers in breast cancer, whereas Document A focuses on ER–HER signaling and endocrine resistance without addressing ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700098Z"}
{"comparison_id":"c032f091-7582-4654-8754-56fcf93831d2","query_id":"53","doc_a_id":"15113221","doc_b_id":"7583725","presented_order":["7583725","15113221"],"winner_id":"7583725","reasoning":"A is more relevant — it specifically links expression of a molecular marker to poor outcomes in breast cancer, whereas B discusses a PTEN-related signature across carcinomas and not ALDH1 or breast-specific prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700104Z"}
{"comparison_id":"975e9ed8-42c4-45c1-a2ff-5c3d2addd6a5","query_id":"53","doc_a_id":"2931832","doc_b_id":"7821634","presented_order":["2931832","7821634"],"winner_id":"2931832","reasoning":"Document A is more relevant — it discusses a prognostic biomarker in breast cancer (PDW/P) and prognosis associations, whereas Document B focuses on DUSP4 and chemotherapy resistance in a specific subtype and does not address prognostic expression markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700111Z"}
{"comparison_id":"386e2b74-c09a-4d39-9ac0-6002b65f9c2f","query_id":"53","doc_a_id":"20127522","doc_b_id":"22482820","presented_order":["20127522","22482820"],"winner_id":"20127522","reasoning":"Document A is more relevant — it discusses a biomarker (CTCs) linked to poorer prognosis in breast cancer, which is conceptually related to the claim about ALDH1 as a prognostic marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700117Z"}
{"comparison_id":"e1b01fb1-2c0f-45fa-a7f1-728984146eb3","query_id":"53","doc_a_id":"22482820","doc_b_id":"4889228","presented_order":["4889228","22482820"],"winner_id":"4889228","reasoning":"Reason: Document A discusses a specific biomarker's expression correlating with poor prognosis in breast cancer, which is more related to the claim about ALDH1 expression and prognosis than the treatment-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700123Z"}
{"comparison_id":"1804be5d-3426-4404-9f44-19c28549fda7","query_id":"53","doc_a_id":"19673227","doc_b_id":"20839751","presented_order":["20839751","19673227"],"winner_id":"20839751","reasoning":"Document A is more relevant — it discusses prognostic factors specifically in breast cancer, whereas B focuses on chemosensitivity of circulating tumor cells across epithelial tumors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700129Z"}
{"comparison_id":"70f98953-c15b-4bff-a3be-e327a111594d","query_id":"53","doc_a_id":"16086778","doc_b_id":"2014909","presented_order":["16086778","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers, which relates to ALDH1 as a cancer stem cell/prognostic marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700135Z"}
{"comparison_id":"786bbfd3-1e5a-4fe5-8cea-459c98bd20e8","query_id":"53","doc_a_id":"20333864","doc_b_id":"22482820","presented_order":["22482820","20333864"],"winner_id":"22482820","reasoning":"Document A is more likely to address biomarkers and their clinical implications in breast cancer, including associations with prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700141Z"}
{"comparison_id":"0225566f-29fd-45f7-9f55-2dd0691ef4e4","query_id":"53","doc_a_id":"1379127","doc_b_id":"17648235","presented_order":["1379127","17648235"],"winner_id":"1379127","reasoning":"Document A is more relevant — it discusses tumor metastasis, which directly relates to prognosis, whereas Document B focuses on WNT-driven proliferation without prognostic data. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700147Z"}
{"comparison_id":"06e76c72-f982-4c2d-acf9-d76c87745318","query_id":"53","doc_a_id":"2014909","doc_b_id":"2931832","presented_order":["2014909","2931832"],"winner_id":"2014909","reasoning":"Document A is more relevant — it addresses tumor-initiating cells and analyses of primary breast cancers (ALDH1 is a cancer stem cell marker), whereas Document B concerns platelet indices unrelated to ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700154Z"}
{"comparison_id":"40bfd08c-ddbe-4f05-936e-afe2a899ef28","query_id":"53","doc_a_id":"1379127","doc_b_id":"7583725","presented_order":["7583725","1379127"],"winner_id":"7583725","reasoning":"Neither document mentions ALDH1; both are irrelevant. Document A is slightly more relevant because it links high expression of a marker (TRPM7) with poor patient outcomes, which parallels the claim's structure. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700160Z"}
{"comparison_id":"ea33e657-a05b-4e92-8bea-7d1495275b7f","query_id":"53","doc_a_id":"7583725","doc_b_id":"825728","presented_order":["825728","7583725"],"winner_id":"825728","reasoning":"Document A — it links EMT, acquisition of stem-cell properties and patient survival, which is more related to ALDH1 (a stemness/prognostic marker) than the TRPM7-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700166Z"}
{"comparison_id":"74542642-d879-44bc-a163-a0b6bc3e5975","query_id":"53","doc_a_id":"24341590","doc_b_id":"4702639","presented_order":["4702639","24341590"],"winner_id":"4702639","reasoning":"Document A is more relevant — it addresses tumor stemness markers and poor prognosis/drug resistance in carcinomas, whereas B concerns CYP2D6/tamoxifen polymorphisms unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700172Z"}
{"comparison_id":"09252276-402d-4834-946d-906b29ec9bc6","query_id":"53","doc_a_id":"18953920","doc_b_id":"8963413","presented_order":["8963413","18953920"],"winner_id":"18953920","reasoning":"Document B — it links EMT in mammary epithelial cells to acquisition of stem-cell markers and increased tumorigenic potential, which is directly relevant to ALDH1 as a stem-cell marker associated with prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700179Z"}
{"comparison_id":"7b6e4281-8a6f-4abd-87a4-42ce125c50ce","query_id":"53","doc_a_id":"11484808","doc_b_id":"20183360","presented_order":["20183360","11484808"],"winner_id":"20183360","reasoning":"Reason: Document A directly addresses molecular factors and invasiveness in breast cancer; Document B is a general review on ncRNAs in endocrine cancers and less directly related to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700185Z"}
{"comparison_id":"bfc70b91-11a9-43e7-b73d-0cd744a6970a","query_id":"53","doc_a_id":"17648235","doc_b_id":"19358586","presented_order":["17648235","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it discusses protein/miRNA signatures linked to poor survival in breast cancer (prognosis-related), whereas A focuses on WNT signaling and proliferation without addressing prognosis or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700192Z"}
{"comparison_id":"476a75bc-a4bd-42a9-b06a-4c6a6004a27d","query_id":"53","doc_a_id":"25973484","doc_b_id":"4455466","presented_order":["4455466","25973484"],"winner_id":"4455466","reasoning":"Document A is more relevant — it discusses a gene's expression level being linked to breast cancer prognosis, whereas Document B concerns obesity and breast cancer risk without addressing marker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700198Z"}
{"comparison_id":"d24f1833-7d31-47a9-b338-3e0237c609c6","query_id":"53","doc_a_id":"19358586","doc_b_id":"5649538","presented_order":["19358586","5649538"],"winner_id":"19358586","reasoning":"Document A is more relevant — it addresses protein signatures linked to poor survival in breast cancer (prognosis-related), whereas B focuses on drug-sensitivity predictors. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700204Z"}
{"comparison_id":"ee783375-4fb3-4bd8-bb40-5cee9ffa4506","query_id":"53","doc_a_id":"25973484","doc_b_id":"4583180","presented_order":["4583180","25973484"],"winner_id":"25973484","reasoning":"Document B is more relevant because it specifically addresses breast cancer risk and prognosis; Document A discusses SREBP2 and tumor cholesterol metabolism without mentioning ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700211Z"}
{"comparison_id":"ee1538c9-8af2-4618-a085-8a4f5cf9a8d7","query_id":"53","doc_a_id":"29366489","doc_b_id":"825728","presented_order":["825728","29366489"],"winner_id":"825728","reasoning":"Doc A — it links EMT repression, acquisition of stem-cell properties and patient survival, which is more directly related to ALDH1 (a stem-cell marker) and prognosis than Doc B.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700217Z"}
{"comparison_id":"3bfe9efb-b8de-4c1b-808b-4cde22f04315","query_id":"53","doc_a_id":"4455466","doc_b_id":"8963413","presented_order":["4455466","8963413"],"winner_id":"4455466","reasoning":"Reason: Document A discusses a specific gene's expression level being linked to poor prognosis in breast cancer (an expression–prognosis relationship), whereas Document B focuses on PD-L1 with different outcome patterns.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700223Z"}
{"comparison_id":"99bb23f0-24b8-4ed8-b7fd-f79dc14de45c","query_id":"53","doc_a_id":"1866911","doc_b_id":"3285322","presented_order":["3285322","1866911"],"winner_id":"1866911","reasoning":"Document B — it addresses progenitor/cell-of-origin and marker-defined cell populations in BRCA1-related breast cancer, which is more closely related toALDH1 (a stem/progenitor marker) than the general clinical comparison in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700230Z"}
{"comparison_id":"73ea02a8-67bd-4d2f-8504-db804184845c","query_id":"53","doc_a_id":"2014909","doc_b_id":"4418878","presented_order":["2014909","4418878"],"winner_id":"2014909","reasoning":"Document A is more relevant — it discusses tumor-initiating cells (for which ALDH1 is a marker) and prognosis analyses in primary breast cancers, directly relating to ALDH1's association with outcome.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700236Z"}
{"comparison_id":"915d5104-87d3-41aa-a6a3-576465042bc2","query_id":"53","doc_a_id":"11484808","doc_b_id":"29366489","presented_order":["11484808","29366489"],"winner_id":"11484808","reasoning":"Reason: Document A covers endocrine-related cancers (including breast cancer) and discusses clinical implications and prognostic markers, making it more likely to address biomarker–prognosis links than a paper focused on the DLC-1 tumor suppressor.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700243Z"}
{"comparison_id":"4fd4741d-5f84-44df-bbdb-b3c85f3400c0","query_id":"53","doc_a_id":"1171121","doc_b_id":"5649538","presented_order":["5649538","1171121"],"winner_id":"5649538","reasoning":"Document A is more likely relevant because it analyzes gene expression markers in breast cancer (where ALDH1 expression would be discussed), while Document B focuses on microvessel density and p53 without addressing ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700249Z"}
{"comparison_id":"60381287-0081-4a2b-9443-3e91f6e9132d","query_id":"53","doc_a_id":"4889228","doc_b_id":"825728","presented_order":["825728","4889228"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT/stem-cell properties to patient survival (ALDH1 is a cancer stem-cell marker), so it more directly relates to prognosis associations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700255Z"}
{"comparison_id":"2aa60b9e-83ec-4648-9f89-adca56151214","query_id":"53","doc_a_id":"17648235","doc_b_id":"25973484","presented_order":["17648235","25973484"],"winner_id":"25973484","reasoning":"Document B is more relevant because it discusses factors linked to breast cancer prognosis and aggressive tumor phenotypes, whereas Document A focuses on WNT signaling in cell lines and not clinical prognostic markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700261Z"}
{"comparison_id":"544415d9-6980-401d-b298-21482e826acb","query_id":"53","doc_a_id":"20333864","doc_b_id":"31311495","presented_order":["20333864","31311495"],"winner_id":"20333864","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it addresses progression from in situ to invasive disease, which relates to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700267Z"}
{"comparison_id":"49f730d5-aa6b-446b-a1ce-fe1769e7b3af","query_id":"53","doc_a_id":"15946643","doc_b_id":"313403","presented_order":["313403","15946643"],"winner_id":"313403","reasoning":"Document A is more relevant — it addresses prognostic markers in breast cancer (linking marker levels to survival), whereas Document B focuses on CXCL1-mediated chemoresistance/metastasis and not prognosis markers like ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700274Z"}
{"comparison_id":"e3950942-129e-405c-ac9c-74518bfc4770","query_id":"53","doc_a_id":"15832146","doc_b_id":"4418878","presented_order":["15832146","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures and their link to prognosis in cancers, which relates to claims about marker expression and prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700280Z"}
{"comparison_id":"1954d276-7c2d-44b2-bb86-6a0816b1328e","query_id":"53","doc_a_id":"20183360","doc_b_id":"45638119","presented_order":["20183360","45638119"],"winner_id":"45638119","reasoning":"Document B—directly reports that ALDH1 marks mammary stem cells and predicts poor clinical outcome in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700286Z"}
{"comparison_id":"0d2d37fa-f937-48b0-85a0-555e5d696c41","query_id":"53","doc_a_id":"20839751","doc_b_id":"34066665","presented_order":["20839751","34066665"],"winner_id":"20839751","reasoning":"Document A — it discusses prognostic factors in breast cancer (association with poor prognosis), making it more relevant to a claim about a marker's prognostic association.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700292Z"}
{"comparison_id":"3ab4e396-90ec-49ee-a585-c856f0c48f48","query_id":"53","doc_a_id":"15113221","doc_b_id":"19358586","presented_order":["15113221","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it specifically links a protein signature to poor survival in breast cancer, whereas A discusses a PTEN-related signature in carcinomas more generally.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700298Z"}
{"comparison_id":"d9829fcb-8a91-4a9c-9656-ff880b12810b","query_id":"53","doc_a_id":"22482820","doc_b_id":"34066665","presented_order":["22482820","34066665"],"winner_id":"22482820","reasoning":"Document A is more focused on breast cancer biomarkers, drug resistance, and treatment strategies where prognostic markers like ALDH1 are more likely discussed. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700305Z"}
{"comparison_id":"cd1c0b8a-5c46-4de0-8a76-76f5df7f5772","query_id":"53","doc_a_id":"2014909","doc_b_id":"21033230","presented_order":["2014909","21033230"],"winner_id":"2014909","reasoning":"Document A is more relevant — it analyzes primary breast cancers and tumor-initiating cells (ALDH1 is a known tumor-initiating/cancer stem cell marker) and links tumor-initiating features to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700311Z"}
{"comparison_id":"45f34242-800b-4c17-be14-e8efabf5418d","query_id":"53","doc_a_id":"11484808","doc_b_id":"20839751","presented_order":["11484808","20839751"],"winner_id":"20839751","reasoning":"Document B — it directly addresses prognostic associations in breast cancer, whereas Document A focuses on non-coding RNAs in endocrine cancers and is less directly related.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700318Z"}
{"comparison_id":"97563562-c54f-4adf-8ee6-512d965c0841","query_id":"53","doc_a_id":"21902400","doc_b_id":"27240667","presented_order":["27240667","21902400"],"winner_id":"27240667","reasoning":"Document A is more relevant — it addresses breast cancer prognosis/mortality directly, while Document B discusses tumor hypoxia and not ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700324Z"}
{"comparison_id":"4e18baa1-093d-49ef-8ea3-1afe10f7e22d","query_id":"53","doc_a_id":"11484808","doc_b_id":"4583180","presented_order":["11484808","4583180"],"winner_id":"11484808","reasoning":"Document A is more likely to discuss biomarkers and prognostic markers in endocrine-related cancers (including breast cancer) and thus more relevant to ALDH1's prognostic association.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700331Z"}
{"comparison_id":"c1e5e03e-7721-4ed7-b2ea-fbea7590e5d3","query_id":"53","doc_a_id":"3285322","doc_b_id":"7795952","presented_order":["7795952","3285322"],"winner_id":"7795952","reasoning":"Document A is more relevant — it discusses a specific protein whose overexpression is linked to poor cancer prognosis, which is conceptually closer to a claim about a marker's expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700337Z"}
{"comparison_id":"5b420d1d-4e2a-4547-9c05-9cdfd8cdd2cb","query_id":"53","doc_a_id":"18953920","doc_b_id":"7821634","presented_order":["7821634","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses acquisition of stem-cell markers in mammary cells (which is where ALDH1 is commonly discussed) and links stem-like properties to increased tumorigenicity, so it's more likely to address ALDH1's prognostic relevance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700346Z"}
{"comparison_id":"4ff18371-c854-45c0-a48e-e1eb3e6d2d95","query_id":"53","doc_a_id":"15832146","doc_b_id":"34066665","presented_order":["15832146","34066665"],"winner_id":"34066665","reasoning":"Document B is more relevant — it discusses molecular mechanisms and clinical implications (therapy resistance) related to prognosis in breast cancer, which is closer to ALDH1's role than the CAF/angiogenesis focus of A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700355Z"}
{"comparison_id":"0211cb1a-27cc-4365-800f-3f59c6ce3054","query_id":"53","doc_a_id":"18953920","doc_b_id":"27240667","presented_order":["27240667","18953920"],"winner_id":"18953920","reasoning":"Document B is more relevant — it links EMT to acquisition of stem-cell markers and increased tumorigenicity, which relates to ALDH1 as a breast cancer stem-cell marker associated with poor prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700362Z"}
{"comparison_id":"b52313fd-0557-45bd-b085-b10c4f3bff17","query_id":"53","doc_a_id":"15946643","doc_b_id":"2130391","presented_order":["15946643","2130391"],"winner_id":"15946643","reasoning":"Reason: Document A addresses chemoresistance and metastasis — factors directly tied to prognosis in breast cancer — whereas Document B focuses on adipocyte-driven invasion without linking to prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700369Z"}
{"comparison_id":"564c308c-b732-4ac1-9edf-5716911ac918","query_id":"53","doc_a_id":"2014909","doc_b_id":"22401720","presented_order":["22401720","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers (where ALDH1 is a known stem/tumor-initiating marker), whereas A focuses on angiogenic factors like VEGF unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700376Z"}
{"comparison_id":"cf8fe854-7160-4aa8-9633-75ba4dd55190","query_id":"53","doc_a_id":"29495185","doc_b_id":"313403","presented_order":["29495185","313403"],"winner_id":"29495185","reasoning":"Document A is more relevant because it discusses molecular predictors of cancer prognosis (which would include markers like ALDH1), while Document B focuses on tumor-associated macrophages, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700382Z"}
{"comparison_id":"bfa778ba-d0ec-44ab-b893-5baa8e66af43","query_id":"53","doc_a_id":"2014909","doc_b_id":"24341590","presented_order":["2014909","24341590"],"winner_id":"2014909","reasoning":"Document A is more relevant — it studies tumor-initiating cells and primary breast cancer samples (likely addressing stem cell markers like ALDH1), whereas Document B deals with CYP2D6 and tamoxifen outcomes, unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700389Z"}
{"comparison_id":"1523cc45-f0c2-4ef4-a093-0d552ded44e0","query_id":"53","doc_a_id":"15946643","doc_b_id":"21902400","presented_order":["21902400","15946643"],"winner_id":"15946643","reasoning":"Document B is more directly about molecular mechanisms in breast cancer (chemoresistance and metastasis), making it more relevant to a claim about a prognostic marker in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700395Z"}
{"comparison_id":"4546036a-6b2f-4372-8cd5-39467a9e6378","query_id":"53","doc_a_id":"15946643","doc_b_id":"4455466","presented_order":["15946643","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it discusses a gene's expression level being linked to prognosis in breast cancer (similar concept to ALDH1), whereas A focuses on CXCL1 signaling and chemoresistance without prognosis markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700402Z"}
{"comparison_id":"323f46e0-b6ea-48ed-8e6c-5dd79f90ea65","query_id":"53","doc_a_id":"11484808","doc_b_id":"16086778","presented_order":["11484808","16086778"],"winner_id":"16086778","reasoning":"Document B is more directly about breast cancer biology and prognosis-relevant pathways, whereas Document A focuses broadly on non-coding RNAs in endocrine cancers and does not specifically address ALDH1 or breast prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700408Z"}
{"comparison_id":"d7a4567a-5ded-491a-a412-aae6b79fd553","query_id":"53","doc_a_id":"17648235","doc_b_id":"43385013","presented_order":["43385013","17648235"],"winner_id":"43385013","reasoning":"Document A is more relevant — it addresses stem cell/progenitor properties in breast epithelial/mesenchymal subpopulations, which relates to ALDH1 as a stem cell marker and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700414Z"}
{"comparison_id":"40d4a250-d501-41c7-8959-41ada1f5181a","query_id":"53","doc_a_id":"20127522","doc_b_id":"7795952","presented_order":["20127522","7795952"],"winner_id":"20127522","reasoning":"Document A is more relevant — it deals with prognostic markers in breast cancer (though not ALDH1 specifically), whereas Document B discusses fascin and invasion mechanisms unrelated to ALDH1 or breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700421Z"}
{"comparison_id":"ca6fb96d-7739-478a-8948-5ea17b0f5af7","query_id":"53","doc_a_id":"27240667","doc_b_id":"45638119","presented_order":["45638119","27240667"],"winner_id":"45638119","reasoning":"Document A directly states that ALDH1 is a marker associated with poor clinical outcome in breast cancer, while Document B discusses mortality trends unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700427Z"}
{"comparison_id":"130adf97-c628-43d9-a93d-cd18dd096eb9","query_id":"53","doc_a_id":"15946643","doc_b_id":"22401720","presented_order":["22401720","15946643"],"winner_id":"22401720","reasoning":"A is more relevant — it directly studies marker expression in primary breast cancers and links expression (VEGF) to prognosis, which is closer to the ALDH1–prognosis claim than B's focus on CXCL1-mediated chemoresistance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700436Z"}
{"comparison_id":"395d2eac-13a9-4e44-828b-78c7f82ec514","query_id":"53","doc_a_id":"20839751","doc_b_id":"27240667","presented_order":["27240667","20839751"],"winner_id":"20839751","reasoning":"Reason: Document B discusses a tumor biomarker's (apoptotic index) association with prognosis in breast cancer, which is more directly related to evaluating biomarker–prognosis links than Document A's population mortality trends.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700447Z"}
{"comparison_id":"4a1c13f2-5b2a-4346-afb1-9c0b883e1c0e","query_id":"53","doc_a_id":"2130391","doc_b_id":"25973484","presented_order":["2130391","25973484"],"winner_id":"25973484","reasoning":"Document B — it addresses breast cancer prognosis and factors linked to aggressive tumor phenotypes, so is more related to a claim about prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700456Z"}
{"comparison_id":"eb7abfe4-ff4f-4ad2-a89e-fb319f293a36","query_id":"53","doc_a_id":"21033230","doc_b_id":"7821634","presented_order":["7821634","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it deals with molecular markers in circulating tumor cells and their association with prognosis, whereas Document A focuses on DUSP4 and chemotherapy resistance without addressing ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700463Z"}
{"comparison_id":"05966b70-d6a0-4a31-a7c5-f815a276e7bb","query_id":"53","doc_a_id":"15113221","doc_b_id":"29495185","presented_order":["15113221","29495185"],"winner_id":"29495185","reasoning":"Document B is more relevant — it discusses molecular predictors of cancer prognosis (the category ALDH1 would fall into), while Document A focuses specifically on a PTEN-related signature, not ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700469Z"}
{"comparison_id":"cf113e05-8d7a-4b14-a593-0edad8c7ad9d","query_id":"53","doc_a_id":"15946643","doc_b_id":"21033230","presented_order":["21033230","15946643"],"winner_id":"21033230","reasoning":"Document A is more relevant — it addresses prognostic markers in breast cancer (CTCs and molecular profiling), whereas Document B focuses on CXCL1-mediated chemoresistance/metastasis and not prognosis markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700476Z"}
{"comparison_id":"440425f5-757b-4681-800f-7c1ed46b5aae","query_id":"53","doc_a_id":"29366489","doc_b_id":"4418878","presented_order":["29366489","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures linked to prognosis in cancers, which relates to claims about expression markers like ALDH1; Document A focuses on DLC-1, not ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700482Z"}
{"comparison_id":"86326b73-76ea-4d2a-a103-3e974ad3d141","query_id":"53","doc_a_id":"1379127","doc_b_id":"7821634","presented_order":["1379127","7821634"],"winner_id":"7821634","reasoning":"Document B — it discusses a biomarker (DUSP4) whose low levels correlate with poor outcomes in breast cancer, which is more relevant to a claim about a marker (ALDH1) and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700488Z"}
{"comparison_id":"37a54f14-d0ca-4f27-b55b-e5d6c816df4d","query_id":"53","doc_a_id":"20183360","doc_b_id":"25732836","presented_order":["25732836","20183360"],"winner_id":"25732836","reasoning":"Reason: Document A addresses prognostic markers and survival outcomes in breast cancer (relevant to prognosis), while Document B focuses on molecular regulation of invasion without prognostic correlation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700494Z"}
{"comparison_id":"55193cb8-b8cf-4ff2-b6ab-4c2628bec111","query_id":"53","doc_a_id":"15113221","doc_b_id":"20183360","presented_order":["20183360","15113221"],"winner_id":"20183360","reasoning":"Document A is more relevant — it specifically concerns breast cancer biology, while Document B addresses carcinomas generally and focuses on PTEN pathway signatures, not breast-specific markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700501Z"}
{"comparison_id":"c9ea3cdf-00f7-4f74-a6a9-d8b0845104bc","query_id":"53","doc_a_id":"20127522","doc_b_id":"20839751","presented_order":["20839751","20127522"],"winner_id":"20839751","reasoning":"Document A is more relevant — it discusses tissue-based markers and their association with prognosis in breast cancer, whereas Document B focuses on circulating tumor cells and treatment monitoring. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700507Z"}
{"comparison_id":"068e148a-8590-42ce-8f2e-e0511564764e","query_id":"53","doc_a_id":"19358586","doc_b_id":"20127522","presented_order":["19358586","20127522"],"winner_id":"19358586","reasoning":"Document A is more relevant — it discusses a tumor protein signature linked to poor survival in breast cancer (closer to tissue expression markers), while B addresses circulating tumor cells rather than tumor protein expression like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700514Z"}
{"comparison_id":"9d860637-eeb9-4169-a121-4a347f7ea313","query_id":"53","doc_a_id":"1379127","doc_b_id":"19358586","presented_order":["1379127","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it discusses molecular markers linked to poor survival in breast cancer, whereas A focuses on calcium-channel proteins and metastasis without addressing prognostic markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700520Z"}
{"comparison_id":"0132702a-ca0f-481e-aeb9-a42582a85993","query_id":"53","doc_a_id":"15832146","doc_b_id":"4702639","presented_order":["4702639","15832146"],"winner_id":"4702639","reasoning":"Document A — it discusses tumor stemness and stem-like markers/pathways tied to aggressiveness and therapy resistance, which is more directly related to ALDH1's role as a cancer stem cell marker and prognostic indicator. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700527Z"}
{"comparison_id":"b748256b-1305-4605-8e1a-b168192d8b65","query_id":"53","doc_a_id":"24834968","doc_b_id":"8963413","presented_order":["24834968","8963413"],"winner_id":"24834968","reasoning":"Document A is focused on biological markers in primary breast cancer, making it more relevant to a claim about ALDH1 and breast cancer prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700532Z"}
{"comparison_id":"68139286-5e8a-43bc-8c86-a5955a313f43","query_id":"53","doc_a_id":"20839751","doc_b_id":"8963413","presented_order":["20839751","8963413"],"winner_id":"20839751","reasoning":"Document A is more relevant — it discusses prognostic factors in breast cancer, whereas Document B focuses on PD-L1 and not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700538Z"}
{"comparison_id":"d20b0eaa-70b7-4428-ac8d-52cbcdaf0094","query_id":"53","doc_a_id":"2014909","doc_b_id":"25973484","presented_order":["2014909","25973484"],"winner_id":"2014909","reasoning":"Document A is more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers (likely covering stem-cell markers like ALDH1) while Document B focuses on obesity-related risk factors, not ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700545Z"}
{"comparison_id":"d338d42f-a519-4f5e-9b16-a308b8ebb53b","query_id":"53","doc_a_id":"12762485","doc_b_id":"24341590","presented_order":["24341590","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses a stem-cell phenotype linked to more aggressive, less differentiated tumors (which relates to ALDH1 as a stem-cell marker). Document A is about CYP2D6/tamoxifen and is unrelated.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700551Z"}
{"comparison_id":"1f3057e2-1a45-4ccb-a25a-c9e309e4ee26","query_id":"53","doc_a_id":"1171121","doc_b_id":"1379127","presented_order":["1171121","1379127"],"winner_id":"1171121","reasoning":"Document A is more relevant — it addresses prognostic factors in breast cancer (survival associations), while Document B focuses on migration/metastasis mechanisms and not prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700557Z"}
{"comparison_id":"f4d71042-c592-4aa1-8c74-d581968d403e","query_id":"53","doc_a_id":"19358586","doc_b_id":"2014909","presented_order":["19358586","2014909"],"winner_id":"19358586","reasoning":"Document A is more relevant — it directly links a molecular signature to poor survival in breast cancer, which addresses prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700563Z"}
{"comparison_id":"90f0dea4-3374-4d6a-b7e7-984f55149f05","query_id":"53","doc_a_id":"27240667","doc_b_id":"34066665","presented_order":["34066665","27240667"],"winner_id":"34066665","reasoning":"Document A is more relevant — it addresses molecular mechanisms and markers tied to therapy resistance and prognosis, which is closer to ALDH1's role than population mortality trends. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700569Z"}
{"comparison_id":"3b8b3ed1-f14d-41ee-9ed1-65418eaa9721","query_id":"53","doc_a_id":"18953920","doc_b_id":"21902400","presented_order":["18953920","21902400"],"winner_id":"18953920","reasoning":"Document A is more relevant — it links mammary epithelial cells acquiring stem-cell markers and increased tumorigenic potential, which relates to ALDH1 as a breast cancer stem-cell/prognostic marker.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700575Z"}
{"comparison_id":"978e9898-7322-4f0d-a108-7a5bd18e3050","query_id":"53","doc_a_id":"1171121","doc_b_id":"29366489","presented_order":["29366489","1171121"],"winner_id":"1171121","reasoning":"Reason: Document B addresses prognostic markers in breast cancer, while Document A discusses a different gene (DLC-1) and not breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700582Z"}
{"comparison_id":"ad80270e-622d-4ea0-bad6-9b65fcfee3eb","query_id":"53","doc_a_id":"20839751","doc_b_id":"4583180","presented_order":["20839751","4583180"],"winner_id":"20839751","reasoning":"Document A is more relevant — it discusses prognostic factors in breast cancer, whereas Document B focuses on SREBP2 and tumor metabolism not directly related to ALDH1 or breast prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700588Z"}
{"comparison_id":"5f0447db-71fb-4a05-87cb-3dacde8401be","query_id":"53","doc_a_id":"1866911","doc_b_id":"18953920","presented_order":["1866911","18953920"],"winner_id":"18953920","reasoning":"Document B — it links acquisition of stem-cell markers and increased tumorigenic potential in mammary cells, which is more relevant to ALDH1 as a cancer stem-cell prognostic marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700622Z"}
{"comparison_id":"9a176400-26ee-4e77-a36e-97f4fb19cb63","query_id":"53","doc_a_id":"7821634","doc_b_id":"8963413","presented_order":["8963413","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it links a specific biomarker's expression (DUSP4) to prognosis in breast cancer, whereas A discusses PD-L1 and does not address ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700629Z"}
{"comparison_id":"e1245587-f362-4c9a-8fc3-fc1f87ee2ffd","query_id":"53","doc_a_id":"18953920","doc_b_id":"4429932","presented_order":["4429932","18953920"],"winner_id":"18953920","reasoning":"B — discusses acquisition of stem-cell markers in mammary cells (relevant to ALDH1 as a stem-cell marker and its prognostic implications). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700635Z"}
{"comparison_id":"b3bdd2d3-326d-48aa-a32e-d02165caadd5","query_id":"53","doc_a_id":"22401720","doc_b_id":"29495185","presented_order":["22401720","29495185"],"winner_id":"22401720","reasoning":"Document A is more directly about molecular markers tied to prognosis in breast cancer (though not ALDH1 specifically), whereas B is a general overview.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700641Z"}
{"comparison_id":"20e84c44-687e-4bc1-911c-f17b1bbfbc4d","query_id":"53","doc_a_id":"11484808","doc_b_id":"4455466","presented_order":["11484808","4455466"],"winner_id":"4455466","reasoning":"Document B — it discusses markers tied to breast-cancer prognosis, while A is a general review of ncRNAs not specific to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700647Z"}
{"comparison_id":"7bc941a1-5479-4444-b6ea-732e0ca80df5","query_id":"53","doc_a_id":"4702639","doc_b_id":"5649538","presented_order":["4702639","5649538"],"winner_id":"4702639","reasoning":"Document A discusses tumor stemness and markers/drivers of stem-like properties (relevant to ALDH1, a cancer stem cell marker linked to prognosis), while Document B focuses on dasatinib sensitivity predictors unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700654Z"}
{"comparison_id":"d4c449f7-e307-4254-81bc-c2ccf3c8c9b6","query_id":"53","doc_a_id":"45638119","doc_b_id":"7583725","presented_order":["7583725","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 and states it predicts poor clinical outcome in breast cancer; Document A is about TRPM7, not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700660Z"}
{"comparison_id":"10fd288c-688d-44dd-9462-ab196cc39629","query_id":"53","doc_a_id":"1379127","doc_b_id":"34066665","presented_order":["1379127","34066665"],"winner_id":"34066665","reasoning":"Document B is more relevant — it covers molecular markers and clinical implications in breast cancer (endocrine resistance and prognosis), whereas A focuses narrowly on Orai1/STIM1 and metastasis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700666Z"}
{"comparison_id":"590ce391-d9c8-4084-b82d-b5917d2b8808","query_id":"53","doc_a_id":"22401720","doc_b_id":"8963413","presented_order":["22401720","8963413"],"winner_id":"22401720","reasoning":"Document A is more relevant — it discusses expression of molecular markers in primary breast cancer and relates specific marker levels (e.g., VEGF) to prognosis, whereas Document B focuses on PD-L1 across cancers and does not address ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700672Z"}
{"comparison_id":"30394cac-2dae-4994-9460-264d892ac28d","query_id":"53","doc_a_id":"1379127","doc_b_id":"16086778","presented_order":["16086778","1379127"],"winner_id":"1379127","reasoning":"Document B is more relevant — it links molecular factors to tumor metastasis, which directly affects prognosis, while A focuses on Numb/Notch regulation without prognosis data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700679Z"}
{"comparison_id":"61ee2645-ccf8-4a0d-b47d-b156b4ba442e","query_id":"53","doc_a_id":"29366489","doc_b_id":"313403","presented_order":["313403","29366489"],"winner_id":"313403","reasoning":"Document A is more relevant — it directly addresses prognostic markers in breast cancer and links marker expression to clinical outcome; Document B discusses a different gene and not breast-cancer prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700686Z"}
{"comparison_id":"86bc233a-86fb-4d7d-a040-ca22250fd2a4","query_id":"53","doc_a_id":"1171121","doc_b_id":"15113221","presented_order":["1171121","15113221"],"winner_id":"1171121","reasoning":"Document A — it concerns prognostic factors specifically in breast cancer, whereas B discusses PTEN-related signatures across carcinomas and is less directly related to ALDH1 in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700692Z"}
{"comparison_id":"bc926fb3-6c2f-4817-84f2-2708ea22bbc3","query_id":"53","doc_a_id":"313403","doc_b_id":"7795952","presented_order":["7795952","313403"],"winner_id":"7795952","reasoning":"Document A is more relevant — it discusses a tumor-cell protein whose overexpression is linked to poor cancer prognosis, which is closer to assessing ALDH1 expression as a prognostic marker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700698Z"}
{"comparison_id":"8b103994-38a6-4961-9a63-f792fb1608d8","query_id":"53","doc_a_id":"3285322","doc_b_id":"4702639","presented_order":["4702639","3285322"],"winner_id":"4702639","reasoning":"Document A is more relevant — it addresses tumour stemness and stem-cell markers linked to prognosis and therapy resistance, which is closely related to ALDH1's role. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700705Z"}
{"comparison_id":"b7b460fd-a693-4267-8f0b-a92195161685","query_id":"53","doc_a_id":"11484808","doc_b_id":"8963413","presented_order":["8963413","11484808"],"winner_id":"8963413","reasoning":"Document A is more relevant because it discusses expression of a tumor marker (PD-L1) and its association with clinical outcomes in breast cancer, which is closer to the claim about marker expression and prognosis than a general review of ncRNAs. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700711Z"}
{"comparison_id":"f908a909-36f0-44c5-9da0-44e8829f6549","query_id":"53","doc_a_id":"20839751","doc_b_id":"5649538","presented_order":["20839751","5649538"],"winner_id":"20839751","reasoning":"Document A is more relevant — it discusses prognostic factors in breast cancer (though not ALDH1 specifically), while B focuses on dasatinib response predictors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700718Z"}
{"comparison_id":"2b995ce1-9d35-49dd-910d-d0ed251819d0","query_id":"53","doc_a_id":"15946643","doc_b_id":"4429932","presented_order":["15946643","4429932"],"winner_id":"15946643","reasoning":"Document A is more focused on breast cancer mechanisms (chemoresistance and metastasis) that relate to prognostic markers like ALDH1, whereas Document B centers on LOX and hypoxia without connection to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700724Z"}
{"comparison_id":"75ccc52f-1e9c-4ad1-b745-a6b7a186880d","query_id":"53","doc_a_id":"25973484","doc_b_id":"4702639","presented_order":["25973484","4702639"],"winner_id":"25973484","reasoning":"Document A is more relevant — it discusses breast cancer prognosis directly, while Document B focuses on integrin-driven stemness and drug resistance in other carcinomas and does not address ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700731Z"}
{"comparison_id":"4d7172c5-6614-4cfc-8e3b-b82b6cd45c0e","query_id":"53","doc_a_id":"19358586","doc_b_id":"22482820","presented_order":["19358586","22482820"],"winner_id":"19358586","reasoning":"Document A is more relevant — it discusses protein signatures linked to poor survival in breast cancer (prognostic markers), whereas Document B focuses on treatment strategies and drug delivery.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700737Z"}
{"comparison_id":"5f4cd321-eb5e-44ff-9c49-5eb13e8f6fa8","query_id":"53","doc_a_id":"19358586","doc_b_id":"21902400","presented_order":["21902400","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it discusses molecular signatures linked to poor survival in breast cancer, whereas A focuses on hypoxia generally and doesn't address ALDH1 or breast prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700743Z"}
{"comparison_id":"0260746f-e0f6-4cb2-a28d-67924f5b58a7","query_id":"53","doc_a_id":"1171121","doc_b_id":"4702639","presented_order":["4702639","1171121"],"winner_id":"4702639","reasoning":"Document A — it addresses tumour stemness and stem-cell markers linked to resistance/poor outcomes, which is more directly related to ALDH1 (a cancer stem-cell marker) than Document B on MVD/p53.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700750Z"}
{"comparison_id":"a3591156-870c-4073-a654-f0c73eec8758","query_id":"53","doc_a_id":"20839751","doc_b_id":"4455466","presented_order":["4455466","20839751"],"winner_id":"4455466","reasoning":"Document A is more relevant — it directly discusses the association between expression level of a gene and breast cancer prognosis, which is conceptually closer to the ALDH1 expression–prognosis claim than the apoptosis-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700756Z"}
{"comparison_id":"6efe4c3f-734e-4a95-99ab-555f6de6eab0","query_id":"53","doc_a_id":"12762485","doc_b_id":"7795952","presented_order":["12762485","7795952"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses a stem-cell-like phenotype in breast cancer (linked to poorer differentiation and higher proliferation), which is related to ALDH1 as a stem cell marker. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700762Z"}
{"comparison_id":"9e0b320d-a86f-4921-8858-77a63e845265","query_id":"53","doc_a_id":"16086778","doc_b_id":"19673227","presented_order":["16086778","19673227"],"winner_id":"16086778","reasoning":"Neither paper mentions ALDH1; however, A is marginally more relevant because it addresses breast cancer biology directly, while B focuses on CTC chemosensitivity across epithelial tumors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700768Z"}
{"comparison_id":"9f4d4182-98fa-4993-a925-5b7dc66a46c1","query_id":"53","doc_a_id":"29495185","doc_b_id":"45638119","presented_order":["45638119","29495185"],"winner_id":"45638119","reasoning":"Document A specifically links ALDH1 expression to poor prognosis in breast cancer; Document B is general about molecular predictors. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700774Z"}
{"comparison_id":"9599277f-ce6f-4722-9a4c-6a319ae48475","query_id":"53","doc_a_id":"3285322","doc_b_id":"825728","presented_order":["825728","3285322"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT, acquisition of stem-cell properties and patient survival (closely related to ALDH1 as a stem cell/prognostic marker), whereas B focuses on BRCA status.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700780Z"}
{"comparison_id":"738d52f7-c0da-4b7c-bf65-b7ad89248b50","query_id":"53","doc_a_id":"27240667","doc_b_id":"825728","presented_order":["27240667","825728"],"winner_id":"27240667","reasoning":"Document A discusses breast cancer mortality and prognosis directly; Document B covers Prrx1/EMT in metastasis and not ALDH1 or breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700786Z"}
{"comparison_id":"b4d5ce99-8a16-40a8-bb86-e380648ad48a","query_id":"53","doc_a_id":"15113221","doc_b_id":"45638119","presented_order":["15113221","45638119"],"winner_id":"45638119","reasoning":"Document B — it specifically reports that ALDH1 marks mammary stem cells and predicts poor prognosis in breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700792Z"}
{"comparison_id":"f305d745-93f8-4bcd-87b1-741ff3382de9","query_id":"53","doc_a_id":"21902400","doc_b_id":"22482820","presented_order":["21902400","22482820"],"winner_id":"22482820","reasoning":"Document B is more relevant — it focuses on breast cancer classification and treatment challenges, so it's likelier to discuss biomarkers like ALDH1 and prognosis than a general paper on tumor hypoxia.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700798Z"}
{"comparison_id":"6c5fff47-508e-4d93-9fa8-4ff9dcec971f","query_id":"53","doc_a_id":"20183360","doc_b_id":"22401720","presented_order":["22401720","20183360"],"winner_id":"22401720","reasoning":"Document A is more relevant — it discusses marker expression in breast cancer and links high expression (VEGF) to poor prognosis, which is closer to the claim about marker expression and prognosis than the mechanistic study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700804Z"}
{"comparison_id":"6908c02f-28a1-401c-a757-6a5e3ba7adc8","query_id":"53","doc_a_id":"24834968","doc_b_id":"7821634","presented_order":["7821634","24834968"],"winner_id":"7821634","reasoning":"Document A is more relevant — it links expression of a specific marker (DUSP4) to poor outcomes in breast cancer, which is analogous to the claim about a marker (ALDH1) and prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700811Z"}
{"comparison_id":"04faac51-9f1d-4009-8d84-b4979e2a27f7","query_id":"53","doc_a_id":"21902400","doc_b_id":"45638119","presented_order":["45638119","21902400"],"winner_id":"45638119","reasoning":"Document A is directly about ALDH1 as a marker and predictor of poor clinical outcome in breast cancer; Document B discusses tumor hypoxia and is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700848Z"}
{"comparison_id":"7965e5eb-fdfb-4571-89d6-219d3f348953","query_id":"53","doc_a_id":"25973484","doc_b_id":"43385013","presented_order":["25973484","43385013"],"winner_id":"43385013","reasoning":"Document B — it discusses stem cell/progenitor properties in breast cells (ALDH1 is a stem cell marker), so it's more related to ALDH1's prognostic role than Document A about obesity. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700854Z"}
{"comparison_id":"e998d05d-b96c-4977-b676-7b73342cd981","query_id":"53","doc_a_id":"1379127","doc_b_id":"19673227","presented_order":["19673227","1379127"],"winner_id":"19673227","reasoning":"Document A is more relevant — it discusses prognostic/predictive markers and correlations with disease-free survival and progression, whereas Document B focuses on calcium channels and metastasis mechanisms, not prognosis markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700861Z"}
{"comparison_id":"27f76548-42ed-47b0-8cef-9505ceb74d12","query_id":"53","doc_a_id":"21033230","doc_b_id":"24341590","presented_order":["21033230","24341590"],"winner_id":"21033230","reasoning":"Document A is more relevant — it examines molecular markers and their relation to prognosis in breast cancer, while B focuses on CYP2D6 polymorphisms and tamoxifen outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700867Z"}
{"comparison_id":"e5c08402-693d-446c-86a3-0e7c41686bfc","query_id":"53","doc_a_id":"24341590","doc_b_id":"4583180","presented_order":["4583180","24341590"],"winner_id":"24341590","reasoning":"Document B is more relevant — it directly addresses clinical outcomes/prognosis in breast cancer patients, whereas Document A focuses on SREBP2 and tumor progression generally. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700873Z"}
{"comparison_id":"fc9f2a7c-f337-42bc-bfed-865cc50c88b3","query_id":"53","doc_a_id":"34066665","doc_b_id":"825728","presented_order":["34066665","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it links EMT/stem-cell properties to metastatic colonization and patient survival, which is closer to ALDH1's role as a stem-cell/prognostic marker. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700879Z"}
{"comparison_id":"4fb3370b-e2be-4dfe-a8e9-6ca52ca05ba2","query_id":"53","doc_a_id":"1171121","doc_b_id":"18953920","presented_order":["18953920","1171121"],"winner_id":"18953920","reasoning":"Document A links EMT to acquisition of stem-cell markers and increased tumorigenic potential in mammary cells, which is relevant to ALDH1 (a stem-cell marker) and prognosis. Document B discusses MVD and p53, unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700885Z"}
{"comparison_id":"7d2349e6-7723-497f-a76b-f11cf8163840","query_id":"53","doc_a_id":"29495185","doc_b_id":"4429932","presented_order":["29495185","4429932"],"winner_id":"29495185","reasoning":"Document A is more relevant — it discusses molecular predictors of cancer prognosis broadly, which is closer to assessing markers like ALDH1 than a paper focused specifically on LOX.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700891Z"}
{"comparison_id":"da4ec74c-3324-49ed-8ce0-d598b6cd0506","query_id":"53","doc_a_id":"2931832","doc_b_id":"29366489","presented_order":["2931832","29366489"],"winner_id":"2931832","reasoning":"Document A is more relevant — it discusses prognostic biomarkers directly in breast cancer, whereas Document B is about a different gene (DLC-1) and broader cancers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700897Z"}
{"comparison_id":"a68d6916-44be-404d-954e-d56aaa2ee58f","query_id":"53","doc_a_id":"19358586","doc_b_id":"21033230","presented_order":["19358586","21033230"],"winner_id":"19358586","reasoning":"Document A — it specifically links a protein expression signature to poor survival in breast cancer, so it's more relevant to a claim about marker expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700903Z"}
{"comparison_id":"8ec72de4-5634-48f2-8484-190843ef165a","query_id":"53","doc_a_id":"4583180","doc_b_id":"4889228","presented_order":["4583180","4889228"],"winner_id":"4889228","reasoning":"Document B — it directly studies prognostic markers in triple-negative breast cancer, whereas A focuses on SREBP2 and tumor progression in a broader context. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700909Z"}
{"comparison_id":"bddd6726-934e-4f64-acb1-d1f2cb87ed93","query_id":"53","doc_a_id":"1379127","doc_b_id":"2931832","presented_order":["1379127","2931832"],"winner_id":"2931832","reasoning":"Document B is more relevant — it addresses prognostic biomarkers in breast cancer, whereas Document A focuses on calcium channels and metastasis mechanisms.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700916Z"}
{"comparison_id":"c5702627-04e2-4cfe-a258-48fbe240e821","query_id":"53","doc_a_id":"12762485","doc_b_id":"2014909","presented_order":["12762485","2014909"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses a stem-cell phenotype in breast cancer (which relates to ALDH1 as a stem cell marker) and its association with poorer differentiation and higher proliferation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700922Z"}
{"comparison_id":"561e9e56-d9b1-4a38-889d-9ade4dcc3506","query_id":"53","doc_a_id":"1379127","doc_b_id":"22482820","presented_order":["1379127","22482820"],"winner_id":"1379127","reasoning":"Document A is more relevant — it discusses factors (metastasis) directly tied to prognosis, whereas B focuses on treatment delivery strategies.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700928Z"}
{"comparison_id":"8d075d84-aa0f-464b-b844-110693ee5014","query_id":"53","doc_a_id":"25732836","doc_b_id":"31311495","presented_order":["25732836","31311495"],"winner_id":"25732836","reasoning":"Document A is more relevant — it addresses prognostic markers and outcome prediction in breast cancer, whereas Document B focuses on cellular mechanisms of tamoxifen resistance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700934Z"}
{"comparison_id":"6a28eaa3-0552-448b-93c8-f83d402e44da","query_id":"53","doc_a_id":"20183360","doc_b_id":"7583725","presented_order":["7583725","20183360"],"winner_id":"7583725","reasoning":"Document A is more relevant — it links expression of a marker (TRPM7) to poor patient outcomes in breast cancer, which is closer to the prognosis claim. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700940Z"}
{"comparison_id":"e6ef1b8b-cd6f-4113-939b-abebb1f31810","query_id":"53","doc_a_id":"17648235","doc_b_id":"19673227","presented_order":["19673227","17648235"],"winner_id":"19673227","reasoning":"Document A is more relevant — it addresses prognostic markers and survival correlations in cancer, whereas B focuses on WNT signaling and cell proliferation without prognostic data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700946Z"}
{"comparison_id":"8e278f04-ceb1-48c2-ad9e-6402ae44ae2e","query_id":"53","doc_a_id":"3285322","doc_b_id":"5649538","presented_order":["5649538","3285322"],"winner_id":"5649538","reasoning":"Document A — it discusses gene expression profiling and genomic markers, which is more likely to address expression-based prognostic markers like ALDH1 than the BRCA-focused clinical/pathologic comparison in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700952Z"}
{"comparison_id":"d39f0e79-900c-4a42-b74f-533f25fa95cc","query_id":"53","doc_a_id":"15113221","doc_b_id":"25973484","presented_order":["15113221","25973484"],"winner_id":"15113221","reasoning":"Document A is more relevant — it discusses a gene expression signature linked to poor prognosis in carcinoma, which is closer to the claim about a prognostic marker (ALDH1) than the obesity–breast cancer review.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700959Z"}
{"comparison_id":"30a71f6b-7e99-4796-87d5-5921c6c4bafc","query_id":"53","doc_a_id":"21902400","doc_b_id":"7583725","presented_order":["21902400","7583725"],"winner_id":"7583725","reasoning":"Document B — it discusses a specific breast cancer marker whose expression predicts poor outcome, which is more closely related to the claim about ALDH1 and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700965Z"}
{"comparison_id":"b46d6f36-4731-44e3-bd70-d08a71c29eb5","query_id":"53","doc_a_id":"12762485","doc_b_id":"7583725","presented_order":["7583725","12762485"],"winner_id":"12762485","reasoning":"Document B is more relevant — it discusses a stem cell phenotype in breast cancer (ALDH1 is a stem cell marker) and associated poor-prognosis features, whereas A focuses on TRPM7. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700971Z"}
{"comparison_id":"c759a0b5-c2b0-45a2-8cae-ca21cc795125","query_id":"53","doc_a_id":"22482820","doc_b_id":"31311495","presented_order":["22482820","31311495"],"winner_id":"22482820","reasoning":"Document A is more relevant — it addresses breast cancer classification, treatment challenges and prognosis-related topics, whereas Document B focuses on tamoxifen resistance mechanisms without discussing ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700977Z"}
{"comparison_id":"171b1f0c-ab2b-4a1c-b5e2-9f740f6e4a8a","query_id":"53","doc_a_id":"1866911","doc_b_id":"825728","presented_order":["825728","1866911"],"winner_id":"825728","reasoning":"Document A — it links EMT, acquisition of stem-cell properties and patient survival (more directly related to prognostic stem-cell markers like ALDH1) while B focuses on BRCA1-related progenitors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700983Z"}
{"comparison_id":"86490730-9dd3-427a-a17f-f6d8ba3d41cc","query_id":"53","doc_a_id":"16086778","doc_b_id":"24341590","presented_order":["24341590","16086778"],"winner_id":"16086778","reasoning":"Document B is more relevant — it addresses molecular mechanisms in breast cancer (tumor proliferation and prognosis-related pathways), whereas A focuses on CYP2D6 pharmacogenetics and tamoxifen response.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700990Z"}
{"comparison_id":"ed7ef1ad-e28f-4d9c-be95-7744edd5635c","query_id":"53","doc_a_id":"45638119","doc_b_id":"8963413","presented_order":["8963413","45638119"],"winner_id":"45638119","reasoning":"Document B — it explicitly reports that ALDH1 marks mammary stem cells and correlates with poor prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.700995Z"}
{"comparison_id":"7d2182eb-483d-4dce-8b3d-8e02170c65d2","query_id":"53","doc_a_id":"2014909","doc_b_id":"7583725","presented_order":["7583725","2014909"],"winner_id":"7583725","reasoning":"Document A is more relevant — it discusses a specific gene's expression predicting poor outcomes in breast cancer, matching the query's focus on marker expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701002Z"}
{"comparison_id":"50e55e6d-d988-442c-b731-3290c38ff267","query_id":"53","doc_a_id":"21033230","doc_b_id":"4583180","presented_order":["4583180","21033230"],"winner_id":"21033230","reasoning":"Document B — it discusses molecular markers and prognosis in metastatic breast cancer, which is more directly relevant to a claim about ALDH1 and prognosis than Document A's focus on SREBP2/cholesterol metabolism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701009Z"}
{"comparison_id":"faef40d9-d8a5-4f9a-b7d5-d6fb04283c37","query_id":"53","doc_a_id":"15946643","doc_b_id":"18953920","presented_order":["18953920","15946643"],"winner_id":"18953920","reasoning":"Doc A discusses acquisition of stem-cell markers in breast epithelial cells (traits linked to markers like ALDH1) and increased tumorigenicity, which is directly relevant to ALDH1's prognostic implications; Doc B focuses on CXCL1-related chemoresistance and not ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701015Z"}
{"comparison_id":"2a78f474-cbf1-49f6-a733-a2dac3d2d718","query_id":"53","doc_a_id":"24834968","doc_b_id":"3285322","presented_order":["3285322","24834968"],"winner_id":"24834968","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it evaluates biological markers as predictors in breast cancer, which is closer to assessing marker-associated prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701021Z"}
{"comparison_id":"2193f48f-0d9a-4c24-b1ed-a275eae10383","query_id":"53","doc_a_id":"16086778","doc_b_id":"20839751","presented_order":["16086778","20839751"],"winner_id":"20839751","reasoning":"Document B is more relevant — it discusses associations between a biomarker (apoptotic index) and prognosis in breast cancer, whereas Document A focuses on Numb/Notch signaling without addressing prognostic impact.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701028Z"}
{"comparison_id":"b00333b8-8c8b-4e26-9a58-febc2b29a93e","query_id":"53","doc_a_id":"1866911","doc_b_id":"19673227","presented_order":["1866911","19673227"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses breast cancer cell populations and markers (luminal progenitors) related to tumor biology and prognosis, whereas B focuses on CTC chemosensitivity across epithelial tumors without addressing ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701035Z"}
{"comparison_id":"d9f2db6b-4071-4885-8c51-1ed3181937b3","query_id":"53","doc_a_id":"4418878","doc_b_id":"4889228","presented_order":["4889228","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures and their link to prognosis across cancers, which is closer to evaluating whether a marker like ALDH1 predicts poorer breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701041Z"}
{"comparison_id":"2f24de33-bf4a-47e2-b50b-379d3d8dbfb1","query_id":"53","doc_a_id":"1866911","doc_b_id":"8963413","presented_order":["8963413","1866911"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses biomarker expression and associations with clinical outcomes in breast cancer, whereas Document B focuses on cell-of-origin in BRCA1 carriers and not prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701048Z"}
{"comparison_id":"b2e24b21-aae5-477d-900b-c07e88639559","query_id":"53","doc_a_id":"45638119","doc_b_id":"5649538","presented_order":["5649538","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly reports ALDH1 as a marker linked to poor clinical outcome in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701054Z"}
{"comparison_id":"c5a57cd5-9361-4b41-b426-165ca3ed0fe4","query_id":"53","doc_a_id":"1379127","doc_b_id":"25973484","presented_order":["25973484","1379127"],"winner_id":"25973484","reasoning":"Document A — it discusses factors linked to breast cancer prognosis (whereas B focuses on calcium channels and metastasis), so A is marginally more relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701060Z"}
{"comparison_id":"b78c93b0-e00e-4228-a6df-c405658d7c51","query_id":"53","doc_a_id":"19673227","doc_b_id":"34066665","presented_order":["19673227","34066665"],"winner_id":"34066665","reasoning":"Document B is more relevant — it deals specifically with breast cancer molecular mechanisms and clinical outcomes, whereas A focuses generally on CTC chemosensitivity across epithelial tumors and doesn't address ALDH1 or breast prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701067Z"}
{"comparison_id":"640e78da-6a8a-49a0-85c6-96a683989b0e","query_id":"53","doc_a_id":"1379127","doc_b_id":"313403","presented_order":["1379127","313403"],"winner_id":"313403","reasoning":"Document B — it directly addresses a marker (TAM infiltration) associated with poor prognosis in breast cancer, whereas Document A focuses on calcium-entry proteins and metastasis mechanisms. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701073Z"}
{"comparison_id":"cc39d38d-373c-4ba7-9918-971047ef2057","query_id":"53","doc_a_id":"2931832","doc_b_id":"31311495","presented_order":["31311495","2931832"],"winner_id":"2931832","reasoning":"Document B is more relevant — it reports a clinical prognostic biomarker study in breast cancer, which aligns with the claim about marker expression and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701079Z"}
{"comparison_id":"51ed2780-6055-4fc7-9982-a82f828f7189","query_id":"53","doc_a_id":"15113221","doc_b_id":"1866911","presented_order":["1866911","15113221"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses breast epithelial progenitor populations and markers related to breast cancer origins/subtypes, which is closer to ALDH1 as a stem/progenitor marker than the PTEN-focused, pan-carcinoma study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701086Z"}
{"comparison_id":"83a461ab-172a-428c-b4c0-337c9e528b31","query_id":"53","doc_a_id":"15832146","doc_b_id":"29495185","presented_order":["29495185","15832146"],"winner_id":"29495185","reasoning":"Document A is more relevant — it discusses molecular predictors of cancer prognosis (the category ALDH1 would fall under), whereas Document B focuses on stromal fibroblasts and SDF-1/CXCL12, not ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701093Z"}
{"comparison_id":"2bd259d5-e890-4ca4-998a-bc83f3927f02","query_id":"53","doc_a_id":"4418878","doc_b_id":"7795952","presented_order":["7795952","4418878"],"winner_id":"4418878","reasoning":"Reason: Document B discusses gene expression signatures and their link to prognosis across cancers, which is conceptually relevant to ALDH1 expression as a prognostic marker; Document A focuses specifically on fascin and TGFβ, not ALDH1 or prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701100Z"}
{"comparison_id":"8917186f-7546-4d13-b6ea-6976f24a41e8","query_id":"53","doc_a_id":"2014909","doc_b_id":"2130391","presented_order":["2014909","2130391"],"winner_id":"2014909","reasoning":"Document A is more relevant — it analyzes primary breast cancers and tumor-initiating cells (often marked by ALDH1) and discusses prognosis-related tumor initiation mechanisms, whereas B focuses on adipocytes and invasion unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701107Z"}
{"comparison_id":"b7a6ddf2-14eb-48eb-bff2-ad05d2e8a0a7","query_id":"53","doc_a_id":"22401720","doc_b_id":"45638119","presented_order":["45638119","22401720"],"winner_id":"45638119","reasoning":"Document A directly links ALDH1 expression to poor clinical outcome in breast cancer, while Document B discusses unrelated angiogenic factors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701112Z"}
{"comparison_id":"db516e14-dc36-406b-8b15-339fc7261f6b","query_id":"53","doc_a_id":"20183360","doc_b_id":"2931832","presented_order":["20183360","2931832"],"winner_id":"2931832","reasoning":"Document B addresses prognostic markers and survival in breast cancer, making it more relevant to a claim about prognosis; Document A focuses on molecular invasion mechanisms. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701118Z"}
{"comparison_id":"9b37d1dd-7cae-44b4-9110-7f42112b8494","query_id":"53","doc_a_id":"24834968","doc_b_id":"4429932","presented_order":["4429932","24834968"],"winner_id":"4429932","reasoning":"Document A is slightly more relevant — it discusses a molecular marker (LOX) associated with poor outcomes in breast cancer, while B focuses on HER-2/chemotherapy response and neither mentions ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701124Z"}
{"comparison_id":"3063940f-e2f7-4e18-a13d-d2cc2ccfba24","query_id":"53","doc_a_id":"24341590","doc_b_id":"3285322","presented_order":["3285322","24341590"],"winner_id":"3285322","reasoning":"Document A is more relevant — it discusses clinical and pathologic tumor characteristics and prognosis-related features (grade, triple-negative status) in breast cancer, which is closer to ALDH1's prognostic role than a pharmacogenetic tamoxifen-response study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701132Z"}
{"comparison_id":"a534d930-392f-431a-aece-d4f4d093fa16","query_id":"53","doc_a_id":"11484808","doc_b_id":"4889228","presented_order":["4889228","11484808"],"winner_id":"4889228","reasoning":"Document A is more directly about breast cancer prognosis (identifying markers linked to poor outcome), whereas B is a broad review of ncRNAs in endocrine cancers and doesn't address ALDH1 or breast cancer prognosis specifically.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701139Z"}
{"comparison_id":"9124dc79-e4fc-4184-bb0d-b63e9f2a3747","query_id":"53","doc_a_id":"25973484","doc_b_id":"3285322","presented_order":["3285322","25973484"],"winner_id":"3285322","reasoning":"Document A is more relevant — it discusses tumor subtypes (BRCA1, triple-negative) and higher-grade tumors linked to poorer prognosis, which is closer to ALDH1-associated aggressiveness than an obesity-focused review.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701146Z"}
{"comparison_id":"b9b310cf-a8d5-4f7f-b2fe-206cb2b08607","query_id":"53","doc_a_id":"20839751","doc_b_id":"3285322","presented_order":["3285322","20839751"],"winner_id":"20839751","reasoning":"Document B — it discusses prognostic markers in breast cancer (apoptotic index and prognosis), which is more relevant to a claim about a marker's association with prognosis than a paper focusing on BRCA mutation clinical features.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701152Z"}
{"comparison_id":"4635de2d-a128-4e8f-ac4b-838fae6bcc28","query_id":"53","doc_a_id":"19358586","doc_b_id":"7583725","presented_order":["7583725","19358586"],"winner_id":"19358586","reasoning":"Neither document mentions ALDH1 or provides evidence about its prognostic association; Document B is marginally more relevant because it addresses protein signatures and prognosis in breast cancer (biomarker context).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701158Z"}
{"comparison_id":"0177c985-49ae-4554-a508-af72c3359b41","query_id":"53","doc_a_id":"15946643","doc_b_id":"4583180","presented_order":["4583180","15946643"],"winner_id":"15946643","reasoning":"Document B is more directly about breast cancer progression, chemoresistance, and factors influencing patient outcomes, making it more relevant to a claim about prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701164Z"}
{"comparison_id":"9d2dcb4d-256f-4760-9efc-ae8c72735aaf","query_id":"53","doc_a_id":"15946643","doc_b_id":"7821634","presented_order":["7821634","15946643"],"winner_id":"7821634","reasoning":"Document A is more relevant — it directly discusses a molecular marker (DUSP4) whose levels correlate with poor outcomes in breast cancer, which is closer to prognostic association. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701170Z"}
{"comparison_id":"f2b49191-1aa7-4e04-a182-41dbfb6c6518","query_id":"53","doc_a_id":"22401720","doc_b_id":"5649538","presented_order":["22401720","5649538"],"winner_id":"22401720","reasoning":"Document A is more relevant — it examines marker expression in breast cancer and links high expression (VEGF) to poor prognosis, which is conceptually closer to an ALDH1–prognosis association than a drug-sensitivity genomic study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701177Z"}
{"comparison_id":"39c8f143-8f56-4567-958e-dd185257d254","query_id":"53","doc_a_id":"20183360","doc_b_id":"4418878","presented_order":["20183360","4418878"],"winner_id":"4418878","reasoning":"Document B — it discusses gene expression signatures linked to prognosis and could encompass markers like ALDH1; Document A focuses on GATA3/Smad4 and invasiveness and does not mention ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701183Z"}
{"comparison_id":"6bb65930-e492-4c2c-9bb2-5c0bb69a9cda","query_id":"53","doc_a_id":"25973484","doc_b_id":"5649538","presented_order":["5649538","25973484"],"winner_id":"5649538","reasoning":"Document A — it concerns gene expression markers in breast cancer (more likely to address ALDH1) while Document B focuses on obesity-related epidemiology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701189Z"}
{"comparison_id":"667c9dae-063d-4627-a5ff-a4c97f188f1a","query_id":"53","doc_a_id":"24834968","doc_b_id":"4455466","presented_order":["24834968","4455466"],"winner_id":"4455466","reasoning":"Document B — it discusses a marker whose expression correlates with prognosis in breast cancer, so it's more related to the claim about prognostic marker expression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701195Z"}
{"comparison_id":"caf3f5a6-e4a0-4edd-9352-14e8e609a312","query_id":"53","doc_a_id":"25973484","doc_b_id":"8963413","presented_order":["25973484","8963413"],"winner_id":"8963413","reasoning":"Reason: Document B discusses biomarker expression (PD-L1) and its association with clinical outcomes in breast cancer, making it more relevant to a claim about a biomarker (ALDH1) and prognosis than Document A, which focuses on obesity.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701202Z"}
{"comparison_id":"fdb3b148-b24b-4af6-8e0b-b5404f012860","query_id":"53","doc_a_id":"18953920","doc_b_id":"25973484","presented_order":["25973484","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses acquisition of stem-cell markers and increased tumorigenicity in mammary cells (ALDH1 is a breast cancer stem-cell marker tied to prognosis), so it's more relevant. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701208Z"}
{"comparison_id":"278499d2-9ef4-4f7f-a597-6172f2817476","query_id":"53","doc_a_id":"20839751","doc_b_id":"22482820","presented_order":["20839751","22482820"],"winner_id":"20839751","reasoning":"Document A discusses prognostic factors in breast cancer and links markers to poor prognosis, making it more relevant than Document B which focuses on treatment strategies.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701214Z"}
{"comparison_id":"65eaa020-a67d-4fc0-8f72-e02bc0231878","query_id":"53","doc_a_id":"27240667","doc_b_id":"4889228","presented_order":["4889228","27240667"],"winner_id":"4889228","reasoning":"Document A is more relevant — it discusses a molecular marker whose expression correlates with prognosis in breast cancer, which is closer to the ALDH1 prognosis claim than population mortality trends.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701220Z"}
{"comparison_id":"ca26a69d-5fff-4083-8a0b-fc7d5af63082","query_id":"53","doc_a_id":"25973484","doc_b_id":"29366489","presented_order":["25973484","29366489"],"winner_id":"25973484","reasoning":"Document A — it discusses breast cancer prognosis (though not ALDH1 specifically), so it's more relevant to the claim about prognosis in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701226Z"}
{"comparison_id":"eb984b42-408f-42e6-ab68-b56d5b32fc5c","query_id":"53","doc_a_id":"1866911","doc_b_id":"4702639","presented_order":["1866911","4702639"],"winner_id":"1866911","reasoning":"Document A is more relevant — it deals directly with breast epithelial/progenitor populations and breast tumor origins, whereas Document B focuses on an integrin–KRAS pathway and drug resistance in other carcinomas. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701233Z"}
{"comparison_id":"16f20747-4999-4b78-88f0-c7eb73773931","query_id":"53","doc_a_id":"19673227","doc_b_id":"20333864","presented_order":["19673227","20333864"],"winner_id":"19673227","reasoning":"Document A is more relevant — it addresses prognostic indicators (disease-free survival/time to progression), whereas Document B focuses on cellular mechanisms of DCIS-to-invasive transition without prognosis markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701239Z"}
{"comparison_id":"ad6f7cc8-7d75-4be1-a1a9-8e92a7b4c338","query_id":"53","doc_a_id":"1866911","doc_b_id":"4418878","presented_order":["4418878","1866911"],"winner_id":"4418878","reasoning":"Document A is more relevant — it addresses gene expression signatures and their links to cancer prognosis, which is directly related to whether marker expression (like ALDH1) associates with poorer breast-cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701245Z"}
{"comparison_id":"51328902-3a28-4893-ac2a-2081560fbddb","query_id":"53","doc_a_id":"15946643","doc_b_id":"4702639","presented_order":["15946643","4702639"],"winner_id":"4702639","reasoning":"Document B — it addresses tumour stemness and markers linked to resistance, which is more directly related to ALDH1's role as a cancer stem cell marker and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701251Z"}
{"comparison_id":"d811da8f-9cb3-4b72-b684-3d5e528b74c8","query_id":"53","doc_a_id":"15832146","doc_b_id":"19358586","presented_order":["19358586","15832146"],"winner_id":"19358586","reasoning":"Document A — it discusses protein signatures linked to poor survival in breast cancer (prognosis-related), whereas Document B focuses on stromal fibroblasts and angiogenesis rather than prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701257Z"}
{"comparison_id":"3487d988-fac9-4fee-8366-ea62c77aa077","query_id":"53","doc_a_id":"22482820","doc_b_id":"4455466","presented_order":["22482820","4455466"],"winner_id":"4455466","reasoning":"Document B — it links gene expression to prognosis in breast cancer (though for ZMYND11, not ALDH1), while A focuses on treatment strategies and not prognostic markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701263Z"}
{"comparison_id":"30fa5da4-7694-40c6-875d-6e8c18ab1e48","query_id":"53","doc_a_id":"4429932","doc_b_id":"7795952","presented_order":["7795952","4429932"],"winner_id":"4429932","reasoning":"Document B is more relevant — it explicitly links a protein (LOX) to poor patient outcomes in breast cancer, while A discusses fascin in tumor invasion but not breast-cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701269Z"}
{"comparison_id":"8e5b6227-a4e9-4ed8-8404-42b64bed0f07","query_id":"53","doc_a_id":"2014909","doc_b_id":"31311495","presented_order":["2014909","31311495"],"winner_id":"2014909","reasoning":"Document A is more relevant — it discusses tumor-initiating cells and clinical breast cancer analyses linked to prognosis, which relates to ALDH1 as a stem-cell/prognostic marker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701275Z"}
{"comparison_id":"e14319f3-a76d-44b6-a0d6-056862b5be35","query_id":"53","doc_a_id":"20127522","doc_b_id":"21902400","presented_order":["20127522","21902400"],"winner_id":"20127522","reasoning":"Document A is more relevant — it addresses prognostic markers specifically in breast cancer, whereas B discusses hypoxia across solid tumors without breast-specific prognostic data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701281Z"}
{"comparison_id":"1422afdd-a435-46ac-b872-fe29a847ffa9","query_id":"53","doc_a_id":"25973484","doc_b_id":"4889228","presented_order":["25973484","4889228"],"winner_id":"4889228","reasoning":"Document B is more relevant — it addresses gene expression correlating with prognosis in breast cancer (though a different marker), whereas A discusses obesity and breast cancer risk/prognosis without relevant molecular markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701288Z"}
{"comparison_id":"20580f4f-292d-4e8f-b643-2a5ded6196c0","query_id":"53","doc_a_id":"12762485","doc_b_id":"4429932","presented_order":["4429932","12762485"],"winner_id":"12762485","reasoning":"Document B is more relevant — it discusses stem-cell–like phenotypes in breast cancer (which ALDH1 marks) and their association with poor differentiation/prognosis. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701294Z"}
{"comparison_id":"f3df6ac3-5590-4902-90c3-8bce0e865151","query_id":"53","doc_a_id":"15946643","doc_b_id":"7583725","presented_order":["7583725","15946643"],"winner_id":"7583725","reasoning":"Doc A—it directly reports that high expression of a marker (TRPM7) predicts poor outcomes in breast cancer, which is the same type of evidence sought about ALDH1; Doc B focuses on CXCL1 signaling and chemoresistance, not marker–prognosis association. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701300Z"}
{"comparison_id":"be2e7948-2f8c-4dd3-a120-4cfe3c4d94bc","query_id":"53","doc_a_id":"15113221","doc_b_id":"4418878","presented_order":["15113221","4418878"],"winner_id":"15113221","reasoning":"Document A is more relevant — it directly links a specific gene expression signature to poor prognosis in carcinoma (closer to the claim about a biomarker–prognosis association).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701306Z"}
{"comparison_id":"39979f62-3639-4e8d-8f87-9cc62f7b981c","query_id":"53","doc_a_id":"21902400","doc_b_id":"29366489","presented_order":["21902400","29366489"],"winner_id":"29366489","reasoning":"Document B is more relevant — it discusses a molecular cancer marker and prognosis, which is closer to ALDH1's role as a prognostic biomarker than the general topic of hypoxia. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701312Z"}
{"comparison_id":"5e27cd1b-b272-4097-babe-d4cd68dc518c","query_id":"53","doc_a_id":"15832146","doc_b_id":"24834968","presented_order":["24834968","15832146"],"winner_id":"24834968","reasoning":"Neither paper mentions ALDH1. Document A is slightly more relevant because it deals with breast cancer biomarkers and clinical outcomes, whereas B focuses on fibroblast-mediated tumor growth mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701321Z"}
{"comparison_id":"12c6179f-32a9-47ed-a97b-2dc72a5f289d","query_id":"53","doc_a_id":"1379127","doc_b_id":"20183360","presented_order":["20183360","1379127"],"winner_id":"1379127","reasoning":"Document B is more relevant — it deals directly with tumor cell migration and metastasis, which relate to prognosis, whereas A focuses on transcriptional regulation of invasiveness without linking to clinical outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701329Z"}
{"comparison_id":"6faeb1b6-c621-4168-b083-3b92616e0b15","query_id":"53","doc_a_id":"11484808","doc_b_id":"21033230","presented_order":["11484808","21033230"],"winner_id":"21033230","reasoning":"Document B is more directly about molecular markers and prognosis in breast cancer, so it's more relevant to a claim about ALDH1 as a prognostic marker.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701334Z"}
{"comparison_id":"f002fc2c-de71-4710-be96-f08eb36fc172","query_id":"53","doc_a_id":"2014909","doc_b_id":"29495185","presented_order":["29495185","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — it analyzes tumor-initiating cells and primary breast cancers (contexts where ALDH1, a stem-cell marker, is studied), whereas A is only a general review noting limited molecular predictor data. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701341Z"}
{"comparison_id":"acb2ed22-9b13-454a-9e0a-7a1c34832122","query_id":"53","doc_a_id":"19673227","doc_b_id":"24341590","presented_order":["24341590","19673227"],"winner_id":"24341590","reasoning":"Document A is more relevant — it examines factors linked to outcomes in breast cancer, whereas Document B focuses on CTC chemosensitivity across epithelial tumors and does not address ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701347Z"}
{"comparison_id":"8e378fff-3acf-4416-b8fe-c3ec2872e4af","query_id":"53","doc_a_id":"22401720","doc_b_id":"24834968","presented_order":["24834968","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant — it examines tumor marker expression and links high VEGF to poor prognosis, whereas A focuses on chemo response predictors and doesn't address prognosis markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701353Z"}
{"comparison_id":"270074b7-8bf0-4dcc-a530-016ed53df2dd","query_id":"53","doc_a_id":"11484808","doc_b_id":"4418878","presented_order":["11484808","4418878"],"winner_id":"4418878","reasoning":"Reason: The claim concerns a protein/gene expression marker (ALDH1) and its prognostic association; Document B focuses on gene expression signatures and prognosis in cancers, making it more directly relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T10:34:08.701359Z"}
